The present invention relates to peptides which exhibit potent anti-retroviral activity. The peptides of the invention comprise DP178 (SEQ ID:1) peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178. The invention further relates to the uses of such peptides as inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells.
|
1. An isolated peptide consisting of an amino acid sequence of a 16 to 39 amino acid residue region of an HIV-1 or HIV-2 retrovirus protein wherein said region is identified by an ALLMOTI5, 107×178×4, or PLZIP sequence search motif, and wherein said peptide is not a peptide with an amino acid sequence consisting of:
(a) YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF (SEQ ID NO.1); (b) YTNTIYTLLEESQNQQEKNEQELLELDKWASLWNWF (SEQ ID NO.3); (c) YTGIIYNLLEESQNQQEKNEQELLELDKWANLWNWF (SEQ ID NO.4); (d) YTSLIYSLLEKSQIQQEKNEQELLELDKWASLWNWF (SEQ ID NO.240); (e) NNLLRAIEAQQGLLQLTVWGIKQLQARILAVERYLKDQ (SEQ ID NO.241); (f) CGGNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQ (SEQ ID NO.8); (g) NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQGGC (SEQ ID NO.242); (h) NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQGGC (SEQ ID NO.243); (i) CGGNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYKDQGGC (SEQ ID NO.244); or (j) LSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAV (SEQ ID NO.245), said peptide further consisting of an amino terminal x, and a carboxy terminal z in which: x comprises an amino group, an acetyl group, a 9-fluorenylmethoxy-carbonyl group, a hydrophobic group, or a macromolecular carrier group; and z comprises a carboxyl group, an amido group, a hydrophobic group, or a macromolecular carrier group. 2. An isolated peptide having the formula:
x-NKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO:210); x-SLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQ-z (SEQ. ID. NO. 211); x-LEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQE-z (SEQ. ID. NO. 212); x-EQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEK-z (SEQ. ID. NO. 213); x-QIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKN-z (SEQ. ID. NO. 214); x-IWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNE-z (SEQ. ID. NO. 215); x-WNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQ-z (SEQ. ID. NO. 216); x-NNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQE-z (SEQ. ID. NO. 217); x-NMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQEL-z (SEQ. ID. NO. 218); x-MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNW-z (SEQ. ID. NO. 219); x-TWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLE-z (SEQ. ID. NO. 220); x-WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLEL-z (SEQ. ID. NO. 221); x-WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLE-z SEQ. ID. NO. 222); x-WMEWDREINNYTSLIGSLIEESQNQQEKNEQELLE-z (SEQ. ID. NO. 159); x-MEWDREINNYTSLIHSLIEESQNQQEKNEQELLELD-z (SEQ. ID. NO. 223); x-EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDK-z (SEQ. ID. NO. 224); x-WDREINNYTSLIHSLIEESQNQQEKNEQELLELDKW-z (SEQ. ID. NO. 225); #39# x-DREINNYTSLIHSLIEESQNQQEKNEQELLELDKWA-z (SEQ. ID. NO. 226); x-REINNYTSLIHSLIEESQNQQEKNEQELLELDKWAS-z (SEQ. ID. NO. 227); x-EINNYTSLIHSLIEESQNQQEKNEQELLELDKWASL-z (SEQ. ID. NO. 228); x-INNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW-z (SEQ. ID. NO. 229); x-NYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNW-z (SEQ. ID. NO. 230); x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNW-z (SEQ. ID. NO. 185); x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNITNWLWLIKFI-z (SEQ. ID. NO. 160); x-TSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFN-z (SEQ. ID. NO. 231); x-SLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNI-z (SEQ. ID. NO. 232); x-LIHSLIEESQNQQEKNEQELLELDKWASLWNWFNIT-z (SEQ. ID. NO. 233); x-TSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 234); x-LIHSLIEESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 235); x-ESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 236); x-NQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 237); x-EKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 238); x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNAF-z (SEQ. ID. NO. 178); x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLANWF-z (SEQ. ID. NO. 179); x-YTSLIHSLIEESQNQQEKNEQQLLELDKWASLWNWF-z (SEQ. ID. NO. 180); x-YTSLIHSLIEESQNQQEKNEQELLQLDKWASLWNWF-z (SEQ. ID. NO. 181); x-YTSLIHSLIEESQNQQEKNQQELLQLDKWASLWNWF-z (SEQ. ID. NO. 182); x-YTSLIHSLQEESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 183); x-YTSLIHSLIEQSQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 186); x-YTSLIHSLIQESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 187); x-YTSLIHSLIEESQNQQEKNEQQLLELDKWASLWNWF-z (SEQ. ID. NO. 190); x-YTSLIQSLIEESQNQQEKNEQQLLELDKWASLWNWF-z (SEQ. ID. NO. 191); x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLFNFF-z (SEQ. ID. NO. 192); x-YTSLIHSLIEESQNLQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 193); x-YTSLIHSLIEESQNQQEKLEQELLELDKWASLWNWF-z (SEQ. ID. NO. 194); x-YTSLIHSLIEESQNQQEKNEQELLEFDKWASLWNWF-z (SEQ. ID. NO. 195); x-YTSLIHSLIEESQNQQEKNEQELLELDKWASPWNWF-z (SEQ. ID. NO. 197); x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNSF-z (SEQ. ID. NO. 198); or x-LRAIEAQQHLLQLTVWQIKQLQARILAV-z (SEQ. ID. NO. 239), in which: amino acid residues are presented by the single-letter code; x comprises an amino group, an acetyl group, a 9-fluorenylmethoxy-carbonyl group, a hydrophobic group, or a macromolecular carrier group; and z comprises a carboxyl group, an amido group, a hydrophobic group, or a macromolecular carrier group. 4. The peptide of
8. The peptide of
10. The peptide of
11. The peptide of
12. The peptide of
13. The peptide of
15. The peptide of
x-NKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKASLWNWF-z (SEQ. ID. NO:210).
16. The peptide of
x-SLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQ-z (SEQ. ID. NO. 211).
17. The peptide of
x-LEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQE-z (SEQ. ID. NO. 212).
18. The peptide of
x-EQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEK-z (SEQ. ID. NO. 213).
19. The peptide of
x-QIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKN-z (SEQ. ID. NO. 214).
20. The peptide of
x-IWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNE-z (SEQ. ID. NO. 215).
21. The peptide of
x-WNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQ-z (SEQ. ID. NO. 216).
22. The peptide of
x-NNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQE-z (SEQ. ID. NO. 217).
23. The peptide of
x-NMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQEL-z (SEQ. ID. NO. 218).
24. The peptide of
x-MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNW-z (SEQ. ID. NO. 219).
25. The peptide of
x-TWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLE-z (SEQ. ID. NO. 220).
26. The peptide of
x-WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLEL-z (SEQ. ID. NO. 221).
27. The peptide of
x-WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLE-z (SEQ. ID. NO. 222).
28. The peptide of
x-WMEWDREINNYTSLIGSLIEESQNQQEKNEQELLE-z (SEQ. ID. NO. 159).
29. The peptide of
x-MEWDREINNYTSLIHSLIEESQNQQEKNEQELLELD-z (SEQ. ID. NO. 223).
30. The peptide of
x-EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDK-z (SEQ. ID. NO. 224).
31. The peptide of
x-WDREINNYTSLIHSLIEESQNQQEKNEQELLELDKW-z (SEQ. ID. NO. 225).
32. The peptide of
x-DREINNYTSLIHSLIEESQNQQEKNEQELLELDKWA-z (SEQ. ID. NO. 226).
33. The peptide of
x-REINNYTSLIHSLIEESQNQQEKNEQELLELDKWAS-z (SEQ. ID. NO. 227).
34. The peptide of
x-EINNYTSLIHSLIEESQNQQEKNEQELLELDKWASL-z (SEQ. ID. NO. 228).
35. The peptide of
x-INNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW-z (SEQ. ID. NO. 229).
36. The peptide of
x-NYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNW-z (SEQ. ID. NO. 230).
37. The peptide of
x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNW-z (SEQ. ID. NO. 185).
38. The peptide of
x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNITNWLWLIKFI-z (SEQ. ID. NO. 160).
39. The peptide of
x-TSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFN-z (SEQ. ID. NO. 231).
40. The peptide of
x-SLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNI-z (SEQ. ID. NO. 232).
41. The peptide of
x-LIHSLIEESQNQQEKNEQELLELDKWASLWNWFNIT-z (SEQ. ID. NO. 233).
42. The peptide of
x-TSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 234).
43. The peptide of
x-LIHSLIEESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 235).
44. The peptide of
x-ESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 236).
45. The peptide of
x-NQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 237).
46. The peptide of
x-EKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 238).
47. The peptide of
x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNAF-z (SEQ. ID. NO. 178).
48. The peptide of
x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLANWF-z (SEQ. ID. NO. 179).
49. The peptide of
x-YTSLIHSLIEESQNQQEKNEQQLLELDKWASLWNWF-z (SEQ. ID. NO. 180).
50. The peptide of
x-YTSLIHSLIEESQNQQEKNEQELLQLDKWASLWNWF-z (SEQ. ID. NO. 181).
51. The peptide of
x-YTSLIHSLIEESQNQQEKNQQELLQLDKWASLWNWF-z (SEQ. ID. NO. 182).
52. The peptide of
x-YTSLIHSLQEESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 183).
53. The peptide of
x-YTSLIHSLIEQSQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 186).
54. The peptide of
x-YTSLIHSLIQESQNQQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 187).
55. The peptide of
x-YTSLIHSLIEESQNQQEKNEQQLLELDKWASLWNWF-z (SEQ. ID. NO. 190).
56. The peptide of
x-YTSLIQSLIEESQNQQEKNEQQLLELDKWASLWNWF-z (SEQ. ID. NO. 191).
57. The peptide of
x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLFNFF-z (SEQ. ID. NO. 192).
58. The peptide of
x-YTSLIHSLIEESQNLQEKNEQELLELDKWASLWNWF-z (SEQ. ID. NO. 193).
59. The peptide of
x-YTSLIHSLIEESQNQQEKLEQELLELDKWASLWNWF-z (SEQ. ID. NO. 194).
60. The peptide of
x-YTSLIHSLIEESQNQQEKNEQELLEFDKWASLWNWF-z (SEQ. ID. NO. 195).
61. The peptide of
x-YTSLIHSLIEESQNQQEKNEQELLELDKWASPWNWF-z (SEQ. ID. NO. 197).
62. The peptide of
x-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNSF-z (SEQ. ID. NO. 198).
63. The peptide of
x-LRAIEAQQHLLQLTVWQIKQLQARILAV-z (SEQ. ID. NO. 239).
64. The peptide of any one of
65. The peptide of
66. The peptide of
67. The peptide of
68. The peptide of
69. The peptide of
71. The peptide of
73. The peptide of
75. The peptide of
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This invention was made with Government support under Grant No. AI-30411-02 awarded by the National Institutes of Health. The Government has certain rights in the invention.
This application is a division of Ser. No. 08/470,896, filed Jun. 6, 1995, which is a continuation-in-part of Ser. No. 08/360,107, filed Dec. 20, 1994, which is a continuation-in-part of Ser. No. 08/255,208, filed Jun. 7, 1994, which is a continuation-in-part of Ser. No. 08/073,028, filed Jun. 7, 1993, now U.S. Pat. No. 5,464,933, each of which is incorporated by reference in it's entirety.
The present invention relates, first, to DP178 (SEQ ID NO:1), a peptide corresponding to amino acids 638 to 673 of the HIV-1LAI transmembrane protein (TM) gp41, and portions or analogs of DP178 (SEQ ID NO:1), which exhibit anti-membrane fusion capability, antiviral activity, such as the ability to inhibit HIV transmission to uninfected CD-4+ cells, or an ability to modulate intracellular processes involving coiled-coil peptide structures. Further, the invention relates to the use of DP178 (SEQ ID NO:1) and DP178 portions and/or analogs as antifusogenic or antiviral compounds or as inhibitors of intracellular events involving coiled-coil peptide structures. The present invention also relates to peptides analogous to DP107 (SEQ ID NO:25), a peptide corresponding to amino acids 558 to 595 of the HIV-1LAI transmembrane protein (TM) gp41, having amino acid sequences present in other viruses, such as enveloped viruses, and/or other organisms, and further relates to the uses of such peptides. These peptides exhibit anti-membrane fusion capability, antiviral activity, or the ability to modulate intracellular processes involving coiled-coil peptide structures. The present invention additionally relates to methods for identifying compounds that disrupt the interaction between DP178 and DP107, and/or between DP107-like and DP178-like peptides. Further, the invention relates to the use of the peptides of the invention as diagnostic agents. For example, a DP178 peptide may be used as an HIV subtype-specific diagnostic. The invention is demonstrated, first, by way of an Example wherein DP178 (SEQ ID:1), and a peptide whose sequence is homologous to DP178 are each shown to be potent, non-cytotoxic inhibitors of HIV-1 transfer to uninfected CD-4+ cells. The invention is further demonstrated by Examples wherein peptides having structural and/or amino acid motif similarity to DP107 and DP178 are identified in a variety of viral and nonviral organisms, and in examples wherein a number of such identified peptides derived from several different viral systems are demonstrated to exhibit antiviral activity.
2.1 MEMBRANE FUSION EVENTS
Membrane fusion is a ubiquitous cell biological process (for a review, see White, J. M., 1992, Science 258:917-924). Fusion events which mediate cellular housekeeping functions, such as endocytosis, constitutive secretion, and recycling of membrane components, occur continuously in all eukaryotic cells.
Additional fusion events occur in specialized cells. Intracellularly, for example, fusion events are involved in such processes as occur in regulated exocytosis of hormones, enzymes and neurotransmitters. Intercellularly, such fusion events feature prominently in, for example, sperm-egg fusion and myoblast fusion.
Fusion events are also associated with disease states. For example, fusion events are involved in the formation of giant cells during inflammatory reactions, the entry of all enveloped viruses into cells, and, in the case of human immunodeficiency virus (HIV), for example, are responsible for the virally induced cell-cell fusion which leads to cell death.
2.2. THE HUMAN IMMUNODEFICIENCY VIRUS
The human immunodeficiency virus (HIV) has been implicated as the primary cause of the slowly degenerative immune system disease termed acquired immune deficiency syndrome (AIDS) (Barre-Sinoussi, F. et al., 1983, Science 220:868-870; Gallo, R. et al., 1984, Science 224:500-503). There are at least two distinct types of HIV: HIV-1 (Barre-Sinoussi, F. et al., 1983, Science 220:868-870; Gallo R. et al., 1984, Science 224:500-503) and HIV-2 (Clavel, F. et al., 1986, Science 233:343-346; Guyader, M. et al., 1987, Nature 326:662-669). Further, a large amount of genetic heterogeneity exists within populations of each of these types. Infection of human CD-4+ T-lymphocytes with an HIV virus leads to depletion of the cell type and eventually to opportunistic infections, neurological dysfunctions, neoplastic growth, and ultimately death.
HIV is a member of the lentivirus family of retroviruses (Teich, N. et al., 1984, RNA Tumor Viruses, Weiss, R. et al., eds., CSH-Press, pp. 949-956). Retroviruses are small enveloped viruses that contain a diploid, single-stranded RNA genome, and replicate via a DNA intermediate produced by a virally-encoded reverse transcriptase, an RNA-dependent DNA polymerase (Varmus, H., 1988, Science 240:1427-1439). Other retroviruses include, for example, oncogenic viruses such as human T-cell leukemia viruses (HTLV-I,-II,-III), and feline leukemia virus.
The HIV viral particle consists of a viral core, composed of capsid proteins, that contains the viral RNA genome and those enzymes required for early replicative events. Myristylated Gag protein forms an outer viral shell around the viral core, which is, in turn, surrounded by a lipid membrane enveloped derived from the infected cell membrane. The HIV enveloped surface glycoproteins are synthesized as a single 160 Kd precursor protein which is cleaved by a cellular protease during viral budding into two glycoproteins, gp41 and gp120. gp41 is a transmembrane protein and gp120 is an extracellular protein which remains non-covalently associated with gp41, possibly in a trimeric or multimeric form (Hammarskjold, M. and Rekosh, D., 1989, Biochem. Biophys. Acta 989:269-280).
HIV is targeted to CD-4+ cells because the CD-4 cell surface protein acts as the cellular receptor for the HIV-1 virus (Dalgleish, A. et al., 1984, Nature 312:763-767; Klatzmann et al., 1984, Nature 312:767-768; Maddon et al., 1986, Cell 47:333-348). Viral entry into cells is dependent upon gp120 binding the cellular CD-4+ receptor molecules (McDougal, J. S. et al., 1986, Science 231:382-385; Maddon, P. J. et al., 1986, Cell 47:333-348) and thus explains HIV's tropism for CD-4+ cells, while gp41 anchors the enveloped glycoprotein complex in the viral membrane.
2.3. HIV TREATMENT
HIV infection is pandemic and HIV associated diseases represent a major world health problem. Although considerable effort is being put into the successful design of effective therapeutics, currently no curative anti-retroviral drugs against AIDS exist. In attempts to develop such drugs, several stages of the HIV life cycle have been considered as targets for therapeutic intervention (Mitsuya, H. et al., 1991, FASEB J. 5:2369-2381). For example, virally encoded reverse transcriptase has been one focus of drug development. A number of reverse-transcriptase-targeted drugs, including 2',3'-dideoxynucleoside analogs such as AZT, ddI, ddC, and d4T have been developed which have been shown to been active against HIV (Mitsuya, H. et al., 1991, Science 249:1533-1544). While beneficial, these nucleoside analogs are not curative, probably due to the rapid appearance of drug resistant HIV mutants (Lander, B. et al., 1989, Science 243:1731-1734). In addition, the drugs often exhibit toxic side effects such as bone marrow suppression, vomiting, and liver function abnormalities.
Attempts are also being made to develop drugs which can inhibit viral entry into the cell, the earliest stage of HIV infection. Here, the focus has thus far been on CD4, the cell surface receptor for HIV. Recombinant soluble CD4, for example, has been shown to inhibit infection of CD-4+ T-cells by some HIV-1 strains (Smith, D. H. et al., 1987, Science 238:1704-1707). Certain primary HIV-1 isolates, however, are relatively less sensitive to inhibition by recombinant CD-4 (Daar, E. et al., 1990, Proc. Natl. Acad. Sci. USA 87:6574-6579). In addition, recombinant soluble CD-4 clinical trials have produced inconclusive results (Schooley, R. et al., 1990, Ann. Int. Med. 112:247-253; Kahn, J. O. et al., 1990, Ann. Int. Med. 112:254-261; Yarchoan, R. et al., 1989, Proc. Vth Int. Conf. on AIDS, p. 564, MCP 137).
The late stages of HIV replication, which involve crucial virus-specific secondary processing of certain viral proteins, have also been suggested as possible anti-HIV drug targets. Late stage processing is dependent on the activity of a viral protease, and drugs are being developed which inhibit this protease (Erickson, J., 1990, Science 249:527-533). The clinical outcome of these candidate drugs is still in question.
Attention is also being given to the development of vaccines for the treatment of HIV infection. The HIV-1 enveloped proteins (gp160, gp120, gp41) have been shown to be the major antigens for anti-HIV antibodies present in AIDS patients (Barin, et al., 1985, Science 228:1094-1096). Thus far, therefore, these proteins seem to be the most promising candidates to act as antigens for anti-HIV vaccine development. To this end, several groups have begun to use various portions of gp160, gp120, and/or gp41 as immunogenic targets for the host immune system. See for example, Ivanoff, L. et al., U.S. Pat. No. 5,141,867; Saith, G. et al., WO 92/22,654; Shafferman, A., WO 91/09,872; Formoso, C. et al., WO 90/07,119. Clinical results concerning these candidate vaccines, however, still remain far in the future.
Thus, although a great deal of effort is being directed to the design and testing of anti-retroviral drugs, a truly effective, non-toxic treatment is still needed.
The present invention relates, first, to DP178 (SEQ ID:1), a 36-amino acid synthetic peptide corresponding to amino acids 638 to 673 of the transmembrane protein (TM) gp41 from the HIV-1 isolate LAI (HIV-1LAI), which exhibits potent anti-HIV-1 activity. As evidenced by the Example presented below, in Section 6, the DP178 (SEQ ID:1) antiviral activity is so high that, on a weight basis, no other known anti-HIV agent is effective at concentrations as low as those at which DP178 (SEQ ID:1) exhibits its inhibitory effects.
The invention further relates to those portions and analogs of DP178 which also show such antiviral activity, and/or show anti-membrane fusion capability, or an ability to modulate intracellular processes involving coiled-coil peptide structures. The term "DP178 analog" refers to a peptide which contains an amino acid sequence corresponding to the DP178 peptide sequence present within the gp41 protein of HIV-1LAI, but found in viruses and/or organisms other than HIV-1LAI. Such DP178 analog peptides may, therefore, correspond to DP178-like amino acid sequences present in other viruses, such as, for example, enveloped viruses, such as retroviruses other than HIV-1LAI, as well as non-enveloped viruses. Further, such analogous DP178 peptides may also correspond to DP178-like amino acid sequences present in nonviral organisms.
The invention further relates to peptides DP107 (SEQ ID NO:25) analogs. DP107 is a peptide corresponding to amino acids 558-595 of the HIV-1LAI transmembrane protein (TM) gp41. The term "DP107 analog" as used herein refers to a peptide which contains an amino acid sequence corresponding to the DP107 peptide sequence present within the gp41 protein of HIV-1LAI, but found in viruses and organisms other than HIV-1LAI. Such DP107 analog peptides may, therefore, correspond to DP107-like amino acid sequences present in other viruses, such as, for for example, enveloped viruses, such as retroviruses other than HIV-1LAI, as well as non-enveloped viruses. Further, such DP107 analog peptides may also correspond to DP107-like amino acid sequences present in nonviral organisms.
Further, the peptides of the invention include DP107 analog and DP178 analog peptides having amino acid sequences recognized or identified by the 107×178×4, ALLMOTI5 and/or PLZIP search motifs described herein.
The peptides of the invention may, for example, exhibit antifusogenic activity, antiviral activity, and/or may have the ability to modulate intracellular processes which involve coiled-coil peptide structures. With respect to the antiviral activity of the peptides of the invention, such an antiviral activity includes, but is not limited to the inhibition of HIV transmission to uninfected CD-4+ cells. Additionally, the antifusogenic capability, antiviral activity or intracellular modulatory activity of the peptides of the invention merely requires the presence of the peptides of the invention, and, specifically, does not require the stimulation of a host immune response directed against such peptides.
The peptides of the invention may be used, for example, as inhibitors of membrane fusion-asociated events, such as, for example, the inhibition of human and non-human retroviral, especially HIV, transmission to uninfected cells. It is further contemplated that the peptides of the invention may be used as modulators of intracellular events involving coiled-coil peptide structures.
The peptides of the invention may, alternatively, be used to identify compounds which may themselves exhibit antifusogenic, antiviral, or intracellular modulatory activity. Additional uses include, for example, the use of the peptides of the invention as organism or viral type and/or subtype-specific diagnostic tools.
The terms "antifusogenic" and "anti-membrane fusion", as used herein, refer to an agent's ability to inhibit or reduce the level of membrane fusion events between two or more moieties relative to the level of membrane fusion which occurs between said moieties in the absence of the peptide. The moieties may be, for example, cell membranes or viral structures, such as viral envelopes or pili. The term "antiviral", as used herein, refers to the compound's ability to inhibit viral infection of cells, via, for example, cell-cell fusion or free virus infection. Such infection may involve membrane fusion, as occurs in the case of enveloped viruses, or some other fusion event involving a viral structure and a cellular structure (e.g., such as the fusion of a viral pilus and bacterial membrane during bacterial conjugation).
It is also contemplated that the peptides of the invention may exhibit the ability to modulate intracellular events involving coiled-coil peptide structures. "Modulate", as used herein, refers to a stimulatory or inhibitory effect on the intracellular process of interest relative to the level or activity of such a process in the absence of a peptide of the invention.
Embodiments of the invention are demonstrated below wherein an extremely low concentration of DP178 (SEQ ID:1), and very low concentrations of a DP178 homolog (SEQ ID:3) are shown to be potent inhibitors of HIV-1 mediated CD-4+ cell-cell fusion (i.e., syncytial formation) and infection of CD-4+ cells by cell-free virus. Further, it is shown that DP178 (SEQ ID:1) is not toxic to cells, even at concentrations 3 logs higher than the inhibitory DP-178 (SEQ ID:1) concentration.
The present invention is based, in part, on the surprising discovery that the DP107 and DP178 domains of the HIV gp41 protein non-covalently complex with each other, and that their interaction is required for the normal infectivity of the virus. This discovery is described in the Example presented, below, in Section 8. The invention, therefore, further relates to methods for identifying antifusogenic, including antiviral, compounds that disrupt the interaction between DP107 and DP178, and/or between DP107-like and DP178-like peptides.
Additional embodiments of the invention (specifically, the Examples presents in Sections 9-16 and 19-25, below) are demonstrated, below, wherein peptides, from a variety of viral and nonviral sources, having structural and/or amino acid motif similarity to DP107 and DP178 are identified, and search motifs for their identification are described. Further, Examples (in Sections 17, 18, 25-29) are presented wherein a number of the peptides of the invention are demonstrated exhibit substantial antiviral activity or activity predictive of antiviral activity.
3.1. DEFINITIONS
Peptides are defined herein as organic compounds comprising two or more amino acids covalently joined by peptide bonds. Peptides may be referred to with respect to the number of constituent amino acids, i.e., a dipeptide contains two amino acid residues, a tripeptide contains three, etc. Peptides containing ten or fewer amino acids may be referred to as oligopeptides, while those with more than ten amino acid residues are polypeptides. Such peptides may also include any of the modifications and additional amino and carboxy groups as are described herein.
Peptide sequences defined herein are represented by one-letter symbols for amino acid residues as follows:
A (alanine)
R (arginine)
N (asparagine)
D (aspartic acid)
C (cysteine)
Q (glutamine)
E (glutamic acid)
G (glycine)
H (histidine)
I (isoleucine)
L (leucine)
K (lysine)
M (methionine)
F (phenylalanine)
P (proline)
S (serine)
T (threonine)
W (tryptophan)
Y (tyrosine)
V (valine)
FIG. 1. Amino acid sequence of DP178 (SEQ ID:1) derived from HIVLAI ; DP178 homologs derived from HIV-1SF2 (DP-185; SEQ ID:3), HIV-1RF (SEQ ID:4), and HIV-1MN (SEQ ID:5); DP178 homologs derived from amino acid sequences of two prototypic HIV-2 isolates, namely, HIV-2rod (SEQ ID:6) and HIV-2NIHZ (SEQ ID:7); control peptides: DP-180 (SEQ ID:2), a peptide incorporating the amino acid residues of DP178 in a scrambled sequence; DP-118 (SEQ ID:10) unrelated to DP178, which inhibits HIV-1 cell free virus infection; DP-125 (SEQ ID:8), unrelated to DP178, also inhibits HIV-1 cell free virus infection; DP-116 (SEQ ID:9), unrelated to DP178, is negative for inhibition of HIV-1 infection when tested using a cell-free virus infection assay. Throughout the figures, the one letter amino acid code is used.
FIG. 2. Inhibition of HIV-1 cell-free virus infection by synthetic peptides. IC50 refers to the concentration of peptide that inhibits RT production from infected cells by 50% compared to the untreated control. Control: the level of RT produced by untreated cell cultures infected with the same level of virus as treated cultures.
FIG. 3. Inhibition of HIV-1 and HIV-2 cell-free virus infection by the synthetic peptide DP178 (SEQ ID:1). IC50 : concentration of peptide that inhibits RT production by 50% compared to the untreated control. Control: Level of RT produced by untreated cell cultures infected with the same level of virus as treated cultures.
FIG. 4A-4B. Fusion Inhibition Assays. FIG. 4A: DP178 (SEQ ID:1) inhibition of HIV-1 prototypic isolate-mediated syncytial formation; data represents the number of virus-induced syncytial per cell. FIG. 4B: DP-180 (SEQ ID:2) represents a scrambled control peptide; DP-185 (SEQ ID:3) represents a DP178 homolog derived from HIV-1SF2 isolate; Control, refers to the number of syncytial produced in the absence of peptide.
FIG. 5. Fusion inhibition assay: HIV-1 vs. HIV-2. Data represents the number of virus-induced syncytial per well. ND: not done.
FIG. 6. Cytotoxicity study of DP178 (SEQ ID:1) and DP-116 (SEQ ID:9) on CEM cells. Cell proliferation data is shown.
FIG. 7. Schematic representation of HIV-gp41 and maltose binding protein (MBP)-gp41 fusion proteins. DP107 and DP178 are synthetic peptides based on the two putative helices of gp41. The letter P in the DP107 boxes denotes an Ile to Pro mutation at amino acid number 578. Amino acid residues are numbered according to Meyers et al., "Human Retroviruses and AIDS", 1991, Theoret. Biol. and Biophys. Group, Los Alamos Natl. Lab., Los Alamos, N. Mex. The proteins are more fully described, below, in Section 8.1.1.
FIG. 8. A point mutation alters the conformation and anti-HIV activity of M41.
FIG. 9. Abrogation of DP178 anti-HIV activity. Cell fusion assays were carried out in the presence of 10 nM DP178 and various concentrations of M41Δ178 or M41PΔ178.
FIG. 10. Binding of DP178 to leucine zipper of gp41 analyzed by FAb-D ELISA.
FIGS. 11A-B. Models for a structural transition in the HIV-1 TM protein. Two models are proposed which indicate a structural transition from a native oligomer to a fusogenic state following a trigger event (possibly gp120 binding to CD4). Common features of both models include (1) the native state is held together by noncovalent protein-protein interactions to form the heterodimer of gp120/41 and other interactions, principally though gp41 interactive sites, to form homo-oligomers on the virus surface of the gp120/41 complexes; (2) shielding of the hydrophobic fusogenic peptide at the N-terminus (F) in the native state; and (3) the leucine zipper domain (DP107) exists as a homo-oligomer coiled coil only in the fusogenic state. The major differences in the two models include the structural state (native or fusogenic) in which the DP107 and DP178 domains are complexed to each other. In the first model (FIG. 11A) this interaction occurs in the native state and in the second (FIG. 11B), it occurs during the fusogenic state. When triggered, the fusion complex in the model depicted in (A) is generated through formation of coiled-coil interactions in homologous DP107 domains resulting in an extended α-helix. This conformational change positions the fusion peptide for interaction with the cell membrane. In the second model (FIG. 11B), the fusogenic complex is stabilized by the association of the DP178 domain with the DP107 coiled-coil.
FIG. 12. Motif design using heptad repeat positioning of amino acids of known coiled-coils.
FIG. 13. Motif design using proposed heptad repeat positioning of amino acids of DP107 and DP178.
FIG. 14. Hybrid motif design crossing GCN4 and DP107.
FIG. 15. Hybrid motif design crossing GCN4 and DP178.
FIG. 16. Hybrid motif design 107×178×4, crossing DP107 and DP178. This motif was found to be the most consistent at identifying relevant DP107-like and DP178-like peptide regions;
FIG. 17. Hybrid motif design crossing GCN4, DP107, and DP178.
FIG. 18. Hybrid motif design ALLMOTI5 crossing GCN4, DP107, DP178, c-Fos c-Jun, c-Myc, and Flu Loop 36.
FIG. 19. PLZIP motifs designed to identify N-terminal proline-leucine zipper motifs.
FIG. 20. Search results for HIV-1 (BRU isolate) enveloped protein gp41. Sequence search motif designations: Spades (): 107×178×4; Hearts (♥) ALLMOTI5; Clubs (): PLZIP; Diamonds (♦): transmembrane region (the putative transmembrane domains were identified using a PC/Gene program designed to search for such peptide regions). Asterisk (*): Lupas method. The amino acid sequences identified by each motif are bracketed by the respective characters. Representative sequences chosen based on 107×178×4 searches are underlined and in bold. DP107 and DP178 sequences are marked, and additionally double-underlined and italicized.
FIG. 21. Search results for human respiratory syncytial virus (RSV) strain A2 fusion glycoprotein F1. Sequence search motif designations are as in FIG. 20.
FIG. 22. Search results for simian immunodeficiency virus (SIV) enveloped protein gp41 (AGM3 isolate). Sequence search motif designations are as in FIG. 20.
FIG. 23. Search results for canine distemper virus (strain Onderstepoort) fusion glycoprotein 1. Sequence search motif designations are as in FIG. 20.
FIG. 24. Search results for newcastle disease virus (strain Australia-Victoria/32) fusion glycoprotein F1. Sequence search motif designations are as in FIG. 20.
FIG. 25. Search results for human parainfluenza 3 virus (strain NIH 47885) fusion glycoprotein F1. Sequence search motif designations are as in FIG. 20.
FIG. 26. Search results for influenza A virus (strain A/AICHI/2/68) hemagglutinin precursor HA2. Sequence search designations are as in FIG. 20.
FIGS. 27A-F. Respiratory Syncytial Virus (RSV) peptide antiviral and circular dichroism data. FIGS. 27A-C: Peptides derived from the F2 DP178/DP107-like region. Antiviral and CD data. FIGS. 27D-F:
Peptides derived from the F1 DP107-like region.
Peptide and CD data.
Antiviral activity (AV) is represented by the following qualitative symbols:
"-", negative antiviral activity;
"+/-", antiviral activity at greater than 100 μg/ml;
"+", antiviral activity at between 50-100 μg/ml;
"++", antiviral activity at between 20-50 μg/ml;
"+++", antiviral activity at between 1-20 μg/ml;
"++++", antiviral activity at <1 μg/ml.
CD data, referring to the level of helicity is represented by the following qualitative symbol:
"-", no helicity;
"+", 25-50% helicity;
"++", 50-75% helicity;
"+++", 75-100% helicity.
IC50 refers to the concentration of peptide necessary to produce only 50% of the number of syncytial relative to infected control cultures containing no peptide. IC50 values were obtained using purified peptides only.
FIGS. 28A-C. Respiratory Syncytial Virus (RSV) DP178-like region (F1) peptide antiviral and CD data. Antiviral symbols, CD symbols, and IC50 are as in FIGS. 27A-F. IC50 values were obtained using purified peptides only.
FIGS. 29A-E. Peptides derived from the HPIV3 F1 DP107-like region. Peptide antiviral and CD data. Antiviral symbols, CD symbols, and IC50 are as in FIGS. 27A-F. Purified peptides were used to obtain IC50 values, except where the values are marked by an asterisk (*), in which cases, the IC50 values were obtained using a crude peptide preparation.
FIGS. 30A-C. Peptides derived from the HPIV3 F1 DP178-like region. Peptide antiviral and CD data. Antiviral symbols, CD symbols, and IC50 are as in FIGS. 27A-F. Purified peptides were used to obtain IC50 values, except where the values are marked by an asterisk (*), in which cases, the IC50 values were obtained using a crude peptide preparation.
FIG. 31. Motif search results for simian immunodeficiency virus (SIV) isolate MM251, enveloped polyprotein gp41. Sequence search designations are as in FIG. 20.
FIG. 32. Motif search results for Epstein-Barr Virus (Strain B95-8), glycoprotein gp110 precursor (designated gp115). BALF4. Sequence search designations are as in FIG. 20.
FIG. 33. Motif search results for Epstein-Barr Virus (Strain B95-8), BZLF1 trans-activator protein (designated EB1 or Zebra). Sequence search designations are as in FIG. 20. Additionally, "@" refers to a well known DNA binding domain and "+" refers to a well known dimerization domain, as defined by Flemington and Speck (Flemington, E. and Speck, S. H., 1990, Proc. Natl. Acad. Sci. USA 87:9459-9463).
FIG. 34. Motif search results for measles virus (strain Edmonston), fusion glycoprotein F1. Sequence search designations are as in FIG. 20.
FIG. 35. Motif search results for Hepatitis B Virus (Subtype AYW), major surface antigen precursor S. Sequence search designations are as in FIG. 20.
FIG. 36. Motif search results for simian Mason-Pfizer monkey virus, enveloped (TM) protein gp20. Sequence search designations are as in FIG. 20.
FIG. 37. Motif search results for Pseudomonas aerginosa, fimbrial protein (Pilin). Sequence search designations are as in FIG. 20.
FIG. 38. Motif search results for Neisseria gonorrhoeae fimbrial protein (Pilin). Sequence search designations are as in FIG. 20.
FIG. 39. Motif search results for Hemophilus influenzae fimbrial protein. Sequence search designations are as in FIG. 20.
FIG. 40. Motif search results for Staphylococcus aureus, toxic shock syndrome toxin-1. Sequence search designations are as in FIG. 20.
FIG. 41. Motif search results for Staphylococcus aureus enterotoxin Type E. Sequence search designations are as in FIG. 20.
FIG. 42. Motif search results for Staphylococcus aureus enterotoxin A. Sequence search designations are as in FIG. 20.
FIG. 43. Motif search results for scherichia coli, heat labile enterotoxin A. Sequence search designations are as in FIG. 20.
FIG. 44. Motif search results for human c-fos proto-oncoprotein. Sequence search designations are as in FIG. 20.
FIG. 45. Motif search results for human lupus KU autoantigen protein P70. Sequence search designations are as in FIG. 20.
FIG. 46. Motif search results for human zinc finger protein 10. Sequence search designations are as in FIG. 20.
FIGS. 47A-B. Measles virus (MeV) fusion protein DP178-like region antiviral and CD data. Antiviral symbols, CD symbols, and IC50 are as in FIGS. 27A-F. IC50 values were obtained using purified peptides.
FIGS. 48A-B. Simian immunodeficiency virus (SIV) TM (fusion) protein DP178-like region antiviral data. Antiviral symbols are as in FIGS. 27A-F "NT", not tested.
FIGS. 49A-L. DP178-derived peptide antiviral data. The peptides listed herein were derived from the region surrounding the HIV-1 BRU isolate DP178 region (e.g., gp41 amino acid residues 615-717).
In instances where peptides contained DP178 point mutations, the mutated amino acid residues are shown with a shaded background. In instances in which the test peptide has had an amino and/or carboxy-terminal group added or removed (apart from the standard amido-and acetyl- blocking groups found on such peptides), such modifications are indicated. FIGS. 49A-D: The column to the immediate right of the name of the test peptide indicates the size of the test peptide and points out whether the peptide is derived from a one amino acid peptide "walk" t across the DP178 region. The next column to the right indicates whether the test peptide contains a point mutation, while the column to its right indicates whether certain amino acid residues have been added to or removed from the DP178-derived amino acid sequence. FIGS. 49E-H: The column to the immediate right of the test peptide name indicates whether the peptide represents a DP178 truncation, the next column to the right points out whether the peptide contains a point mutation, and the column to its right indicates whether the peptide contains amino acids which have been added to or removed from the DP178 sequence itself. FIGS. 49I-L: The column to the immediate right of the test peptide name indicates whether the test peptide contains a point mutation, while the column to its right indicates whether amino acid residues have been added to or removed from the DP178 sequence itself. IC50 is as defined in FIGS. 27A-F, and IC50 values were obtained using purified peptides except where marked with an asterisk (*), in which case the IC50 was obtained using a crude peptide preparation.
FIGS. 50A-B. DP107 and DP107 gp41 region truncated peptide antiviral data. IC50 as defined in FIGS. 27A-F, and IC50 values were obtained using purified peptides except where marked with an asterisk (*), in which case the IC50 was obtained using a crude peptide preparation.
FIGS. 51A-C. Epstein-Barr virus Strain B95-8 BZLF1 DP178/DP107 analog region peptide walks and electrophoretic mobility shift assay results. The peptides (T-423 to T-446, FIGS. 51A-B; T-447 to T-461, FIG. 51C) represent one amino acid residue "walks" through the EBV Zebra protein region from amino acid residue 173 to 246.
The amino acid residue within this region which corresponds to the first amino acid residue of each peptide is listed to the left of each peptide, while the amino acid residue within this region which corresponds to the last amino acid residue of each peptide is listed to the right of each peptide. The length of each test peptide is listed at the far right of each line, under the heading "Res".
"ACT" refers to a test peptide's ability to inhibit Zebra binding to its response element. "+" refers to a visible, but incomplete, abrogation of the response element/Zebra homodimer complex; "+++" refers to a complete abrogation of the complex; and "-" represents a lack of complex disruption.
FIGS. 52A-B. Hepatitis B virus subtype AYW major surface antigen precursor S protein DP178/DP107 analog region and peptide walks. 52A depicts Domain I (S protein amino acid residues 174-220), which contains a potential DP178/DP107 analog region. In addition, peptides are listed which represent one amino acid peptide "walks" through domain I. 52B depicts Domain II (S protein amino acid residues 233-291), which contains a second potential DP178/DP107 analog region. In addition, peptides are listed which represent one amino acid peptide "walks" through domain II.
Described herein are peptides which may exhibit antifusogenic activity, antiviral capability, and/or the ability to modulate intracellular processes involving coiled-coil peptide structures. The peptides described include, first, DP178 (SEQ ID NO:1), a gp41-derived 36 amino acid peptide and fragments and analogs of DP178.
In addition, the peptides of the invention described herein include peptides which are DP107 analogs. DP107 (SEQ ID NO:25). is a 38 amino acid peptide corresponding to residues 558 to 595 of the HIV-1LAI transmembrane (TM) gp41 protein. Such DP107 analogs may exhibit antifusogenic capability, antiviral activity or an ability to modulate intracellular processes involving coiled-coil structures.
Further, peptides of the invention include DP107 and DP178 are described herein having amino acid sequences recognized by the 107×178×4, ALLMOTI5, and PLZIP search motifs. Such motifs are also discussed.
Also described here are antifusogenic, antiviral, intracellular modulatory, and diagnostic uses of the peptides of the invention. Further, procedures are described for the use of the peptides of the invention for the identification of compounds exhibiting antifusogenic, antiviral or intracellular modulatory activity.
While not limited to any theory of operation, the following model is proposed to explain the potent anti-HIV activity of DP178, based, in part, on the experiments described in the Examples, infra. In the HIV protein, gp41, DP178 corresponds to a putative α-helix region located in the C-terminal end of the gp41 ectodomain, and appears to associate with a distal site on gp41 whose interactive structure is influenced by the leucine zipper motif, a coiled-coil structure, referred to as DP107. The association of these two domains may reflect a molecular linkage or "molecular clasp" intimately involved in the fusion process. It is of interest that mutations in the C-terminal α-helix motif of gp41 (i.e., the D178 domain) tend to enhance the fusion ability of gp41, whereas mutations in the leucine zipper region (i.e., the DP107 domain) decrease or abolish the fusion ability of the viral protein. It may be that the leucine zipper motif is involved in membrane fusion while the C-terminal α-helix motif serves as a molecular safety to regulate the availability of the leucine zipper during virus-induced membrane fusion.
On the basis of the foregoing, two models are proposed of gp41-mediated membrane fusion which are schematically shown in FIGS. 11A-B. The reason for proposing two models is that the temporal nature of the interaction between the regions defined by DP107 and DP178 cannot, as yet, be pinpointed. Each model envisions two conformations for gp41--one in a "native" state as it might be found on a resting is virion. The other in a "fusogenic" state to reflect conformational changes triggered following binding of gp120 to CD4 and just prior to fusion with the target cell membrane. The strong binding affinity between gp120 and CD4 may actually represent the trigger for the fusion process obviating the need for a pH change such as occurs for viruses that fuse within intracellular vesicles. The two major features of both models are: (1) the leucine zipper sequences (DP107) in each chain of oligomeric enveloped are held apart in the native state and are only allowed access to one another in the fusogenic state so as to form the extremely stable coiled-coils, and (2) association of the DP178 and DP107 sites as they exist in gp41 occur either in the native or fusogenic state. FIG. 11A depicts DP178/DP107 interaction in the native state as a molecular clasp. On the other hand, if one assumes that the most stable form of the enveloped occurs in the fusogenic state, the model in FIG. 11B can be considered.
When synthesized as peptides, both DP107 and DP178 are potent inhibitors of HIV infection and fusion, probably by virtue of their ability to form complexes with viral gp41 and interfere with its fusogenic process; e.g., during the structural transition of the viral protein from the native structure to the fusogenic state, the DP178 and DP107 peptides may gain access to their respective binding sites on the viral gp41, and exert a disruptive influence. DP107 peptides which demonstrate anti-HIV activity are described in Applicants' co-pending application Ser. No. 08/264,531, filed Jun. 23, 1994, which is incorporated by reference herein in its entirety.
As shown in the Examples, infra, a truncated recombinant gp41 protein corresponding to the ectodomain of gp41 containing both DP107 and DP178 domains (excluding the fusion peptide, transmembrane region and cytoplasmic domain of gp41) did not inhibit HIV-1 induced fusion. However, when a single mutation was introduced to disrupt the coiled-coil structure of the DP107 domain--a mutation which results in a total loss of biological activity of DP107 peptides--the inactive recombinant protein was transformed to an active inhibitor of HIV-1 induced fusion. This transformation may result from liberation of the potent DP178 domain from a molecular clasp with the leucine zipper, DP107 domain.
For clarity of discussion, the invention will be described primarily for DP178 peptide inhibitors of HIV. However, the principles may be analogously applied to other viruses, both enveloped and nonenveloped, and to other non-viral organisms.
5.1. DP178 AND DP178-LIKE PEPTIDES
The DP178 peptide (SEQ ID:1) of the invention corresponds to amino acid residues 638 to 673 of the transmembrane protein gp41 from the HIV-1LAI isolate, and has the 36 amino acid sequence (reading from amino to carboxy terminus):
NH2 --YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF--COOH (SEQ ID:1)
In addition to the full-length DP178 (SEQ ID:1) 36-mer, the peptides of the invention may include truncations of the DP178 (SEQ ID:1) peptide which exhibit antifusogenic activity, antiviral activity and/or the ability to modulate intracellular processes involving coiled-coil peptide structures. Truncations of DP178 (SEQ ID:1) peptides may comprise peptides of between 3 and 36 amino acid residues (i.e., peptides ranging in size from a tripeptide to a 36-mer polypeptide), as shown in Tables I and IA, below. Peptide sequences in these tables are listed from amino (left) to carboxy (right) terminus. "X" may represent an amino group (--NH2) and "Z" may represent a carboxyl (--COOH) group. Alternatively, "X" may represent a hydrophobic group, including but not limited to carbobenzyl, dansyl, or T-butoxycarbonyl; an acetyl group; a 9-fluorenylmethoxy-carbonyl (FMOC) group; or a covalently attached macromolecular group, including but not limited to a lipid-fatty acid conjugate, polyethylene glycol, carbohydrate or peptide group. Further, "Z" may represent an amido group; a T-butoxycarbonyl group; or a covalently attached macromolecular group, including but not limited to a lipid-fatty acid conjugate, polyethylene glycol, carbohydrate or peptide group. A preferred "X" or "Z" macromolecular group is a peptide group.
| TABLE I |
| ______________________________________ |
| DP178 (SEQ ID:1) CARBOXY TRUNCATIONS |
| ______________________________________ |
| X-YTS-Z |
| - X-YTSL-Z |
| - X-YTSLI-Z |
| - X-YTSLIH-Z |
| - X-YTSLIHS-Z |
| - X-YTSLIHSL-Z |
| - X-YTSLIHSLI-Z |
| - X-YTSLIHSLIE-Z |
| - X-YTSLIHSLIEE-Z |
| - X-YTSLIHSLIEES-Z |
| - X-YTSLIHSLIEESQ-Z |
| - X-YTSLIHSLIEESQN-Z |
| - X-YTSLIHSLIEESQNQ-Z |
| - X-YTSLIHSLIEESQNQQ-Z |
| - X-YTSLIHSLIEESQNQQE-Z |
| - X-YTSLIHSLIEESQNQQEK-Z |
| - X-YTSLIHSLIEESQNQQEKN-Z |
| - X-YTSLIHSLIEESQNQQEKNE-Z |
| - X-YTSLIHSLIEESQNQQEKNEQ-Z |
| - X-YTSLIHSLIEESQNQQEKNEQE-Z |
| - X-YTSLIHSLIEESQNQQEKNEQEL-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELL-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLE-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLEL-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELD-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDK-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDKW-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDKWA-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDKWAS-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDKWASL-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDKWASLW-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWN-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNW-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| #a 9fluorenylmethoxy-carbonyl (FMOC) group; a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE IA |
| ______________________________________ |
| DP178 (SEQ ID:1) AMINO TRUNCATIONS |
| ______________________________________ |
| X-NWF-Z |
| - X-WNWF-Z |
| - X-LWNWF-Z |
| - X-SLWNWF-Z |
| - X-ASLWNWF-Z |
| - X-WASLWNWF-Z |
| - X-KWASLWNWF-Z |
| - X-DKWASLWNWF-Z |
| - X-LDKWASLWNWF-Z |
| - X-ELDKWASLWNWF-Z |
| - X-LELDKWASLWNWF-Z |
| - X-LLELDKWASLWNWF-Z |
| - X-ELLELDKWASLWNWF-Z |
| - X-QELLELDKWASLWNWF-Z |
| - X-EQELLELDKWASLWNWF-Z |
| - X-NEQELLELDKWASLWNWF-Z |
| - X-KNEQELLELDKWASLWNWF-Z |
| - X-EKNEQELLELDKWASLWNWF-Z |
| - X-QEKNEQELLELDKWASLWNWF-Z |
| - X-QQEKNEQELLELDKWASLWNWF-Z |
| - X-NQQEKNEQELLELDKWASLWNWF-Z |
| - X-QNQQEKNEQELLELDKWASLWNWF-Z |
| - X-SQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-ESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-EESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-IEESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-LIEESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-SLIEESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-HSLIEESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-IHSLIEESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-LIHSLIEESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-SLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-TSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-Z |
| - X-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| #a 9fluorenylmethoxy-carbonyl group; a macromolecular carrier group |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
The peptides of the invention also include DP178-like peptides. "DP178-like", as used herein, refers, first, to DP178 and DP178 truncations which contain one or more amino acid substitutions, insertions and/or deletions. Second, "DP-178-like" refers to peptide sequences identified or recognized by the ALLMOTI5, 107×178×4 and PLZIP search motifs described herein, having structural and/or amino acid motif similarity to DP178. The DP178-like peptides of the invention may exhibit antifusogenic or antiviral activity, or may exhibit the ability to modulate intracellular processes involving coiled-coil peptides. Further, such DP178-like peptides may possess additional advantageous features, such as, for example, increased bioavailability, and/or stability, or reduced host immune recognition.
HIV-1 and HIV-2 enveloped proteins are structurally distinct, but there exists a striking amino acid conservation within the DP178-corresponding regions of HIV-1 and HIV-2. The amino acid conservation is of a periodic nature, suggesting some conservation of structure and/or function. Therefore, one possible class of amino acid substitutions would include those amino acid changes which are predicted to stabilize the structure of the DP178 peptides of the invention. Utilizing the DP178 and DP178 analog sequences described herein, the skilled artisan can readily compile DP178 consensus sequences and ascertain from these, conserved amino acid residues which would represent preferred amino acid substitutions.
The amino acid substitutions may be of a conserved or non-conserved nature. Conserved amino acid substitutions consist of replacing one or more amino acids of the DP178 (SEQ ID:1) peptide sequence with amino acids of similar charge, size, and/or hydrophobicity characteristics, such as, for example, a glutamic acid (E) to aspartic acid (D) amino acid substitution. Non-conserved substitutions consist of replacing one or more amino acids of the DP178 (SEQ ID:1) peptide sequence with amino acids possessing dissimilar charge, size, and/or hydrophobicity characteristics, such as, for example, a glutamic acid (E) to valine (V) substitution.
Amino acid insertions may consist of single amino acid residues or stretches of residues. The insertions may be made at the carboxy or amino terminal end of the DP178 or DP178 truncated peptides, as well as at a position internal to the peptide. Such insertions will generally range from 2 to 15 amino acids in length. It is contemplated that insertions made at either the carboxy or amino terminus of the peptide of interest may be of a broader size range, with about 2 to about 50 amino acids being preferred. One or more such insertions may be introduced into DP178 (SEQ.ID:1) or DP178 truncations, as long as such insertions result in peptides which may still be recognized by the 107×178×4, ALLMOTI5 or PLZIP search motifs described herein, or may, alternatively, exhibit antifusogenic or antiviral activity, or exhibit the ability to modulate intracellular processes involving coiled-coil peptide structures.
Preferred amino or carboxy terminal insertions are peptides ranging from about 2 to about 50 amino acid residues in length, corresponding to gp41 protein regions either amino to or carboxy to the actual DP178 gp41 amino acid sequence, respectively. Thus, a preferred amino terminal or carboxy terminal amino acid insertion would contain gp41 amino acid sequences found immediately amino to or carboxy to the DP178 region of the gp41 protein.
Deletions of DP178 (SEQ ID:1) or DP178 truncations are also within the scope of the invention. Such deletions consist of the removal of one or more amino acids from the DP178 or DP178-like peptide sequence, with the lower limit length of the resulting peptide sequence being 4 to 6 amino acids. Such deletions may involve a single contiguous or greater than one discrete portion of the peptide sequences. One or more such deletions may be introduced into DP178 (SEQ.ID:1) or DP178 truncations, as long as such deletions result in peptides which may still be recognized by the 107×178×4, ALLMOTI5 or PLZIP search motifs described herein, or may, alternatively, exhibit antifusogenic or antiviral activity, or exhibit the ability to modulate intracellular processes involving coiled-coil peptide structures.
DP178 analogs are further described, below, in Section 5.3.
5.2. DP107 AND DP107-LIKE PEPTIDES
Further, the peptides of the invention include peptides having amino acid sequences corresponding to DP107 analogs. DP107 is a 38 amino acid peptide which exhibits potent antiviral activity, and corresponds to residues 558 to 595 of HIV-LL transmembrane (TM) gp41 protein, as shown here:
NH2 --NNLLRAIEAQQHLLQLTVWQIKQLQARILAVERYLKDQ--COOH (SEQ ID:25)
In addition to the full-length DP107 (SEQ ID:25) 38-mer, the peptides of the invention may include truncations of the DP107 (SEQ ID:25) peptide which exhibit antifusogenic activity, antiviral activity and/or the ability to modulate intracellular processes involving coiled-coil peptide structures. Truncations of DP107 (SEQ ID:25) peptides may comprise peptides of between 3 and 38 amino acid residues (i.e., peptides ranging in size from a tripeptide to a 38-mer polypeptide), as shown in Tables II and IIA, below. Peptide sequences in these tables are listed from amino (left) to carboxy (right) terminus. "X" may represent an amino group (--NH2) and "Z" may represent a carboxyl (--COOH) group. Alternatively, "X" may represent a hydrophobic group, including but not limited to carbobenzyl, dansyl, or T-butoxycarbonyl; an acetyl group; a 9-fluorenylmethoxy-carbonyl (FMOC) group; or a covalently attached macromolecular group, including but not limited to a lipid-fatty acid conjugate, polyethylene glycol, carbohydrate or peptide group. Further, "Z" may represent an amido group; a T-butoxycarbonyl group; or a covalently attached macromolecular group, including but not limited to a lipid-fatty acid conjugate, polyethylene glycol, carbohydrate or peptide group. A preferred "X" or "Z" macromolecular group is a peptide group.
| TABLE II |
| ______________________________________ |
| DP107 (SEQ ID: 25) CARBOXY TRUNCATIONS |
| ______________________________________ |
| X-NNL-Z |
| - X-NNLL-Z |
| - X-NNLLR-Z |
| - X-NNLLRA-Z |
| - X-NNLLRAI-Z |
| - X-NNLLRAIE-Z |
| - X-NNLLRAIEA-Z |
| - X-NNLLRAIEAQ-Z |
| - X-NNLLRAIEAQQ-Z |
| - X-NNLLRAIEAQQH-Z |
| - X-NNLLRAIEAQQHL-Z |
| - X-NNLLRAIEAQQHLL-Z |
| - X-NNLLRAIEAQQHLLQ-Z |
| - X-NNLLRAIEAQQHLLQL-Z |
| - X-NNLLRAIEAQQHLLQLT-Z |
| - X-NNLLRAIEAQQHLLQLTV-Z |
| - X-NNLLRAIEAQQHLLQLTVW-Z |
| - X-NNLLRAIEAQQHLLQLTVWQ-Z |
| - X-NNLLRAIEAQQHLLQLTVWQI-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIK-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQ-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQL-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQ-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQA-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQAR-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARI-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARIL-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILA-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILAV-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILAVE-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILAVER-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILAVERY-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILAVERYL-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILAVERYLK-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILAVERYLKD-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| #a 9fluorenylmethoxy-carbonyl (FMOC) group; a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE IIA |
| ______________________________________ |
| DP178 (SEQ ID: 25) AMINO TRUNCATIONS |
| ______________________________________ |
| X-KDQ-Z |
| - X-LKDQ-Z |
| - X-YLKDQ-Z |
| - X-RYLKDQ-Z |
| - X-ERYLKDQ-Z |
| - X-VERYLKDQ-Z |
| - X-AVERYLKDQ-Z |
| - X-LAVERYLKDQ-Z |
| - X-ILAVERYLKDQ-Z |
| - X-RILAVERYLKDQ-Z |
| - X-ARILAVERYLKDQ-Z |
| - X-QARILAVERYLKDQ-Z |
| - X-LQARILAVERYLKDQ-Z |
| - X-QLQARILAVERYLKDQ-Z |
| - X-KQLQARILAVERYLKDQ-Z |
| - X-IKQLQARILAVERYLKDQ-Z |
| - X-QIKQLQARILAVERYLKDQ-Z |
| - X-WQIKQLQARILAVERYLKDQ-Z |
| - X-VWQIKQLQARILAVERYLKDQ-Z |
| - X-TVWQIKQLQARILAVERYLKDQ-Z |
| - X-LTVWQIKQLQARILAVERYLKDQ-Z |
| - X-QLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-LQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-LLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-HLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-QHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-QQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-AQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-EAQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-IEAQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-AIEAQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-RAIEAQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-LRAIEAQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-LLRAIEAQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-NLLRAIEAQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| - X-NNLLRAIEAQQHLLQLTVWQIKQLQARILAVERYLKDQ-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| #a 9fluorenylmethoxy-carbonyl group; a macromolecular carrier group |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
The peptides of the invention also include DP107-like peptides. "DP107-like", as used herein, refers, first, to DP107 and DP107 truncations which contain one or more amino acid substitutions, insertions and/or deletions. Second, "DP-107-like" refers to peptide sequences identified or recognized by the ALLMOTI5, 107×178×4 and PLZIP search motifs described herein, having structural and/or amino acid motif similarity to DP107. The DP107-like peptides of the invention may exhibit antifusogenic or antiviral activity, or may exhibit the ability to modulate intracellular processes involving coiled-coil peptides. Further, such DP107-like peptides may possess additional advantageous features, such as, for example, increased bioavailability, and/or stability, or reduced host immune recognition.
HIV-1 and HIV-2 enveloped proteins are structurally distinct, but there exists a striking amino acid conservation within the DP107-corresponding regions of HIV-1 and HIV-2. The amino acid conservation is of a periodic nature, suggesting some conservation of structure and/or function. Therefore, one possible class of amino acid substitutions would include those amino acid changes which are predicted to stabilize the structure of the DP107 peptides of the invention. Utilizing the DP107 and DP107 analog sequences described herein, the skilled artisan can readily compile DP107 consensus sequences and ascertain from these, conserved amino acid residues which would represent preferred amino acid substitutions.
The amino acid substitutions may be of a conserved or non-conserved nature. Conserved amino acid substitutions consist of replacing one or more amino acids of the DP107 (SEQ ID:25) peptide sequence with amino acids of similar charge, size, and/or hydrophobicity characteristics, such as, for example, a glutamic acid (E) to aspartic acid (D) amino acid substitution. Non-conserved substitutions consist of replacing one or more amino acids of the DP107 (SEQ ID:25) peptide sequence with amino acids possessing dissimilar charge, size, and/or hydrophobicity characteristics, such as, for example, a glutamic acid (E) to valine (V) substitution.
Amino acid insertions may consist of single amino acid residues or stretches of residues. The insertions may be made at the carboxy or amino terminal end of the DP107 or DP107 truncated peptides, as well as at a position internal to the peptide. Such insertions will generally range from 2 to 15 amino acids in length. It is contemplated that insertions made at either the carboxy or amino terminus of the peptide of interest may be of a broader size range, with about 2 to about 50 amino acids being preferred. One or more such insertions may be introduced into DP107 (SEQ.ID:25) or DP107 truncations, as long as such insertions result in peptides which may still be recognized by the 107×178×4, ALLMOTI5 or PLZIP search motifs described herein, or may, alternatively, exhibit antifusogenic or antiviral activity, or exhibit the ability to modulate intracellular processes involving coiled-coil peptide structures.
Preferred amino or carboxy terminal insertions are peptides ranging from about 2 to about 50 amino acid residues in length, corresponding to gp41 protein regions either amino to or carboxy to the actual DP107 gp41 amino acid sequence, respectively. Thus, a preferred amino terminal or carboxy terminal amino acid insertion would contain gp41 amino acid sequences found immediately amino to or carboxy to the DP107 region of the gp41 protein.
Deletions of DP107 (SEQ ID:25) or DP178 truncations are also within the scope of the invention. Such deletions consist of the removal of one or more amino acids from the DP107 or DP107-like peptide sequence, with the lower limit length of the resulting peptide sequence being 4 to 6 amino acids. Such deletions may involve a single contiguous or greater than one discrete portion of the peptide sequences. One or more such deletions may be introduced into DP107 (SEQ.ID:25) or DP107 truncations, as long as such deletions result in peptides which may still be recognized by the 107×178×4, ALLMOTI5 or PLZIP search motifs described herein, or may, alternatively, exhibit antifusogenic or antiviral activity, or exhibit the ability to modulate intracellular processes involving coiled-coil peptide structures.
DP107 and DP107 truncations are more fully described in Applicants' co-pending U.S. patent application Ser. No. 08/374,666, filed Jan. 27, 1995, and which is incorporated herein by reference in its entirety. DP107 analogs are further described, below, in Section 5.3.
5.3. DP107 and DP178 ANALOGS
Peptides corresponding to analogs of the DP178, DP178 truncations, DP107 and DP107 truncation sequences of the invention, described, above, in Sections 5.1 and 5.2 may be found in other viruses, including, for example, non-HIV-1LAI enveloped viruses, non-enveloped viruses and other non-viral organisms.
The term "analog", as used herein, refers to a peptide which is recognized or identified via the 107×178×4, ALLMOTI5 and/or PLZIP search strategies discussed below. Further, such peptides may exhibit antifusogenic capability, antiviral activity, or the ability to modulate intracellular processes involving coiled-coil structures.
Such DP178 and DP107 analogs may, for example, correspond to peptide sequences present in TM proteins of enveloped viruses and may, additionally correspond to peptide sequences present in non enveloped and non-viral organisms. Such peptides may exhibit antifusogenic activity, antiviral activity, most particularly antiviral activity which is specific to the virus in which their native sequences are found, or may exhibit an ability to modulate intracellular processes involving coiled-coil peptide structures.
DP178 analogs are peptides whose amino acid sequences are comprised of the amino acid sequences of peptide regions of, for example, other (i.e., other than HIV-1LAI) viruses that correspond to the gp41 peptide region from which DP178 (SEQ ID:1) was derived. Such viruses may include, but are not limited to, other HIV-1 isolates and HIV-2 isolates. DP178 analogs derived from the corresponding gp41 peptide region of other (i.e., non HIV-1LAI) HIV-1 isolates may include, for example, peptide sequences as shown below.
NH2 --YTNTIYTLLEESQNQQEKNEQELLELDKWASLWNWF--COOH (DP-185; SEQ ID:3);
NH2 --YTGIIYNLLEESQNQQEKNEQELLELDKWANLWNWF--COOH (SEQ ID:4);
NH2 --YTSLIYSLLEKSQIQQEKNEQELLELDKWASLWNWF--COOH (SEQ ID:5),
SEQ ID:3 (DP-185), SEQ ID:4, and SEQ ID:5 are derived from HIV-1SF2, HIV-1RF, and HIV-1MN isolates, respectively. Underlined amino acid residues refer to those residues that differ from the corresponding position in the DP178 (SEQ ID:1) peptide. One such DP178 analog, DP-185 (SEQ ID:3), is described in the Example presented in Section 6, below, where it is demonstrated that DP-185 (SEQ ID:3) exhibits antiviral activity. The DP178 analogs of the invention may also include truncations, as described above. Further, the analogs of the invention modifications such those described for DP178 analogs in Section 5.1., above. It is preferred that the DP178 analogs of the invention represent peptides whose amino acid sequences correspond to the DP178 region of the gp41 protein, it is also contemplated that the peptides of the invention may, additionally, include amino sequences, ranging from about 2 to about 50 amino acid residues in length, corresponding to gp41 protein regions either amino to or carboxy to the actual DP178 amino acid sequence.
Striking similarities, as shown in FIG. 1, exist within the regions of HIV-1 and HIV-2 isolates which correspond to the DP178 sequence. A DP178 analog derived from the HIV-2NIHZ isolate has the 36 amino acid sequence (reading from amino to carboxy terminus):
NH2 --LEANISQSLEQAQIQQEKNMYELQKLNSWDVFTNWL--COOH (SEQ ID:7)
Table III and Table IV show some possible truncations of the HIV-2NIHZ DP178 analog, which may comprise peptides of between 3 and 36 amino acid residues (i.e., peptides ranging in size from a tripeptide to a 36-mer polypeptide). Peptide sequences in these tables are listed from amino (left) to carboxy (right) terminus. "X" may represent an amino group (--NH2) and "Z" may represent a carboxyl (--COOH) group. Alternatively, "X" may represent a hydrophobic group, including but not limited to carbobenzyl, dansyl, or T-butoxycarbonyl; an acetyl group; a 9-fluorenylmethoxy-carbonyl (FMOC) group; or a covalently attached macromolecular group, including but not limited to a lipid-fatty acid conjugate, polyethylene glycol, carbohydrate or peptide group. Further, "Z" may represent an amido group; a T-butoxycarbonyl group; or a covalently attached macromolecular group, including but not limited to a lipid-fatty acid conjugate, polyethylene glycol, carbohydrate or peptide group. A preferred "X" or "Z" macromolecular group is a peptide group.
| TABLE III |
| ______________________________________ |
| HIV-2NIHZ DP178 analog carboxy truncations |
| ______________________________________ |
| X-LEA-Z |
| - X-LEAN-Z |
| - X-LEANI-Z |
| - X-LEANIS-Z |
| - X-LEANISQ-Z |
| - X-LEANISQS-Z |
| - X-LEANISQSL-Z |
| - X-LEANISQSLE-Z |
| - X-LEANISQSLEQ-Z |
| - X-LEANISQSLEQA-Z |
| - X-LEANISQSLEQAQ-Z |
| - X-LEANISQSLEQAQI-Z |
| - X-LEANISQSLEQAQIQ-Z |
| - X-LEANISQSLEQAQIQQ-Z |
| - X-LEANISQSLEQAQIQQE-Z |
| - X-LEANISQSLEQAQIQQEK-Z |
| - X-LEANISQSLEQAQIQQEKN-Z |
| - X-LEANISQSLEQAQIQQEKNM-Z |
| - X-LEANISQSLEQAQIQQEKNMY-Z |
| - X-LEANISQSLEQAQIQQEKNMYE-Z |
| - X-LEANISQSLEQAQIQQEKNMYEL-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQ-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQK-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKL-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLN-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNS-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNSW-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNSWD-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNSWDV-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNSWDVF-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNSWDVFT-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNSWDVFTN-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNSWDVFTNW-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| #a 9fluorenylmethoxy-carbonyl (FMOC) group; a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE IV |
| ______________________________________ |
| HIV-2NIHZ DP178 analog amino truncations |
| ______________________________________ |
| X-NWL-Z |
| - X-TNWL-Z |
| - X-FTNWL-Z |
| - X-VFTNWL-Z |
| - X-DVFTNWL-Z |
| - X-WDVFTNWL-Z |
| - X-SWDVFTNWL-Z |
| - X-NSWDVFTNWL-Z |
| - X-LNSWDVFTNWL-Z |
| - X-KLNSWDVFTNWL-Z |
| - X-QKLNSWDVFTNWL-Z |
| - X-LQKLNSWDVFTNWL-Z |
| - X-ELQKLNSWDVFTNWL-Z |
| - X-YELQKLNSWDVFTNWL-Z |
| - X-MYELQKLNSWDVFTNWL-Z |
| - X-NMYELQKLNSWDVFTNWL-Z |
| - X-KNMYELQKLNSWDVFTNWL-Z |
| - X-EKNMYELQKLNSWDVFTNWL-Z |
| - X-QEKNMYELQKLNSWDVFTNWL-Z |
| - X-QQEKNMYELQKLNSWDVFTNWL-Z |
| - X-IQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-QIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-AQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-QAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-EQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-LEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-SLEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-QSLEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-SQSLEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-ISQSLEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-NISQSLEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-ANISQSLEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-EANISQSLEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| - X-LEANISQSLEQAQIQQEKNMYELQKLNSWDVFTNWL-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| #a 9fluorenylmethoxy-carbonyl (FMOC) group; a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
DP178 and DP107 analogs are recognized or identified, for example, by utilizing one or more of the 107×178×4, ALLMOTI5 or PLZIP computer-assisted search strategies described and demonstrated, below, in the Examples presented in Sections 9 through 16 and 19 through 25. The search strategy identifies additional peptide regions which are predicted to have structural and/or amino acid sequence features similar to those of DP107 and/or DP178.
The search strategies are described fully, below, in the Example presented in Section 9. While this search strategy is based, in part, on a primary amino acid motif deduced from DP107 and DP178, it is not based solely on searching for primary amino acid sequence homologies, as such protein sequence homologies exist within, but not between major groups of viruses. For example, primary amino acid sequence homology is high within the TM protein of different strains of HIV-1 or within the TM protein of different isolates of simian immunodeficiency virus (SIV). Primary amino acid sequence homology between HIV-1 and SIV, however, is low enough so as not to be useful. It is not possible, therefore, to find peptide regions similar to DP107 or DP178 within other viruses, or within non-viral organisms, whether structurally, or otherwise, based on primary sequence homology, alone.
Further, while it would be potentially useful to identify primary sequence arrangements of amino acids based on, for example, the physical chemical characteristics of different classes of amino acids rather than based on the specific amino acids themselves, such search strategies have, until now, proven inadequate. For example, a computer algorithm designed by Lupas et al. to identify coiled-coil propensities of regions within proteins (Lupas, A., et al., 1991 Science 252:1162-1164) is inadequate for identifying protein regions analogous to DP107 or DP178.
Specifically, analysis of HIV-1 gp160 (containing both gp120 and gp41) using the Lupas algorithm does not identify the coiled-coil region within DP107. It does, however, identify a region within DP178 beginning eight amino acids N-terminal to the start of DP178 and ending eight amino acids from the C-terminus. The DP107 peptide has been shown experimentally to form a stable coiled coil. A search based on the Lupas search algorithm, therefore, would not have identified the DP107 coiled-coil region. Conversely, the Lupas algorithm identified the DP178 region as a potential coiled-coil motif. However, the peptide derived from the DP178 region failed to form a coiled coil in solution.
A possible explanation for the inability of the Lupas search algorithm to accurately identify coiled-coil sequences within the HIV-1 TM, is that the Lupas algorithm is based on the structure of coiled coils from proteins that are not structurally or functionally similar to the TM proteins of viruses, antiviral peptides (e.g. DP107 and DP178) of which are an object of this invention.
The computer search strategy of the invention, as demonstrated in the Examples presented below, in Sections 9 through 16 and 19 through 25, successfully identifies regions of proteins similar to DP107 or DP178. This search strategy was designed to be used with a commercially-available sequence database package, preferably PC/Gene.
A series of search motifs, the 107×178×4, ALLMOTI5 and PLZIP motifs, were designed and engineered to range in stringency from strict to broad, as discussed in this Section and in Section 9, with 107×178×4 being preferred. The sequences identified via such search motifs, such as those listed in Tables V-XIV, below, potentially exhibit antifusogenic, such as antiviral, activity, may additionally be useful in the identification of antifusogenic, such as antiviral, compounds, and are intended to be within the scope of the invention.
Coiled-coiled sequences are thought to consist of heptad amino acid repeats. For ease of description, the amino acid positions within the heptad repeats are sometimes referred to as A through G, with the first position being A, the second B, etc. The motifs used to identify DP107-like and DP178-like sequences herein are designed to specifically search for and identify such heptad repeats. In the descriptions of each of the motifs described, below, amino acids enclosed by brackets , i.e., [ ], designate the only amino acid residues that are acceptable at the given position, while amino acids enclosed by braces, i.e., { }, designate the only amino acids which are unacceptable at the given heptad position. When a set of bracketed or braced amino acids is followed by a number in parentheses i.e., (), it refers to the number of subsequent amino acid positions for which the designated set of amino acids hold, e.g, a (2) means "for the next two heptad amino acid positions".
The ALLMOTI5 is written as follows:
{CDGHP}-{CFP}(2)-{CDGHP}-{CFP}(3)--
{CDGHP}-{CFP}(2)-{CDGHP}-{CFP}(3)--
{CDGHP}-{CFP}(2)-{CDGHP}-{CFP}(3)--
{CDGHP}-{CFP}(2)-{CDGHP}-{CFP}(3)--
{CDGHP}-{CFP}(2) -{CDGHP}-{CFP}(3)--
Translating this motif, it would read: "at the first (A) position of the heptad, any amino acid residue except C, D, G, H, or P is acceptable, at the next two (B,C) amino acid positions, any amino acid residue except C, F, or P is acceptable, at the fourth heptad position (D), any amino acid residue except C, D, G, H, or P is acceptable, at the next three (E, F, G) amino acid positions, any amino acid residue except C, F, or P is acceptable. This motif is designed to search for five consecutive heptad repeats (thus the repeat of the first line five times), meaning that it searches for 35-mer sized peptides. It may also be designed to search for 28-mers, by only repeating the initial motif four times. With respect to the ALLMOTI5 motif, a 35-mer search is preferred. Those viral (non-bacteriophage) sequences identified via such an ALLMOTI5 motif are listed in Table V, below, at the end of this Section. The viral sequences listed in Table V potentially exhibit antiviral activity, may be useful in the the identification of antiviral compounds, and are intended to be within the scope of the invention. In those instances wherein a single gene exhibits greater than one sequence recognized by the ALLMOTI5 search motif, the amino acid residue numbers of these sequences are listed under "Area 2", Area 3", etc. This convention is used for each of the Tables listed, below, at the end of this Section.
The 107×178×4 motif is written as follows:
[EFIKLNQSTVWY]-{CFMP}(2)-[EFIKLNQSTVWY]-{CFMP}(3)--
[EFIKLNQSTVWY]-{CFMP}(2)-[EFIKLNQSTVWY]-{CFMP}(3)--
[EFIKLNQSTVWY]-{CFMP}(2)-[EFIKLNQSTVWY]-{CFMP}(3)--
[EFIKLNQSTVWY]-{CFMP}(2)-[EFIKLNQSTVWY]-{CFMP}(3)--
Translating this motif, it would read: "at the first (A) position of the heptad, only amino acid residue E, F, I, K, L, N, Q, S, T, V, W, or Y is acceptable, at the next two (B,C) amino acid positions, any amino acid residue except C, F, M or P is acceptable, at the fourth position (D), only amino acid residue E, F, I, K, L, N, Q, S, T, V, W, or Y is acceptable, at the next three (E, F, G) amino acid positions, any amino acid residue except C, F, M or P is acceptable. This motif is designed to search for four consecutive heptad repeats (thus the repeat of the first line four times), meaning that it searches for 28-mer sized peptides. It may also be designed to search for 35-mers, by repeating the initial motif five times. With respect to the 107×178×4 motif, a 28-mer search is preferred.
Those viral (non-bacteriophage) sequences identified via such a 107×178×4 motif are listed in Table VI, below, at the end of this Section, with those viral (non-bacteriophage) sequences listed in Table VII, below at the end of this Section, being preferred.
The 107×178×4 search motif was also utilized to identify non-viral procaryotic protein sequences, as listed in Table VIII, below, at the end of this Section. Further, this search motif was used to reveal a number of human proteins. The results of this human protein 107×178×4 search is listed in Table IX, below, at the end of this Section. The sequences listed in Tables VIII and IX, therefore, reveal peptides which may be useful as antifusogenic compounds or in the identification of antifusogenic compounds, and are intended to be within the scope of the invention.
The PLZIP series of motifs are as listed in FIG. 19. These motifs are designed to identify leucine zipper coiled-coil like heptads wherein at least one proline residue is present at some predefined distance N-terminal to the repeat. These PLZIP motifs find regions of proteins with similarities to HIV-1 DP178 generally located just N-terminal to the transmembrane anchor. These motifs may be translated according to the same convention described above. Each line depicted in FIG. 19 represents a single, complete search motif. "X" in these motifs refers to any amino acid residue. In instances wherein a motif contains two numbers within parentheses, this refers to a variable number of amino acid residues. For example, X (1,12) is translated to "the next one to twelve amino acid residues, inclusive, may be any amino acid".
Tables X through XIV, below, at the end of this Section, list sequences identified via searches conducted with such PLZIP motifs. Specifically, Table X lists viral sequences identified via PCTLZIP, P1CTLZIP and P2CTLZIP search motifs, Table XI lists viral sequences identified via P3CTLZIP, P4CTLZIP, P5CTLZIP and P6CTLZIP search motifs, Table XII lists viral sequences identified via P7CTLZIP, P8CTLZIP and P9CTLZIP search motifs, Table XIII lists viral sequences identified via P12LZIPC searches and Table XIV lists viral sequences identified via P23TLZIPC search motifs The viral sequences listed in these tables represent peptides which potentially exhibit antiviral activity, may be useful in the identification of antiviral compounds, and are intended to be within the scope of the invention.
The Examples presented in Sections 17, 18, 26 and 27 below, demonstrate that viral sequences identified via the motif searches described herein identify substantial antiviral characteristics. Specifically, the Example presented in Section 17 describes peptides with anti-respiratory syncytial virus activity, the Example presented in Section 18 describes peptides with anti-parainfluenza virus activity, the Example presented in Section 26 describes peptides with anti-measles virus activity and the Example presented in Section 27 describes peptides with anti-simian immunodeficiency virus activity.
The DP107 and DP178 analogs may, further, contain any of the additional groups described for DP178, above, in Section 5.1. For example, these peptides may include any of the additional amino-terminal groups as described above for "X" groups, and may also include any of the carboxy-terminal groups as described, above, for "Z" groups.
Additionally, truncations of the identified DP107 and DP178 peptides are among the peptides of the invention. Further, such DP107 and DP178 analogs and DP107/DP178 analog truncations may exhibit one or more amino acid substitutions, insertion, and/or deletions. The DP178 analog amino acid substitutions, insertions and deletions, are as described, above, for DP178-like peptides in Section 5.1. The DP-107 analog amino acid substitutions, insertions and deletions are also as described, above, for DP107-like peptides in Section 5.2.
Tables XV through XXII, below, present representative examples of such DP107/DP178 truncations. Specifically, Table XV presents Respiratory Syncytial Virus F1 region DP107 analog carboxy truncations, Table XVI presents Respiratory Syncytial Virus F1 region DP107 analog amino truncations, Table XVII presents Respiratory Syncytial Virus F1 region DP178 analog carboxy truncations, Table XVIII presents Respiratory Syncytial Virus F1 region DP178 analog amino truncations, Table XIX presents Human Parainfluenza Virus 3 F1 region DP178 analog carboxy truncations, Table XX presents Human Parainfluenza Virus 3 F1 region DP178 analog amino truncations, Table XXI presents Human Parainfluenza Virus 3 F1 region DP107 analog carboxy truncations and Table XXII presents Human Parainfluenza Virus 3 F1 region DP107 analog amino truncations. Further, Table XXIII, below, presents DP107/DP178 analogs and analog truncations which exhibit substantial antiviral activity. These antiviral peptides are grouped according to the specific virus which they inhibit, including respiratory syncytial virus, human parainfluenza virus 3, simian immunodeficiency virus and measles virus.
| TABLE V |
| - ALLMOTI5 SEARCH RESULTS SUMMARY FOR ALL VIRAL (NON-BACTERIOPHAGE) |
| PROTEINS |
| PCGENE ALMOTIS All Viruses (no bacteriophages) |
| FILENAME PROTEIN VIRUS AREA 1 AREA 2 AREA 3 AREA 4 AREA 5 AREA 6 AREA |
| 7 AREA 8 |
| P170K-- TRVPS POTENTIAL 170 KD PROTEIN TOBACCO RATTLE VIRUS |
| (STRAIN PSG) 113-153 |
| P194K-- TRVSY POTENTIAL 194 KD PROTEIN TOBACCO RATTLE VIRUS |
| (STRAIN SYM 144-178 214-248 391-446 644-678 1045- 1135- 1335- 1618- |
| 1079 1176 1376 1658 |
| P55KD-- HSV6U 55.8 KD PROTEIN HERPES SIMPLEX VIRUS (TYPE 6/STRAIN |
| 228-262 |
| UGANDA-1102) |
| PAANT-- HDVAM DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE |
| AMERICAN) |
| 3-48 100-144 PAANT.sub |
| .-- HDVD3 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE D380) 7-48 |
| 100-144 |
| PAANT-- HDVIT DELTA ANTIGEN(ALPHA ANTIGEN) HEPATITIS DELTA VIRUS |
| (ISOLATE ITALIAN) |
| 3-48 100-144 PAANT-- |
| HDVL1 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE LEBANON-1) 3-48 |
| PAANT-- HDVM1 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE |
| JAPANESE M-1) |
| 3-48 100-144 PAANT-- |
| HDVM2 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE JAPANESE M-2) 3-48 |
| 100-144 |
| PAANT-- HDVNA DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE NAURU) |
| 3-48 100-144 |
| PAANT-- HDVS1 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE JAPANESE |
| S-1) |
| 1-49 100-144 |
| PAANT-- HDVS2 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE JAPANESE |
| S-2) |
| 1-49 100-144 |
| PAANT-- |
| HDVWO DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE WOODCHUCK) 3-48 |
| 100-144 |
| PAT3H-- FOWPM ANTITHROMBIN-III HOMOLOG FOWLPOX VIRUS (ISOLATE |
| HP-438) |
| 71-11 |
| PATI1-- VACCV 94 KD A-TYPE INCLUSION PROTEIN VACCINIA VIRUS (STRAIN |
| WR) 14-57 420-564 570-625 |
| PATI1-- VARV 81 KD A-TYPE INCLUSION PROTEIN VARIOLA VIRUS 425-525 |
| 531-565 571-628 |
| PATI2-- HSVII ALPHA TRANS-INDUCING FACTOR HERPES SIMPLEX VIRUS |
| (TYPE 1) 304-345 |
| PATI2-- HSVIF ALPHA TRANS-INDUCING FACTOR HERPES SIMPLEX VIRUS |
| (TYPE 1) 102-139 304-345 |
| PATI2-- HSVEB ALPHA TRANS-INDUCING FACTOR EQUINE HERPES VIRUS |
| TYPE 1 (STRAIN AB4P) 101-147 268-331 |
| PATI2-- VACCC PUTATIVE A-TYPE INCLUSION PROTEIN VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| 79-124 219-263 PATI2-- VACCV |
| PUTATIVE A-TYPE INCLUSION PROTEIN VACCINIA VIRUS |
| 79-124 PATI2-- VZVD ALPHA TRANS-INDUCING FACTOR |
| VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) 298-361 395-429 |
| PATI3-- VACCV PUTATIVE A-TYPE INCLUSION PROTEIN VACCINIA VIRUS |
| 51-95 |
| PATIN-- HSV23 ALPHA TRANS-INDUCING PROTEIN HERPES SIMPLEX VIRUS |
| (TYPE 2) 178-219 224-381 |
| (VMW65) |
| PATIN-- HSV2H ALPHA TRANS-INDUCING PROTEIN HERPES SIMPLEX VIRUS |
| (TYPE 2) 177-222 324-381 |
| (VMW65) |
| PATIN-- HSVBP ALPHA TRANS-INDUCING PROTEIN BOVINE HERPES VIRUS |
| TYPE 1 195-256 |
| PATIN-- HSVEB ALPHA TRANS-INDUCING PROTEIN EQUINE HERPES VIRUS |
| TYPE 1 241-289 |
| PATIN-- VZVD ALPHA TRANS-INDUCING PROTEIN( VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 206-252 |
| PATI-- COWPX A-TYPE INCLUSION PROTEIN COWPOX VIRUS 14-57 426-526 |
| 532-566 572-629 803-959 1106- |
| 1150 |
| PBDL2-- EBV PROTEIN BDLF2 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 90-131 |
| PBRL1-- EBV TRANSCRIPTION ACTIVATOR BRLF1 EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) 150-187 |
| PCOA1-- |
| POVBA COAT PROTEIN VPI POLYOMAVIRUS BK 107-144 PCOA1-- |
| POVBK COAT PROTEIN VP1 POLYOMAVIRUS BK 107-141 |
| PCOA1-- POVHA COAT PROTEIN VP1 HAMSTER POLYOMAVIRUS 159-195 |
| PCOA1-- SV40 COAT PROTEIN VP1 SIMIAN VIRUS 40 109-143 |
| PCOA2-- BFDV COAT PROTEIN VP2 BUDGERIGAR FLEDGLING DISEASE |
| VIRUS 141-213 |
| PCOA2-- POVBA COAT PROTEIN VP2 POLYOMAVIRUS BK (STRAIN AS) 14-64 |
| 317-315 |
| PCOA2-- PDVBK COAT PROTEIN VP2 POLYOMAVIRUS BK 14-64 317-351 |
| PCOA2-- POVBO COAT PROTEIN VP2 BOVINE POLYOMAVIRUS 35-76 |
| 153-216 |
| PCOA2-- POVHA COAT PROTEIN VP2 HAMSTER POLYOMAVIRUS 7-48 174-288 |
| PCOA2-- POVIC COAT PROTEIN VP2 POLYOMAVIRUS JC 14-64 233-267 |
| PCOA2-- POVLY COAT PROTEIN VP2 LYMPHOTROPIC POLYOMAVIRUS |
| 14-78 156-206 |
| PCOA2-- POVM3 COAT PROTEIN VP2 MOUSE POLYOMAVIRUS (STRAIN 3) |
| 5-72 137-185 |
| PCOA2-- POVMA COAT PROTEIN VP2 MOUSE POLYOMAVIRUS 5-72 137-185 |
| PCOA2-- POVMC COAT PROTEIN VP2 MOUSE POLYOMAVIRUS 5-72 137-185 |
| PCOA2-- POVMK COAT PROTEIN VP2 MOUSE POLYOMAVIRUS 15-56 177-211 |
| PCDA2-- SV40 COAT PROTEIN VP2 SIMIAN VIRUS 40 14-62 228-262 |
| 318-352 |
| PCOAT-- ABMVW COAT PROTEIN VP2 ABUTILON MOSAIC VIRUS (ISOLATE |
| WEST INDIA 180-214 |
| PCOAT-- ACLSV COAT PROTEIN APPLE CHLOROTIC LEAF SPOT VIRUS |
| 154-188 |
| PCOAT-- AEDEV COAT PROTEIN VP1 AEDES DENSONUCLEOSIS VIRUS 243-284 |
| PCOAT-- AMCV COAT PROTEIN ARTICHOKE MOTTLED CRINKLE VIRUS 36-70 |
| 100-134 |
| PCOAT-- BLRV COAT PROTEIN BEAN LEAFROLL VIRUS |
| 89-123 PCOAT-- BMV COAT PROTEIN BROME MOSAIC VIRUS |
| 36-73 |
| PCOAT-- BYDV1 COAT PROTEIN BARLEY YELLOW DWARF VIRUS 163-197 |
| PCOAT-- BYDVM COAT PROTEIN BARLEY YELLOW DWARF VIRUS 163-197 |
| PCOAT-- BYDVP COAT PROTEIN BARLEY YELLOW DWARF VIRUS 164-198 |
| PCOAT-- BYDVR COAT PROTEIN BARLEY YELLOW DWARF VIRUS 164-198 |
| PCOAT-- CAMVC COAT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN 56-90 |
| 186-223 |
| PCOAT-- CAMVD COAT PROTEIN CAULIFLOWER MOSAIC VIRUS 53-91 187-224 |
| PCOAT-- CAMVE COAT PROTEIN CAULIFLOWER MOSAIC VIRUS 56-90 186-223 |
| PCOAT-- CAMVN COAT PROTEIN CAULIFLOWER MOSAIC VIRUS 56-90 185-222 |
| PCOAT-- CAMVS COAT PROTEIN CAULIFLOWER MOSAIC VIRUS 53-91 187-224 |
| PCOAT-- |
| CARMV COAT PROTEIN CARNATION MOTTLE VIRUS 13-51 PCOAT-- |
| CCMV COAT PROTEIN COWPEA CHLOROTIC MOTTLE VIRUS 141-178 |
| PCOAT-- CERV PROBABLE COAT PROTEIN CARNATION ETCHED RING VIRUS |
| 192-226 |
| PCOAT-- CHVP1 MAJOR CAPSID PROTEIN PARAMECIUM BURSARIA CHLORELLA |
| VIRUS 1 393-435 |
| PCOAT-- |
| CLVK COAT PROTEIN CASSAVA LATENT VIRUS 197-231 PCOAT-- |
| CLVN COAT PROTEIN CASSAVA LATENT VIRUS 197-231 |
| PCOAT-- |
| CMVPC COAT PROTEIN CUCUMBER MOSAIC VIRUS 153-187 PCOAT-- |
| CMVI COAT PROTEIN CUCUMBER MOSAIC VIRUS 153-187 |
| PCOAT-- |
| CMVP6 COAT PROTEIN CUCUMBER MOSAIC VIRUS 153-187 PCOAT-- |
| CMVQ COAT PROTEIN CUCUMBER MOSAIC VIRUS 153-187 |
| PCOAT-- |
| CMVWL COAT PROTEIN CUCUMBER MOSAIC VIRUS 153-187 PCOAT-- |
| CMVY COAT PROTEIN CUCUMBER MOSAIC VIRUS 153-187 |
| PCOAT-- |
| CNV COAT PROTEIN CUCUMBER NECROSIS VIRUS 328-365 PCOAT-- |
| CSMV COAT PROTEIN CHLORIS STRIATE MOSAIC VIRUS 184-218 |
| PCOAT-- CTV36 COAT PROTEIN CITRUS TRISTEZA VIRUS |
| 79-120 PCOAT-- CYMV COAT PROTEIN CLOVER YELLOW MOSAIC |
| VIRUS 162-204 |
| PCOAT-- |
| EPMV COAT PROTEIN EGGPLANT MOSAIC VIRUS 40-74 PCOAT-- |
| FCVC6 COAT PROTEIN FELINE CALICIVIRUS 432-466 566-600 |
| PCOAT-- FCVP4 COAT PROTEIN FELINE CALICIVIRUS 502-550 566-600 |
| PCOAT-- FCVF9 COAT PROTEIN FELINE CALICIVIRUS 519-553 569-603 |
| PCOAT-- FMVD PROBABLE COAT PROTEIN FIGWORT MOSAIC VIRUS 144-199 |
| 206-247 449-483 |
| PCOAT-- |
| FXMV COAT PROTEIN FOXTAIL MOSAIC VIRUS 168-220 PCOAT-- |
| IRV1 CAPSID PROTEIN TIPULA IRIDESCENT VIRUS |
| 90-124 PCOAT-- IRV22 CAPSID PROTEIN SIMULIUM |
| IRIDESCENT VIRUS |
| 90-124 PCOAT-- |
| IRV6 CAPSID PROTEIN CHILO IRIDESCENT VIRUS 51-85 |
| PCOAT-- LSV COAT PROTEIN LILY SYMPTOMLESS VIRUS 32-70 255-289 |
| PCOAT-- MSTV COAT PROTEIN MAIZE STRIPE VIRUS 7-76 84-121 |
| PCOAT-- |
| MSVK COAT PROTEIN MAIZE STREAK VIRUS 187-221 PCOAT-- |
| MSVN COAT PROTEIN MAIZE STREAK VIRUS 187-222 |
| PCOAT-- |
| MSVS COAT PROTEIN MAIZE STREAK VIRUS 187-221 PCOAT-- |
| ORSV COAT PROTEIN ODONTOGLOSSUM RINGSPOT VIRUS 105-139 |
| PCOAT-- PAVBO COAT PROTEIN VP2 BOVINE PARVOVIRUS 380-414 444-480 |
| PCOAT-- |
| PAVC7 COAT PROTEIN VP1 CANINE PARVOVIRUS 497-531 PCOAT-- |
| PEBV COAT PROTEIN PEA EARLY BROWNING VIRUS |
| 73-114 PCOAT-- POPMV COAT PROTEIN POPLAR |
| MOSAIC VIRUS 36-81 |
| PCOAT-- PMVS COAT PROTEIN PEPPER MILD MOTTLE VIRUS 104-138 |
| PCOAT-- PVSP COAT PROTEIN POTATO VIRUS 38-72 251-292 |
| PCOAT-- PYMVV COAT PROTEIN POTATO YELLOW MOSAIC VIRUS |
| 190-224 |
| PCOAT-- RBDV COAT PROTEIN RASPBERRY BUSHY DWARF VIRUS 10-44 |
| 140-199 |
| PCOAT-- RCNMV COAT PROTEIN RED CLOVER NECROTIC MOSAIC VIRUS |
| 272-306 |
| PCOAT-- RSV COAT PROTEIN RICE STRIPE VIRUS 34-68 83-120 259-309 |
| PCOAT-- |
| SLCV COAT PROTEIN SQUASH LEAF CURL VIRUS 190-224 PCOAT-- |
| SMWLM COAT PROTEIN SATELLITE MAIZE WHITE LINE MOSAIC VIRUS 66-100 |
| PCOAT-- SOCMV COAT PROTEIN SOYBEAN CHLOROTIC MOTTLE VIRUS |
| 128-166 |
| PCOAT-- STNV1 COAT PROTEIN SATELLITE TOBACCO NECROSIS VIRUS 1 |
| 2-50 |
| PCOAT-- STNV2 COAT PROTEIN SATELLITE TOBACCO NECROSIS VIRUS 2 |
| 38-72 |
| PCOAT-- TAMV GENOME POLYPROTEIN TAMARILLO MOSAIC VIRUS 7-55 |
| PCOAT-- |
| TAV COAT PROTEIN TOMATO ASPERMY VIRUS 14-48 PCOAT-- |
| TBSVB COAT PROTEIN TOMATO BUSHY STUNT VIRUS |
| 1-37 43-77 PCOAT-- TBSVC COAT PROTEIN TOMATO |
| BUSHY STUNT VIRUS 44-78 100-134 |
| PCOAT-- |
| TCV COAT PROTEIN TURNIP CRINKLE VIRUS 12-46 PCOAT-- |
| TGMV COAT PROTEIN TOMATO GOLDEN MOSAIC VIRUS 186-220 |
| PCOAT-- TMGMV COAT PROTEIN TOBACCO MILD GREEN MOSAIC VIRUS |
| 103-137 |
| PCOAT-- |
| TMV COAT PROTEIN TOBACCO MOSAIC VIRUS 103-137 PCOAT-- |
| TMV06 COAT PROTEIN TOBACCO MOSAIC VIRUS 103-137 |
| PCOAT-- TMVCO COAT PROTEIN TOBACCO MOSAIC VIRUS |
| 76-138 PCOAT-- TMVDA COAT PROTEIN TOBACCO MOSAIC VIRUS |
| 103-137 |
| PCOAT-- |
| TMVER COAT PROTEIN TOBACCO MOSAIC VIRUS 103-137 PCOAT-- |
| TMVHR COAT PROTEIN TOBACCO MOSAIC VIRUS 103-137 |
| PCOAT-- |
| TMVO COAT PROTEIN TOBACCO MOSAIC VIRUS 103-137 PCOAT-- |
| TMVOM COAT PROTEIN TOBACCO MOSAIC VIRUS 103-137 |
| PCOAT-- |
| TMVTO COAT PROTEIN TOBACCO MOSAIC VIRUS 103-137 PCOAT-- |
| TRVCA COAT PROTEIN TOBACCO RATTLE VIRUS |
| 71-109 PCOAT-- TRVTC COAT PROTEIN TOBACCO |
| RATTLE VIRUS |
| 69-103 PCOAT-- |
| TYDVA COAT PROTEIN TOBACCO YELLOW DWARF VIRUS |
| 2-36 PCOAT-- TYMV COAT PROTEIN TURNIP YELLOW |
| MOSAIC VIRUS 41-75 |
| PCOAT-- TYMVA COAT PROTEIN TURNIP YELLOW MOSAIC VIRUS 41-75 |
| PCOAT-- WCMVO COAT PROTEIN WHITE CLOVER MOSAIC VIRUS 163-197 |
| PCORA-- HPBGS CORE ANTIGEN GROUND SQUIRREL HEPATITIS VIRUS |
| 94-135 |
| PCORA-- |
| HPBV9 CORE ANTIGEN HEPATITIS B VIRUS 111-149 PCORA-- |
| WHV1 CORE ANTIGEN WOODCHUCK HEPATITIS VIRUS 1 |
| 62-106 PCORA-- WHV8 CORE ANTIGEN WOODCHUCK |
| HEPATITIS VIRUS 8 |
| 62-186 PD250-- |
| ASFB7 PROTEIN D250R AFRICAN SWINE FEVER VIRUS 198-232 |
| PDNB2-- ADE02 EARLY E2A DNA-BINDING PROTEIN HUMAN ADENOVIRUS TYPE |
| 2 291-336 |
| PDNB2-- ADE05 EARLY E2A DNA-BINDING PROTEIN HUMAN ADENOVIRUS TYPE |
| 5 291-336 |
| PDNBI-- EBV MAJOR DNA-BINDING PROTEIN EPSTEIN-BARR VIRUS 215-252 |
| 718-752 |
| 974- 1027- |
| 1009 1068 |
| PDNBI-- HCMVA MAJOR DNA-BINDING PROTEIN HUMAN CYTOMEGALOVIRUS |
| 338-372 1013- |
| 1070 |
| PDNBI-- HSV11 MAJOR DNA-BINDING PROTEIN HERPES SIMPLEX VIRUS |
| 557-595 599-640 769-803 1079- |
| 1140 |
| PDNBI-- HSV1F MAJOR DNA-BINDING PROTEIN HERPES SIMPLEX VIRUS |
| 557-595 599-640 769-803 1079- |
| 1140 |
| PDNBI-- HSVIK MAJOR DNA-BINDING PROTEIN HERPES SIMPLEX VIRUS |
| 557-595 599-640 769-803 1079- |
| 1140 |
| PDNBI-- HSVB2 MAJOR DNA-BINDING PROTEIN BOVINE HERPES VIRUS TYPE |
| 2 552-591 599-633 1048- |
| 1131 |
| PDNBI-- HVE1 MAJOR DNA-BINDING PROTEIN EQUINE HERPES VIRUS TYPE 1 |
| 273-314 |
| PDNBI-- HSVEB MAJOR DNA-BINDING PROTEIN EQUINE HERPES VIRUS TYPE |
| 1 617-658 1107- |
| 1148 |
| PDNBI-- HSVSA MAJOR DNA-BINDING PROTEIN HERPES VIRUS SAIMIRI |
| 222-259 330-367 506-557 873-907 |
| PDNBI-- MCMVS MAJOR DNA-BINDING PROTEIN MURINE CYTOMEGALOVIRUS |
| 584-618 |
| 987- |
| 1125 |
| PDNBI-- SCMVC MAJOR DNA-BINDING PROTEIN SIMIAN CYTOMEGALOVIRUS |
| 525-562 |
| PDNBI-- VZVD MAJOR DNA-BINDING PROTEIN VARICELLA-ZOSTER VIRUS |
| 613-658 1043- |
| 1077 |
| PDNLI-- ASFM2 DNA LIGASE AFRICAN SWINE FEVER VIRUS 72-106 |
| PDNLI-- |
| VACCC DNA LIGASE VACCINIA VIRUS 395-436 PDNLI-- VACCV |
| DNA LIGASE VACCINIA VIRUS 395-436 |
| PDNLI-- |
| VARV DNA LIGASE VARIOLA VIRUS 395-436 PDPOL-- |
| ADE02 DNA POLYMERASE HUMAN ADENOVIRUS TYPE 2 667-743 |
| PDPOL-- ADE05 DNA POLYMERASE HUMAN ADENOVIRUS TYPE 5 667-743 |
| PDPOL-- ADE07 DNA POLYMERASE HUMAN ADENOVIRUS TYPE 7 733-809 |
| PDPOL-- ADE12 DNA POLYMERASE HUMAN ADENOVIRUS TYPE 12 665-741 |
| PDPOL-- |
| CBEPV DNA POLYMERASE CHORISTONEURA BIENNIS ENTOMOPOXVIRUS 23-64 202-240 |
| PDPOL-- CHVN2 DNA POLYMERASE CHLORELLA VIRUS NY-2A 247-284 |
| PDPOL-- CHVP1 DNA POLYMERASE PARAMECIUM BURSARIA CHLORELLA |
| VIRUS 1 247-284 |
| PDPOL-- FOWPV DNA POLYMERASE FOWLPOX VIRUS 17-51 18-114 371-412 |
| PDPOL-- HCMVA DNA POLYMERASE HUMAN CYTOMEGALOVIRUS(STRAIN AD169) |
| 753-787 1033- |
| 1074 |
| PDPOL-- HPBDB DNA POLYMERASE DUCK HEPATITIS B VIRUS 5-39 |
| PDPOL-- HPBDC DNA POLYMERASE DUCK HEPATITIS B VIRUS |
| (STRAIN CHINA) |
| 5-39 PDPOL-- |
| HPBDW DNA POLYMERASE DUCK HEPATITIS B VIRUS (WHITE SHANGHAI DUCK 5-39 |
| 297-338 |
| ISOLATE S3 |
| PDPOL-- HPBGS DNA POLYMERASE GROUND SQUIRREL HEPATITIS VIRUS |
| 291-325 |
| PDPOL-- HPBHE DNA POLYMERASE HERON HEPATITIS B VIRUS 5-39 |
| 224-265 557-595 |
| PDPOL-- HPBVY DNA POLYMERASE HEPATITIS B VIRUS (SUBTYPE AYW) |
| 201-235 |
| PDPOL-- HPBVZ DNA POLYMERASE HEPATITIS B VIRUS (SUBTYPE ADYW) |
| 201-235 |
| PDPOL-- HSV11 DNA POLYMERASE HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| 17) 511-559 |
| PDPOL-- HSV1A DNA POLYMERASE HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| ANGELOTTI 511-559 |
| PDPOL-- HSV1K DNA POLYMERASE HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| KOS) 511-559 |
| PDPOL-- HSV1S DNA POLYMERASE HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| SC16) 511-559 |
| PDPOL-- HSV21 DNA POLYMERASE HERPES SIMPLEX VIRUS (TYPE 2/STRAIN |
| 186) 512-560 |
| PDPOL-- HSVEB DNA POLYMERASE EQUINE HERPES VIRUS TYPE 1 (STRAIN |
| AB4P) 494-528 |
| PDPOL-- HSV11 DNA POLYMERASE ICTALURID HERPES VIRUS 1 (CHANNEL |
| 33-67 328-366 401-435 706-749 808-858 |
| CATFISH VIRUS) |
| PDPOL-- NPVAC DNA POLYMERASE AUTOGRAPHA CALIFORNICA NUCLEAR |
| 595-646 |
| POLYHEDROSIS VIRUS |
| PDPOL-- VACCC DNA POLYMERASE VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 627-683 770-818 828-862 |
| PDPOL-- VACCV DNA POLYMERASE VACCINIA VIRUS (STRAIN WR) 627-683 |
| 770-818 828-862 |
| PDPOL-- VARV DNA POLYMERASE VARIOLA VIRUS 626-682 769-817 827-861 |
| PDPOL-- VZVD DNA POLYMERASE VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| 473-533 |
| PDPOL-- WHV1 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 1 285-326 |
| PDPOL-- WHVS9 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 59 |
| 290-331 |
| PDPOL-- WHV7 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 7 290-331 |
| PDPOL-- WHV8 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 8 289-330 |
| PDPOL-- WHV81 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 8 290-331 |
| (INFECTIOUS CLONE) |
| PDPOM-- HPBVY DNA POLYMERASE HEPATITIS B VIRUS (SUBTYPE AYW) |
| 201-235 |
| PDUT-- HSVEB DEOXYURIDINE 5'-TRIPHOSPHATE EQUINE HERPES VIRUS |
| TYPE 1 (STRAIN AB4PP 135-169 |
| NUCLEOTIDOHY |
| PDUT-- HSVSA DEOXYURIDINE 5'-TRIPHOSPHATE HERPES VIRUS SAIMIRI |
| (STRAIN 11) 179-223 |
| NUCLEOTIDOHY |
| PE1A-- ADE41 EARLY E1A 27 KD PROTEIN HUMAN ADENOVIRUS TYPE 41 |
| 107-141 |
| PE1BL-- ADE40 E1B PROTEIN, LARGE T-ANTIGEN HUMAN ADENOVIRUS TYPE |
| 40 102-166 |
| PE1BS-- ADE02 E1B PROTEIN, SMALL T-ANTIGEN HUMAN ADENOVIRUS TYPE |
| 2 103-137 |
| PE1BS-- ADE05 E1B PROTEIN, SMALL T-ANTIGEN HUMAN ADENOVIRUS TYPE |
| 5 103-137 |
| PE1BS-- ADE12 E1B PROTEIN, SMALL T-ANTIGEN HUMAN ADENOVIRUS TYPE |
| 12 |
| 96-131 |
| PE1BS-- ADE40 E1B PROTEIN, SMALL T-ANTIGEN HUMAN ADENOVIRUS TYPE 40 |
| 100-134 |
| PE1BS-- AD841 E1B PROTEIN, SMALL T-ANTIGEN HUMAN ADENOVIRUS TYPE |
| 41 100-134 |
| PE1BS-- ADEM1 E1B PROTEIN, SMALL T-ANTIGEN MOUSE ADENOVIRUS TYPE |
| 1 119-173 |
| PE314-- ADE02 EARLY E3B 14 KD PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| 2-39 |
| PE314-- ADE03 EARLY E3 15.3 KD PROTEIN HUMAN ADENOVIRUS TYPE 3 |
| 8-49 |
| PE314-- ADE05 EARLY E3 14.5 KD PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| 2-39 |
| PE314-- ADE07 EARLY E3 15.3 KD PROTEIN HUMAN ADENOVIRUS TYPE 7 |
| 7-48 |
| PE320-- ADE35 EARLY E3 20.3 KD GLYCOPROTEIN HUMAN ADENOVIRUS TYPE |
| 35 |
| 70-107 |
| PE321-- ADE35 EARLY E3 20.6 KD GLYCOPROTEIN HUMAN ADENOVIRUS TYPE |
| 35 125-169 |
| PE411-- ADE02 PROBABLE EARLY E4 11 KD PROTEIN HUMAN ADENOVIRUS |
| TYPE 2 10-44 |
| PE411-- ADE05 PROBABLE EARLY E4 11 KD PROTEIN HUMAN ADENOVIRUS |
| TYPE 5 10-44 |
| PEAR-- EBV EARLY ANTIGEN PROTEIN R EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 123-157 |
| PEBN4-- EBV EBNA-4 NUCLEAR PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 487-521 |
| PEFT1-- VARV EARLY TRANSCRIPTION FACTOR VARIOLA VIRUS 23-71 |
| 307-34 |
| 70 KD SUBUNIT |
| PENV1-- |
| FRSFV ENV POLYPROTEIN PRECURSOR FRIEND SPLEEN FOCUS-FORMING VIRUS |
| 341-375 |
| PENV2-- |
| FRSFV ENV POLYPROTEIN PRECURSOR FRIEND SPLEEN FOCUS-FORMING VIRUS |
| 341-378 |
| PENV-- AVIRE ENV POLYPROTEIN AVIAN RETICULOENDOTHELIOSIS VIRUS |
| 420-472 |
| PENV-- AVISN ENV POLYPROTEIN AVIAN SPLEEN NECROSIS VIRUS 426-478 |
| PENV-- BAEVM ENV POLYPROTEIN BABOON ENDOGENOUS VIRUS (STRAIN M7) |
| 390-456 |
| PENV-- BIV06 ENV POLYPROTEIN PRECURSOR BOVINE IMMUNODEFICIENCY |
| VIRUS (ISOLATE 106) 10-44 |
| 88-122 221-255 530-610 635-691 PENV-- BIV27 ENV |
| POLYPROTEIN PRECURSOR BOVINE IMMUNODEFICIENCY VIRUS (ISOLATE 127) 10-44 |
| 88-122 159-193 250-284 559-639 664-724 |
| PENV-- BLVAF ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (AMERICAN |
| ISOLATE 304-379 |
| FLK) |
| PENV-- BLVAU ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (AUSTRALIAN |
| ISOLATE) 304-379 |
| FENV-- BLVAV ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (AMERICAN |
| 304-379 |
| ISOLATE VDM) |
| PENV-- BLVB2 ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (BELGIUM |
| ISOLATE 304-379 |
| LB285) |
| PENV-- BLVB5 ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (BELGIUM |
| ISOLATE 304-379 |
| LB59) |
| PENV-- BLVJ ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (JAPANESE |
| ISOLATE 304-379 |
| BLV-I) |
| PENV-- |
| CAEVC ENV POLYPROTEIN PRECURSOR CAPRINE ARTHRITIS ENCEPHALITIS VIRUS |
| 157-196 615-720 751-785 847-895 |
| (STRAIN CORK) |
| PENV-- |
| CAEVG ENV POLYPROTEIN PRECURSOR CAPRINE ARTHRITIS ENCEPHALITIS VIRUS |
| 154-193 613-718 749-783 845-893 |
| (STRAIN G63) |
| PENV-- EIAV1 ENV POLYPROTEIN PRECURSOR EQUINE INFECTIOUS ANEMIA |
| VIRUS (CLONE P3.2-1) 39-76 436-525 559-593 668-716 |
| PENV-- EIAV2 ENV POLYPROTEIN PRECURSOR EQUINE INFECTIOUS ANEMIA |
| VIRUS (CLONE P3.2-2) 39-76 436-525 559-593 658-692 |
| PENV-- EIAV3 ENV POLYPROTEIN PRECURSOR EQUINE INFECTIOUS ANEMIA |
| VIRUS (CLONE P3.2-3) 39-76 436-525 559-593 658-716 |
| PENV-- EIAV5 ENV POLYPROTEIN PRECURSOR EQUINE INFECTIOUS ANEMIA |
| VIRUS (CLONE P3.2-5) 38-76 437-526 560-594 659-693 |
| PENV-- EIAV9 ENY POLYPROTEIN PRECURSOR EQUINE INFECTIOUS ANEMIA |
| VIRUS (CLONE 1369) 39-76 436-525 559-593 658-716 |
| PENV-- EIAVC ENV POLYPROTEIN PRECURSOR EQUINE INFECTIOUS ANEMIA |
| VIRUS (CLONE CL22) 39-76 436-525 559-593 658-716 |
| PENV-- EIAVW ENV POLYPROTEIN PRECURSOR EQUINE INFECTIOUS ANEMIA |
| VIRUS (STRAIN WSU5) 39-76 436-525 559-593 658-716 |
| PENV-- EIAVY ENV POLYPROTEIN PRECURSOR EQUINE INFECTIOUS ANEMIA |
| VIRUS (ISOLATE 39-76 436-525 559-593 658-716 |
| WYOMING) |
| PENV-- FENV1 ENV POLYPROTEIN PRECURSOR FELINE ENDOGENOUS VIRUS |
| ECE I 503-555 567-604 |
| PENV-- |
| FIVPE ENVELOPE POLYPROTEIN PRECURSOR FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE 610-690 715-756 |
| PETALUMA) |
| PENV-- |
| FIVSD ENVELOPE POLYPROTEIN PRECURSOR FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE 601-688 713-754 |
| SAN DIEGO) |
| PENV-- |
| FIVT2 ENVELOPE POLYPROTEIN PRECURSOR FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE TM2) |
| 60-122 609-689 714-755 PENV-- |
| FLVC6 ENY POLYPROTEIN PRECURSOR FELINE LEUKEMIA PROVIRUS (CLONE CFE-6) |
| 497-549 561-595 |
| PENV-- FLVGL ENV POLYPROTEIN PRECURSOR FELINE LEUKEMIA VIRUS |
| (STRAIN A/GLASGOW-1) 478-530 542-576 |
| PENV-- FLVLB ENV POLYPROTEIN PRECURSOR FELINE LEUKEMIA VIRUS |
| (STRAIN LAMBDA-BI) 498-550 562-596 |
| PENV-- FLVSA ENV POLYPROTEIN PRECURSOR FELINE LEUKEMIA VIRUS |
| (STRAIN SARMA) 475-527 539-573 |
| PENV-- FOAMV ENV POLYPROTEIN HUMAN SPUMARETROVIRUS 1-41 154-205 |
| 321-355 563-693 866-903 |
| PENV-- FSVGA ENV POLYPROTEIN PRECURSOR FELINE SARCOMA VIRUS |
| (STRAIN 498-550 562-596 |
| GARDNER-ARNSTEIN) |
| PENV-- FSVGB ENV POLYPROTEIN PRECURSOR FELINE SARCOMA VIRUS |
| (STRAIN GA) 478-530 542-576 |
| PENV-- FSVSM ENV POLYPROTEIN PRECURSOR FELINE SARCOMA VIRUS |
| (STRAIN SM) 481-524 545-579 |
| PENY-- FSVST ENV POLYPROTEIN PRECURSOR FELINE SARCOMA VIRUS |
| (STRAIN SNYDER-THEILEN) 498-532 |
| PENV-- GALV ENV POLYPROTEIN PRECURSOR GIBBON APE LEUKEMIA VIRUS |
| 523-575 587-621 |
| PENV-- HTL1A ENV POLYPROTEIN HUMAN T CELL LEUKEMIA VIRUS TYPE I |
| 321-383 |
| (STRAIN ATK) |
| PENV-- HTLIC ENV POLYPROTEIN HUMAN T CELL LEUKEMIA VIRUS TYPE I |
| 316-383 |
| (CARIBBEAN ISOLATE) |
| PENV-- HTLIM ENV POLYPROTEIN HUMAN T CELL LEUKEMIA VIRUS TYPE I |
| 321-383 |
| (ISOLATE MT-2) |
| PENV-- HTLV2 ENV POLYPROTEIN PRECURSOR HUMAN T CELL LEUKEMIA |
| VIRUS TYPE II 317-377 |
| PENV-- HV1A2 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 497-593 612-711 766-845 |
| PRECURSOR (ARV2/SF2 ISOLATE |
| PENV-- HV1B1 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 505-594 610-712 767-843 |
| PRECURSOR (BH10 ISOLATE) |
| PENV-- HV1B8 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 500-589 605-703 762-838 |
| PRECURSOR (BH8 ISOLATE) |
| PENV-- HV1BN ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 331-365 501-590 609-708 763-831 |
| PRECURSOR(CONT (BRAIN ISOLATE) |
| PENV-- HV1BR ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 510-599 615-717 772-841 |
| PRECURSOR (BRU ISOLATE) |
| PENV-- HVIC4 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 342-376 510-606 626-724 779-855 |
| PRECURSOR (CDC-451 ISOLATE) |
| PENV-- HV1EL ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 255-296 502-591 607-709 768-829 |
| PRECURSOR (ELI ISOLATE) |
| PENV-- HV1H2 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 505-594 610-712 767-836 |
| PRECURSOR (HXB2 ISOLATE) |
| PENV-- HV1H3 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 505-594 610-712 767-843 |
| PRECURSOR (HXB3 ISOLATE) |
| PENV-- HV1J3 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 343-377 517-605 622-723 778-843 |
| PRECURSOR (JH3 ISOLATE) |
| PENV-- HV1JR ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE I 329-363 497-586 603-704 759-835 |
| PRECURSOR (JRCSF ISOLATE) |
| PENV-- HV1KB ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 88-122 338-372 511-545 555-599 618-677 681-718 772-848 |
| PRECURSOR (STRAIN KB-1-GP32) |
| PENV-- HV1MA ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 259-300 507-596 617-714 770-825 |
| PRECURSOR (MAL ISOLATE) |
| PENV-- HV1MF ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 503-592 622-710 765-841 |
| PRECURSOR (MFA ISOLATE) |
| PENV-- HV1MN ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 336-370 506-595 617-713 774-841 |
| PRECURSOR (MN ISOLATE) |
| FENV-- HV1N5 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 326-360 |
| PRECURSOR (NEW YORK-5 ISOL |
| PENV-- HV1ND ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 249-290 495-584 601-702 757-825 |
| PRECURSOR (NDK ISOLATE) |
| PENV-- HV1OY ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 336-370 497-593 610-711 766-842 |
| PRECURSOR (OYI ISOLATE) |
| PENV-- HV1PV ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 505-594 610-712 767-843 |
| PRECURSOR (PV22 ISOLATE) |
| PENV-- HV1RH ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 344-378 507-603 619-721 776-852 |
| PRECURSOR (RF/HAT ISOLATE) |
| PENV-- HV1S1 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 496-585 602-703 758-835 |
| PRECURSOR (SF162 ISOLATE) |
| PENV-- HV1S3 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 332-366 494-590 607-708 763-837 |
| PRECURSOR (SF33 ISOLATE) |
| PENV-- HV1SC ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 331-365 498-594 611-712 767-834 |
| PRECURSOR (SC ISOLATE) |
| PENV-- HV1W1 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 331-365 498-594 611-712 767-836 |
| PRECURSOR (WMJ1 ISOLATE) |
| PENV-- HV1W2 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 327-361 489-584 602-703 758-827 |
| PRECURSOR (WMJ2 ISOLATE) |
| PENV-- HV1Z2 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 255-296 502-591 610-709 764-831 |
| PRECURSOR (Z2/CDC-Z34 ISOLAT |
| PENV-- HV1Z3 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 251-292 |
| PRECURSOR (ZAIRE 3 ISOLATE) |
| PENV-- HV1Z6 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 256-297 504-593 609-711 766-840 |
| PRECURSOR (ZAIRE 6 ISOLATE) |
| PENV-- HV1Z8 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 266-307 512-601 617-675 682-719 774-831 |
| PRECURSOR (Z-84 ISOLATE) |
| PENV-- HV1ZH ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 522-594 612-671 675-712 777-839 |
| PRECURSOR (ZAIRE HZ321 ISOLA |
| PENV-- HV2BE ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 447-481 510-595 617-680 |
| PRECURSOR (ISOLATE BEN) |
| PENV-- HV2CA ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 512-597 619-709 |
| PRECURSOR (ISOLATE CAM2) |
| PENV-- HV2D1 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 501-586 608-698 |
| PRECURSOR (ISOLATE D194) |
| PENV-- HV2G1 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 439-473 502-587 609-699 |
| PRECURSOR (ISOLATE GHANA-1) |
| PENV-- HV2NZ ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 488-587 609-699 |
| PRECURSOR (ISOLATE NIH-Z) |
| PENV-- HV2RO ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 511-596 618-708 |
| PRECURSOR (ISOLATE ROD) |
| PENV-- HV2S2 ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 442-476 505-590 612-702 |
| PRECURSOR (ISOLATE ST/24.1C# |
| PENV-- HV2SB ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 526-588 614-700 |
| PRECURSOR (ISOLATE SBLISY) |
| PENV-- HV2ST ENVELOPE POLYPROTEIN GP160 HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 442-476 505-590 612-702 |
| PRECURSOR (ISOLATE ST) |
| PENV-- IPMAE ENV POLYPROTEIN PRECURSOR MOUSE INTRACISTERNAL |
| A-PARTICLE 367-422 465-527 |
| PENV-- |
| JSRV ENV POLYPROTEIN PRECURSOR SHEEP PULMONARY ADENOMATOSIS VIRUS |
| 403-455 571-605 |
| PENV-- MCFF ENV POLYPROTEIN PRECURSOR MINK CELL FOCUS-FORMING |
| MURINE LEUKEMIA 473-525 537-571 |
| VIRUS |
| PENV-- MCFF3 ENV POLYPROTEIN PRECURSOR MINK CELL FOCUS-FORMING |
| MURINE LEUKEMIA 474-526 538-572 |
| (COAT POLYPROTE VIRUS (ISOLA |
| PENV-- MLVAV ENV POLYPROTEIN PRECURSOR AKV MURINE LEUKEMIA VIRUS |
| 503-555 567-601 |
| PENV-- MLVCB ENV POLYPROTEIN PRECURSOR CAS-BR-E MURINE LEUKEMIA |
| VIRUS 498-550 562-596 |
| PENV-- MLVF5 ENV POLYPROTEIN PRECURSOR FRIEND MURINE LEUKEMIA |
| VIRUS (ISOLATE 57) 520-564 576-610 |
| PENV-- MLVFF ENV POLYPROTEIN PRECURSOR FRIEND MURINE LEUKEMIA |
| VIRUS (ISOLATE FB29) 520-564 576-610 |
| PENV-- MLVFP ENV POLYPROTEIN PRECURSOR FRIEND MURINE LEUKEMIA |
| VIRUS 520-564 576-610 |
| (ISOLATE PVC-211) |
| PENV-- MLVHO ENV POLYPROTEIN PRECURSOR HOMULV MURINE LEUKEMIA |
| VIRUS 504-551 563-597 |
| PENV-- MLVKI ENV POLYPROTEIN KIRSTEN MURINE LEUKEMIA VIRUS 40-92 |
| 104-138 |
| PENV-- MLVMO ENV POLYPROTEIN PRECURSOR MOLONEY MURINE LEUKEMIA |
| VIRUS 502-554 566-600 |
| PENV-- MLVRD ENV POLYPROTEIN PRECURSOR RADIATION MURINE LEUKEMIA |
| VIRUS 497-549 561-595 |
| PENV-- MLVRK ENV POLYPROTEIN PRECURSOR RADIATION MURINE LEUKEMIA |
| VIRUS 497-549 561-595 |
| (STRAIN KAPLAN) |
| PENV-- MMTVB ENV POLYPROTEIN MOUSE MAMMARY TUMOR VIRUS (STRAIN |
| BR6) 477-539 556-612 |
| PENV-- MMTVG ENV POLYPROTEIN MOUSE MAMMARY TUMOR VIRUS (STRAIN |
| GR) 477-539 556-612 |
| PENV-- MPMV ENV POLYPROTEIN SIMIAN MASON-PFIZER VIRUS 408-474 |
| PENV-- MSVFB ENV POLYPROTEIN FBJ MURINE OSTEOSARCOMA VIRUS |
| 43-95 107-141 |
| PENV-- OMVVS ENV POLYPROTEIN PRECURSOR OVINE LENTIVIRUS (STRAIN |
| SA-OMVV) 22-64 185-223 664-746 780-816 |
| PENV-- RMCFV ENV POLYPROTEIN PRECURSOR RAUSCHER MINK CELL |
| FOCUS-INDUCING VIRUS 484-528 540-574 |
| PENV-- |
| RSFFV ENV POLYPROTEIN PRECURSOR RAUSCHER SPLEEN FOCUS-FORMING VIRUS |
| 342-376 |
| PENV-- SFV1 ENV POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 1) 1-41 |
| 101-140 154-205 321-355 563-651 658-693 866-904 |
| PENV-- SFV3L ENV POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 3/STRAIN |
| LK3) |
| 5-46 158-209 319-357 560-706 863-901 |
| PENV-- SIVA ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (AGM155 269-310 551-623 643-693 |
| PRECURSOR ISOLATE) |
| PENV-- SIVAG ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (AGM3 556-628 651-699 808-852 |
| PRECURSOR ISOLATE) |
| PENV-- SIVAI ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (ISOLATE 257-291 336-370 535-607 627-684 792-840 |
| PRECURSOR AGM/CLONE GR1 |
| PENV-- SIVAT ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (TYO-1 264-298 549-621 644-692 796-833 |
| PRECURSOR ISOLATE) |
| PENV-- |
| SIVCZ ENVELOPE POLYPROTEIN GP160 CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| (SIV(CPZ)) 253-291 330-365 512-584 669-703 803-837 |
| PRECURSOR |
| PENV-- SIVGB ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (ISOLATE GB1) 566-654 677-725 |
| PRECURSOR |
| PENV-- SIVM1 ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (MM142-83 114-151 465-506 528-613 635-725 809-864 |
| PRECURSOR ISOLATE) |
| PENV-- SIVM2 ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (MM251 |
| 71-109 161-219 245-286 PRECURSOR |
| ISOLATE) |
| PENV-- SIVMK ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (K6W ISOLATE) 464-505 540.612 638-724 |
| PRECURSOR |
| PENV-- SIVML ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (K78 ISOLATE) 464-505 540-612 638-724 |
| PRECURSOR |
| PENV-- SIVS4 ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (F236/SMH4 466-509 517-606 638-728 812-853 |
| PRECURSOR ISOLATE) |
| PENV-- SIVSP ENVELOPE POLYPROTEIN GP160 SIMIAN IMMUNODEFICIENCY |
| VIRUS (PBJ/BC13 470-513 521-620 642-732 811-848 |
| PRECURSOR ISOLATE) |
| PENV-- SMRVH ENV POLYPROTEIN PRECURSOR SQUIRREL MONKEY RETROVIRUS |
| (SMRV-H) 400-466 |
| PENV-- SRV1 ENV POLYPROTEIN SIMIAN RETROVIRUS SRV-1 409-475 |
| PENV-- VILV ENV POLYPROTEIN PRECURSOR VISNA LENTIVIRUS |
| (STRAIN 1514) 21-62 184-222 637-740 773-809 |
| PENV-- VILV1 ENV POLYPROTEIN PRECURSOR VISNA LENTIVIRUS (STRAIN |
| 1514/CLONE LV1-1KS1) 21-62 184-222 643-746 780-816 |
| PENV-- VILV2 ENV POLYPROTEIN PRECURSOR VISNA LENTIVIRUS (STRAIN |
| 1414/CLONE LV1-1KS2) 21-62 184-222 645-748 782-818 |
| PERBA-- AVTER ERBA ONCOGENE PROTEIN AVIAN ERYTHROBLASTOSIS VIRUS |
| (STRAIN E54) 106-140 |
| PETF1-- FOWP1 EARLY TRANSCRIPTION FACTOR 70 FOWLPOX VIRUS (STRAIN |
| FP-1) 190-224 553-587 |
| KD SUBUNIT |
| PETF1-- SFVKA EARLY TRANSCRIPTION FACTOR 70 SHOPE FIBROMA VIRUS |
| (STRAIN KASZA) 37-71 267-340 550-587 |
| KD SUBUNIT |
| PETF1-- VACCC EARLY TRANSCRIPTION FACTOR 70 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 23-71 307-341 |
| KD SUBUNIT |
| PETF1-- VACCV EARLY TRANSCRIPTION FACTOR 70 VACCINIA VIRUS |
| (STRAIN WR) 23-71 307-341 |
| KD SUBUNIT |
| PETF2-- VACCC EARLY TRANSCRIPTION FACTOR 70 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 52-97 174-208 |
| KD SUBUNIT |
| PETF2-- VARV EARLY TRANSCRIPTION FACTOR 70 VARIOLA VIRUS 52-97 |
| 174-208 |
| KD SUBUNIT |
| PEXON-- HCMVA ALKALINE EXONUCLEASE HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| 80-114 |
| PEXON-- HSVEB ALKALINE EXONUCLEASE EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| 89-141 PEXON-- |
| PRVN3 ALKALINE EXONUCLEASE PSEUDORABIES VIRUS (STRAIN NIA-3) 82-120 |
| PEXON-- VZVD ALKALINE EXONUCLEASE VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 109-157 342-383 |
| PFIB2-- ADE40 41.4 KD FIBER PROTEIN HUMAN ADENOVIRUS TYPE 40 |
| 182-237 |
| PFIB2-- ADE41 41.4 KD FIBER PROTEIN HUMAN ADENOVIRUS TYPE 41 |
| 182-223 |
| PFIBP-- ADE03 FIBER PROTEIN HUMAN ADENOVIRUS TYPE 3 156-194 |
| PFIBP-- ADE07 FIBER PROTEIN HUMAN ADENOVIRUS TYPE 7 176-210 |
| PFIBP-- ADE40 FIBER PROTEIN HUMAN ADENOVIRUS TYPE 40 303-352 |
| PFIBP-- ADE41 FIBER PROTEIN HUMAN ADENOVIRUS TYPE 41 320-366 |
| PFIBP-- ADEB3 FIBER PROTEIN BOVINE ADENOVIRUS TYPE 3 181-215 |
| 585-626 |
| PFOSX-- |
| MSVFR V-FOX/FOX TRANSFORMING PROTEIN FBR MURINE OSTEOSARCOMA VIRUS |
| 131-169 |
| PFOS-- AVINK P55-V-POS TRANSFORMING PROTEIN AVIAN RETROVIRUS NK24 |
| 109-152 |
| PFOS-- |
| MSVFB P55-V-FOS TRANSFORMING PROTEIN FBJ MURINE OSTEOSARCOMA VIRUS |
| 155-193 |
| PGAGC-- AVISC P47(GAG-CRK) PROTEIN AVIAN SARCOMA VIRUS (STRAIN |
| CT10) |
| 57-101 |
| PGAG-- AVEV1 GAG POLYPROTEIN AVIAN ENDOGENOUS VIRUS EV-1 57-94 |
| PGAG-- AVEV2 GAG POLYPROTEIN AVIAN ENDOGENOUS ROUS-ASSOCIATED |
| VIRUS-0 |
| 6-43 PGAG |
| -- AVIMC GAG POLYPROTEIN AVIAN MYELOCYTOMATOSIS VIRUS MC29 57-94 |
| PGAG-- AVIMD GAG POLYPROTEIN AVAIN MYELOCYTOMATOSIS VIRUS |
| HBI 57-94 |
| PGAG-- AVISU CORE PROTEIN P19 AVIAN SARCOMA VIRUS (STRAIN UR2) |
| 57-94 |
| PGAG-- AVISY GAG POLYPROTEIN (P53) AVAIN SARCOMA VIRUS (STRAIN |
| Y73) 57-94 |
| PGAG-- BIV06 GAG POLYPROTEIN BOVINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE 106) |
| 1-41 PGAG-- |
| EIAVY GAG POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE CL22) |
| 61-118 |
| PGAG-- FTVPE GAG POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| 76-110 |
| (ISOLATE PETALUMA) |
| PGAG-- FTVSD GAG POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| 76-110 |
| (ISOLATE SAN DIEGO) |
| PGAG-- FIVT2 GAG POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE TM2) |
| 76-110 PGAG-- |
| FLV GAG POLYPROTEIN FELINE LEUKEMIA VIRUS 496-537 |
| PGAG-- FOAMV GAG POLYPROTEIN HUMAN SPUMARETROVIRUS 130-186 |
| 391-425 439-480 607-655 |
| PGAG-- FSVMD GAG POLYPROTEIN FELINE SARCOMA VIRUS (STRAIN |
| MCDONOUGH) 499-534 |
| PGAG-- FUJSV GAG POLYPROTEIN FUJINAMI SARCOMA VIRUS 57-94 |
| PGAG-- GALVI GAG POLYPROTEIN GIBBON APE LEUKEMIA VIRUS 393-444 |
| PGAG-- HV1A2 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE |
| 1 |
| 87-133 294-328 |
| (ARV2/SF2 ISOLATE |
| PGAG-- HV1B1 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 90-131 292-326 |
| (BH10 ISOLATE) |
| PGAG-- HHV1B5 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 90-131 292-326 |
| (BH5 ISOLATE) |
| PGAG-- HV1BR GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 99-131 292-326 |
| (BRU ISOLATE) |
| PGAG-- HV1C4 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 90-131 292-326 |
| (CDC-451 ISOLATE) |
| PGAG-- HV1EL GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 93-131 292-326 |
| (ELI ISOLATE) |
| PGAG-- HV1H2 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 90-131 292-326 |
| (HXB2 ISOLATE) |
| PGAG-- HV1J3 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 87-131 292-326 |
| (JH3 ISOLATE) |
| PGAG-- HVIJR GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 87-131 292-326 |
| (JRCSF ISOLATE) |
| PGAG-- HV1MA GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 93-137 |
| (MAL ISOLATE) |
| PGAG-- HV1MN GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 87-134 295-329 |
| (MN ISOLATE) |
| PGAG-- HV1N5 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 90-131 292-326 |
| (NEW YORK-5 ISOL |
| PGAG-- HV1ND GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 87-128 289-323 |
| (NDK ISOLATE) |
| PGAG-- HV1OY GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 90-131 292-326 |
| (OYI ISOLATE) |
| PGAG-- HV1PV GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 90-131 292-326 |
| (PV22 ISOLATE) |
| PGAG-- HV1RH GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 90-131 292-326 |
| (RF/HAT ISOLATE) |
| PGAG-- HV1U4 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 87-127 |
| (STRAIN UGANDAN |
| PGAG-- HV1W2 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 292-326 |
| (WMJ2 ISOLATE) |
| PGAG-- HV1Z2 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 87-132 293-327 |
| (Z2/CDC-Z34 ISOLAT |
| PGAG-- HV2SB GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 292-326 |
| (ISOLATE SBLISY) |
| PGAG-- IPHA RETROVIRUS-RELATED GAG HAMSTER INTRACISTERNAL |
| A-PARTICLE |
| 93-127 320-357 POLYPROTE |
| IN |
| PGAG-- |
| IPMA RETROVIRUS-RELATED GAG MOUSE INTRACISTERNAL A-PARTICLE 67-103 |
| POLYPROTEIN |
| PGAG-- |
| IPMAE RETROVIRUS-RELATED GAG MOUSE INTRACISTERNAL A-PARTICLE 89-133 |
| 138-172 |
| POLYPROTEIN |
| PGAG-- JSRV GAG POLYPROTEIN SHEEP PULMONARY ADENOMATOSIS VIRUS |
| 470-504 |
| PGAG-- MMTVB GAG POLYPROTEIN MOUSE MAMMARY TUMOR VIRUS (STRAIN |
| BR6) |
| 83-151 156-190 |
| PGAG-- MMTVG GAG POLYPROTEIN MOUSE MAMMARY TUMOR VIRUS (STRAIN GR) |
| 83-151 156-199 |
| PGAG-- MPMV GAG POLYPROTEIN SIMIAN MASON-PFIZER VIRUS 222-260 |
| PGAG-- RSVP GAG POLYPROTEIN ROUS SARCOMA VIRUS (STRAIN PRAGUE |
| C) 57-94 |
| PGAG-- SCVLA MAJOR COAT PROTEIN SACCHAROMYCES CEREVISIAE VIRUS |
| L-A (SCV-L-A) 102-139 490-531 |
| PGAG-- SPV1 GAG POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 1) 128-177 |
| 378-416 583-634 |
| PGAG-- SFV3L GAG POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 3/STRAIN |
| LK3) 373-407 435-522 591-632 |
| PGAG-- SIVA1 GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (AGM155 302-336 |
| ISOLATE) |
| PGAG-- SIVAG GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (AGM3 |
| 306-340 |
| ISOLATE) |
| PGAG-- SIVAI GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (ISOLATE 183-217 473-507 |
| AGM/CLONE GR |
| PGAG-- SIVAT GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (TYO-1 |
| 302-336 |
| ISOLATE) |
| PGAG-- SIVCZ GAG POLYPROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| (SIV(CPZ)) 301-335 |
| PGAG-- SIVGB GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (ISOLATE GB1) 163-204 223-267 283-317 |
| PGAG-- SMSAV GAG POLYPROTEIN SIMIAN SARCOMA VIRUS 394-431 |
| PHELI-- HSV11 PROBABLE HELICASE HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 172-206 769-820 |
| PHELI-- HSV2H PROBABLE HELICASE HERPES SIMPLEX VIRUS (TYPE |
| 2/STRAIN HG52) 468-502 670-721 |
| PHELI-- HSVSA PROBABLE HELICASE HERPES VIRUS SAIMIRI (STRAIN 11) |
| 158-203 413-449 599-633 |
| PHELI-- VZVD PROBABLE HELICASE VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 445-517 782-821 |
| PHEMA-- CVBF HEMAGGLUTITIN-ESTERASE BOVINE CORONAVIRUS (STRAIN |
| F15) 208-242 |
| PRECURSOR |
| PHEMA-- CVBLY HEMAGGLUTININ-ESTERASE BOVINE CORONAVIRUS (STRAIN |
| LY-138) 208-242 |
| PRECURSOR |
| PHEMA-- CVBM HEMAGGLUTININ-ESTERASE BOVINE CORONAVIRUS (STRAIN |
| MEBUS) 208-242 |
| PRECURSOR |
| PHEMA-- CVBQ HEMAGGLUTININ-ESTERASE BOVINE CORONAVIRUS (STRAIN |
| QUEBEC), 208-242 |
| PRECURSOR |
| PHEMA-- CVHOC HEMAGGLUTININ-ESTERASE HUMAN CORONAVIRUS (STRAIN |
| OC43) 208-242 |
| PRECURSOR |
| PHEMA-- IAAIC HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/A1CH1/2/68) 380-456 |
| PHEMA-- IABAN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/BANGKOK/1/79) 364-440 |
| PHEMA-- IABUD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/BUDGERIGAR/ 378-454 |
| HOKKAIDO/1/77) |
| PHEMA-- IACKA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ 378-454 |
| ALABAMA/1/175) |
| PHEMA-- IACKG HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ 108-142 375-475 494-528 |
| GERMANY/N/49) |
| PHEMA-- IACKP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ 360-452 487-532 |
| PENNSYLVANIA/1/83) |
| PHEMA-- IACKQ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ 360-452 487-532 |
| PENNSYLVANIA/1370/ |
| PHEMA-- IACKS HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ 377-469 504-549 |
| SCOTLAND/59) |
| PHEMA-- IACKV HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ 112-146 377-469 |
| VICTORIA/1/185) |
| PHEMA-- IADA1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 378-454 |
| ALBERTA/28/76) |
| PHEMA-- IADA2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 377-476 495-547 |
| ALBERTA/60/76) |
| PHEMA-- IADA3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 380-453 |
| ALBERTA/78/76) |
| PHEMA-- IADA4 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 379-478 506-548 |
| ALBERTA/35/76) |
| PHEMA-- IADCZ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/(DUCK/ 378-454 |
| CZECHOSLOVAKIA/56) |
| PHEMA-- IADEI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 21-55 377-472 |
| ENGLAND/1/56) |
| PHEMA-- IADH1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 364-440 |
| HOKKAIDO/5/77) |
| PHEMA-- IADH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 364-440 |
| HOKKAIDO/8/80) |
| PHEMA-- IADH3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 364-440 |
| HOKKAIDO/33/80) |
| PHEMA-- IADH4 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 364-440 |
| HOKKAIDO/7/82) |
| PHEMA-- IADH5 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 364-440 |
| HOKKAIDO/21/82) |
| PHEMA-- IADH6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 364-440 |
| HOKKAIDO/9/85) |
| PHEMA-- IADH7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 364-440 |
| HOKKAIDO/10/85) |
| PHEMA-- IADIR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 379-471 506-551 |
| IRELAND/113/83) |
| PHEMA-- IADM1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 21-55 |
| MEMPHIS/546/76 |
| PHEMA-- IADM2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 380-456 |
| MEMPHIS/928/74) |
| PHEMA-- IADNY HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 21-55 |
| NEW YORK/12/78) |
| PHEMA-- IADNZ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 378-454 |
| NEW ZEALAND/31/76) |
| PHEMA-- IADU1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 21-55 |
| UKRAINE/1/60) |
| PHEMA-- IADU3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 380-456 |
| UKRAINE/1/63) |
| PHEMA-- IAEN7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ENGLAND/321/77 380-456 |
| PHEMA-- IAFPR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/FOWL PLAGUE 377-477 |
| VIRUS/ROSTOCK |
| PHEMA-- IAGRE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/GREY TEAL/ 378-454 |
| AUSTRALIA/2/79 |
| PHEMA-- IAGU2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/GULL/ 378-473 |
| MARYLAND/704/77) |
| PHEMA-- IAGUA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/GULL/ASTRAKHAN/ 377-476 |
| 227/84) |
| PHEMA-- IAHAL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ALGIERS/72) 379-455 |
| PHEMA-- IAHC6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 112-146 360-484 503-537 |
| CAMBRIDGE/1/63) |
| PHEMA-- IAHC7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 112-146 360-484 503-537 |
| CAMBRIDGE/1/73) |
| PHEMA-- IAHCD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 360-484 503-537 |
| C. DETROIT/1/64) |
| PHEMA-- IANDE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/DETROIT/ 360-484 503-537 |
| 1/64) |
| PHEMA-- IAHFO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 379-455 |
| FONTAINEBLEAU/76) |
| PHEMA-- IAHK6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 379-455 |
| KENTUCKY/2/86) |
| PHEMA-- IAHK7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/KENTUCKY/ 379-455 |
| 1/87) |
| PHEMA-- IAHLE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 112-146 360-484 503-537 |
| LEXINGTON/1/66) |
| PHEMA-- IAHLO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/LONDON/ 112-146 360-484 503-537 |
| 1416/73) |
| PHEMA-- IAHMI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/MIAMI/ 379-455 |
| 1/63 |
| PHEMA-- IAHNM HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/NEW 379-455 |
| MARKET/76) |
| PHEMA-- IAHNN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/NEW 112-146 360-484 503-537 |
| MARKET/1/77) |
| PHEMA-- IAHPR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 112-146 360-484 503-537 |
| PRAGUE/1/56) |
| PHEMA-- IAHRO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 379-455 |
| ROMANIA/80) |
| PHEMA-- IAHSA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 379-455 |
| SANTIAGO/1/85) |
| PHEMA-- IAHSP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 112-146 360-484 503-537 |
| SAO PAULO/1/76) |
| PHEMA-- IAHSW HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 112-146 360-484 503-537 |
| SWITZERLAND/137/72) |
| PHEMA-- IAHTE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 379-455 |
| TENNESSEE/5/86) |
| PHEMA-- IAHTO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 379-455 |
| TOKYO/71) |
| PHEMA-- IAHUR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 379-455 |
| URUGUAY/1/63) |
| PHEMA-- IAJAP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/JAPAN/305/57 375-467 502-547 |
| PHEMA-- IAKIE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/KIEV/59/79) 376-478 506-541 |
| PHEMA-- IALEN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/54/1) 376-478 506-548 |
| PHEMA-- IAMAA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 377-453 |
| ASTRAKHAN/244/82) |
| PHEMA-- IAMAB HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 382-458 |
| ASTRAKHAN/263/82) |
| PHEMA-- IAMAO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 380-456 |
| NEW YORK/6874/78) |
| PHEMA-- IAME1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MEMPHIS/1/71) 380-456 |
| PHEMA-- IAME2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MEMPHIS/102/72) 380-456 |
| PHEMA-- IAME6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MEMPHIS/6/86) 364-440 |
| PHEMA-- IAMTN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MINK/SWEDEN/84) 108-142 375-475 |
| PHEMA-- IANT6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/NT/60/68) 389-456 |
| PHEMA-- IAPIL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/PILOT WHALE/ 378-477 496-534 |
| MAINE/328/84) |
| PHEMA-- IAPUE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/PUERTO RICO/8/34) 376-478 506-548 |
| PHEMA-- IARUD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/RUDDY 376-454 |
| TURNSTONE/NEW JERSE |
| PHEMA-- IASE2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SEAL/ 378-454 |
| MASSACHUSETTS/133/82) |
| PHEMA-- IASH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SHEARWATER/ 379-474 506-552 |
| AUSTRALIA/72) |
| PHEMA-- IASTA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/STARLING/ 112-146 377-469 |
| VICTORIA/5156/85) |
| PHEMA-- IATKI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/IRELAND/ 379-471 506-551 |
| 1378/83) |
| PHEMA-- IATKM HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 378-454 |
| MINNESOTA/833/60 |
| PHEMA-- IATKO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ONTARIO/ 392-470 504-548 |
| 7732/66) |
| PHEMA-- IATKP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ONTARIO/ 378-454 493-540 |
| 6118/68) |
| PHEMA-- IATKR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/OREGON/ 30-64 374-474 |
| 71) |
| PHEMA-- IATKW HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 373-472 487-539 |
| WISCONSIN/1/66) |
| PHEMA-- IATRA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TERN/AUSTRALIA/ 21-55 |
| G70C/75) |
| PHEMA-- IAUDO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/UDORN/ 387-456 |
| 307/72) |
| PHEMA-- IAUSS HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/USSR/ 376-478 506-548 |
| 90/77 |
| PHEMA-- IAVI7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/VICTORIA/3/75) 381-457 |
| PHEMA-- IAWIL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/WILSON-SMITH/33) 375-477 505-547 |
| PHEMA-- IAZCO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/ 380-456 |
| COLORADO/1/77) |
| PHEMA-- IAZH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/HONG 364-440 |
| KONG/81/78) |
| PHEMA-- IAZH3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/HONG 364-440 |
| KONG/126/82) |
| PHEMA-- IAZIN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/ 379-478 506-548 |
| INDIANA/1726/88) |
| PHEMA-- IAZNJ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/ 379-478 506-547 |
| NEW JERSEY/11/76) |
| PHEMA-- IAZUK HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/ 380-456 |
| UKKEL/1/84 |
| PHEMA-- INBBE HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/BEIJING/1/87 388-473 |
| PHEMA-- INBBO HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/BONN/43) 378-463 |
| PHEMA-- INBEN HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/ENGLAND/222/82) 396-471 |
| PHEMA-- INBHK HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/HONG KONG/8/73) 381-463 |
| PHEMA-- INBLE HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/LEE/40) 387-472 |
| PHEMA-- INBMD HEMAGGLUTITIN PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/MARYLAND/59) 377-462 |
| PHEMA-- INBME HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/MEMPHIS/6/86) 381-468 |
| PHEMA-- INBOR HEMAGGLUTITIN PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/OREGON/5/80) 386-471 |
| PHEMA-- INBSI HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/SINGAPORE/222/79) 386-471 |
| PHEMA-- INBUS HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/USSR/100/83) 379-464 |
| PHEMA-- INBVI HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/VICTORIA/3/85) 381-466 |
| PHEMA-- INBVK HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/VICTORIA/2/87) 388-473 |
| PHEMA-- INCCA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/CALIFORNIA/78) 483-571 |
| PHEMA-- INCEN HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/ENGLAND/892/63) 471-559 |
| PHEMA-- INCGL HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/GREAT 471-559 |
| LAKES/1167/54) |
| PHEMA-- |
| INCHY HEMAGGLUTININ INFLUENZA C VIRUS (STRAIN C/HYOGO/1/83) 470-558 |
| PHEMA-- INCJH HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS |
| (STRAIN C/ 484-572 |
| JOHANNESBURG/1/166) |
| PHEMA-- |
| INCKY HEMAGGLUTININ INFLUENZA C VIRUS (STRAIN C/KYOTO/41/82) 470-558 |
| PHEMA-- INCMI HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/MISSISSIPPI/80) 470-558 |
| PHEMA-- INCNA HEMAGGLUTININ INFLUENZA C VIRUS (STRAIN C/NARA/82) |
| 470-558 |
| PHEMA-- INCP1 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/PIG/BEIJING/10/81) 471-559 |
| PHEMA-- INCP2 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/PIG/BEIJING/115/81) 471-559 |
| PHEMA-- INCP3 MEASLES VIRUS (STRAIN HALLE) INFLUENZA C VIRUS |
| (STRAIN C/PIG/BEIJING/439/82) 471-559 |
| PHEMA-- INCTA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/TAYLOR/1233/147 471-559 |
| PHEMA-- INCYA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/YAMAGATA/10/81) 471-559 |
| PHEMA-- MEASE HEMAGGLUTININ-NEURAMINIDASE MEASLES VIRUS (STRAIN |
| EDMONSTON) 46-90 |
| PHEMA-- MEASH HEMAGGLUTININ-NEURAMINIDASE MEASLES VIRUS (STRAIN |
| HALLE) 46-90 |
| PHEMA-- MEASI HEMAGGLUTININ-NEURAMINIDASE MEASLES VIRUS (STRAIN |
| IP-3-CA) 46-87 |
| PHEMA-- MEASY HEMAGGLUTININ-NEURAMINIDASE MEASLES VIRUS (STRAIN |
| YAMAGATA-1) 46-87 |
| PHEMA-- MUMPI HEMAGGLUTININ-NEURAMINIDASE MUMPS VIRUS (STRAIN |
| SBL-1 34-99 |
| PHEMA-- MUMPM HEMAGGLUTININ-NEURAMINIDASE MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) 34-99 |
| PHEMA-- MUMPR HEMAGGLUTININ-NEURAMINIDASE MUMPS VIRUS (STRAIN RW) |
| 34-99 |
| PHEMA-- MUMPS HEMAGGLUTININ-NEURAMINIDASE MUMPS VIRUS (STRAIN |
| SBL) 34-99 |
| PHEMA-- NDVA HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN AUSTRALIA- |
| 8-52 477-529 VICTORIA/32) |
| PHEMA-- NDVB HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE |
| VIRUS (STRAIN BEAUDETTE |
| 1-49 C/45) |
| PHEMA-- NDVD HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN D26/76) |
| 1-52 PHEMA-- |
| NDVM HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS (STRAIN |
| MIYADERA/51) |
| 1-52 PHEMA-- |
| NDVQ HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS (STRAIN 1-52 |
| QUEENSLAND/66) |
| PHEMA-- NDVTG HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN TEXAS G.B./48) |
| 1-49 PHEMA-- NDVU |
| HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS (STRAIN ULSTER/67) |
| 1-52 |
| PHEMA-- PHODV HEMAGGLUTININ-NEURAMINIDASE PHOCINE DISTEMPER VIRUS |
| 39-73 |
| PHEMA-- PI1HW HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN |
| 66-110 WASHINGTON/ |
| 1957) |
| PHEMA-- PI2H HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 2 |
| VIRUS 247-281 |
| PHEMA-- PI2HT HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN 247-281 |
| TOSHIBA) |
| PHEMA-- PI3B HEMAGGLUTININ-NEURAMINIDASE BOVINE PARAINFLUENZA 3 |
| VIRUS 38-93 |
| PHEMA-- PI3H4 HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN NIH |
| 13-110 394-428 47585) |
| PHEMA-- |
| PI3HA HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 VIRUS (STRAIN |
| 20-110 394-428 |
| AUS/124854/74) |
| PHEMA-- PI3HT HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN |
| 13-110 394-425 TEX/545/80) |
| PHEMA-- PI3HU HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN |
| 13-110 394-428 TEX/9305/82 |
| ) |
| PHEMA-- PI3HV HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN |
| 13-110 394-428 TEX/12677/8 |
| 3) |
| PHEMA-- PI3HW HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN |
| 13-110 394-428 WASH/641/79 |
| ) |
| PHEMA-- PI3HX HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN WASH/ |
| 13-110 394-428 1511/73) |
| PHEMA-- |
| PI4HA HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 4A VIRUS (STRAIN |
| 54-85 |
| TOSHIBA) |
| PHEMA-- RACVI HEMAGGLUTININ PRECURSOR RACCOON POXVIRUS 166-214 |
| 256-290 |
| PHEMA-- RINDK HEMAGGLUTININ-NEURAMINIDASE RINDERPEST VIRUS |
| (STRAIN KABETE O) 46-87 |
| PHEMA-- RINDL HEMAGGLUTININ-NEURAMINIDASE RINDERPEST VIRUS |
| (STRAIN L) 46-87 191-225 |
| PHEMA-- SEND5 HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) |
| 57-110 PHEMA-- |
| SENDF HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN FUSHIMI) 57-110 |
| PHEMA-- SENDH HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN |
| HARRIS) |
| 57-110 |
| PHEMA-- SENDJ HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN HVJ) |
| 57-110 |
| PHEMA-- SENDZ HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN Z) |
| 57-110 |
| PHI(MA-- SV41 HEMAGGLUTININ-NEURAMINIDASE SIMIAN VIRUS 41 18-52 |
| 387-421 |
| PHEMA-- SV5 HEMAGGLUTININ-NEURAMINIDASE SIMIAN VIRUS 5 (STRAIN |
| W3) 27-82 |
| PHEMA-- SV5LN HEMAGGLUTININ-NEURAMINIDASE SIMIAN VIRUS 5 (ISOLATE |
| HUMAN/LN) 27-82 |
| PHEMA-- VARV HEMAGGLUTININ PRECURSOR VARIOLA VIRUS 177-211 |
| PEMX3-- |
| ADE02 PERIPENTONAL HEXON-ASSOCIATED HUMAN ADENOVIRUS TYPE 2 90-134 |
| PROTEIN |
| PEMX3-- ADE05 PERIPENTONAL HEXON-ASSOCIATED HUMAN ADENOVIRUS TYPE |
| 5 |
| 90-134 |
| PROTEIN |
| PHEX9-- ADE02 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| 85-134 |
| PHEX9-- ADE05 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| 85-134 |
| PHEX9-- ADE07 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 7, |
| AND HUMAN |
| 93-138 |
| ADENOVIRUS TYPE |
| PHEX9-- ADE12 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 12 |
| 88-137 |
| PHEX9-- ADE41 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 41 |
| 67-126 |
| PHEX9-- ADEC2 HEXON-ASSOCIATED PROTEIN CANINE ADENOVIRUS TYPE 2 |
| 53-103 |
| PHEX9-- -- ADENT HEXON-ASSOCIATED PROTEIN TUPAIA ADENOVIRUS |
| 61-109 |
| PHEX-- ADE02 HEXON PROTEIN HUMAN ADENOVIRUS TYPE 2 341-386 |
| 433-467 583-624 |
| PHEX-- ADE05 HEXON PROTEIN HUMAN ADENOVIRUS TYPE 5 330-379 |
| PHEX-- ADE40 HEXON PROTEIN HUMAN ADENOVIRUS TYPE 40 303-352 |
| 408-449 553-587 |
| PHEX-- ADE41 HEXON PROTEIN HUMAN ADENOVIRUS TYPE 41 306-355 |
| 555-589 |
| PHEX-- ADEB3 HEXON PROTEIN BOVINE ADENOVIRUS TYPE 3 301-346 |
| 385-419 544-578 705-739 |
| PHRG-- COWPX HOST RANGE PROTEIN COWPOX VIRUS 320-395 455-469 |
| PI226-- ASFB7 LATE PROTEIN 1226R AFRICAN SWINE FEVER VIRUS |
| (STRAIN BA71V) 110-151 |
| PIBMP-- CAMV4 INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN D4) |
| 3-44 371-419 PIBMP-- |
| CAMVB INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| BARI 1) 379-420 |
| PIBMP-- CAMVC INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN CM-1841) |
| 3-37 378-419 PIBMP-- CAMVD |
| INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN D/H) |
| 3-44 379-419 |
| PIBMP-- CAMVE INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN BBC) |
| 3-37 371-419 PIBMP-- |
| CAMVJ INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| S-JAPAN) |
| 3-37 378-419 |
| PIBMP-- CAMVN INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN NY8153) |
| 3-37 378-419 PIBMP-- CAMVP |
| INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN PV147) |
| 3-37 374-419 |
| PIBMP-- CAMVS INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN |
| 3-37 378-419 STRASBOURG) |
| PIBMP-- CERV INCLUSION BODY MATRIX PROTEIN CARNATION ETCHED RING |
| VIRUS |
| 3-37 |
| PIBMP-- FMVD INCLUSION BODY MATRIX PROTEIN FIGWORT MOSAIC VIRUS |
| (STRAIN DXS) |
| 1-51 372-406 PIBMP-- |
| SOCMV INCLUSION BODY MATRIX PROTEIN |
| 1-48 132-179 PIC18-HCMVA PROBABLE PROCESSING AND |
| HUMAN CYTOMEGALOVIRUS (STRAIN AD169) 53-98 290-324 498-132 |
| TRANSPORT PROTEIN |
| PIC18-- HSV11 PROCESSING AND TRANSPORT HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 331-365 |
| PROTEIN |
| PIC18-- HSV1A PROCESSING AND TRANSPORT HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 331-365 |
| PROTEIN ANGELOTTI) |
| PIC18-- HSV1F PROCESSING AND TRANSPORT HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN F) 324-362 |
| PROTEIN |
| PIC18-- HSVE2 PROBABLE PROCESSING AND BOVINE HERPES VIRUS TYPE 2 |
| (STRAIN BMV) 466-500 |
| TRANSPORT PROTEIN |
| PIC18-- HSVEB PROBABLE PROCESSING AND HERPES VIRUS TYPE 1 |
| (ISOLATE HVS25A) 341-375 |
| TRANSPORT PROTEIN |
| PIC18-- HSVSA PROBABLE PROCESSING AND HERPES VIRUS SAIMIRI |
| (STRAIN 11) 58-99 361-395 |
| TRANSPORT PROTEIN |
| PIC18-- MCMVS PROBABLE PROCESSING AND MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) |
| 60-112 290-340 647-691 TRANSPORT |
| PROTEIN |
| PIC18-- PRVIF PROBABLE PROCESSING AND PSEUDORABIES VIRUS (STRAIN |
| INDIANA- 299-333 303-337 |
| TRANSPORT PROTEIN FUNCKHAUSER/BECKE |
| PIC18-- HSVBJ TRANS-ACTING TRANSCRIPTIONAL BOVINE HERPES VIRUS |
| TYPE 1 (STRAIN JURA) 190-224 |
| PROTEIN ICP0 |
| P8CP0-- HSVBK TRANS-ACTING TRANSCRIPTIONAL BOVINE HERPES VIRUS |
| TYPE 1 (STRAIN K22) 190-224 |
| PROTEIN ICP0 |
| PICP4-- HSVMG TRANS-ACTING TRANSCRIPTIONAL MAREK'S DISEASE HERPES |
| VIRUS (STRAIN GA) 1022- |
| ACTIVATOR PR 1056 |
| PICP4-- VZVD TRANS-ACTING TRANSCRIPTIONAL VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 920-954 |
| PROTEIN ICP4 |
| PIE63-- HCMVA TRANSCRIPTIONAL REGULATOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 207-241 |
| IE63 HOMOLOG |
| PIE63-- HSV11 TRANSCRIPTIONAL REGULATOR IE63 HERPES SIMPLEX VIRUS |
| (TYPE 1/STRAIN 17) 241-275 |
| PIE63-- HSVEB TRANSCRIPTIONAL REGULATOR IE63 EQUINE HERPES VIRUS |
| TYPE 1 (STRAIN AB4P) 282-316 |
| HOMOLOG |
| PIE63-- VZVD TRANSCRIPTIONAL REGULATOR IE63 VARICELLA-ZOSTER |
| VIRUS (STRAIN DUMAS) 195-229 258-306 |
| HOMOLOG |
| PIE68-- HSVE4 IMMEDIATE-EARLY PROTEIN IE68 EQUINE HERPES VIRUS |
| TYPE 4 (STRAIN 1942) |
| 87-121 PIE68-HSVEB |
| IMMEDIATE-EARLY PROTEIN IE68 EQUINE HERPES VIRUS TYPE 1 (STRAIN AB4P) |
| 99-133 |
| PIE68-- HSVSA IMMEDIATE-EARLY PROTEIN HERPES VIRUS SAIMIRI |
| (STRAIN 11) 48-85 |
| PIR05-- HCMVA HYPOTHETICAL PROTEIN IRL5 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 13-47 |
| PIR12-- HCMVA HYPOTHETICAL PROTEIN IRL12 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 74-162 PKABL-- |
| FSVHY TYROSINE-PROTEIN KINASE FELINE SARCOMA VIRUS (STRAIN HARDY- |
| 280-314 |
| TRANSFORMING PROT ZUCKERMAN 2) |
| PKABL-- MLVAB TYROSINE-PROTEIN KINASE ABELSON MURINE LEUKEMIA |
| VIRUS 217-251 |
| TRANSFORMING PROT |
| PKAKT-- MLVAT AKT KINASE TRANSFORMING ART8 MURINE LEUKEMIA VIRUS |
| 172-227 263-384 |
| PROTEIN |
| PKFES-- FSVGA TYROSINE-PROTEIN KINASE FELINE SARCOMA VIRUS |
| (STRAIN 23-64 104-178 |
| TRANSFORMING PROT GARDNER-ARNSTEIN) |
| PKFGR-- FSVGR TYROSINE-PROTEIN KINASE FELINE SARCOMA VIRUS |
| (STRAIN 218-252 |
| TRANSFORMING PROT GARDNER-RASHEED) |
| PKFMS-- FSVMD FMS TYROSINE KINASE FELINE SARCOMA VIRUS (STRAIN |
| MCDONOUGH) 313-362 638-679 812-849 |
| TRANSFORMING PROTEIN |
| PKFPS-- AVISP TYROSINE-PROTEIN KINASE AVIAN SARCOMA VIRUS (STRAIN |
| PRCII) 65-99 |
| TRANSFORMING PROT |
| PKFPS-- FUJSV TYROSINE-PROTEIN KINASE FUJINAMI SARCOMA VIRUS |
| 65-99 152-251 348-398 |
| TRANSFORMING PROT |
| PKITH-- AMEPV THYMIDINE KINASE AMSACTA MOOREI ENTOMOPOXVIRUS |
| 47-81 |
| PKITH-- CAPVK THYMIDINE KINASE CAPRIPOXVIRUS (STRAIN KS-1 38-82 |
| PKITH-- EBV THYMIDINE KINASE EPSTEIN-BARR VIRUS (STRAIN B95.8) |
| 228-262 431-472 |
| PKITH-- HSV11 THYMIDINE KINASE HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| 90-124 PKITH-- |
| HSV1C THYMIDINE KINASE HERPES SIMPLEX VIRUS (TYPE 1/STRAIN CL101) |
| 90-124 |
| PKITH-- HSV1E THYMIDINE KINASE HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN HFEM) |
| 90-124 PKITH-- |
| HSV1K THYMIDINE KINASE HERPES SIMPLEX VIRUS (TYPE 1/STRAIN KOS) 90-124 |
| PKITH-- HSV1S THYMIDINE KINASE HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN SC16) |
| 90-124 PKITH-- |
| HSV23 THYMIDINE KINASE HERPES SIMPLEX VIRUS (TYPE 2/STRAIN 333) 91-125 |
| PKITH-- HSVBM THYMIDINE KINASE BOVINE HERPES VIRUS TYPE 3 (STRAIN |
| WC11) 616-665 |
| PKITH-- HSVE4 THYMIDINE KINASE EQUINE HERPES VIRUS-TYPE 4 (STRAIN |
| 1942) 19-53 178-219 |
| PKITH-- HSVEB THYMIDINE KINASE EQUINE HERPES VIRUS TYPE 1 (STRAIN |
| AB4P) 19-53 178-230 |
| PKITH-- HSVF THYMIDINE KINASE FELINE HERPES VIRUS (FELID HERPES |
| VIRUS 1) 180-214 |
| PKITH-- HSVMR THYMIDINE KINASE MARMOSET HERPES VIRUS 52-86 |
| PKITH-- HSVSA THYMIDINE KINASE HERPES VIRUS SAIMIRI (STRAIN |
| 11) 337-389 |
| PKITH-- PRVN3 THYMIDINE KINASE PSEUDORABIES VIRUS (STRAIN NIA-3) |
| 161-202 |
| PKMIL-- AVIMH MIL SERINE/THREONINE-PROTEIN AVIAN RETROVIRUS MH2 |
| 69-103 |
| KINASE TRANSF |
| PKR15-- HSV11 GENE 15 PROTEIN KINASE ICTALURID HERPES VIRUS 1 |
| 190-224 |
| PKR2-- HSV11 PROBABLE SERINE/THREONINE- HERPES SIMPLEX VIRUS |
| (TYPE 1/STRAIN 17) 57-91 281-315 |
| PROTEIN KINASE |
| PKR74-- HSV11 GENE 74 PROTEIN KINASE ICTALURID HERPES VIRUS 1 |
| 487-528 597-631 |
| PKRAF-- MSV36 RAP SERINE/THREONINE-PROTEIN MURINE SARCOMA VIRUS |
| 3611 11-45 |
| KINASE TRANSF |
| PKRBI-- VACCC 30 KD PROTEIN KINASE HOMOLOG VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 127-168 |
| PKRBI-- VACCV 30 KD PROTEIN KINASE HOMOLOG VACCINIA VIRUS (STRAIN |
| WR) 127-168 |
| PKRB1-- VARV 30 KD PROTEIN KINASE HOMOLOG VARIOLA VIRUS 123-171 |
| PKRB2-- VACCC POSSIBLE PROTEIN KINASE B12 VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 147-181 |
| PKRB2-- VACCV POSSIBLE PROTEIN KINASE B12 VACCINIA VIRUS (STRAIN |
| WR) 147-181 |
| PKRF1-- VACCC POSSIBLE PROTEIN KINASE F10 VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 169-203 |
| PKRF1-- VACCP POSSIBLE PROTEIN KINASE F10 VACCINIA VIRUS (STRAIN |
| L-IVP) 136-170 |
| PKRF1-- VARV POSSIBLE PROTEIN KINASE F10 VARIOLA VIRUS 169-203 |
| PKROS-- AVISU ROS TYROSINE KINASE AVIAN SARCOMA VIRUS (STRAIN |
| UR2) 111-145 |
| TRANSFORMING PROTEIN |
| PKRYK-- AVIR3 TYROSINE-PROTEIN KINASE AVIAN RETROVIRUS RPL30 |
| 15-66 |
| TRANSFORMING PROT |
| PKTHY-- VACCV THYMIDYLATE KINASE VACCINIA VIRUS (STRAIN WR), |
| 135-169 |
| (STRAIN COPENHAGEN) |
| PKYES-- AVISY TYROSINE-PROTEIN KINASE AVIAN SARCOMA VIRUS (STRAIN |
| Y73) 174-233 |
| TRANSFORMING PROT |
| PL100-- ADE02 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 2 441-475 |
| PL100-- ADE05 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 5 223-264 |
| PL100-- ADE40 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 40 |
| 191-232 408-442 |
| PL100-- ADE41 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 41 |
| 199-233 |
| PL52-- ADE02 LATE L1 52 KD PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| 238-284 301-349 |
| PL52-- ADE05 LATE L2 52 KD PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| 238-284 301-349 |
| PLMP2-- EBV GENE TERMINAL PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 144-179 294-338 |
| PMCEL-- SFVKA MRNA CAPPING ENZYME SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) |
| 54-152 622-656 |
| PMCEL-- |
| VACCC MRNA CAPPING ENZYME VACCINIA VIRUS (STRAIN COPENHAGEN) 1-41 |
| 623-657 |
| PMCEL-- VACCV MRNA CAPPING ENZYME VACCINIA VIRUS (STRAIN WR) |
| 1-41 623-657 |
| PMCEL-- VARV MRNA CAPPING ENZYME VARIOLA VIRUS 1-39 623-657 |
| PMCES-- VACCC MRNA CAPPING ENZYME VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| 72-137 245-286 PMCES- |
| - VACCV MRNA CAPPING ENZYME VACCINIA VIRUS (STRAIN WR) 72-137 245-286 |
| PMCES-- VARV MRNA CAPPING ENZYME VARIOLA VIRUS 72-137 245-286 |
| PMCE-- ASFB7 MRNA CAPPING ENZYME AFRICAN SWINE FEVER VIRUS |
| (STRAIN BA71V) 116-157 279-313 738-772 |
| PMOVP-- ORSV MOVEMENT PROTEIN ODONTOGLOSSUM RINGSPOT VIRUS 53-90 |
| PMOVP-- PPMVS MOVEMENT PROTEIN PEPPER MILD MOTTLE VIRUS (STRAIN |
| 26-66 |
| SPAIN) |
| PMOVP-- TMGMV MOVEMENT PROTEIN TOBACCO MILD GREEN MOSAIC VIRUS |
| 29-66 |
| (TMV STRAIN U2) |
| PMOVP-- TMVTO MOVEMENT PROTEIN TOBACCO MOSAIC VIRUS (STRAIN |
| TOMATO/L) 32-66 |
| PMOVP-- TOMVA MOVEMENT PROTEIN TOMATO MOSAIC VIRUS (STRAIN LIIA) |
| 32-80 |
| PMOVP-- TOMVL MOVEMENT PROTEIN TOMATO MOSAIC VIRUS (STRAIN LII) |
| 32-80 |
| PMTC1-- CHVN1 MODIFICATION METHYLASE CVIBI CHLORELLA VIRUS NC-1A |
| 222-256 |
| PMTC2-- CHVP1 MODIFICATION METHYLASE CVIAII PARAMECIUM BURSARIA |
| CHLORELLA VIRUS 1 116-164 |
| PMYC-- AVIM2 MYC TRANSFORMING PROTEIN AVIAN MYELOCYTOMATOSIS |
| VIRUS CM11 229-266 375-419 |
| PMYC-- AVIMC MYC TRANSFORMING PROTEIN AVIAN MYELOCYTOMATOSIS |
| VIRUS MC29 230-267 376-420 |
| PMYC-- AVIMD MYC TRANSFORMING PROTEIN AVIAN MYELOCYTOMATOSIS |
| VIRUS HB1 230-267 376-420 |
| PMYC-- AVIME MYC TRANSFORMING PROTEIN AVIAN RETROVIRUS MH2E21 |
| 377-421 |
| PMYC-- AVIOK MYC TRANSFORMING PROTEIN AVIAN RETROVIRUS OK10 |
| 224-261 370-414 |
| PMYC-- FLV MYC TRANSFORMING PROTEIN FELINE LEUKEMIA VIRUS 393-437 |
| PMYC-- FLVTT MYC TRANSFORMING PROTEIN FELINE LEUKEMIA PROVIRUS |
| FTT 393-437 |
| PNCA2-- CVMAS NUCLEOCAPSID PROTEIN MURINE CORONAVIRUS MHV (STRAIN |
| A59) 12-46 |
| PNCAP-- |
| AINOV NUCLEOCAPSID PROTEIN AINO VIRUS 177-211 PNCAP-- |
| BEV NUCLEOCAPSID PROTEIN BERNE VIRUS 46-83 122-156 |
| PNCAP-- BRSVA NUCLEOCAPSID PROTEIN BOVINE RESPIRATORY SYNCYTIAL |
| VIRUS |
| 62-108 163-200 248-303 343-383 |
| (STRAIN A51908) |
| PNCAP-- BUNGE NUCLEOCAPSID PROTEIN BUNYAVIRUS GERMISTON 176-228 |
| PNCAP-- BUNLC NUCLEOCAPSID PROTEIN BUNYAVIRUS LA CROSSE 176-229 |
| PNCAP-- BUNSH NUCLEOCAPSID PROTEIN BUNYAVIRUS SNOWSHOE HARE |
| 176-229 |
| PNCAP-- BUNYW NUCLEOCAPSID PROTEIN BUNYAMWERA VIRUS 175-228 |
| PNCAP-- CCHFV NUCLEOCAPSID PROTEIN CRIMEAN-CONGO HEMORRHAGIC |
| FEVER VIRUS 223-306 427-461 |
| (ISOLATE C6803 |
| PNCAP-- CDVO NUCLEOCAPSID PROTEIN CANINE DISTEMPER VIRUS (STRAIN |
| 137-174 179-217 354-402 |
| ONDERSTEPOORT) |
| PNCAP-- CHAV NUCLEOCAPSID PROTEIN CHANDIPURA VIRUS (STRAIN |
| 1653514) 40-84 321-369 |
| PNCAP-- CVBF NUCLEOCAPSID PROTEIN BOVINE CORONAVIRUS (STRAIN F15) |
| 349-383 |
| PNCAP-- CVBM NUCLEOCAPSID PROTEIN BOVINE CORONAVIRUS (STRAIN |
| MEBUS) 349-383 |
| PNCAP-- CVCAE NUCLEOCAPSID PROTEIN CANINE ENTERIC CORONAVIRUS |
| (STRAIN K378) 165-227 |
| PNCAP-- CVHOC NUCLEOCAPSID PROTEIN HUMAN CORONAVIRUS (STRAIN |
| OC43) 349-383 |
| PNCAP-- CVMJH NUCLEOCAPSID PROTEIN MURINE CORONAVIRUS MHV (STRAIN |
| JHM) 12-46 |
| PNCAP-- |
| CVPFS NUCLEOCAPSID PROTEIN PORCINE TRANSMISSIBLE GASTROENTERITIS |
| 149-206 |
| CORONAVIRUS (S |
| PNCAP-- |
| CVPPU NUCLEOCAPSID PROTEIN PORCINE TRANSMISSIBLE GASTROENTERITIS |
| 165-227 |
| CORONAVIRUS (S |
| PNCAP-- |
| CVPR8 NUCLEOCAPSID PROTEIN PORCINE RESPIRATORY CORONAVIRUS (STRAIN 86/ |
| 149-228 |
| 137004/BRIT |
| PNCAP-- |
| CVPRM NUCLEOCAPSID PROTEIN PORCINE RESPIRATORY CORONAVIRUS (STRAIN |
| 149-228 |
| RM4) |
| PNCAP-- CVRSD NUCLEOCAPSID PROTEIN RAT CORONAVIRUS (STRAIN 681) |
| 12-46 |
| PNCAP-- CVTKE NUCLEOCAPSID PROTEIN TURKEY ENTERIC CORONAVIRUS |
| 349-383 |
| PNCAP-- |
| DUGBV NUCLEOCAPSID PROTEIN DUGBE VIRUS 230-306 PNCAP-- |
| FIPV NUCLEOCAPSID PROTEIN FELINE INFECTIOUS PERITONITIS VIRUS (STRAIN |
| 151-206 |
| 79-1146) |
| PNCAP-- HANTV NUCLEOCAPSID PROTEIN HANTAAN VIRUS (STRAIN 76-118) |
| 1-35 40-74 333-381 |
| PNCAP-- HAZVJ NUCLEOCAPSID PROTEIN HAZARA VIRUS (ISOLATE JC280) |
| 233-237 |
| PNCAP-- HRSV1 NUCLEOCAPSID PROTEIN HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS |
| 62-145 163-200 248-303 343-380 |
| (SUBGROUP B/STRAI |
| PNCAP-- HRSVA NUCLEOCAPSID PROTEIN HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS |
| 62-145 163-200 248-303 343-380 |
| (STRAIN A2) |
| PNCAP-- IBVG NUCLEOCAPSID PROTEIN AVIAN INFECTIOUS BRONCHITIS |
| VIRUS 186-227 |
| (STRAIN GRAY) |
| PNCAP-- IBVK NUCLEOCAPSID PROTEIN AVIAN INFECTIOUS BRONCHITIS |
| VIRUS 186-220 |
| (STRAIN KB8523) |
| PNCAP-- JUNIN NUCLEOCAPSID PROTEIN JUNIN ARENA VIRUS 96-151 |
| PNCAP-- LASSG NUCLEOCAPSID PROTEIN LASSA VIRUS (STRAIN GA391) |
| 65-113 126-174 |
| PNCAP-- LASSJ NUCLEOCAPSID PROTEIN LASSA VIRUS (STRAIN JOSIAH) |
| 65-113 122-174 467-504 |
| PNCAP-- LDV NUCLEOCAPSID PROTEIN LACTATE DEHYDROGENASE-ELEVATING |
| VIRUS( |
| 3-40 |
| PNCAP-- LYCVA NUCLEOCAPSID PROTEIN LYMPHOCYTIC CHORIOMENINGITIS |
| VIRUS (STRAIN |
| 45-117 460-497 ARMSTRON |
| PNCAP-- LYCVW NUCLEOCAPSID PROTEIN LYMPHOCYTIC CHORIOMENINGITIS |
| VIRUS (STRAIN 45-79 |
| 83-117 460-497 WE) |
| PNCAP-- |
| MAGV NUCLEOCAPSID PROTEIN MAGUARI VIRUS 175-228 PNCAP-- |
| MEASE NUCLEOCAPSID PROTEIN MEASLES VIRUS (STRAIN EDMONSTON) 188-226 |
| 363-411 |
| PNCAP-- MEASH NUCLEOCAPSID PROTEIN MEASLES VIRUS (STRAIN HALLE) |
| 188-226 363-411 |
| PNCAP-- MEAS1 NUCLEOCAPSID PROTEIN MEASLES VIRUS (STRAIN IP-3-CA) |
| 188-226 363-411 |
| PNCAP-- |
| MEASY NUCLEOCAPSID PROTEIN MEASLES VIRUS (STRAIN YAMAGATA-1) 188-226 |
| 363-411 |
| PNCAP-- MOPEI NUCLEOCAPSID PROTEIN MOPEIA VIRUS 65-106 471-505 |
| PNCAP-- MUMP1 NUCLEOCAPSID PROTEIN MUMPS VIRUS (STRAIN SBL-1) |
| 214-255 500-534 |
| PNCAP-- MUMPM NUCLEOCAPSID PROTEIN MUMPS VIRUS (STRAIN MIYAHARA |
| VACCINE) 214-255 |
| PNCAP-- PHV NUCLEOCAPSID PROTEIN PROSPECT HILL VIRUS 1-35 40-74 |
| 337-392 |
| PNCAP-- PI1HC NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 1 VIRUS |
| (STRAIN C39) 212-272 441-510 |
| PNCAP-- PI1HW NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 1 VIRUS |
| (STRAIN 212-272 441-510 |
| WASHINGTON/1957) |
| PNCAP-- PI2HT NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 2 VIRUS |
| (STRAIN 214-266 344-378 |
| TOSHIBA) |
| PNCAP-- PI3B NUCLEOCAPSID PROTEIN BOVINE PARAINFLUENZA 3 VIRUS |
| 200-403 446-490 |
| PNCAP-- PI3H4 NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 3 VIRUS |
| (STRAIN |
| 87-135 208-266 344-403 440-491 NIH |
| 47885) |
| PNCAP-- PI4HA NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 4A VIRUS |
| (STRAIN 58-94 191-267 |
| TOSHIBA) |
| PNCAP-- PI4HB NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 4B VIRUS |
| (STRAIN 68-33) 58-94 191-267 |
| PNCAP-- PIARV NUCLEOCAPSID PROTEIN PICHINDE ARENAVIRUS 65-112 |
| PNCAP-- PIRYV NUCLEOCAPSID PROTEIN PIRY VIRUS 71-116 325-359 |
| PNCAP-- PUUMH NUCLEOCAPSID PROTEIN PUUMALA VIRUS (STRAIN HALLNAS |
| B1) |
| 1-35 40-75 337-392 |
| PNCAP-- PUMMS NUCLEOCAPSID PROTEIN PUUMALA VIRUS (STRAIN SOTAKAMO) |
| 1-35 40-75 337-385 |
| PNCAP-- PVM NUCLEOCAPSID PROTEIN PNEUMONIA VIRUS OF MICE 93-141 |
| 248-303 344-388 |
| PNCAP-- RABVA NUCLEOCAPSID PROTEIN RABIES VIRUS (STRAIN AVO1) |
| 133-167 |
| PNCAP-- SEND5 NUCLEOCAPSID PROTEIN SENDAI VIRUS (STRAIN Z/HOST |
| MUTANTS) 212-272 345-404 |
| PNCAP-- SENDE NUCLEOCAPSID PROTEIN SENDAI VIRUS (STRAIN ENDERS) |
| 212-272 345-404 |
| PNCAP-- SENDZ NUCLEOCAPSID PROTEIN SENDAI VIRUS (STRAIN Z) |
| 212-272 345-408 |
| PNCAP-- SEOUS NUCLEOCAPSID PROTEIN SEOUL VIRUS (STRAIN SR-11) |
| 1-35 40-74 333-381 |
| PNCAP-- SV41 NUCLEOCAPSID PROTEIN SIMIAN VIRUS 41 215-267 372-406 |
| 418-466 |
| PNCAP-- SYNV NUCLEOCAPSID PROTEIN SONCHUS YELLOW NET VIRUS |
| 332-366 |
| PNCAP-- TACV NUCLEOCAPSID PROTEIN TACARIBE VIRUS 50-84 230-264 |
| PNCAP-- TOSV NUCLEOCAPSID PROTEIN TOSCANA VIRUS 215-249 |
| PNCAP-- TSWVB NUCLEOCAPSID PROTEIN TOMATO SPOTTED WILT |
| VIRUS (BRAZILIAN |
| 79-120 ISOLATE |
| CHPNH1/BR- |
| PNCAP-- TSWVH NUCLEOCAPSID PROTEIN TOMATO SPOTTED WILT VIRUS |
| (HAWAIIAN |
| 79-120 |
| ISOLATE) |
| PNCAP-- TSWVL NUCLEOCAPSID PROTEIN TOMATO SPOTTED WILT VIRUS |
| (STRAIN L3) |
| 79-120 PNCAP- |
| - UUK NUCLEOCAPSID PROTEIN UUKUNIEMI VIRUS |
| 51-102 PNCAP-- VHSV0 NUCLEOCAPSID PROTEIN |
| VIRAL HEMORRHAGIC SEPTICEMIA VIRUS (STRAIN 249-325 |
| 07-71) |
| PNCAP-- VHSVM NUCLEOCAPSID PROTEIN VIRAL HEMORRHAGIC SEPTICEMIA |
| VIRUS 142-180 249-325 |
| (STRAIN MAKAH) |
| PNCAP-- VSVIG NUCLEOCAPSID PROTEIN VESICULAR STOMATITIS VIRUS |
| (SEROTYPE |
| 42-108 |
| INDIANA/STRAIN G |
| PNCAP-- VSVJO NUCLEOCAPSID PROTEIN VESICULAR STOMATITIS VIRUS |
| (SEROTYPE |
| 67-115 NEW |
| JERSEY/STRA |
| PNCAP-- VSVSJ NUCLEOCAPSID PROTEIN VESICULAR STOMATITIS VIRUS |
| (STRAIN SAN JUAN) |
| 42-115 PNEF-- |
| HV2BE NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 7-48 (ISOLATE BEN) |
| PNEF-- HV2D1 NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 7-41 |
| (ISOLATE D194) |
| PNEF-- HV2RO NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 112-160 |
| (ISOLATE ROD) |
| PNEF-- HV2SB NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 109-150 |
| (ISOLATE SBLISY) |
| PNEF-- HV2ST NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 108-149 |
| (ISOLATE ST) |
| PNEF-- SIVAI NEGATIVE FACTOR SIMIAN IMMUNODEFICIENCY VIRUS |
| 96-140 |
| (ISOLATE AGM/CLONE GR1 |
| PNEF-- SIVS4 NEGATIVE FACTOR SIMIAN IMMUNODEFICIENCY VIRUS 9-43 |
| 233-267 |
| (F236/SMH4 ISOLATE) |
| PNRAM-- IABDA NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/BLACK |
| DUCK/ 47-81 |
| AUSTRALIA/702/78 |
| PNRAM-- |
| IACAO NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/CAMEL/MONGOLIA/ 33-74 |
| 82) |
| PNRAM-- IACHI NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/CHILE/83) |
| 50-91 |
| PNRAM-- IACKQ NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/CHICKEN/ |
| 349-383 |
| PENNSYLVANIA/1370/ |
| PNRAM-- IACKR NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/CHICKEN/ |
| 349-383 |
| PENNSYLVANIA/1370/ |
| PNRAM-- |
| IADGE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/DUCK/GERMANY/49) 14-48 |
| PNRAM-- IAFPW NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/FOWL |
| PLAGUE 14-48 194-229 |
| VIRUS/WEYBRID |
| PNRAM-- |
| IAHCO NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/EQUINE/COR/16/74 10-47 |
| 193-227 |
| PNRAM-- |
| IAHKI NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/EQUINE/KENTUCKY/ 5-44 |
| 361-402 |
| 1/81) |
| PNRAM-- |
| IAKIE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/KIEV/59/79) 50-91 |
| PNRAM-- IALEN NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/ |
| 50-91 |
| LENINGRAD/54/1) |
| PNRAM-- IAME1 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/ 50-88 |
| MEMPHIS/1/71H-A/BELLAMY/42N |
| PNRAM-- IARUE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/RUDDY |
| 49-91 |
| TURNSTONE/NEW JERSE |
| PNRAM-- |
| IASH2 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/SHEARWATER/ 10-44 |
| AUSTRALIA/72) |
| PNRAM-- |
| IATKR NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/TURKEY/OREGON/ 7-41 |
| 71) |
| PNRAM-- |
| IATRA NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/TERN/AUSTRALIA/ 49-83 |
| G70C/75) |
| PNRAM-- |
| IAUSS NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/USSR/90/77) 49-91 |
| PNRAM-- IAWHM NEURAMINIDASE INFLUENZA A VIRUS (STRAIN |
| A/WHALE/MAINE/1/84) 49-91 |
| PNRAM-- |
| INBBE NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/BEIJING/1/87) 5-46 |
| 348-382 |
| PNRAM-- INBHK NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/HONG |
| KONG/8/73) |
| 5-46 349-383 PNRAM |
| -- INBLE NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/LEE/40) 5-46 |
| 349-383 |
| PNRAM-- |
| INBLN NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/LENINGRAD/179/86), |
| 5-39 348-382 |
| (STRAIN B/M |
| PNRAM-- |
| INBMD NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/MARYLAND/59) 5-39 |
| 349-383 |
| PNRAM-- |
| INBMF NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/MEMPHIS/3/89) 5-46 |
| 348-282 |
| PNRAM-- |
| INBOR NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/OREGON/5/80) 5-46 |
| 349-383 |
| PNRAM-- |
| INBSI NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/SINGAPORE/222/79) 5-39 |
| 349-383 |
| PNRAM-- |
| INBUS NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/USSR/100/83) 5-39 |
| 349-383 |
| PNRAM-- |
| INBVI NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/VICTORIA/3/85 5-39 |
| 348-382 |
| PNS2-- SIDEV PROBABLE STRUCTURAL PROTEIN BOMBYX DENSONUCLEGSIS |
| VIRUS 790-828 |
| PRECURSOR |
| PNSS-- INSVN NON-STRUCTURAL PROTEIN IMPATIENS NECROTIC SPOT VIRUS |
| (STRAIN NL-07) |
| 95-129 204-238 PNSS-- |
| TSWVB NON-STRUCTURAL PROTEIN TOMATO SPOTTED WILT VIRUS (BRAZILIAN 3-37 |
| ISOLATE CPNH1/BR3 |
| PNSS-- TSWVL NON-STRUCTURAL PROTEIN TOMATO SPOTTED WILT VIRUS |
| (STRAIN L3) |
| 3-37 PNTP1- |
| - AMEPV NUCLEOSIDE TRIPHOSPHATASE I AMSACTA MOOREI ENTOMOPOXVIRUS 28-69 |
| 110-144 |
| PNTP1-- CBEPV NUCLEOSIDE TRIPHOSPHATASE I CHORISTONEURA BIENNIS |
| ENTOSIOPOXVIRUS 122-169 415-449 514-555 |
| PNTP1-- VACCC NUCLEOSIDE TRIPHOSPHATASE I VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 56-83 248-289 549-599 |
| PNTP1-- VACCV NUCLEOSIDE TRIPHOSPHATASE I VACCINIA VIRUS (STRAIN |
| WR) 56-90 248-289 549-599 |
| PNTP1-- VARV NUCLEOSIDE TRIPHOSPHATASE I VARIOLA VIRUS 154-195 |
| 455-505 |
| PP100-- HSV6U MAJOR ANTIGENIC STRUCTURAL HERPES SIMPLEX VIRUS |
| (TYPE 6/STRAIN 189-223 689-735 |
| PROTEIN UGANDA-1102) |
| PPAP1-- VACCC POLY(A)POLYMERASE CATALYTIC VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 121-180 |
| SUBUNIT |
| PPAP1-- VACCV POLY(A)POLYMERASE CATALYTIC VACCINIA VIRUS (STRAIN |
| WR) 121-180 |
| SUBUNIT |
| PPAP1-- VARV POLY(A)POLYMERASE CATALYTIC VARIOLA VIRUS 121-180 |
| SUBUNIT |
| PPAP2-- CAPVK POLY(A)POLYMERASE REGULATORY CAPRIPOXVIRUS (STRAIN |
| KS-1) 112-146 |
| SUBUNIT |
| PPAP2-- FOWPV POLY(A)POLYMERASE REGULATORY FOWLPOX VIRUS 95-154 |
| SUBUNIT |
| PPAP2-- VACCC POLY(A)POLYMERASE REGULATORY VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 203-249 |
| SUBUNIT |
| PPAP2-- VACCV POLY(A)POLYMERASE REGULATORY VACCINIA VIRUS (STRAIN |
| WR) 203-249 |
| SUBUNIT |
| PPAP2-- VARV POLY(A)POLYMERASE REGULATORY VARIOLA VIRUS 203-249 |
| SUBUNIT |
| PPE12-- |
| NPVAC 12.1 KD PROTEIN IN PE 5'REGION AUTOGRAPHA CALIFORNICA NUCLEAR |
| 15-56 |
| 60-105 |
| POLYHEDROSIS VIRUS |
| PPE12-- |
| NPVOP 11.5 KD PROTEIN IN P26 5'REGION ORGYIA PSEUDOTSUGATA MULTICAPSID |
| 11-98 |
| POLYHEDROSIS VIRUS |
| PPE38-- |
| NPVAC MAJOR IMMEDIATE EARLY PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| 19-77 197-249 |
| POLYHEDROSIS VIRUS |
| PPE38-- NPVOP MAJOR IMMEDIATE EARLY PROTEIN ORGYIA PSEUDOTSUGATA |
| MULTICAPSID 190-240 |
| POLYHEDROSIS VIRUS |
| PPE48-- NPVAC 48.3 KD PROTEIN IN PE-P26 AUTOGRAPHA CALIFORNICA |
| NUCLEAR |
| 4-42 48-89 97-131 |
| INTERGENIC REGION POLYHEDROSIS VIRUS |
| PPE48-- NPVOP 47.3 KD PROTEIN IN PE-P26 ORGYIA PSEUDOTSUGATA |
| MULTICAPSID 47-82 165-199 |
| INTERGENIC REGION POLYHEDROSIS VIRUS |
| PPIV2-- ADE07 MATURATION PROTEIN HUMAN ADENOVIRUS TYPE 7 414-448 |
| PPIV6-- ADE02 PROTEIN VI PRECURSOR HUMAN ADENOVIRUS TYPE 2 37-71 |
| PPIV6-- ADE05 PROTEIN VI PRECURSOR HUMAN ADENOVIRUS TYPE 5 37-71 |
| PPOL1-- BAYMG GENOME POLYPROTEIN 1 BARLEY YELLOW MOSAIC VIRUS |
| (GERMAN 329-363 743-777 957-991 1265- 2229- 2309- 2368- |
| ISOLATE) 1299 2266 2352 2404 |
| PPOL1-- BAYMJ GENOME POLYPROTEIN 1 BARLEY YELLOW MOSAIC VIRUS |
| (JAPANESE 329-363 671-705 743-777 957-994 1265- 2227- 2307- 2366- |
| STRAIN II-1) 1299 2264 2350 2402 |
| PPOL1-- GCMV RNA1 POLYPROTEIN HUNGARIAN GRAPEVINE CHROME MOSAIC |
| VIRUS 120-161 165-216 230-273 377-415 |
| PPOL1-- GFLV RNA1 POLYPROTEIN GRAPEVINE FANLEAF VIRUS 170-212 |
| 480-519 636-677 691-725 1157- 1378- 1906- |
| 1196 1412 1943 |
| PPOL1-- TBRVS RNA1 POLYPROTEIN TOMATO BLACK RING VIRUS (STRAIN S) |
| 223-278 929-977 |
| PPOL2-- TRSVR RNA1 POLYPROTEIN TOMATO RINGSPOT VIRUS (ISOLATE |
| RASPBERRY) 161-206 |
| PPOL2-- BAYMG GENOME POLYPROTEIN 2 BARLEY YELLOW MOSAIC VIRUS |
| (GERMAN 240-281 669-732 739-773 787-628 |
| ISOLATE) |
| PPOL2-- BAYMJ GENOME POLYPROTEIN 2 BARLEY YELLOW MOSAIC VIRUS |
| (JAPANESE 669-732 739-773 787-828 |
| STRAIN II-I) |
| PPOL2-- GFLV RNA2 POLYPROTEIN GRAPEVINE FANLEAF VIRUS 365-406 |
| 542-602 |
| PPOL2-- TBRVS RNA2 POLYPROTEIN TOMATO BLACK RING VIRUS (STRAIN S) |
| 4-38 |
| PPOL2-- TRSVR RNA2 POLYPROTEIN TOMATO RINGSPOT VIRUS (ISOLATE |
| RASPBERRY) 158-206 334-368 |
| PPOLG-- BOVEV GENOME POLYPROTEIN BOVINE ENTEROVIRUS (STRAIN |
| VG-5-27) 849-886 1008- 1382- 1459- 1576- |
| 1064 1416 1507 1617 |
| PPOLG-- BVDVN GENOME POLYPROTEIN BOVINE VIRAL DIARRHEA VIRUS |
| (ISOLATE NADL) 244-289 446-491 629-663 1033- 1303- 1392- 1869- 2226- |
| 1074 1344 1443 1910 2260 |
| PPOLG-- BVDVS GENOME POLYPROTEIN BOVINE VIRAL DIARRHEA VIRUS |
| (STRAIN SD-1) 245-289 446-491 629-663 1033- 1303- 1392- 1779- 2136- |
| 1074 1344 1443 1829 2170 |
| PPOLG-- BYMV GENOME POLYPROTEIN BEAN YELLOW MOSAIC VIRUS 96-130 |
| PPOLG-- COXA2 GENOME POLYPROTEIN COXSACKIE VIRUS A21 (STRAIN COE) |
| 9-43 562-596 664-698 1045- 1498- 1607- 1805- 1901- |
| 1100 1546 1648 1839 1946 |
| PPOLG-- COXA9 GENOME POLYPROTEIN COXSACKIE VIRUS A9 (STRAIN |
| GRIGGS) 15-49 1040- 1895- |
| 1086 1940 |
| PPOLG-- COXB1 GENOME POLYPROTEIN COXSACKIE VIRUS B1 15-49 1021- |
| 1876- |
| 1067 1921 |
| PPOLG-- COXB3 GENOME POLYPROTEIN COXSACKIE VIRUS B3 15-49 1024- |
| 1879- |
| 1970 1924 |
| PPOLG-- COXB4 GENOME POLYPROTEIN COXSACKIE VIRUS B4 15-49 642-681 |
| 1022- 1877- |
| 1068 1922 |
| PPOLG-- COXB5 GENOME POLYPROTEIN COXSACKIE VIRUS B5 15-49 1024- |
| 1879- |
| 1070 1924 |
| PPOLG-- CYVV GENOME POLYPROTEIN CLOVER YELLOW VEIN VIRUS 120-154 |
| PPOLG-- DEN18 GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN |
| 836-1) |
| 74-108 |
| PPOLG-- DEN1A GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN AHF |
| 82-80) |
| 74-108 |
| PPOLG-- DEN1C GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN |
| CV1636/77) |
| 74-108 PPOLG |
| -- DEN1S GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN SINGAPORE |
| S275/90) |
| 74-108 832-873 960-994 1142- 1386- 1614- 2518- 2946- |
| 1179 1420 1648 2554 3016 |
| PPOLG-- DEN1W GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN |
| WESTERN PACIFIC) |
| 74-108 833-874 961-995 1143- 1180 |
| PPOLG-- DEN21 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (ISOLATE |
| MALAYSIA M1) 448-492 |
| PPOLG-- DEN22 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (ISOLATE |
| MALAYSIA M2) 448-495 |
| PPOLG-- DEN26 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| 16681) 74-108 728-777 961-995 1146-1180 1246-1280 1418-1452 1615-1649 |
| 2517-2551 |
| PPOLG-- DEN27 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| 16681-PDK53) 74-108 728-777 961-995 1146-1180 1246-1280 1418-1452 |
| 1615-1649 2485-2551 |
| PPOLQ-- DEN2D GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| D2-04) 728-777 |
| PPOLG-- DEN2H GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| TH-36) 497-546 |
| PPOLG-- DEN2J GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| JAMAICA) 74-108 728-777 961-995 1146-1180 1246-1280 1418-1452 1615-1649 |
| 2517-2551 |
| PPOLG-- DEN2N GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN NEW |
| GUINEA C) 213-247 398-432 |
| PPOLG-- DEN2P GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| PR159/S1) 74-108 728-777 832-875 961-995 1146-1180 1246-1280 1418-1452 |
| 1615-1649 |
| PPOLG-- DEN2T GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| TONGA 1974) 448-497 552-595 681-715 866-900 |
| 966-1000 1205-1239 PPOLG-- DEN2U GENOME POLYPROTEIN |
| DENGUE VIRUS TYPE 2 (STRAIN PUO-218) 614-663 |
| PPOLG-- DEN3 GENOME POLYPROTEIN DENGUE VIRUS TYPE 3 830-872 |
| 959-993 1385-1419 2224-2258 2480-2521 2704-2738 2940-2978 2980-3014 |
| PPOLG-- DEN4 GENOME POLYPROTEIN DENGUE VIRUS TYPE 4 957-993 |
| 1380-1414 2514-2555 2701-2735 2941-2975 2977-3011 |
| PPOLG-- EC11G GENOME POLYPROTEIN ECHOVIRUS 11 (STRAIN GREGORY) |
| 213-259 1079-1113 |
| PPOLG-- EMCV GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS VIRUS |
| 1074-1115 1472-1518 1522-1570 1665-1706 1789-1823 |
| PPOLG-- EMCVB GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS VIRUS |
| (STRAIN EMC-B 145-179 1076-1117 1474-1520 1524-1572 1667-1708 |
| NONDIABETO |
| PPOLG-- EMCVD GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS VIRUS |
| (STRAIN EMC-D 145-179 1076-1117 1474-1520 1524-1572 1667-1708 |
| DIABETOGEN |
| PPOLG-- ENMG3 GENOME POLYPROTEIN MENGO ENCEPHALOMYOCARDITIS VIRUS |
| (STRAIN 145-179 |
| 37A) |
| PPOLG-- ENMGO GENOME POLYPROTEIN MENGO ENCEPHALOMYOCARDITIS VIRUS |
| 78-112 |
| PPOLG-- FMDV1 GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAIN A10-61) 221-255 294-328 578-612 1103-1153 1493-1528 2165-2200 |
| PPOLG-- FMDVA GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAIN A12) 220-254 293-327 577-611 1103-1164 1493-1528 2164-2199 |
| PPOLG-- FMDVO GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE |
| VIRUS (STRAINS O1K 221-255 1103-1153 1493-1528 2164-2199 |
| AND O1BFS) |
| PPOLG-- FMDVS GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAIN |
| 87-128 693-728 |
| C1-SANTA PAU [C--S |
| PPOLG-- FMDVT GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAIN C1) 221-255 283-317 577-611 |
| PPOLG-- HCV1 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE 1) |
| 364-398 |
| PPOLG-- HCVA GENOME POLYPROTEIN HOG CHOLERA VIRUS (STRAIN ALFORT) |
| 440-493 626-660 695-729 1033-1070 1190-1235 1307-1343 1779-1820 |
| 2136-2170 |
| 2466-2500 2525-2559 2667-2708 3057-3098 3152-3193 3406-3440 |
| PPOLG-- HCVB GENOME POLYPROTEIN HOG CHOLERA VIRUS (STRAIN |
| BRESCIA) 440-493 626-660 695-729 1033-1070 1173-1235 1779-1820 2136-2170 |
| 2388-2436 |
| PPOLG-- HCVBK 2466-2500 2525-2559 2667-2708 3057-3098 3152-3195 |
| 3406-3440 3521-3562 |
| PPOLG-- HCVE0 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE BK) |
| 357-398 2328-2365 |
| PPOLG-- HCVH GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE EC10) |
| 65-99 |
| PPOLG-- HCVH4 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE H) |
| 364-398 |
| PPOLG-- HCVH7 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HCV-476) 364-398 |
| PPOLG-- HCVH8 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HCT27) 236-270 |
| PPOLG-- HCVHK GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HCT18) 248-282 |
| PPOLG-- HCVJ2 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HCV-KF) 357-398 |
| PPOLG-- HCVJ5 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HC-J2) 357-388 |
| PPOLG-- HCVJ6 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HC-J5) 364-398 |
| PPOLG-- HCVJ7 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HC-J6) 364-401 1716-1750 2082-2116 |
| PPOLG-- HCVJ8 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HC-J7) 364-398 |
| PPOLG-- HCVJA GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HC-J8) 364-398 1716-1750 2082-2116 2468-2502 2538-2572 |
| PPOLG-- HCVJT GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| JAPANESE) 357-405 2331-2365 |
| PPOLG-- HCVTW GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HC-JT) 357-391 2331-2365 |
| PPOLG-- HPAV2 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| TAIWAN) 357-398 2328-2365 2444-2503 |
| PPOLG-- HPAV4 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN 24A) |
| 2-43 101-135 203-237 870-904 1021-1055 1117-1151 |
| PPOLG-- HPAV8 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN 43C) |
| 2-43 101-135 203-237 870-904 1021-1055 1117-1151 |
| PPOLG-- HPAVC GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN 18F) |
| 2-43 101-135 203-237 870-904 1021-1055 1117-1151 |
| PPOLG-- HPAVG GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN CR326) |
| 2-43 101-135 203-237 |
| PPOLG-- HPAVH GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN GA76) |
| 80-114 182-216 |
| PPOLG-- HPAVL GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| HM-175) |
| 2-43 101-135 203-237 870-904 1021-1055 1103-1151 |
| PPOLG-- HPAVM GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN LA) |
| 2-43 101-135 203-237 870-904 1021-1055 1103-1151 |
| PPOLG-- HPAVS GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN MBB) |
| 2-43 101-135 203-237 870-984 1021-1055 1103-1158 |
| PPOLG-- HPAVT GENOME POLYPROTEIN SIMIAN HEPATITIS A VIRUS (STRAIN |
| AGM-27) 6-47 105-139 207-241 849-908 1025-1059 1115-1155 1158-1198 |
| PPOLG-- HRV14 GENOME POLYPROTEIN SIMIAN HEPATITIS A VIRUS |
| (STRAIN CY-145) |
| 2-43 101-135 203-237 PPOLG-- |
| HRV1A GENOME POLYPROTEIN HUMAN RHINOVIRUS 14 (HRV-14) 1020-1054 1393-1427 |
| 1479-1513 1877-1920 |
| PPOLG-- HRV1B GENOME POLYPROTEIN HUMAN RHINOVIRUS 1A (HRV-1A) |
| 362-396 |
| PPOLG-- HRV2 GENOME POLYPROTEIN HUMAN RHINOVIRUS 1B (HRV-1B) |
| 387-421 863-904 1133-1168 |
| PPOLG-- HRV89 GENOME POLYPROTEIN HUMAN RHINOVIRUS 2 (HRV-2) |
| 856-897 1126-1169 1552-1593 |
| PPOLG-- HUEV7 GENOME POLYPROTEIN HUMAN RHINOVIRUS 89 (HRV-89) |
| 1566-1607 |
| PPOLG-- IBDVO GENOME POLYPROTEIN HUMAN ENTEROVIRUS 70 (STRAIN |
| J670/71) 359-397 876-917 1032-1088 1403-1441 1896-1934 |
| PPOLG-- JAEV1 STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS 134-168 250-291 475-524 |
| (STRAIN OH) |
| PPOLG-- JAEV5 GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN SA-14) 74-122 211-256 539-576 980-1014 1409-1450 2463-2497 |
| 2739-2777 2782-2823 |
| 3322-3359 3387-3428 |
| PPOLG-- JAEVJ GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN SA(V)) 74-122 211-256 539-576 980-1014 1409-1450 2463-2497 |
| 2739-2777 2782-2823 |
| 3322-3359 3387-3428 |
| PPOLG-- JAEVN GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STAIN JAOARS982) 74-128 211-256 539-576 980-1014 1409-1450 2463-2497 |
| 2739-2777 2782-2823 |
| 3322-3359 3387-3428 |
| PPOLG-- KUNJM GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN |
| 7-48 138-183 467-504 908-942 1337-1378 |
| NAKAYAMA) |
| PPOLG-- LANVT GENOME POLYPROTEIN KUNJIN VIRUS (STRAIN MRM61C) |
| 74-108 207-251 851-885 2464-2498 2528-2579 2740-2778 3325-3359 3389-3423 |
| PPOLG-- LANVY GENOME POLYPROTEIN LANGAT VIRUS (STRAIN TP21) |
| 68-102 431-465 962-996 1431-1472 1932-1966 2536-2591 2967-3001 3003-3037 |
| 3102-3145 |
| PPOLG-- LIV GENOME POLYPROTEIN LANGAT VIRUS (STRAIN YELANTSEV) |
| 68-102 431-465 |
| PPOLG-- LIVSB GENOME POLYPROTEIN LOUPING ILL VIRUS (LI) 68-123 |
| 231-272 431-465 |
| PPOLG-- MCFA GENOME POLYPROTEIN LOUPING ILL VIRUS (STRAIN SB 526) |
| 151-185 |
| PPOLG-- MVEV GENOME POLYPROTEIN MOSQUITO CELL FUSING AGENT (CFA |
| FLAVIVIRUS) 80-114 908-942 2049-2087 2630-2689 3036-3095 3290-3341 |
| PPOLG-- OMV GENOME POLYPROTEIN MURRAY VALLEY ENCEPHALITIS |
| VIRUS 67-115 209-253 853-887 |
| 979-1013 1408-1449 PPOLG-- PEMVC GENOME |
| POLYPROTEIN ORNITHOGALUM MOSAIC VIRUS 481-515 946-984 1072-1106 |
| PPOLG-- POLIM GENOME POLYPROTEIN PEPPER MOTTLE VIRUS (CALIFORNIA |
| ISOLATE) 55-100 207-248 377-411 704-738 827-862 877-947 1021-1055 |
| 1167-1201 |
| 1488-1529 1787-1821 1948-1982 2202-2236 2258-2310 2805-2839 |
| 3003-3037 |
| PPOLG-- POL1S GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN |
| MAHONEY) 9-43 1046-1101 1414-1448 1500-1548 1806-1840 1902-1947 |
| PPOLG-- POL2L GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN |
| SABIN) 9-43 899-933 1047-1102 1415-1449 1501-1549 1610-1651 1808-1842 |
| 1904-1949 |
| PPOLG-- POL2W GENOME POLYPROTEIN POLIOVIRUS TYPE 2 (STRAIN |
| LANSING) 9-43 897-831 1045-1100 1413-1447 1502-1547 1608-1649 1806-1840 |
| 1902-1947 |
| PPOLG-- POL32 GENOME POLYPROTEIN POLIOVIRUS TYPE 2 (STRAIN-2) |
| 9-43 897-831 1045-1100 1413-1447 1502-1547 1608-1649 1806-1840 1902-1947 |
| PPOLG-- POL3L GENOME POLYPROTEIN POLIOVIRUS TYPE 3 (STRAIN 23127) |
| 9-43 896-930 1044-1098 1412-1446 1498-1546 1607-1648 1805-1839 |
| 1901-1946 |
| PPOLG-- PPVD GENOME POLYPROTEIN POLIOVIRUS TYPE 3 (STRAINS |
| P3/LEON/37 AND 9-43 896-930 1044-1099 1412-1446 1498-1546 1607-1648 |
| 1805-1839 1901-1946 |
| P3/LEON 12A[1]B) |
| PPOLG-- PPVEA GENOME POLYPROTEIN PLUM POX POTYVIRUS (STRAIN D) |
| 164-208 441-503 728-769 815-867 921-955 1741-1782 |
| PPOLG-- PPVNA GENOME POLYPROTEIN PLUM POX POTYVIRUS (STRAIN EL |
| AMAR) 116-157 784-818 1146-1197 |
| PPOLG-- PPVRA GENOME POLYPROTEIN PLUM POX POTYVIRUS (ISOLATE NAT) |
| 164-208 403-437 440-502 727-768 814-873 920-954 1740-1781 |
| PPOLG-- PRSVH GENOME POLYPROTEIN PLUM POX POTYVIRUS (STRAIN |
| RANKOVIC) 164-208 403-437 440-502 727-768 814-866 920-954 1740-1781 |
| PPOLG-- PRSVP GENOME POLYPROTEIN PAPAYA RINGSPOT VIRUS |
| (STRAIN P/MUTANT HA) |
| 68-102 434-468 PPOLG-- PRSVW |
| GENOME POLYPROTEIN PAPAYA RINGSPOT VIRUS (STRAIN P/MUTANT 325-359 |
| HA 5-1) |
| PPOLG-- PSBMV GENOME POLYPROTEIN PAPAYA RINGSPOT VIRUS (STRAIN W) |
| 325-359 |
| PPOLG-- PVYC GENOME POLYPROTEIN PEA SEED-BORNE MOSAIC VIRUS |
| (STRAIN DPD1) 253-315 355-389 529-589 935-976 984-1018 1080-1177 |
| 1588-1627 1808-1860 |
| 1971-2015 2379-2413 2712-2746 2870-2907 |
| PPOLG-- PVYHU GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN C) |
| 131-196 701-735 802-856 |
| PPOLG-- PVYN GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN HUNGARIAN) |
| 144-181 701-735 802-863 901-949 1401-1441 1492-1526 1728-1772 1777-1818 |
| 2272-2306 |
| PPOLG-- PVYO GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN N) 140-196 |
| 211-245 701-735 802-863 1401-1441 1492-1526 1728-1772 1777-1818 |
| 1929-1970 |
| PPOLG-- PWVSE GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN O) |
| 140-196 211-245 701-735 802-856 |
| PPOLG-- PWVTB GENOME POLYPROTEIN PASSIONFRUIT WOODINESS VIRUS |
| (STRAIN SEVERE) 203-237 |
| PPOLG-- PYFVI GENOME POLYPROTEIN PASSIONFRUIT WOODINESS VIRUS |
| (STRAIN TIP 203-237 |
| BRIGHT) |
| PPOLG-- STEVM GENOME POLYPROTEIN PARSNIP YELLOW FLECK VIRUS |
| (ISOLATE P-121) 194-228 1111-1172 1379-1413 1858-1899 1950-1991 2703-2737 |
| PPOLG-- SVDVH GENOME POLYPROTEIN ST. LOUIS ENCEPHALITIS VIRUS |
| (STRAIN MS1-7) 106-143 673-707 739-773 |
| 975-1009 1404-1438 PPOLG-- SVDVU GENOME POLYPROTEIN |
| SWINE VESICULAR DISEASE VIRUS (STRAIN H/3 '76) 15-49 1024-1070 |
| 1779-1813 1890-1924 |
| PPOLG-- TBEVS GENOME POLYPROTEIN SWINE VESICULAR DISEASE VIRUS |
| (STRAIN UKG/27/72) 15-49 1024-1070 1890-1924 |
| PPOLG-- TBEVW GENOME POLYPROTEIN TICK-BORNE ENCEPHALITIS VIRUS |
| (STRAIN SOFJIN) 68-140 231-272 431-465 1158-1192 1431-1472 1929-1966 |
| 2182-2216 2535-2590 |
| 2965-2999 3051-3092 3100-3143 |
| PPOLG-- TEV GENOME POLYPROTEIN TICK-BORNE ENCEPHALITIS VIRUS |
| (WESTERN 68-140 231-272 431-465 1158-1192 1431-1472 1932-1966 2536-2591 |
| 2967-3001 |
| SUBTYPE) 3003-3037 3053-3094 3102-3145 |
| PPOLG-- TMEVB THEILER'S MURINE TOBACCO ETCH VIRUS 73-124 166-222 |
| 540-584 720-782 828-925 1148-1192 1416-1460 1494-1535 |
| ENCEPHALOMYELITIS VIRUS (S 1668-1702 1747-1781 1792-1826 2395-2434 |
| 2787-2821 |
| PPOLG-- |
| TMEVD GENOME POLYPROTEIN THEILER'S MURINE ENCEPHALOMYELITIS VIRUS |
| 1306-1340 1483-1518 1601-1635 |
| (STRAIN BEAN |
| PPOLG-- |
| TMEVG GENOME POLYPROTEIN THEILER'S MURINE ENCEPHALOMYELITIS VIRUS |
| 1304-1338 1481-1516 1599-1663 |
| (STRAIN DA) |
| PPOLG-- |
| TUMV GENOME POLYPROTEIN THEILER'S MURINE ENCEPHALOMYELITIS VIRUS |
| 1306-1340 1483-1518 1601-1635 - (STRAIN GDVII) |
| PPOLG-- TVMV GENOME POLYPROTEIN TURNIP MOSAIC VIRUS 216-259 |
| 314-362 494-528 768-839 1443-1477 |
| PPOLG-- WMV2 GENOME POLYPROTEIN TOBACCO VEIN MOTTLING VIRUS 34-68 |
| 408-449 667-704 761-813 851-885 |
| 969-1017 1031-1072 1643-1677 1686-1725 2316-2374 2701-2749 |
| 2814-2848 |
| PPOLG-- WNV GENOME POLYPROTEIN WATERMELON MOSAIC VIRUS II 68-105 |
| 202-236 |
| PPOLG-- YEFVI GENOME POLYPROTEIN WEST NILE VIRUS 74-108 207-251 |
| 847-881 |
| 973-1007 1413-1447 2461-2495 2525-2576 2737-2775 |
| 3320-3357 3385-3426 |
| PPOLG-- YEFV2 GENOME POLYPROTEIN YELLOW FEVER VIRUS (STRAIN 17D) |
| 418-452 525-563 728-768 1388-1444 2231-2276 2477-2565 2958-2996 3097-3143 |
| PPOLG-- YEFV8 GENOME POLYPROTEIN YELLOW FEVER VIRUS (STRAIN |
| PASTEUR 17D-204) 418-452 525-563 728-768 1388-1444 2231-2276 2477-2565 |
| 2958-2996 3097-3143 |
| PPOLH-- POLIM GENOME POLYPROTEIN YELLOW FEVER VIRUS (STRAIN |
| 1899/81) |
| 75-116 418-452 525-563 728-768 |
| PPOLN-- EEVVT GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN MAHONEY) |
| 9-43 1047-1102 1415-1449 1501-1549 1610-1651 1808-1842 1904-1949 |
| PPOLN-- FCVC6 NONSTRUCTURAL POLYPROTEIN VENEZUELAN EQUINE |
| ENCEPHALITIS VIRUS 345-382 898-932 1945-1979 |
| (STRAIN TRINIDAD |
| PPOLN-- FCVF9 NON-STRUCTURAL POLYPROTEIN FELINE CALICIVIRUS |
| (STRAIN CFI/68 FIV) 510-544 |
| PPOLN-- HEVBU NON-STRUCTURAL POLYPROTEIN FELINE CALICIVIRUS |
| (STRAIN F9) 4-45 369-410 |
| 986-1020 1023-1061 PPOLN-- HEVME |
| NON-STRUCTURAL POLYPROTEIN HEPATITIS E VIRUS (STRAIN BURMA) 338-379 |
| 1139-1177 |
| PPOLN-- HEVMY NON-STRUCTURAL POLYPROTEIN HEPATITIS E VIRUS |
| (STRAIN MEXICO) 338-379 |
| PPOLN-- HEVPA NON-STRUCTURAL POLYPROTEIN HEPATITIS E VIRUS |
| (STRAIN MYANMAR) 338-379 1139-1184 |
| PPOLN-- MIDDV NON-STRUCTURAL POLYPROTEIN HEPATITIS E VIRUS |
| (STRAIN PAKISTAN) 337-378 1138-1176 |
| PPOLN-- ONNVG NONSTRUCTURAL POLYPROTEIN MIDDELBURG VIRUS 922-977 |
| PPOLN-- RHDV NONSTRUCTURAL POLYPROTEIN O'NYONG-NYONG VIRUS |
| (STRAIN GULU) 899-933 1942-1986 2444-2502 |
| PPOLN-- RRVN NONSTRUCTURAL POLYPROTEIN RABBIT HEMORRHAGIC DISEASE |
| VIRUS 188-234 306-347 409-457 1657-1716 |
| PPOLN-- RRVT NONSTRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| NB5092) 895-929 1928-1962 2414-2467 |
| PPOLN-- RUBVT NONSTRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| T48) 597-631 1083-1136 |
| PPOLN-- SFV NONSTRUCTURAL POLYPROTEIN RUBELLA VIRUS (STRAIN |
| THERIEN) 1506-1540 1551-1585 1730-1767 1862-1896 |
| PPOLN-- SINDO NONSTRUCTURAL POLYPROTEIN SEMLIKI FOREST VIRUS |
| 1094-1128 2358-2392 |
| PPOLN-- SINDV NONSTRUCTURAL POLYPROTEIN SINDBIS VIRUS (SUBTYPE |
| OCKELBO/STRAIN 919-971 1491-1525 1961-1996 2444-2478 |
| EDSBYN 82-5) |
| PPOLR-- EPMV NONSTRUCTURAL POLYPROTEIN SINDBIS VIRUS (STRAIN |
| HRSP) 1491-1525 1959-1994 2442-2476 |
| PPOLS-- EEEV RNA REPLICASE POLYPROTEIN EGGPLANT MOSAIC VIRUS |
| 899-933 1127-1161 |
| PPOLS-- EEEV3 STRUCTURAL POLYPROTEIN EASTERN EQUINE ENCEPHALITIS |
| VIRUS 372-406 914-952 |
| PPOLS-- EEVV8 STRUCTURAL POLYPROTEIN EASTERN EQUINE ENCEPHALITIS |
| VIRUS (STRAIN 373-407 915-952 |
| VA33[TEN BRO |
| PPOLS-- |
| EEVVT STRUCTURAL POLYPROTEIN VENEZUELAN EQUINE ENCEPHALITIS VIRUS |
| 1216-1250 |
| (STRAIN TC-83) |
| PPOLS-- |
| IBDV5 STRUCTURAL POLYPROTEIN VENEZUELAN EQUINE ENCEPHALITIS VIRUS |
| 1216-1250 |
| (STRAIN TRINIDAD |
| PPOLS-- IBDVA STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS 134-168 231-286 470-523 |
| (STRAIN 52/70) |
| PPOLS-- IBDVC STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS 134-168 231-286 470-523 |
| (STRAIN AUSTURALI |
| PPOLS-- IBDVE STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS 134-168 231-286 470-523 |
| (STRAIN CU-1) |
| PPOLS-- IBDVP NONSTRUCTURAL PROTEIN VP4 AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS 134-168 231-286 304-340 |
| (STRAIN E) |
| PPOLS-- IBDVS STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS EURSAL |
| DISEASE VIRUS 115-149 212-267 451-504 |
| (STRAIN PBG-98) |
| PPOLS-- IPNVJ STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS 134-168 249-283 470-523 |
| (STRAIN STC) |
| PPOLS-- IPNVN STRUCTURAL POLYPROTEIN INFECTIOUS PANCREATIC |
| NECROSIS VIRUS |
| 69-103 723-785 (SEROTYPE |
| JASPER) |
| PPOLS-- ONNVG STRUCTURAL POLYPROTEIN INFECTIOUS PANCREATIC |
| NECROSIS VIRUS 716-786 |
| (STRAIN N1) |
| PPOLS-- RRV2 STRUCTURAL POLYPROTEIN O'NYONG-NYONG VIRUS (STRAIN |
| GULU) 1204-1238 |
| PPOLS-- RRVN STRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| 213970) 35-69 |
| PPOLS-- RRVT STRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| NB5092) 369-403 939-973 |
| PPOLS-- RUBVH STRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| T48) 939-973 |
| PPOLS-- RUBVR STRUCTURAL POLYPROTEIN RUBELLA VIRUS (VACCINE |
| STRAIN HPV77) |
| 999-1036 PPOLS-- |
| RUBVT STRUCTURAL POLYPROTEIN RUBELLA VIRUS (VACCINE STRAIN RA27/3) |
| 999-1036 |
| PPOLS-- SINDO STRUCTURAL POLYPROTEIN RUBELLA VIRUS (STRAIN |
| THERIEN) |
| 999-1036 |
| PPOLS-- SINDV STRUCTURAL POLYPROTEIN SINDBIS VIRUS (SUBTYPE |
| OCKELBO/STRAIN EDSBYN 362-396 |
| 82-5) |
| PPOLS-- SINDW STRUCTURAL POLYPROTEIN SINDBIS VIRUS (STRAINS HRSP |
| AND HRLP) 362-396 |
| PPOLS-- WEEV STRUCTURAL POLYPROTEIN SINDBIS VIRUS WILD TYPE SB |
| DERIVED FROM 34-68 |
| STRAIN AR339) |
| PPOL-- BAEVM STRUCTURAL POLYPROTEIN WESTERN EQUINE ENCEPHALITIS |
| VIRUS 913-947 |
| PPOL-- BLVAU POL POLYPROTEIN BABOON ENDOGENOUS VIRUS (STRAIN M7) |
| 42-80 676-743 794-832 1001-1042 |
| PPOL-- BLVJ POL POLYPROTEIN BOVINE LEUKEMIA VIRUS (AUSTRALIAN |
| ISOLATE) 625-673 |
| PPOL-- CAEVC POL POLYPROTEIN BOVINE LEUKEMIA VIRUS (JAPANESE |
| ISOLATE BLV-1) 625-673 |
| PPOL-- CAMVD POL POLYPROTEIN CAPRINE ARTHRITIS ENCEPHALITIS VIRUS |
| (STRAIN 879-934 |
| CORK) |
| PPOL-- COYMV ENZYMATIC POLYPROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN D/H) 177-211 |
| PPOL-- EIAV9 PUTATIVE POLYPROTEIN COMMELINA YELLOW MOTTLE VIRUS |
| 87-121 333-367 447-498 838-876 896-930 1310-1351 |
| PPOL-- EIAVC POL POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS |
| (CLONE 1369) 513-566 1022- |
| 1056 |
| PPOL-- EIAVY POL POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS |
| (CLONE CL22) 513-566 1022- |
| 1056 |
| PPOL-- FENVI POL POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS |
| (ISOLATE 512-565 1021- |
| WYOMING) 1055 |
| PPOL-- FIVPE POL POLYPROTEIN FELINE ENDOGENOUS VIRUS ECE1 533-600 |
| 623-659 858-899 |
| PPOL-- FIVSD POL POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE 429-473 606-663 |
| PETALUMA) |
| PPOL-- FIVT2 POL POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE 428-473 606-642 |
| SAN DIEGO) |
| PPOL-- FMVD POL POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE TM2) 428-472 595-662 |
| PPOL-- FOAMV ENZYMATIC POLYPROTEIN FIGWORT MOSAIC VIRUS (STRAIN |
| DXS) 403-437 |
| PPOL-- GALV POL POLYPROTEIN HUMAN SPUMARETROVIRUS (FOAMY VIRUS) |
| 140-174 217-256 285-326 |
| PPOL-- HTL1A POL POLYPROTEIN GIBBON APE LEUKEMIA VIRUS 528-562 |
| 673-740 |
| PPOL-- HTL1C POL POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE I |
| (STRAIN 670-711 |
| ATK) |
| PPOL-- HV1A2 POL POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE I |
| 670-711 |
| (CARIBBEAN ISOLATE) |
| PPOL-- HV1B1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 501-537 606-664 |
| (ARV2/SF2 ISOLATE) |
| PPOL-- HV1B5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 513-549 639-676 |
| (BH10 ISOLATE) |
| PPOL-- HVIBR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 513-549 618-676 |
| (BH5 ISOLATE) |
| PPOL-- HVIEL POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 513-549 618-676 |
| (BRU ISOLATE) |
| PPOL-- HV1H2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 500-536 626-663 |
| (ELI ISOLATE) |
| PPOL-- HV1JR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 501-537 606-664 |
| (HXB2 ISOLATE) |
| PPOL-- HV1MA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 505-541 610-668 |
| (JRCSF ISOLATE) |
| PPOL-- HVIMN POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 476-536 601-663 |
| (MAL ISOLATE) |
| PPOL-- HV1N5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 504-540 609-667 |
| (MN ISOLATE) |
| PPOL-- HV1ND POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 501-537 627-664 |
| (NEW YORK-5 ISOL |
| PPOL-- HV1OY POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 500-536 626-663 |
| (NDK ISOLATE) |
| PPOL-- HV1PV POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 501-537 606-664 |
| (OYI ISOLATE) |
| PPOL-- HV1RH POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 513-549 693-676 |
| (PV22 ISOLATE) |
| PPOL-- HV1U4 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 500-536 605-663 |
| (RF/HAT ISOLATE) |
| PPOL-- HV1Z2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 500-536 601-663 |
| (STRAIN UGANDAN |
| PPOL-- HV2BE POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 500-536 626-663 |
| (Z2/CDC-Z34 ISOLA |
| PPOL-- HV2CA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 49-83 484-582 653-687 817-851 |
| (ISOLATE BEN) |
| PPOL-- HV2D1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 356-390 464-562 632-666 |
| (ISOLATE CAM2) |
| PPOL-- HV2D2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 502-600 671-705 |
| (ISOLATE D194) |
| PPOL-- HV2G1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 376-410 484-526 529-577 653-687 |
| (ISOLATE D205.7) |
| PPOL-- HV2NZ POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 464-562 633-667 |
| (ISOLATE GHANA-1 |
| PPOL-- HV2RO POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 44-78 356-390 464-529 633-667 |
| (ISOLATE NIH-Z) |
| PPOL-- HV2SB POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 357-391 465-563 634-668 |
| (ISOLATE ROD) |
| PPOL-- HV2ST POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 46-80 473-562 633-667 |
| (ISOLATE SBLISY) |
| PPOL-- IPHA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 484-518 522-577 653-687 |
| (ISOLATE ST) |
| PPOL-- JSRV PUTATIVE POL POLYPROTEIN HAMSTER INTRACISTERNAL |
| A-PARTICLE 462-503 |
| PPOL-- MLVAK POL POLYPROTEIN SHEEP PULMONARY ADENOMATOSIS VIRUS |
| 190-231 |
| PPOL-- MLVAV POL POLYPROTEIN AKR MURINE LEUKEMIA VIRUS 325-392 |
| PPOL-- MLVF5 POL POLYPROTEIN AKV MURINE LEUKEMIA VIRUS 677-744 |
| PPOL-- MLVFF POL POLYPROTEIN FRIEND MURINE LEUKEMIA VIRUS |
| (ISOLATE 57) 682-749 |
| PPOL-- MLVFP POL POLYPROTEIN FRIEND MURINE LEUKEMIA VIRUS |
| (ISOLATE FB29) 682-749 |
| PPOL-- MLVMO POL POLYPROTEIN FRIEND MURINE LEUKEMIA VIRUS |
| (ISOLATE 682-749 |
| PVC-211) |
| PPOL-- MLVRD POL POLYPROTEIN MOLONEY MURINE LEUKEMIA VIRUS |
| 677-744 |
| PPOL-- MLVRK POL POLYPROTEIN RADIATION MURINE LEUKEMIA VIRUS |
| 677-744 |
| PPOL-- MPMV POL POLYPROTEIN RADIATION MURINE LEUKEMIA VIRUS |
| (STRAIN |
| 62-129 |
| KAPLAN) |
| PPOL-- OMVVS POL POLYPROTEIN SIMIAN MASON-PFIZER VIRUS 470-504 |
| 578-613 |
| PPOL-- RSVP POL POLYPROTEIN OVINE LENTIVIRUS (STRAIN SA-OMVV) |
| 470-505 855-910 |
| PPOL-- RTBV POL POLYPROTEIN ROUS SARCOMA VIRUS (STRAIN PRAGUE C) |
| 646-684 |
| PPOL-- RTBVP POLYPROTEIN RICE TUNGRO BACILLIFORM VIRUS 7-44 |
| 59-96 101-135 176-236 325-362 433-474 1005- 1405- |
| 1039 1439 |
| PPOL-- SFV1 POLYPROTEIN RICE TUNGRO BACILLIFORM VIRUS (ISOLATE |
| 7-44 59-96 101-135 176-236 325-362 433-474 1005- 1405- |
| PHILIPPINES) 1039 1439 |
| PPOL-- SFV3L POL POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 1) 349-383 |
| 427-464 494-535 |
| PPOL-- SIVA1 POL POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 3/STRAIN |
| LK3) 124-165 429-467 496-530 |
| PPOL-- SIVA2 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (AGM155 351-385 637-678 737-771 938-979 |
| ISOLATE) |
| PPOL-- SIVAG POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (AGM266 45-86 |
| ISOLATE) |
| PPOL-- SIVAI POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (AGM3 |
| 477-516 642-683 742-783 |
| ISOLATE) |
| PPOL-- SIVAT POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (ISOLATE 175-209 476-515 641-700 942-983 1020- |
| AGM/CLONE GRI 1054 |
| PPOL-- SIVCZ POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (TYO-1 |
| 657-698 757-798 |
| ISOLATE) |
| PPOL-- SIVGB POL POLYPROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| 527-561 626-688 |
| (SIV(CPZ)) |
| PPOL-- SIVMI POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (ISOLATE GB1) |
| 9-57 446-483 629-673 793-827 912-946 PPOL-- |
| SIVMK POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (MM142-83 485-519 |
| 654-688 |
| ISOLATE) |
| PPOL-- SIVS4 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (K6W |
| ISOLATE) 485-519 654-688 |
| PPOL-- SIVSP POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (F236/SMH4 446-482 617-651 |
| ISOLATE) |
| PPOL-- SOCMV POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (PBJ/BC13 451-485 620-654 |
| ISOLATE) |
| PPOL-- SRV1 ENZYMATIC POLYPROTEIN SOYBEAN CHLOROTIC MOTTLE VIRUS |
| 247-295 372-416 |
| PPOL-- VILV POL POLYPROTEIN SIMIAN RETROVIRUS SRV-1 470-504 |
| 578-63 |
| PPOL-- VILV1 POL POLYPROTEIN VISNA LENTIVIRUS (STRAIN 1514) |
| 489-524 874-929 |
| PPOL-- VILV2 POL POLYPROTEIN VISNA LENTIVIRUS (SIMIAN 1514/CLONE |
| LVI-1KS1) 489-524 874-929 |
| PPP15-- HCMVA POL POLYPROTEIN VISNA LENTIVIRUS (STRAIN 1514/CLONE |
| LVI-1KS2) 489-524 874-929 |
| PPR73-- MMVB LARGE STRUCTURAL HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) 116-150 187-221 |
| PHOSPHOPROTEIN PP150 |
| PPR73-- MMTVC PROTEIN PR73 MOUSE MAMMARY TUMOR VIRUS (STRAIN BR6) |
| 152-200 |
| PPR73-- MMTVG PROTEIN PR73 MOUSE MAMMARY TUMOR VIRUS (STRAIN C3H) |
| 20-79 |
| PPR7L-- MMTVG PROTEIN PR73 MOUSE MAMMARY TUMOR VIRUS (STRAIN GR) |
| 61-95 142-201 |
| PPR7R-- MMTVG PROTEIN PR73 MOUSE MAMMARY TUMOR VIRUS (STRAIN GR) |
| 145-204 270-311 |
| PPYHD-- CPVBM PROTEIN PR73 MOUSE MAMMARY TUMOR VIRUS (STRAIN GR) |
| 141-200 266-307 |
| PPYHD-- NPVAC POLYHEDRIN PRECURSOR BOMBYX MORI CYTOPLASMIC |
| POLYHEDROSIS VIRUS 13-85 |
| PPYHD-- NPVAS POLYHEDRIN AUTOGRAPRA CALIFORNICA NUCLEAR 13-47 |
| POLYHEDROSIS VIRUS |
| PPYHD-- |
| NPVBM POLYHEDRIN AGROTIS SEGETUM NUCLEAR 14-48 POLYHEDROSI |
| S VIRUS |
| PPYHD-- NPVBS POLYHEDRIN BOMBYX MORI NUCLEAR POLYHEDROSIS VIRUS |
| 12-54 |
| PPYHD-- NPVLD POLYHEDRIN BUZURA SUPRESSARIA NUCLEAR POLYHEDROSIS |
| 14-48 |
| VIRUS |
| PPYHD-- NPVMB POLYHEDRIN LYMANTRIA DISPAR MULTICAPSID NUCLEAR |
| 14-48 |
| POLYHEDROSIS V |
| PPYHD-- NPVOP POLYHEDRIN MAMESTRA BRASSICAE NUCLEAR POLYHEDROSIS |
| 14-48 |
| VIRUS |
| PPYHD-- NPVOS POLYHEDRIN ORGYIA PSEUDOTSUGATA MULTICAPSID 13-47 |
| POLYHEDROSIS VIRUS |
| PPYHD-- NPVPF POLYHEDRIN ORGYIA PSEUDOTSUGATA SINGLE CAPSID |
| NUCLEAR 14-48 |
| POLYHED |
| PPYHD-- NPVSE POLYHEDRIN PANOLIS FLAMMEA MULTIPLE NUCLEOCAPSID |
| 14-48 |
| POLYHEDROSIS |
| PPYHD-- NPVSF POLYHEDRIN SPODOPTHRA EXIGUA NUCLEAR POLYHEDROSIS |
| 14-48 |
| VIRUS (STRAIN |
| PPYHD-- NPVSL POLYHEDRIN SPODOPTHRA FRUGIPERDA NUCLEAR 14-48 |
| POLYHEDROSIS VIRUS |
| PRASK-- MSVKI POLYHEDRIN SPODOGTHRA LITTGRALIS NUCLEAR 17-51 |
| POLYHEDROSIS VIRUS |
| PREV-- BIV27 TRANSFORMING PROTEIN 21 KIRSTEN MURINE SARCOMA VIRUS |
| 142-176 |
| PREV-- EIAV9 REV PROTEIN BOVINE IMMUNODEFICIENCY VIRUS (ISOLATE |
| 127) |
| 77-115 |
| PREV-- EIAVC REV PROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| 1369) 51-89 |
| PREV-- EIAVY REV PROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| CL22) 51-89 |
| PREV-- HV112 REV PROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (ISOLATE |
| 81-119 |
| WYOMING) |
| PREV-- HV1A2 REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 35-69 |
| (CLONE 12) |
| PREV-- HV1B1 REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 32-69 |
| (ARV2/SF2 ISOLATE |
| PREV-- HV1B8 REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 35-69 |
| (BH10 ISOLATE) |
| PREV-- HV1BN REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 25-59 |
| (B8 ISOLATE) |
| PREV-- HV1BR REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 22-59 |
| (BRAIN ISOLATE) |
| PREV-- HV1EL REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 35-69 |
| (BRU ISOLATE) |
| PREV-- HV1H2 REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 32-66 |
| (ELI ISOLATE) |
| PREV-- HV1J3 REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 35-69 |
| (HXB2 ISOLATE) |
| PREV-- HV1JR REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 29-63 |
| (JH3 ISOLATE) |
| PREV-- HV1MA REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 31-66 |
| (JRCSF ISOLATE) |
| PREV-- HV1MN REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 31-66 |
| (MAL ISOLATE) |
| PREV-- HV1OY REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 31-66 |
| (MN ISOLATE) |
| PREV-- HV1PV REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 32-69 |
| (OY1 ISOLATE) |
| PREV-- HV1S3 REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 35-69 |
| (PV22 ISOLATE) AN |
| PREV-- HV1SC REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 35-69 |
| (SF33 ISOLATE) |
| PREV-- SIVA1 REV PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 32-69 |
| (SC ISOLATE) |
| PREV-- SIVAG REV PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS 26-77 |
| (AGM155 ISOLATE) |
| PREV-- SIVA1 REV PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (AGM3 |
| 26-77 |
| ISOLATE) |
| PREV-- SIVAT REV PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (ISOLATE |
| 29-77 |
| AGM/CLONE GR |
| PREV-- SIVCZ REV PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (TYO-1 |
| 28-75 |
| ISOLATE) |
| PREV-- VILV REV PROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS 33-67 |
| PRIRI-- ASFM2 REV PROTEIN VISNA LENTIVIRUS (STRAIN 1514) 21-62 |
| PRIRI-- EBV RIBONUCLEOSIDE-DIPHOSPHATE AFRICAN SWINE FEVER VIRUS |
| (ISOLATES MALAWI 7-41 |
| 88-133 635-683 REDUCTASE LAR LIL |
| 20/1) |
| PRIRI-- HCMVA RIBONUCLEOSIDE-DIPHOSPHATE EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) 213-247 689-723 |
| REDUCTASE LAR |
| PRIR1-- HSVEB RIBONUCLEOSIDE-DIPHOSPHATE HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 632-668 |
| REDUCTASE LAR |
| PRIR1-- HSVSA RIBONUCLEOSIDE-DIPHOSPHATE EQUINE HERPES VIRUS TYPE |
| 1 (STRAIN AB4P) |
| 76-110 REDUCTASE LAR |
| PRIR1-- VACCC RIBONUCLEOSIDE-DIPHOSPHATE HERPESVIRUS SAIMIRI |
| (STRAIN 11) 324-365 |
| REDUCTASE LAR |
| PRIR1-- VACCV RIBONUCLEOSIDE-DIPHOSPHATE VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 367-402 |
| REDUCTASE LAR |
| PRIR1-- VARV RIBONUCLEOSIDE-DIPHOSPHATE VACCINIA VIRUS (STRAIN |
| WR) 367-402 |
| REDUCTASE LAR |
| PRIR1-- VZVD RIBONUCLEOSIDE-DIPHOSPHATE VARIOLA VIRUS 367-402 |
| REDUCTASE LAR |
| PRIR2-- EBV RIBONUCLEOSIDE-DIPHOSPHATE VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 223-257 |
| REDUCTASE LAR |
| PRIR2-- HSVB3 RIBONUCLEOSIDE-DIPHOSPHATE EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) |
| 89-137 REDUCTASE |
| SMA |
| PRIR2-- HSVEB RIBONUCLEOSIDE-DIPHOSPHATE BOVINE HERPESVIRUS TYPE |
| 1 (STRAIN 34) 101-135 |
| REDUCTASE SMA |
| PRIR2-- HSVSA RIBONUCLEOSIDE-DIPHOSPHATE EQUINE HERPESVIRUS TYPE |
| 1 (STRAIN AB4P) 106-140 |
| REDUCTASE SMA |
| PRIR2-- SFVKA RIBONUCLEOSIDE-DIPHOSPHATE HERPESVIRUS SAIMIRI |
| (STRAIN 11) 125-159 |
| REDUCTASE SMA |
| PRIR2-- VACCC RIBONUCLEOSIDE-DIPHOSPHATE SHOPE FIBROMA VIRUS |
| (STRAIN KASZA) |
| 98-132 REDUCTASE |
| SMA |
| PRIR2-- VACCP RIBONUCLEOSIDE-DIPHOSPHATE VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| 98-132 REDUCTASE |
| SMA |
| PRIR2-- VACCV RIBONUCLEOSIDE-DIPHOSPHATE VACCINIA VIRUS (STRAIN |
| L-IVP) |
| 98-132 |
| REDUCTASE SMA |
| PRIR2-- VARV RIBONUCLEOSIDE-DIPHOSPHATE VACCINIA VIRUS (STRAIN |
| WR) |
| 98-132 |
| REDUCTASE SMA |
| PRL1-- HSV2H RIBONUCLEOSIDE-DIPHOSPHATE VARIOLA VIRUS 98-132 |
| REDUCTASE SMA |
| PRP94-- VACCV NEUROVIRULENCE FACTOR HERPES SIMPLEX VIRUS (TYPE |
| 2/STRAIN HG52) 171-212 |
| PRP94-- VARV RNA-POLYMERASE-ASSOCIATED VACCINIA VIRUS (STRAIN |
| WR), AND (STRAIN 116-150 465-540 757-791 |
| TRANSCRIPTION S COPENHAGEN |
| PRPO1-- VACCC RNA-POLYMERASE-ASSOCIATED VARIOLA VIRUS 41-75 |
| 116-150 465-540 757-791 |
| TRANSCRIPTION S |
| PRPO1-- VACCV DNA-DIRECTED RNA POLYMERASE VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 243-291 622-656 754-791 954-988 1006- |
| 147 KD POLYPE 1057 |
| PRPO1-- VARV DNA-DIRECTED RNA POLYMERASE VACCINIA VIRUS (STRAIN |
| WR) 243-291 622-656 754-791 954-988 1024- |
| 147 KD POLYPE 1058 |
| PRPO2-- CAPVK DNA-DIRECTED RNA POLYMERASE VARIOLA VIRUS 243-291 |
| 622-656 754-791 954-988 1006- |
| 147 KD POLYPE 1057 |
| PRPO2-- COWPX DNA-DIRECTED RNA POLYMERASE CAPRIPOXVIRUS (STRAIN |
| KS-1) 19-60 114-155 589-630 |
| 132 KD POLYPE |
| PRPO2-- VACCV DNA-DIRECTED RNA POLYMERASE COWPOX VIRUS 211-245 |
| 359-400 833-874 |
| 132 KD POLYPE |
| PRPO2-- VARV DNA-DIRECTED RNA POLYMERASE VACCINIA VIRUS (STRAIN |
| WR), AND 211-245 359-400 833-874 |
| 132 KD POLYPE (STRAIN COPENHAGEN) |
| PRPO4-- VACCC DNA-DIRECTED RNA POLYMERASE VARIOLA VIRUS 211-245 |
| 359-400 833-874 |
| 132 KD POLYPE |
| PRPO4-- VACCV DNA-DIRECTED RNA POLYMERASE VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| 62-116 35 KD |
| POLYPEP |
| PRPO4-- VARV DNA-DIRECTED RNA POLYMERASE VACCINIA VIRUS (STRAIN |
| WR) |
| 62-116 |
| 35 KD POLYPEP |
| PRPO5-- VACCC DNA-DIRECTED RNA POLYMERASE VARIOLA VIRUS 62-116 |
| 35 KD POLYPEP |
| PRPO5-- VACCV DNA-DIRECTED RNA POLYMERASE VACCINIA VIRUS (STRAIN |
| COPEHAGEN) |
| 1-71 30 KD |
| POLYPEP |
| PRPO5-- VARV DNA-DIRECTED RNA POLYMERASE VACCINIA VIRUS (STRAIN |
| WR) |
| 1-71 |
| 30 KD POLYPEP |
| PRPO6-- VACCV DNA-DIRECTED RNA POLYMERASE VARIOLA VIRUS 1-71 |
| 30 KD POLYPEP |
| PRPO6-- VARV DNA-DIRECTED RNA POLYMERASE VACCINIA VIRUS (STRAIN |
| WR), AND 25-59 |
| 22 KD POLYPEP STRAIN COPEHAGEN) |
| PRPO7-- VACCV DNA-DIRECTED RNA POLYMERASE VARIOLA VIRUS 25-59 |
| 22 KD POLYPEP |
| PRPO7-- VARV DNA-DIRECTED RNA POLYMERASE VACCINIA VIRUS (STRAIN |
| WR), AND 43-93 |
| 19 KD POLYPEP STRAIN COPEHAGEN) |
| PRPOA-- LELV DNA-DIRECTED RNA POLYMERASE VARIOLA VIRUS 43-93 |
| 19 KD POLYPEP |
| PRPOL-- EAV RNA-DIRECTED RNA POLYMERASE LELYSTAND VIRUS 1533- |
| 1721- 1958- 2109- |
| 1567 1758 1992 2157 |
| PRRP1-- IAANN RNA-DIRECTED RNA POLYMERASE EQUINE ARTERITIS VIRUS |
| 1083- 1477- 1633- |
| 1117 1518 1673 |
| PRRP1-- IABEI RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/ANN ARBOR/6/60) 171-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IADUN RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/BEIJING/11/56) 171-242 279-313 350-391 |
| SUBUNIT P1 |
| PRRP1-- IAGU2 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/DUNEDIN/4/73) 171-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IAHLO RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/GULL/MARYLAND/ 171-242 279-313 |
| SUBUNIT P1 704/77) |
| PRRP1-- IAHTE RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/QUINE/LONDON/ 168-242 279-313 |
| SUBUNIT P1 1416/73) |
| PRRP1-- IAKIE RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/EQUINE/ 168-242 279-313 |
| SUBUNIT P1 TENNESSEE/5/86) |
| PRRP1-- IAKOR RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/KIEV/59/79) 171-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IALE1 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/KOREA/426/68) 171-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IALE2 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/134/57) 171-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IALE3 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/134/ 171-242 279-313 |
| SUBUNIT P1 17/57) |
| PRRP1-- IAMAN RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/134/ 171-242 279-313 |
| SUBUNIT P1 47/57) |
| PRRP1-- IAME8 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/MALLARD/NEW 171-242 279-313 |
| SUBUNIT P1 YORK/6750/78 |
| PRRP1-- IANT6 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/MEMPHIS/8/88) 171-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IAPUE RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/NT/60/68) 171-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IASIN RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/PUERTO RICO/8/34) 168-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IATKM RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SINGAPORE/1/57) 171-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IAV17 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/TURKEY/ 171-242 279-313 |
| SUBUNIT P1 MINNESOTA/833/80 |
| PRRP1-- IAWIL RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/VICTORIA/3/75) 171-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IAWIS RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/WILSON-SMITH/33) 168-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IAZH3 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/WISCONSIN/3523/88) 168-242 279-313 |
| SUBUNIT P1 |
| PRRP1-- IAZON RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SWINE/HONG 187-242 279-313 |
| SUBUNIT P1 KONG/126/82) |
| PRRP1-- IAZTF RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SWINE/ONTARIO/ 171-242 279-313 |
| SUBUNIT P1 2/81) |
| PRRP1-- INBAC RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SWINE/TENNESSE/ 171-242 279-313 |
| SUBUNIT P1 26/77) |
| PRRP1-- INBAD RNA-DIRECTED RNA POLYMERASE INFLUENZA B VIRUS |
| (STRAIN B/ANN ARBOR/1/66) 208-249 |
| SUBUNIT P1 |
| PRRP1-- INBLE RNA-DIRECTED RNA POLYMERASE INFLUENZA B VIRUS |
| (STRAIN B/ANN ARBOR/1/66 208-249 |
| SUBUNIT P1 [WILD-TYPE] |
| PRRP1-- INCJI RNA-DIRECTED RNA POLYMERASE INFLUENZA B VIRUS |
| (STRAIN B/LEE/40) 208-249 |
| SUBUNIT P1 |
| PRRP2-- IAANN RNA-DIRECTED RNA POLYMERASE INFLUENZA C VIRUS |
| (STRAIN C/JJ/50) 350-384 648-686 707-752 |
| SUBUNIT P1 |
| PRRP2-- IADH2 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/ANN 110-144 177-218 |
| SUBUNIT P2 ARBOR/6/60) |
| PRRP2-- IAFPR RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/DUCK/ 110-144 177-218 |
| SUBUNIT P2 HOKKAIDO/8/80) |
| PRRP2-- IAGU2 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/FOWL PLAGUE 110-144 177-218 |
| SUBUNIT P2 VIRUS/ROSTOCK |
| PRRP2-- IAHLO RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/GULL/MARYLAND/ 110-144 177-218 |
| SUBUNIT P2 704/77) |
| PRRP2-- IAHTE RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/EQUINE/LONDON/ 110-144 177-218 |
| SUBUNIT P2 1416/73) |
| PRRP2-- IAKOR RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/EQUINE/ 110-144 177-218 |
| TENNESSEE/5/86) |
| PRRP2-- IALE1 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/KOREA/426/68) 110-144 177-218 |
| SUBUNIT P2 |
| PRRP2-- IALE2 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/134/57) 110-144 177-218 |
| SUBUNIT P2 |
| PRRP2-- IAMAN RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/134/ 110-144 177-218 |
| SUBUNIT P2 17/157) |
| PRRP2-- IANT6 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/MALLARD/NEW 110-144 177-218 |
| SUBUNIT P2 YORK/6750/78) |
| PRRP2-- IAP10 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/NT/60/68) 110-144 177-218 |
| SUBUNIT P2 |
| PRRP2-- IAPUE RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/PINTAIL/ 110-144 177-218 |
| SUBUNIT P2 ALBERTA/119/79) |
| PRRP2-- IARUD RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/PUERTO RICO/8/34) 110-144 177-218 |
| SUBUNIT P2 |
| PRRP2-- IASIN RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/RUDDY 110-144 177-218 |
| SUBUNIT P2 TURNSTONE/NEW JERS |
| PRRP2-- IATKM RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SINGAPORE/1/57) 110-144 177-218 |
| SUBUNIT P2 |
| PRRP2-- IAV17 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/TURKEY/ 110-144 177-218 |
| SUBUNIT P2 MINNESOTA/833/80) |
| PRRP2-- IAWIL RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/VICTORIA/3/75) 110-144 177-218 |
| SUBUNIT P2 |
| PPRP2-- IAZH2 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/WILSON-SMITH/33) 110-144 177-218 |
| SUBUNIT P2 |
| PRRP2-- IAZH3 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SWINE/HONG 110-144 177-218 |
| SUBUNIT P2 KONG/81/78 |
| PRRP2-- IAZI1 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SWINE/HONG 110-144 177-218 |
| SUBUNIT P2 KONG/126/82) |
| PRRP2-- IAZTF RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SWINE/IOWA/15/30 110-141 177-218 |
| SUBUNIT P2 |
| PRRP2-- INBAC RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SWINE/TENNESSE/ 110-144 177-218 |
| SUBUNIT P2 26/77) |
| PRRP2-- INBAD RNA-DIRECTED RNA POLYMERASE INFLUENZA B VIRUS |
| (STRAIN B/ANN ARBOR/ 111-196 349-393 |
| SUBUNIT P2 1/66 [COLD-ADAPTE |
| PRRP2-- INBSI RNA-DIRECTED RNA POLYMERASE INFLUENZA B VIRUS |
| (STRAIN B/ANN ARBOR/ 111-196 349-390 |
| SUBUNIT P2 1/66 [WILD-TYPE]) |
| PRRP3-- IAANN RNA-DIRECTED RNA POLYMERASE INFLUENZA B VIRUS |
| (STRAIN B/SINGAPORE/222/79) 111-196 349-383 |
| SUBUNIT P2 |
| PRRP3-- IABUD RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/ANN ARBOR/6/60) |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- IACHI RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN BUDGERIGAR/ |
| 1-42 363-402 473-514 518-567 707-755 SUBUNIT P3 |
| HOKKAIDO/1/77) |
| PRRP3-- IAFPR RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/CHILE/1/83) |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- IAFPW RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/FOWL PLAGUE |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 VIRUS/ROS |
| TOCK |
| PRRP3-- IAGU2 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/FOWL PLAGUE |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 VIRUS/WEY |
| BRID |
| PRRP3-- IAGUA RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/GULL/ |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| MARYLAND/704/77 |
| PRRP3-- IAHK6 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/GULL/ |
| 7-41 363-402 473-514 707-755 SUBUNIT P3 |
| ASTRAKHAN/227/84) |
| PRRP3-- IAHLO RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/EQUINE/ |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| KENTUCKY/1416/73) |
| PRRP3-- IAHPR RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/EQUINE/ |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| LONDON/1416/73) |
| PRRP3-- IAKIE RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/EQUINE/ |
| 1-42 363-402 473-514 721-755 SUBUNIT P3 |
| PRAGUE/1/56) |
| PRRP3-- IAKOR RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/KIEV/59/79) |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- IALE1 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/KOREA/ |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| 426/68) |
| PRRP3-- IALE2 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/ |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 134/57) |
| PRRP3-- IALE3 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/ |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| 134/17/57) |
| PRRP3-- IAMAN RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/ |
| 1-2 363-482 473-514 707-755 SUBUNIT P3 |
| 134/47/57) |
| PRRP3-- IAME8 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/MALLARD/NEW 363-402 473-514 707-755 |
| SUBUNIT P3 YORK/6750/78) |
| PRRP3-- IANT6 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/MEMPIS/8/88) |
| 7-41 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- IAPUE RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/NT/60/68) |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- IARUD RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/PUERTO RICO/8(34) |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- IASE2 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/RUDDY |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| TURNSTONE/NEW JERSE |
| PRRP3-- IASIN RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SEAL/ |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| MASSACHUSETTS/133/82) |
| PRRP3-- IATKM RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SINGAPORE/1/57) |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- IAV17 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/TURKEY/ |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| MINNESOTA/833/80) |
| PRRP3-- IAWIL RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/VICTORIA/3/75) |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- IAZI1 RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/WILSON-SMITH/33 |
| 1-2 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- IAZTE RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SWINE/IOWA/15/30) |
| 1-42 363-402 473-514 707-755 SUBUNIT P3 |
| PRRP3-- INBAC RNA-DIRECTED RNA POLYMERASE INFLUENZA A VIRUS |
| (STRAIN A/SWINE/TENNESSEE/ |
| 7-41 363-402 473-514 707-755 SUBUNIT P3 24/77 |
| PRRP3-- INBAD RNA-DIRECTED RNA POLYMERASE INFLUENZA B |
| VIRUS (STRAIN B/ANN ARBOR/1/66 458-533 |
| SUBUNIT P3 [COLD-ADAPTE |
| PRRP3-- INCBE RNA-DIRECTED RNA POLYMERASE INFLUENZA B VIRUS |
| (STRAIN B/ANN ARBOR/1/66 458-533 |
| SUBUNIT P3 [WILD-TYPE]) |
| PRRP3-- INCJJ RNA-DIRECTED RNA POLYMERASE INFLUENZA C VIRUS |
| (STRAIN C/BERLIN/1/85) 235-269 275-309 |
| SUBUNIT P3 |
| PRRP3-- THOGV RNA-DIRECTED RNA POLYMERASE INFLUENZA C VIRUS |
| (STRAIN C/JJ/50) 235-269 275-316 |
| SUBUNIT P3 |
| PRRPA-- CVH22 RNA-DIRECTED RNA POLYMERASE THOGOTO VIRUS 343-401 |
| SUBUNIT P3 |
| PRRPA-- CVMJH RNA-DIRECTED RNA POLYMERASE HUMAN CORONAVIRUS |
| (STRAIN 229E) 358-392 495-571 1742- 1971- 3664- 3912- |
| 1776 2008 3724 3946 |
| PRRPB-- BEV RNA-DIRECTED RNA POLYMERASE MURINE CORONAVIRUS MHV |
| (STRAIN JHM) 617-651 1364- 2769- 3586- 3821- 4075- 4319- |
| 1398 2803 3620 3855 4121 4353 |
| PRRPB-- CVMA5 RNA-DIRECTED RNA POLYMERASE BERNE VIRUS 20-64 |
| 617-651 943- |
| 1009 |
| PRRPB-- CVMJH RNA-DIRECTED RNA POLYMERASE MURINE CORONAVIRUS MHV |
| (STRAIN A59) 1129- 1303- 1453- 1692- 2629- |
| 1170 1337 1494 1726 2670 |
| PRRPB-- IBVB RNA-DIRECTED RNA POLYMERASE MURINE CORONAVIRUS MV |
| (STRAIN JHM) 1129- 1303- 1453- 1690- 2627- |
| 1170 1337 1494 1724 2668 |
| PRRPB-- IBVK RNA-DIRECTED RNA POLYMERASE AVIAN INFECTIOUS |
| BRONCHITIS VIRUS 499-550 650-695 1460- 1509- 2246- |
| (STRAIN BEAUDETTE) 1494 1548 2287 |
| PRRPL-- BTV10 RNA-DIRECTED RNA POLYMERASE AVIAN INFECTIOUS |
| BRONCHITIS VIRUS 115-156 |
| (STRAIN KB8523) |
| PRRPL-- BUNYW RNA-DIRECTED RNA POLYMERASE BLUETONGUE VIRUS |
| (SEROTYPE 10/ISOLATE USA) 308-342 705-748 825-903 1021- 1114- |
| 1076 1201 |
| PRRPL-- CDVO RNA POLYMERASE BUNYAMWERA VIRUS 2-36 80-114 |
| 308-363 371-412 1704- 1802- 1889- |
| 1741 1861 1935 |
| PRRPL-- HANTV RNA POLYMERASE BETA SUBUNIT CANINE DISTEMPER VIRUS |
| (STRAIN 20-54 |
| ONDERSTEPOORT) |
| PRRPL-- HRSVA RNA POLYMERASE HANTAAN VIRUS (STRAIN 76-118) |
| 98-139 174-208 372-431 557-591 655-696 731-783 905-949 1276- |
| 1419- 1742- 1993- 1310 |
| 1453 1776 2027 |
| PRRPL-- MABVM RNA POLYMERASE BETA SUBUNIT HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS |
| 87-188 827-861 1131- 1185- 1465- (STRAIN A2 |
| 1179 1220 1517 |
| PRRPL-- MASVP RNA-DIRECTED RNA POLYMERASE MARBURG VIRUS (STRAIN |
| MUSOKE) 597-631 1046- 1490- 1804- 2029- 2194- |
| 1092 1552 1838 2063 2266 |
| PRRPL-- MEASE RNA-DIRECTED RNA POLYMERASE MARBURG VIRUS (STRAIN |
| POPP) 597-631 1046- 1490- |
| 1092 1552 |
| PRRPL-- MUMPM RNA POLYMERASE BETA SUBUNIT MEASLES VIRUS (STRAIN |
| EDMONSTON) 197-231 790-824 869-903 1064- 1283- 2121- |
| 1109 1317 2155 |
| PRRPL-- NDVB RNA POLYMERASE BETA SUBUNIT MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) 164-214 220-254 267-304 576-627 752-807 1231- 1447- |
| 1487- |
| 1566- 2191- 1286 1481 1531 |
| 1600 2225 |
| PRRPL-- PI2HT RNA POLYMERASE BETA SUBUNIT NEWCASTLE DISEASE VIRUS |
| (STRAIN BEAUDETTE 167-208 230-295 1969- 2043- 2108- |
| C/45) 2013 2077 2142 |
| PRRPL-- PI3H4 RNA POLYMERASE BETA SUBUNIT HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN 136-170 575-628 750-785 1226- 1316- 1417- 1564- 1687- |
| TOSHIBA) 1901- 1284 1357 1479 1630 1721 |
| 1955 |
| PRRPL-- PUUMH RNA POLYMERASE BETA SUBUNIT HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN 48-91 107-163 540-574 747-781 1064- 1293- 1499- 1994- |
| NIH 47885) 1129 1356 1536 2036 |
| PRRPL-- RABVP RNA-DIRECTED RNA POLYMERASE PUUMALA VIRUS (STRAIN |
| HALLNAS B1) 98-132 381-415 444-488 557-591 655-696 731-783 922-976 |
| 1119- |
| 1742- 1940- 1993- 1153 |
| 1776 1975 2032 |
| PRRPL-- RABVS RNA POLYMERASE BETA SUBUNIT RABIES VIRUS (STRAIN |
| PV) |
| 73-114 197-231 696-730 1174- 1522- 1584- 2068- |
| 1222 1580 1618 2123 |
| PRRPL-- RDV RNA POLYMERASE BETA SUBUNIT RABIES VIRUS (STRAIN SAD |
| B19) |
| 73-114 197-231 696-730 749-783 1174- 1522- 1584- |
| 1222 1580 2123 |
| PRRPL-- RVFVZ RNA-DIRECTED RNA POLYMERASE RICE DWARF VIRUS 17-61 |
| 534-575 844-878 918-985 1037- |
| 1071 |
| PRRPL-- SEND5 RNA-DIRECTED RNA POLYMERASE RIFT VALLEY FEVER VIRUS |
| (STRAIN ZH-548 M12) 398-439 641-678 832-887 1081- 1653- 1819- |
| 1115 1687 1870 |
| PRRPL-- SENDE RNA POLYMERASE BETA SUBUNIT SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) 398-343 540-600 612-656 747-781 1064- 1239- 1499- 2000- |
| 2146- 1119 1280 1536 2034 |
| 2216 |
| PRRPL-- SENDZ RNA POLYMERASE BETA SUBUNIT SENDAI VIRUS (STRAIN |
| ENDERS) 129-163 360-420 432-476 567-601 884-939 1059- 1319- 1820- |
| 1966- 1100 1356 1854 |
| 2036 |
| PRRPL-- SEOU8 RNA POLYMERASE BETA SUBUNIT SENDAI VIRUS (STRAIN Z) |
| 309-343 540-600 612-656 747-781 1064- 1239- 1499- 2000- |
| 2146- 1119 1280 1536 2034 |
| 2216 |
| PRRPL-- SV5WR RNA-DIRECTED RNA POLYMERASE SEOUL VIRUS (STRAIN |
| 80-39) 98-139 174-208 557-591 655-696 731-765 1742- 1947- 1993- |
| 1776 1981 2027 |
| PRRPL-- SYNV RNA POLYMERASE BETA SUBUNIT SIMIAN VIRUS 5 (STRAIN |
| 21004-WR) 547-627 747-781 1225- 1319- 1592- 1676- 2024- |
| 1280 1353 1626 1715 2058 |
| PRRPL-- TSWVB RNA POLYMERASE RNA BETA SONCHUS YELLOW NET VIRUS |
| 760-794 825-859 977- 1089- 1978- 2059- |
| SUBUNIT 1014 1137 2032 2107 |
| PRRPL-- UUK RNA-DIRECTED RNA POLYMERASE TOMATO SPOTTED WILT VIRUS |
| (BRAZILIAN 46-101 399-433 539-573 589-634 1119- 1195- 1321- 1538- |
| ISOLATE CPNH1/BR- 1153 1236 1379 1572 |
| 1684- 1857- 2073- 2156- 2206- 2315- 2378- 2809- |
| 1725 1898 2127 2200 2247 2368 2419 2843 |
| PRRPL-- VSVJH RNA POLYMERASE UUKUNIEMI VIRUS 127-183 282-323 |
| 836-874 1030- 1481- 2015- 2061- |
| 1071 1515 2049 2098 |
| PRRPL-- VSVJO RNA POLYMERASE BETA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE NEW 319-358 674-715 720-763 1522- 1802- |
| JERSEY/STRA 1567 1836 |
| PRRPL-- VSVSJ RNA POLYMERASE BETA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE NEW 319-358 674-715 720-763 1802- |
| JERSEY/STRA 1836 |
| PRRPO-- ACLSV RNA POLYMERASE BETA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (STRAIN SAN JUAN) 674-715 720-763 1019- 1742- 2066- |
| 1074 1799 2107 |
| PRRPO-- BWYVF RNA-DIRECTED RNA POLYMERASE APPLE CHLOROTIC LEAF |
| SPOT VIRUS 228-262 557-596 916-950 1235- |
| 1269 |
| PRRPO-- BYDV1 PUTATIVE RNA-DIRECTED RNA BEET WESTERN YELLOWS |
| VIRUS (ISOLATE FL-1) 304-341 |
| POLYMERASE |
| PRRPO-- BYDVP PUTATIVE RNA-DIRECTED RNA BARLEY YELLOW DWARF VIRUS |
| (ISOLATE MAV-PS1) 234-285 |
| POLYMERASE |
| PRRPO-- BYDVR PUTATIVE RNA-DIRECTED RNA BARLEY YELLOW DWARF VIRUS |
| (ISOLATE PAV) 234-285 |
| POLYMERASE |
| PRRPO-- CARMV PUTATIVE RNA-DIRECTED RNA BARLEY YELLOW DWARF VIRUS |
| (ISOLATE P-PAV) 234-285 |
| POLYMERASE |
| PRRPO-- CGMVS PROBABLE RNA-DIRECTED RNA CARNATION MOTTLE VIRUS |
| 93-131 |
| POLYMERASE |
| PRRPO-- IBDV5 PUTATIVE RNA-DIRECTED RNA CUCUMBER GREEN MOTTLE |
| MOSAIC VIRUS |
| 7-41 387-428 446-480 726-767 1445- POLYMERASE |
| (WATERMELON STR 1479 |
| PRRPO-- IBDVA PUTATIVE RNA-DIRECTED RNA AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS 384-432 446-484 |
| POLYMERASE (STRAIN 52170) |
| PRRPO-- IPNVJ PUTATIVE RNA-DIRECTED RNA AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS 144-185 266-307 709-757 771-809 |
| POLYMERASE (STRAIN AUSTURALI |
| PRRPO-- IPNVS PUTATIVE RNA-DIRECTED RNA INFECTIOUS PANCREATIC |
| NECROSIS VIRUS 147-181 268-407 501-535 750-802 |
| POLYMERASE (SEROTYPE JASPER) |
| PRRPO-- LYCVA PUTATIVE RNA-DIRECTED RNA INFECTIOUS PANCREATIC |
| NECROSIS VIRUS 147-181 366-407 501-535 753-802 |
| POLYMERASE (SEROTYPE SP) |
| PRRPO-- LYCVW RNA POLYMERASE LYMPHOCYTIC CHORIOMENINGITIS VIRUS |
| (STRAIN 301-346 805-886 926-960 1509- 2090- |
| ARMSTRON 1543 2124 |
| PRRPO-- MCMV RNA POLYMERASE LYMPHOCYTIC CHORIOMENINGITIS VIRUS |
| (STRAIN 301-345 |
| WE) |
| PRRPO-- PEAMV PROBABLE RNA-DIRECTED RNA MAIZE CHLOROTIC MOTTLE |
| VIRUS 181-215 697-731 |
| POLYMERASE |
| PRRPO-- PLRV1 RNA-DIRECTED RNA POLYMERASE PEA ENATION MOSAIC |
| VIRUS 321-358 |
| PRLPO-- PLRVW PUTATIVE RNA-DIRECTED RNA POTATO LEAFROLL VIRUS |
| (STRAIN 1) 336-373 423-457 |
| POLYMERASE |
| PRRPO-- PPMVS PUTATIVE RNA-DIRECTED RNA POTATO LEAFROLL VIRUS |
| (STRAIN WAGENINGEN) 336-373 423-457 |
| POLYMERASE |
| PRRPP-- RCNMV PUTATIVE RNA-DIRECTED RNA PEPPER MILD MOTTLE VIRUS |
| (STRAIN SPAIN 321-362 402-454 627-661 862-896 |
| POLYMERASE |
| PRRPO-- REOVD PUTATIVE RNA-DIRECTED RNA RED CLOVER NECROTIC |
| MOSAIC VIRUS 666-700 |
| POLYMERASE |
| PRLPO-- REOVJ RNA-DIRECTED RNA POLYMERASE REOVIRUS (TYPE 3/STRAIN |
| DEARING) 310-361 |
| PRRPO-- REOVL RNA-DIRECTED RNA POLYMERASE REOVIRUS (TYPE 2/STRAIN |
| D5/JONES) 310-344 |
| PRRPO-- ROTBR RNA-DIRECTED RNA POLYMERASE REOVIRUS (TYPE 1/STRAIN |
| LANG) 310-361 |
| PRRPO-- ROTBU RNA-DIRECTED RNA POLYMERASE BOVINE ROTAVIRUS |
| (STRAIN RF) 60-96 133-167 204-245 535-569 579-631 639-686 690-724 |
| 771-805 |
| SUBUNIT VP1 |
| PRRPO-- ROTPC RNA-DIRECTED RNA POLYMERASE BOVINE ROTAVIRUS |
| (STRAIN UK) 60-96 133-167 204-245 535-569 579-631 639-686 690-724 |
| 771-805 |
| SUBUNIT VP1 |
| PRRPO-- ROTPG RNA-DIRECTED RNA POLYMERASE PORCINE ROTAVIRUS |
| (GROUP C/STRAIN COWDEN) 3-44 255-299 335-397 476-510 518-620 966-1007 |
| SUBUNIT VP1 |
| PRRPO-- ROTS1 RNA-DIRECTED RNA POLYMERASE PORCINE ROTAVIRUS |
| (STRAIN GOTTFRIED) 62-96 133-167 336-377 581-631 636-686 690-724 771-842 |
| SUBUNIT VP1 |
| PRRPO-- SBMV RNA-DIRECTED RNA POLYMERASE SIMIAN 11 ROTAVIRUS |
| (STRAIN SA11) 60-96 133-167 535-569 579-631 639-686 690-724 771-805 |
| SUBUNIT VP1 |
| PRRPO-- SCVLA PROBABLE RNA-DIRECTED RNA SOUTHERN BEAN MOSAIC |
| VIRUS 628-665 |
| POLYMERASE |
| PRRPO-- TACV RNA-DIRECTED RNA POLYMERASE SACCHAROMYCES CEREVISIAE |
| VIRUS L-A 100-134 147-191 |
| PRRPO-- TMGMV RNA POLYMERASE TACARIBE VIRUS 155-204 220-278 |
| 375-416 484-518 891-925 1030- 1285- 1981- |
| 1081 1319 2015 |
| PRRPO-- TMV PUTATIVE RNA-DIRECTED RNA TOBACCO MILD GREEN MOSAIC |
| VIRUS (TMV 401-449 682-720 765-818 |
| POLYMERASE STRAIN U2) |
| PRRPO-- TMVKR PUTATIVE RNA-DIRECTED RNA TOBACCO MOSAIC VIRUS |
| (VULGARE) |
| 3-37 401-453 665-699 |
| POLYMERASE |
| PRRPO-- TMVTO PUTATIVE RNA-DIRECTED RNA TOBACCO MOSAIC VIRUS |
| (STRAIN KOREAN) |
| 3-37 401-453 665-699 POLYMERASE |
| PRRPO-- TNVD PUTATIVE RNA-DIRECTED RNA TOBACCO MOSAIC VIRUS |
| (STRAIN TOMATO/L) |
| 3-37 401-453 860-894 POLYMERASE |
| PRRPP-- BRSVA RNA-DIRECTED RNA POLYMERASE TOBACCO NECROSIS |
| VIRUS (STRAIN D) 102-144 |
| PRRPP-- CDVO RNA POLYMERASE ALPHA SUBUNIT BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN |
| 99-158 160-216 A51908) |
| PRRPP-- HRSV RNA POLYMERASE ALPHA SUBUNIT CANINE DISTEMPER VIRUS |
| (STRAIN 312-373 |
| ONDERSTEPOORT) |
| PRRPP-- HRSV1 RNA POLYMERASE ALPHA SUBUNIT HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS |
| 99-158 160-216 PRRPP-- |
| HRSVA RNA POLYMERASE ALPHA SUBUNIT HUMAN RESPIRATORY SYNCYTIAL VIRUS |
| 99-158 160-216 |
| (SUBGROUP B/STRA1 |
| PRRPP-- HRSVL RNA POLYMERASE ALPHA SUBUNIT HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN |
| 99-158 160-216 A2) |
| PRRPP-- MEASE RNA POLYMERASE ALPHA SUBUNIT HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS |
| 99-158 160-216 (SUBGROUP |
| A/STRAI |
| PRRPP-- MEASI RNA POLYMERASE ALPHA SUBUNIT MEASLES VIRUS (STRAIN |
| EDMONSTON) 315-374 460-495 |
| PRRPP-- MEASY RNA POLYMERASE ALPHA SUBUNIT MEASLES VIRUS (STRAIN |
| IP-3-CA) 315-374 460-495 |
| PRRPP-- MUMP1 RNA POLYMERASE ALPHA SUBUNIT MEASLES VIRUS (STRAIN |
| YAMAGATA-1) 315-374 460-495 |
| PRRPP MUMPE RNA POLYMERASE ALPHA SUBUNIT MUMPS VIRUS (STRAIN SBL-1) |
| 149-183 213-275 |
| PRRPP-- MUMPM RNA POLYMERASE ALPHA SUBUNIT MUMPS VIRUS (STRAIN |
| ENDERS) 214-276 |
| PRRPP-- NDVA RNA POLYMERASE ALPHA SUBUNIT MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) 214-276 |
| PRRPP-- NDVB RNA POLYMERASE ALPHA SUBUNIT NEWCASTLE DISEASE VIRUS |
| (STRAIN AUSTRALIA- 100-134 |
| VICTORIA/32) |
| PRRPP-- PI1HB RNA POLYMERASE ALPHA SUBUNIT NEWCASTLE DISEASE |
| VIRUS (STRAIN BEAUDETTE 100-138 |
| C/45) |
| PRRPP-- PI1HC RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN C35) |
| 80-114 313-364 375-437 PRRPP-- |
| PI1HD RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 1 VIRUS (STRAIN |
| C39) |
| 80-114 313-364 375-437 |
| PRRPP-- PI1HE RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN CI-5/73) |
| 80-114 313-364 375-437 PRRPP-- PI2H RNA |
| POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 1 VIRUS (STRAIN CI-14/830) |
| 66-114 237-271 313-364 375-437 |
| PRPPP-- PI2HT RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 2 |
| VIRUS 218-281 |
| PRRPP-- PI3B RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN 218-281 |
| TOSHIBA) |
| PRRPP-- PIHH4 RNA POLYMERASE ALPHA SUBUNIT BOVINE PARAINFLUENZA 3 |
| VIRUS |
| 31-130 414-470 |
| PRRPP-- PI4HA RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN NIH 410-499 |
| 47885) |
| PRRPP-- PI4HB RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 4A |
| VIRUS (STRAIN |
| 4-38 222-285 TOSHIBA) |
| PRRPP-- PIRYV RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA |
| 4B VIRUS (STRAIN 222-285 |
| 68-333) |
| PRRPP-- RABVA RNA POLYMERASE ALPHA SUBUNIT PIRY VIRUS 137-174 |
| PRRPP-- RABVC RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS |
| (STRAIN AVO1) |
| 93-127 PRRPP-- |
| RABVE RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS (STRAIN CVS-11) |
| 93-127 |
| PRRPP-- RABVP RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS (STRAIN |
| ERA), AND (STRAIN PM) |
| 93-127 PRRPP-- RABVS |
| RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS (STRAIN PV) |
| 93-127 PRRPP-- SEND5 RNA POLYMERASE ALPHA SUBUNIT |
| RABIES VIRUS (STRAIN SAD B19 |
| 93-127 PRRPP-- SEND6 RNA |
| POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN Z/HOST MUTANTS) 313-364 |
| 375-447 |
| PRRPP-- SENDF RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| 6/94) 323-364 375-447 |
| PRRPP-- SENDH RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| FUSHIMI) 313-364 375-447 |
| PRRPP-- SENDZ RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| HARRIS) 313-364 375-447 |
| PRRPP-- SV5 RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN Z) |
| 313-364 375-447 |
| PRRPP-- SYNV RNA POLYMERASE ALPHA SUBUNIT SIMIAN VIRUS 5 (STRAIN |
| W3) 205-278 |
| PRRPP-- VSVIG RNA POLYMERASE ALPHA SUBUNIT SONCHUS YELLOW NET |
| VIRUS 138-173 233-281 |
| PRRPP-- VSVIM RNA POLYMERASE ALPHA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE |
| 3-43 INDIANA/STRAI |
| N G |
| PRRPP-- VSVJM RNA POLYMERASE ALPHA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE |
| 3-43 INDIANA/STRAI |
| N M |
| PRRPP-- VSVJO RNA POLYMERASE ALPHA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE |
| 3-37 NEW JERSEY/ST |
| RAI |
| PRRPP-- VSVSJ RNA POLYMERASE ALPHA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE |
| 3-37 NEW JERSEY/ST |
| RAI |
| PSPHR-- AMEPV RNA POLYMERASE ALPHA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (STRAIN SAN JUAN) |
| 3-43 PSPI2-- VACCV |
| SPHEROIDIN AMSACTA MOOREI ENTOMOPOXVIRUS 223-264 361-395 |
| PSPI2-- VARV SERINE PROTEINASE INHIBITOR VACCINIA VIRUS (STRAIN |
| WR) 21-86 |
| PSPI3-- VACCC SERINE PROTEINASE INHIBITOR 2 VARIOLA VIRUS 21-86 |
| PSPI3-- VACCV SERINE PROTEINASE INHIBITOR 3 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 118-167 225-266 |
| PSPI3-- VARV SERINE PROTEINASE INHIBITOR 3 VACCINIA VIRUS (STRAIN |
| WR) 118-167 225-266 |
| PSPIA-- VACCC SERINE PROTEINASE INHIBITOR 3 VARIOLA VIRUS 122-171 |
| 229-270 |
| PT2C2-- CHVP1 SERINE PROTEINASE INHIBITOR 2 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 11-65 |
| HOMOLOG FIRST |
| PTAA2-- VACCV TYPE II RESTRICTION ENZYME CVIAI1 PARAMECIUM |
| BURSARIA CHLORELLA VIRUS 45-85 |
| PTAG8-- FOWPV TRANS-ACTIVATOR PROTEIN A2 VACCINIA VIRUS (STRAIN |
| WR, COPENHAGEN, AND |
| 95-133 173-207 VARIOLA VI |
| PTAG8-- VACCV TRANS-ACTIVATOR PROTEIN FP0 FOWLPOX VIRUS |
| 3-51 |
| PTAG8-- VARV TRANS-ACTIVATOR PROTEIN GK1 VACCINIA VIRUS (STRAIN |
| WR), (STRAIN |
| 3-51 COPENHAGEN |
| ) |
| PTALA-- BFDV TRANS-ACTIVATOR PROTEIN GK1 VARIOLA VIRUS 3-51 |
| PTALA-- POVBO LARGE T ANTIGEN BUDGERIGAR FLEDGLLNG DISEASE |
| VIRUS 291-325 464-498 |
| PTALA-- POVHA LARGE T ANTIGEN BOVINE POLYOMAVIRUS 303-337 495-537 |
| PTALA-- POVJC LARGE T ANTIGEN HAMSTER POLYOMAVIRUS 464-501 |
| 587-621 |
| PTALA-- POVLY LARGE T ANTIGEN POLYOMAVIRUS JC 153-187 589-623 |
| PTALA-- POVM3 LARGE T ANTIGEN LYMPHOTROPIC POLYOMAVIRUS 3-41 |
| 206-258 437-478 |
| PTALA-- POVMA LARGE T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN 3) |
| 509-544 |
| PTALA-- POVMC LARGE T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN A2) |
| 507-542 |
| PTAMI-- POVHA LARGE T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN CRAWFORD |
| 504-539 |
| SMALL-PLAQUE) |
| PTAMI-- POVM3 MIDDLE T ANTIGEN HAMSTER POLYOMAVIRUS 339-378 |
| PTAMI-- POVMA MIDDLE T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN 3) |
| 211-245 388-422 |
| PTAMI-- POVMC MIDDLE T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN A2) |
| 192-226 369-403 |
| PTASM-- POVBO MIDDLE T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN |
| CRAWFORD 192-226 369-403 |
| SMALL-PLAQUE) |
| PTASM-- |
| POVLY SMALL T ANTIGEN BOVINE POLYOMAVIRUS 41-85 PTATR-- |
| NPVAC SMALL T ANTIGEN LYMPHOTROPIC POLYOMAVIRUS |
| 3-41 PTATR-- NPVBM TRANS-ACTIVATING AUTOGRAPHA |
| CALIFORNICA NUCLEAR 408-442 |
| 46-480 489-523 TRANSCRIPTIONAL REGULAT |
| POLYHEDROSIS VIRUS |
| PTATR-- NPVOP TRANS-ACTIVATING BOMBYX MORI NUCLEAR POLYHEDROSIS |
| VIRUS 413-447 451-485 494-528 |
| TRANSCRIPTIONAL REGULAT |
| PTAT-- SIVA1 TRANS-ACTIVATING ORGYIA PSEUDOTSUGATA MULTICAPSID |
| 391-455 511-554 |
| TRANSCRIPTIONAL REGULAT POLYHEDROSIS VIRUS |
| PTAT-- SIVAI TAT PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS 73-109 |
| (AGM155 ISOLATE) |
| PTAT-- VILV TAT PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS 137-185 |
| (ISOLATE AGM/CLONE GRI |
| PTAT-- VILV1 TRANS-ACTIVATING VISNA LENTIVIRUS (STRAIN 1514) |
| 28-74 |
| TRANSCRIPTIONAL REGULAT |
| PTAT-- VILV2 TRANS-ACTIVATING VISNA LENTIVIRUS (STRAIN 1514/CLONE |
| LV1-1kS1) 40-74 |
| TRANSCRIPTIONAL REGULAT |
| PTCB-- FLV TRANS-ACTIVATING VISNA LENTIVIRUS (STRAIN 1514/CLONE |
| LV1-1KS2) 40-74 |
| TRANSCRIPTIONAL REGULAT |
| PTEGP-- HSVII T-CELL RECEPTOR BETA CHAIN FELINE LEUKEMIA VIRUS |
| 279-321 |
| PRECURSOR |
| PTEGP-- HSVEA TEGUMENT PHOSPHOPROTEIN US9 HERPES SIMPLEX VIRUS |
| (TYPE 1/STRAIN 17) 27-61 |
| PTEGP-- |
| HSVEB NONSENSE PTEGP-- |
| HSVEK NONSENSE |
| PTEGP-- |
| HSVSB NONSENSE PTEGU-- |
| EBV NONSENSE |
| PTEGU-- HCMVA LARGE TEGUMENT PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 768-802 821-855 938-972 1101- 1208- 1479- 1700- 1809- |
| 1138 1242 1516 1753 1867 |
| 1870- 1920- 3108- |
| 1916 1954 3149 |
| PTEGU-- HSV11 PROBABLE LARGE TEGUMENT HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 34-71 215-249 543-581 700-738 868-909 936-977 1004- 1163- |
| PROTEIN 1038 1200 |
| 1237- 2200- |
| 1296 2235 |
| PTEGU-- HSV6G LARGE TEGUMENT PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 731-765 801-842 1022- 1223- 1275- 1315- 1520- 1609- |
| 1059 1269 1309 1370 1531 1669 |
| 1673- 1749- 1820- 2670- |
| 1714 1783 1854 2704 |
| PTEGU-- HSVEB LARGE TEGUMENT PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 30-71 224-262 567-608 712-757 951- 1091- 1192- 1357- |
| 1000 1181 1233 1400 |
| PTEGU-- HSVSA LARGE TEGUMENT PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 560-597 635-683 794-848 908-956 1108- 1155- 1399- 1487- |
| 1151 1246 1458 1549 |
| 1619- 1661- 1702- 1806- 1947- |
| 1657 1695 1736 1843 1981 |
| PTEGU-- VZVD PROBABLE LARGE TEGUMENT HERPESVIRUS SAIMIRI (STRAIN |
| 11) 520-558 560-598 615-652 672-710 777-822 846-898 948-986 1287- |
| PROTEIN 1332 |
| 1434- |
| 1502 |
| PTERM-- ADE02 LARGE TEGUMENT PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 657-696 713-747 804-841 933-972 1117- 1415- 1528- 1572- |
| 1158 1471 1562 1620 |
| 1633- 1719- 1945- 2727- |
| 1705 1756 1986 2761 |
| PTERM-- ADE05 DNA TERMINAL PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| 490-572 |
| PTERM-- ADE07 DNA TERMINAL PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| 490-592 |
| PTERM-- ADE12 DNA TERMINAL PROTEIN HUMAN ADENOVIRUS TYPE 7 |
| 491-559 |
| PTJUN-- AVIS1 DNA TERMINAL PROTEIN HUMAN ADENOVIRUS TYPE 12 |
| 443-491 497-538 |
| PTMAF-- AVIS4 TRANSFORMING PROTEIN JUN AVIAN SARCOMA VIRUS |
| (STRAIN 17) 210-284 |
| PTOP1-- SFVKA TRANSFORMING PROTEIN MAF AVIAN MUSCULOAPONEUROTIC |
| FIBROSARCOMA 247-288 295-340 |
| VIRUS AS42 |
| PTOP2-- ASFB7 DNA TOPOISOMERASE SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) 127-183 269-310 |
| PTOP2-- ASFM2 DNA TOPOISOMERASE II AFRICAN SWINE FEVER VIRUS |
| (STRAIN BA71V) 146-180 481-515 601-642 945-979 1038- 1123- |
| 1093 1162 |
| PTSIS-- SMSAV DNA TOPOISOMERASE II AFRICAN SWINE FEVER VIRUS |
| (ISOLATE MALAWI 146-180 480-514 600-641 902-936 944-978 1038- 1122- |
| LIL 20/1) 1091 1161 |
| PTYSY-- VZVD PDGF-RELATED TRANSFORMING SIMIAN SARCOMA VIRUS 16-71 |
| PROTEIN P28-SIS |
| PUBIL-- NPVOP THYMIDYLATE SYNTHASE VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 215-260 |
| PUL01-- HCMVA UBIQUITIN-LIKE PROTEIN ORGYIA PSEUDOTSUGATA |
| MULTICAPSID 43-80 |
| POLYHEDROSIS VIRUS |
| PUL03-- HSV11 HYPOTHETICAL PROTEIN UL1 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 169-203 |
| PUL03-- HSV2H PROTEIN UL3 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| 94-128 |
| PUL03-- HSVEB PROTEIN UL3 HERPES SIMPLEX VIRUS (TYPE 2/STRAIN HG52) |
| 92-126 |
| PUL04-- HSV11 GENE 60 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) |
| 70-104 |
| PUL06-- EBV PROTEIN UL4 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| 102-136 |
| PUL06-- HCMVA VIRION PROTEIN BBRF1 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 104-145 313-347 376-410 |
| PUL06-- HSV11 HYPOTHETICAL PROTEIN UL6 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 216-250 |
| PUL06-- HSVEB VIRION PROTEIN UL6 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 36-94 103-141 294-329 337-371 416-479 |
| PUL06-- HSVSA VIRION GENE 56 PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| 62-170 357-413 448-503 PUL06-- |
| VZVD VIRION GENE 43 PROTEIN HERPES VIRUS SAIMIRI (STRAIN 11) 90-140 |
| 151-194 302-336 364-405 |
| PUL08-- HCMVA VIRION GENE 54 PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| 87-131 350-409 704-738 PUL09-- |
| HSVEB HYPOTHETICAL PROTEIN UL8 HUMAN CYTOMEGALOVIRUS (STRAIN AD 169) |
| 6-50 |
| PUL09-- VZVD ORIGIN OF REPLICATION BINDING EQUINE HERPESVIRUS |
| TYPE 1 (STRAIN AB4P) 174-208 |
| PROTEIN |
| PUL11-- HCMVA ORIGIN OF REPLICATION BINDING VARICELLA-ZOSTER |
| VIRUS (STRAIN DUMAS) 122-163 |
| PROTEIN |
| PUL13-- |
| HCMVA NONSENSE PUL14-- |
| HCMVA HYPOTHETICAL PROTEIN UL13 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 47-81 185-227 |
| PUL14-- HSVEB HYPOTHETICAL PROTEIN UL14 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 305-343 |
| PUL14-- PRVN3 HYPOTHETICAL GENE 45 PROTEIN EQUINE HERPESVIRUS |
| TYPE 1 (STRAIN AB4P) 52-96 246-283 |
| PUL14-- VZVD UL14 PROTEIN HOMOLOG PSEUDORABIES VIRUS (STRAIN |
| NIA-3) 43-95 |
| PUL16-- HSVEB HYPOTHETICAL GENE 46 PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| 61-103 PUL17-- |
| HSV6U GENE 45 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN AB4P) 266-300 |
| PUL21-- HSVEB PROTEIN 10R HERPES SIMPLEX VIRUS (TYPE 6/STRAIN |
| 239-280 |
| UGANDA-1102 |
| PUL23-- HCMVA GENE 40 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) 44-75 421-474 |
| PUL24-- HCMVA HYPOTHETICAL PROTEIN UL23 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 213-253 |
| PUL24-- ILTVT HYPOTHETICAL PROTEIN UL14 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 5-39 PUL25-- |
| HCMVA PROTEIN UL24 HOMOLOG INFECTIOUS LARYNGOTRACHEITIS VIRUS (STRAIN |
| 161-195 |
| THORNE V88 |
| PUL25-- HSV11 HYPOTHETICAL PROTEIN UL25 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 255-341 351-399 |
| PUL25-- HSVEB VIRION PROTEIN UL25 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 370-411 |
| PUL25-- HSVSA VIRION PROTEIN UL25 EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 364-413 |
| PUL25-- ILTVT VIRION GENE 19 PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) 29-92 183-231 365-406 |
| PUL25-- VZVD 64.1 KD VIRION PROTEIN INFECTIOUS LARYNGOTRACHEITIS |
| VIRUS (STRAIN 38-84 165-206 |
| THORNE V88 |
| PUL31-- HCMVA VIRION GENE 34 PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 340-388 |
| PUL31-- HSVEB HYPOTHETICAL PROTEIN UL31 HUN CYTOMEGALOVIRUS |
| (STRAIN AD169) 244-285 |
| PUL31-- VZVD GENE 29 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) 153-157 |
| PUL32-- HSVEB GENE 27 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 163-197 |
| PUL32-- VZVD MAJOR ENVELOPE GLYCOPROTEIN EQUINE HERPESVIRUS TYPE |
| 1 (STRAIN AB4P) 342-376 |
| 300 (STRAIN ABI) |
| PUL33-- HCMVA PROBABLE MAJOR ENVELOPE VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| 72-106 296-344 GLYCOPROTEIN |
| 26 |
| PUL33-- VZVD PROTEIN COUPLED RECEPTOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 94-135 309-352 HOMOLOG UL33 |
| PUL34-- EBV GENE 25 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| 29-63 |
| PUL34-- HCMVA BFRF1 PROTEIN EPSTEIN-BARR VIRUS (STRAIN B95.8) |
| 159-200 |
| PUL34-- HSV11 HYPOTHETICAL PROTEIN UL34 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 113-147 |
| PUL35-- HCMVA VIRION PROTEIN UL34 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 187-221 |
| PUL37-- EBV HYPOTHETICAL PROTEIN UL35 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 231-268 |
| PUL37-- HSV11 PROTEIN BOLF1 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 708-742 |
| PUL37-- HSVEB PROTEIN UL37 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| 17) 853-891 |
| PUL37-- HSVSA GENE 23 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) |
| 82-137 311-345 614-648 715-750 781-822 |
| PUL37-- VZVD GENE 63 PROTEIN HERPESVIRUS SAIMIRI (STRAIN 11) 6-65 |
| 682-741 |
| PUL38-- HCMVA GENE 21 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 719-753 786-827 |
| PUL41-- VZVD HYPOTHETICAL PROTEIN UL38 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 10-51 |
| PUL42-- HSV11 HOST SHUTOFF VIRION PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 330-366 |
| PUL42-- HSVEB DNA-BINDING PROTEIN UL42 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 134-168 221-263 |
| PUL43-- HCMVA DNA-BINDING GENE 18 PROTEIN EQUINE HERPESVIRUS TYPE |
| 1 (STRAIN AB4P) 138-172 |
| PUL43-- HSVE4 HYPOTHETICAL PROTEIN UL43 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 72-109 PUL43-- |
| VZVD MEMBRANE PROTEIN UL43 HOMOLOG EQUINE HERPESVIRUS TYPE 4 (STRAIN |
| 1942) 27-68 |
| PUL45-- HSVIK GENE 15 MEMBRANE PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 312-363 |
| PUL45-- HSV1M PROTEIN UL45 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| KOS) |
| 96-137 |
| PUL47-- HCMVA PROTEIN UL45 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN MP) |
| 96-137 |
| PUL47-- HSV11 PROTEIN UL47 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 114-165 448-485 745-856 |
| PUL47-- HSV1F VIRION PROTEIN UL47 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 473-518 |
| PUL47-- HSVBP VIRION PROTEIN UL47 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN F 473-518 |
| PUL47-- HSVE4 80.7 KD ALPHA TRANS-INDUCING BOVINE HERPESVIRUS |
| TYPE 1 (STRAIN P8-2) 561-612 |
| PROTEIN |
| PUL47-- HSVEB 97 KD ALPHA TRANS-INDUCING EQUINE HERPESVIRUS TYPE |
| 4 (STRAIN 1942) 183-246 582-620 825-866 |
| PROTEIN |
| PUL47-- VZVD 97 KD ALPHA TRANS-INDUCING EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 219-253 371-412 817-866 |
| PROTEIN |
| PUL50-- HCMVA ALPHA TRANS-INDUCING FACTOR VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| 84-135 156-209 664-701 91.8 KD |
| PROTEIN |
| PUL51-- HSV11 PROTEIN UL50 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 155-189 |
| PUL51-- HSVE4 PROTEIN UL51 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| 17) 118-169 |
| PUL51-- HSVEB GENE 8 PROTEIN EQUINE HERPES VIRUS TYPE 4 (STRAIN |
| 1942) 121-162 |
| PUL51-- VZVD GENE 8 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) 120-161 |
| PUL52-- EBV GENE 7 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| 122-163 |
| PUL52-- HSV11 PROBABLE DNA REPLICATION EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 188-255 |
| PROTEIN BSLF 1 |
| PUL52-- HSVEB DNA REPLICATION PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 189-223 |
| UL52 |
| PUL52-- HSVSA DNA REPLICATION PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 141-182 929-970 |
| UL52 |
| PUL52-- VZVD PROBABLE DNA REPLICATION GENE HERPESVIRUS SAIMIRI |
| (STRAIN 11) 445-483 |
| 56 PROTEIN |
| PUL53-- HCMVA PROBABLE DNA REPLICATION GENE VARICELLA-ZOSTER |
| VIRUS (STRAIN DUMAS) 301-342 |
| 6 PROTEIN |
| PUL55-- HSV2H PROTEIN UL53 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 12-48 |
| PUL64-- HCMVA PROTEIN UL55 HERPES SIMPLEX VIRUS (TYPE 2/STRAIN |
| HG52) 151-185 |
| PUL70-- HCMVA HYPOTHETICAL PROTEIN UL64 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 32-73 |
| PUL74-- HCMVA PROBABLE DNA REPLICATION HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 39-99 |
| PROTEIN UL70 |
| PUL87-- HSV6U HYPOTHETICAL PROTEIN UL74 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 43-79 |
| PUL87-- HSVSA HYPOTHETICAL PROTEIN SR HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN 729-770 |
| UGANDA-1102) |
| PUL88-- HCMVA HYPOTHETICAL GENE 24 PROTEIN HERPES VIRUS SAIMIRI |
| (STRAIN 11) 366-400 582-616 |
| PUL91-- HSVSA HYPOTHETICAL PROTEIN UL88 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 357-391 |
| PUL92-- EBV HYPOTHETICAL GENE 30 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) 24-58 |
| PUL92-- HCMVA HYPOTHETICAL PROTEIN BDLF4 EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) 107-144 188-222 |
| PUL92-- HSV6U HYPOTHETICAL PROTEIN UL92 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 79-116 PUL92-- |
| HSVSA HYPOTHETICAL PROTEIN 9R HERPES SIMPLEX VIRUS (TYPE 6/STRAIN |
| 101-145 174-216 |
| UGANDA-1102) |
| PUL93-- HCMVA HYPOTHETICAL GENE 31 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| 88-122 PUL95- |
| - HCMVA PROTEIN UL93 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) 23-57 299-384 |
| PUL95-- HSV6U HYPOTHETICAL PROTEIN UL95 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 34-71 259-293 |
| PUL96-- HCMVA HYPOTHETICAL PROTEIN 13R HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN |
| 73-151 233-270 |
| UGANDA-1102) |
| PUL96-- HSV6U HYPOTHETICAL PROTEIN UL96 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 51-103 PUL96-- |
| HSVSA HYPOTHETICAL PROTEIN 14R HERPES SIMPLEX VIRUS (TYPE 6/STRAIN |
| 53-113 |
| UGANDA-1102) |
| PULA2-- HCMVA HYPOTHETICAL GENE 35 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| 45-100 PULA4- |
| - HCMVA HYPOTHETICAL PROTEIN UL102 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 6-40 758-792 |
| PULD0-- HCMVA VIRION PROTEIN UL104 HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| 1-56 130-171 330-764 439-492 541-575 |
| PUNG-- HSV11 HYPOTHETICAL PROTEIN UL130 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 84-125 PUNG-- |
| HSV23 URACIL-DNA GLYCOSYLASE HERPES SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| 227-268 |
| PUNG-- HSV2H URACIL-DNA GLYCOSYLASE HERPES SIMPLEX VIRUS (TYPE |
| 2/STRAIN 333) 188-229 |
| PUNG-- HSVSA URACIL-DNA GLYCOSYLASE HERPES SIMPLEX VIRUS (TYPE |
| 2/STRAIN HG52 148-189 |
| PUNG-- SFVKA URACIL-DNA GLYCOSYLASE HERPESVIRUS SAIMIRI (STRAIN |
| 11) 135-176 |
| PUS02-- HSVEB URACIL-DNA GLYCOSYLASE SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) |
| 81-115 |
| PUS02-- HSVEK GENE 68 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) |
| 79-120 |
| PUS07-- HCMVA US1 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN 86-120 |
| KENTUCKY A) |
| PUS11-- HCMVA HYPOTHETICAL PROTEIN HXLF5 |
| 2-36 PUS14-- HCMVA HYPOTHETICAL PROTEIN HXLF1 |
| HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PUS18-- HCMVA HYPOTHETICAL PROTEIN HVLF4 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 3-51 PUS23-- |
| HCMVA MEMBRANE PROTEIN HWLF5 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 187-225 |
| PUS24-- HCMVA HYPOTHETICAL PROTEIN HHLF7 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 294-335 535-578 |
| PUS26-- HCMVA HYPOTHETICAL PROTEIN HHLF6 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 135-172 |
| PUS27-- HCMVA HYPOTHETICAL PROTEIN HHLF5 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 535-584 |
| PUS30-- HCMVA G-PROTEIN COUPLED RECEPTOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 6-40 HOMOLOG US27 |
| PV125-- AMVLE HYPOTHETICAL PROTEIN HHRF5 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 135-169 274-312 |
| PV143-- NPVAC 125 KD PROTEIN ALFALFA MOSAIC VIRUS (STRAIN 425/ |
| 18-52 326-367 591-649 |
| ISOLATE LEIDEN |
| PV16K-- TRVPS HELICASE AUTOGRAPHA CALIFORNICA NUCLEAR 313-350 |
| 1114- 1179- |
| POLYHEDROSIS VIRUS 1150 1213 |
| PV16K-- TRVSY 16 KD PROTEIN TOBACCO RATTLE VIRUS (STRAIN PSG) |
| 75-117 |
| PV1A-- BBMV 16 KD PROTEIN TOBACCO RATTLE VIRUS (STRAIN SYM) |
| 75-117 |
| PV1A-- BMV 1A PROTEIN BROAD BEAN MOTTLE VIRUS 21-55 349-405 |
| 492-526 710-751 837-884 890-924 |
| PV1A-- CCMV 1A PROTEIN BROME MOSAIC VIRUS |
| 4-66 348-411 PV1A-- CMVFN 1A PROTEIN COWPEA CHLOROTIC |
| MOTTLE VIRUS |
| 4-53 242-276 348-389 487-526 PV1A-- |
| CMVO 1A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN FNY) 11-66 393-434 |
| 584-619 868-916 |
| PV1A-- CMVQ 1A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN O) 11-66 |
| 393-434 584-619 868-916 |
| PV1A-- PSVJ 1A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN Q) 11-66 |
| 393-434 |
| PV1A-- TAV 1A PROTEIN PEANUT STUNT VIRUS (STRAIN J) 4-66 |
| PVS3K-- HSVTH 1A PROTEIN TOMATO ASPERMY VIRUS 11-59 |
| 392-433 857-923 |
| PV24K-- BDV 23.5 KD PROTEIN TURKEY HERPESVIRUS (STRAIN H2) |
| 177-211 |
| PV25K-- NPVAC 24 KD ANTIGEN BORNA DISEASE VIRUS 63-121 130-171 |
| PV28K-- PLRV1 25 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR 4-50 |
| POLYHEDROSIS VIRUS |
| PV28K-- PLRVW 28 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN 1) |
| 116-150 |
| PV290-- ASFL5 28 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN |
| WAGENINGEN) 116-150 |
| PV29K-- PEBV LIS 290 PROTEIN AFRICAN SWINE FEVER VIRUS (STRAIN |
| LIS57) 138-183 |
| PV29K-- TRVSY 29.6 KD PROTEIN EARLY BROWNING VIRUS 115-192 |
| PVS9K-- TRVTC 29 KD PROTEIN TOBACCO RATTLE VIRUS (STRAIN |
| SYM), AND 167-201 |
| (STRAIN PSG) |
| PV2A-- CCMV 29 KD PROTEIN TOBACCO RATTLE VIRUS (STRAIN TCM) 45-79 |
| PV2A-- CMVFN 2A PROTEIN COWPEA CHLOROTIC MOTTLE VIRUS 768-806 |
| PV2A-- PSVJ 2A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN FNY) |
| 386-420 |
| PV2A-- TAV 2A PROTEIN PEANUT STUNT VIRUS (STRAIN J) 717-751 |
| PV30K-- TRVTC 2A PROTEIN TOMATO ASPERMY VIRUS 722-756 |
| PV360-- ASFB7 29.1 KD PROTEIN TOBACCO RATTLE VIRUS (STRAIN |
| TCM) 105-218 |
| PV362-- ASFB7 K'360 PROTEIN AFRICAN SWINE FEVER VIRUS (STRAIN |
| BA71V) 53-87 151-192 |
| PV363-- ASFB7 K'362 PROTEIN AFRICAN SWINE FEVER VIRUS (STRAIN |
| BA71V) |
| 54-102 161-212 290-324 |
| PV3A-- BMV D'363 PROTEIN AFRICAN SWINE FEVER VIRUS (STRAIN BA71V) |
| 153-199 |
| PV3A-- |
| CMVFN 3A PROTEIN BROME MOSAIC VIRUS 11-45 PV3A-- |
| CMVM 3A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN FNY) 215-255 |
| PV3A-- CMVO 3A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN M) 215-255 |
| PV3A-- CMVY 3A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN O) 215-255 |
| PV51K-- ACLSV 3A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN Y) 215-255 |
| PV51K-- BWYVF 58.8 KD PROTEIN APPLE CHLOROTIC LEAF SPOTVIRUS |
| 72-106 |
| PV51K-- BWYVG 51 KD PROTEIN BEET WESTERN YELLOWS VIRUS (ISOLATE |
| FL-1) 113-147 196-233 404-451 |
| PV56K-- PLRV1 51 KD PROTEIN BEET WESTERN YELLOWS VIRUS (ISOLATE |
| GBI) 113-147 196-233 407-451 |
| PV56K-- PLRVW 56 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN 1) |
| 47-81 438-472 |
| PV58K-- |
| BSMV 56 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN WAGENINGEN) 47-81 |
| 438-475 |
| PV66K-- BWYVF 58 KD PROTEIN BARLEY STRIPE MOSAIC VIRUS 128-162 |
| 323-371 |
| PV70K-- PLRV1 66.2 KD PROTEIN BEET WESTERN YELLOWS VIRUS (ISOLATE |
| FL-1) 480-521 |
| PV70K-- PLRVW 69.7 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN 1) |
| 98-144 514-548 |
| PV90K-- AMVLE 69.7 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN |
| WAGENINGEN) |
| 98-144 409-443 514-548 PVA04- |
| - VACCC 90 KD PROTEIN ALFALFA MOSAIC VIRUS (STRAIN 425/ISOLATE 107-141 |
| LEIDEN) |
| PVA04-- VACCV PROTEIN A4 VACCINIA VIRUS (STRAIN COPENHAGEN) 32-66 |
| 231-275 |
| PVA04-- VARV PROTEIN A4 VACCINIA VIRUS (STRAIN WR) 32-66 231-275 |
| PVA06-- |
| VACCC PROTEIN A4 VARIOLA VIRUS 22-66 210-265 PVA06-- |
| VACCV PROTEIN A6 VACCINIA VIRUS (STRAIN COPENHAGEN) 97-213 314-355 |
| PVA06-- VARV PROTEIN A6 VACCINIA VIRUS (STRAIN WR) 96-212 |
| 313-354 |
| PVA08-- VACCC PROTEIN A6 VARIOLA VIRUS |
| 97-213 313-358 PVA08-- VARV PROTEIN A8 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 176-236 |
| PVA09-- |
| VACCC PROTEIN A8 VARIOLA VIRUS 176-236 PVA09-- |
| VARV PROTEIN A9 VACCINIA VIRUS (STRAIN COPENHAGEN) 46-81 |
| PVA11-- |
| VACCC PROTEIN A9 VARIOLA VIRUS 46-95 PVA11-- |
| VARV PROTEIN A11 VACCINIA VIRUS (STRAIN COPENHAGEN) 97-134 141-175 |
| 219-283 |
| PVA12-- VACCC PROTEIN A11 VARIOLA VIRUS |
| 98-176 220-284 PVA12-- VARV PROTEIN A12 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 114-148 |
| PVA18-- |
| VACCC PROTEIN A12 VARIOLA VIRUS 111-152 PVA18-- |
| VACCV 56 KD ABORTIVE LATE PROTEIN VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 433-467 |
| PVA18-- VARV 56 KD ABORTIVE LATE PROTEIN VACCINIA VIRUS (STRAIN |
| WR) 307-341 433-467 |
| PVA20-- VACCC 56 KD ABORTIVE LATE PROTEIN VARIOLA VIRUS 307-341 |
| 433-467 |
| PVA20-- VARV PROTEIN A20 VACCINIA VIRUS (STRAIN COPENHAGEN) 1-67 |
| PVA22-- VACCC PROTEIN A20 VARIOLA VIRUS |
| 1-67 PVA22-- VARV PROTEIN A22 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 28-69 |
| PVA23-- |
| VACCC PROTEIN A22 VARIOLA VIRUS 39-80 PVA23-- |
| VARV PROTEIN A23 VACCINIA VIRUS (STRAIN COPENHAGEN) 95-143 173-207 |
| 255-289 344-382 |
| PVA31-- VARV PROTEIN A23 VARIOLA VIRUS 95-143 173-207 255-289 |
| 344-382 |
| PVA32-- VACCV PROTEIN A31 VARIOLA VIRUS |
| 88-126 PVA32-- VARV PROTEIN A32 VACCINIA VIRUS |
| (STRAIN WR), AND (STRAIN |
| COPENHAGEN |
| PVA33-- |
| VARV PROTEIN A32 VARIOLA VIRUS 217-251 PVA36-- |
| VACCV PROTEIN A33 VARIOLA VIRUS 63-97 |
| PVA36-- VARV PROTEIN A36 PRECURSOR VACCINIA VIRUS (STRAIN WR), |
| AND (STRAIN 26-67 109-155 |
| COPENHAGEN) |
| PVA37-- |
| VACCC PROTEIN A36 PRECURSOR VARIOLA VIRUS 26-67 PVA37-- |
| VACCV PROTEIN A37 VACCINIA VIRUS (STRAIN COPENHAGEN) 24-65 |
| PVA38-- VACCC PROTEIN A37 VACCINIA VIRUS (STRAIN WR) 24-65 |
| PVA38-- |
| VACCV PROTEIN A38 VACCINIA VIRUS (STRAIN COPENHAGEN) 44-91 |
| PVA38-- VARV PROTEIN A38 VACCINIA VIRUS (STRAIN WR) 44-91 |
| PVA39-- |
| VACCC PROTEIN A38 VARIOLA VIRUS 44-91 PVA39-- VACCV |
| PROTEIN A39 VACCINIA VIRUS (STRAIN COPENHAGEN) 37-71 |
| PVA46-- VACCC PROTEIN A39 VACCINIA VIRUS (STRAIN WR) 75-109 |
| PVA46-- VACCV PROTEIN A46 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 81-126 |
| PVA46-- VARV PROTEIN A46 VACCINIA VIRUS (STRAIN WR) 81-126 |
| PVA47-- VACCC PROTEIN A46 VARIOLA VIRUS |
| 81-126 PVA47-- VACCV PROTEIN A47 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 62-96 143-184 |
| PVA47-- VARV PROTEIN A47 VACCINIA VIRUS (STRAIN WR) 62-96 143-184 |
| PVA49-- |
| VACCC PROTEIN A47 VARIOLA VIRUS 62-96 143-184 PVA49-- |
| VACCV PROTEIN A49 VACCINIA VIRUS (STRAIN COPENHAGEN) 3-40 126-160 |
| PVA49-- VARV PROTEIN A49 VACCINIA VIRUS (STRAIN WR) 3-40 |
| 126-160 |
| PVA52-- VACCC PROTEIN A49 VARIOLA VIRUS |
| 3-40 126-160 PVA52-- VACCV PROTEIN A52 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| 91-132 PVA57-- VACCC |
| PROTEIN A52 VACCINIA VIRUS (STRAIN WR) |
| 91-132 PVA57-- VACCV GUANYLATE KINASE |
| HOMOLOG VACCINIA VIRUS (STRAIN COPENHAGEN) 134-168 |
| PVAL1-- MSVK GUANYLATE KINASE HOMOLOG VACCINIA VIRUS (STRAIN WR) |
| 134-168 |
| PVAL1-- MSVN AL1 PROTEIN MAIZE STREAK VIRUS (KENYAN ISOLATE) |
| 230-269 |
| PVAL1-- MSVS AL1 PROTEIN MAIZE STREAK VIRUS (NIGERIAN ISOLATE) |
| 228-262 |
| PVAL1-- SLCV AL1 PROTEIN MAIZE STREAK VIRUS (SOUTH-AFRICAN |
| 228-262 |
| ISOLATE) |
| PVAL1-- |
| TYDVA AL1 PROTEIN SQUASH LEAF CURL VIRUS 117-151 PVAL3-- |
| ABMVW AL1 PROTEIN TOBACCO YELLOW DWARF VIRUS (STRAIN 191-225 |
| AUSTRALIA) |
| PVAL3-- BGMV AL3 PROTEIN ABUTILON MOSAIC VIRUS (ISOLATE WEST |
| INDIA) 44-78 |
| 83-124 PVAL3-- |
| PYMVV AL3 PROTEIN BEAN GOLDEN MOSAIC VIRUS 44-78 |
| 83-124 PVAL3-- SLCV AL3 PROTEIN POTATO YELLOW |
| MOSAIC VIRUS (ISOLATE 30-78 |
| 87-121 VENEZUELA) |
| PVAL3-- TGMV AL3 PROTEIN SQUASH LEAF CURL VIRUS 46-80 91-125 |
| PVAT-- CAMVC AL3 PROTEIN TOMATO GOLDEN MOSAIC VIRUS 44-78 |
| PVAT-- CAMVD APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN CM-1841) 22-70 |
| 84-127 PVAT-- CAMVE APHID |
| TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN DIH) 22-70 |
| PVAT-- CAMVN APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN BBC) 22-70 |
| 93-127 PVAT-- CAMVP APHID |
| TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN NY8153) 22-70 |
| 93-127 |
| PVAT-- CAMVS APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN PV147) 22-70 |
| 93-127 PVAT-- CAMVW |
| APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN 22-70 |
| 93-130 |
| STRASBOURG) |
| PVAT-- CERV APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN W260) 36-70 |
| PVB03-- VACCV APHID TRANSMISSION PROTEIN CARNATION ETCHED RING |
| VIRUS |
| 99-138 |
| PVB04-- VACCC PROTEIN B3 VACCINIA VIRUS (STRAIN WR) 108-142 |
| PVB04-- |
| VACCV PROTEIN B4 VACCINIA VIRUS (STRAIN COPENHAGEN) 89-123 321-372 |
| 496-530 |
| PVB04-- VARV PROTEIN B4 VACCINIA VIRUS (STRAIN WR) 89-123 |
| 321-372 |
| PVB05-- VACC0 PROTEIN B4 VARIOLA VIRUS 89-134 324-372 492-530 |
| PVB05-- VACCC PLAQUE-SIZE/HOST RANGE PROTEIN VACCINIA VIRUS |
| (STRAIN LC16MO) 254-298 |
| PRECURSOR |
| PVB05-- VACCL PLAQUE-SIZE/HOST RANGE PROTEIN VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 254-298 |
| PRECURSOR |
| PVB05-- VACCV PLAQUE-SIZE/HOST RANGE PROTEIN VACCINIA VIRUS |
| (STRAIN LISTER) 254-298 |
| PRECURSOR |
| PVB07-- VACCV PLAQUE-SIZE/HOST RANGE PROTEIN VACCINIA VIRUS |
| (STRAIN WR) 254-298 |
| PRECURSOR |
| PVB08-- VACCC PROTEIN B7 PRECURSOR VACCINIA VIRUS (STRAIN WR), |
| AND (STRAIN 28-62 |
| COPENHAGEN) |
| PVB08-- VACCV PROTEIN B8 PRECURSOR VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 26-60 |
| PVB18-- VACCC PROTEIN B8 PRECURSOR VACCINIA VIRUS (STRAIN WR) |
| 26-60 |
| PVB18-- VACCV PROTEIN B18 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 337-375 491-532 |
| PVB18-- VARV PROTEIN B18 VACCINIA VIRUS (STRAIN WR) 337-375 |
| 491-532 |
| PVB19-- |
| VACCC PROTEIN B18 VARIOLA VIRUS 337-378 491-532 PVB19-- |
| VACCD SURFACE ANTIGEN S PRECURSOR VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 87-121 |
| PVB19-- VACCV SURFACE ANTIGEN S PRECURSOR VACCINIA VIRUS (STRAIN |
| DAIREN 1) |
| 85-119 PVB20.sub |
| .-- VACCC SURFACE ANTIGEN S PRECURSOR VACCINIA VIRUS (STRAIN WR) |
| 85-119 |
| PVB21-- VACCV PROTEIN B20 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 48-85 |
| PVBL1-- BMGV PROTEIN B21 VACCINIA VIRUS (STRAIN WR) 61-95 |
| PVBL1-- SLCV BL1 PROTEIN BEAN GOLDEN MOSAIC VIRUS 159-193 |
| PVBL1-- |
| TGMV BL1 PROTEIN SQUASH LEAF CURL VIRUS 159-193 PVBR1-- |
| BGMV BL1 PROTEIN TOMATO GOLDEN MOSAIC VIRUS 159-193 |
| PVBR1-- SLCV BR1 PROTEIN BEAN GOLDEN MOSAIC VIRUS 172-206 |
| PVBR1-- TGMV BR1 PROTEIN SQUASH LEAF CURL VIRUS 20-61 |
| PVC02-- VACCC BR1 PROTEIN TOMATO GOLDEN MOSAIC VIRUS 25-59 |
| PVC02-- VACCV PROTEIN C2 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 37-82 262-302 391-442 |
| PCC04-- SFVKA PROTEIN C2 VACCINIA VIRUS (STRAIN WR) 37-82 262-302 |
| 391-442 |
| PVC04-- VACCC PROTEIN C4 SHOPE FIBROMA VIRUS (STRAIN KASZA) |
| 175-223 374-408 |
| PVC04-- VACCV PROTEIN C4 VACCINIA VIRUS (STRAIN COPENHAGEN) 12-46 |
| PVC04-- |
| VARV PROTEIN C4 VACCINIA VIRUS (STRAIN WR) 12-46 PVC05-- |
| SFVKA PROTEIN C4 VARIOLA VIRUS 12-46 |
| PVC05-- VACCC HYPOTHETICAL PROTEIN C5 SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) |
| 82-125 |
| PVC05-- VACCV PROTEIN C5 VACCINIA VIRUS (STRAIN COPENHAGEN) 31-68 |
| PVC05-- VARV PROTEIN C5 VACCINIA VIRUS (STRAIN WR) 31-68 |
| PVC08-- SFVKA PROTEIN C5 VARIOLA VIRUS 32-70 73-121 |
| PVC09-- SFVKA HYPOTHETICAL PROTEIN C8 SHOPE FIBROMA VIRUS |
| (STRAIN KASZA) 45-86 |
| PVC09-- VACCC HYPOTHETICAL PROTEIN C9 SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) |
| 63-106 |
| PVC09-- VACCV PROTEIN C9 VACCINIA VIRUS (STRAIN COPENHAGEN) 82-116 |
| 168-226 289-325 575-612 |
| PVC10-- VACCC PROTEIN C9 VACCINIA VIRUS (STRAIN WR) 82-116 |
| 168-226 289-323 575-612 |
| PVC10-- VACCV PROTEIN C10 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 136-180 |
| PVC10-- VARV PROTEIN C10 VACCINIA VIRUS (STRAIN WR) 136-176 |
| PVC12-- |
| SFVKA PROTEIN C10 VARIOLA VIRUS 136-170 PVC13-- |
| SFVKA HYPOTHETICAL PROTEIN C12 SHOPE FIBROMA VIRUS (STRAIN KASZA) 2-36 |
| PVC16-- VACCC PROTEIN C13 SHOPE FIBROMA VIRUS (STRAIN KASZA) |
| 3-66 137-182 189-240 |
| PVC17-- VACCC PROTEIN C16/B22 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 142-176 |
| PVC18-- VACCC PROTEIN C17/B23 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 100-155 325-359 |
| PVC19-- SFVKA PROTEIN C18/B24 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 40-98 |
| PVC19-- VACCC PROTEIN C19 SHOPE FIBROMA VIRUS (STRAIN KASZA) |
| 56-97 |
| PVCAP-- EBV PROTEIN C19/B25 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 218-252 |
| PVCAP-- HCMVA MAJOR CAPSID PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 150-184 670-709 |
| PVCAP-- HSV11 MAJOR CAPSID PROTEIN HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) 136-174 191-225 260-294 |
| PVCAP-- HSV6U MAJOR CAPSID PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 116-175 308-356 |
| PVCAP-- HSVEB MAJOR CAPSID PROTEIN HERPES SIMPLEX VIRUS 136-174 |
| 230-266 311-382 |
| PVCAP-- HSVSA MAJOR CAPSID PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 150-184 304-352 |
| PVCAP-- PRVIS MAJOR CAPSID PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) 479-520 673-714 755-799 |
| PVCAP-- VZVD MAJOR CAPSID PROTEIN PSEUDORABIES VIRUS (STRAIN |
| INDIANA S) 105-160 292-326 |
| PVCG3-- NPVAC MAJOR CAPSID PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 128-198 316-350 |
| PVD05-- FOWP1 DNA-BINDING PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| 110-248 |
| POLYHEDROSIS VIRUS |
| PVD05-- VACCC 92.6 KD PROTEIN FOWLPOX VIRUS (STRAIN FP-1) 145-181 |
| PVD05-- VACCV PROTEIN D5 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 123-157 |
| PVD05-- VARV PROTEIN D5 VACCINIA VIRUS (STRAIN WR) 123-157 |
| PVD09-- |
| VACCC PROTEIN D5 VARIOLA VIRUS 123-157 PVD09-- VACCV |
| PROTEIN D9 VACCINIA VIRUS (STRAIN COPENHAGEN) 126-160 |
| PVD09-- VARV PROTEIN D9 VACCINIA VIRUS (STRAIN WR) 126-160 |
| PVD10-- |
| FOWP1 PROTEIN D9 VARIOLA VIRUS 126-160 PVD10-- SFVKA |
| PROTEIN D10 FOWLPOX VIRUS (STRAIN FP-1) 65-99 188-222 |
| PVD10-- VARV PROTEIN D10 SHOPE FIBROMA VIRUS (STRAIN KASZA) 4-52 |
| PVDBP-- CAMVC PROTEIN D10 VARIOLA VIRUS |
| 67-105 PVDBP-- CAMVD DNA-BINDING PROTEIN |
| CAULIFLOWER MOSAIC VIRUS (STRAIN CM-1841) |
| 1-35 PVDBP-- CAMVE DNA-BINDING PROTEIN |
| CAULIFLOWER MOSAIC VIRUS (STRAIN D/H) |
| 1-35 PVDBP-- CAMVN DNA-BINDING |
| PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN BBC) |
| 1-35 PVDBP-- CAMVS DNA-BINDING PROTEIN |
| CAULIFLOWER MOSAIC VIRUS (STRAIN NY8153) |
| 1-35 PVE02-- VACCC DNA-BINDING PROTEIN |
| CAULIFLOWER MOSAIC VIRUS (STRAIN |
| 1-35 STRASBOURG) |
| PVE02-- VACCV PROTEIN E2 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 282-336 |
| PVE02-- VARV PROTEIN E2 VACCINIA VIRUS (STRAIN WR) 282-336 |
| PVE03-- |
| VACCC PROTEIN E2 VARIOLA VIRUS 282-336 PVE03-- VACCV |
| PROTEIN E3 VACCINIA VIRUS (STRAIN COPENHAGEN) 17-61 |
| PVE03-- |
| VARV PROTEIN E3 VACCINIA VIRUS (STRAIN WR) 17-61 PVE05-- |
| VACCC PROTEIN E3 VARIOLA VIRUS 17-61 |
| PVE05-- VACCD PROTEIN E5 VACCINIA VIRUS (STRAIN COPENHAGEN) 28-93 |
| PVE05-- VACCV PROTEIN E5 VACCINIA VIRUS (STRAIN DAIREN I) 38-103 |
| PVE05-- VARV PROTEIN ES VACCINIA VIRUS (STRAIN WR) 38-103 |
| PVE06-- VACCC PROTEIN E5 VARIOLA VIRUS |
| 38-103 PVE06-- VACCV PROTEIN E6 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 105-139 232-266 |
| PVE06-- VARV PROTEIN E6 VACCINIA VIRUS (STRAIN WR) 105-139 |
| 232-266 |
| PVE18-- |
| NPVAC PROTEIN E6 VARIOLA VIRUS 105-139 367-401 PVE1-- |
| HPV1A EARLY 18.5 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR 112-163 |
| POLYHEDROSIS VIRUS |
| PVE1-- HPV31 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 1A 137-171 |
| PVE1-- HPV33 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 31 56-90 |
| PVE1-- HPV35 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 33 33-67 |
| 133-167 |
| PVE1-- HPV39 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 35 56-90 |
| PVE1-- HPV41 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 39 59-96 |
| PVE1-- HPV42 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 55-89 |
| 312-346 |
| PVE1-- MPV58 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 42 25-87 |
| PVE1-- HPV6B E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 58 33-67 |
| 119-174 |
| PVE1-- PAPVE E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 6B 265-299 |
| PVE26-- NPVAC E1 PROTEIN EUROPEAN ELK PAPILLOMAVIRUS 176-210 |
| PVE2-- CRPVK EARLY 25.9 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| 72-117 |
| POLYHEDROSIS VIRUS |
| PVE2-- HPV05 PROBABLE E2 PROTEIN COTTONTAIL RABBIT (SHOPE) |
| PAPILLOMAVIRUS |
| 3-44 (STRAIN |
| KANS |
| PVE2-- HPV08 PROBABLE E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5 |
| 5-57 276-310 342-383 437-471 |
| PVE2-- HPV16 PROBABLE E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 8 |
| 5-55 148-182 |
| PVE2-- HPV18 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 16 61-105 |
| 315-349 |
| PVE2-- HPV1A E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 18 65-100 |
| PVE2-- HPV2A E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 1A 3-37 |
| 159-193 |
| PVE2-- HPV31 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 2A 13-47 |
| 159-193 |
| PVE2-- HPV33 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 31 61-105 |
| PVE2-- HPV35 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 33 63-101 |
| 297-331 |
| PVE2-- HPV39 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 35 62-106 |
| 158-192 |
| PVE2-- HPV41 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 39 74-110 |
| 323-357 |
| PVE2-- HPV47 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 6-54 |
| PVE2-- HPV51 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 47 5-55 |
| 148-182 |
| PVE2-- HPV57 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 51 154-191 |
| PVE2-- HPV58 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 57 13-47 |
| 179-213 |
| PVE2-- HPV5B E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 58 2-36 |
| PVE2-- PAPVD PROBABLE E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE |
| 5B |
| 5-57 |
| PVE2-- PAPVE PROBABLE E2 PROTEIN DEER PAPILLOMAVIRUS 107-141 |
| PVE2-- |
| PCPV1 PROBABLE E2 PROTEIN EUROPEAN ELK PAPILLOMAVIRUS 113-150 |
| PVE2-- RHPV1 E2 PROTEIN PYGMY CHIMPANZEE PAPILLOMAVIRUS TYPE 1 |
| 318-361 |
| PVE39-- NPVAC E2 PROTEIN RHESUS PAPILLOMAVIRUS TYPE 1 62-106 |
| 307-341 |
| PVE39-- NPVOP EARLY 39 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| 20-57 |
| POLYHEDROSIS VIRUS |
| PVE4-- HPV18 EARLY 39 KD PROTEIN ORGYIA PSEUDOTSUGATA MULTICAPSID |
| 119-156 |
| POLYHEDROSIS VIRUS |
| PVE4-- HPV41 PROBABLE E4 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 18 |
| 42-86 |
| PVE5-- HPV5B PROBABLE E4 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 |
| 63-97 |
| PVEF-- GVTN PROBABLE E5 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5B |
| 3-40 |
| 96-130 |
| PVENV-- BEV VIRAL ENHANCING FACTOR TRICHOPLUSIA NI GRANULOSIS VIRUS |
| (TNGV) 681-719 |
| (VEF) (104 KD GLYCOP |
| PVENV-- |
| DHVI1 ENVELOPE PROTEIN BERNE VIRUS (BEV) 195-229 PVENV-- |
| MCV1 ENVELOPE GLYCOPROTEIN DHORI VIRUS (STRAIN INDIAN/1313/61) (DHO) |
| 318-366 |
| PRECURSOR |
| PVENV-- MCV2 MAJOR ENVELOPE PROTEIN (43 KD MOLLUSCUM CONTAGIOSUM |
| VIRUS SUBTYPE 252-286 |
| PROTEIN P43K) 1 (MCVI) |
| PVENV-- THOGV MAJOR ENVELOPE PROTEIN (43 KD MOLLUSCUM CONTAGIOSUM |
| V IRUS SUBTYPE 252-286 |
| PROTEIN P43K) 2 (MCVII) |
| PVENV-- VACCC ENVELOPE GLYCOPROTEIN THOGOTO VIRUS (THO) 313-354 |
| PRECURSOR (SURFACE |
| PVENV-- VACC1 MAJOR ENVELOPE PROTEIN (37 KD VACCINIA VIRUS |
| (STRAIN COPENHAGEN) 257-295 |
| PROTEIN) (P37K) |
| PVENV-- VACCP MAJOR ENVELOPE PROTEIN (37 KD VACCINIA VIRUS |
| (STRAIN IHD-J) 257-295 |
| PROTEIN) (P37K) |
| PVENV-- VACCV MAJOR ENVELOPE PROTEIN (37 KD VACCINIA VIRUS |
| (STRAIN L-IVP) 257-295 |
| PROTEIN) (P37K) |
| PVENV-- VARV MAJOR ENVELOPE PROTEIN (37 KD VACCINIA VIRUS (STRAIN |
| WR) 257-295 |
| PROTEIN) (P37K) |
| PVETS-- NPVAC MAJOR ENVELOPE PROTEIN (37 KD VARIOLA VIRUS 257-295 |
| PROTEIN) (P37K) |
| PVF01-- VACCC ECORI-T SITE PROTEIN ETS AUTOGRAPHA CALIFORNICA |
| NUCLEAR |
| 1-53 |
| POLYHEDROSIS VIRUS ( |
| PVF01-- VACCV PROTEIN F1 VACCINIA VIRUS (STRAIN COPENHAGEN), AND |
| 46-80 124-158 |
| VACCINIA VIRUS |
| PVF03-- VACCC PROTEIN F1 (FRAGMENT) VACCINIA VIRUS (STRAIN WR) |
| 46-80 124-158 |
| PVF03-- VACCV PROTEIN F3 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 71-110 |
| PVF05-- VACCC PROTEIN F3 VACCINIA VIRUS (STRAIN WR) 71-110 |
| PVF05-- VACCP 36 KD MAJOR MEMBRANE PROTEIN VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| 81-129 282-320 PRECURSOR |
| PVF05-- VACCV 36 KD MAJOR MEMBRANE PROTEIN VACCINIA VIRUS |
| (STRAIN L-1VP) |
| 81-129 282-320 PRECURSOR |
| PVF05-- VARV 36 KD MAJOR MEMBRANE PROTEIN VACCINIA VIRUS |
| (STRAIN WR) |
| 81-129 283-321 PRECURSOR |
| PVF06-- VARV 36 KD MAJOR MEMBRANE PROTEIN VARIOLA VIRUS 81-122 |
| 281-322 |
| PRECURSOR |
| PVF11-- VACCC PROTEIN F6 VARIOLA VIRUS |
| 8-44 PVF11-- VACCP PROTEIN F11 VACCINIA |
| VIRUS (STRAIN COPENHAGEN) 217-258 269-315 |
| PVF11-- VARV PROTEIN F11 VACCINIA VIRUS (STRAIN L-1VP) 213-254 |
| 265-311 |
| PVF12-- |
| VACCC PROTEIN F11 VARIOLA VIRUS 41-75 269-311 PVF12-- |
| VACCP PROTEIN F12 VACCINIA VIRUS (STRAIN COPENHAGEN) 1-67 102-143 |
| 199-236 350-388 544-581 |
| PVF12-- VARV PROTEIN F12 VACCINIA VIRUS (STRAIN L-IVP) 1-67 |
| 102-143 199-236 350-388 544-581 |
| PVF16-- VACCC PROTEIN F12 VARIOLA VIRUS 1-67 199-236 350-388 |
| 547-581 |
| PVF16-- VACCP PROTEIN F16 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 155-194 |
| PVF16-- VARV PROTEIN F16 VACCINIA VIRUS (STRAIN L-1VP) 155-194 |
| PVFP3-- |
| FOWPV PROTEIN F16 VARIOLA VIRUS 155-194 PVFP4-- |
| FOWPV PROTEIN FP3 FOWLPOX VIRUS |
| 1-43 PVFP7-- FOWPV PROTEIN FP4 |
| FOWLPOX VIRUS 139-173 239-273 |
| PVFPL-- |
| FOWP1 PROTEIN FP7 FOWLPOX VIRUS 23-57 PVFUS-- |
| VACCC FPLEFT PROTEIN (FRAGMENT) FOWLPOX VIRUS (STRAIN FP-1) 77-111 |
| PVFUS-- VACCV 14 KD FUSION PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 30-64 |
| PVG01-- HSVII 14 KD FUSION PROTEIN VACCINIA VIRUS (STRAIN WR) |
| 30-64 |
| PVG01-- VACCC HYPOTHETICAL GENE 1 PROTEIN ICTALURID HERPESVIRUS |
| (CHANNEL CATFISH 271-306 512-563 591-647 730-764 |
| VIRUS) (CCV) |
| PVG01-- VACCV PROTEIN G1 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 301-339 |
| PVG01-- VARV PROTEIN G1 (FRAGMENT) VACCINIA VIRUS (STRAIN WR) |
| 240-278 |
| PVG03-- |
| HSVEB PROTEIN G1 VARIOLA VIRUS 301-339 PVG03-- |
| HSVEK GENE 3 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN AS14P) 143-177 |
| (EHV-1) |
| PVG03-- VARV GENE 3 PROTEIN (ORF L1) EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN 143-177 |
| KENTUCKY A) (EHV-1) |
| PVG05-- |
| VACCC PROTEIN G3 VARIOLA VIRUS 64-98 PVG05-- |
| VARV PROTEIN G5 VACCINIA VIRUS (STRAIN COPENHAGEN) 117-158 255-289 |
| 355-389 |
| PVG06-- HSVII PROTEIN G5 VARIOLA VIRUS 117-158 255-289 355-359 |
| PVG07-- |
| HSVII HYPOTHETICAL GENE 6 MEMBRANE ICTALURID HERPESVIRUS 1 (CHANNEL |
| CATFISH |
| 61-109 |
| PROTEIN VIRUS) (CCV) |
| PVG07-- VACCC HYPOTHETICAL GENE 7 MEMBRANE ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH |
| 69-103 PROTEIN VIRUS) |
| (CCV) |
| PVG07-- VARV PROTEIN G7 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 114-175 324-358 |
| PVG09-- |
| VACCC PROTEIN G7 VARIOLA VIRUS 114-175 324-358 PVG09-- |
| VACCV PROTEIN F1 (PROTEIN G9) VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 304-338 |
| PVG09-- VARV PROTEIN F1 (PROTEIN G9) VACCINIA VIRUS (STRAIN WR) |
| 304-338 |
| (FRAGMENT) |
| PVG10-- HSVII PROTEIN F1 (PROTEIN 09) VARIOLA VIRUS 304-338 |
| PVG12-- SPVIR HYPOTHETICAL GENE 10 MEMBRANE ICTALURID |
| HERPESVIRUS 1 (CHANNEL CATFISH 63-97 |
| PROTEIN VIRUS) (CCV) |
| PVG16-- HSVSA GENE 12 PROTEIN SPIOPLASMA VIRUS SPV1-R8A2 B 11-45 |
| PVG17-- HSVII HYPOTHETICAL GENE 16 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) 38-95 |
| PVG18-- HSVII HYPOTHETICAL GENE 17 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH |
| 92-129 177-211 VIRUS) (CCV) |
| PVGIL-- |
| AMEPV HYPOTHETICAL GENE 18 PROTEIN ICTALURID HERPESVIRUS 1 (CHANNEL |
| CATFISH 174-208 215-256 |
| VIRUS) (CCV) |
| PVG1-- SPVIR GIL PROTEIN AMSACTA MOOREI ENTOMOPOXVIRUS (AMEPV) |
| 407-441 |
| PVG1-- SPV4 CAPSID PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B 136-170 |
| 256-297 320-357 |
| PVG22-- HSVII CAPSID PROTEIN SPIROPLASMA VIRUS 4 (SPV4) 287-321 |
| PVG24-- HSVII HYPOTHETICAL GENE 22 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 117-158 437-629 660-892 899-1055 |
| VIRUS) (CCV) |
| PVG27-- HSVII HYPOTHETICAL GENE 24 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 7-72 |
| 74-108 VIRUS) (CCV) |
| PVG28-- HSVII HYPOTHETICAL GENE 27 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 164-219 |
| VIRUS) (CCV) |
| PVG2R-- AMEPV HYPOTHETICAL GENE 28 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 253-290 |
| VIRUS) (CCV) |
| PVG2-- |
| SPVIR HYPOTHETICAL G2R PROTEIN AMSACTA MOOREI ENTOMOPOXVIRUS (AMPEV) |
| 29-63 184-218 |
| PVG2-- SPV4 GENE 2 PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B 222-256 |
| 285-326 |
| PVG33-- HSVII GENE 2 PROTEIN SPIROPLASMA VIRUS 4 (SPV4) 255-310 |
| PVG34-- HSVII HYPOTHETICAL GENE 33 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 149-183 |
| VIRUS) (CCV) |
| PVG35-- HSVII HYPOTHETICAL GENE 34 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 345-379 |
| VIRUS) (CCV) |
| PVG37-- HSVII HYPOTHETICAL GENE 35 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 17-90 |
| VIRUS) (CCV) |
| PVG38-- HSVII HYPOTHETICAL GENE 37 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 435-472 |
| VIRUS) (CCV) |
| PVG39-- HSVII HYPOTHETICAL GENE 38 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH |
| 84-118 VIRUS) (CCV) |
| PVG3-- SPVIR HYPOTHETICAL GENE 39 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 124-158 266-300 |
| VIRUS) (CCV) |
| PVG3-- SPV4 GENE 3 PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B 8-49 |
| 162-196 203-244 |
| PVG43-- HSVII GENE 3 PROTEIN SPIROPLASMA VIRUS 4 (SPV4) 6-54 |
| 87-121 |
| PVG45-- HSVSA HYPOTHETICAL GENE 43 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 116-150 262-296 324-361 643-677 |
| VIRUS) (CCV) |
| PVG46-- HSVII HYPOTHETICAL GENE 45 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) 121-162 |
| PVG48-- HSVII PROBABLE MAJOR GLYCOPROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH 45-86 939- 1251- |
| VIRUS) (CCV) 1078 1321 |
| PVG48-- HSVSA HYPOTHETICAL GENE 48 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 169-207 |
| VIRUS) (CCV) |
| PVG49-- HSVSA HYPOTHETICAL GENE 48 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) 160-417 611-666 733-767 |
| PVG4R-- AMEPV HYPOTHETICAL GENE 49 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| 68-102 PVG4-- |
| SPV4 G4R PROTEIN AMSACTA MOOREI ENTOMOPOXVIRUS (AMPEV) |
| 4-38 PVG51-- HSVII GENE 4 PROTEIN SPIROPLASMA VIRUS 4 |
| (SPV4) |
| 89-130 |
| PVG51-- HSVSA HYPOTHETICAL GENE 51 MEMBRANE ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH 34-73 |
| 890-123 PROTEIN VIRUS) (CCV) |
| PVG53-- HSVII GENE 51 GLYCOPROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) 29-70 123-157 162-196 |
| PVG54-- HSVII HYPOTHETICAL GENE 53 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH |
| 67-127 VIRUS) (CCV) |
| PVG55-- |
| HSVII HYPOTHETICAL GENE 54 PROTEIN ICTALURID HERPESVIRUS 1 (CHANNEL |
| CATFISH 355-396 |
| VIRUS) (CCV) |
| PVG55-- HSVSA HYPOTHETICAL GENE 55 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 101-135 |
| VIRUS) (CCV) |
| PVG56-- HSVII HYPOTHETICAL GENE 55 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) 126-178 |
| PVG59-- HSVII HYPOTHETICAL GENE 56 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 151-192 578-612 644-678 750-784 846-880 1111- |
| VIRUS) (CCV) 1145 |
| PVG59-- HSVSA HYPOTHETICAL GENE 59 MEMBRANE ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 10-72 |
| 89-123 PROTEIN VIRUS) (CCV) |
| PVG5-- SPVIR GENE 59 PROTEIN HERPESVIRUS SAIMIRI (STRAIN 11) |
| 169-209 |
| PVG61-- HSVII GENE 5 PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B |
| 65-103 |
| PVG63-- HSVII HYPOTHETICAL GENE 61 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 265-299 |
| VIRUS) (CCV) |
| PVG65-- HSVII HYPOTHETICAL GENE 63 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 546-584 |
| VIRUS) (CCV) |
| PVG66-- HSVII HYPOTHETICAL GENE 65 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 805-839 1213- |
| VIRUS) (CCV) 1254 |
| PVG67-- HSVII HYPOTHETICAL GENE 66 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 154-188 328-410 |
| VIRUS) (CCV) |
| PVG68-- HSVII HYPOTHETICAL GENE 67 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 379-413 501-546 1321- 1478- |
| VIRUS) (CCV) 1369 1541 |
| PVG72-- HSVII HYPOTHETICAL GENE 68 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 245-288 |
| VIRUS) (CCV) |
| PVG75-- HSVII HYPOTHETICAL GENE 72 PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH 447-484 723-757 912-949 |
| VIRUS) (CCV) |
| PVG8-- SPVIR HYPOTHETICAL GENE 75 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH 271-305 388-422 |
| VIRUS) (CCV) |
| PVGF1-- IBVB GENE 8 PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B 5-51 |
| PVGH3-- HCMVA F1 PROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| 142-179 1233- 2119- 3388- 3475- 3517- 3761- |
| (STRAIN BEAUDETTE) (1 1267 2156 3424 3513 3556 3795 |
| PVGL1-- CVPR8 GLYCOPROTEIN H301 PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVGL2-- CVBF E1 GLYCOPROTEIN PRECURSOR PORCINE RESPIRATORY |
| CORONAVIRUS 212-257 |
| (MATRIX GLYCOP (STRAIN 86/137004/BRI |
| PVGL2-- CVBL9 E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS |
| (STRAIN F15 642-676 850-885 993- 1263- |
| (SPIKE GLYCOPRO 1088 1305 |
| PVGL2-- CVBLY E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS |
| (STRAIN L9) 850-885 993- 1263- |
| (SPIKE GLYCOPRO 1109 1305 |
| PVGL2-- CVBM E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS (STRAIN |
| LY-138) 642-676 850-885 993- 1263- |
| (SPIKE GLYCOPRO 1109 1305 |
| PVGL2-- CVBQ E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS (STRAIN |
| MEBUS 642-676 850-885 993- 1263- |
| (SPIKE GLYCOPRO 1109 1305 |
| PVGL2-- CVBV E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS (STRAIN |
| QUEBEC) 642-676 850-885 993- 1263- |
| (SPIKE GLYCOPRO 1109 1305 |
| PVGL2-- CVH22 E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS |
| (STRAIN VACCINE) 642-676 850-885 993- 1263- |
| (SPIKE GLYCOPRO 1109 1305 |
| PVGL2-- CVM4 E2 GLYCOPROTEIN PRECURSOR HUMAN CORONAVIRUS (STRAIN |
| 229E) 770-916 1055- |
| (SPIKE GLYCOPRO 1112 |
| PVGL2-- CVMA5 E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS MHV |
| (STRAIN WILD 643-684 1001- 1270- |
| (SPIKE GLYCOPRO TYPE 4)(MHV-4) 1117 1315 |
| PVGL2-- CVMJC E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS MHV |
| (STRAIN A59) 591-632 949- 1218- |
| (SPIKE GLYCOPRO 1079 1263 |
| PVGL2-- CVMJH E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS MHV |
| (STRAIN 643-684 1001- 1270- |
| (SPIKE GLYCOPRO JHMV/VARIANT CL-2) 1117 1315 |
| PVGL2-- CVPFS E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS MHV |
| (STRAIN JHM) 503-543 860-976 1129- |
| (SPIKE GLYCOPRO 1174 |
| PVGL2-- CVPMI E2 GLYCOPROTEIN PRECURSOR PROCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| 69-110 448-482 692-733 889-923 1040- 1352- (SPIKE |
| GLYCOPRO CORONAVIRUS (S 1186 1389 |
| PVGL2-- CVPPR E2 GLYCOPROTEIN PRECURSOR PROCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| 69-110 448-482 692-733 889-923 1040- 1352- (SPIKE |
| GLYCOPRO CORONAVIRUS (S 1186 1389 |
| PVGL2-- CVPPU E2 GLYCOPROTEIN PRECURSOR PROCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| 70-110 446-480 690-731 887-921 1038- 1350- (SPIKE |
| GLYCOPRO CORONAVIRUS (S 1184 1387 |
| PVGL2-- CVPR8 E2 GLYCOPROTEIN PRECURSOR PROCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| 69-110 446-480 690-731 887-921 1038- 1350- (SPIKE |
| GLYCOPRO CORONAVIRUS (S 1184 1387 |
| PVGL2-- CVPRM E2 GLYCOPROTEIN PRECURSOR PROCINE RESPIRATORY |
| CORONAVIRUS (STRAIN 224-258 468-509 665-699 816-962 1128- |
| (SPIKE GLYCOPRO 86/137004/BRIT 1165 |
| PVGL2-- CVPRT E2 GLYCOPROTEIN PRECURSOR PROCINE RESPIRATORY |
| CORONAVIRUS (STRAIN 224-258 468-509 665-699 816-962 1128- |
| (SPIKE GLYCOPRO RM4)(PRCV) 1165 |
| PVGL2-- EBV E2 GLYCOPROTEIN PRECURSOR PROCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| 69-110 446-480 690-731 887-921 1038- 1350- (SPIKE |
| GLYCOPRO CORONAVIRUS (S 1184 1387 |
| PVGL2-- FIPV PROBABLE MEMBRANE |
| 68-102 GLYCOPROTEIN |
| PVGL2-- |
| IBV6 E2 GLYCOPROTEIN PRECURSOR FELINE INFECTIOUS PERITONITIS VIRUS |
| 189-245 451-485 695-736 892-926 1043- 1355- |
| (STRAIN 79-1146) 1189 1392 |
| PVGL2-- |
| IBVB E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS VIRUS |
| 791-905 1057- |
| (STRAIN 6/82) 1091 |
| PVGL2-- |
| IBVD2 E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS VIRUS |
| 437-78 772-904 1056- |
| (STRAIN BEAUDETTE) 1090 |
| PVGL2-- |
| IBVK E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS VIRUS |
| 773-905 1057- |
| (STRAIN D274) 1091 |
| PVGL2-- |
| IBVM E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN 437-478 722-904 1056- |
| KB8523) 1090 |
| PVGLB-- |
| HCMVA E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS VIRUS |
| 437-478 722-904 1056- |
| (STRAIN M41) 1090 |
| PVGLB-- HCMVT GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 43-88 128-162 436-484 844-878 |
| PVGLB-- HSVII GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN TOWNE) 22-88 128-162 437-478 451-485 845-879 |
| PVGLB-- HSV1F GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 828-890 |
| PVGLB-- HSV1K GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN F)] 827-889 |
| PVGLB-- HSV1P GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN KOS) 827-889 |
| PVGLB-- HSV23 GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN PATTON) 828-890 |
| PVGLB-- HSV2H GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 2/STRAIN 333) 828-890 |
| PVGLB-- HSV2S GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 2/STRAIN HG52) 828-890 |
| PVGLB-- HSV6U GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 2/STRAIN SA8) 817-871 |
| PVGLB-- HSVB1 GLYCOPROTEIN B HERPES SIMPLEX VIRUS (TYPE 6/STRAIN |
| 37-71 185-223 |
| UGANDA-1102) |
| PVGLB-- HSVB2 GLYCOPROTEIN I PRECURSOR BOVINE HERPESVIRUS TYPE 1 |
| 859-913 |
| PVGLB-- HSVBC GLYCOPROTEIN B-1 PRECURSOR BOVINE HERPESVIRUS TYPE |
| 2 (STRAIN BMV) 440-474 848-902 |
| PVGLB-- HSVE1 GLYCOPROTEIN I PRECURSOR BOVINE HERPESVIRUS TYPE 1 |
| (STRAIN COOPER) 863-900 |
| PVGLB-- HSVE4 GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (ISOLATE HVS25A) 542-576 911-961 |
| PVGLB-- HSVEA GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 4 |
| (STRAIN 1942) 474-515 847-900 |
| PVGLB-- HSVEB GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB1) 542-576 911-961 |
| PVGLB-- HSVEL GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 542-576 911-961 |
| PVGLB-- HSVMD GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN 542-576 910-960 |
| KENTUCKY D) |
| PVGLB-- |
| HSVSA GLYCOPROTEIN B PRECURSOR MAREK'S DISEASE HERPESVIRUS 390-435 |
| 649-683 787-845 |
| (STRAIN RB-1B) |
| PVGLB-- MCMVS GLYCOPROTEIN B PRECURSOR HERPESVIRUS SAIMIRI |
| (STRAIN 11) 240-288 406-447 |
| PVGLB-- PRV1F GLYCOPROTEIN B PRECURSOR MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) 206-260 427-475 693-734 744-778 860-894 |
| PVGLB-- VZVD GLYCOPROTEIN GII PRECURSOR PSEUDORABIES VIRUS |
| (STRAIN 847-881 |
| INDIANA-FUNKHAUSER/BECKE |
| PVGLC-- HSVII GLYCOPROTEIN B PRECURSOR VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| 92-133 596-630 809-867 PVGLC-- |
| HSV1K GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| 469-510 |
| PVGLC-- HSV2 GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN KOS) 469-510 |
| PVGLC-- HSV23 GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 2) 442-476 |
| PVGLC-- HSVBC GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 2/STRAIN 333) 443-477 |
| PVGLC-- HSVEB GLYCOPROTEIN GIII PRECURSOR BOVINE HERPESVIRUS TYPE |
| 1 (STRAIN COOPER) 235-269 |
| PVGLC-- HSVMB GLYCOPROTEIN C PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) AND 182-218 |
| (STRAIN KEN |
| PVGLC-- HSVMD SECRETORY GLYCOPROTEIN GP57-65 MAREK'S DISEASE |
| HERPESVIRUS (STRAIN BC-1) 63-97 |
| PRECURSOR |
| PVGLC-- HSVMG SECRETORY GLYCOPROTEIN GP57-65 MAREK'S DISEASE |
| HERPESVIRUS (STRAIN RB-1B 63-97 |
| PRECURSOR |
| PVGLC-- HSVMM SECRETORY GLYCOPROTEIN GP57-65 MAREK'S DISEASE |
| HERPESVIRUS (STRAIN GA) 62-96 |
| PRECURSOR |
| PVGLC-- PRV1F SECRETORY GLYCOPROTEIN GP57-65 MAREK'S DISEASE |
| HERPESVIRUS (STRAIN MD5) 63-97 |
| PRECURSOR |
| PVGLC-- VZVD GLYCOPROTEIN GIII PRECURSOR PSEUDORABIES VIRUS |
| (STRAIN 183-235 |
| INDIANA-FUNKHAUSER/BECKE |
| PVGLC-- VZVS GLYCOPROTEIN GPV VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 280-321 |
| PVGLD-- HSVEA GLYCOPROTEIN GPV VARICELLA-ZOSTER VIRUS (STRAIN |
| SCOTT) 280-321 |
| PVGLD-- HSVEB GLYCOPROTEIN D PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB1) |
| 89-123 PVGLD-- |
| HSVEK GLYCOPROTEIN D PRECURSOR EQUINE HERPESVIRUS TYPE 1 (STRAIN AB4P) |
| AND 139-173 |
| (STRAIN KEN |
| PVGLE-- HSVII GLYCOPROTEIN D PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN 139-173 |
| KENTUCKY A) |
| PVGLE-- HSV2 GLYCOPROTEIN E PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 111-145 |
| PVGLF-- BRSVA GLYCOPROTEIN E PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 2) 111-159 |
| PVGLF-- BRSVC FUSION GLYCOPROTEIN PRECURSOR BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS 146-202 504-545 |
| (STRAIN AS 1908) |
| PVGLF-- BRSVR FUSION GLYCOPROTEIN PRECURSOR BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS 146-202 504-545 |
| (STRAIN COPENHAGE |
| PVGLF-- CDVO FUSION GLYCOPROTEIN PRECURSOR BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 146-202 267-302 506-554 |
| RB94) |
| PVGLF-- HRSV1 FUSION GLYCOPROTEIN PRECURSOR CANINE DISTEMPER |
| VIRUS (STRAIN 228-297 340-381 568-602 |
| ONDERSTEPOORT) |
| PVGLF-- HRSVA FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 116-203 267-302 506-549 |
| SUBGROUP B/STRAI |
| PVGLF-- HRSVL FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN A2 116-202 267-302 506-549 |
| PVGLF-- HRSVR FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 116-202 267-302 506-547 |
| SUBGROUP A/STRAI |
| PVGLF-- MEASE FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS 116-202 267-302 506-549 |
| (STRAIN RSS-2 |
| PVGLF-- MEASI FUSION GLYCOPROTEIN PRECURSOR MEASLES VIRUS (STRAIN |
| EDMONSTON) AND 116-184 228-269 452-500 |
| STRAIN HALLE) |
| PVGLF-- MEASY FUSION GLYCOPROTEIN PRECURSOR MEASLES VIRUS (STRAIN |
| IP-3-CA) 119-187 231-272 455-503 |
| PVGLF-- MUMPI FUSION GLYCOPROTEIN PRECURSOR MEASLES VIRUS (STRAIN |
| YAMAGATA-1) 116-184 228-269 452-500 |
| PVGLF-- MUMPM FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| SBL-1) 20-54 103-179 235-272 447-502 |
| PVGLF-- MUMPR FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) 20-54 103-179 235-272 447-502 |
| PVGLF-- MUMPS FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| RW) 20-54 103-179 235-272 447-502 |
| PVGLF-- NDVA FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| SBL) 20-54 103-179 235-272 447-502 |
| PVGLF-- NDVB FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN 117-182 231-272 426-512 |
| AUSTRALIA-VICTORIA/32) |
| PVGLF-- NDVH3 FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN 122-182 231-272 426-517 |
| BEAUDETTE C/45) |
| PVGLF-- NDVH4 FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN 117-182 231-272 426-517 |
| HER/33) |
| PVGLF-- NDVI FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN 122-182 231-272 426-517 |
| B1-HITCHNER/47) |
| PVGLF-- NDVL FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN ITALIEN/45) 133-182 238-272 426-517 |
| PVGLF-- NDVM FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN LAS/46) 133-182 231-272 426-517 |
| PVGLF-- NDVQ FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN MIYADERA/51) 117-182 231-272 426-512 |
| PVGLF-- NDVT FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN 122-182 231-272 433-512 |
| QUEENSLAND/66) |
| PVGLF-- NDVTG FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN TEXAS) 117-182 231-272 426-517 |
| PVGLF-- NDVU FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN TEXAS G.B./48) 122-182 231-272 433-517 |
| PVGLF-- PHODV FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN ULSTER/67) 122-182 231-272 433-512 |
| PVGLF-- PI1HC FUSION GLYCOPROTEIN PRECURSOR PHOCINE DISTEMPER |
| VIRUS 29-63 197-266 309-350 533-581 |
| PVGLF-- PI2H FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN C39) 123-174 207-267 459-503 |
| PVGLF-- PI2HG FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 2 |
| VIRUS |
| 93-183 477-528 |
| PVGLF-- PI2HT FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN GREER) |
| 93-183 477-528 PVGLF-- PI3B |
| FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 2 VIRUS (STRAIN |
| 93-185 477-528 |
| TOSHIBA) |
| PVGLF-- PI3H4 FUSION GLYCOPROTEIN PRECURSOR BOVINE PARAINFLUENZA |
| 3 VIRUS 117-182 207-241 456-518 |
| PVGLF-- RINDK FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN 117-182 207-241 462-532 |
| NIH 47885) |
| PVGLF-- RINDL FUSION GLYCOPROTEIN PRECURSOR RINDERPEST VIRUS |
| (STRAIN KABETE O) 112-180 224-265 448-493 |
| PVGLF-- SEND5 FUSION GLYCOPROTEIN PRECURSOR RINDERPEST VIRUS |
| (STRAIN L) 112-180 224-265 448-506 |
| PVGLF-- SENDF FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) 127-188 211-271 463-533 |
| PVGLF-- SENDH FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| FUSHIMI) 127-188 211-271 463-533 |
| PVGLF-- SENDJ FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| HARRIS) 127-188 218-271 463-533 |
| PVGLF-- SENDZ FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| HVJ) 127-188 211-271 463-533 |
| PVGLF-- SV41 FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| Z) 127-188 211-271 463-533 |
| PVGLF-- SV5 FUSION GLYCOPROTEIN PRECURSOR SIMIAN VIRUS 4) 96-186 |
| 454-508 |
| PVGLF-- TRTV FUSION GLYCOPROTEIN PRECURSOR SIMIAN VIRUS 5 (STRAIN |
| W3) 103-171 241-275 451-467 |
| PVGLG-- BEFV FUSION GLYCOPROTEIN PRECURSOR TURKEY PHINOTRACHEITIS |
| VIRUS 105-161 190-224 457-498 |
| PVGLG-- BRSVC SPIKE GLYCOPROTEIN PRECURSOR BOVINE EPHEMERAL FEVER |
| VIRUS 506-612 |
| PVGLG-- HRSV1 MAJOR SURFACE GLYCOPROTEIN G BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 30-70 104-138 |
| COPENHAGE |
| PVGLG-- HRSV2 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS 30-81 |
| (SUBGROUP B/STRAI |
| PVGLG-- HRSV3 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 30-85 |
| RSB642 |
| PVGLG-- HRSV4 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 30-85 |
| RSB1734 |
| PVGLG-- HRSV5 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN |
| 30-107 RSB5857) |
| PVGLG-- HRSV6 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 30-85 |
| RSB6190) |
| PVGLG-- HRSV7 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 30-85 |
| RSB6256) |
| PVGLG-- HRSV8 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 30-85 |
| RSB6614) |
| PVGLG-- HRSVA MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS 30-81 |
| (SUBGROUP B/STRAI |
| PVGLG-- HRSVL MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN 30-67 |
| A2) |
| PVGLG-- HRVE4 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS 25-85 |
| (SUBGROUP A/STRAI |
| PVGLG-- SIGMA GLYCOPROTEIN G PRECURSOR EQUINE HERPESVIRUS TYPE 4 |
| (STRAIN 1942) 271-305 |
| PVGLG-- SYNV SPIKE GLYCOPROTEIN PRECURSOR SIGMA VIRUS 344-381 |
| 464-498 |
| PVGLG-- VHSV0 SPIKE GLYCOPROTEIN PRECURSOR SONCHUS YELLOW NET |
| VIRUS 488-523 |
| PVGLG-- VSVIG SPIKE GLYCOPROTEIN PRECURSOR VIRAL HEMORRHAGIC |
| SEPTICEMIA VIRUS 363-397 |
| (STRAIN 07-71) |
| PVGLH-- EBV SPIKE GLYCOPROTEIN PRECURSOR VESICULAR STOMATITIS |
| VIRUS (SEROTYPE 476-510 |
| INDIANA/STRAIN G |
| PVGLH-- HCMVA GLYCOPROTEIN GP85 PRECURSOR EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) 53-87 160-201 336-380 653-694 |
| PVGLH-- HCMVT GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 103-137 270-311 693-741 |
| PVGLH-- HSVII GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN TOWNE) 102-136 692-740 |
| PVGLH-- HSVIE GLYCOPROTEIN H PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 447-481 |
| PVGLH-- HSV6G GLYCOPROTEIN H PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN HFEM) 447-481 |
| PVGLH-- HSVBC GLYCOPROTEIN H PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 357-406 |
| PVGLH-- HSVE4 GLYCOPROTEIN H PRECURSOR BOVINE HERPESVIRUS TYPE 1 |
| (STRAIN COOPER) 364-416 |
| PVGLH-- HSVEB GLYCOPROTEIN H PRECURSOR EQUINE HERPESVIRUS TYPE 4 |
| (STRAIN 1942) 334-379 414-455 |
| PVGLH-- HSVSA GLYCOPROTEIN H PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) AND 327-372 407-448 |
| ISOLATE HV |
| PVGLH-- MCMVS GLYCOPROTEIN H PRECURSOR HERPESVIRUS SAIMIRI |
| (STRAIN 11) 32-66 374-453 664-712 |
| PVGLH-- PRVKA GLYCOPROTEIN H PRECURSOR MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH 440-474 |
| PVGLH-- PRVN3 GLYCOPROTEIN H PRECURSOR PSEUDORABIES VIRUS (STRAIN |
| KAPLAN) 226-260 |
| PVGLH-- PRVRI GLYCOPROTEIN H PRECURSOR PSEUDORABIES VIRUS (STRAIN |
| NIA-3) 226-260 |
| PVGLH-- VZVD GLYCOPROTEIN H PRECURSOR PSEUDORABIES VIRUS (STRAIN |
| RICE) 226-260 |
| PVGLI-- HCMVA PROBABLE GLYCOPROTEIN H VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 455-506 |
| PRECURSOR |
| PVGLM-- BUNGE IMMEDIATE EARLY GLYCOPROTEIN HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 47-111 323-359 PRECURSOR |
| PVGLM-- BUNL7 M POLYPROTEIN PRECURSOR BUNYAVIRUS GERMISTON |
| 512-567 685-737 1228- |
| 1262 |
| PVGLM-- BUNSH M POLYPROTEIN PRECURSOR BUNYAVIRUS LA CROSSE |
| (ISOLATE L74) 643-677 916-950 |
| PVGLM-- BUNYW M POLYPROTEIN PRECURSOR BUNYAVIRUS SNOWSHOE HARE |
| 643-677 |
| PVGLM-- DUGBV M POLYPROTEIN PRECURSOR BUNYAMWERA VIRUS 340-374 |
| 504-563 905-939 |
| PVGLM-- HANTB M POLYPROTEIN PRECURSOR DUGBE VIRUS 937-989 1239- |
| 1300 |
| PVGLM-- HANTH M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN B-1) |
| 693-727 |
| PVGLM-- HANTL M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN HOJO) |
| 72-106 |
| PVGLM-- HANTV M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN LEE) |
| 72-106 |
| PVGLM-- INSV M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN |
| 76-118) |
| 72-106 |
| PVGLM-- PHV M POLYPROTEIN PRECURSOR IMPATIENS NECROTIC SPOT VIRUS |
| 1067- |
| 1101 |
| PVGLM-- PTPV M POLYPROTEIN PRECURSOR PROSPECT HILL VIRUS 73-111 |
| PVGLM-- SEOU8 M POLYPROTEIN PRECURSOR PUNTA TORO PHLEBOVIRUS |
| 149-251 |
| PVGLM-- SEOUR M POLYPROTEIN PRECURSOR SEOUL VIRUS (STRAIN 30-39) |
| 693-727 |
| PVGLM-- SEOUS M POLYPROTEIN PRECURSOR SEOUL VIRUS (STRAIN R22) |
| 694-728 |
| PVGLN-- BEFV M POLYPROTEIN PRECURSOR SEOUL VIRUS (STRAIN SR-11) |
| 693-730 |
| PVGLP-- BEV NONSTRUCTURAL GLYCOPROTEIN BOVINE EPHEMERAL FEVER |
| VIRUS 377-414 513-459 |
| GNS PRECURSO |
| PVGLX-- PRVRI PEPLOMER GLYCOPROTEIN BERNE VIRUS 43-82 90-124 |
| 622-656 1128- |
| PRECURSOR 1236 |
| PVGLY-- JUNIN SECRETED GLYCOPROTEIN GX PSEUDORABIES VIRUS (STRAIN |
| RICE) 420-461 |
| PVGLY-- LASSG GLYCOPROTEIN POLYPROTEIN JUNIN ARENAVIRUS 301-349 |
| PRECURSOR |
| PVGLY-- LASSJ GLYCOPROTEIN POLYPROTEIN LASSA VIRUS (STRAIN GA391) |
| 317-360 388-422 |
| PRECURSOR |
| PVGLY-- LYCVA GLYCOPROTEIN POLYPROTEIN LASSA VIRUS (STRAIN |
| JOSIAH) 318-361 389-423 |
| PRECURSOR |
| PVGLY-- |
| LYCVW GLYCOPROTEIN POLYPROTEIN LYMPHOCYTIC CHORIOMENINGITIS VIRUS |
| (STRAIN 333-367 395-432 |
| PRECURSOR ARMSTON) |
| PVGLY-- |
| MOPEI GLYCOPROTEIN POLYPROTEIN LYMPHOCYTIC CHORIOMENINGITIS VIRUS |
| (STRAIN 124-158 333-367 395-432 |
| PRECURSOR WE) |
| PVGLY-- PIARV GLYCOPROTEIN POLYPROTEIN MOPEIA VIRUS 316-359 |
| PRECURSOR |
| PVGLY-- TACV GLYCOPROTEIN POLYPROTEIN PICHINDE ARENA VIRUS |
| 334-375 |
| PRECURSOR |
| PVGLY-- TACV5 GLYCOPROTEIN POLYPROTEIN TACARIBE VIRUS 315-363 |
| PRECURSOR |
| PVGLY-- TACV7 GLYCOPROTEIN POLYPROTEIN TACARIBE VIRUS (STRAIN V5) |
| 303-351 382-416 |
| PRECURSOR |
| PVGLY-- TACVT GLYCOPROTEIN POLYPROTEIN TACARIBE VIRUS (STRAIN V7) |
| 302-350 381-415 |
| PRECURSOR |
| PVGNB-- CPMV GLYCOPROTEIN POLYPROTEIN TACARIBE VIRUS (STRAIN TRVL |
| 11598) 303-351 382-416 |
| PRECURSOR |
| PVGNM-- CPMV GENOME POLYPROTEIN B COWPEA MOSAIC VIRUS 835-869 |
| PVGNM-- CPSMV GENOME POLYPROTEIN M COWPEA MOSAIC VIRUS 160-201 |
| PVGNM-- RCMV GENOME POLYPROTEIN M COWPEA SEVERE MOSAIC VIRUS |
| (STRAIN DG) 192-226 758-792 874-915 |
| PVGP8-- EBV GENOME POLYPROTEIN M RED CLOVER MOTTLE VIRUS 837-871 |
| 912-946 |
| PVGP-- EBOV PROBABLE MEMBRANE ANTIGEN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| 94-149 |
| GP85 |
| PVGP-- MABVM STRUCTURAL GLYCOPROTEIN EBOLA VIRUS 280-31 334-368 |
| 469-503 |
| PRECURSOR |
| PVGP-- MABVP STRUCTURAL GLYCOPROTEIN MARBURG VIRUS (STRAIN |
| MUSOKE) 562-596 |
| PRECURSOR |
| PVH02-- VACCC STRUCTURAL GLYCOPROTEIN MARBURG VIRUS (STRAIN POPP) |
| 562-596 |
| PRECURSOR |
| PVH02-- VACCV LATE PROTEIN H2 VACCINIA VIRUS (STRAIN COPEHAGEN) |
| 58-92 |
| PVH02-- VARV LATE PROTEIN H2 VACCINIA VIRUS (STRAIN WR) 58-94 |
| PVH05-- |
| VACCC LATE PROTEIN H2 VARIOLA VIRUS 58-92 PVH05-- |
| VACCV PROTEIN H5 VACCINIA VIRUS (STRAIN COPEHAGEN) 118-185 |
| PVH05-- VARV PROTEIN H5 VACCINIA VIRUS (STRAIN WR) 118-185 |
| PVHEL-- |
| LSV PROTEIN H5 VARIOLA VIRUS 136-203 PVHRP-- VACCC |
| PROBABLE HELICASE LILY SYMPTOMLESS VIRUS 126-160 |
| PVHRP-- |
| VACCV HOST RANGE PROTEIN VACCINIA VIRUS (STRAIN COPEHAGEN) 216-279 |
| PVI03-- VACCC HOST RANGE PROTEIN VACCINIA VIRUS (STRAIN WR) |
| 216-279 |
| PVI03-- VACCV PROTEIN I3 VACCINIA VIRUS (STRAIN COPEHAGEN) |
| 150-193 210-244 |
| PVI03-- VARV PROTEIN I3 VACCINIA VIRUS (STRAIN WR) 150-193 |
| 210-244 |
| PVI06-- |
| VACCV PROTEIN I3 VARIOLA VIRUS 150-193 210-244 PVI06-- |
| VARV PROTEIN I6 VACCINIA VIRUS (STRAIN WR) 58-92 |
| PVI07-- |
| VARV PROTEIN I6 VARIOLA VIRUS 58-92 PVI08-- |
| VACCC PROTEIN I7 VARIOLA VIRUS 373-407 |
| PVI08-- VACCV PUTATIVE RNA HELICASE I8 VACCINIA VIRUS (STRAIN |
| COPEHAGEN) 548-589 |
| PVI08-- VARV PUTATIVE RNA HELICASE I8 VACCINIA VIRUS (STRAIN WR) |
| 548-589 |
| PVIE1-- HCMVA PUTATIVE RNA HELICASE I8 VARIOLA VIRUS 548-589 |
| PVIE1-- |
| HCMVT 55 KD IMMEDIATE-EARLY PROTEIN 1 HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| 78-112 171-205 368-402 416-450 |
| PVIE1-- MCMVS 55 KD IMMEDIATE-EARLY PROTEIN 1 HUMAN CYTOMEGALOVIRUS |
| (STRAIN TOWNE) |
| 78-112 171-205 368-402 416-450 PVIE2-- |
| NPVOP IMMEDIATE-EARLY PROTEIN 1 MURINE CYTOMEGALOVIRUS (STRAIN SMITH) |
| 244-297 |
| PVIEN-- NPVAC IMMEDIATE-EARLY PROTEIN IE-2 ORGYIA PSEUDOTSUGATA |
| MULTICAPSID |
| 94-128 305-395 POLYHEDRO |
| SIS VIRUS |
| PVIF-- CAEVC IMMEDIATE-EARLY REGULATORY AUTOGRAPHA CALIFORNICA |
| NUCLEAR 277-407 |
| PROTEIN IE-N POLYHEDROSIS VIRUS |
| PVIF-- |
| FIVPE VIRION INFECTIVITY FACTOR CAPRINE ARTHRITIS ENCEPHALITIS VIRUS |
| 23-92 |
| (STRAIN CORK) |
| PVIF-- FIVSD VIRION INFECTIVITY FACTOR FELINE IMMUNODEFICIENCY |
| VIRUS (ISOLATE 53-94 |
| PETALUMA) |
| PVIF-- HVIA2 VIRION INFECTIVITY FACTOR FELINE IMMUNODEFICIENCY |
| VIRUS (ISOLATE 32-80 |
| SAN DIEGO) |
| PVIF-- HVIB1 VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 |
| 1-42 62-96 (ARV2/SF2 |
| ISOLATE |
| PVIF-- HVIB5 VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 (BH10, |
| 1-42 62-96 BRU, HXB, PV |
| PVIF-- HVIEL VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 (BHS |
| 1-42 62-96 ISOLATE) |
| PVIF-- |
| HVIJR VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ELI |
| 1-42 62-96 |
| ISOLATE) |
| PVIF-- HVIMA VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 (JRCSF |
| 1-42 62-96 ISOLATE) |
| PVIF-- |
| HVIMN VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (MAL |
| 2-36 |
| ISOLATE) |
| PVIF-- HVIN5 VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 (MN |
| 1-42 62-96 ISOLATE) |
| PVIF-- HVINA VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 (NEW |
| 1-42 62-96 YORK-5 ISOL |
| PVIF-- HV1ND VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 |
| 1-42 62-96 (ISOLATE |
| NIT-A) |
| PVIF-- HV1OY VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 |
| 1-42 62-96 (NDK |
| ISOLATE) |
| PVIF-- HV1RH VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 |
| 1-42 62-96 (OYI |
| ISOLATE) |
| PVIF-- HV1U4 VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 |
| 1-42 62-96 (RF/HAT |
| ISOLATE) |
| PVIF-- HV1Z2 VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 (STRAIN |
| 1-42 UGANDAN |
| PVIF-- HV1Z6 VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 |
| 1-42 62-96 (Z2/CDC-Z3 |
| 4 ISOLAT |
| PVIF-- HV2D2 VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 |
| 1-42 62-96 (ZAIRE 6 |
| ISOLATE |
| PVIF-- HV2NZ VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 147-195 |
| (ISOLATE D205.7) |
| PVIF-- HV2RO VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 152-193 |
| (ISOLATE NIH-Z) |
| PVIF-- OMVVS VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 2 163-197 |
| (ISOLATE ROD) |
| PVIF-- SIVAI VIRION INFECTIVITY FACTOR OVINE LENTIVIRUS (STRAIN |
| SA-OMVV) |
| 44-114 |
| PVIF-- SIVAG VIRION INFECTIVITY FACTOR SIMIAN IMMUNODEFICIENCY |
| VIRUS (AGM155 |
| 2-58 150-202 ISOLATE) |
| PVIF-- SIVAI VIRION INFECTIVITY FACTOR SIMIAN IMMUNODEFICIENCY |
| VIRUS (AGM3 17-58 |
| ISOLATE) |
| PVIF-- SIVAT VIRION INFECTIVITY FACTOR SIMIAN IMMUNODEFICIENCY |
| VIRUS (ISOLATE |
| 2-36 143-187 AGM/CLONE |
| GRI |
| PVIF-- SIVCZ VIRION INFECTIVITY FACTOR SIMIAN IMMUNODEFICIENCY |
| VIRUS (TYO-1 20-58 150-195 |
| ISOLATE) |
| PVIF-- |
| SIVGB VIRION INFECTIVITY FACTOR CHIMPANZEE IMMUNODEFICIENCY VIRUS 1-42 |
| PVIMP-- HSV11 VIRION INFECTIVITY FACTOR SIMIAN IMMUNODEFICIENCY |
| VIRUS (ISOLATE GB1) |
| 1-39 PVIMP-- HSVEB |
| PROBABLE INTEGRAL MEMBRANE HERPES SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| 85-134 |
| PROTEIN |
| PVIMP-- HSVSA PROBABLE INTEGRAL MEMBRANE EQUINE HERPESVIRUS TYPE |
| 1 (STRAIN AB4P) 148-182 335-369 |
| PROTEIN |
| PVIMP-- VZVD INTEGRAL MEMBRANE PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| 80-129 PVINT- |
| - SSV1 PROBABLE INTEGRAL MEMBRANE VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| 107-151 155-189 267-301 |
| PROTEIN |
| PVJ01-- VACCC PROBABLE INTEGRASE SULFOLOBUS VIRUS-LIKE PARTICLE |
| SSV1 |
| 85-130 138-172 |
| PVJ01-- VACCV PROTEIN J1 VACCINIA VIRUS (STRAIN COPENHAGEN) 22-56 |
| PVJ01-- VARV PROTEIN J1 VACCINIA VIRUS (STRAIN WR) 22-56 |
| PVK03-- |
| VACCC PROTEIN J1 VARIOLA VIRUS 22-56 PVK03-- VACCV |
| PROTEIN K3 VACCINIA VIRUS (STRAIN COPENHAGEN) 38-82 |
| PVK07-- VACCV PROTEIN K3 VACCINIA VIRUS (STRAIN WR) 38-82 |
| PVL02-- VACCC PROTEIN K7 VACCINIA VIRUS (STRAIN WR), AND |
| (STRAIN 115-149 |
| COPENHAGEN) |
| PVL02-- VACCV PROTEIN L2 VACCINIA VIRUS (STRAIN COPENHAGEN) 47-81 |
| PVL02-- |
| VARV PROTEIN L2 VACCINIA VIRUS (STRAIN WR) 47-92 PVL1-- |
| CRPVK PROTEIN L2 VARIOLA VIRUS 47-81 |
| PVL1-- FPVL PROBABLE L1 PROTEIN COTTONTAIL RABBIT (SHOPE) |
| PAPILLOMAVIRUS 261-295 331-383 |
| (STRAIN KANS |
| PVL1-- HPV05 PROBABLE L1 PROTEIN AVIAN PAPILLOMAVIRUS FPV-L 38-90 |
| PVL1-- HPV08 PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5 |
| 355-393 |
| PVL1-- HPV1A PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 8 |
| 354-392 |
| PVL1-- HPV47 PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 1A |
| 345-379 |
| PVL1-- PAPVD PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 47 |
| 353-391 |
| PVL2-- REOVD PROBABLE L1 PROTEIN DEER PAPILLOMAVIRUS 23-57 |
| PVL2-- HPV05 MAJOR CORE PROTEIN LAMBDA 1 REOVIRUS (TYPE |
| 3/STRAIN DEARING) |
| 94-142 437-471 PVL2-- |
| HPV08 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 341-375 |
| PVL2-- HPV16 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 8 |
| 354-392 |
| PVL2-- HPV1A PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 16 |
| 295-333 |
| PVL2-- HPV31 PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 1A |
| 345-379 |
| PVL2-- HPV35 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 31 |
| 228-326 |
| PVL2-- HPV47 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 35 |
| 292-333 |
| PVL2-- HPV58 PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 47 |
| 341-375 |
| PVL2-- HPV5B PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 58 |
| 293-327 |
| PVL3-- REOVD PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5B |
| 341-375 |
| PVL3-- REOVJ MINOR CORE PROTEIN LAMBDA 3 REOVIRUS (TYPE 3/STRAIN |
| DEARING) 107-148 1112- |
| 1178 |
| PVL3-- REOVL MINOR CORE PROTEIN LAMBDA 3 REOVIRUS (TYPE 2/STRAIN |
| D5/JONES) 1112- |
| 1178 |
| PVL96-- IRV1 MINOR CORE PROTEIN LAMBDA 3 REOVIRUS (TYPE 1/STRAIN |
| LANG) 107-148 331-365 1112- |
| 1178 |
| PVM01-- VACCC L96 PROTEIN TIPULA IRIDESCENT VIRUS 146-180 198-236 |
| PVM1-- REOVL PROTEIN MI VACCINIA VIRUS (STRAIN COPEHAGEN) 5-56 |
| PVM21-- REOVD MINOR VIRION STRUCTURAL REOVIRUS (TYPE 1/STRAIN |
| LANG) 287-321 |
| PROTEIN MU-2 |
| PVM22-- |
| REOVD MAJOR VIRION STRUCTURAL REOVIRUS (TYPE 3/STRAINDEARING) 416-450 |
| 619-663 |
| PROTEIN MU-1/MU-1C |
| PVM2-- |
| REOVJ MAJOR VIRION STRUCTURAL REOVIRUS (TYPE 3/STRAINDEARING) 416-450 |
| 619-662 |
| PROTEIN MU-1/MU-1C |
| PVM2-- |
| REOVL MAJOR VIRION STRUCTURAL REOVIRUS (TYPE 2/STRAIND5/JONES) 416-450 |
| 619-662 |
| PROTEIN MU-1/MU-1C |
| PVM3-- REOVD MAJOR VIRION STRUCTURAL REOVIRUS (TYPE 1/STRAINLANG) |
| 416-450 619-662 |
| PROTEIN MU-1/MU-1C |
| PVMA2-- |
| BRSVA MAJOR NONSTRUCTURAL PROTEIN REOVIRUS (TYPE 3/STRAINDEARING) |
| 135-190 337-371 523-558 618-690 |
| MU-NS |
| PVMA2-- HRSVA MATRIX GLYCOPROTEIN M2 BOVINE RESPIRATORY SYNCYTIAL |
| VIRUS 42-90 |
| (STRAIN A51908) |
| PVMA2-- TRTV MATRIX GLYCOPROTEIN M2 HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS 42-90 |
| (STRAIN A2) |
| PVMAT-- CDVO MATRIX GLYCOPROTEIN M2 TURKEY RHINOTRACHEITIS VIRUS |
| 36-70 |
| PVMAT-- INCJJ MATRIX PROTEIN CANINE DISTEMPER VIRUS (STRAIN |
| 193-234 |
| ONDERSTEPOORT) |
| PVMAT-- NDVA MATRIX (M) PROTEIN INFLUENZA C VIRUS (STRAIN |
| C/JJ/50) |
| 73-114 151-208 |
| PVMAT-- NDVB MATRIX PROTEIN NEWCASTLE DISEASE VIRUS (STRAIN 310-358 |
| AUSTRALIA-VICTORIA/32) |
| PVMAT-- PI3B MATRIX PROTEIN NEWCASTLE DISEASE VIRUS (STRAIN |
| 324-358 |
| BEAUDETTE C/45) |
| PVMAT-- PI3H4 MATRIX PROTEIN BOVINE PARAINFLUENZA 3 VIRUS 99-133 |
| 204-252 |
| PVMAT-- RABVA MATRIX PROTEIN HUMAN PARAINFLUENZA 3 VIRUS (STRAIN |
| 99-133 204-252 |
| N111 47885) |
| PVMAT-- RABVC MATRIX PROTEIN RABIES VIRUS (STRAIN AVO1) 69-103 |
| PVMAT-- RABVE MATRIX PROTEIN RABIES VIRUS (STRAIN CVS-11) |
| 69-103 |
| PVMAT-- RABVN MATRIX PROTEIN RABIES VIRUS (STRAIN ERA) 69-103 |
| PVMAT-- RABVP MATRIX PROTEIN RABIES VIRUS (STRAIN NISHIGAHARA |
| 69-103 |
| RCEH) |
| PVMAT-- RABVS MATRIX PROTEIN RABIES VIRUS (STRAIN PV) 69-103 |
| PVMAT-- SYNV MATRIX PROTEIN RABIES VIRUS (STRAIN SAD B19) |
| 69-103 |
| PVMAT-- VSVIG MATRIX PROTEIN SONCHUS YELLOW NET VIRUS 246-280 |
| PVMEI-- CVBM MATRIX PROTEIN VESICULAR STOMATITIS VIRUS |
| (SEROTYPE 198-232 |
| INDIANA/STRAIN G |
| PVMEI-- CVPFS E1 GLYCOPROTEIN BOVINE CORONAVIRUS (STRAIN MEBUS) |
| 175-209 |
| PVMEI-- CVPPU E1 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| 98-146 212-257 CORONAVIRUS |
| (S |
| PVMEI-- CVPRM E1 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS 212-257 |
| CORONAVIRUS (S |
| PVMEI-- CVTKE E1 GLYCOPROTEIN PRECURSOR PORCINE RESPIRATORY |
| CORONAVIRUS (STRAIN 212-257 |
| RM4) |
| PVMEI-- FIPV E1 GLYCOPROTEIN TURKEY ENTERIC CORONAVIRUS 28-62 |
| 175-209 |
| PVMEI-- |
| IBV6 E1 GLYCOPROTEIN PRECURSOR FELINE INFECTIOUS PERITONITIS VIRUS |
| 212-257 |
| (STRAIN 79-1146) |
| PVMEI-- IBVB E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN 21-55 177-218 |
| 6/82) |
| PVMEI-- IBVB2 E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN 21-55 177-218 |
| BEAUDETTE) |
| PVMEI-- IBVK E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN 21-55 177-218 |
| BEAUDETTE M4 |
| PVMEM-- EBV E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN 177-218 |
| KB8522) |
| PVMP-- CAMVC PROBABLE MEMBRANE PROTEIN EPSTEIN-BARR VARIOUS |
| (STRAIN B95-8) 36-94 |
| PVMP-- CAMVD MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| CM-1841) 187-254 270-324 |
| PVMP-- CAMVE MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| D/H) 187-254 270-324 |
| PVMP-- CAMVN MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| BBC) 187-254 270-324 |
| PVMP-- CAMVS MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| NY8153) 187-254 270-324 |
| PVMP-- CAMVW MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| 187-254 270-324 |
| STRASBOURG) |
| PVMP-- CERV MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| W260) 187-254 270-324 |
| PVMP-- FMVD MOVEMENT PROTEIN CARNATION ETCHED RING VIRUS 212-246 |
| PVMP-- SOCMV MOVEMENT PROTEIN FIGWORT MOSAIC VIRUS (STRAIN DXS) |
| 217-251 |
| PVMSA-- HPBDB MOVEMENT PROTEIN SOYBEAN CHLOROTIC MOTTLE VIRUS |
| 76-118 |
| PVMSA-- HPBDC MAJOR SURFACE ANTIGEN DUCK HEPATITIS B VIRUS (BROWN |
| SHANGHAI 272-313 324-361 |
| PRECURSOR DUCK ISOLATE S |
| PVMSA-- HPBDU MAJOR SURFACE ANTIGEN DUCK HEPATITIS B VIRUS |
| (STRAIN CHINA) 271-312 323-360 |
| PRECURSOR |
| PVMSA-- HPBDW MAJOR SURFACE ANTIGEN DUCK HEPATITIS B VIRUS |
| 234-275 289-323 |
| PRECURSOR |
| PVMSA-- HPBGS MAJOR SURFACE ANTIGEN DUCK HEPATITIS B VIRUS (WHITE |
| SHANGHAI 272-313 324-361 |
| PRECURSOR DUCK ISOLATE S3 |
| PVMSA-- HPBHE MAJOR SURFACE ANTIGEN GROUND SQUIRREL HEPATITIS |
| VIRUS 210-244 |
| PRECURSOR |
| PVMSA-- WHV1 MAJOR SURFACE ANTIGEN HERON HEPATITIS B VIRUS |
| 294-328 |
| PRECURSOR |
| PVMSA-- WHV59 MAJOR SURFACE ANTIGEN WOODCHUCK HEPATITIS VIRUS 1 |
| 208-242 |
| PRECURSOR |
| PVMSA-- WHV7 MAJOR SURFACE ANTIGEN WOODCHUCK HEPATITIS VIRUS 59 |
| 213-247 |
| PRECURSOR |
| PVMSA-- WHV81 MAJOR SURFACE ANTIGEN WOODCHUCK HEPATITIS VIRUS 7 |
| 213-247 |
| PRECURSOR |
| PVMT1-- DHV11 PROBABLE MAJOR SURFACE ANTIGEN WOODCHUCK HEPATITIS |
| VIRUS 8 (INFECTIOUS 213-247 |
| PRECURSOR CLONE) |
| PVMT1-- |
| IAANN MATRIX PROTEIN 1 DHORI VIRUS (STRAIN INDIAN/1313/61) 201-235 |
| PVMT1-- IABAN MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| A/ANN ARBOR/6/60) |
| 92-126 174-222 PVMT1-- |
| IACAO MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN A/BANGKOK/1/79) |
| 92-126 174-222 |
| PVMT1-- IAFOW MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| A/CAMEL/ 31-79 |
| MONGOLIA/82) |
| PVMT1-- IAFPR MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| A/FORT WARREN/1/50), |
| 92-126 174-222 AND (STR |
| PVMT1-- IAFPW MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| A/FOWL PLAGUE |
| 92-126 174-222 VIRUS/ROSTO |
| CK |
| PVMT1-- IALE1 MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| A/FOWL PLAGUE |
| 92-126 174-222 VIRUS/WEYBR |
| ID |
| PVMT1-- IALE2 MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| A/LENINGRAD/134/57) |
| 92-126 174-222 PVMT1-- IAMAN |
| MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN A/LENINGRAD/134/ 92-126 |
| 174-222 |
| 17/57) |
| PVMT1-- IAPOC MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| A/MALLARD/NEW |
| 92-126 174-222 YORK/6750/7 |
| 8) |
| PVMT1-- IAPUE MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| A/PORT CHALMERS/ |
| 92-126 174-222 1/73) |
| PVMT1-- IAUDO MATRIX (M1) PROTEIN INFLUENZA A VIURS |
| (STRAIN A/PUERTO RICO/8/34) |
| 92-126 174-222 PVMT1-- IAWIL MATRIX |
| (M1) PROTEIN INFLUENZA A VIURS (STRAIN A/UDORN/307/7) 92-126 174-222 |
| PVMT1-- IAZ11 MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| A/WILSON-SMITH/33 |
| 92-126 174-222 PVMT1-- |
| INBAC MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN A/SWINE/IOWA/15/30 |
| 92-126 174-222 |
| PVMT1-- INBAD MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN B/ANN |
| ARBOR/1/66 175-209 |
| [COLD-ADATE |
| PVMT1-- INBLE MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN B/ANN |
| ARBOR/1/66 175-209 |
| [WILD-TYPE]) |
| PVMT1-- INBSI MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| B/LEE/40) 175-209 |
| PVMT2-- INBAC MATRIX (M1) PROTEIN INFLUENZA A VIURS (STRAIN |
| B/SINGAPORE/222/79) 175-209 |
| PVMT2-- INBAD PROBABLE MATRIX (M2) PROTEIN INFLUENZA A VIURS |
| (STRAIN B/ANN ARBOR/1/66 132-184 |
| [COLD-ADAPTE |
| PVMT2-- INBLE PROBABLE MATRIX (M2) PROTEIN INFLUENZA A VIURS |
| (STRAIN B/ANN ARBOR/1/66 132-184 |
| [WILD-TYPE]) |
| PVMT2-- INBSI PROBABLE MATRIX (M2) PROTEIN INFLUENZA A VIURS |
| (STRAIN B/LEE/40) 132-184 |
| PVMT8-- MYXVL PROBABLE MATRIX (M2) PROTEIN INFLUENZA A VIURS |
| (STRAIN B/SINGAPORE/222/79) 132-184 |
| PVN01-- VACCC M-T8 PROTEIN MYXOMA VIRUS (STRAIN LAUSANNE) 46-80 |
| 145-197 |
| PVN01-- VACCV PROTEIN N1 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 64-112 |
| PVN34-- ROTBS PROTEIN N1 VACCINIA VIRUS (STRAIN WR) 64-112 |
| PVN34-- ROTPC NONSTRUCTURAL PROTEIN NS34 BOVINE ROTAVIRUS |
| (GROUP C/STRAIN SHINTOKU) |
| 64-169 PVNCA-- AAV2 |
| NONSTRUCTURAL PROTEIN NS34 PORCINE ROTAVIRUS (GROUP C/STRAIN COWDEN) |
| 64-117 121-169 |
| PVNCA-- RSV DNA REPLICATION PROTEIN ADENO-ASSOCIATED VIRUS 2 |
| 91-125 217-251 |
| PVNCN-- PAVBO MAJOR NONCAPSID PROTEIN RICE STRIPE VIRUS 129-163 |
| PVNCS-- ADVG PROBABLE NONCAPSID PROTEIN NP1 BOVINE PARVOVIRUS |
| 221-255 |
| PVNCS-- AEDEV NONCAPSID PROTEIN NS-1 ALEUTIAN MINK DISEASE |
| PARVOVIRUS (STRAIN G) 19-60 270-304 |
| PVNCS-- FPV19 NONCAPSID PROTEIN NS-1 AEDES DENSONUCLEOSIS VIRUS |
| (STRAIN 276-339 521-571 585-640 715-760 780-849 |
| GKV 002 002) |
| PVNCS-- MEVA NONCAPSID PROTEIN NS-1 FELINE PANLEUKOPENIA VIRUS |
| (STRAIN 193) 53-98 |
| PVNCS-- MUMIM NONCAPSID PROTEIN NS-1 MINK ENTERITIS VIRUS (STRAIN |
| ABASHIRI) 53-98 |
| PVNCS-- MUMIV NONCAPSID PROTEIN NS-1 MURINE MINUTE VIRUS (STRAIN |
| MVMI) 35-91 261-297 |
| PVNCS-- PAVBO NONCAPSID PROTEIN NS-1 MURINE MINUTE VIRUS 35-87 |
| 259-297 |
| PVNCS-- PAVCN PROBABLE NONCAPSID PROTEIN NS1 BOVINE PARVOVIRUS |
| 181-222 |
| PVNCS-- PAVHB NONCAPSID PROTEIN NS-1 CANINE PARVOVIRUS (STRAIN N) |
| 53-98 |
| PVNCS-- PAVHH NONCAPSID PROTEIN NS-1 HUMAN PARVOVIRUS B19 236-270 |
| PVNCS-- PAVPN NONCAPSID PROTEIN NS-1 HAMSTER PARVOVIRUS H1 35-76 |
| 259-297 |
| PVNC1-- BTVI0 NONCAPSID PROTEIN NS-1 PORCINE PARVOVIRUS (STRAIN |
| NADL-2) 24-77 169-210 309-346 |
| PVNC1-- |
| BTVI7 NONSTRUCTURAL PROTEIN NS1 BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE |
| USA) 107-141 |
| PVNC1-- |
| BTVIA NONSTRUCTURAL PROTEIN NS1 BLUETONGUE VIRUS (SEROTYPE 17/ISOLATE |
| USA) 107-141 |
| PVNC1-- |
| BTVIS NONSTRUCTURAL PROTEIN NS1 BLUETONGUE VIRUS (SEROTYPE 1/ISOLATE |
| 107-141 |
| AUSTRALIA) |
| PVNC1-- |
| BTV20 NONSTRUCTURAL PROTEIN NS1 BLUETONGUE VIRUS (SEROTYPE 1/ISOLATE |
| 107-141 |
| SOUTH AFRICA) |
| PVNC1-- |
| EHDV2 NONSTRUCTURAL PROTEIN NS1 BLUETONGUE VIRUS (SEROTYPE 20/ISOLATE |
| 107-141 |
| AUSTRALIA) |
| PVNC1-- IAANN NONSTRUCTURAL PROTEIN NS1 EPIZOOTIC HEMORRHAGIC |
| DISEASE VIRUS 401-454 |
| (SEROTYPE 2/STRAI |
| PVNC1-- IACAO NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ANN ARBOR/6/60) 49-83 |
| PVNC1-- IACKG NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/CAMEL/ 37-71 |
| MONGOLIA/82 |
| PVNS1-- IACKJ NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ 49-83 |
| GERMANY/N/49) |
| PVNS1-- IADA2 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/JAPAN/24) 46-80 |
| PVNS1-- IADE1 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ALBERTA/ 49-83 |
| 60/76) |
| PVNS1-- IADU3 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ENGLAND/ 46-80 |
| 1/56) |
| PVNS1-- IAFOM NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/DUCK/UKRAINE/1/63) 46-80 |
| PVNS1-- IAFOW NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/FORT MONMOUTH/ 49-83 |
| 1/47) |
| PVNS1-- IAFPR NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/FORT WARREN/1/50), 49-83 |
| AND STRA |
| PVNS1-- IALEI NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/FOWL PLAGUE 49-83 |
| VIRUS/ROSTOCK |
| PVNS1-- IALEN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/ 49-83 |
| 134/57) |
| PVNS1-- IAMA6 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ 49-83 |
| LENINGRAD/54/1) |
| PVNS1-- IAMAN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ 49-83 |
| MALLARD/ALBERTA/88/76 |
| PVNS1-- IAMAO NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/NEW 49-83 |
| YORK/6750/78) |
| PVNS1-- IAMYN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/NEW 49-83 |
| YORK/687/78 |
| PVNS1-- IAP10 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/MYNAH/ 46-80 |
| HANEDA-THAI/76) |
| PVNS1-- IAP11 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 49-83 |
| ALBERTA/119/79 |
| PVNS1-- IAP12 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 49-83 |
| ALBERTA/121/79) |
| PVNS1-- IAP13 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 49-83 |
| ALBERTA/268/78 |
| PVNS1-- IAPUE NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 49-83 |
| ALBERTA/358/79) |
| PVNS1-- IATKB NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PUERTO 49-83 |
| RICO/8/34) |
| PVNS1-- IATKC NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 49-83 |
| BETHLEHEM-GLILIT/14 |
| PVNS1-- IATKR NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 49-83 |
| CANADA/63) |
| PVNS1-- IATRS NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 49-83 |
| OREGON/71) |
| PVNS1-- IATRT NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TERN/ 46-80 |
| SOUTH AFRICA/61 |
| PVNS1-- IAZII NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TERN/ 49-83 |
| TURKMENIA/18/72) |
| PVNS1-- INBAC NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/SWINE/IOWA/15/30) 49-83 |
| PVNS1-- INBGA NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/ANN ARBOR/ 143-177 |
| 1/66 [COLD-ADAPTE |
| PVNS1-- INGHK NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/GA/86) 143-177 |
| PVNS1-- INBHT NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/HONG KONG/ 143-177 |
| 8/73), AND (STRAIN |
| PVNS1-- INBID NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/HT/84) 143-177 |
| PVNS1-- INBLE NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/ID/86) 143-177 |
| PVNS1-- INBMD NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/LEE/40) 143-177 |
| PVNS1-- INBPA NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/MARYLAND/59) 143-177 |
| PVNS1-- INBRU NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/PA/79) 143-177 277-337 |
| PVNS1-- INBSI NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/RU/69) 139-173 |
| PVNS1-- INBSJ NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/ 143-177 |
| SINGAPORE/222/79) |
| PVNS1-- INBVJ NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/ 143-177 |
| SINGAPORE/64) |
| PVNS1-- INVYA NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/ 143-177 |
| VICTORIA/87) |
| PVNS2-- AHSV9 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| B/ 143-177 |
| YAMAGATA/1/73) |
| PVNS2-- BTV17 NONSTRUCTURAL PROTEIN NS2 AFRICAN HORSE SICKNESS |
| VIRUS |
| 67-101 |
| (SEROTYPE 9) |
| PVNS2-- |
| BTV1X NONSTRUCTURAL PROTEIN NS2 BLUETONGUE VIRUS (SEROTYPE 17/ 203-237 |
| ISOLATE USA) |
| PVNS2-- |
| CVMJH NONSTRUCTURAL PROTEIN NS2 BLUETONGUE VIRUS (SEROTYPE 10) 203-237 |
| PVNS2-- EHDV2 NONSTRUCTURAL PROTEIN NS2 MURINE CORONAVIRUS MHV |
| (STRAIN JHM) |
| 71-105 PVNS2-- |
| IAALA NONSTRUCTURAL PROTEIN NS2 EPIZOOTIC HEMORRHAGIC DISEASE 206-272 |
| 276-311 |
| VIRUS (SEROTYPE 2/STRAI |
| PVNS2-- IAANA NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/ALASKA/6/77), 14-93 |
| AND (STRAIN A/U |
| PVNS2-- IAANN NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/ANAS ACUTA/ 14-93 |
| PRIMORJE/695/76) |
| PVNS2-- IACHI NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/ANN ARBOR/6/60), 14-93 |
| AND STRAIN |
| PVNS2-- IACKG NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/CHILE/1/83) 14-93 |
| PVNS2-- IACKJ NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ 14-79 |
| GERMANY/N/49) |
| PVNS2-- IADA2 NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ 11-90 |
| JAPAN/24) |
| PVNS2-- IADE1 NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 14-79 |
| ALBERTA/60/76) |
| PVNS2-- IADU3 NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 11-90 |
| ENGLAND/1/56) |
| PVNS2-- IAFOM NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ 11-90 |
| UKRAINE/1/63) |
| PVNS2-- IAFOW NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/FORT 14-93 |
| MONMOUTH/1/47) |
| PVNS2-- IAFPR NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/FORT 14-93 |
| WARREN/1/50) |
| PVNS2-- IALE2 NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/FOWL PLAGUE 14-93 |
| VIRUS/ROSTOCK |
| PVNS2-- IALEN NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/ 14-93 |
| 134/17/57) |
| PVNS2-- IAMA6 NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/ 14-93 |
| 54/1) |
| PVNS2-- IAMA8 NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 14-79 |
| ALBERTA/88/76) |
| PVNS2-- IAMAN NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 14-79 |
| ALBERTA/827/78) |
| PVNS2-- IAMAO NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/NEW 14-93 |
| YORK/6750/78) |
| PVNS2-- IAMYN NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/NEW 14-93 |
| YORK/6874/78) |
| PVNS2-- IAPI0 NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/MYNAH/ 11-90 |
| HANEDA-THAI/76) |
| PVNS2-- IAPI1 NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 14-93 |
| ALBERTA/119/79) |
| PVNS2-- IAPI2 NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 14-79 |
| ALBERTA/121/79) |
| PVNS2-- IAPUE NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 14-93 |
| ALBERTA/268/78) |
| PVNS2-- IATKB NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/PUERTO 14-93 |
| RICO/8/34) |
| PVNS2-- IATKR NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 14-79 |
| BETHLEHEM-GLILIT/14 |
| PVNS2-- IATRS NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 14-79 |
| OREGON/71 |
| PVNS2-- IAUSS NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/TERN/SOUTH 11-52 |
| AFRICA/61) |
| PVNS2-- INBLE NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/USSR/90/77) 14-93 |
| PVNS2-- INBYA NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| B/LEE/40) 2-43 |
| 59-119 PVNS2-- |
| INCJJ NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN B/YAMAGATA/1/73 |
| ) 2-43 |
| 59-119 |
| PVNS2-- PVM NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| C/JJ/50 57-98 |
| PVNS3-- AHSV3 NONSTRUCTURAL PROTEIN 2 PNEUMONIA VIRUS OF MICE |
| 70-104 |
| PVNS3-- AHSV9 NONSTRUCTURAL PROTEIN NS3 AFRICAN HORSE SICKNESS |
| VIRUS (SEROTYPE 3) 44-78 166-215 |
| PVNS3-- BRD NONSTRUCTURAL PROTEIN NS3 AFRICAN HORSE SICKNESS |
| VIRUS (SEROTYPE 9) 37-78 |
| 88-122 166-215 PVNS3-- CVPFS |
| NONSTRUCTURAL PROTEIN NS3 BROADHAVEN VIRUS 26-98 102-147 |
| PVNS4-- CVH22 NONSTRUCTURAL PROTEIN 3-1 PORCINE TRANSMISSIBLE |
| GASTROENTERITIS 13-51 |
| CORONAVIRUS S) |
| PVNS4-- RSV NONSTRUCTURAL PROTEIN 4 HUMAN CORONAVIRUS (STRAIN |
| 229E) 11-52 |
| PVNS7-- CVCAE NONSTRUCTURAL PROTEIN NS4 RICE STRIPE VIRUS 2-40 |
| PVNS7-- CVFE3 NONSTRUCTURAL PROTEIN 7 CANINE ENTERIC CORONAVIRUS |
| (STRAIN K378) 11-47 |
| PVNS7-- FIPV NONSTRUCTURAL PROTEIN 7 FELINE ENTERIC CORONAVIRUS |
| (STRAIN 79-1683) |
| 1-42 PVNSC-- |
| CDVO NONSTRUCTURAL PROTEIN 7 FELINE INFECTIOUS PERITONITIS VIRUS 1-42 |
| (STRAIN 79-1146) |
| PVNSC-- MEASE NONSTRUCTURAL PROTEIN C CANINE DISTEMPER VIRUS |
| (STRAIN 50-84 |
| 95-152 ONDERSTEPOO |
| RT) |
| PVNSC-- MEASI NONSTRUCTURAL PROTEIN C MEASLES VIRUS (STRAIN |
| EDMONSTON) 43-84 |
| PVNSC-- MEASY NONSTRUCTURAL PROTEIN C MEASLES VIRUS (STRAIN |
| IP-3-CA) 43-84 |
| PVNSC-- PIIHB NONSTRUCTURAL PROTEIN C MEASLES VIRUS (STRAIN |
| YAMAGATA-1) 43-84 |
| PVNSC-- PIIHC NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 VIRUS |
| (STRAIN C35) 133-167 |
| PVNSC-- PIIHD NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 VIRUS |
| (STRAIN C39) 133-167 |
| PVNSC-- PIIHE NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 VIRUS |
| (STRAIN C1-5/73) 133-167 |
| PVNSC-- PI3H4 NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 VIRUS |
| (STRAIN C1-14/83) 40-75 133-167 |
| PVNSC-- SEND6 NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 3 VIRUS |
| (STRAIN NIH |
| 58-133 161-199 47885) |
| PVNSC-- SENDH NONSTRUCTURAL PROTEIN C SENDAI VIRUS (STRAIN |
| 6/94) 133-167 |
| PVNSC-- SENDZ NONSTRUCTURAL PROTEIN C SENDAI VIRUS (STRAIN |
| HARRIS) 133-167 |
| PVNSM-- INSV NONSTRUCTURAL PROTEIN C SENDAI VIRUS (STRAIN Z) |
| 133-167 |
| PVNST-- BUNGE NONSTRUCTURAL PROTEIN NS-M IMPATIENS NECROTIC SPOT |
| VIRUS (INSV) |
| 44-102 262-296 PVNST-- |
| BUNL7 NONSTRUCTURAL PROTEIN NS-S BUNYAVIRUS GERMISTON 34-75 |
| PVNST-- BUNLC NONSTRUCTURAL PROTEIN NS-S BUNYAVIRUS LA CROSSE |
| (ISOLATE L74) |
| 5-39 PVNST-- |
| MAGV NONSTRUCTURAL PROTEIN NS-S BUNYAVIRUS LA CROSSE |
| 5-39 PVNST-- TOSV NONSTRUCTURAL PROTEIN NS-S MAGUARI |
| VIRUS 35-69 |
| PVNST-- UUK NONSTRUCTURAL PROTEIN NS-S TOSCANA VIRUS (TOS) |
| 144-183 |
| PVNUA-- PRVKA NONSTRUCTURAL PROTEIN NS-S UUKUNIEMI VIRUS (UUK) |
| 139-173 |
| PVNUC-- DHVI1 PROBABLE NUCLEAR ANTIGEN PSEUDORABIES VIRUS (STRAIN |
| KAPLAN)(PRV) 1134- |
| 1175 |
| PVNUC-- |
| EBOV NUCLEOPROTEIN DHORI VIRUS (STRAIN INDIAN/1313/61)(DHO) 209-243 |
| PVNUC-- IAANA NUCLEOPROTEIN EBOLA VIRUS 191-225 227-261 |
| 329-369 |
| PVNUC-- IAANN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ANAS |
| ACUTA/ 1-42 |
| 96-154 357-408 PRIMORJE/6 |
| 95/76) |
| PVNUC-- IABRA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ANN |
| ARBOR/6/60) |
| 1-42 357-408 PVNUC- |
| - IABUD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/BRAZIL/11/78) 1-42 |
| 357-408 |
| PVNUC-- |
| IACAL NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/BUDGERIGAR/ 1-42 |
| 96-154 357-408 |
| HOKKAIDO/1/77) |
| PVNUC-- |
| IACKG NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/CALIFORNIA/10/78) 1-42 |
| 357-409 |
| PVNUC-- IACKP NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/CHICKEN/ |
| 1-42 |
| 96-154 357-408 |
| GERMANY/N/49) |
| PVNUC-- IADAU NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/CHICKEN/ |
| 1-42 |
| 96-154 357-408 |
| PENNSYLVANIA/1/83) |
| PVNUC-- |
| IADBE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/AUSTRALIA/ 1-42 |
| 96-154 357-408 |
| 749/80) |
| PVNUC-- |
| IADCZ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/BEIJING/1/78) |
| 1-42 |
| 96-154 357-408 |
| PVNUC-- IADE1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ 1-42 |
| 96-154 360-408 |
| CZECHOSLOVAKIA/56) |
| PVNUC-- |
| IADE2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ENGLAND/ 1-42 |
| 96-154 357-408 |
| 1/56) |
| PVNUC-- IADHK NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| 1-42 |
| 96-154 357-408 |
| ENGLAND/1/62) |
| PVNUC-- IADM2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| 1-42 |
| 96-154 357-408 |
| HONG KONG/7/75) |
| PVNUC-- IADMA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| 1-42 |
| 96-154 357-408 |
| MEMPHIS/928/74 |
| PVNUC-- IADNZ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| 1-42 |
| 96-154 357-408 |
| MANITOBA/1/53) |
| PVNUC-- IADU2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/NEW |
| 1-42 |
| 96-154 357-408 |
| ZEALAND/31/76) |
| PVNUC-- IAEN5 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| 96-154 357-408 |
| UKRAINE/2/60) |
| PVNUC-- IAFOM NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ENGLAND/ |
| 1-42 357-409 |
| 19/55) |
| PVNUC-- IAFOW NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FORT |
| 1-42 357-409 |
| MONMOUTH/1/47) |
| PVNUC-- IAFPD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FORT |
| 357-408 |
| WARREN/1/50) |
| PVNUC-- IAFPR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FOWL |
| PLAGUE 1-42 |
| 96-154 357-408 VIRUS/DOBS |
| ON/ |
| PVNUC-- IAGRE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FOWL |
| PLAGUE 1-42 |
| 96-154 360-408 VIRUS/ROST |
| OCK |
| PVNUC-- IAGU1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GREY |
| TEAL/ |
| 1-42 113-154 357-408 |
| AUSTRALIA/2/79) |
| PVNUC-- |
| IAGU2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/MARYLAND/ 1-42 |
| 357-408 |
| 5/77) |
| PVNUC-- |
| IAGU3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/MARYLAND/ 96-154 |
| 357-409 |
| 704/77) |
| PVNUC-- |
| IAGU4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/MARYLAND/ 1-42 |
| 96-154 357-409 |
| 1824/78) |
| PVNUC-- |
| IAGUA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/MARYLAND/ 1-42 |
| 96-154 357-409 |
| 1815/79) |
| PVNUC-- |
| IAGUM NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ASTRAKHAN/ 1-42 |
| 96-154 357-409 |
| 2227/84) |
| PVNUC-- IAGUN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| 1-42 |
| 96-154 357-409 |
| MASSACHUSETTS/26/80) |
| PVNUC-- |
| IAHIC NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/MINNESOTA/ 1-42 |
| 96-154 357-409 |
| 945/80) |
| PVNUC-- |
| IAHJI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/HICKOX/40) 1-42 |
| 357-409 |
| PVNUC-- IAHLO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| 1-42 |
| 96-154 357-408 |
| JILLIN/1/89) |
| PVNUC-- |
| IAHMI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/LONDON/ 1-42 |
| 96-154 357-408 |
| 1416/73) |
| PVNUC-- |
| IAHO1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/MIAMI/1/63) |
| 1-42 |
| 96-154 |
| PVNUC-- IAHO2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/HONG |
| KONG/1/68) |
| 1-42 357-409 PVNUC |
| -- IAHPR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/HONG KONG/5/83) |
| 1-42 357-409 |
| PVNUC-- |
| IAHTE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/PRAGUE/ 96-154 |
| 357-408 |
| 1/56) |
| PVNUC-- IAKIE NUCLEOPROTEIN INFLUENZA A VIRUS 1-42 96-154 |
| 357-408 |
| PVNUC-- |
| IALEN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/KIEV/59/79) 1-42 |
| 357-409 |
| PVNUC-- |
| IAMAA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/LENINGRAD/54/1) 1-42 |
| 357-409 |
| PVNUC-- IAMAN NUCLEOPROTEIN INFLUENZA A VIRUS 1-42 96-154 |
| 357-408 |
| PVNUC-- |
| IAMIN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/MALLARD/NEW 1-42 |
| 96-154 357-408 |
| YORK/6750/78) |
| PVNUC-- |
| IANEJ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/MINK/SWEDEN/84) 1-42 |
| 96-154 357-408 |
| PVNUC-- IANT6 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/NEW |
| JERSEY/8/76) 1-42 |
| 96-154 357-408 PVNUC-- |
| IAOHI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/NT/60/68) 1-42 357-409 |
| PVNUC-- |
| IAPAR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/OHIO/4/83) 1-42 |
| 357-409 |
| PVNUC-- |
| IAPUE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/PARROT/ULSTER/ 1-42 |
| 96-154 357-408 |
| 73) |
| PVNUC-- IARUD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/PUERTO |
| RICO/ |
| 1-42 357-409 |
| 8/34) |
| PVNUC-- IASE0 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/RUDDY |
| 1-42 |
| 96-154 357-408 |
| TURNSTONE/NEW JERSE |
| PVNUC-- IASH2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SEAL/ |
| 1-42 |
| 96-154 357-408 |
| MASSACHUSETTS/1/80) |
| PVNUC-- |
| IASIN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SHEARWATER/ 1-42 |
| 357-408 |
| AUSTRALIA/72) |
| PVNUC-- |
| IATEI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SINGAPORE/1/57) 1-42 |
| 357-409 |
| PVNUC-- IATKN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TEAL/ |
| 1-42 |
| 96-154 357-408 |
| ICELAND/29/80) |
| PVNUC-- IATKO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TURKEY/ |
| 1-42 |
| 96-154 357-408 |
| MINNESOTA/1661/81) |
| PVNUC-- IATRS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TURKEY/ |
| 1-42 |
| 96-154 357-408 |
| ONTARIO/7732/66) |
| PVNUC-- |
| IATRT NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TERN/SOUTH 1-42 |
| 96-154 360-408 |
| AFRICA/61) |
| PVNUC-- IATX7 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TERN/ |
| 1-42 |
| 96-154 357-405 |
| TURKMENIA/18/72) |
| PVNUC-- |
| IAUDO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TEXAS/1/77) 1-42 |
| 357-409 |
| PVNUC-- |
| IAUSS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/UDORN/307/72) 1-42 |
| 357-409 |
| PVNUC-- |
| IAVI6 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/USSR/90/77) 1-42 |
| 357-408 |
| PVNUC-- |
| IAWHN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/VICTORIA/5/68) 357-408 |
| PVNUC-- IAWHP NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WHALE/ |
| 1-42 |
| 96-154 357-409 |
| MAINE/328/84) |
| PVNUC-- |
| IAWIL NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WHALE/PACIFIC 1-42 |
| 96-154 357-408 |
| OCEAN/19/76) |
| PVNUC-- |
| IAWIS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WILSON-SMITH/33) 1-42 |
| 357-409 |
| PVNUC-- |
| IAZ29 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WISCONSIN/3523/88) |
| 1-42 |
| 96-154 357-408 |
| PVNUC-- |
| IAZ41 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/29/37) 1-42 |
| 96-154 357-408 |
| PVNUC-- |
| IAZCA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/41/49) 1-42 |
| 96-154 357-408 |
| PVNUC-- IAZDA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 1-42 357-409 |
| CAMBRIDGE/1/35) |
| PVNUC-- |
| IAZGE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/DANDONG/ 1-42 |
| 357-409 |
| 9/83) |
| PVNUC-- |
| IAZH1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/GERMANY/ 1-42 |
| 96-154 357-408 |
| 2/81) |
| PVNUC-- |
| IAZH3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/HONG KONG/ 1-42 |
| 357-409 |
| 6/76) |
| PVNUC-- |
| IAZH4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/HONG KONG/ 1-42 |
| 96-154 357-408 |
| 126/82) |
| PVNUC-- |
| IAZI1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/HONG 1-42 |
| 96-154 357-408 |
| KONG/127/82) |
| PVNUC-- |
| IAZI2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/IOWA/ 1-42 |
| 96-154 357-408 |
| 15/30) |
| PVNUC-- |
| IAZI3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/IOWA/ 1-42 |
| 96-154 357-408 |
| 1976/31) |
| PVNUC-- IAZJ1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/46) |
| 1-42 |
| 96-154 357-408 |
| PVNUC-- |
| IAZJ2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ITALY/ 1-42 |
| 96-154 357-408 |
| 437/76) |
| PVNUC-- |
| IAZJ3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ITALY/ 1-42 |
| 96-154 357-408 |
| 2/79) |
| PVNUC-- |
| IAZJ4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ITALY/ 1-42 |
| 96-154 357-408 |
| 141/81) |
| PVNUC-- |
| IAZJA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ITALY/ 1-42 |
| 96-154 357-408 |
| 839/89) |
| PVNUC-- |
| IAZMA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/JAMESBURG/ 1-42 |
| 96-154 357-408 |
| 42) |
| PVNUC-- |
| IAZNE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/MAY/54) 1-42 |
| 96-154 357-408 |
| PVNUC-- IAZOH NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 1-42 |
| 96-154 357-408 |
| NETHERLANDS/12/85) |
| PVNUC-- |
| IAZON NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/OHIO/23/35) 1-42 |
| 96-154 357-408 |
| PVNUC-- |
| IAZTE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ONTARIO/ 1-42 |
| 96-154 357-408 |
| 2/81) |
| PVNUC-- IAZW1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 1-42 |
| 96-154 357-408 |
| TENNESSEE/24/77) |
| PVNUC-- IAZW2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 1-42 |
| 96-154 357-408 |
| WISCONSIN/1/57) |
| PVNUC-- INBAA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 1-42 |
| 96-154 357-408 |
| WISCONSIN/1/61) |
| PVNUC-- INBAC NUCLEOPROTEIN INFLUENZA B VIRUS (STRAIN B/ANN |
| ARBOR/1/86) |
| 75-142 480-514 PVNUC- |
| - INBAD NUCLEOPROTEIN INFLUENZA B VIRUS (STRAIN B/ANN ARBOR/1/66 |
| 75-142 480-514 |
| [COLD-ADAPTE |
| PVNUC-- INBLE NUCLEOPROTEIN INFLUENZA B VIRUS (STRAIN B/ANN |
| ARBOR/1/66 |
| 75-145 480-514 |
| [WILD-TYPE]) |
| PVNUC-- INBSI NUCLEOPROTEIN INFLUENZA B VIRUS (STRAIN B/LEE/40 |
| 75-146 480-514 |
| PVNUC-- |
| INCCA NUCLEOPROTEIN INFLUENZA B VIRUS (STRAIN B/SINGAPORE/222/ 75-142 |
| 480-514 |
| 79) |
| PVNUC-- |
| MABVM NUCLEOPROTEIN INFLUENZA C VIRUS (STRAIN C/CALIFORNIA/78) 92-203 |
| 406-447 |
| PVNUC-- MABVP NUCLEOPROTEIN MARBURG VIRUS (STRAIN MUSOKE) 173-207 |
| 322-407 |
| PVO01-- VACCC NUCLEOPROTEIN MARBURG VIRUS (STRAIN POPP) 173-207 |
| 322-407 |
| PVO01-- VARV PROTEIN O1 VACCINIA VIRUS (STRAIN COPEHAGEN) 102-145 |
| 245-279 341-382 581-615 |
| PVOR1-- FXMV PROTEIN O1 VARIOLA VIRUS 102-145 245-279 341-382 |
| 581-615 |
| PVOR1-- |
| NMV 152 KD PROTEIN FOXTAIL MOSAIC VIRUS 293-327 PVOR1-- |
| PMV 186 KD PROTEIN NARCISSUS MOSAIC VIRUS (NMV) 1519- |
| 1575 |
| PVOR1-- PVMR 176 KD PROTEIN PAPAYA MOSAIC POTEXIVIRUS (PMV) 1-39 |
| 299-337 1474- |
| 1532 |
| PVOR1-- PVX 223 KD PROTEIN POTATO VIRUS M (STRAIN RUSSIAN) (PVM) |
| 597-638 682-759 |
| PVOR1-- PVXCP 165 KD PROTEIN POTATO VIRUS X (PVX) 516-550 |
| PVOR1-- SMYEA 165 KD PROTEIN POTATO VIRUS X (STRAIN CP) |
| (PVX) 510-547 |
| PVOR1-- |
| WCMVM 150 KD PROTEIN STRAWBERRY MILD YELLOW EDGE-ASSOCIATED 308-342 |
| 931-965 |
| VIRUS (SMYE |
| PVOR1-- WCMVO 147 KD PROTEIN WHITE CLOVER MOSAIC VIRUS (STRAIN M) |
| (WCMV) 1240- |
| 1289 |
| PVO10-- NPVAC 147 KD PROTEIN WHITE CLOVER MOSAIC VIRUS (STRAIN O) |
| (WCMV) 1240- |
| 1289 |
| PVO10-- NPVOP P10 PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR 7-41 |
| POLYHEDROSIS VIRUS( |
| PVO10-- RBSDV P10 PROTEIN ORGYIA PSEUDOTSUGATA MULTICAPSID 7-50 |
| POLYHEDROSIS VIRUS |
| PVO10-- RGDV PROTEIN S10 RICE BLACK STREAKED DWARF VIRUS (RBSDV) |
| 339-382 395-429 506-556 |
| PVO10-- WTV NONSTRUCTURAL PROTEIN PNS10 RICE GALL DWARF VIRUS |
| (RGDV) 186-273 |
| PVO11-- RDV NONSTRUCTURAL PROTEIN PNS10 WOUND TUMOR VIRUS (WTV) |
| 220-254 |
| PVO11-- WTV NONSTRUCTURAL PROTEIN PNS11 RICE DWARF (RDV) 25-80 |
| 273-314 |
| PVO12-- RDV NONSTRUCTURAL PROTEIN PNS11 WOUND TUMOR VIRUS (WTV) |
| 16-74 |
| PVO12-- WTV NONSTRUCTURAL PROTEIN P11 RICE DWARF VIRUS (RDV)) |
| 140-181 |
| PVO18-- WTVNJ NONSTRUCTURAL PROTEIN PNS12 WOUND TUMOR VIRUS (WTV) |
| 68-108 |
| PVO19-- HSVEB NONSTRUCTURAL PROTEIN PNS12 WOUND TUMOR VIRUS (STRAIN |
| NJ) |
| 68-108 |
| (WTV) |
| PVO23-- HCMVA CAPSID ASSEMBLY AND DNA EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P)(EHV-1) 189-231 |
| MATURATION PROTE |
| PVO23-- HSV6U PROBABLE CAPSID PROTEIN VP23 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 41-82 146-180 |
| PVO24-- EBOV PROBABLE CAPSID PROTEIN VP23 HERPES SIMPLEX VIRUS |
| (TYPE 6/STRAIN 47-81 |
| UGANDA-1102) |
| PVO26-- |
| HSVEB MEMBRANE-ASSOCIATED EBOLA VIRUS 166-200 STRUCTURAL |
| PROTEIN V |
| PVO26-- HSVSA CAPSID PROTEIN VP26 EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) (EHV-1) 36-77 |
| PVO26-- NPVOP CAPSID PROTEIN VP26 HERPESVIRUS SAIMIRI (STRAIN 11) |
| 41-78 |
| PVO26-- VZVD P26 PROTEIN ORGYIA PSEUDOTSUGATA MULTICAPSID 118-159 |
| POLYHEDROSIS VIRUS |
| PVP2-- AHSV4 CAPSID PROTEIN VP26 VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS)(VZV) 47-81 |
| PVP2-- BTV10 OUTER CAPSID PROTEIN VP2 AFRICAN HORSE SICKNESS |
| VIRUS (SEROTYPE 136-188 270-304 410-465 614-662 684-720 976- |
| 4/STRAIN VACCI 1056 |
| PVP2-- BTV11 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 10/ISOLATE USA) 168-225 |
| PVP2-- BTV17 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 11/ISOLATE USA) |
| 77-111 559-593 PVP2-- |
| BTV1S OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE 17/ISOLATE |
| USA) |
| 77-111 168-209 |
| PVP2-- EHDV1 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE SOUTH 119-153 576-610 668-702 |
| AFRICA) |
| PVP2-- ROTBR OUTER CAPSID PROTEIN VP2 EPIZOOTIC HEMORRHAGIC |
| DISEASE VIRUS |
| 72-106 247-301 405-453 461-495 895-929 (SEROTYPE |
| 1)(EHDV |
| PVP2-- ROTBU RNA-BINDING PROTEIN VP2 BOVINE ROTAVIRUS (STRAIN RF) |
| 2-94 482-516 523-557 607-655 675-754 |
| PVP2-- ROTHW RNA-BINDING PROTEIN VP2 BOVINE ROTAVIRUS (STRAIN UK) |
| 2-94 483-517 524-558 608-656 676-755 |
| PVP2-- ROTPC RNA-BINDING PROTEIN VP2 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN WA) 17-97 492-526 533-567 617-658 685-764 |
| PVP2-- ROTSI RNA-BINDING PROTEIN VP2 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) |
| 1-50 52-99 194-228 515-551 599-643 705-746 PVP30-- |
| ASFE7 RNA-BINDING PROTEIN VP2 SIMIAN II ROTAVIRUS (STRAIN SA11) 36-96 |
| 483-517 608-656 680-755 |
| PVP31-- FRG3V PHOSPHOPROTEIN P30 AFRICAN SWINE FEVER VIRUS |
| (STRAIN 29-89 |
| E-75)(ASFV) |
| PVP32-- ASFB7 EARLY 31 KD PROTEIN FROG VIRUS 3 (FV3) 227-261 |
| PVP35-- EBOV PHOSPHOPROTEIN P32 AFRICAN SWINE FEVER VIRUS |
| (STRAIN 29-89 |
| BA71V)(ASFV) |
| PVP35-- NPVAC POLYMERSASE COMPLEX PROTEIN EBOLA VIRUS 80-119 |
| VP35 |
| PVP35-- NPVBM EARLY 35 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| 54-102 |
| POLYHEDROSIS VIRUS( |
| PVP35-- |
| VACCC EARLY 35 KD PROTEIN BOMBYX MORI NUCLEAR POLYHEDROSIS 54-102 |
| 224-258 |
| VIRUS (BMNPV) |
| PVP35-- VACCP IMMUNODOMINANT ENVELOPE VACCINIA VIRUS (STRAIN |
| COPEHAGEN) 140-181 |
| PROTEIN P35 |
| PVP35-- VACCV IMMUNODOMINANT ENVELOPE VACCINIA VIRUS (STRAIN |
| L-IVP) 17-51 |
| PROTEIN P35 |
| PVP35-- VARV IMMUNODOMINANT ENVELOPE VACCINIA VIRUS (STRAIN WR) |
| 140-181 |
| PROTEIN P35 |
| PVP3-- AHSV4 IMMUNODOMINANT ENVELOPE VARIOLA VIRUS 141-182 |
| PROTEIN P35 |
| PVP3-- BTV10 VP3 CORE PROTEIN AFRICAN HORSE SICKNESS VIRUS |
| (SEROTYPE 4/ 173-214 240-274 667-704 |
| STRAIN VACCI |
| PVP3-- |
| BTV17 VP3 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE USA) |
| 214-255 853-894 |
| PVP3-- |
| BTV1A VP3 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 17/ISOLATE USA) |
| 214-255 853-894 |
| PVP3-- |
| EHDV1 VP3 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 1/ISOLATE 214-255 |
| 853-894 |
| AUSTRALIA |
| PVP3-- EHDVA VP3 CORE PROTEIN EPIZOOTIC HEMORRHAGIC DISEASE VIRUS |
| 208-246 798-832 851-892 |
| (SEROTYPE 1)(EHDV |
| PVP3-- GFLV VP3 CORE PROTEIN EPIZOOTIC HEMORRHAGIC DISEASE VIRUS |
| 208-246 735-770 798-832 851-892 |
| PVP3-- RDV P3 PROTEIN GRAPEVINE FANLEAF VIRUS (GFLV) 96-133 |
| PVP3-- ROTPC MAJOR 114 KD STRUCTURAL PROTEIN RICE DWARF VIRUS |
| (RDV) 299-337 817-872 |
| PVP3-- ROTSI INNER CORE PROTEIN VP3 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) 24-58 229-263 329-395 406-446 640-688 |
| PVP40-- EBV INNER CORE PROTEIN VP3 SIMIAN II ROTAVIRUS(STRAIN |
| SAII) 26-76 244-278 331-365 451-492 662-696 |
| PVP40-- HSVII INNER CORE PROTEIN VP3 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8)(HUMAN 433-467 |
| HERPESVIRUS 4) |
| PVP40-- HSVEB CAPSID PROTEIN P40 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 206-257 599-633 |
| PVP40-- ILTVT CAPSID PROTEIN P40 EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P)(EHV-1) 180-245 |
| PVP40-- SCMVC CAPSID PROTEIN P40 INFECTIOUS LARYNGOTRACHEITIS |
| VIRUS (STRAIN |
| 1-35 509-557 THORNE V88 |
| PVP40-- VZVD CAPSID PROTEIN P40 SIMIAN CYTOMEGALOVIRUS (STRAIN |
| COLBURN) 457-498 |
| PVP41-- NPVAC CAPSID PROTEIN P40 VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS)(VZV) 167-246 486-522 |
| PVP41-- ROTSI CAPSID PROTEIN P40 AUTOGRAPHA CALIFORNICA NUCLEAR |
| 132-166 |
| POLYHEDROSIS VIRUS ( |
| PVP42-- ROTSI STRUCTURAL GLYCOPROTEIN GP41 SIMIAN II ROTAVIRUS |
| (STRAIN SAII) |
| 1-35 484-518 528-630 PVP4A-- |
| VACCC OUTER CAPSID PROTEIN VP4 SIMIAN II ROTAVIRUS (STRAIN SAII) 1-35 |
| 237-518 531-646 |
| PVP4A-- VACCV OUTER CAPSID PROTEIN VP4 VACCINIA VIRUS (STRAIN |
| COPEHAGEN) 355-359 718-763 794-828 857-891 |
| PVP4A-- VARV MAJOR CORE PROTEIN P4A VACCINIA VIRUS (STRAIN WR) |
| 262-296 355-359 718-763 794-828 857-891 |
| PRECURSOR |
| PVP4B-- FOWPV MAJOR CORE PROTEIN P4A VARIOLA VIRUS 355-389 |
| 719-764 795-829 858-892 |
| PRECURSOR |
| PVP4B-- VACCC MAJOR CORE PROTEIN P4A FOWLPOX VIRUS 131-172 |
| 296-330 |
| PRECURSOR |
| PVP4B-- VACCV MAJOR CORE PROTEIN P4B VACCINIA VIRUS (STRAIN |
| COPEHAGEN) |
| 3-37 125-163 249-283 PRECURSOR |
| PVP4B-- VARV MAJOR CORE PROTEIN P4B VACCINIA VIRUS (STRAIN WR) |
| 3-37 125-163 249-283 |
| PRECURSOR |
| PVP4-- BTV10 MAJOR CORE PROTEIN P4B VARIOLA VIRUS 3-37 125-163 |
| 249-283 |
| PRECURSOR |
| PVP4-- BTV11 MAJOR CORE PROTEIN P4B BLUETONGUE VIRUS (SEROTYPE |
| 10/ISOLATE USA) 579-617 619-643 |
| PRECURSOR |
| PVP4-- |
| BTV13 VP4 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 11/ISOLATE USA) |
| 569-607 609-643 |
| PVP4-- |
| BTV2A VP4 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 13/ISOLATE USA) |
| 569-607 609-643 |
| PVP4-- NCDV VP4 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 2/ISOLATE |
| USA) 569-607 609-643 |
| PVP4-- RDV OUTER CAPSID PROTEIN VP4 NEBRASKA CALF DIARRHEA VIRUS |
| (STRAIN 484-518 528-630 |
| NCDV-LINCOLN) |
| PVP4-- ROTB4 NONSTRUCTURAL PROTEIN PNS4 RICE DWARF VIRUS (RDV) |
| 388-437 444-478 627-679 |
| PVP4-- ROTBC OUTER CAPSID PROTEIN VP4 BOVINE ROTAVIRUS (SEROTYPE |
| 6/STRAIN C486) |
| 1-35 112-146 338-379 484-518 528-653 PVP4-- |
| ROTBU OUTER CAPSID PROTEIN VP4 BOVINE ROTAVIRUS (STRAIN C486) 1-35 |
| 484-518 528-630 |
| PVP4-- ROTEH OUTER CAPSID PROTEIN VP4 BOVINE ROTAVIRUS (STRAIN |
| UK) |
| 1-35 112-146 338-379 484-518 538-653 |
| PVP4-- ROTGI OUTER CAPSID PROTEIN VP4 EQUINE ROTAVIRUS (STRAIN H-2) |
| 1-35 112-146 227-274 345-379 484-518 528-653 |
| PVP4-- ROTHI OUTER CAPSID PROTEIN VP4 ROTAVIRUS (GROUP B/STRAIN |
| IDIR) 117-151 476-519 |
| PVP4-- ROTHS OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN 1076 |
| 1-35 236-273 337-378 483-517 530-645 PVP4-- |
| ROTH6 OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN RV-5) |
| 1-35 236-273 337-378 483-517 527-652 |
| PVP4-- ROTHD OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN 69M) |
| 1-35 112-146 237-274 338-379 484-518 531-646 PVP4-- |
| ROTHJ OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN DS1) |
| 1-35 236-273 337-378 483-517 527-652 |
| PVP4-- ROTHK OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (STRAIN K8) |
| 1-35 237-274 345-379 484-518 528-588 |
| PVP4-- ROTHL OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (STRAIN KU) |
| 1-35 337-378 483-517 527-652 |
| PVP4-- ROTHM OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (STRAIN |
| L26) |
| 1-35 236-273 337-378 483-517 527-652 |
| PVP4-- ROTHN OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN M37) |
| 1-35 337-378 483-517 530-645 PVP4-- |
| ROTHP OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE 3/STRAIN MCN13) |
| 1-35 237-274 338-379 484-518 531-645 |
| PVP4-- ROTHR OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 3/STRAIN P) |
| 1-35 236-273 337-378 483-517 527-652 PVP4-- |
| ROTHT OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE 3/STRAIN RRV) |
| 1-38 |
| 91-146 227-274 |
| PVP4-- ROTHV OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 4/STRAIN |
| 1-35 236-273 337-378 483-517 530-644 ST. |
| THOMAS 3) |
| PVP4-- ROTHW OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 4/STRAIN VA70 |
| 1-35 237-273 337-378 483-517 527-652 PVP4-- |
| ROTP5 OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN WA) |
| 1-35 237-273 344-378 483-517 527-652 |
| PVP4-- ROTPC OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (SEROTYPE |
| 5/STRAIN OSU) 112-146 484-518 528-629 |
| PVP4-- ROTPG OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) |
| 6-40 127-161 241-278 293-334 580-614 PVP4-- |
| ROTPY OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (STRAIN GOTTFRIED) |
| 1-35 236-273 337-378 483-517 530-564 569-639 |
| PVP4-- ROTRH OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (STRAIN |
| YM) |
| 1-35 112-146 237-274 484-518 528-629 |
| PVP4-- ROTSF OUTER CAPSID PROTEIN VP4 RHESUS ROTAVIRUS 1-38 |
| 112-146 237-274 338-379 484-522 531-646 |
| PVP4-- ROTSS OUTER CAPSID PROTEIN VP4 SIMIAN II ROTAVIRUS (STRAIN |
| SA11-FEM) |
| 1-35 484-518 528-630 PVP4-- |
| WTV DE OUTER CAPSID PROTEIN VP4 SIMIAN II ROTAVIRUS (STRAIN SA11-SEM) |
| 1-35 237-274 345-379 484-518 531-646 |
| PVP5-- ASHV4 NONSTRUCTURAL PROTEIN PNS4 WOUND TUMOR VIRUS (WTV) |
| 28-62 565-621 |
| PVP5-- BRD OUTER CAPSID PROTEIN VP4 AFRICAN HORSE SICKNESS VIRUS |
| 7-58 113-229 |
| (SEROTYPE 4/STRAIN VACCI |
| PVP5-- BTV10 OUTER CAPSID PROTEIN VP4 BROADHAVEN VIRUS (BRD) |
| 45-86 |
| 98-226 |
| PVP5-- BTV11 OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 10/ISOLATE USA) 14-58 |
| 92-150 154-222 404-438 PVP5-- BTV13 |
| OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE 11/ISOLATE USA) |
| 14-58 |
| 92-150 154-222 404-445 |
| PVP5-- BTV1A OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 13/ISOLATE USA) 14-58 154-222 404-438 |
| PVP5-- BTV1S OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 11/ISOLATE 14-58 |
| 92-143 148-222 404-448 AUSTRALIA) |
| PVP5-- |
| BTV2A OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE 11/ISOLATE |
| 14-58 |
| 92-143 148-222 404-438 |
| SOUTH AFRICA) |
| PVP5-- EHDV1 OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 2/ISOLATE USA) 14-58 92-222 404-438 |
| PVP5-- RDV OUTER CAPSID PROTEIN VP5 EPIZOOTIC HEMORRHAGIC DISEASE |
| VIRUS 24-58 |
| 92-126 163-233 291-325 399-433 (SEROTYPE |
| 1)(EHDV |
| PVP5-- WTV OUTER COAT PROTEIN P5 RICE DWARF VIRUS (RDV) 38-86 |
| 95-136 550-594 |
| PVP5-- BTV10 OUTER COAT PROTEIN P5 WOUND TUMOR VIRUS (WTV) |
| 434-503 4547-581 751-798 |
| PVP61-- MRDV VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE |
| USA) 163-215 |
| PVP61-- NPVAC PROBABLE NONSTRUCTURAL 41.0 KD MAIZE ROUGH DWARF |
| VIRUS (MRDV) 128-202 |
| PROTEIN |
| PVP62-- BTV10 61 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR 29-96 |
| 351-386 |
| POLYHEDROSIS VIRUS ( |
| PVP64-- NPVOP VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE |
| USA) 47-88 159-207 214-251 |
| PVP67-- NPVAC MAJOR ENVELOPE GLYCOPROTEIN ORGYIA PSEUDOTSUGATA |
| MULTICAPSID 396-361 431-479 |
| PRECURSOR POLYHEDROSIS VIRUS |
| PVP67-- NPVGM MAJOR ENVELOPE GLYCOPROTEIN AUTOGRAPHA CALIFORNICA |
| NUCLEAR 44-78 289-364 443-477 |
| PRECURSOR POLYHEDROSIS VIRUS ( |
| PVP6-- BTV11 MAJOR ENVELOPE GLYCOPROTEIN GALLERIA MELLONELLA |
| NUCLEAR 206-281 |
| POLYHEDROSIS VIRUS (CMN |
| PVP6-- BTV13 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 11/ISOLATE |
| USA) 159-211 |
| PVP6-- BTV17 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 13/ISOLATE |
| USA) 159-211 |
| PVP6-- BTV15 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 17/ISOLATE |
| USA) |
| 68-102 159-211 |
| PVP6-- BTV2A VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 1/ISOLATE 12-78 |
| 163-211 |
| SOUTH AFRICA) |
| PVP6-- RDV VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 2/ISOLATE USA) |
| 44-78 135-187 |
| PVP6-- WTV STRUCTURAL PROTEIN P6 RICE DWARF VIRUS (RDV) 150-191 |
| 296-344 360-401 |
| PVP6-- WTVNJ STRUCTURAL PROTEIN P6 WOUND TUMOR VIRUS (WTV) 144-78 |
| 286-334 400-434 |
| PVP74-- NPVAC STRUCTURAL PROTEIN P6 WOUND TUMOR VIRUS (STRAIN |
| NJ)(WTV) 144-178 286-334 |
| PVP74-- NPVCF P74 PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR 387-456 |
| POLYHEDROSIS VIRUS ( |
| PVP75-- HSVSA P74 PROTEIN CHORISTONEURA FUMIFERANA NUCLEAR |
| 385-453 |
| POLYHEDROSIS VIRU |
| PVP79-- NPVAC PROBABLE MEMBRANE ANTIGEN 75 HERPESVIRUS SAIMIRI |
| (STRAIN 11) 50-99 163-211 931-984 |
| PVP7-- BTV10 79 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR 44-78 |
| 363-397 406-440 |
| POLYHEDROSIS VIRUS ( |
| PVP7-- |
| BTV13 VP7 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE USA) |
| 184-228 |
| PVP7-- |
| BTV17 VP7 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 11/ISOLATE USA) |
| 201-235 |
| PVP7-- |
| BTV1A VP7 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 13/ISOLATE USA) |
| 184-228 |
| PVP7-- |
| BTV1S VP7 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 17/ISOLATE 184-235 |
| AUSTRALIA) |
| PVP7-- |
| BTV2A VP7 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 1/ISOLATE 184-228 |
| SOUTH AFRICA) |
| PVP7-- |
| EHDV1 VP7 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 2/ISOLATE USA) |
| 184-228 |
| PVP7-- RDV VP7 CORE PROTEIN EPIZOOTIC HEMORRHAGIC DISEASE VIRUS |
| 16-50 134-178 |
| (SEROTYPE 1)(EHDV |
| PVP7-- WTV NONSTRUCTURAL PROTEIN PN57 RICE DWARF VIRUS (RDV) |
| 47-95 172-255 |
| PVP80-- NPVAC NONSTRUCTURAL PROTEIN PN57 WOUND TUMOR VIRUS (WTV) |
| 47-84 195-243 458-495 |
| PVP87-- NPVOP CAPSID PROTEIN P80 AUTOGRAPHA CALIFORNICA NUCLEAR |
| 7-51 |
| 99-142 156-204 221-298 |
| POLYHEDROSIS VIRUS ( |
| PVP8-- BTV10 CAPSID PROTEIN P87 ORGYIA PSEUDOTSUGATA MULTICAPSID |
| 80-162 410-451 |
| POLYHEDROSIS VIRUS |
| PVP8-- BTV11 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 10/ISOLATE USA) |
| 54-102 185-219 PVP8-- |
| BTV13 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE 11/ISOLATE |
| USA) |
| 54-102 185-219 |
| PVP8-- BTV17 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 13/ISOLATE USA) |
| 54-102 185-219 PVP8-- |
| BTV1A NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE 17/ISOLATE |
| USA) |
| 54-102 185-219 |
| PVP8-- BTV1S NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE |
| 54-102 185-219 |
| AUSTRALIA) |
| PVP8-- BTV2A NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE |
| 54-102 185-219 SOUTH |
| AFRICA) |
| PVP8-- FOWPV NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 2/ISOLATE USA) |
| 54-102 185-219 PVP9-- |
| RDV STRUCTURAL PROTEIN VP8 FOWLPOX VIRUS 193-245 |
| PRECURSOR |
| PVP9-- WTV NONSTRUCTURAL PROTEIN PN59 RICE DWARF VIRUS (RDV) |
| 13-47 186-226 |
| PVP9-- WTVNJ STRUCTURAL PROTEIN P9 WOUND TUMOR VIRUS (WTV) |
| 140-212 |
| PVPG-- BYDV1 STRUCTURAL PROTEIN P9 WOUND TUMOR VIRUS (STRAIN |
| NJ)(WTV) 140-212 |
| PVPHE-- NPVAC PUTATIVE GENOME-LINKED BARLEY YELLOW DWARF VIRUS |
| (ISOLATE 25-59 |
| PROTEIN PRECURSOR MAV-PSI)(BYDV) |
| PVPHE-- NPVOP 29 KD POLYHEDRAL ENVELOPE AUTOGRAPHA CALIFORNICA |
| NUCLEAR 146-223 |
| PROTEIN POLYHEDROSIS VIRUS ( |
| PVPR-- SIVML 32 KD POLYHEDRAL ENVELOPE ORGYIA PSEUDOTSUGATA |
| MULTICAPSID 131-201 206-265 |
| PROTEIN POLYHEDROSIS VIRUS |
| PVPU-- HVIA2 VPR PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (K78 |
| ISOLATE) |
| 78-115 |
| (SIV-MAC) |
| PVPU-- HVIB1 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 1-38 |
| (ARV2/SF2 ISOLATE |
| PVPU-- HVIB8 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 4-72 |
| (BH10 ISOLATE)(H) |
| PVPU-- HVIBN VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 5-72 |
| (BH8 ISOLATE)(HIV |
| PVPU-- HVIBR VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 4-59 |
| (BRAIN ISOLATE)(H |
| PVPU-- HVIC4 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 4-72 |
| (BRU ISOLATE)(HIV |
| PVPU-- HVIEL VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 3-40 |
| (CDC-451 ISOLATE) |
| PVPU-- HVIH2 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 6-40 |
| (ELI ISOLATE)(HIV- |
| PVPU-- HVIJ3 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 5-72 |
| (HXB2 ISOLATE)(HI |
| PVPU-- HVIJR VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 2-50 |
| (JH3 ISOLATE)(HIV- |
| PVPU-- HVIMA VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 4-59 |
| (JRCSF ISOLATE)(H |
| PVPU-- HVIND VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 5-50 |
| (MAL ISOLATE)(HI |
| PVPU-- HVIPV VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 4-40 |
| (NKD ISOLATE)(HI |
| PVPU-- HVIRH VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 4-72 |
| (PV22 ISOLATE)(HI |
| PVPU-- HVIS1 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 1-39 |
| (RF/HAT ISOLATE)( |
| PVPU-- HVIZ2 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 4-59 |
| (SF162 ISOLATE)(HI |
| PVPU-- SIVCZ VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE I |
| 6-40 |
| (Z2/CSC-Z34 ISOLAT |
| PVPX-- HV2D2 VPR PROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS 21-78 |
| (SIV(CPZ)) (CIV) |
| PVRNA-- BSMV VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 42-85 |
| (ISOLATE D205.7)(H |
| PVS05-- ROTSI ALPHA-A PROTEIN BARELY STRIPE MOSAIC VIRUS (BSMV) |
| 40-74 857-989 |
| PVS06-- ROTBS NONSTRUCTURAL PROTEIN NCVP2 SIMIAN II ROTAVIRUS |
| (STRAIN SA11) 248-287 |
| PVS06-- ROTGA VP6 PROTEIN BOVINE ROTAVIRUS (GROUP C/STRAIN |
| SHINTOKU) |
| 6-44 PVS06.sub |
| .-- ROTGI VP6 PROTEIN ROTAVIRUS (GROUP B/STRAIN ADRV)(ADULT 69-144 |
| DIARRHEA ROT |
| PVS06-- ROTHC VP6 PROTEIN ROTAVIRUS (GROUP B/STRAIN IDIR) 24-58 |
| 64-103 |
| PVS06-- ROTPC VP6 PROTEIN HUMAN ROTAVIRUS (GROUP C/STRAIN |
| BRISTOL) |
| 9-43 |
| PVS07-- ROTBJ VP6 PROTEIN PORCINE ROTAVIRUS (GROUP C/STRAIN COWDEN) |
| 9-43 |
| PVS07-- ROTBU GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN KN-4) 2-36 |
| 282-320 |
| PVS07-- ROTP5 NONSTRUCTURAL PROTEIN NCVP3 BOVINE ROTAVIRUS |
| (STRAIN UK) |
| 88-153 199-236 PVS07- |
| - ROTSI NONSTRUCTURAL PROTEIN NCVP3 PORCINE ROTAVIRUS (SEROTYPE |
| 5/STRAIN OSU) |
| 88-162 202-236 PVS08-- |
| ROTBU NONSTRUCTURAL PROTEIN NCVP3 SIMIAN II ROTAVIRUS (STRAIN SA11) |
| 88-153 199-236 |
| PVS08-- ROTSI NONSTRUCTURAL PROTEIN NS2/VP9 BOVINE ROTAVIRUS |
| (STRAIN UK 2-70 |
| 75-119 160-226 PVS09-- |
| ROTB4 NONSTRUCTURAL PROTEIN NCVP4 SIMIAN II ROTAVIRUS (STRAIN SA11) |
| 2-46 144-212 217-255 |
| PVS09-- ROTB5 GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (SEROTYPE |
| 6/STRAIN B641) |
| 2-54 282-320 PVS09-- |
| ROTB6 GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN A5) 2-43 282-320 |
| PVS09-- ROTBA GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (SEROTYPE |
| 6/STRAIN 61A) |
| 2-54 282-320 PVS09-- |
| ROTBB GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN A44) 2-54 282-320 |
| PVS09-- ROTBK GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (SEROTYPE |
| 10/STRAIN B223) |
| 2-54 282-320 PVS09-- |
| ROTBN GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN KK3 2-54 282-320 |
| PVS09-- ROTBT GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN |
| NCDV) |
| 2-54 282-320 |
| PVS09-- ROTBU GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN (SEROTYPE |
| 1/ |
| 2-43 282-320 |
| STRAIN T449) |
| PVS09-- ROTC7 GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN (STRAIN |
| UK) |
| 2-54 282-320 |
| PVS09-- ROTEL GLYCOPROTEIN VP7 CHICKEN ROTAVIRUS A (SEROTYPE |
| 7/STRAIN CH2) 285-326 |
| PVS09-- ROTGA GLYCOPROTEIN VP7 EQUINE ROTAVIRUS (STRAIN L338) |
| 282-320 |
| PVS09-- ROTG1 GLYCOPROTEIN VP7 PRECURSOR ROTAVIRUS (GROUP |
| B/STRAIN ADRV)(ADULT 43-77 |
| DIARRHEA ROTA |
| PVS09-- ROTH4 GLYCOPROTEIN VP7 PRECURSOR ROTAVIRUS (GROUP |
| B/STRAIN IDIR) 45-79 |
| PVS09-- ROTH9 GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 4/STRAIN |
| RV-4) |
| 2-43 282-320 |
| PVS09-- ROTHA GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE G/STRAIN |
| RK9) 282-320 |
| PVS09-- ROTHB GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN |
| HU5) 282-320 |
| PVS09-- ROTHD GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE G/STRAIN |
| B37) |
| 2-43 282-320 |
| PVS09-- ROTHH GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN |
| DS1) 282-320 |
| PVS09-- ROTHL GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN |
| HN126) 282-320 |
| PVS09-- ROTHM GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (STRAIN L26) 1-35 |
| 282-320 |
| PVS09-- ROTHO GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN |
| M37) |
| 2-43 282-320 |
| PVS09-- ROTHP GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN |
| MO |
| 2-43 282-320 |
| AND STRAIN D) |
| PVS09-- ROTHR GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 3/STRAIN |
| P) 282-320 |
| PVS09-- ROTHS GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 3/STRAIN |
| RRV) 282-320 |
| PVS09-- ROTHT GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN |
| S2) 282-320 |
| PVS09-- ROTHV GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 4/STRAIN |
| 18-56 208-242 282-320 |
| ST. THOMAS 3) |
| PVS09-- ROTHW GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 4/STRAIN |
| VA70) 18-56 208-242 282-320 |
| PVS09-- ROTP2 GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN |
| WA) |
| 2-43 282-320 |
| PVS09-- ROTP3 GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE 3/STRAIN |
| AT/76) 282-320 |
| PVS09-- ROTP4 GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE |
| 3/STRAIN CRW-8) 282-320 |
| PVS09-- ROTP5 GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE |
| 4/STRAIN OSU) |
| 2-56 208-242 282-320 PVS09-- |
| ROTP6 GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE 5/STRAIN OSU) |
| 282-320 |
| PVS09-- ROTPB GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE |
| 5/STRAIN TFR-41) 282-320 |
| PVS09-- ROTPK GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE |
| 4/STRAIN BEN-144) 18-56 208-242 282-320 |
| PVS09-- ROTPM GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (STRAIN K) 18-56 |
| 282-320 |
| PVS09-- ROTPY GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE |
| 4/STRAIN BMI-I) 18-56 208-242 282-320 |
| PVS09-- ROTRH GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (STRAIN YM) |
| 1-35 282-320 |
| PVS09-- |
| ROTSI GLYCOPROTEIN VP7 RHESUS ROTAVIRUS 282-320 PVS10-- |
| ROTBN GLYCOPROTEIN VP7 SIMIAN II ROTAVIRUS (STRAIN SA11) 282-320 |
| PVS10-- ROTBS NONSTRUCTURAL GLYCOPROTEIN BOVINE ROTAVIRUS |
| (STRAIN NCDV) |
| 73-161 NCVP5 |
| PVS10-- ROTBU MINOR OUTER CAPSID PROTEIN BOVINE ROTAVIRUS |
| (STRAIN GROUP C/STRAIN 17-58 |
| SHINTOKU) |
| PVS10-- ROTH2 NONSTRUCTURAL GLYCOPROTEIN BOVINE ROTAVIRUS (STRAIN |
| UK) |
| 73-161 |
| NCVP5 |
| PVS10-- ROTH7 NONSTRUCTURAL GLYCOPROTEIN HUMAN ROTAVIRUS (STRAIN |
| A28) |
| 73-162 |
| NCVP5 |
| PVS10-- ROTH8 NONSTRUCTURAL GLYCOPROTEIN HUMAN ROTAVIRUS (STRAIN |
| A64/CLONE 2) |
| 73-162 NCVP5 |
| PVS10-- ROTHC NONSTRUCTURAL GLYCOPROTEIN HUMAN ROTAVIRUS |
| (STRAIN A64/CLONE 6) |
| 73-162 NCVP5 |
| PVS10-- ROTHW MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (STRAIN |
| GROUP C/ 121-158 |
| STRAIN BRISTOL) |
| PVS10-- |
| ROTSI NONSTRUCTURAL GLYCOPROTEIN HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN WA) |
| 73-136 |
| NCVP5 |
| PVS11-- ROTGA NONSTRUCTURAL GLYCOPROTEIN SIMIAN II ROTAVIRUS |
| (STRAIN SA11) |
| 73-162 NCVP5 |
| PVS11-- ROTGI NONSTRUCTURAL PROTEIN ROTAVIRUS (GROUP B/STRAIN |
| ADRV)(ADULT 24-65 |
| 96-130 DIARRHEA ROTA |
| PVS11-- ROTH5 NONSTRUCTURAL PROTEIN ROTAVIRUS (GROUP B/STRAIN |
| IDIR) |
| 9-68 |
| PVS11-- ROTH6 MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (SEROTYPE |
| 2/STRAIN RV-5) 100-145 |
| PVS11-- |
| ROTHB MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN |
| 69M) 107-144 |
| PVS11-- |
| ROTHD MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (SEROTYPE G/STRAIN |
| B37) 107-144 |
| PVS11-- |
| ROTHW MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN |
| DSI) 111-145 |
| PVS11-- |
| ROTSI MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN WA) |
| 111-145 |
| PVS48-- TBRVC MINOR OUTER CAPSID PROTEIN SIMIAN II ROTAVIRUS |
| (STRAIN SA11) 111-145 |
| PVSH-- MUMP1 SATELLITE RNA 48 KD PROTEIN TOMATO BLACK RING VIRUS |
| (STRAIN C)(TBV) 217-165 |
| PVSH-- MUMP2 SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| SBL-1), AND MUMPS |
| 9-46 VIRUS (STRAIN |
| SBL |
| PVSH-- MUMP4 SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| EDINGBURGH 2), AND 13-47 |
| STRAIN EDINGB |
| PVSH-- MUMPA SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| EDINGBURGH 4) 13-47 |
| PVSH-- MUMPB SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| MATSUYAMA) 13-51 |
| PVSH-- MUMPE SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| BELFAST) 13-52 |
| PVSH-- MUMPJ SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| ENDERS) |
| 9-46 |
| PVSH-- |
| MUMPK SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN JERYL-LYNN) 9-46 |
| PVSH-- MUMPL SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| KILHAM) |
| 9-51 |
| PVSH-- MUMPM SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN BRISTOL |
| I) 13-55 |
| PVSH-- MUMPT SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) 17-51 |
| PVSH-- MUMPU SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| TAKAHASHI) 13-47 |
| PVSH-- REOVD SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN URABE |
| VACCINE AM9) 13-47 |
| PVSH-- REOVJ SIGMA I PROTEIN PRECURSOR REOVIRUS (TYPE 3/STRAIN |
| DEARING) |
| 8-122 127 -175 222-259 |
| PVSH-- REOVL SIGMA I PROTEIN PRECURSOR REOVIRUS (TYPE 2/STRAIN |
| D5/JONES) |
| 1-178 PVSI2.sub |
| .-- REOVD SIGMA 1 PROTEIN PRECURSOR REOVIRUS (TYPE 1/STRAIN LANG) |
| 3-107 112-198 |
| PVSI2-- REOVL SIGMA 2 PROTEIN REOVIRUS (TYPE 3/STRAIN DEARING) |
| 350-384 |
| PVSIS-- REOVD SIGMA 2 PROTEIN REOVIRUS (TYPE 1/STRAIN LANG) |
| 350-384 |
| PVSIS-- REOVJ SIGMA 1-S PROTEIN REOVIRUS (TYPE 3/STRAIN DEARING) |
| 85-119 |
| PVST2-- HEVBU SIGMA 1-S PROTEIN REOVIRUS (TYPE 2/STRAIN D5/JONES) |
| 7-45 |
| PVST2-- HEVME STRUCTURAL PROTEIN 2 PRECURSOR HEPATITIS E VIRUS |
| (STRAIN BURMA)(HEV) 318-352 |
| PVST2-- HEVMY STRUCTURAL PROTEIN 2 PRECURSOR HEPATITIS E VIRUS |
| (STRAIN MEXICO)(HEV) 317-351 |
| PVST2-- HEVPA STRUCTURAL PROTEIN 2 PRECURSOR HEPATITIS E VIRUS |
| (STRAIN MYANMAR)(HEV) 318-352 |
| PVST2-- HEVRH STRUCTURAL PROTEIN 2 PRECURSOR HEPATITIS E VIRUS |
| (STRAIN PAKISTAN)(HEV) 318-352 |
| PVT3A-- CAPVI STRUCTURAL PROTEIN 2 HEPATITIS E VIRUS (ISOLATE |
| RHESUS)(HEV) 186-220 |
| PVT4-- CAPVI PROTEIN T3A CAPRIPOXVIRUS (STRAIN INS-1) 120-158 |
| PVT4-- CAPVK T4 PROTEIN CAPRIPOXVIRUS (STRAIN INS-1) 86-120 |
| PVTER-- EBV T4 PROTEIN CAPRIPOXVIRUS (STRAIN KS-1) 86-120 |
| PVTER-- HCMVA PROBABLE DNA PACKAGING PROTEIN EPSTEIN-BARR |
| VIRUS (STRAIN B95-8)(HUMAN 235-290 595-629 |
| HERPESVIRUS 4) |
| PVTER-- |
| HSV6U PROBABLE DNA PACKAGING PROTEIN HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) 417-451 617-658 |
| PVTER-- HSVEB PROBABLE DNA PACKAGING PROTEIN HERPES SIMPLEX VIRUS |
| (TYPE 6/STRAIN 468-502 |
| UGANDA-1102) |
| PVTER-- HSVI1 PROBABLE DNA PACKAGING PROTEIN EQUINE HERPESVIRUS |
| TYPE 1(STRAIN AB4P) 11-45 |
| (EHV-10 |
| PVTER-- |
| HSVSA PROBABLE DNA PACKAGING PROTEIN ICTALURID HERPESVIRUS I (CHANNEL |
| CATFISH |
| 98-136 698-744 |
| VIRUS)(CCV) |
| PVTER-- VZVD PROBABLE DNA PACKAGING PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) 226-267 |
| PVV-- PI4HA PROBABLE DNA PACKAGING PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS)(VZV) 588-622 |
| PVYI-- SEND6 V PROTEIN HUMAN PARAINFLUENZA 4A VIRUS (STRAIN 4-38 |
| TOSHIBA)(PIV-4A) |
| PY101-- SSVI YI PROTEIN SENDAI VIRUS (STRAIN 6/94) 104-138 |
| PY108-- SSVI HYPOTHETICAL 10.1 KD PROTEIN SULFOLOBUS |
| VIRUS-LIKE PARTICLE SSVI 16-80 |
| PY110-- SSVI HYPOTHETICAL 10.8 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSVI |
| 4-65 PY119-- |
| SSVI HYPOTHETICAL 11.0 KD PROTEIN SULFOLOBUS VIRUS-LIKE PARTICLE SSVI |
| 55-59 |
| PY11K-- TYDVA HYPOTHETICAL 11.9 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSVI 30-96 |
| PY12K-- FCVC6 HYPOTHETICAL 11.2 KD PROTEIN TOBACCO YELLOW DWARF |
| VIRUS (STRAIN 53-87 |
| AUSTRALIA)(TYDV) |
| PY12K-- FCVF9 HYPOTHETICAL 12.2 KD PROTEIN FELINE CALICIVIRUS |
| (STRAIN CF1/68 FIV)(FCV) |
| 4-38 IN COAT PROTEIN |
| PY12K-- |
| RHDV HYPOTHETICAL 12.1 KD PROTEIN FELINE CALICIVIRUS (STRAIN F9)(FCV) |
| 4-38 |
| IN COAT PROTEIN |
| PY12K-- RHDV3 HYPOTHETICAL 12.7 KD PROTEIN RABBIT HEMORRHAGIC |
| DISEASE VIRUS (RHDV) 13-50 |
| IN COAT PROTEI |
| PY13K-- CLVK HYPOTHETICAL 12.7 KD PROTEIN RABBIT HEMORRHAGIC |
| DISEASE VIRUS (STRAIN 13-50 |
| IN COAT PROTEIN V-351)(RHDV) |
| PY13K-- CLVN HYPOTHETICAL 13.1 KD PROTEIN CASSAVA LATENT VIRUS |
| (STRAIN WEST KENYAN 40-77 |
| 844) |
| PY13K-- NPVOP HYPOTHETICAL 13.1 KD PROTEIN CASSAVA LATENT VIRUS |
| (STRAIN NIGERIAN) 43-77 |
| PY13K-- SSVI HYPOTHETICAL 14.5 KD PROTEIN ORGYIA PSEUDOTSUGATA |
| MULTICAPSID 16-67 |
| IN 39 KD PROTEIN POLYHEDROSIS VIRUS |
| PY14K-- SSVI HYPOTHETICAL 13.2 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSVI |
| 2-36 62-96 PY168-- |
| ADE02 HYPOTHETICAL 13.7 KD PROTEIN SULFOLOBUS VIRUS-LIKE PARTICLE SSVI |
| 5-39 |
| PY16K-- SSVI HYPOTHETICAL PROTEIN C-168 HUMAN ADENOVIRUS TYPE 2 |
| 119-166 |
| PY17K-- SSVI HYPOTHETICAL 15.6 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSVI 1-35 |
| 77-111 PY18K-- SSVI |
| HYPOTHETICAL 17.8 KD PROTEIN SULFOLOBUS VIRUS-LIKE PARTICLE SSVI 1-45 |
| 119-153 |
| PY20K-- SSVI HYPOTHETICAL 18.0 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSVI 102-136 |
| PY28K-- SSVI HYPOTHETICAL 20.4 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSVI |
| 73-107 PY2-- |
| SOCMV HYPOTHETICAL 28.5 KD PROTEIN SULFOLOBUS VIRUS-LIKE PARTICLE SSVI |
| 127-180 |
| PY31K-- SSVI HYPOTHETICAL PROTEIN 2 SOYBEAN CHLOROTIC MOTTLE |
| VIRUS 117-154 |
| PY32K-- SSVI HYPOTHETICAL 31.5 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSVI |
| 7-97 100-141 PY38K-- |
| NPVAC HYPOTHETICAL 31.7 KD PROTEIN SULFOLOBUS VIRUS-LIKE PARTICLE SSVI |
| 230-278 |
| PY3-- SCOMV HYPOTHETICAL 37.7 KD PROTEIN AUTOGRAPHA CALIFORNIC |
| NUCLEAR 133-241 |
| POLYHEDROSIS VIRUS ( |
| PY5K9-- SSVI HYPOTHETICAL PROTEIN 3 SOYBEAN CHLOROTIC MOTTLE |
| VIRUS 115-149 |
| PY7-- SOCMV HYPOTHETICAL 5.9 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSVI |
| 1-51 PY85K-- |
| SSVI HYPOTHETICAL PROTEIN 7 SOYBEAN CHLOROTIC MOTTLE VIRUS 56-94 |
| PY8-- |
| SOCMV HYPOTHETICAL 85.7 KD PROTEIN SULFOLOBUS VIRUS-LIKE PARTICLE SSVI |
| 81-125 503-537 546-587 658-700 |
| PYB01-- FOWPM HYPOTHETICAL PROTEIN 8 SOYBEAN CHLOROTIC MOTTLE |
| VIRUS 46-83 |
| PYB04-- FOWPM HYPOTHETICAL BAMHI-ORF1 FOWLPOX VIRUS (ISOLATE |
| HP-438[MUNICH]) |
| 74-115 184-221 PROTEIN |
| PYB05-- FOWPM HYPOTHETICAL BAMHI-ORF4 FOWLPOX VIRUS (ISOLATE |
| HP-438[MUNICH]) 29-70 |
| PROTEIN |
| PYB06-- FOWPM HYPOTHETICAL BAMHI-ORF5 FOWLPOX VIRUS (ISOLATE |
| HP-438[MUNICH]) |
| 3-37 61-95 PROTEIN |
| PYB07-- FOWPM HYPOTHETICAL BAMHI-ORF6 FOWLPOX VIRUS (ISOLATE |
| HP-438[MUNICH]) 115-149 |
| PROTEIN |
| PYB10-- FOWPM HYPOTHETICAL BAMHI-ORF7 FOWLPOX VIRUS (ISOLATE |
| HP-438[MUNICH]) 344-378 |
| PROTEIN |
| PYB12-- FOWPM HYPOTHETICAL BAMHI-ORF10 FOWLPOX VIRUS (ISOLATE |
| HP-438[MUNICH]) 162-253 |
| PROTEIN |
| PYB13-- FOWPM HYPOTHETICAL BAMHI-ORF12 FOWLPOX VIRUS (ISOLATE |
| HP-438[MUNICH]) |
| 4-47 117-153 PROTEIN |
| PYBL2-- EBV HYPOTHETICAL BAMHI-ORF13 FOWLPOX VIRUS (ISOLATE |
| HP-438[MUNICH]) 122-163 |
| PROTEIN |
| PYDH1-- HSVS7 HYPOTHETICAL BBLF2 PROTEIN EPSTEIN-BARR VIRUS |
| (STRAIN B95-8)(HUMAN 458-506 |
| HERPESVIRUS 4) |
| PYF30-- FOWPI HYPOTHETICAL 24.1 KD PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 484-77) 147-188 |
| IN DHFR 3'REGION |
| PYGAI-- HSVMB HYPOTHETICAL 30.9 KD PROTEIN FOWLPOX VIRUS (STRAIN |
| FP-1) 160-204 |
| PYGAI-- HSVMM HYPOTHETICAL 23.6 KD PROTEIN IN MAREK'S DISEASE |
| HERPESVIRUS (STRAIN BC-1) 176-211 |
| GLYCOPROTEI (MDHV) |
| PYH22-- VACCV HYPOTHETICAL 23.6 KD PROTEIN IN MAREK'S DISEASE |
| HERPESVIRUS (STRAIN BC-1) 176-211 |
| GLYCOPROTEI (MDHV) |
| PYHR3-- VACCV HYPOTHETICAL 21.7 KD VACCINIA VIRUS (STRAIN WR) |
| 34-78 |
| 95-139 |
| HINDIII-C PROTEIN |
| PYKR4-- EBV HYPOTHETICAL HOST RANGE 27.4 VACCINIA VIRUS (STRAIN |
| WR) 24-58 181-222 |
| KD PROTEIN |
| PYL15-- ADE41 HYPOTHETICAL BKRF4 PROTEIN EPSTEIN-BARR VIRUS |
| (STRAIN B95-8)(HUMAN 16-58 |
| HERPESVIRUS 4) |
| PYLR2-- EBV HYPOTHETICAL 12.4 KD PROTEIN HUMAN ADENOVIRUS TYPE 41 |
| 39-81 |
| IN 33 KD PROTEIN |
| PYOR1-- COYMV HYPOTHETICAL BLRF2 PROTEIN EPSTEIN-BARR VIRUS |
| (STRAIN B95-8)(HUMAN |
| 64-125 HERPESVIRUS 4) |
| PYOR2-- COYMV HYPOTHETICAL 23 KD PROTEIN COMMELINA YELLOW |
| MOTTLE VIRUS (COYMV) |
| 94-147 PYOR2-- LELV |
| HYPOTHETICAL 15 KD PROTEIN COMMELINA YELLOW MOTTLE VIRUS (COYMV) 33-77 |
| PYOR3-- TTVI HYPOTHETICAL 28.4 KD PROTEIN LELYSTAD VIRUS (LV) |
| 100-134 |
| PYOR5-- ADEGI HYPOTHETICAL 6.9 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS 1 (STRAIN 14-54 |
| KRAI)(TTV1) |
| PYORA-- TTVI HYPOTHETICAL 31.5 KD PROTEIN AVIAN ADENOVIRUS GALI |
| (STRAIN PHELPS)(FOWL |
| 70-127 ADENOVIRU |
| PYORD-- TTVI HYPOTHETICAL 8.1 KD PROTEIN THERMOPROTEUS |
| TENAX VIRUS I (STRAIN KRA1) 21-67 |
| (TTV1) |
| PYORE-- TTVI HYPOTHETICAL 15.4 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS I (STRAIN KRA1) 6-51 |
| 89-130 (TTV1) |
| PYORL-- TTVI HYPOTHETICAL 15.3 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS I (STRAIN KRA1) |
| 78-122 (TTV1) |
| PYORQ-- TTVI HYPOTHETICAL 26.8 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS I (STRAIN KRA1) |
| 1-45 (TTV1) |
| PYORT-- TTVI HYPOTHETICAL 7.3 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS I (STRAIN KRA1) |
| 1-43 (TTV1) |
| PYORW-- TTVI HYPOTHETICAL 38.7 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS I (STRAIN KRA1) |
| 4-38 281-315 (TTV1) |
| PYP12-- RTBV HYPOTHETICAL 12.1 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS I (STRAIN KRA1) |
| 4-89 (TTV1) |
| PYP12-- RTBVP HYPOTHETICAL P12 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS (RTBV) 33-72 |
| PYP24-- RTBV HYPOTHETICAL P12 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS (ISOLATE 33-72 |
| PHILIPPINES)(RTE |
| PYP24-- RTBVP HYPOTHETICAL P24 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS (RTBV) |
| 51-101 106-157 PYP46-- |
| RTBV HYPOTHETICAL P24 PROTEIN RICE TUNGRO BACILLIFORM VIRUS (ISOLATE |
| 51-101 106-157 |
| PHILIPPINES)(RTE |
| PYP46-- RTBVP HYPOTHETICAL P46 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS (RTBV) |
| 49-111 197-231 PYP63-- |
| NPVAC HYPOTHETICAL P46 PROTEIN RICE TUNGRO BACILLIFORM VIRUS (ISOLATE |
| 49-111 197-231 |
| PHILIPPINES)(RTE |
| PYP7A-- TNVA HYPOTHETICAL PROTEIN IN AUTOGRAPHA CALIFORNICA |
| NUCLEAR 32-73 |
| P6.5 5'REGION POLYHEDROSIS VIRUS ( |
| PYPOH-- NPVAC HYPOTHETICAL P7A PROTEIN TOBACCO NECROSIS VIRUS |
| (STRAIN A)(TNV) |
| 1-65 PYPOL-- |
| IPNVJ HYPOTHETICAL 23.6 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| 116-153 |
| IN POLYHEDRIN 5 POLYHEDROSIS VIRUS ( |
| PYQ1-- AMEPV HYPOTHETICAL 17.3 KD PROTEIN INFECTIOUS PANCREATIC |
| NECROSIS 25-66 |
| VIRUS (SEROTYPE JASPER) |
| PYQ3-- |
| AMEPV HYPOTHETICAL 7.6 KD PROTEIN AMSACTA MOOREI ENTOMOPOXVIRUS (AMEPV) |
| 9-61 |
| IN TK 5'REGION |
| PYRF2-- |
| HSV6G HYPOTHETICAL PROTEIN IN AMSACTA MOOREI ENTOMOPOXVIRUS (AMEPV) |
| 1-57 62-96 149-183 |
| TK 3'REGION |
| PYRF3-- HSV6G HYPOTHETICAL PROTEIN RF2 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 193-264 |
| PYRF4-- HSV6G HYPOTHETICAL PROTEIN RF3 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 134-175 |
| PYRP2-- IRV6 HYPOTHETICAL PROTEIN RF4 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 252-286 404-442 |
| PYRR1-- EBV REPETITIVE PROTEIN ORF2 CHILO IRIDESCENT VIRUS |
| (CIV)(INSECT |
| 1-45 IRIDESCENT |
| VIRUS TYP |
| PYSR1-- EBV HYPOTHETICAL BRRF1 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8)(HUMAN |
| 96-130 HERPES |
| VIRUS 4) |
| PYTR1-- EBV HYPOTHETICAL BSRF1 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8)(HUMAN |
| 98-177 HERPES |
| VIRUS 4) |
| PYUB2-- NPVOP HYPOTHETICAL BTRF1 PROTEIN EPSTEIN-BARR VIRUS |
| (STRAIN B95-8)(HUMAN 390-424 |
| HERPES VIRUS 4) |
| PYVAC-- VACCC HYPOTHETICAL 24.0 KD PROTEIN ORGYIA PSEUDOTSUGATA |
| MULTICAPSID 25-69 170-204 |
| IN UBIQUITIN 3'RE POLYHEDROSIS VIRUS |
| PYVAG-- VACCC HYPOTHETICAL 14.4 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 29-63 |
| PYVAH-- VACCC HYPOTHETICAL 9.3 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| 3-37 PYVAN- |
| - VACCC HYPOTHETICAL 14.5 KD PROTEIN VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 78-112 |
| PYVBH-- VACCC HYPOTHETICAL 7.9 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 23-57 |
| PYVCC-- VACCC HYPOTHETICAL 7.4 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| 5-39 PYVDB- |
| - VACCC HYPOTHETICAL 9.2 KD PROTEIN VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 11-48 |
| PYVDB-- VACCC HYPOTHETICAL 8.5 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 29-80 |
| PYVDC-- VACCC HYPOTHETICAL 8.5 KD PROTEIN VACCINIA VIRUS (WR) |
| 46-80 |
| PYVGB-- VACCC HYPOTHETICAL 7.3 KD PROTEIN VACCINIA VIRUS (WR) |
| 7-41 |
| PYVHA-- VACCC HYPOTHETICAL 8.4 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 10-51 |
| HYPOTHETICAL 8.1 KD PROTEIN VACCINIA VIRUS (STRAIN COPENHAGEN) |
| 9-53 |
| TABLE VI |
| __________________________________________________________________________ |
| 107 × 178 × 4 SEARCH MOTIF RESULTS SUMMARY FOR ALL VIRAL |
| (NON-BACTERIOPHAGE) PROTEINS |
| __________________________________________________________________________ |
| PCGENE 107 × 178 × 4 |
| All Viruses (no bacteriophages) |
| FILE NAME PROTEIN VIRUS |
| __________________________________________________________________________ |
| P194K-- TRVSY POT 194 KD PRO TOBACCO RATTLE VIRUS (STRAIN SYM) |
| PAANT-- HDVAM DELTA ANTIGEN |
| HEPATITIS DELTA VIRUS (ISOLATE AMERCIAN) |
| PAANT-- HDVD3 DELTA ANTIGEN |
| HEPATITIS DELTA VIRUS (ISOLATE AMERCIAN) |
| PAANT-- HDVIT DELTA ANTIGEN |
| HEPATITIS DELTA VIRUS (ISOLATE AMERCIAN) |
| PAANT-- HDVM2 DELTA ANTIGEN |
| HEPATITIS DELTA VIRUS (ISOLATE AMERCIAN) |
| PAANT-- HDVS1 DELTA ANTIGEN |
| HEPATITIS DELTA VIRUS (ISOLATE AMERCIAN) |
| PAANT-- HDVS2 DELTA ANTIGEN |
| HEPATITIS DELTA VIRUS (ISOLATE AMERCIAN) |
| PAANT-- HDVWO DELTA ANTIGEN |
| HEPATITIS DELTA VIRUS (ISOLATE AMERCIAN) |
| PATH3H-- FOWPM ANTITHROMBIN-III |
| HOMOLOG FOWLPOX VIRUS (ISOLATE HP-438) |
| [MUNICH]) |
| PATI1-- VACCV 94 KD A-TYPE INCLUSION PRO VACCINIA VIRUS (STRAIN |
| WR) |
| PATI1-- VARV 81 KD A-TYPE INCLUSION PRO VARIOLA VIRUS |
| PATI2-- HSV11 ALPHA TRANS-IND FACTOR 78 KD PRO HERPES SIMPLEX |
| VIRUS (TYPE 1/STRAIN 17) |
| PATI2-- HSVIF ALPHA TRANS-IND FACTOR 77 KD PRO HERPES SIMPLEX |
| CIRUS (TYPE 1/STRAIN F) |
| PATI2-- HSVEB ALPHA TRANS-IND FACTOR 82 KD PRO EQUINE HERPESVIRUS |
| TYPE I (STRAIN AB4P) |
| PATIN-- HSVEB ALPHA TRANS-IND PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| PATI-- COWPX A-TYPE INCLUSION PROTEIN COWPOX VIRUS |
| PBZLF-- EBV BZLF1 TRANS-ACTIVATOR PROTEIN EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) |
| PCAHH-- VACCC CELL SURFACE-BINDING PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PCAHH-- VACCV CELL SURFACE-BINDING PROTEIN VACCINIA VIRUS (STRAIN |
| WR) |
| PCAHH-- VARV CELL SURFACE-BINDING PROTEIN VARIOLA VIRUS |
| PCELF-- HSVEB CELL FUSION PROTEIN PRECURSOR EQUINE HERPESVIRUS |
| TYPE 1 (STRAINS AB4P and Ky A) |
| PCGH2-- HSVSA CYCLIN HOMOLOG HERPESVIRUS SAIMIRI (STRAIN 11) |
| PCOA1-- POVHA COAT PROTEIN VP1 |
| HAMSTER POLYOMAVIRUS |
| PCOA2-- BFDV COAT PROTEIN VP2 BUDGERIGAR FLEDGLING DISEASE VIRUS |
| PCOA2-- POVBO COAT PROTEIN VP2 |
| BOVINE POLYOMAVIRUS |
| PCOA2-- POVJC COAT PROTEIN VP2 POLYOMAVIRUS JC |
| PCOA2-- POVLY COAT PROTEIN VP2 LYMPHOTROPIC POLYOMAVIRUS |
| PCOA2-- POVMK COAT PROTEIN VP2 MOUSE POLYOMAVIRUS (STRAIN KILHAM) |
| PCOA2-- SV40 COAT PROTEIN VP2 |
| SIMIAN VIRUS 40 |
| PCOA3-- AAV2 PROBABLE COAT PROTEIN 3 ADENO-ASSOCIATED VIRUS 2 |
| PCOA3-- TTV1 COAT PROTEIN TP3 |
| THERMOPROTEUS TENAX VIRUS 1 (STRAIN KRA1) |
| PCOAT-- ADVG COAT PROTEIN VP1 ALEUTIAN MINK DISEASE PAPVOVIRUS |
| (STRAIN G) |
| PCOAT-- BLVR COAT PROTEIN BEAN LEAFROLL VIRUS |
| PCOAT-- CAMVC COAT PROTEIN CAULIFLOW MOSAIC VIRUS (STRAIN CM-1841) |
| PCOAT-- CAMVD COAT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN D/H) |
| PCOAT-- CAMVE COAT PROTEIN CAULIFLOW |
| ER MOSAIC VIRUS (STRAIN BBC) |
| PCOAT-- CAMVN COAT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| NY8153) |
| PCOAT-- CAMVS COAT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| STRASBOURG) |
| PCOAT-- CARMV COAT PROTEIN CARNATION MOTTLE VIRUS |
| PCOAT-- CHVP1 MAJOR CAPSID PROTEIN PARAMECIUIM BURSARIA CHLORELLA |
| VIRUS 1 |
| PCOAT-- CNV COAT PROTEIN CUCUMBER NECROSIS VIRUS |
| PCOAT-- CSMV COAT PROTEIN CHLORIS STRIATE MOSAIC VIRUS |
| PCOAT-- CYMV COAT PROTEIN CLOVER YELLOW MOSAIC VIRUS |
| PCOAT-- FCVC6 COAT PROTEIN FELINE CALICIVIRUS (STRAIN CFI/68 FIV) |
| PCOAT-- FCVF4 COAT PROTEIN FELINE |
| CALICIVIRUS (STRAIN JAPANESE F4) |
| PCOAT-- FCVF9 COAT PROTEIN FELINE CALICIVIRUS (STRAIN F9) |
| PCOAT-- FMVD PROBABLE COAT PROTEIN FIGWORT MOSAIC VIRUS (STRAIN |
| DXS) |
| PCOAT-- LSV COAT PROTEIN LILY SYMPTOMLESS VIRUS |
| PCOAT-- MISV COAT PROTEIN MISCANTHUS STREAK VIRUS |
| PCOAT-- ORSV COAT PROTEIN ODONTOGLOSSUM RINGSPOT VIRUS |
| PCOAT-- PAVHB PROBABLE COAT PROTEIN VP1 HUMAN PARVOVIRUS B19 |
| PCOAT-- POPMV COAT PROTEIN POPLAR |
| MOSAIC VIRUS (ISOLATE ATCC PV275) |
| PCOAT-- SOCMV COAT PROTEIN SOYBEAN |
| CHLOROTIC MOTTLE VIRUS |
| PCOAT-- TAMV GENOME POLYPROTEIN TAMARILLO MOSAIC VIRUS |
| PCOAT-- TAV COAT PROTEIN TOMATO ASPERMY VIRUS |
| PCOAT-- TBSVB COAT PROTEIN TOMATO BUSHY STUNT VIRUS (STRAIN BS-3) |
| PCOAT-- TBSVC COAT PROTEIN TOMATO |
| BUSHY STUNT VIRUS (STRAIN CHERRY) |
| PCOAT-- TCV COAT PROTEIN TURNIP |
| CRINKLE VIRUS |
| PCOAT-- TMGMV COAT PROTEIN TOBACCO MILD GREEN MOSAIC VIRUS |
| PCOAT-- TMV COAT PROTEIN TOBACCO |
| MOSAIC VIRUS (VULGARE) |
| PCOAT-- TMVCO COAT PROTEIN TOBACCO MOSAIC VIRUS (STRAIN COWPEA) |
| PCOAT-- TMVDA COAT PROTEIN TOBACCO |
| MOSAIC VIRUS (STRAIN DAHLEMENSE) |
| PCOAT-- TMVER COAT PROTEIN TOBACCO MOSAIC VIRUS (STRAIN ER) |
| PCOAT-- TMVO COAT PROTEIN TOBACCO |
| MOSAIC VIRUS (STRAIN O and KOKUBU) |
| PCOAT-- TMVOM COAT PROTEIN TOBACCO |
| MOSAIC VIRUS (STRAIN OM) |
| PCOAT-- TMVTO COAT PROTEIN TOBACCO MOSAIC VIRUS (STRAIN TOMATO/L) |
| PCOAT-- TNVA COAT PROTEIN TOBACCO |
| NECROSIS VIRUS (STRAIN A) |
| PCOAT-- TRVPS COAT PROTEIN TOBACCO RATTLE VIRUS (STRAINS PSG and |
| PLB), |
| PCOAT-- TYDVA COAT PROTEIN TOBACCO YELLOW DWARF VIRUS (STRAIN |
| AUSTRALIA) |
| PCOAT-- TYMV COAT PROTEIN TURNIP YELLOW MOSAIC VIRUS |
| PCOAT-- TYMVA COAT PROTEIN TURNIP YELLOW MOSAIC VIRUS (AUSTRALIAN |
| ISOLATE) |
| PDNB2-- AD307 EARLY E2A DNA-BINDING PROTEIN HUMAN ADENOVIRUS TYPE |
| 7 |
| PDNB1-- EBV MAJOR DNA-BINDING PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B94-8) |
| PDNB1-- HCMVA MAJOR DNA-BINDING PROTEIN HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PDNB1-- HSVSA MAJOR DNA-BINDING PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PDNB1-- MCMVS MAJOR DNA-BINDING PROTEIN MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) |
| PDNB1-- POVJC DNA-BINDING PROTEIN POLYOMAVIRUS JC |
| PDNB1-- SCMVC MAJOR DNA-BINDING PROTEIN SIMIAN CYTOMEGALOVIRUS |
| (STRAIN COLBURN) |
| PDNL1-- VACCC DNA LIGASE VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PDNL1-- VACCV DNA LIGASE VACCINIA |
| VIRUS (STRAIN WR) |
| PDNL1-- VARV DNA LIGASE VARIOLA VIRUS |
| PDPOL-- ADE12 DNA POLYMERASE HUMAN ADENOVIRUS TYPE 12 |
| PDPOL-- CBEPV DNA POLYMERASE CHORISTONEURA BIENNIS ENTOMOPOXVIRUS |
| PDPOL-- CHVN2 DNA POLYMERASE |
| CHLORELLA VIRUS NY-2A |
| PDPOL-- CHVP1 DNA POLYMERASE PARAMECIUM BURSARIA CHLORELLA VIRUS 1 |
| PDPOL-- FOWPV DNA POLYMERASE FOWLPOX VIRUS |
| PDPOL-- HCMVA DNA POLYMERASE HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PDPOL-- HPBDB DNA POLYMERASE DUCK |
| HEPATITIS B VIRUS (BROWN |
| SHANGAHI DUCK ISOLATE S5) |
| PDPOL-- HPBDC DNA POLYMERASE DUCK HEPATITIS B VIRUS (STRAIN |
| CHINA) |
| PDPOL-- HPBDW DNA POLYMERASE DUCK HEPATITIS B VIRUS (WHITE |
| SHANGHAI DUCK ISOLATE S31) |
| PDPOL-- HPBGS DNA POLYMERASE GROUND SQUIRREL HEPATITIS VIRUS |
| PDPOL-- HPBHE DNA POLYMERASE HERON |
| HEPATITIS B VIRUS |
| PDPOL-- HPBVP DNA POLYMERASE HEPATITIS B VIRUS (SUBTYPE |
| ADW/STRAIN PHILIPPINO/PFDW294) |
| PDPOL-- HPBVZ DNA POLYMERASE HEPATITIS B VIRUS (SUBTYPE ADYW) |
| PDPOL-- HSV11 DNA POLYMERASE |
| ICTALURID HERPESVIRUS 1 |
| PDPOL-- HSVSA DNA POLYMERASE HERPESVIRUS SAIMIRI (STRAIN 11) |
| PDPOL-- NPVAC DNA POLYMERASE |
| AUTOGRAPHA CALIFORNICA |
| NUCLEAR POLYHEDROSIS VIRUS |
| PDPOL-- NPVLD DNA POLYMERASE LYMANTRIA DISPAR MULTICAPSID |
| NUCLEAR POLYHEDROSIS VIRUS |
| PDPOL-- VACCC DNA POLYMERASE VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PDPOL-- VACCV DNA POLYMERASE |
| VACCINIA VIRUS (STRAIN WR) |
| PDPOL-- VARV DNA POLYMERASE VARIOLA VIRUS |
| PDPOL-- WHV1 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 1 |
| PDPOL-- WHV59 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 59 |
| PDPOL-- WHV7 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 7 |
| PDPOL-- WHV8 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 8 |
| PDPOL-- WHV81 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 8 |
| PDTXH-- CORBE DIPHTH TOXIN HOMOLOG CRM228 PREC CORNYEPHAGE BETA |
| PDTX-- CORBE DIPHTHERIA TOXIN |
| PRECURSOR CORYNEPHAGE BETA |
| PDTX-- COROM DIPHTHERIA TOXIN PRECURSOR CORYNEPHAGE OMEGA |
| PDUT-- HSVE4 DEOXYU 5'-TRIPHOSPH NUCHYDROLASE EQUINE |
| HERPESVIRUS TYPE 4 (STRAIN 1942) |
| PDUT-- HSVSA DEOXYU 5'-TRIPHOSPH NUCHYDROLASE HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PE1BL-- ADE07 EIB PROTEIN, LARGE T-ANTIGEN HUMAN ADENOVIRUS TYPE 7 |
| PE1BL-- ADE40 EIB PROTEIN, LARGE T-ANTIGEN HUMAN ADENOVIRUS TYPE |
| 40 |
| PE1BL-- ADE12 EIB PROTEIN, SMALL T-ANTIGEN HUMAN ADENOVIRUS TYPE |
| 12 |
| PE1BL-- ADEM1 EIB PROTEIN, SMALL T-ANTIGEN MOUSE ADENOVIRUS TYPE 1 |
| PE314-- ADE02 EARLY E3B 14 KD PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| PE314-- ADE07 EARLY E3 15.3 KD |
| PROTEIN HUMAN DENOVIRUS TYPE 7 |
| PE320-- ADE03 EARLY E3 20.1 KD GLYCOPROTEIN HUMAN ADENOVIRUS TYPE |
| 3 |
| PE320-- ADE35 EARLY E3 20.3 KD GLYCOPROTEIN HUMAN ADENOVIRUS TYPE |
| 35 |
| PE321-- ADE35 EARLY E3 20.6 KD GLYCOPROTEIN HUMAN ADENOVIRUS TYPE |
| 35 |
| PE3GL-- ADEM1 EARLY E3 17.7 KD GLYCOPROTEIN MOUSE ADENOVIRUS TYPE |
| 1 |
| PEAR-- EBV EARLY ANTIGEN PROTEIN R EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PEFT1-- VARV EARLY TRANS FACTOR 70 KD SUBUNIT VARIOLA VIRUS |
| PENV-- AVIRE ENV POLYPROTEIN AVIAN |
| RETICULOENDOTHELIOSIS VIRUS |
| PENV-- AVISN ENV POLYPROTEIN AVIAN SPLEEN NECROSIS VIRUS |
| PENV-- BAEVM ENV POLYPROTEIN BABOON ENDOGENOUS VIRUS (STRAIN M7) |
| PENV-- BIV06 ENV POLYPROTEIN BOVINE |
| IMMUNODEFICIENCY VIRUS |
| (ISOLATE 106) |
| PENV-- BIV27 ENV POLYPROTEIN BOVINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE 127) |
| PENV-- BLVAF ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (AMERICAN |
| ISOLATE FLK) |
| PENV-- BLVAU ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (AUSTRALIAN |
| ISOLATE) |
| PENV-- BLVAV ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (AMERICAN |
| ISOLATE VDM) |
| PENV-- BLVB2 ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (BELGIUM |
| ISOLATE LB285) |
| PENV-- BLVB5 ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (BELGIUM |
| ISOLATE LB59) |
| PENV-- BLVJ ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (JAPANESE |
| ISOLATE BLV-1) |
| PENV-- CAEVG ENV POLYPROTEIN CPARINE ARTHRITIS ENCEPHALITIS VIRUS |
| (STRAIN G63) |
| PENV-- EIAV1 ENV POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| P3.2-1) |
| PENV-- EIAV2 ENV POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| P3.2-2) |
| PENV-- EIAV3 ENV POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| P3.2-3) |
| PENV-- EIAV5 ENV POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| P3.2-5) |
| PENV-- EIAV9 ENV POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| 1369) |
| PENV-- EIAVC ENV POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| CL22) |
| PENV-- EIAVW ENV POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS |
| (STRAIN WSU5) |
| PENV-- EIAVY ENV POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS |
| (ISOLATE WYOMING) |
| PENV-- FENV1 ENV POLYPROTEIN FELINE ENDOGENOUS VIRUS ECE1 |
| PENV-- FIVPE ENV POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE PETALUMA) |
| PENV-- FIVSD ENV POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE SAN DIEGO) |
| PENV-- FIVT2 ENV POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE TM2) |
| PENV-- FLVC6 ENV POLYPROTEIN FELINE LEUKEMIA PROVIRUS (CLONE |
| CFE-6) |
| PENV-- FLVGL ENV POLYPROTEIN FELINE LEUKEMIA VIRUS (STRAIN |
| A/GLASGOW-1) |
| PENV-- FLVLB ENV POLYPROTEIN FELINE LEUKEMIA VIRUS (STRAIN |
| LAMBDA-B1) |
| PENV-- FLVSA ENV POLYPROTEIN FELINE LEUKEMIA VIRUS (STRAIN SARMA) |
| PENV-- FOAMV ENV POLYPROTEIN HUMAN |
| SPUMARETROVIRUS |
| PENV-- FSVGA ENV POLYPROTEIN FELINE SARCOMA VIRUS (STRAIN GARDNER-A |
| RNSTEIN) |
| PENV-- FSVGB ENV POLYPROTEIN FELINE SARCOMA VIRUS (STRAIN GA) |
| PENV-- FSVSM ENV POLYPROTEIN FELINE |
| SARCOMA VIRUS (STRAIN SM) |
| PENV-- GALV ENV POLYPROTEIN GIBBON APE LEUKEMIA VIRUS |
| PENV-- HTL1A ENV POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 |
| (STRAIN ATK) |
| PENV-- HTL1C ENV POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 |
| (CARIBBEAN |
| ISOLATE) |
| PENV-- HTL1M ENV POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 |
| (ISOLATE MT-2) |
| PENV-- HTLV2 ENV POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE II |
| PENV-- HV1A2 ENV POLYPROTEIN HUMAN |
| IMMUNODEFICIENCY VIRUS TYPE 1 (ARV2/SF2 |
| ISOLATE) |
| PENV-- HV1B1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BH10 |
| ISOLATE) |
| PENV-- HV1B8 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BH8 |
| ISOLATE) |
| PENV-- HV1BN ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BRAIN ISOLATE) |
| PENV-- HV1BR ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BRAIN ISOLATE) |
| PENV-- HV1C4 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (CDC-451 ISOLATE) |
| PENV-- HV1EL ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ELI ISOLATE) |
| PENV-- HV1H2 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (HXB2 ISOLATE) |
| PENV-- HV1H3 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (HXB3 ISOLATE) |
| PENV-- HV1J3 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (JH3 ISOLATE) |
| PENV-- HV1JR ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (JRCSF ISOLATE) |
| PENV-- HV1KB ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (STRAIN KB-1-GP32) |
| PENV-- HV1MA ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (MAL ISOLATE) |
| PENV-- HV1MF ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (MFA ISOLATE) |
| PENV-- HV1MN ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (MN ISOLATE) |
| PENV-- HV1N5 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (NEW YORK-5 ISOLATE) |
| PENV-- HV1ND ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| NDK ISOLATE) |
| PENV-- HV1OY ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (OY1 ISOLATE) |
| PENV-- HV1PV ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (PV22 ISOLATE) |
| PENV-- HV1RH ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (RF/HAT ISOLATE) |
| PENV-- HV1S1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (SF162 ISOLATE) |
| PENV-- HV1S3 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (SF33 ISOLATE) |
| PENV-- HV1SC ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (SC ISOLATE) |
| PENV-- HV1W1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (WMJ1 ISOLATE) |
| PENV-- HV1W2 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (WMJ2 ISOLATE) |
| PENV-- HV1Z2 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (Z2/CDC-Z34 ISOLATE) |
| PENV-- HV1Z3 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ZAIRE 3 ISOLATE) |
| PENV-- HV1Z6 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ZAIRE 6 ISOLATE) |
| PENV-- HV1Z8 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (Z-84 ISOLATE) |
| PENV-- HV1ZH ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ZAIRE HZ321 ISOLATE) |
| PENV-- HV2BE ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE BEN) |
| PENV-- HV2CA ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE CAM2) |
| PENV-- HV2D1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE D194) |
| PENV-- HV2G1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE GHANA-1) |
| PENV-- HV2NZ ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE NIH-Z) |
| PENV-- HV2RO ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE ROD) |
| PENV-- HV2S2 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE ST/24 1C#2) |
| PENV-- HV2SB ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE SBLISY) |
| PENV-- HV2ST ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE ST) |
| PENV-- MCFF ENV POLYPROTEIN MINK CELL FOCUS-FORMING MURINE |
| LEUKEMIA VIRUS |
| PENV-- MCFF3 ENV POLYPROTEIN MINK CELL FOCUS-FORMING MURINE |
| LEUKEMIA VIRUS |
| (ISOLATE C1-3) |
| PENV-- MLVAV ENV POLYPROTEIN AKV MURINE LEUKEMIA VIRUS |
| PENV-- MLVCB ENV POLYPROTEIN CAS-BR-E-MURINE LEUKEMIA VIRUS |
| PENV-- MLVF5 ENV POLYPROTEIN FRIEND |
| MURINE LEUKEMIA VIRUS (ISOLATE 57) |
| PENV-- MLVFF ENV POLYPROTEIN FRIEND |
| MURINE LEUKEMIA VIRUS (ISOLATE FB29) |
| PENV-- MLVFP ENV POLYPROTEIN FRIEND |
| MURINE LEUKEMIA VIRUS (ISOLATE PRC-211) |
| PENV-- MLVHO ENV POLYPROTEIN HOMULV |
| MURINE LEUKEMIA VIRUS |
| PENV-- MLVK1 ENV POLYPROTEIN KIRSTEIN MURINE LEUKEMIA VIRUS |
| PENV-- MLVMO ENV POLYPROTEIN |
| MOLONEY MURINE LEUKEMIA VIRUS |
| PENV-- MLVRD ENV POLYPROTEIN RADIATION MURINE LEUKEMIA VIRUS |
| PENV-- MLVRK ENV POLYPROTEIN |
| RADIATION MURINE LEUKEMIA VIRUS (STRAIN |
| KAPLAN) |
| PENV-- MMTVB ENV POLYPROTEIN MOUSE MAMMARY TUMOR VIRUS (STRAIN |
| BR6) |
| PENV-- MMTVG ENV POLYPROTEIN MOUSE MAMMARY TUMOR VIRUS (STRAIN GR) |
| PENV-- MPMV ENV POLYPROTEIN SIMIAN MASON-PFIZER VIRUS |
| PENV-- MSVFB ENV POLYPROTEIN FBJ MURINE OSTEOSARCOMA VIRUS |
| PENV-- OMVVS ENV POLYPROTEIN OVINE |
| LENTIVIRUS (STRAIN SA-OMVV) |
| PENV-- RMCFV ENV POLYPROTEIN RAUSCHER MINK CELL FOCUS-INDUCING |
| VIRUS |
| PENV-- SFV1 ENV POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 1) |
| PENV-- SFV3L ENV POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 3/STRAIN |
| LK3) |
| PENV-- SIVA1 ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (AGM155 |
| ISOLATE) |
| PENV-- SIVAG ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (AGM3 ISOLATE) |
| PENV-- SIVAI ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (ISOLATE |
| AGM/CLONE GR1-1) |
| PENV-- SIVAT ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (TYO-1 ISOLATE) |
| PENV-- SIVCZ ENV POLYPROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| PENV-- SIVGB ENV POLYPROTEIN SIMIAN |
| IMMUNODEFICIENCY VIRUS (ISOLATE GB1) |
| PENV-- SIVM1 ENV POLYPROTEIN SIMIAN |
| IMMUNODEFICIENCY VIRUS (MM142-83 ISOLATE) |
| PENV-- SIVM2 ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (MM251 |
| ISOLATE) |
| PENV-- SIVMK ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (K6W |
| ISOLATE) |
| PENV-- SIVML ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (K78 |
| ISOLATE) |
| PENV-- SIVS4 ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (F236/SMH4 ISOLATE) |
| PENV-- SIVSP ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (PBJ/BC13 ISOLATE) |
| PENV-- SMRVH ENV POLYPROTEIN SQUIRREL MONKEY RETROVIRUS (SMRV-H) |
| PENV-- SRV1 ENV POLYPROTEIN SIMIAN |
| RETROVIRUS SRV-1 |
| PENV-- VILV ENV POLYPROTEIN VISNA LENTIVIRUS (STRAIN 1514) |
| PENV-- VILV1 ENV POLYPROTEIN VISNA |
| LENTIVIRUS (STRAIN 1514/CLONE LV1-1KS1) |
| PENV-- VIVL2 ENV POLYPROTEIN VISNA |
| LENTIVIRUS (STRAIN 1514/CLONE LV1-1KS2) |
| PETF1-- FOWP1 EARLY TRANS FACTOR 70 |
| KD SUBUNIT FOWLPOX VIRUS (STRAIN FP-1) |
| PETF1-- SFVKA EARLY TRANS FACTOR 70 |
| KD SUBUNIT SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) |
| PETF1-- VACCC EARLY TRANS FACTOR 70 KD SUBUNIT VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| PETF1-- VACCV EARLY TRANS FACTOR 70 KD SUBUNIT VACCINIA VIRUS |
| (STRAIN WR) |
| PETF2-- VACCC EARLY TRANSCRIPTION FACTOR 82 VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PETF2-- VARV EARLY TRANSCRIPTION FACTOR 82 VARIOLA VIRUS |
| PEXON-- VZVD ALKALINE EXONUCLEASE VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| PFIB2-- ADE40 41.4 KD FIBER PROTEIN HUMAN ADENOVIRUS TYPE 40 |
| PFIB2-- ADE41 41.4 KD FIBER PROTEIN |
| HUMAN ADENOVIRUS TYPE 41 |
| PFIBP-- ADE02 FIBER PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| PFIBP-- ADE40 FIBER PROTEIN HUMAN ADENOVIRUS TYPE 40 |
| PFIBP-- ADE41 FIBER PROTEIN HUMAN ADENOVIRUS TYPE 41 |
| PFIBP-- ADEB3 FIBER PROTEIN BOVINE ADENOVIRUS TYPE 3 |
| PFIBP-- ADEM1 FIBER PROTEIN MOUSE ADENOVIRUS TYPE 1 |
| PFOSX-- MSVFR V-FOS/FOX TRANSFORMING PROTEIN FBR MURINE OSTEOSARCOM |
| A VIRUS |
| PFOS-- AVINK PSS-V-FOS TRANSFORMING PROTEIN AVIAN RETROVIRUS NK24 |
| PFOS-- MSVFB PSS-V-FOS TRANSFORMING |
| PROTEIN FBJ MURINE OSTEOSARCOMA VIRUS |
| PGAG-- AVISN GAG POLYPROTEIN AVIAN |
| SPLEEN NECROSIS VIRUS |
| PGAG-- EIAVY GAG POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS |
| (ISOLATE WYOMING) |
| PGAG-- FOAMV GAG POLYPROTEIN HUMAN SPUMARETROVIRUS |
| PGAG-- GALV GAG POLYPROTEIN GIBBON APE LEUKEMIA VIRUS |
| PGAG-- HV1A2 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ARV2/SF2 ISOLATE) |
| PGAG-- HV1J3 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (JH3 ISOLATE) |
| PGAG-- HV1MN GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (MN ISOLATE) |
| PGAG-- HV2BE GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE BEN) |
| PGAG-- HV2D1 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE D194) |
| PGAG-- HV2NZ GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE NIH-Z) |
| PGAG-- HV2ST GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE ST) |
| PGAG-- IPHA RETROVIRUS-RELATED GAG POLYPROTEIN HAMSTER INTRACISTERN |
| AL A-PARTICLE |
| PGAG-- IPMA RETROVIRUS-RELATED GAG POLYPROTEIN MOUSE INTRACISTERNAL |
| A-PARTICLE |
| PGAG-- IPMAE RETROVIRUS-RELATED GAG POLYPROTEIN MOUSE INTRACISTERNA |
| L A-PARTICLE |
| PGAG-- MMTVB GAG POLYPROTEIN MOUSE MAMMARY TUMOR VIRUS (STRAIN |
| BR6) |
| PGAG-- MMTVC GAG POLYPROTEIN MOUSE MAMMARY TUMOR VIRUS (STRAIN |
| C3H) |
| PGAG-- MMTVG GAG POLYPROTEIN MOUSE MAMMARY TUMOR VIRUS (STRAIN GR) |
| PGAG-- MPMV GAG POLYPROTEIN SIMIAN MASON-PFIZER VIRUS (MPMV) |
| PGAG-- SCVLA MAJOR COAT PROTEIN |
| SACCHAROMYCES CEREVISIAE VIRUS L-A |
| PGAG-- SIVA1 GAG POLYPROTEIN SIMIAN |
| IMMUNODEFICIENCY VIRUS |
| (ISOLATE AGM/CLONE GR1-1) |
| PGAG-- SIVMK GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (K6W |
| ISOLATE) |
| PGAG-- SIVMS GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (STM |
| ISOLATE) |
| PGAG-- SIVS4 GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (F236/SMH4 ISOLATE) |
| PGAG-- SIVSP GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (PBJ/BC13 ISOLATE) |
| PGAG-- SMSAV GAG POLYPROTEIN SIMIAN SARCOMA VIRUS |
| PGAG-- SRV1 GAG POLYPROTEIN SIMIAN RETROVIRUS SRV-1 |
| PHELI-- HSVEB PROBABLE HELICASE EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) |
| PHELI-- HSVSA PROBABLY HELICASE HERPESVIRUS SAIMIRI (STRAIN 11) |
| PHELI-- VZVD PROBABLE HELICASE |
| VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| PHEMA-- CVBF HEMAGGLUTININ-ESTERASE |
| PRECURSOR BOVINE CARONAVIRUS (STRAIN F15) |
| PHEMA-- CVBLY HEMAGGLUTININ-ESTERASE PRECURSOR BOVINE CARONAVIRUS |
| (STRAIN LY-138) |
| PHEMA-- CVBM HEMAGGLUTININ-ESTERASE PRECURSOR BOVINE CARONAVIRUS |
| (STRAIN MEBUS) |
| PHEMA-- CVBQ HEMAGGLUTININ-ESTERASE PRECURSOR BOVINE CARONAVIRUS |
| (STRAIN QUEBEC) |
| PHEMA-- CVHOC HEMAGGLUTININ-ESTERASE PRECURSOR HUMAN CARONAVIRUS |
| (STRAIN OC43) |
| PHEMA-- IAAIC HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/AICH1/2/68) |
| PHEMA-- IABAN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/BANGKOK/1/79) |
| PHEMA-- IABUD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/BUDGERIGAR/HOKKAIDO/1/77) |
| PHEMA-- IACAO HEMAGGLUTININ INFLUENZA A VIRUS (STRAIN A/CAMEL/MONGO |
| LIA/82) |
| PHEMA-- IACKA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ALABAMA/1/75) |
| PHEMA-- IACKG HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/GERMANY/N/49) |
| PHEMA-- IACKP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/PENNSYLVANIA/1/83) |
| PHEMA-- IACKQ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/PENNSYLVANIA/ |
| 1370/ 83) |
| PHEMA-- IACKV HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/VICTORIA/1/85) |
| PHEMA-- IADA1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ALBERTA/28/76) |
| PHEMA-- IADA2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ALBERTA/60/76) |
| PHEMA-- IADA3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ALBERTA/78/76) |
| PHEMA-- IADA4 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ALBERTA/35/76) |
| PHEMA-- IADCZ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/CZECHOSLOVAKIA/56) |
| PHEMA-- IADE1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ENGLAND/1/56) |
| PHEMA-- IADH1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/HOKKAIDO/5/77) |
| PHEMA-- IADH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/HOKKAIDO/8/80) |
| PHEMA-- IADH3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/HOKKAIDO/33/80) |
| PHEMA-- IADH4 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/HOKKAIDO/7/82) |
| PHEMA-- IADH5 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/HOKKAIDO/21/82) |
| PHEMA-- IADH6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/HOKKAIDO/9/85) |
| PHEMA-- IADH7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/HOKKAIDO/10/85) |
| PHEMA-- IADIR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/IRELAND/113/83) |
| PHEMA-- IADM2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/MEMPHIS/546/76) |
| PHEMA-- IADM2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/MEMPHIS/928/74) |
| PHEMA-- IADMA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/MANITOBA/1/53) |
| PHEMA-- IADNY HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/NEW YORK/12/78) |
| PHEMA-- IADNZ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/NEW ZEALAND/31/76) |
| PHEMA-- IADU1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/UKRAINE/1/60) |
| PHEMA-- IADU3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/UKRAINE/1/63) |
| PHEMA-- IAEN6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ENGLAND/878/69) |
| PHEMA-- IAEN7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ENGLAND/321/77) |
| PHEMA-- IAFPR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/FOWL PLAGUE |
| VIRUS/ROSTOCK/34) |
| PHEMA-- IAGRE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/GREY TEAL/AUSTRALIA/2/79) |
| PHEMA-- IAGU2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/GULL/MARYLAND/704/77) |
| PHEMA-- IAGUA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/GULL/ASTRAKHAN/227/84) |
| PHEMA-- IAHAL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ALGIERS/72) |
| PHEMA-- IAHAR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/HARBIN/1/88) |
| PHEMA-- IAHC6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/CAMBRIDGE/1/63) |
| PHEMA-- IAHC7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/CAMBRIDGE/1/73) |
| PHEMA-- IAHCD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/C.DETROIT/1/64) |
| PHEMA-- IAHDE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/DETROIT/1/64) |
| PHEMA-- IAHFO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/FONTAINEBLEAU/76) |
| PHEMA-- IAHK6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/KENTUCKY/2/86) |
| PHEMA-- IAHK7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/KENTUCKY/1/87) |
| PHEMA-- IAHLE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/LEXINGTON/1/66) |
| PHEMA-- IAHLO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/LONDON/1416/73) |
| PHEMA-- IAHMI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/MIAMI/1/63) |
| PHEMA-- IAHNM HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/NEW MARKET/76) |
| PHEMA-- IAHNN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/NEW MARKET/1/77) |
| PHEMA-- IAHPR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/PRAGUE/1/56) |
| PHEMA-- IAHRO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ROMANIA/80) |
| PHEMA-- IAHSA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/SANTIAGO/1/85) |
| PHEMA-- IAHSP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/SAO PAULO/1/76) |
| PHEMA-- IAHSW HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/SWITZERLAND/137/72 |
| PHEMA-- IAHTE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/TENNESSEE/5/86) |
| PHEMA-- IAHTO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/TOKYO/71) |
| PHEMA-- IAHUR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/URUGUAY/1/63) |
| PHEMA-- IAJAP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/JAPAN/305/57) |
| PHEMA-- IAKIE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/KIEV/59/79) |
| PHEMA-- IALEN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/54/1) |
| PHEMA-- IAMAA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ATRAKHAN/244/82) |
| PHEMA-- IAMAB HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ASTRAKHAN/263/82) |
| PHEMA-- IAMAO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/NEW YORK/6874/78) |
| PHEMA-- IAME1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MEMPHIS/1/71) |
| PHEMA-- IAME2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MEMPHIS/102/72) |
| PHEMA-- IAME6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MEMPHIS/6/86) |
| PHEMA-- IAMIN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MINK/SWEDEN/84) |
| PHEMA-- IANT6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/NT/60/68) |
| PHEMA-- IAPIL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/PILOT WHALE/MAINE/328/84) |
| PHEMA-- IAPUE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/PUERTO RICO/8/34) |
| PHEMA-- IAQU7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/QU/7/70) |
| PHEMA-- IARUD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/RUDDY TURNSTONE/NEW |
| JERSEY/47/85) |
| PHEMA-- IASE2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SEAL/MASSACHUSETTS/133/82) |
| PHEMA-- IASH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SHEARWATER/AUSTRALIA/72) |
| PHEMA-- IASTA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/STARLING/VICTORIA/5156/85) |
| PHEMA-- IATAI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TAIWAN/1/86) |
| PHEMA-- IATKI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/IRELAND/1378/83) |
| PHEMA-- IATKM HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/MINNESOTA/833/80) |
| PHEMA-- IATKO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ONTARIO/7732/66) |
| PHEMA-- IATKP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ONTARIO/6118/68) |
| PHEMA-- IATKR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/OREGON/71) |
| PHEMA-- IATKW HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/WISCONSIN/1/66) |
| PHEMA-- IATRA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TERN/AUSTGRALIA/G70C/75) |
| PHEMA-- IAUDO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/UDORN/307/72) |
| PHEMA-- IAUSS HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/USSR/90/77) |
| PHEMA-- IAV17 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/VICTORIA/3/75) |
| PHEMA-- IAWIL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/WILSON-SMITH/33) |
| PHEMA-- IAX1A HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/XIANFENG/3/89) |
| PHEMA-- IAZCO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/COLORADO/1/77) |
| PHEMA-- IAZH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/HONG KONG/81/78) |
| PHEMA-- IAZH3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/HONG KONG/126/82) |
| PHEMA-- IAZIN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/INDIANA/1726/88) |
| PHEMA-- IAZNJ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/NEW JERSEY/11/76) |
| PHEMA-- IAZUK HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/UKKEL/1/84) |
| PHEMA-- INBBE HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/BEIJING/1/87) |
| PHEMA-- INBBO HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/BONN/43) |
| PHEMA-- INBEN HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/ENGLAND/222/82) |
| PHEMA-- INBHK HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/HONG KONG/8/73) |
| PHEMA-- INBLE HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/LEE/40) |
| PHEMA-- INBMD HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/MARYLAND/59) |
| PHEMA-- INBME HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/MEMPHIS/6/86) |
| PHEMA-- INBOR HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/OREGON/5/80) |
| PHEMA-- INBSI HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/SINGAPORE/222/79) |
| PHEMA-- INBUS HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/USSR/100/83) |
| PHEMA-- INBVI HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/VICTORIA/3/85) |
| PHEMA-- INBVK HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/VICTORIA/2/87) |
| PHEMA-- INCCA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/CALIFORNIA/78) |
| PHEMA-- INCEN HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/ENGLAND/892/83) |
| PHEMA-- INCGL HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/GREAT LAKES/1167/54) |
| PHEMA-- INCHY HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/HYOGO/1/83) |
| PHEMA-- INCJH HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/JOHANNESBURG/1/66) |
| PHEMA-- INCKY HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/KYOTO/41/820 |
| PHEMA-- INCMI HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/MISSISSIPPI/80) |
| PHEMA-- INCNA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/NARA/82) |
| PHEMA-- INCP1 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/PIG/BEIJING/10/81) |
| PHEMA-- INCP2 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/PIG/BEIGING/115/81) |
| PHEMA-- INCP3 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/PIG/BEIJING/439/82) |
| PHEMA-- INCTA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/TAYLOR/1233/47) |
| PHEMA-- INCYA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/YAMAGATA/10/81) |
| PHEMA-- NDVA HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN AUSTRALIA- |
| VICTORIA/32) |
| PHEMA-- NDVB HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN BEAUDETTE C/45) |
| PHEMA-- NDVD HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN D26/76) |
| PHEMA-- NDVH HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN BI-HITCHNER/47) |
| PHEMA-- NDVI HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN ITALIEN/45) |
| PHEMA-- NDVM HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN MIYADERA/51) |
| PHEMA-- NDVQ HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN QUEENSLAND/66) |
| PHEMA-- NDVTG HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN TEXAS G.B./48) |
| PHEMA-- NDVU HEMAGGLUTININ-NEURAMINIDASE NEWCASTLE DISEASE VIRUS |
| (STRAIN ULSTER/67) |
| PHEMA-- PHODV HEMAGGLUTININ-NEURAMINIDASE PHOCINE DISTEMPER VIRUS |
| PHEMA-- P11HW HEMAGGLUTININ-NEURAMIN |
| IDASE HUMAN PARAINFLUENZA 1 VIRUS (STRAIN |
| WASHINGTON/1957) |
| PHEMA-- P13B HEMAGGLUTININ-NEURAMINIDASE BOVINE PARAINFLUENZA 3 |
| VIRUS |
| PHEMA-- P13H4 HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN NIH 47885) |
| PHEMA-- P13HA HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN AUS/124854/74) |
| PHEMA-- P13HT HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN TEX/545/80) |
| PHEMA-- P13HU HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN TEX/9305/82) |
| PHEMA-- P13HV HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN TEX/12677/83) |
| PHEMA-- P13HW HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN WASH/641/79) |
| PHEMA-- P13HX HEMAGGLUTININ-NEURAMINIDASE HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN WASH/1511/73) |
| PHEMA-- RACVI HEMAGGLUTININ PRECURSOR RACCOON POXVIRUS |
| PHEMA-- SEND5 HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) |
| PHEMA-- SENDF HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN |
| FUSHIMI) |
| PHEMA-- SENDH HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN |
| HARRIS) |
| PHEMA-- SENDJ HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN |
| HVJ) |
| PHEMA-- SENDZ HEMAGGLUTININ-NEURAMINIDASE SENDAI VIRUS (STRAIN Z) |
| PHEMA-- SV41 HEMAGGLUTININ-NEURAMINI |
| DASE SIMIAN VIRUS 41 |
| PHEMA-- VACCC HEMAGGLUTININ PRECURSOR VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PHEMA-- VACCI HEMAGGLUTININ PRECURSOR VACCINIA VIRUS (STRAIN |
| IHD-J) |
| PHEMA-- VACCT HEMAGGLUTININ PRECURSOR VACCINIA VIRUS (STRAIN TIAN |
| TAN) |
| PHEMA-- VACCV HEMAGGLUTININ PRECURSOR VACCINIA VIRUS (STRAIN WR) |
| PHEMA-- VARV HEMAGGLUTININ PRECURSOR |
| VARIOLA VIRUS |
| PHEX9-- ADE02 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| PHEX9-- ADE05 HEXON-ASSOCIATED |
| PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| PHEX9-- ADE07 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPES 3 |
| and 7 |
| PHEX-- ADE02 HEXON PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| PHEX-- ADE05 HEXON PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| PHEX-- ADE40 HEXON PROTEIN HUMAN ADENOVIRUS TYPE 40 |
| PHEX-- ADEB3 HEXON PROTEIN HUMAN ADENOVIRUS TYPE 3 |
| PH138-- COWPX HEMORRHAGE-INDUCING 38 KD PROTEIN COWPOX VIRUS |
| PHRG-- COWPX HOST RANGE PROTEIN |
| COWPOX VIRUS |
| PI196-- ASFB7 LATE PROTEIN I196L AFRICAN SWINE FEVER VIRUS (STRAIN |
| BA71V) |
| PI226-- ASFB7 LATE PROTEIN I226R AFRICAN SWINE FEVER VIRUS (STRAIN |
| BA71V) |
| PIBMP-- CAMV4 INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN D4) |
| PIBMP-- CAMVD INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN D/H) |
| PIBMP-- CAMVP INCLUSION BODY MATRIX PROTEIN CAULIFLOWER MOSAIC |
| VIRUS (STRAIN PV147) |
| PIBMP-- CERV INCLUSION BODY MATRIX PROTEIN CARNATION ETCHED RING |
| VIRUS |
| PIBMP-- FMVD INCLUSION BODY MATRIX PROTEIN FIGWORT MOSAIC VIRUS |
| (STRAIN DXS) |
| PIBMP-- SOCMV INCLUSION BODY MATRIX PROTEIN SOYBEAN CHLOROTIC |
| MOTTLE VIRUS |
| PIC18-- HCMVA PROB PROC & TRANSPORT PRO UL56 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PIC18-- HSVSA PROBABLE PROC & TRANSPORT PRO HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PIC18-- MCMVS PROB PROC & TRANSPORT PRO MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) |
| PIE63-- HSV11 TRANSCRIPTIONAL REGULATOR IE63 HERPES SIMPLEX VIRUS |
| (TYPE 1/STRAIN 17) |
| PIE68-- HSV11 IMMEDIATE-EARLY PROTEIN IE68 HERPES SIMPLEX VIRUS |
| (TYPE 1/STRAIN 17) |
| PIE68-- HSVSA IMMEDIATE-EARLY PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| PIR05-- HCMVA HYPOTHETICAL PROTEIN IRL5 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PIR12-- HCMVA HYPOTHETICAL PROTEIN IRL12 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PIR13-- HCMVA HYPOTHETICAL PROTEIN IRL13 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PKFES-- FSVGA TYROSINE KINASE TRANSF PROTEIN FES FELINE SARCOMA |
| VIRUS (STRAIN GARDNER-ARNSTEIN) |
| PKFGR-- FSVGR TYROSINE KINASE TRANSF PROTEIN FGR FELINE SRACOMA |
| VIRUS (STRAIN GARDNER-RASHEED) |
| PKFMS-- FSVMD FMS TYROSINE KINASE TRANSF PROTEIN FELINE SRACOMA |
| VIRUS (STRAIN MCDONOUGH) |
| PKFPS-- FUJSV TYROSINE KINASE TRANSF PROTEIN FPS FUJINAMI SARCOMA |
| VIRUS |
| PKITH-- AMEPV THYMIDINE KINASE AMSACTA MOOREI ENTOMOPOXVIRUS |
| PKITH-- CAPVK THYMIDINE KINASE |
| CAPRIPOXVIRUS (STRAIN KS-1) |
| PKITH-- HSVSA THYMIDINE KINASE HERPESVIRUS SAIMIRI (STRAIN 11) |
| PKITH-- ILTVT THYMIDINE KINASE |
| INFECTIOUS LARYNGOTRACHEITIS VIRUS |
| (STRAIN |
| THORNE V882) |
| PKR74-- HSV11 GENE 74 PROTEIN KINASE ICTALURID HERPESVIRUS 1 |
| PKRB1-- VACCC 30 KD PROTEIN KINASE |
| HOMOLOG VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PKRB1-- VACCV 30 KD PROTEIN KINASE HOMOLOG VACCINIA VIRUS (STRAIN |
| WR) |
| PKRB2-- VACCC POSSIBLE PROTEIN KINASE B12 VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PKRB2-- VACCV POSSIBLE PROTEIN KINASE B12 VACCINIA VIRUS (STRAIN |
| WR) |
| PKRF1-- VACCC POSSIBLE PROTEIN KINASE F10 VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PKRF1-- VACCV POSSIBLE PROTEIN KINASE F10 VARIOLA VIRUS |
| PKROS-- AVISU ROS TYROSINE KINASE TRANSF PROTEIN AVIAN SARCOMA |
| VIRUS (STRAIN UR2) |
| PKRYK-- AVIR3 TYROSINE KINASE TRANSF PROTEIN RYK AVIAN RETROVIRUS |
| RPL30 |
| PKYES-- AVISY TYROSINE KINASE TRANSF PROTEIN YES AVIAN SARCOMA |
| VIRUS (STRAIN Y73) |
| PL100-- ADE02 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| PL100-- ADE05 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| PL100-- ADE40 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 40 |
| PL100-- ADE41 LATE 100 KD PROTEIN |
| HUMAN ADENOVIRUS TYPE 41 |
| PLPM1-- EBV LATENT MEMBRANE PROTEIN 1 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PLPM1-- EBVC LATENT MEMBRANE PROTEIN 1 EPSTEIN-BARR VIRUS (STRAIN |
| CAO) |
| PLPM1-- EBVR LATENT MEMBRANE PROTEIN 1 EPSTEIN-BARR VIRUS (STRAIN |
| RAJ1) |
| PLMP2-- EBV GENE TERMINAL PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PMCEL-- SFVKA MRNA CAPPING ENZYME, LARGE SUBUNI SHOPE FIBROMA |
| VIRUS (STRAIN KASZA) |
| PMCEL-- VACCC MRNA CAPPING ENZYME, LARGE SUBUNI VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| PMCEL-- VACCV MRNA CAPPING ENZYME, LARGE SUBUNI VACCINIA VIRUS |
| (STRAIN WR) |
| PMCEL-- VARV MRNA CAPPING ENZYME, LARGE SUBUNI VARIOLA VIRUS |
| PMCE-- ASFB7 MRNA CAPPING ENZYME |
| AFRICAN SWINE FEVER VIRUS (STRAIN BA71V) |
| PMOVP-- CGMVS MOVEMENT PROTEIN |
| CUCUMBER GREEN MOTTLE MOSAIC VIRUS |
| (WATERMELON |
| STRAIN W) |
| PMOVP-- CGMVW MOVEMENT PROTEIN CUCUMBER GREEN MOTTLE MOSAIC VIRUS |
| (WATERMELON |
| STRAIN SH) |
| PMOVP-- ORSV MOVEMENT PROTEIN ODONTOGLOSSUM RINGSPOT VIRUS |
| PMOVP-- TOMVA MOVEMENT PROTEIN |
| TOMATO MOSAIC VIRUS (STRAIN LI1A) |
| PMOVP-- TOMVL MOVEMENT PROTEIN |
| TOMATO MOSAIC VIRUS (STRAIN LI1) |
| PMTCI-- CHVN1 MODIFICATION METHYLASE CVIBI CHLORELLA VIRUS NC-1A |
| PMTC2-- CHVP1 MODIFICATION METHYLASE |
| CVIAII PARAMECIUIM BURSARIA CHLORELLA |
| VIRUS 1 |
| PMYC-- AVIM2 MYC TRANSFORMING PROTEIN AVIAN MYELOCYTOMATOSIS VIRUS |
| CMII |
| PMYC-- AVIMC MYC TRANSFORMING PROTEIN AVIAN MYELOCYTOMATOSIS VIRUS |
| MC29 |
| PMYC-- AVIMD MYC TRANSFORMING PROTEIN AVIAN MYELOCYTOMATOSIS VIRUS |
| HB1 |
| PMYC-- AVIME MYC TRANSFORMING PROTEIN AVIAN RETROVIRUS VIRUS |
| MH2E21 |
| PMYC-- AVIOK MYC TRANSFORMING PROTEIN AVIAN RETROVIRUS VIRUS OK10 |
| PMYC-- FLV MYC TRANSFORMING PROTEIN |
| FELINE LEUKEMIA VIRUS |
| PMYC-- FLVTT MYC TRANSFORMING PROTEIN FELINE LEUKEMIA PROVIRUS FTT |
| PNCAP-- BEV NUCLEOCAPSID PROTEIN BERNE VIRUS |
| PNCAP-- BUNLC NUCLEOCAPSID PROTEIN BUNYAVIRUS LA CROSSE |
| PNCAP-- BUNSH NUCLEOCAPSID PROTEIN BUNYAVIRUS SNOWSHOE HARE |
| PNCAP-- BUNYW NUCLEOCAPSID PROTEIN |
| BUNYAMWERA VIRUS |
| PNCAP-- CCHFV NUCLEOCAPSID PROTEIN CRIMEAN-CONGO HEMORRHAGIC FEVER |
| VIRUS |
| (ISOLATE C68031) |
| PNCAP-- CDVO NUCLEOCAPSID PROTEIN CANINE DISTEMPER VIRUS (STRAIN |
| ONDERSTEPOORT) |
| PNCAP-- CHAV NUCLEOCAPSID PROTEIN CHANDIPURA VIRUS (STRAIN |
| 1653514) |
| PNCAP-- CVCAE NUCLEOCAPSID PROTEIN CANINE ENTERIC CORONAVIRUS |
| (STRAIN K378) |
| PNCAP-- CVPPU NUCLEOCAPSID PROTEIN PORCINE TRANSMISSIBLE GASTROENTE |
| RITIS CORONAVIRUS |
| (STRAIN PURD |
| PNCAP-- CVPR8 NUCLEOCAPSID PROTEIN PORCINE RESPIRATORY CORONAVIRUS |
| (STRAIN 86/137004/ |
| BRITISH ISOLAT |
| PNCAP-- CVPRM NUCLEOCAPSID PROTEIN PORCINE RESPIRATORY CORONAVIRUS |
| (STRAIN RM4) |
| PNCAP-- DUGBV NUCLEOCAPSID PROTEIN DUGBE VIRUS |
| PNCAP-- FIPV NUCLEOCAPSID PROTEIN FELINE INFECTIOUS PERITONITIS |
| VIRUS (STRAIN 79-1146) |
| PNCAP-- HAZVJ NUCLEOCAPSID PROTEIN HAZARA VIRUS (ISOLATE JC280) |
| PNCAP-- HRSV1 NUCLEOCAPSID PROTEIN |
| HUMAN RESPIRATORY SYNCYTIAL VIRUS |
| (SUBGROUP |
| B/STRAIN 18537) |
| PNCAP-- HRSVA NUCLEOCAPSID PROTEIN HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS (STRAIN A2) |
| PNCAP-- LASSG NUCLEOCAPSID PROTEIN LASSA VIRUS (STRAIN GA391) |
| PNCAP-- LASSJ NUCLEOCAPSID PROTEIN |
| LASSA VIRUS (STRAIN JOSIAH) |
| PNCAP-- LYCVA NUCLEOCAPSID PROTEIN LYMPHOCYTIC CHORIOMENINGITIS |
| VIRUS |
| (STRAIN ARMSTRONG) |
| PNCAP-- MAGV NUCLEOCAPSID PROTEIN MAGUARI VIRUS |
| PNCAP-- MOPEI NUCLEOCAPSID PROTEIN MOPEIA VIRUS |
| PNCAP-- PI1HC NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 1 VIRUS |
| (STRAIN C39) |
| PNCAP-- PI1HW NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 1 VIRUS |
| (STRAIN WASHINGTON/1957) |
| PNCAP-- P13H4 NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 3 VIRUS |
| (STRAIN NIH) 47885 |
| PNCAP-- PTPV NUCLEOCAPSID PROTEIN PUNTA TORO PHLEBOVIRUS |
| PNCAP-- PUUMH NUCLEOCAPSID PROTEIN PUUMALA VIRUS (STRAIN HALLNAS |
| B1) |
| PNCAP-- PUUMS NUCLEOCAPSID PROTEIN PUUMALA VIRUS (STRAIN SOTKAMO) |
| PNCAP-- PVM NUCLEOCAPSID PROTEIN |
| PNEUMONIA VIRUS OF MICE |
| PNCAP-- RABVA NUCLEOCAPSID PROTEIN RABIES VIRUS (STRAIN AVO1) |
| PNCAP-- RABVP NUCLEOCAPSID PROTEIN |
| RABIES VIRUS (STRAIN PV) |
| PNCAP-- RABVS NUCLEOCAPSID PROTEIN RABIES VIRUS (STRAIN SAD B19) |
| PNCAP-- SEND5 NUCLEOCAPSID PROTEIN |
| SENDAI VIRUS (STRAIN Z/HOST MUTANTS) |
| PNCAP-- SENDE NUCLEOCAPSID PROTEIN |
| SENDAI VIRUS (STRAIN ENDERS) |
| PNCAP-- SEDNZ NUCLEOCAPSID PROTEIN SENDAI VIRUS (STRAIN Z) |
| PNCAP-- SFSV NUCLEOCAPSID PROTEIN |
| SANDFLY FEVER SICILIAN VIRUS |
| PNCAP-- SV41 NUCLEOCAPSID PROTEIN SIMIAN VIRUS 41 |
| PNCAP-- TACV NUCLEOCAPSID PROTEIN TACARIBE VIRUS |
| PNCAP-- TOSV NUCLEOCAPSID PROTEIN TOSCANA VIRUS |
| PNCAP-- UUK NUCLEOCAPSID PROTEIN UUKUNIEMI VIRUS |
| PNCAP-- VHSV0 NUCLEOCAPSID PROTEIN VIRAL HEMORRHAGIC SEPTICEMIA |
| VIRUS (STRAIN 07-71) |
| PNCAP-- VHSVM NUCLEOCAPSID PROTEIN VIRAL HEMORRHAGIC SEPTICEMIA |
| VIRUS (STRAIN |
| MAKAH) |
| PNCAP-- VSVIG NUCLEOCAPSID PROTEIN VESICULAR STOMATITIS VIRUS |
| (SEROTYPE) |
| INDIANA/STRAIN GLASGOW |
| PNCAP-- VSVJO NUCLEOCAPSID PROTEIN VESICULAR STOMATITIS VIRUS |
| (SEROTYPE NEW |
| JERSEY/STRAIN OGDEN |
| PNCAP-- VSVSJ NUCLEOCAPSID PROTEIN VESICULAR STOMATITIS VIRUS |
| (STRAIN SAN JUAN) |
| PNEF-- HV1EL NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ELI ISOLATE) |
| PNEF-- HV1ND NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (NDK ISOLATE) |
| PNEF-- HV1Z6 NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ZAIRE 6 ISOLATE) |
| PNEF-- SIVAI NEGATIVE FACTOR SIMIAN IMMUNODEFICIENCY VIRUS |
| (ISOLATE AGM/CLONE |
| GRI-1) |
| PNRAM-- IABDA NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/BLACK |
| DUCK/AUSTRALIA/702/78) |
| PNRAM-- IACAO NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/CAMEL/MONGO |
| LIA/82 |
| PNRAM-- IACHI NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/CHILE/1/83) |
| PNRAM-- IADAI NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/DUCK/ALBERT |
| A/28/76) |
| PNRAM-- IADGE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/DUCK/GERMAN |
| Y/49) |
| PNRAM-- IAFPW NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/FOWL |
| PLAGUE |
| VIRUS/ WEYBRIDGE) |
| PNRAM-- IAHCO NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/EQUINE/COR/ |
| 16/74) |
| PNRAM-- IAHK1 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/EQUINE/KENT |
| UCKY/1/81) |
| PNRAM-- IAKIE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/KIEV/59/79) |
| PNRAM-- IALEN NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/LENINGRAD/5 |
| 4/1) |
| PNRAM-- IAME1 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/MEMPHIS/1/7 |
| 1H-A/ |
| BELLAMY/42N) |
| PNRAM-- IAPAR NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/PARROT/ULST |
| ER/73) |
| PNRAM-- IAPUE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/PURETO |
| RICO/8/34) |
| PNRAM-- IARUE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/RUDDY |
| TURNSTONE/NEW |
| JERSEY/60/85) |
| PNRAM-- IATRA NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/TERN/AUSTRA |
| LIA/G70C/75) |
| PNRAM-- IAUSS NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/USSR/90/77) |
| PNRAM-- IAWHM NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/WHALE/MAINE |
| /1/84) |
| PNRAM-- IAWIL NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/WILSON-SMIT |
| H/33) |
| PNRAM-- INBLE NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/LEE/40) |
| PNS1-- SIDEV PROB NONSTRUC PRO |
| PRECURSOR BOMBYX DENSONUCLEOSIS VIRUS |
| PNS2-- SIDEV PROB NONSTRUC PRO |
| PRECURSOR BOMBYX DENSONUCLEOSIS VIRUS |
| PNSS-- INSVN NON-STRUCTURAL PROTEIN |
| IMPATIENS NECROTIC SPOT VIRUS (STRAIN |
| NL-07) |
| PNSS-- TSWVB NON-STRUCTURAL PROTEIN TOMATO SPOTTED WILT VIRUS |
| (BRAZILIAN ISOLATE |
| CPNH1/BR-01) |
| PNSS-- TSWVL NON-STRUCTURAL PROTEIN TOMATO SPOTTED WILT VIRUS |
| (STRAIN L3) |
| PNTP1-- AMEPV NUCLEOSIDE TRIPHOSPHATASE 1 AMSACTA MOORE1 ENTOMOPOXV |
| IRUS |
| PNTP1-- CBEPV NUCLEOSIDE TRIPHOSPHATASE 1 CHORISTONEURA BIENNIS |
| ENTOMOPOXVIRUS |
| PNTP1-- VACCC NUCLEOSIDE TRIPHOSPHATASE 1 VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PNTP1-- VACCV NUCLEOSIDE TRIPHOSPHATASE 1 VACCINIA VIRUS (STRAIN |
| WR) |
| PNTP1-- VARV NUCLEOSIDE TRIPHOSPHATASE 1 VARIOLA VIRUS |
| PP100-- HSV6U MAJOR ANTIGENIC STRUCTL PROTEIN HERPES SIMPLEX VIRUS |
| (TYPE 6/STRAIN UGANDA-1102) |
| PPAP1-- VACCC POLY(A)POL CATALYTIC SUBUNIT VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PPAP1-- VACCV POLY(A)POL CATALYTIC SUBUNIT VACCINIA VIRUS (STRAIN |
| WR) |
| PPAP1-- VARV POLY(A)POL CATALYTIC SUBUNIT VARIOLA VIRUS |
| PPAP2-- CAPVK POLY(A)POL REG SUBUNIT CAPRIPOXVIRUS (STRAIN KS-1) |
| PPAP2-- FOWPV POLY(A)POL REG |
| SUBUNIT FOWLPOX VIRUS |
| PPE12-- NPVAC 12.1 KD PROTEIN IN PE 5'REGION AUTOGRAPHA CALIFORNICA |
| NUCLEAR POLYHEDROSIS VIRUS |
| PPE12-- NPVOP 11.5 KD PROTEIN IN P26 5'REGION ORGYIA PSEUDOTSUGATA |
| ULTICAPSID POLYHEDROSIS VIRUS |
| PPE38-- NPVAC MAJOR IMMEDIATE EARLY PROTEIN AUTOGRAPHA CALIFORNICA |
| UCLEAR POLYHEDROSIS VIRUS |
| PPE48-- NPVAC 48.3 KD IN PE-P26 INTERGENIC REGION AUTOGRAPHA |
| CALIFORNICA NUCLEAR POLYHEDROSIS VIRUS |
| PPEN3-- ADEGX PENTON PROTEIN AVIAN |
| ADENOVIRUS GAL10 (STRAIN SA2) |
| PPOL1-- BAYMG GENOME POLYPROTEIN 1 BARLEY YELLOW MOSAIC VIRUS |
| (GERMAN ISOLATE) |
| PPOL1-- BAYMJ GENOME POLYPROTEIN 1 BARLEY YELLOW MOSAIC VIRUS |
| (JAPANESE STRAIN II-1) |
| PPOL1-- GCMV RNA1 POLYPROTEIN HUNGARIAN GRAPEVINE CHROME MOSAIC |
| VIRUS |
| PPOL1-- GFLV RNA1 POLYPROTEIN GRAPEVINE FANLEAF VIRUS |
| PPOL1-- TBRVS RNA1 POLYPROTEIN TOMATO BLACK RING VIRUS (STRAIN S) |
| PPOL2-- BAYMG GENOME POLYPROTEIN 2 |
| BARLEY YELLOW MOSAIC VIRUS (GERMAN |
| ISOLATE) |
| PPOL2-- BAYMJ GENOME POLYPROTEIN 2 BARLEY YELLOW MOSAIC VIRUS |
| (JAPANESE STRAIN II-1) |
| PPOL2-- GCMV RNA2 POLYPROTEIN HUNGARIAN GRAPEVINE CHROME MOSAIC |
| VIRUS |
| PPOL2-- GFLV RNA2 POLYPROTEIN GRAPEVINE FANLEAF VIRUS |
| PPOL2-- TRSVR RNA2 POLYPROTEIN TOMATO RINGSPOT VIRUS (ISOLATE |
| RASPBERRY) |
| PPOLG-- BOVEV GENOME POLYPROTEIN BOVINE ENTEROVIRUS (STRAIN |
| VG-5-27) |
| PPOLG-- BVDVN GENOME POLYPROTEIN BOVINE VIRAL DIARRHEA VIRUS |
| (ISOLATE NADL) |
| PPOLG-- BVDVS GENOME POLYPROTEIN BOVINE VIRAL DIARRHEA VIRUS |
| (STRAIN SD-1) |
| PPOLG-- BYMV GENOME POLYPROTEIN BEAN YELLOW MOSAIC VIRUS |
| PPOLG-- COXA2 GENOME POLYPROTEIN COXSACKIEVIRUS A21 (STRAIN COE) |
| PPOLG-- COXA9 GENOME POLYPROTEIN |
| COXSACKIEVIRUS A9 (STRAIN GRIGGS) |
| PPOLG-- COXB1 GENOME POLYPROTEIN |
| COXSACKIEVIRUS B1 |
| PPOLG-- COXB3 GENOME POLYPROTEIN COXSACKIEVIRUS B3 |
| PPOLG-- COXB4 GENOME POLYPROTEIN COXSACKIEVIRUS B4 |
| PPOLG-- COXB5 GENOME POLYPROTEIN COXSACKIEVIRUS B5 |
| PPOLG-- CYVV GENOME POLYPROTEIN CLOVER YELLOW VEIN VIRUS |
| PPOLG-- DEN1S GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN |
| SIGNAPORE S275/90) |
| PPOLG-- DEN26 GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN |
| 16681) |
| PPOLG-- DEN27 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| 16681-PDK53) |
| PPOLG-- DEN2J GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| JAMAICA) |
| PPOLG-- DEN2P GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| PR159/51) |
| PPOLG-- DEN2T GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN TONGA |
| 1974) |
| PPOLG-- DEN3 GENOME POLYPROTEIN DENGUE VIRUS TYPE 3 |
| PPOLG-- DEN4 GENOME POLYPROTEIN DENGUE VIRUS TYPE 4 |
| PPOLG-- EC11G GENOME POLYPROTEIN ECHOVIRUS 11 (STRAIN GREGORY) |
| PPOLG-- EMCV GENOME POLYPROTEIN |
| ENCEPHALOMYOCARDITIS VIRUS |
| PPOLG-- EMCVB GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS VIRUS |
| (STRAIN |
| EMC-B NONDIABETOGENIC) |
| PPOLG-- EMCVD GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS VIRUS |
| (STRAIN |
| EMC-D DIABETOGENIC) |
| PPOLG-- ENMG3 GENOME POLYPROTEIN MENGO ENECPHALOMYOCARDITIS VIRUS |
| (STRAIN 37A) |
| PPOLG-- ENMGO GENOME POLYPROTEIN MENGO ENCEPHALOMYOCARDITIS VIRUS |
| PPOLG-- FMDV1 GENOME POLYPROTEIN |
| FOOT-AND-MOUTH DISEASE VIRUS (STRAIN |
| A10-61) |
| PPOLG-- FMDVA GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAIN A12) |
| PPOLG-- FMDVO GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAINS O1K AND O1BFS) |
| PPOLG-- FMDVS GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAIN |
| C1-SANTA PAU[C-58]) |
| PPOLG-- HCV1 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE 1) |
| PPOLG-- HCVA GENOME POLYPROTEIN HOG |
| CHOLERA VIRUS (STRAIN ALFORT) |
| PPOLG-- HCVB GENOME POLYPROTEIN HOG CHOLERA VIRUS (STRAIN BRESCIA) |
| PPOLG-- HCVBK GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE BK) |
| PPOLG-- HCVH GENOME POLYPROTEIN |
| HEPATITIS C VIRUS (ISOLATE H) |
| PPOLG-- HCVJ6 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE HC-J6) |
| PPOLG-- HCVJ8 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE HC-J8) |
| PPOLG-- HCVJA GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| JAPANESE) |
| PPOLG-- HCVJT GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE HC-JT) |
| PPOLG-- HCVTW GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| TAIWAN) |
| PPOLG-- HPAV2 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN 24A) |
| PPOLG-- HPAV4 GENOME POLYPROTEIN |
| HEPATITIS A VIRUS (STRAIN 43C) |
| PPOLG-- HPAV8 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN 18F) |
| PPOLG-- HPAVC GENOME POLYPROTEIN |
| HEPATITIS A VIRUS (STRAIN CR326) |
| PPOLG-- HPAVG GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN GA76) |
| PPOLG-- HPAVH GENOME POLYPROTEIN |
| HEPATITIS A VIRUS (STRAIN HM-175) |
| PPOLG-- HPAVL GENOME POLYPROTEIN |
| HEPATITIS A VIRUS (STRAIN LA) |
| PPOLG-- HPAVM GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN MBB) |
| PPOLG-- HPAVS GENOME POLYPROTEIN |
| SIMIAN HEPATITIS A VIRUS (STRAIN AHM-27) |
| PPOLG-- HPAVT GENOME POLYPROTEIN |
| SIMIAN HEPATITIS A VIRUS (STRAIN CY-145) |
| PPOLG-- HRV14 GENOME POLYPROTEIN |
| HUMAN RHINOVIRUS 14 |
| PPOLG-- HRV1B GENOME POLYPROTEIN HUMAN RHINOVIRUS 1B |
| PPOLG-- HRV2 GENOME POLYPROTEIN HUMAN RHINOVIRUS 2 |
| PPOLG-- HRV89 GENOME POLYPROTEIN HUMAN RHINOVIRUS 89 |
| PPOLG-- HUEV7 GENOME POLYPROTEIN HUMAN ENTEROVIRUS 70 (STRAIN |
| J670/71) |
| PPOLG-- IBDVO STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS (STRAIN OH) |
| PPOLG-- JAEV1 GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN SA-14) |
| PPOLG-- JAEV5 GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN SA(V)) |
| PPOLG-- JAEVJ GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN JAGARS982) |
| PPOLG-- JAEVN GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN NAKAYAMA) |
| PPOLG-- KUNJM GENOME POLYPROTEIN KUNJIN VIRUS (STRAIN MRM61C) |
| PPOLG-- LANVT GENOME POLYPROTEIN |
| LANGAT VIRUS (STRAIN TP21) |
| PPOLG-- LANVY GENOME POLYPROTEIN LANGAT VIRUS (STRAIN YELANTSEV) |
| PPOLG-- LIV GENOME POLYPROTEIN |
| LOUPING ILL VIRUS |
| PPOLG-- LIVSB GENOME POLYPROTEIN LOUPING ILL VIRUS (STRAIN SB 526) |
| PPOLG-- MCFA GENOME POLYPROTEIN MOSQUITO CELL FUSING AGENT |
| PPOLG-- MDMV GENOME POLYPROTEIN |
| MAIZE DWARF MOSAIC VIRUS |
| PPOLG-- MVEV GENOME POLYPROTEIN MURRAY VALLEY ENCEPHALITIS VIRUS |
| PPOLG-- OMV GENOME POLYPROTEIN |
| ORNITHOGALUM MOSAIC VIRUS |
| PPOLG-- PEMVC GENOME POLYPROTEIN PEPPER MOTTLE VIRUS (CALIFORNIA |
| ISOLATE) |
| PPOLG-- POL1M GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN |
| MAHONEY) |
| PPOLG-- POL1S GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN SABIN) |
| PPOLG-- POL2L GENOME POLYPROTEIN |
| POLIOVIRUS TYPE 2 (STRAIN LANSING) |
| PPOLG-- POL2W GENOME POLYPROTEIN |
| POLIOVIRUS TYPE 2 (STRAIN W-2) |
| PPOLG-- POL32 GENOME POLYPROTEIN POLIOVIRUS TYPE 3 (STRAIN 23127) |
| PPOLG-- POL3L GENOME POLYPROTEIN |
| POLIOVIRUS TYPE 3 (STRAIN S P3/LEON/37 |
| AND P3/LEON 12A[1]B) |
| PPOLG-- PPVD GENOME POLYPROTEIN PLUM POX POTYVIRUS (STRAIN D) |
| PPOLG-- PPVEA GENOME POLYPROTEIN |
| PLUM POX POTYVIRUS (STRAIN EL AMAR) |
| PPOLG-- PPVNA GENOME POLYPROTEIN |
| PLUM POX POTYVIRUS (ISOLATE NAT) |
| PPOLG-- PPVRA GENOME POLYPROTEIN PLUM POX POTYVIRUS (STRAIN |
| RANKOVIC) |
| PPOLG-- PRSVH GENOME POLYPROTEIN PAPAYA RINGSPOT VIRUS (STRAIN |
| P/MUTANT HA) |
| PPOLG-- PRSVP GENOME POLYPROTEIN PAPAYA RINGSPOT VIRUS (STRAIN |
| P/MUTANT HA 5-1) |
| PPOLG-- PRSVW GENOME POLYPROTEIN PAPAYA RINGSPOT VIRUS (STRAIN W) |
| PPOLG-- PSBMV GENOME POLYPROTEIN |
| PEAS EED-BORNE MOSAIC VIRUS (STRAIN DPD1) |
| PPOLG-- PVYC GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN C) (PVY) |
| PPOLG-- PVYHU GENOME POLYPROTEIN |
| POTATO VIRUS Y (STRAIN HUNGARIAN) |
| PPOLG-- PVYN GENOME POLYPROTEIN |
| POTATO VIRUS Y (STRAIN N) |
| PPOLG-- PVYO GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN O) |
| PPOLG-- PYFV1 GENOME POLYPROTEIN PARSNIP YELLOW FLECK VIRUS |
| (ISOLATE P-121) |
| PPOLG-- SUMVS GENOME POLYPROTEIN SUGARCNAE MOSAIC VIRUS (STRAIN |
| SC) |
| PPOLG-- SVDVH GENOME POLYPROTEIN SWINE VESICULAR DISEASE VIRUS |
| (STRAIN H/3 '76) |
| PPOLG-- SVDVU GENOME POLYPROTEIN 1024-1060 |
| PPOLG-- TBEVS GENOME POLYPROTEIN ITCK-BORNE ENCEPHALITIS VIRUS |
| (STRAIN SOFJIN) |
| PPOLG-- TBEVW GENOME POLYPROTEIN BORNE ENCEPHALITIS VIRUS (WESTERN |
| SUBTYPE) |
| PPOLG-- TEV GENOME POLYPROTEIN TOBACCO ETCH VIRUS |
| PPOLG-- TMEVB GENOME POLYPROTEIN THEILER'S MURINE ENCEPHALOMYELITIS |
| VIRUS |
| (STRAIN BEAN 8386) |
| PPOLG-- TMEVD GENOME POLYPROTEIN THEILER'S MURINE ENCEPHALOMYELITIS |
| VIRUS (STRAIN DA) |
| PPOLG-- TMEVG GENOME POLYPROTEIN THEILER'S MURINE ENCEPHALOMYELITIS |
| VIRUS |
| (STRAIN GDV11) |
| PPOLG-- TUMV GENOME POLYPROTEIN TURNIP MOSAIC VIRUS |
| PPOLG-- TVMV GENOME POLYPROTEIN TOBACCO VEIN MOTTLING VIRUS |
| PPOLG-- WMV2 GENOME POLYPROTEIN |
| WATERMELON MOSAIC VIRUS II |
| PPOLG-- WNV GENOME POLYPROTEIN WEST NILE VIRUS |
| PPOLG-- YEFV1 GENOME POLYPROTEIN YELLOW FEVER VIRUS (STRAIN 17D) |
| PPOLG-- YEFV2 GENOME POLYPROTEIN |
| YELLOW FEVER VIRUS (STRAIN PASTEUR |
| 17D-204) |
| PPOLG-- ZYMV GENOME POLYPROTEIN ZUCCHINI YELLOW MOSAIC VIRUS |
| PPOLH-- POL1M GENOME POLYPROTEIN |
| POLIOVIRUS TYPE 1 (STRAIN MAHONEY) |
| PPOLN-- EEVVT NONSTRUCTURAL |
| POLYPROTEIN VENEZUELAN EQUINE ENCEPHALITIS |
| VIRUS |
| (STRAIN TRINIDAD DONKEY) |
| PPOLN-- FCVC6 NON-STRUCTURAL POLYPROTEIN FELINE CALICIVIRUS |
| (STRAIN CF1/68 FIV) |
| PPOLN-- FCVF9 NON-STRUCTURAL POLYPROTEIN FELINE CALICIVIRUS |
| (STRAIN F9) |
| PPOLN-- HEVBU NON-STRUCTURAL POLYPROTEIN HEPATITIS E VIRUS (STRAIN |
| BURMA) |
| PPOLN-- HEVME NON-STRUCTURAL POLYPROTEIN HEPATITIS E VIRUS (STRAIN |
| MEXICO) |
| PPOLN-- HEVMY N-STRUCTURAL POLYPROTEIN HEPATITIS E VIRUS (STRAIN |
| MYANMAR) |
| PPOLN-- HEVPA NON-STRUCTURAL POLYPROTEIN HEPATITIS E VIRUS (STRAIN |
| PAKISTAN) |
| PPOLN-- MIDDV NONSTRUCTURAL POLYPROTEIN MIDDELBURG VIRUS |
| PPOLN-- ONNVG NONSTRUCTURAL POLYPROTEIN O'NYONG-NYONG VIRUS |
| (STRAIN GULU) |
| PPOLN-- RHDV NONSTRUCTURAL POLYPROTEIN RABBIT HEMORRAHIG DISEASE |
| VIRUS |
| PPOLN-- RRVN NONSTRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| NB5092) |
| PPOLN-- RRVT NONSTRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| T48) |
| PPOLN-- RUBVT NONSTRUCTURAL POLYPROTEIN RUBELLA VIRUS (STRAIN |
| THERIEN) |
| PPOLN-- SFV NONSTRUCTURAL POLYPROTEIN SEMLIKI FOREST VIRUS |
| PPOLN-- SINDO NONSTRUCTURAL |
| POLYPROTEIN SINDBIS VIRUS (SUBTYPE |
| OCKLEBO/STRAIN EDSBYN 82-5) |
| PPOLN-- WEEV NONSTRUCTURAL POLYPROTEIN WESTERN EQUINE ENCEPHALITIS |
| VIRUS |
| PPOLS-- IBDV5 STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS (STRAIN 52/70) |
| PPOLS-- IBDVA STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS |
| (STRAIN AUSTRALIAN 002-73) |
| PPOLS-- IBDVC STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS (STRAIN CU-1) |
| PPOLS-- IBDVE STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS (STRAIN E) |
| PPOLS-- IBDVP STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS (STRAIN PBG-98) |
| PPOLS-- IBDVS STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS (STRAIN |
| STRAIN STC) |
| PPOLS-- ONNVG STRUCTURAL POLYPROTEIN O'NYONG-NYONG VIRUS (STRAIN |
| GULU) |
| PPOLS-- RRVN STRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| NB5092) |
| PPOLS-- RRVT STRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN T48) |
| PPOLS-- SINDO STRUCTURAL POLYPROTEIN |
| SINDBIS VIRUS (SUBTYPE OCKELBO/STRAIN |
| EDSBYN 82-5) |
| PPOLS-- SINDV STRUCTURAL POLYPROTEIN SINDBIS VIRUS (STRAIN HRSP |
| AND HRLP) |
| PPOLS-- WEEV STRUCTURAL POLYPROTEIN WESTERN EQUINE ENCEPHALITIS |
| VIRUS |
| PPOL-- BAEVM POL POLYPROTEIN BABOON ENDOGENOUS VIRUS (STRAIN M7) |
| PPOL-- CAEVC POL POLYPROTEIN |
| CAPRINE ARTHRITIS ENCEPHALITIS VIRUS |
| (STRAIN CORK) |
| PPOL-- COYMV PUTATIVE POLYPROTEIN COMMELINA YELLOW MOTTLE VIRUS |
| PPOL-- EIAV9 POL POLYPROTEIN EQUINE |
| INFECTIOUS ANEMIA VIRUS (CLONE 1369) |
| PPOL-- IEAVC POL POLYPROTEIN EQUINE |
| INFECTIOUS ANEMIA VIRUS (CLONE CL22) |
| PPOL-- EIAVY POL POLYPROTEIN EQUINE |
| INFECTIOUS ANEMIA VIRUS (ISOLATE WYOMING) |
| PPOL-- FENV1 POL POLYPROTEIN FELINE ENDOGENOUS VIRUS ECE1 |
| PPOL-- FIVPE POL POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE PETALUMA) |
| PPOL-- FMVD ENZYMATIC POLYPROTEIN FIGWORT MOSAIC VIRUS (STRAIN |
| DXS) |
| PPOL-- GALV POL POLYPROTEIN GIBBON APE LEUKEMIA VIRUS |
| PPOL-- HTL1A POL POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 |
| (STRAIN ATK) |
| PPOL-- HTL1C POL POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 |
| (CARIBBEAN |
| ISOLATE) |
| PPOL-- HV1A2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ARV2/SF2 |
| ISOLATE) |
| PPOL-- HV1B1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BH10 ISOLATE) |
| PPOL-- HV1B5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BH5 ISOLATE) |
| PPOL-- HV1BR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BRU ISOLATE) |
| PPOL-- HV1EL POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ELI ISOLATE) |
| PPOL-- HV1H2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (HXB2 ISOLATE) |
| PPOL-- HV1JR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (JRCSF ISOLATE) |
| PPOL-- HV1MA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (MAL ISOLATE) |
| PPOL-- HV1MN POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (MN ISOLATE) |
| PPOL-- HV1N5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (NEW YORK-5 |
| ISOLATE) |
| PPOL-- HV1ND POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (NDK ISOLATE) |
| PPOL-- HV1OY POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (OYI ISOLATE) |
| PPOL-- HV1PV POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (PV22 ISOLATE) |
| PPOL-- HV1RH POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (RF/HAT ISOLATE) |
| PPOL-- HV1U4 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (STRAIN |
| UGANDAN/ISOLATE U |
| PPOL-- HV1Z2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (Z2/CDC-Z34 |
| ISOLATE) |
| PPOL-- HV2BE POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE BEN) |
| PPOL-- HV2CA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE CAM2) |
| PPOL-- HV2D1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE D194) |
| PPOL-- HV2D2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE D205, 7) |
| PPOL-- HV2G1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE |
| GHANA-1) |
| PPOL-- HV2NZ POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE NIH-Z) |
| PPOL-- HV2RO POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE ROD) |
| PPOL-- HV2SB POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE SBLISY) |
| PPOL-- HV2ST POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE ST) |
| PPOL-- IPHA PUTATIVE POL POLYPROTEIN HAMSTER INTRACISTERNAL |
| A-PARTICLE |
| PPOL-- IPMA PUTATIVE POL POLYPROTEIN MOUSE INTRACISTERNAL A-PARTICL |
| E |
| PPOL-- IPMAI PROBABLE POL POLYPROTEIN MOUSE INTRACISTERNAL |
| A-PARTICLE |
| PPOL-- JSRV POL POLYPROTEIN SHEEP PULMONARY ADENOMATOSIS VIRUS |
| PPOL-- MLVAK POL POLYPROTEIN AKR |
| MURINE LEUKEMIA VIRUS |
| PPOL-- MLVAV POL POLYPROTEIN AKV MURINE LEUKEMIA VIRUS |
| PPOL-- MLVRD POL POLYPROTEIN RADIATION MURINE LEUKEMIA VIRUS |
| PPOL-- MLVRK POL POLYPROTEIN |
| RADIATION MURINE LEUKEMIA VIRUS (STRAIN |
| KAPLAN) |
| PPOL-- MPMV POL POLYPROTEIN SIMIAN MASON-PFIZER VIRUS |
| PPOL-- OMVVS POL POLYPROTEIN OVINE LENTIVIRUS (STRAIN SA-OMVV) |
| PPOL-- RSVP POL POLYPROTEIN ROUS |
| SARCOMA VIRUS (STRAIN PRAGUE C) |
| PPOL-- RTBV POLYPROTEIN RICE TUNGRO BACILLIFORM VIRUS |
| PPOL-- RTBVP POLYPROTEIN RICE TUNGRO BACILLIFORM VIRUS (ISOLATE |
| PHILIPPINES) |
| PPOL-- SFV1 POL POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 1) |
| PPOL-- SIVA1 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (AGM155 |
| ISOLATE) |
| PPOL-- SIVA2 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (AGM266 |
| ISOLATE) |
| PPOL-- SIVA3 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (AGM385 |
| ISOLATE) |
| PPOL-- SIVAG POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (AGM3 |
| ISOLATE) |
| PPOL-- SIVAI POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (ISOLATE |
| AGM/CLONE GR1-1) |
| PPOL-- SIVAT POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (TYO-1 |
| ISOLATE) |
| PPOL-- SIVCZ POL POLYPROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| (SIV(CPZ)) |
| PPOL-- SIVGB POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (ISOLATE GB1) |
| PPOL-- SIVM1 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (MM142-83 ISOLATE) |
| PPOL-- SIVMK POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (K6W |
| ISOLATE) |
| PPOL-- SIVS4 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (F236/SMH4 ISOLATE) |
| PPOL-- SIVSP POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| (PBJ/BC13 ISOLATE) |
| PPOL-- SMRVH POL POLYPROTEIN SQUIRREL MONKEY RETROVIRUS (SMRV-H) |
| PPOL-- SOCMV ENZYMATIC POLYPROTEIN |
| SOYBEAN CHLOROTIC MOTTLE VIRUS |
| PPOL-- SRV1 POL POLYPROTEIN SIMIAN RETROVIRUS SRV-1 |
| PPOL-- VILV POL POLYPROTEIN VISNA LENTIVIRUS (STRAIN 1514) |
| PPOL-- VILV1 POL POLYPROTEIN VISNA |
| LENTIVIRUS (STRAIN 1514/CLONE LV1-1KS1) |
| PPOL-- VILV2 POL POLYPROTEIN VISNA |
| LENTIVIRUS (STRAIN 1514/CLONE LV1-1KS2) |
| PPR73-- MMTVB PROTEIN PR73 MOUSE |
| MAMMARY TUMOR VIRUS (STRAIN BR6) |
| PPR73-- MMTVC PROTEIN PR73 MOUSE MAMMARY TUMOR VIRUS (STRAIN C3H) |
| PPR73-- MMTVG PROTEIN PR73 MOUSE |
| MAMMARY TUMOR VIRUS (STRAIN GR) |
| PPYHD-- CPVBM POLYHEDRIN PRECURSOR BOMBYX MORI CYTOPLASMIC |
| POLYHEDROSIS VIRUS |
| PPYHD-- NPVAC POLYHEDRIN AUTOGRAPHA CALIFORNICA NUCLEAR POLYHEDROSI |
| S VIRUS |
| PPYHD-- NPVAS POLYHEDRIN AGROTIS SEGETUM NUCLEAR POLYHEDROSIS |
| VIRUS |
| PPYHD-- NPVBM POLYHEDRIN BOMBYX MORI NUCLEAR POLYHEDROSIS VIRUS |
| PPYHD-- NPVBS POLYHEDRIN BUZURA |
| SUPPRESSARIA NUCLEAR POLYHEDROSIS VIRUS |
| PPYHD-- NPVHC POLYHEDRIN HYPHANTRIA |
| CUNEA NUCLEAR POLYHEDROSIS VIRUS |
| PPYHD-- NPVLD POLYHEDRIN LYMANTRIA DISPAR MULTICAPSID NUCLEAR |
| POLYHEDROSIS VIRUS |
| PPYHD-- NPVMB POLYHEDRIN MAMESTRA BRASSICAE NUCLEAR POLYHEDROSIS |
| VIRUS |
| PPYHD-- NPVOP POLYHEDRIN ORGYIA PSEUDOTSUGATA MULTICAPSID POLYHEDRO |
| SIS VIRUS |
| PPYHD-- NPVOS POLYHEDRIN ORGYIA PSEUDOTSUGATA SINGLE CAPSID |
| NUCLEAR |
| POLYHEDROSIS VIRUS |
| PPYHD-- NPVPF POLYHEDRIN PANOLIS FLAMMEA MULTIPLE NUCLEOCAPSID |
| POLYHEDROSIS VIRUS |
| PPYHD-- NPVSE POLYHEDRIN SPODOPTERA EXIGUA NUCLEAR POLYHEDROSIS |
| VIRUS |
| (STRAIN US) |
| PPYHD-- NPVSF POLYHEDRIN SPODOPTERA FRUGIPERDA NUCLEAR POLYHEDROSIS |
| VIRUS |
| PREV-- SIVAT REV PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (TYO-1 |
| ISOLATE) |
| PREV-- VILV REV PROTEIN VISNA LENTIVIRUS (STRAIN 1514) |
| PRIR1-- ASFM2 RIBONUC-DIPHOSPH REDUCT LARGE CHA AFRICAN SWINE |
| FEVER VIRUS (ISOLATE MALAWI LIL 20/1) |
| PRIR1-- HCMVA RIBONUC-DIPHOSPH |
| REDUCT LARGE CHA HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PRIR1-- HSVEB RIBONUC-DIPHOSPH REDUCT LARGE CHA EQUINE HERPESVIRUS |
| TYPE 1 (STRAIN AB4P) |
| PRIR1-- HSVSA RIBONUC-DIPHOSPH REDUCT LARGE CHA HERPESVIRUS |
| SAIMIRI (STRAIN 11) |
| PRIR1-- VACCC RIBONUC-DIPHOSPH REDUCT LARGE CHA VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| PRIR1-- VACCV RIBONUC-DIPHOSPH REDUCT LARGE CHA VACCINIA VIRUS |
| (STRAIN WR) |
| PRIR1-- VARV RIBONUC-DIPHOSPH REDUCT LARGE CHA VARIOLA VIRUS |
| PRIR1-- VZVD RIBONUC-DIPHOSPH |
| REDUCT LARGE CHA VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| PRIR2-- HSVB3 RIBONUC-DIPHOSPH REDUCT SMALL CHA BOVINE HERPESVIRUS |
| TYPE 1 (STRAIN 324) |
| PRP94-- VACCV RNA-POL-ASSOC TRANS SPEC FACTOR VACCINIA VIRUS |
| (STRAIN WR) |
| PRP94-- VARV RNA-POL-ASSOC TRANS SPEC FACTOR VARIOLA VIRUS |
| PRPO1-- VACCC DNA-DIRECTED RNA POL |
| 147 KD VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PRPO1-- VACCV DNA-DIRECTED RNA POL 147 KD VACCINIA VIRUS (STRAIN |
| WR) |
| PRPO1-- VARV DNA-DIRECTED RNA POL 147 KD VARIOLA VIRUS |
| PRPO2-- CAPVK DNA-DIRECTED RNA POL 132 KD CAPRIPOXVIRUS (STRAIN |
| KS-1) |
| PRPO2-- COWPX DNA-DIRECTED RNA POL 132 KD COWPOX VIRUS |
| PRPO2-- VACCV DNA-DIRECTED RNA POL 132 KD VACCINIA VIRUS (STRAIN |
| WR) |
| PRPO2-- VARV DNA-DIRECTED RNA POL 132 KD VARIOLA VIRUS |
| PRPO4-- CAPVK DNA-DIRECTED RNA POL 35 KD CAPRIPOXVIRUS (STRAIN |
| KS-1) |
| PRPO7-- VACCV DNA-DIRECTED RNA POL 19 KD VACCINIA VIRUS (STRAIN |
| WR) |
| PRPO7-- VARV DNA-DIRECTED RNA POL 19 KD VARIOLA VIRUS |
| PRPOA-- ELV RNA-DIRECTED RNA POLYMERASE LELYSTAD VIRUS |
| PRPOL-- EAV RNA-DIRECTRED RNA POLYMERASE EQUINE ARTERITIS VIRUS |
| PRRP1-- IAKOR RNA-DIRECTED RNA POL |
| SUB P1 INFLUENZA A VIRUS (STRAIN A/KOREA/4 |
| 26/68) |
| PRRP2-- IAANN RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/ANN ARBOR/6/60) |
| PRRP2-- IADH2 RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/DUCK/HOKKAIDO/8/80) |
| PRRP2-- IAFPR RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/FOWL PLAGUE |
| VIRUS/ROSTOCK/34) |
| PRRP2-- IAGU2 RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/GULL/MARYLAND/704/77) |
| PRRP2-- IAHLO RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/EQUINE/LONDON/1416/73) |
| PRRP2-- IAHTE RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/EQUINE/TENNESSEE/5/86) |
| PRRP2-- IAKOR RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/KOREA/426/68) |
| PRRP2-- IALE1 RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/134/57) |
| PRRP2-- IALE2 RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/LENINGRAD/134/17/57) |
| PRRP2-- IAMAN RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/MALLARD/NEW YORK/6750/78) |
| PRRP2-- IANT6 RNA-DIRECTED RNA POL |
| SUB P2 INFLUENZA A VIRUS (STRAIN A/NT/60/6 |
| 8) |
| PRRP2-- IAP10 RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/PINTAIL/ALBERTA/119/79) |
| PRRP2-- IAPUE RNA-DIRECTED RNA POL |
| SUB P2 INFLUENZA A VIRUS (STRAIN A/PUERTO |
| RICO/8/34) |
| PRRP2-- IARUD RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/RUDDY TURNSTONE/NEW |
| JERSEY/47/85) |
| PRRP2-- IASIN RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/SINGAPORE/1/57) |
| PRRP2-- IATKM RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/TURKEY/MINNESOTA/833/80) |
| PRRP2-- IAVI7 RNA-DIRECTED RNA POL |
| SUB P2 INFLUENZA A VIRUS (STRAIN A/VICTORI |
| A/3/75) |
| PRRP2-- IAWIL RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/WILSON-SMITH/33) |
| PRRP2-- IAZH2 RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/SWINE/HONG KONG/81/78) |
| PRRP2-- IAZH3 RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/SWINE/HONG KONG/126/82) |
| PRRP2-- IAZH RNA-DIRECTED RNA POL |
| SUB P2 INFLUENZA A VIRUS (STRAIN A/SWINE/I |
| OWA/15/30) |
| PRRP2-- IAZTF RNA-DIRECTED RNA POL SUB P2 INFLUENZA A VIRUS |
| (STRAIN A/SWINE/TENNESSEE/26/77) |
| PRRP2-- INBAC RNA-DIRECTED RNA POL SUB P2 INFLUENZA B VIRUS |
| (STRAIN B/ANN ARBOR/1/66 |
| [COLD-ADAPTED]) |
| PRRP2-- INBAD RNA-DIRECTED RNA POL SUB P2 INFLUENZA B VIRUS |
| (STRAIN B/ANN ARBOR/1/66[WILD-TYPE) |
| PRRP2-- INBSI RNA-DIRECTED RNA POL |
| SUB P2 INFLUENZA B VIRUS (STRAIN B/SINGAPO |
| RE/222/79) |
| PRRP3-- IABUD RNA-DIRECTED RNA POL SUB P3 INFLUENZA A VIRUS |
| (STRAIN A/BUDGERIGAR/HOKKAIDO/1/77) |
| PRRP3-- IACH1 RNA-DIRECTED RNA POL |
| SUB P3 INFLUENZA A VIRUS (STRAIN A/CHILE/1 |
| /83) |
| PRRP3-- IAHPR RNA-DIRECTED RNA POL SUB P3 INFLUENZA A VIRUS |
| (STRAIN A/EQUINE/PRAGUE/1/56) |
| PRRP3-- IAZTE RNA-DIRECTED RNA POL SUB P3 INFLUENZA A VIRUS |
| (STRAIN A/SWINE/TENNESSEE/24/77) |
| PRRP3-- INBAC RNA-DIRECTED RNA POL SUB P3 INFLUENZA B VIRUS |
| (STRAIN B/ANN ARBOR/1/66 |
| [COLD-ADAPTED]) |
| PRRP3-- INBAD RNA-DIRECTED RNA POL SUB P3 INFLUENZA B VIRUS |
| (STRAIN B/ANN ARBOR/1/66[WILD-TYPE) |
| PRRP3-- INCBE RNA-DIRECTED RNA POL |
| SUB P3 INFLUENZA C VIRUS (STRAIN C/BERLIN/ |
| 1/85) |
| PRRP3-- INCJJ RNA-DIRECTED RNA POL SUB P3 INFLUENZA C VIRUS |
| (STRAIN C/JJ/50) |
| PRRP3-- THOGV RNA-DIRECTED RNA POL SUB P3 THOGOTO VIRUS |
| PRRPA-- CVH22 RNA-DIRECTED RNA POLYMERASE HUMAN CORONAVIRUS |
| (STRAIN 229E) |
| PPRPA-- CVMJH RNA-DIRECTED RNA POLYMERASE MURINE CORONAVIRUS MHV |
| (STRAIN JHM) |
| PPRPB-- BEV RNA-DIRECTED RNA POLYMERASE BERNE VIRUS |
| PPRPB-- CVMA5 RNA-DIRECTED RNA POLYMERASE MURINE CORONAVIRUS MHV |
| (STRAIN A59) |
| PPRPB-- CVMJH RNA-DIRECTED RNA POLYMERASE MURINE CORONAVIRUS MHV |
| (STRAIN JHM) |
| PPRPB-- CVPFS RNA-DIRECTED RNA POLYMERASE PORCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| CORONAVIRUS (STRAIN FS772) |
| PPRPB-- IBVB RNA-DIRECTED RNA POLYMERASE AVIAN INFECTIOUS BRONCHITI |
| S VIRUS (STRAIN BEAUDETTE) |
| PPRPB-- IBVK RNA-DIRECTED RNA POLYMERASE AVIAN INFECTIOUS BRONCHITI |
| S VIRUS (STRAIN KB8523) |
| PRRPL-- BTV10 RNA-DIRECTED RNA POLYMERASE BLUETONGUE VIRUS |
| (SEROTYPE 10/ISOLATE USA) |
| PRRPL-- BUNYW RNA POLYMERASE BUNYAMWERA VIRUS |
| PRRPL-- CDVO RNA POLYMERASE BETA SUBUNIT CANINE DISTEMPER VIRUS |
| (STRAIN ONDERSTEPOORT) |
| PRRPL-- HANTV RNA POLYMERASE HANTAAN VIRUS (STRAIN 76-118) |
| PRRPL-- HRSVA RNA POLYMERASE BETA |
| SUBUNIT HUMAN RESPIRATORY SYNCYTIAL VIRUS |
| (STRAIN A2) |
| PRRPL-- MABVM RNA-DIRECTED RNA POLYMERASE MARBURG VIRUS (STRAIN |
| MUSOKE) |
| PRRPL-- MABVP RNA-DIRECTED RNA POLYMERASE MARBURG VIRUS (STRAIN |
| POPP) |
| PRRPL-- MEASE RNA POLYMERASE BETA SUBUNIT MEASLES VIRUS (STRAIN |
| EDMONSTON) |
| PRRPL-- MUMPM RNA POLYMERASE BETA SUBUNIT MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) |
| PRRPL-- NDVB RNA POLYMERASE BETA SUBUNIT NEWCASTLE DISEASE VIRUS |
| (STRAIN BEAUDETTE C/45) |
| PRRPL-- P12HT RNA POLYMERASE BETA SUBUNIT HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN TOSHIBA) |
| PRRPL-- P13H4 RNA POLYMERASE BETA SUBUNIT HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN NIH 47885) |
| PRRPL-- PUUMH RNA-DIRECTED RNA POLYMERASE PUUMALA VIRUS (STRAIN |
| HALLNAS B1) |
| PRRPL-- RABVP RNA POLYMERASE BETA SUBUNIT RABIES VIRUS (STRAIN PV) |
| PRRPL-- RABVS RNA POLYMERASE BETA SUBUNIT RABIES VIRUS (STRAIN SAD |
| B19) |
| PRRPL-- RDV RNA-DIRECTED RNA POLYMERASE RICE DWARF VIRUS |
| PRRPL-- RVFVZ RNA-DIRECTED RNA POLYMERASE RIFT VALLEY FEVER VIRUS |
| (STRAIN ZH-548 M12) |
| PRRPL-- SEND5 RNA POLYMERASE BETA SUBUNIT SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) |
| PRRPL-- SENDE RNA POLYMERASE BETA SUBUNIT SENDAI VIRUS (STRAIN |
| ENDERS) |
| PRRPL-- SENDZ RNA POLYMERASE BETA SUBUNIT SENDAI VIRUS (STRAIN Z) |
| PRRPL-- SEOU8 RNA-DIRECTED RNA |
| POLYMERASE SEOUL VIRUS (STRAIN 80-39) |
| PRRPL-- SV5WR RNA POLYMERASE BETA |
| SUBUNIT SIMAIN VIRUS 5 (STRAIN 21004-WR) |
| PRRPL-- SYNV RNA POLYMERASE BETA |
| SUBUNIT SONCHUS YELLOW NET VIRUS |
| PRRPL-- TSWVB RNA-DIRECTED RNA POLYMERASE TOMATO SPOTTED WILT |
| VIRUS (BRAZILIAN ISOLATE |
| CPNH1/BR-01) |
| PRRPL-- UUK RNA POLYMERASE UUKUNIEMI VIRUS |
| PRRPL-- VSVJH RNA POLYMERASE BETA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE NEW JERSEY/ |
| STRAIN HAZELHU |
| PRRPL-- VSVJO RNA POLYMERASE BETA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE NEW JERSEY/ |
| STRAIN STRAIN OGDEN) |
| PRRPL-- VSVSJ RNA POLYMERASE BETA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (STRAIN SAN JUAN) |
| PRRPO-- ACLSV RNA-DIRECTED RNA POLYMERASE APPLE CHLOROTIC LEAF |
| SPOT VIRUS |
| PRRPO-- BWYVF PUTATIVE RNA-DIR RNA POL BEET WESTERN YELLOWS VIRUS |
| (ISOLATE FL-1) |
| PRRPO-- BYDV1 PUTATIVE RNA-DIR RNA POL BARLEY YELLOW DWARF VIRUS |
| (ISOLATE MAV-PS1) |
| PRRPO-- BYDVP PUTATIVE RNA-DIR RNA POL BARLEY YELLOW DWARF VISU |
| (ISOLATE PAV) |
| PRRPO-- BYDVR PUTATIVE RNA-DIR RNA POL BARLEY YELLOW DWARF VISU |
| (ISOLATE P-PAV) |
| PRRPO-- CARMV PUTATIVE RNA-DIR RNA POL CARNATION MOTTLE VIRUS |
| PRRPO-- CGMVS PUTATIVE RNA-DIR RNA |
| POL CUCUMBER GREEN MOTTLE MOSAIC VIRUS |
| (WATERMELON |
| STRAIN SH) |
| PRRPO-- IBDV5 PUTATIVE RNA-DIR RNA POL AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS (STRAIN |
| 52/70) |
| PRRPO-- IBDVA PUTATIVE RNA-DIR RNA POL AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS (STRAIN |
| AUSTRALIAN 002-73) |
| PRRPO-- IPNVJ PUTATIVE RNA-DIR RNA POL INFECTIOUS PANCREATIC |
| NECROSIS VIRUS (SEROTYPE |
| JASPER) |
| PRRPO-- IPNVS PUTATIVE RNA-DIR RNA POL INFECTIOUS PANCREATIC |
| NECROSIS VIRUS (SEROTYPE SP) |
| PRRPO-- LYCVA RNA POLYMERASE LYMPHOCYTIC CHORIOMENINGITIS VIRUS |
| (STRAIN |
| ARMSTRONG) |
| PRRPO-- PPMVS PUTATIVE RNA-DIR RNA POL PEPPER MILD MOTTLE VIRUS |
| (STRAIN SPAIN) |
| PRRPO-- REOVD RNA-DIRECTED RNA POLYMERASE REOVIRUS (TYPE 3/STRAIN |
| DEARING) |
| PRRPO-- REOVL RNA-DIRECTED RNA POLYMERASE REOVIRUS (TYPE 1/STRAIN |
| LANG) |
| PRRPO-- ROTBR RNA-DIR RNA POL SUBUNIT VP1 BOVINE ROTAVIRUS (STRAIN |
| RF) |
| PRRPO-- ROTBU RNA-DIR RNA POL SUBUNIT VP1 BOVINE ROTAVIRUS (STRAIN |
| UK) |
| PRRPO-- ROTPC RNA-DIR RNA POL SUBUNIT VP1 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) |
| PRRPO-- ROTPG RNA-DIR RNA POL SUBUNIT VP1 PORCINE ROTAVIRUS |
| (STRAIN GOTTFRIED |
| PRRPO-- ROTS1 RNA-DIR RNA POL SUBUNIT VP1 SIMIAN 11 ROTAVIRUS |
| (STRAIN SA11) |
| PRRPO-- SCVLA RNA-DIRECTED RNA POLYMERASE SACCAROMYCES CEREVISIAE |
| VIRUS L-1 |
| PRRPO-- TACV RNA POLYMERASE TACARIBE VIRUS |
| PRRPO-- TMGMV PUTATIVE RNA-DIR RNA POL TOBACCO MILD GREEN MOSAIC |
| VIRUS (TMV STRAIN U2) |
| PRRPP-- BRSVA RNA POLYMERASE ALPHA SUBUNIT BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN A51908) |
| PRRPP-- CSVO RNA POLYMERASE ALPHA SUBUNIT CANINE DISTEMPER VIRUS |
| (STRAIN ONDERSTEPOORT) |
| PRRPP-- HRSV RNA POLYMERASE ALPHA SUBUNIT HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS |
| PRRPP-- HRSV1 RNA POLYMERASE ALPHA SUBUNIT HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (SUBGROUP |
| B/STRAIN 18537) |
| PRRPP-- HRSVA RNA POLYMERASE ALPHA SUBUNIT HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN A2) |
| PRRPP-- HRSVL RNA POLYMERASE ALPHA SUBUNIT HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS SUBGROUPO |
| A/STRAIN LONG |
| PRRPP-- MEASE RNA POLYMERASE ALPHA SUBUNIT MEASLES VIRUS (STRAIN |
| EDMONSTON) |
| PRRPP-- MEASI RNA POLYMERASE ALPHA SUBUNIT MEASLES VIRUS (STRAIN |
| IP-3-CA) |
| PRRPP-- MEASY RNA POLYMERASE ALPHA SUBUNIT MEASLES VIRUS (STRAIN |
| YAMAGATA-1) |
| PRRPP-- PI1HB RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN C35) |
| PRRPP-- PI1HC RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN C39) |
| PRRPP-- PI1HD RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN CI-5/73) |
| PRRPP-- PI1HE RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN CI-14/83) |
| PRRPP-- PI2H RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 2 |
| VIRUS |
| PRRPP-- PI2HT RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN TOSHIBA) |
| PRRPP-- P13B RNA POLYMERASE ALPHA SUBUNIT BOVINE PARAINFLUENZA 3 |
| VIRUS |
| PRRPP-- P13H4 RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN NIH 47885) |
| PRRPP-- P14HA RNA POLYMERASE ALPHA SUBUNIT HUMAN PARINFLUENZA 4A |
| VIRUS (STRAIN TOSHIBA) |
| PRRPP-- RABVP RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS (STRAIN |
| PV) |
| PRRPP-- SEND5 RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) |
| PRRPP-- SEND6 RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| 6/94) |
| PRRPP-- SENDF RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| FUSHIMI) |
| PRRPP-- SENFH RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| HARRIS) |
| PRRPP-- SENDZ RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN Z) |
| PRRPP-- SV5 RNA POLYMERASE ALPHA SUBUNIT SIMIAN VIRUS 5 (STRAIN |
| W3) |
| PSODC-- VACCV SUPEROXIDE DISMUTASE LIKE PROTEIN VACCINIA VIRUS |
| (STRAIN WR) |
| PSODC-- VARV SUPEROXIDE DISMUTASE LIKE PROTEIN VARIOLA VIRUS |
| PSPHR-- AMEPV SPHEROIDIN AMSACTGA |
| MOOREI ENTOMOPOXVIRUS |
| PSPH-- MYXVL SERPIN 1 MYXOMA VIRUS (STRAIN LAUSANNE) |
| PSP12-- VACCV SERINE PROTEINASE INHIBITOR 2 VACCINIA VIRUS (STRAIN |
| WR) |
| PSPIA-- VACCC SERINE PROTEASE INH 2 HOMOLOG VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PT2C2-- CHVP1 TYPE II RESTICTION ENZYME CVIAII PARMECIUM BURSARIA |
| CHLORELLA VIRUS 1 |
| PTAA2-- VACCV TRANS-ACTIVATOR PROTEIN A2 VACCINIA VIRUS |
| PTAG8-- FOWPV TRANS-ACTIVATOR PROTEIN FP0 FOWLPOX VIRUS |
| PTAG8-- VACCV TRANS-ACTIVATOR PROTEIN GK1 VACCINIA VIRUS |
| PTAG8-- VARV TRANS-ACTIVATOR PROTEIN GK1 VARIOLA VIRUS |
| PTAG8-- BFDV LARGE T ANTIGEN BUDGERJGAR FLEDGLING DISEASE VIRUS |
| PTALA-- POVBO LARGE T ANTIGEN |
| BOVINE POLYOMAVIRUS |
| PTALA-- POVHA LARGE T ANTIGEN HAMSTER POLYOMAVIRUS |
| PTALA-- POVLY LARGE T ANTIGEN LYMPHOTROPIC POLYOMAVIRUS |
| PTALA-- POVM3 LARGE T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN 3) |
| PTALA-- POVMA LARGE T ANTIGEN MOUSE |
| POLYOMAVIRUS (STRAIN A2) |
| PTALA-- POVMC LARGE T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN CRAWFORD |
| SMALL PLAGUE) |
| PTATR-- NPVAC TRANS-ACT TRANS REG PROTEIN AUTOGRAPHA CALIFORNICA |
| NUCLEAR POLYHEDROSIS VIRUS |
| PTATR-- MPVOP TRANS-ACT TRANS REG PROTEIN BOMBYX MORI NUCLEAR |
| POLYHEDROSIS VIRUS |
| PTATR-- NPVOP TRANS-ACT TRANS REG PROTEIN ORGYIA PSEUDOTSUGATA |
| MULTICAPSID POLYHEDROSIS VIRUS |
| PTEGU-- EBV LARGE TEGUMENT PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PTEGU-- HCMVA PROBABLE LARGE TEGUMENT PROTEIN HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PTEGU-- HSV11 LARGE TEGUMENT PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| PTEGU-- HSV6G LARGE TEGUMENT PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) |
| PTEGU-- HSV3B LARGE TEGUMENT PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| PTEGU-- HSVSA PROBABLE LARGE TEGUMENT PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PTEGU-- VZVD LARGE TEGUMENT PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| PTERM-- ADE07 DNA TERMINAL PROTEIN HUMAN ADENOVIRUS TYPE 7 |
| PTMAF-- AVIS4 TRANSFORMING PROTEIN |
| MAF AVIAN MUSCULOAPONEUROTIC FIBROSARCOMA |
| VIRUS AS42 |
| PTOP1-- SFVKA DNA TOPOISOMERASE I SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) |
| PTOP1-- VACCV DNA TOPOISOMERASE I VACCINIA VIRUS |
| PTOP1-- VARV DNA TOPOISOMERASE I VARIOLA VIRUS |
| PTOP2-- ASFM2 DNA TOPOISOMERASE II AFRICAN SWINE FEVER VIRUS |
| (ISOLATE MALAWI LIL 20/1) |
| PTYSY-- HSVAT THYMIDYLATE SYNTHASE HERPESVIRUS ATELES |
| PTYSY-- HSVSA THYMIDYLATE SYNTHASE HERPESVIRUS SAIMIRI (STRAIN 11) |
| PUL06-- EBV VIRION PROTEIN BBRF1 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| PUL06-- HSV11 VIRION PROTEIN UL6 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| PUL06-- HSVEB VIRION GENE 56 PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| PUL06-- HSVSA VIRION GENE 43 PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| PUL08-- HCMVA HYPOTHETICAL PROTEIN UL8 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL11-- EBV HYPOTHETICAL PROTEIN BBLF1 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PUL13-- HCMVA HYPOTHETICAL PROTEIN UL13 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL14-- HSVEB HYPOTHETICAL GENE 48 PROTEIN EQUINE HERPESVIRUS TYPE |
| 1 (STRAIN AB4P) |
| PUL14-- VZVD HYPOTHETICAL GENE 46 PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| PUL16-- HCMVA HYPOTHETICAL PROTEIN UL16 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL20-- HCMVA HYPOTH PRO UL20 PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL21-- HSVEB GENE 40 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) |
| PUL21-- VZVD GENE 38 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| PUL25-- HSVSA VIRION GENE 19 PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| PUL31-- HCMVA HYPOTHETICAL PROTEIN UL31 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL32-- HSVEB MAJOR ENVELOPE GLYCOPROTEIN 300 EQUINE HERPESVIRUS |
| TYPE 1 |
| PUL34-- HSV11 VIRION PROTEIN UL34 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| PUL34-- HSVSA GENE 67 PROTEIN HERPESVIRUS SAIMIRI (STRAIN 11) |
| PUL34-- VZVD VIRION GENE 24 PROTEIN |
| VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| PUL35-- HCMVA HYPOTHETICAL PROTEIN |
| UL35 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PUL37-- HSV11 PROTEIN UL37 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| PUL37-- HSVEB GENE 23 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) |
| PUL37-- HSVSA GENE 63 PROTEIN HERPESVIRUS SAIMIRI (STRAIN 11) |
| PUL37-- VZVD GENE 21 PORTEIN |
| VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| PUL41-- VZVD HOST SHUTOFF VIRION |
| PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| PUL42-- HSV11 DNA-BINDING PROTEIN UL-42 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| PUL43-- VZVD GENE 15 MEMBRANE PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| PUL47-- HCMVA PROTEIN UL47 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PUL47-- HSV11 VIRION PROTEIN UL47 |
| HERPES SIMLEX VIRUS (TYPE 1/STRAIN 17) |
| PUL47-- VSV1F VIRION PROTEIN UL47 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN F) |
| PUL47-- HSVE4 97 KD ALPHA TRANS-INDUCING PROTEIN EQUINE HERPESVIRUS |
| TYPE 4 |
| PUL50-- HCMVA PROTEIN UL50 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PUL52-- EBV PROB DNA REPLICATION |
| PROTEIN BSLF1 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PUL52-- HSVEB DNA REPLICATION PROTEIN UL52 EQUINE HERPESVIRUS TYPE |
| 1 (STRAIN AB4P) |
| PUL52-- HSVSA PROB DNA REP GENE 56 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PUL52-- VZVD PROB DNA REP GENE 6 PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| PUL59-- HCMVA HYPOTHETICAL PROTEIN UL59 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL70-- HCMVA PROB DNA REP PROTEIN UL70 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL73-- HCMVA UL73 GLYCOPROTEIN PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL73-- HSVSA HYPOTHETICAL GENE 53 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PUL74-- HCMVA HYPOTHETICAL PROTEIN UL74 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL87-- EBV HYPOTHETICAL PROTEIN B(C)RF1 EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) |
| PUL87-- HSV6U HYPOTHETICAL PROTEIN 5R HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN UGANDA-1102) |
| PUL87-- HSVSA HYPOTHETICAL GENE 24 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PUL92-- EBV HYPOTHETICAL PROTEIN BDLF4 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PUL92-- HSVSA HYPOTHETICAL GENE 31 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PUL93-- HCMVA PROTEIN UL93 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PUL95-- HCMVA HYPOTHETICAL PROTEIN |
| UL95 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PUL95-- HSV6U HYPOTHETICAL PROTEIN 13R HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN UGANDA-1102) |
| PULA4-- HCMVA VIRION PROTEIN UL104 HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| PULB9-- HCMVA HYPOTHETICAL PROTEIN UL119 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PULD0-- HCMVA HYOTHETICAL PROTEIN UL130 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUNG-- HSVSA URACIL-DNA GLYCOSYLASE HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| PUNG-- SFVKA URACIL-DNA GLYCOSYLASE SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) |
| PUNG-- VACCC URACIL-DNA GLYCOSYLASE VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PUNG-- VACCV URACIL-DNA GLYCOSYLASE VACCINIA VIRUS (STRAIN WR) |
| PUNG-- VARV URACIL-DNA GLYCOSYLASE |
| VARIOLA VIRUS |
| PUS09-- HCMVA HYPOTHETICAL PROTEIN HXLF3 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS14-- HCMVA HYPOTHETICAL PROTEIN HVLF4 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS18-- HCMVA MEMBRANE PROTEIN HWLF5 HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| PV121-- ASFL5 LIS 121-1 PROTEIN AFRICAN SWINE FEVER VIRUS (STRAIN |
| LIS57) |
| PV125-- AMVLE 125 KD PROTEIN ALFALFA MOSAIC VIRUS (STRAIN 425/ISOLA |
| TE LEIDEN) |
| PV137-- ASFL5 LIS 147 PROTEIN AFRICAN SWINE FEVER VIRUS (STRAIN |
| LIS57) |
| PV13K-- TRVPL 16 KD PROTEIN TOBACCO RATTLE VIRUS (STRAIN PLB) |
| PV143-- NPVAC HELICASE AUTOGRAPHA |
| CALIFORNICA NUCLEAR POLYHEDROSIS VIRUS |
| PV16K-- TRVPS 16 KD PROTEIN TOBACCO |
| RATTLE VIRUS (STRAIN PSG) |
| PV1A-- BBMV 1A PROTEIN BROAD BEAN MOTTLE VIRUS |
| PV1A-- BMV 1A PROTEIN BROME MOSAIC VIRUS |
| PV1A-- CCMV 1A PROTEIN COWPEA CHLOROTIC MOTTLE VIRUS |
| PV1A-- CMVFN 1A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN FNY) |
| PV1A-- CMVO 1A PROTEIN CUCUMBER |
| MOSAIC VIRUS (STRAIN O) |
| PV1A-- CMVQ 1A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN O) |
| PV1A-- PSVJ 1A PROTEIN PEANUT STUNT VIRUS (STRAIN J) |
| PV1A-- TAV 1A PROTEIN TOMATO ASPERMY VIRUS |
| PV25K-- NPVAC 25 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| POLYHEDROSIS VIRUS |
| PV29K-- PEBV 29.6 KD PROTEIN PEA EARLY BROWNING VIRUS |
| PV29K-- TRVSY 29 KD PROTEIN TOBACCO RATTLE VIRUS |
| PV29K-- TRVTC 29 KD PROTEIN TOBACCO RATTLE VIRUS (STRAIN TCM) |
| PV2A-- BBMV 2A PROTEIN BROAD BEAN |
| MOTTLE VIRUS |
| PV2A-- CCMV 2A PROTEIN COWPEA CHLOROTIC MOTTLE VIRUS |
| PV2A-- CMVFN 2A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN ENY) |
| PV2A-- PSVJ 2A PROTEIN PEANUT STUNT |
| VIRUS (STRAIN J) |
| PV2A-- TAV 2A PROTEIN TOMATO ASPERMY VIRUS |
| PV30K-- HCMVE 30 KD MAJOR EARLY PROTEIN HUMAN CYTOMEGALOVIRUS |
| (STRAIN EISENHARDT) |
| PV30K-- TRVTC 29.I KD PROTEIN TOBACCO RATTLE CYRUS (STRAIN TCM) |
| PV33P-- ADE41 33 KD PHOSPHOPROTEIN |
| HUMAN ADENOVIRUS TYPE 41 |
| PV362-- ASFB7 K'362 PROTEIN AFRICAN SWINE FEVER VIRUS (STRAIN |
| BA7IV) |
| PV363-- ASFB7 D'363 PROTEIN AFRICAN SWINE FEVER VIRUS (STRAIN |
| BA7IV) |
| PV3A-- BMV 3A PROTEIN BROME MOSAIC VIRUS |
| PV3A-- CMVFN 3A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN ENY) |
| PV3A-- CMVM 3A PROTEIN CUCUMBER |
| MOSAIC VIRUS (STRAIN M) |
| PV3A-- CMVO 3A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN O) |
| PV3A-- CMVY 3A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN Y) |
| PV3A-- IBVB 3A PROTEIN AVAIN INFECTIOUS BRONCHITIS VIRUS (STRAIN |
| BEAUDETTE) |
| PV3A-- IBCU3 3A PROTEIN AVAIN INFECTIOUS BRONCHITIS VIRUS (STRAIN |
| UK/IXI66) |
| PV3B-- IBVB 3B PROTEIN AVAIN INFECTIOUS BRONCHITIS VIRUS (STRAIN |
| BEAUDETTE) |
| PV50K-- BYDVP 50 KD PROTEIN BARLEY YELLOW DWARF VIRUS (ISOLATE |
| PAV) |
| PV51K-- BWYVF 51 KD PROTEIN BEET WESTERN YELLOWS VIRUS (ISOLATE |
| FLI) |
| PV51K-- BWYVG 51 KD PROTEIN BEET WESTERN YELLOWS VIRUS (ISOLATE |
| GBI) |
| PV56K-- PLRVI 56 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN I) |
| PV56K-- PLRVW 56 KD PROTEIN POTATO |
| LEAFROLL VIRUS (STRAIN WAGENINGEN) |
| PV58K-- BSMV 58 KD PROTEIN BARLEY |
| STRIPE MOSAIC VIRUS |
| PV70K-- PLRVI 69 7 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN I) |
| PV70K-- PLRVW 69 7 KD PROTEIN |
| POTATO LEAFROLL VIRUS (STRAIN WAGENINGEN) |
| PV90K-- AMVLE 90 KD PROTEIN ALFALFA MOSAIC VIRUS (STRAIN 425/ISOLAT |
| E LEIDEN) |
| PVA06-- VACCC PROTEIN A6 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA06-- VACCV PROTEIN A6 VACCINIA |
| VIRUS (STRAIN WR) |
| PVA06-- VARV PROTEIN A6 VARIOLA VIRUS |
| PVA08-- VACCC PROTEIN A8 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA08-- VARV PROTEIN A8 VARIOLA |
| VIRUS |
| PVA09-- VARV PROTEIN A9 VARIOLA VIRUS |
| PVA11-- VACCC PROTEIN A11 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA11-- VARV PROTEIN A11 VARIOLA |
| VIRUS |
| PVA18-- VARV 56 KD ABORTIVE LATE PROTEIN VARIOLA VIRUS |
| PVA20-- VACCC PROTEIN A20 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA20-- VARV PROTEIN A20 VARIOLA |
| VIRUS |
| PVA22-- VACCC PROTEIN A22 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA22-- VARV PROTEIN A22 VARIOLA |
| VIRUS |
| PVA23-- VACCC PROTEIN A23 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA23-- VARV PROTEIN A23 VARIOLA |
| VIRUS |
| PVA28-- VACCC PROTEIN A28 VACCINIA VIRUS (STRAIN WR) |
| PVA28-- VARV PROTEIN A28 VARIOLA VIRUS |
| PVA30-- VACCC PROTEIN A30 VACCINIA VIRUS (STRAIN WR) |
| PVA31-- VACCC PROTEIN A31 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA31-- VARV PROTEIN A31 VARIOLA |
| VIRUS |
| PVA34-- VACCC PROTEIN A34 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA34-- VACCC PROTEIN A34 VACCINIA |
| VIRUS (STRAIN WR) |
| PVA34-- VARV PROTEIN A34 VARIOLA VIRUS |
| PVA36-- VACCC PROTEIN A36 PRECURSOR VACCINIA VIRUS (STRAIN WR) |
| PVA36-- VARV PROTEIN A36 PRECURSOR |
| VARIOLA VIRUS |
| PVA38-- VACCC PROTEIN A38 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA38-- VACCV PROTEIN A38 VACCINIA |
| VIRUS (STRAIN WR) |
| PVA38-- VARV PROTEIN A38 VARIOLA VIRUS |
| PVA39-- VACCC PROTEIN A39 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA39-- VACCV PROTEIN A39 VACCINIA |
| VIRUS (STRAIN WR) |
| PVA43-- VACCC PROTEIN A43 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA43-- VACCV PROTEIN A43 VACCINIA |
| VIRUS (STRAIN WR) |
| PVA43-- VARV PROTEIN A43 VARIOLA VIRUS |
| PVA47-- VACCC PROTEIN A47 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA47-- VACCV PROTEIN A47 VACCINIA |
| VIRUS (STRAIN WR) |
| PVA47-- VARV PROTEIN A47 VARIOLA VIRUS |
| PVA49-- VACCC PROTEIN A49 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA49-- VACCV PROTEIN A49 VACCINIA |
| VIRUS (STRAIN WR) |
| PVA49-- VARV PROTEIN A49 VARIOLA VIRUS |
| PVA55-- VACCC PROTEIN A55 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA55-- VACCV PROTEIN A55 VACCINIA |
| VIRUS (STRAIN WR) |
| PVAL1-- BCTV AL1 PROTEIN BEET CURLY TOP VIRUS |
| PVAL3-- CLVK AL3 PROTEIN CASSAVA LATENT VIRUS (STRAIN WEST KENYAN |
| 844) |
| PVAL3-- CLVN AL3 PROTEIN CASSAVA LATENT VIRUS (STRAIN NIGERIAN) |
| PVAL3-- SLVN AL3 PROTEIN SQUASH |
| LEAF CURL VIRUS |
| PVAL3-- TYLCV AL3 PROTEIN TOMATO YELLOW LEAF CURL VIRUS |
| PVAT-- CAMVC APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN CM-1841) |
| PVAT-- CAMVD APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN D/H) |
| PVAT-- CAMVE APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN BBC) |
| PVAT-- CAMVN APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN NY8153) |
| PVAT-- CAMVP APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN PV147) |
| PVAT-- CAMVS APHID TRANSMISSION PROTEIN |
| PVAT-- CAMVW APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN W260) |
| PVAT-- CERV APHID TRANSMISSION PROTEIN CARNATION ETCHED RING VIRUS |
| PVB03-- FMVD APHID TRANSMISSION PROTEIN FIGWORT MOSAIC VIRUS |
| (STRAIN DXS) |
| PVB04-- VACCV PROTEIN B3 VACCINIA VIRUS (STRAIN WR) |
| PVB04-- VACCC PROTEIN B4 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVB04-- VACCV PROTEIN B4 VACCINIA |
| VIRUS (STRAIN WR) |
| PVB04-- VARV PROTEIN B4 VARIOLA VIRUS |
| PVB05-- VACC0 PLAQUE-SIZE/HOST RANGE PRO PREC VACCINIA VIRUS |
| (STRAIN LC16MO) |
| PVB05-- VACCC PLAQUE-SIZE/HOST RANGE PRO PREC VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| PVB05-- VACCL PLAQUE-SIZE/HOST RANGE PRO PREC VACCINIA VIRUS |
| (STRAIN LISTER) |
| PVB05-- VACCV PLAQUE-SIZE/HOST RANGE PRO PREC VACCINIA VIRUS |
| (STRAIN WR) |
| PVB07-- VACCV PROTEIN B7 PRECURSOR VACCINIA VIRUS (STRAIN WR) |
| PVB08-- VACCC PROTEIN B8 PRECURSOR |
| VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVB08-- VACCV PROTEIN B8 PRECURSOR |
| VACCINIA VIRUS (STRAIN WR) |
| PVB11-- VACCC PROTEIN B11 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVB11-- VACCV PROTEIN B11 VACCINIA |
| VIRUS (STRAIN WR) |
| PVB16-- COWPX IL-1 BIND PRO PRECURSOR COWPOX VIRUS |
| PVB17-- VACCC PROTEIN B17 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVB17-- VACCV PROTEIN B17 VACCINIA |
| VIRUS (STRAIN WR) |
| PVB18-- VACCC PROTEIN B18 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVB18-- VACCV PROTEIN B18 VACCINIA |
| VIRUS (STRAIN WR) |
| PVB18-- VARV PROTEIN B18 VARIOLA VIRUS |
| PVB19-- VACCC SURFACE ANTIGEN S PRECURSOR VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PVB19-- VACCD SURFACE ANTIGEN S PRECURSOR VACCINIA VIRUS (STRAIN |
| DAIREN I) |
| PVB19-- VACCV SURFACE ANTIGEN S PRECURSOR VACCINIA VIRUS (STRAIN |
| WR) |
| PVB19-- VARV SURFACE ANTIGEN S PRECURSOR VARIOLA VIRUS |
| PVB20-- VACCC PROTEIN B20 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVB21-- VACCV PROTEIN B21 VACCINIA |
| VIRUS (STRAIN WR) |
| PVBLI-- BGMV BL1 PROTEIN BEAN GOLDEN MOSAIC VIRUS |
| PVBLI-- CLVK BL1 PROTEIN CASSAVA LATENT VIRUS (STRAIN WEST KENYAN |
| 844) |
| PVBLI-- CLVN BL1 PROTEIN CASSAVA LATENT VIRUS (STRAIN NIGERIAN) |
| PVBLI-- PYMVV BL1 PROTEIN POTATO |
| YELLOW MOSAIC VIRUS (ISOLATE VENEZUELA) |
| PVC02-- VACCC PROTEIN C2 VACCINIA |
| VIRUS (STRAIN COPENHAGEN) |
| PVC02-- VACCV PROTEIN C2 VACCINIA VIRUS (STRAIN WR) |
| PVC04-- SFVKA PROTEIN C4 SHOPE FIBROMA VIRUS (STRAIN KASZA) |
| PVC04-- VACCC PROTEIN C4 VACCINIA |
| VIRUS (STRAIN COPENHAGEN) |
| PVC04-- VACCV PROTEIN C4 VACCINIA VIRUS (STRAIN WR) |
| PVC04-- VARV PROTEIN C4 VARIOLA VIRUS |
| PVC05-- SFVKA HYPOTHETICAL PROTEIN C5 SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) |
| PVC05-- VACCC PROTEIN C5 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC05-- VACCV PROTEIN C5 VACCINIA |
| VIRUS (STRAIN WR) |
| PVC05-- VARV PROTEIN C5 VARIOLA VIRUS |
| PVC07-- VACCV PROTEIN C7 VACCINIA VIRUS (STRAIN WR) |
| PVC07-- VARV PROTEIN C7 VARIOLA VIRUS |
| PVC09-- VACCV PROTEIN C9 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC09-- VACCC PROTEIN C9 VACCINIA |
| VIRUS (STRAIN WR) |
| PVC10-- VACCC PROTEIN C10 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC10-- VACCV PROTEIN C10 VACCINIA |
| VIRUS (STRAIN WR) |
| PVC10-- VARV PROTEIN C10 VARIOLA VIRUS |
| PVC13-- SFVKA PROTEIN C13 SHOPE FIBROMA VIRUS (STRAIN KASZA) |
| PVC17-- VACCC PROTEIN C17/B23 |
| VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC18-- VACCC PROTEIN C18/B24 |
| VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC19-- SFVKA PROTEIN C19 SHOPE |
| FIBROMA VIRUS (STRAIN KASZA) |
| PVC20-- VACCC PROTEIN C20/B26 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC22-- VARV PROTEIN C22/B28 |
| HOMOLOG VARIOLA VIRUS |
| PVCAP-- EBV MAJOR CAPSID PROTEIN EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| PVCAP-- HSV6U MAJOR CAPSID PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN UGANDA-1102) |
| PVCAP-- HSVSA MAJOR CAPSID PROTEIN HERPES VIRUS SAIMIRI (STRAIN |
| 11) |
| PVCG3-- NPVAC DNA-BINDING PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| POLYHEDROSIS VIRUS |
| PVCOM-- ADE02 MINOR CORE PROTEIN HUMAN ADENAVIRUS TYPE 2 |
| PVCOM-- ADE05 MINOR CORE PROTEIN HUMAN ADENAVIRUS TYPE 5 |
| PVD05-- FOWP1 92.6 KD PROTEIN FOWLPOX VIRUS (STRAIN FP-1) |
| PVD05-- VACCC PROTEIN D5 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVD05-- VACCV PROTEIN D5 VACCINIA |
| VIRUS (STRAIN WR) |
| PVD05-- VARV PROTEIN D5 VARIOLA VIRUS |
| PVD09-- VACCC PROTEIN D9 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVD09-- VACCV PROTEIN D9 VACCINIA |
| VIRUS (STRAIN WR) |
| PVD09-- VARV PROTEIN D9 VARIOLA VIRUS |
| PVD10-- SFVKA PROTEIN D10 SHOPE FIBROMA VIRUS (STRAIN KASZA) |
| PVDBP-- CERV DNA-BINDING PROTEIN |
| CARNATION ETCHED RING VIRUS |
| PVE02-- VARV PROTEIN E2 VARIOLA VIRUS |
| PVE06-- VACCC PROTEIN E6 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVE06-- VACCV PROTEIN E6 VACCINIA |
| VIRUS (STRAIN WR) |
| PVE06-- VARV PROTEIN E6 VARIOLA VIRUS |
| PVE1-- HPV18 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 18 |
| PVE1-- HPV2A E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 2A |
| PVE1-- HPV33 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 33 |
| PVE1-- HPV39 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 39 |
| PVE1-- HPV41 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 |
| PVE1-- HPV42 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 42 |
| PVE1-- HPV47 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 47 |
| PVE1-- HPV57 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 57 |
| PVE26-- NPVAC EARLY 25.9 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| POLYHEDROSIS VIRUS |
| PVE2-- CRPVK PROBABLE E2 PROTEIN COTTONTAIL RABBIT (SHOPE) |
| PAPILLOMAVIRUS |
| (STRAIN KANSAS) |
| PVE2-- HPV05 PROBABLE E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5 |
| PVE2-- HPV13 E2 PROTEIN HUMAN |
| PAPILLOMAVIRUS TYPE 13 |
| PVE2-- HPV16 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 16 |
| PVE2-- HPV18 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 18 |
| PVE2-- HPV1A E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 1A |
| PVE2-- HPV2A E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 2A |
| PVE2-- HPV33 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 33 |
| PVE2-- HPV35 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 35 |
| PVE2-- HPV39 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 39 |
| PVE2-- HPV47 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 47 |
| PVE2-- HPV51 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 51 |
| PVE2-- HPV57 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 57 |
| PVE2-- HPV58 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 58 |
| PVE2-- HPV5B PROBABLE E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5B |
| PVE2-- PAPVE PROBABLE E2 PROTEIN |
| EUROPEAN ELK PAPILLOMAVIRUS |
| PVE2-- PCPV1 E2 PROTEIN PYGMY CHIMPANZEE PAPILLOMAVIRUS TYPE I |
| PVE4-- HPV05 PROBABLE E4 PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 5 |
| PVE4-- HPV11 PROBABLE E4 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 11 |
| PVE4-- HPV16 PROBABLE E4 PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 16 |
| PVE4-- HPV18 PROBABLE E4 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 18 |
| PVE4-- HPV31 PROBABLE E4 PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 31 |
| PVE4-- HPV41 PROBABLE E4 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 |
| PVE4-- HPV5B PROBABLE E4 PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 5B |
| PVE5A-- HPV11 PROBABLE E5A PROTEIN HUMAN PAPILLOMAVIRUS TYPE 11 |
| PVE5A-- HPV6B PROBABLE E5A PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 6B |
| PVE5A-- HPV6C PROBABLE E5A PROTEIN HUMAN PAPILLOMAVIRUS TYPE 6C |
| PVE5-- HPV35 PROBABLE E5 PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 35 |
| PVE5-- HPV5B PROBABLE E5 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5B |
| PVE5-- PCPV1 PROBABLE E5 PROTEIN |
| PYGMY CHIMPANZEE PAPILLOMAVIRUS TYPE I |
| PVE6-- HPV18 E6 PROTEIN HUMAN |
| PAPILLOMAVIRUS TYPE 18 |
| PVE6-- HPV31 E6 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 31 |
| PVE6-- HPV39 E6 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 39 |
| PVE6-- HPV41 E6 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 |
| PVE6-- HPV45 E6 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 45 |
| PVE6-- HPV51 E6 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 51 |
| PVE6-- HPVME E6 PROTEIN HUMAN PAPILLOMAVIRUS TYPE ME180 |
| PVE94-- NPVAC EARLY 94 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR |
| POLYHEDROSIS VIRUS |
| PVEF-- GVTN VIRAL ENHANCING FACTOR TRICHOPLUSIA NI GRANULOSIS |
| VIRUS |
| PVENV-- DHV11 ENVELOPE GLYCOPROTEIN PRECURSOR DHORI VIRUS (STRAIN |
| INDIAN/1313/61) |
| PVENV-- EAV PROBABLE ENVELOPE PROTEIN EQUINE ARTERITIS VIRUS |
| PVENV-- THOGV ENVELOPE GLYCOPROTEIN |
| PRECURSOR THOGOTO VIRUS |
| PVF03-- VACCC PROTEIN F3 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVF03-- VACCV PROTEIN F3 VACCINIA |
| VIRUS (STRAIN WR) |
| PVF05-- VACCP 36 KD MAJOR MEMBRANE PRO PRECURSOR VACCINIA VIRUS |
| (STRAIN L-IVP) |
| PVF05-- VACCV 36 KD MAJOR MEMBRANE PRO PRECURSOR VARIOLA VIRUS |
| PVF06-- VARV PROTEIN F6 VACCINIA |
| VIRUS (STRAIN COPENHAGEN) |
| PVF11-- VACCC PROTEIN F11 VACCINIA VIRUS (STRAIN L-IVP) |
| PVF11-- VACCP PROTEIN F11 VARIOLA VIRUS |
| PVF11-- VARV PROTEIN F11 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVF12-- VACCC PROTEIN F12 VACCINIA |
| VIRUS (STRAIN L-IVP) |
| PVF12-- VACCP PROTEIN F12 VARIOLA VIRUS |
| PVF12-- VARV PROTEIN F12 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVF16-- VACCC PROTEIN F16 VACCINIA |
| VIRUS (STRAIN L-IVP) |
| PVF16-- VACCP PROTEIN F16 VARIOLA VIRUS |
| PVF16-- VARV PROTEIN F16 FOWLPOX VIRUS |
| PVF16-- FOWPV PROTEIN FP4 ORF VIRUS (STRAIN NZ2) |
| PVFUS-- ORFNZ 10 KD FUSION PROTEIN VACCINIA VIRUS (STRAIN COPENHAGE |
| N) |
| PVFUS-- VACCC 14 KD FUSION PROTEIN VACCINIA VIRUS (STRAIN WR) |
| PVFUS-- VACCV KD FUSION PROTEIN |
| VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVG01-- VACCC PROTEIN G1 VACCINIA |
| VIRUS (STRAIN COPENHAGEN) |
| PVG01-- VACCV PROTEIN G1 VACCINIA VIRUS (STRAIN WR) |
| PVG01-- VARV PROTEIN G1 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVG02-- VACCV ISATIN-B-TSC DEP |
| PROTEIN VACCINIA VIRUS (STRAIN WR) |
| PVG02-- VARV ISATIN-B-TSC DEP |
| PROTEIN VARIOLA VIRUS |
| PVG03-- HSVEB GENE 3 PROTEIN EQUINE HERPES VIRUS TYPE 1 (STRAIN |
| AN4P) |
| PVG03-- HSVEK GENE 3 PROTEIN EQUINE HERPES VIRUS TYPE 1 (STRAIN |
| KENTUCKY A) |
| PVG05-- VACCC PROTEIN G5 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVG05-- VARV PROTEIN G5 VARIOLA |
| VIRUS |
| PVG07-- HSV11 HYPOTH GENE 7 MEMB PRO ICTALURID HERPES VIRUS I |
| PVG09-- VACCC PROTEIN F1 VACCINIA |
| VIRUS (STRAIN COPENHAGEN) |
| PVG09-- VACCV PROTEIN F1 VACCINIA VIRUS (STRAIN WR) |
| PVG09-- VARV PROTEIN F1 VARIOLA VIRUS |
| PVG12-- SPVIR GENE 12 PROTEIN SPIROPLASMA VIRUS SPV1-RRA2 B |
| PVG17-- HSV11 HYPOTHETICAL GENE 17 |
| PROTEIN ICTALURID HERPES VIRUS I |
| PVG18-- HSV11 HYPOTHETICAL GENE 18 |
| PROTEIN ICTALURID HERPES VIRUS I |
| PVG1-- SPVIR CAPSID 2 PROTEIN |
| SPIROPLASMA VIRUS SPV1-R8A2 B |
| PVG1-- SPV4 CAPSID 2 PROTEIN SPIROPLASMA VIRUS 4 |
| PVG22-- HSV11 HYPOTHETICAL GENE 22 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG24-- HSV11 HYPOTHETICAL GENE 24 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG28-- HSV11 HYPOTHETICAL GENE 28 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG2R-- AMEPV HYPOTHETICAL G2R PROTEIN AMSACTA MOOREI ENTOMOPOXVIR |
| US |
| PVG2-- SPVIR GENE 2 PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B |
| PVG2-- SPV4 GENE 2 PROTEIN |
| SPIROPLASMA VIRUS 4 |
| PVG34-- HSV11 HYPOTHETICAL GENE 34 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG37-- HSV11 HYPOTHETICAL GENE 37 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG39-- HSV11 HYPOTHETICAL GENE 39 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG3L-- AMEPV HYPOTHETICAL G3L PROTEIN AMSACTA MOOREI ENTOMOPOXVIR |
| US |
| PVG3-- SPVIR GENE 3 PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B |
| PVG3-- SPV4 GENE 3 PROTEIN |
| SPIROPLASMA VIRUS 4 |
| PVG45-- HSVSA HYPOTHETICAL GENE 45 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN II) |
| PVG46-- HSV11 PROBABLE MAJOR GLYCOPROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG48-- HSVSA HYPOTHETICAL GENE 48 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN II) |
| PVG4R-- AMEPV G4R PROTEIN AMSACTA MOOREI ENTOMOPOXVIRUS |
| PVG4-- SPVIR GENE PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B |
| PVG51-- HSV11 HYPOTH GENE 51 MEMBRANE PROTEIN ICTALURID HERPES |
| VIRUS I |
| PVG52-- HSVSA HYPOTHETICAL GENE 52 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN II) |
| PVG56-- HSV11 HYPOTHETICAL GENE 56 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG5-- SPVIR GENE 5 PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B |
| PVG5-- SPV4 GENE 5 PROTEIN |
| SPIROPLASMA VIRUS 4 |
| PVG63-- HSV11 HYPOTHETICAL GENE 63 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG64-- HSV11 HYPOTHETICAL GENE 64 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG65-- HSV11 HYPOTHETICAL GENE 65 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG66-- HSV11 HYPOTHETICAL GENE 66 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG67-- HSV11 HYPOTHETICAL GENE 67 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG68-- HSV11 HYPOTHETICAL GENE 68 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG72-- HSV11 HYPOTHETICAL GENE 72 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG75-- HSV11 HYPOTHETICAL GENE 75 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG76-- HSV11 HYPOTHETICAL GENE 76 PROTEIN ICTALURID HERPES VIRUS |
| I |
| PVG7-- SPV4 GENE 7 PROTEIN SPIROPLASMA VIRUS 4 |
| PVGF1-- IBVB F1 PROTEIN ANAIN INFECTIOUS BRONCHITIS VIRUS |
| PVGL2-- CVBF E2 GLYCOPROTEIN |
| PRECURSOR BOVINE CORONA VIRUS (STRAIN |
| F15) |
| PVGL2-- CVBL9 E2 GLYCOPROTEIN PRECURSOR BOVINE CORONA VIRUS |
| (STRAIN L9) |
| PVGL2-- CVBLY E2 GLYCOPROTEIN PRECURSOR BOVINE CORONA VIRUS |
| (STRAIN LY-138) |
| PVGL2-- CVBM E2 GLYCOPROTEIN PRECURSOR BOVINE CORONA VIRUS |
| (STRAIN MEBUS) |
| PVGL2-- CVBQ E2 GLYCOPROTEIN PRECURSOR BOVINE CORONA VIRUS |
| (STRAIN QUEBEC) |
| PVGL2-- CVBV E2 GLYCOPROTEIN PRECURSOR BOVINE CORONA VIRUS |
| (STRAIN VACCINE) |
| PVGL2-- CVH22 E2 GLYCOPROTEIN PRECURSOR HUMAN CORONA VIRUS |
| (STRAIN 229E) |
| PVGL2-- CVM4 E2 GLYCOPROTEIN PRECURSOR MURINE CORONA VIRUS MHV |
| (STRAIN WILD TYPE 4) |
| PVGL2-- CVMA5 E2 GLYCOPROTEIN PRECURSOR MURINE CORONA VIRUS MHV |
| (STRAIN A59) |
| PVGL2-- CVMJC E2 GLYCOPROTEIN PRECURSOR MURINE CORONA VIRUS MHV |
| (STRAIN JHMV/VARIANT CL-2) |
| PVGL2-- CVMJH E2 GLYCOPROTEIN PRECURSOR MURINE CORONA VIRUS MHV |
| (STRAIN WILD JHM) |
| PVGL2-- CVPFS E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS CORONAVIRUS |
| (STRAIN FS7772/ |
| PVGL2-- CVPM1 E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS CORONAVIRUS |
| (STRAIN MILLE |
| PVGL2-- CVPPR E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS CORONAVIRUS |
| (STRAIN PUR46 |
| PVGL2-- CVPPU E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS CORONAVIRUS |
| (STRAIN PURD |
| PVGL2-- CVPR8 E2 GLYCOPROTEIN PRECURSOR PORCINE RESPIRATORY |
| CORONAVIRUS (STRAIN |
| 86/137004/BRITISH ISOLAT |
| PVGL2-- CVPRM E2 GLYCOPROTEIN PRECURSOR PORCINE RESPIRATORY |
| CORONAVIRUS (STRAIN RM4) |
| PVGL2-- CVPRT E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS CORONAVIRUS |
| (STRAIN NEB72 |
| PVGL2-- EBV PROBABLE MEMBRANE GLYCOPROTEIN EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) |
| PVGL2-- FIPV E2 GLYCOPROTEIN PRECURSOR FELINE INFECTIOUS PERITONITI |
| S VIRUS (STRAIN 79-1146) |
| PVGL2-- IBV6 E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS |
| VIRUS (STRAIN 6/82) |
| PVGL2-- IBVB E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS |
| VIRUS (STRAIN BEAUDETTE) |
| PVGL2-- IBVD2 E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS |
| VIRUS (STRAIN D274) |
| PVGL2-- IBVK E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS |
| VIRUS (STRAIN KB8523) |
| PVGL2-- IBVM E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS |
| VIRUS (STRAIN M41) |
| PVGLB-- EBV GLYCOPROTEIN GP110 PRECURSOR EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) |
| PVGLB-- HCMVA GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVGLB-- HCMVT GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN TOWNE) |
| PVGLB-- HSVB1 GLYCOPROTEIN 1 PRECURSOR BOVINE HERPESVIURS TYPE 1 |
| PVGLB-- HSVB2 GLYCOPROTEIN B-1 |
| PRECURSOR BOVINE HERPESVIURS TYPE 2 |
| (STRAIN TOWNE) |
| PVGLB-- HSVE1 GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (ISOLATE HVS25A) |
| PVGLB-- HSVE4 GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 4 |
| PVGLB-- HSVEA GLYCOPROTEIN B |
| PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AV1) |
| PVGLB-- HSVEB GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| PVGLB-- HSVEL GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN KENTUCKY D) |
| PVGLB-- HSVMD GLYCOPROTEIN B PRECURSOR MAREK'S DISEASE HERPESVIRUS |
| (STRAIN RB-1B) |
| PVGLB-- MCMVS GLYCOPROTEIN B PRECURSOR MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) |
| PVGLC-- HSV11 GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| PVGLC-- HSVIK GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN KOS) |
| PVGLC-- HSVEB GLYCOPROTEIN C PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| PVGLC-- VZVD GLYCOPROTEIN GPV |
| VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| PVGLC-- VZVS GLYCOPROTEIN GPV |
| VARICELLA-ZOSTER VIRUS (STRAIN SCOTT) |
| PVGLE-- HSV2 GLYCOPROTEIN E |
| PRECURSOR HERPES SIMPLEX VIRUS (TYPE 2) |
| PVGLF-- BRSVA FUSION GLYCOPROTEIN |
| PRECURSOR BOVINE RESPIRATORY SYNCYTIAL |
| VIRUS (STRAIN 51908) |
| PVGLF-- BRSVC FUSION GLYCOPROTEIN PRECURSOR BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN |
| COPENHAGEN) |
| PVGLF-- BRSVR FUSION GLYCOPROTEIN PRECURSOR BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN RB94) |
| PVGLF-- CDVO FUSION GLYCOPROTEIN PRECURSOR CANINE DISTEMPER VIRUS |
| (STRAIN ONDERSTEPOORT) |
| PVGLF-- HRSV1 FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (SUBGROUP |
| B/STRAIN 18537) |
| PVGLF-- HRSVA FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN A2) |
| PVGLF-- HRSVL FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (SUBGROUP |
| B/STRAIN LONG) |
| PVGLF-- HRSVR FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN RSS-2) |
| PVGLF-- MEASE FUSION GLYCOPROTEIN PRECURSOR MEASLES VIRUS (STRAINS |
| EDMONSTON AND HALLE) |
| PVGLF-- MEASI FUSION GLYCOPROTEIN PRECURSOR MEASLES VIRUS (STRAIN |
| IP-3-CA) |
| PVGLF-- MEASY FUSION GLYCOPROTEIN PRECURSOR MEASLES VIRUS (STRAIN |
| YAMAGATA-1) |
| PVGLF-- MUMP1 FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| SBL-1) |
| PVGLF-- MUMPM FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) |
| PVGLF-- MUMPR FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| RW) |
| PVGLF-- MUMPS FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| SBL) |
| PVGLF-- NDVA FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN |
| AUSTRALIA-VICTORIA/32) |
| PVGLF-- NDVB FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN |
| BEAUDETTE C/45) |
| PVGLF-- NDVH3 FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN |
| HER/33) |
| PVGLF-- NDVH4 FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN B1-HITCHNER/47) |
| PVGLF-- NDVI FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN ITALIEN/45) |
| PVGLF-- NDVL FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN LAS/46) |
| PVGLF-- NDVM FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN MIYADERA/51) |
| PVGLF-- NDVQ FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN QUEENSLAND/66) |
| PVGLF-- NDVT FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN TEXAS) |
| PVGLF-- NDVTG FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE |
| VIRUS (STRAIN TEXAS G.B./48) |
| PVGLF-- NDVU FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN ULSTER/67) |
| PVGLF-- PHODV FUSION GLYCOPROTEIN PRECURSOR PHOCINE DISTEMPER |
| VIRUS |
| PVGLF-- PI1HC FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN C39) |
| PVGLF-- PI1H FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 2 |
| VIRUS |
| PVGLF-- PI2HG FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN GREER) |
| PVGLF-- PI2HT FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN TOSHIBA) |
| PVGLF-- PI3B FUSION GLYCOPROTEIN PRECURSOR BOVINE PARAINFLUENZA 3 |
| VIRUS |
| PVGLF-- PI3H4 FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN NIH 47885) |
| PVGLF-- RINDK FUSION GLYCOPROTEIN PRECURSOR RINDERPEST VIRUS |
| (STRAIN KABETE O) |
| PVGLF-- RINDL FUSION GLYCOPROTEIN PRECURSOR RINDERPEST VIRUS |
| (STRAIN L) |
| PVGLF-- SEND5 FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) |
| PVGLF-- SENDF FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| FUSHIMI) |
| PVGLF-- SENDH FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| HARRIS) |
| PVGLF-- SENDJ FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| HVJ) |
| PVGLF-- SENDZ FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| Z) |
| PVGLF-- SV41 FUSION GLYCOPROTEIN PRECURSOR SIMIAN VIRUS 41 |
| PVGLF-- SV5 FUSION GLYCOPROTEIN |
| PRECURSOR SIMIAN VIRUS 5 (STRAIN W3) |
| PVGLF-- TRTV FUSION GLYCOPROTEIN |
| PRECURSOR TURKEY RHINOTRACHEITIS VIRUS |
| PVGLG-- BEPV SPIKE GLYCOPROTEIN |
| PRECURSOR BOVINE EPHEMERAL FEVER VIRUS |
| PVGLG-- BRSVC MAJOR SURFACE |
| GLYCOPROTEIN G BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN |
| COPENHAGEN) |
| PVGLG-- HRSV1 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (SUBGROUP |
| 13/STRAIN 18537) |
| PVGLG-- HRSV4 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN RSB5857) |
| PVGLG-- HRSV5 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN KSB6190) |
| PVGLG-- HRSV8 MAJOR SURFACE GLYCOPROTEIN G HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS (SUBGROUP |
| B/STRAIN 8/60) |
| PVGLG-- HSVE4 GLYCOPROTEIN G PRECURSOR EQUINE HERPESVIRUS TYPE 4 |
| PVGLG-- HSVEB GLYCOPROTEIN G |
| PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| PVGLG-- RABYT SPIKE GLYCOPROTEIN PRECURSOR RABIES VIRUS (STRAIN |
| STREET) |
| PVGLG-- VSVIG SPIKE GLYCOPROTEIN PRECURSOR VESICULAR STOMATITIS |
| VIRUS (SEROTYPE |
| INDIANA/STRAIN GLASGOW) |
| PVGLH-- EBV GLYCOPROTEIN GP85 PRECURSOR EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PVGLH-- HCMVA GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVGLH-- HCCMVT GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN TOWNE) |
| PVGLH-- HSV6G GLYCOPROTEIN H PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) |
| PVGLH-- HSVSA GLYCOPROTEIN H PRECURSOR HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| PVGLI-- HCMVA IE GLYCOPROTEIN PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVGLM-- BUNGE M POLYPROTEIN PRECURSOR BUNYAVIRUS GERMISTON |
| PVGLM-- BUNL7 M POLYPROTEIN |
| PRECURSOR BUNYAVIRUS LA CROSSE (ISOLATE |
| L74) |
| PVGLM-- BUNYW M POLYPROTEIN PRECURSOR BUNYAMWERA VIRUS |
| PVGLM-- DUGBV M POLYPROTEIN PRECURSOR DUGBE VIRUS |
| PVGLM-- HANTV M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN B-1) |
| PVGLM-- HANTH M POLYPROTEIN |
| PRECURSOR HANTAAN VIRUS (STRAIN HOJO) |
| PVGLM-- HANTL M POLYPROTEIN |
| PRECURSOR HANTAAN VIRUS (STRAIN LEE) |
| PVGLM-- HANTV M POLYPROTEIN |
| PRECURSOR HANTAAN VIRUS (STRAIN 76-118) |
| PVGLM-- INSV M POLYPROTEIN PRECURSOR |
| IMPATIENS NECROTIC SPOT VIRUS |
| PVGLM-- PHV M POLYPROTEIN PRECURSOR PROSPECT HILL VIRUS |
| PVGLM-- PUUMH M POLYPROTEIN PRECURSOR PUUMALA VIRUS (STRAIN |
| HALLNAS B1) |
| PVGLM-- PUUMS M POLYPROTEIN PRECURSOR PUUMALA VIRUS (STRAIN |
| SOTKAMO) |
| PVGLM-- SEOU8 M POLYPROTEIN PRECURSOR SEOUL VIRUS (STRAIN 80-39) |
| PVGLM-- SEOUR M POLYPROTEIN |
| PRECURSOR SEOUL VIRUS (STRAIN R22) |
| PVGLM-- SEOUS M POLYPROTEIN |
| PRECURSOR SEOUL VIRUS (STRAIN SR-11) |
| PVGLN-- BEFV NONSTRUCT GLYCOPRO GNS |
| PRECURSOR BOVINE EPHEMERAL FEVER VIRUS |
| PVGLP-- BEV PEPLOMER GLYCOPROTEIN |
| PRECURSOR BERNE VIRUS |
| PVGLY-- JUNIN GLYCOPROTEIN POLYPROTEIN PRECURSOR JUNIN ARENA VIRUS |
| PVGLY-- LASSG GLYCOPROTEIN POLYPROTEIN PRECURSOR LASSA VIRUS |
| (STRAIN GA391) |
| PVGLY-- MOPEI GLYCOPROTEIN POLYPROTEIN PRECURSOR MOPEIA VIRUS |
| PVGLY-- PIARV GLYCOPROTEIN POLYPROTE |
| IN PRECURSOR PICHINDE ARENA VIRUS |
| PVGLY-- TACV GLYCOPROTEIN POLYPROTEI |
| N PRECURSOR TACARIBE VIRUS |
| PVGLY-- TACV5 GLYCOPROTEIN POLYPROTEIN PRECURSOR TACARIBE VIRUS |
| (STRAIN V5) |
| PVGLY-- TACV7 GLYCOPROTEIN POLYPROTEIN PRECURSOR TACARBIE VIRUS |
| (STRAIN V7) |
| PVGLY-- TACVT GLYCOPROTEIN POLYPROTEIN PRECURSOR TACARBIE VIRUS |
| (STRAIN TRVL 11598) |
| PVGNM-- CPMV GENOME POLYPROTEIN M COWPEA SEVERE MOSAIC VIRUS |
| (STRAIN DG) |
| PVGP8-- EBV PROBABLE MEMBRANE ANTIGEN GP85 EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) |
| PVGP-- EBOV STRUCTURAL GLYCOPROTEIN PRECURSOR EBOLA VIRUS |
| PVGP-- MABVM STRUCTURAL GLYCOPROTEIN PRECURSOR MARBURG VIRUS |
| (STRAIN MUSOKE) |
| PVGP-- MABVP STRUCTURAL GLYCOPROTEIN PRECURSOR MARBURG VIRUS |
| (STRAIN POPP) |
| PVH05-- VACCC PROTEIN H5 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVH05-- VACCV PROTEIN H5 VACCINIA |
| VIRUS (STRAIN WR) |
| PVH05-- VARV PROTEIN H5 VARIOLA VIRUS |
| PVHEL-- LSV PROBABLE HELICASE LILY SYMPTOMLESS VIRUS |
| PVHRP-- VACCC HOST RANGE PROTEIN VACCINIA VIRUS (STRAIN COPEHAGEN) |
| PVHRP-- VACCV HOST RANGE PROTEIN VACCINIA VIRUS (STRAIN WR) |
| PVI01-- VACCC PROTEIN I1 VACCINIA |
| VIRUS (STRAIN COPEHAGEN) |
| VI01-- VARV PROTEIN I1 VARIOLA VIRUS |
| VI03-- VACCC PROTEIN I3 VACCINIA VIRUS (STRAIN COPEHAGEN) |
| VI03-- VACCV PROTEIN I3 VACCINIA VIRUS (STRAIN WR) |
| VI03-- VARV PROTEIN I3 VARIOLA VIRUS |
| VI08-- VACCC PUTATIVE RNA HELICASE I8 VACCINIA VIRUS (STRAIN |
| COPEHAGEN) |
| VI08-- VACCV PUTATIVE RNA HELICASE I8 VACCINIA VIRUS (STRAIN WR) |
| VI08-- VARV PUTATIVE RNA HELICASE |
| I8 VARIOLA VIRUS |
| VIE1-- MCMVS IMMEDIATE-EARLY PROTEIN 1 MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) |
| VIE2-- NPVOP IMMEDIATE-EARLY PROTEIN IE-2 ORGYIA PSEUDOTSUGATA |
| MULTICAPSID POLYHEDROSIS VIRUS |
| VIEN-- NPVAC IE-REG PROTEIN IE-N AUTOGRAPHA CALIFORNICA NUCLEAR |
| POLYHEDROSIS VIRUS |
| VIF-- HVIRH VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY VIRUS |
| TYPE 1 (RF/HAT ISOLATE) |
| VIF-- SIVAI VIRION INFECTIVITY FACTOR SIMIAN IMMUNODEFICIENCY |
| VIRUS (ISOLATE |
| AGM/CLONE GRI-1) |
| VIMP-- HSVEB PROB INTEGRAL MEMBRANE PROTEIN EQUINE HERPESVIRUS |
| TYPE 1 (STRAIN AB4P) |
| VIMP-- HSVSA INTEGRAL MEMBRANE PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| VINT-- SSVI PROBABLE INTEGRASE SULFOLOBUS VIRUS-LIKE PARTICLE SSV1 |
| VJ01-- VACCC PROTEIN J1 VACCINIA VIRUS (STRAIN COPEHAGEN) |
| VJ01-- VACCV PROTEIN J1 VACCINIA VIRUS (STRAIN WR) |
| VJ01-- VARV PROTEIN J1 VARIOLA VIRUS |
| VL1-- CRPVK PROBABLE L1 PROTEIN COTTONTAIL RABBIT (SHOPE) PAPILLOMA |
| VIRUS |
| (STRAIN KANSAS) |
| VL1-- FPVL PROBABLE L1 PROTEIN AVIAN PAPILLOMA VIRUS FPV-L |
| VL1-- HPV08 PROBABLE L1 PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 8 |
| VL1-- HPV18 PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 18 |
| VL1-- HPV33 PROBABLE L1 PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 33 |
| VL1-- HPV41 PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 |
| VL1-- HPV51 PROBABLE L1 PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 51 |
| VL1-- HPV58 PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 58 |
| VL2-- HPV1A PROBABLE L2 PROTEIN |
| HUMAN PAPILLOMAVIRUS TYPE 1A |
| VL2-- HPV41 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 |
| VL3-- REOVD MINOR CORE PROTEIN |
| LAMBDA 3 REOVIRUS (TYPE 3/STRAIN DEARING) |
| VL3-- REOVL MINOR CORE PROTEIN LAMBDA 3 REOVIRUS (TYPE 1/STRAIN |
| LAND) |
| VL96-- IRV1 L96 PROTEIN TIPULA IRIDESCENT VIRUS |
| PVM1-- REOVL MINOR VIRION STRUCTURAL PROTEIN MU REOVIRUS (TYPE |
| 1/STRAIN LAND) |
| PVM21-- REOVD MAJOR VIRION STRUC PROTEIN MU-1/MU- REOVIRUS (TYPE |
| 3/STRAIN DEARING) |
| PVM22-- REOVD MAJOR VIRION STRUC PROTEIN MU-1/MU- REOVIRUS (TYPE |
| 3/STRAIN DEARING) |
| PVM2-- REOVJ MAJOR VIRION STRUC PROTEIN MU-1/MU- REOVIRUS (TYPE |
| 2/STRAIN D5/JONES) |
| PVM3-- REOVD MAJOR NONSTRUCUTRAL PROTEIN MU-N REOVIRUS (TYPE |
| 3/STRAIN DEARING) |
| PVMA2-- BRSVA MATRIX GLYCOPROTEIN M2 BOVINE RESPIRATORY SYNCYTIAL |
| VIRUS (STRAIN A51908) |
| PVMA2-- HRSVA MATRIX GLYCOPROTEIN M2 HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS (STRAIN A2) |
| PVMAT-- BRSVA MATRIX PROTEIN BOVINE RESPIRATORY SYNCYTIAL VIRUS |
| (STRAIN A51908) |
| PVMAT-- HRSVA MATRIX PROTEIN HUMAN RESPIRATORY SYNCYTIAL VIRUS |
| (STRAIN A2) |
| PVMAT-- INCJJ MATRIX (M) PROTEIN INFLUENZA C VIRUS (STRAIN |
| C/JJ/50) |
| PVMAT-- NDVA MATRIX PROTEIN NEWCASTLE DISEASE VIRUS (STRAIN |
| AUSTRALIA-VICTORIA/32) |
| PVMAT-- PI2HT MATRIX PROTEIN HUMAN PARAINFLUENZA 2 VIRUS (STRAIN |
| TOSHIBA) |
| PVMAT-- PI3B MATRIX PROTEIN BOVINE PARAINFLUENZA 3 VIRUS |
| PVMAT-- PI3H4 MATRIX PROTEIN HUMAN PARAINFLUENZA 3 VIRUS (STRAIN |
| NIH 47885) |
| PVMAT-- SV41 MATRIX PROTEIN SIMIAN VIURS 41 |
| PVME1-- CVBM E1 GLYCOPROTEIN BOVINE CORONAVIRUS (STRAIN MEBUS) |
| PVME1-- CVTKE E1 GLYCOPROTEIN |
| TURKEY ENTERIC CORONAVIRUS |
| PVME1-- IBV6 E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN 6/82) |
| PVME1-- IBVB E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN BEAUDETTE) |
| PVME1-- IBVB2 E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN |
| BEAUDETTE M42) |
| PVME1-- IBVK E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN KB8523) |
| PVMP-- CAMVC MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| CM-1841) |
| PVMP-- CAMVD MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| D/H) |
| PVMP-- CAMVE MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| BBC) |
| PVMP-- CAMVN MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| NY8153) |
| PVMP-- CAMVS MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| STRASBOURG) |
| PVMP-- CAMVW MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS (STRAIN |
| W260) |
| PVMP-- CERV MOVEMENT PROTEIN CARNATION ETCHED RING VIRUS |
| PVMP-- SOCMV MOVEMENT PROTEIN SOYBEAN CHLOROTIC MOTTLE VIRUS |
| PVMP-- HPBHE MAJOR SURFACE ANTIGEN |
| PRECURSOR HERON HEPATITIS B VIURS |
| PVMSA-- DHVI1 MATRIX PROTEIN 1 |
| DHORI VIRUS (STRAIN INDIAN/1313/61) |
| PVMT1-- MYXVL M-T8 PROTEIN MYXOMA |
| VIRUS (STRAIN LAUSANNE) |
| PVMT8-- MYXVL MT-9 PROTEIN MYXOMA VIRUS (STRAIN LAUSANNE) |
| PVMT9-- ROTPC NONSTRUCUTRAL PROTEIN NS34 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) |
| PVN34-- PAVBO PROBABLE NONCAPSID PROTEIN NP1 BOVINE PARVOVIRUS |
| PVNCN-- ADVG NONCAPSID PROTEIN NS-1 |
| ALEUTIAN MINK DISEASE PARVOVIRUS (STRAIN |
| G) |
| PVNCS-- AEDEV NONCAPSID PROTEIN NS-1 AEDES DENONUCLEOSIS VIRUS |
| (STRAIN GKV 002 002) |
| PVNCS-- MUMIM NONCAPSID PROTEIN NS-1 MURINE MINUTE VIRUS (STRAIN |
| MVMI) |
| PVNCS-- MUMIV NONCAPSID PROTEIN NS-1 MURINE MINUTE VIRUS |
| PVNCS-- PAVHB NONCAPSID PROTEIN NS-1 HUMAN PARVOVIRUS B19 |
| PVNCS-- PAVHH NONCAPSID PROTEIN NS-1 HAMSTER PARVOVIRUS H1 |
| PVNCS-- PAVPN NONCAPSID PROTEIN |
| NS-1 PORCINE PARVOVIRUS (STRAIN NADL-2) |
| PVNCS-- EHDV2 NONSTRUCTURAL PROTEIN |
| NS1 EPIZOOTIC HEMORRHAGIC DISEASE VIRUS |
| (SEROTYPE |
| 2/STRAIN ALBERTA) |
| PVNS1-- IAALA NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ ALASKA/6/77) |
| PVNS1-- IAANN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ ANN ARBOR/6/60) |
| PVNS1-- IACHI NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ CHILE/1/83) |
| PVNS1-- IACKG NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ CHICKEN/GERMANY/49) |
| PVNS1-- IACKJ NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ CHICKEN/JAPAN/24) |
| PVNS1-- IADA2 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ DUCK/ALBERTA/60/76) |
| PVNS1-- IAFOM NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ FORT MONMOUTH/1/47) |
| PVNS1-- IAFOW NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ FORT WARREN/1/50) |
| PVNS1-- IALE1 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ LENINGRAD/134/57) |
| PVNS1-- IAMA6 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ MALLARD/ALBERTA/88/76) |
| PVNS1-- IAPI1 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ PINTAIL/ALBERTA/121/79 |
| PVNS1-- IAPI3 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ PINTAIL/ALBERTA/358/79) |
| PVNS1-- IATKB NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ TURKEY/BETHLEHEM- |
| GLILIT/1492-B/82) |
| PVNS1-- IATKC NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ CANADA/63) |
| PVNS1-- IATRT NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TERN/ TURKMENIA/18/72) |
| PVNS1-- IAUDO NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/UDORN/ 30/72) |
| PVNS1-- IAUSS NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/USSR/ 90/77) |
| PVNS1-- INBPA NONSTRUCTURAL PROTEIN NS1 INFLUENZA B VIRUS (STRAIN |
| B/PA/79) |
| PVNS2-- IATKR NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ OREGON/71) |
| PVNS2-- INBLE NONSTRUCTURAL PROTEIN NS2 INFLUENZA B VIRUS (STRAIN |
| B/LEE/40) |
| PVNS2-- INBYA NONSTRUCTURAL PROTEIN NS2 INFLUENZA B VIRUS (STRAIN |
| B/ YAMAGATA/1/73) |
| PVNS2-- INCJJ NONSTRUCTURAL PROTEIN NS2 INFLUENZA C VIRUS (STRAIN |
| C/JJ/50) |
| PVNS3-- CVPFS NONSTRUCTURAL PROTEIN 3-1 PROCINE TRANSMISSIBLE |
| GASTROENTERITIS CORONA |
| VIRUS (STRAIN FS772/ |
| PVNS4-- CVH22 NONSTRUCTURAL PROTEIN 4 HUMAN CORONAVIRUS (STRAIN |
| 229E) |
| PVNS4-- RSV NONSTRUCTURAL PROTEIN NS4 RICE STRIPE VIRUS |
| PVNS7-- CVCAE NONSTRUCTURAL PROTEIN 7 CANINE ENTERIC CORONA VIRUS |
| (STRAIN K378) |
| PVNS7-- CVFE3 NONSTRUCTURAL PROTEIN 7 FELINE ENTERIC CORONAVIRUS |
| (STRAIN 79-1683) |
| PVNS7-- CVPFS NONSTRUCTURAL PROTEIN 7 PORCINE TRANSMISSIBLE |
| GASTROENTERITIS CORONAVIRUS |
| (STRAIN FS772/ |
| PVNS7-- CVPPU NONSTRUCTURAL PROTEIN 7 PORCINE TRANSMISSIBLE |
| GASTROENTERITIS CORONAVIRUS |
| (STRAIN PURD |
| PVNS7-- CVPRM NONSTRUCTURAL PROTEIN 7 PROCINE RESPIRATORY CORONAVIR |
| US |
| PVNS7-- FIPV NONSTRUCTURAL PROTEIN 7 FELINE INFECTIOUS PERITONITIS |
| VIRUS (STRAIN 79-1146) |
| PVNSC-- PI1HE NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 VIRUS |
| (STRAIN C1-14/83) |
| PVNSC-- PI3H4 NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 3 VIRUS |
| (STRAIN NIH 47885) |
| PVNSM-- INSV NONSTRUCTURAL PROTEIN NS-M IMPATIENS NECROTIC SPOT |
| VIRUS |
| PVNST-- BUNLC NONSTRUCTURAL PROTEIN NS-S BUNYAVIRUS LA CROSSE |
| PVNST-- TOSV NONSTRUCTURAL PROTEIN |
| NS-S TOSCANA VIRUS |
| PVNUC-- EBOV NUCLEOPROTEIN EBOLA VIRUS |
| PVNUC-- IAANA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ANAS |
| ACUTA/PRIMORJE/695/76) |
| PVNUC-- IAANN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ANN |
| ARBOR/6/60) |
| PVNUC-- IABRA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ BRAZIL/11/ |
| 78) |
| PVNUC-- IABUD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ BUDGERIGAR |
| /HOKKAIDO/1/77) |
| PVNUC-- IACAL NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ CALIFORNIA |
| /10/78) |
| PVNUC-- IACKG NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ CHICKEN/GE |
| RMANY/N/49) |
| PVNUC-- IACKP NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ CHICKEN/PE |
| NN- |
| SYLVANIA/1/83) |
| PVNUC-- IADAU NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ DUCK/AUSTR |
| ALIA/749/80) |
| PVNUC-- IADBE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ DUCK/BEIJI |
| NG/1/78) |
| PVNUC-- IADCZ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| CZECHOSLOVAKIA/56) |
| PVNUC-- IADE1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| ENGLAND/1/) |
| PVNUC-- IADE2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| ENGLAND/1/62) |
| PVNUC-- IADHK NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ HONG |
| KONG/7/75) |
| PVNUC-- IADM2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| MEMPHIS/928/74) |
| PVNUC-- IADMA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| MANITOBA/1/53) |
| PVNUC-- IADNZ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ NEW |
| ZEALAND/31/76) |
| PVNUC-- IADU2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/ |
| UKRAINE/2/60) |
| PVNUC-- IAEN5 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ENGLAND/ |
| 19/55) |
| PVNUC-- IAFOM NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FORT |
| MONMOUTH/1/47) |
| PVNUC-- IAFOW NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FORT |
| WARREN/1/50) |
| PVNUC-- IAFPD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FOWL |
| /PLAGUE |
| VIRUS/DOBSON/`DUTCH`/27) |
| PVNUC-- IAFPR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FOWL |
| PLAGUE |
| VIRUS/ROSTOCK/34) |
| PVNUC-- IAGRE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GREY |
| TEAL/AUSTRALIA/2/79) |
| PVNUC-- IAGU1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| MARYLAND/5/77) |
| PVNUC-- IAGU2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| MARYLAND/704/77) |
| PVNUC-- IAGU3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| MARYLAND/1824/78) |
| PVNUC-- IAGU4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| MARYLAND/1815/79) |
| PVNUC-- IAGUA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| ASTRAKHAN/227/84) |
| PVNUC-- IAGUM NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| MASSACHUSETTS/26/80) |
| PVNUC-- IAGUN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| MINNESOTA/945/80) |
| PVNUC-- IAHIC NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/HICKOX/40) |
| PVNUC-- IAHJI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| JILLIN/1/89) |
| PVNUC-- IAHLO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| LONDON/1416/73) |
| PVNUC-- IAHMI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| MIAMI/1/63) |
| PVNUC-- IAHO1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/HONG |
| KONG/1/68) |
| PVNUC-- IAHO2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/HONG |
| KONG/5/83) |
| PVNUC-- IAHPR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| PRAGUE/1/56) |
| PVNUC-- IAHTE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| TENNESSEE/5/86) |
| PVNUC-- IAKIE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/KIEV/ |
| 59/79) |
| PVNUC-- IALEN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ LENINGRAD/ |
| 54/1) |
| PVNUC-- IAMAA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ MALLARD/ |
| ASTRAKHAN/244/82) |
| PVNUC-- IAMAN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ MALLARD/NE |
| W YORK/6750/78) |
| PVNUC-- IAMIN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ MINK/SWEDE |
| N/84) |
| PVNUC-- IANEJ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ NEW |
| JERSEY/8/76) |
| PVNUC-- IANT6 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ NT/60/68) |
| PVNUC-- IAOHI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ OHIO/4/83) |
| PVNUC-- IAPAR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/PARROT/ULST |
| ER/73) |
| PVNUC-- IAPUE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/PUERTO |
| RICO/8/34) |
| PVNUC-- IARUD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/RUDDY |
| TURNSTONE/NEW JERSEY/47/85) |
| PVNUC-- IASE0 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SEAL/ |
| MASSACHUSETTS/1/80) |
| PVNUC-- IASH2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SHEARWATER/ |
| AUSTRALIA/72) |
| PVNUC-- IASIN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SINGAPORE/1 |
| /57) |
| PVNUC-- IATEI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TEAL/ |
| ICELAND/29/80) |
| PVNUC-- IATKN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TURKEY/ |
| MINNESOTA/166/81) |
| PVNUC-- IATKO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TURKEY/ |
| ONTARIO/7732/66) |
| PVNUC-- IATRS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TERN/ |
| SOUTH AFRICA/61) |
| PVNUC-- IATRT NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TERN/ |
| TURKMENIA/18/72) |
| PVNUC-- IATX7 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TEXAS/ |
| 1/77) |
| PVNUC-- IAUDO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/UDORN/ |
| 307/72) |
| PVNUC-- IAUSS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/USSR/ |
| 90/77) |
| PVNUC-- IAVI6 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/VICTORIA/ |
| 5/68) |
| PVNUC-- IAWHN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WHALE/ |
| MAINE/328/84) |
| PVNUC-- IAWHP NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WHALE/ |
| PACIFIC OCEAN/19/76) |
| PVNUC-- IAWIL NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WILSON- |
| SMITH/33) |
| PVNUC-- IAWIS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WISCONSIN/ |
| 3523/88) |
| PVNUC-- IAZ29 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/29/37 |
| ) |
| PVNUC-- IAZ41 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/41/49 |
| ) |
| PVNUC-- IAZCA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| PVNUC-- IAZDA NUCLEOPROTEIN |
| INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| DANDONG/9/83) |
| PVNUC-- IAZGE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| GERMANY/2/81) |
| PVNUC-- IAZH1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| HONG KONG/6/76) |
| PVNUC-- IAZH3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| HONG KONG/126/82) |
| PVNUC-- IAZH4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| HONG KONG/127/82) |
| PVNUC-- IAZI1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| IOWA/15/30) |
| PVNUC-- IAZI2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| IOWA/1976/31) |
| PVNUC-- IAZI3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/IOWA/ |
| 46) |
| PVNUC-- IAZJ1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ITALY |
| /437/76) |
| PVNUC-- IAZJ2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ITALY |
| /2/79) |
| PVNUC-- IAZJ3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ITALY |
| /141/81) |
| PVNUC-- IAZJ4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ITALY |
| /839/89) |
| PVNUC-- IAZJA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/JAMES |
| BURG/ 42) |
| PVNUC-- IAZMA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/MAY/5 |
| 4) |
| PVNUC-- IAZNE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| NETHERLANDS/12/85) |
| PVNUC-- IAZOH NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/OHIO/ |
| 23/35) |
| PVNUC-- IAZON NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| ONTARIO/2/81) |
| PVNUC-- IAZTE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/TENNE |
| SSEE/ 24/77) |
| PVNUC-- IAZW1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| WISCONSIN/1/57) |
| PVNUC-- IAZW2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| WISCONSIN/1/61) |
| PVNUC-- INCCA NUCLEOPROTEIN INFLUENZA C VIRUS (STRAIN C/CALIFORNIA/ |
| 78) |
| PVNUC-- MABVM NUCLEOPROTEIN MARBURG VIRUS (STRAIN MUSOKE) |
| PVNUC-- MABVP NUCLEOPROTEIN MARBURG VIRUS (STRAIN POPP) |
| PVO01-- VACCC PROTEIN O1 VACCINIA VIRUS (STRAIN COPEHAGEN) |
| PVO01-- VARV PROTEIN O1 VARIOLA |
| VIRUS |
| PVOR1-- FXMV 152 KD PROTEIN FOXTAIL MOSAIC VIRUS |
| PVOR1-- NMV 186 KD PROTEIN NARCISSUS MOSAIC VIRUS |
| PVOR1-- PMV 176 KD PROTEIN PAPAYA MOSAIC POTEXVIRUS |
| PVOR1-- PVMR 223 KD PROTEIN POTATO VIRUS M (STRAIN RUSSIAN) |
| PVOR1-- PVX 165 KD PROTEIN POTATO |
| VIRUS X |
| PVOR1-- PVXX3 165 KD PROTEIN POTATO VIRUS X (STRAIN X3) |
| PVOR1-- SMYEA 150 KD PROTEIN STRAWBERRY MILD YELLOW EDGE- ASSOCIATE |
| D VIRUS |
| PVP10-- NPVAC P10 PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR POLYHEDROS |
| IS VIRUS |
| PVP10-- NPVOP P10 PROTEIN ORGYIA PSEUDOTSUGATA MULTICAPSID |
| POLYHEDROSIS VIRUS |
| PVP10-- NPVSE P10 PROTEIN SPODOPTERA EXIGUA NUCLEAR POLYHEDROSIS |
| VIRUS |
| (STRAIN US) |
| PVP10-- RGDV NONSTRUCTURAL PROTEIN PNS10 RICE GALL DWARF VIRUS |
| PVP10-- WTV NONSTRUCTURAL PROTEIN |
| PNS10 WOUND TUMOR VIRUS |
| PVP11-- RDV NONSTRUCTURAL PROTEIN PNS11 RICE DWARF VIRUS |
| PVP12-- WTV NONSTRUCTURAL PROTEIN PNS12 WOUND TUMOR VIRUS |
| PVP18-- WTVNJ NONSTRUCTURAL PROTEIN PNS12 WOUND TUMOR VIRUS |
| (STRAIN NJ) |
| PVP19-- AMCV CORE PROTEIN P19 ARTICHOKE MOTTLED CRINKLE VIRUS |
| PVP19-- TBSVC CORE PROTEIN P19 |
| TOMATO BUSHY STUNT VIRUS (STRAIN CHERRY) |
| PVP23-- HSVSA PROBABLE CAPSID |
| PROTEIN VP23 HERPES VIRUS SAIMIRI (STRAIN |
| 11) |
| PVP26-- HSVEB CAPSID PROTEIN VP26 EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| PVP26-- HSVSA CAPSID PROTEIN VP26 HERPESVIRUS SAIMIRI (STRAIN 11) |
| PVP2-- AHSV4 OUTER CAPSID PROTEIN |
| VP2 AFRICAN HORSE SICKNESS VIRUS (SEROTYPE |
| 4/STRAIN VACCINE) |
| PVP2-- BTV13 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 13/ISOLATE USA) |
| PVP2-- BTV1A OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE AUSTRALIA) |
| PVP2-- BTV1S OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE SOUTH AFRICA) |
| PVP2-- EHDV1 OUTER CAPSID PROTEIN VP2 EPIZOOTIC HEMORRHAGIC |
| DISEASE VIRUS (SEROTYPE 1) |
| PVP2-- ROTBR RNA-BINDING PROTEIN VP2 BOVINE ROTAVIRUS (STRAIN RF) |
| PVP2-- ROTBU RNA-BINDING PROTEIN |
| VP2 BOVINE ROTAVIRUS (STRAIN UK) |
| PVP2-- ROTHW RNA-BINDING PROTEIN VP2 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN WA) |
| PVP2-- ROTPC RNA-BINDING PROTEIN VP2 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) |
| PVP2-- ROTS1 RNA-BINDING PROTEIN VP2 SIMIAN 11 ROTAVIRUS (STRAIN |
| SA11) |
| PVP30-- ASFE7 PHOSPHOPROTEIN P30 AFRICAN SWINE FEVER VIRUS (STRAIN |
| E-75) |
| PVP32-- ASFB7 PHOSPHOPROTEIN P32 AFRICAN SWINE FEVER VIRUS (STRAIN |
| BA71V) |
| PVP35-- EBOV POLYMERASE COMPLEX PROTEIN VP35 EBOLA VIRUS |
| PVP35-- MABVM POLYMERASE COMPLEX PROTEIN VP35 MARBURG VIRUS |
| (STRAIN MUSOKE) |
| PVP35-- MABVP POLYMERASE COMPLEX PROTEIN VP35 MARBURG VIRUS |
| (STRAIN POPP) |
| PVP35-- NPVAC EARLY 35 KD PROTEIN AUTOGRAPHS CALIFONICA NUCLEAR |
| POLYHEDROSIS VIRUS |
| PVP35-- NPVBM EARLY 35 KD PROTEIN BOMBYX MORI NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP35-- VACCV IMMUNODOM ENV PRO P35 VACCINIA VIRUS (STRAIN WR) |
| PVP39-- NPVAC MAJOR CAPSID PROTEIN |
| AUTOGRAPHA CALIFORNICA NUCLEAR POLYHEDROSI |
| S VIRUS |
| PVP39-- NPVOP MAJOR CAPSID PROTEIN ORGYIA PSEUDOTSUGATA MULTICAPSID |
| POLYHEDROSIS VIRUS |
| PVP3-- AHSV4 VP3 CORE PROTEIN AFRICAN HORSE SICKNESS VIRUS |
| (SEROTYPE |
| 4/STRAIN VACCINE) |
| PVP3-- BTV10 VP3 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE |
| USA) |
| PVP3-- BTV17 VP3 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 17/ISOLATE |
| USA) |
| PVP3-- BTV1A VP3 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 1/ISOLATE |
| AUSTRALIA) |
| PVP3-- EHDV1 VP3 CORE PROTEIN EPIZOOTIC HEMORRHAGIC DISEASE VIRUS |
| (SEROTYPE 1) |
| PVP3-- EHDVA VP3 CORE PROTEIN EPIZOOTIC HEMORRHAGIC DISEASE VIRUS |
| (SEROTYPE |
| 2/STRAIN AUSTRAL |
| PVP3-- GFLV P3 PROTEIN GRAPEVINE FANLEAF VIRUS |
| PVP3-- ROTPC INNER CORE PROTEIN VP3 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) |
| PVP3-- ROTS1 INNER CORE PROTEIN VP3 SIMIAN 11 ROTAVIRUS (STRAIN |
| SA11) |
| PVP40-- EBV CAPSID PROTEIN P40 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| PVP40-- HSVSA CAPSID PROTEIN P40 |
| HERPESVIRUS SAIMIRI (STRAIN 11) |
| PVP40-- ILTVT CAPSID PROTEIN P40 INFECTIOUS LARYNGOTRACHEITIS |
| VIRUS (STRAIN |
| THORNE V882) |
| PVP40-- VZVD CAPSID PROTEIN P40 VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| PVP41-- ROTS1 OUTER CAPSID PROTEIN VP4 SIMIAN 11 ROTAVIRUS (STRAIN |
| SA11) |
| PVP42-- ROTS1 OUTER CAPSID PROTEIN VP4 SIMIAN 11 ROTAVIRUS (STRAIN |
| SA11) |
| PVP4A-- VACCC MAJOR CORE PROTEIN P4A PRECURSOR VACCINIA VIRUS |
| (STRAIN COPEHAGEN |
| PVP4A-- VACCV MAJOR CORE PROTEIN P4A PRECURSOR VACCINIA VIRUS |
| (STRAIN WR) |
| PVP4A-- VARV MAJOR CORE PROTEIN P4A PRECURSOR VARIOLA VIRUS |
| PVP4B-- FOWPV MAJOR CORE PROTEIN |
| P4B PRECURSOR FOWLPOX VIRUS |
| PVP4B-- VACCC MAJOR CORE PROTEIN P4B PRECURSOR VACCINIA VIRUS |
| (STRAIN COPEHAGEN) |
| PVP4B-- VACCV MAJOR CORE PROTEIN P4B PRECURSOR VACCINIA VIRUS |
| (STRAIN WR) |
| PVP4B-- VARV MAJOR CORE PROTEIN P4B PRECURSOR VARIOLA VIRUS |
| PVP4-- BTV10 VP4 CORE PROTEIN |
| BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE |
| USA) |
| PVP4-- BTV11 VP4 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 13/ISOLATE |
| USA) |
| PVP4-- BTV13 VP4 CORE PROTEIN BLUETONGUE VIRUS (SEROTYPE 2/ISOLATE |
| USA) |
| PVP4-- BTV2A OUTER CAPSID PROTEIN VP4 NEBRASKA CALF DIARRHEA VIRUS |
| (STRAIN NCDV-LINCOLN) |
| PVP4-- NCDV OUTER CAPSID PROTEIN VP4 BOVINE ROTAVIRUS (SEROTYPE |
| 6/STRAIN B641) |
| PVP4-- ROTB4 OUTER CAPSID PROTEIN VP4 BOVINE ROTAVIRUS (STRAIN |
| C486) |
| PVP4-- ROTBC OUTER CAPSID PROTEIN VP4 BOVINE ROTAVIRUS (STRAIN UK) |
| PVP4-- ROTBU OUTER CAPSID PROTEIN VP4 EQUINE ROTAVIRUS (STRAIN |
| H-2) |
| PVP4-- ROTEH OUTER CAPSID PROTEIN VP4 ROTAVIRUS (GROUP B/STRAIN |
| IDIR) |
| PVP4-- ROTG1 OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN 1076) |
| PVP4-- ROTH1 OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 2/STRAIN RV-5) |
| PVP4-- ROTH5 OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN 69M) |
| PVP4-- ROTH6 OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN 69M) |
| PVP4-- ROTHD OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 2/STRAIN DS1) |
| PVP4-- ROTHJ OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (STRAIN K8) |
| PVP4-- ROTHK OUTER CAPSID PROTEIN |
| VP4 HUMAN ROTAVIRUS (STRAIN KU) |
| PVP4-- ROTHL OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (STRAIN L26) |
| PVP4-- ROTHM OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN M37) |
| PVP4-- ROTHN OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 3/STRAIN MCN13 |
| PVP4-- ROTHP OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 3/STRAIN P) |
| PVP4-- ROTHR OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 3/STRAIN RRV) |
| PVP4-- ROTHT OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 4/STRAIN ST. THOMAS 3) |
| PVP4-- ROTHV OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 4/STRAIN VA70) |
| PVP4-- ROTHW OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN WA |
| PVP4-- ROTP5 OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (SEROTYPE |
| 5/STRAIN OSU) |
| PVP4-- ROTPC OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) |
| PVP4-- ROTPG OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (STRAIN |
| GOTTFRIED) |
| PVP4-- ROTPY OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (STRAIN |
| YM) |
| PVP4-- ROTRH OUTER CAPSID PROTEIN VP4 RHESUS ROTAVIRUS |
| PVP4-- ROTSF OUTER CAPSID PROTEIN VP4 SIMIAN 11 ROTAVIRUS (STRAIN |
| SA11-FEM) |
| PVP4-- ROTSS OUTER CAPSID PROTEIN VP4 SIMIAN 11 ROTAVIRUS (STRAIN |
| SA11-FEM) |
| PVP4-- WTV NONSTRUCTURAL PROTEIN PNS4 WOUND TUMOR VIRUS |
| PVP5-- AHSV4 OUTER CAPSID PROTEIN VP5 AFRICAN HORSE SICKNESS VIRUS |
| (SEROTYPE |
| 4/STRAIN VACCINE) |
| PVP5-- BTV10 OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 10/ISOLATE USA) |
| PVP5-- BTV11 OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 11/ISOLATE USA) |
| PVP5-- BTV13 OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 13/ISOLATE USA) |
| PVP5-- BTV1A OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE AUSTRALIA) |
| PVP5-- BTV1S OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE SOUTH AFRICA) |
| PVP5-- BTV2A OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 2/ISOLATE USA) |
| PVP5-- EHDV1 OUTER CAPSID PROTEIN VP5 EPIZOOTIC HEMORRHAGIC |
| DISEASE VIRUS (SEROTYPE 1) |
| PVP5-- WTV OUTER COAT PROTEIN VP5 WOUND TUMOR VIRUS |
| PVP61-- BTV10 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE |
| USA) |
| PVP61-- MRDV PROB NONSTRUCT 41.0 KD PRO MAIZE ROUGH DWARF VIRUS |
| PVP61-- NPVAC 61 KD PROTEIN |
| AUTOGRAPHS CALIFONICA NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP62-- BTV10 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE |
| USA) |
| PVP64-- NPVOP MAJOR ENV GLYCOPRO PRECURSOR ORGYIA PSEUDOTSUGATA |
| MULTICAPSID POLYHEDROSIS VIRUS |
| PVP67-- NPVAC MAJOR ENV GLYCOPRO PRECURSOR AUTOGRAPHS CALIFONICA |
| NUCLEAR POLYHEDROSIS VIRUS |
| PVP6-- BTV11 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 11/ISOLATE |
| USA) |
| PVP6-- BTV13 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 13/ISOLATE |
| USA) |
| PVP6-- BTV17 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 17/ISOLATE |
| USA) |
| PVP6-- BTV1S VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 1/ISOLATE |
| SOUTH AFRICA) |
| PVP6-- BTV2A VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 2/ISOLATE USA) |
| PVP6-- RDV STRUCTURAL PROTEIN P6 RICE DWARF VIRUS |
| PVP74-- NPVAC P74 PROTEIN AUTOGRAPHS CALIFONICA NUCLEAR POLYHEDROSI |
| S VIRUS |
| PVP75-- HSVSA PROBABLE MEMBRANE ANTIGEN 75 HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PVP79-- NPVAC 79 KD PROTEIN AUTOGRAPHS CALIFONICA NUCLEAR POLYHEDRO |
| SIS VIRUS |
| PVP7-- EHDV1 VP7 CORE PROTEIN EPIZOOTIC HEMORRHAGIC DISEASE VIRUS |
| (SEROTYPE 1) |
| PVP7-- WTV NONSTRUCTURAL PROTEIN PNS7 WOUND TUMOR VIRUS |
| PVP80-- NPVAC CAPSID PROTEIN P80 AUTOGRAPHS CALIFONICA NUCLEAR |
| POLYHEDROSIS VIRUS |
| PVP87-- NPVOP CAPSID PROTEIN P87 ORGYIA PSEUDOTSUGATA MULTICAPSID |
| POLYHEDROSIS VIRUS |
| PVP8-- BTV10 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 10/ISOLATE USA) |
| PVP8-- FOWPV STRUCTURAL PROTEIN VP8 PRECURSOR FOWLPOX VIRUS |
| PVP8-- WTV OUTER CAPSID PROTEIN P8 |
| WOUND TUMOR VIRUS |
| PVP9-- RDV NONSTRUCTURAL PROTEIN PNS9 RICE DWARF VIRUS |
| PVP9-- WTV STRUCTURAL PROTEIN P9 WOUND TUMOR VIRUS |
| PVP9-- WTVNJ STRUCTURAL PROTEIN P9 WOUND TUMOR VIRUS (STRAIN NJ) |
| PVPHE-- NPVAC 29 KD POLYHEDRAL |
| ENVELOPE PROTEIN AUTOGRAPHA CALIFORNICA |
| NUCLEAR POLYHEDROSIS VIRUS |
| PVPHE-- NPVOP 32 KD POLYHEDRAL ENVELOPE PROTEIN ORGYIA PSEUDOTSUGAT |
| A MULTICAPSID POLYHEDROSIS VIRUS |
| PVPRT-- ADEM1 ENDOPROTEASE MOUSE ADENOVIRUS TYPE 1 |
| PVPU-- HV1A2 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ARV2/SF2 |
| ISOLATE) |
| PVPU-- HV1B1 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (BH10 |
| AND |
| HXB3 ISOLATES) |
| PVPU-- HV1B8 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (BH8 |
| ISOLATE) |
| PVPU-- HV1BN VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BRAIN ISOLATE) |
| PVPU-- HV1BR VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (BRU |
| ISOLATE) |
| PVPU-- HV1C4 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (CDC-451 ISOLATE) |
| PVPU-- HV1EL VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (ELI |
| ISOLATE) |
| PVPU-- HV1H2 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HXB2 |
| ISOLATE) |
| PVPU-- HV1J3 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (JH3 |
| ISOLATE) |
| PVPU-- HV1JR VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (JRCSF ISOLATE) |
| PVPU-- HV1MA VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (MAL |
| ISOLATE) |
| PVPU-- HV1ND VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (NDK |
| ISOLATE) |
| PVPU-- HV1PV VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (PV22 |
| ISOLATE) |
| PVPU-- HV1S1 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (SF162 ISOLATE) |
| PVPU-- SIVCZ VPU PROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| PVPX-- LDV VPU PROTEIN LACTATE |
| DEHYDROGENASE-ELEVATING VIRUS |
| PVRNA-- BSMV ALPHA-A PROTEIN BARLEY STRIPE MOSAIC VIRUS |
| PVS06-- ROTBS VP6 PROTEIN BOVINE ROTAVIRUS (GROUP C/STRAIN |
| SHINTOKU) |
| PVS06-- ROTGA VP6 PROTEIN ROTAVIRUS (GROUP B/STRAIN ADRV) |
| PVS06-- ROTGI VP6 PROTEIN ROTAVIRUS (GROUP B/STRAIN IDIR) |
| PVS06-- ROTHC VP6 PROTEIN HUMAN ROTAVIRUS |
| PVS06-- ROTPC VP6 PROTEIN PORCINE ROTAVIRUS (GROUP C/STRAIN |
| COWDEN) |
| PVS07-- ROTBJ GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN KN-4) |
| PVS07-- ROTBU NONSTRUCTURAL PROTEIN |
| NCVP3 BOVINE ROTAVIRUS (STRAIN UK) |
| PVS07-- ROTP5 NONSTRUCTURAL PROTEIN |
| NCVP3 PORCINE ROTAVIRUS (SEROTYPE |
| 5/STRAIN OSU) |
| PVS07-- ROTS1 NONSTRUCTURAL PROTEIN NCVP3 SIMIAN 11 ROTAVIRUS |
| (STRAIN SA11) |
| PVS08-- ROTBU NONSTRUCTURAL PROTEIN NS2/VP9 BOVINE ROTAVIRUS |
| (STRAIN UK) |
| PVS08-- ROTS1 NONSTRUCTURAL PROTEIN NCVP4 SIMIAN 11 ROTAVIRUS |
| (STRAIN SA11) |
| PVS09-- ROTB4 GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (SEROTYPE 6/STRAIN |
| B641) |
| PVS09-- ROTB5 GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN A5) |
| PVS09-- ROTBU GLYCOPROTEIN VP7 |
| BOVINE ROTAVIRUS (STRAIN UK) |
| PVS09-- ROTGA GLYCOPROTEIN VP7 PRECURSOR ROTAVIRUS (GROUP B/STRAIN |
| ADRV) |
| PVS09-- ROTH4 GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 4/STRAIN |
| RV-4) |
| PVS09-- ROTHA GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN |
| HU5) |
| PVS09-- ROTHB GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE G/STRAIN |
| B37) |
| PVS09-- ROTHD GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN |
| DS1) |
| PVS09-- ROTHH GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN |
| HN126) |
| PVS09-- ROTHM GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN |
| M37) |
| PVS09-- ROTHO GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN |
| MO AND STRAIN D) |
| PVS09-- ROTHP GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 3/STRAIN |
| P) |
| PVS09-- ROTHS GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN |
| S2) |
| PVS09-- ROTHW GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN |
| WA) |
| PVS09-- ROTP2 GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE |
| 3/STRAIN AT/76) |
| PVS09-- ROTP3 GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE |
| 3/STRAIN CRW-8) |
| PVS09-- ROTS1 GLYCOPROTEIN VP7 SIMIAN 11 ROTAVIRUS (STRAIN SA11) |
| PVS10-- ROTBS MINOR OUTER CAPSID |
| PROTEIN BOVINE ROTAVIRUS (SEROTYPE |
| C/STRAIN SHINTOKU) |
| PVS10-- ROTS1 NONSTRUCTURAL GLYCOPROTEIN NCVP5 SIMIAN 11 ROTAVIRUS |
| (STRAIN SA11) |
| PVS11-- ROTBU MINOR OUTER CAPSID PROTEIN BOVINE ROTAVIRUS (STRAIN |
| UK) |
| PVS11-- ROTBV MINOR OUTER CAPSID PROTEIN BOVINE ROTAVIRUS (STRAIN |
| VMRI) |
| PVS11-- ROTGA NONSTRUCTURAL PROTEIN ROTAVIRUS (GROUP B/STRAIN |
| ADRV) (ADULT |
| DIARRHEA ROTAVIRUS) |
| PVS11-- ROTH5 MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (SEROTYPE |
| 2/STRAIN RV-5) |
| PVS11-- ROTHD MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (SEROTYPE |
| 2/STRAIN DS1) |
| PVS11-- ROTHW MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN WA) |
| PVS11-- ROTRA MINOR OUTER CAPSID PROTEIN RABBIT ROTAVIRUS (STRAIN |
| ALABAMA) |
| PVS11-- ROTS1 MINOR OUTER CAPSID PROTEIN SIMIAN 11 ROTAVIRUS |
| (STRAIN SA11) |
| PVSH-- MUMP1 SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS |
| PVSH-- MUMPA SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| MATSUYAMA) |
| PVSH-- MUMPB SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| BELFAST) |
| PVSH-- MUMPE SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN ENDERS) |
| PVSH-- MUMPJ SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| JERYL-LYNN) |
| PVSH-- MUMPK SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN KILHAM) |
| PVSH-- MUMPL SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN BRISTOL |
| 1) |
| PVSH-- MUMPM SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) |
| PVSH-- MUMPR SMALL HYDROPHOBIC PROTEIN MUMPS VIRUS (STRAIN RW) |
| PVSH-- MUMPU SMALL HYDROPHOBIC |
| PROTEIN MUMPS VIRUS (STRAIN URABE VACCINE |
| AM9) |
| PVSI1-- REOVD SIGMA 1 PROTEIN PRECURSOR REOVIRUS (TYPE 3/STRAIN |
| DEARING) |
| PVSI1-- REOVJ SIGMA 1 PROTEIN PRECURSOR REOVIRUS (TYPE 2/STRAIN |
| D5/JONES) |
| PVSI1-- REOVL SIGMA 1 PROTEIN PRECURSOR REOVIRUS (TYPE 1/STRAIN |
| LANG) |
| PVSI2-- REOVD SIGMA 2 PROTEIN REOVIRUS (TYPE 3/STRAIN DEARING) |
| PVSI3-- REOVJ SIGMA 3 PROTEIN |
| REOVIRUS (TYPE 2/STRAIN D5/JONES) |
| PVSIS-- REOVD SIGMA 1-S PROTEIN |
| REOVIRUS (TYPE 3/STRAIN DEARING) |
| PVSIS-- REOVL SIGMA 1-S PROTEIN REOVIRUS (TYPE 1/STRAIN LANG) |
| PVT3A-- CAPVI PROTEIN T3A CAPRIPOXVI |
| RUS (STRAIN INS-1) |
| PVT5-- SFVKA PROTEIN T5 SHOPE FIBROMA VIRUS (STRAIN KASZA) |
| PVTER-- EBV PROBABLE DNA PACKAGING |
| PROTEIN EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| PVTER-- HCMVA PROBABLE DNA PACKAGING PROTEIN HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVTER-- HSV6U PROBABLE DNA PACKAGING PROTEIN HERPES SIMPLEX VIRUS |
| (TYPE 6/STRAIN UGANDA-1102) |
| PVTER-- HSVI1 PROBABLE DNA PACKAGING PROTEIN ICTALURID HERPESVIRUS |
| 1 |
| PVTER-- VZVD PROBABLE DNA PACKAGING PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| PVTP3-- TTV1V VIRAL PROTEIN TPX THERMOPROTEUS TENAX VIRUS 1 |
| (STRAIN VT3) |
| PVTPX-- TTV1 VIRAL PROTEIN TPX THERMOPROTEUS TENAX VIRUS 1 (STRAIN |
| KRA1) |
| PVV-- PI4HA V PROTEIN HUMAN PARAINFLUENZA 4A VIRUS (STRAIN |
| TOSHIBA) |
| PY101-- SSV1 HYPOTHETICAL 10.1 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY108-- SSV1 HYPOTHETICAL 10.8 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY119-- SSV1 HYPOTHETICAL 11.9 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY11K-- TYDVA HYPOTHETICAL 11.2 KD PROTEIN TOBACCO YELLOW DWARF |
| VIRUS (STRAIN AUSTRALIA) |
| PY13K-- NPVAC HYPOTH 13.1 KD IN 39 KD 5'REGION AUTOGRAPHS CALIFONIC |
| A NUCLEAR POLYHEDROSIS VIRUS |
| PY13K-- SSV1 HYPOTHETICAL 13.2 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY14K-- SSV1 HYPOTHETICAL 13.7 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY16K-- NPVAC HYPOTH 39 KD IN 39 KD 5'REGION AUTOGRAPHS CALIFONICA |
| UCLEAR POLYHEDROSIS VIRUS |
| PY16K-- SSV1 HYPOTHETICAL 15.6 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY17K-- SSV1 HYPOTHETICAL 17.8 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY18K-- MSVN HYPOTHETICAL 17.7 KD PROTEIN MAIZE STREAK VIRUS |
| (NIGERIAN ISOLATE) |
| PY18K-- MSVS HYPOTHETICAL 17.2 KD PROTEIN MAIZE STREAK VIRUS |
| (SOUTH-AFRICAN ISOLATE) |
| PY20K-- SSV1 HYPOTHETICAL 20.4 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY28K-- SSV1 HYPOTHETICAL 28.5 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY2-- SOCMV HYPOTHETICAL PROTEIN 2 SOYBEAN CHLOROTIC MOTTLE VIRUS |
| PY31K-- SSV1 HYPOTHETICAL 31.5 KD |
| PROTEIN SULFOLOBUS VIRUS-LIKE PARTICLE |
| SSV1 |
| PY32K-- SSV1 HYPOTHETICAL 31.7 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY38K-- NPVAC HYPOTHETICAL 37.7 KD PROTEIN AUTOGRAPHS CALIFONICA |
| NUCLEAR POLYHEDROSIS VIRUS |
| PY3-- SOCMV HYPOTHETICAL PROTEIN 3 SOYBEAN CHLOROTIC MOTTLE VIRUS |
| PY7-- SOCMV HYPOTHETICAL PROTEIN 7 |
| SOYBEAN CHLOROTIC MOTTLE VIRUS |
| PY85K-- SSV1 HYPOTHETICAL 85.7 KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY8-- SOCMV HYPOTHETICAL PROTEIN 8 SOYBEAN CHLOROTIC MOTTLE VIRUS |
| PYB01-- FOWPM HYPOTHETICAL BAMHI-ORF |
| 1 PROTEIN FOWLPOX VIRUS (ISOLATE HP-438[MU |
| NICH]) PROTEIN |
| PYB05-- FOWPM HYPOTHETICAL BAMHI-ORF5 PROTEIN FOWLPOX VIRUS |
| (ISOLATE HP-438[MUNICH]) |
| PYB10-- FOWPM HYPOTHETICAL BAMHI-ORF10 PROTEIN FOWLPOX VIRUS |
| (ISOLATE HP-438[MUNICH]) |
| PYB12-- FOWPM HYPOTHETICAL BAMHI-ORF12 PROTEIN FOWLPOX VIRUS |
| (ISOLATE HP-438[MUNICH]) |
| PYB13-- FOWPM HYPOTHETICAL BAMHI-ORF12 PROTEIN FOWLPOX VIRUS |
| (ISOLATE HP-438[MUNICH]) |
| PYBL3-- FOAMV BEL-3 PROTEIN HUMAN SPUMARETROVIRUS |
| PYDH1-- HSVS7 HYPOTH 24.1 KD IN DHFR 3'REGION HERPESVIRUS SAIMIRI |
| (STRAIN 484-77) |
| PYDH1-- HSVSC HYPOTH 28.7 KD IN DHFR 3'REGION HERPESVIRUS SAIMIRI |
| (SUBGROUP C/STRAIN 488) |
| PYDH4-- HSVSC HYPOTH 9.9 KD IN DHFR 3'REGION HERPESVIRUS SAIMIRI |
| (SUBGROUP C/STRAIN 488) |
| PYF26-- FOWP1 HYPOTHETICAL 25.9 KD PROTEIN FOWLPOX VIRUS (STRAIN |
| FP-1) |
| PYF30-- FOWP1 HYPOTHETICAL 30.9 KD PROTEIN FOWLPOX VIRUS (STRAIN |
| FP-1) |
| PYH22-- VACCV HYPOTH 21.7 KD HINDIII-C PRO VACCINIA VIRUS (STRAIN |
| WR) |
| PYHR3-- VACCV HYPOTH HOST RANGE 27.4 KD PRO VACCINIA VIRUS (STRAIN |
| WR) |
| PYKR2-- EBV HYPOTHETICAL BKRF2 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PYKR4-- EBV HYPOTHETICAL BKRF4 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PYL15-- ADE41 HYPOTH 12.4 KD IN 33 KD REGION HUMAN ADENOVIRUS TYPE |
| 41 |
| PYLR3-- EBV HYPOTHETICAL BLRF3 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| PYOR1-- COYMV HYPOTHETICAL 23 KD PROTEIN COMMELINA YELLOW MOTTLE |
| VIRUS |
| PYOR2-- COYMV HYPOTHETICAL 15 KD PROTEIN COMMELINA YELLOW MOTTLE |
| VIRUS |
| PYOR3-- WCMVM HYPOTHETICAL 13 KD PROTEIN WHITE CLOVER MOSAIC VIRUS |
| (STRAIN M) |
| PYOR3-- WCMVO HYPOTHETICAL 13 KD PROTEIN WHITE CLOVER MOSAIC VIRUS |
| (STRAIN O) |
| PYOR5-- ADEG1 HYPOTHETICAL 31.5 KD PROTEIN AVIAN ADENOVIRUS GAL 1 |
| (STRAIN PHELOPS) |
| PYORA-- TTV1 HYPOTHETICAL 8.1 KD PROTEIN THERMOPROTEUS TENAX VIRUS |
| 1 (STRAIN KRA1) |
| PYORL-- TTV1 HYPOTHETICAL 26.8 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS 1 (STRAIN KRA1) |
| PYORQ-- TTV1 HYPOTHETICAL 7.3 KD PROTEIN THERMOPROTEUS TENAX VIRUS |
| 1 (STRAIN KRA1) |
| PYORW-- TTV1 HYPOTHETICAL 12.1 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS 1 (STRAIN KRA1) |
| PYP12-- RTBV HYPOTHETICAL P12 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS |
| PYP12-- RTBVP HYPOTHETICAL P12 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS (ISOLATE PHILIPPINES) |
| PYP24-- RTBV HYPOTHETICAL P24 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS |
| PYP24-- RTBVP HYPOTHETICAL P24 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS (ISOLATE PHILIPPINES) |
| PYP46-- RTBV HYPOTHETICAL P46 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS |
| PYP46-- RTBVP HYPOTHETICAL P46 PROTEIN RICE TUNGRO BACILLIFORM |
| VIRUS (ISOLATE PHILIPPINES) |
| PYP63-- NPVAC HYPOTH PRO P6.5 5'REGION AUTOGRAPHS CALIFONICA |
| NUCLEAR POLYHEDROSIS VIRUS |
| PYP63-- NPVOP HYPOTH 40.0 KD IN P6.5 5'REGION ORGYIA PSEUDOTSUGATA |
| ULTICAPSID POLYHEDROSIS VIRUS |
| PYPOH-- NPVAC HYPOTH 23.6 KD IN POLYHEDRIN 5'REGION AUTOGRAPHS |
| CALIFONICA NUCLEAR POLYHEDROSIS VIRUS |
| PYPOL-- IPNVN HYPOTHETICAL 17.0 KD |
| PROTEIN INFECTIOUS PANCREATIC NECROSIS |
| VIRUS (STRAIN N1) |
| PYQ3 -- AMEPV HYPOTHETICAL PROTEIN IN TK 3'REGION AMSACTA MOOREI |
| ENTOMOPOXVIRUS |
| PYRF1-- HSV6G HYPOTHETICAL PROTEIN RF1 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) |
| PYRF2-- HSV6G HYPOTHETICAL PROTEIN RF2 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) |
| PYRF3-- HSV6G HYPOTHETICAL PROTEIN RF3 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) |
| PYRF4-- HSV6G HYPOTHETICAL PROTEIN RF4 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) |
| PYRP2-- IRV6 REPETITIVE PROTEIN ORF2 CHILO IRIDESCENT VIRUS |
| PYVAG-- VACCC HYPOTHETICAL 9.3 KD |
| PROTEIN VACCINIA VIRUS (STRAIN COPEHAGEN) |
| PYVAH-- VACCC HYPOTHETICAL 14.5 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPEHAGEN) |
| PYVDB-- VACCC HYPOTHETICAL 8.5 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPEHAGEN) |
| PYVDB-- VACCV HYPOTHETICAL 8.5 KD PROTEIN VACCINIA VIRUS (STRAIN |
| WR) |
| PYVDH-- VACCV HYPOTHETICAL 7.2 KD PROTEIN VACCINIA VIRUS (STRAIN |
| WR) |
| PYVGB-- VACCC HYPOTHETICAL 8.4 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPEHAGEN) |
| PYZL2-- EBV HYPOTHETICAL BZLF2 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) |
| __________________________________________________________________________ |
| FILE NAME AREA 1 |
| AREA 2 |
| AREA 3 |
| AREA 4 |
| AREA 5 |
| AREA 6 |
| AREA 7 |
| AREA 8 |
| AREA 9 |
| __________________________________________________________________________ |
| P194K-- TRVSY 387-414 1087-1114 1142-1169 |
| PAANT-- HDVAM 106-133 |
| PAANT-- HDVD3 106-133 |
| PAANT-- HDVIT 106-133 |
| PAANT-- HDVM2 106-133 |
| PAANT-- HDVS1 16-43 106-133 |
| PAANT-- HDVS2 16-43 106-133 |
| PAANT-- HDVWO 106-133 |
| PATH3H-- FOWPM 72-106 |
| PATI1-- VACCV 14-56 67-94 424-472 570-625 |
| PATI1-- VARV 67-94 425-504 571-605 |
| PATI2-- HSV11 308-335 |
| PATI2-- HSVIF 308-335 |
| PATI2-- HSVEB 294-321 |
| PATIN-- HSVEB 255-289 |
| PATI-- COWPX 14-56 67-94 426-498 572-620 837-841 934-990 1234-1261 |
| PBZLF-- EBV 193-220 |
| PCAHH-- VACCC 84-111 117-144 |
| PCAHH-- VACCV 84-111 117-144 |
| PCAHH-- VARV 84-111 117-144 |
| PCELF-- HSVEB 312-339 |
| PCGH2-- HSVSA 127-154 |
| PCOA1-- POVHA 159-186 |
| PCOA2-- BFDV 160-187 |
| PCOA2-- POVBO 49-76 |
| PCOA2-- POVJC 37-64 |
| PCOA2-- POVLY 170-204 |
| PCOA2-- POVMK 22-49 |
| PCOA2-- SV40 178-205 |
| PCOA3-- AAV2 120-147 |
| PCOA3-- TTV1 3-30 |
| PCOAT-- ADVG 194-221 |
| PCOAT-- BLVR 96-123 |
| PCOAT-- CAMVC 63-90 193-220 461-488 |
| PCOAT-- CAMVD 64-91 194-221 |
| PCOAT-- CAMVE 63-90 193-220 |
| PCOAT-- CAMVN 63-90 192-219 461-488 |
| PCOAT-- CAMVS 64-91 194-221 |
| PCOAT-- CARMV 16-43 |
| PCOAT-- CHVP1 41-86 |
| PCOAT-- CNV 328-362 |
| PCOAT-- CSMV 62-89 |
| PCOAT-- CYMV 170-200 |
| PCOAT-- FCVC6 566-600 |
| PCOAT-- FCVF4 516-543 566-600 |
| PCOAT-- FCVF9 519-546 569-603 |
| PCOAT-- FMVD 220-247 358-385 |
| PCOAT-- LSV 32-700 246-273 |
| PCOAT-- MISV 139-166 |
| PCOAT-- ORSV 106-133 |
| PCOAT-- PAVHB 524-551 569-596 |
| PCOAT-- POPMV 46-73 |
| PCOAT-- SOCMV 128-162 |
| PCOAT-- TAMV 21-48 |
| PCOAT-- TAV 23-50 |
| PCOAT-- TBSVB 3-30 |
| PCOAT-- TBSVC 97-134 |
| PCOAT-- TCV 232-259 |
| PCOAT-- TMGMV 104-131 |
| PCOAT-- TMV 104-131 |
| PCOAT-- TMVCO 78-32 |
| PCOAT-- TMVDA 104-131 |
| PCOAT-- TMVER 104-131 |
| PCOAT-- TMVO 104-131 |
| PCOAT-- TMVOM 104-131 |
| PCOAT-- TMVTO 104-131 |
| PCOAT-- TNVA 90-117 |
| PCOAT-- TRVPS 118-145 |
| PCOAT-- TYDVA 10-37 |
| PCOAT-- TYMV 41-68 |
| PCOAT-- TYMVA 41-68 |
| PDNB2-- AD307 46-73 |
| PDNB1-- EBV 977-1004 1041-1068 |
| PDNB1-- HCMVA 437-464 |
| PDNB1-- HSVSA 333-368 512-539 |
| PDNB1-- MCMVS 584-618 |
| PDNB1-- POVJC 2-29 |
| PDNB1-- SCMVC 435-462 532-559 |
| PDNL1-- VACCC 104-131 172-199 358-385 |
| PDNL1-- VACCV 104-131 172-199 358-385 |
| PDNL1-- VARV 104-131 172-199 358-385 |
| PDPOL-- ADE12 403-431 |
| PDPOL-- CBEPV 23-64 202-240 |
| PDPOL-- CHVN2 338-365 |
| PDPOL-- CHVP1 338-365 |
| PDPOL-- FOWPV 17-51 370-416 621-655 772-799 |
| PDPOL-- HCMVA 753-780 |
| PDPOL-- HPBDB 5-39 |
| PDPOL-- HPBDC 5-39 |
| PDPOL-- HPBDW 5-39 304-331 |
| PDPOL-- HPBGS 271-325 |
| PDPOL-- HPBHE 5-39 |
| PDPOL-- HPBVP 456-483 |
| PDPOL-- HPBVZ 443-470 |
| PDPOL-- HSV11 328-366 710-737 |
| PDPOL-- HSVSA 625-652 |
| PDPOL-- NPVAC 598-641 |
| PDPOL-- NPVLD 357-384 |
| PDPOL-- VACCC 770-797 |
| PDPOL-- VACCV 770-797 |
| PDPOL-- VARV 769-796 |
| PDPOL-- WHV1 285-326 |
| PDPOL-- WHV59 290-331 |
| PDPOL-- WHV7 212-242 290-331 |
| PDPOL-- WHV8 211-241 289-330 |
| PDPOL-- WHV81 212-242 290-331 |
| PDTXH-- CORBE 516-533 |
| PDTX-- CORBE 523-560 |
| PDTX-- COROM 516-533 |
| PDUT-- HSVE4 90-117 |
| PDUT-- HSVSA 179-213 |
| PE1BL-- ADE07 126-153 |
| PE1BL-- ADE40 136-163 |
| PE1BL-- ADE12 3-30 |
| PE1BL-- ADEM1 122-173 |
| PE314-- ADE02 2-29 |
| PE314-- ADE07 21-48 |
| PE320-- ADE03 5-32 70-100 |
| PE320-- ADE35 70-107 |
| PE321-- ADE35 125-161 |
| PE3GL-- ADEM1 38-66 |
| PEAR-- EBV 55-82 |
| PEFT1-- VARV 307-141 470-497 |
| PENV-- AVIRE 420-468 |
| PENV-- AVISN 6-33 426-474 |
| PENV-- BAEVM 395-452 |
| PENV-- BIV06 17-44 544-603 631-695 |
| PENV-- BIV27 17-44 573-632 660-724 |
| PENV-- BLVAF 304-377 |
| PENV-- BLVAU 304-377 |
| PENV-- BLVAV 304-377 |
| PENV-- BLVB2 311-377 |
| PENV-- BLVB5 304-377 |
| PENV-- BLVJ 304-377 |
| PENV-- CAEVG 165-192 |
| PENV-- EIAV1 668-712 |
| PENV-- EIAV2 668-695 |
| PENV-- EIAV3 668-712 |
| PENV-- EIAV5 669-696 |
| PENV-- EIAV9 668-712 |
| PENV-- EIAVC 668-712 |
| PENV-- EIAVW 668-712 |
| PENV-- EIAVY 668-712 |
| PENV-- FENV1 33-60 517-544 |
| PENV-- FIVPE 650-680 722-749 |
| PENV-- FIVSD 639-668 720-747 |
| PENV-- FIVT2 640-679 721-748 |
| PENV-- FLVC6 509-538 |
| PENV-- FLVGL 490-519 |
| PENV-- FLVLB 510-539 |
| PENV-- FLVSA 487-516 |
| PENV-- FOAMV 14-41 318-355 866-893 |
| PENV-- FSVGA 510-539 |
| PENV-- FSVGB 490-519 |
| PENV-- FSVSM 493-522 |
| PENV-- GALV 176-203 523-564 |
| PENV-- HTL1A 342-376 |
| PENV-- HTL1C 342-376 |
| PENV-- HTL1M 342-376 |
| PENV-- HTLV2 336-370 |
| PENV-- HV1A2 544-592 630-682 790-825 |
| PENV-- HV1B1 545-594 631-683 791-818 |
| PENV-- HV1B8 540-589 626-678 786-813 |
| PENV-- HV1BN 267-294 338-365 562-590 628-679 787-815 |
| PENV-- HV1BR 550-599 636-688 796-823 |
| PENV-- HV1C4 397-424 557-606 643-695 803-835 |
| PENV-- HV1EL 255-296 386-413 543-591 628-680 |
| PENV-- HV1H2 545-594 631-683 791-818 |
| PENV-- HV1H3 545-594 631-683 791-818 |
| PENV-- HV1J3 350-377 556-605 642-694 802-829 |
| PENV-- HV1JR 336-363 622-675 783-811 |
| PENV-- HV1KB 274-301 555-596 637-677 776-824 |
| PENV-- HV1MA 547-595 633-707 794-826 |
| PENV-- HV1MF 543-592 629-681 789-816 |
| PENV-- HV1MN 343-370 567-595 632-684 791-819 |
| PENV-- HV1N5 326-360 |
| PENV-- HV1ND 249-290 536-583 621-673 783-813 |
| PENV-- HV1OY 544-593 630-704 789-820 |
| PENV-- HV1PV 545-594 631-683 791-818 |
| PENV-- HV1RH 280-307 351-378 554-602 640-692 800-832 |
| PENV-- HV1S1 333-363 536-585 622-674 782-809 |
| PENV-- HV1S3 541-589 627-679 787-815 |
| PENV-- HV1SC 338-365 545-593 631-683 |
| PENV-- HV1W1 338-365 545-593 631-683 791-818 |
| PENV-- HV1W2 334-361 536-584 622-674 782-809 |
| PENV-- HV1Z2 255-296 542-591 628-680 790-820 |
| PENV-- HV1Z3 251-292 |
| PENV-- HV1Z6 256-297 545-593 630-682 792-822 |
| PENV-- HV1Z8 266-307 573-601 634-678 797-828 |
| PENV-- HV1ZH 545-594 627-666 791-823 |
| PENV-- HV2BE 61-88 532-591 621-648 653-697 |
| PENV-- HV2CA 534-593 623-650 655-699 |
| PENV-- HV2D1 61-88 523-550 555-582 644-688 |
| PENV-- HV2G1 60-87 524-551 556-583 613-640 645-693 |
| PENV-- HV2NZ 61-88 524-551 556-583 613-640 662-689 |
| PENV-- HV2RO 58-85 533-592 622-698 |
| PENV-- HV2S2 442-476 527-554 559-586 648-682 |
| PENV-- HV2SB 557-584 614-673 |
| PENV-- HV2ST 442-476 527-554 559-586 648-692 |
| PENV-- MCFF 473-512 |
| PENV-- MCFF3 488-515 |
| PENV-- MLVAV 517-544 |
| PENV-- MLVCB 510-539 |
| PENV-- MLVF5 523-553 |
| PENV-- MLVFF 523-553 |
| PENV-- MLVFP 523-553 |
| PENV-- MLVHO 510-540 |
| PENV-- MLVK1 40-81 |
| PENV-- MLVMO 502-543 |
| PENV-- MLVRD 497-538 |
| PENV-- MLVRK 497-538 |
| PENV-- MMTVB 458-485 562-589 |
| PENV-- MMTVG 458-485 562-589 |
| PENV-- MPMV 422-470 |
| PENV-- MSVFB 57-84 |
| PENV-- OMVVS 42-69 196-223 780-807 |
| PENV-- RMCFV 487-517 |
| PENV-- SFV1 14-41 866-901 |
| PENV-- SFV3L 18-45 319-357 673-700 863-898 |
| PENV-- SIVA1 269-310 561-588 592-619 652-679 697-724 |
| PENV-- SIVAG 270-301 566-593 597-624 658-685 703-770 |
| PENV-- SIVAI 257-291 336-372 548-603 634-708 |
| PENV-- SIVAT 3-30 268-298 590-617 651-678 |
| PENV-- SIVCZ 160-187 253-289 336-366 526-584 627-654 |
| PENV-- SIVGB 8-35 158-185 589-650 784-816 |
| PENV-- SIVM1 120-150 550-609 671-715 |
| PENV-- SIVM2 156-215 217-289 |
| PENV-- SIVMK 553-608 |
| PENV-- SIVML 549-608 |
| PENV-- SIVS4 281-308 553-612 642-669 691-718 |
| PENV-- SIVSP 286-313 554-595 646-722 |
| PENV-- SMRVH 400-462 |
| PENV-- SRV1 409-471 |
| PENV-- VILV 22-62 773-800 |
| PENV-- VILV1 22-62 780-807 |
| PENV-- VIVL2 22-62 782-809 |
| PETF1-- FOWP1 190-224 |
| PETF1-- SFVKA 306-340 469-496 550-587 |
| PETF1-- VACCC 307-341 470-497 |
| PETF1-- VACCV 307-341 470-497 |
| PETF2-- VACCC 66-79 174-210 302-332 |
| PETF2-- VARV 66-97 174-210 302-332 |
| PEXON-- VZVD 109-139 |
| PFIB2-- ADE40 179-237 |
| PFIB2-- ADE41 178-216 |
| PFIBP-- ADE02 308-335 |
| PFIBP-- ADE40 324-351 446-473 |
| PFIBP-- ADE41 339-366 461-488 |
| PFIBP-- ADEB3 118-145 164-191 |
| PFIBP-- ADEM1 275-305 325-352 |
| PFOSX-- MSVFR 138-169 |
| PFOS-- AVINK 116-147 |
| PFOS-- MSVFB 162-193 |
| PGAG-- AVISN 270-297 |
| PGAG-- EIAVY 144-171 |
| PGAG-- FOAMV 621-648 |
| PGAG-- GALV 396-442 447-474 |
| PGAG-- HV1A2 91-118 |
| PGAG-- HV1J3 91-118 |
| PGAG-- HV1MN 87-118 |
| PGAG-- HV2BE 88-115 |
| PGAG-- HV2D1 88-115 |
| PGAG-- HV2NZ 88-115 |
| PGAG-- HV2ST 88-115 |
| PGAG-- IPHA 270-297 |
| PGAG-- IPMA 33-60 69-103 232-259 |
| PGAG-- IPMAE 96-130 |
| PGAG-- MMTVB 84-151 156-187 |
| PGAG-- MMTVC 84-116 |
| PGAG-- MMTVG 84-151 156-187 |
| PGAG-- MPMV 222-260 |
| PGAG-- SCVLA 497-531 624-651 |
| PGAG-- SIVA1 473-507 |
| PGAG-- SIVMK 88-115 |
| PGAG-- SIVMS 88-115 |
| PGAG-- SIVS4 88-115 |
| PGAG-- SIVSP 88-115 |
| PGAG-- SMSAV 397-443 |
| PGAG-- SRV1 223-261 |
| PHELI-- HSVEB 184-211 321-348 |
| PHELI-- HSVSA 418-449 |
| PHELI-- VZVD 490-517 701-728 |
| PHEMA-- CVBF 208-242 |
| PHEMA-- CVBLY 208-242 |
| PHEMA-- CVBM 208-242 |
| PHEMA-- CVBQ 208-242 |
| PHEMA-- CVHOC 208-242 |
| PHEMA-- IAAIC 387-453 |
| PHEMA-- IABAN 24-51 371-437 |
| PHEMA-- IABUD 381-451 |
| PHEMA-- IACAO 9-36 |
| PHEMA-- IACKA 381-451 |
| PHEMA-- IACKG 31-58 382-441 494-528 |
| PHEMA-- IACKP 396-426 |
| PHEMA-- IACKQ 396-426 |
| PHEMA-- IACKV 119-146 384-443 |
| PHEMA-- IADA1 381-451 |
| PHEMA-- IADA2 423-453 499-543 |
| PHEMA-- IADA3 387-453 |
| PHEMA-- IADA4 29-56 418-478 |
| PHEMA-- IADCZ 381-451 |
| PHEMA-- IADE1 21-55 4024-453 506-533 |
| PHEMA-- IADH1 371-437 |
| PHEMA-- IADH2 371-437 |
| PHEMA-- IADH3 371-437 |
| PHEMA-- IADH4 371-437 |
| PHEMA-- IADH5 371-437 |
| PHEMA-- IADH6 371-437 |
| PHEMA-- IADH7 371-437 |
| PHEMA-- IADIR 415-445 |
| PHEMA-- IADM2 21-56 |
| PHEMA-- IADM2 387-453 |
| PHEMA-- IADMA 31-58 |
| PHEMA-- IADNY 21-55 |
| PHEMA-- IADNZ 381-451 |
| PHEMA-- IADU1 21-55 |
| PHEMA-- IADU3 387-453 |
| PHEMA-- IAEN6 24-51 |
| PHEMA-- IAEN7 40-67 387-453 |
| PHEMA-- IAFPR 177-221 384-442 |
| PHEMA-- IAGRE 381-451 |
| PHEMA-- IAGU2 505-532 |
| PHEMA-- IAGUA 504-531 |
| PHEMA-- IAHAL 386-452 |
| PHEMA-- IAHAR 29-56 |
| PHEMA-- IAHC6 29-56 194-221 388-457 |
| PHEMA-- IAHC7 29-56 194-221 388-457 |
| PHEMA-- IAHCD 29-56 194-221 388-457 |
| PHEMA-- IAHDE 29-56 194-221 388-457 |
| PHEMA-- IAHFO 386-452 |
| PHEMA-- IAHK6 386-452 |
| PHEMA-- IAHK7 386-452 |
| PHEMA-- IAHLE 194-221 388-457 |
| PHEMA-- IAHLO 29-56 194-221 388-457 |
| PHEMA-- IAHMI 386-452 |
| PHEMA-- IAHNM 386-452 |
| PHEMA-- IAHNN 29-56 194-221 388-457 |
| PHEMA-- IAHPR 29-56 194-221 388-457 |
| PHEMA-- IAHRO 386-452 |
| PHEMA-- IAHSA 386-452 |
| PHEMA-- IAHSP 29-56 194-221 388-457 |
| PHEMA-- IAHSW 29-56 194-221 388-457 |
| PHEMA-- IAHTE 386-452 |
| PHEMA-- IAHTO 386-455 |
| PHEMA-- IAHUR 386-452 |
| PHEMA-- IAJAP 196-223 |
| PHEMA-- IAKIE 29-56 425-478 |
| PHEMA-- IALEN 29-56 425-478 |
| PHEMA-- IAMAA 380-450 |
| PHEMA-- IAMAB 384-455 |
| PHEMA-- IAMAO 387-453 |
| PHEMA-- IAME1 40-67 387-453 |
| PHEMA-- IAME2 40-67 387-453 |
| PHEMA-- IAME6 24-51 371-437 |
| PHEMA-- IAMIN 31-58 382-441 |
| PHEMA-- IANT6 387-453 |
| PHEMA-- IAPIL 505-534 |
| PHEMA-- IAPUE 29-56 425-478 |
| PHEMA-- IAQU7 24-51 |
| PHEMA-- IARUD 381-451 |
| PHEMA-- IASE2 381-451 |
| PHEMA-- IASH2 28-56 160-187 506-547 |
| PHEMA-- IASTA 119-146 384-443 |
| PHEMA-- IATAI 29-56 |
| PHEMA-- IATKI 415-445 |
| PHEMA-- IATKM 381-451 |
| PHEMA-- IATKO 507-534 |
| PHEMA-- IATKP 424-454 493-539 |
| PHEMA-- IATKR 32-62 194-221 381-422 |
| PHEMA-- IATKW 419-449 500-536 |
| PHEMA-- IATRA 21-55 |
| PHEMA-- IAUDO 40-67 387-453 |
| PHEMA-- IAUSS 29-56 425-478 |
| PHEMA-- IAV17 41-68 388-454 |
| PHEMA-- IAWIL 414-477 |
| PHEMA-- IAX1A 29-56 |
| PHEMA-- IAZCO 40-67 387-453 |
| PHEMA-- IAZH2 371-437 |
| PHEMA-- IAZH3 371-437 |
| PHEMA-- IAZIN 418-478 506-547 |
| PHEMA-- IAZNJ 418-478 506-547 |
| PHEMA-- IAZUK 387-453 |
| PHEMA-- INBBE 400-431 439-483 |
| PHEMA-- INBBO 390-421 429-473 |
| PHEMA-- INBEN 398-429 437-481 |
| PHEMA-- INBHK 391-418 429-473 |
| PHEMA-- INBLE 399-430 438-482 |
| PHEMA-- INBMD 389-420 428-472 |
| PHEMA-- INBME 393-424 432-476 |
| PHEMA-- INBOR 398-429 437-481 |
| PHEMA-- INBSI 398-429 437-481 |
| PHEMA-- INBUS 391-422 430-474 |
| PHEMA-- INBVI 393-424 432-476 |
| PHEMA-- INBVK 400-431 439-483 |
| PHEMA-- INCCA 495-571 |
| PHEMA-- INCEN 483-559 |
| PHEMA-- INCGL 483-559 |
| PHEMA-- INCHY 482-558 |
| PHEMA-- INCJH 496-572 |
| PHEMA-- INCKY 482-558 |
| PHEMA-- INCMI 482-558 |
| PHEMA-- INCNA 482-558 |
| PHEMA-- INCP1 483-559 |
| PHEMA-- INCP2 483-559 |
| PHEMA-- INCP3 483-559 |
| PHEMA-- INCTA 483-559 |
| PHEMA-- INCYA 483-559 |
| PHEMA-- NDVA 64-91 |
| PHEMA-- NDVB 64-91 |
| PHEMA-- NDVD 64-91 |
| PHEMA-- NDVH 64-91 |
| PHEMA-- NDVI 64-91 |
| PHEMA-- NDVM 64-91 |
| PHEMA-- NDVQ 64-91 |
| PHEMA-- NDVTG 64-91 |
| PHEMA-- NDVU 64-91 |
| PHEMA-- PHODV 39-66 46-73 |
| PHEMA-- P11HW 79-110 366-393 |
| PHEMA-- P13B 66-93 |
| PHEMA-- P13H4 27-61 |
| PHEMA-- P13HA 27-61 |
| PHEMA-- P13HT 27-76 |
| PHEMA-- P13HU 23-70 |
| PHEMA-- P13HV 27-61 |
| PHEMA-- P13HW 27-61 |
| PHEMA-- P13HX 27-61 |
| PHEMA-- RACVI 166-214 256-283 |
| PHEMA-- SEND5 79-106 |
| PHEMA-- SENDF 79-106 |
| PHEMA-- SENDH 79-106 |
| PHEMA-- SENDJ 79-106 |
| PHEMA-- SENDZ 79-106 |
| PHEMA-- SV41 22-52 394-421 |
| PHEMA-- VACCC 119-146 175-202 216-243 |
| PHEMA-- VACCI 109-146 175-202 216-243 |
| PHEMA-- VACCT 119-146 175-202 216-243 |
| PHEMA-- VACCV 109-146 175-202 215-242 |
| PHEMA-- VARV 111-148 177-211 214-244 |
| PHEX9-- ADE02 100-134 |
| PHEX9-- ADE05 100-134 |
| PHEX9-- ADE07 97-127 |
| PHEX-- ADE02 146-173 359-386 433-460 |
| PHEX-- ADE05 348-375 |
| PHEX-- ADE40 396-423 |
| PHEX-- ADEB3 305-338 |
| PH138-- COWPX 28-55 |
| PHRG-- COWPX 462-489 |
| PI196-- ASFB7 12-43 |
| PI226-- ASFB7 113-147 |
| PIBMP-- CAMV4 17-44 |
| PIBMP-- CAMVD 17-44 |
| PIBMP-- CAMVP 383-410 |
| PIBMP-- CERV 6-33 |
| PIBMP-- FMVD 372-407 |
| PIBMP-- SOCMV 3-48 331-358 |
| PIC18-- HCMVA 294-324 |
| PIC18-- HSVSA 58-85 482-522 |
| PIC18-- MCMVS 661-691 |
| PIE63-- HSV11 248-275 |
| PIE68-- HSV11 40-67 |
| PIE68-- HSVSA 48-78 |
| PIR05-- HCMVA 22-49 |
| PIR12-- HCMVA 74-162 |
| PIR13-- HCMVA 31-62 |
| PKFES-- FSVGA 106-150 |
| PKFGR-- FSVGR 218-252 |
| PKFMS-- FSVMD 327-362 |
| PKFPS-- FUJSV 155-243 349-397 |
| PKITH-- AMEPV 47-84 |
| PKITH-- CAPVK 41-68 |
| PKITH-- HSVSA 340-386 |
| PKITH-- ILTVT 334-361 |
| PKR74-- HSV11 491-518 |
| PKRB1-- VACCC 141-168 |
| PKRB1-- VACCV 141-168 |
| PKRB2-- VACCC 147-174 |
| PKRB2-- VACCV 147-174 |
| PKRF1-- VACCC 47-74 |
| PKRF1-- VACCV 47-74 |
| PKROS-- AVISU 111-138 |
| PKRYK-- AVIR3 22-49 |
| PKYES-- AVISY 199-233 |
| PL100-- ADE02 386-413 |
| PL100-- ADE05 386-413 |
| PL100-- ADE40 191-231 |
| PL100-- ADE41 206-233 |
| PLPM1-- EBV 148-175 |
| PLPM1-- EBVC 148-175 |
| PLPM1-- EBVR 148-175 |
| PLMP2-- EBV 294-321 |
| PMCEL-- SFVKA 54-156 289-316 497-524 622-656 |
| PMCEL-- VACCC 85-112 291-318 630-657 |
| PMCEL-- VACCV 85-112 291-318 630-657 |
| PMCEL-- VARV 85-112 291-318 630-657 |
| PMCE-- ASFB7 279-313 |
| PMOVP-- CGMVS 170-197 |
| PMOVP-- CGMVW 170-197 |
| PMOVP-- ORSV 53-90 |
| PMOVP-- TOMVA 46-80 |
| PMOVP-- TOMVL 46-80 |
| PMTCI-- CHVN1 143-170 229-256 |
| PMTC2-- CHVP1 4-31 130-172 |
| PMYC-- AVIM2 232-266 375-402 |
| PMYC-- AVIMC 233-267 376-403 |
| PMYC-- AVIMD 233-267 376-403 |
| PMYC-- AVIME 239-268 377-404 |
| PMYC-- AVIOK 227-261 370-397 |
| PMYC-- FLV 393-420 |
| PMYC-- FLVTT 393-420 |
| PNCAP-- BEV 49-76 129-156 |
| PNCAP-- BUNLC 85-112 |
| PNCAP-- BUNSH 96-123 |
| PNCAP-- BUNYW 48-75 189-220 |
| PNCAP-- CCHFV 223-271 |
| PNCAP-- CDVO 140-174 |
| PNCAP-- CHAV 40-74 |
| PNCAP-- CVCAE 191-277 |
| PNCAP-- CVPPU 191-227 |
| PNCAP-- CVPR8 191-227 |
| PNCAP-- CVPRM 191-227 |
| PNCAP-- DUGBV 238-265 |
| PNCAP-- FIPV 182-209 |
| PNCAP-- HAZVJ 6-33 256-283 |
| PNCAP-- HRSV1 4-31 74-108 112-141 |
| PNCAP-- HRSVA 4-31 |
| PNCAP-- LASSG 64-99 147-174 |
| PNCAP-- LASSJ 64-99 467-504 |
| PNCAP-- LYCVA 64-97 |
| PNCAP-- MAGV 41-68 192-219 |
| PNCAP-- MOPEI 64-99 |
| PNCAP-- PI1HC 377-404 455-482 |
| PNCAP-- PI1HW 377-404 444-488 |
| PNCAP-- P13H4 376-403 |
| PNCAP-- PTPV 3-30 |
| PNCAP-- PUUMH 2-29 |
| PNCAP-- PUUMS 2-29 |
| PNCAP-- PVM 93-120 |
| PNCAP-- RABVA 133-167 |
| PNCAP-- RABVP 133-167 |
| PNCAP-- RABVS 133-167 |
| PNCAP-- SEND5 363-404 |
| PNCAP-- SENDE 363-404 |
| PNCAP-- SEDNZ 363-404 |
| PNCAP-- SFSV 4-31 |
| PNCAP-- SV41 507-534 |
| PNCAP-- TACV 50-77 |
| PNCAP-- TOSV 6-33 |
| PNCAP-- UUK 68-102 |
| PNCAP-- VHSV0 284-314 |
| PNCAP-- VHSVM 149-176 284-314 |
| PNCAP-- VSVIG 56-83 |
| PNCAP-- VSVJO 67-94 338-365 |
| PNCAP-- VSVSJ 56-83 |
| PNEF-- HV1EL 81-119 |
| PNEF-- HV1ND 81-119 |
| PNEF-- HV1Z6 86-124 |
| PNEF-- SIVAI 96-137 |
| PNRAM-- IABDA 47-81 |
| PNRAM-- IACAO 33-64 |
| PNRAM-- IACHI 16-43 50-91 |
| PNRAM-- IADAI 51-81 |
| PNRAM-- IADGE 21-48 |
| PNRAM-- IAFPW 10-48 52-80 197-224 |
| PNRAM-- IAHCO 197-224 386-413 |
| PNRAM-- IAHK1 5-44 46-76 364-400 |
| PNRAM-- IAKIE 50-81 |
| PNRAM-- IALEN 50-81 |
| PNRAM-- IAME1 16-43 50-81 |
| PNRAM-- IAPAR 16-43 50-81 |
| PNRAM-- IAPUE 16-43 |
| PNRAM-- IARUE 49-88 |
| PNRAM-- IATRA 49-82 |
| PNRAM-- IAUSS 50-81 |
| PNRAM-- IAWHM 49-88 |
| PNRAM-- IAWIL 16-43 |
| PNRAM-- INBLE 4-35 |
| PNS1-- SIDEV 283-310 |
| PNS2-- SIDEV 42-69 |
| PNSS-- INSVN 95-122 |
| PNSS-- TSWVB 5-32 432-462 |
| PNSS-- TSWVL 5-32 |
| PNTP1-- AMEPV 28-69 |
| PNTP1-- CBEPV 122-166 347-374 524-551 |
| PNTP1-- VACCC 65-92 394-421 514-587 |
| PNTP1-- VACCV 65-92 394-421 514-587 |
| PNTP1-- VARV 300-327 420-447 455-493 |
| PP100-- HSV6U 81-108 189-216 688-715 785-812 |
| PPAP1-- VACCC 88-115 |
| PPAP1-- VACCV 88-115 |
| PPAP1-- VARV 88-115 |
| PPAP2-- CAPVK 118-145 |
| PPAP2-- FOWPV 27-54 |
| PPE12-- NPVAC 61-105 |
| PPE12-- NPVOP 61-95 |
| PPE38-- NPVAC 204-248 |
| PPE48-- NPVAC 4-38 51-78 |
| PPEND3-- ADEGX 96-123 |
| PPOL1-- BAYMG 1272-1299 1775-1802 2236-2263 |
| PPOL1-- BAYMJ 1774-1801 2234-2261 |
| PPOL1-- GCMV 481-508 1909-1941 |
| PPOL1-- GFLV 170-197 636-677 958-985 1161-1195 |
| PPOL1-- TBRVS 1096-1123 |
| PPOL2-- BAYMG 240-281 801-828 |
| PPOL2-- BAYMJ 240-267 801-828 |
| PPOL2-- GCMV 11-38 |
| PPOL2-- GFLV 549-576 |
| PPOL2-- TRSVR 982-1009 |
| PPOLG-- BOVEV 17-44 1030-1057 1145-1172 |
| PPOLG-- BVDVN 629-660 1082-1112 1303-1330 2233-2261 2476-2503 |
| 2609-2636 |
| 3613-3642 |
| PPOLG-- |
| BVDVS 1303-1333 |
| 2143-2171 |
| 2519-2546 |
| 2802-2829 |
| 3523-3550 |
| PPOLG-- |
| BYMV 96-123 |
| PPOLG-- |
| COXA2 7-34 |
| 664-694 |
| 1062-1099 |
| 1900-1930 |
| PPOLG-- |
| COXA9 1040-1076 |
| PPOLG-- COXB1 645-672 841-868 1021-1057 |
| PPOLG-- COXB3 1024-1060 1881-1908 |
| PPOLG-- COXB4 644-673 1022-1058 |
| PPOLG-- COXB5 1024-1060 |
| PPOLG-- CYVV 120-154 |
| PPOLG-- DEN1S 1858-1885 2890-2915 2989-3016 |
| PPOLG-- DEN26 1544-1571 1858-1885 2908-2935 2982-3016 3117-3147 |
| PPOLG-- |
| DEN27 1544-1571 |
| 1858-1885 |
| 2485-2519 |
| 2908-2935 |
| 2982-3016 |
| 3117-3147 |
| PPOLG-- |
| DEN2J 1544-1571 |
| 1858-1885 |
| 2908-2935 |
| 3117-3147 |
| 3346-3373 |
| PPOLG-- |
| DEN2P 1544-1571 |
| 1858-1885 |
| 2905-2932 |
| 2979-3013 |
| 3114-3144 |
| 3343-3370 |
| PPOLG-- |
| DEN2T 1134-1161 |
| 1448-1475 |
| PPOLG-- |
| DEN3 837-864 |
| 1542-1569 |
| 1857-1884 |
| 2494-2521 |
| 2980-3014 |
| 3345-3372 |
| PPOLG-- |
| DEN4 2885-2930 |
| 2977-3011 |
| 3342-3369 |
| PPOLG-- |
| EC11G 213-249 |
| PPOLG-- |
| EMCV 70-108 |
| 1484-1518 |
| 1522-1563 |
| PPOLG-- |
| EMCVB 70-97 |
| 1486-1520 |
| 1524-1565 |
| PPOLG-- |
| EMCVD 70-97 |
| 1486-1520 |
| 1524-1565 |
| PPOLG-- |
| ENMG3 70-108 |
| PPOLG-- |
| ENMGO 3-41 |
| PPOLG-- |
| FMDV1 302-329 |
| 1119-1146 |
| PPOLG-- |
| FMDVA 301-328 |
| 1119-1146 |
| PPOLG-- |
| FMDVO 1119-1146 |
| PPOLG-- FMDVS 101-128 |
| PPOLG-- HCV1 702-729 |
| PPOLG-- HCVA 699-726 1195-1232 1303-1333 1434-1461 3068-3095 |
| 3406-3340 |
| PPOLG-- |
| HCVB 699-726 |
| 1195-1232 |
| 3068-3095 |
| 3406-3440 |
| 3532-3559 |
| PPOLG-- |
| HCVBK 702-729 |
| 1045-1072 |
| PPOLG-- |
| HCVH 702-729 |
| 1045-1072 |
| PPOLG-- |
| HCVJ6 374-401 |
| 2089-2116 |
| PPOLG-- |
| HCVJ8 1049-1076 |
| 2089-2116 |
| PPOLG-- |
| HCVJA 378-405 |
| 702-729 |
| 1045-1072 |
| PPOLG-- |
| HCVJT 702-729 |
| 1045-1072 |
| PPOLG-- |
| HCVJW 702-729 |
| 1045-1072 |
| PPOLG-- |
| HPAV2 203-237 |
| 1021-1048 |
| 1117-1149 |
| 1454-1481 |
| PPOLG-- |
| HPAV4 203-237 |
| 1021-1048 |
| 1117-1149 |
| 1454-1481 |
| PPOLG-- |
| HPAV8 203-237 |
| 1021-1048 |
| 1117-1149 |
| 1454-1481 |
| PPOLG-- |
| HPAVC 203-237 |
| PPOLG-- |
| HPAVG 182-216 |
| PPOLG-- |
| HPAVH 203-237 |
| 1021-1048 |
| 1103-1149 |
| PPOLG-- |
| HPAVL 203-237 |
| 1021-1048 |
| 1103-1149 |
| PPOLG-- |
| HPAVM 203-237 |
| 1021-1048 |
| 1103-1149 |
| PPOLG-- |
| HPAVS 207-241 |
| 1025-1052 |
| 1115-1192 |
| PPOLG-- |
| HPAVT 203-237 |
| PPOLG-- |
| HRV14 17-44 |
| 559-586 652-679 |
| 1877-1904 |
| PPOLG-- |
| HRV1B 1132-1159 |
| 1855-1882 |
| PPOLG-- |
| HRV2 1125-1152 |
| 1552-1593 |
| PPOLG-- |
| HRV89 883-910 |
| 1141-1168 |
| 1566-1607 |
| 1862-1889 |
| PPOLG-- |
| HUEV7 876-910 |
| PPOLG-- |
| IBDVO 231-277 |
| PPOLG-- |
| JAEV1 214-248 |
| 983-1010 |
| 2796-2823 |
| PPOLG-- |
| JAEV5 214-248 |
| 983-1010 |
| 2796-2823 |
| PPOLG-- |
| JAEVJ 214-248 |
| 983-1010 |
| 2796-2823 |
| PPOLG-- |
| JAEVN 141-175 |
| 911-938 |
| PPOLG-- |
| KUNJM 980-1007 |
| PPOLG-- LANVT 431-465 1634-1661 |
| PPOLG-- LANVY 431-465 |
| PPOLG-- LIV 431-465 |
| PPOLG-- LIVSB 151-185 |
| PPOLG-- MCFA 671-698 3056-3083 3303-3330 |
| PPOLG-- MDMV 10-37 |
| PPOLG-- MVEV 212-256 |
| PPOLG-- OMV 24-51 946-973 |
| PPOLG-- PEMVC 377-404 704-738 831-858 900-927 1167-1201 1485-1512 |
| 1787-1814 2433- |
| 2464 |
| PPOLG-- POL1M 1060-1100 1901-1931 |
| PPOLG-- POL1S 670-697 1063-1101 1903-1933 |
| PPOLG-- POL2L 1061-1099 1901-1931 |
| PPOLG-- POL2W 1061-1099 1901-1931 |
| PPOLG-- POL32 1060-1098 1900-1930 |
| PPOLG-- POL3L 1060-1098 1900-1930 |
| PPOLG-- PPVD 921-948 1498-1525 2771-2798 |
| PPOLG-- PPVEA 1146-1187 |
| PPOLG-- PPVNA 920-947 1497-1524 2770-2800 |
| PPOLG-- PPVRA 920-947 1497-1524 2770-2797 |
| PPOLG-- PRSVH 500-527 |
| PPOLG-- PRSVP 391-418 |
| PPOLG-- PRSVW 489-516 |
| PPOLG-- PSBMV 271-315 1132-1177 1510-1537 |
| PPOLG-- PVYC 433-460 701-735 |
| PPOLG-- PVYHU 218-245 433-460 701-735 1486-1513 1777-811 |
| PPOLG-- PVYN 433-460 701-735 1486-1513 1777-1811 |
| PPOLG-- PVYO 433-460 701-735 |
| PPOLG-- PYFV1 1124-1151 2707-2734 |
| PPOLG-- SUMVS 10-37 |
| PPOLG-- SVDVH 1024-1060 |
| PPOLG-- SVDVU |
| PPOLG-- TBEVS 87-121 234-272 1632-1661 2265-2292 2909-2936 |
| PPOLG-- |
| TBEVW 1632-1659 |
| PPOLG-- TEV 845-872 1148-1175 1416-1443 1773-1800 |
| PPOLG-- TMEVB 79-117 200-227 |
| PPOLG-- TMEVD 90-117 200-227 |
| PPOLG-- TMEVG 90-117 200-227 |
| PPOLG-- TUMV 232-262 773-800 |
| PPOLG-- TVMV 406-433 670-704 2708-2742 |
| PPOLG-- WMV2 202-229 |
| PPOLG-- WNV 210-254 3385-3412 |
| PPOLG-- YEFV1 436-463 |
| PPOLG-- YEFV2 436-463 |
| PPOLG-- ZYMV 69-96 |
| PPOLH-- POL1M 1063-1101 1903-1933 |
| PPOLN-- EEVVT 1402-1467 1894-1921 |
| PPOLN-- FCVC6 445-472 |
| PPOLN-- FCVF9 1034-1061 |
| PPOLN-- HEVBU 219-246 349-376 |
| PPOLN-- HEVME 219-246 349-376 |
| PPOLN-- HEVMY 219-246 349-376 |
| PPOLN-- HEVPA 218-245 348-375 |
| PPOLN-- MIDDV 955-982 |
| PPOLN-- ONNVG 2453-2480 |
| PPOLN-- RHDV 313-347 1657-1684 |
| PPOLN-- RRVN 1057-1084 1477-1504 2418-2445 |
| PPOLN-- RRVT 146-173 1087-1114 |
| PPOLN-- RUBVT 2060-2087 |
| PPOLN-- SFV 1154-1181 |
| PPOLN-- SINDO 936-970 |
| PPOLN-- WEEV 4-31 |
| PPOLS-- IBDV5 231-258 |
| PPOLS-- IBDVA 231-258 |
| PPOLS-- IBDVC 231-258 |
| PPOLS-- IBDVE 231-258 |
| PPOLS-- IBDVP 212-239 |
| PPOLS-- IBDVS 231-258 |
| PPOLS-- ONNVG 356-383 |
| PPOLS-- RRVN 939-973 |
| PPOLS-- RRVT 939-973 |
| PPOLS-- SINDO 1138-1165 |
| PPOLS-- SINDV 1138-1165 |
| PPOLS-- SINDV 920-947 |
| PPOL-- BAEVM 675-706 715-742 |
| PPOL-- CAEVC 886-924 |
| PPOL-- COYMV 333-360 838-865 1075-1102 1178-1205 1313-1347 |
| PPOL-- |
| EIAV9 472-505 |
| 826-853 |
| PPOL-- |
| IEAVC 472-505 |
| 826-853 |
| PPOL-- |
| EIAVY 471-504 |
| 825-852 |
| PPOL-- |
| FENV1 531-599 |
| 627-654 |
| PPOL-- |
| FIVPE 442-473 |
| PPOL-- |
| FMVD 403-430 |
| PPOL-- |
| GALV 535-562 |
| 676-703 |
| PPOL-- |
| HTL1A 674-712 |
| PPOL-- |
| HTL1C 674-712 |
| PPOL-- |
| HV1A2 218-245 |
| 620-661 |
| PPOL-- |
| HV1B1 230-257 |
| 637-673 |
| PPOL-- |
| HV1B5 230-257 |
| 632-673 |
| PPOL-- |
| HV1BR 230-257 |
| 632-673 |
| PPOL-- |
| HV1EL 217-244 |
| 624-660 |
| PPOL-- |
| HV1H2 218-245 |
| 620-661 921-951 |
| PPOL-- HV1JR 222-249 624-665 |
| PPOL-- HV1MA 217-244 476-510 619-660 |
| PPOL-- HV1MN 221-248 623-664 |
| PPOL-- HV1N5 218-245 625-661 |
| PPOL-- HV1ND 217-244 624-660 |
| PPOL-- HV1OY 218-245 620-661 |
| PPOL-- HV1PV 230-257 637-673 |
| PPOL-- HV1RH 217-244 619-660 |
| PPOL-- HV1U4 217-244 513-540 619-660 |
| PPOL-- HV1Z2 217-244 619-660 |
| PPOL-- HV2BE 491-582 |
| PPOL-- HV2CA 471-562 |
| PPOL-- HV2D1 509-600 |
| PPOL-- HV2D2 491-568 |
| PPOL-- HV2G1 471-562 |
| PPOL-- HV2NZ 471-529 |
| PPOL-- HV2RO 472-563 |
| PPOL-- HV2SB 473-562 |
| PPOL-- HV2ST 491-582 |
| PPOL-- IPHA 200-227 354-381 461-499 |
| PPOL-- IPMA 211-238 302-329 400-427 |
| PPOL-- IPMAI 130-157 221-248 |
| PPOL-- JSRV 204-231 |
| PPOL-- MLVAK 453-480 |
| PPOL-- MLVAV 805-832 |
| PPOL-- MLVRD 716-743 805-832 |
| PPOL-- MLVRK 101-128 190-217 |
| PPOL-- MPMV 574-612 670-697 |
| PPOL-- OMVVS 67-94 471-505 873-900 |
| PPOL-- RSVP 797-824 |
| PPOL-- RTBV 7-44 59-93 176-203 202-229 410-437 447-476 1022-1049 |
| PPOL-- |
| RTBVP 7-44 |
| 59-93 176-203 |
| 202-229 410-437 |
| 447-476 |
| 1022-1049 |
| PPOL-- |
| SFV1 427-454 |
| PPOL-- |
| SIVA1 431-458 |
| 547-574 637-671 |
| PPOL-- SIVA2 45-72 |
| PPOL-- SIVA3 71-98 |
| PPOL-- SIVAG 436-463 482-516 642-669 |
| PPOL-- SIVAI 478-515 |
| PPOL-- SIVAT 657-691 |
| PPOL-- SIVCZ 242-269 626-685 |
| PPOL-- SIVGB 227-254 636-670 |
| PPOL-- SIVM1 533-560 |
| PPOL-- SIVMK 533-560 |
| PPOL-- SIVS4 496-523 |
| PPOL-- SIVSP 499-526 |
| PPOL-- SMRVH 601-628 |
| PPOL-- SOCMV 268-295 348-419 |
| PPOL-- SRV1 578-612 670-697 |
| PPOL-- VILV 490-524 881-919 |
| PPOL-- VILV1 89-116 490-524 881-919 |
| PPOL-- VILV2 490-524 881-919 |
| PPR73-- MMTVB 288-315 |
| PPR73-- MMTVC 45-79 |
| PPR73-- MMTVG 167-201 |
| PPYHD-- CPVBM 37-71 |
| PPYHD-- NPVAC 13-47 |
| PPYHD-- NPVAS 14-48 201-228 |
| PPYHD-- NPVBM 12-46 |
| PPYHD-- NPVBS 14-48 |
| PPYHD-- NPVHC 13-40 |
| PPYHD-- NPVLD 14-48 |
| PPYHD-- NPVMB 14-48 |
| PPYHD-- NPVOP 13-47 |
| PPYHD-- NPVOS 14-48 |
| PPYHD-- NPVPF 14-48 |
| PPYHD-- NPVSE 14-48 |
| PPYHD-- NPVSF 14-48 |
| PREV-- SIVAT 41-68 |
| PREV-- VILV 22-62 |
| PRIR1-- ASFM2 7-41 88-119 363-390 |
| PRIR1-- HCMVA 622-649 |
| PRIR1-- HSVEB 75-102 |
| PRIR1-- HSVSA 324-351 |
| PRIR1-- VACCC 367-401 |
| PRIR1-- VACCV 367-401 |
| PRIR1-- VARV 367-401 |
| PRIR1-- VZVD 119-146 |
| PRIR2-- HSVB3 90-117 |
| PRP94-- VACCV 41-68 513-540 |
| PRP93-- VARV 41-75 77-104 513-540 |
| PRPO1-- VACCC 237-264 587-616 810-837 961-992 |
| PRPO1-- VACCV 237-264 587-616 810-837 961-992 1011-1038 |
| PRPO1-- VARV 237-264 587-616 810-837 961-992 |
| PRPO2-- CAPVK 19-65 114-155 |
| PRPO2-- COWPX 211-241 481-509 |
| PRPO2-- VACCV 211-241 481-509 |
| PRPO2-- VARV 211-241 481-509 |
| PRPO4-- CAPVK 36-63 |
| PRPO7-- VACCV 8-35 43-70 |
| PRPO7-- VARV 43-70 |
| PRPOA-- ELV 1533-1560 |
| PRPOL-- EAV 888-915 1639-1673 |
| PRRP1-- IAKOR 575-602 |
| PRRP2-- IAANN 119-146 |
| PRRP2-- IADH2 119-146 |
| PRRP2-- IAFPR 119-146 |
| PRRP2-- IAGU2 119-146 |
| PRRP2-- IAHLO 119-146 |
| PRRP2-- IAHTE 119-146 |
| PRRP2-- IAKOR 119-146 |
| PRRP2-- IALE1 119-146 |
| PRRP2-- IALE2 119-146 |
| PRRP2-- IAMAN 119-146 |
| PRRP2-- IANT6 119-146 |
| PRRP2-- IAP10 119-146 |
| PRRP2-- IAPUE 119-146 |
| PRRP2-- IARUD 119-146 |
| PRRP2-- IASIN 119-146 |
| PRRP2-- IATKM 119-146 |
| PRRP2-- IAV17 119-146 327-354 |
| PRRP2-- IAWIL 119-146 |
| PRRP2-- IAZH2 119-146 |
| PRRP2-- IAZH3 119-146 |
| PRRP2-- IAZH 119-146 |
| PRRP2-- IAZTF 119-146 |
| PRRP2-- INBAC 157-194 |
| PRRP2-- INBAD 164-194 |
| PRRP2-- INBSI 157-194 |
| PRRP3-- IABUD 537-567 |
| PRRP3-- IACH1 331-358 |
| PRRP3-- IAHPR 331-361 480-507 |
| PRRP3-- IAZTE 487-514 |
| PRRP3-- INBAC 2-33 472-509 |
| PRRP3-- INBAD 2-33 472-509 |
| PRRP3-- INCBE 509-536 |
| PRRP3-- INCJJ 509-536 |
| PRRP3-- THOGV 149-176 358-385 |
| PRRPA-- CVH22 516-543 724-751 1971-2008 3781-3811 |
| PPRPA-- CVMJH 624-651 4326-4353 |
| PPRPB-- BEV 27-54 557-584 943-984 |
| PPRPB-- CVMA5 885-915 1129-1170 |
| PPRPB-- CVMJH 885-915 1129-1170 |
| PPRPB-- CVPFS 20-47 353-380 385-412 |
| PPRPB-- IBVB 1510-1547 2296-2331 2547-2574 |
| PPRPB-- IBVK 165-200 416-443 |
| PRRPL-- BTV10 1032-1059 |
| PRRPL-- BUNYW 80-114 317-350 1802-1861 1892-1919 |
| PRRPL-- CDVO 24-51 |
| PRRPL-- HANTV 404-433 461-510 564-591 738-765 905-946 1993-2020 |
| PRRPL-- |
| HRSVA 103-192 |
| 210-237 667-694 |
| 788-815 |
| 1007-1034 |
| 1138-1165 |
| 1453-1480 1776- |
| 2062- |
| 1803 2089 |
| PRRPL-- MABVM 991-1018 1143-1170 1490-1524 1811-1838 2029-2067 |
| 2216-2266 |
| PRRPL-- |
| MABVP 991-1018 |
| 1490-1524 |
| 2239-2267 |
| PRRPL-- |
| MEASE 95-122 |
| 196-223 |
| 2121-2148 |
| PRRPL-- |
| MUMPM 111-142 |
| 780-807 |
| 1602-1632 |
| PRRPL-- |
| NDVB 250-284 |
| 477-504 |
| 1979-2013 |
| PRRPL-- |
| P12HT 322-349 |
| 1564-1598 |
| 1687-1721 |
| 1901-1946 |
| PRRPL-- |
| P13H4 52-86 |
| 136-163 608-638 |
| 1081-1123 |
| 1994-2036 |
| 2115-2142 |
| PRRPL-- |
| PUUMH 388-415 |
| 557-591 731-758 |
| 864-891 926-953 |
| 1940-1971 |
| 998-2025 |
| PRRPL-- |
| RABVP 204-231 |
| 605-632 |
| 2068-2123 |
| PRRPL-- |
| RABVS 204-231 |
| 605-632 |
| 2068-2123 |
| PRRPL-- |
| RDV 855-882 |
| PRRPL-- |
| RVFVZ 1536-1563 |
| 1653-1687 |
| PRRPL-- |
| SEND5 629-656 |
| 1082-1116 |
| 1729-1756 |
| 2145-2180 |
| PRRPL-- |
| SENDE 449-476 |
| 902-936 |
| 1549-1576 |
| 1965-2000 |
| PRRPL-- |
| SENDZ 629-656 |
| 1082-1116 |
| 1729-1756 |
| 2145-2180 |
| PRRPL-- |
| SEOU8 461-488 |
| 564-591 731-758 |
| 905-932 |
| PRRPL-- |
| SV5WR 1096-1123 |
| 1250-1277 |
| 1680-1710 |
| 2120-2147 |
| PRRPL-- |
| SYNV 825-859 |
| 1092-1119 |
| 1490-1520 |
| 1973-2000 |
| 2080-2107 |
| PRRPL-- |
| TSWVB 477-504 |
| 542-5734 |
| 1119-1150 |
| 1195-1229 |
| 1330-1357 |
| 1415-1442 |
| 1671-1698 1857- |
| 2083- |
| 2166-2193 2324-2368 2771-2798 1884 2110 |
| PRRPL-- UUK 142-187 1037-1071 1304-1331 |
| PRRPL-- VSVJH 1530-1557 1809-1836 |
| PRRPL-- VSVJO 1205-1232 1809-1836 |
| PRRPL-- VSVSJ 1540-1567 1768-1798 |
| PRRPO-- ACLSV 228-264 564-591 |
| PRRPO-- BWYVF 356-383 |
| PRRPO-- BYDV1 772-799 |
| PRRPO-- BYDVP 772-799 |
| PRRPO-- BYDVR 772-799 |
| PRRPO-- CARMV 93-127 277-304 667-694 |
| PRRPO-- CGMVS 387-414 1040-1067 |
| PRRPO-- IBDV5 336-363 392-419 |
| PRRPO-- IBDVA 661-688 717-744 |
| PRRPO-- IPNVJ 773-800 |
| PRRPO-- IPNVS 773-800 |
| PRRPO-- LYCVA 834-886 1052-1079 |
| PRRPO-- PPMVS 402-429 709-736 1072-1099 |
| PRRPO-- REOVD 61-88 |
| PRRPO-- REOVL 61-88 |
| PRRPO-- ROTBR 68-95 218-245 791-818 |
| PRRPO-- ROTBU 65-95 218-245 791-841 975-1002 |
| PRRPO-- ROTPC 3-44 75-102 363-390 543-585 |
| PRRPO-- ROTPO 65-95 102-129 791-839 973-1002 |
| PRRPO-- ROTS1 65-95 791-839 975-1002 |
| PRRPO-- SCVLA 147-188 |
| PRRPO-- TACV 163-204 241-271 1107-1134 1978-2008 |
| PRRPO-- TMGMV 230-257 1316-1343 1397-1424 |
| PRRPP-- BRSVA 99-133 |
| PRRPP-- CSVO 315-370 |
| PRRPP-- HRSV 99-141 |
| PRRPP-- HRSV1 99-141 |
| PRRPP-- HRSVA 99-141 |
| PRRPP-- HRSVL 99-141 |
| PRRPP-- MEASE 315-370 |
| PRRPP-- MEASI 315-370 |
| PRRPP-- MEASY 315-370 |
| PRRPP-- PI1HB 84-111 234-261 375-416 |
| PRRPP-- PI1HC 84-111 234-261 375-416 |
| PRRPP-- PI1HD 84-111 232-262 375-416 |
| PRRPP-- PI1HE 84-111 244-271 375-416 |
| PRRPP-- PI2H 167-194 222-256 |
| PRRPP-- PI2HT 167-194 222-256 |
| PRRPP-- P13B 34-91 255-282 285-314 |
| PRRPP-- P13H4 114-144 269-299 |
| PRRPP-- P14HA 4-38 |
| PRRPP-- RABVP 93-127 |
| PRRPP-- SEND5 330-357 379-420 |
| PRRPP-- SEND6 330-357 379-420 |
| PRRPP-- SENDF 330-357 379-420 |
| PRRPP-- SENFH 330-357 379-420 |
| PRRPP-- SENDZ 330-357 379-420 |
| PRRPP-- SV5 205-232 236-263 |
| PSODC-- VACCV 72-99 |
| PSODC-- VARV 72-99 |
| PSPHR-- AMEPV 91-118 140-167 227-261 361-390 |
| PSPH-- MYXVL 286-313 |
| PSP12-- VACCV 59-86 |
| PSPIA-- VACCC 18-65 |
| PT2C2-- CHVP1 16-43 |
| PTAA2-- VACCV 95-133 |
| PTAG8-- FOWPV 3-51 |
| PTAG8-- VACCV 3-30 |
| PTAG8-- VARV 3-30 |
| PTAG8-- BFDV 291-318 |
| PTALA-- POVBO 502-537 |
| PTALA-- POVHA 587-621 |
| PTALA-- POVLY 224-258 616-684 |
| PTALA-- POVM3 513-540 |
| PTALA-- POVMA 511-538 |
| PTALA-- POVMC 508-535 |
| PTATR-- NPVAC 407-434 489-523 532-559 |
| PTATR-- MPVOP 412-439 494-528 537-564 |
| PTATR-- NPVOP 512-554 |
| PTEGU-- EBV 145-172 1215-1242 1344-1371 1876-1903 |
| PTEGU-- HCMVA 1251-1281 2202-2229 |
| PTEGU-- HSV11 667-694 1673-1710 |
| PTEGU-- HSV6G 102-129 228-262 567-611 962-993 1098-1181 1661-1688 |
| 1884-1911 |
| PTEGU-- |
| HSV3B 229-256 |
| 566-593 |
| 1205-1232 |
| PTEGU-- |
| HSVSA 524-607 |
| 672-700 777-814 |
| 846-898 949-986 |
| 990-1017 |
| 1467-1497 2102- |
| 2135 |
| PTEGU-- VZVD 1121-1158 1579-1609 |
| PTERM-- ADE07 375-413 |
| PTMAF-- AVIS4 302-336 |
| PTOP1-- SFVKA 38-65 132-176 |
| PTOP1-- VACCV 38-65 |
| PTOP1-- VARV 38-65 |
| PTOP2-- ASFM2 902-936 |
| PTYSY-- HSVAT 116-143 |
| PTYSY-- HSVSA 120-147 |
| PUL06-- EBV 115-142 313-340 542-569 |
| PUL06-- HSV11 586-613 |
| PUL06-- HSVEB 640-667 |
| PUL06-- HSVSA 15-42 302-358 368-402 |
| PUL08-- HCMVA 6-47 |
| PUL11-- EBV 15-42 |
| PUL13-- HCMVA 347-374 |
| PUL14-- HSVEB 247-286 |
| PUL14-- VZVD 64-101 |
| PUL16-- HCMVA 81-112 |
| PUL20-- HCMVA 34-61 |
| PUL21-- HSVEB 44-71 |
| PUL21-- VZVD 380-407 |
| PUL25-- HSVSA 34-61 204-231 362-389 |
| PUL31-- HCMVA 167-194 254-284 |
| PUL32-- HSVEB 345-375 |
| PUL34-- HSV11 116-143 |
| PUL34-- HSVSA 208-235 |
| PUL34-- VZVD 112-139 |
| PUL35-- HCMVA 535-562 |
| PUL37-- HSV11 470-497 853-884 |
| PUL37-- HSVEB 715-749 987-1014 |
| PUL37-- HSVSA 31-65 685-737 |
| PUL37-- VZVD 107-134 485-512 719-746 976-1003 |
| PUL41-- VZVD 330-364 |
| PUL42-- HSV11 231-258 |
| PUL43-- VZVD 129-156 312-349 |
| PUL47-- HCMVA 114-148 448-485 763-790 802-853 |
| PUL47-- HSV11 488-515 |
| PUL47-- VSV1F 488-515 |
| PUL47-- HSVE4 190-217 |
| PUL50-- HCMVA 159-186 |
| PUL52-- EBV 185-212 787-814 |
| PUL52-- HSVEB 193-220 943-970 |
| PUL52-- HSVSA 130-157 |
| PUL52-- VZVD 301-337 |
| PUL59-- HCMVA 74-101 |
| PUL70-- HCMVA 65-92 |
| PUL73-- HCMVA 5-73 |
| PUL73-- HSVSA 9-36 |
| PUL74-- HCMVA 45-79 |
| PUL87-- EBV 409-436 |
| PUL87-- HSV6U 536-563 729-768 |
| PUL87-- HSVSA 582-609 |
| PUL92-- EBV 107-144 168-196 |
| PUL92-- HSVSA 92-122 |
| PUL93-- HCMVA 26-53 314-381 |
| PUL95-- HCMVA 37-71 |
| PUL95-- HSV6U 73-100 105-134 |
| PULA4-- HCMVA 4-31 443-477 |
| PULB9-- HCMVA 33-78 |
| PULD0-- HCMVA 90-124 |
| PUNG-- HSVSA 135-176 |
| PUNG-- SFVKA 81-115 |
| PUNG-- VACCC 85-116 129-156 |
| PUNG-- VACCV 85-116 129-156 |
| PUNG-- VARV 85-116 |
| PUS09-- HCMVA 20-47 |
| PUS14-- HCMVA 277-308 |
| PUS18-- HCMVA 191-218 |
| PV121-- ASFL5 2-29 |
| PV125-- AMVLE 702-729 |
| PV137-- ASFL5 2-29 |
| PV13K-- TRVPL 59-86 |
| PV143-- NPVAC 496-560 945-972 |
| PV16K-- TRVPS 79-113 |
| PV1A-- BBMV 23-54 710-737 840-868 |
| PV1A-- BMV 22-58 384-411 836-863 892-919 |
| PV1A-- CCMV 249-276 |
| PV1A-- CMVFN 11-38 |
| PV1A-- CMVO 11-38 864-902 |
| PV1A-- CMVQ 11-38 |
| PV1A-- PSVJ 4-38 372-399 |
| PV1A-- TAV 11-38 271-298 376-403 857-884 |
| PV25K-- NPVAC 4-31 |
| PV29K-- PEBV 140-170 |
| PV29K-- TRVSY 170-197 |
| PV29K-- TRVTC 48-75 |
| PV2A-- BBMV 301-328 |
| PV2A-- CCMV 178-205 |
| PV2A-- CMVFN 792-819 |
| PV2A-- PSVJ 325-352 717-751 |
| PV2A-- TAV 313-340 722-756 |
| PV30K-- HCMVE 194-221 |
| PV30K-- TRVTC 130-160 |
| PV33P-- ADE41 15-42 |
| PV362-- ASFB7 75-102 |
| PV363-- ASFB7 3-30 172-199 |
| PV3A-- BMV 11-18 |
| PV3A-- CMVFN 222-252 |
| PV3A-- CMVM 217-252 |
| PV3A-- CMVO 222-253 |
| PV3A-- CMVY 222-253 |
| PV3A-- IBVB 25-57 |
| PV3A-- IBCU3 29-56 |
| PV3B-- IBVB 6-33 |
| PV50K-- BYDVP 119-146 |
| PV51K-- BWYVF 113-147 424-451 |
| PV51K-- BWYVG 113-147 424-451 |
| PV56K-- PLRVI 124-151 438-472 |
| PV56K-- PLRVW 124-151 438-477 |
| PV58K-- BSMV 128-155 |
| PV70K-- PLRVI 110-140 |
| PV70K-- PLRVW 110-140 |
| PV90K-- AMVLE 107-134 |
| PVA06-- VACCC 157-216 250-277 283-310 314-355 |
| PVA06-- VACCV 156-215 249-276 282-309 313-354 |
| PVA06-- VARV 157-216 250-277 283-310 314-355 |
| PVA06-- VACCC 176-206 |
| PVA06-- VARV 176-206 |
| PVA09-- VARV 60-95 |
| PVA11-- VACCC 219-283 |
| PVA11-- VARV 220-284 |
| PVA18-- VARV 440-467 |
| PVA20-- VACCC 8-67 330-357 |
| PVA20-- VARV 8-67 330-357 |
| PVA22-- VACCC 45-72 |
| PVA22-- VARV 56-83 |
| PVA23-- VACCC 95-144 |
| PVA23-- VARV 95-144 |
| PVA28-- VACCC 22-49 |
| PVA28-- VARV 22-49 |
| PVA30-- VACCC 12-55 |
| PVA31-- VACCC 88-115 |
| PVA31-- VARV 88-122 |
| PVA34-- VACCC 87-114 |
| PVA34-- VACCC 87-114 |
| PVA34-- VARV 87-114 |
| PVA36-- VACCC 120-155 |
| PVA36-- VARV 127-154 |
| PVA38-- VACCC 44-81 |
| PVA38-- VACCV 44-81 |
| PVA38-- VARV 44-91 |
| PVA39-- VACCC 37-71 115-182 |
| PVA39-- VACCV 75-109 193-220 |
| PVA43-- VACCC 145-172 |
| PVA43-- VACCV 145-172 |
| PVA43-- VARV 146-173 |
| PVA47-- VACCC 143-184 |
| PVA47-- VACCV 143-184 |
| PVA47-- VARV 142-184 |
| PVA49-- VACCC 61-91 |
| PVA49-- VACCV 61-91 |
| PVA49-- VARV 61-91 |
| PVA55-- VACCC 55-82 126-156 435-462 |
| PVA55-- VACCV 55-82 126-156 435-462 |
| PVAL1-- BCTV 22-49 |
| PVAL3-- CLVK 79-106 |
| PVAL3-- CLVN 79-106 |
| PVAL3-- SLVN 101-128 |
| PVAL3-- TYLCV 79-129 |
| PVAT-- CAMVC 22-70 93-129 |
| PVAT-- CAMVD 22-70 |
| PVAT-- CAMVE 22-70 93-129 |
| PVAT-- CAMVN 22-70 93-129 |
| PVAT-- CAMVP 22-70 93-129 |
| PVAT-- CAMVS 22-70 93-129 |
| PVAT-- CAMVW 36-70 |
| PVAT-- CERV 102-138 |
| PVB03-- FMVD 52-82 103-130 |
| PVB04-- VACCV 108-135 |
| PVB04-- VACCC 92-123 182-211 286-313 324-361 |
| PVB04-- VACCV 92-123 182-211 286-313 324-361 |
| PVB04-- VARV 89-127 182-211 286-313 324-361 |
| PVB05-- VACC0 254-284 |
| PVB05-- VACCC 254-284 |
| PVB05-- VACCL 254-284 |
| PVB05-- VACCV 254-284 |
| PVB07-- VACCV 28-62 |
| PVB08-- VACCC 26-53 |
| PVB08-- VACCV 26-53 |
| PVB11-- VACCC 21-54 |
| PVB11-- VACCV 5-38 |
| PVB16-- COWPX 113-140 |
| PVB17-- VACCC 258-285 |
| PVB17-- VACCV 258-285 |
| PVB18-- VACCC 337-375 |
| PVB18-- VACCV 337-375 |
| PVB18-- VARV 337-378 |
| PVB19-- VACCC 182-212 |
| PVB19-- VACCD 180-210 |
| PVB19-- VACCV 180-210 |
| PVB19-- VARV 180-210 |
| PVB20-- VACCC 48-82 |
| PVB21-- VACCV 64-91 |
| PVBLI-- BGMV 120-147 248-275 |
| PVBLI-- CLVK 118-145 |
| PVBLI-- CLVN 118-145 |
| PVBLI-- PYMVV 120-147 |
| PVC02-- VACCC 405-432 |
| PVC02-- VACCV 41-71 405-432 |
| PVC04-- SFVKA 209-236 484-585 |
| PVC04-- VACCC 12-46 |
| PVC04-- VACCV 12-46 |
| PVC04-- VARV 12-46 |
| PVC05-- SFVKA 85-125 152-179 |
| PVC05-- VACCC 38-65 |
| PVC05-- VACCV 38-65 |
| PVC05-- VARV 36-66 |
| PVC07-- VACCV 80-111 |
| PVC07-- VARV 80-111 |
| PVC09-- VACCV 42-69 82-116 178-205 252-279 289-325 575-605 |
| PVC09-- |
| VACCC 42-69 |
| 82-116 178-205 |
| 252-279 289-323 |
| 575-605 |
| PVC10-- |
| VACCC 136-180 |
| PVC10-- |
| VACCV 136-163 |
| PVC10-- |
| VARV 136-163 |
| PVC13-- |
| SFVKA 3-30 |
| 39-66 137-182 |
| 206-240 |
| PVC17-- |
| VACCC 111-152 |
| PVC18-- |
| VACCC 40-74 |
| PVC19-- |
| SFVKA 56-97 |
| PVC20-- |
| VACCC 72-99 |
| PVC22-- |
| VARV 299-326 |
| PVCAP-- |
| EBV 847-875 |
| PVCAP-- |
| HSV6U 136-170 |
| 355-382 |
| PVCAP-- |
| HSVSA 769-799 |
| PVCG3-- |
| NPVAC 133-165 |
| 199-248 |
| PVCOM-- |
| ADE02 88-115 |
| PVCOM-- |
| ADE05 87-114 |
| PVD05-- |
| FOWP1 6-33 |
| 184-211 321-348 |
| PVD05-- VACCC 240-267 333-360 |
| PVD05-- VACCV 240-267 |
| PVD05-- VARV 240-267 |
| PVD09-- VACCC 123-150 |
| PVD09-- VACCV 123-150 |
| PVD09-- VARV 123-160 |
| PVD10-- SFVKA 18-52 |
| PVDBP-- CERV 2-35 |
| PVE02-- VARV 282-322 |
| PVE06-- VACCC 89-116 437-464 |
| PVE06-- VACCV 89-116 437-464 |
| PVE06-- VARV 89-116 367-394 437-464 |
| PVE1-- HPV18 60-87 |
| PVE1-- HPV2A 21-48 |
| PVE1-- HPV33 180-207 |
| PVE1-- HPV39 103-130 |
| PVE1-- HPV41 55-89 |
| PVE1-- HPV42 25-59 |
| PVE1-- HPV47 146-173 |
| PVE1-- HPV57 21-48 |
| PVE26-- NPVAC 72-113 |
| PVE2-- CRPVK 5-34 |
| PVE2-- HPV05 17-51 |
| PVE2-- HPV13 157-184 334-361 |
| PVE2-- HPV16 61-105 312-342 |
| PVE2-- HPV18 313-186 |
| PVE2-- HPV1A 159-193 |
| PVE2-- HPV2A 159-193 |
| PVE2-- HPV33 304-311 |
| PVE2-- HPV35 158-192 327-354 |
| PVE2-- HPV39 7-34 323-357 |
| PVE2-- HPV47 17-51 148-175 276-303 |
| PVE2-- HPV51 137-184 |
| PVE2-- HPV57 166-193 |
| PVE2-- HPV58 2-36 309-336 |
| PVE2-- HPV5B 17-51 |
| PVE2-- PAPVE 120-150 |
| PVE2-- PCPV1 267-294 327-361 |
| PVE4-- HPV05 202-229 |
| PVE4-- HPV11 81-108 |
| PVE4-- HPV16 66-93 |
| PVE4-- HPV18 59-86 |
| PVE4-- HPV31 75-102 |
| PVE4-- HPV41 63-97 |
| PVE4-- HPV5B 202-229 |
| PVE5A-- HPV11 30-60 |
| PVE5A-- HPV6B 30-60 |
| PVE5A-- HPV6C 30-60 |
| PVE5-- HPV35 27-54 |
| PVE5-- HPV5B 11-41 |
| PVE5-- PCPV1 35-62 |
| PVE6-- HPV18 75-102 |
| PVE6-- HPV31 69-96 |
| PVE6-- HPV39 71-102 |
| PVE6-- HPV41 119-146 |
| PVE6-- HPV45 75-102 |
| PVE6-- HPV51 72-99 |
| PVE6-- HPVME 71-102 |
| PVE94-- NPVAC 620-647 |
| PVEF-- GVTN 411-438 |
| PVENV-- DHV11 318-366 |
| PVENV-- EAV 120-147 |
| PVENV-- THOGV 313-347 |
| PVF03-- VACCC 71-110 185-212 |
| PVF03-- VACCV 71-110 185-212 |
| PVF05-- VACCP 33-60 |
| PVF05-- VACCV 33-60 |
| PVF06-- VARV 10-44 |
| PVF11-- VACCC 274-321 |
| PVF11-- VACCP 270-317 |
| PVF11-- VARV 274-321 |
| PVF12-- VACCC 10-37 113-140 554-581 |
| PVF12-- VACCP 10-37 113-140 554-581 |
| PVF12-- VARV 10-37 202-236 554-581 |
| PVF16-- VACCC 35-62 152-179 |
| PVF16-- VACCP 35-62 152-179 |
| PVF16-- VARV 35-62 149-179 |
| PVF16-- FOWPV 146-173 |
| PVFUS-- ORFNZ 59-86 |
| PVFUS-- VACCC 37-64 |
| PVFUS-- VACCV 37-64 |
| PVG01-- VACCC 225-252 301-335 |
| PVG01-- VACCV 164-191 240-274 |
| PVG01-- VARV 225-252 301-335 |
| PVG02-- VACCV 96-123 |
| PVG02-- VARV 96-123 |
| PVG03-- HSVEB 146-176 |
| PVG03-- HSVEK 146-176 |
| PVG05-- VACCC 48-75 131-161 225-289 355-189 |
| PVG05-- VARV 48-75 131-161 225-289 355-189 |
| PVG07-- HSV11 71-98 |
| PVG09-- VACCC 308-338 |
| PVG09-- VACCV 271-308 |
| PVG09-- VARV 308-338 |
| PVG12-- SPVIR 11-45 |
| PVG17-- HSV11 177-204 |
| PVG18-- HSV11 174-208 |
| PVG1-- SPVIR 260-287 |
| PVG1-- SPV4 287-314 383-410 |
| PVG22-- HSV11 373-400 581-622 668-705 766-824 |
| PVG24-- HSV11 31-58 |
| PVG28-- HSV11 253-290 497-528 |
| PVG2R-- AMEPV 33-64 91-118 |
| PVG2-- SPVIR 285-326 |
| PVG2-- SPV4 146-173 175-205 262-310 |
| PVG34-- HSV11 95-122 |
| PVG37-- HSV11 442-469 |
| PVG39-- HSV11 651-678 1088-1115 |
| PVG3L-- AMEPV 2-29 |
| PVG3-- SPVIR 15-49 |
| PVG3-- SPV4 18-52 87-148 |
| PVG45-- HSVSA 138-165 |
| PVG46-- HSV11 142-169 346-373 897-924 973-1007 |
| PVG48-- HSVSA 360-394 |
| PVG4R-- AMEPV 4-31 |
| PVG4-- SPVIR 116-146 |
| PVG51-- HSV11 34-61 87-114 |
| PVG52-- HSVSA 47-74 |
| PVG56-- HSV11 582-609 |
| PVG5-- SPVIR 65-92 |
| PVG5-- SPV4 56-83 |
| PVG63-- HSV11 550-584 |
| PVG64-- HSV11 477-504 |
| PVG65-- HSV11 1213-1254 |
| PVG66-- HSV11 362-406 |
| PVG67-- HSV11 1342-1369 |
| PVG68-- HSV11 261-288 |
| PVG72-- HSV11 447-481 |
| PVG75-- HSV11 388-422 |
| PVG76-- HSV11 200-227 |
| PVG7-- SPV4 14-44 |
| PVGF1-- IBVB 1230-1260 2408-2435 |
| PVGL2-- CVBF 399-426 642-676 1022-1084 1278-1305 |
| PVGL2-- CVBL9 399-426 1022-1084 1278-1305 |
| PVGL2-- CVBLY 399-426 642-676 1022-1084 1278-1305 |
| PVGL2-- CVBM 399-426 642-676 1022-1084 1278-1305 |
| PVGL2-- CVBQ 399-426 642-676 1022-1084 1278-1305 |
| PVGL2-- CVBV 399-426 642-676 1022-1084 1278-1305 |
| PVGL2-- CVH22 770-797 809-875 1056-1112 |
| PVGL2-- CVM4 643-684 1030-1092 |
| PVGL2-- CVMA5 36-63 591-632 978-1040 |
| PVGL2-- CVMJC 643-684 1030-1092 |
| PVGL2-- CVMJH 502-543 889-951 |
| PVGL2-- CVPFS 69-110 692-733 1072-1145 1353-1389 |
| PVGL2-- CVPM1 69-110 692-733 1069-1145 1353-1389 |
| PVGL2-- CVPPR 73-107 690-731 1067-1143 1351-1387 |
| PVGL2-- CVPPU 69-107 690-731 1067-1143 1351-1387 |
| PVGL2-- CVPR8 468-509 845-921 1129-1165 |
| PVGL2-- CVPRM 468-509 845-921 1129-1165 |
| PVGL2-- CVPRT 69-107 690-731 1067-1143 1353-1389 |
| PVGL2-- EBV 68-102 |
| PVGL2-- FIPV 189-233 454-481 709-736 1072-1148 1356-1392 |
| PVGL2-- IBV6 809-836 876-903 1057-1091 |
| PVGL2-- IBVB 808-835 875-902 1056-1090 |
| PVGL2-- IBVD2 809-836 876-903 1057-1091 |
| PVGL2-- IBVK 808-835 875-902 1056-1090 |
| PVGL2-- IBVM 808-835 875-902 1056-1090 |
| PVGLB-- EBV 95-122 631-658 |
| PVGLB-- HCMVA 25-88 397-424 440-467 851-878 |
| PVGLB-- HCMVT 50-88 397-424 435-462 852-879 |
| PVGLB-- HSVB1 427-454 |
| PVGLB-- HSVB2 447-474 |
| PVGLB-- HSVE1 443-470 934-961 |
| PVGLB-- HSVE4 486-513 616-643 |
| PVGLB-- HSVEA 443-470 934-961 |
| PVGLB-- HSVEB 443-470 934-961 |
| PVGLB-- HSVEL 443-470 933-960 |
| PVGLB-- HSVMD 93-120 352-379 |
| PVGLB-- MCMVS 381-408 441-475 |
| PVGLC-- HSV11 469-510 |
| PVGLC-- HSVIK 469-510 |
| PVGLC-- HSVEB 124-151 |
| PVGLC-- VZVD 295-322 |
| PVGLC-- VZVS 295-322 |
| PVGLE-- HSV2 111-148 |
| PVGLF-- BRSVA 38-65 154-202 216-243 442-469 486-531 |
| PVGLF-- BRSVC 38-65 154-202 216-243 444-471 486-533 |
| PVGLF-- BRSVR 38-65 154-202 216-243 444-471 486-533 |
| PVGLF-- CDVO 252-293 340-367 |
| PVGLF-- HRSV1 38-65 154-203 442-471 488-515 |
| PVGLF-- HRSVA 38-65 154-202 213-243 488-518 |
| PVGLF-- HRSVL 38-65 154-202 216-243 444-471 488-515 |
| PVGLF-- HRSVR 38-65 154-202 213-243 442-471 488-518 |
| PVGLF-- MEASE 228-262 |
| PVGLF-- MEASI 231-265 |
| PVGLF-- MEASY 228-262 |
| PVGLF-- MUMP1 20-54 447-486 |
| PVGLF-- MUMPM 20-54 447-486 |
| PVGLF-- MUMPR 20-54 447-486 |
| PVGLF-- MUMPS 151-178 426-511 |
| PVGLF-- NDVA 151-178 426-512 |
| PVGLF-- NDVB 151-178 426-512 |
| PVGLF-- NDVH3 151-178 426-512 |
| PVGLF-- NDVH4 151-178 426-512 |
| PVGLF-- NDVI 151-178 426-512 |
| PVGLF-- NDVL 151-178 192-219 426-512 |
| PVGLF-- NDVM 151-178 437-512 |
| PVGLF-- NDVQ 151-178 433-512 |
| PVGLF-- NDVT 151-178 426-512 |
| PVGLF-- NDVTG 151-178 426-512 |
| PVGLF-- NDVU 151-178 426-512 |
| PVGLF-- PHODV 36-63 221-262 309-336 |
| PVGLF-- PI1HC 147-174 210-266 |
| PVGLF-- PI1H 90-117 141-175 238-266 483-528 |
| PVGLF-- PI2HG 90-117 141-175 238-266 483-528 |
| PVGLF-- PI2HT 90-117 141-175 238-266 483-528 |
| PVGLF-- PI3B 115-182 207-241 459-497 |
| PVGLF-- PI3H4 115-182 207-241 457-497 |
| PVGLF-- RINDK 224-265 458-485 |
| PVGLF-- RINDL 224-265 458-506 |
| PVGLF-- SEND5 122-149 211-245 480-507 |
| PVGLF-- SENDF 122-149 211-245 480-507 |
| PVGLF-- SENDH 122-149 211-245 480-507 |
| PVGLF-- SENDJ 122-149 211-245 480-507 |
| PVGLF-- SENDZ 122-149 211-245 480-507 |
| PVGLF-- SV41 144-185 241-269 459-496 |
| PVGLF-- SV5 137-171 417-444 |
| PVGLF-- TRTV 124-161 193-200 457-484 |
| PVGLG-- BEPV 523-557 |
| PVGLG-- BRSVC 92-123 |
| PVGLG-- HRSV1 63-93 |
| PVGLG-- HRSV4 66-107 |
| PVGLG-- HRSV5 243-273 |
| PVGLG-- HRSV8 66-93 |
| PVGLG-- HSVE4 271-298 |
| PVGLG-- HSVEB 383-410 |
| PVGLG-- RABYT 489-519 |
| PVGLG-- VSVIG 472-499 |
| PVGLH-- EBV 549-576 619-648 |
| PVGLH-- HCMVA 107-136 270-297 |
| PVGLH-- HCCMVT 106-135 |
| PVGLH-- HSV6G 62-89 360-403 |
| PVGLH-- HSVSA 388-415 |
| PVGLI-- HCMVA 47-111 |
| PVGLM-- BUNGE 512-546 914-941 1128-1255 |
| PVGLM-- BUNL7 913-950 |
| PVGLM-- BUNYW 340-374 594-535 682-709 |
| PVGLM-- DUGBV 945-972 |
| PVGLM-- HANTV 73-100 693-720 |
| PVGLM-- HANTH 75-102 |
| PVGLM-- HANTL 75-102 |
| PVGLM-- HANTV 75-102 |
| PVGLM-- INSV 628-655 1069-1101 |
| PVGLM-- PHV 69-96 |
| PVGLM-- PUUMH 72-110 |
| PVGLM-- PUUMS 72-110 |
| PVGLM-- SEOU8 513-540 693-720 |
| PVGLM-- SEOUR 73-100 513-540 694-721 |
| PVGLM-- SEOUS 73-100 513-540 694-721 |
| PVGLN-- BEFV 523-564 |
| PVGLP-- BEV 48-82 1145-1179 1184-1211 1505-1532 |
| PVGLY-- JUNIN 14-41 |
| PVGLY-- LASSG 86-113 |
| PVGLY-- MOPEI 86-113 316-346 |
| PVGLY-- PIARV 334-375 |
| PVGLY-- TACV 109-136 315-350 |
| PVGLY-- TACV5 303-338 |
| PVGLY-- TACV7 302-337 |
| PVGLY-- TACVT 303-338 |
| PVGNM-- CPMV 192-221 |
| PVGP8-- EBV 104-149 |
| PVGP-- EBOV 280-314 |
| PVGP-- MABVM 559-589 619-646 |
| PVGP-- MABVP 559-589 619-646 |
| PVH05-- VACCC 132-166 |
| PVH05-- VACCV 132-166 |
| PVH05-- VARV 64-91 150-184 |
| PVHEL-- LSV 130-160 |
| PVHRP-- VACCC 241-275 |
| PVHRP-- VACCV 241-275 |
| PVI01-- VACCC 90-117 153-180 |
| VI01-- VARV 90-117 153-180 |
| VI03-- VACCC 160-190 |
| VI03-- VACCV 160-190 |
| VI03-- VARV 160-190 |
| VI08-- VACCC 290-317 548-575 593-632 |
| VI08-- VACCV 290-317 548-575 593-632 |
| VI08-- VARV 290-317 548-575 593-632 |
| VIE1-- MCMVS 261-288 |
| VIE2-- NPVOP 355-385 |
| VIEN-- NPVAC 217-325 343-400 |
| VIF-- HVIRH 62-89 |
| VIF-- SIVAI 2-36 |
| VIMP-- HSVEB 147-174 |
| VIMP-- HSVSA 80-107 |
| VINT-- SSVI 73-100 |
| VJ01-- VACCC 22-56 |
| VJ01-- VACCV 22-56 |
| VJ01-- VARV 22-56 |
| VL1-- CRPVK 331-383 |
| VL1-- FPVL 38-65 |
| VL1-- HPVO8 354-392 |
| VL1-- HPV18 183-210 |
| VL1-- HPV33 19-46 |
| VL1-- HPV41 345-372 |
| VL1-- HPV51 19-46 |
| VL1-- HPV58 45-72 |
| VL2-- HPV1A 407-445 |
| VL2-- HPV41 415-442 |
| VL3-- REOVD 330-357 |
| VL3-- REOVL 330-357 |
| VL96-- IRV1 146-180 625-652 |
| PVM1-- REOVL 290-317 |
| PVM21-- REOVD 625-662 |
| PVM22-- REOVD 624-661 |
| PVM2-- REOVJ 624-661 |
| PVM3-- REOVD 159-186 343-370 456-483 631-690 |
| PVMA2-- BRSVA 124-152 |
| PVMA2-- HRSVA 124-151 |
| PVMAT-- BRSVA 219-246 |
| PVMAT-- HRSVA 219-246 |
| PVMAT-- INCJJ 151-185 |
| PVMAT-- NDVA 247-274 |
| PVMAT-- PI2HT 96-123 |
| PVMAT-- PI3B 201-231 |
| PVMAT-- PI3H4 201-231 |
| PVMAT-- SV41 323-353 |
| PVME1-- CVBM 175-209 |
| PVME1-- CVTKE 175-209 |
| PVME1-- IBV6 21-48 184-218 |
| PVME1-- IBVB 21-48 184-218 |
| PVME1-- IBVB2 21-48 184-218 |
| PVME1-- IBVK 184-218 |
| PVMP-- CAMVC 220-254 273-324 |
| PVMP-- CAMVD 29-56 220-254 273-324 |
| PVMP-- CAMVE 227-254 273-324 |
| PVMP-- CAMVN 220-254 273-324 |
| PVMP-- CAMVS 220-254 273-324 |
| PVMP-- CAMVW 220-254 273-324 |
| PVMP-- CERV 26-53 100-127 |
| PVMP-- SOCMV 4-31 78-118 |
| PVMP-- HPBHE 294-328 |
| PVMSA-- DHVI1 38-65 237-264 |
| PVMT1-- MYXVL 163-190 |
| PVMT8-- MYXVL 465-492 |
| PVMT9-- ROTPC 83-113 |
| PVN34-- PAVBO 149-176 |
| PVNCN-- ADVG 86-148 |
| PVNCS-- AEDEV 14-41 279-339 487-517 585-612 780-817 821-848 |
| PVNCS-- |
| MUMIM 35-62 |
| 262-289 |
| PVNCS-- |
| MUMIV 35-62 |
| 262-289 |
| PVNCS-- |
| PAVHB 236-270 |
| PVNCS-- |
| PAVHH 35-62 |
| PVNCS-- |
| PAVPN 24-55 |
| 169-196 316-346 |
| PVNCS-- EHDV2 411-438 |
| PVNS1-- IAALA 171-198 |
| PVNS1-- IAANN 171-198 |
| PVNS1-- IACHI 171-198 |
| PVNS1-- IACKG 171-198 |
| PVNS1-- IACKJ 168-195 |
| PVNS1-- IADA2 171-198 |
| PVNS1-- IAFOM 171-198 |
| PVNS1-- IAFOW 171-198 |
| PVNS1-- IALE1 171-198 |
| PVNS1-- IAMA6 171-198 |
| PVNS1-- IAPI1 171-198 |
| PVNS1-- IAPI3 171-198 |
| PVNS1-- IATKB 171-198 |
| PVNS1-- IATKC 171-198 |
| PVNS1-- IATRT 171-198 |
| PVNS1-- IAUDO 171-198 |
| PVNS1-- IAUSS 171-198 |
| PVNS1-- INBPA 171-198 |
| PVNS2-- IATKR 87-114 |
| PVNS2-- INBLE 51-78 |
| PVNS2-- INBYA 51-78 |
| PVNS2-- INCJJ 71-98 |
| PVNS3-- CVPFS 9-36 |
| PVNS4-- CVH22 9-36 |
| PVNS4-- RSV 6-40 |
| PVNS7-- CVCAE 11-45 |
| PVNS7-- CVFE3 8-42 |
| PVNS7-- CVPFS 34-61 |
| PVNS7-- CVPPU 34-61 |
| PVNS7-- CVPRM 34-61 |
| PVNS7-- FIPV 8-42 |
| PVNSC-- PI1HE 41-75 |
| PVNSC-- PI3H4 58-99 |
| PVNSM-- INSV 262-296 |
| PVNST-- BUNLC 57-84 |
| PVNST-- TOSV 146-180 |
| PVNUC-- EBOV 331-369 |
| PVNUC-- IAANA 378-405 |
| PVNUC-- IAANN 378-405 |
| PVNUC-- IABRA 378-405 |
| PVNUC-- IABUD 378-405 |
| PVNUC-- IACAL 378-405 |
| PVNUC-- IACKG 378-405 |
| PVNUC-- IACKP 378-405 |
| PVNUC-- IADAU 378-405 |
| PVNUC-- IADBE 378-405 |
| PVNUC-- IADCZ 378-405 |
| PVNUC-- IADE1 378-405 |
| PVNUC-- IADE2 378-405 |
| PVNUC-- IADHK 378-405 |
| PVNUC-- IADM2 378-405 |
| PVNUC-- IADMA 378-405 |
| PVNUC-- IADNZ 378-405 |
| PVNUC-- IADU2 378-405 |
| PVNUC-- IAEN5 378-405 |
| PVNUC-- IAFOM 378-405 |
| PVNUC-- IAFOW 378-405 |
| PVNUC-- IAFPD 378-405 |
| PVNUC-- IAFPR 378-405 |
| PVNUC-- IAGRE 378-405 |
| PVNUC-- IAGU1 378-405 |
| PVNUC-- IAGU2 378-405 |
| PVNUC-- IAGU3 378-405 |
| PVNUC-- IAGU4 378-405 |
| PVNUC-- IAGUA 378-405 |
| PVNUC-- IAGUM 378-405 |
| PVNUC-- IAGUN 378-405 |
| PVNUC-- IAHIC 378-405 |
| PVNUC-- IAHJI 378-405 |
| PVNUC-- IAHLO 378-405 |
| PVNUC-- IAHMI 378-405 |
| PVNUC-- IAHO1 378-405 |
| PVNUC-- IAHO2 378-405 |
| PVNUC-- IAHPR 378-405 |
| PVNUC-- IAHTE 378-405 |
| PVNUC-- IAKIE 378-405 |
| PVNUC-- IALEN 378-405 |
| PVNUC-- IAMAA 378-405 |
| PVNUC-- IAMAN 378-405 |
| PVNUC-- IAMIN 378-405 |
| PVNUC-- IANEJ 378-405 |
| PVNUC-- IANT6 378-405 |
| PVNUC-- IAOHI 378-405 |
| PVNUC-- IAPAR 378-405 |
| PVNUC-- IAPUE 378-405 |
| PVNUC-- IARUD 378-405 |
| PVNUC-- IASE0 378-405 |
| PVNUC-- IASH2 378-405 |
| PVNUC-- IASIN 378-405 |
| PVNUC-- IATEI 378-405 |
| PVNUC-- IATKN 378-405 |
| PVNUC-- IATKO 378-405 |
| PVNUC-- IATRS 378-405 |
| PVNUC-- IATRT 378-405 |
| PVNUC-- IATX7 378-405 |
| PVNUC-- IAUDO 378-405 |
| PVNUC-- IAUSS 378-405 |
| PVNUC-- IAVI6 378-405 |
| PVNUC-- IAWHN 378-405 |
| PVNUC-- IAWHP 378-405 |
| PVNUC-- IAWIL 378-405 |
| PVNUC-- IAWIS 378-405 |
| PVNUC-- IAZ29 378-405 |
| PVNUC-- IAZ41 378-405 |
| PVNUC-- IAZCA 378-405 |
| PVNUC-- IAZDA 378-405 |
| PVNUC-- IAZGE 378-405 |
| PVNUC-- IAZH1 378-405 |
| PVNUC-- IAZH3 378-405 |
| PVNUC-- IAZH4 378-405 |
| PVNUC-- IAZI1 378-405 |
| PVNUC-- IAZI2 378-405 |
| PVNUC-- IAZI3 378-405 |
| PVNUC-- IAZJ1 378-405 |
| PVNUC-- IAZJ2 378-405 |
| PVNUC-- IAZJ3 378-405 |
| PVNUC-- IAZJ4 378-405 |
| PVNUC-- IAZJA 378-405 |
| PVNUC-- IAZMA 378-405 |
| PVNUC-- IAZNE 378-405 |
| PVNUC-- IAZOH 378-405 |
| PVNUC-- IAZON 378-405 |
| PVNUC-- IAZTE 378-405 |
| PVNUC-- IAZW1 378-405 |
| PVNUC-- IAZW2 378-405 |
| PVNUC-- INCCA 99-126 416-443 451-478 |
| PVNUC-- MABVM 366-407 |
| PVNUC-- MABVP 366-407 |
| PVO01-- VACCC 7-37 109-138 581-608 |
| PVO01-- VARV 7-37 109-138 581-608 |
| PVOR1-- FXMV 1023-1050 |
| PVOR1-- NMV 996-1023 1527-1561 |
| PVOR1-- PMV 948-978 1481-1532 |
| PVOR1-- PVMR 597-627 |
| PVOR1-- PVX 698-725 1017-1044 |
| PVOR1-- PVXX3 698-725 1017-1044 |
| PVOR1-- SMYEA 312-342 691-721 |
| PVP10-- NPVAC 7-41 |
| PVP10-- NPVOP 7-48 |
| PVP10-- NPVSE 6-33 37-64 |
| PVP10-- RGDV 205-252 |
| PVP10-- WTV 151-181 227-254 |
| PVP11-- RDV 53-80 |
| PVP12-- WTV 81-108 |
| PVP18-- WTVNJ 81-108 |
| PVP19-- AMCV 73-100 |
| PVP19-- TBSVC 73-100 |
| PVP23-- HSVSA 2-29 |
| PVP26-- HSVEB 36-63 |
| PVP26-- HSVSA 48-75 |
| PVP2-- AHSV4 277-304 410-437 632-662 907-934 |
| PVP2-- BTV13 815-846 |
| PVP2-- BTV1A 989-925 |
| PVP2-- BTV1S 119-146 |
| PVP2-- EHDV1 72-103 415-453 |
| PVP2-- ROTBR 39-94 523-553 |
| PVP2-- ROTBU 39-94 524-554 |
| PVP2-- ROTHW 70-101 533-567 |
| PVP2-- ROTPC 52-99 128-156 518-545 705-746 |
| PVP2-- ROTS1 36-96 |
| PVP30-- ASFE7 39-75 |
| PVP32-- ASFB7 39-75 |
| PVP35-- EBOV 83-119 |
| PVP35-- MABVM 80-107 231-258 |
| PVP35-- MABVP 80-107 231-258 |
| PVP35-- NPVAC 270-297 |
| PVP35-- NPVBM 68-102 |
| PVP35-- VACCV 178-205 |
| PVP39-- NPVAC 134-161 264-291 |
| PVP39-- NPVOP 263-290 |
| PVP3-- AHSV4 132-159 |
| PVP3-- BTV10 214-252 |
| PVP3-- BTV17 214-252 |
| PVP3-- BTV1A 214-252 |
| PVP3-- EHDV1 209-243 798-832 |
| PVP3-- EHDVA 798-832 |
| PVP3-- GFLV 99-133 |
| PVP3-- ROTPC 39-66 329-384 |
| PVP3-- ROTS1 26-67 350-377 451-497 619-692 |
| PVP40-- EBV 440-470 |
| PVP40-- HSVSA 205-232 344-372 |
| PVP40-- ILTVT 515-549 |
| PVP40-- VZVD 174-208 495-522 |
| PVP41-- ROTS1 8-35 589-619 |
| PVP42-- ROTS1 8-35 584-622 |
| PVP4A-- VACCC 48-75 |
| PVP4A-- VACCV 48-75 |
| PVP4A-- VARV 48-75 |
| PVP4B-- FOWPV 80-110 |
| PVP4B-- VACCC 7-37 |
| PVP4B-- VACCV 7-37 |
| PVP4B-- VARV 7-37 |
| PVP4-- BTV10 34-61 576-603 |
| PVP4-- BTV11 34-61 576-603 |
| PVP4-- BTV13 34-61 576-603 |
| PVP4-- BTV2A 552-622 |
| PVP4-- NCDV 595-629 |
| PVP4-- ROTB4 8-35 584-622 |
| PVP4-- ROTBC 595-629 |
| PVP4-- ROTBU 112-146 235-269 552-629 |
| PVP4-- ROTEH 5-32 |
| PVP4-- ROTG1 8-35 572-628 |
| PVP4-- ROTH1 8-35 279-306 565-621 |
| PVP4-- ROTH5 8-35 112-139 584-629 |
| PVP4-- ROTH6 8-35 279-306 565-621 |
| PVP4-- ROTHD 8-35 279-306 565-621 |
| PVP4-- ROTHJ 8-35 111-138 |
| PVP4-- ROTHK 8-35 77-104 279-306 577-621 |
| PVP4-- ROTHL 8-35 279-306 565-621 |
| PVP4-- ROTHM 8-35 572-610 |
| PVP4-- ROTHN 8-35 573-628 |
| PVP4-- ROTHP 8-35 577-621 |
| PVP4-- ROTHR 8-38 105-135 235-262 |
| PVP4-- ROTHT 8-35 572-627 |
| PVP4-- ROTHV 8-35 279-306 590-617 |
| PVP4-- ROTHW 8-35 577-621 |
| PVP4-- ROTP5 112-146 584-625 |
| PVP4-- ROTPC 5-33 115-161 293-320 |
| PVP4-- ROTPG 8-35 572-628 |
| PVP4-- ROTPY 8-35 112-146 584-625 |
| PVP4-- ROTRH 8-38 584-622 |
| PVP4-- ROTSF 8-35 589-619 |
| PVP4-- ROTSS 8-35 130-157 584-622 |
| PVP4-- WTV 28-62 |
| PVP5-- AHSV4 113-183 191-218 |
| PVP5-- BTV10 53-80 99-126 |
| PVP5-- BTV11 53-80 92-126 |
| PVP5-- BTV13 53-80 |
| PVP5-- BTV1A 53-80 89-126 |
| PVP5-- BTV1S 53-80 92-126 148-182 |
| PVP5-- BTV2A 53-80 89-126 |
| PVP5-- EHDV1 31-80 191-218 399-426 |
| PVP5-- WTV 648-675 |
| PVP61-- BTV10 161-193 |
| PVP61-- MRDV 153-202 |
| PVP61-- NPVAC 36-63 |
| PVP62-- BTV10 157-189 |
| PVP64-- NPVOP 45-72 |
| PVP67-- NPVAC 44-81 |
| PVP6-- BTV11 157-189 |
| PVP6-- BTV13 157-189 |
| PVP6-- BTV17 157-189 |
| PVP6-- BTV1S 161-193 |
| PVP6-- BTV2A 133-172 |
| PVP6-- RDV 10-37 354-381 |
| PVP74-- NPVAC 413-440 |
| PVP75-- HSVSA 181-208 929-977 |
| PVP79-- NPVAC 44-78 370-397 |
| PVP7-- EHDV1 16-43 |
| PVP7-- WTV 458-485 |
| PVP80-- NPVAC 101-142 240-298 |
| PVP87-- NPVOP 132-159 |
| PVP8-- BTV10 105-132 |
| PVP8-- FOWPV 211-238 |
| PVP8-- WTV 29-56 112-143 |
| PVP9-- RDV 197-224 |
| PVP9-- WTV 22-49 |
| PVP9-- WTVNJ 22-49 |
| PVPHE-- NPVAC 196-223 |
| PVPHE-- NPVOP 127-186 238-265 |
| PVPRT-- ADEM1 167-194 |
| PVPU-- HV1A2 3-31 |
| PVPU-- HV1B1 5-48 |
| PVPU-- HV1B8 21-48 |
| PVPU-- HV1BN 22-49 |
| PVPU-- HV1BR 5-48 |
| PVPU-- HV1C4 3-30 |
| PVPU-- HV1EL 6-33 |
| PVPU-- HV1H2 5-48 |
| PVPU-- HV1J3 2-29 |
| PVPU-- HV1JR 22-49 |
| PVPU-- HV1MA 5-32 |
| PVPU-- HV1ND 6-33 |
| PVPU-- HV1PV 5-48 |
| PVPU-- HV1S1 22-49 |
| PVPU-- SIVCZ 51-78 |
| PVPX-- LDV 64-94 |
| PVRNA-- BSMV 1051-1078 |
| PVS06-- ROTBS 6-43 |
| PVS06-- ROTGA 114-144 |
| PVS06-- ROTGI 28-55 |
| PVS06-- ROTHC 9-44 |
| PVS06-- ROTPC 9-44 |
| PVS07-- ROTBJ 2-29 |
| PVS07-- ROTBU 91-146 199-236 |
| PVS07-- ROTP5 91-146 202-236 |
| PVS07-- ROTS1 91-146 199-236 |
| PVS08-- ROTBU 164-201 |
| PVS08-- ROTS1 164-201 217-251 |
| PVS09-- ROTB4 2-29 |
| PVS09-- ROTB5 2-29 |
| PVS09-- ROTBU 2-29 |
| PVS09-- ROTGA 210-237 |
| PVS09-- ROTH4 2-29 |
| PVS09-- ROTHA 2-29 |
| PVS09-- ROTHB 2-29 |
| PVS09-- ROTHD 2-29 |
| PVS09-- ROTHH 2-29 |
| PVS09-- ROTHM 2-29 |
| PVS09-- ROTHO 2-29 |
| PVS09-- ROTHP 2-29 |
| PVS09-- ROTHS 2-29 |
| PVS09-- ROTHW 2-29 |
| PVS09-- ROTP2 2-29 |
| PVS09-- ROTP3 2-29 |
| PVS09-- ROTS1 2-29 |
| PVS10-- ROTBS 125-152 |
| PVS10-- ROTS1 113-140 |
| PVS11-- ROTBU 13-40 114-145 |
| PVS11-- ROTBV 13-40 114-145 |
| PVS11-- ROTGA 31-60 |
| PVS11-- ROTH5 13-40 111-145 |
| PVS11-- ROTHD 13-40 111-145 |
| PVS11-- ROTHW 111-145 |
| PVS11-- ROTRA 118-145 |
| PVS11-- ROTS1 111-146 |
| PVSH-- MUMP1 9-46 |
| PVSH-- MUMPA 12-41 |
| PVSH-- MUMPB 9-41 |
| PVSH-- MUMPE 9-46 |
| PVSH-- MUMPJ 9-46 |
| PVSH-- MUMPK 9-46 |
| PVSH-- MUMPL 9-46 |
| PVSH-- MUMPM 12-41 |
| PVSH-- MUMPR 9-41 |
| PVSH-- MUMPU 12-41 |
| PVSI1-- REOVD 26-63 71-122 127-168 222-259 |
| PVSI1-- REOVJ 4-104 130-193 |
| PVSI1-- REOVL 4-52 75-104 112-160 |
| PVSI2-- REOVD 350-384 |
| PVSI3-- REOVJ 289-316 |
| PVSIS-- REOVD 90-117 |
| PVSIS-- REOVL 50-77 |
| PVT3A-- CAPVI 124-158 |
| PVT5-- SFVKA 250-277 |
| PVTER-- EBV 234-290 |
| PVTER-- HCMVA 417-451 |
| PVTER-- HSV6U 176-203 |
| PVTER-- HSVI1 710-737 |
| PVTER-- VZVD 394-421 |
| PVTP3-- TTV1V 169-196 |
| PVTPX-- TTV1 169-196 |
| PVV-- PI4HA 4-38 |
| PY101-- SSV1 25-565 |
| PY108-- SSV1 4-61 |
| PY119-- SSV1 30-78 |
| PY11K-- TYDVA 53-87 |
| PY13K-- NPVAC 85-112 |
| PY13K-- SSV1 59-86 |
| PY14K-- SSV1 5-39 |
| PY16K-- NPVAC 80-107 |
| PY16K-- SSV1 77-111 |
| PY17K-- SSV1 9-36 119-153 |
| PY18K-- MSVN 34-61 |
| PY18K-- MSVS 34-61 |
| PY20K-- SSV1 76-103 |
| PY28K-- SSV1 93-164 |
| PY2-- SOCMV 118-148 |
| PY31K-- SSV1 24-97 |
| PY32K-- SSV1 233-267 |
| PY38K-- NPVAC 133-184 |
| PY3-- SOCMV 122-149 |
| PY7-- SOCMV 56-94 |
| PY85K-- SSV1 81-121 546-573 658-700 |
| PY8-- SOCMV 13-40 |
| PYB01-- FOWPM 74-108 152-179 184-218 |
| PYB05-- FOWPM 62-89 |
| PYB10-- FOWPM 162-197 214-241 |
| PYB12-- FOWPM 11-38 |
| PYB13-- FOWPM 128-167 |
| PYBL3-- FOAMV 87-116 |
| PYDH1-- HSVS7 161-188 |
| PYDH1-- HSVSC 52-82 |
| PYDH4-- HSVSC 52-83 |
| PYF26-- FOWP1 8-35 |
| PYF30-- FOWP1 170-204 |
| PYH22-- VACCV 37-64 95-126 144-171 |
| PYHR3-- VACCV 31-58 179-206 |
| PYKR2-- EBV 90-121 |
| PYKR4-- EBV 19-53 |
| PYL15-- ADE41 47-86 |
| PYLR3-- EBV 27-54 |
| PYOR1-- COYMV 94-143 |
| PYOR2-- COYMV 35-76 |
| PYOR3-- WCMVM 64-94 |
| PYOR3-- WCMVO 65-95 |
| PYOR5-- ADEG1 92-119 |
| PYORA-- TTV1 23-57 |
| PYORL-- TTV1 15-42 |
| PYORQ-- TTV1 3-31 |
| PYORW-- TTV1 4-40 |
| PYP12-- RTBV 44-71 |
| PYP12-- RTBVP 44-71 |
| PYP24-- RTBV 59-101 106-157 |
| PYP24-- RTBVP 51-101 105-157 |
| PYP46-- RTBV 58-107 197-231 |
| PYP46-- RTBVP 58-107 197-231 |
| PYP63-- NPVAC 44-71 |
| PYP63-- NPVOP 325-352 |
| PYPOH-- NPVAC 116-153 |
| PYPOL-- IPNVN 5-32 |
| PYQ3 -- AMEPV 8-57 59-96 156-183 |
| PYRF1-- HSV6G 208-235 |
| PYRF2-- HSV6G 233-257 268-299 |
| PYRF3-- HSV6G 141-168 |
| PYRF4-- HSV6G 404-441 |
| PYRP2-- IRV6 10-45 |
| PYVAG-- VACCC 7-34 |
| PYVAH-- VACCC 81-112 |
| PYVDB-- VACCC 29-77 |
| PYVDB-- VACCV 46-77 |
| PYVDH-- VACCV 20-50 |
| PYVGB-- VACCC 10-44 |
| PYZL2-- EBV 152-179 |
| __________________________________________________________________________ |
| TABLE VII |
| - 107 × 178 × 4 SEARCH MOTIF RESULTS SUMMARY (PREFERRED |
| VIRAL SEQUENCES) |
| PCGENE 107 × 178 × 4 All Viruses (no bacteriophages) |
| FILE NAME PROTEIN VIRUS AREA 1 AREA 2 AREA 3 AREA 4 AREA 5 AREA 6 AREA |
| 7 AREA 8 AREA 9 |
| PPOL-- MLVAK POL POLYPROTEIN AKR MURINE LEUKEMIA VIRUS 453-480 |
| PENV-- MLVAV ENV POLYPROTEIN AKR MURINE LEUKEMIA VIRUS 517-544 |
| PPOL-- MLVAV POL POLYPROTEIN AKR MURINE LEUKEMIA VIRUS 805-832 |
| PMYC-- AVIM2 MYC TRANSFORMING PROTEIN AVIAN MYELOCYTOMATOSIS |
| VIRUS CMII 232-266 375-402 |
| PMYC-- AVIMD MYC TRANSFORMING PROTEIN AVIAN MYELOCYTOMATOSIS |
| VIRUS HBI 233-267 376-403 |
| PMYC-- AVIMC MYC TRANSFORMING PROTEIN AVIAN MYELOCYTOMATOSIS |
| VIRUS MC29 233-267 376-403 |
| VL1-- FPVL PROBABLE L1 PROTEIN AVIAN PAPILLOMAVIRUS FPV-L 38-65 |
| PVGLB-- HSVB1 GLYCOPROTEIN I PRECURSOR BOVINE HERPESVIRUS TYPE 1 |
| 427-454 |
| PRIR2-- HSVB3 RIBONUC-DIPHOSPH REDUCT BOVINE HERPESVIRUS TYPE 2 |
| (STRAIN 34) |
| 90-117 SMALL CHA |
| PVGLB-- HSVB2 GLYCOPROTEIN B-1 BOVINE HERPESVIRUS TYPE 2 (STRAIN |
| BMV) 447-474 |
| PRECURSOR |
| PENV-- BIV06 ENV POLYPROTEIN BOVINE IMMUNODEFICIENCY VIRUS 17-44 |
| 544-603 631-695 |
| (ISOLATE 106) |
| PENV-- BIV27 ENV POLYPROTEIN BOVINE IMMUNODEFICIENCY VIRUS 17-44 |
| 573-632 660-724 |
| (ISOLATE 127) |
| PENV-- BLVAF ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (AMERICAN |
| 304-377 |
| ISOLATE FLK) |
| PENV-- BLVAV ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (AMERICAN |
| 304-377 |
| ISOLATE VDM) |
| PENV-- BLVAU ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (AUSTRALIAN |
| 304-377 |
| ISOLATE) |
| PENV-- BLVB2 ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (BELGIUM |
| 311-377 |
| ISOLATE LB285) |
| PENV-- BLVB5 ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (BELGIUM |
| 304-377 |
| ISOLATE LB59) |
| PENV-- BLVJ ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS (JAPANESE |
| 304-377 |
| ISOLATE BLV-1) |
| PHEMA-- PI3B HEMAGGLUTININ- BOVINE PARAINFLUENZA 3 VIRUS 66-93 |
| NEURAMINIDASE |
| PRPPP-- PI3B RNA POLYMERASE ALPHA BOVINE PARAINFLUENZA 3 VIRUS |
| 34-91 255-282 285-314 |
| SUBUNIT |
| PVGLF-- PI3B FUSION GLYCOPROTEIN BOVINE PARAINFLUENZA 3 VIRUS |
| 115-182 207-241 459-497 |
| PRECURSOR |
| PVMAT-- PI3B MATRIX PROTEIN BOVINE PARAINFLUENZA 3 VIRUS 201-231 |
| PRPPP-- BRSVA RNA POLYMERASE ALPHA BOVINE RESPIRATORY SYNCYTIAL |
| VIRUS |
| 99-133 |
| SUBUNIT (STRAIN A51908) |
| PVGLF-- BRSVA FUSION GLYCOPROTEIN BOVINE RESPIRATORY SYNCYTIAL |
| VIRUS 38-65 154-202 216-243 442-469 486-531 |
| PRECURSOR (STRAIN A51908) |
| PVMA2-- BRSVA MATRIX GLYCOPROTEIN M2 BOVINE RESPIRATORY SYNCYTIAL |
| VIRUS 124-152 |
| (STRAIN A51908) |
| PVMAT-- BRSVA MATRIX PROTEIN BOVINE RESPIRATORY SYNCYTIAL VIRUS |
| 219-246 |
| (STRAIN A51908) |
| PVGLF-- BRSVC FUSION GLYCOPROTEIN BOVINE RESPIRATORY SYNCYTIAL |
| VIRUS 38-65 154-202 216-243 444-471 488-535 |
| PRECURSOR (STRAIN COPENHAGEN) |
| PVGLG-- BRSVC MAJOR SURFACE BOVINE RESPIRATORY SYNCYTIAL VIRUS |
| 92-123 |
| GLYCOPROTEIN G (STRAIN COPENHAGEN) |
| PVGLF-- BRSVR FUSION GLYCOPROTEIN BOVINE RESPIRATORY SYNCYTIAL |
| VIRUS 38-65 154-202 216-243 444-471 488-533 |
| PRECURSOR (STRAIN RB94) |
| PENV-- MLVCB ENV POLYPROTEIN CAS-BR-E MURINE LEUKEMIA VIRUS |
| 510-539 |
| PENV-- SIVCZ ENV POLYPROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| 160-187 253-289 336-366 526-584 627-654 |
| PVPU-- SIVCZ VPU PROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS 51-78 |
| PPOL-- SIVCZ POL POLYPROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| 242-269 626-685 |
| (SIV(CPZ) |
| PVE2-- CRPVK PROBABLE E2 PROTEIN COTTONTAIL RABBIT (SHOPE) |
| PAPILLOMAVIRUS |
| 5-34 (STRAIN |
| KANSAS) |
| VL1-- CRPVK PROBABLE L1 PROTEIN COTTONTAIL RABBIT (SHOPE) |
| PAPILLOMAVIRUS 331-383 |
| (STRAIN KANSAS) |
| PPOLG-- DEN1S GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN |
| SINGAPORE 1858- 2890- 2989- |
| 5275/90) 1885 2935 3016 |
| PPOLG-- DEN26 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| 16681) 1544- 1858- 2908- 2982- 3117- |
| 1571 1885 2935 3016 3147 |
| PPOLG-- DEN27 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| 16681-PDK53) 1544- 1858- 2485- 2908- 2982- 3117- |
| 1571 1885 2519 2935 3016 3147 |
| PPOLG-- DEN2J GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| JAMAICA) 1544- 1858- 2908- 3117- 3346- |
| 1571 1885 2935 3147 3373 |
| PPOLG-- DEN2P GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| PR159/S1) 1544- 1858- 2405- 2979- 3114- 3343- |
| 1571 1885 2932 3013 3144 3370 |
| PPOLG-- DEN2T GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| TONGA 1974) 1134- 1448- |
| 1161 1475 |
| PPOLG-- DEN3 GENOME POLYPROTEIN DENGUE VIRUS TYPE 3 837-864 1542- |
| 1857- 2494- 2980- 3345- |
| 1569 1884 2521 3014 3372 |
| PPOLG-- DEN4 GENOME POLYPROTEIN DENGUE VIRUS TYPE 4 2885- 2977- |
| 3342- |
| 2930 3011 3369 |
| PDPOL-- HPBDB DNA POLYMERASE DUCK HEPATITIS B VIRUS (BROWN |
| SHANGHAI |
| 5-39 DUCK |
| ISOLATE S5) |
| PDPOL-- HPBDC DNA POLYMERASE DUCK HEPATITIS B VIRUS (STRAIN |
| CHINA) |
| 5-39 |
| PDPOL-- HPBDW DNA POLYMERASE DUCK HEPATITIS B VIRUS (WHITE SHANGHAI |
| 5-39 304-331 |
| DUCK ISOLATE S31) |
| PTEGU-- EBV LARGE TEGUMENT PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 145-172 1215- 1344- 1876- |
| 1242 1371 1903 |
| PUL06-- EBV VIRION PROTEIN BBRF1 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 115-142 313-340 542-569 |
| PUL11-- EBV HYPOTHETICAL PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 15-42 |
| B(C)RF1 |
| PUL52-- EBV PROB DNA REPLICATION EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 185-212 787-814 |
| PROTEIN BSLF1 |
| PUL87-- EBV HYPOTHETICAL PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 409-436 |
| B(C)RF1 |
| PUL92-- EBV HYPOTHETICAL PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 107-144 168-196 |
| BDLF4 |
| PVCAP-- EBV MAJOR CAPSID PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 847-874 |
| PVGL2-- EBV PROBABLE MEMBRANE EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 68-102 |
| GLYCOPROTEIN |
| PVGLB-- EBV GLYCOPROTEIN GP110 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 95-122 631-658 |
| PRECURSOR |
| PVGLH-- EBV GLYCOPROTEIN GP85 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 549-576 619-648 |
| PRECURSOR |
| PVGP8-- EBV PROBABLE MEMBRANE EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 104-149 |
| ANTIGEN GP85 |
| PVP40-- EBV CAPSID PROTEIN P40 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 440-470 |
| PVTER-- EBV PROBABLE DNA PACKAGING EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 234-290 |
| PROTEIN |
| PYKR2-- EBV HYPOTHETICAL BKRF2 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 90-121 |
| PROTEIN |
| PYKR4-- EBV HYPOTHETICAL BKRF4 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 19-53 |
| PROTEIN |
| PYLR3-- EBV HYPOTHETICAL BLRF3 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 27-54 |
| PROTEIN |
| PYZL2-- EBV HYPOTHETICAL BZLF2 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 152-179 |
| PROTEIN |
| PBZLF-- EBV BZLF1 TRANS-ACTIVATOR EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 193-220 |
| PROTEIN |
| PDNBI-- EBV MAJOR DNA-BINDING EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| 977- 1041- |
| PROTEIN 1004 1068 |
| PEAR-- EBV EARLY ANTIGEN PROTEIN R EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 55-82 |
| PLMP1-- EBV LATENT MEMBRANE PROTEIN 1 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 148-175 |
| PLMP2-- EBV GENE TERMINAL PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) 294-321 |
| PLMP1-- EBVC LATENT MEMBRANE PROTEIN 1 EPSTEIN-BARR VIRUS (STRAIN |
| CAO) 148-175 |
| PLMP1-- EBVR LATENT MEMBRANE PROTEIN 1 EPSTEIN-BARR VIRUS (STRAIN |
| RAJI) 148-175 |
| PUL32-- HSVEB MAJOR ENVELOPE EQUINE HERPESVIRUS TYPE 1 345-375 |
| GLYCOPROTEIN 300 |
| PVGLC-- HSVEB GLYCOPROTEIN C PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| 124-151 |
| PVGLB-- HSVE1 GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (ISOLATE HVS25A) 443-470 934-961 |
| PVGLB-- HSVEA GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB1) 443-470 934-961 |
| PATI2-- HSVEB ALPHA TRANS-IND FACTOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 294-321 |
| 82 KD PRO |
| PATIN-- HSVEB ALPHA TRANS-IND PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 255-289 |
| PHELI-- HSVEB PROBABLE HELICASE EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) 184-211 321-348 |
| PRIR1-- HSVEB RIBONUC-DIPHOSPH REDUCT EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| 75-102 LARGE CHA |
| PTEGU-- HSVEB LARGE TEGUMENT PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 229-256 566-593 1205- |
| 1232 |
| PUL06-- HSVEB VIRION GENE 56 PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 640-667 |
| PUL14-- HSVEB HYPOTHETICAL GENE 48 EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 247-286 |
| PROTEIN |
| PUL21-- HSVEB GENE 40 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) 44-71 |
| PUL37-- HSVEB GENE 23 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) 715-749 987- |
| 1014 |
| PUL52-- HSVEB DNA REPLICATION EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) 193-220 943-970 |
| PROTEIN UL52 |
| PVG03-- HSVEB GENE 3 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) 146-176 |
| PVGLB-- HSVEB GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 443-470 934-961 |
| PVGLG-- HSVEB GLYCOPROTEIN G PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 383-410 |
| VIMP-- HSVEB PROB INTEGRAL MEMBRANE EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 147-174 |
| PROTEIN |
| PVP26-- HSVEB CAPSID PROTEIN VP26 EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) 36-63 |
| PVG03-- HSVEK GENE 3 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| 146-176 |
| KENTUCKY A) |
| PVGLB-- HSVEL GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN 443-470 933-960 |
| KENTUCKY D) |
| PCELF-- HSVEB CELL FUSION PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P 312-339 |
| PRECURSOR AND Ky A) |
| PUL47-- HSVE4 97 KD ALPHA EQUINE HERPESVIRUS TYPE 4 190-217 |
| TRANS-INDUCING PROTEIN |
| PVGLB-- HSVE4 GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 4 |
| 486-513 616-643 |
| PVGLG-- HSVE4 GLYCOPROTEIN G PRECURSOR EQUINE HERPESVIRUS TYPE 4 |
| 271-298 |
| PDUT-- HSVE4 DEOXYU 5'-TRIPHOSPH EQUINE HERPESVIRUS TYPE 4 |
| (STRAIN 1942) |
| 90-117 NUCHYDROLASE |
| PVE2-- PAPVE PROBABLE E2 PROTEIN EUROPEAN ELK PAPILLOMA VIRUS |
| 120-150 |
| PENV-- FIVPE ENV POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| 650-680 722-749 |
| (ISOLATE PETALUMA) |
| PPOL-- FIVPE POL POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| 442-473 |
| (ISOLATE PETALUMA) |
| PENV-- PIVSD ENV POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| 639-668 720-747 |
| (ISOLATE SAN DIEGO) |
| PENV-- FIVT2 ENV POLYPROTEIN FELINE IMMUNODEFICIENCY VIRUS |
| 640-679 721-748 |
| (ISOLATE TM2) |
| PENV-- FLVC6 ENV POLYPROTEIN FELINE LEUKEMIA PROVIRUS (CLONE |
| CFE-6) 509-538 |
| PMYC-- FLVTT MYC TRANSFORMING PROTEIN FELINE LEUKEMIA PROVIRUS |
| (FTT) 393-420 |
| PMYC-- FLV MYC TRANSFORMING PROTEIN FELINE LEUKEMIA VIRUS 393-420 |
| PENV-- FLVGL ENV POLYPROTEIN FELINE LEUKEMIA VIRUS (STRAIN |
| 490-519 |
| A/GLASGOW-1) |
| PENV-- FLVLB ENV POLYPROTEIN FELINE LEUKEMIA VIRUS (STRAIN |
| 510-539 |
| LAMBDA-B1) |
| PENV-- FLVSA ENV POLYPROTEIN FELINE LEUKEMIA VIRUS (STRAIN |
| 487-516 |
| SARMA) |
| PENV-- MLVF5 ENV POLYPROTEIN FRIEND MURINE LEUKEMIA VIRUS 523-553 |
| (ISOLATE 57) |
| PENV-- MLVFF ENV POLYPROTEIN FRIEND MURINE LEUKEMIA VIRUS 523-553 |
| (ISOLATE FB29) |
| PENV-- MLVFP ENV POLYPROTEIN FRIEND MURINE LEUKEMIA VIRUS 523-553 |
| (ISOLATE PVC-211) |
| PENV-- GALV ENV POLYPROTEIN GIBBON APE LEUKEMIA VIRUS 176-203 |
| 523-564 |
| PGAG-- GALV GAG POLYPROTEIN GIBBON APE LEUKEMIA VIRUS 396-442 |
| 447-474 |
| PPOL-- GALV POL POLYPROTEIN GIBBON APE LEUKEMIA VIRUS 535-562 |
| 676-703 |
| PDPOL-- HPBGS DNA POLYMERASE GROUND SQUIRREL HEPATITIS VIRUS |
| 271-325 |
| PPOLG-- HPAV8 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN 18F) |
| 203-237 1021- 1117- 1454- |
| 1048 1149 1481 |
| PPOLG-- HPAV2 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN 24A) |
| 203-237 1021- 1117- 1454- |
| 1048 1149 1481 |
| PPOLG-- HPAV4 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN 43C) |
| 203-237 1021- 1117- 1454- |
| 1048 1149 1481 |
| PPOLG-- HPAVC GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN CR326) |
| 203-237 |
| PPOLG-- HPAVG GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN GA76) |
| 182-216 |
| PPOLG-- HPAVH GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN HM175) |
| 203-237 1021- 1103- |
| 1048 1149 |
| PPOLG-- HPVAL GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN LA) |
| 203-237 1021- 1103- |
| 1048 1149 |
| PPOLG-- HPAVM GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN MBB) |
| 203-237 1021- 1103- |
| 1048 1149 |
| PDPOL-- |
| HPBVP DNA POLYMERASE HEPATITIS B VIRUS (SUBTYPE ADW/STRAIN 456-483 |
| PHILIPPINO/PFDW294) |
| PDPOL-- HPBVZ DNA POLYMERASE HEPATITIS B VIRUS (SUBTYPE ADYW) |
| 443-470 |
| PPOLG-- HCV1 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE I) |
| 702-729 |
| PPOLG-- HCVBK GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE BK) |
| 702-729 1045- |
| 1072 |
| PPOLG-- HCVH GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE H) |
| 702-729 1045- |
| 1072 |
| PPOLG-- HCVJ6 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HC-J6) 374-401 2089- |
| 2116 |
| PPOLG-- HCVJ8 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HC-J8) 1049- 2089- |
| 1076 2116 |
| PPOLG-- HCVJT GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HC-JT) 702-729 1045- |
| 1072 |
| PPOLG-- HCVJA GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| JAPANESE) 378-405 702-729 1045- |
| 1072 |
| PPOLG-- HCVTW GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| TAIWAN) 702-729 1045- |
| 1072 |
| PAANT-- HDVAM DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE |
| AMERICAN) 106-133 |
| PAANT-- HDVD3 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE |
| AMERICAN) 106-133 |
| PAANT-- HDVS1 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE |
| AMERICAN) 16-43 106-133 |
| PAANT-- HDVS2 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE |
| AMERICAN) 16-43 106-133 |
| PAANT-- HDVWO DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE |
| AMERICAN) 106-133 |
| PAANT-- HDVIT DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE |
| AMERICAN) 106-133 |
| PAANT-- HDVM2 DELTA ANTIGEN HEPATITIS DELTA VIRUS (ISOLATE |
| AMERICAN) 106-133 |
| PPOLN-- HEVBU NON-STRUCTURAL HEPATITIS E VIRUS (STRAIN BURMA) |
| 219-246 349-376 |
| POLYPROTEIN |
| PPOLN-- HEVME NON-STRUCTURAL HEPATITIS E VIRUS (STRAIN MEXICO) |
| 219-246 349-376 |
| POLYPROTEIN |
| PPOLN-- HEVMY N-STRUCTURAL HEPATITIS E VIRUS (STRAIN MYANMAR) |
| 219-246 349-376 |
| POLYPROTEIN |
| PPOLN-- HEVPA NON-STRUCTURAL HEPATITIS E VIRUS (STRAIN PAKISTAN) |
| 218-245 348-375 |
| POLYPROTEIN |
| PDPOL-- HPBHE DNA POLYMERASE HERON HEPATITIS B VIRUS 5-39 |
| PVMSA-- HPBHE MAJOR SURFACE ANTIGEN HERON HEPATITIS B VIRUS |
| 294-328 |
| PRECURSOR |
| PIE63-- HSV11 TRANSCRIPTIONAL HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| 17) 248-275 |
| REGULATOR IE63 |
| PIE68-- HSV11 IMMEDIATE-EARLY HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| 17) 40-67 |
| PROTEIN IE68 |
| PTEGU-- HSV11 LARGE TEGUMENT PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 667-694 1673- |
| 1710 |
| PUL06-- HSV11 VIRION PROTEIN UL6 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 586-613 |
| PUL34-- HSV11 VIRION PROTEIN UL34 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 116-143 |
| PUL37-- HSV11 PROTEIN UL37 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| 17) 470-497 853-884 |
| PUL42-- HSV11 DNA-BINDING PROTEIN UL42 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 231-258 |
| PUL47-- HSV11 VIRION PROTEIN UL47 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 488-515 |
| PUGLC-- HSV11 GLYCOPROTEIN C HERPES SIMPLEX VIRUS (TYPE 1/STRAIN |
| 17) 469-510 |
| PRECURSOR |
| PATI2-- HSV11 ALPHA TRANS-IND FACTOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) 308-335 |
| 78 KD PRO |
| PUL47-- HSV1F VIRION PROTEIN UL47 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN F) 488-515 |
| PATI2-- HSV1F ALPHA TRANS-IND FACTOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN F) 308-335 |
| 77 KD PRO |
| PVGLC-- HSV1K GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN KOS) 469-510 |
| PVGLE-- HSV2 GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 2) 111-148 |
| PTEGU-- HSV6G LARGE TEGUMENT PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 102-129 228-262 567-611 962-993 1098- 1661- 1884- |
| 1181 1688 1911 |
| PVGLH-- HSV6G GLYCOPROTEIN H PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 62-89 360-403 |
| PYRF1-- HSV6G HYPOTHETICAL PROTEIN RF1 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 208-235 |
| PYRF2-- HSV6G HYPOTHETICAL PROTEIN RF2 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 223-257 268-299 |
| PYRF3-- HSV6G HYPOTHETICAL PROTEIN RF3 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 141-168 |
| PYRF4-- HSV6G HYPOTHETICAL PROTEIN RF4 HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) 404-441 |
| PP100-- HSV6U MAJOR ANTIGENIC STRUCTL HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN |
| 81-108 189-216 688-715 785-812 |
| PROTEIN UGANDA-1102) |
| PUL87-- HSV6U HYPOTHETICAL PROTEIN 5R HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN 536-563 729-768 |
| UGANDA-1102) |
| PUL95-- HSV6U HYPOTHETICAL PROTEIN 13R HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN |
| 73-100 105-134 |
| UGANDA-1102) |
| PVCAP-- HSV6U MAJOR CAPSID PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN 136-170 355-382 |
| UGANDA-1102) |
| PVTER-- HSV6U PROBABLE DNA PACKAGING HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN 176-203 |
| PROTEIN UGANDA-1102) |
| PTYSY-- HSVAT THYMIDYLATE SYNTHASE HERPESVIRUS ATELES 116-143 |
| PDPOL-- HSVSA DNA POLYMERASE HERPESVIRUS SAIMIRI (STRAIN 11) |
| 625-652 |
| PDUT-- HSVSA DEOXYU 5'-TRIPHOSPH HERPESVIRUS SAIMIRI (STRAIN 11) |
| 179-213 |
| NUCHYDROLASE |
| PHELI-- HSVSA PROBABLE HELICASE HERPESVIRUS SAIMIRI (STRAIN 11) |
| 418-449 |
| P1C18-- HSVSA PROBABLE PROC & TRANSPORT HERPESVIRUS SAIMIRI |
| (STRAIN 11) 58-85 482-522 |
| PRO |
| PIE68-- HSVSA IMMEDIATE-EARLY PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) 48-78 |
| PKITH-- HSVSA THYMIDINE KINASE HERPESVIRUS SAIMIRI (STRAIN 11) |
| 340-386 |
| PRIR1-- HSVSA RIBONUC-DIPHOSPH REDUCT HERPESVIRUS SAIMIRI (STRAIN |
| 11) 324-351 |
| LARGE CHA |
| PTEGU-- HSVSA PROBABLE LARGE TEGUMENT HERPESVIRUS SAIMIRI (STRAIN |
| 11) 524-607 672-700 777-814 846-898 949-986 990- 1467- 2102- |
| PROTEIN 1017 1497 2135 |
| PTYSY-- HSVSA THYMIDYLATE SYNTHASE HERPESVIRUS SAIMIRI (STRAIN |
| 11) 120-147 |
| PUL06-- HSVSA VIRION GENE 43 PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) 15-42 302-358 368-402 |
| PUL25-- HSVSA VIRION GENE 19 PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) 34-61 204-231 362-389 |
| PUL34-- HSVSA GENE 67 PROTEIN HERPESVIRUS SAIMIRI (STRAIN 11) |
| 208-235 |
| PUL37-- HSVSA GENE 63 PROTEIN HERPESVIRUS SAIMIRI (STRAIN 11) |
| 31-65 685-737 |
| PUL52-- HSVSA PROB DNA REP GENE 56 HERPESVIRUS SAIMIRI (STRAIN |
| 11) 130-157 |
| PROTEIN |
| PUL73-- HSVSA HYPOTHETICAL GENE 53 HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| 9-36 |
| PROTEIN |
| PUL87-- HSVSA HYPOTHETICAL GENE 24 HERPESVIRUS SAIMIRI (STRAIN |
| 11) 582-609 |
| PROTEIN |
| PUL92-- HSVSA HYPOTHETICAL GENE 31 HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| 92-122 |
| PROTEIN |
| PUNG-- HSVSA URACIL-DNA GLYCOSYLASE HERPESVIRUS SAIMIRI (STRAIN |
| 11) 135-176 |
| PVCAP-- HSVSA MAJOR CAPSID PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) 769-799 |
| PVG45-- HSVSA HYPOTHETICAL GENE 45 HERPESVIRUS SAIMIRI (STRAIN |
| 11) 138-165 |
| PROTEIN |
| PVG48-- HSVSA HYPOTHETICAL GENE 48 HERPESVIRUS SAIMIRI (STRAIN |
| 11) 360-394 |
| PROTEIN |
| PVG52-- HSVSA HYPOTHETICAL GENE 31 HERPESVIRUS SAIMIRI (STRAIN |
| 11) 47-74 |
| PROTEIN |
| PVGLH-- HSVSA GLYCOPROTEIN H PRECURSOR HERPESVIRUS SAIMIRI |
| (STRAIN 11) 388-415 |
| VIMP-- HSVSA INTEGRAL MEMBRANE HERPESVIRUS SAIMIRI (STRAIN 11) |
| 80-107 |
| PROTEIN |
| PVP23-- HSVSA PROBABLE CAPSID PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| 2-29 |
| VP23 |
| PVP26-- HSVSA CAPSID PROTEIN VP26 HERPESVIRUS SAIMIRI (STRAIN 11) |
| 48-75 |
| PVP40-- HSVSA CAPSID PROTEIN P40 HERPESVIRUS SAIMIRI (STRAIN 11) |
| 205-232 344-372 |
| PVP75-- HSVSA PROBABLE MEMBRANE HERPESVIRUS SAIMIRI (STRAIN 11) |
| 181-208 929-977 |
| ANTIGEN 75 |
| PDNBI-- HSVSA MAJOR DNA-BINDING PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) 333-368 512-539 |
| PCGH2-- HSVSA CYCLIN HOMOLOG HERPESVIRUS SAIMIRI (STRAIN 11) |
| 127-154 |
| PYDH1-- HSVS7 HYPOTH 24.1 KD IN DHFR HERPESVIRUS SAIMIRI (STRAIN |
| 484-77) 161-188 |
| 3'REGION |
| PYDH1-- |
| HSVSC HYPOTH 28.7 KD IN DHFR HERPESVIRUS SAIMIRI (SUBGROUP 52-82 |
| 3'REGION C/STRAIN 488) |
| PYDH4-- HSVSC HYPOTH 9.9 KD IN DHFR HERPESVIRUS SAIMIRI (SUBGROUP |
| 53-83 |
| 3'REGION C/STRAIN 488) |
| PENV-- MLVHO ENV POLYPROTEIN HOMULV MURINE LEUKEMIA VIRUS 510-540 |
| PDPOL-- HCMVA DNA POLYMERASE HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 753-780 |
| PIC18-- HCMVA PROB PROC & TRANSPORT HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) 294-324 |
| PRO UL56 |
| PIR05-- HCMVA HYPOTHETICAL PROTEIN IRL5 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 22-49 |
| PIR12-- HCMVA HYPOTHETICAL PROTEIN IRL12 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 74-162 PIR13-- |
| HCMVA HYPOTHETICAL PROTEIN IRL13 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 31-62 |
| PRIR1-- HCMVA RIBONUC-DIPHOSPH REDUCT HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 622-649 |
| LARGE CHA |
| PTEGU-- HCMVA PROBABLE LARGE TEGUMENT HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 1251- 2202- |
| PROTEIN 1281 2229 |
| PUL08-- HCMVA HYPOTHETICAL PROTEIN UL8 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 6-47 PUL13-- |
| HCMVA HYPOTHETICAL PROTEIN UL13 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 347-374 |
| PUL16-- HCMVA HYPOTHETICAL PROTEIN UL16 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 81-112 PUL20-- |
| HCMVA HYPOTH PRO UL20 PRECURSOR HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 34-61 |
| PUL31-- HCMVA HYPOTHETICAL PROTEIN UL31 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 167-194 254-284 |
| PUL35-- HCMVA HYPOTHETICAL PROTEIN UL35 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 535-562 |
| PUL47-- HCMVA PROTEIN UL47 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 114-148 448-485 763-790 802-853 |
| PUL50-- HCMVA PROTEIN UL50 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 159-186 |
| PUL59-- HCMVA HYPOTHETICAL PROTEIN UL59 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 74-101 PUL70-- |
| HCMVA PROB DNA REP PROTEIN UL70 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 65-92 |
| PUL73-- HCMVA UL73 GLYCOPROTEIN HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| 5-73 |
| PRECURSOR |
| PUL74-- HCMVA HYPOTHETICAL PROTEIN UL74 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 45-79 |
| PUL93-- HCMVA PROTEIN UL93 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| 26-53 314-381 |
| PUL95-- HCMVA HYPOTHETICAL PROTEIN UL95 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 37-71 |
| PULA4-- HCMVA VIRION PROTEIN UL104 HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| 4-31 443-477 |
| PULB9-- HCMVA HYPOTHETICAL PROTEIN UL119 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) 33-78 |
| PULD0-- HCMVA HYPOTHETICAL PROTEIN UL130 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| 90-124 PUS09-- |
| HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 20-47 |
| HXLF3 (STRAIN AD169) |
| PUS14-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 277-308 |
| HVLF4 (STRAIN AD169) |
| PUS18-- HCMVA MEMBRANE PROTEIN HWFL5 HUMAN CYTOMEGALOVIRUS |
| 191-218 |
| (STRAIN AD169) |
| PVGLB-- HCMVA GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 25-88 397-424 440-467 851-878 |
| (STRAIN AD169) |
| PVGLH-- HCMVA GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 107-136 270-297 |
| (STRAIN AD169) |
| PVGLI-- HCMVA IE GLYCOPROTEIN PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 47-111 |
| (STRAIN AD169) |
| PVTER-- HCMVA PROBABLE DNA PACKAGING HUMAN CYTOMEGALOVIRUS |
| 417-451 |
| PROTEIN (STRAIN AD169) |
| PDNBI-- HCMVA MAJOR DNA-BINDING PROTEIN HUMAN CYTOMEGALOVIRUS |
| 437-464 |
| (STRAIN AD169) |
| PV30K-- HCMVE 30 KD MAJOR EARLY PROTEIN HUMAN CYTOMEGALOVIRUS |
| 194-221 |
| (STRAIN EISENHARDT) |
| PVGLB-- HCMVT GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 50-88 397-424 435-462 852-879 |
| (STRAIN TOWNE) |
| PVGLH-- HCMVT GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 106-135 |
| (STRAIN TOWNE) |
| PENV-- HV1A2 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 544-592 630-682 790-825 |
| (ARV2/SF2 ISOLATE) |
| PGAG-- HV1A2 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 91-118 |
| (ARV2/SF2 ISOLATE) |
| PPOL-- HV1A2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 218-245 620-661 |
| (ARV2/SF2 ISOLATE) |
| PVPU-- HV1A2 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 3-31 |
| (ARV2/SF2 ISOLATE) |
| PVPU-- HV1B1 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 5-48 |
| (BH10 AND HXB3 ISOLATES) |
| PENV-- HV1B1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 545-594 631-683 791-818 |
| (BH10 ISOLATE) |
| PPOL-- HV1B1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 230-257 637-673 |
| (BH10 ISOLATE) |
| PPOL-- HV1B5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 230-257 637-673 |
| (BH5 ISOLATE) |
| PENV-- HV1B8 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 540-589 626-678 786-813 |
| (BH8 ISOLATE) |
| PVPU-- HV1B8 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 21-48 |
| (BH8 ISOLATE) |
| PENV-- HV1BN ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 267-294 338-365 562-590 628-679 787-815 |
| (BRAIN ISOLATE) |
| PVPU-- HV1BN VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 22-49 |
| (BRAIN ISOLATE) |
| PENV-- HV1BR ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 550-599 636-688 796-823 |
| (BRU ISOLATE) |
| PPOL-- HV1BR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 230-257 632-673 |
| (BRU ISOLATE) |
| PVPU-- HV1BR VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 5-48 |
| (BRU ISOLATE) |
| PENV-- HV1C4 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 397-424 557-606 643-695 803-835 |
| (CDC-451 ISOLATE) |
| PVPU-- HV1C4 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 3-30 |
| (CDC-451 ISOLATE) |
| PENV-- HV1EL ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 255-296 386-413 543-591 628-680 |
| (ELI ISOLATE) |
| PNEF-- HV1EL NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 81-119 |
| (ELI ISOLATE) |
| PPOL-- HV1EL POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 217-244 624-660 |
| (ELI ISOLATE) |
| PVPU-- HV1EL VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 6-33 |
| (ELI ISOLATE) |
| PENV-- HV1H2 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 545-594 631-683 791-818 |
| (HXB2 ISOLATE) |
| PPOL-- HV1H2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 218-245 620-661 921-951 |
| (HXB2 ISOLATE) |
| PVPU-- HV1H2 VPU POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 5-48 |
| (HXB2 ISOLATE) |
| PENV-- HV1H3 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 545-594 631-683 791-818 |
| (HXB3 ISOLATE) |
| PENV-- HV1J3 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 350-377 556-605 642-694 802-829 |
| (JH3 ISOLATE) |
| PGAG-- HV1J3 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 91-118 |
| (JH3 ISOLATE) |
| PVPU-- HV1J3 VPU POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 2-29 |
| (JH3 ISOLATE) |
| PENV-- HV1JR ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 336-363 622-675 783-811 |
| (JRCSF ISOLATE) |
| PPOL-- HV1JR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 222-249 624-665 |
| (JRCSF ISOLATE) |
| PVPU-- HV1JR VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 22-49 |
| (JRCSF ISOLATE) |
| PENV-- HV1MA ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 547-595 633-707 794-826 |
| (MAL ISOLATE) |
| PPOL-- HV1MA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 217-244 476-510 619-660 |
| (MAL ISOLATE) |
| PVPU-- HV1MA VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 5-32 |
| (MAL ISOLATE) |
| PENV-- HV1MF ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 543-592 629-681 789-816 |
| (MFA ISOLATE) |
| PENV-- HV1MN ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 343-370 567-595 632-684 791-819 |
| (MN ISOLATE) |
| PGAG-- HV1MN GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 87-118 |
| (MN ISOLATE) |
| PPOL-- HV1MN POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 221-248 623-664 |
| (MN ISOLATE) |
| PENV-- HV1ND ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 249-290 536-583 621-673 783-813 |
| (NDK ISOLATE) |
| PNEF-- HV1ND NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 81-119 |
| (NDK ISOLATE) |
| PPOL-- HV1ND POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 217-244 624-660 |
| (NDK ISOLATE) |
| PVPU-- HV1ND VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 6-33 |
| (NDK ISOLATE) |
| PENV-- HV1N5 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 326-360 |
| (NEW YORK-5 ISOLATE) |
| PPOL-- HV1N5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 218-245 625-661 |
| (NEW YORK-5 ISOLATE) |
| PENV-- HV1OY ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 544-593 630-704 789-820 |
| (OYI ISOLATE) |
| PPOL-- HV1OY POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 218-245 620-661 |
| (OYI ISOLATE) |
| PENV-- HV1PV ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 545-594 631-683 791-818 |
| (PV22 ISOLATE) |
| PPOL-- HV1PV POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 230-257 637-673 |
| (PV22 ISOLATE) |
| PVPU-- HV1PV VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 5-48 |
| (PV22 ISOLATE) |
| PENV-- HV1RH ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 280-307 351-378 554-602 640-692 800-832 |
| (RF/HAT ISOLATE) |
| PPOL-- HV1RH POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 217-244 619-660 |
| (RF/HAT ISOLATE) |
| VIF-- HV1RH VIRION INFECTIVITY FACTOR HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 62-89 |
| (RF/HAT ISOLATE) |
| PENV-- HV1SC ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 338-365 545-593 631-683 |
| (SC ISOLATE) |
| PENV-- HV1S1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 333-363 536-585 622-674 782-809 |
| (SF162 ISOLATE) |
| PVPU-- HV1S1 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 22-49 |
| (SF162 ISOLATE) |
| PENV-- HV1S3 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 541-589 627-679 787-815 |
| (SF33 ISOLATE) |
| PENV-- HV1KB ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 274-301 555-596 637-677 776-824 |
| (STRAIN KB-1-GP32) |
| PPOL-- HV1U4 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 217-244 513-540 619-660 |
| (STRAIN UGANDAN/ISOLATE U |
| PENV-- HV1W1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 338-365 545-593 631-683 791-818 |
| (WMJ1 ISOLATE) |
| PENV-- HV1W2 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 334-361 536-584 622-674 782-809 |
| (WMJ2 ISOLATE) |
| PENV-- HV1Z8 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 266-307 573-601 634-678 797-828 |
| (Z-84 ISOLATE) |
| PENV-- HV1Z2 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 255-296 542-591 628-680 790-820 |
| (Z2/CDC-Z34 ISOLATE) |
| PPOL-- HV1Z2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 217-244 619-660 |
| (Z2/CDC-Z34 ISOLATE) |
| PENV-- HV1Z3 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 251-292 |
| (ZAIRE 3 ISOLATE) |
| PENV-- HV1Z6 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 256-297 545-593 630-682 792-822 |
| (ZAIRE 6 ISOLATE) |
| PNEF-- HV1Z6 NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 86-124 |
| (ZAIRE 6 ISOLATE) |
| PENV-- HV1ZH ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 545-594 627-666 791-823 |
| (ZAIRE HZ321 ISOLATE) |
| PENV-- HV2BE ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 61-88 532-591 621-648 653-697 |
| (ISOLATE BEN) |
| PGAG-- HV2BE GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 88-115 |
| (ISOLATE BEN) |
| PPOL-- HV2BE POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 491-582 |
| (ISOLATE BEN) |
| PENV-- HV2CA ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 534-593 623-650 655-699 |
| (ISOLATE CAM2) |
| PPOL-- HV2CA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 471-562 |
| (ISOLATE CAM2) |
| PENV-- HV2D1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 61-88 523-550 555-582 644-688 |
| (ISOLATE D194) |
| PGAG-- HV2D1 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 88-115 |
| (ISOLATE D194) |
| PPOL-- HV2D1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 509-600 |
| (ISOLATE D194) |
| PPOL-- HV2D2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 491-568 |
| (ISOLATE D205.7) |
| PENV-- HV2G1 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 60-87 524-551 556-583 613-640 645-693 |
| (ISOLATE GHANA-1) |
| PPOL-- HV2G1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 471-562 |
| (ISOLATE GHANA-1) |
| PENV-- HV2NZ ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 61-88 524-551 556-583 613-640 662-689 |
| (ISOLATE NIH-Z) |
| PGAG-- HV2NZ GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 88-115 |
| (ISOLATE NIH-Z) |
| PPOL-- HV2NZ POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 471-529 |
| (ISOLATE NIH-Z) |
| PENV-- HV2RO ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 58-85 533-592 622-698 |
| (ISOLATE ROD) |
| PPOL-- HV2RO POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 472-563 |
| (ISOLATE ROD) |
| PENV-- HV2SB ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 557-584 614-673 |
| (ISOLATE SBLISY) |
| PPOL-- HV2SB POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 473-562 |
| (ISOLATE SBLISY) |
| PENV-- HV2ST ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 442-476 527-554 559-586 648-692 |
| (ISOLATE ST) |
| PGAG-- HV2ST GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 88-115 |
| (ISOLATE ST) |
| PPOL-- HV2ST POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 491-582 |
| (ISOLATE ST) |
| PENV-- HV2S2 ENV POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| 442-476 527-554 559-586 648-682 |
| (ISOLATE ST/24.1C#2) |
| PVE4-- HPV11 PROBABLE E4 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 11 |
| 81-108 |
| PVE5A-- HPV11 PROBABLE E5A PROTEIN HUMAN PAPILLOMA VIRUS TYPE 11 |
| 30-60 |
| PVE2-- HPV13 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 13 157-184 |
| 334-361 |
| PVE2-- HPV16 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 16 61-105 |
| 312-342 |
| PVE4-- HPV16 PROBABLE E4 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 16 |
| 66-93 |
| PVE1-- HPV16 E1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 18 60-87 |
| PVE2-- HPV18 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 18 |
| 313-340 |
| PVE4-- HPV18 PROBABLE E4 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 18 |
| 59-86 |
| PVE6-- HPV18 E6 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 18 75-102 |
| VL1-- HPV18 PROBABLE L1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 18 |
| 183-210 |
| PVE2-- HPV1A E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 1A 159-196 |
| VL2-- HPV1A PROBABLE L2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 1A |
| 407-445 |
| PVE1-- HPV2A E1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 2A 21-48 |
| PVE2-- HPV2A E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 2A |
| 159-193 |
| PVE4-- HPV31 PROBABLE E4 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 31 |
| 75-102 |
| PVE6-- HPV31 E6 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 31 69-96 |
| PVE1-- HPV33 E1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 33 |
| 180-207 |
| PVE2-- HPV33 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 33 304-331 |
| VL1-- HPV33 PROBABLE L1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 33 |
| 19-46 |
| PVE2-- HPV35 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 35 158-192 |
| 327-354 |
| PVE5-- HPV35 PROBABLE E5 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 35 |
| 27-54 |
| PVE1-- HPV39 E1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 39 103-130 |
| PVE2-- HPV39 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 39 7-34 |
| 323-357 |
| PVE6-- HPV39 E6 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 39 71-102 |
| PVE1-- HPV41 E1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 41 55-89 |
| PVE4-- HPV41 PROBABLE E4 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 41 |
| 63-97 |
| PVE6-- HPV41 E6 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 41 119-146 |
| VL1-- HPV41 PROBABLE L1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 41 |
| 345-372 |
| VL2-- HPV41 PROBABLE L2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 41 |
| 415-442 |
| PVE1-- HPV42 E1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 42 25-59 |
| PVE6-- HPV45 E6 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 45 |
| 75-102 |
| PVE1-- HPV47 E1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 47 146-173 |
| PVE2-- HPV47 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 47 17-51 |
| 148-175 276-303 |
| PVE2-- HPV05 PROBABLE E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 5 |
| 17-51 |
| PVE4-- HPV05 PROBABLE E4 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 5 |
| 202-229 |
| PVE2-- HPV51 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 51 137-184 |
| PVE6-- HPV51 E6 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 51 72-99 |
| VL1-- HPV51 PROBABLE L1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 51 |
| 19-46 |
| PVE1-- HPV57 E1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 51 21-48 |
| PVE2-- HPV57 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 57 |
| 166-193 |
| PVE2-- HPV58 E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 57 2-36 |
| 309-336 |
| VL1-- HPV58 PROBABLE L1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 58 |
| 45-72 |
| PVE2-- HPV5B PROBABLE E2 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 58 |
| 17-51 |
| PVE4-- HPV5B PROBABLE E4 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 5B |
| 202-229 |
| PVE5-- HPV5B PROBABLE E5 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 5B |
| 11-41 |
| PVE5A-- HPV6B PROBABLE E5A PROTEIN HUMAN PAPILLOMA VIRUS TYPE 5B |
| 30-60 |
| PVE5A-- HPV6C PROBABLE E5A PROTEIN HUMAN PAPILLOMA VIRUS TYPE 6B |
| 30-60 |
| VL1-- HPV08 PROBABLE L1 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 6C |
| 354-392 |
| PVE6-- HPVME E6 PROTEIN HUMAN PAPILLOMA VIRUS TYPE 8 71-102 |
| PRRPP-- PI1HB RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 1 |
| VIRUS |
| 84-111 234-261 375-416 |
| SUBUNIT (STRAIN C35) |
| PNCAP-- PI1HC NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 1 VIRUS |
| 377-404 455-482 |
| (STRAIN C39) |
| PRRPP-- PI1HC RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 1 VIRUS |
| 84-111 234-261 375-416 |
| SUBUNIT (STRAIN C39) |
| PVGLF-- PI1HC FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 1 VIRUS |
| 147-174 210-266 |
| PRECURSOR (STRAIN C39) |
| PRRPP-- PI1HE RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 1 VIRUS |
| 84-111 244-271 375-416 |
| SUBUNIT (STRAIN CI-14/83) |
| PVNSC-- PI1HE NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 VIRUS |
| 41-75 |
| (STRAIN CI-14/83) |
| PRRPP-- PI1HD RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 1 VIRUS |
| 84-111 232-262 375-416 |
| SUBUNIT (STRAIN CI-5/73) |
| PHEMA-- PI1HW HEMAGGLUTININ- HUMAN PARAINFLUENZA 1 VIRUS 79-110 |
| 366-393 |
| NEURAMINIDASE (STRAIN WASHINGTON/1957) |
| PNCAP-- PI1HW NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 1 VIRUS |
| 377-404 444-488 |
| (STRAIN WASHINGTON/1957) |
| PRRPP-- PI2H RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 1 VIRUS |
| 167-194 222-256 |
| SUBUNIT (STRAIN VIRUS) |
| PVGLF-- PI2H FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 2 VIRUS |
| 90-117 141-175 238-266 483-528 |
| PRECURSOR (STRAIN VIRUS) |
| PVGLF-- PI2HG FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 2 VIRUS |
| 90-117 141-175 238-266 483-528 |
| PRECURSOR (STRAIN VIRUS GREER) |
| PRRPL-- PI2HT RNA POLYMERASE BETA HUMAN PARAINFLUENZA 2 VIRUS |
| 322-349 1564- 1687- 1901- |
| SUBUNIT (STRAIN TOSHIBA) 1598 1721 1946 |
| PRRPP-- PI2HT RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 2 VIRUS |
| 167-194 222-256 |
| SUBUNIT (STRAIN TOSHIBA) |
| PVGLF-- PI2HT FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 2 VIRUS |
| 90-117 141-175 238-266 483-528 |
| PRECURSOR (STRAIN TOSHIBA) |
| PVMAT-- PI2HT MATRIX PROTEIN HUMAN PARAINFLUENZA 2 VIRUS 96-123 |
| (STRAIN TOSHIBA) |
| PHEMA-- PI3HA HEMAGGLUTININ- HUMAN PARAINFLUENZA 2 VIRUS 27-61 |
| NEURAMINIDASE (STRAIN AUS/124854/74) |
| PNCAP-- PI3H4 NUCLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 2 VIRUS |
| 376-403 |
| (STRAIN NIH)47885 |
| PHEMA-- PIEH4 HEMAGGLUTININ- HUMAN PARAINFLUENZA 2 VIRUS 27-61 |
| NEURAMINIDASE (STRAIN NIH 47885) |
| PRRPL-- PIEH4 RNA POLYMERASE BETA HUMAN PARAINFLUENZA 2 VIRUS |
| 52-86 136-163 608-638 1081- 1994- 2115- |
| SUBUNIT (STRAIN NIH 47885) 1123 2036 2142 |
| PRRPP-- PIEH4 RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 2 VIRUS |
| 114-144 269-299 |
| SUBUNIT (STRAIN NIH 47885) |
| PVGLF-- PI3H4 FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 3 VIRUS |
| 115-182 207-241 457-497 |
| PRECURSOR (STRAIN NIH 47885) |
| PVMAT-- PI3H4 MATRIX PROTEIN HUMAN PARAINFLUENZA 3 VIRUS 201-231 |
| (STRAIN NIH 47885) |
| PVNSC-- PI3H4 NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 3 VIRUS |
| 58-99 |
| (STRAIN NIH 47885) |
| PHEMA-- PI3HV HEMAGGLUTININ- HUMAN PARAINFLUENZA 3 VIRUS 27-61 |
| NEURAMINIDASE (STRAIN TEX/12677/83) |
| PHEMA-- PI3HT HEMAGGLUTININ- HUMAN PARAINFLUENZA 3 VIRUS 27-76 |
| NEURAMINIDASE (STRAIN TEX/545/80) |
| PHEMA-- PI3HU HEMAGGLUTININ- HUMAN PARAINFLUENZA 3 VIRUS 23-70 |
| NEURAMINIDASE (STRAIN TEX/9305/82) |
| PHEMA-- PI3HX HEMAGGLUTININ- HUMAN PARAINFLUENZA 3 VIRUS 27-61 |
| NEURAMINIDASE (STRAIN WASH/1511/72) |
| PHEMA-- PI3HW HEMAGGLUTININ- HUMAN PARAINFLUENZA 3 VIRUS 27-61 |
| NEURAMINIDASE (STRAIN WASH/641/79) |
| PRRPP-- PI4HA RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 4A VIRUS |
| 4-38 |
| SUBUNIT (STRAIN TOSHIBA) |
| PVV-- PI4HA V PROTEIN HUMAN PARAINFLUENZA 4A VIRUS |
| 4-38 (STRAIN TOSHIBA) |
| PRRPP-- HRSV RNA POLYMERASE ALPHA HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS |
| 99-141 |
| SUBUNIT |
| PNCAP-- HRSVA NUCLEOCAPSID PROTEIN HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS |
| 4-31 |
| (STRAIN A2) |
| PRRPL-- HRSVA RNA POLYMERASE ALPHA HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS 103-192 210-237 667-694 788-815 1007- 1138- 1453- 1776- 2062- |
| SUBUNIT (STRAIN A2) 1034 1165 1480 1803 2089 |
| PRRPP-- HRSVA RNA POLYMERASE ALPHA HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS |
| 99-141 |
| SUBUNIT (STRAIN A2) |
| PVGLF-- HRSVA FUSION GLYCOPROTEIN HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS 38-65 154-202 213-243 488-518 |
| PRECURSOR (STRAIN A2) |
| PVMA2-- HRSVA MATRIX GLYCOPROTEIN M2 HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS 124-151 |
| (STRAIN A2) |
| PVMAT-- HRSVA MATRIX PROTEIN HUMAN RESPIRATORY SYNCYTIAL VIRUS |
| 219-246 |
| (STRAIN A2) |
| PVGLG-- HRSV4 MAJOR SURFACE HUMAN RESPIRATORY SYNCYTIAL VIRUS |
| 66-107 |
| GLYCOPROTEIN G (STRAIN RSB5857) |
| PVGLG-- HRSV5 MAJOR SURFACE HUMAN RESPIRATORY SYNCYTIAL VIRUS |
| 243-273 |
| GLYCOPROTEIN G (STRAIN RSB6190) |
| PVGLF-- HRSVR FUSION GLYCOPROTEIN HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS 38-65 154-202 213-243 442-471 488-518 |
| PRECURSOR (STRAIN RSS-2) |
| PRRPP-- HRSVL RNA POLYMERASE ALPHA HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS |
| 99-141 |
| SUBUNIT (SUBGROUP A/STRAIN LONG) |
| PVGLF-- HRSVL FUSION GLYCOPROTEIN HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS 38-65 154-202 216-243 442-471 488-515 |
| PRECURSOR (SUBGROUP A/STRAIN LONG) |
| PNCAP-- HRSV1 NUCLEOCAPSID PROTEIN HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS 4-31 |
| 74-108 112-141 (SUBGROUP |
| B/STRAIN 18537) |
| PRRPP-- HRSV1 RNA POLYMERASE ALPHA HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS |
| 99-141 |
| SUBUNIT (SUBGROUP B/STRAIN 18537) |
| PVGLF-- HRSV1 FUSION GLYCOPROTEIN HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS 38-65 154-203 442-471 488-515 |
| PRECURSOR (SUBGROUP B/STRAIN 18537) |
| PVGLG-- HRSV1 MAJOR SURFACE HUMAN RESPIRATORY SYNCYTIAL VIRUS |
| 63-93 |
| GLYCOPROTEIN G (SUBGROUP B/STRAIN 18537) |
| PVGLG-- HRSV8 MAJOR SURFACE HUMAN RESPIRATORY SYNCYTIAL VIRUS |
| 66-93 |
| GLYCOPROTEIN G (SUBGROUP B/STRAIN 8/60) |
| PENV-- HTL1C ENV POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE |
| 342-376 |
| I (CARIBBEAN ISOLATE) |
| PPOL-- HTL1C POL POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE |
| 674-712 |
| I (CARIBBEAN ISOLATE) |
| PENV-- HTL1M ENV POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE |
| 342-376 |
| I (ISOLATE MT-2) |
| PENV-- HTL1A ENV POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE |
| 342-376 |
| I (STRAIN ATK) |
| PPOL-- HTL1A POL POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE |
| 674-712 |
| I (STRAIN ATK) |
| PENV-- HTLV2 ENV POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE II |
| 336-370 |
| PDPOL-- HSVI1 DNA POLYMERASE ICTALURID HERPESVIRUS 1 328-366 |
| 710-737 |
| PKR74-- HSVI1 GENE 74 PROTEIN KINASE ICTALURID HERPESVIRUS 1 |
| 491-518 |
| PVG07-- HSVI1 HYPOTH GENE 7 MEMB PRO ICTALURID HERPESVIRUS 1 |
| 71-98 |
| PVG17-- HSVI1 HYPOTHETICAL GENE 17 ICTALURID HERPESVIRUS 1 |
| 177-204 |
| PROTEIN |
| PVG18-- HSVI1 HYPOTHETICAL GENE 18 ICTALURID HERPESVIRUS 1 |
| 174-208 |
| PROTEIN |
| PVG22-- HSVI1 HYPOTHETICAL GENE 22 ICTALURID HERPESVIRUS 1 |
| 373-400 581-622 668-705 766-824 |
| PROTEIN |
| PVG24-- HSVI1 HYPOTHETICAL GENE 24 ICTALURID HERPESVIRUS 1 31-58 |
| PROTEIN |
| PVG28-- HSVI1 HYPOTHETICAL GENE 28 ICTALURID HERPESVIRUS 1 |
| 253-290 497-528 |
| PROTEIN |
| PVG34-- HSVI1 HYPOTHETICAL GENE 34 ICTALURID HERPESVIRUS 1 |
| 95-122 |
| PROTEIN |
| PVG37-- HSVI1 HYPOTHETICAL GENE 37 ICTALURID HERPESVIRUS 1 |
| 442-469 |
| PROTEIN |
| PVG39-- HSVI1 HYPOTHETICAL GENE 39 ICTALURID HERPESVIRUS 1 |
| 651-678 1088- |
| PROTEIN 1115 |
| PVG46-- HSVI1 PROBABLE MAJOR ICTALURID HERPESVIRUS 1 142-169 |
| 346-373 897-924 973-1007 |
| GLYCOPROTEIN |
| PVG51-- HSVI1 HYPOTH GENE 51 MEMBRANE ICTALURID HERPESVIRUS 1 |
| 34-61 |
| 87-114 |
| PROTEIN |
| PVG56-- HSVI1 HYPOTHETICAL GENE 56 ICTALURID HERPESVIRUS 1 |
| 582-609 |
| PROTEIN |
| PVG63-- HSVI1 HYPOTHETICAL GENE 63 ICTALURID HERPESVIRUS 1 |
| 550-584 |
| PROTEIN |
| PVG64-- HSVI1 HYPOTHETICAL GENE 64 ICTALURID HERPESVIRUS 1 |
| 477-504 |
| PROTEIN |
| PVG65-- HSVI1 HYPOTHETICAL GENE 65 ICTALURID HERPESVIRUS 1 1213- |
| PROTEIN 1254 |
| PVG66-- HSVI1 HYPOTHETICAL GENE 66 ICTALURID HERPESVIRUS 1 |
| 362-406 |
| PROTEIN |
| PVG67-- HSVI1 HYPOTHETICAL GENE 67 ICTALURID HERPESVIRUS 1 1342- |
| PROTEIN 1369 |
| PVG68-- HSVI1 HYPOTHETICAL GENE 68 ICTALURID HERPESVIRUS 1 |
| 447-481 |
| PROTEIN |
| PVG72-- HSVI1 HYPOTHETICAL GENE 72 ICTALURID HERPESVIRUS 1 |
| 261-288 |
| PROTEIN |
| PVG75-- HSVI1 HYPOTHETICAL GENE 75 ICTALURID HERPESVIRUS 1 |
| 388-422 |
| PROTEIN |
| PVG76-- HSVI1 HYPOTHETICAL GENE 76 ICTALURID HERPESVIRUS 1 |
| 200-227 |
| PROTEIN |
| PVTER-- HSVI1 PROBABLE DNA PACKAGING ICTALURID HERPESVIRUS 1 |
| 710-737 |
| PROTEIN |
| PHEMA-- IAHSW HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN) |
| A/EQUINE/ 29-56 194-221 388-457 |
| SWITZERLAND/137/72) |
| PHEMA-- IAAIC HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 387-453 |
| AICHI/2/68) |
| PVNS1-- IAALA NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ 171-198 |
| ALASKA/6/77) |
| PVNUC-- IAANA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| ANAS ACUTA/PRIMORJE/695/76) |
| PVNS1-- IAANN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ 171-198 |
| ANN ARBOR/6/60) |
| PVNCU-- IAANN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| ANN ARBOR/6/60) |
| PHEMA-- IABAN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 24-51 371-437 |
| BANGKOK/1/79) |
| PNRAM-- IABDA NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/ 47-81 |
| BLACK DUCK/AUSTRALIA/702/78) |
| PVNUC-- IABRA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| BRAZIL/11/78) |
| PHEMA-- IABUD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 381-451 |
| BUDGERIGAR/HOKKAIDO/1/77) |
| PRRP3-- IABUD RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN A/ |
| 537-567 |
| SUB P3 BUDGERIGAR/HOKKAIDO/1/77) |
| PVNUC-- IABUD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| BUDGERIGAR/HOKKAIDO/1/77) |
| PVNUC-- IACAL NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| CALIFORNIA/10/78) |
| PNRAM-- IACAO NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/ 33-64 |
| CAMEL/MONGOLIA/82 |
| PHEMA-- IACAO HEMAGGLUTININ INFLUENZA A VIRUS (STRAIN A/ 9-36 |
| CAMEL/MONGOLIA/82) |
| PHEMA-- IACKA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 381-451 |
| CHICKEN/ALABAMA/1/75) |
| PHEMA-- IACKG HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 31-58 382-441 494-528 |
| CHICKEN/GERMANY/N/49) |
| PVNS1-- IACKG NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ 171-198 |
| CHICKEN/GERMANY/N/49) |
| PVNUC-- IACKG NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| CHICKEN/GERMANY/N/49) |
| PVNS1-- IACKJ NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ 168-195 |
| CHICKEN/JAPAN/24) |
| PHEMA-- IACKP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 396-426 |
| CHICKEN/PENNSYLVANIA/1/83) |
| PVNUC-- IACKP NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| CHICKEN/PENNSYLVANIA/1/83) |
| PHEMA-- IACKQ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 396-426 |
| CHICKEN/PENNSYLVANIA/1370/83) |
| PHEMA-- IACKV HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 119-146 384-443 |
| CHICKEN/VICTORIA/1/85) |
| PNRAM-- IACHI NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/ 16-43 |
| 50-91 |
| CHILE/1/83) |
| PRRP3-- IACHI RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN A/ |
| 331-358 |
| SUB P3 CHILE/1/83) |
| PVNS1-- IACHI NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ 171-198 |
| CHILE/1/83) |
| PHEMA-- IADA1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 381-451 |
| DUCK/ALBERTA/28/76) |
| PNRAM-- IADA1 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/ 51-81 |
| DUCK/ALBERTA/28/76) |
| PHEMA-- IADA4 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 29-56 418-478 |
| DUCK/ALBERTA/35/76) |
| PHEMA-- IADA2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 423-453 499-543 |
| DUCK/ALBERTA/60/76) |
| PVNS1-- IADA2 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ 171-198 |
| DUCK/ALBERTA/60/76) |
| PHEMA-- IADA3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 387-453 |
| DUCK/ALBERTA/78/76) |
| PVNUC-- IADAU NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| DUCK/AUSTRALIA/749/80) |
| PVNUC-- IADBE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| BEIJING/1/78) |
| PHEMA-- IADCZ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 381-451 |
| DUCK/CZECHOSLOVAKIA/56) |
| PVNUC-- IADCZ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| DUCK/CZECHOSLOVAKIA/56) |
| PVNUC-- IADE1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| DUCK/ENGLAND/1/) |
| PHEMA-- IADE1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 21-55 402-453 506-533 |
| DUCK/ENGLAND/1/56) |
| PVNUC-- IADE2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| DUCK/ENGLAND/1/62) |
| PNRAM-- IADGE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/ 21-48 |
| DUCK/GERMANY/49) |
| PHEMA-- IADH7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 371-437 |
| DUCK/HOKKAIDO/10/85) |
| PHEMA-- IADH5 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 371-437 |
| DUCK/HOKKAIDO/21/82) |
| PHEMA-- IADH3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 371-437 |
| DUCK/HOKKAIDO/33/80) |
| PHEMA-- IADH1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 371-437 |
| DUCK/HOKKAIDO/5/77) |
| PHEMA-- IADH4 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 371-437 |
| DUCK/HOKKAIDO/7/82) |
| PHEMA-- IADH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 371-437 |
| DUCK/HOKKAIDO/8/80) |
| PRRP2-- IADH2 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN A/ |
| 119-146 |
| SUB P2 DUCK/HOKKAIDO/8/80) |
| PHEMA-- IADH6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 371-437 |
| DUCK/HOKKAIDO/9/85) |
| PVNCU-- IADHK NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| DUCK/HONG KONG/7/75) |
| PHEMA-- IADIR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 415-445 |
| DUCK/IRELAND/113/83) |
| PHEMA-- IADMA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 31-58 |
| DUCK/MANITOBA/1/53) |
| PVNUC-- IADMA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| DUCK/MANITOBA/1/53) |
| PHEMA-- IADM2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 21-56 |
| DUCK/MEMPHIS/546/76) |
| PHEMA-- IADM2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 387-453 |
| DUCK/MEMPHIS/928/74) |
| PVNUC-- IADM2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| DUCK/MEMPHIS/928/74) |
| PHEMA-- IADNY HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/NEW 21-55 |
| YORK/12/78) |
| PHEMA-- IADNZ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/NEW 381-451 |
| ZEALAND/31/76) |
| PVNUC-- IADNZ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/NEW |
| 378-405 |
| ZEALAND/31/76) |
| PHEMA-- IADU1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/UKRAINE/ 21-55 |
| 1/60) |
| PHEMA-- IADU3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/DUCK/UKRAINE/ 387-453 |
| 1/63) |
| PVNUC-- |
| IADU2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/DUCK/UKRAINE/ 378-405 |
| 2/60) |
| PVNUC-- |
| IAEN5 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ENGLAND/19/ 378-405 |
| 55) |
| PHEMA-- IAEN7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ENGLAND/321/ 40-67 387-453 |
| 77) |
| PHEMA-- IAEN6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ENGLAND/878/ 24-51 |
| 69) |
| PHEMA-- IAHAL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| ALGIERS/72) |
| PHEMA-- IAHCD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/C. 29-56 194-221 388-457 |
| DETROIT/1/64) |
| PHEMA-- IAHC6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 29-56 194-221 388-457 |
| CAMBRIDGE/1/63) |
| PHEMA-- IAHC7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 29-56 194-221 388-457 |
| CAMBRIDGE/1/73) |
| PNRAM-- IAHCO NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| 197-224 386-413 |
| COR/16/74) |
| PHEMA-- IAHDE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 29-56 194-221 388-457 |
| DETROIT/1/64) |
| PHEMA-- IAFO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| FONTAINEBLEAU/76) |
| PVNUC-- IAHJI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| 378-405 |
| JILLIN/1/89) |
| PNRAM-- IAHK1 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| 5-44 46-76 364-400 |
| KENTUCKY/1/81) |
| PHEMA-- IAHK7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| KENTUCKY/1/87) |
| PHEMA-- IAHK6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| KENTUCKY/2/86) |
| PHEMA-- IAHLE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 29-56 194-221 388-457 |
| LEXINGTON/1/66) |
| PHEMA-- IAHLO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 29-56 194-221 388-457 |
| LONDON/1416/73) |
| PRRP2-- IAHLO RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 119-146 |
| SUB P2 LONDON/1416/73) |
| PVNUC-- IAHLO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| 378-405 |
| LONDON/1416/73) |
| PHEMA-- IAHMI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| MIAMI/1/63) |
| PVNUC-- IAHMI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| 378-405 |
| MIAMI/1/63) |
| PHEMA-- IAHNN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 29-56 194-221 388-457 |
| NEW MARKET/1/77) |
| PHEMA-- IAHNM HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| NEW MARKET/76) |
| PHEMA-- IAHPR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 29-56 194-221 388-457 |
| PRAGUE/1/56) |
| PRRP3-- IAHPR RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 331-361 480-507 |
| SUB P3 PRAGUE/1/56) |
| PVNUC-- IAHPR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| 378-405 |
| PRAGUE/1/56) |
| PHEMA-- IAHRO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| ROMANIA/80) |
| PHEMA-- IAHSA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| SANTIAGO/1/85) |
| PHEMA-- IAHSP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 29-56 194-221 388-457 |
| SAO PAULO/1/76) |
| PHEMA-- IAHTE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| TENNESSEE/5/86) |
| PRRP2-- IAHTE RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 119-146 |
| SUB P2 TENNESSEE/5/86) |
| PVNUC-- IAHTE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/ |
| 378-405 |
| TENNESSEE/5/86) |
| PHEMA-- IAHTO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-455 |
| TOKYO/71) |
| PHEMA-- IAHUR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/EQUINE/ 386-452 |
| URUGUAY/1/63) |
| PVNS1-- IAFOM NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/FORT 171-198 |
| MONMOUTH/1/47) |
| PVNUC-- IAFOM NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FORT |
| 378-405 |
| MONMOUTH/1/47) |
| PVNS1-- IAFOW NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/FORT 171-198 |
| WARREN/1/50) |
| PVNUC-- IAFOW NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FORT |
| 378-405 |
| WARREN/1/50) |
| PVNUC-- IAFPD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FOWL |
| 378-405 |
| PLAGUE VIRUS/DOBSON/`DUTCH`/27) |
| PHEMA-- IAFPR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/FOWL 177-221 384-442 |
| PLAGUE VIRUS/ROSTOCK/34) |
| PRRP2-- IAFPR RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/FOWL 119-146 |
| SUB P2 PLAGUE VIRUS/ROSTOCK/34) |
| PVNUC-- IAFPR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/FOWL |
| 378-405 |
| PLAGUE VIRUS/ROSTOCK/34) |
| PNRAM-- IAFPW NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/FOWL |
| PLAGUE 10-48 52-80 197-224 |
| VIRUS/WEYBRIDGE) |
| PHEMA-- IAGRE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/GREY TEAL/ 381-451 |
| AUSTRALIA/2/79) |
| PVNUC-- IAGRE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GREY |
| TEAL/ 378-405 |
| AUSTRALIA/2/79) |
| PHEMA-- IAGUA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/GULL/ 504-531 |
| ASTRAKHAN/227/84) |
| PVNUC-- IAGUA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| 378-405 |
| ASTRAKHAN/227/84) |
| PVNUC-- IAGU4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| 378-405 |
| MARYLAND/1815/79) |
| PVNUC-- IAGU3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| 378-405 |
| MARYLAND/1824/78) |
| PVNUC-- IAGU1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| 378-405 |
| MARYLAND/5/77) |
| PHEMA-- IAGU2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/GULL/ 505-532 |
| MARYLAND/704/77) |
| PRRP2-- IAGU2 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/GULL/ 119-146 |
| SUB P2 MARYLAND/704/77) |
| PVNUC-- IAGU2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| 378-405 |
| MARYLAND/704/77) |
| PVNUC-- IAGUM NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| 378-405 |
| MASSACHUSETTS/26/80) |
| PVNUC-- IAGUN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/GULL/ |
| 378-405 |
| MINNESOTA/945/80) |
| PHEMA-- IAHAR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/HARBIN/1/88) 29-56 |
| PVNUC-- |
| IAHIC NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/HICKOX/40) 378-405 |
| PVNUC-- IAHO1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/HONG |
| 378-405 |
| KONG/1/68) |
| PVNUC-- IAHO2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/HONG |
| 378-405 |
| KONG/5/83) |
| PHEMA-- IAJAP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/JAPAN/305/ 196-223 |
| 57) |
| PHEMA-- IAKIE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/KIEV/59/79) 29-56 425-478 |
| PNRAM-- |
| IAKIE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/KIEV/59/79) 50-81 |
| PVNUC-- IAKIE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN |
| A/KIEV/59/79) 378-405 |
| PRRP1-- IAKOR RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/KOREA/426/ 575-602 |
| SUB P1 68) |
| PRRP2-- IAKOR RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/KOREA/426/ 119-146 |
| SUB P2 68) |
| PRRP2-- IALE2 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/ 119-146 |
| SUB P2 134/17/57) |
| PRRP2-- IALE1 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/ 119-146 |
| SUB P2 134/57) |
| PVNS1-- IALE1 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/ 171-198 |
| 134/57) |
| PHEMA-- IALEN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/ 29-56 425-478 |
| 54/1) |
| PNRAM-- |
| IALEN NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/LENINGRAD/ 50-81 |
| 54/1) |
| PVNUC-- |
| IALEN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/LENINGRAD/ 378-405 |
| 54/1) |
| PVNS1-- IAMA6 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 171-198 |
| ALBERTA/88/76) |
| PHEMA-- IAMAA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 380-450 |
| ASTRAKHAN/244/82) |
| PVNUC-- IAMAA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/MALLARD/ |
| 378-405 |
| ASTRAKHAN/244/82) |
| PHEMA-- IAMAB HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 385-455 |
| ASTRAKHAN/263/82) |
| PRRP2-- IAMAN RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 119-146 |
| SUB P2 NEW YORK/6750/78) |
| PVNUC-- IAMAN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/MALLARD/ |
| 378-405 |
| NEW YORK/6750/78) |
| PHEMA-- IAMAO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ 387-453 |
| NEW YORK/6874/78) |
| PHEMA-- IAME1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MEMPHIS/1/71) 40-67 387-453 |
| PNRAM-- |
| IAME1 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/MEMPHIS/1/ 16-43 50-81 |
| 71H-A/BELLAMY/42N) |
| PHEMA-- IAME2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MEMPHIS/102/72) 40-67 387-453 |
| PHEMA-- IAME6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MEMPHIS/6/86) 24-51 371-437 |
| PHEMA-- IAMIN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/MINK/ 31-58 382-441 |
| SWEDEN/84) |
| PVNUC-- IMAIN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/MINK/ |
| 378-405 |
| SWEDEN/84) |
| PVNUC-- IANEJ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/NEW |
| 378-405 |
| JERSEY 8/76) |
| PHEMA-- IANT6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/NT/ 387-453 |
| 60/68) |
| PRRP2-- IANT6 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/NT/60/68) 119-146 |
| SUB P2 |
| PVNUC-- IANT6 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/NT/60/68) |
| 378-405 |
| PVNUC-- |
| IAOHI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/OHIO/4/83) 378-405 |
| PNRAM-- IAPAR NEURAMINIDASE INFLUENZA A VIRUS (STRAIN |
| A/PARROT/ 16-43 50-81 |
| ULSTER/73) |
| PVNUC-- IAPAR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/PARROT/ |
| 378-405 |
| ULSTER/73) |
| PHEMA-- IAPIL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/PILOT 505-534 |
| WHALE/MAINE/328/84) |
| PRRP2-- IAPI0 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 119-146 |
| SUB P2 ALBERTA/119/79) |
| PVNS1-- IAPI1 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 171-198 |
| ALBERTA/121/79) |
| PVNS1-- IAPI3 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ 171-198 |
| ALBERTA/358/79) |
| PHEMA-- IAPUE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/PUERTO 29-56 425-478 |
| RICO/8/34) |
| PNRAM-- IAPUE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/PUERTO |
| 16-43 |
| RICO/8/34) |
| PRRP2-- IAPUE RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/PUERTO 119-146 |
| SUB P2 RICO/8/34) |
| PVNUC-- IAPUE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/PUERTO |
| 378-405 |
| RICO/8/34) |
| PHEMA-- IAQU7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/QU/7/70) 24-51 |
| PHEMA-- IARUD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/RUDDY 381-451 |
| TURNSTONE/NEW JERSEY/47/85) |
| PRRP2-- IARUD RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/RUDDY 119-146 |
| SUB P2 TURNSTONE/NEW JERSEY/47/85) |
| PVNUC-- IARUD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/RUDDY |
| 378-405 |
| TURNSTONE/NEW JERSEY/47/85) |
| PNRAM-- IARUE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/RUDDY |
| 49-88 |
| TURNSTONE/NEW JERSEY/47/85) |
| PVNUC-- IASE0 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SEAL/ |
| 378-405 |
| MASSACHUSETTS/1/30) |
| PHEMA-- IASE2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SEAL/ 381-451 |
| MASSACHUSETTS/133/82) |
| PHEMA-- IASH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 28-56 160-187 506-547 |
| SHEARWATER/AUSTRALIA/72) |
| PVNUC-- IASH2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| SHEARWATER/AUSTRALIA/72) |
| PRRP2-- IASIN RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/SINGAPORE/1/57) 119-146 |
| SUB P2 |
| PVNUC-- IASIN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 378-405 |
| A/SWINE/SINGAPORE/1/57) |
| PHEMA-- IASTA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/STARLING/ 119-146 384-443 |
| VICTORIA/5156/85) |
| PVNUC-- IAZ29 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| SWINE/29/37) |
| PVNUC-- IAZ41 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| SWINE/41/49) |
| PVNUC-- IAZCA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| CAMBRIDGE/1/35) |
| PHEMA-- IAZCO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/ 40-67 387-453 |
| COLORADO/1/77) |
| PVNUC-- IAZDA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| DANDONG/9/83) |
| PVNUC-- IAZGE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| GERMANY/2/81) |
| PHEMA-- IAZH3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/HONG 371-437 |
| KONG/126/82) |
| PRRP2-- IAZH3 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/SWINE/HONG 119-146 |
| SUB P2 KONG/126/82) |
| PVNUC-- |
| IAZH3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/HONG 378-405 |
| KONG/126/82) |
| PVNUC-- |
| IAZH4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/HONG 378-405 |
| KONG/127/82) |
| PVNUC-- |
| IAZH1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/HONG 378-405 |
| KONG/6/76) |
| PHEMA-- IAZH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/HONG 371-437 |
| KONG/81/78) |
| PRRP2-- IAZH2 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/SWINE/HONG 119-146 |
| SUB P2 KONG/81/78) |
| PHEMA-- IAZIN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/INDIANA/ 418-478 506-547 |
| 1726/88) |
| PRRP2-- IAZI1 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/SWINE/ 119-146 |
| SUB P2 IOWA/15/30) |
| PVNUC-- IAZI1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| IOWA/15/30) |
| PVNUC-- IAZI2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| IOWA/197/31) |
| PVNUC-- |
| IAZI3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/IOWA/46 378-405 |
| PVNUC-- |
| IAZJ3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ITALY/ 378-405 |
| 141/81) |
| PVNUC-- IAZJ2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| ITALY/2/79) |
| PVNUC-- IAZJ1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| ITALY/437/76) |
| PVNUC-- IAZJ4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| ITALY/839/89) |
| PVNUC-- IAZJA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| JAMESBURG/42) |
| PVNUC-- |
| IAZMA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/MAY/54) 378-405 |
| PVNUC-- IAZNE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| NETHERLANDS/12/85) |
| PHEMA-- IAZNJ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/NEW 418-478 506-547 |
| JERSEY/11/76) |
| PVNUC-- IAZOH NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| OHIO/23/35) |
| PVNUC-- IAZON NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| ONTARIO/2/81) |
| PRRP3-- IAZTE RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/SWINE/ 487-514 |
| SUB P3 TENNESSEE/24/77) |
| PVNUC-- IAZTE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| TENNESSEE/24/77) |
| PRRP2-- IAZTF RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/SWINE/ 119-146 |
| SUB P2 TENNESSEE/26/77) |
| PHEMA-- IAZUK HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/SWINE/ 387-453 |
| UKKEL/1/84) |
| PVNUC-- IAZW1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| WISCONSIN/1/57) |
| PVNUC-- IAZW2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/SWINE/ |
| 378-405 |
| WISCONSIN/1/61) |
| PHEMA-- IATAI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TAIWAN/1/86) 29-56 |
| PVNUC-- IATEI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TEAL/ |
| 378-405 |
| ICELAND/29/80) |
| PHEMA-- IATRA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TERN/ 21-55 |
| AUSTRALIA/G670/75) |
| PNRAM-- IATRA NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/TERN/ |
| 48-82 |
| AUSTRALIA/G670/75) |
| PVNUC-- IATRS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TERN/ |
| 378-405 |
| SOUTH AFRICA/61) |
| PVNS1-- IATRT NONSTRUCTURAL PROTEIN INFLUENZA A VIRUS (STRAIN |
| A/TERN/ 171-198 |
| NS1 TURKMENIA/18/72) |
| PVNUC-- IATRT NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TERN/ |
| 378-405 |
| TURKMENIA/18/72) |
| PVNUC-- |
| IATX7 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TEXAS/1/77) 378-405 |
| PVNS1-- IATKB NONSTRUCTURAL PROTEIN INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 171-198 |
| NS1 BETHLEHEM-GLILIT/1492-B/82) |
| PVNS1-- IATKC NONSTRUCTURAL PROTEIN INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 171-198 |
| NS1 CANADA/63) |
| PHEMA-- IATKI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 415-445 |
| IRELAND/1378/83) |
| PVNUC-- IATKN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TURKEY/ |
| 378-405 |
| MINNESOTA/1661/81) |
| PHEMA-- IATKM HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 381-451 |
| MINNESOTA/833/80) |
| PRRP2-- IATKM RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 119-146 |
| SUB P2 MINNESOTA/833/80) |
| PHEMA-- IATKP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 424-454 493-539 |
| ONTARIO/6118/68) |
| PHEMA-- IATKO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 507-534 |
| ONTARIO/7732/66) |
| PVNUC-- IATKO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/TURKEY/ |
| 378-405 |
| ONTARIO/7732/66) |
| PHEMA-- IATKR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 32-62 194-221 381-422 |
| OREGON/71) |
| PVNS2-- IATKR RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ |
| 87-114 SUB P2 |
| OREGON/71) |
| PHEMA-- IATKW HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ 419-449 500-536 |
| WISCONSIN/1/66) |
| PHEMA-- IAUDO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/UDORN/307/72) 40-67 387-453 |
| PVNSI-- IAUDO NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/UDORN/307/72) 171-198 |
| PVNUC-- |
| IAUDO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/UDORN/307/72) 378-405 |
| PHEMA-- IAUSS HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/USSR/90/77) 29-56 425-478 |
| PNRAM-- |
| IAUSS NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/USSR/90/77) 50-81 |
| PVNS1-- IAUSS NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS |
| (STRAIN A/USSR/90/77) 171-198 |
| PVNUC-- |
| IAUSS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/USSR/90/77) 378-405 |
| PHEMA-- IAVI7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS |
| (STRAIN A/VICTORIA/3/75) 41-68 388-454 |
| PRRP2-- IAVI7 RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN |
| A/VICTORIA/3/75) 119-146 327-354 |
| SUB P2 |
| PVNUC-- |
| IAVI6 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/VICTORIA/5/68) 378-405 |
| PNRAM-- IAWHM NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/WHALE/ |
| 49-88 |
| MAINE/1/84) |
| PVNUC-- IAWHN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WHALE/ |
| 378-405 |
| MAINE/328/84) |
| PVNUC-- IAWHP NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/WHALE/ |
| 378-405 |
| PACIFIC OCEAN/19/76) |
| PHEMA-- IAWIL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 424-477 |
| WILSON-SMITH/33) |
| PNRAM-- IAWIL NEURAMINIDASE INFLUENZA A VIRUS (STRAIN A/ 16-43 |
| WILSON-SMITH/33) |
| PRRP2-- IAWIL RNA-DIRECTED RNA POL INFLUENZA A VIRUS (STRAIN A/ |
| 119-146 |
| SUB P2 WILSON-SMITH/33) |
| PVNUC-- IAWIL NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| WILSON-SMITH/33) |
| PVNUC-- IAWIS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/ 378-405 |
| WISCONSIN/3523/88) |
| PHEMA-- IAXIA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS (STRAIN |
| A/ 29-56 |
| XIANFENG/3/89) |
| PRRP2-- INBAC RNA-DIRECTED RNA POL INFLUENZA B VIRUS (STRAIN |
| A/ANN ARBOR/ 157-194 |
| SUB P2 1/66 [COLD-ADAPTED]) |
| PRRP3-- INBAC RNA-DIRECTED RNA POL INFLUENZA B VIRUS (STRAIN |
| A/ANN ARBOR/ |
| 2-33 472-509 SUB P3 |
| 1/66 [COLD-ADAPTED]) |
| PRRP2-- INBAD RNA-DIRECTED RNA POL INFLUENZA B VIRUS (STRAIN |
| A/ANN ARBOR/ 164-194 |
| SUB P2 1/66 [WILD-TYPE]) |
| PPRR3-- INBAD RNA-DIRECTED RNA POL INFLUENZA B VIRUS (STRAIN |
| A/ANN ARBOR/ |
| 2-33 472-509 SUB P3 |
| 1/66 [WILD-TYPE]) |
| PHEMA-- INBBE HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/BEIJING/1/87) 400-431 439-483 |
| PHEMA-- INBBO HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/BONN/43) 390-421 429-473 |
| PHEMA-- INBEN HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/ENGLAND/22/82) 398-429 437-481 |
| PHEMA-- INBHK HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/HONG 391-418 429-473 |
| KONG/8/73) |
| PHEMA-- INBLE HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/LEE/40) 399-430 438-482 |
| PNRAM-- INBLE NEURAMINIDASE INFLUENZA B VIRUS (STRAIN B/LEE/40) |
| 4-35 |
| PVNS2-- INBLE NONSTRUCTURAL PROTEIN NS1 INFLUENZA B VIRUS (STRAIN |
| B/LEE/40) 51-78 |
| PHEMA-- INBMD HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/MARYLAND/59) 389-420 428-472 |
| PHEMA-- INBME HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/MEMPHIS/6/86) 393-424 432-476 |
| PHEMA-- INBOR HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/OREGON/5/80) 398-429 437-481 |
| PVNS1-- INBPA NONSTRUCTURAL PROTEIN NS1 INFLUENZA B VIRUS (STRAIN |
| B/PA/79) 171-198 |
| PHEMA-- INBSI HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/SINGAPORE/ 398-429 437-481 |
| 222/79) |
| PRRP2-- INBSI RNA-DIRECTED RNA POL INFLUENZA B VIRUS (STRAIN |
| B/SINGAPORE/ 157-194 |
| SUB P2 222/79) |
| PHEMA-- INBUS HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/USSR/100/83) 391-422 430-474 |
| PHEMA-- INBVK HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/VICTORIA/2/87) 400-431 439-483 |
| PHEMA-- INBVI HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS (STRAIN |
| B/VICTORIA/3/85) 393-424 432-476 |
| PVNS2-- INBYA NONSTRUCTURAL PROTEIN NS2 INFLUENZA B VIRUS (STRAIN |
| B/YAMAGATA/ 51-78 |
| 1/73) |
| PRRP3-- INCBE RNA-DIRECTED RNA POL INFLUENZA C VIRUS (STRAIN |
| C/BERLIN/1/85) 509-536 |
| SUB P3 |
| PHEMA-- INCCA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/CALIFORNIA/78) 495-571 |
| PVNUC-- |
| INCCA NUCLEOPROTEIN INFLUENZA C VIRUS (STRAIN C/CALIFORNIA/78) 99-126 |
| 416-443 451-478 |
| PHEMA-- INCEN HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/ENGLAND/ 483-559 |
| 892/83) |
| PHEMA-- INCGL HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/GREAT LAKES/ 483-559 |
| 1167/54) |
| PHEMA-- INCHY HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/YOGO/1/83) 482-558 |
| PRRP3-- INCJJ RNA-DIRECTED RNA POL INFLUENZA C VIRUS (STRAIN |
| C/JJ/50) 509-536 |
| SUB P3 |
| PVMAT-- INCJJ MATRIX (M) PROTEIN INFLUENZA C VIRUS (STRAIN |
| C/JJ/50) 151-185 |
| PVNS2-- INCJJ NONSTRUCTURAL PROTEIN NS2 INFLUENZA C VIRUS (STRAIN |
| C/JJ/50) 71-98 |
| PHEMA-- INCJH HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/ 496-572 |
| JOHANNESBURG/1/66) |
| PHEMA-- INCKY HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/KYOTO/41/82) 482-558 |
| PHEMA-- INCMI HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/MISSISSIPPI/80) 482-558 |
| PHEMA-- INCNA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/NARA/82) 482-558 |
| PHEMA-- INCP1 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/PIG/ 483-559 |
| BEIJING/10/81) |
| PHEMA-- INCP2 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/PIG/ 483-559 |
| BEIJING/115/81) |
| PHEMA-- INCP3 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/PIG/ 483-559 |
| BEIJING/439/82) |
| PHEMA-- INCTA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/TAYLOR/1233/48) 483-559 |
| PHEMA-- INCYA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS (STRAIN |
| C/ 483-559 |
| YAMAGATA/10/81) |
| PENV-- MLVKI ENV POLYPROTEIN KIRSTEN MURINE LEUKEMIA VIRUS 40-81 |
| PVGLB-- |
| HSVMD GLYCOPROTEIN B PRECURSOR MAREK'S DISEASE HERPESVIRUS (STRAIN |
| 93-120 352-379 |
| RB-1B) |
| PENV-- MCFF ENV POLYPROTEIN MINK CELL FOCUS-FORMING MURINE |
| 473-512 |
| LEUKEMIA VIRUS |
| PENV-- MCFF3 ENV POLYPROTEIN MINK CELL FOCUS-FORMING MURINE |
| 488-515 |
| LEUKEMIA VIRUS (ISOLATE CI-3) |
| PENV-- MLVMO ENV POLYPROTEIN MOLONEY MURINE LEUKEMIA VIRUS |
| 502-543 |
| PDNBI-- MCMVS MAJOR DNA-BINDING PROTEIN MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) 584-618 |
| PIC18-- MCMVS PROB PROC & TRANSPORT PRO MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) 661-691 |
| PVGLB-- MCMVS GLYCOPROTEIN B PRECURSOR MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) 381-408 441-475 |
| VIE1-- MCMVS IMMEDIATE-EARLY PROTEIN 1 MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) 261-288 |
| PVE2-- PCPV1 E2 PROTEIN PYGMY CHIMPANZEE PAPILLOMAVIRUS TYPE 1 |
| 267-294 327-361 |
| PVE5-- PCPV1 PROBABLE E5 PROTEIN PYGMY CHIMPANZEE PAPILLOMAVIRUS |
| TYPE 1 35-62 |
| PENV-- MLVRD ENV POLYPROTEIN RADIATION MURINE LEUKEMIA VIRUS |
| 497-538 |
| PPOL-- MLVRD POL POLYPROTEIN RADIATION MURINE LEUKEMIA VIRUS |
| 716-743 805-832 |
| PENV-- MLVRK ENV POLYPROTEIN RADIATION MURINE LEUKEMIA VIRUS |
| 497-538 |
| (STRAIN KAPLAN) |
| PPOL-- MLVRK POL POLYPROTEIN RADIATION MURINE LEUKEMIA VIRUS |
| 101-128 190-217 |
| (STRAIN KAPLAN) |
| PDNBI-- SCMVC MAJOR DNA-BINDING PROTEIN SIMIAN CYTOMEGALOVIRUS |
| (STRAIN 435-462 532-559 |
| COLBURN) |
| PPOLG-- HPAVS GENOME POLYPROTEIN SIMIAN HEPATITIS A VIRUS (STRAIN |
| AGM27) 207-241 1025- 1115- |
| 1052 1192 |
| PPOLG-- HPAVT GENOME POLYPROTEIN SIMIAN HEPATITIS A VIRUS (STRAIN |
| CY-145) 203-237 |
| PENV-- SIVA1 ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 269-310 561-588 592-619 652-679 697-724 |
| (AGM155 ISOLATE) |
| PPOL-- SIVA1 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 431-458 547-574 637-671 |
| (AGM155 ISOLATE) |
| PPOL-- SIVA2 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS 45-72 |
| (AGM266 ISOLATE) |
| PENV-- SIVAG ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 270-301 566-593 597-624 658-685 703-730 |
| (AGM3 ISOLATE) |
| PPOL-- SIVAG POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 436-463 482-516 642-669 |
| (AGM3 ISOLATE) |
| PPOL-- SIVA3 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS 71-98 |
| (AGM385 ISOLATE) |
| PENV-- SIVS4 ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 281-308 553-612 642-669 691-718 |
| (F236/SMH4 ISOLATE) |
| PGAG-- SIVS4 GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 88-115 |
| (F236/SMH4 ISOLATE) |
| PPOL-- SIVS4 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 496-523 |
| (F236/SMH4 ISOLATE) |
| PENV-- SIVAI ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 257-291 336-372 548-603 634-708 |
| (ISOLATE AGM/CLONE GRI-1) |
| PGAG-- SIVAI GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 473-507 |
| (ISOLATE AGM/CLONE GRI-1) |
| PNEF-- SIVAI NEGATIVE FACTOR SIMIAN IMMUNODEFICIENCY VIRUS |
| 96-137 |
| (ISOLATE AGM/CLONE GRI-1) |
| PPOL-- SIVAI POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 478-515 |
| (ISOLATE AGM/CLONE GRI-1) |
| VIF-- SIVAI VIRION INFECTIVITY FACTOR SIMIAN IMMUNODEFICIENCY |
| VIRUS |
| 2-36 |
| (ISOLATE AGM/CLONE GRI-1) |
| PENV-- SIVGB ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS 8-35 |
| 158-185 589-650 784-816 |
| (ISOLATE BG1) |
| PPOL-- SIVGB POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 227-254 636-670 |
| (ISOLATE BG1) |
| PENV-- SIVMK ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 553-608 |
| (K6W ISOLATE) |
| PGAG-- SIVMK GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 88-115 |
| (K6W ISOLATE) |
| PPOL-- SIVMK POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 533-560 |
| (K6W ISOLATE) |
| PENV-- SIVML ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 549-608 |
| (K78 ISOLATE) |
| PENV-- SIVM1 ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 120-150 550-609 671-715 |
| (MM142-83 ISOLATE) |
| PPOL-- SIVM1 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 533-560 |
| (MM142-83 ISOLATE) |
| PENV-- SIVM2 ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 156-215 277-289 |
| (MM251 ISOLATE) |
| PENV-- SIVSP ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 286-313 554-595 646-722 |
| (PBJ/BC13 ISOLATE) |
| PGAG-- SIVSP GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 88-115 |
| (PBJ/BC13 ISOLATE) |
| PPOL-- SIVSP POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 499-526 |
| (PBJ/BC13 ISOLATE) |
| PGAG-- SIVMS GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 88-115 |
| (STM ISOLATE) |
| PENV-- SIVAT ENV POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS 3-30 |
| 268-298 590-617 651-678 |
| (TYO-1 ISOLATE) |
| PPOL-- SIVAT POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY VIRUS |
| 657-691 |
| (TYO-1 ISOLATE) |
| PREV-- SIVAT REV PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS 41-68 |
| (TYO-1 ISOLATE) |
| PENV-- MPMV ENV POLYPROTEIN SIMIAN MASON-PFIZER VIRUS 422-470 |
| PPOL-- MPMV POL POLYPROTEIN SIMIAN MASON-PFIZER VIRUS 574-612 |
| 670-697 |
| PGAG-- MPMV GAG POLYPROTEIN SIMIAN MASON-PFIZER VIRUS (MPMV) |
| 222-260 |
| PEXON-- VZVD ALKALINE EXONUCLEASE VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 109-139 |
| PHELI-- VZVD PROBABLE HELICASE VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 490-517 701-728 |
| PRIR1-- VZVD RIBONCU-DIPHOSPH VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 119-146 |
| REDUCT LARGE CHA |
| PTEGU-- VZVD LARGE TEGUMENT PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 1121- 1579- |
| 1158 1609 |
| PUL1R-- VZVD HYPOTHETICAL GENE 46 VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| 64-101 |
| PROTEIN |
| PUL21-- VZVD GENE 38 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 380-407 |
| PUL34-- VZVD VIRION GENE 24 PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 112-139 |
| PUL37-- VZVD GENE 21 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 107-134 485-512 719-746 976- |
| 1003 |
| PUL41-- VZVD HOST SHUTOFF VIRION VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 330-364 |
| PROTEIN |
| PUL43-- VZVD GENE 15 MEMBRANE PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 129-156 312-349 |
| PUL52-- VZVD PROB DNA REP GENE 6 PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) 301-337 |
| PVGLC-- VZVD GLYCOPROTEIN GPV VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 295-322 |
| PVP40-- VZVD CAPSID PROTEIN P40 VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) 174-208 495-522 |
| PVTER-- VZVD PROBABLE DNA VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| 394-421 |
| PACKAGING PROTEIN |
| PVGLC-- VZVS GLYCOPROTEIN GPV VARICELLA-ZOSTER VIRUS (STRAIN |
| SCOTT) 295-322 |
| PDPOL-- WHV1 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 1 285-326 |
| PDPOL-- WHV59 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 59 |
| 290-331 |
| PDPOL-- WHV7 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 7 212-242 |
| 290-331 |
| PDPOL-- WHV8 DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 8 211-241 |
| 289-330 |
| PDPOL-- WHV8I DNA POLYMERASE WOODCHUCK HEPATITIS VIRUS 8 212-242 |
| 290-331 |
| TABLE VIII |
| - 107 × 178 × 4 SEARCH MOTIF RESULTS SUMMARY FOR ALL |
| PROCARYOTIC PROTEINS |
| PCGENE 107 × 178 × 4 Prokaryotic Sequences AREA AREA |
| AREA AREA AREA |
| FILE NAME PROTEIN ORGANISM AREA 1 AREA 2 AREA 3 AREA 4 5 6 7 8 |
| 9 |
| P120K-- |
| RICRI 120 KD SURFACE-EXPOSED PROTEIN RICKETTSIA RICKETTSII 83-110 |
| 240-298 355-382 638-672 746- 1168- |
| 838 1202 |
| P17K-- RICTY 17 KD ANTIGEN PRECURSOR RICKETTSIA TYPHI 67-94 |
| P190K-- RICRI 190 KD ANTIGEN PRECURSOR (CELL SURFACE) |
| RICKETTSIA RICKETTSII 241-268 460-487 607-634 754-781 829- 904- 1220- |
| 1544- 1723- |
| 856 931 1254 1571 1750 |
| 2065- 2131- |
| 2096 2168 |
| P22KD-- DESMO 22.6 KD PROTEIN DESULFUROCOCCUS MOBILIS 25-52 59-89 |
| 120-147 |
| P40KD-- VIBAN 40 KD PROTEIN PRECURSOR VIBRIO ANGUILLARUM 153-196 |
| P60IM-- ECOLI 60 KD INNER-MEMBRANE PROTEIN ESCHERICHIA COLI |
| 511-538 |
| P60IM-- PROMI 60 KD INNER-MEMBRANE PROTEIN PROTEUS MIRABILIS |
| 14-41 |
| P65KD-- ZYMMO 65 KD PROTEIN ZYMOMONAS MOBILIS 95-122 44-524 |
| P6PGD-- BACSU PROB 6-PHOSPHOGLUCONATE DEHYDROGENASE BACILLUS |
| SUBTILIS 24-51 218-246 |
| P6PGD-- ECOLI 6-PHOSPHOGLUCONATE DEHYDROGENASE ESCHERICHIA COLI |
| 205-232 |
| P6PGD-- SALTY 6-PHOSPHOGLUCONATE DEHYDROGENASE SALMONELLA |
| TYPHIMURIUM 205-232 |
| PAACA-- |
| STAAU 6'-AMINOGLYCOSIDE N-ACETYLTRANSFERASE STAPHYLOCOCCUS AUREUS |
| 450-477 |
| PAAT-- BACSP ASPARTATE AMINOTRANSFERASE BACILLUS SP 146-173 |
| 185-212 |
| PAAT-- ECOLI ASPARTATE AMINOTRANSFERASE ESCHERICHIA COLI 351-378 |
| PABC-- |
| ECOLI ABC PROTEIN ESCHERICHIA COLI 176-203 PABIC-- |
| LACLA ABORTIVE PHAGE RESISTANCE PROTEIN ABIC LOCTOCOCCUS LACTIS |
| 85-126 170-204 209-273 |
| PACCR-- AGRTU TRANSCRIPTIONAL REPRESSOR ACCR AGROBACTERIUM |
| TUMEFACIENS 127-154 |
| PACEA-- |
| ECOLI ISOCITRATE LYASE ESCHERICHIA COLI 398-432 PACON-- |
| BACSU ACONITATE HYDRATASE BACILLUS SUBTILIS 48-75 |
| PACON-- ECOLI ACONITATE HYDRATASE ESCHERICHIA COLI 41-68 613-640 |
| PACOR-- ALCEU ACETOIN CATABOLISM REG PRO ALCALIGENES EUTROPHUS |
| 85-112 |
| PACP-- ECOLI ACYL CARRIER PROTEIN ESCHERICHIA COLI |
| 4-31 PACRA-- ECOLI ACRIFLAVIN RESISTANCE PROTEIN A |
| PRECURSOR ESCHERICHIA COLI 213-247 |
| PACRB-- ECOLI ACRIFLAVIN RESISTANCE PROTEIN B ESCHERICHIA COLI |
| 520-551 |
| PACRF-- ECOLI ACRIFLAVIN RESISTANCE PROTEIN F ESCHERICHIA COLI |
| 512-550 726-753 |
| PACT3-- STRCO PUTATIVE KETOACYL REDUCTASE STREPTOMYCES COELICOLOR |
| 157-184 |
| PACTA-- LISMO ACTIN-ASSEMBLY INDUCING PROTEIN PRECURSOR LISTERIA |
| MONOCYTOGENES 237-264 576-603 |
| PACVS-- NOCLA ACV SYNTHETASE NOCARDIA LACTAMDURANS 3129-3163 |
| PADAA-- BACSU METPHOSTRIESTER-DNA ALKYLTRANSFERASE BACILLUS |
| SUBTILIS 136-170 |
| PADDA-- BACSU ATP-DEPENDENT NUCLEASE SUBUNIT A BACILLUS SUBTILIS |
| 398-425 454-481 522-556 1005- |
| 1032 |
| PADDB-- BACSU ATP-DEPENDENT NUCLEASE SUBUNIT B BACILLUS SUBTILIS |
| 257-284 870-903 943-977 |
| PADH1-- CLOAB NADPH-DEPENDENT BUTANOL DEHYDROGENASE CLOSTRIDIUM |
| ACETOBUTYLICUM 284-311 |
| PADHA-- CLOAB NADH-DEPENDENT BUTANOL DEHYDROGENASE A CLOSTRIDIUM |
| ACETOBUTYLICUM 298-325 |
| PADHB-- CLOAB NADH-DEPENDENT BUTANOL DEHYDROGENASE B CLOSTRIDIUM |
| ACETOBUTYLICUM 298-325 |
| PADHE-- CLOAB ALCOHOL DEHYDROGENASE CLOSTRIDIUM ACETOBUTYLICUM |
| 653-680 770-806 |
| PADHE-- ECOLI ALCOHOL DEHYDROGENASE ESCHERICHIA COLI 271-298 |
| PADIY-- ECOLI PUTATIVE REGULATORY PROTEIN ADIY ESCHERICHIA |
| COLI 45-72 |
| PADP1-- MYCGE 140 KD ADHESION PRECURSOR MYCOPLASMA GENITALIUM |
| 90-131 697-724 923-950 990- 1169- 1387- |
| 1017 1199 1414 |
| PADP1-- MYCPN ADHESION P1 PRECURSOR MYCOPLASMA PNEUMONIAE 1557- |
| 1584 |
| PADT-- RICPR ADP, ATP CARRIER PROTEIN RICKETTSIA PROWAZEKII |
| 276-307 |
| PAERA-- AERHY AEROLYSIN PRECURSOR AEROMONAS HYDROPHILA 278-305 |
| PAGAL-- STRMU ALPHA-GALACTOSIDASE STREPTOCOCCUS MUTANS 419-483 |
| 597-633 |
| PAGAR-- PSEAT BETA-AGARASE PRECURSOR PSEUDOMONAS ATLANTICA 26-53 |
| PAGR-- STAAU ACCESSORY GENE REGULATOR PROTEIN STAPHYLOCOCCUS |
| AUREUS 129-159 165-192 |
| PAIL-- YEREN ATTACH INVAS LOCUS PROTEIN PRECURSOR YERSINIA |
| ENTEROCOLITICA 19-46 |
| PAK1H-- ECOLI ASPARTOKINASE I ESCHERICHIA COLI 3-30 466-493 |
| 503-530 |
| PAK2H-- ECOLI ASPARTOKINASE II ESCHERICHIA COLI 51-78 608-635 |
| PAK2-- BACSU ASPARTATE KINASE II ALPHA AND BETA SUBUNITS |
| BACILLUS SUBTILIS 266-312 |
| PAKAB-- |
| CORGL ASPARTATE KINASE ALPHA AND BETA SUBUNITS CORYNEBACTERIUM GLUTMICUM |
| 5-32 |
| PALF-- ECOLI FRUCTOSE-BISPHOSPHATE ALDOLASE ESCHERICHIA COLI |
| 286-316 |
| PALGB-- PSEAE ALGINATE BIOSYN TRANSL REG PROTEIN ALGB PSEUDOMONAS |
| AERUGINOSA 160-194 |
| PALGE-- |
| PSEAE ALGINATE PRODUCTION PROTEIN ALGE PRECURSOR PSEUDOMONAS AERUGINOSA |
| 349-376 |
| PALGP-- PSEAE TRANSCRIPTIONAL REGULATORY PROTEIN ALGP PSEUDOMONAS |
| AERUGINOSA |
| 81-115 PALKB-- |
| PSEOL ALKANE-1 MONOOXYGENASE PSEUDOMONAS OLEOVORANS 115-142 |
| PALKT-- PSEOL RUBREDOXIN-NAD(+) REDUCTASE PSEUDOMONAS OLEOVORANS |
| 138-172 338-365 |
| PALR2-- ECOLI ALANINE RACEMASE CATABOLIC PRECURSOR ESCHERICHIA |
| COLI |
| 9-36 |
| PALR-- BACST ALANINE RACEMASE BACILLUS STEAROTHERMOPHILUS 326-353 |
| PALSR-- BACSU ALS OPERON REGULATORY PROTEIN BACILLUS SUBTILIS |
| 119-146 |
| PALYS-- |
| BACSP AUTOLYSIN PRECURSOR BACILLUS SP 157-187 PALYS-- |
| BACSU AUTOLYSIN PRECURSOR BACILLUS SUBTILIS 147-191 |
| PALYS-- |
| STAAU AUTOLYSIN STAPHYLOCOCCUS AUREUS 244-271 PAMIA-- |
| STRPN AMIA PROTEIN PRECURSOR STREPTOCOCCUS PNEUMONIAE 223-264 297-338 |
| 446-473 |
| PAMID-- |
| PSECL AMIDASE PSEUDOMONAS CHLORORAPHIS 72-99 PAMIE-- |
| STRPN OLIGOPEPTIDE TRANSPORT PROTEIN AMIE STREPTOCOCCUS PNEUMONIAE |
| 187-214 |
| PAMPA-- ECOLI AMINOPEPTIDASE A/I ESCHERICHIA COLI 111-138 199-226 |
| PAMPC-- SERMA BETA-LACTAMASE PRECURSOR SERRATIA MARCESCENS |
| 231-258 |
| PAMPL-- RICPR CYTOSOL AMINOPEPTIDASE RICKETTSIA PROWAZEKII 3-47 |
| 72-99 |
| PAMPN-- |
| ECOLI AMINOPEPTIDASE N ESCHERICHIA COLI 655-682 PAMPP-- |
| ECOLI X-PRO AMINOPEPTIDASE ESCHERICHIA COLI 110-137 |
| PAMPT-- |
| THEAQ AMINOPEPTIDASE T THERMUS AQUATICUS 281-308 PAMY1-- |
| DICTH ALPHA-AMYLASE 1 DICTYOGLOMUS THERMOPHILUM 507-534 |
| PAMY2-- DICTH ALPHA-AMYLASE 2 DICTYOGLOMUS THERMOPHILUM 151-178 |
| 507-534 |
| PAMY2-- SALTY CYTOPLASMIC ALPHA-AMYLASE SALMONELLA TYPHIMURIUM |
| 70-104 |
| PAMY3-- DICTH ALPHA-AMYLASE 3 DICTYOGLOMUS THERMOPHILUM 280-307 |
| PAMYB-- BACCI BETA-AMYLASE PRECURSOR BACILLUS CIRCULANS 61-88 |
| PAMYB-- BACPO BETA-AMYLASE BACILLUS POLYMYXA 60-87 266-293 |
| 1143- |
| 1184 |
| PAMYB-- CLOTU BETA-AMYLASE, THERMOPHILIC PRECURSOR CLOSTRIDIUM |
| THERMOSULFUROGENES 269-296 378-405 459-486 |
| PAMYG-- CLOSP GLUCOAMYLASE PRECURSOR CLOSTRIDIUM SP 103-148 |
| 480-510 |
| PAMYM-- BACST MALTOGENIC ALPHA-AMYLASE PRECURSOR BACILLUS |
| STEROTHERMOPHILUS 426-453 |
| PAMYR-- BACS8 RAW-STARCH-DIGESTING AMYLASE BACILLUS SP 210-237 |
| 435-465 615-642 |
| PAMY-- AERHY ALPHA-AMYLASE PRECURSOR AEROMONAS HYDROPHILA 415-453 |
| PAMY-- ALTHA ALPHA-AMYLASE PRECURSOR ALTEROMONAS HALOPLANKTIS |
| 166-913 |
| PAMY-- BACAM ALPHA-AMYLASE PRECURSOR BACILLUS AMYLOLIQUEFACIENS |
| 102-136 |
| PAMY-- BACCI ALPHA-AMYLASE PRECURSOR BACILLUS CIRCULANS 212-239 |
| 437-474 |
| PAMY-- BACME ALPHA-AMYLASE PRECURSOR BACILLUS MEGATERIUM 61-88 |
| 441-482 |
| PAMY-- BACSU ALPHA-AMYLASE PRECURSOR BACILLUS SUBTILIS 165-205 |
| 281-308 |
| PAMY-- BUTFI ALPHA-AMYLASE PRECURSOR BUTYRIVIBRIO FIBRISOLVENS |
| 377-418 546-573 579-606 795-822 |
| PAMY-- CLOAB PUTATIVE ALPHA-AMYLSE CLOSTRIDIUM ACETOBUTYLICUM |
| 283-310 |
| PAMY-- |
| CLOTU ALPHA-AMYLASE PRECURSOR CLOSTRIDIUM THERMOSULFUROGENES 431-468 |
| 612-642 |
| PAMY-- STRLM ALPHA-AMYLASE PRECURSOR STREPTOMYCES LIMOSUS 173-200 |
| PANFA-- |
| AZOVI NITROGEN FIXATION PROTEIN ANFA AZOTOBACTER VINELANDII 232-259 |
| PANFD-- AZOVI NITROGENASE IRON--IRON PROTEIN ALPHA CHAIN |
| AZOTOBACTER VINELANDII |
| 95-122 PANFK-- AZOVI |
| NITROGENASE IRON--IRON PROTEIN BETA CHAIN AZOTOBACTER VINELANDII 369-396 |
| PANGR-- VIBAN ANGR PROTEIN VIBRIO ANGUILLARUM 93-120 169-203 |
| PAPCE-- |
| FREDI PHYCOBILISOME 120 KD LINKER POLYPEPTIDE FREMYELLA DIPLOSIPHON |
| 51-78 |
| PAPCE-- SYNP6 PHYCOBILISOME LINKER POLYPEPTIDE SYNECHOCOCCUS SP |
| 37-64 585-615 |
| PAPCE-- |
| SNYP4 PHYCOBILISOME 120 KD LINKER POLYPEPTIDE SYNECHOCYSTIS SP 52-79 |
| PAPHC-- SALTY ALKYL HYDROPEROXIDE REDUCTASE C22 PROTEIN |
| SALMONELLA TYPHIMURIUM 62-89 |
| PAPI-- ACHLY PROTEASE I PRECURSOR ACHROMOBACTER LYTICUS 478-505 |
| PAPPC-- ECOLI PROBABLE CYTOCHROME OXIDASE SUBUNIT I ESCHERICHIA |
| COLI 118-148 |
| PAPRD-- |
| PSEAE ALKALINE PROTEASE SECRETION PROTEIN APRD PSEUDOMONAS AERUGINOSA |
| 416-450 |
| PAPRE-- |
| PSEAE ALKALINE PROTEASE SECRETION PROTEIN APRE PSEUDOMONAS AERUGINOSA |
| 133-193 208-235 247-277 |
| PAPT-- ECOLI ADENINE PHOSPHORIBOSYLTRANSFERASE ESCHERICHIA COLI |
| 121-148 |
| PAPU-- |
| THEET ALPHA-AMYLASE-PULLULANASE PRECURSOR THERMOANAEROBACTER ETHANOLICUS |
| 276-303 347-374 936-982 987- 1210- 1381- |
| 1014 1254 1408 |
| PARCA-- MYCAR ARGININE DEIMINASE MYCOPLASMA ARGININI 60-87 |
| 218-245 |
| PARCB-- |
| ECOLI AEROBIC RESPIRATION CONTROL PROTEIN ARCB ESCHERICHIA COLI 102-150 |
| 302-329 399-426 |
| PARCD-- PSEAE PROBABLE ARGININE/ORNITHINE ANTIPORTER PSEUDOMONAS |
| AERUGINOSA 274-301 386-420 |
| PARGA-- ECOLI AMINO-ACID ACETYLTRANSFERASE ESCHERICHIA COLI |
| 82-109 |
| PARGT-- |
| ECOLI LYS-ARG-ORN-BINDING PROTEIN (LAO) PRECURSO ESCHERICHIA COLI |
| 84-111 |
| PAROA-- |
| STAAU PHOSPHOSHIKIMATE 1-CARBOXYVINYL TRANSFER STAPHYLOCOCCUS AUREUS |
| 86-120 |
| PAROC-- |
| ECOLI CHORISMATE SYNTHASE ESCHERICHIA COLI 68-95 PAROC-- |
| SALTI CHORISMATE SYNTHASE SALMONELLA TYPHI 68-95 |
| PAROD-- BACSU DEHYDROQUINATE DEHYDRATASE BACILLUS SUBTILIS 49-76 |
| PAROK-- ECOLI SHIKIMATE KINASE I ESCHERICHIA COLI 84-118 |
| PARP4-- STRPY IGA RECEPTOR PRECURSOR STREPTOCOCCUS |
| PYOGENES 12-46 127-157 266-324 |
| PARP-- |
| ECOLI ARP PROTEIN ESCHERICHIA COLI 255-282 PARSA-- |
| ECOLI ARSENICAL PUMP-DRIVING ATPASE ESCHERICHIA COLI 201-238 |
| PARSB-- ECOLI ARSENICAL PUMP MEMBRANE PROTEIN ESCHERICHIA COLI |
| 291-318 |
| PARSB-- STAAU ARSENICAL PUMP MEMBRANE PROTEIN STAPHYLOCOCCUS |
| AUREUS 27-71 295-322 |
| PARSB-- STAZY ARSENICAL PUMP MEMBRANE PROTEIN STAPHYLOCOCCUS |
| XYLOSUS 27-71 295-322 |
| PARSR-- |
| STAAU ARSENICAL RESIST OPERON REPRESSOR PROTEIN STAPHYLOCOCCUS AUREUS |
| 56-93 |
| PARTA-- ECOLI ARTA PROTEIN ESCHERICHIA COLI |
| 3-30 PARTI-- ECOLI TRANSPORT SYSTEM PROTEIN ARTI |
| ESCHERICHIA COLI 105-132 213-240 |
| PARTP-- ECOLI TRANSPORT SYSTEM PROTEIN ARTP ESCHERICHIA COLI |
| 176-206 |
| PASA1-- ENTFA AGGREGATION SUBSTANCE PRECURSOR ENTEROCOCCUS |
| FAECALIS 195-254 478-505 799-826 859-896 |
| PASNA-- ECOLI ASPARTATE-AMMONIA LIGASE ESCHERICHIA COLI 127-158 |
| PASNB-- ECOLI ASPARAGINE SYNTHETASE B ESCHERICHIA COLI 450-477 |
| PASNC-- ECOLI REGULATORY PROTEIN ASNC ESCHERICHIA COLI 116-143 |
| PASPA-- BACSU ASPARTATE AMMONIA-LYASE BACILLUS SUBTILIS 7-34 |
| PASPA-- ECOLI ASPARTATE AMMONIA-LYASE ESCHERICHIA COLI 204-236 |
| PASPA-- SERMA ASPARTATE AMMONIA-LYASE SERRATIA MARCESCENS 204-231 |
| PASPG-- BACLI L-ASPARAGINASE BACILLUS LICHENIFORMIS 252-288 |
| PASPG-- ERWCH L-ASPARAGINASE PRECURSOR ERWINIA CHRYSANTHEMI |
| 188-218 |
| PASPQ-- |
| ACIGL GLUTAMINASE-ASPARAGINASE ACINETOBACTER GLUTAMINASIFICANS 46-80 |
| PASSY-- ECOLI ARGININOSUCCINATE SYNTHASE ESCHERICHIA COLI |
| 354-381 |
| PASSY-- METBA ARGININOSUCCINATE SYNTHASE METHANOSARCINA BARKERI |
| 287-314 |
| PATBP-- STAAU POTENTIAL ATP-BINDING PROTEIN STAPHYLOCOCCUS AUREUS |
| 41-68 201-245 |
| PATKA-- ENTFA POTASSIUM/COPPER-TRANSPORTING ATPASE A ENTEROCOCCUS |
| FAECALIS 41-80 347-374 |
| PATKB-- ENTFA POTASSIUM/COPPER-TRANSPORTING ATPASE B ENTEROCOCCUS |
| FAECALIS 280-310 450-477 |
| PATMB-- |
| SALTY MG(2+) TRANSPORT ATPASE, P-TYPE SALMONELLA TYPHIMURIUM 503-530 |
| PATP6-- SYNP6 ATP SYNTHASE A CHAIN SYNECHOCOCCUS SP 233-260 |
| PATP6-- VIBAL ATP SYNTHASE A CHAIN VIBRIO ALGINOLYTICUS 11-38 |
| PATPA-- ANASP ATP SYNTHASE ALPHA CHAIN ANABAENA SP 9-36 96-130 |
| PATPA-- BACME ATP SYNTHASE ALPHA CHAIN BACILLUS MEGATERIUM 4-36 |
| 453-480 |
| PATPA-- ECOLI ATP SYNTHASE ALPHA CHAIN ESCHERICHIA COLI 486-513 |
| PATPA-- ENTFA ATP SYNTHASE ALPHA CHAIN ENTEROCOCCUS FAECALIS |
| 4-36 484-518 |
| PATPA-- MYCGA ATP SYNTHASE ALPHA CHAIN MYCOPLASMA GALLISEPTICUM |
| 362-409 |
| PATPA-- PROMO ATP SYNTHASE ALPHA CHAIN PROPIONIGENIUM MODESTUM |
| 6-36 |
| PATPA-- PHORU ATP SYNTHASE ALPHA CHAIN RHODOSPIRILLUM RUBRUM |
| 165-200 459-486 |
| PATPA-- SULAC ATPASE ALPHA CHAIN SULFOLOBUS ACIDOCALDARIUS |
| 318-345 562-589 |
| PATPA-- SYNP1 ATP SYNTHASE ALPHA CHAIN SYNECHOCOCCUS SP 7-44 |
| PATPA-- SYNP6 ATP SYNTHASE ALPHA CHAIN SYNECHOCOCCUS SP 8-45 |
| 362-389 |
| PATPA-- SYNY3 ATP SYNTHASE ALPHA CHAIN SYNECHOCYSTIS SP 8-37 |
| 454-500 |
| PATPA-- THEP3 ATP SYNTHASE ALPHA CHAIN THERMOPHILIC BACTERIUM |
| PS-3 |
| 9-36 |
| PATPA-- VIBAL ATP SYNTHASE ALPHA CHAIN VIBRIO ALGINOLYTICUS 464-513 |
| PATPB-- ANASP ATP SYNTHASE BETA CHAIN ANABAENA SP 280-307 370-397 |
| PATPB-- BACFI ATP SYNTHASE BETA CHAIN BACILLUS FIRMUS 163-190 |
| 358-385 |
| PATPB-- MYCGA ATP SYNTHASE BETA CHAIN MYCOPLASMA GALLISPETICUM |
| 375-402 |
| PATPB-- RHORU ATP SYNTHASE BETA CHAIN RHODOSPIRILLUM RUBRUM |
| 359-386 |
| PATPB-- SULAC ATPASE BETA CHAIN SULFOLOBUS ACIDOCALDARIUS 164-191 |
| PATPB-- SYNP1 ATP SYNTHASE BETA CHAIN SYNECHOCOCCUS SP 381-408 |
| PATPB-- SYNP6 ATP SYNTHASE BETA CHAIN SYNECHOCOCCUS SP 291-318 |
| 381-408 |
| PATPD-- SYNY3 ATP SYNTHASE BETA CHAIN SYNECHOCYSTIS SP 381-408 |
| PATPD-- ANASP ATP SYNTHASE DELTA CHAIN ANABAENA SP 109-139 |
| 143-170 |
| PATPD-- BACFI ATP SYNTHASE DELTA CHAIN BACILLUS FIRMUS 63-90 |
| 133-160 |
| PATPD-- BACME ATP SYNTHASE DELTA CHAIN BACILLUS MEGATERIUM |
| 132-159 |
| PATPD-- ENTFA ATP SYNTHASE DELTA CHAIN ENTEROCOCCUS FAECALIS |
| 14-41 |
| PATPD-- PROMO ATP SYNTHASE DELTA CHAIN PROPIONIGENIUM MODESTUM |
| 79-116 118-149 |
| PATPD-- RHOBL ATP SYNTHASE DELTA CHAIN RHODOPSEUDOMANS BLASTICA |
| 125-152 |
| PATPD-- RHORU ATP SYNTHASE DELTA CHAIN RHODOSPIRILLUM RUBRUM |
| 119-146 |
| PATPD-- SYNP1 ATP SYNTHASE DELTA CHAIN SYNECHOCOCCUS SP 100-127 |
| PATPD-- SYNY3 ATP SYNTHASE DELTA CHAIN SYNECHOCYSTIS SP 113-147 |
| PATPD-- VIBAL ATP SYNTHASE DELTA CHAIN VIBRIO ALGINOLYTICUS |
| 110-137 |
| PATPE-- BACFI ATP SYNTHASE EPSILON CHAIN BACILLUS FIRMUS 53-80 |
| PATPE-- |
| MYCGA ATP SYNTHASE EPSILON CHAIN MYCOPLASMA GALLISEPTICUM 99-126 |
| PATPE-- PROMO ATP SYNTHASE EPSILON CHAIN PROPIONIGENIUM |
| MODESTUM 100-127 |
| PATPE-- SYNP1 ATP SYNTHASE EPSILON CHAIN SYNECHOCOCCUS SP 72-106 |
| PATPF-- ANASP ATP SYNTHASE B CHAIN ANABAENA SP 17-44 51-78 |
| 137-164 |
| PATPF-- BACFI ATP SYNTHASE B CHAIN BACILLUS FIRMUS 110-151 |
| PATPF-- BACME ATP SYNTHASE B CHAIN BACILLUS MEGATERIUM |
| 55-85 122-170 |
| PATPF-- MYCGA ATP SYNTHASE B CHAIN MYCOPLASMA GALLISEPTICUM |
| 82-135 170-197 |
| PATPF-- SYNP1 ATP SYNTHASE B CHAIN SYNECHOCOCCUS SP 15-49 111-159 |
| PATPF-- SYNP6 ATP SYNTHASE B CHAIN SYNECHOCOCCUS SP 12-39 128-155 |
| PATPF-- THEP3 ATP SYNTHASE B CHAIN PRECURSOR THERMOPHILIC |
| BACTERIUM PS-3 50-77 |
| PATPG-- ANASP ATP SYNTHASE GAMMA CHAIN ANABAENA SP 276-310 |
| PATPG-- ECOLI ATP SYNTHASE GAMMA CHAIN ESCHERICHIA COLI |
| 253-283 |
| PATPG-- MYCGA ATP SYNTHASE GAMMA CHAIN MYCOPLASMA GALLISEPTICUM |
| 28-62 |
| 92-140 |
| PATPG-- RHORU ATP SYNTHASE GAMMA CHAIN RHODOSPIRILLUM RUBRUM |
| 270-297 |
| PATPG-- SYNP1 ATP SYNTHASE GAMMA CHAIN SYNECHOCOCCUS SP 280-307 |
| PATPG-- SYNY3 ATP SYNTHASE GAMMA CHAIN SYNECHOCYSTIS SP 96-126 |
| 280-307 |
| PATPI-- MYCGA ATP SYNTHASE PROTEIN I MYCOPLASMA GALLISEPTICUM |
| 133-167 |
| PATPX-- ANASP ATP SYNTHASE B' |
| CHAIN ANABAENA SP 129-156 PATPX-- BACFI ATP SYNTHASE |
| BETA CHAIN BACILLUS FIRMUS 162-189 356-383 |
| PATPX-- RHORU ATP SYNTHASE B' CHAIN RHODOSPIRILLUM RUBRUM 40-74 |
| PATPX-- SYNP1 ATP SYNTHASE B' CHAIN SYNECHOCOCCUS SP 57-110 |
| 128-155 |
| PATPX-- SYNP6 ATP SYNTHASE B' CHAIN SYNECHOCOCCUS SP 70-100 |
| PATPX-- SYNY3 ATP SYNTHASE B' CHAIN SYNECHOCYSTIS SP 108-135 |
| PATPZ-- BACME ATP SYNTHASE PROTEIN I BACILLUS MEGATERIUM 14-62 |
| PATPZ-- SYNP1 ATP SYNTHASE PROTEIN I SYNECHOCOCCUS SP 90-131 |
| PAVRB-- PSESG AVIRULENCE B PROTEIN PSEUDOMONAS SYRINGAE 184-211 |
| 233-260 |
| PBA71-- EUBSP 7-ALPHA-HYDROXYSTEROID DEHYDROGENASE EUBACTERIUM SP |
| 26-53 |
| PBA72-- EUBSP 7-ALPHA-HYDROXYSTEROID DEHYDROGENASE EUBACTERIUM SP |
| 26-53 |
| PBACH-- HALHM HALORHODOPSIN HALOBACTERIUM HALOBIUM 145-179 |
| PBACH-- HALSG HALORHODOPSIN PRECURSOR HALOBACTERIUM SP |
| 180-214 |
| PBAES-- ECOLI SENSOR PROTEIN BAES ESCHERICHIA COLI 152-186 |
| PBAG-- STRAG IGA FC RECEPTOR PRECURSOR STREPTOCOCCUS |
| AGALACTIAE |
| 92-119 138-204 267-306 343-385 487- 562- 1014- |
| 524 589 1041 |
| PBAHG-- VITSP BACTERIAL HEMOGLOBIN VITREOSCILLA SP 119-146 |
| PBAIC-- |
| EUBSP BILE ACID-INCUCIBLE OPERON PROTEIN C EUBACTERIUM SP 423-450 |
| PBARA-- ECOLI SENSOR PROTEIN BARA ESCHERICHIA COLI 334-361 |
| 425-455 |
| PBASS-- ECOLI SENSOR PROTEIN BASS ESCHERICHIA COLI 122-156 |
| PBAT-- |
| HALHA PUTATIVE BACTERIO-OPSIN ACTIVATOR HALOBACTERIUM HALOBIUM 408-442 |
| PBAX-- |
| ECOLI BAX PROTEIN ESCHERICHIA COLI 21-64 PBCCP-- |
| ECOLI BIOTIN CARBOXYL CARRIER PROTEIN ESCHERICHIA COLI |
| 6-35 PBCHH-- RHOCA METHYLTRANSFERASE RHODOBACTER |
| CAPSULATUS 1000- |
| 1032 |
| PBCHN-- |
| RHOCA PROTOCHLOROPHYLLIDE REDUCTASE 46 KD CHAIN RHODOBACTER CAPSULATUS |
| 249-276 |
| PBCN5-- CLOPE BACTERIOCIN BCN5 CLOSTRIDIUM PERFRINGENS 72-99 |
| 585-646 |
| PBCPA-- PROAE BACTERIOCHLOROPHYLL A PROTEIN PROSTHECOCHLORIS |
| AESTURAII 63-93 |
| PBCSC-- ACEXY CELLULOSE SYNTHASE OPERON C PROTEIN ACETOBACTER |
| XYLINUM 131-158 1055- |
| 1082 |
| PBCSD-- ACEXY CELLULOSE SYNTHASE OPERON D PROTEIN ACETOBACTER |
| XYLINUM 10-37 |
| PBENA-- |
| ACICA BENZOATE 1,2-DIOXYGENASE ALPHA SUBUNIT ACINETOBACTER CALCOACETICUS |
| 190-217 |
| PBETT-- ECOLI HIGH AFFINITY CHOLINE TRANSPORT PROTEIN ESCHERICHIA |
| COLI 243-270 |
| PBEXA-- |
| HAEIN BEXA PROTEIN HAEMOPHILUS INFLUENZAE 23-50 PBEXC-- |
| HAEIN BEXC PROTEIN HAEMOPHILUS INFLUENZAE 157-184 226-253 |
| PBEXD-- HAEIN BEXD PROTEIN HAEMOPHILUS INFLUENZAE 205-239 |
| PBFR-- NITWI BACTERIOFERRITIN NITROBACTER VINOGRADSKYI |
| 8-35 |
| PBGA2-- |
| ECOLI EVOLVED BETA-GALACTOSIDASE ALPHA-SUBUNIT ESCHERICHIA COLI 955-985 |
| PBGAL-- BACST BETA-GALACTOSIDASE BACILLUS STEAROTHERMOPHILUS |
| 599-633 |
| PBGAL-- CLOAB BETA-GALACTOSIDASE CLOSTRIDIUM ACETOBUTYLICUM |
| 824-851 |
| PBGAL-- CLOTU BETA-GALACTOSIDASE CLOSTRIDIUM THERMOSULFUROGENES |
| 161-191 |
| PBGAL-- KLEPN BETA-GALACTOSIDASE KLEBSIELLA PNEUMONIAE 245-272 |
| PBGAL-- LACDE BETA-GALACTOSIDASE LACTOBACILLUS DELBRUECKII |
| 305-332 |
| PBGAL-- STRTR BETA-GALACTOSIDASE STREPTOCOCCUS THERMOPHILUS |
| 188-215 |
| PBGAL-- SULSO BETA-GALACTOSIDASE SULFOLOBUS SOLFATARICUS 59-86 |
| 179-206 |
| PBGAM-- LEULA BETA-GALACTOSIDASE SMALL SUBUNIT LEUCONOSTOC LACTIS |
| 129-156 |
| PBGAM-- SULSO BETA-GALACTOSIDASE SULFOLOBUS SOLFATARICUS 106-140 |
| PBGLA-- CLOTM BETA-GLUCOSIDASE A CLOSTRIDIUM THERMOCELLUM 353-380 |
| 418-445 |
| PBGLB-- CLOTM THERMOSTABLE BETA-GLUCOSIDASE B CLOSTRIDIUM |
| THERMOCELLUM 259-286 375-409 554-581 631-665 |
| PBGLR-- ECOLI BETA-GLUCURONIDASE ESCHERICHIA COLI 464-494 536-563 |
| PBGLS-- |
| AGRSP BETA-GLUCOSIDASE AGROBACTERIUM SP 421-448 PBGLS-- |
| BUTFI BETA-GLUCOSIDASE A BUTYRIVIBRIO FIBRISOLVENS 85-112 435-462 |
| 692-719 738-765 |
| PBIN3-- STAAU POTENTIAL DNA-INVERTASE BIN3 STAPHYLOCOCCUS AUREUS |
| 60-87 |
| PBINL-- STAAU TRANSPOSON TN552 RESOLVASE STAPHYLOCOCCUS AUREUS |
| 163-197 |
| PBINR-- STAAU DNA-INVERTASE BINR STAPHYLOCOCCUS AUREUS 163-190 |
| PBIOA-- BACSH AMINOTRANSFERASE BACILLUS SPHAERICUS 33-60 |
| PBIOB-- BACSH BIOTIN SYNTHETASE BACILLUS SPHAERICUS 145-172 |
| PBIOB-- |
| ECOLI BIOTIN SYNTHETASE ESCHERICHIA COLI 130-157 PBIOD-- |
| BACSH DETHIOBIOTIN SYNTHASE BACILLUS SPHAERICUS 144-171 |
| PBLA1-- BACCE BETA-LACTAMASE PRECURSOR, TYPE I BACILLUS CEREUS |
| 91-118 275-305 |
| PBLA1-- |
| HAEIN BETA-LACTAMASE ROB-1 PRECURSOR HAEMOPHILUS INFLUENZAE 152-179 |
| 204-231 |
| PBLA2-- BACCE BETA-LACTAMASE PRECURSOR, TYPE II BACILLUS CEREUS |
| 18-67 201-228 |
| PBLA2-- BACSP BETA-LACTAMASE PRECURSOR, TYPE II BACILLUS SP 18-67 |
| PBLA3-- BACCE BETA-LACTAMASE PRECURSOR, TYPE III BACILLUS CEREUS |
| 35-83 |
| 95-129 |
| PBLA4-- PSEAE BETA-LACTAMASE PSE-4 PRECURSOR PSEUDOMONAS AERUGINOSA |
| 19-50 |
| PBLAB-- BACCE BETA-LACTAMASE PRECURSOR, TYPE II BACILLUS CEREUS |
| 20-66 200-227 |
| PBLAB-- BACFR BETA-LACTAMASE PRECURSOR, TYPE II BACTEROIDES |
| FRAGILIS 22-49 |
| PBLAC-- BACCE BETA-LACTAMASE PRECURSOR, TYPE I BACILLUS CEREUS |
| 93-120 276-303 |
| PBLAC-- BACLI BETA-LACTAMASE PRECURSOR BACILLUS LICHENIFORMIS |
| 47-74 |
| 86-115 |
| PBLAC-- PROMI BETA-LACTAMASE PRECURSOR PROTEUS MIRABILIS 191-221 |
| PBLAC-- PROVU BETA-LACTAMASE PROTEUS VULGARIS 4-38 240-267 |
| PBLAC-- STRAL BETA-LACTAMASE PRECURSOR STREPTOMYCES ALBUS G |
| 43-70 |
| PBLAD-- KLEPN BETA-LACTAMASE PRECURSOR KLEBSIELLA PNEUMONIAE |
| 121-148 |
| PBLAI-- STAAU PENICILLINASE REPRESSOR STAPHYLOCOCCUS AUREUS 19-74 |
| 99-126 |
| PBLAO-- ECOLI BETA-LACTAMASE PRECURSOR ESCHERICHIA COLI 118-166 |
| 235-262 |
| PBLAP-- ECOLI BETA-LACTAMASE PSE-2 PRECURSOR ESCHERICHIA COLI |
| 115-196 |
| PBLAR-- BACLI REGULATORY PROTEIN BLAR1 BACILLUS LICHENIFORMIS |
| 129-156 515-552 |
| PBLAR-- STAAU REGULATORY PROTEIN BLAR1 STAPHYLOCOCCUS AUREUS |
| 87-114 122-161 234-261 281-312 503- |
| 539 |
| PBMP-- TREPA BASIC MEMBRANE PROTEIN PRECURSOR TREPONEMA PALLIDUM |
| 312-346 |
| PBMR-- BACSU MULTIDRUG RESISTANCE PROTEIN BACILLUS SUBTILIS |
| 277-304 |
| PBNZA-- PSEPU BENZENE 1,2-DIOXYGENASE ALPHA SUBUNIT PSEUDOMONAS |
| PUTIDA 36-63 |
| PBNZB-- PSEPU BENZENE 1,2-DIOXYGENASE BETA SUBUNIT PSEUDOMONAS |
| PUTIDA 119-153 |
| PBNZD-- |
| PSEPU P4 SUBUNIT PSEUDOMONAS PUTIDA 179-213 PBPS2-- |
| DESAM BPS2 PROTEIN DESULFUROLOBUS AMBIVALENS 157-237 242-290 311-355 |
| 391-425 543- |
| 573 |
| PBRAB-- PSEAE CARRIER PROTEIN PSEUDOMONAS AERUGINOSA 260-287 |
| 313-340 |
| PBRAE-- PSEAE TRANSPORT PROTEIN BRAE PSEUDOMONAS AERUGINOSA |
| 254-281 |
| PBRAG-- PSEAE BRAG PROTEIN PSEUDOMONAS AERUGINOSA |
| 7-34 PBTUB-- ECOLI VITAMIN B12 RECEPTOR PRECURSOR |
| ESCHERICHIA COLI 439-466 |
| PBTUE-- |
| ECOLI VITAMIN B12 TRANSPORT PERIPLASMIC PROTEIN ESCHERICHIA COLI 6-33 |
| PBVGA-- BORPE TRANSCRIPTION REGULATOR BVGA BORDETELLA PERTUSSIS |
| 174-205 |
| BORDETELLA BRONCHISEPTICA |
| PBVGB-- BORPE PERIPLASMIC PROTEIN BVGB PRECURSOR BORDETELLA |
| PERTUSSIS 116-143 |
| PBVGC-- BORPE SENSOR PROTEIN BVGC BORDETELLA PERTUSSIS 39-66 |
| 202-229 |
| PBVGS-- BORBR VIRULENCE BVGS PROTEIN PRECURSOR BORDETELLA |
| BRONCHISEPTICA 113-143 341-368 501-531 |
| PBXA-- CLOBO BOTULINUM NEUORTOXIN TYPE A PRECURSOR CLOSTRIDIUM |
| BOTULINUM 313-340 686-729 733-762 815-842 851- 968- 1159- |
| 893 995 1207 |
| PBXB-- CLOBO BOTULINUM NEUORTOXIN TYPE B PRECURSOR CLOSTRIDIUM |
| BOTULINUM 666-693 720-762 802-832 853- 1004- 1058- |
| 890 1031 1089 |
| PBXC1-- CLOBO BOTULINUM NEUROTOXIN TYPE C1 PRECURSOR CLOSTRIDIUM |
| BOTULINUM |
| 86-113 314-341 730-773 798- 850- |
| 825 892 |
| PBXD-- CLOBO BOTULINUM NEUROTOXIN TYPE D PRECURSOR CLOSTRIDIUM |
| BOTULINUM 473-500 526-576 727-770 804-831 847- 906- 1060- |
| 892 963 1087 |
| PBXE-- CLOBO BOTULINUM NEUROTOXIN TYPE E PRECURSOR CLOSTRIDIUM |
| BOTULINUM 254-291 350-381 704-753 773-811 890- 992- 1115- |
| 917 1019 1149 |
| PBXE-- CLOBU BOTULINUM NEUROTOXIN TYPE E PRECURSOR CLOSTRIDIUM |
| BUTYRICUM 254-291 350-381 704-753 774-808 890- 992- 1115- |
| 917 1019 1149 |
| PBXF-- CLOBO BOTULINUM NEUROTOXIN TYPE F PRECURSOR CLOSTRIDIUM |
| BOTULINUM 669-710 735-772 892-919 1013- 1095- 1183- |
| 1040 1122 1210 |
| PC550-- MICAE CYTOCHROME C550 MICROCYSTIS AERUGINOSA 3-30 |
| PCADA-- BACFI PROBABLE CADMIUM-TRANSPORTING ATPASE BACILLUS |
| FIRMUS 30-57 100-131 165-192 276-306 533- |
| 567 |
| PCADA-- STAAU PROBABLE CADMIUM-TRANSPORTING ATPASE STAPHYLOCOCCUS |
| AUREUS 282-309 536-570 |
| PCADC-- ECOLI TRANSCRIPTIONAL ACTIVATOR CADC ESCHERICHIA COLI |
| 54-85 412-443 |
| PCAFA-- YERPE F1 CAPSULE ANCHORING PROTEIN PRECURSOR YERSINIA |
| PESTIS 203-240 416-457 530-557 619-646 |
| PCAPA-- |
| BACAN CAPA PROTEIN BACILLUS ANTHRACIS 108-138 PCAPB-- |
| BACAN CAPB PROTEIN BACILLUS ANTHRACIS 36-70 |
| PCAPP-- ANANI PHOSPHOENOLPYRUVATE CARBOXYLASE ANACYSTIS NIDULANS |
| 248-293 |
| PCAPP-- ANASP PHOSPHOENOLPYRUVATE CARBOXYLASE ANABAENA SP 98-125 |
| 157-184 687-728 |
| PCAPP-- CORGL PHOSPHOENOLPYRUVATE CARBOXYLASE CORYNEBACTERIUM |
| GLUTMICUM 15-42 |
| PCAPP-- ECOLI PHOSPHOENOLPYRUVATE CARBOXYLASE ESCHERICHIA COLI |
| 35-62 |
| PCARA-- BACSU CARBAMOYL-PHOSPHATE SYNTHASE BACILLUS SUBTILIS |
| 274-319 |
| PCARB-- BACSU CARBAMOYL-PHOSPHATE SYNTHASE BACILLUS SUBTILIS |
| 790-831 |
| PCARB-- ECOLI CARBAMOYL-PHOSPHATE SYNTHASE LARGE CHAI ESCHERICHIA |
| COLI 454-481 |
| PCAT2-- STAAU CHLORAMPHENICOL ACETYLTRANSFERASE STAPHYLOCOCCUS |
| AUREUS 7-34 |
| 87-114 PCAT3-- |
| STAAU CHLORAMPHENICOL ACETYLTRANSFERASE STAPHYLOCOCCUS AUREUS 7-34 |
| 87-114 |
| PCATA-- |
| ACICA CATECHOL 1,2-DIOXYGENASE ACINETOBACTER CALCOACETICUS 31-65 |
| PCATA-- |
| BACST PEROXIDASE/CATALASE BACILLUS STEAROTHERMOPHILUS 440-470 |
| PCATA-- |
| ECOLI CATALASE HPI ESCHERICHIA COLI 579-606 PCATA-- |
| MICLU CATALASE MICROCOCCUS LUTEUS 453-480 |
| PCATA-- SALTY CATALASE HPI SALMONELLA TYPHIMURIUM 515-542 580-607 |
| PCATE-- |
| ECOLI CATALASE HPII ESCHERICHIA COLI 175-202 PCAT-- |
| CAMCO CHLORAMPHENICOL ACETYLTRANSFERASE CAMYLOBACTER COLI 84-111 |
| PCAT-- CLOBU CHLORAMPHENICOL ACETYLTRANSFERASE CLOSTRIDIUM |
| BUTYRICUM |
| 88-115 PCAT |
| -- ECOLI CHLORAMPHENICOL ACETYLTRANSFERASE ESCHERICHIA COLI 92-119 |
| PCAT-- PROMI CHLORAMPHENICOL ACETYLTRANSFERASE PROTEUS |
| MIRABILIS |
| 92-119 PCAT |
| -- STAIN CHLORAMPHENICOL ACETYLTRANSFERASE STAPHYLOCOCCUS INTERMEDIUS |
| 7-34 |
| 87-114 |
| PCAT-- STRAG CHLORAMPHENICOL ACETYLTRANSFERASE STREPTOCOCCUS |
| AGALACTIVE 7-34 |
| 87-114 PCBHE-- |
| COXBU CBHE PROTEIN COXIELLA BURNETII 209-236 |
| PCBPT-- THEVU CARBOXYPEPTIDASE T PRECURSOR THERMOACTINOMYCES |
| VULGARIS 48-75 |
| PCCA-- ECOLI TRNA NUCLEOTIDLYLTRANSFERASE ESCHERICHIA COLI |
| 376-403 |
| PCCMK-- SYNP7 CO2 CONC MECH PROTEIN CCMK SYNECHOCOCCUS SP 29-56 |
| PCCMM-- SYNP7 CO2 CONC MECH PROTEIN CCMM SYNECHOCOCCUS SP |
| 212-256 331-372 445-486 |
| PCDAS-- THEET CYCLOMALTODEXTRINASE THERMOANAEROBACTER ETHANOLICUS |
| 305-332 |
| PCDG1-- BACMA CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS |
| MACERANS 439-466 616-643 |
| PCDG2-- BACMA CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS |
| MACERANS 210-251 436-466 615-642 |
| PCDGT-- BACCI CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS |
| CIRCULRANS 217-244 442-472 594-651 |
| PCDGT-- BACLI CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS |
| LICHENIFORMIS 217-244 442-472 594-647 |
| PCDGT-- BACOH CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS |
| OHBENSIS 430-471 |
| PCDGT-- BACS0 CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS SP |
| 210-237 435-462 615-642 |
| PCDGT-- BACS2 CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS SP |
| 409-471 |
| PCDGT-- BACS3 CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS SP |
| 210-237 435-462 614-641 |
| PCDGT-- BACSP CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS SP |
| 210-237 435-465 615-642 |
| PCDGT-- BACSS CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS SP |
| 217-244 442-472 594-651 |
| PCDGT-- BACST CYCLOMALTODEXT GLUCANOTRANS PRECURSOR BACILLUS |
| STEAROTHERMOPHILUS 586-646 |
| PCDGT-- KLEPN CYCLOMALTODEXT GLUCANOTRANS PRECURSOR KLEBSIELLA |
| PNEUMONIAE 212-239 |
| PCEA1-- ECOLI COLICIN E1 PROTEIN ESCHERICHIA COLI 44-71 285-326 |
| PCEA1-- SHISO COLICIN E1* PROTEIN SHIGELLA SONNEI 44-71 284-325 |
| 413-440 |
| PCEA2-- |
| ECOLI COLICIN E2 ESCHERICHIA COLI 334-368 PCEA3-- |
| ECOLI COLICIN E3 ESCHERICHIA COLI 334-368 |
| PCEA6-- |
| ECOLI COLICIN E6 ESCHERICHIA COLI 334-368 PCEAB-- |
| ECOLI COLICIN B ESCHERICHIA COLI 283-341 |
| PCEAD-- |
| ECOLI COLICIN D ESCHERICHIA COLI 284-311 PCEAM-- |
| ECOLI COLICIN M ESCHERICHIA COLI 178-227 |
| PCEAN-- |
| ECOLI COLICIN N ESCHERICHIA COLI 119-146 173-200 PCEA-- |
| CITFR COLICIN A CITROBACTER FREUNDII 228-258 |
| PCEFD-- STRCL ISOPENICILLIN N EPIMERASE STREPTOMYCES CLAVULIGERUS |
| 370-397 |
| PCEIA-- ECOLI COLICIN IA PROTEIN ESCHERICHIA COLI 68-95 225-282 |
| 378-412 415-452 |
| PCEIB-- ECOLI COLICIN IB PROTEIN ESCHERICHIA COLI 68-95 225-282 |
| 378-412 415-452 |
| PCELA-- ACEXY UTP URIDYLYLTRANSFERASE ACETOBACTER XYLINUM 59-89 |
| PCELA-- ECOLI PROTEIN CELA ESCHERICHIA COLI |
| 76-103 PCFAA-- ECOLI CF A/I FIMBRIAL SUBUNIT A |
| PRECURSOR ESCHERICHIA COLI 27-58 |
| PCFAC-- ECOLI CF A/I FIMBRIAL SUBUNIT C PRECURSOR ESCHERICHIA |
| COLI 138-187 388-456 561-595 |
| PCFAD-- ECOLI CF A/I FIMBRIAL SUBUNIT D ESCHERICHIA COLI 133-160 |
| PCFAE-- ECOLI CF A/I FIMBRIAL SUBUNIT E ESCHERICHIA COLI 180-207 |
| 244-271 |
| PCH10-- ACYPS 10 KD CHAPERONIN ACYRTHOSIPHON PISUM SYMBIOTIC |
| 57-95 |
| BACTERIU |
| PCH10-- |
| BACSU 10 KD CHAPERONIN BACILLUS SUBTILIS 66-93 PCH10-- |
| CHLTR 10 KD CHAPERONIN CHLOAMYDIA TRACHOMATIS 64-91 |
| PCH10-- |
| ECOLI 10 KD CHAPERONIN ESCHERICHIA COLI 57-84 PCH10-- |
| HAEDU 10 KD CHAPERONIN HAEMOPHILUS DUCREYI 68-95 |
| PCH10-- |
| LEGMI 10 KD CHAPERONIN LEGIONELLA MICDADEI 57-84 PCH10-- |
| RICTS 10 KD CHAPERONIN RICKETTSIA TSUTSUGAMUSHI 65-92 |
| PCH10-- THEP3 10 KD CHAPERONIN THERMOPHILIC BACTERIUM PS-3 66-93 |
| PCH60-- ACYPS 60 KD CHAPERONIN ACYRTHOSIPHON PISUM SYMBIOTIC |
| 341-382 |
| BACTERIU |
| PCH60-- AGRTU 60 KD CHAPERONIN AGROBACTERIUM TUMEFACIENS 117-163 |
| 339-370 425-466 |
| PCH60-- AMOPS 60 KD CHAPERONIN AMOEBA PROTEUS SYMBIOTIC 299-333 |
| BACTERIUM |
| PCH60-- BACSU 60 KD CHAPERONIN BACILLUS SUBTILIS 298-332 337-364 |
| PCH60-- BORBU 60 KD CHAPERONIN BORRELIA BURGDORFERI 125-163 |
| 299-358 |
| PCH60-- BRUAB 60 KD CHAPERONIN BRUCELLA ABORTUS 117-144 339-366 |
| PCH60-- CHLPN 60 KD CHAPERONIN CHLAMYDIA PNEUMONIAE 4-31 |
| PCH60-- CHLTR 60 KD CHAPERONIN CHLAMYDIA TRACHOMATIS 4-31 |
| PCH60-- CHRVI 60 KD CHAPERONIN CHROMATIUM VINOSUM 300-327 |
| PCH60-- CLOAB 60 KD CHAPERONIN CLOSTRIDIUM ACETOBUTYLICUM |
| 238-332 337-364 455-482 |
| PCH60-- CLOPE 60 KD CHAPERONIN CLOSTRIDIUM PERFRINGENS 337-368 |
| 417-444 |
| PCH60-- COXBU 60 KD CHAPERONIN COXIELLA BURNETII 300-327 348-382 |
| PCH60-- HAEDU 60 KD CHAPERONIN HAEMOPHILUS DUCREYI 339-366 |
| 417-444 |
| PCH60-- LEGMI 60 KD CHAPERONIN LEGIONELLA MICDADEI 299-333 |
| PCH60-- LEGPN 60 KD CHAPERONIN LEGIONELLA PNEUMOPHILA |
| 298-332 452-479 |
| PCH60-- MYCLE 60 KD CHAPERONIN MYCOBACTERIUM LEPRAE 125-152 |
| 236-263 337-364 |
| PCH60-- MYCTU 60 KD CHAPERONIN MYCOBACTERIUM TUBERCULOSIS 125-152 |
| 337-364 |
| & BOVIS |
| PCH60-- PSEAE 60 KD CHAPERONIN PSEUDOMONAS AERUGINOSA 339-366 |
| PCH60-- RHILV 60 KD CHAPERONIN RHIZOBIUM LEGUMINOSARUM 117-163 |
| 322-370 425-466 |
| PCH60-- RICTS 60 KD CHAPERONIN RICKETTSIA TSUTSUGAMUSHI 103-130 |
| 293-336 360-394 |
| PCH60-- SYNP7 60 KD CHAPERONIN SYNECHOCOCCUS SP 308-335 337-380 |
| PCH60-- SYNY3 60 KD CHAPERONIN SYNECHOCYSTIS SP 338-365 455-489 |
| PCH60-- THEP3 60 KD CHAPERONIN THERMOPHILIC BACTERIUM PS-3 |
| 337-364 |
| PCH62-- STRAL 60 KD CHAPERONIN 2 STREPTOMYCES ALBUS G 116-148 |
| 337-364 |
| PCHB-- VIBHA N,N'-DIACETYLCHITOBIASE PRECURSOR VIBRIO HARVEYI |
| 21-48 772-799 |
| PCHEA-- BACSU CHEMOTAXIS PROTEIN CHEA BACILLUS SUBTILIS 373-400 |
| 590-617 |
| PCHEA-- ECOLI CHEMOTAXIS PROTEIN CHEA ESCHERICHIA COLI 256-286 |
| PCHEA-- SALTY CHEMOTAXIS PROTEIN CHEA SALMONELLA TYPHIMURIUM |
| 162-197 |
| PCHER-- BACSU CHEMOTAXIS PROTEIN METHYLTRANSFERASE BACILLUS |
| SUBTILIS 124-151 |
| PCHEW-- ECOLI PURINE-BINDING CHEMOTAXIS PROTEIN ESCHERICHIA COLI |
| 68-115 |
| PCHEW-- SALTY PURINE-BINDING CHEMOTAXIS PROTEIN SALMONELLA |
| TYPHIMURIUM |
| 88-115 PCHEY- |
| - |
| BACSU CHEMOTAXIS PROTEIN CHEY ESCHERICHIA COLI 22-49 |
| PCHEY-- SALTY CHEMOTAXIS PROTEIN CHEY SALMONELLA TYPHIMURIUM 22-49 |
| PCHI1-- BACCI CHITINASE A1 PRECURSOR BACILLUS CIRCULANS 491-518 |
| 566-593 |
| PCHIA-- ALTSO CHITINASE A PRECURSOR ALTEROMONAS SP 345-372 |
| PCHIA-- SERMA CHITINASE A PRECURSOR SERRATIA MARCESCENS |
| 346-373 |
| PCHID-- BACCI CHITINASE D PRECURSOR BACILLUS CIRCULANS 102-161 |
| 189-216 |
| PCHIT-- SACER CHITINASE SACCHAROPOLYSPORA ERYTHRAEA 92-119 |
| PCHIT-- STRPL CHITINASE 63 PRECURSOR STREPTOMYCES PLICATUS |
| 250-284 |
| PCHMU-- BACSU CHORISMATE MUTASE BACILLUS SUBTILIS |
| 3-37 PCHOD-- BREST CHOLESTEROL OXIDASE PRECURSOR |
| BREVIBACTERIUM STEROLICUM 263-290 |
| PCHTA-- VIBCH CHOLERA ENTEROTOXIN, A CHAIN PRECURSOR VIBRIO |
| CHOLERAE |
| 79-106 |
| PCHVA-- AGRTU BETA-(1->2)GLUCAN EXPORT PROTEIN AGROBACTERIUM |
| TUMEFACIENS |
| 4-31 181-208 PCHVE- |
| - AGRTU RECEPTOR PROTEIN CHVE PRECURSOR AGROBACTERIUM TUMEFACIENS |
| 100-127 |
| PCIR1-- CITFR CITROLYSIN PROTEIN 1 CITROBACTER FREUNDII 435-462 |
| PCIRA-- ECOLI COLICIN 1 RECEPTOR PRECURSOR ESCHERICHIA COLI |
| 146-173 |
| PCISA-- BACSU PUTATIVE DNA RECOMBINASE BACILLUS SUBTILIS 378-405 |
| PCISY-- ACIAN CITRATE SYNTHASE ACINETOBACTER ANITRATIUM 143-170 |
| PCISY-- |
| BACCO CITRATE SYNTHASE BACILLUS COAGULANS 24-51 PCITA-- |
| SALTY CITRATE-PROTON SYMPORT SALMONELLA TYPHIMURIUM 154-181 |
| PCITN-- KLEPN CITRATE-SODIUM SYMPORT KLEBSIELLA PNEUMONIAE |
| 194-221 |
| PCITN-- SALDU CITRATE-SODIUM SYMPORT SALMONELLA DUBLIN 194-221 |
| PCITN-- SALPU CITRATE-SODIUM SYMPORT SALMONELLA PULLORUM |
| 194-221 |
| PCLCA-- PSEPU CHLOROCATECHOL 1,2-DIOXYGENASE PSEUDOMONAS PUTIDA |
| 13-36 |
| PCLD1-- ECOLI CHAIN LENGTH DETERMINANT PROTEIN ESCHERICHIA COLI |
| 133-167 |
| PCLD2-- ECOLI CHAIN LENGTH DETERMINANT PROTEIN ESCHERICHIA COLI |
| 178-212 250-277 |
| PCLD-- |
| SALTY CHAIN LENGTH DETERMINANT PROTEIN SALMONELLA TYPHIMURIUM 96-127 |
| 151-212 |
| PCLOS-- |
| CLOHI ALPHA-CLOSTRIPAIN PRECURSOR CLOSTRIDIUM HISTOLYTICUM 30-58 |
| 497-524 |
| PCLPA-- ECOLI ATP-BINDING SUBUNIT CLPA ESCHERICHIA COLI 655-695 |
| PCLPA-- RHOBL CLPA HOMOLOG PROTEIN RHODOPSEUDOMONAS BLASTICA |
| 439-466 |
| PCLPB-- BACNO CLPB HOMOLOG PROTEIN BACTEROIDES NODOSUS 116-157 |
| 442-476 558-595 |
| PCLPB-- ECOLI CLPB PROTEIN ESHCERICHIA COLI 444-489 563-590 |
| PCLPX-- AZOVI CLPX HOMOLOG PROTEIN AZOTOBACTER VINELANDII |
| 215-242 332-359 |
| PCLPX-- ECOLI ATP-BINDING SUBUNIT CLPX ESHCERICHIA COLI 255-282 |
| PCN16-- ECOLI 2',3'-CYCLIC-NUC 2'-PHOSPHODIESTERASE PRECURS |
| ESHCERICHIA COLI 50-77 |
| PCODA-- ECOLI CYTOSINE DEAMINASE ESHCERICHIA COLI 102-129 |
| PCOM1-- BACSU A COMPETENCE PROTEIN 1 BACILLUS SUBTILIS |
| 108-135 186-213 |
| PCOMQ-- BACSU COMPETENCE REGULATORY PROTEIN BACILLUS SUBTILIS |
| 154-239 |
| PCOP6-- STAAU COP-6 PROTEIN STAPHYLOCOCCUS AUREUS |
| 7-53 PCOPB-- |
| PSESM COPPER RESISTANCE PROTEIN B PRECURSOR PSEUDOMONAS SYRINGAE |
| 140-167 |
| PCORA-- ECOLI MAGNESIUM/COBALT TRANSPORT PROTEIN CORA BACILLUS |
| SUBTILIS 134-161 |
| PCORA-- SALTY MAGNESIUM/COBALT TRANSPORT PROTEIN CORA SALMONELLA |
| TYPHIMURIUM 134-161 |
| PCOTE-- BACSU SPORE COAT PROTEIN E BACILLUS SUBTILIS 42-92 |
| PCOX1-- |
| BRAJA CYTOCHROME C OXIDASE POLYPEPTIDE I BRADYRIZOBIUM JAPONICUM |
| 380-407 |
| PCOX1-- PARDE CYTOCHROME C OXIDASE POLYPEPTIDE I PARACOCCUS |
| DENTIRIFICANS 383-410 |
| PCOX1-- RHOSH CYTOCHROME C OXIDASE POLYPEPTIDE I RHODOBACTER |
| SPHAEROIDES 396-423 |
| PCOXX-- BACFI OXIDASE ASSEMBLY FACTOR BACILLUS FIRMUS 36-63 |
| PCOXX-- BACSU OXIDASE ASSEMBLY FACTOR BACILLUS SUBTILIS |
| 49-76 |
| PCPPB-- NEIGO CRYPTIC PLASMID PROTEIN B NEISSERIA GONORRHOEAE |
| 72-99 165-209 |
| PCPSB-- ECOLI MANNOSE-1-PHOSPHATE GUANYLYLTRANSFERASE ESCHERICHIA |
| COLI 309-336 |
| PCPSB-- SALTY MANNOSE-1-PHOSPHATE GUANYLYLTRANSFERASE SALMONELLA |
| TYPHIMURIUM 311-338 |
| PCPXA-- ECOLI SENSOR PROTEIN CPXA ESCHERICHIA COLI 254-281 |
| PCPXG-- STRSQ CYTOCHROME P450 105C1 STREPTOMYCES SP 157-184 |
| PCPXJ-- |
| SACER 6-DEOXYERYTHRONOLIDE B (DEB) HYDROXYLASE SACCHAROPOLYSPORA |
| ERYTHRAEA 233-260 |
| PCPXM-- BACSU CYTOCHROME P450 109 BACILLUS SUBTILIS 240-283 |
| PCPXN-- ANASP PROBABLE CYTOCHROME P450 ANABAENA SP 98-125 |
| PCR27-- BACTI 27 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 153-187 |
| PCR27-- BACTM 27 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 153-187 |
| PCR41-- BACSH 1.9 KD INSECTICIDAL TOXIN BACILLUS SPHAERICUS |
| 276-308 |
| PCR42-- BACSH 1.9 KD INSECTICIDAL TOXIN BACILLUS SPHAERICUS |
| 276-308 |
| PCR43-- BACSH 41.9 KD INSECTICIDAL TOXIN BACILLUS SPHAERICUS |
| 276-308 |
| PCR70-- BACTD 70 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 207-234 252-279 429-463 |
| PCR70-- BACTO 75 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS 57-84 |
| 125-159 427-464 |
| PCR70-- BACTT 70 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 199-226 244-271 421-455 |
| PCR71-- BACTK 70 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 93-133 191-218 552-615 |
| PCR72-- BACTI 72 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 74-111 383-414 |
| PCR72-- BACTK 70 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 93-133 191-218 552-593 |
| PCR77-- BACTI 77 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 308-335 502-529 |
| PCREC-- ECOLI SENSOR PROTEIN CREC ESCHERICHIA COLI 103-130 |
| PCRED-- ECOLI INNER MEMBRANE PROTEIN CRED ESCHERICHIA COLI |
| 94-121 |
| PCRP-- ECOLI CATABOLITE GENE ACTIVATOR ESCHERICHIA COLI & 26-53 |
| 127-154 |
| SHIGELLA FLEXNERI |
| PCRP-- SALTY CATABOLITE GENE ACTIVATOR SALMONELLA TYPHIMURIUM |
| 26-53 127-154 |
| KLEBSIELLA AEROGENES |
| PCRTI-- ERWHE PHYTOENE DEHYDROGENASE ERWINIA HERBICOLA 231-258 |
| PCRTI-- RHOCA PHYTOENE DEHYDROGENASE RHODOBACTER CAPSULATUS |
| 389-416 |
| PCRTJ-- RHOCA CRTJ PROTEIN RHODOBACTER CAPSULATUS 133-160 334-361 |
| 431-458 |
| PCRYS-- BACTA 132 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 721-755 875-902 |
| PCRYS-- BACTB 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 730-771 865-892 1053- |
| 1080 |
| PCRYS-- BACTE 133 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 736-770 890-917 |
| PCRYS-- BACTI 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 218-252 701-728 775-802 |
| PCRYS-- BACTK 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 737-771 865-892 1053- |
| 1080 |
| PCRYS-- BACTS 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 736-770 890-917 |
| PCRYT-- BACTA 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 730-771 865-892 1053- |
| 1080 |
| PCRYT-- BACTE 134 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 745-779 899-926 |
| PCRYT-- BACTI 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 217-251 354-384 701-728 775-802 |
| PCRYT-- BACTK 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 737-771 865-892 |
| PCRYU-- BACTA 135 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 736-770 890-917 |
| PCRYU-- BACTI 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 217-251 700-727 774-801 |
| PCRYU-- BACTK 131 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 738-772 866-893 1054- |
| 1081 |
| PCRYV-- BACTA 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 737-771 865-892 1053- |
| 1080 |
| PCRYV-- BACTI 135 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 110-151 745-772 819-846 |
| PCRYV-- BACTK 133 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 736-770 890-917 |
| PCRYW-- BACTA 130 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 745-779 |
| PCRYW-- BACTK 133 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 608-659 662-696 892-919 |
| PCRYX-- BACTK 139 KD CRYSTAL PROTEIN BACILLUS THURINGIENSIS |
| 92-119 227-254 605-632 783-817 937- |
| 964 |
| PCS32-- ECOLI CS3 PILI SYNTHESIS 63 KG PROTEIN ESCHERICHIA COLI |
| 42-69 226-253 290-317 344-378 |
| PCS33-- ECOLI CS3 PILI SYNTHESIS 48 KG PROTEIN ESCHERICHIA COLI |
| 90-117 154-181 208-242 |
| PCS34-- ECOLI CS3 PILI SYNTHESIS 33 KG PROTEIN ESCHERICHIA COLI |
| 20-47 |
| 74-108 |
| PCSG-- HALHA CELL SURFACE GLYCOPROTEIN PRECURSOR HALOBACTERIUM |
| HALOBIUM 256-283 584-611 |
| PCSG-- HALVO CELL SURFACE GLYCOPROTEIN PRECURSOR HALOBACTERIUM |
| VOLCANII 143-170 237-271 |
| PCSG-- METFE CELL SURFACE GLYCOPROTEIN PRECURSOR METHANOTHERMUS |
| FERVIDUS |
| 59-107 |
| PCSG-- METSC CELL SURFACE GLYCOPROTEIN PRECURSOR METHANOTHERMUS |
| SOCIABILIS |
| 59-107 PCSOB |
| -- ECOLI CS1 FIMBRIAL SUBUNIT B PRECURSOR ESCHERICHIA COLI 25-56 |
| PCTFA-- CLOAB COA-TRANSFERASE SUBUNIT A CLOSTRIDIUM |
| ACETOBUTYLICUM 118-145 |
| PCTFB-- |
| CLOAB COA-TRANSFERASE SUBUNIT B CLOSTRIDIUM ACETOBUTYLICUM 174-208 |
| PCTRB-- |
| NEIME INNER-MEMBRANE PROTEIN CTRB NEISSERIA MENINGITIDIS 152-193 |
| PCTX-- PSEAE CYTOTOXIN PRECURSOR PSEUDOMONAS AERUGINOSA |
| 78-115 124-151 160-194 217-251 |
| PCVAA-- ECOLI COLICIN V SECRETION PROTEIN CVAA ESCHERICHIA COLI |
| 104-138 163-219 |
| PCVAB-- ECOLI COLICIN V SECRETION PROTEIN CVAB ESCHERICHIA COLI |
| 151-178 |
| PCWPM-- BACBR MIDDLE CELL WALL PROTEIN PRECURSOR BACILLUS BREVIS |
| 197-224 411-438 1010- |
| 1044 |
| PCWPO-- BACBR OUTER CELL WALL PROTEIN PRECURSOR BACILLUS BREVIS |
| 178-216 560-587 947-988 |
| PCYAA-- BORPE ADENYLATE CYCLASE PRECURSOR BORDETELLA PERTUSSIS |
| 48-75 632-659 962-996 |
| PCYAA-- YERIN ADENYLATE CYCLASE YERSINIA INTERMEDIA 343-387 |
| 593-620 |
| PCYAB-- |
| BORPE CYAB PROTEIN BORDETELLA PERTUSSIS 541-568 PCYAD-- |
| BORPE CYAD PROTEIN BORDETELLA PERTUSSIS 178-212 |
| PCYAE-- |
| BORPE CYAE PROTEIN BORDETELLA PERTUSSIS 313-340 PCYB-- |
| RHOCA CYTOCHROME B RHODOBACTER CAPSULATUS 38-65 |
| PCYDD-- ECOLI TRANSPORT PROTEIN CYDD ESCHERICHIA COLI 3-30 |
| 382-409 |
| PCYF-- |
| NOSSP APOCYTOCHROME F PRECURSOR NOSTOC SP 209-243 PCYMO-- |
| ACISP CYCLOHEXANONE MONOOXYGENASE ACINETOBACTER SP 439-473 |
| PCYNT-- SYNP7 CARBONIC ANHYDRASE SYNECHOCOCCUS SP 170-200 |
| PCYNX-- |
| ECOLI CYNX PROTEIN ESCHERICHIA COLI 53-80 PCYOB-- ECOLI |
| CYTOCHROME O UBIQUINOL OXIDASE SUBUNIT 1 ESCHERICHIA COLI 31-58 |
| PCYPH-- SYNP7 PEPTIDYL-PROLYL CIS-TRANS ISOMERASE SYNECHOCOCCUS |
| PS 107-141 |
| PCYSA-- ECOLI SULFATE PERMEASE A PROTEIN ESCHERICHIA COLI 164-191 |
| PCYSB-- ECOLI CYS REGULON TRANSCRIPTIONAL ACTIVATOR ESCHERICHIA |
| COLI |
| 3-30 |
| PCYSB-- SALTY CYS REGULON TRANSCRIPTIONAL ACTIVATOR SALMONELLA |
| TYPHIMURIUM |
| 3-30 PCYSE- |
| - |
| ECOLI SERINE ACETYLTRANSFERASE ESCHERICHIA COLI 164-191 |
| PCYSE-- SALTY SERINE ACETYLTRANSFERASE SALMONELLA TYPHIMURIUM |
| 164-191 |
| PCYSG-- |
| ECOLI SIROHEM SYNTHASE ESCHERICHIA COLI 405-432 PCYSG-- |
| SALTY SIROHEM SYNTHASE SALMONELLA TYPHIMURIUM 405-432 |
| PCYSN-- ECOLI SULFATE ADENYLATE TRANSFERASE SUBUNIT 1 ESCHERICHIA |
| COLI 64-91 |
| PCYSW-- ECOLI SULFATE PERMEASE W PROTEIN ESCHERICHIA COLI 201-228 |
| PCYSW-- SYNP7 SULFATE PERMEASE W PROTEIN SYNECHOCOCCUS SP 211-238 |
| PCZCB-- ALCEU CATION EFFLUX SYSTEM PROTEIN CZCB ALCALIGENES |
| EUTROPHUS 241-268 283-320 364-391 |
| PCZCD-- ALCEU CATION EFFLUX SYSTEM PROTEIN CZCD ALCALIGENES |
| EUTROPHUS 139-169 |
| PDACB-- BACSU PENICILLIN-BINDING PROTEIN 5* PRECURSOR BACILLUS |
| SUBTILIS |
| 80-017 |
| PDADA-- ECOLI D-AMINO ACID DEHYDROGENASE ESCHERICHIA COLI 127-154 |
| PDAGA-- |
| ALTHA NA(+)-LINKED D-ALANINE GLYCINE PERMEASE ALTEROMONAS HALOPLANKTIS |
| 332-373 |
| PDAMX-- ECOLI DAMX PROTEIN ESCHERICHIA COLI 68-95 349-380 |
| PDAPA-- ECOLI DIHYDRODIPICOLINATE SYNTHASE ESCHERICHIA |
| COLI 27-54 157-184 |
| PDATI-- BACSU DNA-PROTEIN-CYSTEINE METHYLTRANSFERASE BACILLUS |
| SUBTILIS 13-47 |
| PDBHA-- ECOLI DNA-BINDING PROTEIN HU-ALPHA ESCHERICHIA COLI 12-39 |
| PDBH-- CLOPA DNA-BINDING PROTEIN HU CLOSTRIDIUM PASTEURIANUM |
| 12-53 |
| PDCAM-- ECOLI DECARBOXYLASE PROENZYME ESCHERICHIA COLI 146-173 |
| PDCDA-- CORGL DIAMINOPIMELATE DECARBOXYLASE CORYNEBACTERIUM |
| GLUTMICUM 134-161 |
| PDCDA-- |
| PSEAE DIAMINOPIMELATE DECARBOXYLASE PSEUDOMONAS AERUGINOSA 57-84 |
| PDCEB-- ECOLI GLUTAMATE DECARBOXYLASE BETA ESCHERICHIA COLI |
| 4-31 |
| PDCHS-- ENTAE HISTIDINE DECARBOXYLASE ENTEROBACTER AEROGENES |
| 111-138 |
| PDCHS-- KLEPL HISTIDINE DECARBOXYLASE KLEBSIELLA PLANTICOLA |
| 111-138 |
| PDCHS-- MORMO HISTIDINE DECARBOXYLASE MORGANELA MORGANII 111-138 |
| PDCID-- BACSU DIPEPTIDE TRANSPORT PROTEIN DCIAD BACILLUS SUBTILIS |
| 188-222 |
| PDCLY-- |
| HAFAL LYSINE DECARBOXYLASE HAFNIA ALVEI 305-332 PDCOA-- |
| KLEPN OXALOACTEATE DECARBOXYLASE ALPHA CHAIN KLEBSIELLA PNEUMONIAE |
| 261-288 342-369 |
| PDCOA-- SALTY OXALOACTEATE DECARBOXYLASE ALPHA CHAIN SALMONELLA |
| TYPHIMURIUM 261-288 342-369 |
| PDCOB-- SALTY OXALOACTEATE DECARBOXYLASE BETA CHAIN SALMONELLA |
| TYPHIMURIUM 299-326 |
| PDCTB-- |
| RHILE TRANSPORT SENSOR PROTEIN DCTB RHIZOBIUM LEGUMINOSARUM 377-411 |
| PDCTB-- RHIME TRANSPORT SENSOR PROTEIN DCTB RHIZOBIUM MELILOTI |
| 511-538 |
| PDEAD-- ECOLI ATP-DEPENDENT RNA HELICASE DEAD ESCHERICHIA COLI |
| 268-295 518-545 |
| PDEAD-- |
| KLEPN ATP-DEPENDENT RNA HELICASE DEAD KLEBSIELLA PNEUMONIAE 267-294 |
| 519-546 |
| PDEDA-- |
| ECOLI DEDA PROTEIN ESCHERICHIA COLI 106-133 PDEGS-- |
| BACSU SENSOR PROTEIN DEGS BACILLUS SUBTILIS 31-70 75-159 292-327 |
| PDEH2-- MORSP HALOACETATE DEHALOGENASE H-2 MORAXELLA SP |
| 114-141 |
| PDEOC-- ECOLI DEOXYRIBOSE-PHOSPHATE ALDOLASE ESCHERICHIA COLI |
| 134-161 |
| PDHAL-- PSEOL ALDEHYDE DEHYDROGENASE PSEUDOMONAS OLEOVORANS 6-33 |
| PDHAS-- BACSU ASPARTATE-SIMIALDEHYDE DEHYDROGENASE BACILLUS |
| SUTILIS 150-184 |
| PDHAS-- |
| CORGL ASPARTATE-SIMIALDEHYDE DEHYDROGENASE CORYNEBACTERIUM GLUTMICUM |
| 43-70 312-339 |
| PDHAS-- ECOLI ASPARTATE-SIMIALDEHYDE DEHYDROGENASE ESCHERICHIA |
| COLI 229-256 |
| PDHAS-- VIBCH ASPARTATE-SIMIALDEHYDE DEHYDROGENASE VIBRIO |
| CHOLERAE 309-336 |
| PDHA-- BACSH ALANINE DEHYDROGENASE BACILLUS SPHAERICUS 149-176 |
| PDHA-- BACST ALANINE DEHYDROGENASE BACILLUS STEAROTHERMOPHILUS |
| 94-121 |
| PDHE2-- CLODI NAD-SPECIFIC GLUTAMATE DEHYDROGENASE CLOSTRIDIUM |
| DIFFICILE 116-143 |
| PDHE2-- |
| PEPAS D-SPECIFIC GLUTAMATE DEHYDROGENASE PEPTOSTREPTOCOCCUS 247-274 |
| 345-380 |
| ASACCHAROLYTICUS |
| PDHE3-- SULSO GLUTAMATE DEHYDROGENASE SULFOLOBUS SOLDATARICUS |
| 2-36 |
| PDHE4-- |
| CORGL NADP-SPECIFIC GLUTAMATE DEHYDROGENASE CORYNEBACTERIUM GLUTMICUM |
| 188-215 229-256 |
| PDHGA-- ACICA GLUCOSE DEHYDROGENASE-A ACINETOBACTER CALCOACETICUS |
| 10-59 190-217 |
| PDHGB-- BACME GLUCOSE 1-DEHYDROGENASE B BACILLUS MEGATERIUM 27-57 |
| PDHG-- ECOLI GLUCOSE DEHYDROGENASE ESCHERICHIA COLI 436-463 |
| PDHK1-- |
| STRVN KETOACYL REDUCTASE 1 STREPTOMYCES VIOLACEORUBER 168-195 |
| PDHLE-- BACST LEUCINE DEHYDROGENASE BACILLUS STREAROTHERMOPHILUS |
| 192-219 |
| PDHLO-- AGRT4 D-LYSOPHINE DEHYDROGENASE AGROBACTERIUM TUMEFACIENS |
| 317-344 |
| PDHM1-- |
| METEX METHANOL DEHYDROGENASE SUBUNIT 1 PREC METHYLOBACTERIUM EXTOQUENS |
| 153-187 190-224 |
| PDHM1-- |
| METOR METHANOL DEHYDROGENASE SUBUNIT 1 PREC METHYLOBACTERIUM ORGANOPHILU |
| M 153-187 190-224 |
| PDHM1-- PARDE METHANOL DEHYDROGENASE SUBUNIT 1 PREC PARAOCOCCUS |
| DENITRIFICANS 195-222 |
| PDHNA-- |
| BACSP NADH DEHYDROGENASE BACILLUS SP 284-314 PDHNA-- |
| ECOLI NADH DEHYDROGENASE ESCHERICHIA COLI 180-214 |
| PDHOM-- BACSU HOMOSERINE DEHYDROGENASE BACILLUS SUBTILIS 73-107 |
| 406-433 |
| PDHOM-- CORGL HOMOSERINE DEHYDROGENASE CORYNEBACTERIUM GLUTMICUM |
| 105-132 |
| PDHPH-- BACSH PHENYLALANINE DEHYDROGENASE BACILLUS SPHAERICUS |
| 212-239 |
| PDHSA-- ECOLI SUCC DEHYDROGENASE FLAVOPROTEIN SUBUNIT ESCHERICHIA |
| COLI 482-512 |
| PDHSS-- |
| ANACY SOLUBLE HYDROGENASE 42 KD SUBUNIT ANABAENA CYLINDRICA 86-113 |
| 130-168 |
| PDHSS-- SYNP1 SOLUBLE HYDROGENASE, SMALL SUBUNIT SYNECHOCOCCUS SP |
| 133-160 |
| PDHTM-- METME TRIMETHYLAMINE DEHYDROGENASE METHYLOTROPHUS |
| METHYLOPHILUS 439-466 |
| PDING-- ECOLI PROBABLE ATP-DEPENDENT HELICASE DING ESCHERICHIA |
| COLI 584-611 |
| PDIVB-- BACSU DIVISION INITIATION PROTEIN BACILLUS SUBTILIS 54-82 |
| 114-141 |
| PDLD3-- PSEPU DIHYDROLIPOAMIDE DEHYDROGENASE PSEUDOMONAS PUTIDA |
| 93-120 |
| PDLDH-- AZOVI LIPOAMIDE DEHYDROGENASE COMP (E3) AZOTOBACTER |
| VINELANDII 18-45 224-276 |
| PDLDH-- |
| BACST LIPOAMIDE DEHYDROGENASE COMP (E3) BACILLUS STEAROTHERMOPHILUS |
| 82-124 |
| PDLDH-- BACSU LIPOAMIDE DEHYDROGENASE COMP (E3) BACILLUS SUBTILIS |
| 82-109 |
| PDLDH-- ECOLI DIHYDROLIPOAMIDE DEHYDROGENASE ESCHERICHIA COLI |
| 108-135 |
| PDLDH-- |
| PSEFL DIHYDROLIPOAMIDE DEHYDROGENASE PSEUDOMONAS FLUORESCENS 124-151 |
| 223-275 |
| PDMPN-- PSEPU PHENOL HYDROXYLASE P3 PROTEIN PSEUDOMONAS PUTIDA |
| 63-90 |
| PDNA1-- BACSU DNAK PROTEIN BACILLUS SUBTILIS 497-524 548-581 |
| PDNA2-- |
| BACSU DNAK PROTEIN BACILLUS SUBTILIS 456-483 PDNAA-- |
| BACSU DNAA PROTEIN BACILLUS SUBTILIS 316-380 |
| PDNAA-- BORBU DNAA PROTEIN BORRELIA BURGDORFERI 182-216 248-275 |
| 341-387 436-463 |
| PDNAA-- BUCAP DNAA PROTEIN BUCHNERA APHIDICOLA 73-100 111-138 |
| 353-380 |
| PDNAA-- |
| ECOLI DNAA PROTEIN ESCHERICHIA COLI 366-400 PDNAA-- |
| MICLU DNAA PROTEIN MICROCOCCUS LUTEUS 385-415 |
| PDNAA-- MYCCA DNAA PROTEIN MYCOPLASMA CAPRICOLUM 8-56 75-112 |
| 274-310 350-389 |
| PDNAA-- |
| PROMI DNAA PROTEIN PROTEUS MIRABILIS 365-399 PDNAA-- |
| PSEPU DNAA PROTEIN PSEUDOMONAS PUTIDA 398-439 |
| PDNAA-- SPICI DNAA PROTEIN SPIROPLASMA CITRI 45-72 76-110 |
| 145-180 |
| PDNAB-- CHLTR DNAB-LIKE PROTEIN CHLAMYDIA TRACHOMATIS 312-353 |
| PDNAB-- ECOLI DNAB PROTEIN ESCHERICHIA COLI |
| 82-109 PDNAB-- |
| SALTY DNAB PROTEIN SALMONELLA TYPHIMURIUM |
| 82-109 PDNAC-- |
| ECOLI DNAC PROTEIN ESCHERICHIA COLI 146-190 |
| PDNAK-- BACME DNAK PROTEIN BACILLUS MEGATERIUM 497-524 548-581 |
| PDNAK-- BORBU DNAK PROTEIN BORRELIA BURGDORFERI 512-594 |
| PDNAK-- BRUOV DNAK PROTEIN BRUCELLA OVIS 248-275 512-546 |
| PDNAK-- CAUCR DNAK PROTEIN CAULOBACTER CRESCENTUS 561-588 |
| PDNAK-- CLOAB DNAK PROTEIN CLOSTRIDIUM ACETOBUTYLICUM |
| 499-526 |
| PDNAK-- CLOPE DNAK PROTEIN CLOSTRIDIUM PERFRINGES 496-527 |
| PDNAK-- METMA DNAK PROTEIN METHANOSARCINA MAZEI 523-550 |
| PDNAK-- MYCTU DNAK PROTEIN MYCOBACTERIUM TUBERCULOSIS 502-529 |
| PDNAK-- STRCO DNAK PROTEIN STREPTOMYCES COELICOLOR 45-72 533-572 |
| PDNIR-- ECOLI REGULATORY PROTEIN DNIR ESCHERICHIA COLI 114-141 |
| PDNLI-- |
| ZYMMO DNA LIGASE ZYMOMONAS MOBILIS 658-712 PDNRJ-- |
| STRPE TRANSDUCTION PROTEIN DNRJ STREPTOMYCES PEUCETIUS 24-51 |
| PDOCK-- |
| SULSO PROBABLE SIGNAL RECOGNITION PARTICLE PROTE SULFOLOBUS SOLFATARICUS |
| 104-172 |
| PDP3A-- BACSU DNA POLYMERASE III, ALPHA CHAIN BACILLUS SUBTILIS |
| 58-85 417-444 1382- |
| 1416 |
| PDP3A-- ECOLI DNA POLYMERASE III, ALPHA CHAIN ESCHERICHIA COLI |
| 77-104 |
| PDP3A-- SACER DNA POLYMERASE III, ALPHA CHAIN SACCHAROPOLYSPORA |
| ERYTHRAEA 230-257 |
| PDP3A-- |
| SALTY DNA POLYMERASE III, ALPHA CHAIN SALMONELLA TYPHIMURIUM 77-104 |
| PDP3B-- BACSU DNA POLYMERASE III, BETA CHAIN BACILLUS SUBTILIS |
| 212-239 |
| PDP3B-- BORBU DNA POLYMERASE III, BETA CHAIN BORRELIA BURGDORFERI |
| 266-313 |
| PDP3B-- BUCAP DNA POLYMERASE III, BETA CHAIN BUCHNERA APHIDICOLA |
| 31-62 308-359 |
| PDP3B-- MICLU DNA POLYMERASE III, BETA CHAIN MICROCOCCUS LUTEUS |
| 191-218 |
| PDP3B-- |
| MYCCA DNA POLYMERASE III, BETA CHAIN MYCOPLASMA CAPRICOLUM36-70 |
| PDP3B-- PSEPU DNA POLYMERASE III, BETA CHAIN PSEUDOMONAS |
| PUTIDA 30-60 |
| PDP3B-- SPICI DNA POLYMERASE III, BETA CHAIN SPIROPLASMA CITRI |
| 78-112 129-177 273-310 |
| PDP3X-- BACSU DNA POLYMERASE III SUBUNITS GAMMA AND TAU BACILLUS |
| SUBTILIS 231-272 |
| PDPC2-- ECOLI DNA PRIMASE TRAC-2 ESCHERICHIA COLI 691-743 |
| PDPC4-- ECOLI DNA PRIMASE TRAC-2 ESCHERICHIA COLI 401-448 |
| PDPND-- STRPN DPND PROTEIN STREPTOCOCCUS PNEUMONIAE 79-120 |
| PDPO1-- BACCA DNA POLYMERASE I BACILLUS CALDOTENAX208-235 |
| PDPO1-- STRPN DNA POLYMERASE I STREPTOCOCCUS PNEUMONIAE198-225 |
| 398-425 571-598 645-672 |
| PDPO1-- THEAQ DNA POLYMERASE THERMUS AQUATICUS 196-223 602-629 |
| PDPO1-- |
| THEFL DNA POLYMERASE THERMUS AQUATICUS 597-628 PDPO2-- |
| ECOLI DNA POLYMERASE II ESCHERICHIA COLI 569-596 |
| PDPOL-- |
| PYRFU DNA POLYMERASE PYROCOCCUS FURIOSUS 746-773 PDPOL-- |
| SULSO DNA POLYMERASE SULFOLOBUS SOLFATARICUS 379-406 436-463 625-659 |
| 747-774 |
| PDPOL-- THELI DNA POLYMERASE THERMOCOCCUS LITORIALIS 332-370 |
| 551-589 892-926 1004- 1153- |
| 1031 1194 |
| PDPP-- LACLA DIPEPTIDYL PEPTIDASE IV LACTOCOCCUS LACTIS 716-753 |
| PDPP-- LACLC DIPEPTIDYL PEPTIDASE IV LACTOCOCCUS LACTIS 716-753 |
| PDPS-- ECOLI DNA PROTECTION DURING STARVATION PROTEIN ESCHERICHIA |
| COLI |
| 4-45 |
| PDRN1-- STREQ DEOXYRIBONUCLEASE PRECURSOR STREPTOCOCCUS EQUISIMILIS |
| 33-60 291-318 |
| PDRRA-- |
| STRPE DAUNORUBICIN RESISTANCE ATP-BINDING PROTEI STREPTOMYCES PEUCETIUS |
| 286-313 |
| PDYRA-- STAAU DIHYDROFOLATE REDUCTASE TYPE I STAPHYLOCOCCUS |
| AUREUS 62-89 |
| PE13B-- BACCI GLUCAN ENDO-1,3-BETA-GLUCOSIDASE A1 PREC BACILLUS |
| CIRCULANS 134-161 305-339 424-451 |
| PEAE-- ECOLI ATTACHING AND EFFACING PROTEIN ESCHERICHIA COLI |
| 66-100 158-185 525-552 691-725 802- 871- |
| 836 905 |
| PEBGR-- ECOLI EBG OPERON REPRESSOR PROTEIN ESCHERICHIA COLI |
| 151-178 |
| PEBR-- STAAU ETHIDIUM BROMIDE RESISTANCE PROTEIN STAPHYLOCOCCUS |
| AUREUS 68-98 |
| PECHH-- RHOCA ENOYL-COA HYDRATASE HOMOLOG RHODOBACTER CAPSULATUS |
| 222-249 |
| PECPD-- ECOLI CHAPERONE PROTEIN ECPD PRECURSOR ESCHERICHIA COLI |
| 20-47 |
| PEDD-- ZYMMO PHOSPHOGLUCONATE DEHYDRATASE ZYMOMONAS MOBILIS 12-39 |
| PEDIN-- STAAU EPIDERMAL CELL DIF INH PRECURSOR STAPHYLOCOCCUS |
| AUREUS 52-79 119-146 |
| PEF2-- DESMO ELONGATION FACTOR 2 DESULFUROCOCCUS MOBILIS 427-461 |
| PEF2-- HALHA ELONGATION FACTOR 2 HALOBACTERIUM HALOBIUM 186-213 |
| PEF2-- METVA ELONGATION FACTOR 2 METHANOCOCCUS VANNIELII 409-436 |
| PEF2-- SULAC ELONGATION FACTOR 2 SULFOLOBUS ACIDOCALDARIUS 36-63 |
| 145-180 |
| PEF2-- THEAC ELONGATION FACTOR 2 THERMOPLASMA ACIDOPHILUM 13-40 |
| 49-76 220-247 |
| PEFG-- ANANI ELONGATION FACTOR G ANACYSTIS NIDULANS 332-359 |
| PEFG-- ECOLI ELONGATION FACTOR G ESCHERICHIA COLI 234-261 |
| PEFG-- MYCLE ELONGATION FACTOR G MYCOBACTERIUM LEPRAE 211-259 |
| 330-357 |
| PEFG-- SALTY ELONGATION FACTOR G SALMONELLA TYPHIMURIUM 234-261 |
| PEFG-- SPIPL ELONGATION FACTOR G SPIRULINA PLATENISI 334-374 |
| 481-511 |
| PEFG-- |
| SYNY3 ELONGATION FACTOR G SYNECHOCYSTIS SP 14-41 PEFT1-- |
| STRRA ELONGATION FACTOR TU1 STREPTOMYCES RAMOCISSIMUS 221-258 |
| PEFT2-- STRRA ELONGATION FACTOR TU2 STREPTOMYCES RAMOCISSIMUS |
| 221-258 |
| PEFT3-- STRRA ELONGATION FACTOR TU3 STREPTOMYCES RAMOCISSIMUS |
| 228-255 |
| PEFTS-- ECOLI ELONGATION FACTOR EF-TS ESCHERICHIA COLI 101-135 |
| PEFTS-- SPICI ELONGATION FACTOR EF-TS SPIROPLASMA CITRI 27-54 |
| 134-161 |
| PEFTU-- BACFR ELONGATION FACTOR TU BACTEROIDES FRAGILIS 18-45 |
| 229-256 |
| PEFTU-- BACSU ELONGATION FACTOR TU BACILLUS SUBTILIS 11-45 |
| 230-257 |
| PEFTU-- BURCE ELONGATION FACTOR TU BURKHOLDERIA CEPACIA 26-53 |
| PEFTU-- |
| CHLTR ELONGATION FACTOR TU CHLAMYDIA TRACHOMATIS218-245 |
| PEFTU-- |
| DEISP ELONGATION FACTOR TU DEINONEMA SP 230-257 PEFTU-- |
| FLESI ELONGATION FACTOR TU FLEXISTIPES SINUSARABICI 221-248 |
| PEFTU-- HALMA ELONGATION FACTOR TU HALOARCULA MARISMORTUI 4-31 |
| PEFTU-- MICLU ELONGATION FACTOR TU MICROCOCCUS LUTEUS 221-248 |
| PEFTU-- MYCHO ELONGATION FACTOR TU MYCOPLASMA HOMINIS 222-249 |
| PEFTU-- MYCLE ELONGATION FACTOR TU MYCOBACTERIUM LEPRAE 220-257 |
| PEFTU-- MYCTU ELONGATION FACTOR TU MYCOBACTERIUM TUBERCULOSIS |
| 220-247 |
| PEFTU-- SHEPU ELONGATION FACTOR TU SHEWANELLA PUTREFACIENS 26-53 |
| PEFTU-- STROR ELONGATION FACTOR TU STREPTOCOCCUS ORALIS 232-259 |
| PELAS-- PSEAE PSEUDOLYSIN PRECURSOR PSEUDOMONAS AERUGINOSA |
| 141-168 |
| PELT1-- ECOLI T-LABILE ENTEROTOXIN A CHAIN PRECURSOR ESCHERICHIA |
| COLI |
| 78-105 |
| PELT3-- ECOLI T-LABILE ENTEROTOXIN A CHAIN PRECURSOR ESCHERICHIA |
| COLI |
| 79-106 |
| PELTB-- CLOPE T-LABILE ENTEROTOXIN B CHAIN PRECURSOR CLOSTRIDIUM |
| PERFRINGENS 228-269 |
| PENTD-- ECOLI ENTEROBACTIN SYNTHETASE COMPONENT D ESCHERICHIA |
| COLI 154-188 |
| PENVM-- |
| SALTY ENVM PROTEIN SALMONELLA TYPHIMURIUM 34-61 PEPIB-- |
| STAEP 117 KD MEMBRANE ASSOCIATED PROTEIN STAPHYLOCOCCUS EPIDERMIDIS |
| 51-80 125-229 290-325 387-421 857- |
| 889 |
| PEPIC-- STAEP EPIDERMIN BIOSYNTHESIS PROTEIN EPIC STAPHYLOCOCCUS |
| EPIDERMIDIS 411-447 |
| PEPIP-- STAEP SERINE PROTEASE EPIP PRECURSOR STAPHYLOCOCCUS |
| EPIDERMIDIS |
| 7-58 297-324 PEPIY- |
| - STAEP HYPOTHETICAL 16.7 KD PROTEIN IN EPIA 5'REGION STAPHYLOCOCCUS |
| EPIDERMIDIS |
| 70-101 PEPIZ- |
| - |
| STAEP HYPOTHETICAL PROTEIN IN EPIA 5'REGION STAPHYLOCOCCUS EPIDERMIDIS |
| 42-100 |
| PERA-- ECOLI GTP-BINDING ERA PROTEIN ESCHERICHIA COLI 18-45 |
| PERBS-- |
| SACER SENSORY TRANSDUCTION PROTEIN ERYC1 SACCHAROPOLYSPORA ERYTHRAEA |
| 209-243 |
| PEREA-- ECOLI ERYTHROMYCIN ESTERASE TYPE I ESCHERICHIA COLI 37-64 |
| 143-170 |
| PERY3-- |
| SACER ERYTHRONOLIDE SYNTHASE, MODULES 5 AND 6 SACCHAROPOLYSPORA |
| ERYTHRAEA |
| 9-36 967-994 1117- |
| 1144 |
| PESTA-- STRSC ESTERASE PRECURSOR STREPTOMYCES SCABIES 128-155 |
| PESTE-- PSEFL ARYLESTERAS PSEUDOMONAS FLUORESCENS 162-189 |
| PETC1-- STAAU ENTEROTOXIN TYPE C-1 PRECURSOR STAPHYLOCOCCUS |
| AUREUS |
| 76-117 115-206 |
| PETC2-- STAAU ENTEROTOXIN TYPE C-2 PRECURSOR STAPHYLOCOCCUS AUREUS |
| 76-117 115-206 |
| PETC3-- STAAU ENTEROTOXIN TYPE C-3 PRECURSOR STAPHYLOCOCCUS |
| AUREUS |
| 76-117 115-206 |
| PETXA-- STAAU ENTEROTOXIN TYPE A PRECURSOR STAPHYLOCOCCUS AUREUS |
| 26-69 165-192 |
| PETXB-- CLOPE EPSILON-TOXIN, TYPE B PRECURSOR CLOSTRIDIUM |
| PERFRINGES 209-236 |
| PETXB-- STAAU ENTEROTOXIN TYPE B PRECURSOR STAPHYLOCOCCUS AUREUS |
| 64-101 173-207 |
| PETXD-- STAAU ENTEROTOXIN TYPE D PRECURSOR STAPHYLOCOCCUS AUREUS |
| 153-200 |
| PETXE-- STAAU ENTEROTOXIN TYPE E PRECURSOR STAPHYLOCOCCUS AUREUS |
| 26-69 |
| 88-115 |
| PEUTC-- SALTY ETHANOLAMINE AMMONIA-LYASE LIGHT CHAIN SALMONELLA |
| TYPHIMURIUM 116-150 |
| PEVGA-- ECOLI PUTATIVE TRANSCRIPTION REG EVGA ESCHERICHIA COLI |
| 62-89 |
| PEVGS-- ECOLI PUTATIVE SENSOR PROTEIN EVGS ESCHERICHIA COLI 45-79 |
| 249-276 431-458 526-553 829- |
| 856 |
| PEX5B-- ECOLI EXODEOXYRIBONUCLEASE V ESCHERICHIA COLI 226-253 |
| PEXBB-- ECOLI BIOPOLYMER TRANSPORT EXBB PROTEIN ESCHERICHIA |
| COLI |
| 80-107 |
| PEXOA-- RHIME SUCCINOGLYCAN BIOSYNTHESIS PROTEIN EXOZ RHIZOBIUM |
| MELILOTI 180-207 |
| PEXOA-- STRPN EXODEOXYRIBONUCLEASE STREPTOCOCCUS PNEUMONIAE |
| 218-254 |
| PEXOF-- RHIME EXOF PROTEIN RHIZOBIUM MELILOTI 236-270 327-361 |
| PEXOH-- |
| RHIME SUCCINOGLYCAN BIOSYNTHESIS PROTEIN EXOH RHIZOBIUM MELILOTI |
| 252-279 |
| PEXOP-- RHIME SUCCINOGLYCAN BIOSYNTHESIS PROTEIN EXOP RHIZOBIUM |
| MELILOTI 211-242 272-299 350-391 |
| PFADB-- ECOLI FATTY OXIDATION COMPLEX ALPHA SUBUNIT ESCHERICHIA |
| COLI 36-63 177-204 |
| PFADL-- ECOLI FATTY ACID TRANSPORT PROTEIN PRECURSOR ESCHERICHIA |
| COLI 220-247 |
| PFAED-- ECOLI OUTER MEMBRANE PROTEIN FAED PRECURSOR ESCHERICHIA |
| COLI 223-257 421-453 507-541 |
| PFAEF-- ECOLI K88 MINOR FIMBRIAL SUBUNIT PRECURSOR ESCHERICHIA |
| COLI 18-48 |
| PFAND-- ECOLI FAND PROTEIN PRECURSOR ESCHERICHIA COLI 160-194 |
| 386-423 596-623 730-757 |
| PFANE-- ECOLI CHAPERONE PROTEIN FANE PRECURSOR ESCHERICHIA COLI |
| 22-58 |
| PFANG-- ECOLI FANG PROTEIN PRECURSOR ESCHERICHIA COLI 104-131 |
| PFANH-- ECOLI FANH PROTEIN PRECURSOR ESCHERICHIA COLI 83-141 |
| PFAB-- PSEFR FATTY OXIDATION COMPLEX ALPHA SUBUNIT PSEUDOMONAS |
| FRAGI |
| 8-42 295-322 |
| PFDHD-- |
| WOLSU FDHD PROTEIN WOLINELLA SUCCINOGENES 64-98 PFDHF- |
| - |
| ECOLI FORMATE DEHYDROGENASE ESCHERICHIA COLI 613-640 |
| PFDH-- PSESR FORMATE DEHYDROGENASE PSEUDOMONAS SP 49-76 366-393 |
| PFDNG-- ECOLI FORMATE DEHYDROGENASE ESCHERICHIA COLI 288-315 |
| 323-350 696-730 |
| PFECA-- ECOLI TRANSPORT PROTEIN FECA PRECURSOR ESCHERICHIA COLI |
| 531-561 |
| PFECC-- ECOLI TRANSPORT PROTEIN 1, CYTOSOLIC ESCHERICHIA COLI |
| 210-237 |
| PFECI-- |
| ECOLI FECI PROTEIN ESCHERICHIA COLI 131-158 PFEMB-- |
| STAAU POSSIBLE PROTEIN FEMB STAPHYLOCOCCUS AUREUS 22-56 |
| PFENR-- SYNP2 FERREDOXIN-NADP REDUCTASE SYNECHOCOCCUS SP 4-31 |
| PFEPC-- ECOLI FERRIC ENTEROBACTIN TRANSPORT PROTEIN FEPC |
| ESCHERICHIA COLI 176-203 |
| PFEPE-- |
| ECOLI FERRIC ENTEROBACTIN TRANSPORT PROTEIN FEPE ESCHERICHIA COLI |
| 182-234 281-308 |
| PFEPG-- |
| ECOLI FERRIC ENTEROBACTIN TRANSPORT PROTEIN FEPG ESCHERICHIA COLI |
| 128-155 |
| PFERH-- ANASP FERREDOXIN, HETEROCYST ANABAENA SP |
| 2-29 PFERX-- ANASP FERREDOXIN-LIKE PROTEIN IN NIF |
| REGION ANABAENA SP 67-94 |
| PFHAB-- BORPE FILAMENTOUS HEMAGGLUTININ BORDETELLA PERTUSSIS |
| 1128- 1359- 2063- 2841- 3051- 3167- |
| 1158 1386 2114 2868 3085 3914 |
| PFHAC-- BORPE HAEMOLYSIN-LIKE PROTEIN FHAC PRECURSOR BORDETELLA |
| PERTUSSIS 342-369 |
| PFHLA-- ECOLI FORMATE HYDROGENLYASE TRANSACTIVATOR ESCHERICHIA |
| COLI 36-63 350-384 401-428 |
| PFHUA-- ECOLI FERRICHROME-IRON RECEPTOR PRECURSOR ESCHERICHIA |
| COLI 458-485 |
| PFHUB-- ECOLI PROTEIN FHUB PRECURSOR ESCHERICHIA COLI 227-254 |
| PFHUE-- ECOLI OUTER-MEMBRANE RECEPTOR ESCHERICHIA COLI 587-614 |
| PFIB-- SPICI FIBRIL PROTEIN SPIROPLASMA CITRI 161-195 326-367 |
| PFIC-- ECOLI CELL FILAMENTATION PROTEIN FIC ESCHERICHIA COLI |
| 151-178 |
| PFIC-- |
| SALTY CELL FILAMENTATION PROTEIN FIC SALMONELLA TYPHIMURIUM 151-178 |
| PFIMC-- BORPE OUTER MEMBRANE PROTEIN FIMC PRECURSOR BORDETELLA |
| PERTUSSIS 208-235 540-567 618-645 |
| PFIMC-- ECOLI CHAPERONE PROTEIN FIMC PRECURSOR ESCHERICHIA COLI |
| 51-78 |
| PFIMD-- ECOLI FIMD PROTEIN PRECURSOR ESCHERICHIA COLI 222-253 |
| 458-485 534-561 563-590 |
| PFIME--ECOLI TYPE 1 FIMBRIAE REGULATORY PROTEIN FIME ESCHERICHIA COLI |
| 165-192 |
| PFIMY-- SALTY FIMBRIAE Y PROTEIN SALMONELLA TYPHIMURIUM 49-76 |
| PFIMZ-- ECOLI FIMBRIAE Z PROTEIN ESCHERICHIA COLI 42-69 |
| 162-192 196-230 |
| PFIMZ-- SALTY FIMBRIAE Z PROTEIN SALMONELLA TYPHIMURIUM 175-209 |
| PFINQ-- |
| ECOLI FINQ PROTEIN ESCHERICHIA COLI 145-172 PFIRA-- |
| RICRI FIRA PROTEIN RICKETTSIA RICKETTSII 162-189 |
| PFIXC-- AZOCA FIXC PROTEIN AZORHIZOBIUM CAULINODANS 129-156 |
| PFIXL-- AZOCA SENSOR PROTEIN FIXL AZORHIZOBIUM CAULINODANS |
| 247-274 |
| PFIXL-- BRAJA SENSOR PROTEIN FIXL BRADYRHIZOBIUM JAPONICUM 27-54 |
| 253-280 |
| PFLA1-- BORBU FLAGELLAR FILAMENT 41 KD CORE PROTEIN BORRELIA |
| BURGDORFERI |
| 8-35 271-298 PFLA1- |
| - HALHA FLAGELLIN A1 PRECURSOR HALOBACTERIUM HALOBIUM 63-92 157-184 |
| PFLA1-- METVO FLAGELLIN B1 PRECURSOR METHANOCOCCUS VOLTAE |
| 28-73 133-160 |
| PFLA2-- METVO FLAGELLIN B2 PRECURSOR METHANOCOCCUS VOLTAE 28-66 |
| PFLA3-- HALHA FLAGELLIN B1 PRECURSOR HALOBACTERIUM HALOBIUM |
| 36-63 |
| PFLA3-- METVO FLAGELLIN B3 PRECURSOR METHANOCOCCUS VOLTAE 35-76 |
| PFLA4-- HALHA FLAGELLIN B2 PRECURSOR HALOBACTERIUM HALOBIUM |
| 36-90 157-184 |
| PFLA5-- HALHA FLAGELLIN B3 PRECURSOR HALOBACTERIUM HALOBIUM 36-63 |
| 154-181 |
| PFLA6-- BACSU FLAA LOCUS 22.9 KD PROTEIN BACILLUS SUBTILIS |
| 73-149 155-186 |
| PFLAA-- CAMCO FLAGELLIN A CAMPYLOBACTER COLI 15-42 144-191 |
| 497-535 |
| PFLAA-- CAMJE FLAGELLIN A CAMPYLOBACTER JEJUNI 220-266 310-337 |
| 500-538 |
| PFLAA-- METVO FLAGELLIN A PRECURSOR METHANOCOCCUS VOLTAE 28-62 |
| PFLAA-- PSEAE FLAGELLIN PSEUDOMONAS AERUGINOSA 3-41 51-88 |
| 97-124 |
| PFLAA-- PHIME FLAGELLIN RHIZOBIUM MELILOTI 181-219 228-265 |
| 360-391 |
| PFLAA-- SPIAU FLAGELLAR FILAMENT PROTEIN PRECURSOR SPIROCHAETA |
| AURANTIA 162-189 |
| PFLAA-- TREHY FLAGELLAR FILAMENT PROTEIN PRECURSOR TREPONEMA |
| HYODYSENTERIAE 55-89 219-285 |
| PFLAA-- TREPA FLAGELLAR FILAMENT OUTER LAYER PROTEIN REPONEMA |
| PALLIDUM243-270 |
| PFLAB-- CAMCO FLAGELLIN B CAMPYLOBACTER COLI144-191 497-535 |
| PFLAB-- CAMJE FLAGELLIN B CAMPYLOBACTER JEJUNI220-266 |
| 310-337 500-538 |
| PFLAB-- RHIME FLAGELLIN RHIZOBIUM MELILOTI 86-113 177-219 |
| 228-255 360-391 |
| PFLAV-- |
| CLOPM FLAVODOXIN CLOSTRIDIUM MP 18-52 PFLAY-- |
| CAUCR REGULATORY PROTEIN FLAY CAULOBACTER CRESCENTUS 291-318 551-578 |
| PFLA-- BACSU FLAGELLIN BACILLUS SUBTILIS 102-129 228-255 |
| PFLGG-- BACSU FLAGELLAR BASAL-BODY ROD PROTEIN FLGG |
| BACILLUS SUBTILIS 62-89 |
| PFLGK-- SALTY FLAGELLAR HOOK-ASSOCIATED PROTEIN 1 SALMONELLA |
| TYPHIMURIUM12-50 333-360 456-540 |
| PFLGL-- ECOLI FLAGELLAR HOOK-ASSOCIATED PROTEIN 3 ESCHERICHIA |
| COLI |
| 61-105 229-266 |
| PFLGL-- SALTY FLAGELLAR HOOK-ASSOCIATED PROTEIN 3 SALMONELLA |
| TYPHIMURIUM |
| 61-105 229-266 PFLHD |
| -- ECOLI FLAGELLAR TRANSCRIPTIONAL ACTIVATOR FLHD ESCHERICHIA COLI |
| 6-33 |
| PFLIA-- PSEAE FLAGELLAR OPERON RNA POL SIGMA FACTOR PSEUDOMONAS |
| AERUGINOSA 198-232 |
| PFLIC-- ECOLI FLAGELLIN ESCHERICHIA COLI 3-41 186-213 295-329 |
| 431-466 |
| PFLIC-- SALCH FLAGELLIN SALMONELLA CHOLERAE-SUIS 5-41 54-125 |
| 136-198 |
| PFLIC-- SALMU FLAGELLIN SALMONELLA MUENCHEN 5-41 54-88 136-177 |
| 232-259 272- 376- |
| 299 403 |
| PFLIC-- SALPA FLAGELLIN SALMONELLA PARATYPHI-A 5-41 54-125 |
| 136-184 |
| PFLIC-- SALRU FLAGELLIN SALMONELLA RUBISLAW 5-41 54-125 136-196 |
| PFLIC-- SALTY FLAGELLIN SALMONELLA TYPHIMURIUM 5-41 54-125 |
| 136-200 |
| PFLIC-- SERMA FLAGELLIN SERRATIA MARCESCENS 15-42 55-89 103-130 |
| 137- 275- |
| 164 321 |
| PFLID-- ECOLI FLAGELLAR HOOK-ASSOCIATED PROTEIN 2 ESCHERICHIA |
| COLI 32-66 106-133 160-187 216-298 386- |
| 445 |
| PFLID-- SALTY FLAGELLAR HOOK-ASSOCIATED PROTEIN 2 SALMONELLA |
| TYPHIMURIUM 32-66 106-133 255-299 407-438 |
| PFLIE-- BACSU FLAG HOOK-BASAL BODY PROTEIN FLIE BACILLUS SUBTILIS |
| 8-35 |
| PFLIF-- BACSU FLAGELLAR M-RING PROTEIN BACILLUS SUBTILIS 327-361 |
| 391-418 |
| PFLIF-- CAUCR FLAGELLAR M-RING PROTEIN CAULOBACTER CRESCENTUS |
| 24-51 297-324 361-388 |
| PFLIF-- SALTY FLAGELLAR M-RING PROTEIN SALMONELLA TYPHIMURIUM |
| 484-529 |
| PFLIG-- BACSU FLAGELLAR SWITCH PROTEIN FLIG BACILLUS SUBTILIS |
| 35-62 |
| PFLIG-- ECOLI FLAGELLAR SWITCH PROTEIN FLIG ESCHERICHIA COLI |
| 44-71 |
| PFLIH-- BACSU PROBABLE FLIH PROTEIN BACILLUS SUBTILIS 19-46 |
| 105-132 |
| PFLIJ-- BACSU FLAGELLAR FLIJ PROTEIN BACILLUS SUBTILIS 7-37 |
| PFLIJ-- SALTY FLAGELLAR FLIJ PROTEIN SALMONELLA TYPHIMURIUM |
| 75-118 |
| PFLIK-- BACSU PROBABLE FLIK PROTEIN BACILLUS SUBTILIS 77-104 |
| 117-144 |
| PFLIL-- BACSU FLIL PROTEIN BACILLUS SUBTILIS 30-71 78-105 |
| 109-136 |
| PFLIL-- |
| ECOLI FLIL PROTEIN ESCHERICHIA COLI 105-132 PFLIL-- |
| SALTY FLIL PROTEIN SALMONELLA TYPHIMURIUM 103-133 |
| PFLIM-- |
| BACSU FLIM PROTEIN BACILLUS SUBTILIS 148-175 PFLIM-- |
| ECOLI FLIM PROTEIN ESCHERICHIA COLI 251-278 |
| PFLIN-- |
| CAUCR FLAGELLAR MOTOR SWITCH PROTEIN CAULOBACTER CRESCENTUS 56-83 |
| PFLIS-- ECOLI FLAGELLAR PROTEIN FLIS ESCHERICHIA COLI 59-86 |
| PFLIT-- SALTY FLAGELLAR PROTEIN FLIT SALMONELLA TYPHIMURIUM 9-46 |
| 67-106 |
| PFM12-- PSEAE FIMBRIAL PROTEIN PRECURSOR PSEUDOMONAS AERUGINOSA |
| 30-67 |
| 80-114 |
| PFM1A-- |
| ECOLI TYPE-1 FIMBRIAL PROTEIN, A CHAIN PRECURSOR ESCHERICHIA COLI 5-32 |
| PFM1C-- |
| ECOLI TYPE-1 FIMBRIAL PROTEIN, C CHAIN PRECURSOR ESCHERICHIA COLI 11-38 |
| PFM1-- ACTIV FIMBRIAL SUBUNIT TYPE 1 PRECURSOR ACTINOMYCES |
| VISCOSUS 248-28 352-379 417-444 |
| PFM98-- ECOLI FIMBRIAL PROTEIN 987P PRECURSOR ESCHERICHIA COLI |
| 114-141 |
| PFMA0-- BACNO FIMBRIAL PROTEIN PRECURSOR BACTEROIDES NODOSUS |
| 110-137 |
| PFMA1-- BACNO FIMBRIAL PROTEIN PRECURSOR BACTEROIDES NODOSUS |
| 107-134 |
| PFMA2-- BACNO FIMBRIAL PROTEIN PRECURSOR BACTEROIDES NODOSUS |
| 107-134 |
| PFMA7-- BACNO FIMBRIAL PROTEIN PRECURSOR BACTEROIDES NODOSUS |
| 110-137 |
| PFMAA-- BACNO FIMBRIAL PROTEIN PRECURSOR BACTEROIDES NODOSUS |
| 123-150 |
| PFMAF-- BACNO FIMBRIAL PROTEIN PRECURSOR BACTEROIDES NODOSUS |
| 107-141 |
| PFMAH-- BACNO FIMBRIAL PROTEIN PRECURSOR BACTEROIDES NODOSUS |
| 95-122 |
| PFMAI-- BACNO FIMBRIAL PROTEIN PRECURSOR BACTEROIDES NODOSUS |
| 111-145 |
| PFMAJ-- BACNO FIMBRIAL PROTEIN PRECURSOR BACTEROIDES NODOSUS |
| 96-123 |
| PFMCD-- PSEAE FIMBRIAL PROTEIN PRECURSOR PSEUDOMONAS AERUGINOSA |
| 70-97 |
| PFMDD-- |
| BACNO POSSIBLE FIMBRIAL ASSEMBLY PRECURSOR FIMD BACTEROIDES NODOSUS |
| 106-144 355-382 |
| PFMDH-- |
| BACNO POSSIBLE FIMBRIAL ASSEMBLY PRECURSOR FIMD BACTEROIDES NODOSUS |
| 106-144 355-382 |
| PFMF3-- ECOLI F17 FIMBRIAL PROTEIN PRECURSOR ESCHERICHIA COLI |
| 97-124 |
| PFMM1-- NEIME FIMBRIAL PROTEIN PRECURSOR NESSERIA MENINGITIDIS |
| 70-97 |
| PFMM2-- NEIGO FIMBRIAL PROTEIN PRECURSOR NESSERIA GONORRHOEAE |
| 66-97 |
| PFMM-- MORNO FIMBRIAL PROTEIN PRECURSOR MORAXELLA NONLIQUEFACIENS |
| 108-146 |
| PFMP1-- PSEAE FIMBRIAL PROTEIN PRECURSOR PSEUDOMONAS AERUGINOSA |
| 30-67 |
| 80-114 |
| PFMP3-- PSEAE FIMBRIAL PROTEIN PRECURSOR PSEUDOMONAS AERUGINOSA |
| 70-97 |
| PFMS1-- ECOLI CS1 FIMBRIAL SUBUNIT A PRECURSOR ESCHERICHIA COLI |
| 60-87 112-139 |
| PFMS3-- ECOLI CS3 FIMBRIAL SUBUNIT A PRECURSOR ESCHERICHIA COLI |
| 49-98 |
| PFM-- |
| HAEIN MAJOR FIMBRIAL SUBUNIT PRECURSOR HAEMOPHILUS INFLUENZAE 102-129 |
| PFNBA-- |
| STAAU FIBRONECTIN-BINDING PROTEIN PRECURSOR STAPHYLOCOCCUS AUREUS 41-83 |
| 188-215 311-365 431-458 517- 652- 722- |
| 555 686 756 |
| PFOLC-- ECOLI FOLYLPOLYGLUTAMATE SYNTHASE ESCHERICHIA COLI |
| 125-159 |
| PFOLC-- LACCA FOLYLPOLYGLUTAMATE SYNTHASE LACTOBACILLUS CASEI |
| 129-156 |
| PFPG-- BACFI FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE BACILLUS FIRMUS |
| 153-180 |
| PFRDA-- ECOLI FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT ESCHERICHIA |
| COLI 395-422 |
| PRFDA-- WOLSU FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT WOLINELLA |
| SUCCINOGENES |
| 8-35 487-514 PFRZE-- |
| MYXXA GLIDING MOTILITY REGULATORY PROTEIN MYXOCOCCUS XANTHUS 15-42 |
| 478-505 |
| PFTHS-- CLOTH FORMATE-TETRAHYDROFOLATE LIGASE CLOSTRIDIUM |
| THERMOACETUM 163-190 |
| PFTR-- METTH FORMYLTRANSFERASE METHANOBACTERIUM |
| 9-43 THERMOAUTOTROPHICU |
| PFTSA-- VACSU CELL DIVISION PROTEIN FTSA BACILLUS SUBTILIS |
| 76-110 |
| PFTSA-- ECOLI CELL DIVISION PROTEIN FTSA ESCHERICHIA COLI 301-338 |
| 375-418 |
| PFTSJ-- ECOLI CELL DIVISION PROTEIN FTSJ ESCHERICHIA COLI 4-31 |
| PFTSL-- ECOLI CELL DIVISION PROTEIN FTSL ESCHERICHIA COLI 63-90 |
| PFTSN-- ECOLI CELL DIVISION PROTEIN FTSN ESCHERICHIA COLI 151-188 |
| PFTSX-- ECOLI CELL DIVISION PROTEIN FTSX ESCHERICHIA COLI 278-305 |
| PFTSY-- ECOLI CELL DIVISION PROTEIN FTSY ESCHERICHIA COLI 230-260 |
| PFUCR-- ECOLI L-FUCOSE OPERON ACTIVATOR ESCHERICHIA COLI 7-45 |
| PFUMA-- BACST FUMARATE HYDRATASE CLASS I, AEROBIC BACILLUS |
| STEAROTHERMOPHILUS 290-317 |
| PFUMH-- BACSU FUMARATE HYDRATASE BACILLUS SUBTILIS 414-445 |
| PFUR-- YERPE FERRIC UPTAKE REGULATION PROTEIN YERSINIA |
| PESTIS |
| 99-130 |
| PG3P1-- ECOLI GLYC 3-PHOS DEHYDROGENASE A ESCHERICHIA COLI 302-329 |
| PG3P2-- ANAVA GLYC 3-PHOS DEHYDROGENASE 2 ANABAENA VARIABLILIS |
| 87-114 |
| PG3P3-- ANAVA GLYC 3-PHOS DEHYDROGENASE 3 ANABAENA VARIABLILIS |
| 162-189 |
| PG3P3-- ECOLI GLYC 3-PHOS DEHYDROGENASE C ESCHERICHIA COLI |
| 236-324 |
| PG3P-- BACME GLYC 3-PHOS DEHYDROGENASE BACILLUS MEGATERIUM 49-76 |
| 237-271 |
| PG3P-- BACSU GLYC 3-PHOS DEHYDROGENASE BACILLUS SUBTILIS 49-76 |
| PG3P-- PYRWO GLYC 3-PHOS DEHYDROGENASE PYROCOCCUS WOESEI |
| 259-286 |
| PG3P-- THEMA GLYC 3-PHOS DEHYDROGENASE THERMOTOGA MARITIMA |
| 290-328 |
| PG6PB-- |
| VACST GLUCOSE-6-PHOSPHATE ISOMERASE B BACILLUS STEAROTHERMOPHILUS |
| 103-143 241-268 |
| PG6PD-- ECOLI GLUCOSE-6-PHOSPHATE 1-DEHYDROGENASE ESCHERICHIA |
| COLI 301-328 |
| PG6PD-- ZYMMO GLUCOSE-6-PHOSPHATE 1-DEHYDROGENASE ZYMOMONAS |
| MOBILIS 165-192 |
| PGACA-- PSEFL CYANIDE CONTROL PROTEIN PSEUDOMONAS FLUORESCENS |
| 178-205 |
| PGAL1-- SALTY GALACTOKINASE SALMONELLA TYPHIMURIUM 86-113 |
| PGAL7-- HAEIN GAL-1-PHOS URIDYLYLTRANSFERASE HAEMOPHILUS |
| INFLUENZAE 124-158 239-269 |
| PGAL7-- LACHE GAL-1-PHOS URIDYLYLTRANSFERASE LACTOBACILLUS |
| HELVETICUS 304-338 |
| PGALF-- SALTY GALACTOSE OPERON REPRESSOR SALMONELLA TYPHIMURIUM |
| 53-91 |
| PGALR-- HAEIN GALACTOSE OPERON REPRESSOR HAEMOPHILUS INFLUENZAE |
| 182-209 |
| PGAL-- |
| PSEFL DE D-GALACTOSE 1-DEHYDROGENASE PSEUDOMONAS FLUORESCENS 251-278 |
| PGCH2-- ECOLI GTP CYCLOHYDROLASE II ESCHERICHIA COLI 78-105 |
| PGCH2-- PHOLE GTP CYCLOHYDROLASE II PHOTOBACTERIUM LEIOGNATHI |
| 197-227 246-273 |
| PGCSH-- ECOLI GLYCINE CLEAVAGE SYSTEM H PROTEIN ESCHERICHIA COLI |
| 10-37 |
| PGCSP-- ECOLI GLYCINE DEHYDROGENASE ESCHERICHIA COLI 216-246 |
| PGCVA-- |
| ECOLI GLYCINE CLEAVAGE SYSTEM TRANSACTIVATOR ESCHERICHIA COLI 60-94 |
| PGENK-- |
| ECOLI PROTEIN K ESCHERICHIA COLI 24-51 PGER1-- |
| BACSU SPORE GERMINATION PROTEIN I BACILLUS SUBTILIS 49-83 182-216 |
| 350-384 |
| PGER3-- BACSU SPORE GERMINATION PROTEIN III PRECURSOR BACILLUS |
| SUBTILIS 293-323 |
| PGERE-- BACSU GERMINATION PROTEIN GERE BACILLUS SUBTILIS 13-40 |
| PGGI2-- |
| STAHA ANTIBACTERIAL PROTEIN 2 STAPHYLOCOCCUS HAEMOLYTICUS 6-33 |
| PGGI3-- STAHA ANTIBACTERIAL PROTEIN 3 STAPHYLOCOCCUS |
| HAEMOLYTICUS |
| 6-33 PGIDA-- |
| BACSU GLUCOSE INHIBITED DIVISION PROTEIN A BACILLUS SUBTILIS 396-423 |
| PGIDA-- ECOLI GLUCOSE INHIBITED DIVISION PROTEIN A ESCHERICHIA |
| COLI 533-568 |
| PGIDA-- PSEPU GLUCOSE INHIBITED DIVISION PROTEIN A PSEUDOMONAS |
| PUTIDA 539-566 |
| PGIDB-- BACSU GLUCOSE INHIBITED DIVISION PROTEIN B BACILLUS |
| SUBTILIS 34-61 |
| PGIDB-- PSEPU GLUCOSE INHIBITED DIVISION PROTEIN B PSEUDOMONAS |
| PUTIDA 25-52 |
| PGLCP-- SYNY3 GLUCOSE TRANSPORT PROTEIN SYNECHOCYSTIS SP 288-322 |
| PGLDA-- VACST GLYCEROL DEHYDROGENASE BACILLUS STEAROTHERMOPHILUS |
| 20-79 |
| PGLGA-- |
| ECOLI GLYCOGEN SYNTHASE ESCHERICHIA COLI 256-283 PGLGC-- |
| ECOLI GLUCOSE-1-PHOSPHATE ADENYLYLTRANSFERASE ESCHERICHIA COLI 114-141 |
| PGLGC-- SALTY GLUCOSE-1-PHOSPHATE ADENYLYLTRANSFERASE SALMONELLA |
| TYPHIMURIUM 114-141 |
| PGLMS-- ECOLI GLUC-FRUC-6-PHOSAMINOTRANSFERASE ESCHERICHIA COLI |
| 209-243 |
| PGLN1-- |
| METTL GLNB-LIKE PROTEIN 1 METHANOCOCCUS 58-85 THERMOLITHO |
| TROPHICUS |
| PGLNA-- ANASP GLUTAMINE SYNTHETASE ANABAENA SP |
| 8-42 PGLNA-- BACSU GLUTAMINE SYNTHETASE BACILLUS |
| SUBTILIS |
| 4-31 |
| PGLNA-- CLOAB GLUTAMINE SYNTHETASE CLOSTRIDIUM ACETOBUTYLICUM |
| 413-440 |
| PGLNA-- ECOLI GLUTAMINE SYNTHETASE ESCHERICHIA COLI 144-171 |
| PGLNA-- METVO GLUTAMINE SYNTHETASE METHANOCOCCUS VOLTAE |
| 203-230 |
| PGLNA-- PROVU GLUTAMINE SYNTHETASE PROTEUS VULGARIS 142-169 |
| PGLNA-- PYRFU GLUTAMINE SYNTHETASE PYROCOCCUS FURIOSUS |
| 391-421 |
| PGLNA-- SALTY GLUTAMINE SYNTHETASE SALMONELLA TYPHIMURIUM 144-171 |
| PGLNA-- STRCO GLUTAMINE SYNTHETASE STREPTOMYCES COELICOLOR |
| 186-213 |
| PGLNB-- AZOBR NITROGEN REGULATORY PROTEIN P-II AZOSPIRILLUM |
| BRASILENSE 15-49 |
| PGLNB-- RHOCA NITROGEN REGULATORY PROTEIN P-II RHODOBACTER |
| CAPSULATUS 15-49 |
| PGLNB-- SYNP6 NITROGEN REGULATORY PROTEIN P-II SYNECHOCOCCUS SP |
| 52-79 |
| PGLND-- ECOLI UDP URIDYLYLTRANSFERASE ESCHERICHIA COLI 1201-147 |
| 151-178 |
| PGLND-- SALTY UDP URIDYLYLTRANSFERASE SALMONELLA TYPHIMURIUM |
| 151-178 |
| PGLNE-- ECOLI ADENYLYLTRANSFERASE ESCHERICHIA COLI 103-130 |
| 433-460 763-790 |
| PGLNH-- ECOLI GLUTAMINE-BINDING PROTEIN PRECURSOR ESCHERICHIA |
| COLI 126-153 |
| PGLNQ-- BACST GLUTAMINE PERMEASE OPERON PROTEIN GLNQ BACILLUS |
| STEAROTHERMOPHILUS |
| 7-34 PGLPD-- |
| BACSU AEROBIC GLYC-3-PHOS DEHYDROGENASE BACILLUS SUBTILIS 194-230 |
| PGLPD-- ECOLI AEROBIC GLYC-3-PHOS DEHYDROGENASE ESCHERICHIA |
| COLI 410-437 |
| PGLPF-- BACSU GLYCEROL UPTAKE FACILITATOR PROTEIN BACILLUS |
| SUBTILIS 235-274 |
| PGLPK-- |
| BACSU GLYCEROL KINASE BACILLUS SUBTILIS 44-93 PGLPK-- |
| ECOLI GLYCEROL KINASE ESCHERICHIA COLI 56-90 |
| PGLPR-- ECOLI GLYCEROL-3-PHOSPHATE REGULON REPRESSOR ESCHERICHIA |
| COLI |
| 5-32 |
| PGLPX-- |
| ECOLI GLPX PROTEIN ESCHERICHIA COLI 297-324 PGLPX- |
| - |
| SHIFL GLPX PROTEIN SHIGELLA FLEXNERI 297-324 |
| PGLRX-- |
| ECOLI GLUTAREDOXIN ESCHERICHIA COLI 24-51 PGLTB- |
| - |
| ECOLI GLUTAMATE SYNTHASE ESCHERICHIA COLI 482-509 |
| PGLTP-- ECOLI PROTON GLUTAMATE SYMPORT PROTEIN ESCHERICHIA COLI |
| 319-346 |
| PGLVB-- ECOLI PHOSPHOTRANSFERASE ENZYME TYPE-IIB ESCHERICHIA COLI |
| 130-157 |
| PGLYA-- BRAJA SERINE HYDROXYMETHYLTRANSFERASE BRADYRHIZOBIUM |
| JAPONICUM 29-60 |
| PGLYA-- CAMJE SERINE HYDROXYMETHYLTRANSFERASE CAMPYLOBACTER |
| JEJUNI 376-403 |
| PGLYA-- HYPME SERINE HYDROXYMETHYLTRANSFERASE HYPHOMICROBIUM |
| METHYLOVORUM 28-55 |
| PGMG7-- BACSU COMG OPERON PROTEIN 7 BACILLUS SUBTILIS 37-67 |
| 88-122 |
| PGNTK-- |
| BACSU GLUCONOKINASE BACILLUS SUBTILIS 238-271 PGP1D-- |
| CHLTR VIRULENCE PROTEIN PGP1-D CHLAMYDIA TRACHOMATIS 312-353 |
| PGP2D-- CHLTR VIRULENCE PROTEIN PGP2-D CHLAMYDIA TRACHOMATIS |
| 97-131 |
| PGP5D-- CHLTR VIRULENCE PROTEIN PGP5-D CHLAMYDIA TRACHOMATIS |
| 25-52 |
| PGP6D-- CHLTR VIRULENCE PROTEIN PGP6-D CHLAMYDIA TRACHOMATIS |
| 63-106 193-220 |
| PGP7D-- CHLTR VIRULENCE PROTEIN PGP7-D CHLAMYDIA TRACHOMATIS |
| 12-60 |
| PGP8D-- CHLTR VIRULENCE PROTEIN PGP8-D CHLAMYDIA TRACHOMATIS |
| 94-121 |
| PGREA-- RICPR TRANSCRIPTION ELONGATION FACTOR GREA RICKETTSIA |
| PROWAZEKII 15-49 |
| PGRPE-- |
| BACSU GRPE-LIKE PROTEIN BACILLUS SUBTILIS 27-73 PGRPE-- |
| BORBU GRPE-LIKE PROTEIN BORRELIA BURGDORFERI |
| 2-79 PGRPE-- |
| CLOAB GRPE-LIKE PROTEIN CLOSTRIDIUM ACETOBUTYLICUM 12-83 |
| PGRSA-- BACBR GRAMICIDIN S SYNTHETASE BACILLUS BREVIS 545-572 |
| 799-826 840-882 1035- |
| 1062 |
| PGRSB-- BACBR GRAMICIDIN S SYNTHETASE II BACILLUS BREVIS 48-75 |
| 94-121 241-282 1126- 1213- 2162- 2559- 2819- 3606- |
| 1153 1240 2189 2586 2846 3633 |
| PGSHI-- ECOLI GLUTAMATE-CYSTEINE LIGASE ESCHERICHIA COLI 239-266 |
| 274-301 |
| PGSHR-- ECOLI GLUTATHIONE REDUCTASE ESCHERICHIA COLI 100-134 |
| 270-311 |
| PGSHR-- PSEAE GLUTATHIONE REDUCTASE PSEUDOMONAS AERUGINOSA |
| 80-114 |
| PGSIA-- BACSU STARVATION-INDUCIBLE PROTEIN A BACILLUS SUBTILIS |
| 74-101 265-296 |
| PGSPD-- ERWCA PROTEIN D PRECURSOR ERWINIA CAROTOVORA 258-285 |
| 516-543 589-619 |
| PGSPD-- ERWCH PROTEIN D PRECURSOR ERWINIA CHRYSANTHEMI 259-302 |
| 307-338 551-578 659-686 |
| PGSPD-- KLEPN PROTEIN D PRECURSOR KLEBSIELLA PNEUMONIAE 259-286 |
| PGSPE-- |
| ERWCA PROTEIN E ERWINIA CAROTOVORA 329-367 PGSPE-- |
| ERWCH PROTEIN E ERWINIA CHRYSANTHEMI 329-367 |
| PGSPE-- |
| LKEPN PROTEIN E KLEBSIELLA PNEUMONIAE 323-361 PGSPE-- |
| PSEAE PROTEIN E PSEUDOMONAS AERUGINOSA 122-149 331-369 |
| PGSPF-- |
| XANCP PROTEIN F XANTHOMONAS CAMPESTRIS 230-257 PGSPH-- |
| PSEAE PROTEIN H PRECURSOR PSEUDOMONAS AERUGINOSA 18-59 |
| PGSPI-- AERHY PROTEIN I PRECURSOR AEROMONAS HYDROPHILA 27-61 |
| PGSPI-- ERWCA PROTEIN I PRECURSOR ERWINIA CAROTOVORA 35-62 |
| PGSPJ-- KLEPN PROTEIN J PRECURSOR KLEBSIELLA PNEUMONIAE 140-167 |
| PGSPK-- |
| ERWCA PROTEIN K ERWINIA CAROTOVORA 28-55 PGSPK-- |
| ERWCH PROTEIN K ERWINIA CHRYSANTHEMI 28-55 |
| PGSPK-- |
| KLEPN PROTEIN K KLEBSIELLA PNEUMONIAE 71-99 PGSPK-- |
| PSEAE PROTEIN K PSEUDOMONAS AERUGINOSA 262-289 |
| PGSPL-- ERWCH PROTEIN L ERWINIA CHRYSANTHEMI 7-42 248-286 |
| 331-358 |
| PGSPL-- XANCP PROTEIN L XANTHOMONAS CAMPESTRIS 39-73 297-324 |
| PGSPM-- |
| ERWCA PROTEIN M ERWINIA CAROTOVORA 108-145 PGSQD-- |
| ERWCH PROTEIN D PRECURSOR ERWINIA CHRYSANTHEMI 259-302 448-475 546-573 |
| 657-684 |
| PGTF1-- STRDO GLUCOSYLTRANSFERASE-I PRECURSOR STREPTOCOCCUS |
| DOWNEI 42-69 177-204 212-239 464-491 1381- 1495- |
| 1416 1529 |
| PGTF2-- STRDO GLUCOSYLTRANSFERASE-I PRECURSOR STREPTOCOCCUS |
| DOWNEI 171-198 206-233 458-485 1382- 1497- |
| 1412 1524 |
| PGTFA-- STRMU GLUCOSYLTRANSFERASE-S STREPTOCOCCUS MUTANS 297-350 |
| PGTFB-- STRMU GLUCOSYLTRANSFERASE-I PRECURSOR STREPTOCOCCUS |
| MUTANS 42-93 110-137 161-188 199-246 313- 592- |
| 347 627 |
| PGTFC-- STRMU GLUCOSYLTRANSFERASE-SI PRECURSOR STREPTOCOCCUS |
| MUTANS |
| 4-40 110-138 235-262 330-361 614- |
| 653 |
| PGTFS-- STRDO GLUCOSYLTRANSFERASE-S PRECURSOR STREPTOCOCCUS |
| DOWNEI 275-316 436-463 1281- |
| 1315 |
| PGTMR-- |
| METTF POSSIBLE G-T MISMATCHES REPAIR ENZYME METHANOBACTERIUM 80-107 |
| 148-175 |
| THERMOFORMICICUM |
| PGUAA-- BACSU GMP SYNTHASE BACILLUS SUBTILIS 314-348 399-436 |
| 478-505 |
| PGUAA-- |
| ECOLI GMP SYNTHASE ESCHERICHIA COLI 105-132 PGUB-- |
| BACCI BETA-GLUCANASE PRECURSOR BACILLUS CIRCULANS 164-191 |
| PGUB-- BACLI BETA-GLUCANASE PRECURSOR BACILLUS LICHENIFORMIS |
| 132-166 |
| PGUB-- BACMA BETA-GLUCANASE PRECURSOR BACILLUS MACERANS 126-160 |
| PGUN1-- |
| BACS4 ENDOGLUCANASE A BACILLUS SP 18-49 PGUN1-- |
| BACSU ENDOGLUCANASE PRECURSOR BACILLUS SUBTILIS 270-304 376-403 |
| PGUN1-- BUTFI ENDOGLUCANASE I BUTYRIVIBRIO FIBRISOLVNES 154-181 |
| 452-495 |
| PGUN2-- BACSU ENDOGLUCANASE PRECURSOR BACILLUS SUBTILIS 270-304 |
| PGUN2-- THEFU ENDOGLUCANASE E-2 PRECURSOR THERMOMONOSPORA FUSCA |
| 201-228 |
| PGUN3-- BACS4 ENDOGLUCANASE C PRECURSOR BACILLUS SP 110-137 |
| 348-378 538-565 |
| PGUN3-- BACSU ENDOGLUCANASE PRECURSOR BACILLUS SUBTILIS 270-304 |
| PGUN3-- FIBSU ENDOGLUCANASE 3 PRECURSOR FIBROBACTER SUCCINOGENES |
| 542-586 |
| PGUN4-- THEFU ENDOGLUCANASE E-4 PRECURSOR THERMOMONOSPORA FUSCA |
| 308-342 |
| PGUN5-- THEFU ENDOGLUCANASE E-5 PRECURSOR THERMOMONOSPORA FUSCA |
| 44-71 |
| PGUNA-- BACLA ENDOGLUCANASE A PRECURSOR BACILLUS LAUTUS 410-437 |
| 454-481 |
| PGUNA-- CLOTM ENDOGLUCANASE A PRECURSOR CLOSTRIDIUM THERMOACETUM |
| 354-384 |
| PGUNA-- PSEFL ENDOGLUCANASE A PRECURSOR PSEUDOMONAS FLUORESCENS |
| 762-789 |
| PGUNA-- |
| RUMAL ENDOGLUCANASE A RUMINOCOCCUS ALBUS 294-321 PGUNA-- |
| RUMFL CELLODEXTRINASE A RUMINOCOCCUS FLAVEFACIENS 276-303 |
| PGUNB-- BACLA ENDOGLUCANASE B PRECURSOR BACILLUS LAUTUS 375-450 |
| PGUNB-- CALSA ENDOGLUCANASE B CALDOCELLUM SACCHAROLYTICUM |
| 151-182 444-478 |
| PGUNB-- CELFI ENDOGLUCANASE B PRECURSOR CELLULOMONAS FIMI 266-293 |
| PGUNB-- CLOCL ENDOGLUCANASE B PRECURSOR CLOSTRIDIUM CELLULOVORANS |
| 144-171 266-300 |
| PGUNB-- CLOTM ENDOGLUCANASE B PRECURSOR CLOSTRIDIUM THERMOCELLUM |
| 514-541 |
| PGUNC-- CELFI ENDOGLUCANASE C PRECURSOR CELLULOMONAS FIMI 881-908 |
| PGUNC-- PSEFL ENDOGLUCANASE C PRECURSOR PSEUDOMONAS FLUORESCENS |
| 52-82 |
| PGUND-- |
| CLOCE ENDOGLUCANASE D PRECURSOR CLOSTRIDIUM CELLULOLYTICUM 382-453 |
| PGUND-- |
| CLOCL ENDOGLUCANASE D PRECURSOR CLOSTRIDIUM CELLULOLYTICUM 145-172 |
| 271-298 |
| PGUNE-- CLOTM ENDOGLUCANASE E PRECURSOR CLOSTRIDIUM THERMOCELLUM |
| 158-185 207-234 284-311 |
| PGUNH-- CLOTM ENDOGLUCANASE H PRECURSOR CLOSTRIDIUM THERMOCELLUM |
| 46-73 425-452 |
| PGUNS-- ERWCA ENDOGLUCANASE PRECURSOR ERWINIA CAROTOVORA 20-47 |
| 115-149 |
| PGUNX-- CLOTM PUTATIVE ENDOGLUCANASE X CLOSTRIDIUM THERMOCELLUM |
| 105-139 |
| PGUNZ-- CLOSR ENDOGLUCANASE Z PRECURSOR CLOSTRIDIUM STERCORARIUM |
| 296-326 522-549 |
| PGUN-- |
| BACPO ENDOGLUCANASE BACILLUS POLYMYXA 198-225 PGUN-- |
| BACS1 ENDOGLUCANASE PRECURSOR BACILLUS SP 321-348 |
| PGUN-- BACS6 ENDOGLUCANASE PRECURSOR BACILLUS SP 198-229 501-528 |
| 623-664 |
| PGUTD-- ECOLI SORBITOL-6-PHOSPHATE 2-DEHYDROGENASE ESCHERICHIA |
| COLI 138-165 |
| PGVP1-- HALHA GAS VESICLE PROTEIN, PLASMID HALOBACTERIUM HALOBIUM |
| 36-63 |
| PGVP2-- HALHA GAS VESICLE PROTEIN, CHROMOSOMAL HALOBACTERIUM |
| HALOBIUM 36-63 |
| PGVPA-- APHFL GAS VESICLE PROTEIN APHANIZOMENON FLOS-AQUAE 4-31 |
| 39-66 |
| PGVPA-- FREDI GAS VESICLE PROTEIN FREMYELLA DIPLOSIPHON 4-31 |
| 39-66 |
| PGVPA-- HALME GAS VESICLE PROTEIN HALOBACTERIUM MEDITERRANEI |
| 37-64 |
| PGVPA-- |
| MICBC GAS VESICLE PROTEIN MICROCYSTIS SP 39-66 PGVPA-- |
| PSEAN GAS VESICLE PROTEIN PSEUDOANABAENA SP |
| 4-31 39-66 PGVPC-- APHFL GAS VESICLE PROTEIN C |
| APHANIZOMENON FLOS-AQUAE |
| 8-49 PGVPC-- HALHA GAS |
| VESICLE PROTEIN C HALOBACTERIUM HALOBIUM 150-249 |
| PGVPC-- HALME GAS VESICLE PROTEIN C HALOBACTERIUM MEDITERRANEI |
| 139-169 |
| PGVPD-- HALHA GVPD PROTEIN, PLASMID HALOBACTERIUM HALOBIUM |
| 110-147 |
| PGVPD-- HALME GVPD PROTEIN HALOBACTERIUM MEDITERRANEI 110-147 |
| PGVPF-- HALHA GVPD PROTEIN, PLASMID HALOBACTERIUM HALOBIUM |
| 13-47 135-169 |
| PGVPF-- HALME GVPF PROTEIN HALOBACTERIUM MEDITERRANEI 13-47 |
| PGVPF-- HALSA GVPF PROTEIN HALOBACTERIUM SALINARIUM 8-49 |
| PGVPG-- HALHA GVPG PROTEIN, PLASMID HALOBACTERIUM HALOBIUM |
| 38-65 |
| PGVPG-- HALME GVPG PROTEIN HALOBACTERIUM MEDITERRANEI 38-72 |
| PGVPH-- HALHA GVPH PROTEIN HALOBACTERIUM HALOBIUM 10-40 |
| PGVPI-- HALME GVPI PROTEIN HALOBACTERIUM MEDITERRANEI 5-32 |
| PGVPK-- |
| HALHA GVPK PROTEIN HALOBACTERIUM HALOBIUM 45-76 PGVPK-- |
| HALME GVPK PROTEIN HALOBACTERIUM MEDITERRANEI 12-39 47-74 |
| PGVPK-- HALHA GVPK PROTEIN HALOBACTERIUM SALINARIUM 11-38 50-77 |
| PGVPL-- HALME GVPL PROTEIN HALOBACTERIUM MEDITERRANEI 44-78 |
| PGVPN-- HALHA GVPN PROTEIN HALOBACTERIUM HALOBIUM 113-140 |
| PGVPN-- HALME GVPN PROTEIN HALOBACTERIUM MEDITERRANEI 15-56 |
| PGYPO-- HALME GVPO PROTEIN HALOBACTERIUM MEDITERRANEI 69-96 |
| 105-132 |
| PGYRA-- BACSU DNA GYRASE SUBUNIT A BACILLUS SUBTILIS 380-407 |
| 429-499 |
| PGYRA-- CAMJE DNA GYRASE SUBUNIT A CAMPYLOBACTER JEJUNI 267-310 |
| 381-408 452-479 665-695 |
| PGYRA-- ECOLI DNA GYRASE SUBUNIT A ESCHERICHIA COLI 266-293 |
| 449-497 |
| PGYRA-- KLEPN DNA GYRASE SUBUNIT A KLEBSIELLA PNEUMONIAE 266-293 |
| 448-496 518-545 |
| PGYRA-- MYCPN DNA GYRASE SUBUNIT A MYCOPLASMA PNEUMONIAE 4-31 |
| PGYRA-- STAAU DNA GYRASE SUBUNIT A STAPHYLOCOCCUS AUREUS |
| 129-156 346-373 430-479 647-674 812- |
| 839 |
| PGYRB-- BACSU DNA GYRASE SUBUNIT B BACILLUS SUBTILIS 198-239 |
| PGYRB-- BORBU DNA GYRASE SUBUNIT B BORRELIA BURGDORFERI |
| 154-181 |
| PGYRB-- ECOLI DNA GYRASE SUBUNIT B ESCHERICHIA COLI 616-643 |
| PGYRB-- HALSQ DNA GYRASE SUBUNIT B HALOFERAX SP 230-257 |
| PGYRB-- MYCPN DNA GYRASE SUBUNIT B MYCOPLASMA PNEUMONIAE |
| 249-283 |
| PGYRB-- NEIGO DNA GYRASE SUBUNIT B NEISSERIA GONORRHOEAE 524-558 |
| 618-645 |
| PGYRB-- PSEPU DNA GYRASE SUBUNIT B PSEUDOMONAS PUTIDA 122-149 |
| 684-711 |
| PGYRB-- SPICI DNA GYRASE SUBUNIT B SPIROPLASMA CITRI 40-74 |
| 189-238 283-310 341-368 540- |
| 579 |
| PGYRB-- STAAU DNA GYRASE SUBUNIT B STAPHYLOCOCCUS AUREUS 252-279 |
| 291-318 |
| PHDHA-- ECOLI 7-ALPHA-HYDROXYSTEROID DEHYDROGENASE ESCHERICHIA |
| COLI 71-98 |
| PHELD-- ECOLI HELICASE IV ESCHERICHIA COLI 100-134 529-556 |
| PHEL-- HAEIN LIPOPROTEIN E PRECURSOR HAEMOPHILUS INFLUENZAE |
| 58-85 |
| PHEM1-- CHLVI GLUTAMYL-TRNA REDUCTASE CHLOROBIUM VIBRIOFORMES |
| 232-259 |
| PHEM1-- ECOLI GLUTAMYL-TRNA REDUCTASE ESCHERICHIA COLI 289-316 |
| PHEM1-- RHOSH 5-AMINOLEVULINIC ACID SYNTHASE RHODOBACTER |
| SPHAEROIDES |
| 73-100 PHEM1- |
| - SALTY GLUTAMYL-TRNA REDUCTASE ( SALMONELLA TYPHIMURIUM 289-316 |
| 344-371 |
| PHEM1-- SYNY3 GLUTAMYL-TRNA REDUCTASE SYNECHOCYSTIS SP 163-190 |
| 350-377 |
| PHEM2-- |
| METSC DELTA-AMINOLEVULINIC ACID DEHYDRATASE METHANOTHERMUS SOCIABILIS |
| 131-158 |
| PHEM4-- BACSU PUTATIVE UROPORPHYRINOGEN-III SYNTHASE BACILLUS |
| SUBTILIS 10-37 |
| PHEM4-- ECOLI UROPORPHYRINOGEN-III SYNTHASE ESCHERICHIA COLI |
| 211-238 |
| PHEMM-- |
| ECOLI HEMM PROTEIN ESCHERICHIA COLI 147-174 PHEMR-- |
| YEREN HEMIN RECEPTOR PRECURSOR YERSINIA ENTEROCOLITICA 234-261 |
| PHEMX-- ECOLI PUTATIVE METHYLTRANSFERASE ESCHERICHIA COLI |
| 69-138 185-219 |
| PHEMY-- |
| BACSU HEMY PROTEIN BACILLUS SUBTILIS 217-262 PHEMZ-- |
| BACSU FERROCHELATASE BACILLUS SUBTILIS 199-226 |
| PHETA-- ANASP HETEROCYST DIFFERENTIATION PROTEIN ANABAENA SP |
| 184-211 357-398 521-565 |
| PHEXA-- STRPN DNA MISMATCH REPAIR PROTEIN HEXA STREPTOCOCCUS |
| PNEUMONIAE 426-460 |
| PHEXB-- STRPN DNA MISMATCH REPAIR PROTEIN HEXB STREPTOCOCCUS |
| PNEUMONIAE 470-497 |
| PHFAB-- CAUCR POS TRANSACTIVATOR PROTEIN HFAB CAULOBACTER |
| CRESCENTUS |
| 98-125 PHFLC |
| -- |
| ECOLI HFLC PROTEIN ESCHERICHIA COLI 113-140 |
| PHFLC-- ECOLI GTP-BINDING PROTEIN HFLX ESCHERICHIA COLI 169-196 |
| PHFLX-- ECOLI HOST FACTOR-I PROTEIN ESCHERICHIA COLI 24-51 |
| PHFQ-- HAEIN PILIATION PROTEIN HIFC PRECURSOR HAEMOPHILUS |
| INFLUENZAE 356-383 404-431 447-474 |
| PHIFC-- LACLA PHOSPHORIBOSYL-AMP CYCLOHYDROLASE LACTOCOCCUS |
| LACTIS 126-174 |
| PHIS2-- ECOLI P-5-A CARBOXAMIDE RIBOTIDE ESCHERICHIA COLI 125-159 |
| PHIS4-- LACLA P-5-A CARBOXAMIDE RIBOTIDE LACTOCOCCUS LACTIS 49-89 |
| 181-228 |
| PHIS4-- METVA P-5-A CARBOXAMIDE RIBOTIDE METHANOCOCCUS VANNIELII |
| 115-142 |
| PHIS4-- SALTY P-5-A CARBOXAMIDE RIBOTIDE SALMONELLA TYPHIMURIUM |
| 125-159 |
| PHIS4-- LACLA AMIDOTRANSFERASE HISH LACTOCOCCUS LACTIS 7-34 |
| PHIS5-- ECOLI HISF PROTEIN ESCHERICHIA COLI 39-66 142-169 |
| PHIS6-- SALTY HISF PROTEIN SALMONELLA TYPHIMURIUM 39-66 |
| 142-169 |
| PHIS7-- ECOLI IMIDAZOLEGLYCEROL-PHOSPHATE DEHYDRATASE ESCHERICHIA |
| COLI 168-199 |
| PHIS7-- SALTY IMIDAZOLEGLYCEROL-PHOSPHATE DEHYDRATASE SALMONELLA |
| TYPHIMURIUM 161-199 |
| PHIS8-- ECOLI HISTIDINOL-PHOSPHATE AMINOTRANSFERASE ESCHERICHIA |
| COLI 290-317 |
| PHIS8-- HALVO HISTIDINOL-PHOSPHATE AMINOTRANSFERASE HALOBACTERIUM |
| VOLCANII 174-201 |
| PHIS8-- LACLA HISTIDINOL-PHOSPHATE AMINOTRANSFERASE LACTOCOCCUS |
| LACTIS 161-188 |
| PHIS8-- SALTY HISTIDINOL-PHOSPHATE AMINOTRANSFERASE SALMONELLA |
| TYPHIMURIUM 293-320 |
| PHISQ-- SALTY HISTIDINE PERMEASE MEMBRANE Q PROTEIN SALMONELLA |
| TYPHIMURIUM |
| 8-35 PHISX- |
| - |
| ECOLI HISTIDINOL DEHYDROGENASE ESCHERICHIA COLI 393-434 |
| PHISX-- LACLA HISTIDINOL DEHYDROGENASE LACTOCOCCUS LACTIS 19-46 |
| 264-303 |
| PHISX-- MYCSM HISTIDINOL DEHYDROGENASE MYCOBACTERIUM SMEGMATIS |
| 288-329 399-430 |
| PHISX-- SALTY HISTIDINOL DEHYDROGENASE SALMONELLA TYPHIMURIUM |
| 393-434 |
| PHLA-- STAAU ALPHA-HEMOLYSIN PRECURSOR STAPHYLOCOCCUS AUREUS |
| 69-103 |
| PHLY1-- ECOLI HEMOLYSIN A, CHROMOSOMAL ESCHERICHIA COLI 5-32 |
| 76-103 161-224 234-261 353- 458- 554- 642- |
| 380 492 581 728 |
| PHLY2-- |
| ECOLI HAEMOLYSIN SECRETION PROTEIN, CHROMOSOMA ESCHERICHIA COLI 487-514 |
| PHLY4-- ECOLI HEMOLYSIN D, CHROMOSOMAL ESCHERICHIA COLI 103-133 |
| 178-215 223-331 |
| PHLYA-- ACTPL HEMOLYSIN ACTINOBACILLUS PLEUROPNEUMONIAE 5-39 |
| 136-170 184-218 273-300 350- 459- 846- |
| 377 527 924 |
| PHLYA-- ACTSU HEMOLYSIN ACTINOBACILLUS SUIS 5-39 136-170 184-218 |
| 273-300 350- 459- 846- |
| 377 500 924 |
| PHLYA-- ECOLI HEMOLYSIN A, PLASMID ESCHERICHIA COLI 5-32 76-103 |
| 161-262 354-381 452- 555- 643- |
| 493 582 729 |
| PHLYA-- PROMI HEMOLYSIN PRECURSOR PROTEUS MIRABILIS 165-196 |
| 299-338 356-400 425-471 498- 528- 610- 705- 747- |
| 525 576 695 742 774 |
| 789-823 841-868 966-993 1113- 1166- 1225- 1301- 1391- 1483- |
| 1140 1193 1273 1342 1461 1527 |
| PHLYA-- SERMA HEMOLYSIN PRECURSOR SERRATIA MARCESCENS 311-345 |
| 477-504 558-585 625-703 718- 830- 1081- 1155- 1249- |
| 745 864 1108 1202 1286 |
| 1516- |
| 1553 |
| PHLYA-- VIBCH HEMOLYSIN PRECURSOR VIBRIO CHOLERAE 335-369 638-665 |
| PHLYB-- ACTPL HAEMOLYSIN SECRETION PROTEIN ACTINOBACILLUS |
| PLEUROPNEUMONIAE 34-61 |
| PHLYB-- ECOLI HAEMOLYSIN SECRETION PROTEIN, PLASMID ESCHERICHIA |
| COLI 487-514 |
| PHLYB-- PROMI HAEMOLYSIN ACTIVATOR PROTEIN PRECURSOR PROTEUS |
| MIRABILIS 16-64 499-547 |
| PHLYB-- PROVU HAEMOLYSIN SECRETION PROTEIN PROTEUS VULGARIS 34-68 |
| 487-514 |
| PHLYB-- SERMA HAEMOLYSIN ACTIVATOR PROTEIN PRECURSOR SERRATIA |
| MARCESCENS 110-137 |
| PHLYB-- VIBCH HAEMOLYSIN SECRETION PROTEIN PRECURSOR VIBRIO |
| CHOLERAE 335-398 413-447 458-524 |
| PHLYC-- ACTPL HAEMOLYSIN C ACTINOBACILLUS PLEUROPNEUMONIAE |
| 130-157 |
| PHLYD-- ACTPL HAEMOLYSIN ACTIVATOR PROTEIN APPD ACTINOBACILLUS |
| PLEUROPNEUMONIAE 191-331 |
| PHLYD-- ECOLI HAEMOLYSIN D, PLASMID ESCHERICHIA COLI 103-133 |
| 178-215 223-331 |
| PHLY-- HALI7 HALOLYSIN PRECURSOR HALOPHILIC BACTERIA STRAIN 172P1 |
| 484-516 |
| PHMC3-- DESVH 43.2 KD PROTEIN IN HMC OPERON DESULFOVIBRIO |
| VULGARIS 156-186 |
| PHMD-- METKA H(2)-FORMING DEHYDROGENASE METHANOPYRUS KANDLERI |
| 36-63 |
| PHNS-- SERMA DNA-BINDING PROTEIN H-NS SERRATIA MARCESCENS 35-62 |
| PHOLA-- ECOLI DNA POLYMERASE III, DELTA SUBUNIT ESCHERICHIA COLI |
| 94-121 288-322 |
| PHOXA-- BRAJA REG PROTEIN HOXA BRADYRHIZOBIUM JAPONICUM 113-163 |
| 444-471 |
| PHOXF-- NOCOP HOXS ALPHA SUBUNIT NOCARDIA OPACA |
| 4-31 PHOXQ-- ALCEU HOXQ PROTEIN ALCALIGENES EUTROPHUS |
| 76-110 |
| PHOXX-- BRAJA HOXX PROTEIN BRADYRHIZOBIUM JAPONICUM 356-383 |
| PHPI-- DEIRA HEXAGONALLY SURFACE PROTEIN PRECURSOR DEINOCOCCUS |
| RADIODURANS 585-612 |
| PHPRT-- LACLA PHOSPHORIBOSYLTRANSFERASE LACTOCOCCUS LACTIS 3-39 |
| 71-105 |
| PHRDD-- STRCO SIGMA FACTOR HRDD STREPTOMYCES COELICOLOR 296-323 |
| PHRPB-- BURSO REGULATORY PROTEIN HRPB BURKHOLDERIA SOLANACEARIUM |
| 371-405 |
| PHRPH-- PSESY OUTER MEMBRANE PROTEIN HRPH PRECURSOR PSEUDOMONAS |
| SYRINGAE 102-129 310-344 |
| PHRPS-- PSESH PROBABLE REGULATORY PROTEIN HRPS PSEUDOMONAS |
| SYRINGAE 24-51 |
| PHS18-- CLOAB 18 KD HEAT SHOCK PROTEIN CLOSTRIDIUM ACETOBUTYLICUM |
| 67-108 |
| PHS70-- HALMA HEAT SHOCK 70 KD PROTEIN HALOARCULA MARISMORTUI |
| 522-576 |
| PHS70-- MYCLE HEAT SHOCK 70 KD PROTEIN MYCOBACTERIUM LEPRAE |
| 461-488 503-530 |
| PHS70-- |
| MYCPA HEAT SHOCK 70 KD PROTEIN MYCOBACTERIUM PARATUBERCULOSIS 460-487 |
| PHTPG-- ECOLI HEAT SHOCK PROTEIN C62.5 ESCHERICHIA COLI 221-248 |
| 482-509 |
| PHTRA-- ECOLI PROTEASE DO PRECURSOR ESCHERICHIA COLI 373-400 |
| PHTRE-- ECOLI HTRE PROTEIN PRECURSOR ESCHERICHIA COLI 454-484 |
| 524-576 |
| PHTRI-- HALHA SENSORY RHODOPSIN I TRANSDUCER HALOBACTERIUM |
| HALOBIUM 413-471 479-506 |
| PHTRI-- HALSA SENSORY RHODOPSIN I TRANSDUCER HALOBACTERIUM |
| SALINARIUM 119-149 413-471 479-506 |
| PHUTP-- BACSU HUT OPERON POSITIVE REGULATORY PROTEIN BACILLUS |
| SUBTILIS |
| 5-36 |
| PHVTJ-- LACHE HELVETICIN J LACTOBACILLUS HELVETICUS 174-212 306-333 |
| PHYCA-- ECOLI FORMATE HYDROGENLYASE SUBUNIT 1 ESCHERICHIA COLI |
| 73-100 106-133 |
| PHYDG-- ECOLI TRANSCRIPTIONAL REGULATORY PROTEIN HYDG ESCHERICHIA |
| COLI 251-278 |
| PHYDG-- SALTY TRANSCRIPTIONAL REGULATORY PROTEIN HYDG SALMONELLA |
| TYPHIMURIUM 251-278 |
| PHYDH-- ECOLI SENSOR PROTEIN HYDH ESCHERICHIA COLI 312-339 |
| 360-387 |
| PHYUB-- PSESN HYDANTOIN UTILIZATION PROTEIN B PSEUDOMONAS SP |
| 554-581 |
| PHYUC-- PSESN HYDANTOIN UTILIZATION PROTEIN PSEUDOMONAS SP 6-40 |
| 96-123 |
| PIAAL-- PSESS INDOLEACETATE-LYSINE LIGASE PSEUDOMONAS SYRINGAE |
| 133-160 297-331 |
| PIAP-- ECOLI ALK PHOS ISOZYME CONVERSION PROTEIN ESCHERICHIA COLI |
| 74-101 |
| PICEN-- ERWAN ICE NUCLEATION PROTEIN ERWINIA ANANAS 326-353 422-449 |
| 534-561 614-641 662- 721- 758- 854- 950- |
| 689 748 785 881 977 |
| 1046- |
| 1073 |
| PICEN-- ERWHE ICE NUCLEATION PROTEIN ERWINIA HERBICOLA 310-337 |
| 406-433 534-561 646-673 694- 838- 886- 982- |
| 721 865 913 1009 |
| PICEN-- PSEFL ICE NUCLEATION PROTEIN PSEUDOMONAS FLUORESCENS |
| 281-308 377-404 425-452 681-708 729- 795- |
| 781 852 |
| PICEN-- PSESY ICE NUCLEATION PROTEIN PSEUDOMONAS SYRINGAE 564-602 |
| 772-847 868-895 909-943 |
| PICEN-- XANCT ICE NUCLEATION PROTEIN XANTHOMONAS CAMPESTRIS |
| 496-534 555-582 1168- 1248- |
| 1204 1275 |
| PICSB-- SHIFL INTERCELLULAR SPREAD PROTEIN SHIGELLA FLEXNERI |
| 41-105 438-467 |
| PIF2-- BACST INITIATION FACTOR IF-2 BACILLUS STEAROTHERMOPHILUS |
| 540-567 681-708 |
| PIF2-- BACSU INITIATION FACTOR IF-2 BACILLUS SUBTILIS 173-208 |
| 394-421 |
| PIF2-- ECOLI INITIATION FACTOR IF-2 ESCHERICHIA COLI 686-724 |
| 835-862 |
| PIF2-- ENTFC INITIATION FACTOR IF-2 ENTEROCOCCUS FAECIUM 579-627 |
| PIF3-- BACST INITIATION FACTOR IF-3 BACILLUS STEAROTHERMOPHILUS |
| 7-34 |
| PIF3-- ECOLI INITIATION FACTOR IF-3 ESCHERICHIA COLI 27-54 70-97 |
| PIF3-- KLEPN INITIATION FACTOR IF-3 KLEBSIELLA PNEUMONIAE 27-54 |
| 70-97 |
| PIF3-- MYCFE INITIATION FACTOR IF-3 MYCOPLASMA FERMENTANS 177-211 |
| PIF3-- PROVU INITIATION FACTOR IF-3 PROTEUS VULGARIS 2-29 70-97 |
| PIF3-- SALTY INITIATION FACTOR IF-3 SALMONELLA TYPHIMURIUM 27-54 |
| 70-97 |
| PIF3-- SERMA INITIATION FACTOR IF-3 SERRATIA MARCESCENS 19-46 |
| 70-97 |
| PIGA-- |
| NEIGO IGA-SPECIFIC SERINE ENDOPEPTIDASE NEISSERIA GONORRHOEAE 245-272 |
| 287-314 833-860 1024- 1377- 1483- |
| 1058 1404 1531 |
| PIGGB-- STRSP IGG BINDING PROTEIN PRECURSOR STREPTOCOCCUS SP |
| 46-76 120-150 195-222 |
| PIGGG-- STRSP IGG BINDING PROTEIN PRECURSOR STREPTOCOCCUS SP |
| 46-76 120-150 195-225 270-297 |
| PILVH-- ECOLI ACETOLACTATE SYNTHASE ESCHERICHIA COLI 47-81 |
| 120-147 |
| PILVH-- SALTY ACETOLACTATE SYNTHASE SALMONELLA TYPHIMURIUM 47-81 |
| 120-147 |
| PILVN-- LACLA ACETOLACTATE SYNTHASE LACTOCOCCUS LACTIS 20-75 |
| PIMPB-- SALTY IMPB PROTEIN SALMONELLA TYPHIMURIUM 185-212 |
| PIMP-- |
| ACICA INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE ACINETOBACTER CALCOACETICUS |
| 166-193 |
| PIMP-- BACSU E-5'-MONOPHOSPHATE DEHYDROGENASE BACILLUS SUBTILIS |
| 159-186 |
| PINA-- BACTL IMMUNE INHIBITOR A PRECURSOR BACILLUS THURINGIENSIS |
| 103-130 324-358 |
| PINLA-- LISMO INTERNALIN A LISTERIA MONCYTOGENES 106-143 161-188 |
| 196-232 |
| PINLB-- LISMO INTERNALIN B PRECURSOR LISTERIA MONCYTOGENES 53-94 |
| 166-200 385-415 |
| PINVA-- |
| YEREN INVASIN YERSINIA ENTEROCOLITICA 501-535 PIPA7-- |
| SHIFL 60 KD ANTIGEN SHIGELLA FLEXNERI 285-312 |
| PIPAA-- SHIFL 70 KD ANTIGEN SHIGELLA FLEXNERI 95-136 437-475 |
| 493-557 596-630 |
| PIPAB-- SHIDY 62 KD MEMBRANE ANTIGEN SHIGELLA DYSENTERIAE 28-55 |
| 71-169 480-507 522-556 |
| PIPAB-- SHIFL 62 KD MEMBRANE ANTIGEN SHIGELLA FLEXNERI 28-55 |
| 71-169 480-507 522-556 |
| PIPAC-- |
| SHIDY 42 KD MEMBRANE ANTIGEN PRECURSOR SHIGELLA DYSENTERIAE 21-57 |
| 113-161 273-300 324-378 |
| PIPAC-- SHIFL 42 KD MEMBRANE ANTIGEN PRECURSOR SHIGELLA FLEXNERI |
| 28-57 113-161 273-300 324-372 |
| PIPAD-- SHIDY 37 KD MEMBRANE ANTIGEN IPAD SHIGELLA DYSENTERIAE |
| 47-86 291-318 |
| PIPAD-- SHIFL 36 KD MEMBRANE ANTIGEN SHIGELLA FLEXNERI 47-86 |
| 259-286 291-318 |
| PIPGB-- |
| SHIDY IPGB PROTEIN SHIGELLA DYSENTERIAE 175-202 PIPGB-- |
| SHIFL IPGB PROTEIN SHIGELLA FLEXNERI 175-202 |
| PIPT-- PSESS ISOPENTENYL TRANSFERASE PSEUDOMONAS SYRINGAE 53-87 |
| 143-173 |
| PIPYR-- ECOLI INORGANIC PYROPHOSPHATASE ESCHERICHIA COLI 138-172 |
| PIRGA-- VIBCH VIRULENCE PROTEIN PRECURSOR VIBRIO CHOLERAE 212-239 |
| 336-377 |
| PIRGB-- VIBCH VIRULENCE REGULATORY PROTEIN IRGB VIBRIO CHOLERAE |
| 67-97 |
| PIRPA-- SYNP7 IRON-REGULATED PROTEIN A SYNECHOCOCCUS SP 167-194 |
| PISBD-- SHIDY INSERTION ELEMENT ISO-ISID PROTEIN INSB SHIGELLA |
| DYSENTERIAE |
| 86-113 PISBN- |
| - SHIDY INSERTION ELEMENT ISO-ISID PROTEIN INSB SHIGELLA DYSENTERIAE |
| 6-37 |
| PISB-- ECOLI INSERTION ELEMENT IS1 PROTEIN INSB ESCHERICHIA COLI |
| 122-149 |
| PISB-- SHIFL INSERTION ELEMENT IS1 PROTEIN INSB SHIGELLA FLEXNERI |
| 86-113 |
| PISB-- SHISO INSERTION ELEMENT IS1 PROTEIN INSB SHIGELLA SONNEI |
| 86-113 |
| PISP1-- BACSU MAJOR INTRACELLULAR SERINE PROTEASE BACILLUS |
| SUBTILIS 115-142 197-224 253-280 |
| PSIP-- BACPO INTRACELLULAR SERINE PROTEASE BACILLUS POLYMYXA |
| 109-143 |
| PISTA-- |
| ECOLI ISTA PROTEIN ESCHERICHIA COLI 183-210 PISTA-- |
| SHISO ISTA PROTEIN SHIGELLA SONNEI 183-210 |
| PIUTA-- ECOLI FERRIC AEROBACTIN RECEPTOR PRECURSOR ESCHERICHIA |
| COLI 186-213 525-552 559-593 |
| PJAG-- |
| BACSU JAG PROTEIN BACILLUS SUBTILIS 68-95 PK6P2-- |
| ECOLI 6-PHOSPHOFRUCTOKINASE ISOZYME 2 ESCHERICHIA COLI 143-170 |
| PKAD-- BACSU ADENYLATE KINASE BACILLUS SUBTILIS 188-215 |
| PKAD-- LACLA ADENYLATE KINASE LACTOCOCCUS LACTIS 186-213 |
| PKANU-- BACSP KANAMYCIN NUCLEOTIDYLTRANSFERASE BACILLUS SP |
| 69-96 |
| PKANU-- STAAU KANAMYCIN NUCLEOTIDYLTRANSFERASE STAPHYLOCOCCUS |
| AUREUS 69-96 |
| PKDGT-- ECOLI 2-KETO-3-DEOXYGLUCONATE PERMEASE ESCHERICHIA COLI |
| 70-97 |
| PKDGT-- |
| ERWCH 2-KETO-3-DEOXYGLUCONATE PERMEASE ERWINIA CHRYSANTHEMI 126-153 |
| PKDTA-- |
| ECOLI 3-DEOXY-D-MANNO-OCTULOSONIC-ACID TRANS ESCHERICHIA COLI 369-396 |
| PKGTP-- ECOLI ALPHA-KETOGLUTARATE PERMEASE ESCHERICHIA COLI |
| 7-34 |
| PKGUA-- |
| ECOLI GUANYLATE KINASE ESCHERICHIA COLI 162-189 PKHSE-- |
| BACSU HOMOSERINE KINASE BACILLUS SUBTILIS 49-76 |
| PKHSE-- FREDI HOMOSERINE KINASE FREMYELLA DIPLOSIPHON 52-79 |
| PKKA4-- BACCI AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERSE BACILLUS |
| CIRCULANS 12-39 |
| PKORB-- ECOLI KORB TRANSCRIPTIONAL REPRESSOR PROTEIN ESCHERICHIA |
| COLI 228-255 |
| PKPY1-- |
| SPICI PYRUVATE KINASE SPIROPLASMA CITRI 112-148 PKPYK-- |
| BACST PYRUVATE KINASE BACILLUS STEAROTHERMOPHILUS 331-374 |
| PLACA-- STAAU ISOMERASE LACA SUBUNIT STAPHYLOCOCCUS AUREUS 9-64 |
| PLACA-- STRMU ISOMERASE LACA SUBUNIT STREPTOCOCCUS MUTANS 26-60 |
| PLACC-- STRMU TAGATOSE-6-PHOSPHATE KINASE STREPTOCOCCUS MUTANS |
| 56-83 283-310 |
| PLACG-- LACCA 6-PHOSPHO-BETA-GALACTOSIDASE LACTOBACILLUS CASEI |
| 290-317 |
| PLACI-- ECOLI LACTOSE OPERON REPRESSOR ESCHERICHIA COLI 9-36 |
| PLACI-- KLEPN LACTOSE OPERON REPRESSOR KLEBSIELLA PNEUMONIAE |
| 195-229 |
| PLACR-- STAAU PHOSPHOTRANSFERASE REPRESSOR STAPHYLOCOCCUS AUREUS |
| 2-29 |
| PLACR-- STRMU PHOSPHOTRANSFERASE REPRESSOR STREPTOCOCCUS MUTANS |
| 2-32 |
| PLACY-- LACDE LACTOSE PERMEASE LACTOBACILLUS DELBRUECKII 196-230 |
| PLAFB-- |
| VIBPA FLAGELLAR HOOK-ASSOCIATED PROTEIN 2 VIBRIO PARAHAEMOLYTICUS 62-89 |
| 388-415 |
| PLAMB-- KLEPN MALTOPORIN PRECURSOR KLEBSIELLA PNEUMONIAE 337-364 |
| PLAMI-- CLOTM ENDO-1,3(4)-BETA-GLUCANASE PRECURSOR CLOSTRIDIUM |
| THERMOCELLUM 132-159 |
| PLASI-- PSEAE OHHL SYNTHESIS PROTEIN LASI PSEUDOMONAS AERUGINOSA |
| 171-198 |
| PLCCI-- LEUGE PROBABLE LEUCOCIN A IMMUNITY PROTEIN LEUCONOSTOC |
| GELIDUM 41-71 |
| PLCNC-- LACLA LACTOCOCCIN A SECRETION PROTEIN LCNC LACTOCOCCUS |
| LACTIS 162-189 207-234 388-433 |
| PLCND-- LACLA LACTOCOCCIN A SECRETION PROTEIN LCND LACTOCOCCUS |
| LACTIS |
| 99-126 140-202 237-307 |
| PLCRD-- YEREN LOW CALCIUM RESPONSE LOCUS PROTEIN D YERSINIA |
| ENTEROCOLITICA 122-149 491-518 |
| PLCRD-- YERPE LOW CALCIUM RESPONSE LOCUS PROTEIN D YERSINIA |
| PESTIS 122-149 491-518 |
| PLCRV-- YERPE VIRULENCE-ASSOCIATED V ANTIGEN YERSINIA PESTIS |
| 22-49 157-184 240-267 |
| PLCRV-- |
| YERPS VIRULENCE-ASSOCIATED V ANTIGEN YERSINIA PSEUDOTUBERCULOSIS 22-49 |
| 240-267 |
| PLCTB-- |
| BACCA LCTB PROTEIN BACILLUS CALDOTENAX 18-45 PLCTB-- |
| BACST LCTB PROTEIN BACILLUS STEAROTHERMOPHILUS 14-45 |
| PLDHD-- LACPL D-LACTATE DEHYDROGENASE LACTOBACILLUS PLANTARUM |
| 51-81 |
| PHLHP-- |
| BACPS D-LACTATE DEHYDROGENASE P BACILLUS PSYCHROSACCHAROLYTICUS 2-43 |
| 241-272 279-306 |
| PLDHX-- |
| BACPS D-LACTATE DEHYDROGENASE X BACILLUS PSYCHROSACCHAROLYTICUS 2-43 |
| 241-275 279-306 |
| PLDH-- BACME D-LACTATE DEHYDROGENASE BACILLUS MEGATERIUM 244-274 |
| PLDH-- BACST D-LACTATE DEHYDROGENASE BACILLUS STEAROTHERMOPHILUS |
| 241-268 279-313 |
| PLDH-- BACSU D-LACTATE DEHYDROGENASE BACILLUS SUBTILIS 8-42 |
| 240-267 |
| PLDH-- BIFLO D-LACTATE DEHYDROGENASE BIFIDOBACTERIUM LONGUM 22-49 |
| PLDH-- LACPL D-LACTATE DEHYDROGENASE LACTOBACILLUS PLANTARUM |
| 197-231 |
| PLDH-- LISMO D-LACTATE DEHYDROGENASE LISTERIA MONOCYTOGENES 42-69 |
| PLDH-- MYCHY D-LACTATE DEHYDROGENASE MYCOPLASMA HYOPNEUMONIAE |
| 276-310 |
| PLDH-- THEAQ D-LACTATE DEHYDROGENASE THERMUS AQUATICUS 3-30 |
| PLEF-- BACAN LETHAL FACTOR PRECURSOR BACILLUS ANTHRACIS |
| 165-192 304-331 480-514 548-578 619- 737- |
| 658 764 |
| PLEPA-- |
| PSEFL LEPA PROTEIN PSEUDOMONAS FLUORESCENS 23-50 PLEP-- |
| BACSU SIGNAL PEPTIDASE I BACILLUS SUBTILIS |
| 3-30 PLEU1-- ECOLI 2-ISOPROPYLMALATE |
| SYNTHASE ESCHERICHIA COLI 437-464 |
| PLEU1-- LACLA 2-ISOPROPYLMALATE SYNTHASE LACTOCOCCUS LACTIS 22-49 |
| 379-484 |
| PLEU3-- BACCO 3-ISOPROPYLMALATE DEHYDROGENASE BACILLUS COAGULANS |
| 331-358 |
| PLEU3-- CLOPA 3-ISOPROPYLMALATE DEHYDROGENASE CLOSTRIDIUM |
| PASTEURIANUM 185-212 |
| PLEUD-- LACLA 3-ISOPROPYLMALATE DEHYDRATASE LACTOCOCCUS LACTIS |
| 163-190 |
| PLEVR-- BACSU TRANSCRIPTIONAL REGULATORY PROTEIN LEVR BACILLUS |
| SUBTILIS 297-324 676-703 744-774 785-822 |
| PLEXA-- |
| ERWCA LEXA REPRESSOR ERWINIA CAROTOVORA 146-173 PLIP1-- |
| MORSP LIPASE 1 MORAXELLA SP 26-53 |
| PLIP2-- |
| MORSP LIPASE 2 MORAXELLA SP 356-383 PLIPB-- |
| ECOLI LIPB PROTEIN ESCHERICHIA COLI 66-93 |
| PLIP-- BURCE LIPASE PRECURSOR BURKHOLDERIA CEPACIA 176-203 |
| PLIP-- PSEFL LIPASE PRECURSOR PSEUDOMONAS FLUORESCENS 8-35 |
| PLIP-- |
| PSES5 LIPASE PRECURSOR PSEUDOMONAS SP 176-203 PLIP-- |
| STAAU LIPASE PRECURSOR STAPHYLOCOCCUS AUREUS |
| 80-146 512-546 PLIVB-- SALTY LEU/ILE/VAL/THR-BINDING |
| PROTEIN PRECURSOR SALMONELLA TYPHIMURIUM 193-220 |
| PLIVC-- |
| SALTY LEUCINE-SPECIFIC BINDING PROTEIN PRECURSOR SALMONELLA TYPHIMURIUM |
| 195-222 |
| PLIVE-- SALTY AMINO ACID TRANSPORT PROTEIN LIVE SALMONELLA |
| TYPHIMURIUM 121-148 |
| PLIVF-- ECOLI AMINO ACID TRANSPORT PROTEIN LIVF ESCHERICHIA COLI |
| 23-50 |
| PLIVJ-- CITFR LEU/ILE/VAL-BINDING PROTEIN PRECURSOR CITROBACTER |
| FREUDII 195-222 |
| PLIVJ-- ECOLI LEU/ILE/VAL-BINDING PROTEIN PRECURSOR ESCHERICHIA |
| COLI 195-222 |
| PLIVK-- |
| ECOLI LEUCINE-SPECIFIC BINDING PROTEIN PRECURSOR ESCHERICHIA COLI |
| 195-222 |
| PLIVM-- ECOLI AMINO ACID TRANSPORT PROTEIN LIVM ESCHERICHIA COLI |
| 121-148 |
| PLKTA-- ACTAC LEUKOTOXIN ACTINOBACILLUS 113-147 173-213 398-443 |
| 451- 593- 655- |
| ACTINOMYCETEMCOMITANS 488 620 711 |
| PLKTA-- PASHA LEUKOTOXIN PASTEURELLA HAEMOLYTICA 53-99 179-216 |
| 345-372 409-436 455- 496- 545- 811- 853- |
| 482 530 572 838 926 |
| PLKTB-- ACTAC LEUKOTOXIN SECRETION PROTEIN ACTINOBACILLUS 487-514 |
| ACTINOMYCETEMCOMITANS |
| PLKTB-- |
| PASHA LEUKOTOXIN SECRETION PROTEIN PASTEURELLA HAEMOLYTICA 42-69 |
| 78-105 488-515 |
| PLKTC-- |
| ACTAC LTC PROTEIN ACTINOBACILLUS 58-85 116-150 ACTINOMYCET |
| EMCOMITANS |
| PLKTC-- PASHA LKTC PROTEIN PASTEURELLA HAEMOLYTICA 123-157 |
| PLKTD-- ACTAC LKTD PROTEIN ACTINOBACILLUS 116-164 205-242 |
| 278-305 364-391 |
| ACTINOMYCETEMCOMITANS |
| PLKTD-- PASHA LKTD PROTEIN PASTEURELLA HAEMOLYTICA 184-289 |
| PLON-- ECOLI ATP-DEPENDENT PROTEASE LA ESCHERICHIA COLI |
| 121-148 |
| PLPXA-- RICRI UDP-N-ACETYLGLUCOSAMINE ACYLTRANSFERASE RICKETTSIA |
| RICKETTSII 229-256 |
| PLSPA-- ECOLI LIPOPROTEIN SIGNAL PEPTIDASE ESCHERICHIA COLI 10-37 |
| PLSPA-- STAAU LIPOPROTEIN SIGNAL PEPTIDASE STAPHYLOCOCCUS AUREUS |
| 134-161 |
| PLUKF-- STAAU LEUKOCIDIN F SUBUNIT PRECURSOR STAPHYLOCOCCUS |
| AUREUS 161-195 |
| PLUKS-- STAAU LEUKOCIDIN S SUBUNIT PRECURSOR STAPHYLOCOCCUS |
| AUREUS 157-207 |
| PLUXA-- KRYAL ALKANAL MONOOXYGENASE ALPHA CHAIN KRYPTOPHANARON |
| ALFREDI 190-217 |
| PLUXB-- PHOPO ALKANAL MONOOXYGENASE BETA CHAIN PHOTOBACTERIUM |
| PHOSPHOREUM 188-217 257-291 |
| PLUXB-- VIBHA ALKANAL MONOOXYGENASE BETA CHAIN VIBRIO HARVEYI |
| 373-400 |
| PLUXC-- PHOLE ACYL-COA REDUCTASE PHOTOBACTERIUM LEIOGNATHI 44-81 |
| PLUXC-- PHOPO ACYL-COA REDUCTASE PHOTOBACTERIUM PHOSPHOREUM 54-91 |
| PLUXC-- |
| VIBFI ACYL-COA REDUCTASE VIBRIO FISCHERI 16-65 PLUXC-- |
| XENLU ACYL-COA REDUCTASE XENORHABDUS LUMINESCENS 39-69 |
| PLUXD-- PHOLE ACYL TRANSFERASE PHOTOBACTERIUM LEIOGNATHI 89-119 |
| 218-245 |
| PLUXE-- VIBHA LUCIFERIN-COMPONENT LIGASE VIBRIO HARVEYI 30-57 |
| PLUXF-- PHOLE NON-FLUORESCENT FLAVOPROTEIN PHOTOBACTERIUM |
| LEIOGNATHI 145-172 |
| PLUXF-- PHOPO NON-FLUORESCENT FLAVOPROTEIN PHOTOBACTERIUM |
| PHOSPHOREUM 37-85 |
| 99-126 PLUXG-- |
| VIBFI PROBABLE FLAVIN REDUCTASE VIBRIO FISCHERI 137-168 |
| PLUXH-- VIBHA LUXH PROTEIN VIBRIO HARVEYI |
| 96-123 PLUXI-- VIBFI OHHL SYNTHESIS PROTEIN LUXI |
| VIBRIO FISCHERI 30-58 |
| PLUXJ-- VIBFI OHHL SYNTHESIS PROTEIN LUXI VIBRIO FISCHERI 30-57 |
| PLUXP-- PHOPO LUMAZINE PROTEIN PHOTOBACTERIUM PHOSPHOREUM 51-85 |
| 162-189 |
| PLUXR-- VIBHA LUXR REGULATORY PROTEIN VIBRIO HARVEYI 61-88 |
| PLXB1-- |
| PHOLE ALKANAL MONOOXYGENASE BETA CHAIN PHOTOBACTERIUM LEIOGNATHI |
| 268-295 |
| PLXB2-- PHOLE ALKANAL MONOOXYGENASE BETA CHAIN PHOTOBACTERIUM |
| LEIOGNATHI 228-255 |
| PLYB-- BACSU B-ENZYME BACILLUS SUBTILIS |
| 87-114 PLYC-- |
| CLOAB AUTOLYTIC LYSOZYME CLOSTRIDIUM ACETOBUTYLICUM |
| 91-118 PLYSP-- ECOLI LYSINE-SPECIFIC PERMEASE |
| ESCHERICHIA COLI 142-176 |
| PLYTB-- BACSU AMIDASE ENHANCER PRECURSOR BACILLUS SUBTILIS 55-82 |
| 150-177 467-53 555-585 |
| PLYTB-- |
| ECOLI LYTB PROTEIN ESCHERICHIA COLI 210-237 PLYTC-- |
| BACSU AMIDASE PRECURSOR BACILLUS SUBTILIS 179-213 225-252 |
| PLYTR-- BACSU MEMBRANE-BOUND PROTEIN LYTR BACILLUS SUBTILIS 13-64 |
| 259-303 |
| PM12-- STRPY M PROTEIN, SEROTYPE 12 PRECURSOR STREPTOCOCCUS |
| PYOGENES 46-92 114-156 191-300 305-342 383- 436- |
| 417 494 |
| PM24-- STRPY M PROTEIN, SEROTYPE 24 PRECURSOR STREPTOCOCCUS |
| PYOGENES 12-46 |
| 89-128 175-202 245-272 280- 399- 313 |
| 457 |
| PM49-- STRPY M PROTEIN, SEROTYPE 49 PRECURSOR STREPTOCOCCUS |
| PYOGENES 12-174 269-327 |
| PM5-- STRPY M PROTEIN, SEROTYPE 5 PRECURSOR STREPTOCOCCUS |
| PYOGENES 5-39 |
| 56-263 306-333 352-410 PM6-- |
| STRPY M PROTEIN, SEROTYPE 6 PRECURSOR STREPTOCOCCUS PYOGENES 12-39 |
| 70-282 290-324 343-401 |
| PMALE-- ECOLI MALTOSE-BINDING PROTEIN PRECURSOR ESCHERICHIA COLI |
| 20-47 |
| PMALE-- ENTAE MALTOSE-BINDING PROTEIN PRECURSOR ENTEROBACTER |
| AEROGENES 20-47 |
| PMALK-- ENTAE INNER MEMBRANE PROTEIN MALK ENTEROBACTER AEROGENES |
| 3-30 |
| PMALT-- ECOLI MALT REGULATORY PROTEIN ESCHERICHIA COLI 852-879 |
| PMALX-- STRPN MALX PROTEIN PRECURSOR STREPTOCOCCUS PNEUMONIAE |
| 40-67 180-207 |
| PMALB-- BACSM 1,4-BETA-MANNOSIDASE A AND B PREC BACILLUS 410-441 |
| PMALB-- CALSA B-MANNANASE/ENDOGLUCANASE A PREC CALOCELLUM |
| SACCHAROLYTICUM 389-423 592-626 1222- 1296- |
| 1256 1323 |
| PMAOX-- BACST MALATE OXIDOREDUCTASE BACILLUS STEAROTHERMOPHILUS |
| 246-273 |
| PMARR-- ECOLI ANTIBIOTIC RESISTANCE PROTEIN MARR ESCHERICHIA COLI |
| 95-122 |
| PMBEB-- ECOLI MOBILIZATION PROTEIN MBEB ESCHERICHIA COLI 38-65 |
| 100-134 |
| PMBHL-- |
| WOLSU QUINONE-REAC NI/FE-HYDROGENASE WOLINELLA SUCCINOGENES 440-471 |
| PMCBB-- ECOLI MCBB PROTEIN ESCHERICHIA COLI 47-74 122-163 |
| PMCBD-- ECOLI MCBD PROTEIN ESCHERICHIA COLI 172-206 226-253 |
| 306-345 |
| PMCP1-- ECOLI METHYL-ACCEPTING CHEMOTAXIS PROTEIN I ESCHERICHIA |
| COLI 272-299 |
| PMCP2-- ECOLI METHYL-ACCEPTING CHEMOTAXIS PROTEIN II ESCHERICHIA |
| COLI 258-306 |
| PCMP2-- SALTY METHYL-ACCEPTING CHEMOTAXIS PROTEIN II SALMONELLA |
| TYPHIMURIUM 258-306 |
| PMCP3-- ECOLI METHYL-ACCEPTING CHEMOTAXIS PROTEIN III ESCHERICHIA |
| COLI 288-315 |
| PCMP4-- ECOLI METHYL-ACCEPTING CHEMOTAXIS PROTEIN IV ESCHERICHIA |
| COLI 111-145 164-191 277-304 |
| PMCPA-- CAUCR CHEMORECEPTOR MCPA CAULOBACTER CRESCENTUS 260-287 |
| 369-403 516-543 |
| PMCPC-- |
| SALTY CHEMOTAXIS CITRATE TRANSDUCER SALMONELLA TYPHIMURIUM 314-348 |
| PMCPD-- ENTAE CHEMOTAXIS ASPARTATE TRANSDUCER ENTEROBACTER |
| AEROGENES 275-302 |
| PMCPS-- ENTAE CHEMOTAXIS SERINE TRANSDUCER ENTEROBACTER AEROGENES |
| 41-68 158-208 317-351 488-522 |
| PMCRA-- ECOLI SPECIFIC RESTRICTION ENZYME A ESCHERICHIA COLI |
| 37-71 |
| PMCRA-- METBA METHYL-COENZYME M REDUCTASE METHANOSARCINA BARKERI |
| 375-405 |
| PMCRA-- METVA METHYL-COENZYME M REDUCTASE METHANOCOCCUS VANNIELII |
| 335-362 |
| PMCRA-- METVO METHYL-COENZYME M REDUCTASE METHANOCOCCUS VOLTAE |
| 336-363 |
| PMCRB-- METFE METHYL-COENZYME M REDUCTASE METHANOTHERMUS FERVIDUS |
| 267-294 |
| PMCRB-- METVO METHYL-COENZYME M REDUCTASE METHANOCOCCUS VOLTAE |
| 247-274 |
| PMCRC-- |
| ECOLI MCRC PROTEIN ESCHERICHIA COLI 111-145 PMCRD-- |
| METVO REDUCTASE OPERON PROTEIN D METHANOCOCCUS VOLTAE 54-91 |
| PMDH-- ECOLI MALATE DEHYDROGENASE ESCHERICHIA COLI 127-154 |
| PMDH-- METFE MALATE DEHYDROGENASE METHANOTHERMUS FERVIDUS |
| 54-88 |
| PMDH-- SALTY MALATE DEHYDROGENASE SALMONELLA TYPHIMURIUM 127-154 |
| PMDL-- ECOLI MDL PROTEIN ESCHERICHIA COLI 464-491 684-711 992- |
| 1019 |
| PMDOH-- ECOLI BIOSYNTHESIS PROTEIN MDOH ESCHERICHIA COLI 119-152 |
| PMECI-- STAEP METHICILLIN RESIS REG PROTEIN MECI STAPHYLOCOCCUS |
| 88-122 |
| EPIDERMIDIS & AUREUS |
| PMECR-- STAEP METHICILLIN RESISTANCE MECR1 PROTEIN STAPHYLOCOCCUS |
| 439-495 546-573 |
| EPIDERMIDIS & AUREUS |
| PMEMB-- METCA METHANE MONOOXYGENASE COMPONENT A METHYLOCOCCUS |
| CAPSULATUS 214-248 |
| PMEMB-- METTR METHANE MONOOXYGENASE COMPONENT A METHYLOSINUS |
| TRICHOSPORIUM 321-348 |
| PMEMD-- |
| ECOLI SHCHC SYNTHASE ESCHERICHIA COLI 333-367 PMER4-- |
| STRLI PROBABLE HG TRANSPORT PROTEIN STREPTOMYCES LIVIDANS 159-186 |
| PMERA-- |
| BACSR MERCURIC REDUCTASE BACILLUS SP 146-180 PMERA-- |
| STAAU MERCURIC REDUCTASE STAPHYLOCOCCUS AUREUS 292-347 352-386 |
| PMERR-- |
| STAAU MERCURIC RESISTANCE OPERON REG PROTEIN STAPHYLOCOCCUS AUREUS |
| 86-113 |
| PMETB-- ECOLI CYSTATHIONINE GAMMA-SYNTHASE ESCHERICHIA COLI |
| 356-383 |
| PMETC-- ECOLI CYSTATHIONINE BETA-LYASE ESCHERICHIA COLI 363-390 |
| PMETC-- SALTY CYSTATHIONINE BETA-LYASE SALMONELLA TYPHIMURIUM |
| 2-29 |
| PMETE-- ECOLI METHIONINE SYNTHASE ESCHERICHIA COLI 448-482 |
| PMETH-- ECOLI METHIONINE SYNTHASE ESCHERICHIA COLI 371-398 |
| 642-676 |
| PMFD-- ECOLI TRANSCRIPTION-REPAIR COUPLING FACTOR ESCHERICHIA |
| COLI 185-212 |
| PMGLA-- ECOLI GALACTOSIDE-BINDING PROTEIN ESCHERICHIA COLI 62-89 |
| 312-380 |
| PMINC-- BACSU SEPTUM SITE-DETERMINING PROTEIN MINC BACILLUS |
| SUBTILIS |
| 65-122 |
| PMIOC-- |
| ECOLI MIOC PROTEIN ESCHERICHIA COLI 102-129 PMIP-- |
| CHLTR 27 KD MEMBRANE PROTEIN PRECURSOR CHLAMYDIA TRACHOMATIS 41-75 |
| PMIP-- LEGMI OUTER MEMBRANE PROTEIN MIP PRECURSOR LEGIONELLA |
| MICDADEI 106-133 |
| PMLS1-- ENTFA RRNA ADENINE N-6-METHYLTRANSFERASE ENTEROCOCCUS |
| FAECALIS |
| 4-81 120-154 |
| PMLS1-- STAAU RRNA ADENINE N-6-METHYLTRANSFERASE STAPHYLOCOCCUS |
| AUREUS |
| 9-47 |
| PMLS2-- ENTFA RRNA ADENINE N-6-METHYLTRANSFERASE ENTEROCOCCUS |
| FAECALIS |
| 4-81 120-154 |
| PMLSB-- BACFR RRNA ADENINE N-6-METHYLTRANSFERASE BACTEROIDES |
| FRAGILIS 16-43 |
| PMLSB-- ECOLI RRNA ADENINE N-6-METHYLTRANSFERASE ESCHERICHIA COLI |
| 4-81 120-154 |
| PMLSB-- STRPN RRNA ADENINE N-6-METHYLTRANSFERASE STREPTOCOCCUS |
| PNEUMONIAE |
| 4-81 120-154 PMLSB |
| -- STRSA RRNA ADENINE N-6-METHYLTRANSFERASE STREPTOCOCCUS SANGUIS 4-81 |
| 120-154 |
| PMLSC-- BACFR RRNA ADENINE N-6-METHYLTRANSFERASE BACTEROIDES |
| FRAGILIS 16-43 |
| PMMOB-- METC METHANE MONOOXYGENASE REG PROTEIN B METHYLOCOCCUS |
| CAPSULATUS 34-64 |
| PMOAB-- ECOLI MOLYBD COFAC BIOSYN PROTEIN B ESCHERICHIA COLI |
| 49-76 |
| PMOBA-- THIFE MOBA PROTEIN THIOBACILLUS FERROOXIDANS 94-121 |
| 251-278 |
| PMOBC-- THIFE MOBC PROTEIN THIOBACILLUS FERROOXIDANS 20-47 |
| PMOBD THIFE MOBD PROTEIN THIOBACILLUS FERROOXIDANS 95-132 |
| PMOB-- |
| ECOLI MOB PROTEIN ESCHERICHIA COLI 45-72 PMOEA-- |
| ECOLI MOLYBDOPTERIN BIOSYNTHESIS MOEA PROTEIN ESCHERICHIA COLI 243-270 |
| PMOP1-- CLOPA MOLYBDENUM-PTERIN BINDING PROTEIN I CLOSTRIDIUM |
| PASTEURIANUM 226-53 |
| PMOP2-- CLOPA MOLYBDENUM-PTERIN BINDING PROTEIN II CLOSTRIDIUM |
| PASTEURIANUM 26-64 |
| PMOXY-- |
| PARDE METHANOL UTIL CONT PROTEIN MOXY PARACOCCUS DENITRIFICANS 200-234 |
| 307-334 |
| PMPEU-- SYNPY BILIN BIOSYNTHESIS PROTEIN MPEU SYNECHOCOCCUS SP |
| 2-36 |
| 80-107 198-225 |
| PMPEV-- SYNPY BILIN BIOSYNTHESIS PROTEIN MPEV SYNECHOCOCCUS SP |
| 2-31 175-216 |
| PMPRA-- |
| ECOLI MPRA PROTEIN ESCHERICHIA COLI 136-163 PMRAY-- |
| BACSU PENT APEPTIDE-TRANSFERASE BACILLUS SUBTILIS 106-133 247-281 |
| PMREB-- BACCE ROD SHAPE-DETERMINING PROTEIN MREB BACILLUS |
| CEREUS 186-213 |
| PMREC-- BACSU ROD SHAPE-DETERMINING PROTEIN MREC BACILLUS |
| SUBTILIS |
| 65-112 |
| PMRKB-- |
| KLEPN CHAPERONE PROTEIN MRKB PRECURSOR KLEBSIELLA PNEUMONIAE 198-232 |
| PMRKC-- KLEPN MRKC PROTEIN PRECURSOR KLEBSIELLA PNEUMONIAE |
| 55-82 452-489 592-622 |
| PMRKD-- KLEPN FIMBRIA ADHESIN PROTEIN PRECURSOR KLEBSIELLA |
| PNEUMONIAE 222-268 |
| PMRKE-- |
| KLEPN MRKE PROTEIN KLEBSIELLA PNEUMONIAE 193-220 PMRP4-- |
| STRPY FIBRINIOGEN-/IG-BINDING PROTEIN PRECURSOR STREPTOCOCCUS PYOGENES |
| 7-46 |
| 99-310 |
| PMRP-- STRUS MURAMIDASE-RELEASED PROTEIN PRECURSOR STREPTOCOCCUS |
| SUIS |
| 75-102 130-177 261-291 421-448 507- 588- 773- 1058- |
| 534 622 800 1085 |
| PMSBA-- ECOLI PROB ATP-BINDING TRANSPORT PROTEIN MSBA ESCHERICHIA |
| COLI 116-150 412-449 |
| PMSRA-- STAEP ERYTHROMYCIN RESISTANCE PROTEIN STAPHYLOCOCCUS |
| EPIDERMIDIS 174-223 323-350 |
| PMSYB-- ECOLI ACIDIC PROTEIN MYSB ESCHERICHIA COLI 73-100 |
| PMT57-- ECOLI MODIFICATION METHYLASE ECO571 ESCHERICHIA |
| COLI 250-284 474-544 |
| PMTA1-- |
| ACICA MODIFICATION METHYLASE ACCI ACINETOBACTER CALCOACETICUS 503-540 |
| PMTAB-- |
| SYNP2 MODIFICATION METHYLASE AQUI BETA SUBUNIT SYNECHOCOCCUS SP 19-46 |
| PMTB1-- BREEP MODIFICATION METHYLASE BEPI BREVIBACTERIUM |
| EPIDERMIDIS 166-200 309-336 |
| PMTB1-- |
| HERAU MODIFICATION METHYLASE HGIBI HERPETOSIPHON AURANTIACUS 281-308 |
| PMTB2-- |
| BACAM MODIFICATION METHYLASE BAMHII BACILLUS AMYLOLIQUEFACIENS 35-62 |
| PMTB3-- |
| BACAR MODIFICATION METHYLASE BANIII BACILLUS ANEURINOLYTICUS 184-211 |
| PMTBA-- |
| BACAR MODIFICATION METHYLASE BANI BACILLUS ANEURINOLYTICUS 121-148 |
| 382-409 |
| PMTBB-- BACSU MODIFICATION METHYLASE BSUBI BACILLUS SUBTILIS |
| 231-258 467-496 |
| PMTBF-- BACSU MODIFICATION METHYLASE BSUFI BACILLUS SUBTILIS |
| 208-235 |
| PMTC1-- CITFR MODIFICATION METHYLASE CFRBI CITROBACTER FREUDII |
| 2-36 55-82 252-279 |
| PMTC1-- |
| HERAU MODIFICATION METHYLASE HGICI HERPETOSIPHON AURANTIACUS 120-147 |
| PMTC2-- HERAU MODIFICATION METHYLASE HGICII HERPETOSIPHON |
| AURANTIACUS 281-311 |
| PMTE1-- ECOLI MODIFICATION METHYLASE ECORI ESCHERICHIA COLI |
| 76-110 145-172 |
| PMTE1-- |
| HERAU MODIFICATION METHYLASE HGIEI HERPETOSIPHON AURANTIACUS 281-308 |
| PMTE2-- ECOLI MODIFICATION METHYLASE ECORII ESCHERICHIA COLI |
| 4-61 |
| PMTE5-- ECOLI MODIFICATION METHYLASE ECO RV ESCHERICHIA COLI |
| 73-100 |
| PMTEC-- ENTCL MODIFICATION METHYLASE ECAI ENTEROBACTER CLOACAE |
| 418-445 |
| PMTF1-- |
| FLAOK MODIFICATION METHYLASE FOKI FLAVOBACTERIUM OKEANOKOITES 184-211 |
| 279-306 337-366 398-425 555- |
| 646 |
| PMTF1-- |
| FUSNU MODIFICATION METHYLASE FNUDI FUSOBACTERIUM NUCLEATUM 22-49 |
| PMTG2-- HAEGA MODIFICATION METHYLASE HGAI-2 HAEMOPHILUS |
| GALLINARIUM 135-165 |
| PMTH2-- |
| HAEIN MODIFICATION METHYLASE HINCII HAEMOPHILUS INFLUENZAE 181-208 |
| 399-426 |
| PMTHZ-- METTF MODIFICATION METHYLASE MITZI METHANOBACTERIUM |
| 188-215 296-323 |
| THERMOFORMICICUM |
| PMTK1-- KLEPN MODIFICATION METHYLASE KPNI KLEBSIELLA PNEUMONIAE |
| 270-297 |
| PMTLD-- STRMU MANNITOL-1-PHOSPHATE 5-DEHYDROGRENASE STREPTOCOCCUS |
| MUTANS 39-66 224-258 349-376 |
| PMTM1-- MORSP MODIFICATION METHYLASE MSPI MORAXELLA SP 5-39 |
| 49-104 |
| PMTN3-- NEILA MODIFICATION METHYLASE NLAIII NEISSERIA LACTAMICA |
| 124-158 183-210 |
| PMTP2-- PROVU MODIFICATION METHYLASE PVU II PROTEUS VULGARIS |
| 308-335 |
| PMTPG-- |
| SULAC MEMBRANE-ASSOCIATED ATPASE SULFOLOBUS ACIDOCALDARIUS 9-67 |
| PMTPS-- PROST MODIFICATION METHYLASE PSTI PROVIDENCIA |
| STUARTII 226-264 |
| PMTR-- ECOLI TRYPTOPHAN-SPECIFIC TRANSPORT PROTEIN ESCHERICHIA |
| COLI |
| 80-107 |
| PMTS1-- STRSA MODIFICATION METHYLASE STSI STREPTOCOCCUS SANGUIS |
| 116-153 434-461 600-645 |
| PMTS2-- SHISO MODIFICATION METHYLASE SSOII SHIGELLA SONNEI |
| 81-108 |
| PMTS9-- STAAU MODIFICATION METHYLASE SAU96I STAPHYLOCOCCUS AUREUS |
| 233-274 |
| PMTSA-- LACLC MODIFICATION METHYLASE SCRFI-1 LACTOCOCCUS LACTIS |
| 88-115 187-214 |
| PMTSB-- LACLC MODIFICATION METHYLASE SCRFI-B LACTOCOCCUS LACTIS |
| 27-61 |
| PMTSI-- SPISQ CPG DNA METHYLASE SPIROPLASMA SP 188-230 256-290 |
| PMTSM-- SERMA MODIFICATION METHYLASE SMAI SERRATIA MARCESCENS |
| 61-88 |
| PMTT8-- THETH MODIFICATION METHYLASE TTHHB81 THERMUS AQUATICUS |
| 120-157 |
| PMTV1-- VIBS3 MODIFICATION METHYLASE BSPI VIBRIO SP 23-66 |
| PMUKB-- ECOLI MUKB PROTEIN ESCHERICHIA COLI 320-381 1014- |
| 1216- |
| 1048 1252 |
| PMULI-- ERWAM MAJOR OUTER MEMBRANE LIPOPROTEIN PREC ERWINIA |
| AMYLOVORA 24-54 |
| PMULI-- MOIMO MAJOR OUTER MEMBRANE LIPOPROTEIN PREC MORGANELA |
| MORGANII 24-54 |
| PMULI-- PROMI MAJOR OUTER MEMBRANE LIPOPROTEIN PREC PROTEUS |
| MIRABILIS 21-63 |
| PMURD-- LACSU UDP-LIGASE BACILLUS SUBTILIS 101-132 299-326 |
| PMURE-- |
| ECOLI LIGASE ESCHERICHIA COLI 107-134 PMURF-- ECOLI |
| UDP-MURNAC-PENTAPEPTIDE SYNTHETASE ESCHERICHIA COLI 407-437 |
| PMURZ-- ECOLI ENOYLPYRUVATE TRANSFERASE ESCHERICHIA COLI 392-419 |
| PMURZ-- ENTCL ENOYLPYRUVATE TRANSFERASE ENTEROCOCCUS CLOACAE |
| 392-419 |
| PMUTA-- STRCM METHYLMALONYL-COA MUTASE BETA-SUBUNIT STREPTOMYCES |
| CINNAMONENSIS 31-58 |
| PMUTB-- |
| PROFR METHYLMALONYL-COA MUTASE ALPHA-SUBUNIT PROPIONBACTERIUM FREUDENREI |
| CHII 549-576 |
| PMUTB-- |
| SALTY /G-SPECIFIC ADENINE GLYCOSYLASE SALMONELLA TYPHIMURIUM 273-300 |
| PMUTB-- |
| STRCM METHYLMALONYL-COA MUTASE ALPHA-SUBUNIT STREPTOMYCES CINNAMONENSIS |
| 481-508 |
| PMUTL-- ECOLI DNA MISMATCH REPAIR PROTEIN MUTL ESCHERICHIA COLI |
| 80-114 |
| PMUTL-- SALTY DNA MISMATCH REPAIR PROTEIN MUTL SALMONELLA |
| TYPHIMURIUM |
| 80-114 PMUTL- |
| - |
| VIBCH PROTEIN MUTL VIBRIO CHOLERAE 134-169 |
| PMUTS-- ECOLI DNA MISMATCH REPAIR PROTEIN MUTS ESCHERICHIA COLI |
| 119-153 |
| PMUTT-- STRAM MUTT-LIKE PROTEIN STREPTOMYCES AMBOFACIENS 60-87 |
| PMVAA-- PSEMV COENZYME A REDUCTASE PSEUDOMONAS MEVALAONII |
| 341-368 |
| PMX-- STRPY M-RELATED PROTEIN PRECURSOR STREPTOCOCCUS PYOGENES |
| 5-129 148-182 190-217 240-301 |
| PMYCO-- STRCI MYCOLYSIN PRECURSOR STREPTOMYCES CACAOI 300-352 |
| PMYFC-- YEREN MYFC PROTEIN PRECURSOR YERSINIA ENTEROCOLITICA |
| 210-237 |
| PNADC-- SALTY NICOTINATE-NUCLEOTIDE PYROPHOSPHORYLASE SALMONELLA |
| TYPHIMURIUM 123-154 255-289 |
| PNADR-- |
| SALTY TRANSCRIPTIONAL REGULATOR NADR SALMONELLA TYPHIMURIUM 233-260 |
| PNAGD-- ECOLI NAGD PROTEIN ESCHERICHIA COLI |
| 75-102 PNAGH-- |
| CLOPE HYALURONOGLUCOSAMINIDASE CLOSTRIDIUM PERFRINGENS 48-75 990- |
| 1017 |
| PNAGR-- |
| ECOLI NAGR PROTEIN ESCHERICHIA COLI 119-153 PNANH-- |
| CLOSE SIALIDASE PRECURSOR CLOSTRIDIUM SEPTICUM 11-42 289-330 922-988 |
| PNANH-- CLOSO SIALIDASE PRECURSOR CLOSTRIDIUM SORDELLII 377-404 |
| PNANH-- |
| SALTY SIALIDASE SALMONELLA TYPHIMURIUM 290-317 PNAPA-- |
| ENTHR NA(+)/H(+) ANTIPORTER ENTEROCOCCUS HIRAE 116-150 |
| PNARG-- |
| ECOLI RESPIRATORY NITRATE REDUCTASE ALPHA CHAIN ESCHERICHIA COLI |
| 386-420 |
| PNARL-- ECOLI REGULATOR PROTEIN NARL ESCHERICHIA COLI 76-103 |
| PNARP-- ECOLI REGULATOR PROTEIN NARP ESCHERICHIA COLI 155-189 |
| PNARX-- ECOLI NITRATE/NITRITE SENSOR PROTEIN NARX ESCHERICHIA |
| COLI 220-247 358-385 431-458 505-538 |
| PNDVA-- RHIME BETA -(1->2)GLUCAN EXPORT PROTEIN RHIZOBIUM |
| MELILOTI 212-239 |
| PNEOR-- STRCY NEOMYCIN RESISTANCE PROTEIN STREPTOMYCES CYANOGENUS |
| 348-375 |
| PNEUA-- ECOLI ACYNEURAMINATE CYTIDYLYLTRANSFERASE ESCHERICHIA |
| COLI 218-252 268-298 |
| PNFRA-- ECOLI N4 ADSORPTION PROTEIN A PRECURSOR ESCHERICHIA COLI |
| 490-517 |
| PNFRB-- ECOLI N4 ADSORPTION PROTEIN B ESCHERICHIA COLI 2-43 |
| 186-220 511-538 |
| PNFRC-- ECOLI N4 ADSORPTION PROTEIN C ESCHERICHIA COLI 315-342 |
| PNFSI-- ENTCL NAD(P)H NITROREDUCTASE ENTEROBACTER CLOACAE 9-36 |
| PNHAA-- ECOLI NA(+)/H(+) ANTIPORTER 1 ESCHERICHIA COLI 206-233 |
| PNHAB-- ECOLI NA(+)/H(+) ANTIPORTER 2 ESCHERICHIA COLI 271-305 |
| PNHAB-- PSCEL NITRILE HYDRATEASE SUBUNIT BETA PSEUDOMONAS |
| CHLORORAPHIS |
| 71-101 PNHB1-- |
| RHORH NITRILE HYDRATEASE SUBUNIT BETA RHODOCOCCUS RHODOCHROUS 63-93 |
| PNIFA-- AZOBR NIF-SPECIFIC REGULATORY PROTEIN AZOSPIRILLUM |
| BRASILENSE |
| 7-44 PNIFA |
| -- BRAJA NIF-SPECIFIC REGULATORY PROTEIN BRADYRHIZOBIUM JAPONICUM |
| 252-279 |
| PNIFA-- HERSE NIF-SPECIFIC REGULATORY PROTEIN HERBASPIRILLUM |
| SEROPEDICAE |
| 9-51 162-203 327-354 PNIFA- |
| - RHILE NIF-SPECIFIC REGULATORY PROTEIN RHIZOBIUM LEGUMINOSARUM 100-127 |
| PNIFA-- RHIME NIF-SPECIFIC REGULATORY PROTEIN RHIZOBIUM MELILOTI |
| 171-198 |
| PNIFA-- RHOCA NIF-SPECIFIC REGULATORY PROTEIN RHODOBACTER |
| CAPSULATUS 260-287 |
| PNIFB-- AZOVI NIFB PROTEIN AZOTOBACTER VINELANDII 342-369 |
| PNIFB-- KLEPN NIFB PROTEIN KLEBSIELLA PNEUMONIAE 154-181 |
| PNIFD-- ANASP NITROG MYOLYBD-IRON PROTEIN ANABAENA SP 374-401 |
| PNIFD-- |
| AZOBR NITROG MYOLYBD-IRON PROTEIN AZOSPIRILLUM BRASILENSE 377-404 |
| PNIFD-- PLEBO NITROG MYOLYBD-IRON PROTEIN PLECTONEMA |
| BORYANUM 387-414 |
| PNIFD-- |
| THIFE NITROG MYOLYBD-IRON PROTEIN THIOBACILLUS FERROOXIDANS 383-410 |
| PNIFE-- |
| CLOPA BIOSYNTHESIS PROTEIN NIFE CLOSTRIDIUM PASTEURIANUM 359-386 |
| PNIFH-- FRASR NITROGENASE IRON PROTEIN FRANKIA SP 56-83 |
| PNIFH-- PLEBO NITROGENASE IRON PROTEIN PLECTONEMA BORYANUM |
| 267-294 |
| PNIFK-- AZOBR NITROG MOLYBD-IRON PROTEIN AZOSPIRILLUM BRASILENSE |
| 430-457 |
| PNIFK-- BRAJA NITROG MOLYBD-IRON PROTEIN BRADYRHIZOBIUM JAPONICUM |
| 483-410 |
| PNIFK-- BRASP NITROG MOLYBD-IRON PROTEIN BRADYRHIZOBIUM SP |
| 478-505 |
| PNIFK-- CLOPA NITROG MOLYBD-IRON PROTEIN CLOSTRIDIUM PASTEURIANUM |
| 227-254 |
| PNIFK-- |
| THIFE NITROG MOLYBD-IRON PROTEIN THIOBACILLUS FERROOXIDANS 479-506 |
| PNIFM-- AZOCH NIFM PROTEIN AZOTOBACTER CHROOCOCCUM MCD I |
| 265-292 |
| PNIFN-- BRAJA BIOSYNTHESIS PROTEIN NIFN BRADYRHIZOBIUM JAPONICUM |
| 339-366 |
| PNIFS-- |
| ANASP NIFS PROTEIN ANABAENA SP 112-139 PNIFS-- |
| LACDE NIFS PROTEIN HOMOLOG LACTOBACILLUS DELBRUECKII 59-86 |
| PNIFT-- AZOVI NIFS PROTEIN AZOTOBACTER VINELANDII |
| 6-33 PNIFU-- ANASL NIFS PROTEIN ANABAENA SP 7-49 |
| PNIFU-- |
| ANASP NIFS PROTEIN ANABAENA SP 148-178 PNIFU-- |
| KLEPN NIFS PROTEIN KLEBSIELLA PNEUMONIAE 66-93 |
| PNIKA-- ECOLI NICKEL TRANSPORT PROTEIN NIKA PRECURSOR ESCHERICHIA |
| COLI 122-149 282-309 356-483 |
| PNIKE-- ECOLI NICKEL TRANSPORT PROTEIN NIKE ESCHERICHIA COLI |
| 177-204 |
| PNIRB-- ECOLI NITRITE REDUCTASE ESCHERICHIA COLI 54-81 345-372 |
| PNIRC-- |
| ECOLI NIRC PROTEIN ESCHERICHIA COLI 212-239 PNIRS-- |
| PSEST PSEUDOMONAS CYTOCHROME OXIDASE PRECURSO PSEUDOMONAS STUTZERI |
| 303-333 |
| PNISB-- LACLA 117 KD MEMBRANE ASSOCIATED PROTEIN LACTOCOCCUS |
| LACTIS 202-229 287-332 663-697 886-920 |
| PNISC-- LACLA NISIN BIOSYNTHESIS PROTEIN NISC LACTOCOCCUS LACTIS |
| 52≧92 1401-188 |
| PNIST-- LACLA NISIN TRANSPORT PROTEIN NIST LACTOCOCCUS LACTIS |
| 223-257 278-305 426-470 |
| PNIVA-- CLOPA HOMOCITRATE SYNTHASE, ALPHA SUBUNIT CLOSTRIDIUM |
| PASTEURIANUM 100-127 234-268 |
| PNIVO-- CLOPA HOMOCITRATE SYNTHASE, OMGEA SUBUNIT CLOSTRIDIUM |
| PASTEURIANUM 63-94 103-132 213-240 283-310 |
| PNMPC-- ECOLI PORIN PROTEIN NMPC PRECURSOR LACTOCOCCUS LACTIS |
| 22-49 69-96 335-362 |
| PNODC-- BRASP NODULATION PROTEIN C BRADYRHIZOBIUM SP 3-30 |
| PNODC-- RHILO NODULATION PROTEIN C RHIZOBIUM LOTI 286-313 |
| PNODC-- RHILT NODULATION PROTEIN C RHIZOBIUM LEGUMINOSARUM 14-48 |
| PNODF-- RHILV NODULATION PROTEIN F RHIZOBIUM LEGUMINOSARUM 31-58 |
| PNODF-- RHIMS NODULATION PROTEIN F RHIZOBIUM MELILOTI 39-66 |
| PNODG-- RHIME NODULATION PROTEIN G RHIZOBIUM MELILOTI 8-35 |
| PNODG-- RHIMS NODULATION PROTEIN G RHIZOBIUM MELILOTI 8-35 |
| PNODL-- RHILV NODULATION PROTEIN L RHIZOBIUM LEGUMINOSARUM |
| 26-53 |
| PNODQ-- AZOBR NODULATION PROTEIN Q AZOSPIRILLUM BRASILENSE 60-87 |
| PNODT-- RHILT NODULATION PROTEIN T RHIZOBIUM LEGUMINOSARUM |
| 104-134 355-382 420-454 |
| PNODT-- RHILV NODULATION PROTEIN T RHIZOBIUM LEGUMINOSARUM |
| 364-391 416-443 |
| PNODU-- RHIFR NODULATION PROTEIN U RHIZOBIUM FREDII 506-536 |
| PNODV-- BRAJA NODULATION PROTEIN V BRADYRHIZOBIUM JAPONICUM |
| 378-419 739-766 |
| PNODX-- RHILV NODULATION PROTEIN X RHIZOBIUM LEGUMINOSARUM |
| 232-259 |
| PNOLB-- RHIFR NODULATION PROTEIN NOLB RHIZOBIUM FREDII 133-160 |
| PNOLR-- RHIME NODULATION PROTEIN NOLR RHIZOBIUM MELILOTI |
| 88-115 |
| PNOSD-- PSEST NOSD PROTEIN PRECURSOR PSEUDOMONAS STUTZERI 319-346 |
| PNOSR-- PSEST REGULATORY PROTEIN NOSR PSEUDOMONAS STUTZERI |
| 127-154 |
| PNOSZ-- RSEAE NITROUS-OXIDE REDUCTASE PRECURSOR PSEUDOMONAS |
| AERUGINOSA 267-294 |
| PNOSZ-- PSEST NITROUS-OXIDE REDUCTASE PRECURSOR PSEUDOMONAS |
| STUTZERI 557-591 |
| PNPRE-- BACAM BACILLOLYSIN PRECURSOR BACILLUS AMYLOLIQUEFACIENS |
| 113-147 217-244 |
| PNPRE-- BACPO BACILLOLYSIN PRECURSOR BACILLUS POLYMYXA 57-91 |
| 187-228 |
| PNPRE-- BACSU BACILLOLYSIN PRECURSOR BACILLUS SUBTILIS 116-146 |
| 307-334 |
| PNQO5-- |
| PARDE NADH-UBIQUINONE OXIDOREDUCTASE 21 KD CHAI PARACOCCUS DENITRIFICANS |
| 4-45 |
| PNQO9-- PARDE NADH-UBIQUINONE OXIDOREDUC 20 KD CHAIN PARACOCCUS |
| DENITRIFICANS 125-152 |
| PNRDD-- ECOLI ANAER RIBONUC-TRIPHOS REDUCTASE ESCHERICHIA COLI |
| 91-125 |
| PNRFA-- ECOLI CYTOCHROME C552 PRECURSOR ESCHERICHIA COLI 319-346 |
| PNRFG-- ECOLI NRFG PROTEIN ESCHERICHIA COLI |
| 72-111 PNRL1-- |
| RHORH ALIPHATIC NITRILASE RHODOCOCCUS RHODOCHROUS 109-136 |
| PNSR-- LACLA NISIN-RESISTANCE PROTEIN LACTOCOCCUS LACTIS 52-79 |
| 135-162 |
| PNTCA-- |
| ANASP DNA-BINDING PROTEIN VFI ANABAENA SP 65-92 PNTCA-- |
| SYNP7 GLOBAL NITROGEN REGULATOR SYNECHOCOCCUS SP 44-91 |
| PNTCA-- SYNY3 GLOBAL NITROGEN REGULATOR SYNECHOCYSTIS SP 67-94 |
| PNTRB-- |
| VIBAL NITROGEN REGULATION PROTEIN NTRB VIBRIO ALGINOLYTICUS 194-223 |
| PNTRC-- PROVU NITROGEN REGULATION PROTEIN NR PROTEUS VULGARIS |
| 385-412 |
| PNTRC-- RHIME NITROGEN ASSIMILATION REGULATORY PROTEIN RHIZOBIUM |
| MELILOTI 451-478 |
| PNU2C-- |
| SYNP7 NADH-PLASTOQUINONE OXIDOREDUCTASE CHAIN SYNECHOCOCCUS SP 80-107 |
| PNU4C-- |
| SYNY3 NADH-PLASTOQUINONE OXIDOREDUCTASE CHAIN SYNECHOCYSTIS SP 27-54 |
| PNU5C-- |
| SYNP2 NADH-PLASTOQUINONE OXIDOREDUCTASE CHAIN SYNECHOCOCCUS SP 614-641 |
| PNUJC-- |
| SYNY3 PROB NADH-UBIQUINONE OXIDOREDUCTASE SUB SYNECHOCYSTIS SP 163-190 |
| PNUCK-- |
| SYNY3 PROB NADH-UBIQUINONE OXIDOREDUCTASE SUB SYNECHOCYSTIS SP 169-199 |
| PNULX-- SYNY3 NADH-PLASTOQUINONE OXIDOREDUCTASE SUB SYNECHOCYSTIS |
| SP 46-90 |
| PNUOG-- ECOLI NADH DEHYDROGENASE I CHAIN G ESCHERICHIA COLI |
| 368-402 |
| PNUOL-- ECOLI NADH DEHYDROGENASE I CHAIN L ESCHERICHIA COLI 30-57 |
| 496-523 |
| PNUON-- ECOLI NADH DEHYDROGENASE I CHAIN N ESCHERICHIA COLI |
| 392-419 |
| PNUPC-- ECOLI NUCLEOTIDE PERMEASE ESCHERICHIA COLI 13-43 134-164 |
| 356-383 |
| PNUSA-- |
| ECOLI NUSA PROTEIN ESCHERICHIA COLI 21-62 PNUSB-- |
| ECOLI N UTILIZATION SUBSTANCE PROTEIN B ESCHERICHIA COLI 17-65 70-97 |
| PNUSG-- |
| ECOLI TRANSCRIPTION ANTITERMINATION PROTEIN NUS ESCHERICHIA COLI |
| 141-168 |
| PNUSG-- |
| THEMA TRANSCRIPTION ANTITERMINATION PROTEIN NUS THERMOTOGA MARITIMA |
| 203-230 |
| PNYLB-- FLASP 6-AMINOHEXANOATE-DIMER HYDROLASE FLAVOBACTERIUM SP |
| 223-250 |
| PNYLC-- FLASP 6-AMINOHEXANOATE-DIMER HYDROLASE FLAVOBACTERIUM SP |
| 223-250 |
| PO16G-- BACCE OLIGO-1,6-GLUCOSIDASE BACILLUS CEREUS 301-328 |
| POCCT-- |
| AGRT6 OCTOPINE-BINDING PROTEIN T PRECURSOR AGROBACTERIUM TUMEFACIENS |
| 172-202 |
| PODO1-- AZOVI 2-OXOGLUTARATE DEHYDROGENASE E1 COMPONE AZOTOBACTER |
| VINELANDII 829-856 |
| PODO1-- BACSU 2-OXOGLUTARATE DEHYDROGENASE E1 COMPONE BACILLUS |
| SUBTILIS 487-524 809-850 |
| PODO1-- ECOLI 2-OXOGLUTARATE DEHYDROGENASE E1 COMPONE ESCHERICHIA |
| COLI |
| 6-33 |
| PODO2-- BACSU DIHYDROLIPOAMIDE SUC-TRANSF COMP BACILLUS SUBTILIS |
| 30-60 |
| PODOB-- PSEPU 2-OXOGLUTARATE DEHYDROGENASE E1 COMPONE PSEUDOMONAS |
| PUTIDA 223-254 |
| PODP1-- ECOLI PYRUVATE DEHYDROGENASE E1 COMPONENT ESCHERICHIA |
| COLI 624-651 |
| PODP2-- |
| AZOVI DIHYDROLIPOAMIDE ACETRANS COMP AZOTOBACTER VINELANDII 518-545 |
| PODP2-- ECOLI DIHYDROLIPOAMIDE ACETRANS COMP ESCHERICHIA COLI |
| 14-41 117-144 |
| PODPA-- BACST PYRUVATE DEHYDROGENASE E1 COMPONENT BACILLUS |
| STEAROTHERMOPHILUS 299-333 |
| PODPA-- BACSU PYRUVATE DEHYDROGENASE E1 COMPONENT BACILLUS |
| SUBTILIS 305-332 |
| PODPB-- BACST PYRUVATE DEHYDROGENASE E1 COMPONENT BACILLUS |
| STEAROTHERMOPHILUS 23-50 |
| PODPB-- BACSU PYRUVATE DEHYDROGENASE E1 COMPONENT BACILLUS |
| SUBTILIS 16-50 |
| POMIE-- CHLTR 15 KD CYSTEINE-RICH PROTEIN, SEROVAR E CHLAMYDIA |
| TRACHOMATIS 38-65 |
| POMA1-- NIEGO OUTER MEMBRANE PROTEIN PI.A PRECURSOR NEISSERIA |
| GONORRHOEAE 63-90 |
| POMA1-- NEIME OUTER MEMBRANE PROTEIN PI.A PRECURSOR NEISSERIA |
| MENINGITIDIS 359-386 |
| POMA2-- NEIME OUTER MEMBRANE PROTEIN PI.A PRECURSOR NEISSERIA |
| MENINGITIDIS 353-380 |
| POMB1-- NEIGO OUTER MEMBRANE PROTEIN P.IB PRECURSOR NEISSERIA |
| GONORRHOEAE 63-90 |
| POMB1-- NEIME OUTER MEMBRANE PROTEIN P.IB PRECURSOR NEISSERIA |
| MENINGITIDIS 63-90 |
| POMB2-- NEIGO OUTER MEMBRANE PROTEIN P.IB PRECURSOR NEISSERIA |
| GONORRHOEAE 63-90 |
| POMB2-- NEIME OUTER MEMBRANE PROTEIN P.IB PRECURSOR NEISSERIA |
| MENINGITIDIS 63-90 |
| POMB3-- NEIME OUTER MEMBRANE PROTEIN P.IB PRECURSOR NEISSERIA |
| MENINGITIDIS 63-90 |
| POMB4-- NEIME OUTER MEMBRANE PROTEIN P.IB PRECURSOR NEISSERIA |
| MENINGITIDIS 24-51 63-90 |
| POMB-- NEILA OUTER MEMBRANE PROTEIN P.IB PRECURSOR NEISSERIA |
| LACTAMICA 116-143 |
| POMB-- NEISI OUTER MEMBRANE PROTEIN P.IB PRECURSOR NEISSERIA |
| SICCA 24-51 63-90 |
| POMLA-- ACTPL OUTER MEMBRANE LIPOPROTEIN PRECURSOR ACTINOBACILLUS |
| PLEUROPNEUMONIAE 114-151 |
| POMP1-- HAEIN OUTER MEMBRANE PROTEIN P1 PRECURSOR HAEMOPHILUS |
| INFLUENZAE 154-184 303-330 341-368 |
| POMP2-- HAEIN OUTER MEMBRANE PROTEIN P2 PRECURSOR HAEMOPHILUS |
| INFLUENZAE 16-71 220-254 326-353 |
| POMP3-- NEIGO OUTER MEMBRANE PROTEIN P.III PRECURSOR NEISSERIA |
| GONORRHOEAE 14-41 |
| POMP7-- |
| STAAU 70 KD OUTER MEMBRANE PROTEIN PRECURSOR STAPHYLOCOCCUS AUREUS |
| 53-80 |
| 88-115 |
| POMPA-- THEMA OUTER MEMBRANE PROTEIN ALPHA PRECURSOR THERMOTOGA |
| MARITIMA 100-138 151-178 183-249 255-292 301- 351- |
| 328 385 |
| POMPC-- ECOLI OUTER MEMBRANE PROTEIN C PRECURSOR ESCHERICHIA COLI |
| 20-47 64-94 |
| POMPC-- NEIGO OUTER MEMBRANE PROTEIN P.IIC PRECURSOR NEISSERIA |
| GONORRHOEAE |
| 89-123 POMPC- |
| - SALTI OUTER MEMBRANE PROTEIN C PRECURSOR SALMONELLA TYPHI 166-193 |
| POMPF-- ECOLI OUTER MEMBRANE PROTEIN F PRECURSOR ESCHERICHIA |
| COLI 21-55 231-258 |
| POMPH-- |
| PHOS9 OMPH PROTEIN PHOTOBACTERIUM SP 292-319 POMPT-- |
| ECOLI PROTEASE VII PRECURSOR ESCHERICHIA COLI 37-64 |
| POP65-- NEIGO OPACITY PROTEIN OPA65 NEISSERIA GONORRHOEAE 71-111 |
| POP67-- NEIGO OPACITY PROTEIN OPA67 NEISSERIA GONORRHOEAE 72-109 |
| POPAA-- NEIGO OPACITY PROTEIN OPA53 NEISSERIA GONORRHOEAE 71-123 |
| 140-167 |
| POPAG-- NEIGO OPACITY PROTEIN OPA52 NEISSERIA GONORRHOEAE 80-107 |
| 140-167 |
| POPAI-- NEIGO OPACITY PROTEIN OPA54 NEISSERIA GONORRHOEAE 80-107 |
| POPAJ-- NEIGO OPACITY PROTEIN OPA58 NEISSERIA GONORRHOEAE 71-105 |
| POPKK-- NEIGO OPACITY PROTEIN OPA57 NEISSERIA GONORRHOEAE 71-105 |
| POPDA-- |
| ECOLI OLIGOPEPTIDASE A ESCHERICHIA COLI 147-174 POPDA-- |
| SALTY OLIGOPEPTIDASE A SALMONELLA TYPHIMURIUM 147-174 |
| POPDE-- PSEAE TRANSCRIPTION FACTOR OPDE PSEUDOMONAS AERUGINOSA |
| 64-91 |
| POPPA-- ECOLI OLIGOPEPTIDE-BINDING PROTEIN PRECURSOR ESCHERICHIA |
| COLI 402-432 |
| POPPB-- SALTY OLIGOPEPTIDE PERMEASE PROTEIN OPPB SALMONELLA |
| TYPHIMURIUM 265-299 |
| POPR1-- |
| NEIME OPACITY-RELATED PROTEIN POPM1 NEISSERIA MENINGITIDIS 108-135 |
| POPR3-- NEIME OPACITY-RELATED PROTEIN POPM3 NEISSERIA |
| MENINGITIDIS |
| 94-135 POSMC-- |
| ECOLI OSMOTICALLY INDUCIBLE PROTEIN OSMC ESCHERICHIA COLI 5-31 |
| POSPA-- BORBU OUTER SURFACE PROTEIN A PRECURSOR BORRELIA |
| BURGDORFERI |
| 63-100 112-139 157-204 223-271 POSPB- |
| - BORBU OUTER SURFACE PROTEIN B PRECURSOR BORRELIA BURGDORFERI 113-259 |
| 262-296 |
| POTC2-- BACSU ORNITHINE CARBAMOYLTRANSFERASE BACILLUS SUBTILIS |
| 188-215 |
| POTCC-- |
| PSEAE ORNITHINE CARBAMOYLTRANSFERASE PSEUDOMONAS AERUGINOSA 17-44 |
| POTCC-- PSEPU ORNITHINE CARBAMOYLTRANSFERASE PSEUDOMONAS |
| PUTIDA |
| 3-33 |
| POUTB-- BACSU SPORE OUTGROWTH FACTOR B BACILLUS SUBTILIS 225-252 |
| POUTO-- ERWCA LEADER PEPTIDASE ERWINIA CAROTOVORA 189-216 |
| PP18K-- STRPA 18 KD PROTEIN IN FIMA 3'REGION STREPTOCOCCUS |
| PARASANGUIS 115-149 |
| PP18K-- STRSA 18 KD PROTEIN IN SSAB 3'REGION STREPTOCOCCUS |
| SANGUIS 10-37 114-148 |
| PP1P-- LACLC PI-TYPE PROTEINASE PRECURSOR LACTOCOCCUS LACTIS |
| 107-155 904-950 1073- 1223- 1466- 1625- |
| 1100 1250 1496 1655 |
| PP29-- MYCHR PROTEIN P29 MYCOPLASMA HYORHINIS 5-56 101-160 |
| 202-246 |
| PP2P-- LACLA PII-TYPE PROTEINASE PRECURSOR LACTOCOCCUS LACTIS |
| 107-155 904-950 1073- 1223- 1466- 1625- |
| 1100 1250 1496 1689 |
| PP2P-- |
| LACPS PII-TYPE PROTEINASE PRECURSOR LACTOBACILLUS PARACASEI 107-155 |
| 904-950 1073- 1223- 1466- 1628- |
| 1100 1250 1496 1655 |
| PP30-- |
| ECOLI P30 PROTEIN ESCHERICHIA COLI 55-82 PP34-- |
| RICRI PROTEIN P34 RICKETTSIA RICKETTSII |
| 9-47 135-173 PP37-- MYCHR PROTEIN P37 PRECURSOR |
| MYCOPLASMA HYORHINIS 38-75 |
| PP3P-- LACLC PIII-TYPE PROTEINASE PRECURSOR LACTOCOCCUS LACTIS |
| 107-155 904-950 1073- 1223- 1446- 1628- |
| 1100 1250 1496 1655 |
| PP47K-- PSECL 47 KD PROTEIN PSEUDOMONAS CHLORORAPHIS 288-315 |
| PP54-- ENTFC P54 PROTEIN PRECURSOR ENTEROCOCCUS FAECIUM 58-92 |
| 141-209 |
| PP60-- LISGR PROTEIN P60 PRECURSOR LISTERIA GRAYI 31-61 101-142 |
| 300-334 431-458 |
| PP60-- LISIN PROTEIN P60 PRECURSOR LISTERIA INNOCUA 67-94 102-143 |
| PP60-- LISIV PROTEIN P60 PRECURSOR LISTERIA IVANOVII 101-140 |
| 315-359 |
| PP60-- LISMO PROTEIN P60 PRECURSOR LISTERIA MONOCYTOGENES 103-144 |
| PP60-- LISSE PROTEIN P60 PRECURSOR LISTERIA SEELIGERI 101-140 |
| 270-298 321-365 395-422 |
| PP60-- LISWE PROTEIN P60 PRECURSOR LISTERIA WELSHIMERI 113-140 |
| 317-361 396-423 |
| PP69-- MYCHR PROTEIN P69 MYCOPLASMA HYORHINIS 264-295 421-464 |
| 487-517 544-575 |
| PPABA-- |
| BACSU ADC SYNTHASE BACILLUS SUBTILIS 12-41 PPABC-- |
| BACSU 4-AMINO-4-DEOXYCHORISMATE LYASE BACILLUS SUBTILIS 250-277 |
| PPABC-- ECOLI 4-AMINO-4-DEOXYCHORISMATE LYASE ESCHERICHIA |
| COLI 140-167 |
| PPABL-- |
| STRGR PROTEIN Y STREPTOMYCES GRISEUS 52-79 PPAC-- |
| ARTVI PENICILLIN ACYLASE PRECURSOR ARTHROBACTER VISCOSUS 170-197 333-363 |
| 571-606 640-674 |
| PPAC-- BACSH PENICILLIN ACYLASE BACILLUS SPHAERICUS 232-259 |
| PPAC-- STRMU PAC PROTEIN PRECURSOR STREPTOCOCCUS MUTANS |
| 146-276 281-465 538-565 576-630 1075- 1159- 1381- |
| 1102 1186 1434 |
| PPAI1-- BACSU REGULATORY PROTEIN PAI 1 BACILLUS SUBTILIS 103-137 |
| PPAI2-- BACSU REGULATORY PROTEIN PAI 2 BACILLUS SUBTILIS 145-172 |
| PPAPE-- ECOLI FIMBRIAL PROTEIN PAPE ESCHERICHIA COLI 42-69 |
| 86-123 |
| PPAPF-- ECOLI MINOR FIMBRIAL PROTEIN PAPF ESCHERICHIA COLI 4-31 |
| PPAPG-- ECOLI FIMBRIAL PROTEIN PAPG PRECURSOR ESCHERICHIA COLI |
| 282-316 |
| PPARA-- AGRTU PARA PROTEIN AGROBACTERIUM TUMEFACIENS 60-87 |
| PPARB-- ECOLI PLASMID PARTITION PAR B PROTEIN ESCHERICHIA |
| COLI 117-154 249-283 |
| PPARE-- ECOLI TOPOISOMERASE IV SUBUNIT B ESCHERICHIA COLI 444-471 |
| 526-553 |
| PPARE-- SALTY TOPOISOMERASE IV SUBUNIT B SALMONELLA TYPHIMURIUM |
| 444-471 526-553 |
| PPA-- BACAP PROTECTIVE ANTIGEN PRECURSOR BACILLUS ANTHRACIS 13-52 |
| 125-152 296-335 585-615 650- |
| 684 |
| PPBP2-- ECOLI PENICILLIN-BINDING PROTEIN 2 ESCHERICHIA COLI |
| 95-122 178-205 207-241 |
| PPBP2-- NEIGO PENICILLIN-BINDING PROTEIN 2 NEISSERIA GONORRHOEAE |
| 193-220 |
| PPBP2-- NEIME PENICILLIN-BINDING PROTEIN 2 NEISSERIA MENINGITIDIS |
| 193-220 |
| PPBP2-- STRPN PENICILLIN-BINDING PROTEIN 2B STREPTOCOCCUS |
| PNEUMONIAE 144-183 216-243 259-286 605-632 |
| PPBP3-- ECOLI PENICILLIN-BINDING PROTEIN 3 PRECURSOR ESCHERICHIA |
| COLI 224-251 334-368 |
| PPBP4-- BACSU PENICILLIN-BINDING PROTEIN 4* BACILLUS SUBTILIS 4 |
| 374-01 |
| PPBP4-- ECOLI PENICILLIN-BINDING PROTEIN 4 PRECURSOR ESCHERICHIA |
| COLI 336-363 |
| PPBPA-- ECOLI PENICILLIN-BINDING PROTEIN 1A ESCHERICHIA COLI |
| 145-172 |
| PPBPB-- ECOLI PENICILLIN-BINDING PROTEIN 1B ESCHERICHIA COLI |
| 62-96 263-290 |
| PPBPX-- STRPN PENICILLIN-BINDING PROTEIN 2X STREPTOCOCCUS |
| PNEUMONIAE |
| 89-116 706-733 PPBP- |
| - STAAU PENICILLIN-BINDING PROTEIN STAPHYLOCOCCUS AUREUS 78-108 |
| 176-203 263-324 502-529 |
| PPCAB-- PSEPU CYCLOISOMERASE PSEUDOMONAS PUTIDA 115-142 226-253 |
| PPEL3-- ERWCA PECTATE LYASE III PRECURSOR ERWINIA CAROTOVORA |
| 110-137 |
| PPELA-- ERWCA PECTATE LYASE A PRECURSOR ERWINIA CAROTOVORA |
| 110-137 |
| PPELB-- ERWCA PECTATE LYASE B PRECURSOR ERWINIA CAROTOVORA |
| 110-137 |
| PPELC-- ERWCA PECTATE LYASE C PRECURSOR ERWINIA CAROTOVORA |
| 110-137 |
| PPELF-- ERWCH PECTATE LYASE E PRECURSOR ERWINIA CHRYSANTHEMI |
| 40-67 209-243 |
| PPELP-- ERWCA PERIPLASMIC PECTATE LYASE PRECURSOR ERWINIA |
| CAROTOVORA 455-482 |
| PPELP-- YERPS PERIPLASMIC PECTATE LYASE PRECURSOR YERSINIA |
| PSEUDOTUBERCULOSIS 459-489 |
| PPELX-- |
| ERWCA PUTATIVE PECTATE LYASE X PRECURSOR ERWINIA CAROTOVORA 188-218 |
| PPELX-- ERWCH EXOPOLYGALACTURONATE LYASE PRECURSOR ERWINIA |
| CHRYSANTHEMI 466-493 |
| PPEPD-- ECOLI AMINOACYL-HISTIDINE DIPEPTIDASE ESCHERICHIA COLI |
| 264-314 |
| PPEPQ-- |
| ECOLI X-PRO DIPEPTIDASE ESCHERICHIA COLI 251-278 PPERT-- |
| BORBR PERTACTIN PRECURSOR BORDETELLA BRONCHISEPTICA 617-644 |
| PPERT-- BORPA PERTACTIN PRECURSOR BORDETELLA PARAPERTUSSIS |
| 628-655 |
| PPERT-- BORPE PERTACTIN PRECURSOR BORDETELLA PERTUSSIS 616-643 |
| PPGK-- CORGL PHOSPHOGLYCERATE KINASE CORYNEBACTERIUM GLUTMICUM |
| 83-117 |
| PPGK-- ECOLI PHOSPHOGLYCERATE KINASE ESCHERICHIA COLI 186-216 |
| PPGK-- METBR PHOSPHOGLYCERATE KINASE METHANOBACTERIUM BRYANTII |
| 36-63 |
| PPGK-- THETH PHOSPHOGLYCERATE KINASE THERMUS AQUATICUS 222-249 |
| PPGL1-- ERWCA ENDO-POLYGALACTURAONASE PRECURSOR ERWINIA |
| CAROTOVORA 237-271 |
| PPGTE-- SALTY OUTER MEMBRANE PROTEASE E PRECURSOR SALMONELLA |
| TYPHIMURIUM 66-93 |
| PPHA1-- FREDI C-PHYCOCYANIN-1 ALPHA CHAIN FREMYELLA DIPLOSIPHON |
| 21-48 |
| PPHA2-- FREDI C-PHYCOCYANIN-2 ALPHA CHAIN FREMYELLA DIPLOSIPHON |
| 21-48 |
| PPHAA-- PSEOL POLY(3-HYDROXYALKANOATE) POLYMERASE 1 PSEUDOMONAS |
| OLEOVORANS 264-291 |
| PPHAB-- ANACY ALLOPHYCOCYANIN BETA CHAIN ANABAENA CYLINDRICA |
| 7-48 |
| PPHAB-- ANAVA ALLOPHYCOCYANIN BETA CHAIN ANABAENA VARIABILIS |
| 14-48 |
| PPHAB-- FREDI ALLOPHYCOCYANIN BETA CHAIN FREMYELLA DIPLOSIPHON |
| 8-49 |
| PPHAB-- MASLA ALLOPHYCOCYANIN BETA CHAIN MASTIGOCLADUS LAMINOSUS |
| 14-41 |
| PPHAB-- SYNP6 ALLOPHYCOCYANIN BETA CHAIN SYNECHOCOCCUS SP 14-41 |
| PPHAC-- SYNP6 ALLOPHYCOCYANIN ALPHA-B CHAIN SYNECHOCOCCUS SP |
| 33-60 |
| PPHAG-- FREDI ALLOPHYCOCYANIN GAMMA CHAIN FREMYELLA DIPLOSIPHON |
| 32-59 |
| PPHB3-- FREDI C-PHYCOCYANIN-3 BETA CHAIN FREMYELLA DIPLOSIPHON |
| 29-56 |
| PPHBB-- ALCEU ACETOACETYL-COA REDUCTASE ALCALIGENES EUTROPHUS |
| 55-85 |
| PPHCA-- SYNY1 C-PHYCOCYANIN ALPHA CHAIN SYNECHOCYSTIS SP 21-55 |
| PPHCB-- SYNP6 C-PHYCOCYANIN BETA CHAIN SYNECHOCOCCUS SP 28-55 |
| PPHCB-- SYNP7 C-PHYCOCYANIN BETA CHAIN SYNECHOCOCCUS SP 28-55 |
| PPHCB-- SYNY1 C-PHYCOCYANIN BETA CHAIN SYNECHOCYSTIS SP 21-55 |
| PPHEA-- |
| ECOLI CHORISMATE MUTASE ESCHERICHIA COLI 10-37 PPHEA-- |
| ERWHE CHORISMATE MUTASE ERWINIA HERBICOLA 10-37 159-186 252-286 |
| PPHEA-- PSESP PHENOL 2-MONOOXYGENASE PSEUDOMONAS SP 171-201 |
| 282-314 437-464 |
| PPHEB-- MASLA PHYCOERYTHROCYANIN BETA CHAIN MASTIGOCLADUS |
| LAMINOSUS 21-62 |
| PPHEB-- PSESP CATECHOL 1,2-DIOXYGENASE PSEUDOMONAS SP 241-51 |
| PPHEG-- SYNPY LINKER POLYPEPTIDE SYNECHOCOCCUS SP 158-185 |
| PPHEP-- ECOLI PHENYLALANINE-SPECIFIC PERMEASE ESCHERICHIA COLI |
| 284-311 |
| PPHF1-- CLOPA PERIPLASMIC [FE] |
| HYDROGENASE 1 CLOSTRIDIUM PASTEURIANUM 434-471 |
| PPHL1-- BACCE SPHINGOMYELINASE C PRECURSOR BACILLUS CEREUS 2-36 |
| PPHL2-- BACCE SPHINGOMYELINASE C PRECURSOR BACILLUS CEREUS 2-36 |
| PPHL3-- BACCE SPHINGOMYELINASE C PRECURSOR BACILLUS CEREUS 2-36 |
| PPHLC-- BACCE PHOSPHOLIPASE C PRECURSOR BACILLUS CEREUS 32-59 |
| 179-206 |
| PPHLC-- CLOBI PHOSPHOLIPASE C PRECURSOR CLOSTRIDIUM BIFERMENTANS |
| 50-77 335-365 |
| PPHLC-- CLOPE PHOSPHOLIPASE C PRECURSOR CLOSTRIDIUM PERFRINGENS |
| 210-237 369-398 |
| PPHLC-- LISMO PHOSPHOLIPASE C PRECURSOR LISTERIA MONOCYTOGENES |
| 147-174 |
| PPHLC-- PSEAE HEMOLYTIC PHOSPHOLIPASE C PRECURSOR PSEUDOMONAS |
| AERUGINOSA 685-712 |
| PPHLC-- STAAU PHOSPHOLIPASE C PRECURSOR STAPHYLOCOCCUS AUREUS |
| 6-33 |
| PPHLD-- BACCE PHOSPHOLIPASE C PRECURSOR BACILLUS CEREUS 179-206 |
| PPHL-- LEPIN SPHINGOMYELINASE C PRECURSOR LEPTOSPIRA INTERROGANS |
| 30-57 394-428 |
| PPHND-- |
| ECOLI PHND PROTEIN ESCHERICHIA COLI 296-326 PPHNK-- |
| ECOLI PHNK PROTEIN ESCHERICHIA COLI 178-205 |
| PPHNM-- ECOLI PHNM PROTEIN ESCHERICHIA COLI |
| 5-35 PPHOE-- CITFR OUTER MEMBRANE PORE PROTEIN E |
| PRECURSOR CITROBACTER FREUDII 13-40 |
| 47-105 PPHOE-- ECOLI OUTER MEMBRANE |
| PORE PROTEIN E PRECURSOR ESCHERICHIA COLI 13-40 64-105 168-195 226-253 |
| PPHOE-- KLEOX OUTER MEMBRANE PORE PROTEIN E PRECURSOR KLEBSIELLA |
| OXYTOCA 13-40 64-91 |
| PPHOE-- KLEPN OUTER MEMBRANE PORE PROTEIN E PRECURSOR KLEBSIELLA |
| PNEUMONIAE 13-40 |
| 64-105 PPHOE-- |
| SALTY OUTER MEMBRANE PORE PROTEIN E PRECURSOR SALMONELLA TYPHIMURIUM |
| 63-104 320-347 |
| PPHOP-- BACSU ALK PHOS SYNTHESIS TRANS REG PROTEIN BACILLUS |
| SUBTILIS 185-219 |
| PPHOQ-- ECOLI SENSOR PROTEIN PHOQ ESCHERICHIA COLI 244-278 |
| PPHOQ-- SALTY VIRULENCE SENSOR PROTEIN PHOQ SALMONELLA |
| TYPHIMURIUM 226-260 |
| PPHOR-- BACSU ALK PHOS SYNTHESIS SENSOR PROTEIN PHOR BACILLUS |
| SUBTILIS |
| 89-145 387-425 |
| PPHRA-- ECOLI PHOTOREPAIR PROTEIN PHRA ESCHERICHIA COLI 63-90 |
| 207-241 |
| PPHRA-- SYNPY R-PHYCOCYANIN II ALPHA CHAIN SYNECHOCOCCUS SP 20-47 |
| PPHRA-- SYNPZ R-PHYCOCYANIN II ALPHA CHAIN SYNECHOCOCCUS SP 20-47 |
| PPHSG-- ECOLI GLYCOGEN PHOSPHORYLASE ESCHERICHIA COLI 157-184 |
| 488-515 |
| PPHSM-- ECOLI MALTODEXTRIN PHOSPHORYLASE ESCHERICHIA COLI 71-108 |
| PPILA-- NEIGO PROB SIGNAL RECOGNITION PARTICLE PROTEIN NEISSERIA |
| GONORRHOEAE 17-68 |
| PPILB-- |
| PSEAE FIMBRIAL ASSEMBLY PROTEIN PILB PSEUDOMONAS AERUGINOSA 16-60 |
| PPILC-- PSEAE PILC PROTEIN PSEUDOMONAS AERUGINOSA 143-170 |
| PPILD-- NEIGO LEADER PEPTIDASE NEISSERIA GONORRHOEAE 110-137 |
| PPILQ-- |
| PSEAE FIMBRIAL ASSEMBLY PROTEIN PILQ PRECURSOR PSEUDOMONAS AERUGINOSA |
| 71-115 639-666 |
| PPILS-- PSEAE SENSOR PROTEIN PILS PSEUDOMONAS AERUGINOSA 9-46 |
| PPIR-- |
| ECOLI PI PROTEIN ESCHERICHIA COLI 156-188 PPIV-- |
| MORBO PILIN GENE INVERTING PROTEIN MORAXELLA BOVIS 42-69 152-182 |
| PPIV-- MORLA PILIN GENE INVERTING PROTEIN MORAXELLA |
| LACUNATA 152-182 |
| PPLC-- BACCE PHOPHODIESTERASE PRECURSOR BACILLUS CEREUS 217-245 |
| PPLC-- BACTU PHOPHODIESTERASE PRECURSOR BACILLUS THURINGIENSIS |
| 216-245 |
| PPLC-- LISMO PHOPHODIESTERASE PRECURSOR LISTERIA MONOCYTOGENES |
| 238-265 |
| PPLSC-- |
| ECOLI ACYLTRANSFERASE ESCHERICHIA COLI 106-133 PPLSX-- |
| ECOLI PLSX PROTEIN ESCHERICHIA COLI 241-270 |
| PPLYD-- |
| ERWCA PECTIN LYASE ERWINIA CAROTOVORA 27-92 PPMBA-- |
| ECOLI PMBA PROTEIN ESCHERICHIA COLI |
| 9-50 PPME-- ERWCH PECTINESTERASE |
| PRECURSOR ERWINIA CHRYSANTHEMI 60-87 |
| PPMGY-- ECOLI PHOSPHOGLYCERATE MUTASE ESCHERICHIA COLI 82-116 |
| PPMGY-- ZYMM PHOSPHOGLYCERATE MUTASE ZYMOMONAS MOBILIS 13-0 |
| 80-110 |
| PPNP-- ECOLI POLYRIBONUC NUCLEOTIDLYTRANSF ESCHERICHIA COLI |
| 260-294 |
| PPNUC-- SALTY PNUC PROTEIN SALMONELLA TYPHIMURIUM 178-205 |
| PPODK-- |
| BACSY PYRUVATE, ORTHOPHOSPHATE DIKINASE BACTEROIDES SYMBIOSUS 51-78 |
| PPORF-- PSESY OUTER MEMBRANE PORIN F PRECURSOR PSEUDOMONAS |
| SYRINGAE 111-138 |
| PPORO-- PSEAE PORIN O PRECURSOR PSEUDOMONAS AERUGINOSA 390-424 |
| PPORP-- PSEAE PORIN P PRECURSOR PSEUDOMONAS AERUGINOSA 139-181 |
| 260-287 369-396 |
| PPOTD-- ECOLI BINDING PROTEIN PRECURSOR ESCHERICHIA COLI 320-347 |
| PPOTE-- ECOLI PUTRESCINE-ORNITHINE ANTIPORTER ESCHERICHIA COLI |
| 91-118 |
| PPOXB-- ECOLI PYRUVATE DEHYDROGENASE ESCHERICHIA COLI 8-38 |
| PPPB3-- BACSU ALKALINE PHOSPHATASE III PRECURSOR BACILLUS |
| SUBTILIS 109-150 433-460 |
| PPPB4-- BACSU ALKALINE PHOSPHATASE IV PRECURSOR BACILLUS SUBTILIS |
| 85-123 336-363 |
| PPPB-- ECOLI ALKALINE PHOSPHATASE PRECURSOR ESCHERICHIA COLI |
| 235-262 |
| PPPB-- |
| ESCFE ALKALINE PHOSPHATASE PRECURSOR ESCHERICHIA FERGUSONII 236-263 |
| PPPCE-- FLAME ALKALINE PHOSPHATASE PRECURSOR FLAVOBACTERIUM |
| MENINGOSEPTICUM 158-199 |
| PPPCF-- FLAME ALKALINE PHOSPHATASE PRECURSOR FLAVOBACTERIUM |
| MENINGOSEPTICUM 158-199 256-283 |
| PPPCK-- ECOLI PHOSPHOENOLPYRUVATE CARBOXYLINASE ESCHERICHIA COLI |
| 45-72 |
| PPPDA-- CLOPE PROTEIN A PRECURSOR CLOSTRIDIUM PERFRINGENS 73-107 |
| PPPSA-- ECOLI PHOSPHOENOLPYRUVATE SYNTHASE ESCHERICHIA COLI 49-76 |
| PPQQ2-- ACICA COENZYME PQQ SYNTHESIS PROTEIN II ACINETOBACTER |
| CALCOACETICUS 40-74 |
| PPRCA-- ANAVA CALCIUM DEPENDENT PROTEASE PRECURSOR ANABAENA |
| VARIABILIS 371-398 |
| PPRCA-- THEAC PROTEASOME, ALPHA SUBUNIT THERMOPLASMA ACIDOPHILUM |
| 88-115 |
| PPRC-- ECOLI TAIL-SPECIFIC PROTEASE PRECURSOR ESCHERICHIA COLI |
| 158-192 366-393 |
| PPRE1-- STAAU PLASMID RECOMBINATION ENZYME STAPHYLOCOCCUS AUREUS |
| 27-78 152-179 264-347 |
| PPRE2-- STAAU PLASMID RECOMBINATION ENZYME STAPHYLOCOCCUS AUREUS |
| 48-75 181-208 310-361 366-393 |
| PPREA-- |
| LACPL PLASMID RECOMBINATION ENZYME LACTOBACILLUS PLANTARUM 37-71 |
| 291-318 |
| PPRE-- BACLI REGULATORY PROTEIN BACILLUS LICHENIFORMIS 2-40 |
| PPRE-- BACSP PLASMID RECOMBINATION ENZYME BACILLUS SP 181-224 |
| 288-345 |
| PPRE-- |
| STRAG PLASMID RECOMBINATION ENZYME STREPTOCOCCUS AGALACTIAE 285-319 |
| 332-359 420-454 |
| PPRFA-- |
| LISMO LISTERIOLYSIN REGULATORY PROTEIN LISTERIA MONOCYTOGENES 76-110 |
| 173-204 |
| PPRIA-- ECOLI PRIMOSOMAL PROTEIN N' ESCHERICHIA COLI 218-245 |
| PPRIM-- |
| BACSU DNA PRIMASE BACILLUS SUBTILIS 383-433 PPRIM-- |
| BUCAP DNA PRIMASE BUCHNERA APHIDICOLA 13-43 282-319 |
| PPRIM-- CLOAB DNA PRIMASE CLOSTRIDIUM ACETOBUTYLICUM 87-114 |
| PPRIM-- |
| LACLA DNA PRIMASE LACTOCOCCUS LACTIS 269-296 PPRIM-- |
| RICPR DNA PRIMASE RICKETTSIA PROWAZEKII 10-37 245-286 477-504 526-593 |
| PPRIS-- DESDE PRISMANE PROTEIN DESULFOVIBRIO DESULFURICANS |
| 30-57 |
| PPRLB-- ACHLY BETA-LYTIC METALLOENDOPEPTIDASE ACHROMOBACTER |
| LYTICUS 317-344 |
| PPRLB-- |
| LYSEN BETA-LYTIC METALLOENDOPEPTIDASE LYSOBACTER ENZYMOGENES 121-148 |
| PPRO1-- LISMO ZINC METALLOPROTEINASE PRECURSOR LISTERIA |
| MONOCYTOGENES 111-145 275-316 |
| PPRO2-- |
| LISMO ZINC METALLOPROTEINASE PRECURSOR LISTERIA MONOCYTOGENES 111-145 |
| PPROA-- SERMA GAMMA-GLUTAMYL PHOSPHATE REDUCTASE SERRATIA |
| MARCESCENS 309-336 |
| PPROA-- STAAU PROTEIN A PRECURSOR STAPHYLOCOCCUS AUREUS 2-29 |
| PPROB-- SERMA GLUTAMATE 5-KINASE SERRATIA MARCESCENS 7-34 |
| PPROB-- STRAG PROTEIN B STREPTOCOCCUS AGALACTIAE 58-85 |
| PPROC-- |
| PSEAE PYRROLINE-5-CARBOXYLATE REDUCTASE PSEUDOMONAS AERUGINOSA 148-175 |
| PPROH-- BACSU PYRROLINE-5-CARBOXYLATE REDUCTASE HOMOL BACILLUS |
| SUBTILIS 200-227 |
| PPROP-- ECOLI PROLINE/BETAINE TRANSPORTER ESCHERICHIA COLI |
| 460-487 |
| PPROV-- ECOLI PERIPHERAL MEMBRANE PROTEIN PROV ESCHERICHIA COLI |
| 24-54 |
| PPROV-- SALTY PERIPHERAL MEMBRANE PROTEIN PROV SALMONELLA |
| TYPHIMURIUM 24-54 |
| PPRRB-- |
| ECOLI PRRB PROTEIN ESCHERICHIA COLI 170-917 PPRRC-- |
| ECOLI ANTICODON NUCLEASE ESCHERICHIA COLI 282-309 |
| PPRRD-- |
| ECOLI PRRD PROTEIN ESCHERICHIA COLI 278-305 PPRSA-- |
| BACSU PROTEIN EXPORT PROTEIN PRSA PRECURSOR BACILLUS SUBTILIS 52-87 |
| 95-157 |
| PPRTA-- STRGR PROTEASE A PRECURSOR STREPTOMYCES GRISEUS 56-110 |
| PPRTC-- ERWCH SECRETED PROTEASE C PRECURSOR ERWINIA CHRYSANTHEMI |
| 103-130 |
| PPRTC-- PORGI COLLAGENASE PRECURSOR PORPHYROMONAS GINGIVALIS |
| 285-312 |
| PPRTD-- |
| ERWCH PROTEASES SECRETION PROTEIN PRTD ERWINIA CHRYSANTHEMI 328-355 |
| PPRTE-- |
| BACNO EXTRACELLULAR SERINE PROTEASE PRECURSOR BACTEROIDES NODOSUS |
| 106-133 219-265 346-384 |
| PPRTE-- |
| ERWCH PROTEASES SECRETION PROTEIN PRTE ERWINIA CHRYSANTHEMI 108-135 |
| 158-192 231-290 |
| PPRTF-- |
| ERWCH PROTEASES SECRETION PROTEIN PRTF ERWINIA CHRYSANTHEMI 280-310 |
| PPRTM-- |
| LACLA PROTEASE MATURATION PROTEIN PRECURSOR LACTOCOCCUS LACTIS 76-103 |
| 112-139 |
| PPRTM-- LACLC PROTEASE MATURATION PROTEIN PRECURSOR LACTOCOCCUS |
| LACTIS 26-53 |
| 76-103 112-139 PPRTM-- |
| LACPA PROTEASE MATURATION PROTEIN PRECURSOR LACTOBACILLUS PARACASEI |
| 76-103 112-139 |
| PPRTS-- SERMA EXTRACELLULAR SERINE PROTEASE PRECURSOR SERRATIA |
| MARCESCENS 304-331 576-607 1007- |
| 1041 |
| PPRTT-- SERMA EXTRACELLULAR SERINE PROTEASE PRECURSOR SERRATIA |
| MARCESCENS 304-331 464-491 1007- |
| 1041 |
| PPRTX-- ERWCH SECRETED PROTEASE C PRECURSOR ERWINIA CHRYSANTHEMI |
| 314-341 |
| PPSAA-- SYNEN CHLOROPHYLL A APOPROTEIN A1 SYNECHOCOCCUS ELONGATUS |
| NAEGEL 120-147 |
| PPSAA-- SYNP2 CHLOROPHYLL A APOPROTEIN A1 SYNECHOCOCCUS SP |
| 109-136 326-356 |
| PPSAA-- SYNVU CHLOROPHYLL A APOPROTEIN A1 SYNECHOCOCCUS VULCANUS |
| 120-147 |
| PPSAA-- SYNY3 CHLOROPHYLL A APOPROTEIN A1 SYNECHOCYSTIS SP 44-71 |
| 120-147 338-368 |
| PPSAB-- YERPE CHAPERONE PROTEIN PSAB PRECURSOR YERSINIA PESTIS |
| 244-271 |
| PPSAD-- |
| SYNP6 PHOTOSYSTEM I REACTION CENTRE SUBUNIT II SYNECHOCOCCUS SP 11-38 |
| PPSAE-- YERPE PSAE PROTEIN PRECURSOR YERSINIA PESTIS 66-118 |
| PPSBO-- ANANI STABILIZING POLYPEPTIDE PRECURSOR ANACYSTIS |
| NIDULANS |
| 99-126 209-243 |
| PPSPA-- |
| ECOLI PHAGE SHOCK PROTEIN A ESCHERICHIA COLI 55-82 PPSRA- |
| - WOLSU POLYSULFIDE REDUCTASE CHAIN A PRECURSOR WOLINELLA SUCCINOGENES |
| 114-141 |
| PPSTS-- ECOLI PHOSPHATE-BINDING PROTEIN PRECURSOR ESCHERICHIA |
| COLI 40-74 |
| PPT1-- |
| BACSU PHOSPHOTRANSFERASE BACILLUS SUBTILIS 26-60 PPT1-- |
| ECOLI PHOSPHOTRANSFERASE ESCHERICHIA COLI 135-162 399-426 |
| PPT1-- SALTY PHOSPHOTRANSFERASE SALMONELLA TYPHIMURIUM 232-259 |
| 399-426 |
| PPT1-- STACA PHOSPHOTRANSFERASE STAPHYLOCOCCUS CARNOSUS 34-61 |
| PPT1-- STRSL PHOSPHOTRANSFERASE STREPTOCOCCUS SALIVARIUS 34-61 |
| 198-232 |
| PPT2B-- ERWCH PHOSPHOTRANSFERASE ENZYME II ERWINIA CHRYSANTHEMI |
| 127-154 |
| PPT2G-- BACSU PHOSPHOTRANSFERASE ENZYME II BACILLUS SUBTILIS |
| 670-697 |
| PPT2L-- LACCA PHOSPHOTRANSFERASE ENZYME II LACTOBACILLUS CASEI |
| 537-564 |
| PPT2L-- LACLA PHOSPHOTRANSFERASE ENZYME II LACTOCOCCUS LACTIS |
| 183-214 409-436 |
| PPT2L-- STAAU PHOSPHOTRANSFERASE ENZYME II STAPHYLOCOCCUS AUREUS |
| 421-448 530-557 |
| PPT2M-- ECOLI PHOSPHOTRANSFERASE ENZYME II ESCHERICHIA COLI |
| 445-489 |
| PPT2M-- STACA PHOSPHOTRANSFERASE ENZYME II STAPHYLOCOCCUS |
| CARNOSUS 388-415 |
| PPT2N-- ECOLI N-ACETYLGLUCOSAMINE-PERMEASE ESCHERICHIA COLI |
| 370-400 |
| PPT2S-- STRMU PHOSPHOTRANSFERASE ENZYME II STREPTOCOCCUS MUTANS |
| 600-627 |
| PPT3F-- |
| SALTY PHOSPHOTRANSFERASE FPR PROTEIN SALMONELLA TYPHIMURIUM 107-134 |
| PPT3L-- LACCA PHOSPHOTRANSFERASE FACTOR III LACTOBACILLUS |
| CASEI 40-67 |
| PPTHP-- ECOLI PHOSPHOCARRIER PROTEIN HPR ESCHERICHIA COLI & 31-65 |
| SALMONELLA TYPHIMURIUM |
| PPTHP-- KLEPN PHOSPHOCARRIER PROTEIN HPR KLEBSIELLA PNEUMONIAE |
| 31-65 |
| PPTRB-- ECOLI PROTEASE II ESCHERICHIA COLI 94-121 217-251 |
| PPULA-- KLEAE PULLULANASE KLEBSIELLA AEROGENES 894-928 |
| PPULA-- KLEPN PULLULANASE KLEBSIELLA PNEUMONIAE 894-928 |
| PPULO-- KLEPN LEADER PEPTIDASE KLEBSIELLA PNEUMONIAE 178-205 |
| PPULS-- |
| KLEPN PULS PRECURSOR KLEBSIELLA PNEUMONIAE 70-97 PPUPA-- |
| PSEPU UPTAKE PROTEIN PRECURSOR PSEUDOMONAS PUTIDA 112-162 210-237 |
| 429-463 736-763 |
| PPUR1-- BACSU AMIDOPHOSPHORIBOSYLTRANSF PREC BACILLUS SUBTILIS |
| 394-421 |
| PPUR2-- BACSU PHOSPHORIBOSYLAMINE-GLYCINE LIGASE BACILLUS |
| SUBTILIS 349-376 |
| PPUR3-- BACSU FORMYLTRANSFERASE BACILLUS SUBTILIS 149-176 |
| PPUR3-- ECOLI FORMYLTRANSFERASE ESCHERICHIA COLI 27-54 |
| PPUR4-- |
| BACSU SYNTHASE I BACILLUS SUBTILIS 18-45 PPUR5-- |
| BACSU CYCLO-LIGASE BACILLUS SUBTILIS 153-194 |
| PPUR6-- |
| ECOLI AIR CARBOXYLASE ESCHERICHIA COLI 131-158 PPUR7-- |
| BACSU SAICAR SYNTHETASE BACILLUS SUBTILIS |
| 3-43 PPUR8-- BACSU ADENYLOSUCCINATE LYASE |
| BACILLUS SUBTILIS |
| 56-130 226-253 PPUR8-- |
| ECOLI ADENYLOSUCCINATE LYASE ESCHERICHIA COLI 194-221 331-372 |
| PPUR9-- BACSU AICAR TRANSFORMYLASE BACILLUS SUBTILIS 19-53 |
| 345-372 |
| PPUR9-- ECOLI AICAR TRANSFORMYLASE ESCHERICHIA COLI 239-268 |
| PPUR9-- SALTY AICAR TRANSFORMYLASE SALMONELLA TYPHIMURIUM |
| 218-247 |
| PPURL-- |
| BACSU SYNTHASE II BACILLUS SUBTILIS 609-636 PPYG1-- |
| ANASP LINKER POLYPEPTIDE CPCG1 ANABAENA SP |
| 88-115 PPYG1-- MASLA LINKER POLYPEPTIDE CPCG1 |
| M ASTIGOCLADUS LAMINOSUS |
| 89-116 PPYG2-- ANASP |
| LINKER POLYPEPTIDE CPCG2 ANABAENA SP |
| 88-115 PPYG2-- |
| MASLA LINKER POLYPEPTIDE CPCG2 MASTIGOCLADUS LAMINOSUS |
| 89-116 PPYG3-- |
| MASLA LINKER POLYPEPTIDE CPCG3 MASTIGOCLADUS LAMINOSUS |
| 91-132 PPYG4-- ANASP LINKER POLYPEPTIDE CPCG4 ANABAENA |
| SP |
| 90-131 |
| PPYR1-- |
| ANASP 32.1 KD LINKER POLYPEPTIDE ANABAENA SP 35-62 PPYR2- |
| - FREDI 27.9 KD LINKER POLYPEPTIDE FREMYELLA DIPLOSIPHON 105-132 |
| PPYR4-- |
| FREDI 31.6 KD LINKER POLYPEPTIDE FREMYELLA DIPLOSIPHON 22-66 |
| PPYR5-- FREDI 37.5 KD LINKER POLYPEPTIDE FREMYELLA DIPLOSIPHON |
| 106-143 |
| PPYR6-- FREDI 30.8 KD LINKER POLYPEPTIDE FREMYELLA DIPLOSIPHON |
| 43-70 113-140 |
| PPYRB-- BACSU ASPARTATE CARBAMOYLTRANSFERASE BACILLUS SUBTILIS |
| 9-36 |
| PPYRB-- SERMA ASPARTATE CARBAMOYLTRANSFERASE SERRATIA MARCESCENS |
| 70-97 |
| PPYRD-- ECOLI DIHYDROOROTATE DEHYDROGENASE ESCHERICHIA COLI |
| 115-142 |
| PPYRD-- SALTY DIHYDROOROTATE DEHYDROGENASE SALMONELLA TYPHIMURIUM |
| 115-142 183-210 |
| PPYRG-- BACSU CTP SYNTHASE BACILLUS SUBTILIS 275-302 322-349 |
| PPYS1-- FREDI PHYCOBILISOME 9.7 KD LINKER POLYPEPTIDE |
| FREMYELLA DIPLOSIPHON 21-48 |
| PQOR-- ECOLI QUINONE OXIDOREDUCTASE ESCHERICHIA COLI 180-215 |
| PQUEA-- ECOLI QUEUOSINE BIOSYNTHESIS PROTEIN QUEA ESCHERICHIA |
| COLI 234-261 |
| PP34K-- CLOPA 34.2 KD PROTEIN IN RUBREDOXIN OPERON CLOSTRIDIUM |
| PASTEURIANUM 23-50 157-232 |
| PRACC-- ECOLI RACC PROTEIN ESCHERICHIA COLI |
| 5-32 PRACD-- |
| STRTR ASPARTATE RACEMASE STREPTOCOCCUS THERMOPHILUS 152-189 |
| PRACX-- BACSU PROBABLE AMINO ACID RACEMASE BACILLUS SUBTILIS |
| 132-162 |
| PRAFA-- ECOLI ALPHA-GALACTOSIDASE ESCHERICHIA COLI 89-116 |
| PRFAD-- ECOLI RAFFINOSE INVERTASE ESCHERICHIA COLI 348-375 |
| PRBSC-- ECOLI RIBOSE TRANSPORT SYSTEM COMPONENT ESCHERICHIA COLI |
| 65-99 195-222 |
| PRBSK-- |
| ECOLI RIBOKINASE ESCHERICHIA COLI 200-239 PRBTR-- |
| KLEAE RIBITOL (RBT) OPERON REPRESSOR KLEBSIELLA AEROGENES 6-47 |
| PRCSA-- ECOLI BIOSYNTHESIS ACTIVATION PROTEIN A ESCHERICHIA |
| COLI 170-197 |
| PRCSA-- ERWAM BIOSYNTHESIS ACTIVATION PROTEIN A ERWINIA AMYLOVORA |
| 92-119 174-201 |
| PRCSA-- ERWST BIOSYNTHESIS ACTIVATION PROTEIN A ERWINIA STEWARTII |
| 174-201 |
| PRCSA-- KLEAE BIOSYNTHESIS ACTIVATION PROTEIN A KLEBSIELLA |
| AEROGENES 168-205 |
| PRCSB-- ECOLI CAPSULE SYNTHESIS B COMPONENT ESCHERICHIA COLI |
| 14-41 159-186 |
| PREC2-- LEGPN RECA PROTEIN LEGIONELLA PNEUMOPHILA 262-310 |
| PRECA-- ACHLA RECA PROTEIN ACHOLEPLASMA LAIDLAWII 283-310 |
| PRECA-- AGRTU RECA PROTEIN AGROBACTERIUM TUMEFACIENS 3-30 |
| 132-159 281-308 |
| PRECA-- |
| ANAVA RECA PROTEIN ANABAENA VARIABILIS 322-349 PRECA-- |
| AQUPY RECA PROTEIN AQUIFEX PYROPHILUS 63-90 126-153 |
| PRECA-- |
| BACFR RECA PROTEIN BACTEROIDES FRAGILIS 108-135 PRECA-- |
| BACSU RECA PROTEIN BACILLUS SUBTILIS 267-294 |
| PRECA-- BRUAB RECA PROTEIN BRUCELLA ABORTUS 3-30 132-159 280-307 |
| PRECA-- BURCE RECA PROTEIN BURKHOLDERIA CEPACIA |
| 75-109 PRECA-- ERWCA RECA PROTEIN ERWINIA CAROTOVORA |
| 284-311 |
| PRECA-- LACDE RECA PROTEIN LACTOBACILLUS DELBRUECKII 20-47 |
| PRECA-- LACHE RECA PROTEIN LACTOBACILLUS HELVETICUS 20-47 |
| PRECA-- LACLA RECA PROTEIN LACTOCOCCUS LACTIS 135-162 232-269 |
| 288-315 |
| PRECA-- |
| METCL RECA PROTEIN METHYLOMONAS CLARA 266-303 PRECA-- |
| METFL RECA PROTEIN METHYLOBACILLUS FLAGELLATUM 276-303 |
| PRECA-- |
| MYCPU RECA PROTEIN MYCOPLASMA PULMONIS 30-57 PRECA-- |
| MYCTU RECA PROTEIN MYCOBACTERIUM TUBERCULOSIS 749-776 |
| PRECA-- |
| NEIGO RECA PROTEIN NEISSERIA GONORRHOEAE 263-310 PRECA-- |
| PROMI RECA PROTEIN PROTEUS MIRABILIS 283-310 |
| PRECA-- PSEAE RECA PROTEIN PSEUDOMONAS AERUGINOSA 282-309 |
| PRECA-- RHILP RECA PROTEIN RHIZOBIUM LEGUMINOSARUM 3-30 |
| 131-158 280-307 |
| PRECA-- RHILV RECA PROTEIN RHIZOBIUM LEGUMINOSARUM 119-146 |
| 268-295 |
| PRECA-- RHIME RECA PROTEIN RHIZOBIUM MELILOTI 119-146 268-295 |
| PRECA-- RHOSH RECA PROTEIN RHODOBACTER SPHAEROIDES 119-146 |
| PRECA-- STRPN RECA PROTEIN STREPTOCOCCUS PNEUMONIAE 134-161 |
| 293-327 |
| PRECA-- |
| SYNP2 RECA PROTEIN SYNECHOCOCCUS SP 124-151 PRECA-- |
| VIBCH RECA PROTEIN VIBRIO CHOLERAE 290-317 |
| PRECF-- BACSU RECA PROTEIN BACILLUS SUBTILIS 4-31 178-205 |
| PRECF-- ECOLI RECA PROTEIN ESCHERICHIA COLI 82-109 147-174 |
| PRECF-- PROMI RECA PROTEIN PROTEUS MIRABILIS |
| 86-113 PRECF-- PSEIU RECA PROTEIN PSEUDOMONAS PUTIDA |
| 84-111 |
| PRECF-- |
| SALTY RECA PROTEIN SALMONELLA TYPHIMURIUM 147-174 PRECJ- |
| - |
| ECOLI EXONUCLEASE RECJ ESCHERICHIA COLI 52-79 |
| PRECN-- BACSU RECOMBINATION PROTEIN BACILLUS SUBTILIS 21-48 156-184 |
| 192-247 299-336 344- |
| 378 |
| PRECQ-- |
| ECOLI DNA HELICASE RECQ ESCHERICHIA COLI 468-495 PRELA-- |
| ECOLI GTP PYROPHOSPHOKINASE ESCHERICHIA COLI 680-707 |
| PREMA-- BACSU REPLICATION AND MAINTENANCE PROTEIN BACILLUS |
| SUBTILIS 2-36 |
| 81-108 PREMA-- |
| STAAU REPLICATION AND MAINTENANCE PROTEIN STAPHYLOCOCCUS AUREUS 2-36 |
| 81-108 |
| PREMA-- STAEP REPLICATION AND MAINTENANCE PROTEIN STAPHYLOCOCCUS |
| EPIDERMIDIS 2-36 |
| 81-108 PREP5-- |
| ECOLI REPLICATION PROTEIN REPA ESCHERICHIA COLI 50-77 |
| 90-117 PREPA-- BACSU REPA PROTEIN BACILLUS SUBTILIS |
| 342-373 |
| PREPA-- ECOLI REPA PROTEIN ESCHERICHIA COLI 91-118 228-255 |
| PREPA-- NEIGO REPLICATION PROTEIN NEISSERIA GONORRHOEAE |
| 57-84 138-172 |
| PREPB-- LACPL REPLICATION PROTEIN REPB LACTOBACILLUS PLANTARUM |
| 184-211 |
| PREPM-- STAAU REPLICATION INITIATION PROTEIN STAPHYLOCOCCUS |
| AUREUS 254-284 |
| PREPN-- STAAU REPLICATION INITIATION PROTEIN STAPHYLOCOCCUS |
| AUREUS 258-285 |
| PREPR-- STRAG REPR PROTEIN STREPTOCOCCUS AGALACTIAE 430-467 |
| PREPS-- STRPY REPS PROTEIN STREPTOCOCCUS PYOGENES 423-467 |
| PREPX-- STAAU REP PROTEIN STAPHYLOCOCCUS AUREUS 111-150 172-210 |
| PREPY-- ECOLI REPLICATION INITIATION PROTEIN ESCHERICHIA COLI |
| 288-315 |
| PREP-- CLOPE REPLICATION PROTEIN CLOSTRIDIUM PERFRINGENS 168-195 |
| 297-324 343-375 |
| PREP-- ECOLI REP HELICASE ESCHERICHIA COLI 119-146 205-243 |
| PREP-- LACPL REP PROTEIN LACTOBACILLUS PLANTARUM 119-199 |
| 260-287 |
| PRESP-- CLOPE RESOLVASE CLOSTRIDIUM PERFRINGENS 68-102 151-185 |
| PRF2-- VACSU PROBABLE PEPTIDE CHAIN RELEASE FACTOR 2 BACILLUS |
| SUBTILIS 34-68 |
| PRF2-- ECOLI PEPTIDE CHAIN RELEASE FACTOR 2 ESCHERICHIA COLI |
| 86-113 163-204 |
| PRF2-- |
| SALTY PEPTIDE CHAIN RELEASE FACTOR 2 SALMONELLA TYPHIMURIUM 86-113 |
| 163-204 |
| PRF3-- ECOLI PEPTIDE CHAIN RELEASE FACTOR 3 ESCHERICHIA COLI |
| 180-210 443-437 |
| PRFAB-- ECOLI 1,6-GALACTOSYLTRANSFERASE ESCHERICHIA COLI 199-226 |
| PRFAG-- ECOLI BIOSYNTHESIS PROTEIN RFAG ESCHERICHIA COLI 185-212 |
| PRFAJ-- ECOLI 1,2-GLUCOSYLTRANSFERASE ESCHERICHIA COLI 39-66 |
| 233-268 |
| PRFAJ-- SALTY 1,2-GLUCOSYLTRANSFERASE SALMONELLA TYPHIMURIUM |
| 68-95 145-172 236-263 |
| PRFAK-- SALTY 1,2-N-ACETYLGLUCOSAMINETRANSFERSE SALMONELLA |
| TYPHIMURIUM 335-369 |
| PRFAL-- |
| ECOLI O-ANTIGEN LIGASE ESCHERICHIA COLI 366-393 PRFAL-- |
| SALTY O-ANTIGEN LIGASE SALMONELLA TYPHIMURIUM 326-360 |
| PRFAP-- ECOLI BIOSYNTHESIS PROTEIN RFAP ESCHERICHIA COLI 8-35 |
| PRFAS-- ECOLI BIOSYNTHESIS PROTEIN RFAS ESCHERICHIA COLI 62-89 |
| 184-240 |
| PRFAY-- ECOLI BIOSYNTHESIS PROTEIN RFAY ESCHERICHIA COLI 18-45 |
| PRFAZ-- ECOLI BIOSYNTHESIS PROTEIN RFAZ ESCHERICHIA COLI 3-30 |
| 85-112 |
| PRFBB-- SALTY DTDP-GLUCOSE 4,6-DEHYDRATASE SALMONELLA TYPHIMURIUM |
| 320-359 |
| PRFBM-- SALTY MANNOSE-1-PHOSPHATE GUANYLYLTRANSFERASE SALMONELLA |
| TYPHIMURIUM 313-361 |
| PRFBS-- SALTI PARATOSE SYNTHASE SALMONELLA TYPHI 22-56 205-232 |
| PRFEA-- |
| VIBAN PRECURSOR FOR FERRIC ANGUIBACTIN VIBRIO ANGUILLARUM 349-376 |
| PRFH-- |
| ECOLI PEPTIDE CHAIN RELEASE FACTOR HOMOLOG ESCHERICHIA COLI 83-110 |
| PRGI2-- BACTU PUTATIVE GI2 SITE-SPECIFIC RECOMBINASE BACILLUS |
| THURINGIENSIS 15-68 190-262 310-383 |
| PRHAB-- |
| ECOLI RHAMNULOKINASE ESCHERICHIA COLI 175-202 PRHAB-- |
| SALTY RHAMNULOKINASE SALMONELLA TYPHIMURIUM 175-202 |
| PRHAR-- ECOLI L-RHAMNOSE OPERON TRANSACTIVATOR ESCHERICHIA COLI |
| 10-41 |
| PRHAS-- ECOLI L-RHAMNOSE OPERON REG PROTEIN RHAS ESCHERICHIA COLI |
| 152-179 |
| PRHIR-- RHILV RHIR REGULATORY PROTEIN RHIZOBIUM LEGUMINOSARUM |
| 206-233 |
| PRHLB-- ECOLI RNA HELICASE RHLB/MMRA ESCHERICHIA COLI 138-165 |
| PRHO-- BORBU TRANS TERM FACTOR RHO BORRELIA BURGDORFERI |
| 215-242 327-369 |
| PRHPR-- BACSU PROTEASE PROD REG PROTEIN HPR BACILLUS SUBTILIS |
| 82-109 |
| PRHSA-- ECOLI RHSA PROTEIN PRECURSOR ESCHERICHIA COLI 667-694 |
| PRHSB-- ECOLI RHSB PROTEIN PRECURSOR ESCHERICHIA COLI 667-694 |
| PRHSC-- ECOLI RHSC PROTEIN PRECURSOR ESCHERICHIA COLI 380-414 |
| 667-694 1056- |
| 1083 |
| PRHSD-- ECOLI RHSD PROTEIN PRECURSOR ESCHERICHIA COLI 671-712 |
| 1071- |
| 1098 |
| PRHSE-- |
| ECOLI RHSE PROTEIN ESCHERICHIA COLI 345-372 PRIML-- |
| ECOLI ACETYLTRANSFERASE ESCHERICHIA COLI |
| 93-127 PRIR2-- |
| ECOLI RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE ESCHERICHIA COLI 167-194 |
| PRISA-- PHOLE RIBOFLAVIN SYNTHASE ALPHA CHAIN PHOTOBACTERIUM |
| LEIOGNATHI |
| 2-47 131-158 PRISB |
| -- BACSU RIBOFLAVIN SYNTHASE BETA CHAIN BACILLUS SUBTILIS 8-35 |
| PRISB-- |
| PHOLE RIBOFLAVIN SYNTHASE BETA CHAIN PHOTOBACTERIUM LEIOGNATHI 14-41 |
| PRL10-- |
| STRAT 50S RIBOSOMAL PROTEIN L10 STREPTOMYCES ANTIBIOTICUS 14-72 106-133 |
| PRL12-- SYNY3 50S RIBOSOMAL PROTEIN L12 SYNECHOCYSTIS SP 2-34 |
| PRL12-- THEMA 50S RIBOSOMAL PROTEIN L12 THERMOTOGA MARITIMA |
| 8-35 56-86 |
| PRL14-- |
| BACST 50S RIBOSOMAL PROTEIN L14 BACILLUS STEAROTHERMOPHILUS 18-45 |
| PRL14-- MICLU 50S RIBOSOMAL PROTEIN L14 MICROCOCCUS LUTEUS |
| 18-45 |
| PRL14-- MYCCA 50S RIBOSOMAL PROTEIN L14 MYCOPLASMA CAPRICOLUM |
| 51-92 |
| PRL15-- BACLI 50S RIBOSOMAL PROTEIN L15 BACILLUS LICHENIFORMIS |
| 21-48 |
| PRL15-- |
| BACST 50S RIBOSOMAL PROTEIN L15 BACILLUS STEAROTHERMOPHILUS 95-134 |
| PRL15-- BACSU 50S RIBOSOMAL PROTEIN L15 BACILLUS SUBTILIS |
| 95-122 |
| PRL15-- CHLTR 50S RIBOSOMAL PROTEIN L15 CHLAMYDIA TRACHOMATIS |
| 110-144 |
| PRL15-- ECOLI 50S RIBOSOMAL PROTEIN L15 ESCHERICHIA COLI 79-113 |
| PRL15-- LACLA 50S RIBOSOMAL PROTEIN L15 LACTOCOCCUS LACTIS 8-35 |
| PRL15-- METVA 50S RIBOSOMAL PROTEIN L15 METHANOCOCCUS VANNIELII |
| 68-102 |
| PRL15-- MYCCA 50S RIBOSOMAL PROTEIN L15 MYCOPLASMA CAPRICOLUM |
| 63-135 |
| PRL18-- |
| BACST 50S RIBOSOMAL PROTEIN L18 BACILLUS STEAROTHERMOPHILUS 31-58 |
| PRL18-- |
| CHLTR 50S RIBOSOMAL PROTEIN L18 CHLAMYDIA TRACHOMATIS 32-86 |
| PRL18-- HALMA 50S RIBOSOMAL PROTEIN L18 HALOARCULA MARISMORTUI |
| 80-107 |
| PRL18-- MYCCA 50S RIBOSOMAL PROTEIN L18 MYCOPLASMA CAPRICOLUM |
| 61-88 |
| PRL19-- ECOLI 50S RIBOSOMAL PROTEIN L19 ESCHERICHIA COLI 25-52 |
| PRL19-- HALMA 50S RIBOSOMAL PROTEIN L19 HALOARCULA MARISMORTUI |
| 101-128 |
| PRL19-- METVA PROBABLE 50S RIBOSOMAL PROTEIN METHANOCOCCUS |
| VANNIELII 45-72 |
| PRL1-- PROVU 50S RIBOSOMAL PROTEIN L1 PROTEUS VULGARIS 159-194 |
| PRL1-- SULSO 50S RIBOSOMAL PROTEIN L1 SULFOLOBUS SOLFATARICUS |
| 5-32 184-211 |
| PRL20-- ECOLI 50S RIBOSOMAL PROTEIN L20 ESCHERICHIA COLI 14-41 |
| PRL20-- MYCFE 50S RIBOSOMAL PROTEIN L20 MYCOPLASMA FERMENTANS |
| 14-41 |
| PRL21-- BACSU 50S RIBOSOMAL PROTEIN L21 BACILLUS SUBTILIS 4-38 |
| PRL22-- ECOLI 50S RIBOSOMAL PROTEIN L22 ESCHERICHIA COLI 28-55 |
| PRL23-- METVA 50S RIBOSOMAL PROTEIN L23 METHANOCOCCUS VANNIELII |
| 30-57 |
| PRL23-- MYCCA 50S RIBOSOMAL PROTEIN L23 MYCOPLASMA CAPRICOLUM |
| 32-59 |
| PRL24-- HALMA 50S RIBOSOMAL PROTEIN L24 HALOARCULA MARISMORTUI |
| 48-75 |
| PRL24-- METVA 50S RIBOSOMAL PROTEIN L24 METHANOCOCCUS VANNIELII |
| 61-90 |
| PRL24-- MICLU 50S RIBOSOMAL PROTEIN L24 MICROCOCCUS LUTEUS 36-63 |
| PRL29-- CHLTR 50S RIBOSOMAL PROTEIN L29 CHLAMYDIA TRACHOMATIS |
| 39-66 |
| PRL29-- ECOLI 50S RIBOSOMAL PROTEIN L29 ESCHERICHIA COLI 36-63 |
| PRL29-- MYCCA 50S RIBOSOMAL PROTEIN L29 MYCOPLASMA CAPRICOLUM |
| 39-85 |
| PRL4-- BACST 50S RIBOSOMAL PROTEIN L4 BACILLUS STEAROTHERMOPHILUS |
| 141-169 |
| PRL4-- MYCCA 50S RIBOSOMAL PROTEIN L4 MYCOPLASMA CAPRICOLUM |
| 144-198 |
| PRL5-- THETH 50S RIBOSOMAL PROTEIN L5 THERMUS AQUATICUS 38-65 |
| PRL6-- |
| BACST 50S RIBOSOMAL PROTEIN L6 BACILLUS STEAROTHERMOPHILUS 79-106 |
| PRL6-- ECOLI 50S RIBOSOMAL PROTEIN L6 ESCHERICHIA COLI 19-46 |
| PRL6-- METVA 50S RIBOSOMAL PROTEIN L6 METHANOCOCCUS VANNIELII |
| 129-159 |
| PRL9-- BACST 50S RIBOSOMAL PROTEIN L9 BACILLUS STEAROTHERMOPHILUS |
| 47-77 |
| PRL9-- ECOLI 50S RIBOSOMAL PROTEIN L9 ESCHERICHIA COLI 122-149 |
| PRLA0-- HALCU ACIDIC RIBOSOMAL PROTEIN P0 HOMOLOG HALOBACTERIUM |
| CUTIRUBRUM 138-182 |
| PRLA0-- HALHA ACIDIC RIBOSOMAL PROTEIN P0 HOMOLOG HALOBACTERIUM |
| HALOBIUM 138-182 |
| PRLA0-- HALMA ACIDIC RIBOSOMAL PROTEIN P0 HOMOLOG HALOARCULA |
| MARISMORTUI 64-91 153-184 |
| PRLA0-- METVA ACIDIC RIBOSOMAL PROTEIN P0 HOMOLOG METHANOCOCCUS |
| VANNIELII 194-221 |
| PRLA-- HALEU RIBOSOMAL PROTEIN `A` HALOPHILIC EUBACTERIUM NRCC |
| 41227 59-86 |
| PRLA-- HALHA 50S RIBOSOMAL PROTEIN L20 HALOBACTERIUM HALOBIUM |
| 2-29 |
| PRLA-- HALMA 50S RIBOSOMAL PROTEIN L12 HALOARCULA MARISMORTUI |
| 2-29 |
| PRLA-- METVA RIBOSOMAL PROTEIN `A` METHANOCOCCUS VANNIELII 2-29 |
| PRLA-- MICLU 70S RIBOSOMAL PROTEIN MA MICROCOCCUS LUTEUS 55-82 |
| 90-117 |
| PRLX1-- SALTY 43 KD RELAXATION PROTEIN SALMONELLA TYPHIMURIUM |
| 226-260 |
| PRLX1-- STAAU RLX PROTEIN STAPHYLOCOCCUS AUREUS 3-30 102-132 |
| 177-218 266-300 |
| PRLX2-- SALTY 22 KD RELAXATION PROTEIN SALMONELLA TYPHIMURIUM |
| 19-53 |
| PRLX2-- STAAU RLX PROTEIN STAPHYLOCOCCUS AUREUS 3-30 102-133 |
| 261-295 |
| PRLX3-- STAAU RLX PROTEIN STAPHYLOCOCCUS AUREUS 3-30 146-216 |
| PRLX-- SULSO 50S RIBOSOMAL PROTEIN LX SULFOLOBUS SOLFATARICUS |
| 32-62 |
| PRNBR-- BACAM RIBONUCLEASE PRECURSOR BACILLUS AMYLOLIQUEFACIENS |
| 33-67 129-156 |
| PRNC-- ECOLI RIBONUCLEASE III ESCHERICHIA COLI 10-37 117-144 |
| PRNE-- ECOLI RIBONUCLEASE E ESCHERICHIA COLI 413-440 628-662 |
| PRNPA-- |
| BUCAP RIBONUCLEASE P PROTEIN COMPONENT BUCHNERA APHIDICOLA 85-114 |
| PRNPH-- BACSU RIBONUCLEASE PH BACILLUS SUBTILIS 159-186 |
| PRNS-- ECOLI REGULATORY PROTEIN RNS ESCHERICHIA COLI 116-160 |
| PRN-- VACCI RIBONUCLEASE BACILLUS CIRCULANS |
| 82-109 PRN-- BACIN RIBONUCLEASE PRECURSOR BACILLUS |
| INTERMEDIUS 38-72 |
| PRP28-- BACTK RNA POLYMERASE SIGMA-28 FACTOR PRECURSOR BACILLUS |
| THURINGIENSIS |
| 73-107 PRP32-- |
| CITFR RNA POLYMERASE SIGMA-32 FACTOR CITROBACTER FREUNDII 30-57 |
| PRP35-- BACTK RNA POLYMERASE SIGMA-35 FACTOR PRECURSOR |
| BACILLUS THURINGIENSIS |
| 8-35 63-90 PRP54-- ALCEU |
| RNA POLYMERASE SIGMA-54 FACTOR ALCALIGENES EUTROPHUS 229-266 |
| PRP54-- AZOCA RNA POLYMERASE SIGMA-54 FACTOR AZORHIZOBIUM |
| CAULINODANS 174-208 |
| PRP54-- BACSU RNA POLYMERASE SIGMA-54 FACTOR BACILLUS SUBTILIS |
| 16-43 |
| 97-124 274-308 396-423 |
| PRP54-- BRAJA RNA POLYMERASE SIGMA-54 FACTOR 1 BRADYRHIZOBIUM |
| JAPONICUM |
| 97-124 PRP54.sub |
| .-- KLEPN RNA POLYMERASE SIGMA-54 FACTOR KLEBSIELLA PNEUMONIAE 148-182 |
| PRP54-- |
| RHOCA RNA POLYMERASE SIGMA-54 FACTOR RHODOBACTER CAPSULATUS 155-185 |
| PRP55-- BRAJA RNA POLYMERASE SIGMA-54 FACTOR 2 BRADYRHIZOBIUM |
| JAPONICUM 145-172 |
| PRP5M-- ALCEU PROBABLE SIGMA (54) MODULATION PROTEIN ALCALIGENES |
| EUTROPHUS 21-51 |
| PRP5M-- ECOLI PROBABLE SIGMA (54) MODULATION PROTEIN ESCHERICHIA |
| COLI 21-67 |
| PRP5M-- SALTY PROBABLE SIGMA (54) MODULATION PROTEIN SALMONELLA |
| TYPHIMURIUM 21-67 |
| PRP70-- BUCAP RNA POLYMERASE SIGMA-70 FACTOR BUCHNERA APHIDICOLA |
| 69-96 109-136 173-217 228-255 303- |
| 337 |
| PRP70-- |
| CHLTR RNA POLYMERASE SIGMA-70 FACTOR CHLAMYDIA TRACHOMATIS 5-32 |
| PRP70-- ECOLI RNA POLYMERASE SIGMA-70 FACTOR ESCHERICHIA |
| COLI 327-361 |
| PRP70-- |
| PSEAE RNA POLYMERASE SIGMA-70 FACTOR PSEUDOMONAS AERUGINOSA 334-368 |
| PRP70-- RICPR RNA POLYMERASE SIGMA-70 FACTOR RICKETTSIA |
| PROWAZEKII 244-321 348-382 |
| PRP80-- MYXXA RNA POLYMERASE SIGMA-80 FACTOR MYXOCOCCUS XANTHUS |
| 208-235 318-347 359-386 |
| PRPCF-- SYNPY BILIN BIOSYNTHESIS PROTEIN RPCF SYNECHOCOCCUS SP |
| 180-207 |
| PRPOA-- VACSU DNA-DIRECTED RNA POLYMERASE ALPHA CHAIN BACILLUS |
| SUBTILIS |
| 55-107 |
| PRPOA-- ECOLI A-DIRECTED RNA POLYMERASE ALPHA CHAIN ESCHERICHIA |
| COLI & |
| 57-105 |
| SALMONELLA TYPHIMURIUM |
| PRPOA-- HALHA DNA-DIRECTED RNA POLYMERASE SUBUNIT A HALOBACTERIUM |
| HALOBIUM 863-904 |
| PRPOA-- HALMO A-DIRECTED RNA POLYMERASE SUBUNIT A HALOCOCCUS |
| MORRHUAE 229-270 |
| PRPOA-- |
| METTH DNA-DIRECTED RNA POLYMERASE SUBUNIT A METHANOBACTERIUM 218-245 |
| 486-513 642-669 |
| THERMOAUTOTROPHICU |
| PRPOA-- SULAC DNA-DIRECTED RNA POLYMERASE SUBUNIT A SULFOLOBUS |
| ACIDOCALDARIUS 222-256 500-527 693-720 |
| PRPOA-- THECE DNA-DIRECTED RNA POLYMERASE SUBUNIT A' THERMOCOCCUS |
| CELER 228-262 |
| PRPOB-- ECOLI DNA-DIRECTED RNA POLYMERASE BETA CHAIN ESCHERICHIA |
| COLI 599-626 1011- |
| 1038 |
| PRPOB-- |
| MYCLE DNA-DIRECTED RNA POLYMERASE BETA CHAIN MYCOBACTERIUM LEPRAE |
| 723-760 1084- |
| 1111 |
| PRPOB-- SALTY A-DIRECTED RNA POLYMERASE BETA CHAIN SALMONELLA |
| TYPHIMURIUM 599-626 958-985 1011- |
| 1038 |
| PRPOB-- SULAC A-DIRECTED RNA POLYMERASE SUBUNIT B SULFOLOBUS |
| ACIDOCALDARIUS 160-187 255-282 534-561 827-861 |
| PRPOB-- THEMA A-DIRECTED RNA POLYMERASE BETA CHAIN THERMOTOGA |
| MARITIMA 350-377 |
| PRPOC-- ANASP DNA-DIRECTED RNA POLYMERASE GAMMA CHAIN ANABAENA SP |
| 152-194 |
| PRPOC-- ECOLI DNA-DIRECTED RNA POLYMERASE BETA CHAIN ESCHERICHIA |
| COLI 786-813 948-994 1223- |
| 1257 |
| PRPOC-- HALHA DNA-DIRECTED RNA POLYMERASE SUBUNIT C HALOBACTERIUM |
| HALOBIUM 175-202 |
| PRPOC-- HALMO DNA-DIRECTED RNA POLYMERASE SUBUNIT C HALOCOCCUS |
| MORRHUAE 27-54 117-144 207-234 |
| PRPOC-- |
| METTH DNA-DIRECTED RNA POLYMERASE SUBUNIT C METHANOBACTERIUM 58-85 |
| 272-302 327-354 |
| THERMOAUTOTROPHICU |
| PRPOC-- MYCLE A-DIRECTED RNA POLYMERASE BETA CHAIN MYCOBACTERIUM |
| LEPRAE 273-300 860-887 911-928 1131- |
| 1158 |
| PRPOC-- NOSCO DNA-DIRECTED RNA POLYMERASE GAMMA CHAIN NOSTOC |
| COMMUNE 150-192 |
| PRPOC-- SULAC DNA-DIRECTED RNA POLYMERASE SUBUNIT C SULFOLOBUS |
| ACIDOCALDARIUS 36-63 172-214 224-251 |
| PRPOC-- THECE DNA-DIRECTED RNA POLYMERASE SUBUNIT A" THERMOCOCCUS |
| CELER 21-58 |
| PRPOD-- NOSCO DNA-DIRECTED RNA POLYMERASE DELTA CHAIN NOSTOC |
| COMMUNE |
| 72-116 402-449 539-566 |
| PRPOE-- ECOLI RNA POLYMERASE SIGMA-E FACTOR ESCHERICHIA COLI 5-39 |
| PROPS-- ECOLI RNA POLYMERASE SIGMA FACTOR KATF ESCHERICHIA COLI |
| 281-308 |
| PRPOU-- |
| HALHA DNA-DIRECTED RNA POLYMERASE SUBUNIT B' HALOBACTERIUM HALOBIUM |
| 91-118 |
| PRPSA-- AGRTU RNA POLYMERASE SIGMA-A FACTOR AGROBACTERIUM |
| TUMEFACIENS 310-347 397-427 |
| PRPSA-- ANASP RNA POLYMERASE SIGMA-A FACTOR ANABAENA SP 71-105 |
| PRPSA-- |
| CLOAB RNA POLYMERASE SIGMA-A FACTOR CLOSTRIDIUM ACETOBUTYLICUM 2-29 |
| PRPSA-- STRAU RNA POLYMERASE SIGMA-A FACTOR RPOD STREPTOMYCES |
| AUREFACIENS 278-305 |
| PRPSB-- ANASP RNA POLYMERASE SIGMA-B FACTOR ANABAENA SP 4-31 |
| PRPSB-- BACSU RNA POLYMERASE SIGMA-B FACTOR BACILLUS SUBTILIS |
| 5-35 169-196 200-230 |
| PRPSB-- MYXXZ RNA POLYMERASE SIGMA-B FACTOR MYXOCOCCUS XANTHUS |
| 47-74 |
| PRPSB-- |
| STIAU RNA POLYMERASE SIGMA-B FACTOR STIGMATELLA AURANTIACA 96-123 |
| PRPSC-- ANASP RNA POLYMERASE SIGMA-C FACTOR ANABAENA SP 58-85 |
| PRPSD-- BACSU RNA POLYMERASE SIGMA-D FACTOR BACILLUS SUBTILIS |
| 192-249 |
| PRPSE-- BACSU RNA POLYMERASE SIGMA-E FACTOR PRECURSOR BACILLUS |
| SUBTILIS 63-90 |
| PRPSE-- |
| CLOAB RNA POLYMERASE SIGMA-E FACTOR CLOSTRIDIUM ACETOBUTYLICUM 14-41 |
| 116-160 |
| PRPSF-- |
| BACLI RNA POLYMERASE SIGMA-F FACTOR BACILLUS LICHENIFORMIS 4-31 |
| 191-248 |
| PRPSF-- BACME RNA POLYMERASE SIGMA-F FACTOR BACILLUS MEGATERIUM |
| 191-225 |
| PRPSF-- BACSU RNA POLYMERASE SIGMA-F FACTOR BACILLUS SUBTILIS |
| 4-31 191-248 |
| PRPSH-- |
| BACLI RNA POLYMERASE SIGMA-H FACTOR BACILLUS LICHENIFORMIS 181-218 |
| PRPSH-- BACSU RNA POLYMERASE SIGMA-H FACTOR BACILLUS SUBTILIS |
| 186-213 |
| PRPSK-- BACSU RNA POLYMERASE SIGMA-K FACTOR BACILLUS SUBTILIS |
| 75-109 189-216 |
| PRPSP-- STAAU RNA POLYMERASE SIGMA FACTOR PLAC STAPHYLOCOCCUS |
| AUREUS 19-46 |
| PRPSW-- STRCO RNA POLYMERASE SIGMA FACTOR WHIG STREPTOMYCES |
| COELICOLOR 232-273 |
| PRPSX-- BACTK POSSIBLE RNA POLYMERASE SIGMA-G FACTOR BACILLUS |
| THURINGIENSIS 33-60 |
| PRS10-- ECOLI 30S RIBOSOMAL PROTEIN S10 ESCHERICHIA COLI 3-30 |
| PRS11-- BACSU 30S RIBOSOMAL PROTEIN S11 BACILLUS SUBTILIS 8-42 |
| PRS13-- BACSU 30S RIBOSOMAL PROTEIN S13 BACILLUS SUBTILIS 44-85 |
| PRS17-- METVA 30S RIBOSOMAL PROTEIN S17 METHANOCOCCUS VANNIELII |
| 34-73 |
| PRS1-- ECOLI 30S RIBOSOMAL PROTEIN S1 ESCHERICHIA COLI 99-126 |
| 144-171 |
| PRS1-- PROSP 30S RIBOSOMAL PROTEIN S1 PROVIDENCIA SP 39-66 |
| 265-292 349-376 |
| PRS1-- RHIME 30S RIBOSOMAL PROTEIN S1 RHIZOBIUM MELILOTI 91-125 |
| 172-217 |
| PRS21-- |
| BACST 30S RIBOSOMAL PROTEIN S21 BACILLUS STEAROTHERMOPHILUS 1-28 |
| PRS2-- SPICI 30S RIBOSOMAL PROTEIN S2 SPIROPLASMA CITRI |
| 9-125 |
| PRS3-- ACHLA 30S RIBOSOMAL PROTEIN S3 ACHOLEPLASMA LAIDLAWII |
| 83-110 |
| PRS3-- MYCCA 30S RIBOSOMAL PROTEIN S3 MYCOPLASMA CAPRICOLUM |
| 77-106 136-163 |
| PRS4-- ECOLI 30S RIBOSOMAL PROTEIN S4 ESCHERICHIA COLI 50-77 |
| PRS5-- HALMA 30S RIBOSOMAL PROTEIN S5 HALOARCULA MARISMORTUI |
| 160-187 |
| PRS5-- MYCCA 30S RIBOSOMAL PROTEIN S5 MYCOPLASMA CAPRICOLUM 35-62 |
| 182-216 |
| PRS6-- THETH 30S RIBOSOMAL PROTEIN S6 THERMUS AQUATICUS 16-43 |
| PRS7-- METVA 30S RIBOSOMAL PROTEIN S7 METHANOCOCCUS VANNIELII |
| 69-96 |
| PRS7-- MYCLE 30S RIBOSOMAL PROTEIN S7 MYCOBACTERIUM LEPRAE 22-49 |
| PRS8-- MICLU 30S RIBOSOMAL PROTEIN S8 MICROCOCCUS LUTEUS 103-130 |
| PRS8-- MYCCA 30S RIBOSOMAL PROTEIN S8 MYCOPLASMA CAPRICOLUM 41-78 |
| PRSGA-- ECOLI FERRITIN LIKE PROTEIN ESCHERICHIA COLI 80-107 |
| PRT67-- ECOLI RNA-DIRECTED DNA POLYMERASE ESCHERICHIA COLI |
| 225-268 |
| PSACB-- BACAM LEVANSUCRASE PRECURSOR BACILLUS AMYLOLIQUEFACIENS |
| 175-202 254-281 |
| PSACB-- BACSU LEVANSUCRASE PRECURSOR BACILLUS SUBTILIS 175-202 |
| 254-288 |
| PSACB-- STRMU LEVANSUCRASE PRECURSOR STREPTOCOCCUS MUTANS 31-65 |
| 155-189 314-369 |
| PSACQ-- BACLI SACQ REGULATORY FACTOR BACILLUS LICHENIFORMIS 2-46 |
| PSACT-- BACSU SACPA OPERON ANTITERMINATOR BACILLUS SUBTILIS |
| 102-129 189-216 |
| PSAGP-- STRPY STREPTOCOCCAL ACID GLYCOPROTEIN STREPTOCOCCUS |
| PYOGENES 294-331 362-389 |
| PSAOX-- |
| BACSN SARCOSINE OXIDASE BACILLUS SP 350-377 PSAS2-- |
| CLOBI SPORE PROTEIN CLOSTRIDIUM BIFERMENTANS 17-47 |
| PSASG-- BACCE SPORE PROTEIN GAMMA-TYPE BACILLUS CEREUS 31-58 |
| PSASG-- |
| BACST SPORE PROTEIN GAMMA-TYPE BACILLUS STEAROTHERMOPHILUS 37-64 |
| PSBCC-- ECOLI EXONUCLEASE SBCC ESCHERICHIA COLI 218-260 |
| 337-364 535-585 622-656 778- 821- 915- |
| 812 865 942 |
| PSBCD-- ECOLI EXONUCLEASE SBCD ESCHERICHIA COLI 137-164 334-397 |
| PSBM-- ECOLI SBM PROTEIN ESCHERICHIA COLI 5-32 436-470 553-580 |
| PSBP-- |
| BACSU SBP PROTEIN BACILLUS SUBTILIS 28-55 PSCPA-- |
| STRPY C5A PEPTIDASE PRECURSOR STREPTOCOCCUS PYOGENES 126-160 784-811 |
| 831-880 |
| PSCRB-- KLEPN SUCROSE-6-PHOSPHATE HYDROLASE KLEBSIELLA PNEUMONIAE |
| 174-201 |
| PSCRB-- LACLA SUCROSE-6-PHOSPHATE HYDROLASE LACTOCOCCUS LACTIS |
| 182-217 354-385 395-422 |
| PSCRB-- STRMU SUCROSE-6-PHOSPHATE HYDROLASE STREPTOCOCCUS MUTANS |
| 335-362 |
| PSCRK-- SALTH FRUCTOKINASE SALMONELLA THOMPSON |
| 97-124 PSCRK-- |
| SALTY FRUCTOKINASE SALMONELLA TYPHIMURIUM 183-210 |
| PSCRY-- KLEPN SURCOSE PORIN PRECURSOR KLEBSIELLA PNEUMONIAE 61-88 |
| 240-267 |
| PSCRY-- SALTY SURCOSE PORIN PRECURSOR SALMONELLA TYPHIMURIUM |
| 16-54 61-88 240-267 |
| PSECA-- BACSU PREPROTEIN TRANSLOCASE SECA SUBUNIT BACILLUS |
| SUBTILIS 12-39 226-260 |
| PSECA-- ECOLI PREPROTEIN TRANSLOCASE SECA SUBUNIT ESCHERICHIA |
| COLI 360-387 453-481 |
| PSECB-- ECOLI PROTEIN-EXPORT PROTEIN SECB ESCHERICHIA COLI 41-68 |
| PSECD-- ECOLI PROTEIN-EXPORT MEMBRANE PROTEIN SECD ESCHERICHIA |
| COLI 46-73 378-412 |
| PSECF-- ECOLI PROTEIN-EXPORT MEMBRANE PROTEIN SECF ESCHERICHIA |
| COLI 174-201 |
| PSECY-- ECOLI PREPROTEIN TRANSLOCASE SECY SUBUNIT ESCHERICHIA |
| COLI 101-128 |
| PSECY-- LACLA PREPROTEIN TRANSLOCASE SECY SUBUNIT LACTOCOCCUS |
| LACTIS 403-430 |
| PSECY-- METVA PREPROTEIN TRANSLOCASE SECY SUBUNIT METHANOCOCCUS |
| VANNIELII 131-161 396-423 |
| PSECY-- STACA PREPROTEIN TRANSLOCASE SECY SUBUNIT STAPHYLOCOCCUS |
| CARNOSUS 149-191 |
| PSEFC-- SALEN SEFC PROTEIN PRECURSOR SALMONELLA ENTERITIDIS |
| 137-164 475-535 |
| PSERA-- BACSU D-3-PHOSPHOGLYCERATE DEHYDROGENASE BACILLUS |
| SUBTILIS 16-43 347-374 |
| PSFAA-- ECOLI 5-FIMBRIAL PROTEIN SUBUNIT PRECURSOR ESCHERICHIA |
| COLI 11-38 |
| PSFSA-- ECOLI SUGAR FERMENTATION STIMULATION PROTEIN ESCHERICHIA |
| COLI |
| 81-115 |
| PSFUA-- SERMA IRON-TRANSPORT SFUA PROTEIN PRECURSOR SERRATIA |
| MARCESCENS 34-61 |
| PSHU1-- ECOLI SHUFFLON PROTEIN A ESCHERICHIA COLI 224-262 |
| PSHU2-- ECOLI SHUFFLON PROTEIN A' ESCHERICHIA COLI 224-262 |
| PSHU3-- ECOLI SHUFFLON PROTEIN B ESCHERICHIA COLI 224-262 |
| PSHU4-- ECOLI SHUFFLON PROTEIN B' ESCHERICHIA COLI 224-262 |
| PSHU5-- ECOLI SHUFFLON PROTEIN C ESCHERICHIA COLI 224-262 402-429 |
| PSHU6-- ECOLI SHUFFLON PROTEIN C' ESCHERICHIA COLI 224-262 |
| PSHU7-- ECOLI SHUFFLON PROTEIN D' ESCHERICHIA COLI 224-262 |
| PSINR-- BACLI SINR PROTEIN BACILLUS LICHENIFORMIS 9-36 43-80 |
| PSINR-- BACSU SINR PROTEIN BACILLUS SUBTILIS 9-36 43-70 |
| PSLAP-- ACEKI CELL SURFACE PROTEIN PRECURSOR ACETOGENIUM |
| KIVUI 237-264 282-309 313-453 458-489 517- 563- 641- 726- |
| 544 593 685 753 |
| PSLPA-- ECOLI PROPHAGE CP4-57 INTEGRASE ESCHERICHIA COLI 93-136 |
| PSMF-- |
| ECOLI SMF PROTEIN ESCHERICHIA COLI 24-51 PSMPB-- |
| ECOLI SMALL PROTEIN B ESCHERICHIA COLI 27-61 |
| 90-117 PSMP-- ECOLI SMP PROTEIN PRECURSOR |
| ESCHERICHIA COLI 71-98 |
| PSMTB-- SNYP7 TRANSCRIPTIONAL REPRESSOR SMTB SYNECHOCOCCUS SP |
| 62-96 |
| PSODF-- COXBU SUPEROXIDE DISMUTASE COXIELLA BURNETII 116-143 |
| PSODF-- ECOLI SUPEROXIDE DISMUTASE ESCHERICHIA COLI 115-142 |
| PSODF-- METTH SUPEROXIDE DISMUTASE METHANOBACTERIUM 25-52 |
| THERMOAUTOTROPHICU |
| PSODF-- PHOLE SUPEROXIDE DISMUTASE PHOTOBACTERIUM LEIOGNATHI |
| 22-63 |
| PSODM-- |
| PROFR SUPEROXIDE DISMUTASE PROPIONBACTERIUM FREUDENREICHII 164-191 |
| PSOHB-- ECOLI SOHB PROTEIN PRECURSOR ESCHERICHIA COLI 7-48 |
| 70-97 273-300 |
| PSOPB-- |
| ECOLI SOPB PROTEIN ESCHERICHIA COLI 252-279 PSOXR-- |
| ECOLI SOXR PROTEIN ESCHERICHIA COLI 16-63 |
| PSP0J-- BACSU STAGE 0 SPORULATION PROTEIN J BACILLUS SUBTILIS |
| 131-158 |
| PSP2A-- BACME STAGE II SPORULATION PROTEIN AA BACILLUS MEGATERIUM |
| 19-53 |
| PSP2A-- VACSU STAGE II SPORULATION PROTEIN AA BACILLUS SUBTILIS |
| 21-55 |
| PSP2B-- |
| BACLI STAGE II SPORULATION PROTEIN AB BACILLUS LICHENIFORMIS 42-69 |
| PSP2B-- BACME STAGE II SPORULATION PROTEIN AB BACILLUS |
| MEGATERIUM 36-73 |
| PSP2D-- BACSU STAGE II SPORULATION PROTEIN D BACILLUS SUBTILIS |
| 134-161 |
| PSP2G-- BACTK POSSIBLE ASPARTYL PROTEASE BACILLUS THURINGIENSIS |
| 4-36 117-144 |
| PSP2J-- BACSU STAGE II SPORULATION PROTEIN J BACILLUS SUBTILIS |
| 14-44 463-500 |
| PSP3D-- BACSU STAGE III SPORULATION PROTEIN D BACILLUS SUBTILIS |
| 9-36 52-86 |
| PSP3J-- BACSU STAGE III SPORULATION PROTEIN J PRECURSOR BACILLUS |
| SUBTILIS 44-75 |
| PSP4A-- BACSU STAGE IV SPORULATION PROTEIN A BACILLUS SUBTILIS |
| 139-180 |
| PSP4B-- BACSU STAGE IV SPORULATION PROTEIN B BACILLUS SUBTILIS |
| 39-66 |
| PSP4G-- BACSU STAGE IV SPORULATION PROTEIN FB BACILLUS SUBTILIS |
| 251-278 |
| PSP5A-- BACSU STAGE V SPORULATION PROTEIN AF BACILLUS SUBTILIS |
| 9-36 |
| PSPAA-- |
| STRDO ANTIGEN I STREPTOCOCCUS DOWNEI 184-218 PSPAB-- |
| BACSU SUBTILIN BIOSYNTHESIS 117 KD PROTEIN BACILLUS SUBTILIS 181-208 |
| PSPAC-- BACSU SUBTILIN BIOSYNTHESIS PROTEIN SPAC BACILLUS |
| SUBTILIS 311-338 |
| PAPAK-- BACSU SENSOR PROTEIN SPAK BACILLUS SUBTILIS 80-107 |
| 224-251 290-324 |
| PSPAP-- STRMU CELL SURFACE ANTIGEN I/II PRECURSOR STREPTOCOCCUS |
| MUTANS 122-276 281-465 538-565 576-630 1071- 115- 1377- |
| 1098 1182 1430 |
| PSPAR-- BACSU REGULATORY PROTEIN BACILLUS SUBTILIS 4-31 172-199 |
| PSPAT-- BACSU SUBTILIN TRANSPORT PROTEIN SPAT BACILLUS SUBTILIS |
| 55-82 226-267 |
| PSPEC-- STRPY EXOTOXIN TYPE C PRECURSOR STREPTOCOCCUS PYOGENES |
| 12-139 |
| PSPIR-- SPICI SPIRALIN SPIROPLASMA CITRI |
| 82-109 155-182 PSPIR-- SPIME SPIRALIN SPIROPLASMA |
| MELLIFERUM 195-222 |
| PSPOT-- ECOLI GUAN-3',5'-BIS(DIPHOS) 3'-PYROPHOSPHOHYDROLA |
| ESCHERICHIA COLI 637-664 |
| SPPA-- |
| ECOLI PROTEASE IV ESCHERICHIA COLI 278-305 PSQHC-- |
| ZYMMO AQUALENE-HOPENE CYCLASE ZYMOMONAS MOBILIS 590-617 |
| PSRFA-- BACSU SUFACTIN SYNTHETASE SUBUNIT A BACILLUS SUBTILIS |
| 159-186 244-271 |
| PSRP5-- ECOLI SIGNAL RECOGNITION PARTICLE PROTEIN ESCHERICHIA |
| COLI 301-328 |
| PSRP5-- MYCMY SIGNAL RECOGNITION PARTICLE PROTEIN MYCOPLASMA |
| MYCOIDES 21-65 107-141 394-428 |
| PSSA1-- PASHA SEROTYPE SPECIFIC ANTIGEN 1 PRECURSOR PASTEURELLA |
| HAEMOLYTICA 151-178 358-385 465-518 529- 860- |
| 570 904 |
| PSSAB-- STRAP ADHESIN B PRECURSOR STREPTOCOCCUS PARASANGUIS 32-59 |
| PSSAB-- STRSA ADHESIN B PRECURSOR STREPTOCOCCUS SANGUIS 21-59 |
| 101-128 |
| PSSB-- ECOLI SINGLE-STRAND BINDING PROTEIN ESCHERICHIA COLI 68-95 |
| PSSB-- PROMI SINGLE-STRAND BINDING PROTEIN PROTEUS MIRABILIS |
| 63-104 |
| PSSB-- SERMA SINGLE-STRAND BINDING PROTEIN SERRATIA MARCESCENS |
| 63-104 |
| PSSP5-- STRSA AGGLUTININ RECEPTOR PRECURSOR STREPTOCOCCUS SANGUIS |
| 131-173 178-287 295-483 565-592 676- 1081- |
| 710 1131 |
| PSTAV-- STRAV STREPTAVIDIN PRECURSOR STREPTOMYCES AVIDINII |
| 125-152 |
| PSTA-- ECOLI STREPTOTHRICIN ACETYLTRANSFERASE ESCHERICHIA COLI |
| 66-93 |
| PSTC1-- STAAU STAPHYLOCOAGULASE PRECURSOR STAPHYLOCOCCUS AUREUS |
| 90-119 172-199 280-311 |
| PSTC2-- STAAU STAPHYLOCOAGULASE PRECURSOR STAPHYLOCOCCUS AUREUS |
| 90-117 264-291 |
| PSTC-- |
| CLOBE L-TRANSD TRANSC CONTROL PROTEIN CLOSTRIDIUM BEIJERINCKII 47-74 |
| PSTPA-- |
| ECOLI STPA PROTEIN ESCHERICHIA COLI 36-63 PSTR1-- |
| STRGR INOSAMINE-PHOSPHATE AMIDINOTRANSFERASE I STREPTOMYCES GRISEUS |
| 183-210 |
| PSTRP-- STREQ STREPTOKINASE C PRECURSOR STREPTOCOCCUS EQUISIMILIS |
| 209-236 281-308 |
| PSTRP-- STRPY STREPTOKINASE A PRECURSOR STREPTOCOCCUS PYOGENES |
| 209-236 |
| PSTRP-- STRSP STREPTOKINASE G PRECURSOR STREPTOCOCCUS SP 209-236 |
| 281-308 |
| PSUBE-- BACSU MINOR EXTRACELLULAR PROTEASE EPR PREC BACILLUS |
| SUBTILIS 435-462 522-563 605-639 |
| PSUBF-- BACSU BACILLOPEPTIDASE F PRECURSOR BACILLUS SUBTILIS |
| 40-67 |
| 89-116 121-148 554-597 |
| PSUBI-- SALTY SULFATE-BINDING PROTEIN SALMONELLA TYPHIMURIUM 37-74 |
| PSUBI-- SYNP7 SULFATE-BINDING PROTEIN PRECURSOR SYNECHOCOCCUS SP |
| 63-94 |
| PSUBI-- SYNY3 SULFATE-BINDING PROTEIN PRECURSOR SYNECHOCYSTIS SP |
| 64-91 |
| PSUBT-- |
| BACLI SUBTILISIN CARLSBERG PRECURSOR BACILLUS LICHENIFORMIS 191-222 |
| PSUBT-- BACMS SUBTILISIN BACILLUS MESENTERICUS 91-118 |
| PSUBT-- BACS9 SUBTILISIN PRECURSOR BACILLUS SP 36-63 |
| 250-277 |
| PSUBT-- BACSA SUBTILISIN AMYOSACCHARITICUS PRECURSOR BACILLUS |
| SUBTILIS 197-224 |
| PSUBT-- BASCD SUBTILISIN BACILLUS SUBTILIS |
| 86-117 PSUBT-- BACST SUBTILISIN J PRECURSOR |
| BACILLUS STEROTHERMOPHILUS 197-224 |
| PSUBT-- BACSU SUBTILISIN E PRECURSOR BACILLUS SUBTILIS 197-224 |
| PSUBV-- BACSU MINOR EXTRACELLULAR PROTEASE VPR PRECUR BACILLUS |
| SUBTILIS |
| 55-108 613-654 741-768 |
| PSUCC-- ECOLI SUCCINYL-COA SYNTHETASE BETA ESCHERICHIA COLI 62-89 |
| PSUCP-- AGRVI SUCROSE PHOSPHORYLASE AGROBACTERIUM VITIS 449-476 |
| PSULA-- ENTAE CELL DIVISION INHIBITOR ENTEROBACTER AEROGENES |
| 112-139 |
| PSYA-- ECOLI ALANYL-TRNA SYNTHETASE ESCHERICHIA COLI 257-287 |
| 725-752 790-821 |
| PSYD-- ECOLI ASPARTYL-TRNA SYTHETASE ESCHERICHIA COLI 330-357 |
| PSYE-- |
| BACST GLUTAMYL-TRNA SYTHETASE BACILLUS STEROTHERMOPHILUS 49-76 |
| PSYE-- BACSU GLUTAMYL-TRNA SYTHETASE BACILLUS SUBTILIS 49-76 |
| 351-386 |
| PSYE-- THETH GLUTAMYL-TRNA SYTHETASE THERMUS AQUATICUS 405-432 |
| PSYFA-- BACSU PHENYLALANYL-TRNA SYNTHETASE A CHAIN BACILLUS |
| SUBTILIS |
| 7-34 |
| PSYFB-- BACSU PHENYLALANYL-TRNA SYNTHETASE BETA CHAIN BACILLUS |
| SUBTILIS 340-367 407-441 |
| PSYFB-- ECOLI PHENYLALANYL-TRNA SYNTHETASE BETA CHAIN ESCHERICHIA |
| COLI 546-573 607-634 744-771 |
| PSYGB-- ECOLI GLYCYL-TRNA SYNTHETASE BETA CHAIN ESCHERICHIA COLI |
| 354-381 487-514 |
| PSYH-- STREQ HISTIDYL-TRNA SYNTHETASE STREPTOCOCCUS EQUISIMILIS |
| 376-403 |
| PSYI-- METTH ISOLEUCYL-TRNA SYNTHETASE METHANOBACTERIUM 1010- |
| THERMOAUTOTROPHICU 1037 |
| PSYK1-- ECOLI LYSYL-TRNA SYNTHETASE ESCHERICHIA COLI 283-310 |
| PSYK2-- |
| ECOLI LYSYL-TRNA SYNTHETASE, HEAT INDUCIBLE ESCHERICHIA COLI 45-72 |
| 283-310 |
| PSYL-- ECOLI LYSYL-TRNA SYNTHETASE ESCHERICHIA COLI 220-247 |
| PSYM-- |
| BACST METHIONYL-TRNA SYNTHETASE BACILLUS STEROTHERMOPHILUS 69-99 |
| PSYM-- ECOLI METHIONYL-TRNA SYNTHETASE ESCHERICHIA COLI |
| 87-127 |
| PSYP-- ECOLI PROLYL-TRNA SYNTHETASE ESCHERICHIA COLI 541-568 |
| PSYQ-- ECOLI GLUTAMINYL-TRNA SYNTHETASE ESCHERICHIA COLI |
| 394-421 |
| PSYRD-- |
| PSESY SYRD PROTEIN PSEUDOMONAS SYRINGAE 449-483 PSYR-- |
| ECOLI AGRINYL-TRNA SYNTHETASE ESCHERICHIA COLI 540-574 |
| PSYT1-- BACSU THREONYL-TRAN SYNTHETASE BACILLUS SUBTILIS 401-428 |
| 605-639 |
| PSYV-- BACST VALYL-TRAN SYNTHETASE BACILLUS STEROTHERMOPHILUS |
| 603-630 809-843 |
| PSYV-- ECOLI VALYL-TRAN SYNTHETASE ESCHERICHIA COLI 300-327 |
| 882-912 924-951 |
| PSYW-- |
| BACST TRYPTOPHANYL-TRAN SYNTHETASE BACILLUS STEROTHERMOPHILUS 204-231 |
| 239-266 |
| PSYY1-- BACSU TYROSYL-TRAN SYNTHETASE 1 BACILLUS SUBTILIS 81-115 |
| 375-409 |
| PSYY2-- BACSU TYROSYL-TRAN SYNTHETASE 2 BACILLUS SUBTILIS 69-96 |
| PSYY-- BACCA TYROSYL-TRAN SYNTHETASE BACILLUS CALDOTENAX 295-322 |
| 372-416 |
| PSYY-- BACST TYROSYL-TRAN SYNTHETASE BACILLUS STEROTHERMOPHILUS |
| 295-322 372-416 |
| PT1M1-- ECOLI ENZYME ECOI 124/3 I M PROTEIN ESCHERICHIA COLI |
| 126-167 405-432 485-512 |
| PT1R1-- ECOLI ENZYME ECOI 124/3 R PROTEIN ESCHERICHIA COLI 30-57 |
| 624-651 702-736 768-795 843- 966- |
| 870 1000 |
| PT1R-- ECOLI ENZYME ECOK I R PROTEIN ESCHERICHIA COLI 158-263 |
| PT1S1-- |
| ECOLI ENZYME ECOR 124/3 I SPECIFICITY PROTEIN ESCHERICHIA COLI 154-181 |
| PT1SA-- ECOLI ENZYME ECOA I SPECIFICITY PROTEIN ESCHERICHIA COLI |
| 279-306 |
| PT1SB-- ECOLI ENZYME ECOB I SPECIFICITY PROTEIN ESCHERICHIA COLI |
| 278-312 |
| PT1SD-- ECOLI ENZYME ECOD I SPECIFICITY PROTEIN ESCHERICHIA COLI |
| 249-283 |
| PT1SE-- ECOLI ENZYME ECOE I SPECIFICITY PROTEIN ESCHERICHIA COLI |
| 279-306 |
| PT1S-- SALPO ENZYME SPECIFICITY PROTEIN SALMONELLA POTSDAM |
| 396-423 |
| PT1S-- SALTY ENZYME SPECIFICITY PROTEIN SALMONELLA TYPHIMURIUM |
| 194-221 276-304 402-429 |
| PT257-- ECOLI TYPE IIS RESTRICTION ENZYME ECO57I ESCHERICHIA COLI |
| 138-196 265-295 406-440 639-682 687- 926- |
| 728 954 |
| PT2A1-- ACICA TYPE II RESTRICTION ENZYME ACCI ACINETOBACTER |
| CALCOACETICUS 49-76 |
| PT2BF-- BACSU TYPE II RESTRICTION ENZYME BSUFI BACILLUS SUBTILIS |
| 3-43 135-223 236-280 |
| PT2BR-- BACSU TYPE II RESTRICTION ENZYME BSURI BACILLUS SUBTILIS |
| 3-45 338-384 401-430 532-559 |
| PT2C1-- CITFR TYPE II RESTRICTION ENZYME CFRBI CITROBACTER |
| FREUNDII 35-62 |
| PT2C1-- HERAU TYPE II RESTRICTION ENZYME HGICI HERPETOSIPHON |
| AURANTIACUS 176-215 |
| PT2C2-- HERAU TYPE II RESTRICTION ENZYME HGICII HERPETOSIPHON |
| AURANTIACUS 243-273 |
| PT2D1-- DESDN TYPE II RESTRICTION ENZYME DDEI DESULFOVIBRIO |
| DESULFURICANS |
| 85-122 PT2D1-- |
| STRPN TYPE II RESTRICTION ENZYME DPNI STREPTOCOCCUS PNEUMONIAE 213-240 |
| PT2E1-- ECOLI TYPE II RESTRICTION ENZYME ECORI ESCHERICHIA COLI |
| 2-29 |
| PT2E2-- ECOLI TYPE II RESTRICTION ENZYME ECORII ESCHERICHIA COLI |
| 333-360 |
| PT2E5-- ECOLI TYPE II RESTRICTION ENZYME ECORV ESCHERICHIA COLI |
| 128-155 214-241 |
| PT2F1-- FLAOK TYPE II RESTRICTION ENZYME FOKI FLAVOBACTERIUM |
| OKEANOKOITES 302-336 |
| PT2H1-- HAEIN TYPE II RESTRICTION ENZYME HINFI HAEMOPHILUS |
| INFLUENZAE |
| 6-38 69-96 PT2H1 |
| -- HAEPA TYPE II RESTRICTION ENZYME HPAI HAEMOPHILUS PARAINFLUENZAE |
| 77-125 |
| PT2H2-- HAEHA TYPE II RESTRICTION ENZYME HHAII HAEMOPHILUS |
| HAEMOLYTICUS 23-50 |
| PT2H2-- HAEIN TYPE II RESTRICTION ENZYME HINCII HAEMOPHILUS |
| INFLUENZAE |
| 97-138 PT2K1 |
| -- KLEPN TYPE II RESTRICTION ENZYME KPNI KLEBSIELLA PNEUMONIAE 18-45 |
| 178-205 |
| PT2M1-- MORBO TYPE II RESTRICTION ENZYME MBOI MORAXELLA BOVIS |
| 15-61 187-215 225-252 |
| PT2M2-- MORBO TYPE II RESTRICTION ENZYME MBOII MORAXELLA BOVIS |
| 3-30 158-185 337-364 |
| PT2MZ-- |
| METTF POSSIBLE TYPE II RESTRICTION ENZYME MTHZI METHANOBACTERIUM |
| 105-151 |
| THERMOFORMICICUM |
| PT2NG-- NEIGO TYPE II RESTRICTION ENZYME NGOPII NEISSERIA |
| GONORRHOEAE 117-144 231-258 |
| PT2S1-- STRSA TYPE II RESTRICTION ENZYME STSI STREPTOCOCCUS |
| SANGUIS |
| 5-32 41-68 395-446 |
| PT2S2-- SHISO TYPE II RESTRICTION ENZYME SSOII SHIGELLA SONNEI |
| 206-243 258-288 |
| PT2S3-- STAAU TYPE II RESTRICTION ENZYME SAUEAI STAPHYLOCOCCUS |
| AUREUS |
| 70-102 |
| PT2SI-- SALIN TYPE II RESTRICTION ENZYME SINI SALMONELLA INFANTIS |
| 144-181 |
| PT2SM-- SERMA TYPE II RESTRICTION ENZYME MAI SERRATIA MARCESCENS |
| 61-88 |
| PT2TA-- THEAQ TYPE II RESTRICTION ENZYME TAQI THERMUS AQUATICUS |
| 147-181 203-237 |
| PTEMO-- ECOLI SYSTEM ECOPI15 ENZYME MOD ESCHERICHIA COLI 37-71 |
| 75-102 236-296 378-405 |
| PT3RE-- BACCE SYSTEM ENZYME RES BACILLUS CEREUS 62-89 256-283 |
| PTA47-- TREPA 47 KD MEMBRANE ANTIGEN PRECURSOR TREPONEMA |
| PALLIDUM 26-53 |
| PTA53-- TREDE 53 KD MEMBRANE ANTIGEN A PRECURSOR TREPONEMA |
| DENTICOLA |
| 99-126 298-329 PTACY.sub |
| .-- |
| BACAL ALVEOLYSIN PRECURSOR BACILLUS ALVEI 272-302 374-401 |
| PTACY-- CLOPE PERFRINGOLYSIN O PRECURSOR CLOSTRIDIUM PERFRINGENS |
| 270-311 372-434 |
| PTACY-- LISIV IVANOLYSIN PRECURSOR LISTERIA IVANOVII 93-120 |
| 167-195 396-423 |
| PTACY-- LISMO LISTERIOLYSIN O PRECURSOR LISTERIA MONOCYTOGENES |
| 98-125 168-196 295-329 397-424 |
| PTACY-- LISSE SEELIGERIOLYSIN PRECURSOR LISTERIA SEELIGERI |
| 99-126 296-323 349-376 398-463 |
| PTACY-- STRPN PNEUMONYSIN STREPTOCOCCUS PNEUMONIAE 234-272 |
| PTACY-- STRPY STREPTOLYSIN O PRECURSOR STREPTOCOCCUS |
| PYOGENES |
| 86-133 355-382 440-470 |
| PTAGB-- BACSU TECHOIC ACID BIOSYN PROTEIN B PREC BACILLUS SUBTILIS |
| 42-69 |
| PTAGC-- BACSU TECHOIC ACID BIOSYNTHESIS PROTEIN C BACILLUS |
| SUBTILIS 348-375 |
| PTAGE-- BACSU TECHOIC ACID BIOSYNTHESIS PROTEIN E BACILLUS |
| SUBTILIS 59-93 144-181 185-243 565-592 600- |
| 627 |
| PTAGF-- BACSU TECHOIC ACID BIOSYNTHESIS PROTEIN F BACILLUS |
| SUBTILIS 182-209 |
| PTBP1-- NEIGO TRANSFERRIN-BINDING PROTEIN 1 PRECURSOR NEISSERIA |
| GONORRHOEAE 39-73 137-164 398-425 810-841 |
| PTBUD-- PSEPI PHENOL 2-MONOOXYGENASE PSEUDOMONAS PICKETTII 38-65 |
| 227-254 375-402 |
| PTCDT-- SALTY TRANSCRIPTIONAL REGULATORY PROTEIN TCDT SALMONELLA |
| TYPHIMURIUM 105-132 |
| PTCPC-- VIBCH MEMBRANE PROTEIN TCPC PRECURSOR VIBRIO CHOLERAE |
| 20-47 |
| 83-128 199-233 263-290 344- 459- |
| 375 486 |
| PTCPE-- VIBCH TCP PILUS BIOSYNTHESIS PROTEIN TCPE VIBRIO CHOLERAE |
| 24-59 |
| 77-111 |
| PTCPF-- VIBCH TCP PILUS SECRETION PROTEIN TCPF VIBRIO CHOLERAE |
| 32-66 211-238 |
| PTCPH-- VIBCH TCP PILUS BIOSYNTHESIS PROTEIN TCPH VIBRIO CHOLERAE |
| 95-122 |
| PTCPI-- VIBCH TCP PILUS BIOSYNTHESIS PROTEIN TCPI VIBRIO CHOLERAE |
| 25-52 234-261 279-306 346-379 |
| PTCPN-- VIBCH TCP PILUS VIRULENCE REGULATORY PROTEIN VIBRIO |
| CHOLERAE 48-75 |
| PTCPO-- VIBCH TCP PILUS BIOSYNTHESIS PROTEIN TCPO VIBRIO CHOLERAE |
| 230-257 |
| PTCPY-- VIBCH TCP PILUS BIOSYNTHESIS PROTEIN TCPY VIBRIO CHOLERAE |
| 121-148 |
| PTCPZ-- VIBCH TCP PILUS BIOSYNTHESIS PROTEIN TCPZ VIBRIO CHOLERAE |
| 44-85 |
| PTCR2-- BACSU TETRACYCLINE RESISTANCE PROTEIN BACILLUS SUBTILIS |
| 404-434 |
| PTCR-- |
| BACST TETRACYCLINE RESISTANCE PROTEIN BACILLUS STEAROTHERMOPHILUS |
| 422-453 |
| PTCR-- STAAU TETRACYCLINE RESISTANCE PROTEIN STAPHYLOCOCCUS |
| AUREUS 404-431 |
| PTCR-- STRAG TETRACYCLINE RESISTANCE PROTEIN STREPTOCOCCUS |
| AGALACTIAE 422-453 |
| PTCR-- STRPN TETRACYCLINE RESISTANCE PROTEIN STREPTOCOCCUS |
| PNEUMONIAE 422-453 |
| PTDCA-- ECOLI TDCABC OPERON TRANSCRIPTIONAL ACTIVATOR ESCHERICHIA |
| COLI 210-239 |
| PTDCC-- |
| ECOLI TDCC PROTEIN ESCHERICHIA COLI 344-361 PTEE6-- |
| STRPY TYPSIN-RESIST SURFACE T6 PROTEIN PREC STREPTOCOCCUS PYOGENES |
| 137-164 361-395 400-437 |
| PTER2-- ECOLI TETRACYCLINE REPRESSOR PROTEIN CLASS B ESCHERICHIA |
| COLI |
| 8-36 |
| PTER4-- ECOLI TETRACYCLINE REPRESSOR PROTEIN CLASS D ESCHERICHIA |
| COLI 183-210 |
| PTERA-- ALCSP TELLURIUM RESISTANCE PROTEIN TERA ALCALIGENES SP |
| 48-86 |
| PTESB-- ECOLI ACYL-COA THIOESTERASE II ESCHERICHIA COLI 4-31 |
| PTET5-- |
| ENTFA TETRACYCLINE RESISTANCE PROTEIN TETM ENTEROCOCCUS FAECALIS 2-36 |
| 130-159 179-206 217-244 |
| PTET9-- ENTFA TETRACYCLINE RESISTANCE PROTEIN TETM ENTEROCOCCUS |
| FAECALIS |
| 2-36 130-159 217-244 260-287 |
| PTETC-- ECOLI TRANSPOSON TN10 TETC PROTEIN ESCHERICHIA COLI 72-106 |
| 116-158 |
| PTETM-- STRLI TETRACYCLINE RESISTANCE PROTEIN STREPTOMYCES |
| LIVIDANS |
| 82-109 |
| PTETM-- UREUR TETRACYCLINE RESISTANCE PROTEIN TETM UREPLASMA |
| UREALYTICUM |
| 2-36 130-159 217-244 260-287 PTETO- |
| - CAMCO TETRACYCLINE RESISTANCE PROTEIN TETO CAMPYLOBACTER COLI 2-29 |
| PTETO-- CAMJE TETRACYCLINE RESISTANCE PROTEIN TETO CAMPYLOBACTER |
| JEJUNI |
| 2-36 |
| PTETO-- STRMU TETRACYCLINE RESISTANCE PROTEIN TETO STREPTOCOCCUS |
| MUTANS |
| 2-29 |
| PTETX-- BACFR TETRACYCLINE RESISTANCE PROTEIN BACTEROIDES FRAGILIS |
| 35-62 |
| PTETX-- CLOTE TETANUS TOXIN PRECURSOR CLOSTRIDIUM TETANI 274-304 |
| 540-567 615-642 692-719 985- 1240- |
| 1012 1277 |
| PTF2B-- PYRWO TRANS INITIATION FACTOR IIB HOMOLOG PYROCOCCUS |
| WOESEI 218-258 |
| PTFDC-- |
| ALCEU CHLOROCATECHOL 1,2-DIOXYGENASE ALCALIGENES EUTROPHUS 2-33 |
| PTGT-- ECOLI QUEUINE TRNA-RIBOSYLTRANSFERASE ESCHERICHIA |
| COLI 173-200 |
| PTHD1-- LACLA THREONINE DEHYDRATASE BIOSYNTHETIC LACTOCOCCUS |
| LACTIS 267-303 |
| PTHD2-- ECOLI THREONINE DEHYDRATASE CATABOLIC ESCHERICHIA COLI |
| 293-320 |
| PTHDF-- BACSU FURAN OXIDATION PROTEIN THDF BACILLUS SUBTILIS |
| 153-180 192-226 282-316 391-418 |
| PTHDF-- ECOLI FURAN OXIDATION PROTEIN THDF ESCHERICHIA COLI |
| 226-260 404-431 |
| PTHDF-- PSEPU FURAN OXIDATION PROTEIN THDF PSEUDOMONAS PUTIDA |
| 226-260 |
| PTHER-- BACCE THERMOLYSIN BACILLUS CEREUS |
| 4-38 240-267 PTHER-- BACST THERMOLYSIN PRECURSOR |
| BACILLUS STEROTHERMOPHILUS 45-72 |
| PTHER-- BACTH THERMOLYSIN BACILLUS STEAROTHERMOPHILUS 86-113 |
| PTHET-- THEVU THERMITASE THERMOACTINOMYCES VULGARIS 131-161 |
| PTHIC-- ECOLI THIC PROTEIN ESCHERICHIA COLI 232-263 301-328 |
| PTHIG-- |
| ECOLI THIG PROTEIN ESCHERICHIA COLI 138-165 PTHPS-- |
| SULAC THERMOPSIN PRECURSOR SULFOLOBUS ACIDOCALDARIUS 135-172 199-233 |
| PTHRC-- BRELA THREONINE SYNTHASE BREVIBACTERIUM LACTOFERMENTUM |
| 288-315 |
| PTHTR-- |
| SACER PUTATIVE THIOSULFATE SULFURTRANSFERASE SACCHAROPOLYSPORA ERYTHRAEA |
| 69-96 |
| PTIG-- |
| ECOLI TRIGGER FACTOR ESCHERICHIA COLI 144-171 PTMPA-- |
| TREPA TREPONEMAL MEMBRANE PROTEIN A PRECURSOR TREPONEMA PALLIDUM |
| 236-266 |
| PTMPB-- TREPA TREPONEMAL MEMBRANE PROTEIN B PRECURSOR TREPONEMA |
| PALLIDUM 44-71 |
| PTMPB-- TREPH TREPONEMAL MEMBRANE PROTEIN B PRECURSOR TREPONEMA |
| PHAGEDENIS 41-68 |
| PTNAB-- ECOLI LOW AFFINITY TRYPTOPHAN PERMEASE ESCHERICHIA COLI |
| 74-108 |
| PTNP4-- STAAU TRANSPOSASE STAPHYLOCOCCUS AUREUS 52-79 322-349 |
| PTNP7-- ENTFA TRANSPOSON TN917 RESOLVASE ENTEROCOCCUS FAECALIS |
| 59-97 111-138 |
| PTNPA-- STAAU TRANSPOSASE A STAPHYLOCOCCUS AUREUS 151-178 |
| PTNPB-- STAAU TRANSPOSASE B STAPHYLOCOCCUS AUREUS 589-625 |
| PTNPI-- BACTU TNPI RESOLVASE BACILLUS THURINGIENSIS 7-62 65-92 |
| 174-201 |
| PTNSB-- |
| ECOLI TRANSPOSON TN7 TRANSPOSITION PROTEIN TNSB ESCHERICHIA COLI |
| 99-126 510-537 |
| PTNSC-- |
| ECOLI TRANSPOSON TN7 TRANSPOSITION PROTEIN TNSC ESCHERICHIA COLI 32-59 |
| 314-341 |
| PTNSD-- |
| ECOLI TRANSPOSON TN7 TRANSPOSITION PROTEIN TNSD ESCHERICHIA COLI |
| 339-366 |
| PTNSE-- |
| ECOLI TRANSPOSON TN7 TRANSPOSITION PROTEIN TNSE ESCHERICHIA COLI |
| 363-490 |
| PTOD1-- PSEPU TOLUENE 1,2-DIOXYGENASE ALPHA SUBUNIT PSEUDOMONAS |
| PUTIDA 36-63 |
| PTOD2-- PSEPU TOLUENE 1,2-DIOXYGENASE BETA SUBUNIT PSEUDOMONAS |
| PUTIDA 119-153 |
| PTODA-- PSEPU TOLUENE 1,2-DIOXYGENASE SYSTEM PSEUDOMONAS PUTIDA |
| 179-213 |
| PTODJ-- PSEPU TODF PRODUCT HYDRATASE PSEUDOMONAS PUTIDA 143-170 |
| PTOLA-- |
| ECOLI TOLA PROTEIN ESCHERICHIA COLI 101-138 PTOLC-- |
| ECOLI OUTER MEMBRANE PROTEIN TOLC PRECURSOR ESCHERICHIA COLI 144-78 |
| 184-211 239-266 348-375 383- |
| 443 |
| PTOP1-- SYNP7 DNA TOPOISOMERASE I SYNECHOCOCCUS SP 203-230 |
| PTORA-- ECOLI TRIMETHYLAMINE-N-OXIDE REDUCTASE ESCHERICHIA |
| COLI 797-824 |
| PTOX1-- BORPE PERTUSSIS TOXIN SUBUNIT 1 (S1) PRECURSOR BORDETELLA |
| PERTUSSIS 179-206 |
| PTOX2-- BORPE PERTUSSIS TOXIN SUBUNIT 2 (S2) PRECURSOR BORDETELLA |
| PERTUSSIS 58-85 |
| PTOXA-- CLODI TOXIN A CLOSTRIDIUM DIFFICILE 20-88 99-159 204-231 |
| 342-369 373- 847- 966- 997- 1348- |
| 414 962 994 1024 1402 |
| PTOXA-- PSEAE EXOTOXIN A PRECURSOR PSEUDOMONAS AERUGINOSA 470-497 |
| PTOXB-- CLODI TOXIN B CLOSTRIDIUM DIFFICILE 38-72 133-163 199-241 |
| 825-869 923- 1334- 1403- 1506- 1716- |
| 950 1388 1433 1565 1747 |
| PTOXS-- VIBCH TRANSMEMBRANE REGULATORY PROTEIN TOXS VIBRIO |
| CHOLERAE 13-40 |
| PTPF1-- |
| TREPA ANTIGEN TPF1 TREPONEMA PALLIDUM 106-143 PTPIS-- |
| ECOLI TRIOSEPHOSPHATE ISOMERASE ESCHERICHIA COLI |
| 83-110 PTPIS-- MORSP TRIOSEPHOSPHATE ISOMERASE |
| MORAXELLA SP 139-166 |
| PTPR-- PROGI THIOL PROTEASE PRECURSOR PORPHYROMONAS GINGIVALIS |
| 117-144 |
| PTR2M-- |
| AGRT3 TRYPTOPHAN 2-MONOOXYGENASE AGROBACTERIUM TUMEFACIENS 239-266 |
| 501-529 |
| PTR2M-- |
| AGRT4 TRYPTOPHAN 2-MONOOXYGENASE AGROBACTERIUM TUMEFACIENS 239-266 |
| 501-529 |
| PTR2M-- PSESS TRYPTOPHAN 2-MONOOXYGENASE PSEUDOMONAS SYRINGAE |
| 41-68 |
| PTRA1-- STAAU TRANSPOSASE STAPHYLOCOCCUS AUREUS |
| 58-113 PTRA2-- STAAU TRANSPOSASE STAPHYLOCOCCUS AUREUS |
| 11-38 |
| 58-113 |
| PTRA3-- |
| ECOLI TRANSPOSASE ESCHERICHIA COLI 721-755 PTRA3- |
| - |
| RHIME TRANSPOSASE RHIZOBIUM MELILOTI 179-206 |
| PTRA3-- STAAU TRANSPOSASE STAPHYLOCOCCUS AUREUS 33-60 68-95 |
| PTRA4-- ECOLI TRANSPOSASE ESCHERICHIA COLI 181-208 308-340 |
| 720-754 |
| PTRA6-- |
| ECOLI TRANSPOSASE ESCHERICHIA COLI 51-78 PTRA6-- |
| SHISO TRANSPOSASE SHIGELLA SONNEI 51-78 200-227 231-258 |
| PTRA7-- |
| ECOLI TRANSPOSASE ESCHERICHIA COLI 729-756 PTRA9-- |
| MYCTU PUTATIVE TRANSPOSASE MYCOBACTERIUM TUBERCULOSIS 159-186 |
| PTRAB-- BACTB IS231B PROBABLE TRANSPOSASE BACILLUS THURINGIENSIS |
| 281-308 419-446 |
| PTRAC-- BACTB IS231C PROBABLE TRANSPOSASE BACILLUS THURINGIENSIS |
| 281-308 419-446 |
| PTRAC-- STAAU TRANSPOSASE STAPHYLOCOCCUS AUREUS 4-31 45-72 |
| PTRAX-- |
| BACTB IS231 PROBABLE TRANSPOSASE BACILLUS THURINGIENSIS 281-308 419-446 |
| PTRA-- BACTU TRANSPOSASE BACILLUS THURINGIENSIS 93-127 509-539 |
| PTRA-- PSEAE TRANSPOSASE PSEUDOMONAS AERUGINOSA 127-154 721-755 |
| PTRB1-- |
| ECOLI TRAB PROTEIN ESCHERICHIA COLI 113-143 PTRBF-- |
| ECOLI TRBF PROTEIN ESCHERICHIA COLI 12-39 |
| PTRB1-- |
| ECOLI TRBI PROTEIN ESCHERICHIA COLI 70-97 PTRC1-- |
| ECOLI TRAC-1 PROTEIN ESCHERICHIA COLI 1006- |
| 1058 |
| PTRC2-- |
| ECOLI TRAC-2 PROTEIN ESCHERICHIA COLI 1102- 1149 |
| PTRC3-- ECOLI TRAC-3 PROTEIN ESCHERICHIA COLI 884-931 |
| PTRD1-- ECOLI TRAD PROTEIN ESCHERICHIA COLI 297-348 |
| PTREA-- ECOLI PERIPLASMIC TREHALASE PRECURSOR ESCHERICHIA |
| COLI 362-403 477-508 |
| PTREC-- |
| ECOLI AMYLOTREHALSE ESCHERICHIA COLI 280-307 PTRFA-- |
| ECOLI TRFA TRANSCRIPTIONAL REPRESSOR PROTEIN ESCHERICHIA COLI 5-32 |
| 105-132 |
| PTRG1-- ECOLI TRAG PROTEIN ESCHERICHIA COLI 61-88 630-657 831-858 |
| 865-895 |
| PTRG5-- |
| ECOLI TRAG PROTEIN ESCHERICHIA COLI 196-223 PTRG6-- |
| ECOLI TRAG PROTEIN ESCHERICHIA COLI 195-222 518-545 |
| PTRI1-- ECOLI TRAI PROTEIN ESCHERICHIA COLI 155-209 597-624 |
| 887-914 1350- |
| 1377 |
| PTRI2-- ECOLI TRAI PROTEIN ESCHERICHIA COLI 155-209 597-624 |
| 887-914 1350- |
| 1377 |
| PTRI5-- ECOLI TRAI PROTEIN ESCHERICHIA COLI 47-74 328-371 |
| PTRJ4-- |
| ECOLI TRAJ PROTEIN ESCHERICHIA COLI 36-63 PTRM8-- ECOLI |
| TRAM PROTEIN ESCHERICHIA COLI |
| 5-32 PTRMA-- ECOLI TRNA |
| (URACIL-5-)-METHYLTRANSFERASE ESCHERICHIA COLI 107-137 |
| PTRMD-- ECOLI TRNA (GUANINE-N1)-METHYLTRANSFERASE ESCHERICHIA |
| COLI 115-142 226-253 |
| PTRPA-- BACSU TRYPTOPHAN SYNTHASE ALPHA CHAIN BACILLUS SUBTILIS |
| 220-247 |
| PTRPA-- CAUCR TRYPTOPHAN SYNTHASE ALPHA CHAIN CAULOBACTER |
| CRESCENTUS 241-275 |
| PRTPA-- PSEAE TRYPTOPHAN SYNTHASE ALPHA CHAIN PSEUDOMONAS |
| AERUGINOSA 176-203 |
| PTRPB-- ACICA TRYPTOPHAN SYNTHASE BETA CHAIN ACINETOBACTER |
| CALCOACETICUS |
| 79-113 PTRPB-- |
| BACSU TRYPTOPHAN SYNTHASE BETA CHAIN BACILLUS SUBTILIS 76-103 318-345 |
| PTRPB-- BRELA TRYPTOPHAN SYNTHASE BETA CHAIN BREVIBACTERIUM |
| LACTOFERMENTUM 172-199 |
| PTRPB-- LACCA TRYPTOPHAN SYNTHASE BETA CHAIN LACTOBACILLUS CASEI |
| 83-117 |
| PTRPB-- LACLA TRYPTOPHAN SYNTHASE BETA CHAIN LACTOCOCCUS LACTIS |
| 77-104 164-191 |
| PTRPB-- |
| VIBPA TRYPTOPHAN SYNTHASE BETA CHAIN VIBRIO PARAHAEMOLYTICUS 56-83 |
| PTRPC-- |
| BRELA INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE BREVIBACTERIUM LACTOFERMENTUM |
| 229-256 |
| PTRPC-- ECOLI INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE ESCHERICHIA |
| COLI 205-232 |
| PTRPC-- LACLA INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE LACTOCOCCUS |
| LACTIS 148-175 |
| PTRPC-- VIBPA INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE VIBRIO |
| PARAHAEMOLYTICUS 346-376 |
| PTRPD-- |
| ACICA ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE ACINETOBACTER CALCOACETICUS |
| 223-250 260-294 |
| PTRPD-- PSEAE ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE PSEUDOMONAS |
| AERUGINOSA 205-232 |
| PTRPD-- PSEPU ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE PSEUDOMONAS |
| PUTIDA 205-232 |
| PTRPD-- VIBPA ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE VIBRIO |
| PARAHAEMOLYTICUS |
| 2-29 PTRPE-- |
| BACPU ANTHRANILATE SYNTHASE COMPONENT I BACILLUS PUMILUS 33-60 |
| PTRPE-- CLOTM ANTHRANILATE SYNTHASE COMPONENT I CLOSTRIDIUM |
| THERMOCELLUM 165-226 |
| PTRPE-- LACLA ANTHRANILATE SYNTHASE COMPONENT I LACTOCOCCUS |
| LACTIS 142-191 |
| PTRPE-- LEPBI ANTHRANILATE SYNTHASE COMPONENT I LEPTOSPIRA |
| BIFLEXA 145-179 |
| PTRPE-- RHIME ANTHRANILATE SYNTHASE RHIZOBIUM MELILOTI 139-166 |
| PTRPE-- SALTY ANTHRANILATE SYNTHASE COMPONENT I SALMONELLA |
| TYPHIMURIUM 191-218 |
| PTRPE-- SULSO ANTHRANILATE SYNTHASE COMPONENT I SULFOLOBUS |
| SOLFATARICUS 143-183 298-328 |
| PTRPE-- |
| VIBPA ANTHRANILATE SYNTHASE COMPONENT I VIBRIO PARAHAEMOLYTICUS 9-36 |
| 54-81 |
| PTRPG-- ACICA ANTHRANILATE SYNTHASE COMPONENT II ACINETOBACTER |
| CALCOACETICUS 12-39 |
| PTRPG-- AZOBR ANTHRANILATE SYNTHASE COMPONENT II AZOSPIRILLUM |
| BRASILENSE |
| 4-31 PTRPG |
| -- ECOLI ANTHRANILATE SYNTHASE COMPONENT II ESCHERICHIA COLI 5-32 |
| PTRPG-- LACLA ANTHRANILATE SYNTHASE COMPONENT II LACTOCOCCUS |
| LACTIS |
| 4-31 |
| PTRPG-- PSEAE ANTHRANILATE SYNTHASE COMPONENT II PSEUDOMONAS |
| AERUGINOSA 12-39 |
| PTRPG-- SALTY ANTHRANILATE SYNTHASE COMPONENT II SALMONELLA |
| TYPHIMURIUM |
| 5-32 PTRPG- |
| - SERMA ANTHRANILATE SYNTHASE COMPONENT II SERRATIA MARCESCENS 9-43 |
| PTRPG-- SHIDY ANTHRANILATE SYNTHASE COMPONENT II SHIGELLA |
| DYSENTERIAE |
| 5-32 PTRPO- |
| - PSEAE PUTATIVE TRANSCRIPTIONAL REGULATOR PSEUDOMONAS AERUGINOSA |
| 147-174 |
| PTRS2-- ECOLI TRAS PROTEIN ESCHERICHIA COLI |
| 85-119 PTRT3-- ECOLI RESISTANCE PROTEIN PRECURSOR |
| ESCHERICHIA COLI 184-221 |
| PTRY1-- SALTY TRAY PROTEIN SALMONELLA TYPHIMURIUM 30-57 |
| PTRYP-- STRGR TRYPSIN PRECURSOR STREPTOMYCES GRISEUS 80-107 |
| PTSR-- STRAZ RRNA METHYLTRANSFERASE STREPTOMYCES AZUREUS |
| 126-153 |
| PTSST-- |
| STAAU TOXIC SHOCK SYNDROME TOXIN-1 PRECURSOR STAPHYLOCOCCUS AUREUS |
| 29-63 102-129 |
| PTSX-- ECOLI CHANNEL-FORMING PROTEIN TSX PRECURSOR ESCHERICHIA |
| COLI 225-252 |
| PTTK-- ECOLI HYPOTHETICAL 24.3 KD PROTEIN ESCHERICHIA COLI |
| 81-115 |
| PTUS-- ECOLI SITE-BINDING PROTEIN ESCHERICHIA COLI 57-91 107-134 |
| PTYCA-- BACBR TYROCIDINE SYNTHETASE I BACILLUS BREVIS 117-147 |
| 534-561 1019- |
| 1051 |
| PTYF1-- |
| TREPE ANTIGEN TYF1 TREPONEMA PERTENUE 106-143 PTYRA-- |
| BACSU POSSIBLE PREPHENATE DEHYDROGENASE BACILLUS SUBTILIS 244-271 |
| 312-342 |
| PTYRA-- |
| ECOLI CHORISMATE MUTASE ESCHERICHIA COLI 329-370 PTYRR-- |
| ECOLI TRANSCRIPTIONAL REGULATORY PROTEIN TYRR ESCHERICHIA COLI 483-510 |
| PTYSY-- LACCA THYMIDYLATE SYNTHASE LACTOBACILLUS CASEI 139-173 |
| PTYSY-- LACLA THYMIDYLATE SYNTHASE LACTOCOCCUS LACTIS 75-109 |
| PTYSY-- STAAU THYMIDYLATE SYNTHASE STAPHYLOCOCCUS AUREUS 69-96 |
| PUHPB-- ECOLI SENSOR PROTEIN UHPB ESCHERICHIA COLI 276-303 |
| 316-343 |
| PUHPB-- SALTY SENSOR PROTEIN UHPB SALMONELLA TYPHIMURIUM 276-303 |
| 316-343 |
| PUMUC-- SALTY UMCU PROTEIN SALMONELLA TYPHIMURIUM 204-231 |
| PUPP-- ECOLI URACIL PHOSPHORIBOSYLTRANSFERASE ESCHERICHIA |
| COLI 30-57 |
| PURAA-- |
| ECOLI URACIL PERMEASE ESCHERICHIA COLI 350-384 PURE1-- |
| HELPY UREASE ALPHA SUBUNIT HELICOBACTER PYLORI 15-42 |
| PURE1-- PROMI UREASE ALPHA SUBUNIT PROTEUS MIRABILIS 72-99 |
| PURE1-- PROVU UREASE ALPHA SUBUNIT PROTEUS VULGARIS 72-99 |
| PURE1-- UREUR UREASE ALPHA SUBUNIT UREAPLASMA UREALYTICUM 13-40 |
| 483-517 |
| PURE2-- HELPY UREASE BETA SUBUNIT HELICOBACTER PYLORI 62-99 |
| PURED-- HELPY UREASE OPERON URED PROTEIN HELICOBACTER PYLORI |
| 17-44 |
| PUREE-- PROMI UREASE ACCESSORY PROTEIN UREE PROTEUS MIRABILIS |
| 57-84 |
| PUREF-- KLEAE UREASE ACCESSORY PROTEIN UREF PRECURSOR KLEBSIELLA |
| AEROGENES 20-47 |
| PUS45-- LACLA SECRETED 45 KD PROTEIN PRECURSOR LACTOCOCCUS LACTIS |
| 44-98 150-223 276-303 |
| PUSHA-- ECOLI P-SUGAR HYDROLASE PRECURSOR ESCHERICHIA COLI 56-83 |
| PUSHA-- SALTY SILENT PROTEIN USHA(0) PRECURSOR SALMONELLA |
| TYPHIMURIUM 56-83 |
| PUVRA-- ECOLI EXCINUCLEASE ABC SUBUNIT A ESCHERICHIA COLI 527-554 |
| 871-898 |
| PUVRA-- MICLU EXCINUCLEASE ABC SUBUNIT A MICROCOCCUS LUTEUS |
| 579-606 619-646 684-718 922-949 |
| PUVRA-- PARDE EXCINUCLEASE ABC SUBUNIT A PARACOCCUS DENITRIFICANS |
| 33-60 |
| PUVRC-- BACSU EXCINUCLEASE ABC SUBUNIT C BACILLUS SUBTILIS |
| 342-372 511-538 |
| PUVRC-- ECOLI EXCINUCLEASE ABC SUBUNIT C ESCHERICHIA COLI 37-64 |
| 332-362 |
| PUVRD-- |
| ECOLI HELICASE II ESCHERICHIA COLI 280-307 PVANA-- |
| ENTFC VANCOMYCIN RESISTANCE PROTEIN VANA ENTEROCOCCUS FAECIUM 182-209 |
| PVANC-- ENTGA VANCOMYCIN RESISTANCE PROTEIN VANC ENTEROCOCCUS |
| GALLINARUM 177-211 |
| PVIB4-- AGRT5 VIRB4 PROTEIN PRECURSOR AGROBACTERIUM TUMEFACIENS |
| 138-172 |
| PVIB6-- AGRT5 VIRB6 PROTEIN AGROBACTERIUM TUMEFACIENS 190-227 |
| PVIB6-- AGRT6 VIRB6 PROTEIN AGROBACTERIUM TUMEFACIENS 190-227 |
| PVIB6-- AGRT9 VIRB6 PROTEIN AGROBACTERIUM TUMEFACIENS 190-227 |
| PVIBX-- AGRT5 VIRB10 PROTEIN AGROBACTERIUM TUMEFACIENS 32-59 |
| 212-239 |
| PVIBX-- AGRT6 VIRB10 PROTEIN AGROBACTERIUM TUMEFACIENS 32-59 |
| 211-238 |
| PVIBX-- AGRT9 VIRB10 PROTEIN AGROBACTERIUM TUMEFACIENS 32-59 |
| 212-239 |
| PVIC1-- AGRRA VIRC1 PROTEIN AGROBACTERIUM RHIZOGENES 81-108 |
| TUMEFACIENS |
| PVIC1-- AGRT5 VIRC1 PROTEIN AGROBACTERIUM TUMEFACIENS 81-108 |
| PVIC1-- AGRT6 VIRC1 PROTEIN AGROBACTERIUM TUMEFACIENS 81-108 |
| PVID3-- AGRRA VIRD3 PROTEIN AGROBACTERIUM RHIZOGENES 149-176 |
| 265-292 |
| PVIRA-- AGRT5 WIDE HOST RANGE (WHR) VIRA PROTEIN AGROBACTERIUM |
| TUMEFACIENS 42-76 113-147 657-684 |
| PVIRA-- AGRT6 WIDE HOST RANGE (WHR) VIRA PROTEIN AGROBACTERIUM |
| TUMEFACIENS 42-69 |
| 84-125 653-680 PVIRA-- |
| AGRT9 WIDE HOST RANGE (WHR) VIRA PROTEIN AGROBACTERIUM TUMEFACIENS 42-69 |
| 84-125 653-680 |
| PVIRB-- SHIFL VIRB TRANSCRIPTIONAL ACTIVATOR SHIGELLA FLEXNERI |
| 37-71 107-134 187-214 252-291 |
| PVIRF-- |
| YEREN VIRULENCE REGULON TRANSACTIVATOR YERSINIA ENTEROCOLITICA 16-46 |
| PVIRG-- AGRRA VIRG REGULATORY PROTEIN AGROBACTERIUM RHIZOGENES |
| 34-61 |
| PVIRL-- |
| AGRT6 LIMITED HOST RANGE (LHR) VIBRA PROTEIN AGROBACTERIUM TUMEFACIENS |
| 106-157 |
| PVISC-- |
| ECOLI VISC PROTEIN ESCHERICHIA COLI 47-74 PVLPA-- |
| MYCHR VARIANT SURFACE ANTIGEN A PRECURSOR MYCOPLASMA HYORHINIS 74-112 |
| PVM03-- BORHE OUTER MEMBRANE LIPOPROTEIN 3 PRECURSOR BORRELIA |
| HERMSII 54-81 |
| PVM07-- BORHE OUTER MEMBRANE LIPOPROTEIN 7 PRECURSOR BORRELIA |
| HERMSII 332-359 |
| PVM21-- BORHE OUTER MEMBRANE LIPOPROTEIN 21 PRECURSOR BORRELIA |
| HERMSII 330-357 |
| PVM24-- BORHE OUTER MEMBRANE LIPOPROTEIN 24 PRECURSOR BORRELIA |
| HERMSII |
| 47-143 |
| PVM25-- BORHE OUTER MEMBRANE LIPOPROTEIN 25 PRECURSOR BORRELIA |
| HERMSII 315-356 |
| PVNFA-- |
| AZOVI NITROGEN FIXATION PROTEIN VNFA AZOTOBACTER VINELANDII 158-188 |
| 218-245 |
| PVNFK-- AZOCH NITROGENASE VANADIUM-IRON PROTEIN AZOTOBACTER |
| CHROOCOCCUM MCD I 68-95 |
| PVNFK-- AZOVI NITROGENASE VANADIUM-IRON PROTEIN AZOTOBACTER |
| VINELANDII 68-95 372-403 |
| PVRP2-- SALCH 65 KD VIRULENCE PROTEIN SALMONELLA CHOLERAE- SUIS |
| 509-536 |
| PVRP2-- SALDU 65 KD VIRULENCE PROTEIN SALMONELLA DUBLIN 511-538 |
| PVSDE-- SALDU VIRULENCE PROTEIN VSDE SALMONELLA DUBLIN 3-36 |
| PVHB-- VIBVU CYTOLYSIN SECRETION PROTEIN VIBRIO VULNIFICUS |
| 30-75 |
| PWAPA-- STRMU WALL-ASSOCIATED PROTEIN PRECURSOR STREPTOCOCCUS |
| MUTANS |
| 4-41 313-386 |
| PWRBA-- ECOLI TRP REPRESSOR BINDING PROTEIN ESCHERICHIA COLI |
| 89-116 |
| PX191-- |
| ECOLI X POLYPEPTIDE ESCHERICHIA COLI 104-131 PX192-- |
| ECOLI X POLYPEPTIDE ESCHERICHIA COLI 104-131 |
| PX193-- |
| ECOLI X POLYPEPTIDE ESCHERICHIA COLI 104-131 PXISA-- |
| ANASP EXCISASE A ANABAENA SP 4-31 |
| 89-116 135-162 PXPRB-- ECOLI POSSIBLE |
| INTEGRASE/RECOMBINASE XPRB ESCHERICHIA COLI 268-295 |
| PXYLA-- STAXY XYLOSE ISOMERASE STAPHYLOCOCCUS XYLOSUS 411-438 |
| PXYLK-- LKEAE XYLULOSE KINASE KLEBSIELLA AEROGENES 2-29 |
| PXYLK-- LACPE XYLULOSE KINASE LACTOBACILLUS PENTOSUS 52-79 |
| 211-238 260-287 |
| PXYLK-- STAXY XYLULOSE KINASE STAPHYLOCOCCUS XYLOSUS 4-31 |
| 96-130 209-236 246-273 |
| PXYLR-- BACSU XYLOSE REPRESSOR BACILLUS SUBTILIS 75-102 260-287 |
| PXYLR-- LACPE XYLOSE REPRESSOR LACTOBACILLUS PENTOSUS 262-289 |
| PXYLR-- STAXY XYLOSE REPRESSOR STAPHYLOCOCCUS XYLOSUS 20-64 |
| 101-158 181-215 221-255 274- |
| 301 |
| PXYLZ-- PSEPU ELECTRON TRANSFER COMPONENT PSEUDOMONAS PUTIDA |
| 51-78 104-131 |
| PXYN4-- |
| CALSA PUTATIVE ENDO-1,4-BETA-XYLANSE CALDOCELLUM SACCHAROLYTICUM |
| 198-225 |
| PXYNA-- BACCI O-1,4-BETA-XYLANASE PRECURSOR BACILLUS CIRCULANS |
| 47-74 |
| PXYNA-- BACS5 ENDO-1,4-BETA-XYLANASE PRECURSOR BACILLUS SP |
| 173-200 |
| PXYNA-- BACSU ENDO-1,4-BETA-XYLANASE PRECURSOR BACILLUS SUBTILIS |
| 47-74 |
| PXYNA-- CALSA ENDO-1,4-BETA-XYLANASE A PRECURSOR CALDOCELLUM |
| SACCHAROLYTICUM 132-159 226-256 |
| PXYNA-- PSEFL ENDO-1,4-BETA-XYLANASE PRECURSOR PSEUDOMONAS |
| FLUORESCENS 33-82 |
| PXYNB-- |
| BACPU BETA-XYLOSIDASE BACILLUS PUMILUS 459-486 PXYNB-- |
| CALSA BETA-XYLOSIDASE CALDOCELLUM SACCHAROLYTICUM 440-474 |
| PXYNB-- PSEFL ENDO-1,4-BETA-XYLANSE PRECURSOR PSEUDOMONAS |
| FLUORESCENS 51-78 251-278 317-344 475-502 |
| PXYNC-- PSEFL ALPHA-L-ARABINOFURANOSIDASE C PRECURSOR PSEUDOMONAS |
| FLUORESCENS 51-78 251-278 |
| PXYNC-- STRLI ENDO-1,4-BETA-XYLANSE PRECURSOR STREPTOMYCES |
| LIVIDANS 183-210 |
| PY14K-- HALMO HYPOTHETICAL 14.9 KD PROTEIN HALOCOCCUS MORRHUAE |
| 56-83 |
| PY23K-- STROR HYPOTHETICAL 23.9 KD PROTEIN STREPTOCOCCUS ORALIS |
| 78-105 |
| PY36K-- METSM HYPOTHETICAL 36.7 KD PROTEIN METHANOBREVIBACTER |
| SMITHII 128-162 172-218 |
| PYAAC-- ECOLI HYPOTHETICAL 34.6 KD PROTEIN ESCHERICHIA COLI |
| 271-298 |
| PYAAC-- |
| PSEFL HYPOTHETICAL 33.9 KD PROTEIN PSEUDOMONAS FLUORESCENS 274-301 |
| PYAAM-- ECOLI HYPOTHETICAL 59.1 KD PROTEIN ESCHERICHIA COLI |
| 45-72 |
| PYAAP-- ECOLI HYPOTHETICAL 56.6 KD PROTEIN ESCHERICHIA COLI |
| 352-379 |
| PYAAQ-- ECOLI HYPOTHETICAL 28.5 KD PROTEIN ESCHERICHIA COLI |
| 155-182 |
| PYABC-- ECOLI HYPOTHETICAL 34.9 KD PROTEIN ESCHERICHIA COLI |
| 131-158 |
| PYABG-- ECOLI HYPOTHETICAL 89.7 KD PROTEIN ESCHERICHIA COLI |
| 446-480 627-654 |
| PYABN-- ECOLI HYPOTHETICAL 63.9 KD PROTEIN ESCHERICHIA COLI |
| 428-455 |
| PYAC3-- PSEAE HYPOTHETICAL 23.9 KD PROTEIN PSEUDOMONAS AERUGINOSA |
| 48-75 150-177 |
| PYAD2-- |
| CLOAB HYPOTHETICAL 21.6 KD PROTEIN CLOSTRIDIUM ACETOBUTYLICUM 75-109 |
| 114-144 |
| PYAD5-- |
| CLOAB HYPOTHETICAL 36.9 KD PROTEIN CLOSTRIDIUM ACETOBUTYLICUM 132-159 |
| 165-196 210-237 |
| PYAD6-- CLOAB HYPOTHETICAL PROTEIN CLOSTRIDIUM ACETOBUTYLICUM |
| 21-55 |
| PYADA-- YEREN INVASIN PRECURSOR YERSINIA ENTEROCOLITICA 196-230 |
| 247-274 318-381 |
| PYADA-- YERPS INVASIN PRECURSOR YERSINIA PSEUDOTUBERCULOSIS |
| 255-282 297-360 |
| PYADC-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 13-40 101-131 |
| PYAEA-- RICRI 17 KD PROTEIN RICKETTSIA RICKETTSII 107-134 |
| PYAFB-- ECOLI HYPOTHETICAL 29.4 KD PROTEIN ESCHERICHIA |
| COLI 221-248 |
| PYAFD-- ECOLI HYPOTHETICAL 29.1 KD PROTEIN ESCHERICHIA COLI 34-71 |
| PYAFE-- ECOLI HYPOTHETICAL 23.0 KD PROTEIN ESCHERICHIA COLI |
| 123-150 |
| PYAIB-- ESCFE HYPOTHETICAL PROTEIN ESCHERICHIA FERGUSONII 2-35 |
| PYAMI-- SALTY PUTATIVE AMIDASE SALMONELLA TYPHIMURIUM 73-100 |
| PYATI-- SYNY3 HYPOTHETICAL 13.0 KD PROTEIN SYNECHOCYSTIS SP |
| 26-60 |
| PYATP-- MYCLE HYPO PROTEIN PUTATIVE ATP OPERON MYCOBACTERIUM |
| LEPRAE 23-57 |
| 91-158 511-538 PYATR-- |
| BACFI HYPOL ATP-BINDING TRANSPORT PROTEIN BACILLUS FIRMUS 211-238 |
| PYATS-- MYCGA HYPOTHETICAL PROTEIN MYCOPLASMA GALLISPETICUM |
| 7-41 |
| PYATU-- MYCGA HYPOTHETICAL PROTEIN MYCOPLASMA GALLISPETICUM 29-56 |
| 60-87 |
| PYAV5-- XANCV HYPOTHETICAL 50 KD AVIRULENCE PROTEIN XANTHOMONAS |
| CAMPESTRIS 68-98 199-226 |
| PYBAH-- ECOLI HYPOTHETICAL 24.8 KD PROTEIN ESCHERICHIA COLI 49-79 |
| PYBBA-- ECOLI HYPOTHETICAL ABC TRANSPORTER ESCHERICHIA COLI 6-69 |
| PYBED-- ECOLI HYPOTHETICAL 9.8 KD PROTEIN ESCHERICHIA COLI 51-82 |
| PYBID-- ECOLI HYPOTHETICAL 14.1 KD PROTEIN ESCHERICHIA COLI |
| 97-124 |
| PYCAE-- ECOLI HYPOTHETICAL 24.5 KD PROTEIN ESCHERICHIA COLI 34-61 |
| PYCBA-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 38-65 |
| PYCBL-- BACUN HYPOTHETICAL 17.3 KD PROTEIN BACTEROIDES |
| UNIFORMIS |
| 66-100 PYCEA.sub |
| .-- |
| BACLA HYPOTHETICAL PROTEIN BACILLUS LAUTUS 111-138 |
| PYCFC-- ECOLI HYPOTHETICAL 22.9 KD PROTEIN ESCHERICHIA COLI 52-79 |
| PYCHR-- ALCEU HYPOTHETICAL PROTEIN ALCALIGENES EUTROPHUS 21-48 |
| PYCIB-- ECOLI HYPOTHETICAL 20.8 KD PROTEIN ESCHERICHIA COLI |
| 16-43 |
| PYCIF-- ECOLI 18.6 KD PROTEIN ESCHERICHIA COLI 7-68 134-166 |
| PYCIK-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 35-62 |
| PYCL1-- ECOLI HYPOTHETICAL 43.3 KD PROTEIN ESCHERICHIA COLI |
| 54-81 |
| PYCP3-- SYNPY HYPOTHETICAL 29.3 KD PROTEIN SYNECHOCOCCUS SP |
| 194-221 |
| PYCP3-- SYNY3 HYPOTHETICAL 28.0 KD PROTEIN SYNECHOCYSTIS SP 7-34 |
| 120-154 |
| PYCP5-- SYNY3 HYPOTHETICAL 39.5 KD PROTEIN SYNECHOCYSTIS SP |
| 277-308 |
| PYCPG-- MASLA HYPOTHETICAL PROTEIN MASTIGOCLADUS LAMINOSUS 2-29 |
| PYCPY-- PSEA9 HYPO PHYCOCYANIN OPERON PROTEIN PSEUDANABAENA SP |
| 380-407 |
| PYCR2-- BACTK HYPOTHETICAL 29.1 KD PROTEIN BACILLUS THURINGIENSIS |
| 42-74 153-180 |
| PYCS5-- ECOLI HYPOTHETICAL PROTEIN PRECURSOR ESCHERICHIA COLI |
| 32-59 |
| PYCW5-- BACSU HYPOTHETICAL PROTEIN BACILLUS SUBTILIS 3-30 |
| PYD3M-- HERAU HYPOTHETICAL 68.4 KD PROTEIN HERPETOSIPHON |
| AURANTIACUS 12-39 151-178 360-416 |
| PYDBA-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 32-66 117-144 |
| 163-216 233-267 295- 458- 676- 1136- 1499- |
| 329 485 717 1163 1530 |
| PYDBD-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 80-107 |
| PYDDB-- ECOLI HYPOTHETICAL 86.7 KD PROTEIN ESCHERICHIA COLI |
| 606-641 683-714 726-753 |
| PYDDC-- ECOLI HYPOTHETICAL 80.8 KD PROTEIN ESCHERICHIA COLI |
| 373-400 421-452 621-648 |
| PYDDD-- ECOLI HYPOTHETICAL 24.1 KD PROTEIN ESCHERICHIA COLI |
| 133-174 |
| PYDEH-- ECOLI HYPOTHETICAL 20.5 KD PROTEIN ESCHERICHIA COLI |
| 96-130 |
| PYDEJ-- ECOLI HYPOTHETICAL 18.3 KD PROTEIN ESCHERICHIA COLI 4-38 |
| PYDEK-- ECOLI HYPOTHETICAL 65.5 KD PROTEIN ESCHERICHIA COLI |
| 333-360 524-551 565-592 |
| PYDNN-- BORBU HYPOTHETICAL 11.2 KD PROTEIN BORRELIA BURGDORFERI |
| 6-36 |
| PYDO1-- |
| SULSO HYPOTHETICAL 14.7 KD PROTEIN SULFOLOBUS SOLFATARICUS 17-58 |
| 71-103 |
| PYDO3-- |
| SULSO HYPOTHETICAL 16.9 KD PROTEIN SULFOLOBUS SOLFATARICUS 11-38 |
| PYEBA-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 93-120 |
| PYEBG-- ECOLI HYPOTHETICAL 10.7 KD PROTEIN ESCHERICHIA COLI |
| 50-77 |
| PYEEE-- ECOLI HYPOTHETICAL 38.1 KD PROTEIN ESCHERICHIA COLI 43-70 |
| PYEEF-- ECOLI HYPO 49.8 KD TRANSPORT PROTEIN ESCHERICHIA COLI |
| 147-174 |
| PYEGA-- ECOLI HYPOTHETICAL IN DCD 3'REGION ESCHERICHIA COLI |
| 145-172 |
| PYEHA-- ECOLI HYPOTHETICAL 36.9 KD PROTEIN ESCHERICHIA COLI |
| 69-106 283-310 |
| PYEHB-- ECOLI HYPOTHETICAL 92.3 KD PROTEIN ESCHERICHIA COLI |
| 151-178 501-545 |
| PYEHD-- ECOLI HYPOTHETICAL 19.1 KD PROTEIN ESCHERICHIA COLI |
| 96-123 |
| PYEHF-- ECOLI HYPOTHETICAL 141.0 KD PROTEIN ESCHERICHIA COLI |
| 543-570 |
| PYEHI-- ECOLI HYPOTHETICAL 138.1 KD PROTEIN ESCHERICHIA COLI |
| 35-70 102-129 |
| PYEHU-- ECOLI HYPOTHETICAL 62.1 KD PROTEIN ESCHERICHIA COLI |
| 326-353 |
| PYEIC-- ECOLI HYPOTHETICAL 33.6 KD PROTEIN ESCHERICHIA COLI 46-80 |
| PYEIF-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 61-88 |
| PYEIJ-- ECOLI HYPOTHETICAL 43.4 KD PROTEIN ESCHERICHIA |
| COLI 15-42 |
| PYEJA-- ECOLI HYPOTHETICAL ABC TRANSPORTER ESCHERICHIA COLI |
| 83-110 |
| PYEJF-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 453-480 |
| PYEJO-- ECOLI HYPOTHETICAL 91.2 KD PROTEIN ESCHERICHIA COLI |
| 399-433 |
| PYFHD-- ECOLI HYPOTHETICAL 40.6 KD PROTEIN ESCHERICHIA COLI |
| 175-202 |
| PYFU2-- |
| BACST HYPOTHETICAL 30.6 KD PROTEIN BACILLUS STEAROTHERMOPHILUS 133-160 |
| PYFXK-- BRAJA HYPOTHETICAL PROTEIN BRADYRHIZOBIUM JAPONICUM |
| 109-150 |
| PYGAP-- BACME HYPOTHETICAL 37.7 KD PROTEIN BACILLUS MEGATERIUM |
| 40-67 |
| PYGFD-- ECOLI HYPOTHETICAL 29.4 KD PROTEIN ESCHERICHIA COLI |
| 214-241 |
| PYGGB-- ECOLI HYPOTHETICAL 30.9 KD PROTEIN ESCHERICHIA COLI |
| 225-252 |
| PYGGG-- ECOLI HYPOTHETICAL 31.8 KD PROTEIN ESCHERICHIA COLI |
| 209-236 |
| PYGI2-- BACTU HYPOTHETICAL 22.8 KD PROTEIN BACILLUS THURINGIENSIS |
| 26-61 |
| PYGI2-- PSEPU HYPOTHETICAL 32.4 KD PROTEIN PSEUDOMONAS PUTIDA |
| 145-172 |
| PYGIF-- ECOLI HYPOTHETICAL 48.4 KD PROTEIN ESCHERICHIA COLI |
| 223-264 |
| PYGL4-- |
| BACTS HYPOTHETICAL 35.5 KD PROTEIN BACILLUS STEAROTHERMOPHILUS 6-33 |
| PYGL5-- BACST HYPOTHETICAL PROTEIN BACILLUS STEAROTHERMOPHILUS |
| 182-209 |
| PYGLN-- BACCE HYPOTHETICAL 15 KD PROTEIN BACILLUS CEREUS 79-124 |
| PYGRD-- BACSU HYPOTHETICAL PROTEIN BACILLUS SUBTILIS 20-47 |
| PYGRE-- BACSU HYPOTHETICAL 17.1 KD PROTEIN BACILLUS |
| SUBTILIS |
| 84-111 |
| PYGRP-- BACSU HYPOTHETICAL 39.0 KD PROTEIN BACILLUS SUBTILIS |
| 98-125 |
| PYGRP-- |
| CLOAB HYPOTHETICAL 38.8 KD PROTEIN CLOSTRIDIUM ACETOBUTYLICUM 160-210 |
| PYGT2-- STRMU HYPOTHETICAL PROTEIN 2 STREPTOCOCCUS MUTANS 4-40 |
| 110-138 235-262 |
| PYHAB-- ECOLI HYPOTHETICAL 20.6 KD PROTEIN ESCHERICHIA COLI 20-66 |
| PYHAC-- ECOLI HYPOTHETICAL 45.2 KD PROTEIN ESCHERICHIA COLI 69-96 |
| PYHAF-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 44-71 138-165 |
| PYHBG-- ECOLI PROBABLE ABC TRANSPORTER ESCHERICHIA COLI 176-203 |
| PYHBG-- PSEPU PROBABLE ABC TRANSPORTER PSEUDOMONAS PUTIDA |
| 74-101 106-133 147-174 |
| PYHBG-- THIFE PROBABLE ABC TRANSPORTER THIOBACILLUS FERROOXIDANS |
| 113-140 |
| PYHDF-- ECOLI HYPOTHETICAL 55.4 KD PROTEIN ESCHERICHIA COLI |
| 267-297 |
| PYHEM-- BACSU HYPOTHETICAL 32.0 KD PROTEIN BACILLUS SUBTILIS |
| 222-253 |
| PYHET-- |
| ANASP HYPOTHETICAL PROTEIN ANABAENA SP 72-99 PYHHA-- |
| ECOLI HYPOTHETICAL 16.6 KD PROTEIN ESCHERICHIA COLI 56-84 |
| PYHHG-- ECOLI HYPOTHETICAL 15.1 KD PROTEIN ESCHERICHIA COLI 43-77 |
| PYHHH-- ECOLI HYPOTHETICAL 14.5 KD PROTEIN ESCHERICHIA COLI 43-73 |
| PYHI1-- LACLA HYPOTHETICAL PROTEIN LACTOCOCCUS LACTIS 167-194 |
| PHYI3-- LACLA HYPOTHETICAL 38.0 KD PROTEIN LACTOCOCCUS LACTIS |
| 90-124 132-159 |
| PYHI6-- LACLA HYPOTHETICAL 30.7 KD PROTEIN LACTOCOCCUS LACTIS |
| 92-148 |
| PYHI8-- LACLA HYPOTHETICAL 30.7 KD PROTEIN LACTOCOCCUS LACTIS |
| 77-104 156-183 |
| PYHLB-- STAAU HYPOTHETICAL PROTEIN STAPHYLOCOCCUS AUREUS 18-67 |
| PYHLB-- VIBCH HYPOTHETICAL 18.3 KD PROTEIN VIBRIO CHOLERAE |
| 99-126 |
| PYHMF-- METFE HYPOTHETICAL 32.2 KD PROTEIN METHANOTHERMUS |
| FERVIDUS 106-133 |
| PYHS1-- |
| CLOAB HYPOTHETICAL 11.0 KD PROTEIN CLOSTRIDIUM ACETOBUTYLICUM 41-85 |
| PYHSA-- CLOAB HYPOTHETICAL 20.6 KD PROTEIN CLOSTRIDIUM |
| ACETOBUTYLICUM |
| 98-125 PYHSC-- |
| CLOAB HYPOTHETICAL 42.4 KD PROTEIN CLOSTRIDIUM ACETOBUTYLICUM 25-52 |
| 208-253 276-310 |
| PYHVI-- LACHE HYPOTHETICAL PROTEIN LACTOBACILLUS HELVETICUS |
| 93-120 127-154 |
| PYHYA-- PSESN HYPOTHETICAL PROTEIN PSEUDOMONAS SP 217-266 |
| PYI11-- HALHA HYPOTHETICAL 38.0 KD PROTEIN HALOBACTERIUM |
| HALOBIUM 245-272 |
| PYI32-- MYCIU IS986 HYPOTHETICAL 6.6 KD PROTEIN MYCOBACTERIUM |
| TUBERCULOSIS 19-46 |
| PYI42-- |
| PSEAY HYPOTHETICAL 42.6 KD PROTEIN PSEUDOMONAS AMYLODERAMOSA 9-36 |
| PYI48-- |
| METSM ISM1 HYPOTHETICAL 48.3 KD PROTEIN METHANOBREVIBACTER SMITHII |
| 73-100 154-184 338-365 |
| PYI52-- HALHA HYPOTHETICAL 31 KD PROTEIN HALOBACTERIUM HALOBIUM |
| 86-113 |
| PYIBB-- ECOLI HYPOTHETICAL 34.0 KD PROTEIN ESCHERICHIA COLI |
| 202-239 |
| PYIBD-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 9-43 |
| PYIBF-- ECOLI HYPOTHETICAL 22.6 KD PROTEIN ESCHERICHIA |
| COLI 131-158 |
| PYIBG-- ECOLI HYPOTHETICAL 18.1 KD PROTEIN ESCHERICHIA COLI 70-97 |
| PYICC-- ECOLI HYPOTHETICAL 33.2 KD PROTEIN ESCHERICHIA COLI |
| 143-170 |
| PYICD-- ECOLI HYPOTHETICAL 31.1 KD PROTEIN ESCHERICHIA COLI |
| 132-159 |
| PYICH-- ECOLI HYPOTHETICAL 62.3 KD PROTEIN ESCHERICHIA COLI |
| 408-435 |
| PYICI-- ECOLI HYPOTHETICAL 88.1 KD PROTEIN ESCHERICHIA COLI |
| 122-149 |
| PYICN-- ECOLI HYPOTHETICAL 18.2 KD PROTEIN ESCHERICHIA COLI |
| 76-103 |
| PYICO-- ECOLI HYPOTHETICAL 49.9 KD PROTEIN ESCHERICHIA COLI |
| 320-347 |
| PYIDB-- ECOLI HYPOTHETICAL 13.8 KD PROTEIN ESCHERICHIA COLI 34-78 |
| PYIDE-- ECOLI HYPOTHETICAL 58.9 KD PROTEIN ESCHERICHIA COLI |
| 86-113 182-209 277-304 |
| PYIDI-- ECOLI HYPOTHETICAL 15.7 KD PROTEIN ESCHERICHIA COLI 56-83 |
| PYIDK-- ECOLI HYPOTHETICAL 62.1 KD PROTEIN ESCHERICHIA COLI 2-39 |
| PYIDP-- ECOLI HYPOTHETICAL 27.3 KD PROTEIN ESCHERICHIA COLI 63-97 |
| PYIEA-- ECOLI HYPOTHETICAL 49.2 KD PROTEIN ESCHERICHIA COLI |
| 221-248 |
| PYIEC-- ECOLI HYPOTHETICAL 60.6 KD PROTEIN ESCHERICHIA COLI 20-58 |
| 270-297 |
| PYIEC-- ERWCH HYPOTHETICAL PROTEIN ERWINIA CHRYSANTHEMI 22-67 |
| PYIED-- ECOLI HYPOTHETICAL 34.8 KD PROTEIN ESCHERICHIA COLI |
| 86-120 |
| PYIEG-- ECOLI HYPOTHETICAL 46.9 KD PROTEIN ESCHERICHIA COLI |
| 293-327 |
| PYIEH-- ECOLI HYPOTHETICAL 24.7 KD PROTEIN ESCHERICHIA COLI 51-78 |
| PYIEM-- ECOLI HYPOTHETICAL 15.0 KD PROTEIN ESCHERICHIA COLI |
| 73-105 |
| PYIEO-- ECOLI HYPOTHETICAL 51.5 KD PROTEIN ESCHERICHIA COLI |
| 201-242 380-407 |
| PYIFC-- ECOLI HYPOTHETICAL 39.6 KD PROTEIN ESCHERICHIA COLI |
| 175-202 |
| PYIGJ-- ECOLI HYPOTHETICAL 14.0 KD PROTEIN ESCHERICHIA COLI 51-92 |
| PYIGM-- ECOLI HYPOTHETICAL 33.7 KD PROTEIN ESCHERICHIA COLI |
| 120-154 |
| PYIGN-- ECOLI HYPOTHETICAL 54.7 KD PROTEIN ESCHERICHIA COLI |
| 207-234 |
| PYIGO-- ECOLI HYPOTHETICAL 28.1 KD PROTEIN ESCHERICHIA COLI 67-94 |
| PYIGP-- ECOLI HYPOTHETICAL 22.3 KD PROTEIN ESCHERICHIA COLI |
| 173-200 |
| PYIGT-- ECOLI HYPOTHETICAL 27.8 KD PROTEIN ESCHERICHIA COLI |
| 132-159 |
| PYIHB-- ECOLI HYPOTHETICAL 21.2 KD PROTEIN ESCHERICHIA COLI 13-40 |
| PYIHD-- ECOLI HYPOTHETICAL 10.3 KD PROTEIN ESCHERICHIA COLI 28-55 |
| PYIHF-- ECOLI HYPOTHETICAL 54.1 KD PROTEIN ESCHERICHIA COLI |
| 272-306 |
| PYIHI-- ECOLI HYPOTHETICAL 19.1 KD PROTEIN ESCHERICHIA COLI |
| 112-139 |
| PYIHK-- ECOLI HYPOTHETICAL 65.4 KD PROTEIN ESCHERICHIA COLI 4-31 |
| PYIHM-- ECOLI HYPOTHETICAL 36.9 KD PROTEIN ESCHERICHIA COLI |
| 83-110 120-154 297-324 |
| PYIHO-- ECOLI HYPOTHETICAL 81.8 KD PROTEIN ESCHERICHIA COLI |
| 612-646 |
| PYIHO-- ECOLI HYPOTHETICAL 53.1 KD PROTEIN ESCHERICHIA COLI |
| 357-384 |
| PYIHV-- ECOLI HYPOTHETICAL 31.9 KD PROTEIN ESCHERICHIA COLI 72-99 |
| PYIHX-- ECOLI HYPOTHETICAL 23.5 KD PROTEIN ESCHERICHIA COLI 9-36 |
| PYIHZ-- ECOLI HYPOTHETICAL 15.9 KD PROTEIN ESCHERICHIA COLI 6-33 |
| PYIIP-- ECOLI HYPOTHETICAL 32.9 KD PROTEIN ESCHERICHIA COLI 22-63 |
| PYIIU-- ECOLI HYPOTHETICAL 9.6 KD PROTEIN ESCHERICHIA COLI 28-71 |
| PYIJC-- ECOLI HYPOTHETICAL 26.6 KD PROTEIN ESCHERICHIA COLI |
| 136-163 |
| PYIJH-- ECOLI HYPOTHETICAL 78.3 KD PROTEIN ESCHERICHIA COLI |
| 225-263 |
| PYIJK-- ECOLI HYPOTHETICAL 11.2 KD PROTEIN ESCHERICHIA COLI 26-53 |
| PYIJO-- ECOLI HYPOTHETICAL 32.1 KD PROTEIN ESCHERICHIA COLI |
| 214-241 |
| PYIJP-- ECOLI HYPOTHETICAL 66.6 KD PROTEIN ESCHERICHIA COLI |
| 110-137 419-446 |
| PYINL-- LISMO HYPOTHETICAL 26.8 KD PROTEIN LISTERIA MONOCYTOGENES |
| 7-34 |
| PYIS1-- SHISO INSERTION ELEMENT IS600 SHIGELLA SONNEI 62-89 |
| PYIS1-- |
| STRCO IS110 HYPOTHETICAL 43.6 KD PROTEIN STREPTOMYCES COELICOLOR |
| 125-152 |
| PYIS3-- SHISO INSERTION ELEMENT IS629 SHIGELLA SONNEI 66-100 |
| PYISP-- BACSP HYPOTHETICAL 42.1 KD PROTEIN BACILLUS SP 312-339 |
| PYJAG-- ECOLI HYPOTHETICAL 22.6 KD PROTEIN ESCHERICHIA COLI 51-78 |
| PYJAI-- ECOLI HYPOTHETICAL 20.4 KD PROTEIN ESCHERICHIA COLI |
| 88-122 |
| PYJBH-- ECOLI HYPOTHETICAL 78.5 KD PROTEIN ESCHERICHIA COLI |
| 93-120 |
| PYJBL-- ECOLI HYPOTHETICAL 9.7 KD PROTEIN ESCHERICHIA COLI 30-57 |
| PYJBM-- ECOLI HYPOTHETICAL 26.7 KD PROTEIN ESCHERICHIA COLI |
| 112-149 |
| PYJBQ-- ECOLI HYPOTHETICAL 15.7 KD PROTEIN ESCHERICHIA COLI 2-29 |
| PYJCC-- ECOLI HYPOTHETICAL 60.8 KD PROTEIN ESCHERICHIA COLI 38-65 |
| 414-441 451-492 |
| PYJCE-- ECOLI HYPOTHETICAL 60.5 KD PROTEIN ESCHERICHIA COLI |
| 454-481 |
| PYJCG-- ECOLI HYPOTHETICAL 59.2 KD PROTEIN ESCHERICHIA COLI |
| 394-421 |
| PYJCO-- ECOLI HYPOTHETICAL 25.1 KD PROTEIN ESCHERICHIA COLI |
| 91-118 |
| PYJCP-- ECOLI HYPOTHETICAL 53.4 KD PROTEIN ESCHERICHIA COLI |
| 242-269 |
| PYJCS-- ECOLI HYPOTHETICAL 73.7 KD PROTEIN ESCHERICHIA COLI |
| 366-396 |
| PYJCW-- ECOLI HYPOTHETICAL ABC TRANSPORTER ESCHERICHIA COLI 50-84 |
| PYJDA-- ECOLI HYPOTHETICAL 84.2 KD PROTEIN ESCHERICHIA COLI 2-29 |
| 451-485 |
| PYJDB-- ECOLI HYPOTHETICAL PROTEIN ESCHERICHIA COLI 103-134 |
| PYJJA-- ECOLI HYPOTHETICAL 17.5 KD PROTEIN PRECURSOR |
| ESCHERICHIA COLI 35-69 |
| 88-129 PYKAB-- BACFI |
| HYPOTHETICAL 48.8 KD PROTEIN BACILLUS FIRMUS 321-355 |
| PYLA1-- LACAC HYPOTHETICAL PROTEIN LACTOBACILLUS ACIDOPHILUS |
| 47-74 |
| PYLA2-- |
| LACAC HYPOTHETICAL 14.5 KD PROTEIN LACTOBACILLUS ACIDOPHILUS 15-42 |
| PYLA3-- LACAC HYPOTHETICAL 14.4 KD PROTEIN LACTOBACILLUS |
| ACIDOPHILUS 47-74 |
| PYLAC-- |
| SULSO HYPOTHETICAL 24.4 KD PROTEIN SULFOLOBUS SOLFATATICUS 23-50 |
| PYLP3-- PSEPU HYPOTHETICAL 44.7 KD PROTEIN PSEUDOMONAS |
| PUTIDA 186-213 314-341 |
| PYLPA-- YEREN YLPA LIPOPROTEIN PRECURSOR YERSINIA ENTEROCOLITICA |
| 184-221 |
| PYLT3-- ANAVA HYPOTHETICAL 22.6 KD PROTEIN ANABAENA VARIABILIS |
| 172-199 |
| PYLUD-- LACLA HYPOTHETICAL 29.7 KD PROTEIN LACTOCOCCUS LACTIS |
| 35-70 |
| PYME2-- BACSU HYPOTHETICAL 35.3 KD PROTEIN BACILLUS SUBTILIS |
| 52-79 |
| PYMG2-- MYCGE HYPOTHETICAL 114.4 KD PROTEIN PRECURSOR MYCOPLASMA |
| GENITALIUM 56-83 159-193 420-445 981- |
| 1008 |
| PYNGA-- CLOPE HYPOTHETICAL PROTEIN CLOSTRIDIUM PERFRINGENS |
| 139-166 |
| PYNGB-- |
| CLOPE HYPOTHETICAL 31.2 KD PROTEIN CLOSTRIDIUM PERFRINGENS 12-49 63-97 |
| 182-211 |
| PYNI1-- |
| METTL HYPOTHETICAL PROTEIN METHANOCOCCUS 55-89 THERMOLITHO |
| TROPHICUS |
| PYNQ1-- |
| PARDE HYPOTHETICAL 9.3 KD PROTEIN PARACOCCUS DENITRIFICANS 52-86 |
| PYNT3-- ANASP HYPOTHETICAL 28.1 KD PROTEIN ANABAENA SP |
| 171-198 |
| PYNT5-- ANASP HYPOTHETICAL PROTEIN ANABAENA SP |
| 87-165 PYOHD-- ECOLI HYPOTHETICAL 21.4 KD PROTEIN |
| ESCHERICHIA COLI |
| 5-32 PYOHG-- |
| ECOLI HYPOTHETICAL 43.3 KD PROTEIN ESCHERICHIA COLI 104-171 289-316 |
| PYOJA-- ECOLI HYPOTHETICAL 15.0 KD PROTEIN ESCHERICHIA COLI |
| 17-44 |
| PYOJE-- ECOLI HYPOTHETICAL 93.5 KD PROTEIN ESCHERICHIA COLI |
| 221-248 |
| PYOJF-- ECOLI HYPOTHETICAL 9.5 KD PROTEIN ESCHERICHIA COLI 41-82 |
| PYOJH-- ECOLI HYPOTHETICAL 54.3 KD PROTEIN ESCHERICHIA COLI |
| 145-193 |
| PYOJJ-- ECOLI HYPOTHETICAL 36.2 KD PROTEIN ESCHERICHIA COLI |
| 94-121 |
| PYOM2-- |
| PHOS9 HYPOTHETICAL PROTEIN IN OMPH 3'REGION PHOTOBACTERIUM SP 32-59 |
| PYOPH-- YEREN PROTEIN-TYROSINE PHOSPHATEASE YOPH YERSINIA |
| ENTEROCOLITICA |
| 63-105 PYOPH-- |
| YERPS PROTEIN-TYROSINE PHOSPHATEASE YOPH YERSINIA PSEUDOTUBERCULOSIS |
| 63-105 |
| PYOPN-- YEREN OUTER MEMBRANE PROTEIN YOPN YERSINIA ENTEROCOLITICA |
| 23-50 66-93 235-262 |
| PYOPN-- |
| YERPS OUTER MEMBRANE PROTEIN YOPN YERSINIA PSEUDOTUBERCULOSIS 23-50 |
| 66-93 235-262 |
| PYOPQ-- YEREN YOPQ PROTEIN PRECURSOR YERSINIA ENTEROCOLITICA |
| 61-88 |
| PYORA-- HAEIN HYPOTHETICAL 31.5 KD PROTEIN HAEMOPHILUS INFLUENZAE |
| 147-174 |
| PYORA-- LISMO HYPOTHETICAL 25.6 KD PROTEIN LISTERIA MONOCYTOGENES |
| 32-77 |
| PYORA-- PYRWO HYPOTHETICAL 24.7 KD PROTEIN PYROCOCCUS WOESEI |
| 183-210 |
| PYORB-- HAEIN HYPOTHETICAL 19.8 KD PROTEIN HAEMOPHILUS INFLUENZAE |
| 39-66 |
| PYORC-- HAEIN HYPOTHETICAL 19.9 KD PROTEIN HAEMOPHILUS INFLUENZAE |
| 49-79 |
| PYORE-- HAEIN 8 KD PROTEIN HAEMOPHILUS INFLUENZAE 47-74 82-109 |
| PYORF-- HAEIN 26.8 KD PROTEIN HAEMOPHILUS INFLUENZAE 199-229 |
| PYORH-- HAEIN HYPOTHETICAL 13.7 KD PROTEIN HAEMOPHILUS |
| INFLUENZAE |
| 7-34 PYORI |
| -- HAEIN 95.4 KD PROTEIN HAEMOPHILUS INFLUENZAE 416-450 688-722 |
| PYORQ-- BACSU HYPOTHETICAL 34 KD PROTEIN BACILLUS SUBTILIS |
| 148-175 |
| PYORX-- PYRWO HYPOTHETICAL PROTEIN PYROCOCCUS WOESEI 66-93 |
| PYORZ-- LISMO HYPOTHETICAL 16.9 KD PROTEIN LISTERIA |
| MONOCYTOGENES 27-54 |
| PYP15-- STAAU HYPOTHETICAL 15.5 KD PROTEIN STAPHYLOCOCCUS AUREUS |
| 71-98 110-137 |
| PYP23-- BACSU HYPOTHETICAL 22.5 KD PROTEIN BACILLUS SUBTILIS |
| 57-84 |
| PYP23-- STAAU HYPOTHETICAL 22.2 KD PROTEIN STAPHYLOCOCCUS AUREUS |
| 29-70 |
| PY2A3-- STAAU HYPOTHETICAL 26.9 KD PROTEIN STAPHYLOCOCCUS AUREUS |
| 34-104 |
| PYP2B-- STAAU HYPOTHETICAL 27.0 KD PROTEIN STAPHYLOCOCCUS AUREUS |
| 23-60 62-89 179-206 |
| PYP2C-- STAAU HYPOTHETICAL 27.7 KD PROTEIN STAPHYLOCOCCUS AUREUS |
| 13-83 129-176 |
| PYP7-- AGRT4 HYPOTHETICAL PROTEIN 7 AGROBACTERIUM TUMEFACIENS |
| 29-56 |
| PYPA2-- LEGPN HYPOTHETICAL PROTEIN LEGIONELLA PNEUMOPHILA 94-135 |
| PYPAS-- ENTFA HYPOTHETICAL 13 KD PROTEIN ENTEROCOCCUS FAECALIS |
| 79-106 |
| PYPA-- BACAN HYPOTHETICAL 21.6 KD PROTEIN BACILLUS ANTHRACIS |
| 13-47 115-162 |
| PYPC1-- ECOLI HYPOTHETICAL 27.6 KD PROTEIN ESCHERICHIA COLI 5-32 |
| PYPDA-- BACSU HYPOTHETICAL 27.3 KD PROTEIN BACILLUS SUBTILIS |
| 184-222 |
| PYPFT-- ECOLI HYPOTHETICAL 12.6 KD PROTEIN ESCHERICHIA COLI 16-3 |
| PYPH1-- SYNP2 HYPOTHETICAL 18.1 KD PROTEIN SYNECHOCOCCUS SP 34-61 |
| PYPI6-- |
| CLOPE HYPOTHETICAL 19.7 KD PROTEIN CLOSTRIDIUM PERFRINGENS 7-34 43-77 |
| 83-149 |
| PYPI9-- |
| CLOPE HYPOTHETICAL 14.5 KD PROTEIN CLOSTRIDIUM PERFRINGENS 2-59 |
| PYPIX-- CLOPE HYPOTHETICAL 38.4 KD PROTEIN CLOSTRIDIUM |
| PERFRINGENS 110-137 263-290 303-340 |
| PYPIY-- PSEAE HYPOTHETICAL 38.5 KD PROTEIN PSEUDOMONAS AERUGINOSA |
| 22-52 |
| PYPP-- BACSU HYPOTHETICAL PROCESSING PROTEASE BACILLUS SUBTILIS |
| 329-356 |
| PYPQQ-- KLEPN HYPOTHETICAL PROTEIN KLEBSIELLA PNEUMONIAE 243-270 |
| PYPS2-- PLEBO HYPOTHETICAL 13.1 KD PROTEIN PLECTONEMA BORYANUM |
| 27-54 |
| PYPV1-- METTF HYPOTHETICAL 40.7 KD PROTEIN METHANOBACTERIUM 58-85 |
| 308-335 |
| THERMOFORMICICUM |
| PYPV3-- METTF HYPOTHETICAL 22.5 KD PROTEIN METHANOBACTERIUM 3-30 |
| THERMOFORMICICUM |
| PYPV7-- METTF HYPOTHETICAL 17.3 KD PROTEIN METHANOBACTERIUM |
| 69-117 |
| THERMOFORMICICUM |
| PYPVB-- METTF HYPOTHETICAL 49.6 KD PROTEIN METHANOBACTERIUM |
| 333-360 389-430 |
| THERMOFORMICICUM |
| PYPYB-- BACSU HYPOTHETICAL 72.4 KD PROTEIN BACILLUS SUBTILIS |
| 602-636 |
| PYPZ1-- METTF HYPOTHETICAL 40.6 KD PROTEIN METHANOBACTERIUM 58-85 |
| 308-335 |
| THERMOFORMICICUM |
| PYPZ2-- METTF HYPOTHETICAL 33.1 KD PROTEIN METHANOBACTERIUM 38-65 |
| 154-188 |
| THERMOFORMICICUM |
| PYPZ5-- METTF HYPOTHETICAL 54.1 KD PROTEIN METHANOBACTERIUM |
| 193-220 226-253 381-408 |
| THERMOFORMICICUM |
| PYPZ7-- METTF HYPOTHETICAL 9.7 KD PROTEIN METHANOBACTERIUM 5-78 |
| THERMOFORMICICUM |
| PYR18-- THEPE HYPOTHETICAL 18.7 KD PROTEIN THERMOFILUM PENDENS |
| 82-109 |
| PYRB1-- |
| HALCU HYPOTHETICAL 40 KD GTP-BINDING PROTEIN HALOBACTERIUM CUTIRUBRUM |
| 20-51 |
| PYREC-- SYNP2 HYPOTHETICAL 28.7 KD PROTEIN SYNECHOCOCCUS SP 49-76 |
| PYRF0-- SALTY HYPOTHETICAL 40.6 KD PROTEIN SALMONELLA TYPHIMURIUM |
| 143-190 |
| PYRF2-- SALTY HYPOTHETICAL 51.0 KD PROTEIN SALMONELLA TYPHIMURIUM |
| 428-455 |
| PYRF5-- SALTY HYPOTHETICAL 20.6 KD PROTEIN SALMONELLA TYPHIMURIUM |
| 29-56 |
| PYRF6-- SALTY HYPOTHETICAL 36.6 KD PROTEIN SALMONELLA TYPHIMURIUM |
| 130-157 |
| PYRG2-- LACLA HYPOTHETICAL PROTEIN LACTOCOCCUS LACTIS 140-167 |
| PYRL1-- METVA HYPOTHETICAL PROTEIN METHANOCOCCUS VANNIELII |
| 40-93 129-156 |
| PYRP2-- |
| METVA HYPOTHETICAL 11.6 KD PROTEIN METHANOCOCCUS VANNIELII 13-40 |
| PYRP2-- SULAC HYPOTHETICAL 11.5 KD PROTEIN SULFOLOBUS |
| ACIDOCALDARIUS |
| 5-51 PYRP3-- |
| SULAC HYPOTHETICAL 14.5 KD PROTEIN SULFOLOBUS ACIDOCALDARIUS 37-71 |
| PYRTP-- BACSU HYPOTHETICAL 25.3 KD PROTEIN BACILLUS SUBTILIS |
| 29-56 |
| PYRTS-- BACSU HYPOTHETICAL 11.4 KD PROTEIN BACILLUS SUBTILIS |
| 3-30 44-81 |
| PYSCB-- |
| YEREN HYPOTHETICAL YSC OPERON PROTEIN B YERSINIA ENTEROCOLITICA 90-121 |
| PYSCC-- |
| YEREN YSC OPERON PROTEIN C PRECURSOR YERSINIA ENTEROCOLITICA 38-72 |
| 365-399 |
| PYSCD-- YEREN YSC OPERON PROTEIN D YERSINIA ENTEROCOLITICA |
| 242-269 |
| PYSCH-- YEREN YSC OPERON PROTEIN H YERSINIA ENTEROCOLITICA 28-58 |
| PYSCH-- YERPS YSC OPERON PROTEIN H YERSINIA PSEUDOTUBERCULOSIS |
| 28-58 |
| PYSCI-- YEREN YSC OPERON PROTEIN I YERSINIA ENTEROCOLITICA 49-76 |
| PYSCI-- YERPS YSC OPERON PROTEIN I YERSINIA PSEUDOTUBERCULOSIS |
| 49-76 |
| PYSCJ-- YEREN YSC OPERON LIPOPROTEIN J PRECURSOR YERSINIA |
| ENTEROCOLITICA |
| 99-126 PYSCJ-- |
| YERPS YSC OPERON LIPOPROTEIN J PRECURSOR YERSINIA PSEUDOTUBERCULOSIS |
| 99-126 |
| PYSCL-- YEREN YSC OPERON PROTEIN L YERSINIA ENTEROCOLITICA 41-68 |
| PYSCL-- YERPS YSC OPERON PROTEIN L YERSINIA PSEUDOTUBERCULOSIS |
| 41-68 |
| PYSMA-- SERMA HYPOTHETICAL 9.5 KD PROTEIN SERRATIA MARCESCENS |
| 11-70 |
| PYSO2-- DESAM HYPOTHETICAL 28.3 KD PROTEIN DESULFUROLOBUS |
| AMBIVALENS |
| 68-109 PYSO3 |
| -- DESAM HYPOTHETICAL PROTEIN DESULFUROLOBUS AMBIVALENS 65-155 |
| PYSP2-- LEPIN HYPOTHETICAL PROTEIN LEPTOSPIRA INTERROGANS |
| 6-33 60-94 |
| PYSR1-- MYCMY HYPOTHETICAL PROTEIN MYCOPLASMA MYCOIDES 35-99 |
| 185-227 300-327 |
| PYSY3-- BACSU HYPOTHETICAL 19.6 KD PROTEIN BACILLUS SUBTILIS |
| 72-99 |
| PYSYN-- METFE HYPOTHETICAL PROTEIN METHANOTHERMUS FERVIDUS |
| 78-105 |
| PYT37-- STRFR HYPOTHETICAL 37.1 KD PROTEIN STREPTOMYCES FRADIAE |
| 246-273 |
| PYTDK-- BACSU HYPOTHETICAL 35.6 KD PROTEIN BACILLUS SUBTILIS |
| 244-271 279-306 |
| PYTRE-- LEPBI HYPOTHETICAL 22 KD PROTEIN LEPTOSPIRA BIFLEXA |
| 84-113 |
| PYTRP-- LACLA HYPOTHETICAL 13.3 KD PROTEIN LACTOCOCCUS LACTIS |
| 76-112 |
| PYTS1-- BACSU HYPOTHETICAL 20 KD PROTEIN BACILLUS SUBTILIS 37-64 |
| PYTSF-- SPICI HYPOTHETICAL 23.8 KD PROTEIN SPIROPLASMA CITRI |
| 102-149 |
| PYX04-- BACSU HYPOTHETICAL 12.8 KD PROTEIN BACILLUS SUBTILIS |
| 37-64 68-95 |
| PYX06-- BACSU HYPOTHETICAL 21.0 KD PROTEIN BACILLUS SUBTILIS |
| 142-169 |
| PYX13-- BACSU HYPOTHETICAL 26.0 KD PROTEIN BACILLUS SUBTILIS |
| 17-51 |
| PYX15-- BACSU HYPOTHETICAL 61.8 KD PROTEIN BACILLUS SUBTILIS |
| 165-207 262-289 |
| PYX18-- BACSU HYPOTHETICAL 66.8 KD PROTEIN BACILLUS SUBTILIS |
| 30-30 35-61 |
| 94-142 PYX19- |
| - BACSU HYPOTHETICAL 31.3 KD PROTEIN BACILLUS SUBTILIS 56-83 85-112 |
| PYX20-- BACSU HYPOTHETICAL 23.2 KD PROTEIN BACILLUS SUBTILIS |
| 24-58 |
| PYXI2-- ANASP HYPOTHETICAL 18.9 KD PROTEIN ANABAENA SP 77-104 |
| PYXYB-- |
| CALSA HYPOTHETICAL 10.7 KD PROTEIN CALDOCELLUM SACCHAROLYTICUM 9-39 |
| PYXYC-- CALSA HYPOTHETICAL PROTEIN CALDOCELLUM SACCHAROLYTICUM |
| 41-94 |
| PYZE1-- ECOLI HYPOTHETICAL 16.7 KD PROTEIN ESCHERICHIA COLI |
| 41-78 |
| TABLE IX |
| - 107 × 178 × 4 SEARCH MOTIF RESULTS SUMMARY FOR ALL HUMAN |
| PROTEINS |
| PCGENE 107 × 178 × 4 Motif Search on All Human Protein |
| Sequences |
| FILE NAME PROTEIN AREA 1 AREA 2 AREA 3 AREA 4 AREA 5 AREA 6 AREA 7 |
| AREA 8 AREA 9 |
| P143F-- HUMAN 14-3-3 PROTEIN ETA (PROTEIN AS1) (FRAGMENT). |
| 101-135 |
| P143S-- |
| HUMAN 14-3-3 PROTEIN HOMOLOG STRATIFIN. 45-72 P143T-- |
| HUMAN 14-3-3 PROTEIN THETA (14-3-3 PROTEIN T-CELL) (HS1 PROTEIN). |
| 61-92 |
| P143Z-- HUMAN 14-3-3 PROTEIN ZETA (PROTEIN KINASE C INHIBITOR |
| PROTEIN-1) (KCIP-1) 28-55 |
| P1A23-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, A-29 |
| (AW-19) A *2901 ALPHA CHAIN 87-114 |
| P1A24-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, A-29 |
| (AW-19) A*2902 ALPHA CHAIN 87-114 |
| P1B02-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-7 B*0702 |
| ALPHA CHAIN 87-114 |
| P1B05-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-13 B*1301 |
| ALPHA CHAIN 87-114 148-182 |
| P1B10-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-75 |
| (B-15) B*1502 ALPHA CHAIN 84-115 |
| P1B11-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-72 |
| (BW-70) B*1503 ALPHA 84-115 |
| P1B12-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-62 B*1504 |
| ALPHA CHAIN 76-107 |
| P1B13-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-18 B*1801 |
| ALPHA CHAIN 84-115 |
| P1B21-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-35 B*3501 |
| ALPHA CHAIN 84-115 |
| P1B22-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-35 B*3502 |
| ALPHA CHAIN 84-115 |
| P1B23-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-35 B*3503 |
| ALPHA CHAIN 84-115 |
| P1B24-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-35 B*3504 |
| ALPHA CHAIN 76-107 |
| P1B25-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-35 B*3505 |
| ALPHA CHAIN 84-115 |
| P1B26-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-35 B*3506 |
| ALPHA CHAIN 84-115 |
| P1B27-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-35 B*3507 |
| ALPHA CHAIN 84-115 |
| P1B28-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-35 B*3508 |
| ALPHA CHAIN 84-115 |
| P1B29-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-37 B*3701 |
| ALPHA CHAIN 88-115 |
| P1B32-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-39 B*3702 |
| ALPHA CHAIN 87-114 |
| P1B33-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-60 |
| (B-40) B*4001 ALPHA CHAIN 60-91 |
| P1B34-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-40 B*4002 |
| ALPHA CHAIN 84-115 |
| P1B35-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-40 B*4003 |
| ALPHA CHAIN 84-115 |
| P1B36-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-40 B*4004 |
| ALPHA CHAIN 84-115 |
| P1B38-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-41 |
| B*4101 ALPHA CHAIN 84-115 |
| P1B39-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-42 |
| B*4201 ALPHA CHAIN 84-114 |
| P1B40-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-44 |
| (B-12) B*4401 ALPHA CHAIN 84-111 |
| P1B41-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-44 |
| (B-12) B*4402 ALPHA CHAIN 87-114 |
| P1B42-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-44 |
| (B-12) B*4403 ALPHA CHAIN 84-114 |
| P1B43-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-45 |
| (B-12) B*4501 ALPHA CHAIN 84-115 |
| P1B44-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-46 |
| B*4601 ALPHA CHAIN 87-114 |
| P1B45-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-47 |
| B*4701 ALPHA CHAIN 88-115 |
| P1B46-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-48 B*4801 |
| ALPHA CHAIN 84-115 |
| P1B47-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, B-49 (B-21) |
| B*4901 ALPHA CHAIN 87-114 |
| P1B48-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-50 |
| (B-21) B*5001 ALPHA CHAIN 84-115 |
| P1B53-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-52 (B-5) |
| B*5201 ALPHA CHAIN 87-114 |
| P1B55-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-54 (B-5) |
| B*5401 ALPHA CHAIN 87-114 |
| P1B56-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-55 |
| (BW-22) B*5501 ALPHA 87-114 |
| P1B57-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-55 |
| (BW-22) B*5502 ALPHA 87-114 |
| P1B58-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-56 |
| (BW-22) B*5601 ALPHA 87-114 |
| P1B59-- HUMAN HLA CLASS 1 HISTOCOMPATIBILITY ANTIGEN, BW-56 |
| (BW-22) B*5602 ALPHA 87-114 |
| P1C01-- HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-1 |
| CW*0101 ALPHA CHAIN 87-114 |
| P1C02-- HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-1 |
| CW*0102 ALPHA CHAIN 87-114 |
| P1C03-- HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-2 |
| CW*0201 ALPHA CHAIN 87-114 |
| P1C04-- HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-2 |
| CW*0202 ALPHA CHAIN 87-114 |
| P1C06-- HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-3 |
| CW*0302 ALPHA CHAIN 87-114 |
| P1C12-- HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-8 |
| CW*0801 ALPHA CHAIN 87-114 |
| P1C13-- HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-8 |
| CW*0802 ALPHA CHAIN 87-114 |
| P1C14-- HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-8 |
| CW*0803 ALPHA CHAIN 87-114 |
| P1C17-- HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW*1401 |
| ALPHA CHAIN PRECURSOR 87-114 |
| P25A6-- HUMAN 69/71 KD (2'-5') OLIGOADENYLATE SYNTHETASE 593-620 |
| P2AAA-- HUMAN PROTEIN PHOSPHATASE PP2A, 65 KD REGULATORY SUBUNIT, |
| ALPHA ISOFORM 12-49 54-81 |
| P2AAB-- HUMAN PROTEIN PHOSPHATASE PP2A, 65 KD REGULATORY SUBUNIT, |
| BETA ISOFORM 9-36 41-68 79-106 |
| P2ABA-- HUMAN PROTEIN PHOSPHATASE PP2A, 55 KD REGULATORY SUBUNIT, |
| ALPHA ISOFORM 177-218 |
| P411-- HUMAN ERYTHROID PROTEIN 4.1 (BAND 4.1, ERYTHROCYTE FORM). |
| 32-66 |
| P412-- HUMAN NON-ERYTHROID PROTEIN 4.1 (BAND 4.1, LYMPHOID FORM). |
| 3-30 708-735 |
| P42-- HUMAN ERYTHROCYTE MEMBRANE PROTEIN BAND 4.2. 173-200 |
| 518-545 |
| P4F2-- HUMAN 4F2 CELL-SURFACE ANTIGEN HEAVY CHAIN (4F2HC) |
| (LYMPHOCYTE ACTIVATION 281-322 |
| P5H1E-- |
| HUMAN 5-HYDROXYTRYPTAMINE 1E RECEPTOR (5-HT-1E) (SEROTONIN RECEPTOR) |
| 311-338 |
| P5H1F-- |
| HUMAN 5-HYDROXYTRYPTAMINE 1E RECEPTOR (5-HT-1F) (SEROTONIN RECEPTOR) |
| 222-253 |
| P5H2A-- |
| HUMAN 5-HYDROXYTRYPTAMINE 2A RECEPTOR (5-HT-2A) (SEROTONIN RECEPTOR) |
| 22-56 |
| P5H7-- HUMAN HYDROXYTRYPTAMINE 7 RECEPTOR (5-HT-7) (5-HT-X) |
| (SEROTONIN RECEPTOR) 72-99 |
| PA1AC-- HUMAN ALPHA-1-ANTICHYMOTRYPSIN PRECURSOR (ACT). 98-132 |
| 330`357 |
| PA1AG-- HUMAN ALPHA-1-ACID GLYCOPROTEIN 1 PRECURSOR (OROSUMUCOID) |
| (OMD) 92-119 |
| PA1AT-- HUMAN ALPHA-1-ANTITRYPSIN PRECURSOR (ALPHA-1 PROTEASE |
| INHIBITOR) (ALPHA-1- 168-202 |
| PA1AU-- HUMAN ALPHA-1-ANTITRYPSIN-RELATED PROTEIN PRECURSOR |
| 163-197 |
| PA2AP-- HUMAN ALPHA-2-ANTIPLASMIN PRECURSOR (ALPHA-2-PLASMIN |
| INHIBITOR) (ALPHA-2- 191-218 365-395 |
| PA2GL-- HUMAN LEUCINE-RICH ALPHA-2-GLYCOPROTEIN (LRG) 104-134 |
| PA2MG-- HUMAN ALPHA-2-MACROGLOBULIN PRECURSOR (ALPHA-2-M) |
| 53-80 319-349 1085- 1402- |
| 1112 1429 |
| PA4-- HUMAN ALZHEIMER'S DISEASE AMYLOID A4 PROTEIN PRECURSOR |
| (PROTEASE NEXIN-11) 428-455 |
| PAACT-- HUMAN ALPHA-ACTININ(F-ACTINCROSS LINKING PROTEIN) 92-119 |
| 720-747 |
| PAATM-- HUMAN ASPARTATE AMINOTRANSFERASE, MITOCHONDRIAL PRECURSOR |
| (EC 2.6.1.1) 109-136 |
| PABP2-- HUMAN ENDOTHELIAL ACTIN-BINDING PROTEIN (ABP-280) |
| (NONMUSCLE FILAMIN) 61-88 119-147 2604- |
| 2633 |
| PAC12-- HUMAN ACTIVATOR 1 37 KD SUBUNIT (REPLICATION FACTOR C 37 |
| KD SUBUNIT) (A) 306-333 |
| PAC15-- HUMAN ACTIVATOR 1 140 KD SUBUNIT (REPLICATION FACTOR C |
| LARGE SUBUNIT) (A) 14-51 182-209 668-700 |
| PACDL-- HUMAN ACYL-COA DEHYDROGENASE PRECURSOR, LONG-CHAIN |
| SPECIFIC (EC 1.3.99.13) 78-108 179-206 313-340 |
| PACET-- |
| HUMAN ANGIOTENSIN-CONVERTING ENZYME PRECURSOR, TESTIS-SPECIFIC (EC |
| 3.4.15.1) 78-115 126-153 676-710 |
| PACE-- HUMAN ANGIOTENSIN-CONVERTING ENZYME PRECURSOR, SOMATIC (EC |
| 3.4.15.1) (ACE) 652-689 700-727 1250- |
| 1284 |
| PACHA-- HUMAN ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA CHAIN |
| PRECURSOR 48-80 |
| PACHE-- HUMAN ACETYLCHOLINE RECEPTOR PROTEIN, EPSILON CHAIN |
| PRECURSOR 46-98 |
| PACHG-- HUMAN ACETYLCHOLINE RECEPTOR PROTEIN, GAMMA CHAIN |
| PRECURSOR 45-79 304-331 |
| PACHP-- HUMAN NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, BETA-4 |
| CHAIN (FRAGMENT) 29-56 70-97 |
| PACRO-- |
| HUMAN ACROSIN PRECURSOR (EC 3.4.21.10) 122-149 PACYM-- |
| HUMAN ACYLPHOSPHATASE, MUSCLE TYPE ISOZYME (EC 3.6.1.7) (ACYLPHOSPHATE) |
| 26-56 |
| PADT2-- HUMAN ADP, ATP CARRIER PROTEIN, FIBROBLAST ISOFORM |
| (ADP/ATP TRANSLOCASE 2) 162-189 |
| PADT3-- HUMAN ADP, ATP CARRIER PROTEIN, LIVER ISOFORM T2 (ADP/ATP |
| TRANSLOCASE 3) 163-190 |
| PAK79-- |
| HUMAN A-KINASE ANCHOR PROTEIN 79 (AKAP 79) (CAMP-DEPENDENT PROTEIN |
| KINASE) 197-238 381-414 |
| PALFA-- HUMAN FRUCTOSE-BISPHOSPHATE ALDOLASE (EC 4.1.2.13) A |
| (MUSCLE) 36-63 |
| PALFB-- HUMAN FRUCTOSE-BISPHOSPHATE ALDOLASE (EC 4.1.2.13) B |
| (LIVER) 79-113 |
| PAMD1-- |
| HUMAN AMP DEAMINASE 1 (EC 3.5.4.6) (MYOADENYLATE DEAMINASE) (AMP |
| DEAMINASE 59-86 |
| PAMD3-- HUMAN AMP DEAMINASE 3 (EC 3.5.4.6) (AMP DEAMINASE ISOFORM |
| E). 49-76 |
| PAMPN-- |
| HUMAN AMINOPEPTIDASE N (EC 3.4.11.2) (MICROSOMAL AMINOPEPTIDASE) |
| (GP150) 492-523 604-648 926-964 |
| PAMPR-- |
| HUMAN AMPHIREGULIN PRECURSOR (AR). 213-247 PAMRP-- |
| HUMAN ALPHA-2-MACROGLOBULIN RECEPTOR-ASSOCIATED PROTEIN PRECURSOR |
| 173-236 263-290 |
| PANFB-- |
| HUMAN BRAIN NATRIURETIC PEPTIDE PRECURSOR 36-63 PANK1-- |
| HUMAN ANKYRIN R (ANKYRINS 2.1 AND 2.2) (ERYTHROCYTE ANKYRIN). 812-839 |
| 1004- 1617- |
| 1031 1644 |
| PANKB-- HUMAN ANKYRIN, BRAIN VARIANT 1 (ANKYRIN B) (ANKYRIN, |
| NONERYTHROID) 1544- |
| 1571 |
| PANKC-- HUMAN ANKYRIN, BRAIN VARIANT 2 (ANKYRIN B) (ANKYRIN, |
| NONERYTHROID) 1811- |
| 1838 |
| PANPA-- HUMAN ATRIAL NATRIURETIC PEPTIDE RECEPTOR A PRECURSOR |
| (ANP-A) (ANPRA) (GC-A) 553-580 825-852 |
| PANPB-- HUMAN ATRIAL NATRIURETIC PEPTIDE RECEPTOR B PRECURSOR |
| (ANP-B) (ANPRB) (GC-B) 810-837 |
| PANT3-- HUMAN ANTITHROMBIN-III PRECURSOR (ATIII). 162-196 |
| PANX2-- HUMAN ANNEXIN II (LIPOCORTIN II) (CALPACTIN I |
| HEAVY CHAIN) (CHROMOBINDIN 8) 40-67 306-333 |
| PANX3-- |
| HUMAN ANNEXIN III (LIPOCORTIN III) (PLACENTAL ANTICOAGULANT PROTEIN |
| III) 215-242 |
| PANX6-- HUMAN ANNEXIN VI (LIPOCORTIN VI) (P68) (P70) (PROTEIN |
| III) (CHROMOBINDIN 20) 60-87 626-653 |
| PANX1-- HUMAN ANNEXIN, INTESTINE-SPECIFIC (ISA). 37-78 137-164 |
| PAOFA-- HUMAN AMINE OXIDASE (FLAVIN-CONTAINING) A (EC 1.4.3.4) |
| (MONOAMINE OXIDASE) 16-43 74-104 |
| PAOFB-- HUMAN AMINE OXIDASE (FLAVIN-CONTAINING) B (EC 1.4.3.4) |
| (MONOAMINE OXIDASE) 68-95 |
| PAPA1-- |
| HUMAN APOLIPROTEIN A-1 PRECURSOR (APO-AI). 57-84 PAPB-- |
| HUMAN APOLIPROTEIN B-100 PRECURSOR (APO B-100/APO B-48). 585-619 1073- |
| 1353- 1524- 2074- 2132- 2181- 2240- 2360- |
| 1100 1380 1584 2113 2159 2215 2271 2389 |
| 2466- 2529- 2850- 3360- 3480- 3620- 4040- 4090- 4135- |
| 2507 2559 3000 3390 3570 3654 4074 4120 4167 |
| 4274- 4397- 4465- 4499- |
| 4301 4438 4492 4544 |
| PAPC2-- HUMAN APOLIPOPROTEIN C-II PRECURSOR (APO-CII). 36-63 |
| PAPC-- |
| HUMAN ADENOMATOUS POLYPOSIS COLI PROTEIN (APC PROTEIN). 145-172 617-651 |
| 834-861 1795- 2172- 2572- |
| 1822 2212 2609 |
| PAPE-- HUMAN APOLIPOPROTEIN E PRECURSOR (APO-E). 48-81 247-274 |
| PAPOA-- HUMAN APOLIPOPROTEIN (A) PRECURSOR (EC 3.4.21.-) |
| (APO(A)) (LP(A)). 4448- |
| 4475 |
| PAQP1-- HUMAN AQUAPORIN-CHIP (WATER CHANNEL PROTEIN FOR RED BLOOD |
| CELLS AND KIDNEY 39-73 |
| PARK1-- HUMAN BETA-ADRENERGIC RECEPTOR KINASE 1 (EC 2.7.1.126) |
| (BETA-ARK-1). 523-553 |
| PARLY-- |
| HUMAN ARGININOSUCCINATE LYASE(EC 4.3.2.1) (ARGINOSUCCINASE). 69-103 |
| PARNT-- HUMAN ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR |
| (ARNT PROTEIN) (DIO 223-250 |
| PARRC-- |
| HUMAN BETA-ARRESTIN 2. 215-242 305-332 PARRS-- |
| HUMAN ARRESTIN (RETINAL S-ANTIGEN) (48 KD PROTEIN) (S-AG). 299-352 |
| PARY1-- HUMAN ARYLAMINE N-ACETYLTRANSFERASE, MONOMORPHIC (EC |
| 2.3.1.5) (MNAT) 7-34 |
| PARY2-- HUMAN ARYLAMINE N-ACETYLTRANSFERASE, POLYMORPHIC (EC |
| 2.3.1.5) (PNAT) 7-34 |
| PASNS-- HUMAN ASPARAGINE SYNTHETASE (GLUTAMINE-HYDROLYZING) (EC |
| 6.3.5.4) (TS11 CELL 311-338 347-374 |
| PATCD-- HUMAN CALCIUM-TRANSPORTING ATPASE SARCOPLASMIC RETICULUM |
| TYPE (EC3.6.1.38). 163-190 |
| PATCE-- HUMAN CALCIUM-TRANSPORTING ATPASE ENDOPLASMIC RETICULUM |
| TYPE (EC 3.6.1.38). 163-190 |
| PATF1-- HUMAN TRANSCRIPTION FACTOR ATF-1 (FRAGMENT) 203-230 |
| PATF3-- HUMAN TRANSCRIPTION FACTOR ATF-3 (FRAGMENT). 155-183 |
| PATF5-- HUMAN TRANSCRIPTION FACTOR ATF-5 (FRAGMENT). 30-61 |
| PATF6-- HUMAN TRANSCRIPTION FACTOR ATF-6 (FRAGMENT). 34-68 |
| PATFA-- HUMAN TRANSCRIPTION FACTOR ATF-A AND ATF-A-DELTA. 351-394 |
| PATPF-- HUMAN ATP SYNTHASE B CHAIN, MITOCHONDRIAL PRECURSOR (EC |
| 3.6.1.34) 129-163 |
| PB232-- HUMAN NUCLEOLAR PHOSPHOPROTEIN B23 (NUCLEOPHOSMIN) |
| (NUMATRIN). 114-141 |
| PB2AR-- HUMAN BETA-2-ADRENERGIC RECEPTOR. 292-319 345-372 |
| PB3A2-- HUMAN ANION EXCHANGE PROTEIN 2 (NON-ERYTHROID BAND |
| 3-LIKE PROTEIN) (BND3L) 1081- |
| 1111 |
| PB94-- |
| HUMAN B94 PROTEIN. 115-142 525-562 609-636 PBAN7-- |
| HUMAN ERYTHROCYTE BAND 7 INTEGRAL MEMBRANE PROTEIN. 106-140 |
| PBASO-- |
| HUMAN BASONUCLIN. 120-147 310-337 773-807 PBC2B-- |
| HUMAN TRANSFORMING PROTEIN BCL-2-BETA. 178-205 |
| PBCGF-- HUMAN B-CELL GROWTH FACTOR PRECURSOR (BCGF-12 KD). 33-63 |
| PBCR-- |
| HUMAN BREAKPOINT CLUSTER REGION PROTEIN. 784-825 PBGLR-- |
| HUMAN BETA-GLUCURONIDASE PRECURSOR (EC 3.2.1.31). 246-280 504-531 |
| PBMP2-- HUMAN BONE MORPHOGENETIC PROTEIN 2 PRECURSOR (BMP-2) |
| (BMP-2A). 216-250 |
| PBMP5-- HUMAN BONE MORPHOGENETIC PROTEIN 5 PRECURSOR (BMP-5). |
| 202-229 |
| PBMP6-- HUMAN BONE MORPHOGENETIC PROTEIN 6 PRECURSOR (BMP-6). |
| 274-301 |
| PBMP7-- HUMAN BONE MORPHOGENETIC PROTEIN 7 PRECURSOR (BMP-7) |
| (OSTEOGENIC PROTEIN 1) 192-219 |
| PBN51-- |
| HUMAN BN51 PROTEIN. 284-311 PBPI-- |
| HUMAN BACTERICIDAL PERMEABILITY INCREASING PROTEIN PRECURSOR (BPI) (CAP |
| 57). 168-195 |
| PBRS3-- |
| HUMAN BOMBESIN RECEPTOR SUBTYPE-3 (BRS-3). 10-37 PBTF2-- |
| HUMAN BASIC TRANSCRIPTION FACTOR 62 KD SUBUNIT (P62). 128-162 353-385 |
| PBTG1-- HUMAN BTG1 PROTEIN (B-CELL TRANSLOCATION GENE 1 PROTEIN). |
| 26-53 |
| PC1TC-- |
| HUMAN C-1-TETRAHYDROFOLATE SYNTHASE, CYTOPLASMIC (METHYLENETETRAHYDROFO |
| 330-363 |
| PC2TA-- |
| HUMAN MHC CLASS II TRANSACTIVATOR CIITA. 921-948 PCA19-- |
| HUMAN COLLAGEN ALPHA 1 (IX)CHAIN PRECURSOR. 120-150 |
| PCA1B-- HUMAN COLLAGEN ALPHA 1 (XI) CHAIN PRECURSOR. 341-368 |
| PCABV-- HUMAN CALBINDIN (VITAMIN D-DEPENDENT CALCIUM-BINDING |
| PROTEIN (CABP), AVIAN- 27-54 |
| PCAD5-- HUMAN CADHERIN 5 PRECURSOR (7B4 ANTIGEN). 723-750 |
| PCADE-- HUMAN EPITHELIAL-CADHERIN PRECURSOR (E-CADHERIN) |
| (UVOMORULIN) (CAM 120/80). 838-865 |
| PCADN-- HUMAN NEURAL-CADHERIN PRECURSOR (N-CADHERIN). 95-122 |
| 323-350 |
| PCADP-- HUMAN PLACENTAL-CADHERIN PRECURSOR (P-CADHERIN). 384-411 |
| 580-607 |
| PCAGA-- HUMAN CALGRANULIN A (MIGRATION INHIBITORY FACTOR-RELATED |
| PROTEIN 8) (MRP-8) 2-29 |
| PCALR-- HUMAN CALCITONIN RECEPTOR PRECURSOR (CT-R). 140-167 |
| PCAMA-- HUMAN CARTILAGE MATRIX PROTEIN PRECURSOR. 297-324 |
| 467-494 |
| PCAP1-- HUMAN CALPAIN I, LARGE (CATALYTIC) SUBUNIT (EC 3.4.22.17) |
| (CALCIUM-ACTIVATED 561-588 |
| PCAP2-- HUMAN CALPAIN 2, LARGE (CATALYTIC) SUBUNIT (EC 3.4.22.17) |
| (CALCIUM-ACTIVATED 257-284 502-529 |
| PCAP3-- |
| HUMAN CALPAIN P94, LARGE (CATALYTIC) SUBUNIT (EC 3.4.22.17) (CALCIUM- |
| 674-701 |
| PCAPL-- |
| HUMAN PLACENTAL CALCIUM-BINDING PROTEIN. 13-40 PCAP-- |
| HUMAN ADENYLYL CYCLASE-ASSOCIATED PROTEIN (CAP). 111-138 163-197 321-355 |
| PCART-- |
| HUMAN CALRETININ (29 KD CALBINDIN) 217-244 PCASB-- |
| HUMAN BETA CASEIN PRECURSOR. 14-48 |
| PCATA-- |
| HUMAN CATALASE (EC 1.11.1.6). 422-456 PCATD-- |
| HUMAN CATHEPSIN D PRECURSOR (EC 3.4.23.5). 253-282 |
| PCATH-- |
| HUMAN CATHEPSIN H PRECURSOR (EC 3.4.22.16) 41-68 PCATL-- |
| HUMAN CATHEPSIN L1 PRECURSOR (EC 3.4.22.15) (MAJOR EXCRETED |
| PROTEIN) (MEP) 278-305 |
| PCATS-- HUMAN CATHEPSIN 5 PRECURSOR (EC 3.4.22.27). 30-57 142-169 |
| PCBFB-- HUMAN CCAAT-BINDING TRANSCRIPTION FACTOR SUBUNIT B |
| (CBF-B) (NF-Y PROTEIN 24-58 138-165 |
| PCBG-- HUMAN CORTICOSTEROID-BINDING GLOBULIN PRECURSOR (CBG) |
| (TRANSCORTIN) 88-122 |
| PCBPB-- |
| HUMAN CARBOXYPEPTIDASE B PRECURSOR (EC 3.4.17.2) (PANCREAS-SPECIFIC |
| PROTEIN) 69-129 278-305 319-346 |
| PCBPH-- HUMAN CARBOXYPEPTIDASE H PRECURSOR (EC 3.4.17.10) |
| (CARBOXYPEPTIDASE E) (CPE) 355-382 |
| PCC21-- |
| HUMAN CDC21 HOMOLOG (P1-CDC21) (FRAGMENT). 35-62 PCC27-- |
| HUMAN PROTEIN CDC27HS. 209-240 |
| PCCG1-- HUMAN TRANSCRIPTION INITIATION FACTOR TFIID 250 KD |
| SUBUNIT (TBP-ASSOCIATED 1298- |
| 1342 |
| PCD14-- HUMAN MONOCYTE DIFFERENTIATION ANTIGEN CD14 PRECURSOR |
| (MYELOID CELL-SPECIFI 142-169 |
| PCD1A-- HUMAN T-CELL SURFACE GLYCOPROTEIN CD1A PRECURSOR (CD1A |
| ANTIGEN) (T-CELL 32-63 281-308 |
| PCD1E-- HUMAN T-CELL SURFACE GLYCOPROTEIN CD1E PRECURSOR (CD1E |
| ANTIGEN) (R2G1). 77-104 |
| PCD20-- HUMAN B-LYMPHOCYTE ANTIGEN CD20 (B-LYMPHOCYTE SURFACE |
| ANTIGEN B1) (LEU-16) 226-255 |
| PCD2R-- |
| HUMAN CD20 RECEPTOR PRECURSOR. 226-255 PCD2-- |
| HUMAN T-CELL SURFACE ANTIGEN CD2 PRECURSOR (T-CELL SURFACE ANTIGEN |
| 88-119 |
| PCD34-- HUMAN HEMOPOIETIC PROGENITOR CELL ANTIGEN CD34 PRECURSOR. |
| 74-108 |
| PCD37-- |
| HUMAN LEUKOCYTE ANTIGEN CD37. 101-128 PCD3G-- |
| HUMAN T-CELL SURFACE GLYCOPROTEIN CD3 GAMMA CHAIN PRECURSOR (T-CELL |
| RECEPT 7-34 |
| PCD3L-- |
| HUMAN CD30 LIGAND (CD30-L). 96-130 183-217 PCD4X-- |
| HUMAN CD44 ANTIGEN,EPITHELIAL FORM PRECURSOR (CD44E) (PHAGOCYTIC |
| 328-355 |
| PCD4-- HUMAN T-CELL SURFACE GLYCOPROTEIN CD4 PRECURSOR (T-CELL |
| SURFACE ANTIGEN 44-71 240-267 |
| PCD53-- |
| HUMAN LEUKOCYTE SURFACE ANTIGEN CD53. 87-114 PCD72-- |
| HUMAN B-CELL DIFFERENTIATION ANTIGEN CD72 (LYB-2). 118-177 |
| PCDK3-- HUMAN CELL DIVISION PROTEIN KINASE 3 (EC 2.7.1-). 5-32 |
| PCDK5-- HUMAN CELL DIVISION PROTEIN KINASE 5 (EC 2.7.1-) |
| (KINASE PSSALRE). 5-32 |
| PCEBB-- HUMAN CCAAT/ENHANCER BINDING PROTEIN BETA (C/EBP BETA) |
| (NUCLEAR FACTOR 296-330 |
| PCENB-- HUMAN MAJOR CENTROMERE AUTOANTIGEN B (CENTROMERE PROTEIN |
| B) (CENP-B). 568-595 |
| PCENC-- |
| HUMAN CENTROMERE PROTEIN C (CENP-C) (CENTROMERE AUTOANTIGEN C). 433-460 |
| PCENE-- HUMAN CENTROMERIC PROTEIN E (CENP-3-PROTEIN). 372-399 |
| 493-520 553-607 715-752 767-825 850-884 903-947 963-995 1080- |
| 1107 |
| 1122- 1179- 1250- 1340- 1440- 1486- 1646- 1684- 1808- |
| 1149 1239 1277 1367 1481 1556 1680 1724 1846 |
| 1852- 1890- 1940- 2021- 2288- 2440- 2498- |
| 1883 1917 1988 2048 2318 2478 2563 |
| PCERU-- |
| HUMAN CERULOPLASMIN PRECURSOR (EC 1.16.3.1) (FERROXIDASE). 913-940 |
| PCETP-- HUMAN CHOLESTERYL ESTER TRANSFER PROTEIN PRECURSOR. |
| 71-108 |
| PCFTR-- HUMAN CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR |
| (CFTR). 158-189 802-829 895-922 1243- |
| 1270 |
| PCGCC-- |
| HUMAN CGMP-GATED CATION CHANNEL PROTEIN (CYCLIC NUCLEOTIDE 216-243 |
| PCGL-- HUMAN CYSTATHIONINE GAMMA-LYASE (EC 4.4.1.1). 315-349 |
| PCHLR-- HUMAN CHLORDECONE REDUCTASE (EC 1.1.1.225) (CDR). 17-51 |
| PCHOL-- HUMAN CHOROIDERAEMIA-LIKE PROTEIN. 56-97 230-257 451-478 |
| PCHOR-- HUMAN CHOROIDERAEMIA PROTEIN (TCD PROTEIN). 112-139 |
| PCINA-- HUMAN SODIUM CHANNEL PROTEIN, CARDIAC AND SKELETAL |
| MUSCLE ALPHA-SUBUNIT. 787-814 943-970 |
| PCLCA-- HUMAN CLATHRIN LIGHT CHAIN A (BRAIN AND LYMPHOCYTE LCA). |
| 121-148 |
| PCLCB-- HUMAN CLATHRIN LIGHT CHAIN B (BRAIN AND LYMPHOCYTE LCB). |
| 123-157 |
| PCLCY-- HUMAN CALCYCLIN (PROLACTIN RECEPTOR ASSOCIATED PROTEIN) |
| (PRA) (GROWTH 9-50 |
| PCLUS-- HUMAN CLUSTERIN PRECURSOR (COMPLEMENT-ASSOCIATED PROTEIN |
| SP-40,40) 36-98 323-350 367-394 |
| PCMGA-- |
| HUMAN CHROMOGRANIN A PRECURSOR (CGA) (CONTAINS: PANCREASTATIN AND |
| WE-14) 93-120 430-457 |
| PCNTF-- |
| HUMAN CILIARY NEUROTROPHIC FACTOR (CNTF). 66-93 PC002-- |
| HUMAN TUMOR-ASSOCIATED ANTIGEN CO-029. 29-56 95-148 |
| PC03-- HUMAN COMPLEMENT C3 PRECURSOR. 242-276 593-620 837-867 |
| PC04-- |
| HUMAN COMPLEMENT C4 PRECURSOR. 1292- 1319 |
| PC05-- HUMAN COMPLEMENT C5 PRECURSOR. 298-342 537-564 |
| 970-997 1270- |
| 1304 |
| PC06-- |
| HUMAN COMPLEMENT C6 PRECURSOR. 367-398 PC07-- |
| HUMAN COMPLEMENT C7 PRECURSOR. 225-261 |
| PCOX1-- HUMAN CYTOCHROME C OXIDASE POLYPEPTIDE I (EC 1.9.3.1). |
| 353-380 |
| PCP70-- |
| HUMAN CYTOCHROME P450 VII (CHOLESTEROL 7-ALPHA-MONOXYGENASE) 263-290 |
| 346-373 |
| PCPCH-- HUMAN CYTOCHROME 0450 IIC17 (EC 1.14.14.1) (P450-254C) |
| (FRAGMENT). 109-136 |
| PCPE1-- HUMAN CYTOCHROME P450 IIE1 (EC 1.14.14.1) (P450-J) |
| (ETHANOL INDUCIBLE). 231-258 |
| PCPSM-- |
| HUMAN CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA) MITOCHONDRIAL PRECURSOR |
| 112-146 420-447 |
| PCPT2-- HUMAN MITOCHONDRIAL CARNITINE PALMITOYLTRANSFERASE II |
| PRECURSOR 410-437 |
| PCPT7-- HUMAN CYTOCHROME P450 XVIIA1 (P450-C17) (EC 1.14.99.9) |
| (STEROID 17-ALPHA- 226-257 |
| PCPV1-- HUMAN CYTOCHROME P450 XIXA1 (AROMATASE) (EC 1.14.14.1) |
| (ESTROGEN 234-271 |
| PCR2-- |
| HUMAN COMPLEMENT RECEPTOR TYPE 2 PRECURSOR (CR2) (COMPLEMENT C3D |
| RECEPTOR) 986-1013 |
| PCRCM-- HUMAN COLORECTAL MUTANT CANCER PROTEIN (MCC PROTEIN). |
| 68-126 379-420 633-678 724-754 763-790 |
| PCREB-- HUMAN CAMP RESPONSE ELEMENT BINDING PROTEINS A AND B |
| (CREB-A AND CREB-B). 94-125 |
| PCREP-- HUMAN CAMP RESPONSE ELEMENT BINDING PROTEIN CRE-BP1. |
| 380-414 |
| PCRP-- |
| HUMAN C-REACTIVE PROTEIN PRECURSOR. 60-87 150-177 PCS1-- |
| HUMAN CLEAVAGE SIGNAL-1 PROTEIN (CS-1). 203-233 |
| PCSF1-- HUMAN MACROPHAGE COLONY STIMULATING FACTOR-1 PRECURSOR |
| (CSF-1) (MCSF). 143-170 |
| PCST3-- HUMAN CLEAVAGE STIMULATION FACTOR, 50 KD SUBUNIT (CSTF 50 |
| KD SUBUNIT) (CF-1 6-33 |
| PCTNA-- HUMAN ALPHA-CATENIN (CADHERIN-ASSOCIATED PROTEIN). |
| 681-718 |
| PCTNR-- HUMAN ALPHA-CATENIN RELATED PROTEIN (CATENIN ALPHA-2). |
| 680-717 |
| PCX26-- HUMAN GAP JUNCTION BETA-2 PROTEIN (CONNEXIN 26) (CX26). |
| 108-139 |
| PCX32-- HUMAN GAP JUNCTION BETA-1 PROTEIN (CONNEXIN 32) (CX32) |
| (GAP JUNCTION 28 KD 117-144 |
| PCX37-- HUMAN GAP JUNCTION ALPHA-4 PROTEIN (CONNEXIN 37) (CX37) |
| 88-115 |
| PCB5-- |
| HUMAN CYTOCHROME B5. 3-42 PCYG1-- |
| HUMAN GUANYLATE CYCLASE SOLUBLE, BETA-1 CHAIN (EC 4.6.1.2) (70 KD |
| CHAIN) 80-107 126-153 352-396 |
| PCYG4-- HUMAN GUANYLATE CYCLASE SOLUBLE, ALPHA-2 CHAIN (EC |
| 4.6.1.2) 106-133 |
| PCYGR-- HUMAN RETINAL GUANYLYL CYCLASE PRECURSOR (EC 4.6.1.2). |
| 824-851 |
| PCYRG-- HUMAN CYTOKINE RECEPTOR COMMON GAMMA CHAIN PRECURSOR |
| (GAMMA-C) 293-320 |
| PCYTA-- |
| HUMAN CYSTATIN A (STEFIN A) (CYSTATIN AS). 27-58 PDBL-- |
| HUMAN PROTO-ONCOGENE DBL PRECURSOR (CONTAINS: MCF2). 233-283 485-524 |
| 766-793 801-845 |
| PDESM-- |
| HUMAN DESMIN. 153-180 272-312 PDESP-- |
| HUMAN DESMOPLAKIN I AND II (DPI AN DPII) (FRAGMENT). 31-79 113-143 |
| 217-244 269-317 382-434 437-467 528-558 563-598 630-674 |
| 697-734 738-789 1456- 1508- |
| 1493 1535 |
| PDHAP-- HUMAN ALDEHYDE DEHYDROGENASE, DIMERIC NADP-PREFERRING (EC |
| 1.2.1.5) 31-58 |
| PDMD-- HUMAN DYSTROPHIN 86-116 338-365 484-511 753-780 976-1003 |
| 1012- 1201- 1364- 1615- |
| 1039 1228 1394 1674 |
| 1838- 2158- 2313- 2752- 2786- 2912- 3014- 3499- |
| 1865 2185 2343 2779 2830 2958 3041 3533 |
| PDNJI-- |
| HUMAN DNAJ PROTEIN HOMOLOG. 45-76 PDNLI-- |
| HUMAN DNA LIGASE I (EC 6.5.1.1) (POLYDEOXYRIBONUCLEOTIDE SYNTHASE |
| (ATP)). 130-157 355-392 732-759 |
| PDPOA-- HUMAN DNA POLYMERASE ALPHA (EC 2.7.7.7). 25-74 1009- |
| 1100- |
| 1057 1127 |
| PDPOD-- HUMAN DNA POLYMERASE DELTA CATALYTIC CHAIN (EC 2.7.7.7). |
| 729-756 |
| PDPP4-- HUMAN DIPEPTIDYL PEPTIDASE IV (EC 3.4.14.5) (DPP IV) |
| (T-CELL ACTIVATION 29-77 114-148 |
| PDRN1-- HUMAN DEOXYRIBONUCLEASE I PRECURSOR (EC 3.1.21.1) (DNASE |
| I). 44-71 |
| PDSC2-- |
| HUMAN DESMOCOLLIN 3A/3B PRECURSOR (DESMOSOMAL GLYCOPROTEIN II AND III). |
| 80-107 355-398 |
| PDSG1-- HUMAN DESMOGLEIN 1 PRECURSOR (DESMOSOMAL GLYCOPROTEIN 1) |
| (DG1). 15-42 271-298 497-531 |
| PDSG3-- HUMAN DESMOGLEIN 3 PRECURSOR (130 KD PEMPHIGUS VULGARIS |
| ANTIGEN) (PVA). 211-248 325-352 |
| PDUG-- |
| HUMAN DIVERGENT UPSTREAM PROTEIN (DUP). 584-618 PEAR1-- |
| HUMAN V-ERBA RELATED PROTEIN EAR-1. 523-550 |
| PEB12-- HUMAN EBV-INDUCED G PROTEIN-COUPLED RECEPTOR 2 (EB12). |
| 44-78 |
| PEF1B-- HUMAN ELONGATION FACTOR 1-BETA (EF-1-BETA). 105-132 |
| PEF1D-- HUMAN ELONGATION FACTOR 1-DELTA (EF-1-DELTA). 84-118 |
| PEGFR-- HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR PRECURSOR (EC |
| 2.7.1.112). 64-91 440-467 |
| PEGF-- HUMAN EPIDERMAL GROWTH FACTOR PRECURSOR, KIDNEY (EGF) |
| (UROGASTRONE) 47-74 |
| PELF1-- HUMAN ETS-RELATED TRANSCRIPTION FACTOR ELF-1. 551-588 |
| PENPL-- HUMAN ENDOPLASMIN PRECURSOR (94 KD GLUCOSE-REGULATED |
| PROTEIN) (GRP94) (GP96 47-74 246-273 |
| PENV1-- HUMAN RETROVIRUS-RELATED ENV POLYPROTEIN. 382-420 |
| PEPC-- |
| HUMAN 1G EPSILON CHAIN C REGION. 161-188 PEPMO-- HUMAN |
| EPIMORPHIN. 35-62 67-94 249-283 |
| PER72-- HUMAN PROTEIN DISULFIDE ISOMERASE-RELATED PROTEIN |
| PRECURSOR (ERP72). 58-85 142-169 458-485 |
| PERC1-- HUMAN DNA EXCISION REPAIR PROTEIN ERCC-1. 240-270 |
| PERC6-- HUMAN EXCISION REPAIR PROTEIN ERCC-6. 160-209 |
| 939-973 |
| PESTR-- |
| HUMAN ESTROGEN RECEPTOR (ER). 451-488 PET2-- |
| HUMAN ENDOTHELIN-2 PRECURSOR (ET-2). 133-160 |
| PET3-- |
| HUMAN ENDOTHELIN-3 PRECURSOR (ET-3). 182-209 PEV2A-- |
| HUMAN EV12A PROTEIN PRECURSOR. 29-56 |
| PEZRI-- HUMAN EZRIN (P81) (CYTOVILLIN) (VILLIN-2). 119-146 |
| 351-392 402-429 512-539 |
| PFA5-- |
| HUMAN COAGULATION FACTOR V PRECURSOR. 2103- 2137 |
| PFA8-- HUMAN COAGULATION FACTOR VIII PRECURSOR (PROCOAGULANT |
| COMPONENT). 871-908 1007- 1194- |
| 1034 1230 |
| PFA9-- HUMAN COAGULATION FACOTR IX PRECURSOR (EC 3.4.21.22) |
| (CHRISTMAS FACTOR). 271-298 |
| PFABI-- HUMAN FATTY ACID-BINDING PROTEIN, INTESTINAL. 98-125 |
| PFASA-- HUMAN APOPTOSIS-MEDIATING SURFACE ANTIGEN FAS |
| PRECURSOR (APO-1 ANTIGEN). 23-50 249-301 306-333 |
| PFCE2-- HUMAN LOW AFFINITY IMMUNOGLOBULIN EPSILON FC RECEPTOR |
| (LYMPHOCYTE IGE 81-115 |
| PFCEA-- HUMAN HIGH AFFINITY IMMUNOGLOBULIN EPSILON RECEPTOR |
| ALPHA-SUBUNIT (FCERI) 140-174 |
| PEGR2-- HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 2 PRECURSOR (EC |
| 2.7.1.112). 310-337 |
| PFIBA-- HUMAN FIBRINOGEN ALPHA CHAIN PRECURSOR. 131-165 427-457 |
| PFIBB-- |
| HUMAN FIBRINOGEN BETA CHAIN PRECURSOR. 149-186 PFIBG-- |
| HUMAN FIBRINOGEN GAMMA-A CHAIN PRECURSOR. 59-93 125-160 |
| PFIBH-- HUMAN FIBRINOGEN GAMMA-B CHAIN (FIBRINOGEN GAMMA'). 59-93 |
| 125-160 |
| PFINC-- |
| HUMAN FIBRONECTIN PRECURSOR. 2168- 2199 |
| PFLI1-- HUMAN FLI-1 ONCOGENE (ERGB TRANSCRIPTION FACTOR). |
| 172-209 |
| PFMO3-- HUMAN DIMETHYLANILINE MONOXYGENASE (N-OXIDE FORMING) 3 |
| (EC 1.14.13.8) 184-218 256-283 301-328 |
| PFOS-- |
| HUMAN P55-C-FOS PROTO-ONCOGENE PROTEIN. 162-193 PFRA1-- |
| HUMAN FOS-RELATED ANTIGEN 1. 133-168 |
| PFRA2-- |
| HUMAN FOS-RELATED ANTIGEN 2. 149-180 PFRIH-- |
| HUMAN FERRITIN HEAVY CHAIN. 7-34 |
| PFRIL-- |
| HUMAN FERRITIN LIGHT CHAIN. 3-33 PFSHR-- |
| HUMAN FOLLICLE STIMULATING HORMONE RECEPTOR PRECURSOR (FSH-4). 364-395 |
| PFUCO-- HUMAN TISSUE ALPHA-L-FUCOSIDASE PRECURSOR (EC 3.2.1.51) |
| (ALPHA-L-FUCOSIDASE 308-335 |
| PFUMH-- HUMAN FUMARATE HYDRATASE, MITOCHONDRIAL (EC 4.2.1.2) |
| (FUMARASE) 424-451 |
| PG0S2-- HUMAN PUTATIVE LYMPHOCYTE G0/G1 SWITCH PROTEIN. 56-83 |
| PG19P-- HUMAN PROTEIN KINASE C SUBSTRATE, 80 KD PROTEIN, HEAVY |
| CHAIN (PKCSH) 146-173 |
| PG6PI-- HUMAN GLUCOSE-6-PHOSPHATE ISOMERASE (GPI) (EC 5.3.1.9) |
| (PHOSPHOGLUCOSE 16-50 |
| PG732-- HUMAN MAJOR GASTROINTESTINAL TUMOR-ASSOCIATED PROTEIN |
| GA733-2 PRECURSOR 181-215 |
| PGA12-- |
| HUMAN GALACTOKINASE 2 (EC 2.7.1.6). 254-281 PGAA1-- |
| HUMAN GAMMA-AMINOBUTYRIC-ACID RECEPTOR ALPHA-1 SUBUNIT PRECURSOR |
| (GABA(A) 210-237 |
| PGAA3-- HUMAN GAMMA-AMINOBUTYRIC-ACID RECEPTOR ALPHA-3 SUBUNIT |
| PRECURSOR (GAGA(A) 211-255 |
| PGASR-- HUMAN GASTRIN/CHOLECYSTOKININ TYPE B RECEPTOR (CCK-B |
| RECEPTOR). 75-105 |
| PGB01-- HUMAN GUANINE NUCLEOTIDE-BINDING PROTEIN G(O), ALPHA |
| SUBUNIT 1. 22-49 |
| PGB02-- HUMAN GUANINE NUCLEOTIDE-BINDING PROTEIN G(O), ALPHA |
| SUBUNIT 2. 22-49 |
| PGBAK-- HUMAN GUANINE NUCLEOTIDE-BINDING PROTEIN G(K), ALPHA |
| SUBUNIT (GoI) ALPHA-3). 22-49 |
| PGBAS-- HUMAN GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), ALPHA |
| SUBUNIT (ADENYLATE 7-34 |
| PGBAY-- HUMAN GUANINE NUCLEOTIDE-BINDING PROTEIN (G(Y), ALPHA |
| SUBUNIT (ALPHA-11). 95-122 |
| PGBB3-- HUMAN GUANINE NUCLEOTIDE-BINDING PROTEIN (G(I)G(S)/G(T) |
| BETA SUBUNIT 3 65-92 |
| PGBLP-- |
| HUMAN GUANINE NUCLEOTIDE-BINDING PROTEIN BETA SUBUNIT-LIKE PROTEIN |
| 12.3. 110-137 255-282 289-316 |
| PGBP2-- HUMAN INTERFERON-INDUCED GUANYLATE-BINDING PROTEIN 2 |
| (GUANINE NUCLEOTIDE- 454-488 |
| PGBT2-- HUMAN GUANINE NUCLEOTIDE-BINDING PROTEIN G(T), ALPHA-2 |
| SUBUNIT (TRANSDUCIN 22-49 |
| PGCF-- |
| HUMAN GC-RICH SEQUENCE DNA-BINDING FACTOR (GCF) (TRANSCRIPTION FACTOR |
| 9) 200-227 293-320 367-394 396-423 647-674 |
| PGCH1-- HUMAN GTP CYCLOHYDROLASE I (EC 3.5.4.16). 165-192 |
| PGCRA-- HUMAN GLUCOCORTICOID RECEPTOR, ALPHA (GR). 167-194 |
| PGCRB-- HUMAN GLUCOCORTICOID RECEPTOR, BETA (GR). 167-194 |
| PGCSP-- HUMAN GLYCINE DEHYDROGENASE (DECARBOXYLATING) |
| PRECURSOR (EC 1.4.4.2) 460-487 |
| PGDN-- HUMAN GLIA DERIVED NEXIN (GDN) (PROTEASE NEXIN I). 83-110 |
| PGELS-- HUMAN GELSOLIN PRECURSOR, PLASMA (ACTIN-DEPOLYMERIZING |
| FACTOR) (ADF) 701-728 |
| PGFAP-- HUMAN GLIAL FIBRILLARY ACIDIC PROTEIN, ASTROCYTE. 189-216 |
| 349-376 384-411 |
| PGL6S-- HUMAN N-ACETYLGLUCOSAMINE-6-SULFATASE PRECURSOR (EC |
| 3.1.6.14) (G6S) 170-221 |
| PGLPK-- HUMAN GLYCEROL KINASE (EC 2.7.1.30) (ATP:GLYCEROL |
| 3-PHOSPHOTRANSFERASE) 78-112 251-278 |
| PGLY1-- HUMAN SERINE HYDROXYMETHYLTRANSFERASE, CYTOSOLIC (EC |
| 2.1.2.1) (SERINE 32-59 344-371 |
| PGLY2-- HUMAN SERINE HYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL (EC |
| 2.1.2.1) (SERINE 417-444 |
| PGR78-- HUMAN 78 KD GLUCOSE REGULATED PROTEIN PRECURSOR (GRP 78) |
| (IMMUNOGLOBULIN 564-591 598-625 |
| PGRA2-- HUMAN GLYCINE RECEPTOR ALPHA-2 CHAIN PRECURSOR. 142-169 |
| 341-368 |
| PGRAV-- |
| HUMAN GRAVIN (FRAGMENT). 9-43 61-88 PGRFR-- |
| HUMAN GROWTH HORMONE-RELEASING HORMONE RECEPTOR PRECURSOR (GHRH RECEPT |
| 128-155 |
| PGTH2-- |
| HUMAN GLUTATHIONE S-TRANSFERASE HA SUBUNIT 2 (EC 2.5.1.18) (GTH2) |
| (CLASS- 64-91 |
| PGTPA-- HUMAN GTPASE-ACTIVATING PROTEIN (GAP) (RAS P21 PROTEIN |
| ACTIVATOR). 474-501 1012- |
| 1047 |
| PGTR1-- HUMAN GLUCOSE TRANSPORTER TYPE 1, ERYTHROCYTE/BRAIN. |
| 274-301 |
| PGTR3-- |
| HUMAN GLUCOSE TRANSPORTER TYPE 3, BRAIN. 272-299 PGTR4-- |
| HUMAN GLUCOSE TRANSPORTER TYPE 4, INSULIN-RESPONSIVE. 290-317 |
| PH10-- |
| HUMAN HISTONE H1'. 44-89 PH1A-- |
| HUMAN HISTONE H1A (H1.1). 73-104 |
| PH1B-- |
| HUMAN HISTONE H1B (H1.4). 70-101 PH1C-- |
| HUMAN HISTONE H1C (H1.3). 71-102 |
| PH1D-- |
| HUMAN HISTONE H1D (H1.2). 70-101 PH1T-- |
| HUMAN HISTONE H1T. 74-105 |
| PH2B0-- |
| HUMAN HISTONE H2B.1. 20-47 PH2B2-- |
| HUMAN HISTONE H2B.2. 20-47 |
| PH2B-- |
| HUMAN HISTONE H2B (H2B.1 A). 20-47 PHA25-- |
| HUMAN HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DQ(5) ALPHA CHAIN |
| PRECURSOR 142-169 |
| PHB2K-- HUMAN HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR-W53 |
| BETA CHAIN PRECURSOR. 56-83 |
| PHB2P-- HUMAN HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DP(W4) |
| BETA CHAIN PRECURSOR. 50-77 |
| PHB2Q-- HUMAN HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DP(22) |
| BETA CHAIN PRECURSOR. 50-77 |
| PHB2S-- HUMAN HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, SB BETA |
| CHAIN (FRAGMENT) 16-43 |
| PHBG1-- HUMAN HEPARIN-BINDING GROWTH FACTOR PRECURSOR 1 (HBGF-1) |
| (ACIDIC FIBROBLAST 102-129 |
| PHB3-- HUMAN INT-2 PROTO-ONCOGENE PROTEIN PRECURSOR (HBGF-3). |
| 61-91 |
| PHBG6-- HUMAN FIBROBLAST GROWTH FACTOR-6 PRECURSOR (FGF-6) |
| (HBGF-6) (HST-2). 41-75 159-186 |
| PHBI-- HUMAN P59 PROTEIN (HSP BINDING IMMUNOPHILIN) (HBI) |
| (POSSIBLE PEPTIDYL-PROLYL 264-312 |
| PHEM4-- HUMAN UROPORPHYRINOGEN-III SYNTHASE (EC 4.2.1.75) |
| (UROPORPHYRINOGEN-III 74-118 |
| PHEP2-- HUMAN HEPARIN COFACTOR II PRECURSOR (HC-II) (PROTEASE |
| INHIBITOR LEUSERPIN 2) 169-196 |
| PHEPS-- HUMAN SERINE PROTEASE HEPSIN (EC 3.4.21.-). 22-49 |
| PHEXA-- HUMAN BETA-HEXOSAMINIDASE ALPHA CHAIN PRECURSOR |
| (EC 3.2.1.52) (N-ACETYL- 356-383 |
| PHEXB-- HUMAN BETA-HEXOSAMINIDASE BETA CHAIN PRECURSOR (EC |
| 3.2.1.52) (N-ACETYL-BETA- 388-415 |
| PHMX1-- |
| HUMAN HOMEOBOX PROTEIN MSX-1 (HOX-7). 178-212 PHNFA-- |
| HUMAN HEPATOCYTE NUCLEAR FACTOR 1-ALPHA (HNF-1A) (LIVER SPECIFIC 2-29 |
| PHO1-- HUMAN HEME OXYGENASE 1 (EC 1.14.99.3) (HO-1). 197-224 |
| PHPPD-- HUMAN 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE (EC |
| 1.13.11.27) (4HPPD). 306-333 |
| PHRX-- HUMAN ZINC FINGER PROTEIN HRX. 521-548 914-974 1637- 2215- |
| 2289- 3317- 3448- |
| 1666 2286 2316 3344 3475 |
| PHS1-- HUMAN HEMATOPOIETIC LINEAGE CELL SPECIFIC PROTEIN. 43-70 |
| PHS9A-- HUMAN HEAT SHOCK PROTEIN HSP 90-ALPHA (HSP 86). 443-470 |
| 640-674 |
| PHSER-- HUMAN HEAT-STABLE ENTEROTOXIN RECEPTOR PRECURSOR (GC-C) |
| (INTESTINAL 511-545 |
| PHSF1-- HUMAN HEAT SHOCK FACTOR PROTEIN 1 (HSF 1) (HEAT SHOCK |
| TRANSCRIPTION FACTOR 113-140 168-209 |
| PHSF2-- HUMAN HEAT SHOCK FACTOR PROTEIN 2 (HSF 2) (HEAT SHOCK |
| TRANSCRIPTION FACTOR 117-198 |
| PHV2I-- HUMAN IG HEAVY CHAIN PRECURSOR V-II REGION (ARH-77). |
| 67-108 |
| PHV3T-- |
| HUMAN IG HEAVY CHAIN V-III REGION (GAL). 47-74 PHX11-- |
| HUMAN HOMEOBOX PROTEIN HOX-11 (TCL-3 PROTO-ONCOGENE). 262-289 |
| PHXB7-- HUMAN HOMEOBOX PROTEIN HOX-B7 (HOX-2C) (HHO.C1). 135-162 |
| PIAPP-- |
| HUMAN ISLET AMYLOID POLYPEPTIDE 53-80 PIBP3-- |
| HUMAN INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 PRECURSOR (IGFBP-3) |
| 183-210 |
| PIC1-- HUMAN PLASMA PROTEASE C1 INHIBITOR PRECURSOR (C1 INH). |
| 251-278 |
| PICA2-- HUMAN INTERCELLULAR ADHESION MOLECULE-2 PRECURSOR |
| (ICAM-2). 57-84 |
| PIDE-- HUMAN INSULIN-DEGRADING ENZYME (EC 3.4.99.45) (INSULINASE) |
| (INSULIN 474-504 907-941 |
| PIF41-- HUMAN EUKARYOTIC INITIATION FACTOR 4A-I (EIF-4A-I). |
| 232-259 322-349 |
| PIF4B-- HUMAN INTRINSIC FACTOR PRECURSOR (IF) (GASTRIC INTRINSIC |
| FACTOR). 149-176 406-433 |
| PIF-- HUMAN INHIBIN BETA A CHAIN PRECURSOR (ACTIVIN BETA-A CHAIN) |
| (ERYTHROID 308-349 |
| PIHBA-- |
| HUMAN INTERLEUKIN-1 ALPHA PRECURSOR (IL-1 ALPHA) (HEMATOPOIETIN-1). |
| 80-107 183-210 |
| PIL1A-- HUMAN INTERLEUKIN-1 RECEPTOR, TYPE I PRECURSOR (IL-1R1) |
| (P80). 76-110 172-199 |
| PIL1R-- HUMAN INTERLEUKIN-1 RECEPTOR, TYPE I PRECURSOR (IL-1R1) |
| (P80). 437-467 |
| PIL1S-- HUMAN INTERLEUKIN-1 RECEPTOR, TYPE II PRECURSOR (IL-1R2). |
| 159-186 |
| PIL5R-- HUMAN INTERLEUKIN-5 RECEPTOR ALPHA CHAIN PRECURSOR |
| (IL-5R-ALPHA). 87-114 |
| PIL6-- HUMAN INTERLEUKIN-6 PRECURSOR (IL-6) (B-CELL STIMULATORY |
| FACTOR 2) (BSF-2) 112-139 |
| PINAI-- |
| HUMAN INTERFERON ALPHA-I PRECURSOR. 94-121 PINAR-- |
| HUMAN INTERFERON-ALPHA RECEPTOR PRECURSOR (IFN-ALPHA-REC). 90-117 |
| 164-191 300-327 508-535 |
| PINB-- HUMAN INTERFERON BETA PRECURSOR (FIBROBLAST). 88-129 |
| PINI1-- HUMAN INTERFERON-INDUCED 17 KD PROTEIN (CONTAINS: |
| INTERFERON-INDUCED 15 KD 83-121 |
| PINI6-- HUMAN INTERFERON-INDUCED 56 KD PROTEIN (IF1-56K). 51-78 |
| 216-245 393-430 |
| PINSR-- HUMAN INSULIN RECEPTOR PRECURSOR (EC 2.7.1.112) (IR). |
| 592-619 |
| PINVO-- HUMAN INVOLUCRIN. 119-146 229-273 326-363 386-450 |
| PIP3K-- HUMAN ID-MYO-INOSITOL-TRISPHOSPHATE 3-KINASE A (EC |
| 2.7.1.127) (INOSITOL 121-162 |
| PIPSP-- HUMAN PLASMA SERINE PROTEASE (PROTEIN C) INHIBITOR |
| PRECURSOR (PCI) 90-117 206-233 |
| PIRBP-- HUMAN INTERPHOTORECEPTOR RETINOID-BINDING PROTEIN |
| PRECURSOR (IRBP) 670-697 |
| PIRF2-- HUMAN INTERFERON REGULATORY FACTOR 2 (IRF-2). 157-193 |
| PIT5P-- HUMAN 75 KD INOSITOL-1,4,5-TRISPHOSPHATE 5-PHOSPHATASE |
| PRECURSOR 235-262 |
| PITA2-- HUMAN PLATELET MEMBRANE GLYCOPROTEIN IA PRECURSOR (GPIA) |
| (COLLAGEN RECEPTO 579-606 900-927 |
| PITA5-- HUMAN FIBRONECTIN RECEPTOR ALPHA SUBUNIT PRECURSOR |
| (INTEGRIN ALPHA-F) 250-284 657-695 765-792 |
| PITA6-- HUMAN INTEGRIN ALPHA-6 PRECURSOR (VLA-6) (INTEGRIN |
| ALPHA-3) (CD49F). 884-911 944-974 |
| PITAL-- HUMAN LEUKOCYTE ADHESION GLYCOPROTEIN LFA-1 ALPHA CHAIN |
| PRECURSOR (LEUKOC 256-283 310-341 795-822 |
| PITAM-- HUMAN CELL SURFACE GLYCOPROTEIN MAC-1 ALPHA SUBUNIT |
| PRECURSOR (CR-3 ALPHA 1044- |
| 1078 |
| PITAV-- HUMAN VITRONECTIN RECEPTOR ALPHA SUBUNIT PRECURSOR |
| (INTEGRIN ALPHA-V) 230-264 |
| PITB1-- HUMAN FIBRONECTIN RECEPTOR BETA SUBUNIT PRECURSOR |
| (INTEGRIN BETA-1) (CD29) 218-245 354-399 |
| PITB2-- HUMAN CELL SURFACE ADHESION GLYCOPROTEINS LFA-1, CR3 AND |
| P150,95, BETA- 339-366 705-732 |
| PITB3-- HUMAN PLATELET MEMBRANE GLYCOPROTEIN IIIA PRECURSOR |
| (GPIIIA) (INTEGRIN BETA- 324-351 |
| PITB4-- HUMAN INTEGRIN BETA-4 SUBUNIT PRECURSOR (GP150). 342-369 |
| PITB5-- |
| HUMAN INTEGRIN BETA-5 SUBUNIT PRECURSOR. 724-751 PITB6-- |
| HUMAN INTEGRIN BETA-6 SUBUNIT PRECURSOR. 311-338 352-393 |
| PITB8-- HUMAN INTEGRIN BETA-8 SUBUNIT PRECURSOR. 362-399 696-737 |
| PIT12-- HUMAN INTER-ALPHA-TRYPSIN INHIBITOR COMPLEX COMPONENT II |
| PRECURSOR. 134-161 425-452 772-818 |
| PK1CJ-- HUMAN KERATIN, TYPE I CYTOSKELETAL 10 (CYTOKERATIN 10) |
| (K10). 154-187 196-227 377-399 428-462 |
| PRICM-- HUMAN KERATIN, TYPE I CYTOSKELETAL 13 (CYTOKERATIN 13) |
| (K13). 112-142 |
| PK1CN-- HUMAN KERATIN, TYPE I CYTOSKELETAL 14 (CYTOKERATIN 14) |
| (K14). 122-152 306-335 393-424 |
| PK1CO-- HUMAN KERATIN, TYPE I CYTOSKELETAL 15 (CYTOKERATIN 15) |
| (K15). 113-143 |
| PK1CP-- HUMAN KERATIN, TYPE I CYTOSKELETAL 16 (CYTOKERATIN 16) |
| (K16). 308-339 |
| PK1CQ-- HUMAN KERATIN, TYPE I CYTOSKELETAL 17 (CYTOKERATIN 17) |
| (K17). 122-152 302-346 393-431 |
| PK1CR-- HUMAN KERATIN, TYPE I CYTOSKELETAL 18 (CYTOKERATIN 18) |
| (K18). 87-114 251-298 337-385 |
| PK1CS-- HUMAN KERATIN, TYPE I CYTOSKELETAL 19 (CYTOKERATIN 19) |
| (K19). 88-118 317-362 370-397 |
| PK2C1-- HUMAN KERATIN, TYPE I CYTOSKELETAL 1 (CYTOKERATIN 1) (K1) |
| (CYTOSKELETAL 67 196-226 346-384 390-467 |
| PK2C2-- HUMAN KERATIN, TYPE II CYTOSKELETAL 65 KD. 215-248 |
| 364-405 461-488 |
| PK2C4-- HUMAN KERATIN, TYPE II CYTOSKELETAL 4 (CYTOKERATIN 4) |
| (K4) (FRAGMENT). 42-73 126-153 189-248 |
| PK2C5-- HUMAN KERATIN, TYPE II CYTOSKELETAL 5 (CYTOKERATIN 5) |
| (K5) (58 KD 185-246 332-373 |
| PK2C6-- HUMAN KERATIN, TYPE II CYTOSKELETAL 6 (CYTOKERATIN 6) |
| (K6B KERATIN). 178-239 325-366 422-449 |
| PK2C8-- HUMAN KERATIN, TYPE II CYTOSKELETAL 8 (CYTOKERATIN 8) |
| (k8). 140-167 |
| PK2CA-- HUMAN KERATIN, TYPE II CYTOSKELETAL 56 KD (K6A KERATIN) |
| (FRAGMENT). 7-34 120-161 217-244 |
| PK6PF-- HUMAN 6-PHOSPHOFRUCTOKINASE, MUSCLE TYPE (EC 2.7.1.11) |
| (PHOSPHOFRUCTOKINASE 140-167 |
| PK6PL-- HUMAN 6-PHOSPHOFRUCTOKINASE, LIVER TYPE (EC 2.7.1.11) |
| (PHOSPHOFRUCTOKINASE 49-80 128-159 |
| PKABL-- HUMAN PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL (EC |
| 2.7.1.112) (P150 498-525 |
| PKAC-- |
| HUMAN IG KAPPA CHAIN C REGION. 37-85 PKALM-- |
| HUMAN KALLMANN SYNDROME PROTEIN PRECURSOR (ADHESION MOLECULE-LIKE |
| X-LINK 380-414 |
| PKAP0-- |
| HUMAN CAMP-DEPENDENT PROTEIN KINASE TYPE I-ALPHA REGULATORY CHAIN |
| 179-206 |
| PKAP1-- |
| HUMAN CAMP-DEPENDENT PROTEIN KINASE TYPE I-BETA REGULATORY CHAIN |
| 177-204 |
| PKAP2-- HUMAN CAMP-DEPENDENT PROTEIN KINASE TYPE II-ALPHA |
| REGULATORY CHAIN 175-202 290-317 |
| PKBF1-- HUMAN NUCLEAR FACTOR KAPPA-B SUBUNIT-1 (NF-KAPPA-B P105 |
| SUBUNIT) 529-570 |
| PKCRB-- HUMAN CREATINE KINASE, B CHAIN (EC 2.7.3.2). 301-328 |
| PKECK-- HUMAN TYROSINE PROTEIN-KINASE ECK PRECURSOR (EC |
| 2.7.1.112) (EPITHELIAL CELL 466-493 |
| PKFER-- HUMAN PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FER (EC |
| 2.7.1.112) (P94-FER) 219-246 564-591 |
| PKFES-- HUMAN PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FES/FPS (EC |
| 2.7.1.112) (C-FES). 101-145 295-322 |
| PKFLT-- HUMAN RECEPTOR-RELATED TYROSINE KINASE FLT PRECURSOR (EC |
| 2.7.1.112). 208-235 319-353 |
| PKFMS-- HUMAN MACROPHAGE COLONY STIMULATING FACTOR I RECEPTOR |
| PRECURSOR (CSF-1-R) 293-320 |
| PKFYN-- HUMAN PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN (EC |
| 2.7.1.112) (P59-FYN) 199-233 |
| PKGPB-- HUMAN CGMP-DEPENDENT PROTEIN KINASE, BETA ISOZYME (CGK) |
| (EC 2.7.1.37). 17-54 |
| PKHEK-- |
| HUMAN TYROSINE KINASE HEK RECEPTOR PRECURSOR (EC 2.7.1.112). 646-673 |
| PKINH-- HUMAN KINESIN HEAVY CHAIN. 125-155 425-452 633-680 |
| 689-716 872-899 |
| PKKIT-- HUMAN KIT PROTO-ONCOGENE TYROSINE KINASE PRECURSOR (EC |
| 2.7.1.112). 235-263 |
| PKMET-- HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR PRECURSOR (MET |
| PROTO-ONCOGENE 898-925 |
| PKNH-- HUMAN KININOGEN, HMW PRECURSOR (ALPHA-2-THIOL PROTEINASE |
| INHIBITOR) 505-532 |
| PKP58-- HUMAN GALACTOSYLTRANSFERASE ASSOCIATED PROTEIN KINASE |
| P58/GTA (EC 2.7.1.-) 81-108 |
| PKP68-- HUMAN INTERFERON-INDUCED, DOUBLE-STRANDED RNA-ACTIVATED |
| PROTEIN KINASE 149-179 191-225 285-312 |
| PKP78-- HUMAN PUTATIVE SERINE/THREONINE-PROTEIN KINASE P78 (EC |
| 2.7.1.-). 582-609 |
| PKPCL-- HUMAN PROTEIN KINASE, C, ETA TYPE (EC 2.7.1.-) (NPKC-ETA) |
| (PKC-L). 318-345 |
| PKPT1-- HUMAN SERINE/THREONINE-PROTEIN KINASE PCTAIRE-1 (EC |
| 2.7.1.-). 149-176 209-253 |
| PKPY1-- HUMAN PYRUVATE KINASE, M1 (MUSCLE) ISOZYME (EC 2.7.1.40) |
| (CYTOSOLIC THYROID 243-289 |
| PKPY2-- HUMAN PYRUVATE KINASE, M2 ISOZYME (EC 2.7.1.40). 243-289 |
| PKPYR-- HUMAN PYRUVATE KINASE, ISOZYME R (EC 2.7.1.40). 2-29 |
| PKRET-- HUMAN PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RET (EC |
| 2.7.1.112). 183-217 |
| PKROS-- HUMAN ROS PROTO-ONCOGENE TYROSINE KINASE (EC 2.7.1.112) |
| (FRAGMENT). 157-203 |
| PKSRC-- HUMAN PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC (EC |
| 2.7.1.112) (P60-SRC) 143-170 |
| PKU7-- HUMAN LUPUS KU AUTOANTIGEN PROTEIN P70 (70 KD SUBUNIT OF |
| KU ANTIGEN). 235-279 |
| PKU86-- HUMAN LUPUS KU AUTOANTIGEN PROTEIN P86 (86 KD SUBUNIT OF |
| KU ANTIGEN). 258-292 |
| PKYES-- HUMAN PROTO-ONCOGENE TYROSINE-PROTEIN KINASE YES (EC |
| 2.7.1.112) (P61-YES) 209-243 |
| PLAM1-- HUMAN LAMIN B1. 32-66 117-144 152-193 214-241 397-424 |
| 480-507 510-539 |
| PLAMA-- HUMAN LAMIN A (70 KD LAMIN). 32-88 114-165 292-343 |
| PLAMC-- |
| HUMAN LAMIN C. 32-88 114-165 292-343 PLAR-- HUMAN |
| LAR PROTEIN PRECURSOR (LEUKOCYTE ANTIGEN RELATED) (EC 3.1.3.48). 935-969 |
| PLA-- HUMAN LUPUS LA PROTEIN (SJOGREN SYNDROME TYPE B ANTIGEN |
| (SS-B)). 191-222 295-342 |
| PLCAT-- |
| HUMAN PHOSPHATIDYLCHOLINE-STEROL ACYLTRANSFERASE PRECURSOR (EC 2.3.1.43) |
| 131-158 |
| PLDHH-- HUMAN L-LACTATE DEHYDROGENASE H CHAIN (EC 1.1.1.27) |
| (LDH-B). 81-108 302-329 |
| PLDHM-- HUMAN L-LACTATE DEHYDROGENASE M CHAIN (EC 1.1.1.27) |
| (LDH-A). 225-252 |
| PLDLR-- HUMAN LOW-DENSITY LIPOPROTEIN RECEPTOR PRECURSOR. 483-510 |
| PLECH-- HUMAN ASIALOGLYCOPROTEIN RECEPTOR 1 (HEPATIC LECTIN H1) |
| (ASGPR). 62-96 |
| PLEM3-- HUMAN P-SELECTIN PRECURSOR (GRANULE MEMBRANE PROTEIN 140) |
| (GMP-140) (PAGDEM) 32-59 87-116 |
| PLGUL-- |
| HUMAN LACTOYLGLUTATHIONE LYASE (EC 4.4.1.5) (METHYLGLYOXALASE) 83-117 |
| PLIF-- HUMAN LEUKAEMIA INHIBITORY FACTOR PRECURSOR (LIF) |
| (DIFFERENTIATION- 95-122 |
| PLIN1-- HUMAN LINE-1 REVERSE TRANSCRIPTASE HOMOLOG. 152-179 |
| 232-263 298-358 671-698 874-901 1036- |
| 1066 |
| PLIPG-- HUMAN TRIACYLGLYCEROL LIPASE PRECURSOR (EC 3.1.1.3) |
| (LIPASE, GASTRIC). 158-185 |
| PLIPS-- HUMAN HORMONE SENSITIVE LIPASE (EC 3.1.1.-) (HSL). |
| 305-332 |
| PLKHA-- HUMAN LEUKOTRIENE A-4 HYDROLASE (EC 3.3.2.6) (LTA-4 |
| HYDROLASE) (LEUKOTRIENE 42-83 290-324 |
| PLMA-- HUMAN LAMININ A CHAIN PRECURSOR. 1318- 1741- 1785- 1824- |
| 1884- 1965- 2026- 2091- |
| 1345 1771 1812 1851 1921 1999 20592118 |
| PLMB1-- HUMAN LAMININ B1 CHAIN PRECURSOR. 1267- 1364- 1597- 1651- |
| 1722- |
| 1314 1394 1631 1714 1781 |
| PLMB2-- |
| HUMAN LAMININ B2 CHAIN PRECURSOR. 1103- 1513- 1135 1547 |
| PLMP2-- HUMAN LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEIN 2 |
| PRECURSOR (LAMP-2) 155-182 |
| PLOX2-- HUMAN ARACHIDONATE 12-LIPOXYGENASE (EC 1.13.11.31) |
| (12-LOX). 341-368 |
| PLOX5-- HUMAN ARACHIDONATE 5-LIPOXYGENASE (EC 1.13.11.34) |
| (5-LIPOXYGENASE) (5-LO). 50-87 |
| PLPH' HUMAN LACTASE-PHLORIZIN HYDROLASE PRECURSOR (EC 3.2.1.108) |
| (EC 3.2.1.62) 776-803 |
| PLRPB-- HUMAN PROTEIN-TYROSINE PHOSPHATASE BETA PRECURSOR (EC |
| 3.1.3.48) (PTP-BETA). 140-167 589-637 |
| PLRPG-- HUMAN PROTEIN-TYROSINE PHOSPHATASE GAMMA PRECURSOR (EC |
| 3.1.3.48) 1081- |
| 1108 |
| PLRPZ-- HUMAN PROTEIN-TYROSINE PHOSPHATASE ZETA PRECURSOR (EC |
| 3.1.3.48) (PTP-ZETA). 553-587 1024- 1973- |
| 1051 2000 |
| PLSHR-- HUMAN LUTROPIN-CHORIOGONADOTROPIC HORMONE RECEPTOR |
| PRECURSOR (LH/CG-R) 66-114 448-480 |
| PLV2B-- |
| HUMAN IG LAMBDA CHAIN V-II REGION (NEI). 61-88 PLYAG-- |
| HUMAN LYSOSOMAL ALPHA-GLUCOSIDASE PRECURSOR (EC 3.2.1.20) (ACID |
| MALTASE). 885-912 |
| PM2OM-- HUMA MITOCHONDRIAL 2-OCOGLUTARATE/MALATE CARRIER PROTEIN |
| (OGCP). 50-77 |
| PMAC2-- |
| HUMAN GALACTOSE-SPECIFIC LECTIN (MAC-2 ANTIGEN) (IGE-BINDING PROTEIN) |
| (35 KD 219-246 |
| PMAN9-- HUMAN MAN(9)-ALPHA-MANNOSIDASE (EC 3.2.1.-). 414-441 |
| PMANA-- HUMA MANNOSE-6-PHOSPHATE ISOMERASE (EC 5.3.1.8) |
| (PHOSPHOMANNOSE ISOMERASE) 60-87 |
| PMANR-- HUMA MACROPHAGE MANNOSE RECEPTOR PRECURSOR. 248-284 1147- |
| 1182 |
| PMAP2-- HUMAN MICROTUBULE-ASSOCIATED PROTEIN 2 (FRAGMENT). |
| 434-478 |
| PMAP4-- |
| HUMAN MICROTUBULE-ASSOCIATED PROTEIN 4. 408-449 PMAX-- |
| HUMAN MAX PROTEIN. 117-144 |
| PMDM2-- HUMA MDM2 PROTEIN (P53-ASSOCIATED PROTEIN). 235-288 |
| PMDR1-- HUMAN MULTIDRUG RESISTANCE PROTEIN 1 (P-GLYCOPROTEIN |
| 1). 561-595 |
| PMERL-- |
| HUMAN MERLIN (SCHWANNOMIN). 377-407 532-566 PMERO-- |
| HUMAN MEROSIN HEAVY CHAIN (LAMININ CHAIN A2) (FRAGMENT). 71-105 |
| 139-173 431-458 791-818 |
| PMGMT-- HUMA METHYLATED-DNA-PROTEIN-CYSTEINE METHYLTRANSFERASE |
| (EC 2.1.1.63) (6-O- 91-118 |
| PMKLP-- HUMAN MITOTIC KINESIN-LIKE PROTEIN-1. 207-234 319-346 |
| 510-537 549-608 |
| PMLCH-- HUMAN MELANIN-CONCENTRATING HORMONE PRECURSOR. 8-35 |
| PMLK1-- |
| HUMAN MIXED LINEAGE KINASE 1 (EC 2.7.1.-) (FRAGMENT). 130-157 321-348 |
| PMMSA-- HUMA METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE 393-420 |
| PMOES-- HUMAN MOESIN (MEMBRANE-ORGANIZING EXTENSION SPIKE |
| PROTEIN). 119-146 351-403 |
| PMPCP-- HUMAN MITOCHONDRIAL PHOSPHATE CARRIER PROTEIN PRECURSOR. |
| 286-313 |
| PMPI3-- HUMAN M-PHASE INDUCER PHOSPHATASE 3 (EC 3.1.3.48). 72-99 |
| PMPKK-- HUMAN DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE |
| KINASE (EC 2.7.1.-) 19-50 |
| PMPRI-- HUMAN CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR |
| PRECURSOR (CI MAN-6- 1569- 2437- |
| 1596 2478 |
| PMRP-- HUMAN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN. 396-423 |
| 507-548 |
| PMSHR-- HUMAN MELANOCYTE STIMULATING HORMONE RECEPTOR (MSH-4) |
| (MELANOTROPIN 38-65 |
| PMSRE-- HUMAN MACROPHAGE SCAVENGER RECEPTOR TYPES I AND II |
| (MACROPHAGE 173-204 230-260 |
| ACETYLATED |
| PMTDM-- HUMA DNA (CYTOSINE-5)-METHYLTRANSFERASE (EC 2.1.1.37) |
| (DNA 387-414 601-628 |
| PMTF1-- HUMAN MITOCHONDRIAL TRANSCRIPTION FACTOR 1 PRECURSOR |
| (MTTF1). 181-212 |
| PMUTA-- HUMAN METHYLMALONYL-COA MUTASE PRECURSOR (EC 5.4.99.2) |
| (MCM). 468-519 |
| PMX1-- HUMAN INTERFERON-REGULATED RESISTANCE GTP-BINDING PROTEIN |
| MXA (INTERFERON- 108-150 |
| PMX2-- HUMAN INTERFERON-REGULATED RESISTANCE GTP-BINDING PROTEIN |
| MXB (P78-RELATED 451-489 670-697 |
| PMYBA-- |
| HUMA MYB-RELATED PROTEIN A (FRAGMENT). 619-646 PMYBB-- |
| HUMAN MYB-RELATED PROTEIN B. 87-117 |
| PMYCN-- HUMA N-MYC PROTO-ONCOGENE PROTEIN. 263-300 413-461 |
| PMYC-- |
| HUMAN MYC PROTO-ONCOGENE PROTEIN. 393-422 PMYF4-- |
| HUMAN MYOGENIC FACTOR MYF-4 (MYOGENIN). 119-146 |
| PMYF5-- |
| HUMAN MYOGENIC FACTOR MYF-5. 121-148 PMYP2-- |
| HUMAN MYELIN P2 PROTEIN. 70-110 |
| PMYPR-- HUMAN MYELIN PROTEOLIPID PROTEIN (PLP) (LIPOPHILIN) |
| (CONTAINS: MYELIN 43-70 |
| PMYSA-- HUMAN MYOSIN HEAVY CHAIN, CARDIAC MUSCLE ALPHA ISOFORM |
| (FRAGMENT). 38-75 84-111 137-178 236-324 398-435 440-485 |
| PMYSB-- HUMAN MYOSIN HEAVY CHAIN, CARDIAC MUSCLE BETA ISOFORM. |
| 48-75 951-981 997-1044 1088- 1192- 1266- 1360- 1442- 1488- |
| 1122 1234 1332 1408 1479 1532 |
| 1541- 1640- 1683- 1801- |
| 1582 1681 1710 1838 |
| PMYSE-- |
| HUMAN MYOSIN HEAVY CHAIN, FAST SKELETAL MUSCLE, EMBRYONIC. 46-73 |
| 860-903 952-1077 1119- 1193- 1267- 1364- 1483- 1641- |
| 1146 1235 1340 1411 1597 1675 |
| 1707- 1827- |
| 1734 1858 |
| PMYSP-- HUMAN MYOSIN HEAVY CHAIN, PERINATAL CARDIAC MUSCLE |
| (FRAGMENT). 50-77 95-125 141-188 215-272 403-483 507-552 586-624 685-736 |
| 784-818 |
| 823-907 946-987 1049- |
| 1076 |
| PMYSS-- HUMAN MYOSIN HEAVY CHAIN, SKELETAL MUSCLE (FRAGMENT). |
| 133-160 193-280 304-349 423-460 468-526 581-608 645-681 743-798 808-835 |
| 846-873 |
| PMYT1-- HUMAN MYELIN TRANSCRIPTION FACTOR 1 (MYTI) (FRAGMENT). |
| 640-678 |
| PNACA-- |
| HUMAN SODIUM/CALCIUM EXCHANGER PRECURSOR (NA+/CA2+-EXCHANGE PROTEIN). |
| 492-519 594-621 705-735 |
| PNCA2-- |
| HUMAN NEURAL CELL ADHESION MOLECULE, PHOSPHATIDYLINOSITOL-LINKED |
| ISOFORM 255-282 |
| PNCF1-- HUMAN NEUTROPHIL CYTOSOL FACTOR 1 (NCF-47K) (47 KD |
| AUTOSOMAL CHRONIC 234-261 310-337 |
| PNCF2-- HUMAN NEUTROPHIL NADPH OXIDASE FACTOR (P67-PHOX). 5-32 |
| PNEFA-- HUMAN DNA-BINDING PROTEIN NEFA PRECURSOR. 50-77 82-112 |
| 343-395 |
| PNEP-- HUMAN NEPRILYSIN (EC 3.4.24.11) (NEUTRAL ENDOPEPTIDASE) |
| (NEP) 170-216 644-671 |
| PNF1-- HUMAN NEUROFIBROMIN (NEUROFIBROMATOSIS-RELATED PROTEIN |
| NF-1) (FRAGMENT). 1145- 1388- 1639- |
| 1172 1422 1666 |
| PNFH-- |
| HUMAN NEUROFILAMENT TRIPLET H PROTEIN (200 KD NEUROFILAMENT PROTEIN) |
| (NF-H). 91-128 431-490 |
| PNFL-- HUMAN NEUROFILAMENT TRIPLET L PROTEIN (68 KD NEUROFILAMENT |
| PROTEIN) (NF-L). 92-126 441-468 |
| PNFM-- |
| HUMAN NEUROFILAMENT TRIPLET M PROTEIN (160 KD NEUROFILAMENT PROTEIN) |
| (NF-M). 101-141 164-194 215-280 315-372 737-764 794-826 872-913 |
| PNK1R-- HUMAN SUBSTANCE-P RECEPTOR (SPR) (NK-1 RECEPTOR) (NK-1R). |
| 338-365 |
| PNK4-- HUMAN NATURAL KILLER CELLS PROTEIN 4 PRECURSOR. 166-193 |
| PNKCR-- HUMAN NK-TUMOR RECOGNITION PROTEIN (NATURAL-KILLER |
| CELLS CYCLOPHILIN- 187-214 448-475 559-599 701-742 816-843 1080- |
| 1133 |
| PNKGA-- HUMAN NKG2-A AND KNG2-B TYPE II INTEGRAL MEMBRANE |
| PROTEINS. 28-55 |
| PNOS1-- HUMAN NITRIC-OXIDE SYNTHASE, BRIN (EC 1.14.13.39) (NOS. |
| TYPE I) 389-416 1116- 1292- |
| 1146 1319 |
| PNOS3-- HUMAN NITRIC-OXIDE SYNTHASE, ENDOTHELIAL (EC.1.14.13.39) |
| (EC-OS)(NOS. 389-416 |
| PNTG1-- HUMAN SODIUM- AND CHLORIDE-DEPENDENT GABA TRANSPORTER 1. |
| 131-158 |
| PNTR-- |
| HUMAN NEUROTENSIN RECEPTOR (NT-4). 57-84 PNTSE-- |
| HUMAN SODIUM-DEPENDENT SEROTONIN TRANSPORTER (5HT TRANSPORTER) (5HTT). |
| 71-98 |
| PNTTA-- HUMAN SODIUM- AND CHLORIDE-DEPENDENT TAURINE TRANSPORTER |
| 120-147 |
| PNU2M-- |
| HUMAN NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 2 (EC 1.6.5.3). 202-240 |
| PNU4M-- HUMAN NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 4 (EC |
| 1.6.5.3). 164-191 372-399 |
| PNUBN-- |
| HUMAN NUCLEOBINDIN PRECURSOR. 46-73 360-387 PNUCL-- |
| HUMAN NUCLEOLIN(PROTEIN C23). 462-508 |
| PNY3R-- HUMAN PUTATIVE NEUROPEPTIDE Y RECEPTOR TYPE 3 (NPY3-R) |
| (FB22) (NPYRL). 115-142 |
| POAT-- HUMAN ORNITHINE AMINOTRANSFERASE PRECURSOR (EC 2.6.1.13) |
| (ORNITHINE-OXO- 98-128 |
| POC3A-- HUMAN OCTAMER-BINDING TRANSCRIPTION FACTOR 3A (OCT-3A). |
| 139-173 |
| POC3B-- HUMAN OCTAMER-BINDING TRANSCRIPTION FACTOR 3B (OCT-3B). |
| 37-78 |
| POCRL-- HUMAN LOWE'S OCULOCEREBRORENAL SYNDROME PROTEIN. 704-735 |
| PODB2-- HUMAN LIPOAMIDE ACYLTRANSFERASE COMPONENT (E2) PRECURSOR |
| OF BRANCHED-CHAI 100-127 375-402 |
| PODP2-- HUMAN DIHYDROLIPOAMIDE ACETYLTRANSFERASE COMPONENT (E2) |
| OF PYRUVATE 72-99 |
| POMGP-- HUMAN OLIGODENDROCYTE-MYELIN GLYCOPROTEIN PRECURSOR |
| (OMG). 53-80 |
| POPSB-- HUMAN BLUE-SENSITIVE OPSIN (BLUE CONE PHOTORECEPTOR |
| PIGMENT). 220-247 |
| POPSG-- HUMAN GREEN-SENSITIVE OPSIN (GREEN CONE PHOTORECEPTOR |
| PIGMENT). 90-117 239-266 |
| POPSR-- HUMAN RED-SENSITIVE OPSIN (RED CONE PHOTORECEPTOR |
| PIGMENT). 90-117 239-266 |
| POSTP-- HUMAN OSTEOPONTIN PRECURSOR (BONE SIALOPROTEIN 1) |
| (URINARY STONE PROTEIN) 239-266 |
| POTC-- HUMAN ORNITHINE CARBAMOYLTRANSFERASE PRECURSOR (EC |
| 2.1.3.3). 170-204 |
| POTNC-- HUMAN OSTEONECTIN PRECURSOR (BASEMENT MEMBRANE PROTEIN |
| BM-40). 173-207 |
| POXYB-- HUMAN OXYSTEROL-BINDING PROTEIN. 89-123 190-217 290-317 |
| 577-604 |
| POXYR-- |
| HUMAN OXYTOCIN RECEPTOR (OT-R). 350-377 PP107-- |
| HUMAN RETINOBLASTOMA-ASSOCIATED PROTEIN-LIKE 107 KD HOMOLOG (P107) |
| 159-186 422-449 |
| PP1DP-- HUMAN DNA POLYMERASE ALPHA HOLOENZYME-ASSOCIATED PROTEIN |
| P1. 19-60 637-664 |
| PP47-- |
| HUMAN PLECKSTRIN (P47). 298-325 PP4HA-- |
| HUMAN PROLYL 4-HYDROXYLASE ALPHA SUBUNIT PRECURSOR (EC 1.14.11.2). |
| 29-69 191-218 |
| PP60-- HUMAN MITOCHONDRIAL MATRIX PROTEIN P1 PRECURSOR (P60 |
| LYMPHOCYTE PROTEIN) 72-99 271-298 361-407 |
| PP85A-- HUMAN PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY ALPHA |
| SUBUNIT (P13-KINASE 12-39 428-476 586-613 688-715 |
| PPAP1-- HUMAN PANCREATITIS ASSOCIATED PROTEIN 1 PRECURSOR. 77-104 |
| PPAX5-- |
| HUMAN PAIRED BOX PROTEIN PAX-5 (B-CELL SPECIFIC TRANSCRIPTION FACTOR) |
| 157-187 |
| PPDGA-- HUMAN PLATELET-DERIVED GROWTH FACTOR, A CHAIN PRECURSOR |
| (PDGF A-CHAIN) 38-65 |
| PPEC1-- HUMAN PLATELET ENDOTHELIAL CELL ADHESION MOLECULE |
| PRECURSOR (PECAM-1) 685-719 |
| PPENK-- |
| HUMAN PROENKEPHALIN A PRECURSOR. 142-176 PPERE-- |
| HUMAN EOSINOPHIL PEROXIDASE PRECURSOR (EC 1.11.1.7) (EPO) (FRAGMENT). |
| 308-335 |
| PPERF-- HUMAN PERFORIN 1 PRECURSOR (P1) (LYMPHOCYTE PORE FORMING |
| PROTEIN) (PFP). 411-438 |
| PPF4L-- HUMAN PLATELET BASIC PROTEIN PRECURSOR (PBP) (CONTAINS: |
| CONNECTIVE-TISSUE 21-55 |
| PPGCA-- HUMAN CARTILAGE-SPECIFIC PROTEOGLYCAN CORE PROTEIN |
| PRECURSOR (CSPCP) 73-100 |
| PPGCS-- HUMAN LARGE FIBROBLAST PROTEOGLYCAN PRECURSOR (VERSICAN) |
| (CHONDROITIN 64-98 1390- 1553- |
| 1417 1580 |
| PPGDH-- HUMAN 15-HYDROXYPROTAGLANDIN DEHYDROGENASE (NAD(+)) (EC |
| 1.1.1.141) (PGDH). 87-118 |
| PPGDR-- HUMAN BETA PLATELET-DERIVED GROWTH FACTOR RECEPTOR |
| PRECURSOR (EC 2.7.1.112). 294-321 354-384 465-495 |
| PPGDS-- HUMAN ALPHA PLATELET-DERIVED GROWTH FACTOR RECEPTOR |
| PRECURSOR 64-94 347-395 461-488 524-551 986-1058 |
| PPGHS-- HUMAN PROSTAGLANDIN G/H SYNTHASE PRECURSOR (EC 1.14.99.1) |
| (CYCLOOXYGENASE) 331-358 |
| PPGS1-- HUMAN BONE/CARTILAGE PROTEOGLYCAN I PRECURSOR (BIGLYCAN) |
| (PG-S1). 100-127 |
| PPH4H-- HUMAN PHENYLALANINE-4-HYDROXYLASE (EC 1.14.16.1) (PAH) |
| (PHE-4- 239-266 |
| PPHB-- |
| HUMAN PROHIBITIN. 41-68 PPHOS-- |
| HUMAN PHOSDUCIN (33 KD PHOTOTRANSDUCING PROTEIN) (MEKA PROTEIN). |
| 184-225 |
| PPHS1-- HUMAN GLYCOGEN PHOSPHORYLASE, LIVER FORM (EC 2.4.1.1). |
| 116-143 |
| PPHS2-- HUMAN GLYCOGEN PHOSPHORYLASE, MUSCLE FORM (EC 2.4.1.1). |
| 532-559 |
| PPHS3-- HUMAN GLYCOGEN PHOSPHORYLASE, BRAIN FORM (EC 2.4.1.1). |
| 533-560 |
| PPIP4-- |
| HUMAN 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE BETA 2 |
| 908-935 |
| PPIP5-- |
| HUMAN 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE GAMMA 2 |
| 142-169 239-266 |
| PPLAK-- |
| HUMAN PLAKOGLOBIN (DESMOPLAKIN III). 373-400 PPSL-- |
| HUMAN L-PLASTIN (FIMBRIN). 507-534 |
| PPLST-- |
| HUMAN T-PLASTIN (FIMBRIN). 510-561 PPM22-- |
| HUMAN PERIPHERAL MYELIN PROTEIN 22 (PMP-22). 3-33 |
| PPMGB-- HUMAN PHOSPHOGLYCERATE MUTASE, BRAIN FORM (EC 5.4.2.1) |
| (PGAM-B) (EC 5.4.2.4) 81-111 |
| PPMGM-- HUMA PHOSPHOGLYCERATE MUTASE, MUSCLE FORM (EC 5.4.2.1) |
| (PGAM-M) 81-115 |
| PPML1-- HUMAN PROBABLE TRANSCRIPTION FACTOR PML-1. 551-585 |
| PPMLX-- HUMAN PROBABLE TRANSCRIPTION FACTOR PML-X. 551-585 |
| PPMSC-- |
| HUMAN AUTOANTIGEN PM-SCL. 103-130 PPOGA-- |
| HUMAN DNA-BINDING PROTEIN PO-GA. 14-51 182-209 610-637 667-699 |
| PPOL1-- HUMAN RETROVIRUS-RELATED POL POLYPROTEIN (REVERSE |
| TRANSCRIPTASE 774-804 |
| PPOL2-- HUMAN RETROVIRUS-RELATED POL POLYPROTEIN (FRAGMENT). |
| 78-138 171-205 |
| PPORI-- |
| HUMAN OUTER MITOCHONDRIAL MEMBRANE PROTEIN PORIN (VOLTAGE-DEPENDENT |
| ANIO 33-76 189-216 |
| PPPAP-- HUMAN PROSTATIC ACID PHOSPHATASE PRECURSOR (EC 3.1.3.2). |
| 235-269 |
| PPAS-- HUMAN RED CELL ACID PHOSPHATASE 1, ISOZYME S (EC 3.1.3.2) |
| (ACP1). 26-53 |
| PPPOL-- HUMAN NAD(+) ADP-RIBOSYLTRANSFERASE (EC 2.4.2.30) (POLY |
| (ADP-RIBOSE) 699-729 972-1003 |
| PPRC2-- HUMAN PROTEASOME COMPONENT C2 (EC 3.4.99.46) (MACROPAIN |
| SUBUNIT C2) 39-66 |
| PPRC3-- HUMAN PROTEASOME COMPONENT C3 (EC 3.4.99.46) (MACROPAIN |
| SUBUNIT C3) 34-61 |
| PPRC9-- HUMAN PROTEASOME COMPONENT C9 (EC 3.4.99.46) (MACROPAIN |
| SUBUNIT C9) 203-261 |
| PPRGR-- HUMAN PROGESTERONE RECEPTOR (PR) (FORMS A AND B). 846-890 |
| PPRTS-- HUMAN VITAMIN K-DEPENDENT PROTEIN S (BLOOD CLOTTING) |
| PRECURSOR. 337-371 |
| PPRTZ-- HUMAN VITAMIN K-DEPENDENT PROTEIN Z PRECURSOR. 29-56 |
| PPSOR-- |
| HUMAN PSORIASIN. 65-92 PPSPD-- |
| HUMAN PULMONARY SURFACTANT-ASSOCIATED PROTEIN D PRECURSOR (PSP0D) |
| (SP-D). 224-251 |
| PPTHY-- HUMAN PARATHYROID HORMONE PRECURSOR (PARATHYRIIN). 86-113 |
| PPTN1-- HUMAN PROTEIN-TYROSINE PHOSPHATASE 1B (EC 3.1.3.48) |
| (PTP-1B). 136-177 |
| PPTN2-- HUMAN T-CELL PROTEIN-TYROSINE PHOSPHATASE (EC 3.1.3.48) |
| (TCPTP). 59-86 138-178 |
| PPTN6-- HUMAN PROTEIN-TYROSINE PHOSPHATASE 1C (EC 3.1.3.48) |
| (PTP-1C) (HEMATOPOIETIC 227-261 512-580 |
| PPTNB-- HUMAN PROTEIN-TYROSINE PHOSPHATASE 2C (EC 3.1.3.48) |
| (PTP02C) (PTP-1D) 41-68 218-245 |
| PPTNC-- HUMAN PROTEIN-TYROSINE PHOSPHATASE G1 (EC 3.1.3.48) |
| (PTPG1). 618-645 695-722 |
| PPTRR-- HUMAN PARATHYROID HORMONE/PARATHYROID HORMONE-RELATED |
| PEPTIDE 368-395 |
| PPTX3-- HUMAN PENTAXIN-RELATED PROTEIN PTX3 PRECURSOR. 74-101 |
| PPUR2-- HUMAN PHOSPHORIBOSYLAMINE-GLYCINE LIGASE (EC 6.3.4.13) |
| (GARS) (GLYCINAMIDE 803-830 |
| PPUR6-- |
| HUMAN MULTIFUNCTIONAL PROTEIN ADE2H1 (PHOSPHORIBOSYLAMINOIMIDAZOLE- |
| 391-418 |
| PPUR8-- |
| HUMAN ADENYLOSUCCINATE LYASE (EC 4.3.2.2) (ADENYLOSUCCINASE) (ASL). |
| 204-231 |
| PPYR5-- HUMAN URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMP SYNTHASE) |
| (OROTATE 120-150 |
| PPYRG-- HUMAN CTP SYNTHASE (EC 6.3.4.2) (UTP-AMMONIA LIGASE) (CTP |
| SYNTHETASE). 86-113 300-334 |
| PPZP-- HUMAN PREGNANCY ZONE PROTEIN PRECURSOR. 315-354 990-1024 |
| 1162- 1405- |
| 1189 1432 |
| PRA74-- HUMAN TRANSCRIPTION FACTOR IIF, ALPHA SUBUNIT (TFIIF, |
| ALPHA SUBUNIT) 474-501 |
| PRAB4-- |
| HUMAN RAS-RELATED PROTEIN RAB-4. 38-65 PRAB6-- |
| HUMAN RAS-RELATED PROTEIN RAB-6. 123-150 |
| PRADI-- |
| HUMAN RADIXIN. 308-335 414-463 510-537 PRB11-- |
| HUMAN RAS-RELATED PROTEIN RAB-11 (24KG) (YL8). 151-178 |
| PRBB3-- |
| HUMAN RETINOBLASTOMA BINDING PROTEIN 3 (RBBP-3) (PRB-BINDING PROTEIN |
| E2F-1) 129-156 161-223 |
| PRDP-- |
| HUMAN RD PROTEIN. 9-53 PRENI-- |
| HUMAN RENIN PRECURSOR, RENAL (EC 3.4.23.15) (ANGIOTENSINOGENASE). |
| 136-163 |
| PREST-- HUMAN RESTIN (CYTOPLASMIC LINKER PROTEIN-170 ALPHA-2) |
| (CLIP-170). 190-217 333-370 445-472 571-619 744-771 784-852 1023- 1088- |
| 1157- |
| 1050 1139 1184 |
| 1216- |
| 1306 |
| PRFA1-- HUMAN REPLICATION PROTEIN A 70 KD DNA-BINDING SUBUNIT |
| (RP-A) (RF-A) 208-235 425-455 |
| PREFP-- HUMAN TRANSFORMING PROTEIN (RFP) (RET FINGER PROTEIN). |
| 183-217 |
| PRH-- |
| HUMAN BLOOD GROUP RH(D) POLYPEPTIDE 361-388 PRIB1- |
| - |
| HUMAN RIBOPHORIN I PRECURSOR. 81-108 496-530 |
| PRIB2-- |
| HUMAN RIBOPHORIN II PRECURSOR. 142-172 361-388 PRIR1- |
| - HUMAN RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE M1 CHAIN (EC 1.17.4.1) |
| 42-69 370-400 |
| PRL22-- HUMAN 60S RIBOSOMAL PROTEIN L22 (EPSTEIN-BARR VIRUS SMALL |
| RNA ASSOCIATED 78-112 |
| PRL26-- |
| HUMAN 60S RIBOSOMAL PROTEIN L26. 55-89 103-137 PRL9-- |
| HUMAN 60S RIBOSOMAL PROTEIN L9. 146-192 |
| PRLA0-- HUMAN 60S ACIDIC RIBOSOMAL PROTEIN P0 (L10E). 138-165 |
| PRO5-- HUMAN 52 KD RO PROTEIN (SJOGREN SYNDROME TYPE A ANTIGEN |
| (SS-A)). 190-235 238-265 |
| PRO6-- HUMAN 60 KD RO PROTEIN (SJOGREN SYNDROME TYPE A ANTIGEN |
| (SS-A)). 192-245 |
| PROC-- HUMAN HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2 |
| (HNRNP C1 AND HNRNP 16-43 |
| PROL-- HUMAN HETEROGENEOUS RIBONUCLEOPROTEIN L (HRNPL). 501-528 |
| PROU-- |
| HUMAN HETEROGENOUS RIBONUCLEOPROTEIN U. 630-657 PRPB1-- |
| HUMAN DNA-DIRECTED RNA POLYMERASE II 215 KD POLYPEPTIDE 269-296 |
| 665-720 879-906 1314- 1371- |
| 1341 1398 |
| PRPB2-- HUMAN DNA-DIRECTED RNA POLYMERASE II 140 KD POLYPEPTIDE |
| 626-667 1008- |
| 1035 |
| PRPB3-- HUMAN DNA-DIRECTED RNA POLYMERASE II 33 KD POLYPEPTIDE |
| 242-274 |
| PRRXA-- |
| HUMAN RETINOIC ACID RECEPTOR RXR-ALPHA. 318-352 PRRXB-- |
| HUMAN RETINOIC ACID RECEPTOR RXR-BETA ISOFORM 1. 376-403 |
| PRRXC-- HUMAN RETINOIC ACID RECEPTOR RXR-BETA ISOFORM 2 396-423 |
| PRS12-- |
| HUMAN 40S RIBOSOMAL PROTEIN S12. 60-87 PRS16-- |
| HUMAN 40S RIBOSOMAL PROTEIN S16. 89-116 |
| PRS25-- |
| HUMAN 40S RIBOSOMAL PROTEIN S25. 26-53 PRS27-- |
| HUMAN 40S RIBOSOMAL PROTEIN S27A. 14-41 |
| PRS7-- |
| HUMAN 40S RIBOSOMAL PROTEIN S7 (S8). 73-100 PRS8-- |
| HUMAN 40S RIBOSOMAL PROTEIN S8 136-161 |
| PRTC1-- |
| HUMAN RAS-LIKE PROTEIN TC21. 123-150 PRU1A-- |
| HUMAN U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A (U1 SNRNP A PROTEIN) 13-47 |
| PRU2B-- HUMAN U2 SMALL NUCLEAR RIBONUCLEOPROTEIN B* 17-44 |
| PRYNR-- HUMAN RYANODINE RECEPTOR, SKELETAL MUSCLE 154-188 |
| 495-522 866-893 2750- 2820- 3304- 3529- 3912- 4921- |
| 2777 2847 3331 3556 3939 4948 |
| PS10A-- |
| HUMAN S-100 PROTEIN, ALPHA CHAIN. 12-54 PS10B-- |
| HUMAN S-100 PROTEIN, BETA CHAIN. 14-56 |
| PS10D-- |
| HUMAN S-100D PROTEIN. 31-58 PSAHH-- |
| HUMAN ADENOSYLHOMOCYSTEINASE (EC 3.3.1.1) (S-ADENOSYL-L-HOMOCYSTEINE |
| 389-416 |
| PSAT1-- |
| HUMAN DNA-BINDING PROTEIN SATB1. 709-736 PSCCA-- |
| HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN (SCCAQ) (PROTEIN T4-A) 78-105 |
| PSCF-- |
| HUMAN STEM CELL FACTOR PRECURSOR (SCF). 74-101 PSEM1-- |
| HUMAN SEMENOGELIN I PROTEIN PRECURSOR (SGI) (CONTAINS: SEMINAL BASIC |
| 64-98 176-226 288-329 334-368 |
| PSEM2-- HUMAN SEMENOGELIN II PRECURSOR (SGII). 71-98 183-226 |
| 034-355 405-439 539-575 |
| PSET-- |
| HUMAN SET PROTEIN. 38-65 154-181 PSG1-- |
| HUMAN SECRETOGRANIN I PRECURSOR (CHROMOGRANIN B). 144-178 |
| PSG2-- HUMAN SECRETOGRANIN II PRECURSOR (CHROMOGRANIN C). 254-281 |
| 290-317 534-561 |
| PSIAL-- HUMAN BONE SIALOPROTEIN II PRECURSOR (BSPII). 84-113 |
| 155-193 256-283 |
| PSN2L-- HUMAN POSSIBLE GLOBAL TRANSCRIPTION ACTIVATOR SNF2L. |
| 231-258 545-572 |
| PSNOB-- |
| HUMAN SKI-RELATED ONCOGENE SNON. 414-441 PSPCA-- |
| HUMAN SPECTRIN ALPHA CHAIN. 193-220 570-621 655-712 1099- 1461- 1882- |
| 1988- 2120- 2223- |
| 1126 1502 1909 2022 2154 2250 |
| 2346- |
| 2373 |
| PSPCB-- HUMAN SPECTRIN BETA CHAIN, ERYTHROCYTE. 150-177 316-350 |
| 486-520 648-675 987-1021 1027- 1287- 1347- 1834- |
| 1083 1324 1374 1861 |
| PSPRE-- HUMAN SEPIAPTERIN REDUCTASE (EC 1.1.1.153) (SPR). 90-124 |
| PSRF-- |
| HUMAN SERUM RESPONSE FACTOR (SRF). 77-104 480-507 PSRPR-- |
| HUMAN SIGNAL RECOGNITION PARTICLE RECEPTOR ALPHA SUBUNIT (SR-ALPHA) |
| 76-110 |
| PSSR1-- |
| HUMAN SOMATOSTATIN RECEPTOR TYPE 1. 289-316 PSTHM-- |
| HUMAN STATHMIN (PHOSPHOPROTEIN P19) (ONCOPROTEIN P18) (LEUKEMIA-ASSOCIA |
| TED 47-74 |
| PSUIS-- HUMAN SUCRASE-ISOMALTASE, INTESTINAL (EC 3.2.1.48)/(EC |
| 3.2.1.10). 1748- |
| 1775 |
| PSYB1-- |
| HUMAN SYNAPTOBREVIN 1. 31-67 PSYD2-- |
| HUMAN ASPARTYL-TRNA SYNTHETASE ALPHA-2 SUBUNIT (EC 6.1.1.12) (ASPARTATE |
| - 44-71 |
| PSYEP-- |
| HUMAN MULTIFUNCTIONAL AMINOACYL-TRNA SYNTHETASE (CONTAINS: GLUTAMYL-TRN |
| 174-201 740-771 |
| PSYH-- |
| HUMAN HISTIDYL-TRNA SYNTHETASE (EC 6.1.1.21) (HISTIDINE-TRNA LIGASE). |
| 380-442 468-502 |
| PSYT1-- |
| HUMAN SYNAPTOTAGMIN I (P65). 140-167 250-277 PSYTC-- |
| HUMAN THREONYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.3) (THREONINE-TRN |
| A 497-524 658-685 |
| PSYV-- HUMAN VALYL-TRNA SYNTHETASE (EC 6.1.1.9) (VALINE-TRNA |
| LIGASE) (VALRS). 230-257 413-440 |
| PSYW-- |
| HUMAN TRYPTOPHANYL-TRNA SYNTHETASE (EC 6.1.1.2) (TRYPTOPHAN-TRNA |
| LIGASE) 93-127 196-223 |
| PT2EB-- HUMAN TRANSCRIPTION INITIATION FACTOR IIE-BETA CHAIN |
| (TFIIE-BETA). 34-68 |
| PTAP4-- HUMAN TRANSCRIPTION FACTOR AP-4 (FRAGMENT). 169-196 |
| 245-272 |
| PTAPB-- |
| HUMAN TRANSCRIPTION FACTOR JUN-B. 296-323 PTAPD-- |
| HUMAN TRANSCRIPTION FACTOR JUN-D. 291-333 |
| PTAU1-- HUMAN MICROTUBULE-ASSOCIATED PROTEIN TAU. 278-305 |
| PTAU2-- HUMAN MICROTUBULE-ASSOCIATED PROTEIN TAU, FETAL. |
| 211-238 |
| PTCO1-- HUMAN TRANSCOBALAMIN I PRECURSOR. 201-241 330-357 |
| PTCP1-- HUMAN T-COMPLEX PROTEIN 1 (TCP-1). 316-343 |
| PTDT-- HUMAN DNA NUCLEOTIDYLEXOTRANSFERASE (EC 2.7.7.31) |
| (TERMINAL ADDITION ENZYME) 61-95 |
| PTEK-- HUMAN RECEPTOR TYROSINE-PROTEIN KINASE TEK PRECURSOR (EC |
| 2.7.1.112) (HPK-6). 644-678 969-996 1007- |
| 1036 |
| PTF2B-- HUMAN TRANSCRIPTION INITIATION FACTOR IIB (TFIIB). |
| 135-162 |
| PTFE3-- HUMAN TRANSCRIPTION FACTOR E3 (FRAGMENT). 43-70 122-149 |
| 178-226 |
| PTFS2-- HUMAN TRANSCRIPTION ELONGATION FACTOR S-II. 29-56 |
| PTF-- HUMAN TISSUE FACTOR PRECURSOR (TF) (COAGULATION |
| FACTOR III). 148-175 |
| PTGF1-- HUMAN TRANSFORMING GROWTH FACTOR BETA 1 PRECURSOR |
| (TGF-BETA 1). 148-185 |
| PTGF2-- HUMAN TRANSFORMING GROWTH FACTOR BETA 2 PRECURSOR |
| (TGF-BETA 2) (GLIOBLASTO 243-270 |
| PTGFA-- |
| HUMAN TRANSFORMING GROWTH FACTOR ALPHA PRECURSOR (TGF-ALPHA) (EGF-LIKE |
| TGF 87-114 |
| PTGLK-- HUMAN PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE K (EC |
| 2.3.2.13) 258-285 |
| PTHBS-- |
| HUMAN THROMBOSPONDIN PRECURSOR. 110-165 284-314 PTHIK-- |
| HUMAN 3-KETOACYL-COA THIOLASE PEROXISOMAL PRECURSOR (EC 2.3.1.16) |
| (BETA- 185-212 |
| PTKNB-- HUMAN PROTACHYKININ BETA PRECURSOR (CONTAINS: SUBSTANCE |
| P, NEUROKININ A 11-38 |
| PTLE1-- HUMAN TRANSDUCIN-LIKE ENHANCER PROTEIN 1. 626-653 |
| PTLE2-- HUMAN TRANSDUCIN-LIKE ENHANCER PROTEIN 2. 94-125 |
| PTLE4-- HUMAN TRANSDUCIN-LIKE ENHANCER PROTEIN 4 (FRAGMENT). |
| 304-331 |
| PTOPA-- HUMAN DNA TOPOISOMERASE II, ALPHA ISOZYME (EC 5.99.1.3). |
| 19-46 503-532 |
| PTOPB-- HUMAN DNA TOPOISOMERASE II, BETA ISOZYME (EC 5.99.1.3). |
| 35-65 616-647 |
| PTPM3-- HUMAN TROPOMYOSIN, FIBROBLAST ISOFORM TM3. 16-74 82-116 |
| PTPMA-- HUMAN TROPOMYOSIN ALPHA CHAIN, SKELETAL MUSCLE. 16-43 |
| 47-74 82-116 147-174 191-237 243-277 |
| PTPMB-- HUMAN TROPOMYOSIN BETA CHAIN, SKELETAL MUSCLE. 37-116 |
| 193-240 |
| PTPMC-- HUMAN TROPOMYOSIN ALPHA CHAIN, CARDIAC MUSCLE. 16-74 |
| 82-116 193-277 |
| PTPMF-- HUMAN TROPOMYOSIN, FIBROBLAST AND EPITHELIAL MUSCLE-TYPE |
| (TM36) (TME1) 37-116 210-240 243-270 |
| PTPMG-- HUMAN TROPOMYOSIN, FIBROBLAST NON-MUSCLE TYPE (TM30PL). |
| 46-80 111-138 158-199 207-234 |
| PTPMI-- HUMAN TROPOMYOSIN, CYTOSKELETAL TYPE (TM30NM). 46-80 |
| 111-138 172-199 |
| PTPMS-- HUMAN TROPOMYOSIN ALPHA CHAIN, SMOOTH MUSCLE (FRAGMENT). |
| 25-59 147-178 |
| PTPP2-- HUMAN TRIPEPTIDYL-PEPTIDASE II (EC 3.4.14.10) (TPP II) |
| (TRIPEPTIDYL 153-187 1004- 1160- |
| 1031 1187 |
| PTPR-- |
| HUMAN TPR ONCOGENE(FRAGMENT). 82-147 PTR36-- |
| HUMAN TREB36 PROTEIN. 18-45 242-269 |
| PTRFR-- HUMAN THYROTROPIN-RELEASING HORMONE RECEPTOR (TRH-R) |
| (THYROLIBERIN 349-383 |
| PTRIC-- |
| HUMAN TROPONIN I, CARDIAC MUSCLE. 36-63 PTRKA-- |
| HUMAN HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR PRECURSOR (EC |
| 2.7.1.112) 66-93 117-148 |
| PTRSR-- HUMAN TRANSFERRIN RECEPTOR PROTEIN (TR) (ANTIGEN CD71) |
| (T9). 188-215 366-393 |
| PTSHR-- HUMAN THYROTROPIN RECEPTOR PRECURSOR (TSH-R). 87-117 |
| 420-447 |
| PTTK-- HUMAN PROTEIN KINASE TKK (EC 2.7.1.-). 170-197 324-359 |
| 510-544 549-583 |
| PTYK2-- HUMAN NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2 (EC |
| 2.7.1.112). 150-177 |
| PUBA1-- HUMAN UBIQUITIN-ACTIVATING ENZYME E1 (A1S9 PROTEIN). |
| 448-475 |
| PUBF1-- HUMAN NUCLEOLAR TRANSCRIPTION FACTOR 1 (UPSTREAM BINDING |
| FACTOR 1) (UBF-1). 227-254 |
| PUDP0-- HUMAN UDP-GLUCURONOSYLTRANSFERASE PRECURSOR, MICROSOMAL |
| (EC 2.4.1.17) 227-254 |
| PUFO-- HUMAN RECEPTOR TYROSINE-PROTEIN KINASE UFO PRECURSOR (EC |
| 2.7.1.112). 488-522 |
| PUSF1-- |
| HUMAN UPSTREAM STIMULATORY FACTOR 1. 251-295 PVATC-- |
| HUMAN VACUOLAR ATP SYNTHASE SUBUNIT C (EC 3.6.1.34) (V-ATPASE C |
| SUBUNIT). 47-74 117-147 |
| PVIL1-- |
| HUMAN VILLIN. 338-372 427-461 717-744 PVIME-- |
| HUMAN VIMENTIN. 119-146 233-260 |
| PVINC-- |
| HUMAN VINCULIN. 108-135 PVPRT-- |
| HUMAN RETROVIRUS-RELATED PROTEASE (EC 3.4.23.-). 95-134 |
| PWEE1-- HUMAN WEE1-LIKE PROTEIN KINASE (EC 2.7.1.112). 354-388 |
| PWT1-- HUMAN WILMS' |
| TUMOR PROTEIN (WT33). 247-274 PXBP1-- HUMAN X BOX |
| BINDING PROTEIN-1 (XBP-1) (TREB5 PROTEIN). 97-135 |
| PXPAC-- HUMAN DNA-REPAIR PROTEIN COMPLEMENTING XP-A CELLS |
| (XERODERMA PIGMENTOSUM 180-211 |
| PXPCC-- HUMAN DNA-REPAIR PROTEIN COMPLEMENTING XP-C CELLS |
| (XERODERMA PIGMENTOSUM 134-168 701-728 |
| PXPDC-- HUMAN DNA-REPAIR PROTEIN COMPLEMENTING XP-D CELLS |
| (XERODERMA PIGMENTOSUM 264-291 |
| PXPGC-- HUMAN DNA-REPAIR PROTEIN COMPLEMENTING XP-G CELLS |
| (XERODERMA PIGMENTOSUM 83-110 715-766 1047- |
| 1081 |
| PXRCC-- |
| HUMAN DNA-REPAIR PROTEIN XRCC1. 23-57 PZN10-- |
| HUMAN ZINC FINGER PROTEIN 10 (ZINC FINGER PROTEIN KOX1) (FRAGMENT). |
| 29-56 |
| PZN40-- HUMAN ZINC FINGER PROTEIN 40 (HUMAN IMMUNODEFICIENCY |
| VIRUS TYPE 1 ENHANCER- 17-62 307-334 1071- 1469- 2013- 2146- |
| 1098 1500 2057 2180 |
| PZN45-- HUMAN ZINC FINGER PROTEIN 45 (BRC1744) (FRAGMENT). 3-30 |
| 201-228 |
| PZN46-- HUMAN ZINC FINGER PROTEIN 46 (ZINC FINGER PROTEIN KUP). |
| 121-149 |
| TABLE X |
| __________________________________________________________________________ |
| Search Results Summary for PCTLZIP, P1CTLZIP, and P2CTLZIP Motifs |
| PCTLZIP P1CTLZIP P2CTLZIP |
| LIBRARY FILE LIBRARY FILE |
| LIBRARY FILE |
| __________________________________________________________________________ |
| PENV-- FOAMV |
| 481-496 PENV-- VIV06 |
| 434-450 PENV-- BIV06 |
| 525-542 |
| PENV-- HV1MA 438-453 PENV-- BIV27 463-479 PENV-- |
| BIV27 554-571 |
| PENV-- HV1MP 183-198 PENV-- FOAMV 481-496 864-880 PENV |
| -- FENV1 |
| 30-47 630- |
| 647 |
| PENV-- HV1RH 445-460 PENV-- HV1KB 752-768 PENV-- |
| FIVPE 781-798 |
| PENV-- HV1SC 186-201 PEVN-- HV1MA 437-453 PENV-- |
| FIVSD 779-796 |
| PENV-- HV1Z2 123-138 PENV-- HV1MP 183-198 PENV-FIVT2 |
| 780-797 |
| PENV-- |
| HV1ZH 438-453 |
| PENV-- |
| HV1RH 444-460 |
| PENV-- |
| FLVC6 38-55 |
| 624- |
| 641 |
| PENV-- HV2BE 750-765 PENV-- HV1S1 738-754 PENV-- |
| FLVGL 605-622 |
| PENV-- HV2D1 741-756 PENV-- HV1SC 186-201 PENV-- |
| FLVLB 625-642 |
| PENV-- HV2G1 741-756 PENV-- HV1Z2 123-138 PENV-- |
| FLVSA 602-619 |
| PENV-- HV2NZ 742-757 PENV-- HV1Z3 117-133 PENV-- |
| FOAMV 710-727 |
| 957- |
| 974 |
| PENV-- HV2RO 751-766 PENV-- HV1ZH 437-453 PENV-- |
| FSVGA 625-642 |
| PENV-- HV2SB 743-758 PENV-- HV2BE 750-765 PENV-- |
| FSVGB 605-622 |
| PENV-- HV2ST 745-760 PENV-- HV2D1 741-756 PENV-- |
| FSVSM 608-625 |
| PENV-- JSRV 104-119 PENV-- HV2G1 741-756 PENV-- |
| HV1OY 123-140 |
| PENV-- MMTVB 618-633 PENV-- HV2NZ 742-757 PENV-- |
| HV1Z2 410-427 |
| PENV-- MMTVG 618-633 PENV-- HV2RO 751-766 PENV-- |
| HV1Z3 154-171 |
| PENV-- SIVMK 139-164 PENV-- HV2SB 743-758 PENV-- |
| HV2CA 750-767 |
| PENV-- SIVML 139-154 PENV-- HV2ST 745-760 PENV-- |
| MCFF 600-617 |
| PHEMA-- |
| CVBLY 391-406 |
| PENV-- |
| JSRV 104-119 |
| 541-557 |
| PENV-- |
| MCFF3 601-618 |
| PHEMA-- CVBM 391-406 PENV-- MCFF 397-413 PENV-- |
| MLVAV 630-647 |
| PHEMA-- CVBQ 391-406 PENV-- MCFF3 397-413 PENV-- |
| MLVCB 625-642 |
| PHEMA-- CVHOC 391-406 PENV-- MLVAV 427-443 PENV-- |
| MLVF5 639-656 |
| PHEMA-- CVMA5 402-417 PENV-- MLVCB 422-438 PENV-- |
| MLVFF 639-656 |
| PHEMA-- CVMS 403-416 PENV-- MLVHO 423-439 PENV-- |
| MLVFP 639-656 |
| PHEMA-- INBAA 295-310 PENV-- MLVMO 426-442 PENV-- |
| MLVHO 626-643 |
| PHEMA-- INBBE 303-318 PENV-- MLVRD 424-440 PENV-- |
| MLVKI 167-184 |
| PHEMA-- INBBO 293-308 PENV-- MLVRK 424-440 PENV-- |
| MLVMO 629-646 |
| PHEMA-- INBEN 301-316 PENV-- MMTVB 618-633 PENV-- |
| MLVRD 624-641 |
| PHEMA-- INBFU 286-301 PENV-- MMTVG 618-633 PENV-- |
| MLVRK 624-641 |
| PHEMA-- INBGL 296-311 PENV-- SFV1 864-880 PENV-- |
| MSVFB 170-187 |
| PHEMA-- INBHK 293-308 PENV-- SFV3L 861-877 PENV-- |
| RMCFV 603-620 |
| PHEMA-- INBIB 288-303 PENV-- SIVGB 93-109 PENV-- |
| SFV1 710-727 |
| 957- |
| 974 |
| PHEMA-- INBID 299-314 PENV-- SIVMK 139-154 802-818 |
| PENV-- |
| SFV3L 707-724 |
| 954- |
| 971 |
| PHEMA-- INBLE 302-317 PENV-- SIVML 139-154 801-817 |
| PENV-- |
| SIVM1 766-783 |
| PHEMA-- INBMD 292-307 PENV-- SIVS4 806-822 PENV-- |
| SIVMK 765-782 |
| PHEMA-- INBME 296-311 PENV-- SIVSP 810-826 PENV-- |
| SIVML 764-781 |
| PHEMA-- INBNA 288-303 PHEMA-- CDVO 36-52 PENV-- |
| SIVS4 769-786 |
| PHEMA-- INBOR 301-316 PHEMA-- CVBLY 391-406 PENV-- |
| SIVSP 773-790 |
| PHEMA-- INBSI 301-316 PHEMA-- CVBM 391-406 PENV-- |
| SMRVH 536-553 |
| PHEMA-- INBSJ 298-313 PHEMA-- CVBQ 391-406 PENV-- |
| SMSAV 42-59 |
| PHEMA-- |
| INBUS 294-309 |
| PHEMA-- |
| CVHOC 391-406 |
| PHEMA- |
| - CDVO 36-53 |
| 200- |
| 217 |
| PHEMA-- INBVI 296-311 PHEMA-- CVMA5 402-417 PHEMA-- |
| CVBLY 391-408 |
| PHEMA-- INBVK 303-318 PHEMA-- CVMS 403-418 PHEMA-- |
| CVBM 391-408 |
| PHEMA-- |
| INBYB 286-301 |
| PHEMA-- |
| IAAIC 237-253 |
| PHEMA- |
| - CVBO |
| 391-408 |
| PHEMA-- |
| MUMPM 133-148 |
| PHEMA-- |
| IABAN 221-237 |
| PHEMA- |
| - CVHOC |
| 391-408 |
| PHEMA-- |
| MUMPR 133-148 |
| PHEMA-- |
| IABUD 234-250 |
| PHEMA- |
| - IAAIC |
| 322-339 |
| PHEMA-- |
| MUMPS 133-148 |
| PHEMA-- |
| IACKA 234-250 |
| PHEMA- |
| - IABAN |
| 306-323 |
| PHEMA-- |
| PI1HW 345-360 |
| PHEMA-- |
| IACKG 231-247 |
| PHEMA- |
| - IABUD |
| 320-337 |
| PHEMA-- |
| PI2H 65-80 |
| PHEMA-- |
| IACKV 230-246 |
| PHEMA- |
| - IACKA |
| 320-337 |
| PHEMA-- |
| PI2HT 65-80 |
| PHEMA-- |
| IADA1 234-250 |
| PHEMA- |
| - IACKG |
| 316-333 |
| PHEMA-- |
| RINDK 368-383 |
| PHEMA-- |
| IADA3 237-253 |
| PHEMA- |
| - IACKP |
| 302-319 |
| PHEMA-- |
| SV5 7-94 |
| PHEMA-- |
| IADCZ 234-250 |
| PHEMA- |
| - IACKQ |
| 302-319 |
| PHEMA-- |
| SV5CM 7-94 |
| PHEMA-- |
| IADH1 221-237 |
| PHEMA- |
| - IACKS |
| 319-336 |
| PHEMA-- |
| SV5CP 7-94 |
| PHEMA-- |
| IADH2 221-237 |
| PHEMA- |
| - IACKV |
| 315-332 |
| PHEMA-- |
| SV5LN 7-94 |
| PHEMA-- |
| IADH3 221-237 |
| PHEMA- |
| - IADA1 |
| 320-337 |
| PVENV-- |
| DHVI1 42-57 |
| PHEMA-- |
| IADH4 221-237 |
| PHEMA- |
| - IADA3 |
| 322-339 |
| PVFP7-- |
| CAPVK 89-104 |
| PHEMA-- |
| IADH5 221-237 |
| PHEMA- |
| - IADCZ |
| 320-337 |
| PVFUS-- |
| VACC6 72-87 |
| PHEMA-- |
| IADH6 221-237 |
| PHEMA- |
| - IADH1 |
| 306-323 |
| PVG01-- |
| BPP22 242-257 |
| PHEMA-- |
| IADH7 221-237 |
| PHEMA- |
| - IADH2 |
| 306-323 |
| PVG01-- |
| HSVEB 169-184 |
| PHEMA-- |
| IADM2 237-253 |
| PHEMA- |
| - IADH3 |
| 306-323 |
| PVG01-- |
| HSVI1 210-225 |
| 317- PHEMA.sub |
| .-- IADNZ |
| 234-250 |
| PHEMA-- |
| IADH4 306-323 |
| 332 |
| PVG06-- BPT4 184-199 PHEMA-- IAEN6 221-237 PHEMA-- |
| IADH6 306-323 |
| PVG07-- BPT4 885-900 PHEMA-- IAEN7 237-253 PHEMA-- |
| IADH7 306-323 |
| PVG08-- HSVI1 134-149 PHEMA-- IAFPR 230-246 PHEMA-- |
| IADM2 322-339 |
| PVG10-- BPPH2 183-198 PHEMA-- IAHAL 236-252 PHEMA-- |
| IADNZ 320-337 |
| PVG10-- BPPZA 183-198 PHEMA-- IAHAR 235-251 PHEMA-- |
| IADU3 322-339 |
| PVG10-- HSVSA 109-124 PHEMA-- IAHC6 230-246 PHEMA-- |
| IAEN6 306-323 |
| PVG16-- BPP1 81-96 PHEMA-- IAHC7 230-246 PHEMA-- |
| IAEN7 322-339 |
| PVG18-- BPT4 468-483 PHEMA-- IAHCD 230-246 PHEMA-- |
| IAFPR 315-332 |
| PVG25-- BPT4 97-112 PHEMA-- IAHDE 230-246 PHEMA-- |
| IAGRE 320-337 |
| PVG29-- HSVI1 20-35 PHEMA-- IAHFO 236-252 PHEMA-- |
| IAGU2 320-337 |
| PVG30-- BPPH8 11-94 PHEMA-- IAHK6 236-252 PHEMA-- |
| IAGUA 319-336 |
| PVG36-- BPOX2 22-37 PHEMA-- IAHK7 236-252 PHEMA-- |
| IAHAL 321-338 |
| PVG36-- HSVSA 108-123 PHEMA-- IAHLE 230-246 PHEMA-- |
| IAHC6 315-332 |
| PVG37-- BPT2 1253- PHEMA-- IAHLO 230-246 PHEMA-- |
| IAHC7 315-332 |
| 1268 |
| PVG37-- HSVI1 284-299 PHEMA-- IAHMI 236-252 PHEMA-- |
| IAHCD 315-332 |
| PVG55-- HSVI1 22-37 143- PHEMA-- IAHNM 236-252 PHEMA-- |
| IAHDE |
| 315-332 |
| 158 |
| PVG56-- |
| HSVI1 268-283 |
| PHEMA-- |
| IAHRO 236-252 |
| PHEMA- |
| - IAHFO |
| 321-338 |
| PVG58-- |
| HSVI1 102-117 |
| PHEMA-- |
| IAHSA 236-252 |
| PHEMA- |
| - IAHK6 |
| 321-338 |
| PVG59-- |
| HSVI1 267-282 |
| PHEMA-- |
| IAHSP 230-246 |
| PHEMA- |
| - IAHK7 |
| 321-338 |
| PVG65-- |
| HSVI1 518-533 |
| PHEMA-- |
| IAHSW 230-246 |
| PHEMA- |
| - IAHLE |
| 315-332 |
| PVG9-- |
| BPPH2 234-249 |
| PHEMA-- |
| IAHTE 236-252 |
| PHEMA- |
| - IAHLO |
| 315-332 |
| PVG9-- |
| BPPZA 234-249 |
| PHEMA-- |
| IAHTO 236-252 |
| PHEMA- |
| - IAHMI |
| 321-336 |
| PVG9-- |
| SPV1R 57-72 |
| PHEMA-- |
| IAHUR 236-252 |
| PHEMA- |
| - IAHNM |
| 321-338 |
| PVGF-- |
| BPPHX 234-249 |
| PHEMA-- |
| IAKIE 235-251 |
| PHEMA- |
| - IAHNN |
| 315-332 |
| PVGL2-- |
| CVBF 264-279 |
| PHEMA-- |
| IALEN 235-251 |
| PHEMA- |
| - IAHPR |
| 315-332 |
| PVGL2-- |
| CVBL9 264-279 |
| PHEMA-- |
| IAMAA 233-249 |
| PHEMA- |
| - IAHRO |
| 321-338 |
| PVGL2-- |
| CVBLY 264-279 |
| PHEMA-- |
| IAMAB 238-254 |
| PHEMA- |
| - IAHSA |
| 321-338 |
| PVGL2-- |
| CVBM 264-279 |
| PHEMA-- |
| IAMAO 237-253 |
| PHEMA- |
| - IAHSP |
| 315-332 |
| PVGL2-- |
| CVBQ 264-279 |
| PHEMA-- |
| IAME1 237-253 |
| PHEMA- |
| - IAHSW |
| 315-332 |
| PVGL2-- |
| CVBV 264-279 |
| PHEMA-- |
| IAME2 237-253 |
| PHEMA- |
| - IAHTE |
| 321-338 |
| PVGL2-- |
| CVPFS 442-457 |
| PHEMA-- |
| IAME6 221-237 |
| PHEMA- |
| - IAHTO |
| 321-338 |
| PVGL2-- |
| CVPPU 440-455 |
| 504- PHEMA.sub |
| .-- IAMIN |
| 85-101 |
| 231-247 |
| PHEMA-- |
| IAHUR 321-338 |
| 519 |
| PVGL2-- CVPR8 218-233 PHEMA-- IANT6 237-253 PHEMA-- |
| IAJAP 317-334 |
| PVGL2-- CVPRM 218-233 PHEMA-- IAQU7 221-237 PHEMA-- |
| IAMAA 319-336 |
| PVGL2-- IBV6 1056- PHEMA-- IARUD 234-250 PHEMA-- |
| IAMAB 324-341 |
| 1071 |
| PVGL2-- IBVB 1055- PHEMA-- IASE2 234-250 PHEMA-- |
| IAMAO 322-339 |
| 1070 |
| PVGL2-- IBVD2 1056- PHEMA-- IASH2 234-250 PHEMA-- |
| IAME1 322-339 |
| 1071 |
| PVGL2-- IBVK 1055- PHEMA-- IASTA 230-246 PHEMA-- |
| IAME2 322-339 |
| 1070 |
| PVGL2-- IBVM 1055- PHEMA-- IATAI 235-251 PHEMA-- |
| IAME6 306-323 |
| 1070 |
| PVGLB-- HSVSA 701-716 PHEMA-- IATKM 234-250 PHEMA-- |
| IAMIN 316-333 |
| PVGLB-- PRVIF 203-216 PHEMA-- IATKO 233-249 PHEMA-- |
| IANT6 322-339 |
| PVGLC-- HSVBC 475-490 PHEMA-- IATKR 230-246 PHEMA-- |
| IAPIL 320-337 |
| PVGLC-- HSVE4 444-459 PHEMA-- IATKW 229-245 PHEMA-- |
| IAQU7 306-323 |
| PVGLC-- HSVEB 427-442 PHEMA-- IAUDO 237-253 PHEMA-- |
| IARUD 320-337 |
| PVGLC-- PRVIF 446-461 PHEMA-- IAUSS 235-251 PHEMA-- |
| IASE2 320-337 |
| PVGLD-- HSV11 79-94 PHEMA-- IAVI7 238-254 PHEMA-- |
| IASH2 321-338 |
| PVGLD-- HSV2 79-94 PHEMA-- IAXIA 235-251 PHEMA-- |
| IASTA 315-332 |
| PVGLF-- BRSVA 265-280 PHEMA-- IAZCO 237-253 PHEMA-- |
| IATKM 320-337 |
| PVGLF-- BRSVC 265-280 PHEMA-- IAZH2 221-237 PHEMA-- |
| IAUDO 322-339 |
| 380- |
| 397 |
| PVGLF-- BRSVR 265-280 PHEMA-- IAZH3 221-237 PHEMA-- |
| IAVI7 323-340 |
| PVGLF-- HRSV1 265-280 PHEMA-- IAZUK 237-253 PHEMA-- |
| IAZCO 322-339 |
| PVGLF-- HRSVA 265-280 PHEMA-- INBAA 115-131 295-310 |
| PHEMA-- |
| IAZH2 306-323 |
| PVGLF-- HRSVL 265-280 PHEMA-- INBBE 123-139 303-318 |
| PHEMA-- |
| IAZH3 306-323 |
| PVGLF-- HRSVR 265-280 PHEMA-- INBBO 116-132 293-308 |
| PHEMA-- |
| IAZUK 322-339 |
| PVGLF-- MUMPS 5-94 PHEMA-- INBEN 123-139 301-316 PHEMA |
| -- MUMPM |
| 101-118 |
| PVGLI-- |
| VZVD 278-293 |
| PHEMA-- |
| INBFU 108-124 |
| 288-301 |
| PHEMA-- |
| MUMPR 101-118 |
| PVGLM-- HANTB 900-915 PHEMA-- INBGL 119-135 296-311 |
| PHEMA-- |
| MUMPS 101-118 |
| PVGLM-- PTPV 743-758 PHEMA-- INBHK 116-132 293-308 |
| PHEMA-- |
| NDVA 93-110 |
| PVGLM-- |
| SEOUR 901-916 |
| PHEMA-- |
| INBIB 108-124 |
| 288-303 |
| PHEMA-- |
| NDVB 93-110 |
| PVGLM-- |
| SEOUS 900-915 |
| PHEMA-- |
| INBID 120-136 |
| 299-314 |
| PHEMA-- |
| NDVD 93-110 |
| PVGLY-- |
| LASSG 426-441 |
| PHEMA-- |
| INBLE 123-139 |
| 302-317 |
| PHEMA-- |
| NDVH 93-110 |
| PVGLY-- |
| LASSJ 427-442 |
| PHEMA-- |
| INBMD 113-129 |
| 292-307 |
| PHEMA-- |
| NDVI 93-110 |
| PVGLY-- |
| MOPEI 425-440 |
| PHEMA-- |
| INBME 116-132 |
| 296-311 |
| PHEMA-- |
| NDVM 93-110 |
| PVM3-- |
| REOVD 521-536 |
| PHEMA-- |
| INBNA 108-124 |
| 288-303 |
| PHEMA-- |
| NDVQ 93-110 |
| PVMSA-- |
| HPBGS 380-395 |
| PHEMA-- |
| INBOR 123-139 |
| 301-316 |
| PHEMA-- |
| NDVTG 93-110 |
| PVMSA-- |
| HPBV9 187-202 |
| PHEMA-- |
| INBBI 123-139 |
| 301-316 |
| PHEMA-- |
| NDVU 93-110 |
| PVMSA-- |
| WHV1 378-393 |
| PHEMA-- |
| INBSJ 119-135 |
| 298-313 |
| PHEMA-- |
| PHODV 36-53 |
| PVMSA-- |
| WHV59 383-398 |
| PHEMA-- |
| INBUS 116-132 |
| 294-309 |
| PHEMA-- |
| PI1HW 486-503 |
| PVMSA-- WHV7 383-398 PHEMA-- INBVI 116-132 296-311 |
| PHEMA-- |
| PI3B 111-128 |
| PVMSA-- |
| WHV8 383-398 |
| PHEMA-- |
| INBVK 123-139 |
| 303-318 |
| PHEMA-- |
| PI3H4 111-128 |
| PVMSA-- WHV8I 383-398 PHEMA-- INBYB 108-124 288-301 |
| PHEMA-- |
| PI3HA 111-128 |
| PVMSA-- WHVW6 234-249 PHEMA-- MUMPM 133-148 PHEMA-- |
| PI3HT 111-128 |
| PVMT2-- IAANN 25-40 PHEMA-- MUMPR 133-148 PHEMA-- |
| PI3HU 111-128 |
| PVMT2-- IABAN 25-40 PHEMA-- MUMPS 133-148 PHEMA-- |
| PI3HV 111-128 |
| PVMT2-- IAFOW 25-40 PHEMA-- PI1HW 345-360 PHEMA-- |
| PI3HW 111-128 |
| PVMT2-- IAFPR 25-40 PHEMA-- PI2H 65-81 PHEMA-- PI3HX |
| 111-128 |
| PVMT2-- |
| IAFPW 25-40 |
| PHEMA-- |
| PI2HT 65-81 |
| PHEMA-- |
| PI4HA 50-67 |
| PVMT2-- |
| IALE1 25-40 |
| PHEMA-- |
| PI3B 324-340 |
| PHEMA-- |
| SV41 85-102 |
| PVMT2-- |
| IALE2 25-40 |
| PHEMA-- |
| PI3H4 324-340 |
| PHEMA- |
| - SV5 84-101 |
| PVMT2-- |
| IAMAN 25-40 |
| PHEMA-- |
| PI3HA 324-340 |
| PHEMA- |
| - SV5CM |
| 64-101 |
| PVMT2-- |
| IAPUE 25-40 |
| PHEMA-- |
| PI3HT 324-340 |
| PHEMA- |
| - SV5CP |
| 84-101 |
| PVMT2-- |
| IASIN 25-40 |
| PHEMA-- |
| PI3HU 324-340 |
| PHEMA- |
| - SV5LN |
| 84-101 |
| PVMT2-- |
| IAUDO 25-40 |
| PHEMA-- |
| PI3HV 324-340 |
| PVFO5- |
| - VACC |
| 280-297 |
| PVMT2-- |
| IAWIL 25-40 |
| PHEMA-- |
| PI3HW 324-340 |
| PVFO5- |
| - VACCP |
| 280-297 |
| PVMT9-- |
| MYXVL 226-241 |
| PHEMA-- |
| PI3HX 324-340 |
| PVFO5- |
| - VACCV |
| 281-298 |
| PHEMA |
| -- RINDK |
| 368-383 |
| PVFO9-- |
| VACCC 176-193 |
| PHEMA-- SV5 7-94 PVFO9-- VACCV 176-193 |
| PHEMA-- SV5CM 7-94 PVG27-- HSVSA 209-226 |
| PHEMA-- SV5CP 7-94 PVG28-- HSVI1 173-190 |
| PHEMA-- SV5LN 7-94 PVG39-- HSVI1 648-665 |
| PVENV-- DHVI1 42-57 PVG43-- HSVI1 109-126 521- |
| 538 |
| PVENV-- EAV 25-41 PVG67-- HSVI1 171-188 |
| PVFP2-- FOWPV 88-104 PVG72-- HSVI1 1252- |
| 1269 |
| PVFP7-- CAPVK 89-104 PVGF1-- IBVB 3073- |
| 3090 |
| PVFUS-- VACC6 72-87 PVGL2-- IBV6 1094- |
| 1111 |
| PVG01-- HSVEB 169-184 PVGLB-- HSVE1 736-753 |
| PVG01-- HSVI1 209-225 317-332 PVGLB-- HSVE4 675-692 |
| PVG08 |
| -- HSVI1 |
| 134-149 |
| PVGLB-- |
| HSVEA 736-753 |
| PVG10-- HSVSA 109-124 PVGLB-- HSVEB 736-753 |
| PVG11-- HSVI1 103-119 PVGLB-- HSVEL 736-753 |
| PVG12-- HSVI1 270-286 PVGLB-- ILTV6 597-614 |
| PVG1-- SPV1R 76-92 PVGLB-- ILTVS 607-624 |
| PVG29-- HSVI1 20-35 PVGLB-- ILTVT 607-624 |
| PVG86-- BPOX2 22-37 PVGLC-- PRVIF 180-197 |
| PVG36-- HSVSA 108-123 PVGLE-- VZVD 469-486 |
| PVG37-- HSVI1 284-299 PVGLF-- SV5 401-418 |
| PVG41-- HSVI1 244-260 PVGLH-- HCMVA 365-382 |
| PVG46-- HSVI1 1244- PVGLH-- HCMVT 364-381 |
| 1260 |
| PVG55-- HSVI1 22-37 143-158 PVGLH-- HSV11 245-262 803- |
| 820 |
| PVG56-- HSVI1 268-283 PVGLH-- HSV1E 245-262 803- |
| 820 |
| PVG58-- HSVI1 101-117 PVGLI-- HSV11 43-60 |
| PVG58-- HSVSA 130-146 330-346 PVGLM-- BUNL7 81-98 |
| PVG59 |
| -- HSVI1 |
| 267-282 |
| PVGLM-- |
| BUNSH 81-98 |
| PVG65 |
| -- HSVI1 |
| 362-378 |
| 518-533 |
| PVGLM-- |
| PUUMH 712-729 |
| PVG71-- HSVSA 89-105 PVGLM-- PUUMS 712-729 |
| PVG9-- BPPH2 234-249 PVGLM-- RVFV 344-361 |
| PVG9-- BPPZA 234-249 PVGLM-- RVFVZ 344-361 |
| PVG9-- SPV1R 57-72 PVGLY-- LASSG 12-94 |
| PVGF1-- IBVB 2210- PVGLY-- LASSJ 12-94 |
| 2226 |
| PVGL2-- CVBF 123-139 174-190 264-279 PVGLY-- LYCVA 12-94 |
| PVGL2 |
| -- CVBL9 |
| 123-139 |
| 174-190 |
| 264-279 |
| PVGLY-- |
| LYCVW 12-94 |
| PVGL2 |
| -- CVBLY |
| 123-139 |
| 174-190 |
| 264-279 |
| PVGLY-- |
| MOPEI 12-94 |
| PVGL2 |
| -- CVBM |
| 123-139 |
| 174-190 |
| 264-279 |
| PVM1-- |
| REOVD 280-297 |
| PVGL2-- CVBQ 31-47 123-139 174-190 264- PVM1-- REOVL |
| 280-297 |
| 279 |
| PVGL2 |
| -- CVBV |
| 123-139 |
| 174-190 |
| 264-279 |
| PVMAT-- |
| CDVO 148-165 |
| PVGL2 |
| -- CVM4 |
| 95-111 1267- |
| PVMAT-- |
| MEASI 87-104 |
| 1283 |
| PVGL2 |
| -- CVMA5 |
| 95-111 1215- |
| PVMP-- |
| CAMVC 147-164 |
| 1231 |
| PVGL2-- CVMJH 95-111 1126- PVMP-- CAMVD 147-164 |
| 1142 |
| PVGL2-- CVPFS 442-457 800-816 1274- PVMP-- CAMVE 147-164 |
| 1290 |
| PVGL2 |
| -- CVPPU |
| 440-455 |
| 504-519 |
| 798-814 1272- |
| PVMP-- |
| CAMVN 147-164 |
| 1288 |
| PVGL2-- CVPRS 218-233 576-592 1050- PVMP-- CAMVS 147-164 |
| 1066 |
| PVGL2 |
| -- CVPRM |
| 218-233 |
| 576-592 1050- |
| PVMP-- |
| CAMVW 147-164 |
| 1066 |
| PVGL2-- FIPV 803-819 1277- PVMSA-- HPBVO 11-94 |
| 1293 |
| PVGL2-- IBV6 1056- PVMSA-- HPBV2 185-202 |
| 1071 |
| PVGL2-- IBVB 1055- PVMSA-- HPBV4 185-202 |
| 1070 |
| PVGL2-- IBVD2 1056- PVMBA-- HPBVA 174-191 |
| 1071 |
| PVGL2-- IBVK 1055- PVMSA-- HPBVD 11-94 |
| 1070 |
| PVGL2-- IBVM 1055- PVMBA-- HPBVJ 174-191 |
| 1070 |
| PVGLB-- HSVSA 701-716 PVMSA-- HPBVL 174-191 |
| PVGLB-- PRVIF 203-218 PVMSA-- HPBVN 11-94 |
| PVGLB-- VZVD 522-538 PVMSA-- HPBVO 174-191 |
| PVGLC-- HSVBC 475-490 PVMSA-- HPBVP 185-202 |
| PVGLC-- HSVE4 444-459 PVMSA-- HPBVR 185-202 |
| PVGLC-- HBVEB 427-442 PVMSA-- HPBVS 11-94 |
| PVGLC-- PRVIF 446-461 PVMSA-- HPBVW 174-191 |
| PVGLC-- VZVD 150-166 PVMSA-- HPBVY 174-191 |
| PVGLC-- VZVS 150-166 PVMSA-- HPBVZ 174-191 |
| PVGLD-- HSV11 79-94 PVMT2-- IAANN 25-42 |
| PVGLD-- HSV2 79-94 PVMT2-- IABAN 25-42 |
| PVGLE-- PRVRI 3-94 PVMT2-- IAFOW 25-42 |
| PVGLF-- BRSVA 205-221 265-280 PVMT2-- IAFPR 25-42 |
| PVGLF |
| -- BRSVC |
| 205-221 |
| 265-280 |
| PVMT2-- |
| IAFPW 25-42 |
| PVGLF |
| -- BRSVR |
| 205-221 |
| 265-280 |
| PVMT2-- |
| IALE1 25-42 |
| PVGLF |
| -- CDVO |
| 398-414 |
| PVMT2-- |
| IALE2 25-42 |
| PVGLF |
| -- HRSV1 |
| 205-221 |
| 265-280 |
| PVMT2-- |
| IAMAN 25-42 |
| PVGLF |
| -- HRSVA |
| 205-221 |
| 265-280 |
| FVMT2-- |
| IAPUE 25-42 |
| PVGLF |
| -- HRSVL |
| 205-221 |
| 265-280 |
| PVMT2-- |
| IASIN 25-42 |
| PVGLF |
| -- HRSVR |
| 205-221 |
| 265-280 |
| PVMT2-- |
| IAUDO 25-42 |
| PVGLF |
| -- MEASE |
| 286-302 |
| PVMT2-- |
| IAWIL 25-42 |
| PVGLF |
| -- MEASI |
| 289-305 |
| PVGLF |
| -- MEASY |
| 286-302 |
| PVGLF |
| -- MUMPM |
| 276-292 |
| PVGLF |
| -- MUMPR |
| 276-292 |
| PVGLF |
| -- MUMPS 5-94 |
| 276-292 |
| PVGLF |
| -- NDVA |
| 273-289 |
| PVGLF |
| -- NDVB |
| 273-289 |
| PVGLF |
| -- NDVT |
| 273-289 |
| PVGLF |
| -- NDVTG |
| 273-289 |
| PVGLF |
| -- NDVU |
| 273-289 |
| PVGLF |
| -- PHODV |
| 269-285 |
| 367-383 |
| PVGLF |
| -- RINDK |
| 282-298 |
| PVGLF |
| -- RINDL |
| 282-298 |
| PVGLF |
| -- TRTV |
| 175-191 |
| PVGLI |
| -- VZVD |
| 278-293 |
| PVGLM |
| -- HANTB |
| 355-371 |
| 900-915 |
| PVGLM |
| -- HANTH |
| 499-515 |
| PVGLM |
| -- HANTL |
| 499-515 |
| PVGLM |
| -- HANTV |
| 499-515 |
| PVGLM |
| -- PTPV |
| 743-758 |
| PVGLM |
| -- PUUMH |
| 509-525 |
| PVGLM |
| -- PUUMS |
| 509-525 |
| PVGLM |
| -- SEOUR |
| 355-371 |
| 901-916 |
| PVGLM |
| -- SEOUS |
| 355-371 |
| 900-916 |
| PVGLM |
| -- UUK |
| 826-842 |
| PVGLP |
| -- BEV |
| 869-885 |
| PVGLY |
| -- LASSG |
| 12-94 426-441 |
| PVGLY-- LASSJ 12-94 427-442 |
| PVGLY-- LYCVA 12-94 |
| PVGLY-- LYCVW 12-94 |
| PVGLY-- MOPEI 12-94 425-440 |
| PVGLY-- PIARV 12-94 |
| PVGNM-- CPMV 1021- |
| 1037 |
| PVM3-- REOVD 521-536 |
| PVMAT-- MUMPS 191-207 |
| PVMAT-- NDVA 135-151 |
| PVMAT-- NDVB 135-151 |
| PVMAT-- PI2HT 189-205 |
| PVMAT-- SV41 189-205 |
| PVMAT-- SV5 98-114 132-148 |
| PVMP-- CAMVC 118-134 |
| PVMP-- CAMVD 118-134 |
| PVMP-- CAMVE 118-134 |
| PVMP-- CAMVN 118-134 |
| PVMP-- CAMVS 118-134 |
| PVMP-- CAMVW 118-134 |
| PVMP-- FMVD 115-131 |
| PVMSA-- HPBGS 380-395 |
| PVMSA-- HPBV9 187-202 |
| PVMSA-- WHV1 378-393 |
| PVMSA-- WHV59 383-398 |
| PVMSA-- WHV7 383-398 |
| PVMSA-- WHV8 383-398 |
| PVMSA-- WHV8I 383-398 |
| PVMSA-- WHVW6 234-249 |
| PVMT2-- IAANN 25-40 |
| PVMT2-- IABAN 25-40 |
| PVMT2-- IAFOW 25-40 |
| PVMT2-- IAFPR 25-40 |
| PVMT2-- IAFPW 25-40 |
| PVMT2-- IALE1 25-40 |
| PVMT2-- IALE2 25-40 |
| PVMT2-- IAMAN 25-40 |
| PVMT2-- IAPUE 25-40 |
| PVMT2-- IASIN 25-40 |
| PVMT2-- IAUDO 25-40 |
| PVMT2-- IAWIL 25-40 |
| PVMT9-- MYXVL 226-241 |
| __________________________________________________________________________ |
| TABLE XI |
| - Search Results Summary for P3CTLZIP, P4CTLZIP, P5CTLZIP, and |
| P6CTLZIP Motifs |
| P3CTLZIP P4CTLZIP P5CTLZIP P6CTLZIP |
| LIBRARY FILE LIBRARY FILE LIBRARY FILE LIBRARY FILE |
| PENV-- BIV27 147-165 PENV1-- FRSFV 380-399 PENV1-- |
| FRSFV 380-400 PEVN-- |
| BIV06 47-68 525-546 PENV-- CAEVC |
| 810-828 PENV-- AVISU 98-117 PENV2-- |
| FRSFV 380-400 PENV-- |
| BIV27 47-68 147-168 564-575 PENV-- CAEVG 808-826 |
| PENV-- BIV27 147-166 PENV-- BAEVM 170-190 PENV-- |
| FENV1 225-246 630-651 |
| PENV-- HV2BE 750-768 PENV-- HV1ZH 123-142 PENV-- |
| FIVPE 781-801 PENV-- |
| FLVC6 624-645 PENV-- HV2D1 |
| 741-759 PENV-- HV2D2 9-29 PENV-- FIVSD 779-799 PENV-- |
| FLVGL 447-468 605-626 |
| PENV-- HV2G1 741-759 PENV-- HV2SB 778-797 PENV-- |
| FIVT2 780-800 PENV-- |
| FLVLB 467-488 625-646 PENV-- HV2NZ |
| 742-760 PENV-- JSRV 541-560 PENV-- FLVGL 9-29 PENV-- |
| FLVSA 444-465 602-623 |
| PENV-- HV2RO 751-769 PENV-- RSVP 533-552 PENV-- FOAMV |
| 255-275 924-944 PENV-- |
| FOAMV 153-174 957-978 PENV-- HV2SB 743-761 |
| PHEMA-- VACCC 173-192 PENV-- FSVGA 9-29 PENV-- FSVGB |
| 447-468 605-626 |
| PENV-- HV2ST 745-763 PHEMA-- VACCI 173-192 PENV-- |
| HV1C4 428-448 PENV-- |
| FSVGB 447-468 605-626 PENV-- JSRV 376-394 |
| PHEMA-- VACCT 173-192 PENV-- HV2CA 750-770 PENV-- |
| FSVSM 450-471 608-629 |
| PHEMA-- PI2H 118-136 PHEMA-- VACCV 173-192 PENV-- |
| MLVF5 400-420 PENV-- |
| FSVST 467-488 PHEMA-- PI2HT |
| 118-136 PHEMA-- BEV 62-81 PENV-- MMTVB 643-663 PENV-- |
| GALV 52-73 519-540 |
| PHEMA-- SV41 55-73 PVENV-- MCV1 61-80 PENV-- MMTVG |
| 643-663 PENV-- |
| HV2BE 750-771 PVENV-- THOGV |
| 473-491 PVENV-- MCV2 61-80 PENV-- OMVVS 75-95 PENV-- |
| HV2G1 741-702 |
| PVG16-- BPP22 83-101 PVFUS-- ORFNZ 29-48 PENV-- RSVP |
| 42-62 PENV-- |
| HV2NZ 742-763 PVG24-- BPT4 |
| 115-133 PVG01-- HSVEB 169-188 PENV-- |
| SFV1 924-944 PENV-- |
| HV2RO 751-772 PVG36-- HSVSA |
| 344-362 PVG01-- VACCC 276-395 PENV-- |
| SFV3L 921-941 PENV-- |
| HV2ST 745-766 PVG40-- HSVI1 14-32 |
| PVG01-- VACCV 315-334 PENV-- SIVM1 766-766 PENV-- |
| MCFF 600-621 |
| PVG50-- HSVSA 5-94 PVG01-- VARV 376-395 PENV-- SIVMK |
| 765-785 PENV-- |
| MCFF3 601-622 PVG51-- BPT4 |
| 63-81 PVG06-- BPT4 627-646 PENV-- SIVML 764-784 PENV-- |
| MLVAV 630-651 |
| PVG51-- HSVI1 84-102 PVG10-- HSVI1 35-54 PENV-- SIVS4 |
| 769-789 PENV-- |
| MLVCB 625-646 PVG65-- HSVI1 |
| 155-173 PVG11-- HSVI1 103-122 150-169 PENV-- SIVSP 773-793 |
| PENV-- |
| MLVF5 639-660 PVGF1 |
| -- IBVB 2788-2806 3374-3392 PVG1-- BPPH2 31-50 PHEMA-- CDVO |
| 493-513 PENV-- |
| MLVFF 639-660 PVGL2-- CVH22 |
| 1053-1071 PVG1-- SPV1R 659-678 PHEMA-- CVBLY 391-411 |
| PENV-- |
| MLVFP 639-660 PVGL2 |
| -- IBV6 1058-1074 PVG20-- BPT4 231-250 PHEMA-- CVBM 391-411 |
| PENV-- |
| MLVHO 626-647 PVGL2-- |
| IBVB 1055-1073 PVG32-- VZVD 90-109 PHEMA-- CVBQ 391-411 |
| PENV-- |
| MLVKI 167-188 PVGL2 |
| -- IBVD2 1056-1074 PVG36-- BPK3 132-151 PHEMA-- CVHOC |
| 391-411 PENV-- |
| MLVMO 629-650 PVGL2-- IBVK |
| 1055-1073 PVG37-- BPT2 19-38 629-648 PHEMA-- CVMA5 402-422 |
| PENV-- |
| MLVRD 624-645 PVGL2 |
| -- IBVM 1055-1073 PVG37-- BPT4 19-38 625-644 PHEMA-- IACKG |
| 81-101 PENV-- |
| MLVRK 624-645 PVGLB-- |
| HSVB1 560-578 689-707 PVG39-- HSVI1 1038-1057 PHEMA-- IADMA |
| 81-101 PENV-- |
| MSVFB 170-191 PVGLB-- |
| HSVBC 692-710 PVG41-- HSVI1 62-81 PHEMA-- MUMPM 397-417 |
| PENV-- |
| RMCFV 603-624 PVGLB |
| -- HSVSA 584-602 PVG43-- BPPF3 380-399 PHEMA-- MUMPR |
| 397-417 PENV-- |
| SFV1 957-978 PVGLB-- ILTV6 |
| 740-758 PVG46-- BPPF1 337-356 PHEMA-- MUMPS 397-417 |
| PENV-- |
| SFV3L 157-178 954-976 PVGLB |
| -- ILTVS 750-768 PVG59-- HSVI1 142-161 PHEMA-- PHODV |
| 493-513 PENV-- |
| SIVA1 437-458 PVGLB-- ILTVT |
| 750-768 PVG61-- HSVI1 117-136 PHEMA-- PI1HW 322-342 |
| PENV-- |
| SIVAG 442-463 PVGLC |
| -- VZVD 431-449 PVG67-- HSVI1 318-337 1072-1091 PHEMA-- PI2H |
| 13-33 PENV-- |
| SIVAI 421-442 PVGLC-- VZVS |
| 431-449 PVGF1-- IBVB 1587-1606 2108-2127 PHEMA-- PI2HT 13-33 |
| PENV-- |
| SIVAT 435-456 PVGLF-- |
| PI3H4 2-94 PVGL2-- CVBF 991-1010 PHEMA-- RINDL 497-517 |
| PENV-- |
| SMSAV 42-63 PVGLH |
| -- HSV6G 314-332 PVGL2-- CVBL9 991-1010 PHEMA-- SEND5 |
| 322-342 PHEMA-- |
| CVMA5 402-423 PVGLH-- HSVE4 |
| 814-832 PVGL2-- CVBLY 991-1010 PHEMA-- SENDF 322-342 |
| PHEMA-- |
| IADE1 266-287 PVGLH- |
| - HSVEB 807-825 PVGL2-- CVBM 991-1010 PHEMA-- SENDH |
| 322-342 PHEMA-- |
| MUMPM 225-246 PVGLI-- HSV11 |
| 5-94 PVGL2-- CVBQ 991-1010 PHEMA-- SENDJ 322-342 |
| PHEMA-- |
| MUMPR 225-246 PVGNM- |
| - BPMV 678-696 PVGL2-- CVBV 991-1010 PHEMA-- SENDZ 322-342 |
| PHEMA-- |
| MUMPS 225-246 PVM01-- |
| VACCC 134-152 177-195 PVGL2-- CVH22 768-787 1115-1134 PVENV-- |
| LELV 27-47 148-168 PHEMA-- |
| PHODV 213-234 PVM01-- VACCV 83-101 |
| 126-144 PVGL2-- CVM4 999-1018 PVENV-- |
| THOGV 356-376 PHEMA-- |
| PI2H 13-34 PVM1-- REOVD 227-245 |
| PVGL2-- CVMA5 947-966 PVG01-- VACCC 298-318 PHEMA-- |
| PI2HT 13-34 |
| PVM1-- REOVL 227-245 PVGL2-- CVMJH 858-877 PVG01-- |
| VACCV 237-257 PHEMA-- SV5 |
| 7-28 379-400 PVMAT-- HRSVA 44-62 |
| PVGL2-- CVPFS 64-83 1038-1057 PVG01-- |
| VARV 298-318 PHEMA-- SV5CM |
| 7-28 379-400 PVMAT-- NDVA 190-208 |
| PVGL2-- CVPPU 64-83 1036-1055 PVG06-- |
| VACCC 31-51 PHEMA-- SV5CP |
| 7-28 379-400 PVMAT-- NDVB 190-208 |
| PVGL2-- CVPR8 814-833 PVG06-- VARV 31-51 PHEMA-- SV5LN |
| 7-28 379-400 |
| PVMP-- CAMVC 183-201 PVGL2-- CVPRM 814-833 PVG09-- |
| BPPF1 25-45 PVG01-- |
| HSVEB 169-190 PVMP-- CAMVD |
| 183-201 PVGL2-- FIPV 1041-1060 PVG12-- HSVI1 151-171 |
| PVG01-- |
| HSVI1 589-610 PVMP-- |
| CAMVE 183-201 PVGL2-- IBV6 588-607 771-790 PVG22-- HSVI1 |
| 300-320 PVG23-- |
| HSVI1 314-335 PVMP-- CAMVN |
| 183-201 PVGL2-- IBVB 587-606 770-789 PVG39-- HSVI1 648-668 |
| 970-990 PVG37-- |
| BPOX2 65-86 PVMP-- CAMVS |
| 183-201 PVGL2-- IBVD2 588-607 771-790 PVG51-- HSVI1 29-49 |
| PVG43-- |
| HSVI1 157-178 PVMP-- |
| CAMVW 183-201 PVGL2-- IBVK 587-606 770-789 PVG63-- HSVI1 |
| 336-356 PVG55-- |
| HSVI1 288-309 PVMP-- FMVD |
| 180-198 PVGL2-- IBVM 587-606 770-789 PVG65-- HSVI1 117-137 |
| PVG55-- HSVSA |
| 85-106 PVGLB-- |
| HCMVA 706-725 PVG74-- HSVSA 124-144 PVG56-- HSVI1 1155-1176 |
| PVGLB-- HCMVT 707-726 PVGL2-- IBV6 328-348 PVG58-- |
| HSVSA 266-287 |
| PVGLB-- HSV6U 117-136 PVGL2-- IBVB 327-347 PVG60-- |
| HSVI1 30-51 |
| PVGLB-- ILTV6 256-275 PVGL2-- |
| IBVD2 328-348 PVG63-- |
| HSVI1 238-259 PVGLB-- ILTVS |
| 266-285 PVGL2-- IBVD3 328-348 PVGF1-- IBVB 1856-1877 |
| PVGLB-- ILTVT 266-285 PVGL2-- IBVK 327-347 |
| PVGH3-- |
| HCMVA 157-178 |
| PVGLC-- HSV11 3-94 467-486 PVGL2-- IBVM 327-347 378-398 |
| PVGL2-- |
| CVBF 1259-1280 |
| PVGLC-- HSV1K 3-94 467-486 PVGL2-- |
| IBVU2 310-330 PVGL2-- |
| CVBL9 1259-1280 PVGLC-- HSVBC |
| 475-494 PVGLB-- EBV 732-752 PVGL2-- |
| CVBLY 1259-1280 PVGLG-- CHAV 436-455 PVGLB-- |
| HCMVA 750-770 PVGL2-- |
| CVBM 1259-1280 PVGLG-- RABVH |
| 372-391 PVGLB-- HCMVT 751-771 PVGL2-- CVBQ 1259-1280 |
| PVGLI-- HSVEB 44-63 PVGLB-- |
| HSV23 79-99 PVGL2-- |
| CVBV 1259-1280 PVGLI-- VZVD |
| 278-297 PVGLB-- HSV2H 79-99 PVGL2-- |
| CVM4 1317-1338 PVGLM-- BUNGE 117-136 PVGLB-- |
| HSV2S 65-85 PVGL2-- |
| CVMA5 1265-1286 PVGLM-- PHV |
| 152-171 PVGLB-- HSV6U 72-92 PVGL2-- |
| CVMJH 1176-1197 PVGLM-- PTPV 997-1016 PVGLB-- |
| HSVB2 279-299 PVGLB-- HSV11 |
| 83-104 PVGLM-- PUUMH 155-174 |
| PVGLB-- HSVSA 63-83 PVGLB-- HSV1F |
| 82-103 PVGLM-- PUUMS 155-174 PVGLB-- |
| MCMVS 738-758 PVGLB-- HSV1K |
| 82-103 PVGLM-- RVFV 830-849 |
| PVGLF-- PI3H4 283-303 PVGLB-- HSV1P |
| 83-104 PVGLM-- RVFVZ 830-849 PVGLG-- |
| RABVE 454-474 PVGLB-- |
| MCMVS 135-156 PVGLM-- UUK |
| 655-674 PVGLG-- RABVH 454-474 PVGLC-- |
| PRVIF 446-467 PVGLY-- LYCVW 89-108 PVGLG-- |
| RABVP 454-474 PVGLF-- |
| CDVO 336-357 PVGNB-- CPMV |
| 1165-1184 PVGLG-- RABVS 454-474 PVGLF-- MEASE 224-245 |
| PVM3-- REOVD 521-540 PVGLG-- RABVT 454-474 |
| PVGLF-- |
| MEASI 227-248 |
| PVME1-- CVBM 171-190 PVGLH-- MCMVS 670-690 PVGLF-- |
| MEASY 224-245 |
| PVME1-- CVH22 136-155 PVGLM-- |
| BUNL7 1325-1345 PVGLF-- |
| MUMPM 446-467 PVME1-- CVPFS |
| 174-193 PVGLM-- BUNSH 1325-1345 PVGLF-- MUMPR 446-467 |
| PVME1-- CVPPU 174-193 PVGLM-- BUNYW 996-1016 |
| PVGLF-- |
| MUMPS 446-467 |
| PVME1-- CVPRM 174-193 PVGLM-- HANTB 999-1019 PVGLF-- |
| PHODV 305-326 |
| PVME1-- CVTKE 171-190 PVGLM-- |
| HANTH 1000-1020 PVGLF-- |
| PI1HC 456-477 PVGLM-- HANTL |
| 1001-1021 PVGLF-- |
| PI2H 450-471 PVGLM-- |
| HANTV 1001-1021 PVGLF-- |
| PI2HG 450-471 PVGLM-- RVFVZ |
| 1156-1176 PVGLF-- |
| PI2HT 450-471 PVGLM-- |
| SEOUR 1000-1020 PVGLF-- |
| PI3B 405-426 453-474 PVGLM-- SEOUS |
| 999-1019 PVGLF-- |
| PI3H4 453-474 PVGLM-- |
| UUK 925-945 PVGLF-- |
| RINDK 220-241 PVGLY-- |
| LYCVA 12-32 PVGLF-- |
| RINDL 220-241 PVGLY- LYCVW |
| 12-32 PVGLF-- |
| SEND5 460-481 PVGLY-- |
| PIARV 12-32 PVGLF-- |
| SENDF 460-481 PVGNB-- CPMV |
| 141-161 PVGLF-- |
| SENDH 460-481 PVMAT-- |
| MUMPS 310-330 PVGLF-- |
| SENDJ 460-481 PVMAT-- NDVA |
| 309-329 PVGLF-- |
| SENDZ 460-481 PVMAT-- |
| NDVB 309-329 PVGLF-- |
| SV41 453-474 PVMAT-- PI2HT |
| 308-328 PVGLF-- |
| SV5 446-467 PVMAT-- |
| PI4HA 312-332 PVGLH-- |
| HCMVA 691-712 PVMAT-- PI4HB |
| 312-332 PVGLH-- |
| HCMVT 690-711 PVMAT-- |
| SV41 308-328 PVGLH-- |
| HSVE4 304-325 PVMAT-- SV5 |
| 308-328 PVGLH-- |
| HSVEB 297-318 PVME1-- |
| IBV6 74-94 PVGLH-- |
| HSVSA 658-679 PVME1-- |
| IBVB 74-94 PVGLI-- HSV2 |
| 2-23 PVME1-- IBVB2 |
| 74-94 PVGLI-- HSV23 |
| 2-23 PVME1-- IBVK |
| 74-94 PVGLM-- |
| BUNGE 197-218 PVMSA-- |
| HPBDB 201-221 PVGLM-- |
| BUNL7 190-211 PVMSA-- HPBGS |
| 209-229 PVGLM-- |
| BUNSH 190-211 PVMSA-- |
| HPBHE 293-313 PVGLM-- |
| BUNYW 193-214 PVMSA-- WHV1 |
| 207-227 PVGLY-- |
| LASSG 237-258 PVMSA-- |
| WHV59 212-232 PVGLY-- |
| LASSJ 238-259 PVMSA-- WHV7 |
| 212-232 PVGPB-- |
| EBV 67-88 PVMSA-- |
| WHV8 212-232 PVM01-- |
| VACCC 281-302 PVMSA-- WHV8I |
| 212-232 PVM01-- |
| VACCV 230-251 PVMSA-- |
| WHVW6 63-83 PVMAT-- |
| HRSVA 139-160 PVMAT-- |
| RINDK 200-221 239-260 |
| PVMAT-- |
| TRTV 122-143 PVME1-- |
| CVHOC 64-85 |
| PVMSA-- |
| HPBDB 201-222 PVMSA-- |
| HPBVO 70-91 |
| PVMSA-- |
| HPBV2 244-265 PVMSA-- |
| HPBV4 24-265 |
| PVMSA-- |
| HPBV9 244-265 PVMSA-- |
| HPBVA 233-254 |
| PVMSA-- |
| HPBVD 70-91 PVMSA-- |
| HPBVI 233-254 |
| PVMSA-- |
| HPBVJ 233-254 PVMSA-- |
| HPBVL 233-254 |
| PVMSA-- |
| HPBVN 70-91 PVMSA-- |
| HPBVO 233-254 |
| PVMSA-- |
| HPBVP 244-265 PVMSA-- |
| HPBVR 244-265 |
| PVMSA-- |
| HPBVS 70-91 PVMSA-- |
| HPBVW 233-254 |
| PVMSA-- |
| HPBVY 233-254 PVMSA-- |
| HPBVZ 233-254 |
| PVMT2-- |
| IAANN 25-46 PVMT2-- |
| IABAN 25-46 |
| PVMT2-- |
| IAFOW 25-46 PVMT2-- |
| IAFPR 25-46 |
| PVMT2-- |
| IAFPW 25-46 PVMT2-- |
| IALE1 25-46 |
| PVMT2-- |
| IALE2 25-46 PVMT2-- |
| IAMAN 25-46 |
| PVMT2-- |
| IAPUE 25-46 PVMT2-- |
| IASIN 25-46 |
| PVMT2-- |
| IAUDO 25-46 PVMT2-- |
| IAWIL 25-46 |
| TABLE XII |
| __________________________________________________________________________ |
| Search Results Summary for P7CTLZIP, |
| P8CTLZIP, and P9CTLZIP Motifs |
| P7CTLZIP P8CTLZIP P9CTLZIP |
| LIBRARY FILE LIBRARY FILE LIBRARY FILE |
| __________________________________________________________________________ |
| PENV-- BAEVM |
| 202-224 PENVA-- FRSFV |
| 380-403 PENV-- BLVAF |
| 303-327 |
| PENV-- HV1B1 498-520 PENV2-- FRSFV 380-403 PENV-- |
| BLVAU 303-327 |
| PENV-- |
| HV1BB 493-515 |
| PENV-- |
| BIV06 178-201 |
| PENV-- |
| BLVAV 303-327 |
| PENV-- |
| HV1BN 494-516 |
| PENV-- |
| BIV27 207-230 |
| PENV-- |
| BLVB2 303-327 |
| PENV-- |
| HV1BR 503-526 |
| PENV-- |
| FOAMV 884-887 |
| PENV-- |
| BLVB5 303-327 |
| PENV-- |
| HV1EL 495-617 |
| PENV-- |
| HV1Z3 176-198 |
| PENV-- BLVJ |
| 303-327 |
| PENV-- HV1H2 498-520 PENV-- HV2BE 3-26 781-804 PENV-- |
| FIVPE 781-805 |
| PENV-- |
| HV1H3 498-520 |
| PENV-- |
| HV2CA 750-773 |
| PENV-- |
| FIVSD 779-803 |
| PENV-- |
| HV1J3 510-532 |
| PENV-- |
| HV2D1 3-26 |
| 772-795 PENV |
| -- FIVT2 780-804 |
| PENV-- HV1JR 490-512 PENV-- HV2G1 772-795 PHEMA-- |
| CVBLY 391-415 |
| PENV-- |
| HV1KB 504-526 |
| PENV-- |
| HV2NZ 777-800 |
| PHEMA-- |
| CVBM 391-415 |
| PENV-- |
| HV1MA 500-522 |
| PENV-- JSRV |
| 541-564 |
| PHEMA-- |
| CVBO 391-415 |
| PENV-- |
| HV1MF 496-518 |
| PENV-- SFV1 |
| 864-887 |
| PHEMA-- |
| CVHOC 391-415 |
| PENV-- |
| HV1ND 488-510 |
| PENV-- |
| SFV3L 861-884 |
| PHEMA-- |
| INCCA 442-466 |
| PENV-- |
| HV1PV 498-520 |
| PENV-- |
| SIVM1 803-826 |
| PHEMA-- |
| INCEN 430-464 |
| PENV-- |
| HV1S1 489-511 |
| PENV-- |
| SIVMK 802-825 |
| PHEMA-- |
| INCGL 430-454 |
| PENV-- |
| HV1Z2 123-145 |
| 495-617 PENV |
| -- SIVML 801-824 |
| PHEMA-- |
| INCHY 429-453 |
| PENV-- |
| HV1Z6 497-519 |
| PENV-- |
| SIV64 806-829 |
| PHEMA-- |
| INCJH 443-467 |
| PENV-- |
| HV1Z8 505-527 |
| PENV-- |
| SIVSP 810-833 |
| PHEMA-- |
| INCKY 429-453 |
| PENV-- |
| HV1ZH 498-520 |
| PHEMA-- |
| CDVO 200-223 |
| PHEMA-- |
| INCMI 429-453 |
| PENV-- |
| JSRV 376-398 |
| PHEMA-- |
| PI2H 65-88 |
| PHEMA-- |
| INCNA 429-453 |
| PENV-- |
| MPMV 213-235 |
| PHEMA-- |
| PI2HT 65-88 |
| PHEMA-- |
| INCP1 430-454 |
| PENV-- |
| SRV1 213-235 |
| PVF11-- |
| VACCC 161-184 |
| PHEMA-- |
| INCP2 430-454 |
| PHEMA-- |
| IAAIC 37-59 |
| PVF15-- |
| VACCC 25-48 |
| PHEMA-- |
| INCP3 430-454 |
| PHEMA-- |
| IABAN 21-43 |
| PVF16-- |
| VACCP 3-26 |
| PHEMA-- |
| INCTA 430-454 |
| PHEMA-- |
| IADA3 37-59 |
| PVG1L-- |
| AMEPV 313-336 |
| PHEMA-- |
| INCYA 430-454 |
| PHEMA-- |
| IADH2 21-43 |
| PVG28-- |
| HSVI1 491-514 |
| PHEMA-- |
| MUMPM 101-125 |
| PHEMA-- |
| IADH3 21-43 |
| PVG43-- |
| HSV11 322-345 |
| PHEMA-- |
| MUMPR 101-125 |
| PHEMA-- |
| IADH4 21-43 |
| PVG52-- |
| HSVI1 229-252 |
| PHEMA-- |
| MUMPS 101-125 |
| PHEMA-- |
| IADH5 21-43 |
| PVG57-- |
| HSVI1 722-745 |
| PHEMA-- |
| PI1HW 29-53 |
| PHEMA-- |
| IADH6 21-43 |
| PVGL2-- |
| CVBF 10-33 |
| PVENV-- BEV |
| 62-86 |
| PHEMA-- IADH7 21-43 PVGL2-- CVBL9 651-674 PVF05-- |
| VACCC 280-304 |
| PHEMA-- |
| IADM2 37-59 |
| PVGL2-- |
| CVBLY 10-33 |
| PVF05-- |
| VACCP 280-304 |
| PHEMA-- |
| IADMA 28-50 |
| PVGL2-- |
| CVM4 1267-1290 |
| PVF05-- |
| VACCV 281-305 |
| PHEMA-- |
| IADU3 37-59 |
| PVGL2-- |
| CVMA5 1215-1238 |
| PVF09-- |
| VACCC 178-200 |
| PHEMA-- |
| IAEN6 21-43 |
| PVGL2-- |
| CVMJH 1126-1149 |
| PVF09-- |
| VACCV 176-200 |
| PHEMA-- |
| IAEN7 37-59 |
| PVGL2-- |
| CVPF8 1274-1207 |
| PVG01-- |
| VZVD 58-82 |
| PHEMA-- |
| IAMA0 37-59 |
| PVGL2-- |
| CVPPU 1272-1295 |
| PVG10-- |
| HSVSA 355-379 |
| PHEMA-- |
| IAME1 37-59 |
| PVGL2-- |
| CVPR8 1050-1073 |
| PVG12-- |
| HSVSA 68-92 |
| PHEMA-- |
| IAME2 37-59 |
| PVGL2-- |
| CVPRM 1050-1073 |
| PVG19-- |
| HSVI1 88-112 |
| PHEMA-- |
| IAME6 21-43 |
| PVGL2-- |
| FIPV 1277-1300 |
| PVG28-- |
| HSVI1 173-197 |
| PHEMA-- |
| IANT6 37-59 |
| PVGL2-- |
| IBV6 196-219 |
| PVG43-- |
| HSVI1 109-133 |
| PHEMA-- |
| IAQU7 21-43 |
| PVGL2-- |
| IBVB 195-218 |
| PVG87-- |
| HSVI1 108-132 |
| 1005-1029 |
| PHEMA-- |
| IATKM 33-55 |
| PVGL2-- |
| IBVD2 198-219 |
| PVG72-- |
| HSVI1 720-744 |
| PHEMA-- |
| IAUDO 37-59 |
| PVGL2-- |
| IBVD3 198-219 |
| PVGF1-- |
| IBVB 3601-3625 |
| PHEMA-- |
| IAV17 38-60 |
| PVGL2-- |
| IBVK 195-216 |
| PVGLB-- |
| HSVMD 589-613 |
| PHEMA-- |
| IAX31 37-59 |
| PVGL2-- |
| IBVM 195-218 |
| PVGLB-- |
| ILTV6 597-621 |
| PHEMA-- |
| IAZCO 37-59 |
| PVGL2-- |
| IBVU1 178-201 |
| PVGLB-- |
| ILTV9 607-631 |
| PHEMA-- |
| IAZH2 21-43 |
| PVGL2-- |
| IBVU2 178-201 |
| PVGLB-- |
| ILTVT 607-631 |
| PHEMA-- |
| IAZH3 21-43 |
| PVGL2-- |
| IBVU3 178-201 |
| PVGLE-- |
| HSV11 413-437 |
| PHEMA-- |
| IAZUK 37-59 |
| PVGLB-- |
| HCMVA 535-558 |
| PVGLE-- |
| VZVD 469-493 |
| PHEMA-- |
| PHODV 36-58 |
| PVGLB-- |
| HCMVT 536-559 |
| PVGLF-- SV6 |
| 401-425 |
| PHEMA-- PI2H 65-87 PVGLB-- HBVBA 483-506 PVGLH-- HCMVA |
| 574-598 |
| PHEMA-- PI2HT 65-87 PVGLB-- MCMVS 566-589 PVGLH-- |
| HCMVT 573-597 |
| PVFP7-- |
| CAPVK 69-111 |
| PVGLC-- |
| H8V11 467-490 |
| PVGLH-- |
| HSV11 443-467 |
| 803-827 |
| PVFU8-- VACC6 72-94 PVGLC-- HSV1K 467-490 PVGLH-- |
| HSV1E 443-467 |
| 803-827 |
| PVG01-- HSVI1 317-339 PVGLC-- HSV2 435-458 PVGLM-- |
| BUNL7 31-55 |
| PVG03-- |
| VACCC 50-72 |
| PVGLC-- |
| HSV23 436-459 |
| PVGLM-- |
| BUNSH 31-55 |
| PVG03-- |
| VARV 60-72 |
| PVGLM-- |
| BUNL7 1387-1410 |
| PVGLM-- |
| HANTH 694-718 |
| PVG04-- |
| VACCC 11-33 |
| PVGLM-- |
| BUNSH 1387-1410 |
| PVGLM-- |
| RVFV 344-368 |
| PVG04-- |
| VARV 11-33 |
| PVGLM-- UUK |
| 966-989 |
| PVGLM-- |
| RVFVZ 344-368 |
| PVG19-- |
| HSVI1 88-110 |
| PVGLY-- |
| JUNIN 12-35 |
| PVGLM-- UUK |
| 561-585 |
| PVG28-- HSVI1 173-195 PVGLY-- LASSG 12-35 PVGNM-- CPMV |
| 311-335 |
| PVG29-- HSVI1 20-42 PVGLY-- LASSJ 12-35 PVGP2-- EBV |
| 657-661 |
| PVG46-- HSVI1 134-156 PVGLY-- LYCVA 12-35 PVGP3-- EBV |
| 854-878 |
| PVG48-- HSVSA 71-93 PVGLY-- LYCVW 12-35 PVM1-- REOVD |
| 280-304 |
| PVG58-- HSVSA 266-288 PVGLY-- MOPEI 12-35 PVM1-- REOVL |
| 280-304 |
| PVG59-- HSVI1 287-289 PVGLY-- TACV 12-35 PVM21-- REOVD |
| 168-192 |
| PVG5-- SPV4 42-64 PVGLY-- TACV5 12-35 PVM22-- REOVD |
| 168-192 |
| PVG60-- HSVI1 53-76 PVGLY-- TACV7 12-35 PVM2-- REOVJ |
| 168-192 |
| PVG65-- HSVI1 1347-1369 PVGLY-- TACVT 12-35 PVM2-- |
| REOVL 168-192 |
| PVG6-- |
| SPV1R 60-82 |
| PVGNM-- |
| CPMV 741-764 |
| PVMAT-- |
| MEASI 87-111 |
| PVGL2-- |
| IBV6 1056-1078 |
| PVM1-- |
| REOVD 324-347 |
| 454-477 PVMAT.sub |
| .-- SSPVB |
| 314-338 |
| PVGL2-- IBVB 1055-1077 PVM1-- REOVL 454-477 PVME1-- |
| CVBM 137-161 |
| PVGL2-- |
| IBVD2 1056-1078 |
| PVMAT-- |
| MUMPS 227-250 |
| PVME1-- |
| CVHOC 137-161 |
| PVGL2-- |
| IBVK 1055-1077 |
| PVMSA-- |
| HPBDB 269-292 |
| PVME1-- |
| VTKE 137-161 |
| PVGL2-- |
| IBVM 1055-1077 |
| PVMSA-- |
| HPBDC 268-291 |
| PVME1-- |
| IBV6 74-98 |
| PVGLB-- |
| HSV6U 117-139 |
| PVMSA-- |
| HPBDU 231-254 |
| PVME1-- |
| IBVB 74-98 |
| PVGLB-- |
| HSVB2 745-767 |
| PVMSA-- |
| HPBDW 289-292 |
| PVME1-- |
| IBVB2 74-98 |
| PVGLC-- |
| HSVMB 399-421 |
| PVMSA-- |
| HPBHE 236-259 |
| PVME1-- |
| IBVK 74-98 |
| PVGLC-- |
| HSMG 398-420 |
| PVMSA-- |
| HPBGS 271-295 |
| PVGLC-- |
| HSVMM 399-421 |
| PVMSA-- |
| WHV1 289-293 |
| PVGLF-- |
| BRSVA 265-287 |
| 482-504 |
| PVMSA-- |
| WHV59 274-298 |
| PVGLF-- |
| BRSVC 484-508 |
| PVMSA-- |
| WHV7 274-298 |
| PVGLF-- |
| BRSVR 484-508 |
| PVMSA-- |
| WHV8 274-298 |
| PVGLF-- |
| HRSV1 484-508 |
| PVMSA-- |
| WHV8I 274-298 |
| PVGLF-- |
| HRSVA 484-508 |
| PVMSA-- |
| WHVW6 125-149 |
| PVGLF-- |
| HRSVL 484-508 |
| PVGLF-- |
| HRSVR 484-508 |
| PVGLF-- |
| TRTV 452-474 |
| PVGLG-- |
| IHNV 77-99 |
| PVGLG-- |
| VHSVO 408-428 |
| PVGLH-- |
| HSVE4 814-836 |
| PVGLH-- |
| HSVEB 807-829 |
| PVGLI-- |
| HCMVA 168-180 |
| PVGLM-- |
| PTPV 743-765 |
| PVGLP-- |
| BEV 430-452 |
| 1546-1568 |
| PVGLY-- |
| LASSG 426-448 |
| PVGLY-- |
| LASSJ 427-449 |
| PVGLY-- |
| MOPEI 425-447 |
| PVGP2-- |
| EBV 657-679 |
| PVGP3-- |
| EBV 854-876 |
| PVM1-- |
| REOVD 414-436 |
| PVM1-- |
| REOVL 414-436 |
| PVM3-- |
| REOVD 303-326 |
| PVMAT-- |
| PI1HC 195-217 |
| PVMAT-- |
| PI2HT 132-154 |
| PVMAT-- |
| BENDF 195-217 |
| PVMAT-- |
| BENDH 195-217 |
| PVMAT-- |
| BENDZ 195-217 |
| PVMAT-- |
| SV41 132-154 |
| PVMEM-- |
| EBV 131-153 |
| PVMP-- |
| CERV 293-316 |
| __________________________________________________________________________ |
| TABLE XIII |
| - SEARCH RESULTS SUMMARY FOR P12LZIPC MOTIF |
| PCGENE P12CTLZIP All Viruses (No Bacteriophages) |
| FILE NAME PROTEIN VIRUS AREA 1 AREA 2 AREA 3 AREA 4 AREA 5 AREA 6 AREA |
| 7 AREA 8 AREA 9 |
| P194K-- TRVSY POTENTIAL 194 KD PROTEIN TOBACCO RATTLE VIRUS |
| 360-378 463-478 641-668 1011-1030 |
| (STRAIN SYM) |
| P3BHS-- |
| VACCC 3BETA-HDS VACCINIA VIRUS (STRAIN |
| COPENHAGEN) 41-56 297-321 |
| P3BHS-- VACCV 3BETA-HSD VACCINIA VIRUS (STRAIN WR) 41-56 297-321 |
| P3BH-- |
| VARV 3BETA-HSD VARIOLA VIRUS 41-56 PAT3H-- |
| FOWPM ANTITHROBMBIN-111 HOMOLOG FOWLPOX VIRUS (ISOLATE 47-69 |
| HP-438[MUNICH]) |
| PAT11-- VACCV 94 KD A-TYPE INCLUSION VACCINA VIRUS (STRAIN WR) |
| 387-410 |
| PROTEIN |
| PAT11-- VARV 81 KD A-TYPE INCLUSION VARIOLA VIRUS 388-411 |
| PROTEIN |
| PAT12-- |
| HSV11 UL46 HERPES SIMPLEX VIRUS 279-305 (TYPE |
| I/STRAIN 17) |
| PAT12-- |
| HSVIF UL46 HERPES SIMPLEX VIRUS 279-305 (TYPE |
| I/STRAIN F) |
| PAT12-- HSVEB ALPHA TRANS-INDUCING EQUINE HERPESVIRUS 197-222 |
| FACTOR 82 KD PROTEIN TYPE I (STRAIN AB4P) |
| PAT12-- VACCC PUTATIVE A-TYPE VACCINIA VIRUS (STRAIN 215-241 |
| INCLUSION PROETIN COPENHAGEN) |
| PAT12-- VZVD ALPHA TRANS- VARICELLA-ZOSTER VIRUS 61-79 377-397 |
| INDUCING FACTOR 74 KD (STRAIN DUMAS) |
| PROTEIN |
| PAT13-- VACCV PUTATIVE A-TYPE VACCINIA VIRUS (STRAIN 47-73 |
| INCLUSION PROETIN WR) |
| PATIN-- HSVBP ALPHA TRANS- BOVINE HERPESVIRUS TYPE I 101-120 |
| 277-292 |
| INDUCING PROTEIN (STRAIN P8-2) |
| PATIN-- HSVE4 ALPHA TRANS- EQUINE HERPESVIRUS TYPE 4 104-123 |
| INDUCING PROTEIN |
| PATIN-- HSVEB ALPHA TRANS- EQUINE HERPESVIRUS TYPE I 129-148 |
| INDUCING PROTEIN (STRAIN AB4P) |
| PATIN-- |
| VZVD ALPHA TRANS- VARICELLA-ZOSTER 203-230 INDUCING |
| PROTEIN VIRUS (STRAIN DUMAS) |
| PATI-- COWPX A-TYPE INCLUSION COWPOX VIRUS 389-412 1102-1128 |
| PROTEIN |
| PB2-- |
| BBV B2 PROTEIN BLACK BEETLE VIRUS 31-52 PB701- |
| - |
| HSV6G TRANSCRIPTIONAL HERPES SIMPLEX VIRUS 55-78 |
| REGULATORY PROTEIN (TYPE 6/STRAIN GS) |
| PBCRF-- EBV BCRFI PROTEIN PRECURSOR EPSTEIN-BARR VIRUS 96-123 |
| (STRAIN B95-8) |
| PBRL1-- EBV TRANSCRIPTION ACTIVATOR EPSTEIN-BARR VIRUS 16-32 |
| 200-224 |
| BRLF1 (STRAIN B95-8) |
| PCAHH-- VACCC CELL SURFACE-BINDING VACCINIA VIRUS 188-203 |
| PROTEIN (STRAIN COPPENHAGEN) |
| PCAHH-- VACCV CELL SURFACE-BINDING VACCINIA VIRUS 188-203 |
| PROTEIN (STRAIN WR) |
| PCAHH-- |
| VARV CELL SURFACE-BINDING VARIOLA VIRUS 188-203 PROTEIN |
| PCCPH-- HSVSA COMPL CONTROL PROTEIN HERPES VIRUS 326-348 |
| HOMOLOG PREC SAIMIRI (STRAIN 11) |
| PCELF-- HSV11 CELL FUSION PROTEIN HERPES SIMPLEX 178-195 212-238 |
| 286-309 |
| PRECURSOR VIRUS (TYPE 1/STRAIN 17) |
| PCELF-- HSV1K CELL FUSION PROTEIN HERPES SIMPLEX VIRUS 178-195 |
| 212-238 |
| PRECURSOR (TYPE 1/STRAIN KOS) |
| PCELF-- HSV2H CELL FUSION PROTEIN HERPES SIMPLEX VIRUS 178-196 |
| 212-238 286-309 |
| PRECURSOR (TYPE 2/STRAIN HG52) |
| PCELF-- HSVEB CELL FUSION PROTEIN HERPES VIRUS TYPE 1 205-223 |
| 249-268 |
| PRECURSOR (STRAIN KENTUCKY A) |
| PCELF-- V2VD CELL FUSION PROTEIN VARICELLA-ZOSTER VIRUS 249-269 |
| PRECURSOR (STRAIN DUMAS) |
| PCGH2-- HSVSA CYCLIN HOMOLOG HERPESVIRUS SAIMIRI 35-61 216-242 |
| (STRAIN 11) |
| PCOA1-- BFDV COAT PROTEIN VP1 BUDGERIGAR FLEDGLING 93-110 |
| DISEASE VIRUS |
| PCOA1-- POVBA COAT PROTEIN VP1 POLYOMAVIRUS BK 25-52 97-123 |
| 233-251 |
| (STRAIN AS) |
| PCOA1-- POVBK COAT PROTEIN VP1 POLYOMAVIRUS BK 25-52 97--123 |
| 233-251 |
| PCOA1-- POVBO COAT PROTEIN VP1 BOVINE POLYOMAVIRUS 96-120 |
| PCOA1-- POVHA COAT PROTEIN VP1 HAMSTER POLYOMAVIRUS 16-43 |
| PCOA1-- POVJC COAT PROTEIN VP1 POLYOMAVIRUS JC 17-44 89-115 |
| 225-243 |
| PCOA1-- POVLY COAT PRTEIN VP1 LYMPHOTROPIC POLYOMA- 97-123 |
| VIRUS |
| PCOA1-- POVMK COAT PROTEIN VP1 MOUSE POLYOMAVIRUS 142-160 231-249 |
| (STRAIN KILHAM) |
| PCOA1-- SV40 COAT PROTEIN VP1 SIMIAN VIRUS 40 27-44 99-125 |
| 235-253 |
| PCOA1-- |
| TTV1 COAT PROTEIN TP1 THERMOPROTEUS TENAX 80-103 VIRUS 1 |
| (STRAIN KRA1) |
| PCOA2-- POVBO COAT PROTEIN VP2 BOVINE POLYOMAVIRUS 77-104 |
| PCOA2-- POVLY COAT PROTEIN VP2 LYMPHOTROPIC POLYOMA- |
| 79-102 |
| VIRUS |
| PCOA2-- POVM3 COAT PROTEIN VP2 MOUSE POLYOMAVIRUS 205-226 |
| (STRAIN 3) |
| PCOA3-- |
| TTV1 COAT PROTEIN TP3 THERMOPROTEUS TENAX 33-55 VIRUS 1 |
| (STRAIN KRA1) |
| PCOAT-- |
| ABMVW COAT PROTEIN ABUTILON MOSAIC VIRUS 148-171 (ISOLATE |
| WEST INDIA) |
| PCOAT-- BOOLV COAT PROTEIN PRECURSOR BOOLARRA VIRUS 383-401 |
| PCOAT-- CHVP1 MAJOR CAPSID PROTEIN PARAMECIUM BURSARIA |
| 364-387 392-409 |
| CHLORELLA VIRUS 1 |
| PCOAT-- |
| CLVK COAT PROTEIN CASSAVA LATENT VIRUS 165-188 (STRAIN |
| WEST KENYAN 844) |
| PCOAT-- |
| CLVN COAT PROTEIN CASSAVA LATENT VIRUS 165-188 (STRAIN |
| NIGERIAN) |
| PCOAT-- |
| CMVSI COAT PROTEIN CYMBIDIUM MOSAIC VIRUS 58-76 (STRAIN |
| SINGAPORE) |
| PCOAT-- |
| CNV COAT PROTEIN CUCUMBER NECROSIS VIRUS 19-42 PCOAT-- |
| CSMV COAT PROTEIN CHLORIS STRIATE MOSAIC 219-238 |
| VIRUS |
| PCOAT-- |
| CTV36 COAT PROTEIN CITRUS TRISTEZA VIRUS 72-94 (ISOLATE |
| T36) |
| PCOAT-- FCVC6 COAT PROTEIN FELINE CALICIVIRUS 564-587 642-664) |
| (STRAIN CFI/68 FIV) |
| PCOAT-- FCVF4 COAT PROTEIN FELINE CALICIVIRUS 564-587 642-657 |
| (STRAIN JAPANESE F4) |
| PCOAT-- FCVF9 COAT PROTEIN FELINE CALICIVIRUS 567-590 645-660 |
| (STRAIN F9) |
| PCOAT-- FPV COAT PROTEIN VP1 FELINE PANLEUKOPENIA 690-705 |
| VIRUS |
| PCOAT-- FPV19 COAT PROTEIN VP1 FELINE PANLEUKOPENIA 690-705 |
| VIRUS (STRAIN 193) |
| PCOAT-- |
| HEVS COAT PROTEIN HELENIUM VIRUS S 47-66 PCOAT-- |
| MEVA COAT PROTEIN VP1 MINK ENTERITIS VIRUS 685-700 |
| (STRAIN ABASHIRI) |
| PCOAT-- MNSV COAT PROTEIN MELON NECROTIC SPOT VIRUS 37-53 |
| PCOAT-- MSTV COAT PROTEIN MAIZE STRIPE VIRUS 176-917 |
| 204-227 |
| PCOAT-- |
| NMV COAT PROTEIN NARCISSUS MOSAIC VIRUS 67-86 PCOAT-- |
| NODAV COAT PROTEIN NODAMURA VIRUS 379-394 |
| PRECURSOR |
| PCOAT-- |
| ORSV COAT PROTEIN ODONTOGLOSSUM RINGSPOT 104-130 VIRUS |
| PCOAT-- |
| OYMV COAT PROTEIN ONONIS YELLOW MOSAIC 35-52 VIRUS |
| PCOAT-- |
| PAVC2 COAT PROTEIN VP2 CANINE PARVOVIRUS 547-562 (TYPE |
| 2/STRAIN A72) |
| PCOAT-- |
| PAVC7 COAT PROTEIN VP1 CANINE PARVOVIRUS 685-700 (STRAIN |
| 780929) |
| PCOAT-- |
| PAVCD COAT PROTEIN VP1 CANINE PARVOVIRUS 700-715 (STRAIN |
| CPV-D CORNELL 32) |
| PCOAT-- |
| PAVCN COAT PROTEIN VP1 CANINE PARVOVIRUS 711-726 (STRAIN N) |
| PCOAT-- PEMV COAT PROTEIN PRECURSOR PEPPER MOTTLE VIRUS 273-295 |
| PCOAT-- PMV COAT PROTEIN PAPAYA MOSAIC POTEXVIRUS 85-103 |
| PCOAT-- PPMVS COAT PROTEIN PEPPER MILD MOTTLE 64-84 |
| 103-129 |
| VIRUS (STRAIN SPAIN) |
| PCOAT-- |
| PVSP COAT PROTEIN POTATO VIRUS S 129-147 (STRAIN |
| PERUVIAN) |
| PCOAT-- |
| RSV COAT PROTEIN RICE STRIP VIRUS 128-152 |
| PCOAT-- |
| SMWLM COAT PROTEIN SATELLITE MAIZE WHITE 51-67 LINE |
| MOSAIC VIRUS |
| PCOAT-- |
| SMYEA COAT PROTEIN STRAWBERRY MILD YELLOW 57-72 EDGE-ASSOCI |
| ATED VIRUS |
| PCOAT-- TAMV GENOME POLYPROTEIN TAMARILLO MOSAIC VIRUS 222-237 |
| PCOAT-- |
| TBSVB TOMATO BUSHY STUNT 359-383 VIRUS |
| (STRAIN BS-3) |
| PCOAT-- |
| TCV COAT PROTEIN TURNIP CRINKLE VIRUS 73-89 PCOAT-- |
| TGMV COAT PROTEIN TOMATO GOLDEN 154-177 |
| MOSAIC VIRUS |
| PCOAT-- |
| TMGMV COAT PROTEIN TOBACCO MILD GREEN 102-128 MOSAIC |
| VIRUS (TMV STRAIN |
| U2) |
| PCOAT-- |
| TMV COAT PROTEIN TOBACCO MOSAIC 102-128 VIRUS |
| (VULGARE) |
| PCOAT-- |
| TMVO6 COAT PROTEIN TOBACCO MOSAIC 102-128 VIRUS |
| (STRAIN 06) |
| PCOAT-- |
| TMVDA COAT PROTEIN TOBACCO MOSAIC 102-128 VIRUS |
| (STRAIN DAHLEMENSE) |
| PCOAT-- |
| TMVER COAT PROTEIN TOBACCO MOSAIC 102-128 VIRUS |
| (STRAIN ER) |
| PCOAT-- |
| TMVHR COAT PROTEIN TOBACCO MOSAIC 102-128 VIRUS |
| (STRAIN HOLMES |
| RIBGRASS (HR)) |
| PCOAT-- |
| TMVO COAT PROTEIN TOBACCO MOSAIC 102-128 VIRUS |
| (STRAIN O) |
| PCOAT-- |
| TMVOM COAT PROTEIN TOBACCO MOSAIC 102-128 VIRUS |
| (STRAIN OM) |
| PCOAT-- |
| TMVTO COAT PROTEIN TOBACCO MOSAIC VIRUS 102-128 (STRAIN |
| TOMATO/L) |
| PCOAT-- |
| TNVA COAT PROTEIN TOBACCO NECROSIS VIRUS 119-142 (STRAIN A) |
| PCOAT-- |
| TNVD COAT PROTEIN TOBACCO NECROSIS VIRUS 108-134 (STRAIN D) |
| PCOLL-- HSVSC COLLAGEN-LIKE PROTEIN HERPESVIRUS SAIMIRI 71-96 |
| (SUBGROUP C/STRAIN 488) |
| PCORA-- |
| HPBV2 CORE ANTIGEN HEPATITIS B VIRUS 79-100 (SUBTYPE |
| ADW2) |
| PCORA-- |
| HPBVA CORE ANTIGEN HEPATITIS B VIRUS 15-31 (STRAIN |
| ALPHA 1) |
| PCORA-- |
| HBPVZ CORE ANTIGEN HEPATITIS B VIRUS 79-100 (SUBTYPE |
| ADYW) |
| PDNBI-- |
| ADE02 PROBABLE HUMAN ADENOVIRUS TYPE 2 71-93 DNA-BINDING |
| PROTEIN |
| PDNBI-- EBV MAJOR DNA-BINDING PROTEIN EPSTEIN-BARR VIRUS 649-673 |
| (STRAIN B95-8) |
| PDBBI-- HCMVA MAJOR DNA-BINDING PROTEIN HUMAN CYTOMEGALOVIRUS |
| 681-708 |
| (STRAIN AD169) |
| PDNBI-- HSV11 MAJOR DNA-BINDING PROTEIN HERPES SIMPLEX VIRUS |
| 459-476 597-620 |
| (TYPE 1/STRAIN 17) |
| PDNBI-- HSV1F MAJOR DNA-BINDING PROTEIN HERPES SIMPLEX VIRUS |
| 459-476 597-620 |
| (TYPE 1/STRAIN F) |
| PDNBI-- HSV1K MAJOR DNA-BINDING PROTEIN HERPES SIMPLEX VIRUS |
| 459-476 597-620 |
| (TYPE 1/STRAIN KOS) |
| PDNBI-- HSVB2 MAJOR DNA-BINDING PROTEIN BOVINE HERPESVIRUS |
| 455-472 596-616 |
| TYPE 2(STRAIN BMV) |
| PDNBI-- HSVEB MAJOR DNA-BINDING PROTEIN EQUINE HERPESVIRUS |
| 810-831 |
| TYPE 1 (STRAIN AB4P) |
| PDNBI-- HSVSA MAJOR DNA-BINDING PROTEIN HERPESVIRUS SAIMIRI |
| 108-127 610-629 869-887 974-1000 |
| (STRAIN 11) |
| PDNBI-- MCMVS MAJOR DNA-BINDING PROTEIN MURINE CYTOMEGALOVIRUS |
| 657-684 |
| (STRAIN SMITH) |
| PDNBI-- SCMVC MAJOR DNA-BINDING PROTEIN SIMIAN CYTOMEGALOVIRUS |
| 188-212 643-670 |
| (STRAIN COLBURN) |
| PDNLI-- |
| VARV DNA LIGASE VARIOLA VIRUS 269-294 PDPOL-- |
| ADE02 DNA POLYMERASE HUMAN ADENOVIRUS TYPE 2 264-283 828-850 |
| PDPOL-- ADE05 DNA POLYMERASE HUMAN ADENOVIRUS TYPE 5 264-283 |
| 828-850 |
| PDPOL-- ADE07 DNA POLYMERASE HUMAN ADENOVIRUS TYPE 7 331-350 |
| 494-517 894-916 |
| PDPOL-- ADE12 DNA POLYMERASE HUMAN ADENOVIRUS TYPE 12 262-281 |
| 562-583 826-848 |
| PDPOL-- CBEPV DNA POLYMERASE CHORISTONEURA BIENNIS 430-454 |
| 654-678 732-757 |
| ENTOMOPOXVIRUS |
| PDPOL-- CHVN2 DNA POLYMERASE CHLORELLA VIRUS NY-2A 424-442 |
| PDPOL-- CHVPI DNA POLYMERASE PARAMECIUM BURSARIA 153-172 |
| 424-442 |
| CHLORELLA VIRUS 1 |
| PDPOL-- EBV DNA POLYMERASE EPSTEIN-BARR VIRUS 354-374 438-463 |
| 524-542 667-687 973-990 |
| (STRAIN B95-8) |
| PDPOL-- |
| FOWPV DNA POLYMERASE FOWLPOX VIRUS 60-77 220-247 PDPOL-- |
| HCMVA DNA POLYMERASE HUMAN CYTOMEGALOVIRUS 569-587 945-960 1029-1053 |
| (STRAIN AD169) |
| PDPOL-- HPBDB DNA POLYMERASE DUCK HEPATITIS B VIRUS 4-29 157-174 |
| 522-541 554-572 |
| (BROWN SHANGHAI DUCK |
| ISOLATE S5) |
| PDPOL-- HPBDC DNA POLYMERASE DUCK HEPATITIS B VIRUS 4-29 157-174 |
| 521-540 553-571 |
| (STRAIN CHINA) |
| PDPOL-- HPBDU DNA POLYMERASE DUCK HEPATITIS B VIRUS 181-200 |
| 213-231 |
| PDPOL-- HPBDW DNA POLYMERASE DUCK HEPATITIS B VIRUS 4-29 157-174 |
| 522-541 554-572 |
| (WHITE SHANGHAI DUCK |
| ISOLATE S31) |
| PDPOL-- |
| HPBGS DNA POLYMERASE GROUND SQUIRREL 448-475 HEPATITIS |
| VIRUS |
| PDPOL-- HPBHE DNA POLYMERASE HERON HEPATITIS B VIRUS 4-29 554-572 |
| PDPOL-- HPBV2 DNA POLYMERASE HEPATITIS B VIRUS 412-439 447-463 |
| 761-780 |
| (SUBTYPE ADW2) |
| PDPOL-- |
| HPBV4 DNA POLYMERASE HEPATITIS B VIRUS 410-417 (SUBTYPE |
| AR4) |
| PDPOL-- HPBV9 DNA POLYMERASE HEPATITIS B VIRUS 412-439 447-463 |
| 763-780 |
| (SUBTYPE ADW/STRAIN 991) |
| PDPOL-- HPBVA DNA POLYMERASE HEPATITIS B VIRUS 80-96 399-426 |
| 434-450 750-767 |
| (STRAIN ALPHA1) |
| PDPOL-- HPBVI DNA POLYMERASE HEPATITIS B VIRUS 80-96 410-437 |
| 445-468 761-778 |
| (SUBTYPE ADW/STRAIN |
| INDONESIA/PIDW420) |
| PDPOL-- HPBVJ DNA POLYMERASE HEPATITIS B VIRUS 80-96 410-437 |
| 445-468 761-778 |
| (SUBTYPE ADW/STRAIN |
| JAPAN/PJDW233) |
| PDPOL-- HPBVL DNA POLYMERASE HEPATITIS B VIRUS 80-96 399-426 |
| 434-457 760-767 |
| (STRAIN LSH/CHIMPANZEE |
| ISOLATE) |
| PDPOL-- HPBVM DNA POLYMERASE HEPATITIS B VIRUS 80-96 410-437 |
| 760-777 |
| (SUBTYPE ADR/MUTANT) |
| PDPOL-- HPBVO DNA POLYMERASE HEPATITIS B VIRUS 80-96 410-437 |
| 445-468 761-778 |
| (SUBTYPE ADW/STRAIN |
| OKINAWA/PODW282) |
| PDPOL-- HPBVP DNA POLYMERASE HEPATITIS B VIRUS 412-439 447-463 |
| (SUBTYPE ADW/STRAIN |
| PHILIPPINO/PFDW294) |
| PDPOL-- HPBVR DNA POLYMERASE HEPATITIS B VIRUS 80-95 410-437 |
| 761-778 |
| (SUBTYPE ADR) |
| PDPOL-- HPBVW DNA POLYMERASE HEPATITIS B VIRUS 82-98 406-432 |
| 440-456 |
| (SUBTYPE ADW) |
| PDPOL-- HPBVY DNA POLYMERASE HEPATITIS B VIRUS 80-96 410-437 |
| 761-778 |
| (SUBTYPE AYW) |
| PDPOL-- HPBVZ DNA POLYMERASE HEPATITIS B VIRUS 80-96 399-426 |
| 434-457 |
| (SUBTYPE ADYW) |
| PDPOL-- HSV11 DNA POLYMERASE HERPES SIMPLEX VIRUS 797-817 887-897 |
| 1073-1090 |
| (TYPE 1/STRAIN 17) |
| PDPOL-- HSV1A DNA POLYMERASE HERPES SIMPLEX VIRUS 797-817 887-897 |
| 1073-1090 |
| (TYPE 1/STRAIN ANGELOTTI) |
| PDPOL-- HSV1K DNA POLYMERASE HERPES SIMPLEX VIRUS 797-817 887-897 |
| 1073-1090 |
| (TYPE 1/STRAIN KOS) |
| PDPOL-- HSV1S DNA POLYMERASE HERPES SIMPLEX VIRUS 797-817 887-897 |
| 1073-1090 |
| (TYPE 1/STRAIN SC16) |
| PDPOL-- HSV21 DNA POLYMERASE HERPES SIMPLEX VIRUS 802-822 882-902 |
| 1078-1095 |
| (TYPE 2/STRAIN 186) |
| PDPOL-- HSV6U DNA POLYMERASE HERPES SIMPLEX VIRUS 652-672 786-803 |
| 858-882 |
| (TYPE 6/STRAIN UGANDA-1102) |
| PDPOL-- HSVEB DNA POLYMERASE EQUINE HERPESVIRUS 283-299 377-392 |
| 454-477 798-818 878-898 |
| TYPE 1 (STRAIN AB4P) |
| PDPOL-- HSVII DNA POLYMERASE ICTALURID HERPESVIRUS 1 257-275 |
| 397-418 |
| PDPOL-- HSVSA DNA POLYMERASE HERPESVIRUS SAIMIRI 118-137 297-319 |
| 344-364 514-532 955-972 |
| (STRAIN 11) |
| PDPOL-- MCMVS DNA POLYMERASE MURINE CYTOMEGALOVIRUS 303-322 |
| 535-553 780-802 |
| (STRAIN SMITH) |
| PDPOL-- NPVAC DNA POLYMERASE AUTOGRAPHA CALIFORNICA 518-536 |
| 676-697 |
| NUCLEAR POLYHEDROSIS VIRUS |
| PDPOL-- |
| VARV DNA POLYMERASE VARIOLA VIRUS 421-437 PDPOL-- |
| VZVD DNA POLYMERASE VARICELLA-ZOSTER 312-331 363-382 440-463 713-740 |
| 757-781 1006-1024 |
| VIRUS (STRAIN DUMAS) |
| PDPOL-- |
| WHVI DNA POLYMERASE WOODCHUCK HEPATITIS 446-473 VIRUS 1 |
| PDPOL-- WHV59 DNA POLYMERASE WOODCHUCK HEPATITIS 451-478 |
| VIRUS 59 |
| PDPOL-- |
| WHV7 DNA POLYMERASE WOODCHUCK HEPATITIS 451-478 VIRUS 7 |
| PDPOL-- WHV8 DNA POLYMERASE WOODCHUCK HEPATITIS 450-477 554-571 |
| VIRUS 8 |
| PDPOL-- |
| WHV8I DNA POLYMERASE WOODCHUCK HEPATITIS 541-478 VIRUS 8 |
| PDPOL-- WHVW6 DNA POLYMERASE WOODCHUCK HEPATITIS 123-150 |
| VIRUS W64 (ISOLATE PWS23) |
| PDPOM-- HPBVY DNA POLYMERASE HEPATITIS B VIRUS 399-426 434-450 |
| 750-767 |
| (SUBTYPE AYW) |
| PDUT-- |
| HCMVA DUTPASE HUMAN CYTOMEGALOVIRUS 107-126 (SUBTYPE |
| AYW) |
| PDUT-- |
| HSVE4 DUTPASE EQUINE HERPESVIRUS 130-154 TYPE 4 |
| (STRAIN 1942) |
| PDUT-- |
| HSVEB DUTPASE EQUINE HERPESVIRUS 130-149 TYPE 1 |
| (STRAIN AB4P) |
| PDUT-- |
| HSV11 DUTPASE ICTALURID HERPESVIRUS 1 72-95 PDUT-- |
| HSVSA DUTPASE HERPESVIRUS SAIMIRI 22-45 79-104 168-183 |
| (STRAIN 11) |
| PE111-- ADEM1 EARLY E1A 11 KD PROTEIN MOUSE ADENOVIRUS TYPE 1 |
| 24-47 |
| PE1A6-- ADE07 EARLY E1A 63 KD PROTEIN HUMAN ADENOVIRUS TYPE 7 |
| 8-35 |
| PE1A-- ADE04 EARLY EIA 28 KD PROTEIN HUMAN ADENOVIRUS TYPE 4 |
| 104-120 |
| PE1A-- ADE07 EARLY E1A 28 KD PROTEIN HUMAN ADENOVIRUS TYPE 7 8-35 |
| PE1A-- ADES7 EARLY E1A 28 KD PROTEIN SIMIAN ADENOVIRUS TYPE 7 |
| 173-189 238-254 |
| PE1BL-- ADE12 E1B PROTEIN, LARGE HUMAN ADENOVIRUS TYPE 12 451-467 |
| T-ANTIGEN |
| PE1BL-- ADEC2 E1B PROTEIN, LARGE CANINE ADENOVIRUS TYPE 2 101-122 |
| T-ANTIGEN |
| PE1BL-- ADENT EARLY E1B 44 KD PROTEIN TUPAIA ADENOVIRUS 75-101 |
| PE1BS-- ADEC2 E1B PROTEIN, CANINE ADENOVIRUS TYPE 2 55-77 |
| SMALL T-ANTIGEN |
| PE1BS-- ADEM1 E1B PROTEIN, MOUSE ADENOVIRUS TYPE 1 118-138 |
| SMALL T-ANTIGEN |
| PE310-- ADE02 EARLY E3B 10 4 KD PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| 3-21 34-60 |
| PRECURSOR |
| PE310-- ADE05 EARLY E3B 10 4 KD PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| 3-21 33-60 |
| PRECURSOR |
| PE310-- ADE07 EARLY E3B 10 4 KD PROTEIN HUMAN ADENOVIRUS TYPE 7 |
| 3-24 |
| PRECURSOR |
| PE311-- ADE02 EARLY E3A 11 6 KD GLYCO- HUMAN ADENOVIRUS TYPE 2 |
| 27-53 |
| PROTEIN |
| PE311-- ADE03 EARLY E3 9 0 KD GLYCO- HUMAN ADENOVIRUS TYPE 3 |
| 19-45 |
| PROTEIN |
| PE311-- ADE05 EARLY E3A 10 5 KD GLYCO- HUMAN ADENOVIRUS TYPE 5 |
| 20-46 |
| PROTEIN |
| PE311-- ADE07 EARLY E3A 7 7 KD GLYCO- HUMAN ADENOVIRUS TYPE 7 |
| 36-62 |
| PROTEIN |
| PE314-- ADE05 EARLY E3 14 5 KD GLYCO- HUMAN ADENOVIRUS TYPE 7 |
| 108-125 |
| PROTEIN |
| PE315-- ADE03 EARLY E3B 14 5 KD PROTEIN HUMAN ADENOVIRUS TYPE 3 |
| 52-72 |
| PRECURSOR |
| PE315-- ADE07 EARLY E3B 14 9 KD PROTEIN HUMAN ADENOVIRUS TYPE 7 |
| 52-72 |
| PRECURSOR |
| PE315-- ADE03 EARLY E3 16 KD GLYCO- HUMAN ADENOVIRUS TYPE 3 |
| 102-125 |
| PROTEIN |
| PE321-- ADE03 EARLY E3 20 5 KD GLYCO- HUMAN ADENOVIRUS TYPE 3 |
| 146-167 |
| PROTEIN |
| PE321-- ADE07 EARLY E3 20 5 KD GLYCO- HUMAN ADENOVIRUS TYPE 7 |
| 146-167 |
| PROTEIN |
| PE322-- ADEC1 EARLY E3 22 2 KD GLYCO- CANINE ADENOVIRUS TYPE 1 |
| (STRAIN GLAXO) 155-177 |
| PROTEIN |
| PE3GL-- ADEM1 EARLY E3 17 7 KD GLYCO- MOUSE ADENOVIRUS TYPE 1 |
| 105-127 |
| PROTEIN |
| PE411-- ADE02 PROBABLE EARLY E4 11 KD HUMAN ADENOVIRUS TYPE 2 |
| 56-77 |
| PROTEIN |
| PE411-- ADE05 PROBABLE EARLY E4 11 KD HUMAN ADENOVIRUS TYPE 5 |
| 56-77 |
| PROTEIN |
| PE433-- ADEM1 PROBABLE EARLY E4 33 KD MOUSE ADENOVIRUS TYPE 1 |
| 61-80 |
| PROTEIN |
| PE434-- ADE02 EARLY E434 KD PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| 80-106 |
| PEAD-- EBV EARLY ANTIGEN PROTEIN D EPSTEIN-BARR VIRUS 263-286 |
| (STRAIN B95-8) |
| PEAR-- EBV EARLY ANTIGEN PROTEIN R EPSTEIN-BARR VIRUS 159-184 |
| (STRAIN B95-8) |
| PEBN2-- EBV EBNA-2 NUCLEAR PROTEIN EPSTEIN-BARR VIRUS 126-141 |
| (STRAIN B95-8) |
| PEBN3-- EBV EBNA-3 NUCLEAR PROTEIN EPSTEIN-BARR VIRUS 113-131 |
| 662-683 |
| (STRAIN B95-8) |
| PEFT1-- |
| VARV EARLY TRANSCRIPTION VARIOLA VIRUS 21-41 FACTOR 70 |
| KD SUBUNIT |
| PENV1-- |
| FRSFV ENV POLYPROTEIN FRIEND SPLEEN 380-407 PRECURSOR |
| FOCUS-FORMING VIRUS |
| PENV2-- |
| FRSFV ENV POLYPROTEIN FRIEND SPLEEN 380-407 PRECURSOR |
| FOCUS-FORMING VIRUS |
| PENV-- AVIR3 ENV POLYPROTEIN AVAIN RETROVIRUS RPL30 206-225 |
| PENV-- AVISU COAT PROTEIN GP37 AVAIN SARCOMA VIRUS 98-117 |
| (STRAIN UR2) |
| PENV-- BAEVM ENV POLYPROTEIN BABOON ENDOGENOUS 170-190 202-224 |
| VIRUS (STRAIN M7) |
| PENV-- BIV06 ENV POLYPROTEIN BOVINE IMMUNODEFICIENCY 47-68 |
| 178-201 434-450 525-546 |
| PRECURSOR VIRUS (ISOLATE 106) |
| PENV-- BIV27 ENV POLYPROTEIN BOVINE IMMUNODEFICIENCY 47-68 |
| 147-168 207-230 463-479 554-575 |
| PRECURSOR VIRUS (ISOLATE 127) |
| PENV-- BLVAF ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS 303-327 |
| (AMERICAN ISOLATE FLK) |
| PENV-- BLVAU ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS 303-327 |
| (AUSTRALIAN ISOLATE) |
| PENV-- BLVAV ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS 303-327 |
| (AMERICAN ISOLATE VDM) |
| PENV-- BLVB2 ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS 303-327 |
| (BELGIUM ISOLATE LB285) |
| PENV-- BLVB5 ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS 303-327 |
| (BELGIUM ISOLATE LB59) |
| PENV-- BLVJ ENV POLYPROTEIN BOVINE LEUKEMIA VIRUS 303-327 |
| (JAPANESE ISOLATE BLV-1) |
| PENV-- FENV1 ENV POLYPROTEIN FELINE ENDOGENOUS 30-47 225-246 |
| 630-651 |
| PRECURSOR VIRUS ECE1 |
| PENV-- FIVPE ENV POLYPROTEIN FELINE ENDOGENOUS 30-47 225-246 |
| 630-651 |
| PRECURSOR VIRUS ECE1 |
| PENV-- FLVC6 ENV POLYPROTEIN FELINE LEUKEMIA PROVIRUS 38-55 |
| 624-645 |
| PRECURSOR (CLONE CFE-6) - PENV-- FLVGL ENV POLYPROTEIN FELINE |
| LEUKEMIA VIRUS 9-29 447-468 605-626 |
| PRECURSOR (STRAIN A/GLASGOW-1) |
| PENV-- FLVLB ENV POLYPROTEIN FELINE LEUKEMIA VIRUS 467-488 |
| 625-646 |
| PRECURSOR (STRAIN LAMBDA-B1) |
| PENV-- FLVSA ENV POLYPROTEIN FELINE LEUKEMIA VIRUS 444-465 |
| 602-623 |
| PRECURSOR (STRAIN SARMA) |
| PENV-- FOAMV ENV POLYPROTEIN HUMAN SPUMARETROVIRUS 153-174 |
| 255-275 300-325 481-496 710-727 864-887 924-951 957-978 |
| (FOAMY VIRUS) |
| PENV-- FSVGA ENV POLYPROTEIN FELINE SARCOMA VIRUS 467-488 625-646 |
| PRECURSOR (STRAIN GARDNER-ARNSTEIN) |
| PENV-- FSVGB ENV POLYPROTEIN FELINE SARCOMA 447-468 605-626 |
| PRECURSOR VIRUS (STRAIN GA) |
| PENV-- FSVSM ENV POLYPROTEIN FELINE SARCOMA VIRUS 450-471 608-629 |
| PRECURSOR (STRAIN SM) |
| PENV-- FSVST ENV POLYPROTEIN FELINE SARCOMA VIRUS 467-488 |
| PRECURSOR (STRAIN SNYDER-THEILEN) |
| PENV-- GALV ENV POLYPROTEIN GIBBON APE LEUKEMIA VIRUS 519-540 |
| PRECURSOR |
| PENV-- HV1B1 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 498-520 |
| VIRUS TYPE 1 (BH10 ISOLATE) |
| PENV-- HV1B8 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 493-515 |
| VIRUS TYPE 1 (BH8 ISOLATE) |
| PENV-- HVIBN GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 494-516 |
| VIRUS TYPE 1 (BRAIN ISOLATE) |
| PENV-- HVIBR GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 503-525 |
| VIRUS TYPE 1 (BRU ISOLATE) |
| PENV-- HVIC4 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 428-448 |
| VIRUS TYPE 1 (CDC-451 |
| ISOLATE) |
| PENV-- HVIEL GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 495-517 |
| VIRUS TYPE 1 (ELIISOLATE) |
| PENV-- HV1H2 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 498-520 |
| VIRUS TYPE 1 (HXB2 ISOLATE) |
| PENV-- HV1H3 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 498-520 |
| VIRUS TYPE 1 (HXB3 ISOLATE) |
| PENV-- HV1J3 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 510-532 |
| VIRUS TYPE 1 (JH3 ISOLATE) |
| PENV-- HVIJR GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 490-512 |
| VIRUS TYPE 1 (JRCSF ISOLATE) |
| PENV-- HVIKB GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 504-526 |
| 552-579 752-768 |
| VIRUS TYPE 1 (STRAIN |
| KB-1-GP32) |
| PENV-- HVIMA GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 500-522 |
| VIRUS TYPE 1 (MAL ISOLATE) |
| PENV-- HVIMG GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 496-518 |
| VIRUS TYPE 1 (MFA ISOLATE) |
| PENV-- HVIN5 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 178-203 |
| VIRUS TYPE 1 (NEW YORK-5 |
| ISOLATE) |
| PENV-- HVIND GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 488-510 |
| VIRUS TYPE 1 (NDK ISOLATE) |
| PENV-- HVIOY GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 123-140 |
| VIRUS TYPE 1 (OY1 ISOLATE) |
| PENV-- HVIPV GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 498-520 |
| VIRUS TYPE 1 (PV22 ISOLATE) |
| PENV-- HVIRH GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 445-460 |
| VIRUS TYPE 1 (RF/HAT |
| ISOLATE) |
| PENV-- HVIS1 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 489-511 |
| 738-754 |
| VIRUS TYPE 1 (SF162 ISOLATE) |
| PENV-- HVIS3 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 300-322 |
| VIRUS TYPE 1 (SF33 ISOLATE) |
| PENV-- HVIZ2 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 123-145 |
| 410-427 495-517 |
| VIRUS TYPE 1 (Z2/CDC-Z34 |
| ISOLATE) |
| PENV-- HVIZ3 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 117-133 |
| 175-198 |
| VIRUS TYPE 1 (ZAIRE 3 |
| ISOLATE) |
| PENV-- HVIZ6 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 497-519 |
| VIRUS TYPE 1 (ZAIRE 6 |
| ISOLATE) |
| PENV-- HVIZ8 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 505-527 |
| VIRUS TYPE 1 (Z-84 ISOLATE) |
| PENV-- HVIZH GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 123-142 |
| 438-453 498-520 |
| VIRUS TYPE 1 (ZAIRE HZ321 |
| ISOLATE) |
| PENV-- HV2BE GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 3-26 750-775 |
| 781-804 |
| VIRUS TYPE 2 (ISOLATE BEN) |
| PENV-- HV2CA GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 750-777 |
| VIRUS TYPE 2 (ISOLATE CAM2) |
| PENV-- HV2D1 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 3-26 741-766 |
| 772-795 |
| VIRUS TYPE 2 (ISOLATE D194) |
| PENV-- |
| HV2D2 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 9-28 VIRUS |
| TYPE 2 (ISOLATE D205.7) |
| PENV-- HV2G1 GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 741-766 |
| 772-795 |
| VIRUS TYPE 2 (ISOLATE |
| GHANA-1) |
| PENV-- HV2NZ GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 742-767 |
| 777-800 |
| VIRUS TYPE 2 (ISOLATE H1H-Z) |
| PENV-- HV2RO GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 751-776 |
| VIRUS TYPE 2 (ISOLATE ROD) |
| PENV-- HV2SB GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 743-768 |
| 778-804 |
| VIRUS TYPE 2 (ISOLATE SBLISY) |
| PENV-- HV2ST GP160 PRECURSOR HUMAN IMMUNODEFICIENCY 745-770 |
| VIRUS TYPE 2 (ISOLATE ST) |
| PENV-- JSRV ENV POLYPROTEIN SHEEP PULMONARY ADENO- 104-119 |
| 299-325 376-398 541-564 |
| PRECURSOR MATOSIS VIRUS |
| PENV-- MCFF ENV POLYPROTEIN MINK CELL FOCUS-FORMING 600-621 |
| PRECURSOR MURINE LEUKEMIA VIRUS |
| PENV-- MCFF3 ENV POLYPROTEIN MINK CELL FOCUS-FORMING 601-622 |
| PRECURSOR MURINE LEUKEMIA VIRUS |
| (ISOLATE CI-) |
| PENV-- MLVAV ENV POLYPROTEIN AKV MURINE LEUKEMIA VIRUS 630-651 |
| PRECURSOR |
| PENV-- |
| MLVCB ENV POLYPROTEIN CAS-BR-E MURINE 625-646 PRECURSOR |
| LEUKEMIA VIRUS |
| PENV-- |
| MLVF5 ENV POLYPROTEIN FRIEND MURINE 639-660 PRECURSOR |
| LEUKEMIA VIRUS (ISOLATE 57) |
| PENV-- |
| MLVFF ENV POLYPROTEIN FRIEND MURINE 639-660 PRECURSOR |
| LEUKEMIA VIRUS (ISOLATE |
| FB29) |
| PENV-- MLVFP ENV POLYPROTEIN FRIEND MURINE LEUKEMIA 639-660 |
| PRECURSOR VIRUS (ISOLATE PVC-211) |
| PENV-- MLVHO ENV POLYPROTEIN HOMULV MURINE LEUKEMIA 626-647 |
| PRECURSOR VIRUS (MUS HORTULANUS |
| VIRUS) |
| PENV-- |
| MLVK1 ENV POLYPROTEIN KIRSTEN MURINE 167-188 LEUKEMIA |
| VIRUS |
| PENV-- |
| MLVMO ENV POLYPROTEIN MOLONEY MURINE 629.650 PRECURSOR |
| LEUKEMIA VIRUS |
| PENV-- |
| MLVRD ENV POLYPROTEIN RADIATION MURINE 624-645 PRECURSOR |
| LEUKEMIA VIRUS |
| PENV-- |
| MLVRK ENV POLYPROTEIN RADIATION MURINE 624-645 PRECURSOR |
| LEUKEMIA VIRUS (STRAIN |
| KAPLAN) |
| PENV-- |
| MMTVB ENV POLYPROTEIN MOUSE MAMMARY TUMOR 643-663 VIRUS |
| (STRAIN BR6) |
| PENV-- |
| MMTVG ENV POLYPROTEIN MOUSE MAMMARY TUMOR 643-663 VIRUS |
| (STRAIN GR) |
| PENV-- MPMV ENV POLYPROTEIN SIMIAN MASON-PFIZER VIRUS 213-235 |
| PENV-- |
| MSVFB ENV POLYPROTEIN FBJ MURINE 170-191 OSTEOSARCOMA |
| VIRUS |
| PENV-- |
| OMVVS ENV POLYPROTEIN OVINE LENTIVIRUS 658-683 PRECURSOR |
| (STRAIN SA-OMVV) |
| PENV-- |
| RMCFV ENV POLYPROTEIN RAUSCHER MINK CELL 603-624 PRECURSOR |
| FOCUS-INDUCING VIRUS |
| PENV-- RSVP ENV POLYPROTEIN ROUS SARCOMA VIRUS 42-69 533-552 |
| (STRAIN PRAGUE C) |
| PENV-- SFV1 ENV POLYPROTEIN SIMIAN FOAMY VIRUS 300-325 710-727 |
| 864-887 924-951 967-978 |
| (TYPE 1) |
| PENV-- SFV3L ENV POLYPROTEIN SIMIAN FOAMY VIRUS 157-178 304-329 |
| 707-724 861-884 921-948 954-975 |
| (TYPE 3/STRAIN LK3) |
| PENV-- SIVA1 GP160 PRECURSOR SIMIAN IMMUNODEFICIENCY 437-458 |
| VIRUS (AGM155 ISOLATE) |
| PENV-- SIVAG GP160 PRECURSOR SIMIAN IMMUNODEFICIENCY 442-463 |
| VIRUS (AGM3 ISOLATE) |
| PENV-- SIVAI GP160 PRECURSOR SIMIAN IMMUNODEFICIENCY 421-442 |
| VIRUS (ISOLATE AGM/CLONE |
| GRI-1) |
| PENV-- SIVAT GP160 PRECURSOR SIMIAN IMMUNODEFICIENCY 435-456 |
| VIRUS (TYO-1 ISOLATE) |
| PENV-- SIVGB GP160 PRECURSOR SIMIAN IMMUNODEFICIENCY 93-109 |
| VIRUS (ISOLATE GBI) |
| PENV-- SIVM1 GP 160 PRECURSER SIMIAN IMMUNODEFICIENCY 766-793 |
| 803-826 |
| VIRUS (MM142-83 ISOLATE) |
| PENV-- SIVMK GP 160 PRECURSER SIMIAN IMMUNODEFICIENCY 139-154 |
| 765-792 802-825 |
| (K6W ISOLATE) |
| PENV-- SIVML GP 160 PRECURSER SIMIAN IMMUNODEFICIENCY 139-154 |
| 764-791 801-824 |
| (K78 ISOLATE) |
| PENV-- SIVS4 GP 160 PRECURSER SIMIAN IMMUNODEFICIENCY 769-789 |
| 806-829 |
| (F236/SMH4 ISOLATE) |
| PENV-- SIVSP GP 160 PRECURSER SIMIAN IMMUNODEFICIENCY 773-793 |
| 810-833 |
| (PBJ/BC13 ISOLATE) |
| PENV-- |
| SMSAV P15E PROTEIN SIMIAN SARCOMA VIRUS 42-63 PENV-- |
| SRV1 ENV POLYPROTEIN SIMIAN RETROVIRUS SRV-1 213-235 |
| PERBA-- AVIER ERBA ONCOGENE AVIAN ERYTHROBLASTOSIS 227-249 |
| PROTEIN VIRUS (STRAIN ES4) |
| PETF1-- FOWP1 EARLY TRANSCRIPTION FOWLPOX VIRUS 21-41 73-92 |
| FACTOR (STRAIN FP-1) |
| PETF1-- SFVKA EARLY TRANSCRIPTION SHOPE FIBROMA VIRUS 21-41 |
| FACTOR (STRAIN KASZA) |
| PETF1-- |
| VACCC EARLY TRANSCRIPTION VACCINA VIRUS 21-41 FACTOR |
| (STRAIN COPENHAGEN) |
| PETF1-- |
| VACCV EARLY TRANSCRIPTION VACCINA VIRUS 21-41 FACTOR |
| (STRAIN WR) |
| PETF2-- VACCC EARLY TRANSCRIPTION VACCINA VIRUS 50-73 101-117 |
| 165-817 285-308 558-582 |
| FACTOR 82 KD SUBUNIT (STRAIN COPENHAGEN) |
| PETF2-- |
| VACCV EARLY TRANSCRIPTION VACCINA VIRUS 48-72 FACTOR 82 |
| KD SUBUNIT (STRAIN WR) |
| PETF2-- VARV EARLY TRANSCRIPTION VARIOLA VIRUS 50-73 101-117 |
| 165-817 285-308 558-582 |
| FACTOR 82 KD SUBUNIT |
| PEXON-- HSV11 ALKALINE EXONUCLEASE HERPES SIMPLEX VIRUS 165-180 |
| (TYPE 1/STRAIN 17) |
| PEXON-- HSV2 ALKALINE EXONUCLEASE HERPES SIMPLEX VIRUS 155-170 |
| (TYPE 2) |
| PEXON-- HSVEB ALKALINE EXONUCLEASE EQUINE HERPESVIRUS 276-291 |
| TYPE 1 (STRAIN AB4P) |
| PEXON-- PRVN3 ALKALINE EXONUCLEASE PSUDORABIES VIRUS 36-51 |
| (STRAIN NIA-3) |
| PEXON-- VZVD ALKALINE EXONUCLEASE VARICELLA-ZOSTER VIRUS 28-44 |
| 217-262 |
| (STRAIN DUMAS) |
| PFIB2-- ADE40 41 4 KD FIBER PROTEIN HUMAN ADENOVIRUS 116-133 |
| TYPE 40 |
| PFIB2-- ADE41 41 4 KD FIBER PROTEIN HUMAN ADENOVIRUS 116-133 |
| TYPE 41 |
| PFIBP-- |
| ADE03 FIBER PROTEIN HUMAN ADENOVIRUS 152-173 TYPE 3 |
| PFIBP-- |
| ADE05 FIBER PROTEIN HUMAN ADENOVIRUS 447-473 TYPE 5 |
| PFIBP-- ADEB3 FIBER PROTEIN BOVINE ADENOVIRUS 347-372 |
| 775-801 |
| TYPE 3 (MASTADENOVIRUS |
| BOS3) |
| PFIBP-- |
| ADEC1 FIBER PROTEIN CANINE ADENOVIRUS 382-397 TYPE 1 |
| (STRAIN GLAXO) |
| PFIBP-- ADEM1 FIBER PROTEIN MOUSE ADENOVIRUS 191-215 227-252 |
| 493-513 548-571 579-599 |
| TYPE 1 |
| PGAG-- |
| AVEV1 GAG POLYPROTEIN AVIAN ENDOGENOUS 53-78 VIRUS |
| EV-1 |
| PGAG-- |
| AVEV2 GAG POLYPROTEIN AVIAN ENDOGENOUS 2-27 ROUS-ASSOC |
| IATED VIRUS-0 |
| PGAG-- AV1MC GAG POLYPROTEIN AVIAN MYELOCYTOMATOSIS 53-78 |
| VIRUS MC29 |
| PGAG-- AV1MD GAG POLYPROTEIN AVIAN MYELOCYTOMATOSIS 53-78 |
| VIRUS HB1 |
| PGAG-- |
| AV1SU CORE PROTEIN P19 AVIAN SARCOMA VIRUS 53-78 (STRAIN |
| UR2) |
| PGAG-- |
| AV1SY GAG POLYPROTEIN AVIAN SARCOMA VIRUS 53-78 (STRAIN |
| Y73) |
| PGAG-- |
| BAEVM GAG POLYPROTEIN BABOON ENDOGENOUS 397-422 VIRUS |
| (STRAIN M7) |
| PGAG-- BLVAU GAG POLYPROTEIN BOVINE LEUKEMIA VIRUS 212-238 |
| (AUSTRALIAN ISOLATE) |
| PGAG-- BLVJ GAG POLYPROTEIN BOVINE LEUKEMIA VIRUS 213-239 |
| (JAPANESE ISOLATE BLV-1) |
| PGAG-- CAEVC GAG POLYPROTEIN CAPRINE ARTHRITIS ENCEPHA- 102-119 |
| LITIS VIRUS (STRAIN CORK) |
| PGAG-- FUJSV GAG POLYPROTEIN FUJINAMI SARCOMA VIRUS 53-78 |
| PGAG-- HTL1A GAG POLYPROTEIN HUMAN T-CELL LEUKEMIA 77-94 |
| VIRUS TYPE 1 (STRAIN ATK) |
| PGAG-- |
| HTL1C GAG POLYPROTEIN HUMAN T-CELL LEUKEMIA 77-94 VIRUS |
| TYPE 1 (CARIBBEAN |
| ISOLATE) |
| PGAG-- |
| HTL1M GAG POLYPROTEIN HUMAN T-CELL LEUKEMIA 77-94 VIRUS |
| TYPE 1 (ISOLATE MT-2) |
| PGAG-- |
| HV1A2 GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (ARV2/SF2 |
| ISOLATE) |
| PGAG-- |
| HV1B1 GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (BH10 ISOLATE) |
| PGAG-- |
| HV1B5 GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (BH5 ISOLATE) |
| PGAG-- |
| HV1BR GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (BRU ISOLATE) |
| PGAG-- |
| HV1C4 GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (IDC-451 |
| ISOLATE) |
| PGAG-- |
| HV1EL GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (ELI ISOLATE) |
| PGAG-- |
| HV1H2 GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (HXB2 ISOLATE) |
| PGAG-- |
| HV1J3 GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (JH3 ISOLATE) |
| PGAG-- |
| HV1JR GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (JRCSF ISOLATE) |
| PGAG-- HV1MA GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 262-285 |
| VIRUS TYPE 1 (MAL ISOLATE) |
| PGAG-- |
| HV1MN GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (MN ISOLATE) |
| PGAG-- |
| HV1N5 GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (NEW YORK-5 |
| ISOLATE) |
| PGAG-- HV1ND GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 352-373 |
| VIRUS TYPE 1 (NDK ISOLATE) |
| PGAG-- |
| HV1OY GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (OYI ISOLATE) |
| PGAG-- |
| HV1PV GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (PV22 ISOLATE) |
| PGAG-- |
| HV1RH GAG POLYPROTEIN HUMAN IMMUNOEFICIENCY 65-91 VIRUS |
| TYPE 1 (RF/HAT |
| ISOLATE) |
| PGAG-- HV1U4 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY 65-91 |
| VIRUS TYPE 1 (STRAIN |
| UGANDAN/ISO |
| PGAG-- HV1W2 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY 65-91 |
| VIRUS TYPE 1 (WMJ2 ISOLATE) |
| PGAG-- HV1Z2 GAG POLYPROTEIN HUMAN IMMUNODEFICIENCY 65-91 |
| VIRUS TYPE 1 (Z2/CDC-Z34 |
| ISOLATE) |
| PGAG-- IPMA RETROVIRUS-RELATED MOUSE INTRACISTERNAL 757-772 |
| GAG POLYPROTEIN A-PARTICLE |
| PGAG-- |
| MMTVB GAG POLYPROTEIN MOUSE MAMMARY TUMOR 82-97 VIRUS |
| (STRAIN BR6) |
| PGAG-- |
| MMTVC GAG POLYPROTEIN MOUSE MAMMARY TUMOR 82-97 VIRUS |
| (STRAIN C3H) |
| PGAG-- |
| MMTVG GAG POLYPROTEIN MOUSE MAMMARY TUMOR 82-97 VIRUS |
| (STRAIN GR) |
| PGAG-- |
| RSVP GAG POLYPROTEIN ROUS SARCOMA VIRUS 53-78 (STRAIN |
| PRAGUE C) |
| PGAG-- SCVLA MAJOR COAT PROTEIN SACCHAROMYCES CEREVISIAE 618-645 |
| VIRUS L-A |
| PGAG-- |
| SFV1 GAG POLYPROTEIN SIMIAN FOAMY VIRUS 85-103 (TYPE 1) |
| PGAG-- |
| SFV3L GAG POLYPROTEIN SIMIAN FOAMY VIRUS 83-101 (TYPE |
| 3/STRAIN LK3) |
| PGAG-- SIVA1 GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY 189-213 |
| VIRUS (AGM155 ISOLATE) |
| PGAG-- SIVAG GAG POLYPROTEIN SIMAIN IMMUNODEFICIENCY 193-217 |
| VIRUS (AGM3 ISOLATE) |
| PGAG-- SIVAT GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY 189-213 |
| VIRUS (TYO-1 ISOLATE) |
| PGAG-- |
| SIVCZ GAG POLYPROTEIN CHIMPANZEE IMMUNO- 66-92 DEFICIENCY |
| VIRUS (SIV(CPZ)) |
| PGAG-- SIVGB GAG POLYPROTEIN SIMIAN IMMUNODEFICIENCY 66-92 |
| VIRUS (ISOLATE GBI) |
| PGAG-- |
| SIVM1 GAG POLYPROTEIN SIMIAN IMMUNODDEFICIENCY VIRUS |
| (MM142-83 ISOLATE) |
| PGAG-- |
| SMRVH GAG POLYPROTEIN SQUIRREL MONKEY 286-307 RETROVIRUS |
| (SMRV-H) |
| PGLRX-- |
| VACCC POSSIBLE GLUTAREDOXIN VACCINIA VIRUS 71-87 (STRAIN |
| COPENHAGEN), |
| AND (STRAIN L-1VP) |
| PGLRX-- |
| VARV POSSIBLE GLUTAREDOXIN VARIOLA VIRUS 71-87 PGRAN-- |
| GVAS GRANULIN AGROTIS SEGUTUM 208-226 |
| GRANULOSIS VIRUS |
| PGRAN-- |
| GVTN GRANULIN TRICHOPLUSIA NI 209-227 GRANULOSIS |
| VIRUS |
| PGRFA-- |
| VACCCC GROWTH FACTOR VACCINIA VIRUS 104-124 (STRAIN |
| COPENHAGEN) |
| PGRFA-- |
| VACCV GROWTH FACTOR VACCINIA VIRUS 104-123 (STRAIN |
| WR) |
| PGRFA-- |
| VARV GROWTH FACTOR VARIOLA VIRUS 104-122 PHELI-- |
| EBV PROBABLE HELICASE EPSTEIN-BARR VIRUS 180-207 338-361 438-464 |
| (STRAIN B95-8) |
| PHELI-- HCMVA PROBABLE HELICASE HUMAN CYTOMEGALOVIRUS 397-420 |
| 539-560 826-852 |
| (STRAIN AD169) |
| PHELI-- HSV11 PROBABLE HELICASE HERPES SIMPLEX VIRUS 389-408 |
| 628-646 |
| (TYPE 1/STRAIN 17) |
| PHELI-- HSV2H PROBABLE HELICASE HERPES SIMPLEX VIRUS 290-309 |
| 529-554 |
| (TYPE 2 /STRAIN HG52) |
| PHELI-- HSVEB PROBABLE HELICASE EQUINE HERPESVIRUS 181-204 |
| 243-266 394-413 |
| TYPE 1 (STRAIN AB4P) |
| PHELI-- HSVSA PROBABLE HELICASE HERPESVIRUS SAIMIRI 327-350 |
| 389-411 658-683 |
| (STRAIN 11) |
| PHELI-- VZVD PROBABLE HELICASE VARICELLA-ZOSTER VIRUS 165-189 |
| 383-402 561-578 761-786 |
| (STRAIN DUMAS) |
| PHEMA-- CDVO HEMAGGLUTININ-NEURAMINIDASE CANINE DISTEMPER VIRUS |
| 36-53 200-223 |
| (STRAIN ONDERSTEPOORT) |
| PHEMA-- CVBF HEMAGGLUTININ-ESTERASE BOVINE CORONAVIRUS 391-415 |
| PRECURSOR (STRAIN F15) |
| PHEMA-- CVBLY HEMAGGLUTININ-ESTERASE BOVINE CORONAVIRUS 391-415 |
| PRECURSOR (STRAIN LY-138) |
| PHEMA-- CVBM HEMAGGLUTININ-ESTERASE BOVINE CORONAVIRUS 391-415 |
| PRECURSOR (STRAIN MEBUS) |
| PHEMA-- CVBQ HEMAGGLUTININ-ESTERASE BOVINE CORONAVIRUS 391-415 |
| PRECURSOR (STRAIN QUEBEC), AND |
| (STRAIN L9) |
| PHEMA-- CVHOC HEMAGGLUTININ-ESTERASE HUMAN CORONAVIRUS 391-415 |
| PRECURSOR (STRAIN OC43) |
| PHEMA-- CVMA5 HEMAGGLUTININ-ESTERASE MURINE CORONAVIRUS 402-423 |
| PRECURSOR MHV (STRAIN A59) |
| PHEMA-- CVMS HEMAGGLUTININ-ESTERASE MURINE CORONAVIRUS 403-418 |
| PRECURSOR MHV (STRAIN S) |
| PHEMA-- IAAIC HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/AICHI/2/68) |
| PHEMA-- IABAN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 306-323 |
| (STRAIN A/BANGKOG/1/89) |
| PHEMA-- IABUD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 320-337 |
| (STRAIN A/BUDGERIGAR/ |
| HOKKAIDO/1/77) |
| PHEMA-- IACKA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 32-337 |
| (STRAIN A/CHICKEN/ |
| ALABAMA/1/75) |
| PHEMA-- IACKG HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 81-101 |
| 231-247 316-333 |
| (STRAIN A/CHICKEN/ |
| GERMANY/N/49) |
| PHEMA-- IACKP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 302-319 |
| (STRAIN A/CHICKEN/PENNSYL- |
| VANIA/1/83) |
| PHEMA-- IACKQ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 302-319 |
| (STRAIN A/CHICKEN/PENNSYL- |
| VANIA/1370/83) |
| PHEMA-- IACKS HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 319-336 |
| (STRAIN A/CHICKEN/SCOT- |
| LAND/59) |
| PHEMA-- IACKV HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-245 |
| 315-332 |
| (STRAIN A/CHICKEN/VICTORIA/ |
| 1/85) |
| PHEMA-- IADA1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 320-337 |
| (STRAIN A/DUCK/ALBERTA/ |
| 28/76) |
| PHEMA-- IADA3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/DUCK/ALBERTA/ |
| 78/76) |
| PHEMA-- IADCZ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 320-337 |
| (STRAIN A/DUCK/CZECHOSLO |
| VAKIA/56) |
| PHEMA-- IADE1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 266-287 |
| 319-336 |
| (STRAIN A/DUCK/ENGLAND/ |
| 1/56) |
| PHEMA-- IADH1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 306-323 |
| (STRAIN A/DUCK/HOKKAIDO/ |
| 5/77) |
| PHEMA-- IADH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 306-323 |
| (STRAIN A/DUCK/HOKKAIDO/ |
| 8/80) |
| PHEMA-- IADH3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 306-323 |
| (STRAIN A/DUCK/HOKKAIDO/ |
| 33/80) |
| PHEMA-- IADH4 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 306-323 |
| (STRAIN A/DUCK/HOKKAIDO/ |
| 7/82) |
| PHEMA-- IADH5 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 215-237 |
| (STRAIN A/DUCK/HOKKAIDO/ |
| 21/82) |
| PHEMA-- IADH6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 306-323 |
| (STRAIN A/DUCK/HOKKAIDO/ |
| 9/85) |
| PHEMA-- IADH7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 322-339 |
| (STRAIN A/DUCK/HOKKAIDO/ |
| 10/85) |
| PHEMA-- IADM2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/DUCK/MEMPHIS/ |
| 928/74) |
| PHEMA-- IADMA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 28-50 |
| 81-101 |
| (STRAIN A/DUCK/MANITOBA/ |
| 1/53) |
| PHEMA-- IADNZ HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 320-337 |
| (STRAIN A/DUCK/NEW |
| ZEALAND/31/76) |
| PHEMA-- IADU3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/DUCK/UKRAINE/ |
| 1/63) |
| PHEMA-- IAEN6 HEMAGGLUTININ INFLUENZA A VIRUS 21-43 306-323 |
| (STRAIN A/ENGLNAD/878/69) |
| PHEMA-- IAEN7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/ENGLAND/321/77) |
| PHEMA-- IAFPR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| 315-332 |
| (STRAIN A/FOWL PLAGUE |
| VIRUS/ROSTOCK/34) |
| PHEMA-- IAGRE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 320-337 |
| (STRAIN A/GREY TEAL/ |
| AUSTRALIA/2/79) |
| PHEMA-- IAGU2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 320-337 |
| (STRAIN A/GULL/ |
| MARYLAND/704/77) |
| PHEMA-- IAGUA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 319-336 |
| (STRAIN A/GULL/ |
| ASTRAKHAN/227/84) |
| PHEMA-- IAHAL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 321-338 |
| (STRAIN A/EQUINE/ALGIERS/72) |
| PHEMA-- IAHC6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| 315-332 |
| (STRAIN A/EQUINE/ |
| CAMBRIDGE/1/63) |
| PHEMA-- IAHC7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| 315-332 |
| (STRAIN A/EQUINE/ |
| CAMBRIDGE/1/73) |
| PHEMA-- IAHCD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| 315-332 |
| (STRAIN A/EQUINE/C |
| DETRIOT/1/64) |
| PHEMA-- IAHDE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| 315-332 |
| (STRAIN A/EQUINE/ |
| DETRIOT/1/64) |
| PHEMA-- IAHFO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 236-252 |
| 321-338 |
| (STRAIN A/EQUINE/ |
| FONTAINEBLEAU/76) |
| PHEMA-- IAHK6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 321-338 |
| (STRAIN A/EQUINE/ |
| KENTUCKY/2/86) |
| PHEMA-- IAHK7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 236-252 |
| 321-338 |
| (STRAIN A/EQUINE/ |
| KENTUCKY/1/87) |
| PHEMA-- IAHLE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| (STRAIN A/EQUINE/ |
| LEXINGTON/1/66) |
| PHEMA-- IAHLO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| 315-332 |
| (STRAIN A/EQUINE/ |
| LONDON/1416/73) |
| PHEMA-- IAHMI HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 236-252 |
| 321-338 |
| (STRAIN A/EQUINE/MIAMI/1/64) |
| PHEMA-- IAHNM HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 236-252 |
| 321-338 |
| (STRAIN A/EQUINE/NEW |
| MARKET/76) |
| PHEMA-- IAHNN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 315-332 |
| (STRAIN A/EQUINE/NEW |
| MARKET/1/77) |
| PHEMA-- IAHPR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 315-332 |
| (STRAIN A/EQUINE/ |
| PRAGUE/1/56) |
| PHEMA-- IAHRO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 236-252 |
| 321-338 |
| (STRAIN A/EQUINE/ |
| ROMANIA/80) |
| PHEMA-- IAHSA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 236-252 |
| 321-338 |
| (STRAIN A/EQUINE/ |
| SANTIAGO/1/85) |
| PHEMA-- IAHSP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| 315-332 |
| (STRAIN A/EQUINE/SAO |
| PAULO/1/76) |
| PHEMA-- IAHSW HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| 315-332 |
| (STRAIN A/EQUINE/ |
| SWITZERLAND/137/72) |
| PHEMA-- IAHTE HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 236-252 |
| 321-338 |
| (STRAIN A/EQUINE/ |
| TENNESSEE/5/86) |
| PHEMA-- IAHTO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 236-252 |
| 321-338 |
| (STRAIN A/EQUINE/TOKYO/71) |
| PHEMA-- IAHUR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 236-252 |
| 321-338 |
| (STRAIN A/EQUINE/URUGUAY/ |
| 1/63) |
| PHEMA-- IAJAP HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 317-334 |
| (STRAIN A/JAPAN/305/57) |
| PHEMA-- IAMAA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 197-223 |
| 319-336 |
| (STRAIN A/MALLARD/ |
| ASTRAKHAN/244/83) |
| PHEMA-- IAMAB HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 202-228 |
| 324-341 |
| (STRAIN A/MALLARD/ |
| ASTRAKHAN/263/82) |
| PHEMA-- IAMAO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/MALLARD/NEW |
| YORK/6874/78) |
| PHEMA-- IAME1 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/MEMPHIS/1/71) |
| PHEMA-- IAME2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/MEMPHIS/102/72) |
| PHEMA-- IAME6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 306-323 |
| (STRAIN A/MEMPHIS/6/86) |
| PHEMA-- IAMIN HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 85-101 |
| 231-247 316-333 |
| (STRAIN A/MINK/SWEDEN/84) |
| PHEMA-- IANT6 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/NT/60/68) |
| PHEMA-- IAPIL HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 320-337 |
| (STRAIN A/PILOT WHALE/ |
| MAINE/328/84) |
| PHEMA-- IAQU7 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 306-323 |
| (STRAIN A/QU/7/70) |
| PHEMA-- IARUD HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 320-337 |
| (STRAIN A/RUDDY TURN- |
| STONE/NEW JERSEY/47/ |
| PHEMA-- IASE2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 320-337 |
| (STRAIN A/SEAL/MASSA- |
| CHUSETTS/133/82) |
| PHEMA-- IASH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 234-250 |
| 321-338 |
| (STRAIN A/SHEARWATER/ |
| AUSTRALIA/72) |
| PHEMA-- IASTA HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| 315-332 |
| (STRAIN A/STARLING/ |
| VICTORIA/5156/85) |
| PHEMA-- IATKM HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 33-55 |
| 320-337 |
| (STRAIN A/TURKEY/ |
| MINNESOTA/833/80) |
| PHEMA-- IATKO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 233-249 |
| (STRAIN A/TURKEY/ |
| ONTARIO/7732/66) |
| PHEMA-- IATKR HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| (STRAIN A/TURKEY/ |
| OREGON/71) |
| PHEMA-- IATKW HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 230-246 |
| (STRAIN A/TURKEY/ |
| WISCONSIN/1/66) |
| PHEMA-- IAUDO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 380-397 |
| (STRAIN A/UDORN/307/72) |
| PHEMA-- IAV17 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 38-60 |
| 323-340 |
| (STRAIN A/VICTORIA/3/75) |
| PHEMA-- IAX31 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| (STRAIN X-31) |
| PHEMA-- IAZCO HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/SWINE/ |
| COLRADO/1/77) |
| PHEMA-- IAZH2 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 306-323 |
| (STRAIN A/SWINE/HONG |
| KONG/81/78) |
| PHEMA-- IAZH3 HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 21-43 |
| 306-323 |
| (STRAIN A/SWINE/HONG |
| KONG/126/82) |
| PHEMA-- IAZUK HEMAGGLUTININ PRECURSOR INFLUENZA A VIRUS 37-59 |
| 322-339 |
| (STRAIN A/SWINE/UKKEL/ - 1/84) |
| PHEMA-- INBAA HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 115-131 |
| 295-310 |
| (STRAIN B/ANN ARBOR/1/86) |
| PHEMA-- INBBE HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 123-139 |
| 303-318 |
| (STRAIN B/BEIJING/1/87) |
| PHEMA-- INBBO HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 116-132 |
| 293-306 |
| (STRAIN B/BONN/43) |
| PHEMA-- INBEN HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 123-139 |
| 301-318 |
| (STRAIN B/ENGLAND/222/82) |
| PHEMA-- INBFU HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 108-124 |
| 286-301 |
| (STRAIN B/FUKUOKA/80/81) |
| PHEMA-- INBGL HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 119-135 |
| 296-311 |
| (STRAIN B/GL/54) |
| PHEMA-- INBHK HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 116-132 |
| 293-308 |
| (STRAIN B/HONG KONG/8/73) |
| PHEMA-- INBIB HEMAGGLUTININ INFLUENZA B VIRUS 108-124 288-303 |
| (STRAIN B/IBARAKI/2/85) |
| PHEMA-- INBID HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 120-136 |
| 299-314 |
| (STRAIN B/ID/86) |
| PHEMA-- INBLE HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 123-139 |
| 302-317 |
| (STRAIN B/LEE/40) |
| PHEMA-- INBMD HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 113-129 |
| 292-307 |
| (STRAIN B/MARYLAND/59) |
| PHEMA-- INBME HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 116-132 |
| 296-311 |
| (STRAIN B/MEMPHIS/6/86) |
| PHEMA-- INBNA HEMAGGLUTININ INFLUENZA B VIRUS 108-124 288-303 |
| (STRAIN B/NAGASAKI/1/87) |
| PHEMA-- INBOR HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 123-139 |
| 301-316 |
| (STRAIN B/OREGON/5/80) |
| PHEMA-- INBSI HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 123-139 |
| 301-316 |
| (STRAIN B/SINGAPORE/ |
| 222/79) |
| PHEMA-- INBSJ HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 119-135 |
| 298-313 |
| (STRAIN B/SINGAPORE/64) |
| PHEMA-- INBUS HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 116-132 |
| 294-309 |
| (STRAIN B/USSR/100/83) |
| PHEMA-- INBVI HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 116-132 |
| 296-311 |
| (STRAIN B/VICTORIA/3/85) |
| PHEMA-- INBVK HEMAGGLUTININ PRECURSOR INFLUENZA B VIRUS 108-124 |
| 288-303 |
| (STRAIN B/VICTORIA/2/87) |
| PHEMA-- INBYB HEMAGGLUTININ INFLUENZA B VIRUS 108-124 286-301 |
| (STRAIN B/AMAGATA/16/88) |
| PHEMA-- INCCA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 442-466 |
| (STRAIN C/CALIFORNIA/78) |
| PHEMA-- INCEN HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 430-454 |
| (STRAIN C/ENGLAND/892/83) |
| PHEMA-- INCGL HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 430-454 |
| (STRAIN C/GREAT LAKES/ |
| 1167/54) |
| PHEMA-- |
| INCHY HEMAGGLUTININ INFLUENZA C VIRUS 429-453 (STRAIN |
| C/HYOGO/1/83) |
| PHEMA-- INCJH HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 443-467 |
| (STRAIN C/JOHANNESBURG/ |
| 1/66) |
| PHEMA-- |
| INCKY HEMAGGLUTININ INFLUENZA C VIRUS 429-453 (STRAIN |
| C/KYOTO/41/82) |
| PHEMA-- INCMI HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 429-453 |
| (STRAIN C/MISSISSIPPI/80) |
| PHEMA-- |
| INCNA HEMAGGLUTININ INFLUENZA C VIRUS 429-453 (STRAIN |
| C/NARA/82) |
| PHEMA-- INCP1 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 43-454 |
| (STRAIN C/PIG/BEIJING/ |
| 10/81) |
| PHEMA-- INCP2 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 430-454 |
| (STRAIN C/PIG/BEIJING/ |
| 115/81) |
| PHEMA-- INCP3 HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 430-454 |
| (STRAIN C/PIG/BEIJING/ |
| 439/82) |
| PHEMA-- INCTA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 430-454 |
| (STRAIN C/TAYLOR/ |
| 1233/47) |
| PHEMA-- INCYA HEMAGGLUTININ PRECURSOR INFLUENZA C VIRUS 430-454 |
| (STRAIN C/YAMAGATA/10/81) |
| PHEMA-- MUMP1 HEMAGGLUTININ-NEURA- MUMPS VIRUS 101-125 133-148 |
| 225-246 367-394 397-417 |
| MINIDASE (STRAIN SBL-1) |
| PHEMA-- MUMPM HEMAGGLUTININ-NEURA- MUMPS VIRUS (STRAIN 101-125 |
| 133-148 225-246 367-394 397-417 |
| MINIDASE MIYAHARA VACCINE) |
| PHEMA-- MUMPS HEMAGGLUTININ-NEURA- MUMPS VIRUS (STRAIN RW) |
| 101-125 133-148 225-246 367-394 397-417 |
| PHEMA-- NDVA HEMAGGLUTININ-NEURA- NEWCASTLE DISEASE VIRUS 93-110 |
| MINIDASE (STRAIN AUSTRALIA- |
| VICTORIA/32) |
| PHEMA-- NDVB HEMAGGLUTININ-NEURA- NEWCASTLE DISEASE VIRUS 93-110 |
| MINIDASE (STRAIN BEAUDETTE C/45) |
| PHEMA-- NDVD HEMAGGLUTININ-NEURA- NEWCASTLE DISEASE VIRUS 93-110 |
| MINIDASE (STRAIN D26/76) |
| PHEMA-- NDVH4 HEMAGGLUTININ-NEURA- NEWCASTLE DISEASE VIRUS 93-110 |
| MINIDASE (STRAIN BI-HITCHNER/47) |
| PHEMA-- NDVI HEMAGGLUTININ-NEURA- NEWCASTLE DISEASE VIRUS 93-110 |
| MINIDASE (STRAIN ITALIEN/45) |
| PHEMA-- NDVM HEMAGGLUTININ-NEURA- NEWCASTLE DISEASE VIRUS 93-110 |
| MINIDASE (STRAIN MIYADERA/51) |
| PHEMA-- NDVQ HEMAGGLUTININ-NEURA- NEWCASTLE DISEASE VIRUS 93-110 |
| MINIDASE (STRAIN QUEENSLAND/66) |
| PHEMA-- NDVTG HEMAGGLUTININ-NEURA- NEWCASTLE DISEASE VIRUS 93-110 |
| MINIDASE (STRAIN TEXAS GB/48) |
| PHEMA-- NDVU HEMAGGLUTININ-NEURA- NEWCASTLE DISEASE VIRUS 93-110 |
| MINIDASE (STRAIN ULSTER/67) |
| PHEMA-- PHODV HEMAGGLUTININ-NEURA- PHOCINE DISTEMPER VIRUS 36-58 |
| 213-234 493-513 |
| MINIDASE |
| PHEMA-- P11HW HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 1 29-53 |
| 322-342 345-360 486-503 |
| MINIDASE VIRUS (STRAIN WASHINGTON/ |
| 1957) |
| PHEMA-- P12H HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 2 13-40 |
| 65-88 118-136 |
| MINIDASE VIRUS (PIV-2) |
| PHEMA-- P12HT HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 2 13-40 |
| 65-88 118-136 |
| MINIDASE VIRUS (STRAIN TOSHIBA) |
| PHEMA-- P13B HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 3 111-128 |
| 272-229 324-340 |
| MINIDASE VIRUS |
| PHEMA-- P13H4 HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 3 111-128 |
| 272-229 324-340 |
| MINIDASE VIRUS (STRAIN NIH 47885) |
| PHEMA-- P13HA HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 3 111-128 |
| 272-229 324-340 |
| MINIDASE VIRUS (STRAIN AUS/124854/74) |
| PHEMA-- P13HT HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 3 111-128 |
| 272-229 324-340 |
| MINIDASE VIRUS (STRAIN TEX/545/80) |
| PHEMA-- P13HU HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 3 111-128 |
| 272-299 324-340 |
| MINIDASE VIRUS (STRAIN TEX/9305/82) |
| PHEMA-- P13HV HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 3 111-128 |
| 272-299 324-340 |
| MINIDASE VIRUS (STRAIN TEX/12677/83) |
| PHEMA-- P13HW HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 3 111-128 |
| 272-299 324-340 |
| MINIDASE VIRUS (STRAIN WASH/641/79) |
| PHEMA-- P13HX HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 3 111-128 |
| 272-299 324-340 |
| MINIDASE VIRUS (STRAIN WASH/1511/73) |
| PHEMA-- P14HA HEMAGGLUTININ-NEURA- HUMAN PARAINFLUENZA 4A 50-67 |
| MINIDASE VIRUS (STRAIN TOSHIBA) |
| PHEMA-- RINDK HEMAGGLUTININ-NEURA- RINDERPEST VIRUS 368-383 |
| MINIDASE STRAIN KABETE O) |
| PHEMA-- RINDL HEMAGGLUTININ-NEURA- RINDERPEST VIRUS (STRAIN L) |
| 4-30 |
| MINIDASE |
| PHEMA-- SEND5 HEMAGGLUTININ-NEURA- SENDAI VIRUS (STRAIN 322-342 |
| MINIDASE Z/HOST MUTANTS) |
| PHEMA-- SENDF HEMAGGLUTININ-NEURA- SENDAI VIRUS (STRAIN 322-342 |
| MINIDASE FUSHMI) |
| PHEMA-- SENDH HEMAGGLUTININ-NEURA- SENDAI VIRUS (STRAIN 322-342 |
| MINIDASE HARRIS) |
| PHEMA-- SENDJ HEMAGGLUTININ-NEURA- SENDAI VIRUS (STRAIN HVI) |
| 322-342 |
| MINIDASE |
| PHEMA-- SENDZ HEMAGGLUTININ-NEURA- SENDAI VIRUS (STRAIN Z) |
| 322-342 |
| MINIDASE |
| PHEMA-- SV41 HEMAGGLUTININ-NEURA- SIMIAN VIRUS 41 55-73 85-102 |
| 107-132 |
| MINIDASE |
| PHEMA-- SV5 HEMAGGLUTININ-NEURA- SIMIAN VIRUS 5 (STRAIN W3) 7-28 |
| 84-101 379-400 |
| MINIDASE |
| PHEMA-- SV5CM HEMAGGLUTININ-NEURA- SIMIAN VIRUS 5 (ISOLATE 7-28 |
| 84-101 379-400 |
| MINIDASE CANINE/CPI-) |
| PHEMA-- SV5CP HEMAGGLUTININ-NEURA- SIMIAN VIRUS 5 (ISOLATE 7-28 |
| 84-101 379-400 |
| MINIDASE CANINE/CPI+) |
| PHEMA-- |
| SV5LN HEMAGGLUTININ-NEURA- 7-28 84-101 379-400 MINIDASE |
| PHEMA-- VACCC HEMAGGLUTININ PRECURSOR VACCINIA VIRUS (STRAIN |
| 173-192 |
| COPENHAGEN) |
| PHEMA-- VACCI HEMAGGLUTININ PRECURSOR VACCINIA VIRUS (STRAIN |
| 173-192 |
| 1HD-J) |
| PHEMA-- VACCT HEMAGGLUTININ PRECURSOR VACCINIA VIRUS (STRAIN |
| 173-192 |
| TIAN TAN) |
| PHEMA-- VACCV HEMAGGLUTININ PRECURSOR VACCINIA VIRUS (STRAIN WR) |
| 173-192 |
| PHEMA-- VARV HEMAGGLUTININ PRECURSOR VARIOLA VIRUS 175-194 |
| PHEX8-- ADE02 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS |
| TYPE 2 38-61 119-140 |
| PRECURSOR |
| PHEX8-- ADE03 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 3 |
| 27-48 |
| PRECURSOR |
| PHEX8-- ADE05 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| 38-61 119-140 |
| PRECURSOR |
| PHEX8-- ADE41 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 41 |
| 38-51 128-146 |
| PRECURSOR |
| PHEX8-- ADEM1 HEXON-ASSOCIATED PROTEIN MOUSE ADENOVIRUS TYPE 1 |
| 36-52 |
| PRECURSOR |
| PHEX9-- ADE07 HEXON-ASSOCIATED PROTEIN HUMAN ADENOVIRUS TYPE 7, |
| 92-117 |
| AND 3 |
| PHEX9-- ADEC2 HEXON-ASSOCIATED PROTEIN CANINE ADENOVIRUS TYPE 2 |
| 52-77 |
| PHEX9-- ADENT HEXON-ASSOCIATED PROTEIN TUPAIA ADENOVIRUS 60-82 |
| PHRG-- COWPX HOST RANGE PROTEIN COWPOX VIRUS 517-533 558-583 |
| 609-636 |
| P1177-- ASFB7 LATE PROTEIN 1177L AFRICAN SWINE FEVER VIRUS 68-83 |
| (STRAIN BA71V) |
| P1196-- ASFB7 LATE PROTEIN 1196L AFRICAN SWINE FEVER VIRUS |
| 169-190 |
| (STRAIN BA71V) |
| P1226-- ASFB7 LATE PROTEIN 1226R AFRICAN SWINE FEVER VIRUS 60-77 |
| (STRAIN BA71V) |
| P1329-- ASFB7 LATE PROTEIN 1329L AFRICAN SWINE FEVER VIRUS |
| 239-260 |
| PRECURSOR (STRAIN BA71V) |
| P178-- ASFB7 EARLY PROTEIN 178R AFRICAN SWINE FEVER VIRUS 2-29 |
| (STRAIN BA71V) |
| PIBMP-- SOCMV INCLUSION BODY MATRIX SOYBEAN CHLOROTIC MOTTLE |
| 97-119 |
| PROTEIN VIRUS |
| PIC18-- EBV PROBABLE PROCESSING AND EPSTEIN-BARR VIRUS (STRAIN |
| 101-123 131-153 759-777 |
| TRANSPORT PROTEIN B95-8) |
| PIC18-- HSMVA PROBABLE PROCESSING AND HUMAN CYTOMEGALOVIRUS |
| 156-176 202-222 |
| TRANSPORT PROTEIN (STRAIN AD169) |
| PIC18-- HSV11 PROCESSING AND TRANSPORT HERPES SIMPLEX VIRUS (TYPE |
| 8-29 45-61 122-143 751-768 |
| PROTEIN 1/STRAIN 17) |
| PIC18-- HSV1A PROCESSING AND TRANSPORT HERPES SIMPLEX VIRUS (TYPE |
| 8-29 45-61 122-143 751-768 |
| PROTEIN 1/STRAIN ANGELOTTI) |
| PIC18-- HSVIF PROCESSING AND TRANSPORT HERPES SIMPLEX VIRUS (TYPE |
| 8-29 122-143 746-763 |
| PROTEIN 1/STRAIN F) |
| PIC18-- HSVB2 PROBABLE PROCESSING AND BOVINE HERPESVIRUS TYPE 2 |
| 12-37 130-151 |
| TRANSPORT PROTEIN (STRAIN BMV) |
| PIC18-- HSVEB PROBABLE PROCESSING AND EQUINE HERPESVIRUS TYPE 1 |
| 37-56 129-144 732-755 |
| TRANSPORT PROTEIN |
| PIC18-- HSVSA PROBABLE PROCESSING AND HERPESVIRUS SAIMIRI 27-49 |
| 51-78 647-672 |
| TRANSPORT PROTEIN (STRAIN 11) |
| PIC18-- MCMVS PROBABLE PROCESSING AND MURINE CYTOMEGALOVIRUS |
| 126-144 202-229 386-411 |
| TRANSPORT PROTEIN (STRAIN SMITH) |
| PIC18-- PRVIF PROBABLE PROCESSING AND PSEUDORABIES VIRUS (STRAIN |
| 285-307 698-718 |
| TRANSPORT PROTEIN INDIAN-FUNKHAUSER/BECKER) |
| PIC18-- VZVD PROBABLE PROCESSING AND VARICELLA-ZOSTER VIRUS 69-88 |
| 619-639 725-744 |
| TRANSPORT PROTEIN (STRAIN DUMAS) |
| PICP0-- HSV11 IMMEDIATE-EARLY PROTEIN HERPES SIMPLEX VIRUS |
| 668-684 |
| (TYPE 1/STRAIN 17) |
| PICP0-- HSV2H VMW118 PROTEIN HERPES SIMPLEX VIRUS 713-729 |
| (TYPE 2/STRAIN HG52) |
| PICP0-- PRVIF EARLY PROTEIN 0 PSEUDORABIES VIRUS (STRAIN 82-102 |
| INDIANA-FUNKHAUSER/ |
| BECKER) |
| PICP3-- HSVIF INFECTED CELL PROTEIN HERPES SIMPLEX VIRUS 211-227 |
| (TYPE 1/STRAIN F) |
| PICP4-- HSV11 TRANS-ACTING TRANS- HERPES SIMPLEX VIRUS 81-98 |
| 621-637 |
| CRIPTIONAL PROTEIN (TYPE 1/STRAIN 17) |
| PICP4-- HSVEB TRANS-ACTING TRANS- EQUINE HERPESVIRUS TYPE 1 |
| 708-725 736-759 |
| CRIPTIONAL PROTEIN (STRAIN AB4P) |
| PICP4-- HSVEK TRANS-ACTING TRANS- EQUINE HERPESVIRUS TYPE 1 |
| 708-725 736-759 |
| CRIPTIONAL PROTEIN (STRAIN KENTUCKY A) |
| PICP4-- HSVMG TRANS-ACTING TRANS- MAREK'S DISEASE HERPES- 488-506 |
| 585-611 1202-1218 |
| ACTIVATOR PROTEIN VIRUS (STRAIN GA) |
| PICP4-- VZVD TRANS-ACTING TRANS- VARICELLA-ZOSTER VIRUS 547-563 |
| CRIPTIONAL PROTEIN (STRAIN DUMAS) |
| PIE18-- PRVIF IMMEDIATE-EARLY PROTEIN PSEUDORABIES VIRUS (STRAIN |
| 731-748 |
| IE180 INDIANA-FUNKHAUSER/ |
| BECKER) |
| PIE18-- PRVKA IMMEDIATE-EARLY PROTEIN PSEUDORABIES VIRUS 720-737 |
| IE180 (STRAIN KAPLAN) |
| PIE63-- HCMVA TRANSCRIPTIONAL REGU- HUMAN CYTOMEGALOVIRUS 286-304 |
| 364-383 |
| LATOR IE63 HOMOLOG( (STRAIN AD169) |
| PIE63-- HSV11 TRANSCRIPTIONAL REGU- HERPES SIMPLEX VIRUS 378-394 |
| LATOR IE63 (TYPE 1/STRAIN 17) |
| PIE63-- HSV2H TRANSCRIPTIONAL REGU- HERPES SIMPLEX VIRUS 378-394 |
| LATOR IE63 HOMOLOG (TYPE 2/STRAIN HG52) |
| PIE63-- HSVEB TRANSCRIPTIONAL REGU- EQUINE HERPESVIRUS TYPE 1 |
| 337-353 385-406 |
| LATOR IEG63 HOMOLOG (STARIN AB4P) |
| PIE63-- HSVSA 52 KD IMMEDIATE-EARLY HERPESVIRUS SAIMIRI 301-326 |
| PHOSPHORPROTEIN (STRAIN 11) |
| PIE68-- HSV11 IMMEDIATE-EARLY PROTEIN HERPES SIMPLEX VIRUS |
| 189-205 |
| IE68 (TYPE 1/STRAIN 17) |
| PIE68-- HSVE4 IMMEDIATE-EARLY PROTEIN EQUINE HERPESVIRUS Type 4 |
| 81-104 |
| IE68 |
| PIE68-- HSVEB IMMEDIATE-EARLY PROTEIN EQUINE HERPESVIRUS Type 1 |
| 91-116 |
| PIE68-- PRVKA IMMEDIATE-EARLY PROTEIN PSEUDORABIES VIRUS 85-108 |
| (STRAIN KAPLAN) |
| PIE68-- VZVD GENE 63/70 PROTEIN VARICELLA-ZOSTER VIRUS 57-78 |
| (STRAIN DUMAS) |
| PIR14-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 117-137 |
| (STRAIN AD169) |
| PKERB-- AVIER ERBB TYROSINE KINASE AVAIN ERYTHROBLASTOSIS 64-84 |
| 297-324 |
| TRANSFORMING PROTEIN VIRUS |
| PKFES-- FSVGA TYROSINE-PROTEIN KINASE FELINE SARCOMA VIRUS 73-88 |
| TRANSFORMING PROT (STRAIN GARDNER-ARNSTEIN) |
| PKFES-- FSVST TYROSINE-PROTEIN KINASE FELINE SARCOMA VIRUS 2-22 |
| TRANSFORMING PROT (STRAIN SNYDER-THEILEN) |
| PKFES-- FSVGR TYROSINE-PROTEIN KINASE FELINE SARCOMA VIRUS |
| 269-288 |
| TRANSFORMING PROT (STRAIN GARDNER-RASHEED) |
| PKFMS-- FSVMD FMS TYROSINE KINASE FELINE SARCOMA VIRUS 141-159 |
| 243-263 434-450 548-563 781-801 856-877 |
| TRANSFORMING PROTEIN (STRAIN MCDONOUGH) |
| PKFPS-- AVISP TYROSINE-PROTEIN KINASE AVIAN SARCOMA VIRUS |
| (247-274 |
| TRANSFORMING PROT STRAIN PRCH) |
| PKFPS-- FUJSV TYROSINE-PROTEIN KINASE FUJINAMI SARCOMA VIRUS |
| 259-275 346-370 400-420 587-614 |
| TRANSFORMING PROT |
| PKITH-- ASFB7 THYMIDINE KINASE AFRICAN SWINE FEVER VIRUS 18-41 |
| (STRAIN BA71V) |
| PKITH-- EBV THYMIDINE KINASE EPSTEIN-BARR VIRUS 403-418 428-446 |
| (STRAIN B95-8) |
| PKITH-- FLDV THYMIDINE KINASE FISH LYMPHOCYSTIS DISEASE 96-117 |
| 252-275 |
| VIRUS |
| PKITH-- HSV11 THYMIDINE KINASE HERPES SIMPLEX VIRUS 223-249 |
| (TYPE 1/STRAIN 17) |
| PKITH-- HSVIC THYMIDINE KINASE HERPES SIMPLEX VIRUS 223-249 |
| (TYPE 1/STRAIN CL101) |
| PKITH-- HSVIE THYMIDINE KINASE HERPES SIMPLEX VIRUS 223-249 |
| (TYPE 1/STRAIN HFEM) |
| PKITH-- HSVIK THYMIDINE KINASE HERPES SIMPLEX VIRUS 223-249 |
| (TYPE 1/STRAIN KOS) |
| PKITH-- HSVIS THYMIDINE KINASE HERPES SIMPLEX VIRUS 223-249 |
| (TYPE 1/STRAIN SC16) |
| PKITH-- HSV23 THYMIDINE KINASE HERPES SIMPLEX VIRUS 224-250 |
| 333-348 |
| (TYPE 2/STRAIN 333) |
| PKITH-- HSVB6 THYMIDINE KINASE BOVINE HERPESVIRUS TYPE 1 193-219 |
| 280-304 |
| (STRAIN 6660) |
| PKITH-- HSVBH THYMIDINE KINASE BOVINE HERPESVIRUS TYPE 2 180-202 |
| (STRAIN BHM-1) |
| PKITH-- HSVBM THYMIDINE KINASE BOVINE HERPES VIRUS TYPE 3 381-399 |
| 609-633 |
| (STRAIN WC11) |
| PKITH-- HSVBQ THYMIDINE KINASE BOVINE HERPESVIRUS TYPE 1 2 |
| 194-220 282-306 |
| (STRAIN Q3932) |
| PKITH-- HSVE4 THYMIDINE KINASE EQUINE HERPESVIRUS TYPE 4 174-193 |
| 261-284 |
| (STRAIN 1942) |
| PKITH-- HSVEB THYMIDINE KINASE EQUINE HERPESVIRUS TYPE 1 18-33 |
| 184-193 274-298 |
| (STRAIN AB4P) AND (ISOLATE |
| HVS25A) |
| PKITH-- HSVF THYMIDINE KINASE FELINE HERPESVIRUS (FELID 171-189 |
| HERPESVIRUS 1) |
| PKITH-- HSV11 THYMIDINE KINASE ICTALURID HERPESVIRUS 1 14-32 |
| PKITH-- HSVMR THYMIDINE KINASE MARMOSET HERPESVIRUS 189-215 |
| PKITH-- HSVSA THYMIDINE KINASE HERPESVIRUS SAIMIRI 208-232 |
| (STRAIN 11) |
| PKITH-- ILTVT THYMIDINE KINASE INFECTIOUS LARYNGOTRA- 183-202 |
| 208-234 |
| CHEITIS VIRUS (STRAIN |
| THORNE V882) |
| PKITH-- VZV4 THYMIDINE KINASE VARICELLA-ZOSTER VIRUS 197-216 |
| (ACYCLOVIR-RESISTANT |
| STRAIN 40A2) |
| PKITH-- VZV7 THYMIDINE KINASE VARICELLA-ZOSTER VIRUS 197-216 |
| (ACYCLOVIR-RESISTANT |
| STRAIN 7-1-3) |
| PKITH-- VZVD THYMIDINE KINASE VARICELLA-ZOSTER VIRUS 197-216 |
| (STRAIN DUMAS) |
| PKITH-- VZVG THYMIDINE KINASE VARICELLA-ZOSTER VIRUS 197-216 |
| (ACYCLOVIR-RESISTANT |
| STRAIN GK) |
| PKITH-- VZVW THYMIDINE KINASE VARICELLA-ZOSTER VIRUS 197-216 |
| (VZV) |
| PKKIT-- FSVHZ KIT TYROSINE KINASE FELINE SARCOMA VIRUS 192-214 |
| 276-297 |
| TRANSFORMING PROTEIN (STRAIN HARDY-ZUCKERMAN |
| 4) |
| PKR15-- HSVII GENE 15 PROTEIN KINASE ICTALURID HERPESVIRUS 1 |
| 151-167 358-374 |
| PKR16-- HSVII GENE 16 PROTEIN KINASE ICTALURID HERPESVIRUS 1 |
| 197-217 286-311 |
| PKR1-- HSVII SERINE/THREONINE-PROTEIN HERPES SIMPLEX VIRUS |
| 280-296 358-377 |
| KINASE (TYPE 1/STRAIN 17) |
| PKR1-- HSV2 SERINE/THREONINE-PROTEIN HERPES SIMPLEX VIRUS 276-296 |
| 358-377 |
| KINASE (TYPE 2) |
| PKR1-- HSVEB SERINE/THREONINE-PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| 289-307 |
| KINASE (STRAIN AB4P) |
| PKR1-- HSVEK SERINE/THREONINE-PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| 289-307 |
| KINASE (STRAIN KENTUCKKY A) |
| PKR1-- VZVD SERINE/THREONINE-PROTEIN VARICELLA-ZOSTER VIRUS |
| 179-197 |
| KINASE (STRAIN DUMAS) |
| PKR1-- EBV PROBABLE SERINE/THREONINE- EPSTEIN-BARR VIRUS (STRAIN |
| 196-211 313-338 |
| PROTEIN KINASE B95-8) |
| PKR1-- HSV11 PROBABLE SERINE/THREONINE- HERPES SIMPLEX VIRUS |
| 247-267 |
| PROTEIN KINASE (TYPE 1/STRAIN 17) |
| PKR1-- HSVEB PROBABLE SERINE/THREONINE- EQUINE HERPESVIRUS TYPE 1 |
| 317-339 441-462 |
| PROTEIN KINASE (STRAIN AB4P) |
| PKR1-- PRVN3 PROBABLE SERINE/THREONINE- PSEUDORABIES VIRUS |
| 164-185 282-305 |
| PROTEIN KINASE (STRAIN NIA-3) |
| PKR2-- VZVD PROBABLE SERINE/THREONINE- VARICELLA-ZOSTER VIRUS |
| 116-131 226-247 354-373 |
| PROTEIN KINASE (STRAIN DUMAS) |
| PKR73-- HSVII GENE 73 PROTEIN KINASE ICTALURID HERPES VIRUS 1 |
| 841-858 |
| PKR74-- HSVII GENE 74 PROTEIN KINASE ICTALURID HERPES VIRUS 1 |
| 359-380 548-575 |
| PKRBI-- VACCC 30 KD PROTEIN KINASE VACCINIA VIRUS (STRAIN 199-214 |
| HOMOLOG COPENHAGEN) |
| PKRBI-- VACCV 30 KD PROTEIN KINASE VACCINIA VRUS (STRAIN WR) |
| 199-214 |
| HOMOLOG |
| PKRBI-- |
| VARV 30 KD PROTEIN KINASE VARIOLA VIRUS 199-214 HOMOLOG |
| PKRFI-- SFVKA POSSIBLE PROTEIN KINASE C20 SHOPE FIBROMA VIRUS |
| 83-98 |
| (STRAIN KASZA) |
| PKRFI-- VACCC POSSIBLE PROTEIN KINASE F10 VACCINIA VIRUS (STRAIN |
| 85-100 |
| COPENHAGEN) |
| PKRF1 -- VACCP POSSIBLE PROTEIN KINASE F10 VACCINIA VIRUS (STRAIN |
| 52-67 |
| L-1VP) |
| PKRFI-- VARV POSSIBLE PROTEIN KINASE F10 VARIOLA VIRUS 85-100 |
| PKROS-- AVISU ROS TYR KINASE TRANS- AVAIAN SARCOMA VIRUS 6-29 |
| 202-223 284-305 |
| FROMING PROTEIN (STRAIN UR2) |
| PKRYK-- AVIR3 TYR-PROTEIN KINASE TRANS- AVIAN RETROVIRUS RPL30 |
| 154-172 221-241 |
| FORMING PROTEIN R |
| PKSEA-- AVIET TYR-PROTEIN KINASE TRANS- AVIAN ERTHROBLASTOSIS |
| 158-177 |
| FORMING PROTEIN SE VIRUS (STRAIN S13) |
| PKSRC-- AVIS2 TYR-PROTEIN KINASE TRANS- AVIAN SARCOMA VIRUS |
| 361-377 |
| FORMING PROTEIN SR (STRAIN PR2257) |
| PKSRC-- AVISR TYR-PROTEIN KINASE TRANS- AVIAN SARCOMA VIRUS |
| 361-377 |
| FORMING PROTEIN SR (STRAIN RASV1441) |
| PKSRC-- AVISS TYR-PROTEIN KINASE TRANS- AVAIAN SARCOMA VIRUS |
| 361-377 |
| FORMING PROTEIN SR (STRAIN S1) |
| PKSRC-- AVIST TYR-PROTEIN KINASE TRANS- AVIAN SARCOMA VIRUS |
| 361-377 |
| FORMING PROTEIN SR (STRAIN S2) |
| PKSRC-- RSVH1 TYR-PROTEIN KINASE TRANS- ROUSE SARCOMA VIRUS |
| 361-377 |
| FORMING PROTEIN SR (STRAIN H-19) |
| PKSRC-- RSVP TYR-PROTEIN KINASE TRANS- ROUS SARCOMA VIRUS 361-377 |
| FORMING PROTEIN SR (STRAIN PRAGUE C) |
| PKSRC-- RSVPA TYR-PROTEIN KINASE TRANS- ROUS SARCOMA VIRUS |
| 358-374 |
| FORMING PROTEIN SR (STRAIN PA101T) |
| PKSRC-- RSVSR TYR-PROTEIN KINASE TRANS- ROUS SARCOMA VIRUS |
| 361-377 |
| FORMING PROTEIN SR (STRAIN SCHMIDT-RUPPIN) |
| PKYES-- AVISY TYR-PROTEIN KINASE TRANS- AVIAN SARCOMA VIRUS |
| 361-377 |
| FORMING PROTEIN Y (STRAIN Y73 |
| PL100-- ADE02 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 2 489-511 |
| PL100-- ADE05 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 5 489-511 |
| PL100-- ADE41 LATE 100 KD PROTEIN HUMAN ADENOVIRUS TYPE 41 |
| 458-480 |
| PL52-- ADE02 LATE L1 52 KD PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| 237-259 |
| PL52-- ADE05 LATE L1 52 KD PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| 237-259 |
| PLEC1-- FOWPM HEPATIC LECTIN HOMOLOG FOWLPOX VIRUS (ISOLATE 2-26 |
| HP-438[MUNICH]) |
| PLMP1-- EBV LATENT MEMBRANE PROTEIN 1 EPSTEIN-BARR VIRUS (STRAIN |
| 20-43 79-100 |
| B95-8) |
| PLMP1-- EBVC LATENT MEMBRANE PROTEIN 1 EPSTEIN-BARR VIRUS (STRAIN |
| 20-43 79-100 |
| B95-8) |
| PLMP1-- EBVR LATENT MEMBRANE PROTEIN 1 EPSTEIN-BARR VIRUS (STRAIN |
| 20-43 79-100 |
| B95-8) |
| PLMP2-- EBV GENE TERMINAL PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| 181-196 204-226 267-288 291-315 346-369 390-410 |
| B95-8) |
| PMCEL-- SFVKA MRNA CAPPING ENZYME, SHOPE FIBROMA VIRUS 244-260 |
| 556-578 679-699 |
| LARGE SUBUNIT (STRAIN KASZA) |
| PMCEL-- VACCC MRNA CAPPING ENZYME, VACCINIA VIRUS (STRAIN 81-102 |
| 265-282 289-312 687-707 |
| LARGE SUBUNIT COPENHAGEN) |
| PMCEL-- VACCV MRNA CAPPING ENZYME, VACCINIA VIRUS (STRAIN WR) |
| 81-102 265-282 289-312 687-707 |
| LARGE SUBUNIT |
| PMCEL-- VARV MRNA CAPPING ENZYME, VARIOLIA VIRUS 81-102 265-282 |
| 289-312 687-707 |
| LARGE SUBUNIT |
| PMCE-- ASFB7 MRNA CAPPING ENZYME AFRICAN SWINE FEVER VIRUS |
| 217-243 |
| (STRAIN BA71V) |
| PMCE-- REOVD MRNA CAPPING ENZYME REOVIRUS (TYPE 3/STRAIN 358-284 |
| 567-588 714-741 |
| DEARING) |
| PMOVP-- CGMVS MOVEMENT PROTEIN CUCUMBER GREEN MOTTLE 157-172 |
| MOSAIC VIRUS (WATERMELON |
| STRAIN S |
| PMOVP-- CGMVW MOVEMENT PROTEIN CUCUMBER GREEN MOTTLE 157-172 |
| MOSAIC VIRUS (WATERMELON |
| STRAIN |
| PMOVP-- ORSV MOVEMENT PROTEIN ODONTOGLOSSUM RINGSPOT 49-74 |
| 178-205 |
| VIRUS |
| PMOVP-- PPMVS MOVEMENT PROTEIN PEPPER MILD MOTTLE 25-50 186-201 |
| VIRUS (STRAIN SPAIN) |
| PMOVP-- TMGMV MOVEMENT PROTEIN TOBACCO MILD GREEN MOSAIC 186-201 |
| VIRUS (TMV STRAIN U2) |
| PMOVP-- TMVCO MOVEMENT PROTEIN TOBACCO MOSAIC VIRUS 88-107 |
| 156-171 |
| (STRAIN COWPEA) |
| PMTC1-- CHVN1 MODIFICATION METHYLASE CHLORELLA VIRUS NC-1A |
| 129-156 |
| CVIBI |
| PMTC2-- CHVPI MODIFICTION METHYLASE PARAMECIUM BURSARIA 72-94 |
| CVIAII CHLORELLA VIRUS 1( |
| PMTC3-- CHVNI MODIFICATION METHYLASE CHLORELLA VIRUS NC-1A |
| 177-192 265-286 |
| CVIBIII |
| PMYBE-- AVILE P135-GAG-MYB-ETS TRANS- AVIAN LEUKEMIA VIRUS E26 |
| 104-124 |
| FORMING PROTEIN( |
| PMYB-- AVIMB MYB TRANSFORMING PROTEIN AVIAN MYELOBLASTOSIS |
| 218-238 301-326 |
| VIRUS |
| PNCAP-- |
| AINOV NECLEOCAPSID PROTEIN AINO VIRUS 159-181 PNCAP-- |
| BUNLC NECLEOCAPSID PROTEIN BUNYAVIRUS LA CROSSE 84-99 |
| PNCAP-- BUNSH NECLEOCAPSID PROTEIN BUNYAVIRUS SNOWSHOE HARE 84-99 |
| PNCAP-- CDVO NECLEOCAPSID PROTEIN CANINE DISTEMPER VIRUS 31-50 |
| (STRAIN ONDERSTEPOORT) |
| PNCAP-- FIPV NECLEOCAPSID PROTEIN FELINE INFECTIOUS PERITON- |
| 57-74 |
| ITIS VIRUS (STRAIN 79-1146) |
| PNCAP-- HANTV NECLEOCAPSID PROTEIN HANTAN VIRUS (STRAIN 76-118) |
| 317-342 |
| PNCAP-- HAZVJ NECLEOCAPSID PROTEIN HAZARA VIRUS (ISOLATE JC280) |
| 428-446 |
| PNCAP-- IHNV NECLEOCAPSID PROTEIN INFECTIOUS HEMATOPOIETIC |
| 110-137 239-265 |
| NECROSIS VIRUS (STRAIN |
| ROUND BUT |
| PNCAP-- INSV NECLEOCAPSID PROTEIN IMPATIENS NECROTIC SPOT 155-179 |
| VIRUS |
| PNCAP-- MEASE NECLEOCAPSID PROTEIN MEASLES VIRUS (STRAIN 40-59 |
| EDMONSTON) |
| PNCAP-- MEASH NECLEOCAPSID PROTEIN MEASLES VIRUS (STRAIN 40-59 |
| HALLE) |
| PNCAP-- MEASY NECLEOCAPSID PROTEIN MEASLES VIRUS (STRAIN 40-59 |
| YAMAGATA-1) |
| PNCAP-- MUMP1 NECLEOCAPSID PROTEIN MUMPS VIRUS (STRAIN SBL-1) |
| 156-178 |
| PNCAP-- MUMPM NECLEOCAPSID PROTEIN MUMPS VIRUS (STRAIN 156-178 |
| MIYAHARA VACCINE) |
| PNCAP-- PHV NECLEOCAPSID PROTEIN PROSPECT HILL VIRUS 36-568 |
| 218-236 256-277 321-346 |
| PNCAP-- PIIHC NECLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 1 42-58 |
| 86-102 |
| VIRUS (STRAIN C39) |
| PNCAP-- PIIHW NECLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 1 42-58 |
| 86-102 |
| VIRUS (STRAIN WASHINGTON/ |
| 1957) |
| PNCAP-- P13B NECLEOCAPSID PROTEIN BOVINE PARAINFLUENZA 3 163-184 |
| VIRUS |
| PNCAP-- P13H4 NECLEOCAPSID PROTEIN HUMAN PARAINFLUENZA 3 163-184 |
| VIRUS (STRAIN NIH 47885) |
| PNCAP-- PUUMH NECLEOCAPSID PROTEIN PUUMALA VIRUS (STRAIN 36-58 |
| 321-346 |
| HALLNAS B1) |
| PNCAP-- PUUMS NECLEOCAPSID PROTEIN PUUMALA VIRUS (STRAIN 36-58 |
| 218-236 321-346 |
| SOTKAMO) |
| PNCAP-- RABVA NECLEOCAPSID PROTEIN RABIES VIRUS (STRAIN AVOI) |
| 299-322 |
| PNCAP-- RABVP NECLEOCAPSID PROTEIN RABIES VIRUS (STRAIN PV) |
| 299-322 |
| PNCAP-- RABVS NECLEOCAPSID PROTEIN RABIES VIRUS (STRAIN SAD |
| 299-322 |
| B19) |
| PNCAP-- RVFVZ NECLEOCAPSID PROTEIN RIFT VALLEY FEVER VIRUS |
| 158-180 |
| (STRAIN ZH-548 M12) |
| PNCAP-- SEND5 NECLEOCAPSID PROTEIN SENDAI VIRUS (STRAIN Z/HOST |
| 29-51 86-102 |
| MUTANTS) |
| PNCAP-- SENDE NECLEOCAPSID PROTEIN SENDAI VIRUS (STRAIN 42-58 |
| 86-102 |
| ENDERS) |
| PNCAP-- SENDH NECLEOCAPSID PROTEIN SENDAI VIRUS (STRAIN 42-58 |
| 86-102 |
| HARRIS) |
| PNCAP-- SENDZ NECLEOCAPSID PROTEIN SENDAI VIRUS (STRAIN Z) 29-51 |
| 86-102 |
| PNCAP-- SEOUS NECLEOCAPSID PROTEIN SEOUL VIRUS (STRAIN SR-11) |
| 112-138 317-342 |
| PNCAP-- SFSV NECLEOCAPSID PROTEIN SANDFLY FEVER SICILIAN 156-181 |
| VIRUS |
| PNCAP-- |
| TACV NECLEOCAPSID PROTEIN TACARIBE VIRUS 219-241 PNCAP-- |
| UUK NECLEOCAPSID PROTEIN UUKUNIEMI VIRUS 167-189 |
| PNCAP-- VHSV0 NECLEOCAPSID PROTEIN VIRAL HEMORRHAGIC SEPTICE- |
| 240-266 |
| MIA VIRUS (STRAIN 07-71) |
| PNCAP-- VHSVM NECLEOCAPSID PROTEIN VIRAL HEMORRHAGIC SEPTICE- |
| 240-266 |
| MIA VIRUS (STRAIN MAKAH) |
| PNCAP-- VSVJO NECLEOCAPSID PROTEIN VESICULAR STOMATITIS VIRUS |
| 64-80 |
| (SEROTYPE NEW JERSEY/ |
| STRAIN OG |
| PNCAP-- |
| VSVSJ PNEF-- |
| HV2RO NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY 110-129 |
| VIRUS TYPE 2 (ISOLATE ROD) |
| PNEF-- HV2ST NEGATIVE FACTOR HUMAN IMMUNODEFICIENCY 106-128 |
| VIRUS TYPE 2 (ISOLATE ST) |
| PNRAM-- IABDA NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-29 |
| A/BLACK DUCK/AUSTRALIA/ |
| 702/78) |
| PNRAM-- IACHI NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-24 |
| A/CHILE/1/83) |
| PNRAM-- IADAI NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-24 |
| A/DUCK/ALBERTA/28/76) |
| PNRAM-- IADGE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-24 |
| A/DUCK/GERMANY/49) |
| PNRAM-- IAFPW NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-29 |
| 301-317 |
| A/FOWL PLAGUE VIRUS/ |
| WEYBRIDGE) |
| PNRAM-- IAHCO NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 299-315 |
| A/EQUINE/COR/16/74) |
| PNRAM-- IAHK1 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-29 |
| A/EQUINE/KENTUCKY/1/81) |
| PNRAM-- IAKIE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-24 |
| A/KIEV/59/79) |
| PNRAM-- IALEN NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-24 |
| A/LENINGRAD/54/1) |
| PNRAM-- IAME1 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-30 |
| A/MEMPHIS/1/71H-A/BELLAMY/ |
| 42N) |
| PNRAM-- IAPAR NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-30 |
| A/PARROT/ULSTER/73) |
| PNRAM-- IAPUE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-30 |
| A/PUERTO RICO/8/34) |
| PNRAM-- IARUE NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-29 |
| A/RUDDY TURNSTONE/NEW |
| JERSEY/60/ |
| PNRAM-- IASH2 NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-29 |
| A/SHEARWATER/AUSTRALIA/72) |
| PNRAM-- IATKR NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-24 56-77 |
| A/TURKEY/OREGON/71) |
| PNRAM-- IATRA NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-29 |
| A/TERN/AUSTRALIA/G70C/75) |
| PNRAM-- IAUSS NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-24 |
| A/USSR/90/77) |
| PNRAM-- IAWHM NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-29 |
| A/WHALE/MAINE/1/84) |
| PNRAM-- IAWIL NEURAMINIDASE INFLUENZA A VIRUS (STRAIN 3-30 |
| A/WILSON-SMITH/33) |
| PNRAM-- INBBE NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/BEIJING/1/87) |
| PNRAM-- INBHK NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/HONG KONG/8/73) |
| PNRAM-- INBLE NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/LEE/40) |
| PNRAM-- INBLN NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/LENINGRAD/179/86) |
| PNRAM-- INBMD NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/MARYLAND/59) |
| PNRAM-- INBMF NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/MEMPHIS/3/89) |
| PNRAM-- INBOR NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/OREGON/5/80) |
| PNRAM-- INBSI NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/SINGAPORE/222/79) |
| PNRAM-- INBUS NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/USSR/100/83) |
| PNRAM-- INBVI NEURAMINIDASE INFLUENZA B VIRUS (STRAIN 3-20 |
| B/VICTORIA/3/85) |
| PNS1-- SIDEV PROBABLE NONSTRUCTURAL BOMBYX DENSONUCLEOSIS 135-151 |
| PROTEIN PRECURSOR VIRUS |
| PNS2-- SIDEV PROBABLE STRUCTURAL BOMBYX DENSONUCLEOSIS 2-26 |
| 196-221 783-806 |
| PROTEIN PRECURSOR VIRUS |
| PNS3-- SIDEV PROBABLE NONSTRUCTURAL BOMBYX DENSONUCLEOSIS 60-78 |
| PROTEIN PRECURSOR VIRUS |
| PNSS-- TSWVB NON-STRUCTURAL PROTEIN TOMATO SPOTTED WILT VIRUS |
| 80-105 431-455 |
| (BRAZILIAN ISOLATE CPNH/ |
| BR-01) |
| PNSS-- TSWVL NON-STRUCUTRAL PROTEIN TOMATO SPOTTED WILT VIRUS |
| 80-105 436-458 |
| (STRAIN L3) |
| PNTP1-- VACCC NUCLEOSIDE TRIPHOSPHA- VACCINIA VIRUS (STRAIN 20-45 |
| 387-403 |
| TASE I COPENHAGEN) |
| PNTP1-- VACCV NUCLEOSIDE TRIPHOSPHA- VACCINIA VIRUS (STRAIN WR) |
| 20-45 387-403 |
| TASE I |
| PNTPI-- VARV NUCLEOSIDE TRIPHOSPHA- VARIOLA VIRUS 293-309 |
| TASE I |
| PP100-- HSV6U MAJOR ANTIFENIC HERPES SIMPLEX VIRUS (TYPE 182-204 |
| 250-270 344-366 |
| STRUCTURAL PROTEIN 6/STRAIN UGANDA-1102) |
| PPAP2-- |
| FOWPV POLY(A) POLYMERASE FOWLPOX VIRUS 79-100 REGULATORY |
| SUBUNIT |
| PPAP2-- MYXVA POLY(A) POLYMERASE MYXOMA VIRUS (ISOLATE 101-116 |
| REGULATORY SUBUNIT AUST/URIARRA/VERG086/1) |
| PPAP2-- VACCC POLY(A) POLYMERASE VACCINIA VIRUS (STRAIN 101-116 |
| REGULATORY SUBUNIT COPENHAGEN) |
| PPAP2-- VACCV POLY(A) POLYMERASE VACCINIA VIRUS (STRAIN WR) |
| 101-116 |
| REGULATORY SUBUNIT |
| PPAP2-- |
| VARV POLY(A) POLYMERASE VARIOLA VIRUS 101-116 REGULATORY |
| SUBUNIT |
| PPCNA-- NPVAC PROLIFERATING CELL AUTOGRAPHA CALIFORNICA 67-89 |
| 227-244 |
| NUCLEAR ANTIGEN NUCLEAR POLYHEDROSIS |
| VIRUS |
| PPE21-- NPVOP 21 2 KD PROTEIN IN PE ORGYIA PSEUSOTSUGATA 117-139 |
| 5'REGION MULTICAPSID POLYHEDROSIS |
| VIRUS |
| PPE25-- NPVAC 25 1 KD PROTEIN IN PE-P26 AUTOGRAPHA CALIFORNICA |
| 57-83 |
| INTERGENIC REGION NUCLEAR POLYHEDROSIS |
| VIRUS |
| PPE38-- NPVAC MAJOR IMMEDIATE EARLY AUTOGRAPHA CALIFORNICA 17-33 |
| PROTEIN NUCLEAR POLYHEDROSIS |
| VIRUS |
| PPEN3-- ADE02 PENTON PROTEIN HUMAN ADENOVIRUS TYPE 2 171-195 |
| PPEN3-- ADE05 PENTON PROTEIN HUMAN ADENOVIRUS TYPE 5 171-195 |
| PPEN3-- ADEGX PENTON PROTEIN AVIAN ADENOVIRUS GAL 10 194-214 |
| 307-324 |
| (STRAIN SA2) |
| PPIV2-- ADE07 MATURATION PROTEIN HUMAN ADENOVIRUS TYPE 7 412-431 |
| PPIV2-- ADEMI MATURATION PROTEIN MOUSE ADENOVIRUS TYPE 1 409-428 |
| PPOL1-- BAYMG GENOME POLYPROTEIN 1 BARLEY YELLOW MOSAIC 739-755 |
| 835-856 1072-1094 1889-1910 |
| VIRUS (GERMAN ISOLATE) |
| PPOL1-- BAYMJ GENOME POLYPROTEIN 1 BARLEY YELLOW MOSAIC 739-755 |
| 835-856 1072-1094 1465-1485 1888-1909 |
| VIRUS (JAPANESE STRAIN II-1) |
| PPOL1-- GCMV RNA1 POLYPROTEIN HUNGARIAN GRAPEVINE 691-717 |
| 1040-1062 1116-1143 |
| CHROME MOSAIC VIRUS |
| PPOL1-- GFLV RNA1 POLYPROTEIN GRAPEVINE FANLEAF VIRUS 380-396 |
| 477-503 545-564 1079-1098 1149-1171 1341-1356 1761-1785 1821-1848 |
| 2020-2044 |
| PPOL1-- TBRVS RNA1 POLYPROTEIN TOMATO BLACK RING VIRUS 1132-1159 |
| (STRAIN 5) |
| PPOL2-- ARMV RNA2 POLYPROTEIN ARABIS MOSAIC VIRUS 129-150 243-266 |
| 345-367 |
| PPOL2-- BAYMG GENOME POLYPROTEIN 2 BARLEY YELLOW MOSAIC 325-350 |
| 463-485 |
| VIRUS (GERMAN ISOLATE) |
| PPOL2-- BAYMJ GENOME POLYPROTEIN 2 BARLEY YELLOW MOSAIC 325-350 |
| 463-485 |
| VIRUS (JAPANESE STRAIN 11-1) |
| PPOL2-- GFLV RNA2 POLYPROTEIN GRAPEVINE FANLEAF VIRUS 808-829 |
| 1021-1045 |
| PPOL2-- TBRVS RNA2 POLYPROTEIN TOMATO BLACKRING VIRUS 425-446 |
| 541-557 856-876 1203-1223 |
| (STRAIN S) |
| PPOL2-- TRSVR RNA2 POLYPROTEIN TOMATO RINGSPOT VIRUS 316-340 |
| 427-448 1527-1554 |
| (ISOLATE RASPBERRY) |
| PPOLG-- BOVEV GENOME POLYPROTEIN BOVINE ENTEROVIRUS (STRAIN |
| 1833-1859 |
| VG-5-27) |
| PPOLG-- BVDVN GENOME POLYPROTEIN BOVINE VIRAL DIARRHEA 627-653 |
| 943-965 1119-1134 1282-1297 1363-1387 1868-1892 2460-2487 2608-2628 |
| 2883-2898 |
| VIRUS (ISOLATE NADL) 3141-3161 3220-3241 3856-3871 3967-3986 |
| PPOLG-- BVDVS GENOME POLYPROTEIN BOVINE VIRAL DIARRHEA |
| 627-653 943-965 1119-1134 1138-1163 1189-1205 1282-1297 1363-1387 |
| 1778-1802 2370-2397 |
| VIRUS (STRAIN SD-1) 2518-2538 2741-2766 2793-2808 3766-3781 |
| PPOLG-- COXA2 GENOME POLYPROTEIN COXSACKIEVIRUS A21 (850-867 |
| (STRAIN COE) |
| PPOLG-- COXA3 GENOME POLYPROTEIN COXSACKIEVIRUS A23 (ECHO 67-92 |
| 9 VIRUS) |
| PPOLG-- COXA9 GENOME POLYPROTEIN COXSACKIEVIRUS A9 1491-1517 |
| 1601-1626 |
| (STRAIN GRIGGS) |
| PPOLG-- COXB1 GENOME POLYPROTEIN COXSACKIEVIRUS B1 1472-1498 |
| 1582-1607 |
| PPOLG-- COXB3 GENOME POLYPROTEIN COXSACKIEVIRUS B3 228-255 |
| 1475-1501 1585-1610 |
| PPOLG-- COXB4 GENOME POLYPROTEIN COXSACKIEVIRUS B4 821-846 |
| 1473-1499 1583-1608 |
| PPOLG-- COXB5 GENOME POLYPROTEIN COXSACKIEVIRUS B5 1475-1501 |
| 1585-1610 |
| PPOLG-- DENIS GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 918-943 |
| 111-1138 1211-1236 1243-1260 1612-1628 2222-2248 2348-2365 2401-2426 |
| 3050-3069 |
| (STRAIN SINGAPORE S275/90) |
| PPOLG-- DENIW GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 919-944 |
| 1112-1139 |
| (STRAIN WESTERN PACIFIC) |
| PPOLG-- DEN23 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 336-354 |
| (ISOLATE MALAYSIA M3) |
| PPOLG-- DEN26 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 848-868 |
| 919-944 1112-1139 1244-1261 1283-1301 1613-1629 2293-2318 2347-2364 |
| 2405-2425 |
| (STRAIN 16681) 2700-2726 |
| PPOLG-- DEN27 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 848-868 |
| 919-944 1112-1139 1244-1261 1283-1301 1376-1396 1613-1629 2293-2318 |
| 2347-2364 |
| (STRAIN 16681-PDK53) 2405-2425 2700-2726 |
| PPOLG-- DEN2D GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 848-868 |
| 919-944 |
| (STRAIN D2-04) |
| PPOLG-- DEN2J GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 848-868 |
| 919-944 1112-1139 1244-1261 1376-1796 1613-1629 2291-2318 2147-2364 |
| 2405-2425 |
| (STRAIN JAMAICA) 2700-2726 |
| PPOLG-- DEN2N GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 100-120 |
| 171-196 364-391 |
| (STRAIN NEW GUINEA C) |
| PPOLG-- DEN2P GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 919-944 |
| 112-1139 1244-1261 1283-1301 1376-1397 1613-1629 2290-2315 2344-2361 |
| 2402-2422 |
| (STRAIN PR159/S1) 2697-2723 |
| PPOLG-- DEN2T GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 6349-664 |
| 832-859 964-981 1203-1219 |
| (STRAIN TONGA 1974) |
| PPOLG-- DEN3 GENOME POLYPROTEIN DENGUE VIRUS TYPE 3 917-942 |
| 1210-1228 1242-1259 1174-1194 1611-1627 2141-2162 2221-2247 2145-2361 |
| 2399-2424 |
| 2698-2724 3048-3067 |
| PPOLG-- DEN4 GENOME POLYPROTEIN DENGUE VIRUS TYPE 4 1209-1227 |
| 1241-1258 1611-1627 2220-2246 2342-2359 2400-2420 3045-3064 |
| PPOLG-- EC11G GENOME POLYPROTEIN ECHOVIRUS 11 (STRAIN 664-690 |
| 774-799 |
| GREGORY |
| PPOLG-- EMCV GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS 225-247 |
| 558-578 1194-1215 1650-1667 |
| VIRUS |
| PPOLG-- EMCVB GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS 560-580 |
| 1120-1141 1196-1217 |
| VIRUS (STRAIN EMC-B- |
| NONDIABETOGENIC |
| PPOLG-- EMCVD GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS 560-580 |
| 1120-1141 1196-1217 |
| VIRUS (STRAIN EMC-D |
| DIABETOGENIC) |
| PPOLG-- ENMG3 GENOME POLYPROTEIN MENGO ENCEPHALOMYO- 560-580 |
| CARDITIS VIRUS (STRAIN 37A) |
| PPOLG-- ENMGO GENOME POLYPROTEIN MENGO ENCEPHALOMYO-493-513 |
| CARDITIS VIRUS |
| PPOLG-- FMDV1 GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE 121-141 |
| 984-1003 1036-1057 1396-1411 1465-1487 1764-1791 |
| VIRUS (STRAIN A10-61) |
| PPOLG-- FMDV5 GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE 162-187 |
| VIRUS (STRAIN A5) |
| PPOLG-- FMDVA GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE 121-140 |
| 984-1003 1036-1057 1396-1411 1465-1487 1763-1790 |
| VIRUS (STRAIN 12) |
| PPOLG-- FMDVO GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE 121-141 |
| 948-1003 1036-1057 1396-1411 1465-1487 1763-1790 |
| VIRUS (STRAIN O1K AND |
| O1BFS)( |
| PPOLG-- FMDVS GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE 301-320 |
| VIRUS (STRAIN C1-SANTA PAU |
| [C-S8]) |
| PPOLG-- FMDVT GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE 121-141 |
| 979-998 |
| VIRUS (STRAIN C1) |
| PPOLG-- HCVI GENOME POLYPROTEIN HEPATITIC C VIRUS (ISOLATE 1) |
| 112-133 143-169 619-640 683-699 833-857 2327-2347 2442-2457 2837-2859 |
| PPOLG-- HCVA GENOME POLYPROTEIN HOG CHOLERA VIRUS (STRAIN |
| 102-128 1143-1163 1282-1301 1778-1802 2370-2397 2518-2538 3131-3152 |
| 3737-3753 3767-3782 |
| ALFORT) 3877-3893 |
| PPOLG-- HCVB GENOME POLYPROTEIN HOG CHOLERA VIRUS (STRAIN 102-128 |
| 1143-1163 1282-1301 1778-1802 2370-2397 2518-2538 3131-3152 3737-3753 |
| 3767-3782 |
| BRESCIA) 3877-3893 |
| PPOLG-- HCVBK GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 112-133 143-169 619-640 683-699 2327-2347 2441-2456 2836-2858 2988-3007 |
| BK) |
| PPOLG-- HCVE1 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE 27-53 |
| ECI) |
| PPOLG-- HCVH GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE H) |
| 112-133 143-169 619-640 683-699 833-853 863-880 2442-2457 2837-2859 |
| PPOLG-- HCVH4 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 112-133 143-169 |
| HCV-476) |
| PPOLG-- HCVH7 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE 15-41 |
| HCT27) |
| PPOLG-- HCVH8 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE 27-53 |
| HCT18) |
| PPOLG-- HCVHK GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 112-133 143-169 |
| HCV-KF) |
| PPOLG-- HCVJ2 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 112-133 143-169 |
| HC-J2) |
| PPOLG-- HCVJ5 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 112-133 143-169 623-644 687-703 |
| HC-J5) |
| PPOLG-- HCVJ6 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 112-133 143-169 623-644 687-703 837-861 1827-1853 2327-2347 2859-2881 |
| 3011-3030 |
| HC-J6) |
| PPOLG-- HCVJ7 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 143-169 623-644 687-703 |
| HC-J7) |
| PPOLG-- HCVJ8 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 112-133 143-169 687-703 837-861 867-884 1172-1188 1827-1853 2859-2881 |
| 3011-3030 |
| HC-J8) |
| PPOLG-- HCVJA GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 112-133 143-169 619-640 638-699 833-857 863-880 2327-2347 2836-2858 |
| 2988-3007 |
| JAPANESE) |
| PPOLG-- HCVJT GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| 112-133 143-169 619-640 683-699 833-857 2327-2347 2441-2456 2836-2858 |
| HC-JT) |
| PPOLG-- HCVTH GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE 27-53 |
| TH) |
| PPOLG-- |
| HCVTW GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE112-133 143-169 |
| 619-640 683-699 833-857 2327-2347 2441-2456 2836-2858 2988-3007 |
| TAIWAN) |
| PPOLG-- HPAV1 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| 303-323 |
| LCDC-1) |
| PPOLG-- HPAV2 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| 401-428 799-819 1195-1210 1687-1708 2008-2033 2068-2092 |
| 24A) |
| PPOLG-- HPAV4 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| 799-819 1195-1210 1687-1708 2008-2033 2068-2092 |
| 43C) |
| PPOLG-- HPAV8 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| 799-819 1195-1210 1687-1708 2008-2033 2068-2092 |
| 18F) |
| PPOLG-- HPAVC GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| 799-819 |
| CR326) |
| PPOLG-- HPAVG GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| 778-798 |
| GA76) |
| PPOLG-- HPAVH GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| 799-819 1195-1210 1688-1709 2009-2034 2069-2093 |
| HM-175) |
| PPOLG-- HPAVL GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| 799-819 1195-1210 1688-1709 2009-2034 2069-2093 |
| LA) |
| PPOLG-- HPAVM GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN |
| 799-819 1195-1210 1688-1709 2009-2034 2069-2093 |
| MBB) |
| PPOLG-- HPAVS GENOME POLYPROTEIN SIMIAN HEPATITIS A VIRUS |
| 1199-1214 1690-1711 2012-2037 2072-2096 |
| (STRAIN AGM-27) |
| PPOLG-- HRV14 GENOME POLYPROTEIN HUMAN RHINOVIRUS 14 1383-1406 |
| 1962-1982 |
| (HRV-14 |
| PPOLG-- HRV1A GENOME POLYPROTEIN HUMAN RHINOVIRUS 1A 361-379 |
| 547-562 |
| (HRV-1A) |
| PPOLG-- HRV1B GENOME POLYPROTEIN HUMAN RHINOVIRUS 1B 386-404 |
| 572-587 859-876 1029-1052 1453-1478 1625-1641 1816-1842 1941-1961 |
| (HRV-1B) |
| PPOLG-- HRV2 GENOME POLYPROTEIN HUMAN RHINOVIRUS 2 (HRV-2) |
| 569-584 694-713 1022-1045 1446-1469 1618-1634 1809-1835 1843-1866 |
| PPOLG-- HRV89 GENOME POLYPROTEIN HUMAN RHINOVIRUS 89 |
| 576-591 1038-1061 1229-1253 1332-1358 1460-1485 1632-1648 1823-1849 |
| 1948-1968 |
| (HRV-89) |
| PPOLG-- HUBV7 GENOME POLYPROTEIN HUMAN ENTEROVIRUS 70 1492-1515 |
| (STRAIN J670/71) |
| PPOLG-- IBDVO STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| 904-922 |
| DISEASE VIRUS (STRAIN 011) |
| PPOLG-- JAEV1 GENOME POLYPROTEIN JAPANESE ENCEPHALITIS 938-963 |
| 1306-1325 1642-1658 2245-2270 2326-2351 2462-2481 |
| VIRUS (STRAIN SA-14) |
| PPOLG-- JAEV5 GENOME POLYPROTEIN JAPANESE ENCEPHALITIS 938-963 |
| 1306-1325 1642-1658 2245-2270 2326-2351 2462-2481 |
| VIRUS (STRAIN SA(V)) |
| PPOLG-- JAEVJ GENOME POLYPROTEIN JAPANESE ENCEPHALITIS 938-963 |
| 1306-1325 1642-1658 2245-2270 2326-2351 2462-2481 |
| VIRUS (STRAIN JAOARS982) |
| PPOLG-- JAEVN GENOME POLYPROTEIN JAPANESE ENCEPHALITIS 866-891 |
| 1234-1253 |
| VIRUS (STRAIN NAKAYAMA) |
| PPOLG-- KUNJM GENOME POLYPROTEIN KUNJIN VIRUS (STRAIN 561-576 |
| 935-960 1307-1326 1642-1659 2246-2271 2327-2352 2440-2460 2463-2483 |
| 2641-2658 |
| MRM61C) 2798-2814 |
| PPOLG-- LANVT GENOME POLYPROTEIN LANGAT VIRUS (STRAIN TP21) 67-89 |
| 527-551 736-756 835-862 1157-1178 1519-1544 1630-1653 2158-2812 |
| 2230-2257 |
| 2366-2387 2424-2451 2766-2784 |
| PPOLG-- LANVY GENOME POLYPROTEIN LANGAT VIRUS (STRAIN 67-89 |
| 527-551 |
| YELANTSEV) |
| PPOLG-- LIV GENOME POLYPROTEIN LOUPING ILL VIRUS (L1) 67-89 |
| 527-551 835-862 |
| PPOLG-- LIVSB GENOME POLYPROTEIN LOUPING ILL VIRUS (STRAIN |
| 247-271 |
| SB 526) |
| PPOLG-- MCFA GENOME POLYPROTEIN MOSQUITO CELL FUSING AGENT |
| 120-137 1174-1199 1402-1428 1788-1805 1872-1887 2012-2029 2810-2827 |
| (CFA FLAVIVIRUS) |
| PPOLG-- MDMV GENOME POLYPROTEIN MAIZE DWARF MOSAIC VIRUS 39-56 |
| PPOLG-- MVEV GENOME POLYPROTEIN MURRAY VALLEY ENCEPHA- 331-347 |
| 563-578 937-962 1304-1024 1523-1548 1585-1602 1641-1657 |
| LITIS VIRUS |
| PPOLG-- OMV GENOME POLYPROTEIN ORNITHOGALUM MOSAIC 90-110 111-126 |
| 678-696 898-914 |
| VIRUS |
| PPOLG-- PEMVC GENOME POLYPROTEIN PEPPER MOTTLE VIRUS 690-717 |
| 826-846 1009-1034 1301-1318 1455-1482 1484-1500 1676-1697 1921-1945 |
| 2002-2022 |
| (CALIFORNIA ISOLATE) |
| PPOLG-- POLIM GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN |
| 1409-1432 |
| MAHONEY) |
| PPOLG-- POLIS GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN |
| 1410-1433 |
| SABIN) |
| PPOLG-- POL2L GENOME POLYPROTEIN POLIOVIRUS TYPE 2 (STRAIN |
| 1408-1431 |
| LANSING) |
| PPOLG-- POL2W GENOME POLYPROTEIN POLIOVIRUS TYPE 2 (STRAIN |
| 1408-1431 |
| W-2) |
| PPOLG-- POL32 GENOME POLYPROTEIN POLIOVIRUS TYPE 3 (STRAIN |
| 577-594 1407-1430 |
| 23127) |
| PPOLG-- POL3L GENOME POLYPROTEIN POLIOVIRUS TYPE 3 (STRAINS |
| 577-594 1407-1430 |
| P3/LEON/37 AND P3/LEON |
| 12A[1]B) |
| PPOLG-- PPVD GENOME POLYPROTEIN PLUM POX POTYVIRUS 153-178 |
| 551-571 714-741 1098-1115 1458-1495 1497-1513 2606-2624 3084-3106 |
| (STRAIN D) |
| PPOLG-- PPVEA GENOME POLYPROTEIN PLUM POX PTOYVIRUS 981-999 |
| 1451-1483 |
| (STRAIN EL AMAR) |
| PPOLG-- PPVNA GENOME POLYPROTEIN PLUM POX POTYVIRUS 153-178 |
| 713-740 1097-1114 1467-1494 1496-1512 2605-2623 3068-3090 |
| (ISOLATE NAT) |
| PPOLG-- PPVRA GENOME POLYPROTEIN PLUM POX POTYVIRUS 153-178 |
| 713-740 1097-1114 1467-1494 1496-1512 2605-2623 3086-3105 |
| (STRAIN RANKOVIC) |
| PPOLG-- PRSVH GENOME POLYPROTEIN PAPAYA RINGSPOT VIRUS 272-290 |
| (STRAIN P/MUTANT HA) |
| PPOLG-- PRSVP GENOME POLYPROTEIN PAPAYA RINGSPOT VIRUS 163-181 |
| (STRAIN P/MUTANT HA 5-1) |
| PPOLG-- PRSVW GENOME POLYPROTEIN PAPAYA RINGSPOT VIRUS 163-181 |
| (STRAIN W) |
| PPOLG-- PSBMV GENOME POLYPROTEIN PEA SEED-BORNE MOSAIC 47-62 |
| 251-268 339-357 654-674 981-1001 1411-1428 1565-1592 2708-2726 |
| VIRUS (STRAIN DPD1) |
| PPOLG-- PVYC GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN C) 755-776 |
| PPOLG-- PYHU GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN 755-776 |
| 945-982 1010-1036 1109-1125 1456-1483 1485-1501 1677-16978 1922-1946 |
| 2588-2606 |
| HUNGARIAN) 3004-3026 |
| PPOLG-- PVYN GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN N) 755-776 |
| 945-982 1010-1036 1109-1125 1456-1483 1485-1501 1677-16978 1922-1946 |
| 2590-2608 |
| PPOLG-- PVYO GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN O) 775-776 |
| PPOLG-- PYFV1 GENOME POLYPROTEIN PARSNIP YELLOW FLECK 592-616 |
| 1326-1353 1626-1651 1903-1924 2621-2642 2702-2729 2766-2783 |
| VIRUS (ISOLATE P-121) |
| PPOLG-- STEVM GENOME POLYPROTEIN ST LOUIS ENCEPHALITIS VIRUS |
| 1301-1324 |
| (STRAIN MS1-7) |
| PPOLG-- SUMVS GENOME POLYPROTEIN SUGARCANE MOSAIC VIRUS 39-56 |
| (STRAIN SC) |
| PPOLG-- |
| SVDVH GENOME POLYPROTEIN SWINE VESICULAR DISEASE 1475-1501 1585-1610 |
| VIRUS (STRAIN H/3 `76) |
| PPOLG-- |
| SVDVU GENOME POLYPROTEIN SWINE VESICULAR DISEASE 1475-1401 1585-1610 |
| VIRUS (STRAIN UKG/27/72) |
| PPOLG-- TBEVS GENOME POLYPROTEIN TICK-BORNE ENCEPHALITIS 67-89 |
| 527-551 1363-1378 1519-1544 1630-1653 1740-1761 2230-2257 2366-2387 |
| 2765-2783 |
| VIRUS (STRAIN SOFJIN) |
| PPOLG-- TBEVW GENOME POLYPROTEIN TICK-BORNE ENCEPHALITIS 67-89 |
| 527-551 835-862 1519-1544 1630-1653 2230-2257 2366-2387 2766-2784 |
| VIRUS (WESTERN SUBTYPE) |
| PPOLG-- TEV GENOME POLYPROTEIN TOBACCO ETCH VIRUS (TEV 827-853 |
| 953-980 1016-1042 1114-1130 1307-1324 1490-1506 |
| PPOLG-- TMEVB GENOME POLYPROTEIN THEILER'MURINE ENCEPHA- 924-941 |
| 1074-1095 119-1140 1520-1546 1658-1677 |
| LOMYELITIS VIRUS (STRAIN |
| BEAN 8386) |
| PPOLG-- TMEVD GENOME POLYPROTEIN THEILER'MURINE ENCEPHALO- |
| 1072-1093 1117-1138 1518-1544 1656-1675 |
| MYELITIS VIRUS (STRAIN DA) |
| PPOLG-- TMEVG GENOME POLYPROTEIN THEILER'MURINE ENCEPHA- 645-670 |
| 924-941 1074-1095 1119-1140 1520-1546 1658-1677 |
| LOMYELITIS VIRUS (STRAIN |
| GDVII) |
| PPOLG-- TUMV GENOME POLYPROTEIN TURNIP MOSAIC VIRUS 23-39 970-991 |
| 1138-1156 1573-1595 |
| PPOLG-- TVMV GENOME POLYPROTEIN TOBACCO VEIN MOTTLING 404-428 |
| 497-517 660-687 850-866 967-992 1257-1274 2537-2562 |
| VIRUS |
| PPOLG-- WMV2 GENOME POLYPROTEIN WATERMELON MOSAIV VIRUS II |
| 198-218 |
| PPOLG-- WNV GENOME POLYPROTEIN WEST NILE VIRUS 557-572 931-956 |
| 1303-1322 1639-1655 2240-2267 2324-2349 2437-2457 2638-2655 2795-2811 |
| PPOLG-- YEFV1 GENOME POLYPROTEIN YELLOW FEVER VIRUS 74-95 |
| 1157-1179 1228-1248 1385-1405 1495-1511 1625-1641 1761-1778 2229-2254 |
| (STRAIN 17D) |
| PPOLG-- YEFV2 GENOME POLYPROTEIN YELLOW FEVER VIRUS 74-95 |
| 1157-1179 1228-1248 1386-1405 1495-1511 1625-1641 1761-1778 2229-2254 |
| (STRAIN PASTEUR 17D-204) |
| PPOLG-- YEFV8 GENOME POLYPROTEIN YELLOW FEVER VIRUS 74-95 |
| (STRAIN 1899/81) |
| PPOLG-- POLIM GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN |
| 1410-1433 |
| MAHONEY) |
| PPOLG-- EEVVT NON-STRUCTURAL VENEZUELAN EQUINE EN- 90-107 235-254 |
| 613-634 1001-1018 1153-1178 1923-1939 2129-2144 2201-2221 |
| POLYPROTEIN CEPHALITIS VIRUS (STRAIN |
| TRINIDAD DON |
| PPOLN-- FCVC6 NON-STRUCTURAL FELINE CALICIVIRUS (STRAIN 443-469 |
| 748-766 902-923 1069-1088 |
| POLYPROTEIN CFI/68 FIV) |
| PPOLN-- FCVF4 NON-STRUCTURAL FELINE CALICIVIRUS (STRAIN 300-326 |
| POLYPROTEIN JAPANESE F4) |
| PPOLN-- FCVF9 NON-STRUCTURAL FELINE CALICIVIRUS (STRAIN 171-186 |
| 262-283 919-945 1224-1242 1378-1399 1545-1564 |
| POLYPROTEIN F9) |
| PPOLN-- HEVBU NON-STRUCTURAL HEPATITIS E VIRUS (STRAIN 250-266 |
| 1274-1291 |
| POLYPROTEIN BURMA) |
| PPOLN-- HEVME NON-STRUCTURAL HEPATITIS E VIRUS (STRAIN 250-266 |
| 1272-1289 |
| POLYPROTEIN MEXICO) |
| PPOLN-- HEVMY NON-STRUCTURAL HEPATITIS E VIRUS (STRAIN 250-266 |
| 1274-1291 |
| POLYPROTEIN MYANMAR) |
| PPOLN-- HEVPA NON-STRUCTURAL HEPATITIS E VIRUS (STRAIN 249-265 |
| 1273-1290 |
| POLYPROTEIN PAKISTAN) |
| PPOLN-- MIDDV NONSTRUCTURAL MIDDELBURG VIRUS 488-512 628-643 |
| 700-720 |
| POLYPROTEIN |
| PPOLN-- ONNVG NONSTRUCTURAL O'NYONG-NYONG VIRUS 90-107 613-634 |
| 2148-2163 2220-2240 |
| POLYPROTEIN (STRAIN GULU) |
| PPOLN-- RHDV NON-STRUCTURAL RABBIT HEMORRHAGIC 156-180 270-292 |
| 299-320 479-502 1330-1353 1429-1455 1471-1490 |
| POLYPROTEIN DISEASE VIRUS |
| PPOLN-- |
| RHDV3 NON-STRUCTURAL RABBIT HEMORRHAGIC 115-135 POLYPROTEIN |
| DISEASE VIRUS (STRAIN V-351) |
| PPOLN-- RRVN NONSTRUCTURAL ROSS RIVER VIRUS (STRAIN 89-106 |
| 611-632 2113-2128 2185-2205 |
| POLYPROTEIN NB5092) |
| PPOLN-- RRVT NONSTRUCTURAL ROSS RIVER VIRUS (STRAIN 782-797 |
| 854-874 |
| POLYPROTEIN T48) |
| PPOLN-- RUBVT NONSTRUCTURAL RUBELLA VIRUS (STRAIN 14-37 97-113 |
| 263-279 670-694 901-918 1374-1393 2035-2052 |
| POLYPROTEIN THEREIN) |
| PPOLN-- SFV NONSTRUCTURAL SEMLIKI FOREST VIRUS 91-108 617-643 |
| 2062-2077 2134-2154 |
| POLYPROTEIN |
| PPOLN-- SINDO NONSTRUCTURAL SINBIS VIRUS (SUBTYPE 620-646 |
| 1123-1150 1790-1814 2148-2163 2220-2240 |
| POLYPROTEIN OCKELBO/STRAIN EDSBYN |
| 82-5) |
| PPOLN-- SINDV NONSTRUCTURAL SINDBIS VIRUS (STRAIN HRSP) 620-646 |
| 1123-1150 1744-1763 1790-1812 2146-2161 2218-2238 |
| POLYPROTEIN |
| PPOLR-- EPMV RNA REPLICASE POLYPROTEIN EGGPLANT MOSAIC VIRUS |
| 808-833 |
| PPOLR-- OYMV RNA REPLICASE POLYPROTEIN ONONIS YELLOW MOSAIC |
| 707-727 941-962 |
| VIRUS |
| PPOLR-- TYMV RNA REPLICASE POLYPROTEIN TURNIP YELLOW MOSAIC |
| 212-233 436-453 1173-1192 |
| VIRUS |
| PPOLR-- TYMVA RNA REPLICASE POLYPROTEIN TURNIP YELLOW MOSAIC |
| 212-233 436-453 1173-1192 |
| VIRUS (AUSTRALIAN ISOLATE) |
| PPOLR-- TYMVC RNA REPLICASE POLYPROTEIN TURNIP YELLOW MOSAIC |
| 212-233 436-453 1173-1192 |
| VIRUS (ISOLATE TYMC) |
| PPOLS-- EEEV STRUCTURAL POLYPROTEIN EASTERN EQUINE ENCEPHA- 35-50 |
| 213-229 491-507 |
| LITIS VIRUS |
| PPOLS-- EEEV3 STRUCTURAL POLYPROTEIN EASTERN EQUINE ENCEPHA- |
| 35-50 214-230 492-508 |
| LITIS VIRUS |
| PPOLS-- EEVV8 STRUCTURAL POLYPROTEIN VENEZUELAN EQUINE ENCEPH- |
| 32-48 229-245 504-522 |
| ALITIS VIRUS (STRAIN TC-83) |
| PPOLS-- EEVVT STRUCTURAL POLYPROTEIN VENEZUELAN EQUINE EN- 32-48 |
| 229-245 504-522 |
| CEPHALITIS VIRUS (STRAIN |
| TRINIDAD DON |
| PPOLS-- IBDV5 STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| 900-922 |
| DISEASE VIRUS (STRAIN 52/70) |
| PPOLS-- IBDVA STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| 900-922 |
| DISEASE VIRUS (STRAIN |
| AUSTRALIAN 00 |
| PPOLS-- IBDVC STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| 900-922 |
| DISEASE VIRUS (STRAIN CU-1) |
| PPOLS-- IBDVP STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| 881-903 |
| DISEASE VIRUS (STRAIN |
| PBG-98) |
| PPOLS-- IBDVS STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| 900-922 |
| DISEASE VIRUS (STRAIN STC) |
| PPOLS-- ONNVG STRUCTURAL POLYPROTEIN O'NYONG-NYONG VIRUS 688-708 |
| (STRAIN GULU) |
| PPOLS-- RRVT STRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| 1216-1243 |
| T48) |
| PPOLS-- RUBVH STRUCTURAL POLYPROTEIN RUBELLA VIRUS (VACCINE |
| 281-302 |
| STRAIN HPV77) |
| PPOLS-- RUBVM STRUCTURAL POLYPROTEIN RUBELLA VIRUS (STRAIN M33) |
| 280-301 |
| PPOLS-- RUBVR STRUCTURAL POLYPROTEIN RUBELLA VIRUS (VACCINE |
| 281-302 |
| STRAIN RA27/3) |
| PPOLS-- RUBVT STRUCTURAL POLYPROTEIN RUBELLA VIRUS (STRAIN |
| 281-302 1041-1060 |
| THEREIN) |
| PPOLS-- SFV STRUCTURAL POLYPROTEIN SEMLIKI FOREST VIRUS 35-59 |
| 751-772 780-801 |
| PPOLS-- SINDO STRUCTURAL POLYPROTEIN SINDBIS VIRUS (SUBTYPE 33-52 |
| OCKELBO/STRAIN EDSBYN |
| 82-5) |
| PPOLS-- SINDV STRUCTURAL POLYPROTEIN SINDBIS VIRUS (STRAIN HRSP |
| 33-52 |
| AND HRLP) |
| PPOLS-- WEEV STRUCTURAL POLYPROTEIN WESTERN EQUINE ENCEPH- 36-51 |
| 909-933 |
| ALITIS VIRUS |
| PPOL-- AVIRE POL POLYPROTEIN AVIAN RETICULOENDOTHELI- 283-303 |
| OSIS VIRUS |
| PPOL-- BAEVM POL POLYPROTEIN BABOON ENDOGENOUS VIRUS 526-544 |
| 973-993 99-1019 1070-1091 |
| (STRAIN M7) |
| PPOL-- BIVO6 POL POLYPROTEIN BOVINE IMMUNODEFICIENCY 101-119 |
| 742-768 868-889 |
| VIRUS (ISOLATE 106) |
| PPOL-- BIV27 POL POLYPROTEIN BOVINE IMMUNODEFICIENCY 101-119 |
| 742-768 868-889 |
| VIRUS (ISOLATE 127) |
| PPOL-- BLVAU POL POLYPROTEIN BOVINE LEUKEMIA VIRUS 487-504 |
| (AUSTRALIAN ISOLATE) |
| PPOL-- BLVJ POL POLYPROTEIN BOVINE LEUKEMIA VIRUS 487-504 |
| (REVERSE TRANSCRIPTASE (JAPANESE ISOLATE BLV-1) |
| PPOL-- CAEVC POL POLYPROTEIN CAPRINE ARTHRITIS ENCEPH- 393-419 |
| 656-671 |
| ALITIS VIRUS (STRAIN CORK) |
| PPOL-- CAMVC ENZYMATIC POLYPROTEIN CAULIFLOWER MOSAIC VIRUS |
| 184-204 380-407 471-494 |
| (STRAIN CM-1841) |
| PPOL-- CAMVD ENZYMATIC POLYPROTEIN CAULIFLOWER MOSAIC VIRUS |
| 175-199 375-402 466-489 |
| (STRAIN D/H) |
| PPOL-- CAMVE ENZYMATIC POLYPROTEIN CAULIFLOWER MOSAIC VIRUS |
| 184-204 380-407 471-494 |
| (STRAIN BBC) |
| PPOL-- CAMVN ENZYMATIC POLYPROTEIN CAULIFLOWER MOSAIC VIRUS 70-97 |
| 185-205 381-408 472-495 |
| (STRAIN NY8153) |
| PPOL-- CAMVS ENZYMATIC POLYPROTEIN CAULIFLOWER MOSAIC VIRUS |
| 184-204 380-407 471-494 |
| (STRAIN STRASBOURG) |
| PPOL-- CERV ENZYMATIC POLYPROTEIN CARNATION ETCHED RING 161-186 |
| 455-478 |
| IRUS |
| PPOL-- COYMV PUTATIVE POLYPROTEIN COMMELINA YELLOW MOTTLE 320-343 |
| 1286-1311 1606-1622 1641-1665 |
| VIRUS |
| PPOL-- EIAV9 POL POLYPROTEIN EQUINE INFECTIOUS ANEMIA 437-456 |
| VIRUS (CLONE 1369) |
| PPOL-- EIAVC POL POLYPROTEIN EQUINE INFECTIOUS ANEMIA 437-456 |
| VIRUS (CLONE CL22) |
| PPOL-- EIAVY POL POLYPROTEIN EQUINE INFECTIOUS ANEMIA 435-455 |
| VIRUS (ISOLATE WYOMING) |
| PPOL-- FENVI POL POLYPROTEIN FELINE ENDOGENOUS VIRUS 383-401 |
| 856-876 |
| ECEI |
| PPOL-- FIVPE POL POLYPROTEIN FELINE IMMUNODEFICIENCY 407-426 |
| 755-755 |
| VIRUS (ISOLATE PETALUMA) |
| PPOL-- FIVSD POL POLYPROTEIN FELINE IMMUNODEFICIENTY 407-426 |
| 755.755 |
| CIRUS (ISOLATE SAN DIEGO) |
| PPOL-- FIVT2 POL POLYPROTEIN FELINE IMMUNODEFICIENCY 406-425 |
| 665-690 755-775 1041-1060 |
| VIRUS (ISOLATE TM2) |
| PPOL-- FMVD ENZYMATIC POLYPROTEIN FIGWORT MOSAIC VIRUS 191-212 |
| 464-487 |
| (STRAIN DXS) |
| PPOL-- FOAMV POL POLYPROTEIN HUMAN SPUMARETROVIRUS 126-147 |
| 768-788 |
| PPOL-- GALV POL POLYPROTEIN GIBBON APE LEUKEMIA VIRUS 59-80 |
| 971-991 1048-1071 |
| PPOL-- HTLIA POL POLYPROTEIN HUMAN T-CELL LEUKEMIA 330-346 |
| VIRUS TYPE I (STRAIN ATK) |
| PPOL-- HTLIC POL POLYPROTEIN HUMAN T-CELL LEUKEMIA 330-346 |
| VIRUS TYPE I (CARIBBEAN |
| ISOLATE) |
| PPOL-- HTLV2 POL POLYPROTEIN HUMAN T-CELL LEUKEMIA 609-627 |
| VIRUS TYPE II |
| PPOL-- HVIA2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 860-887 |
| VIRUS TYPE 1 (ARV2/SF2 |
| ISOLATE) |
| PPOL-- HV1B1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 635-660 |
| 872-899 |
| VIRUS TYPE 1 (BH10 ISOLATE) |
| PPOL-- HV1B5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 872-899 |
| VIRUS TYPE 1 (BH5 ISOLATE) |
| PPOL-- HV1BR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 872-899 |
| VIRUS TYPE 1 (BRU ISOLATE) |
| PPOL-- HVIEL POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 622-647 |
| 859-886 |
| VIRUS TYPE 1 (ELI ISOLATE) |
| PPOL-- HVIH2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 860-887 |
| VIRUS TYPE 1 (HXB2 ISOLATE) |
| PPOL-- HVIJR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 865-891 |
| VIRUS TYPE 1 (JRCSF ISOLATE) |
| PPOL-- HVIMA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 859-886 |
| VIRUS TYPE 1 (MAL ISOLATE) |
| PPOL-- HVIMN POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 863-890 |
| VIRUS TYPE I (MN ISOLATE) |
| PPOL-- HVIN5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 623-648 |
| 860-887 |
| VIRUS TYPE 1 (NEW YORK-5 |
| ISOLATE) |
| PPOL-- HVIND POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 622-647 |
| 859-886 |
| VIRUS TYPE 1 (NDK ISOLATE) |
| PPOL-- HVIOY POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 860-887 |
| VIRUS TYPE 1 (OYI ISOLATE) |
| PPOL-- HVIPV POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 635-660 |
| 872-899 |
| VIRUS TYPE 1 (PV22 ISOLATE) |
| PPOL-- HV1RH POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 859-886 |
| VIRUS TYPE 1 (RF/HAT ISOLATE) |
| PPOL-- HV1U4 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 859-886 |
| VIRUS TYPE 1 (STRAIN UGAN- |
| DAN/ISO |
| PPOL-- HV1Z2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 622-647 |
| 859-886 |
| VIRUS TYPE 1 (Z2/CDC-Z34 |
| ISOLATE) |
| PPOL-- |
| HVIZ6 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 5-32 VIRUS |
| TYPE 1 (ZAIRE 6 |
| ISOLATE) |
| PPOL-- HV2BE POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 379-406 |
| 907-934 |
| VIRUS TYPE 2 (ISOLATE BEN) |
| PPOL-- HV2CA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 886-913 |
| VIRUS TYPE 2 (ISOLATE CAM2) |
| PPOL-- HV2D1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 397-424 |
| 925-952 |
| VIRUS TYPE 2 (ISOLATE D194) |
| PPOL-- HV2NZ POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 907-934 |
| VIRUS TYPE 2 (ISOLATE D205,7) |
| PPOL-- HV2G1 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 359-386 |
| 887-914 |
| VIRUS TYPE 2 (ISOLATE |
| GHANA-1) |
| PPOL-- HV2NZ POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 543-564 |
| 771-792 887-914 |
| VIRUS TYPE 2 (ISOLATE NH-Z) |
| PPOL-- HV2RO POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 888-915 |
| VIRUS TYPE 2 (ISOLATE ROD) |
| PPOL-- HV2SB POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 359-386 |
| 887-907 |
| VIRUS TYPE 2 (ISOLATE SBLISY) |
| PPOL-- HV2ST POL POLYPROTEIN HUMAN IMMUNODEFICIENCY 379-406 |
| 907-934 |
| VIRUS TYPE 2 (ISOLATE ST) |
| PPOL-- IPHA PUTATIVE POL POLYPROTEIN HAMSTER INTRACISTERNAL |
| 166-190 198-225 460-477 |
| A-PARTICLE |
| PPOL-- IPMA PUTATIVE POL POLYPROTEIN MOUSE INTRACISTERNAL 183-201 |
| 209-236 506-523 531-552 769-789 |
| A-PARTICLE |
| PPOL-- IPMAI PROBABLE POL POLYPROTEIN MOUSE INTRACISTERNAL |
| 102-120 128-155 407-423 425-442 |
| A-PARTICLE |
| PPOL-- JSRV POL POLYPROTEIN SHEEP PULMONARY ADENO- 186-213 |
| 507-526 660-679 |
| MATOSIS VIRUS (JAAGSIEKTE |
| SHEEP RET |
| PPOL-- MCFF3 POL POLYPROTEIN MINK CELL FOCU-FORMING 37-53 |
| MURINE LEUKEMIA VIRUS |
| (ISOLATE CI- |
| PPOL-- MLVAK POL POLYPROTEIN AKR MURINE LEUKEMIA VIRUS 651-671 |
| 728-744 |
| PPOL-- MLVAV POL POLYPROTEIN AKV MURINE LEUKEMIA VIRUS 335-354 |
| 978-998 1004-1024 1081-1097 |
| PPOL-- MLVCB POL POLYPROTEIN CAS-BR-E MURINE LEUKEMIA 64-84 |
| 90-110 167-183 |
| VIRUS |
| PPOL-- MLVF5 POL POLYPROTEIN FRIEND MURINE LEUKEMIA 340-359 |
| 983-1003 1009-1029 1086-1102 |
| VIRUS (ISOLATE 57) |
| PPOL-- MLVFF POL POLYPROTEIN FRIEND MURINE LEUKEMIA 340-359 |
| 983-1003 1009-1029 1086-1102 |
| VIRUS (ISOLATE FB29) |
| PPOL-- MLVFP POL POLYPROTEIN FRIEND MURINE LEUKEMIA 340-359 |
| 983-1003 1009-1029 1086-1102 |
| VIRUS (ISOLATE PVC-211) |
| PPOL-- MLVMO POL POLYPROTEIN MOLONEY MURINE LEUKEMIA 335-354 |
| 978-998 |
| VIRUS |
| PPOL-- MLVRD POL POLYPROTEIN RADIATION MURINE LEU- 335-354 |
| 978-998 1004-1024 1081-1097 |
| KEMIA VIRUS |
| PPOL-- MLVRK POL POLYPROTEIN RADIATION MURINE LEU- 363-383 |
| 389-409 466-482 |
| KEMIA VIRUS (STRAIN KAPLAN) |
| PPOL-- MMTVB POL POLYPROTEIN MOUSE MAMMARY TUMOR 196-219 731-751 |
| VIRUS (STRAIN BR6) |
| PPOL-- MPMV POL POLYPROTEIN SIMIAN MASON-PFIZER VIRUS 743-763 |
| PPOL-- OMVVS POL POLYPROTEIN OVINE LENTIVIRUS (STRAIN 369-395 |
| 469-488 632-647 1045-1063 |
| SA-OMVV) |
| PPOL-- RSVP POL POLYPROTEIN ROUS SARCOMA VIRUS (STRAIN 719-742 |
| PRAGUE C) |
| PPOL-- RTBV POLYPROTEIN RICE TUNGRO BACILLIFORM 891-915 1058-1083 |
| VIRUS (RTBV) |
| PPOL-- |
| RTBVP POLYPROTEIN RICE TUNGRO BACILLIFORM 891-915 1058-1083 |
| VIRUS (ISOLATE PHILIPPINES) |
| PPOL-- SFVI POL POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 1) 188-204 |
| 335-356 845-869 967-996 |
| PPOL-- SFV3L POL POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 186-206 |
| 337-358 847-871 978-996 |
| 3/STRAIN LK3) |
| PPOL-- SIVA1 POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY 895-915 |
| VIRUS (AGM155 ISOLATE) |
| PPOL-- SIVAG POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY 711-726 |
| 900-920 |
| VIRUS (AGM3 ISOLATE) |
| PPOL-- SIVAI POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY 899-926 |
| VIRUS (ISOLATE AGM/CLOND |
| GRI-1) |
| PPOL-- SIVAT POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY 726-741 |
| 915-935 |
| VIRUS (TYO-1 ISOLATE) |
| PPOL-- |
| SIVCZ POL POLYPROTEIN CHIMPANZEE IMMUNO- 884-911 DEFICIENCY |
| VIRUS |
| PPOL-- SIVGB POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY 680-695 |
| 869-896 |
| VIRUS (ISOLATE GBI) |
| PPOL-- SIVMI POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY 380-407 |
| 908-935 |
| VIRUS (MM142-83 ISOLATE) |
| PPOL-- SIVMK POL POLYPROTEIN SIMIAN IMMUNODEFICIENCY 380-407 |
| 712-737 906-933 |
| VIRUS (K6W ISOLATE) |
| PPOL-- SIVS4 POL POLYPROTEIN SIMIAN IMMUNOFEFICIENCY 343-370 |
| 871-898 |
| VIRUS (F236/2MH4 ISOLATE) |
| PPOL-- SIVSP POL POLYPROTEIN SIMIAN IMMUNOFEFICIENCY 346-373 |
| 874-901 |
| VIRUS (PBJ/BC13 ISOLATE) |
| PPOL-- SMRVH POL POLYPROTEIN SQUIRREL MONKEY RETRO- 748-768 |
| VIRUS |
| PPOL-- SMSAV POL POLYPROTEIN SIMIAN SARCOMA VIRUS 100-120 177-200 |
| PPOL-- SOCMV ENZMATIC POLYPROTEIN SOYBEAN CHLOROTIC MOTTLE |
| 131-155 |
| VIRUS |
| PPOL-- |
| SRV1 POL POLYPROTEIN SIMIAN RETROVIRUS 743-763 PPOL-- |
| VILV POL POLYPROTEIN VISNA LENTIVIRUS (STRAIN 488-507 651-666 971-991 |
| 1514) |
| PPOL-- VILV1 POL POLYPROTEIN VISNA LENTIVIRUS (STRAIN 488-507 |
| 651-666 971-991 |
| 1514/CLONE LV1-1KS1) |
| PPOL-- VILV2 POL POLYPROTEIN VISNA LENTIVIRUS (STRAIN 488-507 |
| 651-666 971-991 |
| 1514/CLONE LV1-1KS2) |
| PPP15-- HCMVA LARGE STRUCTURAL PHOS- HUMAN CYTOMEGALOVIRUS |
| 153-171 183-210 |
| PHOPROTEIN PP150 (STRAIN AD169) |
| PPP28-- HCMVA 28 KD STRUCTURAL PHOS- HUMAN CYTOMEGALOVIRUS |
| 116-141 |
| PHOPROTEIN (STRAIN AD169) |
| PPP41-- HSV6G PHOSPHOPROTEIN P41 HERPES SIMPLEX VIRUS (TYPE |
| 158-175 396-411 |
| 6/STRAIN GS) |
| PPP65-- HCMVA 65 KD LOWER MATRIX HUMAN CYTOMEGALOVIRUS 311-333 |
| PHOSPHOPROTEIN (STRAIN AD169) |
| PPP65-- HCMVT 65 KD LOWER MATRIX HUMAN CYTOMEGALOVIRUS 301-323 |
| PHOSPHOPROTEIN (STRAIN TOWNE) |
| PPP71-- HCMVA 71 KD UPPER MATRIX HUMAN CYTOMEGALOVIRUS 79-102 |
| PHOSPHOPROTEIN (STRAIN AD169) |
| PPR73-- |
| MMTVB PROTEIN PR73 MOUSE MAMMARY TUMOR 40-61 VIRUS |
| (STRAIN BR6) |
| PPR73-- |
| MMTVG PROTEIN PR73 MOUSE MAMMARY TUMOR 40-61 VIRUS |
| (STRAIN GR) |
| PPR7L-- |
| MMTVG PROTEIN PR73 MOUSE MAMMARY TUMOR 44-65 VIRUS |
| (STRAIN GR) |
| PPR7R-- |
| MMTVG PROTEIN PR73 MOUSE MAMMARY TUMOR 40-61 VIRUS |
| (STRAIN GR) |
| PRASH-- MSVHA TRANSFORMING PROTEINS HARVEY MURINE SARCOMA 49-73 |
| P21 AND P29 VIRUS |
| PRASH-- RRASV TRANSFORMING PROTEINS RASHEED RAT SARCOMA VIRUS |
| 56-80 |
| P21 AND P29 |
| PREEP-- CSV REPEAT ELEMENT PROTEIN CAMPOLETIS SONORENSIS 14-36 |
| VIRUS |
| PREFR-- VACCV RIFAMPICIN RESISTANCE VACCINIA VIRUS (STRAIN WR), |
| 274-298 316-335 517-535 |
| PROTEIN AND (STRAIN COPENHAGEN) |
| PREFR-- VARV RIFAMPICIN RESISTANCE VIROLA VIRUS 274-298 316-335 |
| 517-535 |
| PROTEIN |
| PREV-- |
| SIVAG REV PROTEIN SIMIAN IMMUNODEFICIENCY 2-17 VIRUS |
| (AGM3 ISOLATE) |
| PREV-- |
| SIVGB REV PROTEIN SIMIAN IMMUNODEFICIENCY 45-72 VIRUS |
| (ISOLATE GB1) |
| PRIR1-- ASFM2 RIBONUCLEOSIDE-DISPHOS- AFRICAN SWINE FEVER VIRUS |
| 139-164 189-210 495-510 |
| PHATE REDUCTASE (ISOALTE MALAWI LIL 20/1) |
| PRIR1-- EBV RIBONUCLEOTIDE REDUCTASE EPSTEIN-BARR VIRUS 793-812 |
| (STRAIN B95-8) |
| PRIR1-- HCMVA RIBONUCLEOTIDE REDUCTASE HUMAN CYTOMEGALOVIRUS |
| 192-212 669-684 |
| (STRAIN AD169) |
| PRIR1-- HSVII RIBONUCLEOTIDE REDUCTASE HERPES SIMPLEX VIRUS (TYPE |
| 415-430 587-613 |
| 1/STRAIN 17) |
| PRIR1-- HSVEB RIBONUCLEOTIDE REDUCTASE EQUINE HERPESVIRUS TYPE 1 |
| 60-85 266-288 668-694 |
| (STRAIN AB4P) |
| PRIR1-- HSVSA RIBONUCLEOTIDE REDUCTASE HERPES VIRUS SAIMIRI |
| 136-151 |
| (STRAIN 11) |
| PRIR1-- VACCC RIBONUCLEOTIDE REDUCTASE VACCINIA VIRUS (STRAIN |
| 36-51 |
| COPENHAGEN) |
| PRIR1-- VACCV RIBONUCLEOTIDE REDUCTASE VACCINIA VIRUS (STRAIN WR) |
| 36-51 |
| PRIR1-- VARV RIBONUCLEOTIDE REDUCTASE VARIOLA VIRUS 36-51 |
| PRIR1-- VZVD RIBONUCLEOTIDE REDUCTASE VARICELLA-ZOSTER |
| VIRUS 34-58 221-247 258-280 |
| (STRAIN DUMAS) |
| PRIR2-- EBV RIBONUCLEOTIDE REDUCTASE EPSTEIN-BARR VIRUS (STRAIN |
| 209-236 |
| B95-8) |
| PRIR2-- HSVII RIBONUCLEOTIDE REDUCTASE HERPES SIMPLEX VIRUS 44-66 |
| 275-292 |
| (TYPE 1/STRAIN 17) |
| PRIR2-- HSVIK RIBONUCLEOTIDE REDUCTASE HERPES SIMPLEX VIRUS 43-65 |
| 245-261 274-291 |
| (TYPE 1/STRAIN KOS) |
| PRIR2-- HSV23 RIBONUCLEOTIDE REDUCTASE HERPES SIMPLEX VIRUS 41-63 |
| 272-289 |
| (TYPE 2/STRAIN 333) |
| PRIR2-- HSVB3 RIBONUCLEOTIDE REDUCTASE BOVINE HERPESVIRUS TYPE 1 |
| 244-266 |
| (STRAIN 34) |
| PRIR2-- HSVEB RIBONUCLEOTIDE REDUCTASE EQUINE HERPESVIRUS TYPE 1 |
| 61-88 251-273 |
| (STRAIN AB4P) |
| PRIR2-- HSVSA RIBONUCLEOTIDE REDUCTASE HERPESVIRUS SAIMIRI |
| 212-239 |
| (STRAIN 11) |
| PRIR2-- SFVKA RIBONUCLEOTIDE REDUCTASE SHOPE FIBROMA VIRUS |
| 184-206 215-237 |
| (STRAIN KASZA) |
| PRIR2-- VACCC RIBONUCLEOTIDE REDUCTASE VACCINIA VIRUS (STRAIN |
| 184-206 |
| COPPENHAGEN) |
| PRIR2-- VACCP RIBONUCLEOTIDE REDUCTASE VACCINIA VIRUS (STRAIN |
| 184-206 |
| L-1VP |
| PRIR2-- VACCV RIBONUCLEOTIDE REDUCTASE VACCINIA VURS (STRAIN WR) |
| 184-206 |
| PRIR2-- VARV RIBONUCLEOTIDE REDUCTASE VARIOLA VIRUS 48-206 |
| 215-237 |
| PRIR2-- VZVD RIBONUCLEOTIDE REDUCTASE VARICELLA-ZOSTER VIRUS |
| 237-258 |
| (STRAIN DUMAS) |
| PRMIL-- AVEVR RMIL SER/THR-PROTEIN AVIAN ROUS-ASSOCIATED 380-405 |
| KINASE TRANSFORMING P VIRUS TGYPE 1 |
| PRP94-- VACCV RNA-POL-ASSOCIATED TRAN- VACCINIA VIRUS (STRAIN |
| WR), 173-189 265-290 371-394 561-578 |
| SCRIPTION SPEC FACT AND (STRAIN COPENHAGEN) |
| PRP94-- VARV RNA-POL-ASSOCIATED TRAN- VARIOLA VIRUS 173-189 |
| 265-290 371-394 561-578 |
| SCRIPTION SPEC FACT |
| PRPO1-- VACCC DNA-DIRECTED RNA POL VACCINIA VIRUS (STRAIN 76-96 |
| 304-329 848-871 1005-1032 |
| 147 KD POLYPEPTIDE COPENHAGEN) |
| PRPO1-- VACCV DNA-DIRECTED RNA POLY- VACCINIA VIRUS (STRAIN WR) |
| 76-96 304-329 848-871 |
| MERASE 147 KD POLYPE |
| PRPO2-- COWPX DNA-DIRECTED RNA POLY- COWPOX VIRUS 150-170 258-274 |
| 480-505 |
| MERASE 132 KD POLYPE |
| PRPO2-- VACCV DNA-DIRECTED RNA POLY- VACCINIA VIRUS (STRAIN WR), |
| 150-170 258-274 480-505 |
| MERASE 132 KD POLYPE AND (STRAIN COPENHAGEN) |
| PRPO2-- VARV DNA-DIRECTED RNA POLY- VARIOLA VIRUS 150-170 258-274 |
| 480-505 |
| MERASE 132 KD POLYPE |
| PRPO4-- VACCC DNA-DIRECTED RNA POLY- VACCINIA VIRUS (STRAIN 33-48 |
| MERASE 35 KD POLYPEP COPENHAGEN) |
| PRPO4-- VACCV DNA-DIRECTED RNA POLY- VACCINIA VIRUS (STRAIN WR) |
| 33-48 |
| MERASE 35 KD POLYPEP |
| PRPO4-- |
| VARV DNA-DIRECTED RNA POLY- VARIOLA VIRUS 33-55 MERASE 35 |
| KD POLYPEP |
| PRPO6-- VACCV DNA-DIRECTED RNA POLY- VACCINIA VIRUS (STRAIN WR), |
| 38-59 |
| MERASE 19 KD POLYPEP AND (STRAIN COPENHAGEN) |
| PRPO6-- VACCV DNA-DIRECTED RNA POLY- VACCINIA VIRUS (STRAIN WR), |
| 38-59 |
| MERASE 19 KD POLYPEP AND (STRAIN COPENHAGEN) |
| PRPO7-- VACCV DNA-DIRECTED RNA POLY- VACCINIA VIRUS (STRAIN WR), |
| 38-59 |
| MERASE 19 KD POLYPEP AND (STRAIN COPENHAGEN) |
| PRPO7-- |
| VARV DNA-DIRECTED RNA POLY- VARIOLA VIRUS 38-59 MERASE 19 |
| KD POLYPEP |
| PRPO8-- FOWP1 DNA-DIRECTED RNA POLY- FOWL POX VIRUS (STRAIN FP-1) |
| 57-81 |
| MERASE 18 KD POLYPEP |
| PRPOA-- LELV RNA-DIREECTED RNA POLY- LELYSTAD VIRUS 175-197 |
| 707-729 1164-1180 1233-1258 1513-1530 1531-1546 1955-1977 2320-2343 |
| 2802-2823 |
| MERASE 3133-3156 |
| PRPOL-- EAV RNA-DIRECTED RNA POLY- EQUINE ARTERITIS VIRUS 97-118 |
| 602-517 754-774 825-851 2530-2553 3041-3068 |
| MERASE |
| PRRP1-- DHVII RNA-DIRECTED RNA POLY- DHORI VIRUS (STRAIN 247-264 |
| 275-299 337-39 377-394 569-591 |
| MERASE SUBUNIT P1 INDIAN/1313/61) |
| PRRP1-- IAANN RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/ANN ARBOR/6/60) |
| PRRP1-- IABEI RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/BEIJING/11/56) |
| PRRP1-- IADUN RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/DUNNEDIN/4/73) |
| PRRP1-- IAGU2 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/GULL/MARYLAND/704/77) |
| PRRP1-- IAHLO RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/EQUINE/LONDON/1416/73) |
| PRRP1-- IAHTE RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/EQUINE/TENNESSEE/5/86) |
| PRRP1-- IAKIE RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/KIEV/59/79 |
| PRRP1-- IAKOR RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/KOREA/426/68) |
| PRRP1-- IALE1 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/LENINGRAD/134/57) |
| PRRP1-- IALE2 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/LENINGRAD/134/17/57) |
| PRRP1-- IALE3 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/LENINGRAD/134/47/57) |
| PRRP1-- IAMAN RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/MALLARD/NEW YORK/ |
| 6750/78) |
| PRRP1-- IAME8 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/MEMPHIS/8/88) |
| PRRP1-- IANT6 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/NT/60/68) |
| PRRP1-- IAPUE RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/PUERTO RICO/8/34) |
| PRRP1-- IASIN RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/SINGAPORE/1/57) |
| PRRP1-- IATKM RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/TURKEY/MINNESOTA/833/80) |
| PRRP1-- IAV17 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 138-163 |
| MERASE SUBUNIT P1 A/VICTORIA/3/75) |
| PRRP1-- IAWIL RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/WILSON-SMITH/33) |
| PRRP1-- IAWIS RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/WISCONSIN/3523/88) |
| PRRP1-- IAZH3 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/SWINE/HONG KONG/126/82) |
| PRRP1-- IAZON RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/SWINE/ONTARIO/2/81) |
| PRRP1-- IAZTF RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 244-262 |
| MERASE SUBUNIT P1 A/SWINE/TENNESSEE/26/77) |
| PRRP1-- INBAC RNA-DIRECTED RNA POLY- INFLUENZA B VIRUS (STRAIN |
| 205-222 |
| MERASE SUBUNIT P1 B/ANN ARBOR/1/66 [COLD- |
| ADAPTED]) |
| PRRP1-- INBAD RNA-DIRECTED RNA POLY- INFLUENZA B VIRUS (STRAIN |
| 205-222 |
| MERASE SUBUNIT P1 B/ANN ARBOR/1/66 [WILD- |
| TYPE]) |
| PRRP1-- INBLE RNA-DIRECTED RNA POLY- INFLUENZA B VIRUS (STRAIN |
| 205-222 |
| MERASE SUBUNIT P1 B/LEE/40) |
| PRRP1-- INCJJ RNA-DIRECTED RNA POLY- INFLUENZA C VIRUS (STRAIN |
| 317-341 564-591 |
| MERASE SUBUNIT P1 C/JJ/50) |
| PRRP1-- IAANN RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/ANN ARBOR/6/60) |
| PRRP2-- IADH2 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/DUCK/HOKKAID0/8/80) |
| PRRP2-- IAFPR RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/FOWL PLAGUE VIRUS/ |
| ROSTTOCK/34) |
| PRRP2-- IAGU2 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/GULL,MARYLAND/704/77) |
| PRRP2-- IAHLO RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/EQUINE/LONDON/1416/73) |
| PRRP2-- IALE1 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/LENINGRAD/134/57) |
| PRRP2-- IALE2 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/LENINGRAD/134/17/57) |
| PRRP2-- IAP10 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/PINTAIL/ALBERTA/119/79) |
| PRRP2-- IAPUE RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/PUERTO RICO/8/34) |
| PRRP2-- IARUD RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/RUDDY TURNSTONE/NEW |
| JERSEY/47/ |
| PRRP2-- IASIN RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/SINGAPORE/1/57) |
| PRRP2-- IATKM RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/TURKEY/MINNESOTA/833/80) |
| PRRP2-- IAWIL RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 68-86 534-557 |
| MERASE SUBUNIT P2 A/WILSON-SMITH/33) |
| PRRP2-- IAZH2 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/SWINE/HONG KONG/81/78) |
| PRRP2-- IAZH3 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/SWINE/HONG KONG/126/82) |
| PRRP2-- IAZII RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 534-557 |
| MERASE SUBUNIT P2 A/SWINE/IOWA/15/30) |
| PRRP2-- IAZTF RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 530-557 |
| MERASE SUBUNIT P2 A/SWINE/TENNESSEE/26/77) |
| PRRP2-- INBAC RNA-DIRECTED RNA POLY- INFLUENZA B VIRUS (STRAIN |
| 32-54 |
| MERASE SUBUNIT P2 B/ANN ARBOR/1/66[COLD- |
| ADAPTED]) |
| PRRP2-- INBAD RNA-DIRECTED RNA POLY- INFLUENZA B VIRUS (STRAIN |
| 32-54 |
| MERASE SUBUNIT P2 B/ANN ARBOR/1/66[WILD- |
| TYPE]) |
| PRRP2-- INBSI RNA-DIRECTED RNA POLY- INFLUENZA B VIRUS (STRAIN |
| 32-54 |
| MERASE SUBUNIT P2 B/SINGAPORE/222/79) |
| PRRP2-- INCJJ RNA-DIRECTED RNA POLY- INFLUENZA C VIRUS (STRAIN |
| 406-425 |
| MERASE SUBUNIT P2 C/JJ/50) |
| PRRP3-- IAANN RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/ANN ARBOR/6/60) |
| PRRP3-- IABUD RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 |
| MERASE SUBUNIT P3 A/BUDGERIGAR/KOKKAIDO/ |
| 1/77) |
| PRRP3-- IACHI RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/CHILE/1/83) |
| PRRP3-- IAFPR RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542- 567 |
| MERASE SUBUNIT P3 ROSTOCK/34) |
| PRRP3-- IAFPW RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/FOWL PLAGUE VIRUS/ |
| WEYBRIDGE) |
| PRRP3-- IAGU2 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/GULL/MARYLAND/704/77) |
| PRRP3-- IAGUA RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/GULLASTRAKHAN/227/84) |
| PRRP3-- IAHK6 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/EQUINE/KENTUCKY/2/86) |
| PRRP3-- IAHLO RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/EQUINE/LONDON/1416/73) |
| PRRP3-- IAHPR RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/EQUINE/PRAGUE/1/56) |
| PRRP3-- IAKIE RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 542-560 |
| MERASE SUBUNIT P3 A/KIEV/59/79) |
| PRRP3-- IAKOR RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/KOREA/426/68) |
| PRRP3-- IALE1 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/LENINGRAD/134/57) |
| PRRP3-- IALE2 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/LENINGRAD/134/17/57) |
| PRRP3-- IALE3 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/LENINGRAD/134/47/57) |
| PRRP3-- IAMAN RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN A/ |
| 219-234 542-560 |
| MERASE SUBUNIT P3 MALLARD/NEW YORK/6750/78) |
| PRRP3-- |
| IAME8 RNA-DIRECTED RNA POLY- 219-234 542-560 MERASE |
| SUBUNIT P3 |
| PRRP3-- IANT6 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/NT/60/68) |
| PRRP3-- IAPUE RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 469-485 542-560 |
| MERASE SUBUNIT P3 A/PUERTO RICO/8/34) |
| PRRP3-- IARUD RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/RUDDY TURNSTONE/NEW |
| JERSEY/47/ |
| PRRP3-- IASE2 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/SEAL/MASSACHUSETTS/133/82) |
| PRRP3-- IASIN RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/SINGAPORE/1/57) |
| PRRP3-- IATKM RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/TURKEY/MINNESOTA/833/80) |
| PRRP3-- IAV17 RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/VICTORIA/3/75) |
| PRRP3-- IAWIL RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/WILSON-SMITH/33) |
| PRRP3-- IAZII RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/SWINE/IOWA/15/30) |
| PRRP3-- IAZTE RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 219-234 542-560 |
| MERASE SUBUNIT P3 A/SWINE/TENNESSEE/24/77) |
| PRRP3-- INBAC RNA-DIRECTED RNA POLY- INFLUENZA B VIRUS (STRAIN |
| 71-86 535-561 |
| MERASE SUBUNIT P3 B/ANN ARBOR/1/66[COLD- |
| ADAPTED]) |
| PRRP3-- INBAD RNA-DIRECTED RNA POLY- INFLUENZA B VIRUS (STRAIN |
| 71-86 535-561 |
| MERASE SUBUNIT P3 B/ANN ARBOR/1/66[WILD-TYPE]) |
| PRRP3-- INCBE RNA-DIRECTED RNA POLY- INFLUENZA C VIRUS (STRAIN |
| 74-96 552-571 |
| MERASE SUBUNIT P3 C/BERLIN/1/85) |
| PRRP3-- INCJJ RNA-DIRECTED RNA POLY- INFLUENZA A VIRUS (STRAIN |
| 74-96 552-571 |
| MERASE SUBUNIT P3 C/JJ/50) |
| PRRP3-- |
| THOGV RNA-DIRECTED RNA POL THOGOTO VIRUS 85-101 SUBUNIT P3 |
| PRRPA-- CVH22 RNA-DIRECTED RNA POLY- HUMAN CORONAVIRUS 82-104 |
| 410-436 858-878 1482-1507 1523-1542 1543-1568 2125-2149 2974-2992 |
| 3537-3559 |
| MERASE (STRAIN 229E) |
| PRRPA-- CVMJD RNA-DIRECTED RNA POLY- MURINE HEPATITIS VIRUS |
| 440-467 |
| MERASE (STRAIN DEFECTIVE JHM) |
| PRRPA-- CVMJH RNA-DIRECTED RNA POLY- MURINE CORONAVIRUS MHV |
| 917-938 1188-1215 1338-1354 1422-1449 1461-1480 1567-1585 1783-1806 |
| 2165-2192 2337-2354 |
| MERASE (STRAIN JHM) |
| 2470-2494 2660-2676 2944-2961 3229-3255 3405-3425 3933-3954 |
| PRRPB-- BEV RNA-DIRECTED RNA POLY- BERNE VIRUS 806-832 |
| 1509-1527 1738-1757 2137-2154 |
| MERASE |
| PRRPB-- CVMA5 RNA-DIRECTED RNA POLY- MURINE CORONAVIRUS MHV |
| 385-412 1302-1324 1835-1850 2698-2723 |
| MERASE (STRAIN A59) |
| PRRPB-- CVMJH RNA-DIRECTED RNA POLY- MURINE CORONAVIRUS MHV |
| 385-412 746-770 1302-1324 1833-1848 2696-2721 |
| MERASE (STRAIN JHM) |
| PRRPB-- CVPFS RNA-DIRECTED RNA POLY- PRCINE TRANSMISSIBLE GAS- |
| 173-200 482-508 |
| MERASE TROENTERITIS CORONAVIRUS |
| (STRAI |
| PRRPB-- CVPR8 RNA-DIRECTED RNA POLY- PORCINE RESPIRATORY CORO- |
| 80-106 |
| MERASE NAVIRUS (STRAIN 86/137004/ |
| BRITISH I) |
| PRRPB-- IBVB RNA-DIRECTED RNA POLY- AVIAN INFECTIOUS BRONCHITIS |
| 140-164 338-365 887-911 1335-1352 1654-1674 |
| MERASE VIRUS (STRAIN BEAUDETTE) |
| PRRPB-- BTV10 RNA-DIRECTED RNA POLY- BLUETONGUE VIRUS (SERO- |
| 21-41 146-161 |
| MERASE TYPE 10/ISOLATE USA) |
| PRRPL-- BUNYW RNA POLYMERASE BUNYAMWERA VIRUS 78-104 303-324 |
| 440-465 1096-1116 1317-1338 1343-1365 1539-1554 1869-1886 2001-2027 |
| PRRPL-- |
| EBOV RNA-IRECTED RNA POLY- EBOLA VIRUS 16-31 MERASE |
| PRRPL-- HANTV RNA POLYMERASE HANTAAN VIRUS (STRAIN 151-168 |
| 173-194 596-611 1561-1585 2081-2105 |
| 76-118) |
| PRRPL-- |
| HRSV RNA POLYMERASE BETA HUMAN RESPIRATORY 3-19 SUBUNIT |
| SYNCYTIAL VIRUS |
| PRRPL-- HRSVA RNA POLYMERASE BETA HUMAN RESPIRATORY SYNCY- 3-19 |
| 1181-1206 1425-1447 1633-1653 1929-1948 2018-2037 |
| SUBUNIT TIAL VIRUS (STRAIN A2) |
| PRRPL-- MABVM RNA-DIRECTED RNA POLY- MARBURG VIRUS (STRAIN 15-30 |
| 144-169 223-248 317-341 471-492 546-569 931-946 1042-1067 1410-1436 |
| MERASE MUSOKE) 1711-1731 1990-2017 2071-2094 |
| PRRPL-- MABVP RNA-DIRECTED RNA POLY- MARBURG VIRUS (STRAIN 15-30 |
| 144-169 223-248 471-492 546-569 931-946 1042-1067 1410-1436 1677-1696 |
| MERASE POPP) 1715-1731 1805-1832 1990-2017 2071-2094 2223-2246 |
| PRRPL-- MEASE RNA POLYMERASE BETA MEASLES VIRUS (STRAIN |
| 285-312 617-632 998-1023 1160-1185 1279-1304 1920-1940 2038-2063 |
| SUBUNIT EDMONSTON) |
| PRRPL-- MUMPM RNA POLYMERASE BETA MUMPS VIRUS (STRAIN 43-66 |
| 110-135 265-280 962-988 1100-1124 1132-1153 1601-1622 2128-2143 |
| SUBUNIT MIYAHARA VACCINE) |
| PRRPL-- NDVB RNA POLYMERASE BETA NEWCASTLE DISEASE VIRUS 704-724 |
| 1571-1592 1967-1994 2040-2067 |
| SUBUNIT (STRAIN BEAUDETTE C/45) |
| PRRPL-- P12HT RNA POLYMERASE BETA HUMAN PARAINFLUENZA 2 109-124 |
| 268-291 308-334 1309-1335 1562-1588 1985-2010 2215-2234 |
| SUBUNIT VIRUS (STRAIN TOSHIBA) |
| PRRPL-- P13H4 RNA POLYMERASE BETA HUMAN PARAINFLUENZA 3 172-193 |
| 304-330 844-861 885-900 1848-1868 2068-2084 2111-2134 |
| SUBUNIT VIRUS (STRAIN NIH 47885) |
| PRRPL-- PUUMH RNA-DIRECTED RNA POLY- PUUMALA VIRUS (STRAIN |
| 173-194 596-569 931-946 1042-1067 1410-1436 1677-1696 |
| MERASE HALLNAS B1) |
| PRRPL-- RABVP RNA POLYMERASE BETA RABIES VIRUS (STRAIN PV) |
| 266-286 542-563 741-762 1446-1461 1492-1517 |
| SUBUNIT |
| PRRPL-- RABVS RNA POLYMERASE BETA RABIES VIRUS (STRAIN 266-286 |
| 542-563 741-762 1446-1461 1492-1517 1744-1761 |
| SUBUNIT SAD B19) |
| PRRPL-- RDV RNA-DIRECTED RNA POLY- RICE DWARF VIRUS 10-27 533-560 |
| 680-697 1293-1316 |
| MERASE |
| PRRPL-- RVFVZ RNA-DIRECTED RNA POLY- RIFT VALLEY FEVER VIRUS |
| 582-609 2009-2035 |
| MERASE (STRAIN ZH-548 M12) |
| PRRPL-- SEND5 RNA POLYMERASE BETA SENDAI VIRUS (STRAIN Z/HOST |
| 64-83 104-120 194-218 844-861 885-900 14015-1420 1844-1864 2107-2128 |
| SUBUNIT MUTANTS) |
| PRRPL-- SENDE RNA POLYMERASE BETA SENDAI VIRUS (STRAIN 14-38 |
| 664-681 704-720 1225-1240 1664-1684 1927-1948 |
| SUBUNIT ENDERS) |
| PRRPL-- SENDZ RNA POLYMERASE BETA SENDAI VIRUS (STRAIN Z) 64-84 |
| 104-120 194-218 844-861 885-900 1405-1420 1844-1864 2107-2128 |
| SUBUNIT |
| PRRPL-- SEOU8 RNA-DIRECTED RNA POLY- SEOUL VIRUS (STRAIN 80-39) |
| 151-168 173-194 394-419 596-511 1561-1585 2081-2105 |
| MERASE |
| PRRPL-- SV5WR RNA POLYMERASE BETA SIMIAN VIRUS 5 (STRAIN 43-66 |
| 108-124 263-289 1094-1118 1125-1147 1558-1580 2117-2137 |
| SUBUNIT 21004-WR) |
| PRRPL-- SYNV RNA POLYMERASE BETA SONCHUS YELLOW NET VIRUS 126-145 |
| 391-406 605-627 704-731 863-883 886-911 1484-1510 1776-1792 |
| SUBUNIT |
| PRRPL-- TSWVB RNA-DIRECTED RNA POLY- TOMATO SPOTTED WILT VIRUS |
| 958-974 1385-1410 1778-1800 2609-2627 2678-2702 |
| MERASE (BRAZILIAN ISOLATE CPNH- |
| 1/BR-01 |
| PRRPL-- UUK RNA POLYMERASE UUKUNIEMI VIRUS 698-714 923-948 |
| 1404-1431 1570-1591 2060-2081 |
| PRRPL-- VSVJH RNA POLYMERASE BETA VESICULAR STOMATITIS VIRUS |
| 156-183 312-339 902-928 1956-1982 2080-2097 |
| SUBUNIT (SEROTYPE NEW JERSEY/ |
| STRAIN HA |
| PRRPL-- VSVJO RNA POLYMERASE BETA VESICULAR STOMATITIS VIRUS |
| 156-183 312-339 1956-1982 2080-2101 |
| SUBUNIT (SEROTYPE NEW JERSEY/ |
| STRAIN OG |
| PRRPL-- VSVSJ RNA POLYMERASE BETA VESICULAR STOMATITIS VIRUS |
| 1956-1982 |
| SUBUNIT (STRAIN SAN JUAN) |
| PRRPO-- ACLSV RNA-DIRECTED RNA POLY- APPLE CHLOROTIC LEAF |
| 226-247 1036-1054 1132-1155 1775-1201 |
| MERASE SPOT VIRUS |
| PRRPO-- BWYVF PUTATIVE RNA-DIRECTED BEET WESTERN YELLOWS 299-326 |
| RNA POL VIRUS (ISOLATE FL01) |
| PRRPO-- BYDV1 PUTATIVE RNA-DIRECTED BARLEY YELLOW DWARF 359-386 |
| 391-416 505-532 |
| RNA POL VIRUS (ISOLATE MAV-PS1) |
| PRRPO-- BYDVP PUTATIVE RNA-DIRECTED BARLEY YELLOW DWARF 359-386 |
| 391-416 505-532 |
| RNA POL VIRUS (ISOLATE PAV) |
| PRRPO-- BYDVR PUTATIVE RNA-DIRECTED BARLEY YELLOW DWARF 359-386 |
| 391-416 505-532 |
| RNA POL VIRUS (ISOLATE P-PAV) |
| PRRPO-- CARMV PROBABLE RNA-DIRECTED CARNATION MOTTLE VIRUS 4-30 |
| 92-017 327-350 818-833 |
| RNA POL |
| PRRPO-- CGMVS PUTATIVE RNA-DIRECTED CUCUMBER GREEN MOTTLE 443-466 |
| 574-591 1017-1032 1523-1539 |
| RNA POL MOSAIC VIRUS (WATERMELON |
| STRAIN S |
| PRRPO-- CNV PROBABLE RNA-DIRECTED CUCUMBER NECROSIS VIRUS 277-300 |
| 345-371 470-494 |
| RNA POL |
| PRRPO-- CRV PROBABLE RNA-DIRECTED CYMBIDIUM RINGSPOT VIRUS 95-111 |
| 345-371 470-494 |
| RNA POL |
| PRRPO-- IPNVJ PUTATIVE RNA-DIRECTED INFECTIOUS PANCRATIC 221-238 |
| RNA POL NECROSIS VIRUS (SEROTYPE |
| JASPER) |
| PRRPO-- LYCVA RNA POLYMERASE LYMPHOCYTIC CHORIOMEN- 35-52 597-613 |
| 659-682 988-1008 1234-1258 1770-1795 2077-2099 |
| INGITIS VIRUS (STRAIN |
| ARMSTRONG) |
| PRRPO-- LYCVW RNA POLYMERASE LYMPHOCYTIC CHORIOMEN- 35-52 |
| INGITIS VIRUS (STRAIN WE) |
| PRRPO-- MCMV PROBABLE RNA-DIRECTED MAIZE CHLOROTIC MOTTLE 16-41 |
| 101-127 573-599 |
| RNA POL VIRUS |
| PRRPO-- PEAMV RNA-DIRECTED RNA POLY- PEA ENATION MOSAIC VIRUS |
| 144-161 316-336 431-456 558-574 |
| MERASE |
| PRRPO-- PLRV1 PUTATIVE RNA-DIRECTED POTATO LEAFROLL VIRUS 331-358 |
| 576-600 |
| RNA POL (STRAIN 1) |
| PRRPO-- PLRVW PUTATIVE RNA-DIRECTED POTATO LEAFROLL VIRUS 331-358 |
| 576-600 |
| RNA POL (STRAIN WAGENINGEN) |
| PRRPO-- PPMVS PUTATIVE RNA-DIRECTED PEPPER MILD MOTTLE VIRUS |
| 375-395 702-726 1069-1096 1491-1507 |
| RNA POL (STRAIN SPAIN) |
| PRRPO-- RCNMV PUTATIVE RNA-DIRECTED RED CLOVER NECROTIC 278-300 |
| RNA POL MOSAIC VIRUS |
| PRRPO-- REOVJ RNA-DIRECTED RNA POLY- REOVIRUS (TYPE 2/STRAIN |
| 161-176 |
| MERASE D5/JONES) |
| PRRPO-- REOVL RNA-DIRECTED RNA POLY- REOVIRUS (TYPE 1/STRAIN |
| 161-176 |
| MERASE LANG) |
| PRRPO-- ROTBR RNA-DIRECTED RNA POL BOVINE ROTAVIRUS (STRAIN |
| 132-156 247-269 844-861 904-921 9242-967 1027-1046 |
| SUBUNIT VP1 RF) |
| PRRPO-- ROTBU RNA-DIRECTED RNA POL BOVINE ROTAVIRUS (STRAIN |
| 123-156 247-269 844-861 904-921 942-967 1027-1046 |
| SUBUNIT VP1 UK) |
| PRRPO-- ROTPC RNA-DIRECTED RNA POL PORCINE ROTAVIRUS (GROUP |
| 198-223 254-274 318-337 768-784 856-878 936-952 |
| SUBUNIT VP1 C/STRAIN COWDEN) |
| PRRPO-- ROTPG RNA-DIRECTED RNA POL PORCINE ROTAVIRUS (STRAIN |
| 32-53 57-72 132-156 247-269 844-861 904-921 942-967 1027-1046 |
| SUBUNIT VP1 GOTTFRIED) |
| PRRPO-- ROTS1 RNA-DIRECTED RNA POL SIMIAN 11 ROTAVIRUS (STRAIN |
| 132-156 247-269 844-861 904-921 942-967 1027-1046 |
| SUBUNIT VP1 SA11) |
| PRRPO-- SBMV PROBABLE RNA-DIRECTED SOUTHERN BEAN MOSAIC 38-64 |
| 122-143 188-206 287-302 444-466 625-643 825-846 |
| RNA POL VIRUS |
| PRRPO-- TACV RNA POLYMERASE TACARIBE VIRUS 88-107 369-389 |
| 1281-1301 1676-1692 2019-2046 |
| PRRPO-- TBSVC PUTATIVE RNA-DIRECTED RNA TOMATO BUSHY STUNT VIRUS |
| 277-300 345-371 470-494 |
| POL (STRAIN CHERRY) |
| PRRPO-- TCV PUTATIVE RNA-DIRECTED RNA TURNIP CRINKLE VIRUS 31-58 |
| 241-263 |
| POL |
| PRRPO-- TMGMV PUTATIVE RNA-DIRECTED RNA TOBACCO MILD GREEN MO- |
| 209-231 1085-1100 |
| POL SAIC VIRUS (TMV STRAIN US) |
| PRRPO-- TMV PUTATIVE RNA-DIRECTED RNA TOBACCO MOSAIC VIRUS |
| 700-724 1090-1105 1587-1610 |
| POL (VULGARE) |
| PRRPO-- TMVKR PUTATIVE RNA-DIRECTED RNA TOBACCO MOSACI VIRUS |
| 700-724 1090-1105 1587-1610 |
| POL (STRAIN KOREAN) |
| PRRPO-- TMVTO PUTATIVE RNA-DIRECTED RNA TOBACCO MOSAIC VIRUS |
| 700-724 1090-1105 1151-1170 1587-1610 |
| POL (STRAIN TOMATO/L) |
| PRRPO-- TNVA RAN-DIRECTED RNA TOBACCO NECROSIS VIRUS 113-135 |
| POLYMERASE (STRAIN A) |
| PRRPO-- TNVD RNA-DIRECTED RNA TOBACCO NECROSIS VIRUS 5-26 |
| POLYMERASE (STRAIN D) |
| PRRPP-- CHAV RNA POLYMERASE ALPHA CHANDIPURA VIRUS (STRAIN |
| 124-146 |
| SUBUNIT 1653514) |
| PRRPP-- MUMP1 RNA POLYMERASE ALPHA MUMPS VIRUS (STRAIN SBL-1) |
| 211-238 |
| SUBUNIT |
| PRRPP-- MUMPE RNA POLYMERASE ALPHA MUMPS VIRUS (STRAIN212-239 |
| SUBUNIT ENDERS) |
| PRRPP-- MUMPM RNA POLYMERASE ALPHA MUMPS VIRUS (STRAIN 212-239 |
| SUBUNIT MIYAHARA VACCINE) |
| PRRPP-- NDVA RNA POLYMERASE ALPHA NEWCASTLE DISEASE VIRUS 256-276 |
| SUBUNIT (STRAIN AUSTRALIA-VIC- |
| TORIA/32) |
| PRRPP-- NDVB RNA POLYMERASE ALPHA NEWCASTLE DISEASE VIRUS 256-276 |
| SUBUNIT (STRAIN BEAUDETTE C/45) |
| PRRPP-- P12H RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 2 216-243 |
| SUBUNIT VIRUS |
| PRRPP-- P12HT RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 2 216-243 |
| SUBUNIT VIRUS (STRAIN TOSHIBA) |
| PRRPP-- P14HA RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 4A 220-247 |
| SUBUNIT VIRUS (STRAIN TOSHIBA) |
| PRRPP-- P14HB RNA POLYMERASE ALPHA HUMAN PARAINFLUENZA 4B 220-247 |
| SUBUNIT VIRUS (STRAIN 68-333) |
| PRRPP-- |
| PIRYV RNA POLYMERASE ALPHA PIRY VIRUS 134-161 SUBUNIT |
| PRRPP-- RABVA RNA POLYMERASE ALPHA RABIES VIRUS (STRAIN AVO1) |
| 8-32 |
| SUBUNIT |
| PRRPP-- RABVC RNA POLYMERASE ALPHA RABIES VIRUS (STRAIN CVS-011) |
| 8-32 |
| SUBUNIT |
| PRRPP-- RABVE RNA POLYMERASE ALPHA RABIES VIRUS (STRAIN ERA), |
| 8-32 216-237 |
| SUBUNIT AND (STRAIN PM) |
| PRRPP-- RABVP RNA POLYMERASE ALPHA RABIES VIRUS (STRAIN PV) 8-32 |
| 215-237 |
| SUBUNIT |
| PRRPP-- RABVS RNA POLYMERASE ALPHA RABIES VIRUS (STRAIN SAD 8-32 |
| 216-237 |
| SUBUNIT B19) |
| PRRPP-- SV5 RNA POLYMERASE ALPHA SIMIAN VIRUS 5 (STRAIN W3) |
| 199-226 282-301 |
| SUBUNIT |
| PRRPP-- VSVJO RNA POLYMERASE ALPHA VESICULAR STOMATITIS VIRUS |
| 197-223 |
| SUBUNIT (SEROTYPE NEW JERSEY/ |
| STRAIN OG |
| PS27R-- ASFB7 S273R PROTEIN AFRICAN SWINE FEVER VIRUS 196-218 |
| (STRAIN BA71V) |
| PSODC-- VACCC SUPEROXIDE DISMUTASE LIKE VACCINIA VIRUS (STRAIN |
| 19-40 |
| PROTEIN COPENHAGEN) |
| PSODC-- VACCV SUPEROXIDE DISMUTASE LIKE VACCINIA VIRUS (STRAIN |
| WR) 19-40 |
| PROTEIN |
| PSODC-- VARV SUPEROXIDE DISMUTASE LIKE VARIOLA VIRUS 19-40 |
| PROTEIN |
| PSPHR-- AMEPV SPHEROIDIN AMSACTA MOOREI ENTOMO- 58-79 627-646 |
| POXVIRUS |
| PSPHR-- CBEPV SPHEROIDIN PRECURSOR CHORISTONURA BIENNIS ENTO- |
| 177-201 |
| MOPOXVIRUS |
| PSP11-- MYXVL SERPIN 1 MYXOMA VIRUS (STRAIN 62-80 217-243 |
| LAUSANNE) |
| PSWFA-- SPVKA SWF8A PROTEIN SWINEPOX VIRUS (STRAIN 61-83 |
| KASZA) |
| PTALA-- BFDV LARGE T ANTIGEN BUDGERIGAR FLEDGLING 354-369 |
| DISEASE VIRUS |
| PTALA-- POVBA LARGE T ANTIGEN POLYOMAVIRUS BK (STRAIN 202-224 |
| 429-444 |
| AS) |
| PTALA-- POVBK LARGE T ANTIGEN POLYOMAVIRUS BK 202-224 429-444 |
| PTALA-- POVBO LARGE T ANTIGEN BOVINE POLYOMAVIRUS 385-400 |
| PTALA-- POVHA LARGE T ANTIGEN HAMSTER POLYOMAVIRUS 43-69 |
| 549-564 |
| PTALA-- POVJC LARGE T ANTIGEN POLYOMAVIRUS JC 201-223 428-443 |
| PTALA-- POVLY LARGE T ANTIGEN LYMPHOTROPIC POLYOMA- 43-69 |
| 516-542 |
| VIRUS |
| PTALA-- |
| POVM3 LARGE T ANTIGEN MOUSE POLYOMAVIRUS 576-591 (STRAIN 3) |
| PTALA-- |
| POVMA LARGE T ANTIGEN MOUSE POLYOMAVIRUS 574-589 (STRAIN |
| A2) |
| PTALA-- |
| POVMC LARGE T ANTIGEN MOUSE POLYOMAVIRUS 571-586 (STRAIN |
| CRAWFORD SMALL- |
| PLAQUE) |
| PTALA-- POVMK LARGE T ANTIGEN MOUSE POLYOMAVIRUS 173-191 278-304 |
| 446-472 |
| (STRAIN KILHAM) |
| PTALA-- SV40 LARGE T ANTIGEN SIMIAN VIRUS 40 (SV40) 200-222 |
| 427-442 |
| PTAMI-- |
| POVHA MIDDLE T ANTIGEN HAMTER POLYOMAVIRUS 43-69 PTASM-- |
| POVHA SMALL T ANTIGEN HAMSTER POLYOMAVIRUS 43-69 |
| PTASM-- POVLY SMALL T ANTIGEN LYMPHOTROPIC POLYOMA- 43-69 |
| VIRUS |
| PTASM-- POVMK SMALL T ANTIGEN MOUSE POLYOMAVIRUS 43-69 67-89 |
| (STRAIN KILHAM) |
| PTATR-- NPVAC TRANS-ACTIVATING TRANS AUTOGRAPHA CALIFORNICA |
| 406-431 |
| REG PROTEIN NUCLEAR POLYHEDROSIS |
| VIRUS |
| PTATR-- NPVBM TRANS-ACTIVATING TRANS BOMBYX MORI NUCLEAR 411-436 |
| REG PROTEIN POLYHEDROSIS VIRUS |
| PTATR-- NPVOP TRANS-ACTIVATING TRANS ORGYIA PSEUDOTSUGATA 389-414 |
| REG PROTEIN MULTICAPSID POLYHEDROSIS |
| VIRUS |
| PTAT-- BIVO6 TRANS-ACTIVATING TRANS BOVINE IMMUNODEFICIENCY 44-59 |
| REG PROTEIN VIRUS (ISOLTE 106) |
| PTAT-- BIV27 TRANS-ACTIVATING TRANS BOVINE IMMUNODEFICIENCY 44-59 |
| REG PROTEIN VIRUS (ISOLATE 127) |
| PTAT-- HTLIA TRANS-ACTIVATING TRANS HUMAN T-CELL LEUKEMIA 192-210 |
| REG PROTEIN VIRUS TYPE I (STRAIN ATK) |
| PTAT-- HTLIC TRANS-ACTIVATING TRANS HUMAN T-CELL LEUKEMIA 192-210 |
| REG PROTEIN VIRUS TYPE I (CARIBBEAN |
| ISOLATE) |
| PTAT-- |
| HVIU4 TAT PROTEIN HUMAN IMMUNODEFICIENCY 18-43 VIRUS |
| TYPE I (STRAIN |
| UGANDAN/ISO |
| PTCB-- FLV T-CELL RECEPTOR BETA CHAIN FELINE LEUKEMIA VIRUS 6-22 |
| 98-118 |
| PRECURSOR |
| PTEGP-- HSVEB PROBABLE TEGUMENT PHOS- EQUINE HERPESVIRUS TYPE 1 |
| 101-118 |
| PHOPROTEIN (STRAIN AB4P) |
| PTEGP-- HSVEK TEGUMENT PROTEIN EQUINE HERPESVIRUS TYPE 1 101-118 |
| (STRAIN KENTUCKY A) |
| PTEGP-- EBV LARGE TEGUMENT PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| 143-166 767-789 814-835 1052-1075 1194-1220 1469-1496 1869-1893 3061-3077 |
| 3102-3126 |
| B95-8) |
| PTEGU-- HCMVA PROBABLE LARGE TEGUMENT HUMAN CYTOMEGALOVIRUS |
| 342-358 644-668 1061-1077 1307-1322 1323-1345 1419-1446 1509-1536 |
| 1957-1974 2199-2221 |
| PROTEIN (STRAIN AD169) |
| PTEGU-- HSVII LARGE TEGUMENT PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 12-27 623-646 1732-1759 |
| 1/STRAIN 18) |
| PTEGU-- HSV6G LARGE TEGUMENT PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 131-152 356-365 615-636 1027-1043 1308-1328 1562-1579 |
| 6/STRAIN GS) |
| PTEGU-- HSVEB LARGE TEGUMENT PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| 432-456 559-582 1072-1099 1107-1132 1618-1640 1764-1791 2263-2285 |
| (STRAIN AB4P) |
| PTEGU-- HSVSA PROBABLE LARGE TEGUMENT HERPESVIRUS SAIMIRI 467-491 |
| 714-737 989-1008 1121-1137 1155-1175 1177-1193 1503-1525 1607-1622 |
| 1898-1915 |
| PROTEIN (STRAIN 11) 2421-2439 |
| PTEGU-- VZVD LARGE TEGUMENT PROTEIN VARICELLA-ZOSTER VIRUS |
| 433-456 494-511 711-728 801-823 895-920 1013-1034 1360-1376 1632-1657 |
| 1780-1807 |
| (STRAIN DUMAS) 2008-2029 2270-2287 2694-2711 |
| PTERM-- ADE02 DNA TERMINAL PROTEIN HUMAN ADENOVIRUS TYPE 2 63-80 |
| 593-616 |
| PTERM-- ADE05 DNA TERMINAL PROTEIN HUMAN ADENOVIRUS TYPE 5 63-80 |
| 593-616 |
| PTERM-- ADE07 DNA TERMINAL PROTEIN HUMAN ADENOVIRUS TYPE 7 63-80 |
| 580-603 |
| PTERM-- ADE12 DNA TERMINAL PROTEIN HUMNA ADENOVIRUS TYPE 12 46-63 |
| 334-350 546-569 |
| PTOP2-- ASFB7 DNA TOPOISOMERASE II AFRICAN SWINE FEVER VIRUS |
| 119-156 686-707 |
| (STRAIN BA71V) |
| PTOP2-- ASFM2 DNA TOPOISOMERASE II AFRICAN SWINE FEVER VIRUS |
| 119-146 685-706 |
| (ISOLATE MALAWI LIL 20/1) |
| PTR14-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 139-165 |
| TRL14 (STRAIN AD169) |
| PTREL-- AVIRE REL TRANSFORMING PROTEIN AVIAN RETICULOENDOTHE- |
| 56-74 |
| LIOSIS VIRUS |
| PTYSY-- VZVD THYMIDYLATE SYNTHASE VARICELLA-ZOSTER VIRUS 11-29 |
| (STRAIN DUMAS) |
| PU15R-- HSV6U POSSIBLE GANCICLOVIR HERPES SIMPLEX VIRUS (TYPE |
| 400-415 |
| KINASE 6/STRAIN UGANDA-1102) |
| PU2L-- |
| HSV6U PROTEIN 2L HERPES SIMPLEX VIRUS (TYPE 4-27 6/STRAIN |
| UGANDA-1102) |
| PUDPE-- NPVAC UDP-GLUCOSYL TRANFERASE AUTOGRAPHA CALIFORNICA |
| 452-477 |
| PRECURSOR NUCLEAR POLYHEDROSIS |
| VIRUS |
| PUL02-- HCMVA HYPOTHETICAL PROTEIN UL2 HUMAN CYTOMEGALOVIRUS |
| 25-49 |
| (STRAIN AD169) |
| PUL05-- HCMVA HYPOTHETICAL PROTEIN UL5 HUMAN CYTOMEGALOVIRUS |
| 11-37 |
| (STRAIN AD169) |
| PUL06-- EBV VIRION PROTEIN BBRF1 EPSTEIN-BARR VIRUS (STRAIN |
| 253-268 |
| B95-8) |
| PUL06-- HSVEB VIRION GENE 56 PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| 437-461 |
| (STRAIN AB4P) |
| PUL06-- HSVSA VIRION GENE 43 PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 44-60 |
| 11) |
| PUL07-- EBV BBRF2 PROTEIN EPSTEIN-BARR VIRUS (STRAIN 127-149 |
| B95-8) |
| PUL07-- HCMVA HYPOTHETICAL PROTEIN UL7 HUMAN CYTOMEGALOVIRUS |
| 88-108 186-209 |
| (STRAIN AD169) |
| PUL07-- HSVII PROTEIN UL7 HERPES SIMPLEX VIRUS (TYPE 177-200 |
| 1/STRAIN 17) |
| PUL07-- HSVEB GENE 55 PROTEIN EQUINE HERPESVIRUS TYPE 1 11-32 |
| (STRAIN AB4P) |
| PUL07-- HSVSA GENE 42 PROTEIN HERPESVIRUS SAIMIRI (STRAIN 44-61 |
| 11) |
| PUL07-- VZVD GENE 53 PROTEIN VARICELLA-ZOSTER VIRUS 158-176 |
| 202-224 |
| (STRAIN DUMAS) |
| PUL08-- HSVII PROTEIN UL8 HERPES SIMPLEX VIRUS (TYPE 514-538 |
| 705-726 |
| 1/STRAIN 17) |
| PUL08-- VZVD GENE 52 PROTEIN VARICELLA-ZOSTER VIRUS 228-255 |
| 593-616 |
| (STRAIN DUMAS) |
| PUL09-- HSVII ORIGIN OF REPLICATION HERPES SIMPLEX VIRUS (TYPE |
| 564-584 |
| BINDING PROTEIN 1/STRAIN 17) |
| PUL09-- HSVEB ORIGIN OF REPLICATION EQUINE HERPESVIRUS TYPE 1 |
| 171-196 612-628 |
| BINDING PROTEIN (STRAIN AB4P) |
| PUL09-- VZVD ORIGIN OF REPLICATION VARICELLA-ZOSTER VIRUS 68-92 |
| 168-190 484-508 |
| BINDING PROTEIN (STRAIN DUMAS) |
| PUL11-- HCMVA HYPOTHETICAL PROTEIN UL11 HUMAN CYTOMEGALOVIRUS |
| 223-247 |
| (STRAIN AD169) |
| PUL13-- HCMVA HYPOTHETICAL PROTEIN UL13 HUMAN CYTOMEGALOVIRUS |
| 449-467 |
| (STRAIN AD169) |
| PUL14-- HCMVA HYPOTHETICAL PROTEIN UL14 HUMAN CYTOMEGALOVIRUS |
| 280-299 |
| (STRAIN AD169) |
| PUL14-- HSVII HYPOTHETICAL UL14 PROTEIN HERPES SIMPLEX VIRUS |
| (TYPE 96-116 |
| 1/STRAIN 17) |
| PUL14-- HSVEB HYPOTHETICAL GENE 48 PROTEIN EQUINE HERPESVIRUS |
| TYPE I 100-127 |
| (STRAIN AB4P) |
| PUL16-- HSVII PROTEIN UL16 HERPES SIMPLEX VIRUS (TYPE 22-49 |
| 1/STRAIN 17) |
| PUL16-- HSVEB GENE 46 PROTEIN EQUINE HERPESVIRUS TYPE 1 26-43 |
| 98-119 324-339 |
| (STRAIN AB4P) |
| PUL16-- HSVSA GENE 33 PROTEIN HERPESVIRUS SAIMIR 69-87 278-295 |
| (STRAIN 11) |
| PUL16-- VZVD GENE 44 PROTEIN VARICELLA-ZOSTER VIRUS 65-80 317-332 |
| (STRAIN DUMAS) |
| PUL17-- EBV PROTEIN BGLF1 EPSTEIN-BARR VIRUS (STRAIN 373-393 |
| B95-8) |
| PUL17-- HCMVA HYPOTHETICAL PROTEIN UL17 HUMAN CYTOMEGALOVIRUS |
| 60-82 |
| (STRAIN AD169) |
| PUL17-- HSVII PROTEIN UL17 HERPES SIMPLEX VIRUS (TYPE 156-181 |
| 1/STRAIN 17) |
| PUL17-- HSVSA GENE 32 PROTEIN HERPESVIRUS SAIMIRI 94-118 348-370 |
| (STRAIN 11) |
| PUL19-- HCMVA HYPOTHETICAL PROTEIN UL19 HUMAN CYTOMEGALOVIRUS |
| 61-85 |
| (STRAIN AD169) |
| PUL20-- PRVN3 UL20 MEMBRANE PROTEIN PSEUDORABIES VIRUS (STRAIN |
| 54-76 |
| HOMOLOG NIA-3) |
| PUL20-- VZVD GENE 39 MEMBRANE PROTEIN VARICELLA-ZOSTER VIRUS |
| 201-224 |
| (STRAIN DUMAS) |
| PUL21-- |
| HCMVA HYPOTHETICAL PROTEIN UL21 HUMAN CYTOMEGALAOVIRUS |
| 91-110 (STRAIN AS169) |
| PUL21-- HSV1I PROTEIN UL21 HERPES SIMPLEX VIRUS 98-114 130-146 |
| (TYPE 1 / STRAIN 17) |
| PUL21-- HSV1E PROTEIN UL21 HERPES SIMPLEX VIRUS 98-114 130-146 |
| (TYPE 1 /1 STRAIN HFEM) |
| PUL21-- HSVEB GENE 40 PROTEIN EQUINE HERPES VIRUS TYPE 1 119-142 |
| 294-321 379-403 412-427 |
| (STRAIN AB4P) |
| PUL21-- VZVD GENE 38 PROTEIN VARICELLA-ZOSTER VIRUS 270-293 |
| 300--327 |
| (STRAIN DUMAS) |
| PUL22-- HCMVA HYPOTHETICAL PROTEIN UL22 HUMAN CYTOMEGALAOVIRUS |
| 44-67 |
| (STRAIN AS169) |
| PUL24-- |
| EBV PROTEIN BXRF1 EPSTEIN-BARR VIRUS 134-155 (STRAIN |
| B95-8) |
| PUL24-- HCMVA HYPOTHETICAL PROTEIN UL24 HUMAN CYTOMEGALAOVIRUS |
| 206-222 |
| (STRAIN AS169) |
| PUL24-- |
| HSV1I PROTEIN UL24 HERPES SIMPLEX VIRUS 147-166 (TYPE 1 / |
| STRAIN 17) |
| PUL24-- ILTVT PROTEIN UL24 HOMOLOG INFECTIOUS LARYNGO- 158-179 |
| TRACHEITIS VIRUS |
| (STRAIN THORNE V882) |
| PUL25-- HCMVA HYPOTHETICAL PROTEIN UL25 HUMAN CYTOMEGALAOVIRUS |
| 484-500 |
| (STRAIN AS169) |
| PUL25-- HSV1I VIRION PROTEIN UL25 HERPES SIMPLEX VIRUS 86-101 |
| (TYPE 1 / STRAIN 17) |
| PUL25-- HSVEB VIRION PROTEIN UL25 EQUINE HERPES VIRUS TYPE 1 |
| 89-104 130-147 |
| (STRAIN AB4P) |
| PUL25-- HSVSA VIRION GENE 19 PROTEIN HERPES SIMPLEX SAIMARI |
| 244-26 334-368 |
| (STRAIN II) |
| PUL25-- ILTVT 64 1 KD VIRION PROTEIN INFECTIOUS LARYNGO- 270-287 |
| 316-336 |
| TRACHEITIS VIRUS |
| (STRAIN THORNE V882) |
| PUL27-- HCMVA HYPOTHETICAL PROTEIN UL27 HUMAN CYTOMEGALAOVIRUS |
| 307-324 486-507 |
| (STRAIN AS169) |
| PUL29-- HCMVA HYPOTHETICAL PROTEIN UL29 HUMAN CYTOMEGALAOVIRUS |
| 239-266 |
| (STRAIN AS169) |
| PUL30-- HCMVA HYPOTHETICAL PROTEIN UL30 HUMAN CYTOMEGALAOVIRUS |
| 9-32 |
| (STRAIN AS169) |
| PUL31-- |
| EBV PROTEIN BFLF2 EPSTEIN-BARR VIRUS 273-296 (STRAIN |
| B95-8) |
| PUL31-- HCMVA HYPOTHETICAL PROTEIN UL31 HUMAN CYTOMEGALAOVIRUS |
| 410-437 582-602 |
| (STRAIN AS169) |
| PUL31-- HSV1I PROTEIN UL31 HERPES SIMPLEX |
| 95-116 (TYPE 1 / STRAIN 17) |
| PUL31-- HSVEB GENE 29 PROTEIN EQUINE HERPES VIRUS TYPE 1 104-125 |
| 288-309 |
| (STRAIN AB4P) |
| PUL31-- HSVSA GENE 69 PROTEIN HERPES SIMPLEX SAIMARI 145-161 |
| 163-190 |
| (STRAIN II) |
| PUL31-- VZVD GENE 27 PROTEIN VARICELLA-ZOSTER VIRUS 117-138 |
| 295-316 |
| (STRAIN DUMAS) |
| PUL32-- HSV1I PROBABLE MAJOR ENV HERPES SIMPLEX 127-143 564-585 |
| GLYCOPROTEIN UL32 (TYPE 1 / STRAIN 17) |
| PUL32-- HSVEB MAJOR ENVELOPE EQUINE HERPES VIRUS TYPE 1 81-108 |
| GLYCOPROTEIN 300 (STRAIN AB4P) |
| PUL32-- VZVD PROBABLE MAJOR ENV VARICELLA-ZOSTER VIRUS 553-574 |
| GLYCOPROTEIN UL33 (STRAIN DUMAS) |
| PUL33-- HCMVA G-PROTEIN COUPLED REC HUMAN CYTOMEGALAOVIRUS |
| 76-102 |
| HOMOLOG UL33 (STRAIN AS169) |
| PUL34-- HCMVA HYPOTHETICAL PROTEIN UL34 HUMAN CYTOMEGALAOVIRUS |
| 214-232 297-321 |
| (STRAIN AS169) |
| PUL34-- |
| HSV1I VIRION PROTEIN UL34 HERPES SIMPLEX 251-275 (TYPE 1 / |
| STRAIN 17) |
| PUL34-- HSVEB VIRION GENE 26 PROTEIN EQUINE HERPES VIRUS TYPE 1 |
| 249-265 |
| (STRAIN AB4P) |
| PUL34-- HSVSA GENE 67 PROTEIN HERPES SIMPLEX SAIMARI 207-229 |
| (STRAIN II) |
| PUL34-- VZVD VIRION GENE 24 PROTEIN VARICELLA-ZOSTER VIRUS |
| 244-266 |
| (STRAIN DUMAS) |
| PUL35-- HCMVA HYPOTHETICAL PROTEIN UL35 HUMAN CYTOMEGALAOVIRUS |
| 229-252 310-329 -331-348 |
| (STRAIN AS169) |
| PUL36-- HCMVA HYPOTHETICAL PROTEIN UL36 HUMAN CYTOMEGALAOVIRUS |
| 143-168 387-410 |
| (STRAIN AS169) |
| PUL37-- EBV PROTEIN BOLF1 EPSTEIN-BARR VIRUS 21-36 135-155 |
| 707-730 984-1004 |
| (STRAIN B95-8) |
| PUL37-- HSV1I PROTEIN UL37 HERPES SIMPLEX 229-252 262-277 445-467 |
| 665-681 758-777 925-947 1009-1028 |
| (TYPE 1 / STRAIN 17) |
| PUL37-- HSVEB GENE 23 PROTEIN EQUINE HERPES VIRUS TYPE 1 414-440 |
| 491-510 664-690 778-805 901-919 |
| (STRAIN AB4P) |
| PUL37-- HSVSA GENE 63 PROTEIN HERPES SIMPLEX SAIMARI 45-20 |
| (STRAIN II) |
| PUL37-- VZVD GENE 21 PROTEIN VARICELLA-ZOSTER VIRUS 4-19 104-124 |
| 140-165 168-191 196-212 229-244 248-269 670-694 776-803 |
| (STRAIN DUMAS) 904-923 |
| PUL38-- HCMVA HYPOTHETICAL PROTEIN UL38 HUMAN CYTOMEGALAOVIRUS |
| 199-220 |
| (STRAIN AS169) |
| PUL40-- HCMVA HYPOTHETICAL PROTEIN UL40 HUMAN CYTOMEGALAOVIRUS |
| 18-35 |
| (STRAIN AS169) |
| PUL41-- HCMVA HYPOTHETICAL PROTEIN UL41 HUMAN CYTOMEGALAOVIRUS |
| 15-31 116-134 |
| (STRAIN AS169) |
| PUL43-- HSV1I MEMBRANE PROTEIN UL43 HERPES SIMPLEX 41-63 139-160 |
| 363-365 394-421 |
| (TYPE 1 / STRAIN 17) |
| PUL43-- HSVEB GENE 17 MEMBRANE PROTEIN EQUINE HERPES VIRUS TYPE 1 |
| 34-60 86-107 |
| (STRAIN AB4P) |
| PUL43-- VZVD GENE 15 MEMBRANE PROTEIN VARICELLA-ZOSTER VIRUS |
| 88-114 127-149 160-180 277-299 374-400 |
| (STRAIN DUMAS) |
| PUL45-- HSV1I PROTEIN UL45 HERPES SIMPLEX |
| 25-46 (TYPE 1 / STRAIN 17) |
| PUL45-- HSV1K PROTEIN UL45 HERPES SIMPLEX |
| 25-46 (TYPE 1 / STRAIN 17) |
| PUL45-- HSV1M PROTEIN UL45 HERPES SIMPLEX |
| 25-46 (TYPE 1 / STRAIN 17) |
| PUL47-- HCMVA PROTEIN UL47 HUMAN CYTOMEGALAOVIRUS 193-218 438-464 |
| 533-556 614-640 741-766 |
| (STRAIN AS169) |
| PUL47-- |
| HSV1I VIRION PROTEIN UL47 HERPES SIMPLEX 404-425 (TYPE 1 / |
| STRAIN 17) |
| PUL47-- |
| HSV1F VIRION PROTEIN UL47 HERPES SIMPLEX 404-425 (TYPE 1 / |
| STRAIN 17) |
| PUL47-- HSVBP 80 7 KD ALPHA TRANS- BOVINE HERPES VIRUS TYPE 1 |
| 681-702 |
| INDUCING PROTEIN (STRAIN P8-2) |
| PUL47-- HSVE4 97 KD ALPHA TRANS- EQUINE HERPES VIRUS TYPE 4 |
| 580-601 |
| INDUCING PROTEIN |
| PUL47-- HSSVEB 97 KD ALPHA TRANS-INDUCING EQUINE HERPESVIRUS TYPE |
| 1 587-608 |
| PROTEIN (STRAIN AB4P) |
| PUL47-- VZVD ALPHA TRANS-INDUCING VARICELLA-ZOSTER VIRUS 42-58 |
| 608-627 |
| FACTOR 91 8 KD PROTEIN (STRAIN DUMAS) |
| PUL49-- EBV HYPOTHETICAL BFRF2 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| 336-358 |
| B95-8) |
| PUL49-- HCMVA HYPOTHETICAL PROTEIN UL49 HUMAN CYTOMEGALOVIRUS |
| 248-264 528-543 |
| (STRAIN AD169) |
| PUL49-- HSVII TEGUMENT PROTEIN UL49 HERPES SIMPLEX VIRUS (TYPE |
| 226-252 |
| 1/STRAIN 17) |
| PUL49-- HSVSA HYPOTHETICAL GENE 66 HERPESVIRUS SAIMIR 232-253 |
| PROTEIN (STRAIN 11) |
| PUL50-- |
| HCMVA PROTEIN UL50 HUMAN CYTOMEGALOVIRUS 96-119 (STRAIN |
| AD169) |
| PUL51-- HSVII PROTEIN UL51 HERPES SIMPLEX VIRUS (TYPE 49-66 |
| 1/STRAIN 17) |
| PUL51-- HSVE4 GENE 8 PROTEIN EQUINE HERPESVIRUS TYPE 4 169-190 |
| (STRAIN 1942) |
| PUL51-- HSVEB GENE 8 PROTEIN EQUINE HERPESVIRUS TYPE 1 166-189 |
| (STRAIN AB4P) |
| PUL51-- |
| VZVD GENE 7 PROTEIN VARICELLA-ZOSTER VIRUS 30-49 (STRAIN |
| DUMAS) |
| PUL52-- EBV PROBABLE DNA REPLICATION EPSTEIN-BARR VIRUS (STRAIN |
| 44-59 |
| PROTEIN BSLF1 B95-8) |
| PUL52-- HSVII DNA REPLICATION PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 17-37 65-91 |
| UL52 1/STRAIN 17) |
| PUL52-- HSVE4 DNA REPLICATION PROTEIN EQUINE HERPESVIRUS TYPE 4 |
| 8-27 |
| UL52 (STRAIN 1942) |
| PUL52-- HSVEB DNA REPLICATION PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| 8-27 135-159 316-337 |
| UL52 (STRAIN AB4P) |
| PUL52-- HSVSA PROBABLE DNA REPLICATION HERPESVIRUS SAIMIRI |
| 489-508 586-605 |
| GENE 56 PROTEIN (STRAIN 11) |
| PUL52-- VZVD PROBABLE DNA REPLICATION VARICELLA-ZOSTER VIRUS |
| 446-466 645-670 |
| GENE 6 PROTEIN (STRAIN DUMAS) |
| PUL53-- |
| HCMVA PROTEIN UL53 HUMAN CYTOMEGALOVIRUS 173-188 (STRAIN |
| AD169) |
| PUL53-- HSV6U UL53 PROTEIN HOMOLOG HERPES SIMPLEX VIRUS (TYPE |
| 64-80 |
| 6/STRAIN UGANDA-1102) |
| PUL60-- HCMVA HYPOTHETICAL PROTEIN UL60 HUMAN CYTOMEGALOVIRUS |
| 120-141 |
| (STRAIN AD169) |
| PUL62-- HCMVA HYPOTHETICAL PROTEIN UL62 HUMAN CYTOMEGALOVIRUS |
| 62-84 178-205 |
| (STRAIN AD169) |
| PUL68-- HCMVA HYPOTHETICAL PROTEIN UL68 HUMAN CYTOMEGALOVIRUS |
| 87-107 |
| (STRAIN AD169) |
| PUL70-- HCMVA PROBABLE DNA REPLICATION HUMAN CYTOMEGALOVIRUS |
| 225-252 409-430 499-514 626-645 770-793 |
| PROTEIN UL70 (STRAIN AD169) |
| PUL71-- HCMVA HYPOTHETICAL PROTEIN UL71 HUMAN CYTOMEGALOVIRUS |
| 234-250 |
| (STRAIN AD169) |
| PUL73-- EBV HYPOTHETICAL BLRF1 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| 62-87 |
| B95-8) |
| PUL73-- HSVSA HYPOTHETICAL GENE 53 HERPESVIRUS SAIMIRI 51-73 |
| PROTEIN (STRAIN 11) |
| PUL74-- HCMVA HYPOTHETICAL PROTEIN UL74 HUMAN CYTOMEGALOVIRUS |
| 12-32 |
| (STRAIN AD169) |
| PUL77-- HCMVA VIRION PROTEIN UL77 HUMAN CYTOMEGALOVIRUS 268-291 |
| 607-628 |
| (STRAIN AD169) |
| PUL78-- HCMVA HYPOTHETICAL PROTEIN UL78 HUMAN CYTOMEGALOVIRUS |
| 71-90 190-205 |
| (STRAIN AD169) |
| PUL79-- HCMVA HYPOTHETICAL PROTEIN UL79 HUMAN CYTOMEGALOVIRUS |
| 40-58 |
| (STRAIN AD169) |
| PUL84-- HCMVA 65 KD EARLY NONSTRUCTURAL HUMAN CYTOMEGALOVIRUS |
| 100-116 |
| PROTEIN (STRAIN AD169) |
| PUL84-- HCMVT 64 KD EARLY NONSTRUCTURAL HUMAN CYTOMEGALOVIRUS |
| 100-116 |
| PROTEIN (STRAIN TOWNE) |
| PUL87-- EBV HYPOTHETICAL PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| 406-422 530-557 |
| B(C)RF1 B95-8) |
| PUL87-- HCMVA HYPOTHETICAL PROTEIN UL87 HUMAN CYTOMEGALOVIRUS |
| 205-231 309-335 606-628 633-653 757-781 |
| (STRAIN AD169) |
| PUL87-- HSV6U HYPOTHETICAL PROTEIN 5R HERPES SIMPLEX VIRUS (TYPE |
| 301-322 507-529 |
| 6/STRAIN UGANDA-1102) |
| PUL88-- HCMVA HYPOTHETICAL PROTEIN UL88 HUMAN CYTOMEGALOVIRUS |
| 173-191 252-279 |
| (STRAIN AD169) |
| PUL88-- HSV6U HYPOTHETICAL PROTEIN 6R HERPES SIMPLEX VIRUS (TYPE |
| 150-173 |
| 6/STRAIN UGANDA-1102) |
| PUL90-- HCMVA HYPOTHETICAL PROTEIN UL90 HUMAN CYTOMEGALOVIRUS |
| 35-50 |
| (STRAIN AD169) |
| PUL91-- HSV6U HYPOTHETICAL PROTEIN 8R HERPES SIMPLEX VIRUS (TYPE |
| 43-65 |
| 6/STRAIN UGANDA-1102) |
| PUL92-- HCMVA HYPOTHETICAL PROTEIN UL92 HUMAN CYTOMEGALOVIRUS |
| 76-99 |
| (STRAIN AD169) |
| PUL92-- HSV5U HYPOTHETICAL PROTEIN 9R HERPES SIMPLEX VIRUS (TYPE |
| 36-55 100-119 |
| 6/STRAIN UGANDA-1102) |
| PUL94-- |
| HCMVA PROTEIN UL94 HUMAN CYTOMEGALOVIRUS 49-70 (STRAIN |
| AD169) |
| PUL95-- EBV HYPOTHETICAL PROTEIN BGLF3 EPSTEIN-BARR VIRUS (STRAIN |
| 201-223 |
| B95-8) |
| PUL95-- HCMVA HYPOTHETICAL PROTEIN UL95 HUMAN CYTOMEGALOVIRUS |
| 508-526 |
| (STRAIN AD169) |
| PUL95-- HSV6U HYPOTHETICAL PROTEIN 13R HERPES SIMPLES VIRUS (TYPE |
| 9-30 328-346 |
| 6/STRAIN UGANDA-1102) |
| PUL95-- HSVSA HYPOTHETICAL GENE 34 HERPESVIRUS SAIMIR 187-209 |
| PROTEIN (STRAIN 11) |
| PUL97-- HCMVA GANCICLOVIR KINASE HUMAN CYTOMEGALOVIRUS 208-228 |
| 541-567 |
| (STRAIN AD169) |
| PULA2-- HCMVA HYPOTHETICAL PRTOEIN HUMAN CYTOMEGALOVIRUS 168-183 |
| UL102 (STRAIN AD169) |
| PULA3-- |
| HCMVA PORTEIN UL103 HUMAN CYTOMEGALOVIRUS 26-47 (STRAIN |
| AD169) |
| PULA8-- HCMVA HYPOTHETICAL PROTEIN UL108 HUMAN CYTOMEGALOVIRUS |
| 93-118 |
| (STRAIN AD169) |
| PULB1-- HCMVA HYPOTHETICAL PROTEIN UL111 HUMAN CYTOMEGALOVIRUS |
| 60-81 |
| (STRAIN AD169) |
| PULB3-- HCMVA HYPOTHETICAL PROTEIN UL113 HUMAN CYTOMEGALOVIRUS |
| 298-319 |
| (STRAIN AD169) |
| PULB7-- HCMVA HYPOTHETICAL PROTEIN UL117 HUMAN CYTOMEGALOVIRUS |
| 178-195 |
| (STRAIN AD169) |
| PULB8-- HCMVA HYPOTHETICAL PROTEIN UL118 HUMAN CYTOMEGALOVIRUS |
| 103-130 |
| (STRAIN AD169) |
| PULC1-- HCMVA HYPOTHETICAL PROTEIN UL121 HUMAN CYTOMEGALOVIRUS |
| 129-153 |
| (STRAIN AD169) |
| PULD2-- HCMVA HYPOTHETICAL PROTEIN UL132 HUMAN CYTOMEGALOVIRUS |
| 4-22 |
| (STRAIN AD169) |
| PUNG-- FOWP1 URACIL-DNA GLYCOSYLASE FOWLPOX VIRUS (STRAIN FP-1) |
| 12-37 |
| PUNG-- HSVEB URACIL-DNA GLYCOSYLASE EQUINE HERPESVIRUS TYPE 1 |
| 224-250 |
| (STRAIN AB4P) |
| PUNG-- VACCC URACIL-DNA GLYCOSYLASE VACCINIA VIRUS (STRAIN 82-103 |
| COPENHAGEN) |
| PUNG-- VACCV URACIL-DNA GLYCOSYLASE VACCINIA VIRUS (STRAIN WR) |
| 82-103 |
| PUNG-- |
| VARV URACIL-DNA GLYCOSYLASE VARIOLA VIRUS 82-103 PUNG-- |
| VZVD URACIL-DNA GLYCOSYLASE VARICELLA-ZOSTER VIRUS 217-243 |
| (STRAIN DUMAS) |
| PUS02-- HSVEB GENE 68 PROTEIN EQUINE HERPESVIRUS TYPE 1 48-63 |
| (STRAIN AB4P) |
| PUS02-- HSVEK US1 PROTEIN EQUINE HERPESVIRUS TYPE 1 48-63 |
| (STRAIN KENTUCKY A) |
| PUS02-- PRVN3 PROTEIN US2 HOMOLOG PSEUDORABIES VIRUS (STRAIN |
| 120-136 |
| NIA-3) |
| PUS03-- |
| HCMVA HQLFQ PROTEIN HUMAN CYTOMEGALOVIRUS 24-39 (STRAIN |
| AD169) |
| PUS05-- HSVII PUTATIVE GLYCOPROTEIN US5 HERPES SIMPLES VIRUS |
| (TYPE 53-70 |
| 1/STRAIN 17) |
| PUS05-- HSV2 PUTATIVE GLYCOPROTEIN US5 HERPES SIMPLEX VIRUS |
| (53-70 |
| (TYPE 2) |
| PUS09-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 179-206 |
| HXLF3 (STRAIN AD169) |
| PUS11-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 98-113 |
| HXLF1 (STRAIN AD169) |
| PUS12-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 29-50 |
| 113-135 195-222 |
| HXLF6 (STRAIN AD169) |
| PUS13-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 11-33 |
| 208-231 |
| HXLF5 (STRAIN AD169) |
| PUS14-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 236-260 |
| HXLF4 (STRAIN AD169) |
| PUS15-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 387-402 |
| 443-466 |
| HXLF3 (STRAIN AD169) |
| PUS16-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 151-174 |
| 243-267 |
| HXLF2 (STRAIN AD169) |
| PUS17-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 110-126 |
| HXLF1 (STRAIN AD169) |
| PUS19-- HCMVA MEMBRANE PROTEIN HWLFR HUMAN CYTOMEGALOVIRUS |
| 120-142 178-202 214-232 |
| (STRAIN AD169) |
| PUS21-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 41-67 |
| 155-182 |
| HWLF2 (STRAIN AD169) |
| PUS22-- HCMVA EARLY NUCLEAR PROTEIN HUMAN CYTOMEGALOVIRUS 270-292 |
| HWLF1 (STRAIN AD169) |
| PUS23-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 292-310 |
| HHLF7 (STRAIN AD169) |
| PUS24-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 352-373 |
| HHLF6 (STRAIN AD169) |
| PUS28-- HCMVA G-PROTEIN COUPLED REC HUMAN CYTOMEGALOVIRUS 34-49 |
| 140-160 |
| HOMOLOG US28 (STRAIN AD169) |
| PUS28-- HCMVT G-PROTEIN COUPLED REC HUMAN CYTOMEGALOVIRUS 34-49 |
| 140-160 |
| HOMOLOG US28 (STRAIN TOWNE) |
| PUS29-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 246-269 |
| HHRF4 (STRAIN AD169) |
| PUS30-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 102-128 |
| 208-233 |
| HHRF5 (STRAIN AD169) |
| PUS33-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 41-59 |
| HHRF3 (STRAIN AD169) |
| PV07K-- |
| LSV 7 KD PROTEIN LILY SYMTOMLESS VIRUS 17-46 PV07K-- |
| NMV 7 KD PROTEIN POTATO VIRUS S (STRAIN 28-49 |
| PERUVIAN) |
| PV07K-- |
| PVSP 7 KD PROTEIN POTATO VIRUS X (PVX) 31-48 PV07K-- |
| PVX 7 KD PROTEIN POTATO VIRUS X (STRAIN X3) 31-48 |
| PV07K-- PVXX3 7 KD PROTEIN POTATO VIRUS X (STRAIN XC) 31-48 |
| (STRAIN CP) |
| PV117-- ASFL5 LIS 121-1 PROTEIN AFRICAN SWINE FEVER VIRUS 73-94 |
| (STRAIN L1S57) |
| PV121-- |
| ASFL5 125 KD PROTEIN ALFALFA MOSAIC VIRUS 59-79 (STRAIN |
| 425/ISOLATE LEIDEN) |
| PV12K-- |
| PRVMR 12 KD PROTEIN POTATO VIRUS M (STRAIN 79-96 RUSSIAN) |
| PV13K-- |
| TRVPL 16 KD PROTEIN TOBACCO RATTLE VIRUS 24-51 (STRAIN |
| PLB) |
| PV143-- NPVAC HELICASE AUTOGRAPHA CALIFORNICA79-102 846-863 |
| 1013-1037 |
| NUCLEAR POLYHEDROSIS VIRUS |
| PV14K-- BSMV 14 KD PROTEIN BARLEY STRIPE MOSAIC VIRUS 14-29 80-99 |
| (BSMV) |
| PV18K-- MLVAB 18 KD PROTEIN ABELSON MURINE LEUKEMIA 29-44 128-154 |
| VIRUS |
| PV19R-- VACCV PROTEIN B19 VACCINIA VIRUS (STRAIN WR) 114-132 |
| 152-172 |
| PV1A-- BBMV 1A PROTEIN BROAD BEAN MOTTLE VIRUS 196-220 752-771 |
| PV1A-- |
| BMV 1A PROTEIN BROME MOSAIC VIRUS 747-767 PV1A-- |
| CCMV 1A PROTEIN COWPEA CHLOROTIC MOTTLE 744-763 |
| VIRUS |
| PV1A-- |
| CMVFN 1A PROTEIN CUCUMBER MOSAIC VIRUS 775-800 (STRAIN |
| FNY) |
| PV1A-- |
| CMVO 1A PROTEIN CUCUMBER MOSAIC VIRUS 775-800 (STRAIN |
| O) |
| PV1A-- |
| CMVQ 1A PROTEIN CUCUMBER MOSAIC VIRUS 774-799 (STRAIN |
| Q) |
| PV1A-- PSVJ 1A PROTEIN PEANUT STUNT VIRUS 472-493 783-808 |
| (STRAIN J) |
| PV23K-- |
| HSVTH 23 5 KD PROTEIN TURKEY HERPESVIRUS 176-191 (STRAIN |
| H2) |
| PV28K-- PLRV1 28 KD PROTEIN POTATO LEAFROLL VIRUS 60-76 192-207 |
| (STRAIN I)( |
| PV28K-- PLRVW 28 KD PROTEIN POTATO LEAFROLL VIRUS 60-76 192-207 |
| (STRAIN WAGENINGEN) |
| PV29K-- BWYVF 29 KD PROTEIN BEET WESTERN YELLOWS22-43 136-157 |
| VIRUS (ISOLATE FL-1) |
| PV29K-- PEBV 29 6 KD PROTEIN PEA EARLY BROWNING VIRUS 114-132 |
| PV2A-- BMV 2A PROTEIN BROME MOSAIC VIRUS 285-303 759-777 |
| PV2A-- CCMV 2A PROTEIN COWPEA CHLOROTIC MOTTLE 296-314 |
| VIRUS |
| PV2A-- |
| TAV 21 PROTEIN TOMATO ASPERMY VIRUS 234-255 PV30K-- |
| TRVTC 29 1 KD PROTEIN TOBACCO RATTLE VIRUS 62-82 |
| (STRAIN TCM) |
| PV31K-- TOBSV 31 7 KD PROTEIN TOBACCO STREAK VIRUS 226-250 |
| (STRAIN WC) |
| PV362-- ASFB7 K'362 PROTEIN AFRICAN SWINE FEVER VIRUS 145-164 |
| (STRAIN BA71V) |
| PV375-- ASFL5 LIS 375 PROTEIN AFRICAN SWINE FEVER VIRUS 114-135 |
| (STRAIN LIS57) |
| PV382-- ASFL5 LIS 382 PROTEIN AFRICAN SWINE FEVER VIRUS 114-135 |
| (STRAIN LIS57) |
| PV3A-- |
| CCMV COWPEA CHLOROTIC MOTTLE 160-187 VIRUS |
| PV3A-- CMVFM 3A PROTEIN CUCUMBER MOSAIC VIRUS 214-235 |
| (STRAIN FNY) |
| PV3A-- |
| CMVM 3A PROTEIN CUCUMBER MOSAIC VIRUS 214-235 (STRAIN |
| M) |
| PV3A-- |
| CMVO 3A PROTEIN CUCUMBER MOSAIC VIRUS 214-235 (STRAIN |
| O) |
| PV3A-- |
| CMVQ 3A PROTEIN CUCUMBER MOSAIC VIRUS 214-235 (STRAIN |
| Q) |
| PV3A-- |
| CMVY 3A PROTEIN CUCUMBER MOSAIC VIRUS 214-235 (STRAIN |
| Y) |
| PV3A-- |
| IBVB 3A PROTEIN AVIAN INFECTIOUS BRONCHI- 5-28 TIS VIRUS |
| (STRAIN BEAUDETTE) |
| PV3A-- |
| IBVM 3A PROTEIN AVIAN INFECTIOUS BRONCHI- 5-28 TIS VIRUS |
| (STRAIN M41) |
| PV3A-- |
| IBVP3 3A PROTEIN AVIAN INFECTIOUS BRONCHI- 5-28 TIS VIRUS |
| (STRAIN PORTUGAL/ |
| 322/82) |
| PV3A-- |
| IBVU5 3A PROTEIN AVIAN INFECTIOUS BRONCHI- 5-28 TIS VIRUS |
| (STRAIN UK/183/66) |
| PV3A-- |
| TAV 3A PROTEIN TOMATO ASPERMY VIRUS 147-168 PV58-- |
| BSMV 58 KD PROTEIN BARLEY STRIPE MOSAIC VIRUS 320-340 |
| PV66-- |
| BWYVK PROTEIN 6B CANINE ENTERIC CORONA- 97-116 VIRUS |
| (STRAIN K378) |
| PV70K-- |
| TYMVA 69 KD PROTEIN TURNIP YELLOW MOSAIC 12-35 VIRUS |
| (AUSTRIAN ISOLATE) |
| PV90K-- |
| AMVLE 90 KD PROTEIN ALFALFA MOSAIC VIRUS 44-59 (STRAIN |
| 425/ISOLATE LEIDEN) |
| PVA04-- |
| VACCC PROTEIN A4 VACCINIA VIRUS (STRAIN 217-244 COPENHAGEN) |
| PVA04-- VACCV PROTEIN A4 VACCINIA VIRUS (STRAIN WR) 217-244 |
| PVA04-- |
| VARV PROTEIN A4 VARIOLA VIRUS 207-234 PVA09-- |
| VACCC PROTEIN A9 VACCINIA VIRUS (STRAIN 41-66 |
| COPENHAGEN) |
| PVA09-- |
| VARV PROTEIN A9 VARIOLA VIRUS 41-66 PVA11-- |
| VACCC PROTEIN A11 VACCINIA VIRUS (STRAIN 23-44 140-159 299-317 |
| COPENHAGEN) |
| PVA11-- VARV PROTEIN A11 VARIOLA VIRUS 23-44 141-160 300-318 |
| PVA14-- VACCC PROTEIN A14 VACCINIA VIRUS (STRAIN 39-62 |
| COPENHAGEN) |
| PVA14-- |
| VARV PROTEIN A14 VARIOLA VIRUS 39-62 PVA16-- |
| VACCC PROTEIN A16 VACCINIA VIRUS (STRAIN 341-362 |
| COPENHAGEN) |
| PVA16-- |
| VARV PROTEIN A16 VARIOLA VIRUS 340-361 PVA18-- |
| VACCC 56 KD ABORTIVE LATE PROTEIN VACCINIA VIRUS (STRAIN 429-447 |
| COPENHAGEN) |
| PVA18-- VACCV 56 KD ABORTIVE LATE PROTEIN VACCINIA VIRUS (STRAIN |
| WR) 429-447 |
| PVA18-- VARV 56 KD ABORTIVE LATE PROTEIN VARIOLA VIRUS 429-447 |
| PVA20-- VACCC PROTEIN A20 VACCINIA VIRUS (STRAIN 107-131 |
| 193-209 |
| COPENHAGEN) |
| PVA20-- |
| VARV PROTEIN A20 VARIOLA VIRUS 107-131 193-209 PVA23-- |
| VARV PROTEIN A23 VARIOLA VIRUS 58-82 |
| PVA28-- VACCV PROTEIN A28 VACCINIA VIRUS (STRAIN WR) 53-76 |
| AND (STRAIN COPENHAGEN) |
| PVA28-- |
| VARV PROTEIN A28 VARIOLA VIRUS 53-76 PVA32-- |
| VACCV PROTEIN A32 VACCINIA VIRUS (STRAIN WR) 205-220 |
| AND (STRAIN COPENHAGEN) |
| PVA32-- |
| VARV PROTEIN A32 VARIOLA VIRUS 175-190 PVA35-- |
| VACCC PROTEIN A35 PRECURSOR VACCINIA VIRUS (STRAIN 33-49 |
| COPENHAGEN) |
| PVA35-- VACCV PROTEIN A35 PRECURSOR VACCINIA VIRUS (STRAIN WR) |
| 33-49 141-164 |
| PVA37-- |
| VACCC PROTEIN A37 VACCINIA VIRUS (STRAIN 66-90 COPENHAGEN) |
| PVA37-- |
| VACCV PROTEIN A37 VARIOLA VIRUS 66-90 PVA40-- |
| VACCC PROTEIN A40 VACCINIA VIRUS (STRAIN 4-30 |
| COPENHAGEN) |
| PVA41-- VACCC PROTEIN A41 PRECURSOR VACCINIA VIRUS (STRAIN 47-71 |
| COPENHAGEN) |
| PVA41-- VACCV PROTEIN A41 PRECURSOR VACCINIA VIRUS STRAIN WR) |
| 47-71 |
| PVA41-- |
| VARV PROTEIN A41 PRECURSOR VARIOLA VIRUS 47-71 PVA47-- |
| VACCC PRTOEIN A47 VACCINIA VIRUS (STRAIN 59-79 201-226 |
| COPENHAGEN) |
| PVA47-- VACCV PROTEIN A47 VACCINIA VIRUS (STRAIN WR) 59-79 |
| 201-226 |
| PVA47-- |
| VARV PROTEIN A47 VARIOLA VIRUS 59-79 201-226 PVA55-- |
| VACCC PROTEIN A55 VACCINIA VIRUS (STRAIN 247-266 384-404 |
| COPENHAGEN) |
| PVA55-- VACCV PROTEIN A55 VACCINIA VIRUS (STRAIN WR) 247-266 |
| 384-404 |
| PVAL1-- |
| BCTV AL1 PROTEIN BEET CURLY TOP VIRUS 56-75 PVAL1-- |
| CLVK AL1 PROTEIN CASSAVA LATENT VIRUS 55-74 |
| (STRAIN WEST KENYAN 844) |
| PVAL1-- |
| CLVN AL1 PROTEIN CASSAVA LATENT VIRUS 55-74 (STRAIN |
| NIGERIAN) |
| PVAL3-- |
| BCTV AL3 PROTEIN BEET CURLY TOP VIRUS 82-108 PVAL3-- |
| CLVK AL3 PROTEIN CASSAVA LATENT VIRUS 77-97 |
| (STRAIN NIGERIAN) |
| PVAL3-- |
| CLVN AL3 PROTEIN CASSAVA LATENT VIRUS 77-97 (STRAIN |
| NIGERIAN) |
| PVAL3-- |
| TYLCM AL3 PROTEIN TOMATO YELLOW LEAF CURL 78-97 VIRUS |
| (STRAIN MARMANDE) |
| PVAL3-- |
| TYLCV AL3 PROTEIN TOMATO YELLOW LEAF CURL 77-97 VIRUS |
| PVAT-- CAMVC APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC |
| VIRUS 134-157 |
| (STRAIN CM-1841) |
| PVAT-- CAMVD APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| 134-157 |
| (STRAIN D/H) |
| PVAT-- CAMVE APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| 134-157 |
| (STRAIN BBC) |
| PVAT-- CAMVN APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| 134-157 |
| (STRAIN NY8153) |
| PVAT-- CAMVP APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| 134-157 |
| (STRAIN PV147) |
| PVAT-- CAMVS APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| 134-157 |
| (STRAIN STRASBOURG) |
| PVAT-- CAMVW APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| 34-60 |
| (STRAIN W260) |
| PVAT-- CERV APHID TRANSMISSION PROTEIN CARNATION ETCHED RING |
| 141-161 |
| VIRUS |
| PVAT-- FMVD APHID TRANSMISSION PROTEIN FIGWORT MOSAIC VIRUS |
| 132-159 |
| (STRAIN DXS) |
| PVB02-- |
| VACCC PROTEIN B2 VACCINIA VIRUS (STRAIN 155-170 COPENHAGEN) |
| PVB02-- VACCV PROTEIN B2 VACCINIA VIRUS (STRAIN WR) 155-170 |
| PVB04-- |
| VACCC PROTEIN B4 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVB04-- VACCV PROTEIN B4 VACCINIA VIRUS (STRAIN WR) 489-511 |
| PVB04-- |
| VARV PROTEIN B4 VARIOLA VIRUS 489-511 PVB05-- |
| VACC0 PLAQUE-SIZE/HOST RANGE VACCINIA VIRUS (STRAIN 251-271 |
| PROTEIN PRECURSOR LC16MO) |
| PVB05-- VACCC PLAQUE-SIZE/HOST RANGE VACCINIA VIRUS (STRAIN |
| 251-271 |
| PROTEIN PRECURSOR COPENHAGE) |
| PVB05-- VACCL PLAQUE-SIZE/HOST RANGE VACCINIA VIRUS (STRAIN |
| 251-271 |
| PROTEIN PRECURSOR LISTER) |
| PVB05-- VACCV PLAQUE-SIZE/HOST RANGE VACCINIA VIRUS (STRAIN WR) |
| 251-271 |
| PROTEIN PRECURSOR |
| PVB06-- VACCV PROTEIN B6 VACCINIA VIRUS (STRAIN WR), 59-82 |
| AND (STRAIN COPENHAGEN) |
| PVB15-- |
| VACCC PROTEIN B15 VACCINIA VIRUS (STRAIN 121-143 COPENHAGEN) |
| PVB15-- VACCV PROTEIN B15 VACCINIA VIRUS (STRAIN WR) 121-143 |
| PVB15-- |
| VARV PROTEIN B15 VARIOLA VIRUS 121-143 PVB17-- |
| VACCC PROTEIN B17 VACCINIA VIRUS (STRAIN 157-179 |
| COPENHAGEN) |
| PVB17-- VACCV PROTEIN B17 VACCINIA VIRUS (STRAIN WR) 157-179 |
| PVBL1-- |
| CLVK BLI PROTEIN CASSAVA LATENT VIRUS 34-51 (STRAIN WEST |
| KENYAN 844) |
| PVBL1-- |
| CLVN BL1 PROTEIN CASSAVA LATENT VIRUS 34-51 (STRAIN |
| NIGERIAN) |
| PVBL1-- |
| SLCV BL1 PROTEIN SQUASH LEAF CURL VIRUS 245-268 PVBR1-- |
| ABMVW BR1 PROTEIN ABUTILON MOSAIC VIRUS 166-191 |
| (ISOLATE WEST INDIA) |
| PVBR1-- BGMV BR1 PROTEIN BEAN GOLDEN MOSAIC VIRUS 166-191 |
| PVBR1-- PYMVV BR1 PROTEIN POTATO YELLOW MOSAIC 166-191 |
| VIRUS (ISOLATE VENEZUELA) |
| PVBR1-- |
| SLCV BR1 PROTEIN SQUASH LEAF CURL VIRUS 193-218 PVCO1-- |
| VACCC PROTEIN C1 VACCINIA VIRUS (STRAIN 70-90 |
| COPENHAGEN) |
| PVCO1-- VACCV PROTEIN C1 VACCINIA VIRUS (STRAIN WR) 75-95 |
| PVCO1-- |
| VARV PROTEIN C1 VARIOLA VIRUS 58-78 PVC02-- SFVKA |
| HYPOTHETICAL PROTEIN C2 SHOPE FIBROMA VIRUS 8-31 |
| (STRAIN KASZA) |
| PVC03-- SFVKA G-PROTEIN COUPLED SHOPE FIBROMA VIRUS 98-123 |
| 179-197 |
| RECEPTOR HOMOLOG C3 (STRAIN KASZA) |
| PVC04-- |
| VACCC PROTEIN C4 VACCINIA VIRUS (STRAIN 182-209 COPENHAGEN) |
| PVC04-- VACCV PROTEIN C4 VACCINIA VIRUS (STRAIN WR) 183-208 |
| PVC06-- SFVKA HYPOTHETICAL PROTEIN C6 SHOPE FIBROMA VIRUS |
| 20-47 |
| (STRAIN KASZA) |
| PVC08-- SFVKA HYPOTHETICAL PROTEIN C8 SHOPE FIBROMA VIRUS 14-30 |
| (STRAIN KASZA) |
| PVC09-- |
| VACCC PROTEIN C9 VACCINIA VIRUS (STRAIN 40-59 COPENHAGEN) |
| PVC09-- VACCV PROTEIN C9 VACCINIA VIRUS (STRAIN WR) 40-59 |
| PVC10-- SFVKA HYPOTHETICAL PROTEIN C10 SHOPE FIBROMA VIRUS |
| 85-109 |
| (STRAIN KASZA) |
| PVC10-- |
| VACCC PROTEIN C10 VACCINIA VIRUS (STRAIN 42-64 COPENHAGEN) |
| PVC10-- VACCV PROTEIN C10 VACCINIA VIRUS (STRAIN WR) 42-64 |
| PVC10-- |
| VARV PROTEIN C10 VARIOLA VIRUS 42-64 PVC16-- VACCC |
| PROTEIN C16/B22 VACCINIA VIRUS (STRAIN 41-68 |
| COPENHAGEN) |
| PVC17-- VACCC PROTEIN C17/B23 VACCINIA VIRUS (STRAIN 301-326 |
| COPENHAGEN) |
| PVC21-- VACCC PROTEIN C21/B27 VACCINIA VIRUS (STRAIN 3-28 |
| COPENHAGEN) |
| PVCAP-- EBV MAJOR CAPSID PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| 148-172 366-381 1072-1095 |
| B95-8) |
| PVCAP-- HCMVA MAJOR CAPSID PROTEIN HUMAN CYTOMEGALOVIRUS 668-684 |
| 842-860 871-893 |
| (STRAIN AD169) |
| PVCAP-- HASVII MAJOR CAPSID PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 283-302 358-384 1137-1152 |
| 1/STRAIN 17) |
| PVCAP-- HSVEB MAJOR CAPSID PROTEIN EQUINE HERPESVRIUS TYPE I |
| 357-383 837-898 |
| (STRAIN AB4P) |
| PVCAP-- HSVSA MAJOR CAPSID PROTEIN HERPESVIRUS SAIMIRI 144-168 |
| 269-287 357-372 1062-1089 |
| (STRAIN 11) |
| PVCAP-- PRVIS MAJOR CAPSID PROTEIN PSEUDORABIES VIRUS (STRAIN |
| 335-362 |
| INDIANA 5) |
| PVCAP-- VZVD MAJOR CAPSID PROTEIN VARICELLA-ZOSTER VIRUS 381-401 |
| 891-910 1156-1176 |
| (STRAIN DUMAS) |
| PVCG3-- NPVAC DNA-BINDING PROTEIN AUTOGRAPHA CALIFORNICA 60-81 |
| NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVD03-- |
| VACCC PROTEIN D3 VACCINIA VIRUS (STRAIN 12-39 COPENHAGEN) |
| PVD03-- VACCV PROTEIN D3 VACCINIA VIRUS (STRAIN WR) 12-39 |
| PVD03-- |
| VARV PROTEIN D3 VARIOLA VIRUS 12-39 PVD05-- FOWP1 |
| 92 6 KD PROTEIN FOWLPOX VIRUS (STRAIN 246-265 315-337 |
| FP-1) |
| PVD05-- SFVKA PROTEIN D5 SHOPE IBROMA VIRUS (STRAIN 54-78 171-198 |
| KASZA) |
| PVD05-- VACCC PROTEIN D5 VACCINIA VIRUS (STRAIN 320-340 694-714 |
| 715-734 |
| COPENHAGEN) |
| PVD05-- VACCV PROTEIN D5 VACCINIA VIRUS (STRAIN WR) 320-340 |
| 694-714 715.734 |
| PVD05-- VARV PROTEIN D5 VARIOLA VIRUS 320-340 694-714 715-734 |
| PVDBP-- CAMVC DNA-BINDING PROTEIN CAULIFLOWER MOSAIC VIRUS |
| 37-56 |
| (STRAIN CM-1841) |
| PVDBP-- CAMVD DNA-BINDING PROTEIN CAULIFLOWER MOSAIC VIRUS 37-56 |
| (STRAIN D/H) |
| PVDBP-- CAMVE DNA-BINDING PROTEIN CAULIFLOWER MOSAIC VIRUS 37-56 |
| (STRAIN BBC) |
| PVDBP-- CAMVN DNA-BINDING PROTEIN CAULIFLOWER MOSAIC VIRUS 37-56 |
| (STRAIN NY8153) |
| PVDBP-- CAMVS DNA-BINDING PROTEIN CAULIFLOWER MOSAIC VIRUS 37-56 |
| (STRAIN STRASBOURG) |
| PVE02-- VACCC PROTEIN E2 VACCINIA VIRUS (STRAIN 70-97 355-380 |
| 540-558 |
| COPENHAGEN) |
| PVE02-- VACCV PROTEIN E2 VACCINIA VIRUS (STRAIN WR) 70-97 355-380 |
| 540-558 |
| PVE02-- VARV PROTEIN E2 VARIOLA VIRUS 70-97 355-380 540-558 |
| PVE05-- VACCC PROTEIN E5 VACCINIA VIRUS (STRAIN 314-329 |
| COPENHAGEN) |
| PVE05-- |
| VACCD PROTEIN E5 VACCINIA VIRUS (STRAIN 324-339 DAIREN 1) |
| PVE05-- VACCV PROTEIN E5 VACCINIA VIRUS (STRAIN WR) 324-339 |
| PVE05-- |
| VARV PROTEIN E5 VARIOLA VIRUS 324-339 PVE06-- |
| VACCC PROTEIN E6 VACCINIA VIRUS (STRAIN 430-451 |
| COPENHAGEN) |
| PVE06-- VACCV PROTEIN E6 VACCINIA VIRUS (STRAIN WR) 430-451 |
| PVE06-- |
| VARV PROTEIN E6 VARIOLA VIRUS 430-451 PVE08-- |
| VACCC PROTEIN E8 VACCINIA VIRUS (STRAIN 254-270 |
| COPENHAGEN) |
| PVE08-- VACCV PROTEIN E8 VACCINIA VIRUS (STRAIN WR) 254-270 |
| PVE08-- |
| VARV PROTEIN E8 VARIOLA VIRUS 254-270 PVE12-- |
| HPV16 PROBABLE E1 PROTEIN 2 HUMAN PAPILLOMAVIRUS 167-183 |
| TYPE 16 |
| PVE18-- NPVAC EARLY 18 5 KD PROTIN AUTOGRAPHA CALIFORNICA 106-133 |
| NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVE1-- BPV1 E1 PROTEIN BOVINE PAPILLOMAVIRUS 265-282 517-533 |
| TYPE 1 |
| PVE1-- BPV2 E1 PROTEIN BOVINE PAPILLOMAVIRUS 265-281 516-532 |
| TYPE 2 |
| PVE1-- |
| CRPVK E1 PROTEIN COTTONTAIL RABBIT (SHOPE) 7-22 PAPILLOMAV |
| IRUS (STRAIN |
| KANSAS) |
| PVE1-- HPV11 E1 PROTEIN HUMAN PAPILLOMAVIRUS 258-275 311-334 |
| TYPE 11 |
| PVE1-- |
| HPV13 E1 PROTEIN HUMAN PAPILLOMAVIRUS 308-324 TYPE 13 |
| PVE1-- HPV18 E1 PROTEIN HUMAN PAPILLOMAVIRUS 264-281 317-333 |
| 344-364 |
| TYPE 18 |
| PVE1-- |
| HPV31 E1 PROTEIN HUMAN PAPILLOMAVIRUS 237-254 TYPE 31 |
| PVE1-- |
| HPV33 E1 PROTEIN HUMAN PAPILLOMAVIRUS 238-260 TYPE 33 |
| PVE1-- |
| HPV39 E1 PROTEIN HUMAN PAPILLOMAVIRUS 334-354 TYPE 39 |
| PVE1-- |
| HPV41 E1 PROTEIN HUMAN PAPILLOMAVIRUS 363-380 TYPE 41 |
| PVE1-- |
| HPV42 E1 PROTEIN HUMAN PAPILLOMAVIRUS 304-320 TYPE 42 |
| PVE1-- HPV58 E1 PROTEIN HUMAN PAPILLOMAVIRUS 238-260 |
| TYPE 58 |
| PVE1-- HPV6B E1 PROTEIN HUMAN PAPILLOMAVIRUS 258-275 311-334 |
| TYPE 6B |
| PVE1-- PCPV1 E1 PROTEIN PYGMY CHIMPANZEE PAPILLO- 257-274 310-326 |
| MAVIRUS TYPE 1 |
| PVE1-- |
| RHPVI E1 PROTEIN RHESUS PAPILLOMAVIRUS 286-309 TYPE 1 |
| PVE2-- CRPVK PROBABLE E2 PROTEIN COTTONTAIL RABBIT (SHOPE) |
| 308-333 |
| PAPILLOMAVIRUS (STRAIN |
| KANSAS) |
| PVE2-- |
| HPV11 E2 PROTEIN HUMAN PAPILLOMAVIRUS 285-310 TYPE 11 |
| PVE2-- |
| HPV13 E2 PROTEIN HUMAN PAPILLOMAVIRUS 295-320 TYPE 13 |
| PVE2-- |
| HPV18 E2 PROTEIN HUMAN PAPILLOMAVIRUS 288-306 TYPE 18 |
| PVE2-- |
| HPV1A E2 PROTEIN HUMAN PAPILLOMAVIRUS 284-300 TYPE 1A |
| PVE2-- |
| HPV2A E2 PROTEIN HUMAN PAPILLOMAVIRUS 311-336 TYPE 2A |
| PVE2-- HPV31 E2 PROTEIN HUMAN PAPILLOMAVIRUS 294-312 |
| TYPE 31 |
| PVE2-- |
| HPV33 E2 PROTEIN HUMAN PAPILLOMAVIRUS 275-293 TYPE 33 |
| PVE2-- |
| PPV35 E2 PROTEIN HUMAN PAPILLOMAVIRUS 289-307 TYPE 35 |
| PVE2-- |
| PPV39 E2 PROTEIN HUMAN PAPILLOMAVIRUS 292-310 TYPE 39 |
| PVE2-- |
| HPV42 E2 PROTEIN HUMAN PAPILLOMAVIRUS 321-338 TYPE 42 |
| PVE2-- |
| HPV57 E2 PROTEIN HUMAN PAPILLOMAVIRUS 303-328 TYPE 57 |
| PVE2-- HPV6B E2 PROTEIN HUMAN PAPILLOMAVIRUS 286-311 |
| TYPE 6B |
| PVE2-- PAPVD PROBABLE E2 PROTEIN DEER PAPILLOMAVIRUS 333-351 |
| PVE2-- PCPVI E2 PROTEIN PYGMY CHIMPANZEE PAPILLO- 295-320 |
| MAVIRUS TYPE 1 |
| PVE2-- |
| RHPVI E2 PROTEIN RHESUS PAPILLOMAVIRUS 290-408 TYPE 1 |
| PVE4-- HPV18 PROBABLE E4 PROTEIN HUMAN PAPILLOMAVIRUS 39-59 |
| TYPE 18 |
| PVE4-- HPV41 PROBABLE E4 PROTEIN HUMAN PAPILLOMAVIRUS 56-76 |
| TYPE 41 |
| PVE4-- HPV51 PROBABLE E4 PROTEIN HUMAN PAPILLOMAVIRUS 59-83 |
| TYPE 51 |
| PVE4-- RHPVI PROBABLE E4 PROTEIN RHESUS PAPILLOMAVIRUS 63-87 |
| TYPE 1 |
| PVE5A-- HPVII PROBABLE E5A PROTEIN HUMAN PAPILLOMAVIRUS 19-32 |
| TYPE 11 |
| PVE5A-- HPV6C PROBABLE E5A PROTEIN HUMAN PAPILLOMAVIRUS 19-42 |
| TYPE 6C |
| PVE5-- |
| BPVI E5 PROTEIN BOVINE PAPPILLOMAVIRUS 2-26 TYPE 1, |
| AND TYPE 2 |
| PVE5-- HPV13 PROBABLE E5 PROTEIN HUMAN PAPILLOMAVIRUS 19-42 |
| TYPE 13 |
| PVE5-- HPV31 PROBABLE E5 PROTEIN HUMAN PAPILLOMAVIRUS 31-52 |
| TYPE 31 |
| PVE5-- HPV42 PROBABLE E5 PROTEIN HUMAN PAPILLOMAVIRUS 45-65 |
| TYPE 42 |
| PVE5-- HPV51 PROBABLE E5 PROTEIN HUMAN PAPILLOMAVIRUS 31-52 |
| TYPE 51 |
| PVE5-- HPV5B PROBABLE E5 PROTEIN HUMAN PAPILLOMAVIRUS 89-113 |
| TYPE 5B |
| PVE5-- RHPVI PROBABLE E5 PROTEIN RHESUS PAPILLOMAVIRUS 109-132 |
| TYPE 1 |
| PVE6-- |
| BPVI E6 PROTEIN BOVINE PAPILLOMAVIRUS 23-41 TYPE 1 |
| PVE6-- |
| CRPVK E6 PROTEIN COTTONTAIL RABBIT (SHOPE) 6-23 PAPILLOMAVIR |
| US (STRAIN |
| KANSAS) |
| PVE6-- |
| HPVO8 E6 PROTEIN HUMAN PAPILLOMAVIRUS 133-151 TYPE 8 |
| PVE6-- |
| HPV2A E6 PROTEIN HUMAN PAPILLOMAVIRUS 8-27 TYPE 2A |
| PVE6-- |
| HPV33 E6 PROTEIN HUMAN PAPILLOMAVIRUS 9-26 TYPE 33 |
| PVE6-- |
| HPV35 E6 PROTEIN HUMAN PAPILLOMAVIRUS 9-26 TYPE 35 |
| PVE6-- |
| HPV51 E6 PROTEIN HUMAN PAPILLOMAVIRUS 9-26 TYPE 51 |
| PVE6-- |
| HPV57 E6 PROTEIN HUMAN PAPILLOMAVIRUS 8-27 TYPE 57 |
| PVE6-- |
| HPV58 E6 PROTEIN HUMAN PAPILLOMAVIRUS 9-26 TYPE 58 |
| PVE6-- MMPV E6 PROTEIN MICROMYS MINUTUS PAPILLO-7-33 36-60 |
| MAVIRUS |
| PVE7-- |
| CRPVK E7 PROTEIN COTTONTAIL RABBIT (SHOPE) 71-88 PAPILLOMAV |
| IRUS (STRAIN |
| KANSAS) |
| PVE7-- |
| HPV13 E7 PROTEIN HUMAN PAPILLOMAVIRUS 77-93 TYPE 13 |
| PVE7-- |
| HPV51 E7 PROTEIN HUMAN PAPILLOMAVIRUS 61-87 TYPE 51 |
| PVE7-- |
| HPV6B E7 PROTEIN HUMAN PAPILLOMAVIRUS 20-37 TYPE 6B |
| PVE7-- |
| RHPVI E7 PROTEIN RHESUS PAPILLOMAVIRUS 79-105 TYPE 1 |
| PVE94-- NPVAC EARLY 94 KD PROTEIN AUTOGRAPHA CALIFORNICA |
| 78-99 203-222 |
| NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVEF-- GVTN VIRAL ENHANCING FACTOR TRICHOPLUSIA JI GRANULOSIS |
| 154-175 237-260 677-696 |
| VIRUS |
| PVENV-- |
| BEV ENVELOPE PROTEIN BERNE VIRUS 62-86 87-114 PVENV-- |
| DHVII ENVELOPE GLYCOPROTEIN DHORI VIRUS (STRAIN 42-57 484-511 |
| PRECURSOR INDIAN/1313/61) |
| PVENV-- EAV PROBABLE ENVELOPE PROTEIN EQUINE ARTERITIS VIRUS |
| 25-41 |
| PVENV-- LELV PROBABLE ENVELOPE PROTEIN LELYSTAD VIRUS 27-47 |
| 148-168 |
| PVENV-- MCV1 MAJOR ENVELOPE PROTEIN MOLLUSCUM CONTAGIOSUM 61-80 |
| VIRUS SUBTYPE 1 |
| PVENV-- MCV2 MAJOR ENVELOPE PROTEIN MOLLUSCUM CONTAGIOSUM 61-80 |
| 306-333 |
| VIRUS SUBTYPE 2 |
| PVENV-- THOGV ENVELOPE GLYCOPROTEIN 196-221 356-383 473-491 |
| PRECURSOR THOGOTO VIRUS |
| PVETM-- NPVAC ECORI-T SITE PROTEIN ETM AUTOGRAPHA CLAIFORNICA |
| 82-105 |
| NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVF05-- VACCC 36 KD MAJOR MEMBRANE VACCINIA VIRUS (STRAIN 280-305 |
| PROTEIN PRECURSOR COPENHAGEN) |
| PVF05-- VACCP 36 KD MAJOR MEMBRANE VACCINIA VIRUS (STRAIN 280-305 |
| PROTEIN PRECURSOR L-1VP) |
| PVF05-- VACCV 36 KD MAJOR MEMBRANE VACCINIA VIRUS (STRAIN WR) |
| 281-306 |
| PROTEIN PRECURSOR |
| PVF05-- |
| VARV 36 KD MAJOR MEMBRANE VARIOLA VIRUS 280-305 PROTEIN |
| PRECURSOR |
| PVF09-- |
| VACCC PROTEIN F9 VACCINIA VIRUS (STRAIN 176-200 COPENHAGEN) |
| , AND (STRAIN |
| L-1VP) |
| PVF09-- VACCV PROTEIN F9 VACCININA VIRUS (STRAIN WR) 176-200 |
| PVF09-- |
| VARV PROTEIN F9 VARIOLA VIRUS 176-200 PVF11-- |
| VACCC PROTEIN F11 VACCINIA VIRUS (STRAIN 161-184 |
| COPENHAGEN) |
| PVF11-- |
| VARV PROTEIN F11 VARIOLA VIRUS 161-184 PVF15-- |
| VACCC PROTEIN F15 VACCINIA VIRUS (STRAIN 25-48 |
| COPENHAGEN) |
| PVF15-- |
| VACCP PROTEIN F15 VACCINIA VIRUS (STRAIN 3-26 L-1VP) |
| PVF15-- |
| VARV PROTEIN F15 VARIOLA VIRUS 28-51 PVFP1-- |
| FOWPV PROTEIN FP1 FOWLPOX VIRUS 297-323 |
| PVFP2-- |
| FOWPV PROTEIN FP2 FLWLPOX FIVURS 88-104 PVFP7-- |
| CAPVK PRTOEIN F7 CAPRIPOXVIRUS (STRAIN KS-1) 89-111 |
| PVFP7-- |
| FOWPV PRTOEIN FP7 FOWLPOX VIRUS 65-90 PVFP8-- |
| CAPVK CF8A PROTEIN CAPRIPOX VIRUS (STRAIN KS-1) 51-76 |
| PVFUS-- ORFNZ 10 KD FUSION PROTEIN ORF VIRUS (STRAIN NZ2) 29-48 |
| PVFUS-- VACC6 14 KD FUSION PROTEIN VACCINIA VIRUS (STRAIN 72-94 |
| WR 65-16) |
| PVG01-- HSVEB HYPOTHETICAL GENE 1 EQUINE HERPESVIRUS TYPE 1 |
| 169-195 |
| PROTEIN (STRAIN AB4P) |
| PVG01-- HSVII HYPOTHETICAL GENE 1 ICTALURID HERPES VIRUS 1 |
| 210-225 317-339 589-616 |
| PROTEIN |
| PVG01-- VACCC PROTEIN G1 VACCINIA VIRUS (STRAIN 398-318 376-395 |
| COPENHAGEN) |
| PVG01-- VACCV PROTEIN G1 VACCINIA VIRUS (STRAIN WR) 237-257 |
| 315-334 |
| PVG01-- |
| VARV PROTEIN G1 VARIOLA VIRUS 298-318 376-395 PVG01-- |
| VZVD HYPOTHETICAL GENE 1 VARICELLA-ZOSTER VIRUS 58-82 |
| PROTEIN (STRAIN DUMAS) |
| PVG03-- |
| VACC PROTEIN G3 VACCINIA VIRUS (STRAIN 50-72 COPENHAGEN) |
| PVG03-- |
| VARV PROTEIN G3 VARIOLA VIRUS 50-72 PVG04-- |
| VACCC PROTEIN G4 VACCINIA VIRUS (STRAIN 11-33 |
| COPENHAGEN) |
| PVG04-- |
| VARV PROTEIN G4 VARIOLA VIRUS 11-33 PVG06-- |
| VACCC PROTEIN G6 VACCINIA VIRUS (STRAIN 31-51 |
| COPENHAGEN) |
| PVG06-- |
| VARV PROTEIN G6 VARIOLA VIRUS 31-51 PVG08-- |
| HSVII HYPOTHETICAL GENE 8 ICTALURID HERPESVIRUS 1 134-49 159-185 |
| MEMBRANE PROTEIN |
| PVG10-- HSVII HYPOTHETICAL GENE 10 ICTALURID HERPESVIRUS 1 35-54 |
| MEMBRANE PROTEIN |
| PVG10-- HSVSA HERPESVIRUS SAIMIRI HERPESVIRUS SAIMIRI 109-124 |
| 355-379 |
| (STRAIN 11) |
| PVG11-- HSVII HYPOTHETICAL GENE 11 ICTALURID HERPESVIRUS 1 |
| 103-122 150-176 |
| ZINC-BINDING PROTEIN |
| PVG12-- HSVII HYPOTHETICAL GENE 12 ICTALURID HERPESVIRUS 1 |
| 151-178 270-286 |
| ZINC-BINDING PROTEIN |
| PVG12-- HSVSA HYPOTHETICAL GENE 12 HERPESVIRUS SAIMIRI 68-92 |
| PROTEIN (STRAIN 11) |
| PVG19-- HSVII HYPOTHETICAL GENE 19 ICTALURID HERPESVIRUS 1 88-112 |
| MEMBRANE PROTEIN |
| PVGIL-- |
| AMEPV GIL PROTEIN AMSACTA MOOREI ENTO- 313-336 MOPOXVIRUS |
| PVGI-- SPVIR CAPSID PROTEIN SPIROPLASMA VIRUS 76-92 659-678 |
| SPV1-R8A2 B |
| PVG22-- HSVII HYPOTHETICAL GENE 22 ICTALURID HERPESVIRUS 1 |
| 300-327 |
| PROTEIN |
| PVG23-- HSVII HYPOTHETICAL GENE 23 ICTALURID HERPESVIRUS 1 |
| 314-335 |
| PROTEIN |
| PVG27-- HSVII HYPOTHETICAL GENE 27 ICTALURID HERPESVIRUS 1 |
| 158-184 |
| PROTEIN |
| PVG28-- HSVII HYPOTHETICAL GENE 28 ICTALURID HERPESVIRUS 1 |
| 209-226 |
| PROTEIN |
| PVG28-- HSVSA HYPOTHETICAL GENE 28 HERPESVIRUS SAIMIRI 14-40 |
| PROTEIN (STRAIN 11) |
| PVG29-- HSVII HYPOTHETICAL GENE 29 ICTALURID HERPESVIRUS 1 20-42 |
| PROTEIN |
| PVG30-- HSVII HYPOTHETICAL GENE 30 ICTALURID HERPESVIRUS 1 |
| 166-191 |
| PROTEIN |
| PVG32-- VZVD GENE 32 PROTEIN VARICELLA-ZOSTER VIRUS 90-109 |
| (STRAIN DUMAS) |
| PVG36-- HSVSA POSSIBLE TYROSINE-PROTEIN HEREPESVIRUS SAIMIRI |
| 108-123 344-362 |
| KINASE (STRAIN 11) |
| PVG37-- HSVII HYPOTHETICAL GENE 37 ICTALURID HERPESVIRUS 1 |
| 284-299 |
| PROTEIN |
| PVG38-- HSVII HYPOTHETICAL GENE 38 ICTALURID HERPESVIRUS 1 |
| 648-675 970-990 1038-1065 |
| PROTEIN |
| PVG39-- HSVII HYPOTHETICAL GENE 39 ICTALURID HERPESVIRUS 1 14-32 |
| PROTEIN |
| PVG40-- HSVII HYPOTHETICAL GENE 40 ICTALURID HERPESVIRUS 1 11-38 |
| 62-81 244-260 |
| PROTEIN |
| PVG41-- HSVII HYPOTHETICAL GENE 41 ICTALURID HERPESVIRUS 1 |
| 109-133 157-178 322-345 521-538 |
| PROTEIN |
| PVG43-- HSVII HYPOTHETICAL GENE 43 ICTALURID HERPESVIRUS 1 |
| 134-156 580-607 937-963 1244-1270 |
| PROTEIN |
| PVG46-- HSVII PROBABLE MAJOR GLYCO- ICTALURID HERPESVIRUS 1 |
| 71-93 |
| PROTEIN |
| PVG48-- HSVII HYPOTHETICAL GENE 48 ICTALURID HERPESVIRUS 1 5-30 |
| 58-83 |
| PROTEIN |
| PVG50-- HASVSA PROB TRANSCRIPTION ACTIVA- HERPESVIRUS SIMIARI |
| 5-30 58-83 |
| TOR EDRF1 (STRAIN 11) |
| PVG51-- HSVII HYP GENE 51 MEMBRANE ICTALURID HERPESVIRUS 1 29-49 |
| 84-102 |
| PROTEIN |
| PVG52-- HSVII HYPOTHETICAL GENE 52 ICTALURID HERPESVIRUS 1 |
| 229-252 |
| PROTEIN |
| PVG55-- HSVII HYPOTHETICAL GENE 55 ICTALURID HERPESVIRUS 1 22-37 |
| 143-158 288-309 |
| PROTEIN |
| PVG55-- HSVSA HYPOTHETICAL GENE 55 HERPESVIRUS SAIMIRI 85-106 |
| PROTEIN (STRAIN 11) |
| PVG56-- HSVII HYPOTHETICAL GENE 56 ICTALURID HERPESVIRUS 1 |
| 1155-1176 |
| PROTEIN |
| PVG58-- HSVSA GENE 58 PROTEIN HERPESVIRUS SAIMIRI 130-146 266-288 |
| 293-319 330-346 |
| (STRAIN 11) |
| PVG59-- HSVII HYP GENE 59 MEMBRANE ICTALURID HERPESVIRUS 1 |
| 142-161 267-289 |
| PROTEIN |
| PVG5-- |
| SPV4 GENE 5 PROTEIN SPIROPLASMA VIRUS 4 42-64 PVG60-- |
| HSVII HYPOTHETICAL GENE 60 ICTALURID HERPESVIRUS 1 30-51 53-75 |
| PROTEIN |
| PVG61-- HSVII HYPOTHETICAL GENE 61 ICTALURID HERPESVIRUS 1 76-102 |
| 117-136 |
| PROTEIN |
| PVG63-- HSVII HYPOTHETICAL GENE 63 ICTALURID HERPESVIRUS 1 |
| 238-259 336-363 |
| PROTEIN |
| PVG64-- HSVII HYPOTHETICAL GENE 64 ICTALURID HERPESVIRUS 1 |
| 420-445 |
| PROTEIN |
| PVG65-- HSVII HYPOTHETICAL GENE 65 ICTALURID HERPESVIRUS 1 |
| 117-137 155-173 362-378 518-533 1147-1174 1347-1369 |
| PROTEIN |
| PVG67-- HSVII HYPOTHETICAL GENE 67 ICTALURID HERPESVIRUS 1 |
| 108-132 171-188 318-355 722-745 1005-1029 1072-1091 1315-1341 |
| PROTEIN |
| PVG6-- SPVIR GENE 6 PROTEIN SPIROPLASMA VIRUS 60-82 |
| SPV1-R8A2 B |
| PVG70-- HSVII HYPOTHETICAL GENE 70 ICTALURID HERPESVIRUS 1 |
| 184-209 |
| PROTEIN |
| PVG71-- HSVSA HYPOTHEICAL GENE 71 HERPESVIRUS SAIMIRI 89-105 |
| PROTEIN (STRAIN 11) |
| PVG72-- HSVII HYPOTHETICAL GENE 72 ICTALURID HERPESVIRUS 1 |
| 445-471 535-561 720-744 1252-1269 |
| PROTEIN |
| PVG74-- HSVSA G-PROTEIN COUPLED REC HERPESVIRUS SAIMIRI 124-151 |
| HOMOLOG ECRF3 (STRAIN 11) |
| PVG9-- SPVIR GENE 9 PROTEIN SPIROPLASMA VIRUS 57-72 |
| SPV1-R8A2B |
| PVGF1-- IBVB F1 PROTEIN AVIAN INFECTIOUS BRONCHI- 1587-1606 |
| 1856-1877 2108-2127 2210-2226 2788-2806 2973-2999 3073-3090 3120-3145 |
| 3374-3399 |
| TIS VIRUS (STRAIN 3601-3625 |
| BEAUDETTE) |
| PVGH3-- HCMVA GLYCOPROTEIN H301 HUMAN CYTOMEGALOVIRUS 157-178 |
| PRECURSOR (STRAIN AD169) |
| PVGL1-- CVPR8 E1 GLYCOPROTEIN PRECURSOR PORCINE RESPITATORY CORO- |
| 174-193 |
| NAVIRUS (STRAIN 86/137004/ |
| BRITISH IS |
| PVGL2-- CVBF E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS 10-33 |
| 12-139 174-190 264-279 991-1017 1259-1280 |
| (STRAIN F15) |
| PVGL2-- CVBL9 E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS |
| 123-139 174-190 264-279 651-674 991-1017 1259-1280 |
| (STRAIN L9) |
| PVGL2-- CVBLY E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS 10-33 |
| 12-139 174-190 264-279 991-1017 1259-1280 |
| (STRAIN LY-138) |
| PVGL2-- CVBM E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS 123-139 |
| 174-190 264-279 991-1017 1259-1280 |
| (STRAIN MEBUS) |
| PVGL2-- CVBQ E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS 31-47 |
| 12-139 174-190 264-279 991-1017 1259-1280 |
| (STRAIN QUEBEC) |
| PVGL2-- CVBV E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS 123-139 |
| 174-190 264-279 991-1017 1259-1280 |
| (STRAIN VACCINE) |
| PVGL2-- CVH22 E2 GLYCOPROTEIN PRECURSOR HUMAN CORONAVIRUS 768-794 |
| 1053-1071 1115-1134 |
| (STRAIN 229E) |
| PVGL2-- CVM4 E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS 95-111 |
| 999-1025 1267-1290 1317-1338 |
| (STRAIN WILD TYPE 4) |
| PVGL2-- CVMA5 E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS 95-111 |
| 947-973 1215-1238 1265-1286 |
| (STRAIN A59) |
| PVGL2-- CVMJC E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS 95-111 |
| 999-1025 1267-1290 1317-1338 |
| (STRAIN JHMV/VARIANT CL-2) |
| PVGL2-- CVMJH E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS 95-111 |
| 858-884 1126-1149 1176-1197 |
| (STRAIN JHM) |
| PVGL2-- CVPFS E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| 65-83 442-457 800-816 1038-1064 1274-1297 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVGL2-- CVPMI E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| 64-83 442-457 506-521 800-816 1038-1064 1274-1297 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVGL2-- CVPPR E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| 64-83 440-455 504-519 798-814 1036-1062 1272-1295 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVGL2-- CVPPU E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| 64-83 440-455 504-519 798-814 1036-1062 1272-1295 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVGL2-- CVPR8 E2 GLYCOPROTEIN PRECURSOR PORCINE RESPIRATORY CORO- |
| 218-233 576-592 814-840 1050-1073 |
| NAVIRUS (STRAIN 86/137004/ |
| BRITISH I |
| PVGL2-- CVPRM E2 GLYCOPROTEIN PRECURSOR PORCINE RESPIRATORY CORO- |
| 218-233 576-592 814-840 1050-1073 |
| NAVIRUS (STRAIN RM4) |
| PVGL2-- CVPRT E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| 64-83 440-455 504-519 798-814 1035-1062 1272-1295 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVGL2-- FIBV E2 GLYCOPROTEIN PRECURSOR FELINE INFECTIOUS PERITO- |
| 803-819 1041-1067 1277-1300 |
| NITIS VIRUS (STRAIN 79-1146) |
| PVGL2-- |
| IBV6 E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS 196-219 |
| 588-607 771-797 1056-1081 1094-1111 |
| VIRUS (STRAIN 6/82) |
| PVGL2-- |
| IBVB E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS 195-218 |
| 587-606 770-796 1055-1080 |
| VIRUS (STRAIN BEAUDETTE) |
| PVGL2-- |
| IBVD2 E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS 196-219 |
| 588-607 771-797 1056-1081 |
| VIRUS (STRAIN D274)( |
| PVGL2-- |
| IBVD3 E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS 196-219 |
| VIRUS (STRAIN D3896) |
| PVGL2-- |
| IBVK E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS 195-218 |
| 587-606 770-796 1056-1081 |
| VIRUS (STRAIN KB8523) |
| PVGL2-- |
| IBVM E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS 195-218 |
| 378-398 587-606 770-796 1055-1080 |
| VIRUS (STRAIN M41) |
| PVGL2-- IBVU1 E2 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS 178-201 |
| VIRUS (STRAIN UK/123/82) |
| PVGL2-- IBVU2 E2 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS 178-201 |
| VIRUS (STRAIN UK/142/86) |
| PVGL2-- IBVU3 E2 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS 178-201 |
| VIRUS (STRAIN UK/167/84) |
| PVGLB-- EBV GLYCOPROTEIN GP110 PRECURSOR EPSTEIN-BARR VIRUS |
| (STRAIN 732-752 |
| B95-8) |
| PVGLB-- HCMVA GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 535-558 706-732 750-777 |
| (STRAIN AD169) |
| PVGLB-- HCMVT GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 536-559 707-733 751-778 |
| (STRAIN TOWNE) |
| PVGLB-- HSV11 GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 84-104 |
| 1/STRAIN 17) |
| PVGLB-- HSVIF GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 82-103 |
| 1/STRAIN F) |
| PVGLB-- HSVIK GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 82-103 |
| 1/STRAIN KOS) |
| PVGLB-- HSVIP GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 83-104 |
| 1/STRAIN PATTON) |
| PVGLB-- HSV23 GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 79-99 |
| 2/STRAIN 333) |
| PVGLB-- HSV2H GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 79-99 |
| 2/STRAIN HG52) |
| PVGLB-- HSV2S GLYCOPROTEIN B PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 65-85 |
| 2/STRAIN SA8) |
| PVGLB-- HSV6U GLYCOPROTEIN B (FRAGMENT) HERPES SIMPLEX VIRUS |
| (TYPE 72-92 117-144 |
| 6/STRAIN UGANDA-1102) |
| PVGLB-- HSVB1 GLYCOPROTEIN 1 PRECURSOR BOVINE HERPESVIRUS TYPE 1 |
| 560-578 689-707 |
| PVGLB-- HSVB2 GLYCOPROTEIN B-1 PRE- BOVINE HERPESVIRUS TYPE 2 |
| 279-299 745-767 |
| CURSOR (STRAIN BMV) (BOVINE MAM- |
| MILLITIS |
| PVGLB-- HSVBC GLYCOPROTEIN 1 PRECURSOR BOVINE HERPESVIRUS TYPE 1 |
| 692-710 |
| (STRAIN COOPER) |
| PVGLB-- HSVE1 GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| 736-753 |
| (ISOLATE HVS25A) (EHV-1) |
| PVGLB-- HSVE4 GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| 675-692 |
| (STRAIN AB1) |
| PVGLB-- HSVEA GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| 736-753 |
| (STRAIN AB1) |
| PVGLB-- HSVEB GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| 736-753 |
| (STRAIN AB4P) |
| PVGLB-- HSVEL GLYCOPROTEIN B PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| 736-753 |
| (STRAIN KENTUCKY D) |
| PVGLB-- HSVMD GLYCOPROTEIN B PRECURSOR MAREK'DISEASE HERPESVIRUS |
| 589-613 |
| (STRAIN RB-1B) |
| PVGLB-- HSVSA GLYCOPROTEIN B PRECURSOR HERPESVIRUS SAIMIRI |
| 483-506 584-602 701-716 |
| (STRAIN 11) |
| PVGLB-- ILTV6 GLYCOPROTEIN B PRECURSOR INFECTIOUS LARYNGOTRA- |
| 256-276 597-621 740-758 |
| CHEITIS VIRUS (STRAIN 632) |
| PVGLB-- ILTVS GLYCOPROTEIN B PRECURSOR INFECTIOUS LARYNGOTRA- |
| 266-285 607-631 750-768 |
| CHEITIS VIRUS (STRAIN SA-2) |
| PVGLB-- ILTVT GLYCOPROTEIN B PRECURSOR INFECTIOUS LARYNGOTRA- |
| 266-285 607-631 750-768 |
| CHEITIS VIRUS (STRAIN |
| THORNE V882) |
| PVGLB-- MCMVS GLYCOPROTEIN B PRECURSOR MURINE CYTOMEGALOVIRUS |
| 135-156 566-589 738-765 |
| (STRAIN SMITH) |
| PVGLB-- PRVIF GLYCOPROTEIN G11 PRECURSOR PSEUDORABIES VIRUS |
| (STRAIN 203-218 |
| INDIANA-FUNDKHAUSER/ |
| BECKER) |
| PVGLB-- VZVD GLYCOPROTEIN B PRECURSOR VARICELLA-ZOSTER VIRUS |
| 522-538 |
| (STRAIN DUMAS) |
| PVGLC-- HSVII GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 3-22 467-493 |
| 1/STRAIN 17) |
| PVGLC-- HSVIK GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 3-22 467-493 |
| 1/STRAIN KOS) |
| PVGLC-- HSV2 GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS |
| 435-458 |
| (TYPE 2) |
| PVGLC-- HSV23 GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 436-459 |
| 2/STRAIN 333) |
| PVGLC-- HSVBC GLYCOPROTEIN GIII PRE- BOVINE HERPESVIRUS TYPE 1 |
| 475-494 |
| CURSOR (STRAIN COOPER) |
| PVGLC-- HSVMB SECRETORY GLYCOPROTEIN MAREK'S DISEASE HERPES- |
| 399-421 |
| GP57-65 PRECURSOR VIRUS (STRAIN BC-1) |
| PVGLC-- HSVMD SECRETORY GLYCOPROTEIN MAREK'S DISEASE HERPES- |
| 399-421 |
| GP57-65 PRECURSOR VIRUS (STRAIN RB-1B) |
| PVGLC-- HSVMG SECRETORY GLYCOPROTEIN MAREK'S DISEASE HERPES- |
| 398-420 |
| GP57-65 PRECURSOR VIRUS (STRAIN GA) |
| PVGLC-- HSVMM SECRETORY GLYCOPROTEIN MAREK'S DISEASE HERPES- |
| 399-421 |
| GP57-65 PRECURSOR VIRUS (STRAIN MD5) |
| PVGLC-- PRVIF GLYCOPROTEIN GIII PRE- PSEUDORABIES VIRUS (STRAIN |
| 180-197 446-472 |
| CURSOR INDIANA-FUNKHAUSER/ |
| BECKER) |
| PVGLC-- VZVD GLYCOPROTEIN GPV VARICELLA-ZOSTER VIRUS 431-449 |
| (STRAIN DUMAS) |
| PVGLC-- VZVS GLYCOPROTEIN GPV VARICELLA-ZOSTER VIRUS 431-449 |
| (STRAIN SCOTT) |
| PVGLD-- HSVII GLYCOPROTEIN D PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 79-94 |
| 1/STRAIN 17), AND (TYP1 |
| 1/STRAIN |
| PVGLD-- HSV2 GLYCOPRTOEIN D PRECURSOR HERPES SIMPLEX VIRUS 79-94 |
| (TYP3 2) |
| PVGLE-- HSVII GLYCOPROTEIN E PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 104-129 413-437 |
| 1/STRAIN 17) |
| PVGLE-- VZVD GLYCOPROTEIN E PRECURSOR VARICELLA-ZOSTER VIRUS |
| 469-493 |
| (STRAIN DUMAS) |
| PVGLF-- BRSVA FUSION GLYCOPROTEIN BOVINE RESPIRATORY SYNCY- |
| 205-221 265-287 482-504 |
| PRECURSOR TIAL VIRUS (STRAIN A51908) |
| PVGLF-- BRSVC FUSION GLYCOPROTEIN BOVINE RESPIRATORY 205-221 |
| 265-280 484-506 |
| PRECURSOR SYNCYTIAL VIRUS (STRAIN |
| COPENHAGEN) |
| PVGLF-- BRSVR FUSION GLYCOPROTEIN BOVINE RESPIRATORY SYNCY- |
| 205-221 265-280 484-506 |
| PRECURSOR TIAL VIRUS (STRAIN RB94) |
| PVGLF-- CDVO FUSION GLYCOPROTEIN CANINE DISTEMPER VIRUS 336-361 |
| 398-414 562-589 |
| PRECURSOR (STRAIN ONDERSTEPOORT) |
| PVGLF-- HRSV1 FUSION GLYCOPROTEIN HUMAN RESPIRATORY 205-221 |
| 265-280 484-506 |
| PRECURSOR SYNCYTIAL VIRUS (SUB- |
| GROUP B/STRAIN 185 |
| PVGLF-- HRSVA FUSION GLYCOPROTEIN HUMAN RESPIRATORY SYNCY- |
| 205-221 264-280 484-506 |
| PRECURSOR TIAL VIRUS (STRAIN A2) |
| PVGLF-- HRSVL FUSION GLYCOPROTEIN HUMAN RESPIRATORY SYNCY- |
| 205-221 265-280 484-506 |
| PRECURSOR TIAL VIRUS (SUBGROUP |
| A/STRAIN LO |
| PVGLF-- HRSVR FUSION GLYCOPROTEIN HUMAN RESPIRATORY SYNCY- |
| 205-221 265-280 484-506 |
| PRECURSOR TIAL VIRUS (STRAIN RSS-2) |
| PVGLF-- MEASE FUSION GLYCOPROTEIN MEASLES VIRUS (STRAIN 224-245 |
| 286-302 451-477 |
| PRECURSOR EDMONSTON) AND (STRAIN |
| HALLE) |
| PVGLF-- MEAS1 FUSION GLYCOPROTEIN MEASLES VIRUS (STRAIN 227-248 |
| 289-305 454-480 |
| PRECURSOR IP-3-CA) |
| PVGLF-- MEASY FUSION GLYCOPROTEIN MEASLES VIRUS (STRAIN 224-245 |
| 286-302 451-477 |
| PRECURSOR YAMAGATA-1) |
| PVGLF-- MUMP1 FUSION GLYCOPROTEIN MUMPS VIRUS (STRAIN SBL-1) 5-20 |
| 276-292 446-467 |
| PRECURSOR |
| PVGLF-- MUMPM FUSION GLYCOPROTEIN MUMPS VIRUS (STRAIN 276-292 |
| 446-467 |
| PRECURSOR MIYAHARA VACCINE) |
| PVGLF-- MUMPR FUSION GLYCOPROTEIN MUMPS VIRUS (STRAIN RW) 276-292 |
| 446-467 |
| PRECURSOR |
| PVGLF-- MUMPS FUSION GLYCOPROTEIN MUMPS VIRUS (STRAIN SBL) 5-20 |
| 276-292 446-467 |
| PRECURSOR |
| PVGLF-- NDVA FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN AUSTRALIA- |
| VICTORIA/32) |
| PVGLF-- NDVB FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN BEAUDETTE C/45) |
| PVGLF-- NDVH3 FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN HER/33) |
| PVGLF-- NDVH4 FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN B1-HITCHNER/47) |
| PVGLF-- NDVL FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN LAS/46) |
| PVGLF-- NDVM FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN MIYADERA/51) |
| PVGLF-- NDVQ FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN QUEENSLAND/66) |
| PVGLF-- NDVT FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN TEXAS) |
| PVGLF-- NDVTG FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN TEXAS G B/48) |
| PVGLF-- NDVU FUSION GLYCOPROTEIN NEWCASTLE DISEASE VIRUS 273-289 |
| PRECURSOR (STRAIN ULSTER/67) |
| PVGLF-- PHODV FUSION GLYCOPROTEIN PHOCINE DISTEMBER VIRUS 269-285 |
| 305-326 367-383 531-558 |
| PRECURSOR |
| PVGLF-- PIIHC FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 1 456-477 |
| PRECURSOR VIRUS (STRAIN C39) |
| PVGLF-- P12H FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 2 450-471 |
| PRECURSOR VIRUS (PIV-2) |
| PVGLF-- P12HG FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 2 450-471 |
| PRECURSOR VIRUS (STRAIN GREER) |
| PVGLF-- P12HT FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 2 450-471 |
| PRECURSOR VIRUS (STRAIN TOSHIBA) |
| PVGLF-- P13B FUSION GLYCOPROTEIN BOVINE PARAINFLUENZA 3 405-426 |
| 453-474 |
| PRECURSOR VIRUS |
| PVGLF-- P13H4 FUSION GLYCOPROTEIN HUMAN PARAINFLUENZA 3 2-20 |
| 283-310 453-474 |
| PRECURSOR VIRUS (STRAIN HIH 47885) |
| PVGLF-- RINDK FUSION GLYCOPROTEIN RINDERPEST VIRUS (STRAIN |
| 220-241 282-298 447-473 |
| PRECURSOR KABETE O) |
| PVGLF-- RINDL FUSION GLYCOPROTEIN RINDERPEST VIRUS (STRAIN L) |
| 220-241 282-298 447-473 |
| PRECURSOR |
| PVGLF-- SEND5 FUSION GLYCOPROTEIN SENDAI VIRUS (STRAIN 450-481 |
| PRECURSOR Z/HOST MUTANTS) |
| PVGLF-- SENDF FUSION GLYCOPROTEIN SENDAI VIRUS (STRAIN 460-481 |
| PRECURSOR FUSHIMI) |
| PVGLF-- SENDH FUSION GLYCOPROTEIN SENDAI VIRUS (STRAIN 460-481 |
| PRECURSOR HARRIS) |
| PVGLF-- SENDJ FUSION GLYCOPROTEIN SENDAI VIRUS (STRAIN HVJ) |
| 460-481 |
| PRECURSOR |
| PVGLF-- SENDZ FUSION GLYCOPROTEIN SENDAI VIRUS (STRAIN Z) 460-481 |
| PRECURSOR |
| PVGLF-- |
| SV41 FUSION GLYCOPROTEIN SIMIAN VIRUS 41 453-474 PRECURSOR |
| PVGLF-- SV5 FUSION GLYCOPROTEIN SIMIAN VIRUS 5 (STRAIN W3) |
| 401-425 446-467 |
| PRECURSOR |
| PVGLF-- TRTV FUSION GLYCOPROTEIN TURKEY RHINOTRACHEITIS 175-191 |
| 452-474 |
| PRECURSOR VIRUS |
| PVGLG-- IHNV SPIKE GLYCOPROTEIN INFECTIOUS HEMATOPOIETIC 77-99 |
| PRECURSOR NECROSIS VIRUS (STRAIN |
| ROUND BUT |
| PVGLG-- RABVE SPIKE GLYCOPROTEIN RABIES VIRUS (STRAIN ERA) |
| 454-474 |
| PRECURSOR |
| PVGLG-- RABVH SPIKE GLYCOPROTEIN RABIES VIRUS (STRAIN 372-391 |
| 454-474 |
| PRECURSOR HEP-FLURY) |
| PVGLG-- RABVP SPIKE GLYCOPROTEIN RABIES VIRUS (STRAIN PV) 454-474 |
| PRECURSOR |
| PVGLG-- RABVS SPIKE GLYCOPROTEIN RABIES VIRUS (STRAIN SAD 454-474 |
| PRECURSOR B19) |
| PVGLG-- RABVT SPIKE GLYCOPROTEIN RABIES VIRUS (STRAIN 454-474 |
| PRECURSOR STREET) |
| PVGLG-- TRTV MAJOR SURFACE GLYCO- TURKEY RHINOTRACHEITIS 199-216 |
| PROTEIN G VIRUS |
| PVGLG-- VHSV0 SPIKE GLYCOPROTEIN VIRAL HEMORRHAGIC SEPTICE- |
| 406-428 |
| PRECURSOR MIA VIRUS (STRAIN 07-710 |
| PVGLH-- HCMVA GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 211-237 365-382 574-598 691-712 |
| (STRAIN AD169) |
| PVGLH-- HCMVT GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 210-236 364-381 573-597 690-711 |
| (STRAIN TOWNE) |
| PVGLH-- HSVII GLYCOPROTEIN H PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 245-262 443-467 803-827 |
| 1/STRAIN 17) |
| PVGLH-- HSVIE GLYCOPROTEIN H PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 245-262 443-467 803-827 |
| 1/STRAIN HFEM) |
| PVGLH-- HSV6G GLYCOPROTEIN H PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 314-332 |
| 6/STRAIN GS) |
| PVGLH-- HSVE4 GLYCOPROTEIN H PRECURSOR EQUINE HERPESVIRUS TYPE 4 |
| 304-325 814-839 |
| (STRAIN 1942) |
| PVGLH-- HSVEB GLYCOPROTEIN H PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| 297-318 807-832 |
| (STRAIN AB4P) and (ISOLATE |
| HVS25A) |
| PVGLH-- HSVSA GLYCOPROTEIN H PRECURSOR HERPESVIRUS SAIMIRI |
| 454-479 658-679 |
| (STRAIN 11) |
| PVGLH-- MCMVS GLYCOPROTEIN H PRECURSOR MURINE CYTOMEGALOVIRUS |
| 670-690 |
| (STRAIN SMITH) |
| PVGLI-- HCMVA IE GLYCOPROTEIN PRECURSOR HUMAN CYTOMEGALOVIRUS |
| 158-180 |
| (STRAIN D 169) |
| PVGLI-- HSVII GLYCOPROTEIN I HERPES SIMPLEX VIRUS (TYPE 43-60 |
| A/STRAIN 17) |
| PVGLI-- HSVEB GLYCOPROTEIN I PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| 44-63 |
| PVGLI-- VZVD GLYCOPROTEIN I VARICELLA-ZOSTER VIRUS 278-297 |
| (STRAIN DUMAS) |
| PVGLM-- BUNGE M POLYPROTEIN PRECURSOR BUNYAVIRUS GERMISTON |
| 117-136 197-222 |
| PVGLM-- BUNL7 M POLYPROTEIN PRECURSOR BUNYAVIRUS LA CROSSE 31-55 |
| 81-98 190-211 1325-1345 1387-1410 |
| (ISOLATE L74) |
| PVGLM-- BUNSH M POLYPROTEIN PRECURSOR BUNYAVIRUS SNOWSHOE HARE |
| 31-55 81-98 190-211 1325-1345 1387-1410 |
| PVGLM-- BUNYW M POLYPROTEIN PRECURSOR BUNYAMWERA VIRUS 193-218 |
| 1379-1404 |
| PVGLM-- |
| DUGBV M POLYPROTEIN PRECURSOR DUGBE VIRUS PVGLM-- |
| HANTB M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN B-1) 355-371 |
| 692-717 900-914 999-1019 |
| PVGLM-- HANTH M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN |
| 499-515 694-718 100-1020 |
| HOJO) |
| PVGLM-- HANTL M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN LEE) |
| 499-415 694-719 1001-1021 |
| PVGLM-- HANTV M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN |
| 499-515 694-719 1001-1021 |
| 76-118) |
| PVGLM-- INSV M POLYPROTEIN PRECURSOR IMPATIENS NECROTIC SPOT |
| 18-44 269-293 348-367 531-551 815-841 |
| VIRUS (INSV) |
| PVGLM-- PHV M POLYPROTEIN PRECURSOR PROSPECT HILL VIRUS 152-171 |
| PVGLM-- PTPV M POLYPROTEIN PRECURSOR PUNTA TORO PHLEBOVIRUS |
| 743-765 997-1016 1275-1302 |
| PVGLM-- PUUMH M POLYPROTEIN PRECURSOR PUUMALA VIRUS (STRAIN |
| 155-174 509-525 712-729 |
| HALLNAS B1) |
| PVGLM-- PUUMS M POLYPROTEIN PRECURSOR PUUMALA VIRUS (STRAIN |
| 155-174 509-525 712-729 1092-1117 |
| SOTKAMO) |
| PVGLM-- RVFV M POLYPROTEIN PRECURSOR RIFT VALLEY FEVER VIRUS |
| 53-80 344-368 830-856 |
| PVGLM-- RVFVZ M POLYPROTEIN PRECURSOR RIFT VALLEY FEVER VIRUS |
| 53-80 344-368 830-856 1156-1176 |
| (STRAIN ZH-548 M12) |
| PVGLM-- SEOU8 M POLYPROTEIN PRECURSOR SEOUL VIRUS (STRAIN 80-39) |
| 355-371 692-717 900-915 999-1019 |
| PVGLM-- SEOUR M POLYPROTEIN PRECURSOR SEOUL VIRUS (STRAIN R22) |
| 355-371 623-718 901-916 1000-1020 |
| PVGLM-- SEOUS M POLYPROTEIN PRECURSOR SEOUL VIRUS (STRAIN SR-11) |
| 355-371 692-717 900-915 999-1019 |
| (SAPPORO RAT VIRUS) |
| PVGLM-- UUK M POLYPROTEIN PRECURSOR UUKUNIEMI VIRUS 561-585 |
| 655-674 826-842 925-952 966-989 |
| PVGLP-- BEV PEPLOMER GLYCOPROTEIN BERNE VIRUS 430-452 869-885 |
| 1099-1124 1546-1568 |
| PRECURSOR |
| PVGLX-- HSVEB GLYCOPROTEIN X PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| PVGLX-- HSVEK GLYCOPROTEIN GX PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN KENTUCKY A) |
| PVGLX-- |
| HSVEL GLYCOPROTEIN GX EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| KENTUCKY D) |
| PVGLX-- PRVRI SECRETED GLYCOPROTEIN GX PSEUDORAVIES VIRUS (STRAIN |
| 149-176 |
| RICE) |
| PVGLY-- JUNIN GLYCOPROTEIN POLYPROTEIN JUNIN ARENAVIRUS 12-38 |
| PRECURSOR |
| PVGLY-- LASSG GLYCOPROTEIN POLYPROTEIN LASSA VIRUS (STRAIN GA391) |
| 12-38 237-258 426-448 |
| PRECURSOR |
| PVGLY-- LASSJ GLYCOPROTEIN POLYPROTEIN LASSA VIRUS (STRAIN |
| JOSIAH) 12-35 138-259 427-449 |
| PRECURSOR |
| PVGLY-- LYCVA GLYCOPROTEIN POLYPROTEIN LYMPHOCYTIC CHORIO- 12-35 |
| PRECURSOR MENINGITIS VIRUS (STRAIN |
| ARMSTRONG) |
| PVGLY-- LYCVW GLYCOPROTEIN POLYPROTEIN LYMPHOCYTIC CHORIOMEN- |
| 12-35 89-108 |
| PRECURSOR INGITIS VIRUS (STRAIN WE) |
| PVGLY-- MOPEI GLYCOPROTEIN POLYPROTEIN MOPEIA VIRUS 12-35 425-447 |
| PRECURSOR |
| PVGLY-- PIARV GLYCOPROTEIN POLYPROTEIN PICHINDE ARENAVIRUS 12-38 |
| 441-466 |
| PRECURSOR |
| PVGLY-- TACV GLYCOPROTEIN POLYPROTEIN TACARIBE VIRUS 12-38 |
| PRECURSOR |
| PVGLY-- TACV5 GLYCOPROTEIN POLYPROTEIN TACARIBE VIRUS (STRAIN V5) |
| 12-38 |
| PRECURSOR |
| PVGLY-- TACV7 GLYCOPROTEIN POLYPROTEIN TACARIBE VIRUS (STRAIN V7) |
| 12-38 |
| PRECURSOR |
| PVGLY-- TACVT GLYCOPROTEIN POLYPROTEIN TACARIBE VIRUS (STRAIN |
| 12-38 |
| PRECURSOR TRVL 11598) |
| PVGNB-- CPMV GENOME POLYPROTEIN B COWPEA MOSAIC VIRUS 141-161 |
| 569-594 757-783 1110-1135 1165-1184 |
| PVGNM-- CPMV GENOME POLYPROTEIN M COWPEA MOSAIC VIRUS 311-335 |
| 741-764 |
| PVGP2-- EBV PROBABLE MEMBRANE EPSTEIN-BARR VIRUS (STRAIN 657-681 |
| ANTIGEN GP220 B95-8) (HUMAN HERPESVIRUS 4) |
| PVGP3-- EBV ENVELOPE GLYCOPROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| 854-878 |
| GP340 B95-8) (HUMAN HERPESVIRUS 4) |
| PVGP8-- EBV PROBABLE MEMBRANE EPSTEIN-BARR VIRUS (STRAIN 67-88 |
| ANTIGEN GP85 B95-8) (HUMAN HERPESVIRUS 4) |
| PVGP-- EBOV STRUCTURAL GLYCOPROTEIN EBOLA VIRUS 34-52 537-561 |
| 653-675 |
| PRECURSOR |
| PVGP-- MABVM STRUCTURAL GLYCOPROTEIN MARBURG VIRUS (STRAIN |
| 538-562 607-627 |
| PRECURSOR MUSOKE) |
| PVGP-- MABVP STRUCTURAL GLYCOPROTEIN MARBURG VIRUS (STRAIN |
| 538-562 607-627 |
| PRECURSOR POPP) |
| PVHO1-- VACCC PROTEIN-TYROSINE VACCINIA VIRUS (STRAIN 76-92 |
| 105-121 |
| PHOSPHATASE COPENHAGEN) |
| PVH01-- VACCV PROTEIN-TYROSINE VACCINIA VIRUS (STRAIN WR) 76-92 |
| 105-121 |
| PHOSPHATASE |
| PVH01-- VARV PROTEIN-TYROSINE VARIOLA VIRUS 76-92 105-121 |
| PHOSPHATASE |
| PVH07-- VACCV LATE PRTOEIN H7 VACCINIA VIRUS (STRAIN WR) 70-97 |
| PVH07-- |
| VARV LATE PROTEIN H7 VARIOLA VIRUS 70-97 PVHEL-- |
| FXMV PROBABLE HELICASE FOXTAIL MOSAIC VIRUS 182-205 |
| PVHEL -- PMV PROBABLE HELICASE PAPAYA MOSAIC POTEXVIRUS 153-168 |
| PV101-- |
| VACCC PROTEIN 11 VACCINIA VIRUS (STRAIN 120-135 COPENHAGEN) |
| PV101-- |
| VARV PRTOEIN 11 VARIOLA VIRUS 120-135 PV103-- |
| VACCC PROTEIN 13 VACCINIA VIRUS (STRAIN 194-220 |
| COPENHAGEN) |
| PV103-- |
| VACCV PROTEIN 13 VACCINIA VIRUS (WR) 194-220 PV103-- |
| VARV PROTEIN 13 VARIOLA VIRUS 194-220 |
| PV106-- VACCC PROTEIN 16 VACCINIA VIRUS (STRAIN WR) 106-128 |
| 133-155 |
| PV106-- VACCV PROTEIN 16 VACCINIA VIRUS (STRAIN 106-128 133-135 |
| COPENHAGEN) |
| PV106-- |
| VARV PROTEIN 16 VARIOLA VIRUS 106-128 133-155 PV107-- |
| VACCC PROTEIN 17 VACCINIA VIRUS (STRAIN 13-34 344-367 |
| COPENHAGEN) |
| PV107-- VACCV PROTEIN 17 VACCINIA VIRUS (STRAIN WR) 13-34 344-367 |
| PV107-- |
| VARV PROTEIN 17 VARIOLA VIRUS 13-34 344-367 PV108-- |
| VACCC PUTATIVE RNA HELICASE 18 VACCINIA VIRUS (STRAIN 196-212 418-438 |
| COPENHAGEN) |
| PV108-- VACCV PUTATIVE RNA HELICASE 18 VACCINIA VIRUS (STRAIN WR) |
| 196-212 418-438 |
| PV108-- VARV PUTATIVE RNA HELICASE 18 VARIOLA VIRUS 196-212 |
| 418-438 |
| PVIE1-- HCMVA 55 KD IMMEDIATE-EARLY HUMAN CYTOMEGALOVIRUS 77-100 |
| 333-350 |
| PROTEIN 1 (STRAIN AD169) |
| PVIE1-- HCMVT 55 KD IMMEDIATE-EARLY HUMAN CYTOMEGALOVIRUS 77-100 |
| 333-350 |
| PROTEIN 1 (STRAIN TOWNE) |
| PVIE2-- HCMVA 45 KD IMMEDIATE-EARLY HUMAN CYTOMEGALOVIRUS 14-32 |
| 389-406 |
| PROTEIN 1 (STRAIN AD169) |
| PVIE2-- HCMVT 45 KD IMMEDIATE-EARLY HUMAN CYTOMEGALOVIRUS 14-32 |
| 389-406 |
| PROTEIN 1 (STRAIN TOWN) |
| PVIE2-- MCMVS IMMEDIATE-EARLY PROTEIN 2 MURINE CYTOMGEALOVIRUS |
| 251-272 |
| (STRAIN SMITH) |
| PVIE3-- HCMVT 30 KD IMMEDIATE-EARLY HUMAN CYTOMEGALOVIRUS 14-32 |
| PROTEIN 1 (STRAIN TOWNE) |
| PVIEG-- HSVSA IMMEDIATE-EARLY PROTEIN HERPESVIRUS SAIMIRI 65-80 |
| IE-G (STRAIN 11) |
| PVIEN-- NPVAC IMMEDIATE-EARLY REG AUTOGRAPHA CALIFORNICA 100-116 |
| 273-290 |
| PROTEIN IE-N NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVIMP-- EBV PROB INTEGRAL MEMBRANE EPSTEIN-BARR VIRUS (STRAIN |
| 75-100 125-152 203-222 |
| PROTEIN BBRF3 B95-8) |
| PVIMP-- HCMVA PROBABLE INTEGRAL HUMAN CYTOMEGALOVIRUS 68-89 |
| 190-217 |
| MEMBRANE PROTEIN (STRAIN AD169) |
| PVIMP-- HSVII PROBABLE INTEGRAL HERPES SIMPLEX VIRUS (TYPE 83-110 |
| 250-270 |
| MEMBRANE PROTEIN 1/STRAIN 17) |
| PVIMP-- HSVEB PROBABLE INTEGRAL EQUINE HERPESVIRUS TYPE 1 24-49 |
| 93-20 145-172 247-263 301-321 332-358 |
| MEMBRANE PROTEIN (STRAIN AB4P) |
| PVIMP-- HSVSA INTEGRAL MEMBRANE HERPESVIRUS SAIMIRI 76-101 |
| 313-331 |
| PROTEIN (STRAIN 11) |
| PVIMP-- VZVD PROBABLE INTEGRAL VARICELLA-ZOSTER VIRUS 21-47 |
| 154-181 230-252 |
| MEMBRANE PROTEIN (STRAIN DUMAS) |
| PVJ01-- |
| VACCC PROTEIN J1 VACCINIA VIRUS (STRAIN 89-110 COPENHAGEN) |
| PVJ01-- VACCV PROTEIN J1 VACCINIA VIRUS (STRAIN WR) 89-110 |
| PVJ01-- |
| VARV PROTEIN J1 VARIOLA VIRUS 89-110 PVK04-- VACCC |
| PROTEIN K4 VACCINIA VIRUS (STRAIN 87-113 208-234 319-337 |
| COPENHAGEN) |
| PVK04-- VACCV PROTEIN K4 VACCINIA VIRUS (STRAIN WR) 87-113 |
| 208-234 391-337 |
| PVK05-- |
| VACCC PROTEIN K5 VACCINIA VIRUS (STRAIN 106-133 COPENHAGEN) |
| PVL02-- |
| VACCC PROTEIN L2 VACCINIA VIRUS (STRAIN 39-61 COPENHAGEN) |
| PVL02-- VACCV PROTEIN L2 VACCINIA VIRUS (STRAIN WR) 39-61 |
| PVL02-- |
| VARV PROTEIN L2 VARIOLA VIRUS 39-61 PVL03-- VACCC |
| PROTEIN L3 VACCINIA VIRUS (STRAIN 148-164 186-208 292-315 |
| COPENHAGEN) |
| PVL03-- VACCV PROTEIN L3 VACCINIA VIRUS (STRAIN WR) 148-164 |
| 186-208 292-315 |
| PVL03-- VARV PROTEIN L3 VARIOLA VIRUS 148-164 185-207 291-314 |
| PVL05-- VACCV PROTEIN L5 VACCINIA VIRUS (STRAIN WR), 16-39 |
| AND (STRAIN COPPENHAGEN) |
| PVL05-- |
| VARV PROTEIN L5 VARIOLA VIRUS 16-39 PVL1-- |
| CRPVK PROBABLE L1 PROTEIN COTTONTAIL RABBIT (SHOPE) 299-317 |
| PAPILLOMAVIRUS (STRAIN |
| KANSAS) |
| PVL1-- HPV18 PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS 28-55 |
| TYPE 18 |
| PVL1-- HPV41 PROBABLE L1 PROTEIN HUMNA PAPILLOMAVIRUS 38-63 |
| TYPE 41 |
| PVL1-- REOVD MAJOR CORE PORTEIN REOVIRUS (TYPE 3/STRAIN 327-346 |
| 351-366 752-774 |
| LAMBDA 1 DEARING) |
| PVL2-- HPV08 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 254-270 |
| TYPE 8 |
| PVL2-- HPVII PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 32-58 |
| TYPE 11 |
| PVL2-- HPV13 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 33-59 |
| TYPE 13 |
| PVL2-- HPV16 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 34-60 |
| TYPE 16 |
| PVL2-- HPV18 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 33-59 |
| TYPE 18 |
| PVL2-- HPV1A PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 213-228 |
| TYPE 1A |
| PVL2-- HPV2A PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 88-114 |
| TYPE 2A |
| PVL2-- HPV31 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 34-60 |
| 443-462 |
| TYPE 31 |
| PVL2-- HPV33 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS33-59 99-114 |
| TYPE 33 |
| PVL2-- HPV35 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 34-60 |
| TYPE 35 |
| PVL2-- HPV41 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 39-58 |
| 414-436 |
| TYPE 41 |
| PVL2-- HPV42 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 33-59 |
| 344-370 |
| TYPE 42 |
| PVL2-- HPV47 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 250-265 |
| TYPE 47 |
| PVL2-- HPV57 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 32-58 |
| TYPE 57 |
| PVL2-- HPV58 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 33-59 |
| 99-114 |
| TYPE 58 |
| PVL2-- HPV6B PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS 33-59 |
| TYPE 6B |
| PVL2-- PAPVE PROBABLE L2 PROTEIN EUROPEAN ELK PAPILLOMA- 30-56 |
| VIRUS |
| PVL2-- RHPV1 PROBABLE L2 PROTEIN RHESUS PAPILLOMAVIRUS 45-71 |
| TYPE 1 |
| PVL3-- HPV5B PROBABLE L3 PROTEIN HUMAN PAPILLOMAVRIUS 6-28 |
| TYPE 5B |
| PVL3-- REOVD MINOR CORE PORTEIN REOVIRUS (TYPE 3/STRAIN 714-737 |
| LAMBDA 3 DEARING |
| PVL3-- REOVJ MINOR CORE PROTEIN REOVIRUS (TYPE 2/STRAIN 714-737 |
| 1213-1236 |
| LAMBDA 3 D5/JONES) |
| PVL3-- REOVL MINOR CORE PROTEIN REOVIRUS (TYPE 1/STRAIN 714-737 |
| LAMBDA 3 LANG) |
| PVL96-- IRVI L96 PROTEIN TIPULA IRIDESCENT VIRUS 144-170 196-220 |
| 686-711 845-861 |
| (TIV) (INSECT IRIDESCENT |
| VIRUS TYPE 1) |
| PVM01-- VACCC PROTEIN M1 VACCINIA VIRUS (STRAIN 134-159 177-195 |
| 281-302 |
| COPENHAGEN) |
| PVM01-- VACCV PROTEIN M1 VACCINIA VIRUS (STRAIN WR) 83-108 |
| 126-144 23-251 |
| PVM01-- VARV PROTEIN M1 VARIOLA VIRUS 81-106 124-42 228-249 |
| PVM1-- REOVD MINOR VIRION STRUCTURAL REOVIRUS (TYPE 3/STRAIN |
| 141-168 227-245 280-304 324-347 414-436 454-477 |
| PROTEIN MU-2 DEARING) |
| PVM1-- REOVL MINOR VIRION STRUCTURAL REOVIRUS (TYPE 1/STRAIN |
| 141-168 227-245 280-304 414-436 454-477 |
| PROTEIN MU-2 LANG) |
| PVM21-- REOVD MAJOR VIRION STRUCT REOVIRUS (TYPE 3/STRAIN 168-192 |
| PROTEIN MU-1/MU-1C DEARING) |
| PVM22-- REOVD MAJOR VIRION STRUCT REOVIRUS (TYPE 3/STRAIN 168-192 |
| PROTEIN MU-1/MU-1C DEARING) |
| PVM2-- REOVJ MAJOR VIRION STRUCT REOVIRUS (TYPE 2/STRAIN 168-192 |
| PROTEIN MU-1/MU-1C D5/JONES) |
| PVM2-- REOVL MAJOR VIRION STRUCT REOVIRUS (TYPE 1/STRAIN 168-192 |
| PROTEIN MU-1/MU-1C LANG) |
| PVM3-- REOVD MAJOR NONSTRUCTURL REOVIRUS (TYPE 3/STRAIN 304-326 |
| 521-540 |
| PROTEIN MU-NS DEARING) |
| PVMAT-- BRSVA MATRIX PROTEIN BOVINE RESPIRATORY SYNCY- 37-62 |
| TIAL VIRUS (STRAIN A51908) |
| PVMAT-- CDVO MATRIX PROTEIN CANINE DISTEMPER VIRUS 148-165 |
| 283-309 |
| (STRAIN ONDERSTEPOORT) |
| PVMAT-- HRSVA MATRIX PROTEIN HUMAN RESPIRATORY SYNCY- 44-62 |
| 139-160 |
| TIAL VIRUS (STRAIN A2) |
| PVMAT-- |
| LPMV MATRIX PROTEIN LA PIEDAD-MICHOACAN- 311-338 MEXICO |
| VIRUS |
| PVMAT-- MEASE MATRIX PROTEIN MEASLES VIRUS (STRAIN 283-309 |
| EDMONSTON) |
| PVMAT-- MEASH MATRIX PROTEIN MEASLES VIRUS (STRAIN 283-309 |
| HALLE) |
| PVMAT-- MEASI MATRIX PROTEIN MEASLES VIRUS (STRAIN 87-111 |
| IP-3-CA) |
| PVMAT-- MEASU MATRIX PROTEIN MEASLES VIRUS (STRAIN HU2) 283-309 |
| PVMAT-- MUMP1 MATRIX PROTEIN MUMPS VIRUS (STRAIN SBL-1) 191-207 |
| 227-250 310-330 |
| PVMAT-- MUMPS MATRIX PROTEIN MUMPS VIRUS (STRAIN SBL) 191-207 |
| 227-250 310-330 |
| PVMAT-- NDVA MATRIX PROTEIN NEWCASTEL DISEASE VIRUS 135-151 |
| 190-208 309-329 |
| (STRAIN AUSTRALIA- |
| VICTORIA /32) |
| PVMAT-- NDVB MATRIX PROTEIN NEWCASTLE DISEASE VIRUS 135-151 |
| 190-208 309-329 |
| (STRAIN BEAUDETTE C/45) |
| PVMAT-- PIIHC MATRIX PROTEIN HUMAN PARAINFLUENZA 1 195-217 |
| VIRUS (STRAIN C39) |
| PVMAT-- P12HT MATRIX PROTEIN HUMAN PARAINFLUENZA 2 132-154 |
| 189-205 308-328 |
| VIRUS (STRAIN TOSHIBA) (PIV-2) |
| PVMAT-- P14HA MATRIX PROTEIN HUMAN PARAINFLUENZA 4A 312-332 |
| VIRUS (STRAIN TOSHIBA) |
| (PIV-4A) |
| PVMAT-- P14HB MATRIX PROTEIN HUMAN PARAINFLUENZA 4B 312-322 |
| VIRUS (STRAIN 68-333) (PIV-4B) |
| PVMAT-- RINDK MATRIX PROTEIN RINDERPEST VIRUS (STRAIN 200-221 |
| 239-260 283-309 |
| KABETE O) |
| PVMAT-- SENDF MATRIX PROTEIN SENDAI VIRUS (STRAIN 195-217 |
| FUSHIMI) |
| PVMAT-- SENDH MATRIX PROTEIN SENDAI VIRUS (STRAIN 195-217 |
| HARRIS) |
| PVMAT-- SENHZ MATRIX PROTEIN SENDAI VIRUS (STRAIN Z) 195-217 |
| PVMAT-- SSPVB MATRIX PROTEIN SUBACUTE SCLEROSING 283-309 |
| 314-338 |
| PANENCEPHALITIS VIRUS |
| (STRAIN BIKEN) |
| PVMAT-- SV41 MATRIX PROTEIN SIMIAN VIRUS 41 132-154 189-205 |
| 308-328 |
| PVMAT-- SV5 MATRIX PROTEIN SIMIAN VIRUS 5 (STRAIN W3) 98-114 |
| 132-148 308-335 |
| PVMAT-- SVCV MATRIX PROTEIN SPRING VIREMIA OF CARP 141-167 |
| VIRUS (RHABDOVIRUS CARPIA) |
| PVMAT-- TRTV MATRIX PROTEIN TURKEY RHINOTRACHEITIS 122-143 |
| VIRUS |
| PVME1-- CVBM E1 GLYCOPROTEIN BOVINE CORONAVIRUS 9-36 137-161 |
| 171-190 |
| (STRAIN MEBUS) |
| PVME1-- |
| CVH22 E1 GLYCOPROTEIN HUMAN CORONAVIRUS 136-155 (STRAIN |
| 229E) |
| PVME1-- CVHOC E1 GLYCOPROTEIN HUMAN CORONAVIRUS 9-36 64-85 |
| 137-161 |
| (STRAIN OC43) |
| PVME1-- |
| CVMA5 E1 GLYCOPROTEIN MURINE CORONAVIRUS 10-37 MHV |
| (STRAIN A59) |
| PVME1-- |
| CVMJH E1 GLYCOPROTEIN MURINE CORONAVIRUS 10-37 MHV |
| (STRAIN JHM) |
| PVME1-- CVPFS E1 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| 174-193 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVME1-- CVPPU E1 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| 169-193 174-193 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVME1-- CVPRM E1 GLYCOPROTEIN PRECURSOR PORCINE RESPIRATORY CORO- |
| 174-193 |
| NAVIRUS (STRAIN RM4) |
| PVME1-- CVTKE E1 GLYCOPROTEIN TURKEY ENTERIC CORONA- 9-36 137-161 |
| 171-190 |
| VIRUS |
| PVME1-- IBV6 E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS 74-98 |
| VIRUS (STRAIN 6/82) |
| PVME1-- IBVB E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS 74-101 |
| VIRUS (STRAIN BEAUDETTE) |
| PVME1-- IBVB2 E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS 74-101 |
| VIRUS (STRAIN BEAUDETTE |
| M42) |
| PVME1-- IBVK E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS 74-98 |
| VIRUS (STRAIN KB8523) |
| PVMEM-- EBV PROBABLE MEMBRANE EPSTEIN-BARR VIRUS (STRAIN 131-157 |
| 178-203 |
| PROTEIN B95-8) |
| PVMP-- CAMVC MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS 118-134 |
| 147-164 183-201 |
| (STRAIN CM-1841) |
| PVMP-- CAMVD MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS 118-134 |
| 147-164 183-201 |
| (STRAIN D/H) |
| PVMP-- CAMVE MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS 118-134 |
| 147-164 183-201 |
| (STRAIN BBC) |
| PVMP-- CAMVN MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS 118-134 |
| 147-164 183-201 |
| (STRAIN NY8153) |
| PVMP-- CAMVS MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS 118-134 |
| 147-164 183-201 |
| (STRAIN STRASBOURG) |
| PVMP-- CAMVW MOVEMENT PROTEIN CAULIFLOWER MOSAIC VIRUS 118-134 |
| 147-164 183-201 |
| (STRAIN W260) |
| PVMP-- CERV MOVEMENT PROTEIN CARNATION ETCHED RING 293-318 |
| VIRUS |
| PVMP-- FMVD MOVEMENT PROTEIN FIGWORT MOSAIC VIRUS 115-131 180-198 |
| (STRAIN DXS) |
| PVMP-- SOCMV MOVEMENT PROTEIN SOYBEAN CHLOROTIC MOTTLE 122-147 |
| 273-299 |
| VIRUS |
| PVMSA-- HPBDB MAJOR SURFACE ANTIGEN DUCK HEPATITIS B VIRUS 21-228 |
| 269-295 |
| PRECURSOR (BROWN SHANGHAI DUCK |
| ISLATE S5) |
| PVMSA-- HPBDC MAJOR SURFACE ANTIGEN DUCK HEPATITIS B VIRUS |
| 194-221 268-294 |
| PRECURSOR (STRAIN CHINA) |
| PVMSA-- HPBDU MAJOR SURFACE ANTIGEN DUCK HEPATITIS B VIRUS |
| 157-184 231-257 |
| PRECURSOR |
| PVMSA-- HPBDW MAJOR SURFACE ANTIGEN DUCK HEPATITIS B VIRUS |
| 194-221 269-295 |
| PRECURSOR (WHITE SHANGHAI DUCK |
| ISOLATE S31) |
| PVMSA-- HPBGS MAJOR SURFACE ANTIGEN GROUND SQUIRREL HEPATITIS |
| 209-236 271-295 380-395 |
| PRECURSOR VIRUS |
| PVMSA-- HPBHE MAJOR SURFACE ANTIGEN HERON HEPATITIS B VIRUS |
| 236-262 293-320 |
| PRECURSOR |
| PVMSA-- HPBV0 MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS 11-28 70-96 |
| PVMSA-- HPBV2 MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 185-202 244-270 |
| PRECURSOR ADW2) |
| PVMSA-- HPBV4 MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 185-202 244-270 |
| PRECURSOR ADR4) |
| PVMSA-- HPBV9 MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 244-270 |
| PRECURSOR ADW/STRAIN 991) |
| PVMSA-- HPBVA MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (STRAIN |
| 174-191 233-259 |
| PRECURSOR ALPHA1) |
| PVMSA-- HPBVD MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 11-28 70-96 |
| AD) |
| PVMSA-- HPBVI MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 233-259 |
| PRECURSOR ADW/STRAIN INDONESIA/ |
| PIDW420) |
| PVMSA-- HPBVJ MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 174-191 233-259 |
| PRECURSOR ADW/STRAIN JAPAN/PJDW233) |
| PVMSA-- HPBVL MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (STRAIN |
| 174-191 233-259 |
| PRECURSOR LSH/CHIMPANZEE ISOLATE |
| PVMSA-- HPBVN MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 11-28 70-96 |
| PRECURSOR ADR/STRAIN NC-1) |
| PVMSA-- HPBVO MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 174-191 233-259 |
| PRECURSOR ADW/STRAIN OKINAWA/ |
| PODW282) |
| PVMSA-- HPBVP MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 185-202 244-270 |
| PRECURSOR ADW/STRAIN PHILIPPINO/ |
| PFDW294) |
| PVMSA-- HPBVR MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 185-202 244-270 |
| PRECURSOR ADR) |
| PVMSA-- HPBVS MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 11-28 70-96 |
| PRECURSOR AR) |
| PVMSA-- HPBVW MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 174-191 233-259 |
| PRECURSOR ADW) |
| PVMSA-- HPBVY MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 174-191 233-259 |
| PRECURSOR AYW) |
| PVMSA-- HPBVZ MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| 174-191 233-259 |
| PRECURSOR ADYW) |
| PVMSA-- WHVI MAJOR SURFACE ANTIGEN WOODCHUCK HEPATITIS 207-234 |
| 269-293 378-393 |
| PRECURSOR VIRUS 1 |
| PVMSA-- WHV59 MAJOR SURFACE ANTIGEN WOODCHUCK HEPATITIS 212-239 |
| 274-298 383-398 |
| PRECURSOR VIRUS 59 |
| PVMSA-- WHV7 MAJOR SURFACE ANTIGEN WOODCHUCK HEPATITIS 212-239 |
| 274-298 383-398 |
| PRECURSOR VIRUS 7 |
| PVMSA-- WHV8 MAJOR SURFACE ANTIGEN WOODCHUCK HEPATITIS 212-239 |
| 274-298 383-398 |
| PRECURSOR VIRUS 8 |
| PVMSA-- WHV81 PROB MAJOR SURFACE WOODCHUCK HEPATITIS VIRUS |
| 212-239 274-298 383-398 |
| ANTIGEN PREC 8 (INFECTIOUS CLONE) |
| PVMSA-- WHVW6 MAJOR SURFACE ANTIGEN WOODCHUCK HEPATITIS VIRUS |
| 125-149 234-249 |
| PRECURSOR W64 (ISOLATE PWS23) |
| PVMT2-- IAANN MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/ANN ARBOR/6/60) |
| PVMT2-- IABAN MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/BANGKOK/1/79) |
| PVMT2-- IAFOW MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/FORT WARREN/1/50) |
| PVMT2-- IAFPR MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/FOWL PLAGUE VIRUS/ |
| ROSTOCK/34) |
| PVMT2-- IAFPW MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/FOWL PLAGUE VIRUS/ |
| WEYBRIDGE) |
| PVMT2-- IALE1 MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/LENINGRAD/134/57) |
| PVMT2-- IALE2 MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/LENINGRAD/134/17/57) |
| PVMT2-- IAMAN MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/MALLARD/NEW YORK/6750/78) |
| PVMT2-- IAPUE MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/PUERTO RICO/8/34) |
| PVMT2-- IASIN MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/SINGAPORE/1/57) |
| PVMT2-- IAUDO MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/UDORN/307/72) |
| PVMT2-- IAWIL MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN 25-46 |
| A/WILSON-SMITH/33) |
| PVMT9-- |
| MYXVL MT-9 PROTEIN MYXOMA VIRUS (STRAIN 226-241 LAUSANNE) |
| PVN34-- ROTBS NONSTRUCTURAL PROTEIN BOVINE ROTAVIRUS (GROUP |
| 334-351 |
| NS34 C/STRAIN SHINTOKU) |
| PVNBP-- PVSP 10 7 KD PROTEIn POTATO VIRUS S (STRAIN 21-36 |
| PERUVIAN) |
| PVNB-- INBBE NB GLYCOPROTEIN INFLUENZA B VIRUS (STRAIN 13-39 |
| B/BEIJING/1/87) |
| PVNB-- INBHK NB GLYCOPROTEIN INFLUENZA B VIRUS (STRAIN 13-39 |
| B/HONG KONG/8/73) |
| PVNB-- INBLE NB GLYCOPROTEIN INFLUENZA B VIRUS (STRAIN 13-39 |
| B/LEE/40) |
| PVNB-- INBLN NB GLYCOPROTEIN INFLUENZA B VIRUS (STRAIN 13-39 |
| B/LENINGRAD/179/86) |
| PVNB-- INBMD NB GLYCOPROTEIN INFLUENZA B VIRUS (STRAIN 13-39 |
| B/MARYLAND/59) |
| PVNB-- INBMF NB GLYCOPROTEIN INFLUENZA B VIRUS (STRAIN 13-39 |
| B/MEMPHIS/3/89) |
| PVNB-- INBOR NB GLYCOPROTEIN INFLUENZA B VIRUS (STRAIN 13-39 |
| B/OREGON/5/80 |
| PVNCS-- ADVG NONCAPSID PROTEIN NS-1 ALEUTIAN MINK DISEASE 81-96 |
| 169-190 |
| PARVOVIRUS (STRAIN G) |
| PVNCS-- AEDEV NONCAPSID PROTEIN NS-1 AEDES DENSONUCLEOSIS 675-690 |
| VIRUS (STRAIN GKV 002 002) |
| (AEDES DENS |
| PVNCS-- PAVHB NONCAPSID PROTEIN NS-1 HUMAN PARVOVIRUS B19 575-597 |
| PVNCS-- PAVHH NONCAPSID PROTEIN NS-1 HAMSTER PARVOVIRUS H1 |
| 140-165 |
| PVNS1-- AHSV4 NONSTRUCTURAL PROTEIN NS1 AFRICAN HORSE SICKNESS |
| 256-272 |
| VIRUS (SEROTYPE 4/STRAIN |
| VACCINE) |
| PVNS1-- IAALA NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/ALASKA/6/77) |
| PVNS1-- IAANN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/ANN ARBOR/6/60) |
| PVNS1-- IACAO NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 19-38 |
| A/CAMEL/MONGOLIA/82) |
| PVNS1-- IACHI NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/CHILE/1/83) |
| PVNS1-- IACKG NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/CHICKEN/GERMANY/N/49) |
| PVNS1-- IACKJ NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 28-47 164-189 |
| A/CHICKEN/JAPAN/24) |
| PVNS1-- IADA2 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/DUCK/ALBERTA/60/76) |
| PVNS1-- IADE1 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 27-47 164-189 |
| A/DUCK/ENGLAND/1/56) |
| PVNS1-- IADU3 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 28-47 164-189 |
| A/DUCK/UKRAINE/1/63) |
| PVNS1-- IAFOM NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/FORT MONMOUTH/1/47) |
| PVNS1-- IAFOW NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/FORT WARREN/1/50), AND |
| (STRAIN A/ |
| PVNS1-- IAFPR NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/FOWL PLAGUE VIRUS/ |
| ROSTOCK/34) |
| PVNS1-- IALE1 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/LENINGRAD/134/57) |
| PVNS1-- IALEN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/LENINGRAD/54/1) |
| PVNS1-- IAMA6 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/MALLARD/ALBERTA/88/76) |
| PVNS1-- IAMAN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/MALLARD/NEW YORK/ |
| 6750/78) |
| PVNS1-- IAMAO NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/MALLARD/NEW YORK/674/78) |
| PVNS1-- IAMYN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 28-47 164-189 |
| A/MYNAH/HANEDA-THAI/76) |
| PVNS1-- IAP10 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 167-192 |
| A/PINTAINL/ALBERTA/119/79) |
| PVNS1-- IAP11 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/PINTAIL/ALBERTA/121/79) |
| PVNS1-- IAP12 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/PINTAIL/ALBERTA/268/78) |
| PVNS1-- IAP13 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/PINTAIL/ALBERTA/358/79) |
| PVNS1-- IAPUE NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/PUERTO RICO/8/34) |
| PVNS1-- IATKB NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/TURKEY/BETHLEHEM- |
| GLILIT/1492-B/ |
| PVNS1-- IATKC NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/TURKEY/CANADA/63 |
| PVNS1-- IATKR NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 |
| A/TURKEY/OREGON/71) |
| PVNS1-- IATRS NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 28-47 164-189 |
| A/TERN/SOUTH AFRICA/61) |
| PVNS1-- IATRT NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/TERN/TURKMENIA/18/72) |
| PVNS1-- IAUDO NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/UDORN/307/772) |
| PVNS1-- IAUSS NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 114-137 167-192 |
| A/USSR/90/77) |
| PVNS1-- IZAII NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| 31-50 167-192 |
| A/SWINE/IOWA/15/30) |
| PVNS1-- INCAA NONSTRUCTURAL PROTEIN NS1 INFLUENZA C VIRUS (STRAIN |
| 222-248 |
| C/ANN ARBOR/1/50) |
| PVNS1-- INCCA NONSTRUCTURAL PROTEIN NS1 INFLUENZA C VIRUS (STRAIN |
| 222-248 |
| C/CALIFORNIA/78) |
| PVNS2-- BTV10 NONSTRUCTURAL PROTEIN NS2 BLUETONGUE VIRUS (SERO- |
| 145-161 201-223 |
| TYPE 10/ISOLATE USA) |
| PVNS2-- BTV17 NONSTRUCTURAL PROTEIN NS2 BLUETONGUE VIRUS (SERO- |
| 145-161 201-223 |
| TYPE 17/ISOLATE USA) |
| PVNS2-- BTV1S NONSTRUCTURAL PROTEIN NS2 BLUETONGUE VIRUS (SERO- |
| 145-161 |
| TYPE 1/ISOLATE SOUTH AFRICA) |
| PVNS2-- BTV1X NONSTRUCTURAL PROTEIN NS2 BLUETONGUE VIRUS (SERO- |
| 145-161 |
| TYPE 10) |
| PVNS2-- EHDV2 NONSTRUCTURAL PROTEIN NS2 EPIZOOTIC HEMORRHAGIC |
| 145-161 |
| DISEASE VIRUS (SEROTYPE |
| 2/STRAIN AL |
| PVNS2-- IAPUE NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| 3-28 |
| A/PUERTO RICO/8/34) |
| PVNS2-- IATRS NONSTRUCTURAL PROTEIN NS2 INFLUENZA A VIRUS (STRAIN |
| 56-80 |
| A/TERN/SOUTH AFRICA/61) |
| PVNS2-- PVM NONSTRUCTURAL PROTEIN 2 PNEUMONIA VIRUS OF MICE 52-68 |
| PVNS3-- CVPFS NONSTRUCTURAL PROTEIN 3-1 PORCINE TRANSMISSIBLE |
| 177-201 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVNS3-- CVPPU NONSTRUCTURAL PROTEIN 3-1 PORCINE TRANSMISSIBLE |
| 98-22 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVNS3-- CVPRM NONSTRUCTURAL PROTEIN 3-1 PORCINE TRANSMISSIBLE |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVNS3-- RSV NONSTRUCTURAL PROTEIN NS3 RICE STRIPE VIRUS 16-40 |
| PVNS4-- CVH22 NONSTRUCTURAL PROTEIN 4 HUMAN CORONAVIRUS 84-100 |
| (STRAIN 229E) |
| PVNS4-- CVMS NONSTRUCTURAL PROTEIN 4 MURINE CORONAVIRUS MHV) |
| 17-38 |
| STRAIN S) |
| PVNS4-- CVPFS NONSTRUCTURAL PROTEIN 4 PORCINE TRANSMISSIBLE 4--31 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVNS4-- CVPPU NONSTRUCTURAL PROTEIN 4 PORCINE TRANSMISSIBLE 4--31 |
| GASTROENTERITIS CORONA- |
| VIRUS (STRAI |
| PVNS4-- CVPRM NONSTRUCTURAL PROTEIN 4 PORCINE RESPIRATORY CORO- |
| 4-31 |
| NAVIRUS (STRAIN RM4) |
| PVNS4-- MSTV NONSTRUCTURAL PROTEIN NS4 MAIZE STRIPE VIRUS 41-56 |
| PVNS4-- RSV NONSTRUCTURAL PROTEIN NS4 RICE STRIPE VIRUS 41-56 |
| 60-82 152-167 |
| PVNS7-- CVFE3 NONSTRUCTURAL PROTEIN 7 FELINE ENTERIC CORONAVIRUS |
| 59-84 |
| (STRAIN 79-1643) |
| PVNS7-- FIBV NONSTRUCTURAL PROTEIN 7 FELINE INFECTIOUS PERITON- |
| 59-84 |
| ITIS VIRUS (STRAIN 79-1146) |
| PVNSC-- P11HB NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 76-92 |
| VIRUS (STRAIN C35) |
| PVNSC-- P11HC NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 76-92 |
| VIRUS (STRAIN C39) |
| PVNSC-- P11HD NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 76-92 |
| 179-197 |
| VIRUS (STRAIN CI-5/73) |
| PVNSC-- H11HE NONSTRUCTURAL PROTEIN C HUMAN PARAINFLUENZA 1 76-92 |
| VIRUS (STRAIN CI-14/83) |
| PVNST-- CVBQ 32 KD NONSTRUCTURAL BOVINE CORONAVIRUS 88-109 |
| PROTEIN (STRAIN QUEBEC) |
| PVNST-- INCGL NONSTRUCTURAL PROTEINS INFLUENZA C VIRUS (STRAIN |
| 222-248 |
| NS1-NS2 C/GREAT LAKES/1167/54) |
| PVNST-- INCJH NONSTRUCTURAL PROTEINS INFLUENZA C VIRUS (STRAIN |
| 222-248 |
| NS1-NS2 C/JOHANNESBURG/1/66) |
| PVNST-- INCMI NONSTRUCTURAL PROTEINS INFLUENZA C VIRUS (STRAIN |
| 222-248 |
| NS1-NS2 C/MISSISSIPPI/80) |
| PVNST-- INCYA NONSTRUCTURAL PROTEINS INFLUENZA C VIRUS (STRAIN |
| 222-248 |
| NS1-NS2 C/YAMAGATA/10/81) |
| PVNST-- PTPV NONSTRUCTURAL PROTEIN PUNTA TORO PHLEBOVIRUS 48-63 |
| NS-S |
| PVNST-- SFSV NONSTRUCTURAL PROTEIN SANDFLY FEVER SICILIAN 16-34 |
| NS-S VIRUS |
| PVNST-- UUK NONSTRUCTURAL PROTEIN UUKUNIEMI VIRUS 52-73 89-104 |
| NS-S |
| PVNUA-- PRVKA PROBABLE NUCLEAR ANTIGEN PSEUDORABIES VIRUS (STRAIN |
| 756-777 1563-1583 |
| KAPLAN) |
| PVNUC-- DHVII NUCLEOPROTEIN DHORI VIRUS (STRAIN INDIAN/ 123-139 |
| 297-324 |
| 1313/61) |
| PVNUC-- |
| EBOV NUCLEOPROTEIN EBOLA VIRUS 159-176 PVNUC-- |
| IAANA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 266-287 |
| A/ANAS ACUTA/PRIMORJE/ |
| 695/76) |
| PVNUC-- IAANN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/ANN ARBOR/6/60) |
| PVNUC-- IABRA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/BRAZIL/11/78) |
| PVNUC-- IABUD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/BUDGERIGAR/HOKKAIDO/1/77) |
| PVNUC-- IACAL NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/CALIFORNIA/10/78) |
| PVNUC-- IACKG NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/CHICKEN/GERMANY/N/49) |
| PVNUC-- IACKP NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/CHICKEN/PENNSYLVANIA/ |
| 1/83) |
| PVNUC-- IADAU NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/AUSTRALIA/749/80) |
| PVNUC-- IADBE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/BEIJING/1/78) |
| PVNUC-- IADCZ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/CZECHOSLOVAKIA/56) |
| PVNUC-- IADE1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/ENGLAND/1/56) |
| PVNUC-- IADE2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/ENGLNAD/1/62) |
| PVNUC-- IADHK NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/HONG KONG/7/75) |
| PVNUC-- IADM2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/MEMPHIS/928/74) |
| PVNUC-- IADMA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/MANITOBA/1/53) |
| PVNUC-- IADNZ NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/NEW ZEALAND/31/76) |
| PVNUC-- IADU2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/DUCK/UKRAINE/2/60) |
| PVNUC-- IAEN5 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/ENGLNAD/19/55) |
| PVNUC-- IAFOM NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/FORT MONMOUTH/1/47) |
| PVNUC-- IAFOW NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/FORT WARREN/1/50) |
| PVNUC-- IAFPD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/FOWL PLAGUE VIRUS/ |
| DOBSON/DUTC |
| PVNUC-- IAFPR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/FOWL PLAGUE VIRUS/ |
| ROSTROCK/34) |
| PVNUC-- IAGRE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/GREY TEAL/AUSTRALIA/2/79) |
| PVNUC-- IAGU1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/GULL/MARYLAND/5/77) |
| PVNUC-- IAGU2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/GULL/MARYLAND/704/77) |
| PVNUC-- IAGU3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/GULL/MARYLAND/1824/78) |
| PVNUC-- IAGU4 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/GULL/MARYLAND/1815/79) |
| PVNUC-- IAGUA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/GULL/ASTRAKHAN/227/84) |
| PVNUC-- IAGUM NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/GULL/MASSSACHUSETTS/ |
| 26/80) |
| PVNUC-- IAGUN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/GULL/MINNESOTA/945/80) |
| PVNUC-- IAHIC NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/HICKOX/40) |
| PVNUC-- IAHJI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/EQUINE/JILLIN/1/89) |
| PVNUC-- IAHLO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/EQUINE/LONDON/1416/73) |
| PVNUC-- IAHMI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/EQUINE/MIAMI/1/63) |
| PVNUC-- IAH01 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/HONG KONG/1/68) |
| PVNUC-- IAH02 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/HONG KONG/5/83) |
| PVNUC-- IAHPR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/EQUINE/PRAGUE/1/56) |
| PVNUC-- IAHTE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/EQUINE/TENNESSEE/5/86) |
| PVNUC-- IAKIE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/KIEV/59/79) |
| PVNUC-- IALEN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/LENINGRAD/54/1) |
| PVNUC-- IAMAA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/MALLARD/ASTRAKHAN/ |
| 244/82) |
| PVNUC-- IAMAN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/MALLARD/NEW YORK/ |
| 6750/78) |
| PVNUC-- IAMIN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/MINK/SWEDEN/84) |
| PVNUC-- IANT6 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/NT/60/68) |
| PVNUC-- IAOHI NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/OHIO/4/83) |
| PVNUC-- IAPAR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/PARROT/ULSTER/73) |
| PVNUC-- IAPUE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/PUERTO RICO/8/34) |
| PVNUC-- IARUD NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/RUDDY TRUNSTONE/NEW |
| JERSEY/47/ |
| PVNUC-- IASE0 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SEAL/MASSACHUSETTS/1/80) |
| PVNUC-- IASH2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SHEARWATER/AUSTRALIA/72 |
| PVNUC-- IASIN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SINGAPORE/1/57) |
| PVNUC-- IATE1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/TEAL/ICELAND/29/80) |
| PVNUC-- IATKN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/TURKEY/MINNESOTRA/ |
| 1661/81) |
| PVNUC-- IATKO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/TURKEY/ONTARIO/7732/66) |
| PVNUC-- IATRS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/TERN/SOUTH AFRICA/61) |
| PVNUC-- IATRT NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/TERN/TURKMENIA/18/72) |
| PVNUC-- IATX7 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/TEXAS/1/77) |
| PVNUC-- IAUDO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/UDORN/307/72) |
| PVNUC-- IAUSS NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/USSR/90/77) |
| PVNUC-- IAV16 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/VICTORIA/5/68) |
| PVNUC-- IAWHN NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/WHALE/MAIN/328/84) |
| PVNUC-- IAWHP NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/WHALE/PACIFIC OCEAN/19/76) |
| PVNUC-- IAWIL NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/WILSON-SMITH/33) |
| PVNUC-- IAZ29 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/29/37) |
| PVNUC-- IAZ41 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/41/49) |
| PVNUC-- IAZCA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/CAMBRIDGE/1/35) |
| PVNUC-- IAZDA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/DANDONG/9/83) |
| PVNUC-- IAZGE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/GERMANY/2/81) |
| PVNUC-- IZAH1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/HONG KONG/6/76) |
| PVNUC-- IAZH3 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/HONG KONG/126/82) |
| PVNUC-- IAZ11 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/IOWA/15/30) |
| PVNUC-- IAZ12 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/IOWA/1967/31) |
| PVNUC-- IAZ13 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/IOWA/46) |
| PVNUC-- IAZ14 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/ITALY/839/89) |
| PVNUC-- IAZJA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/JAMESBURG/42) |
| PVNUC-- IAZMA NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/MAY/54) |
| PVNUC-- IAZNE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/NETHERLANDS/12/85) |
| PVNUC-- IAZOH NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/OHIO/23/35) |
| PVNUC-- IAZW1 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/WISCONSIN/1/57) |
| PVNUC-- IAZW2 NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN 173-197 |
| A/SWINE/WISCONSIN/1/61) |
| PVNUC-- INBAC NUCLEOPROTEIN INFLUENZA B VIRUS (STRAIN 234-258 |
| B/ANN ARBOR/1/66[COLD- |
| ADAPTED]) |
| PVNUC-- INBAD NUCLEOPROTEIN INFLUENZA B VIRUS (STRAIN 234-258 |
| B/ANN ARBOR/1/66[WILD-TYPE]) |
| PVNUC-- INBLE NUCLEOPROTEIN INFLUENZA B VIRUS (STRAIN 234-258 |
| B/LEE/40) |
| PVNUC-- INBSI NUCLEOPROTEIN INFLUENZA B VIRUS (STRAIN 234-258 |
| B/SINGAPORE/222/79) |
| PVNUC-- MABVM NUCLEOPROTEIN MARBURG VIRUS (STRAIN 16-39 141-158 |
| MUSOKE) |
| PVNUC-- MABVP NUCLEOPROTEIN MARBURG VIRUS (STRAIN 16-39 141-158 |
| POPP) |
| PVO01-- VACCC PROTEIN O1 VACCINA VIRUS (STRAIN 189-204 242-262 |
| 336-358 |
| COPENHAGEN) |
| PVO01-- VARV PROTEIN O1 VARIOLA VIRUS 189-204 242-262 336-358 |
| PVOR1-- FXMV 152 KD PROTEIN FOXTAIL MOSAIC VIRUS 846-865 |
| PVOR1-- NMV 186 KD PROTEIN NARCISSUS MOSAIC VIRUS 409-424 |
| 990-1010 |
| PVOR1-- PVMR 223 KD PROTEIN POTATO VIRUS M (STRAIN 87-104 |
| 986-1009 1251-1270 1893-1909 |
| RUSSIAN) |
| PVOR1-- PVSP 223 KD PROTEIN POTATO VIRUS S (STRAIN 279-295 |
| PERUVIAN) |
| PVOR1-- PVX 165 KD PROTEIN POTATO VIRUS X 128-153 234-256 306-322 |
| 1010-1030 |
| PVOR1-- PVXCP 165 KD PROTEIN POTATO VIRUS X (STRAIN CP) 128-153 |
| 234-256 306-322 385-404 1010-1030 |
| PVOR1-- PVXX3 165 KD PROTEIN POTATO VIRUS X (STRAIN X3) 128-153 |
| 234-256 306-322 1010-1030 |
| PVOR1-- SMYEA 150 KD PROTEIN OS STRAWBERRY MILD 121-146 155-175 |
| YELLOW EDGE-ASSOCIATED |
| VIRUS |
| PVOR1-- WCMVM 147 KD PROTEIN WHITE CLOVER MOSAIC VIRUS 121-146 |
| (STRAIN M) |
| PVOR1-- WCMVO 147 KD PROTEIN WHITE CLOVER MOSAIC VIRUS 121-146 |
| 408-430 |
| (STRAIN O) |
| PVP03-- HSVSA PROBABLE MEMBRANE ANTIGEN 3 HERPESVIRUS SAIMIRI |
| 424-446 462-486 551-575 579-595 1051-1072 |
| (STRAIN 11) |
| PVP10-- NPVAC P10 PROTEIN AUTOGRAPHA CALIFORNICA 4-26 42-59 |
| NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP10-- |
| NPVOP P10 PROTEIN ORGYIA PSEUDOTSUGATA 4-31 MULTICAPSID |
| POLYHEDROSIS |
| VIRUS |
| PVP10-- NPVSE P10 PROTEIN SPODOPTERA EXIGUA NUCLEAR 35-58 |
| POLYHEDROSIS VIRUS |
| (STRAIN US) |
| PVP10-- RBSDV PROTEIN S10 RICE BLACK STREAKED DWARF 31-49 52-77 |
| 105-129 195-214 260-283 504-528 |
| VIRUS |
| PVP10-- WTV NONSTRUCTURAL PROTEIN WOUND TUMOR VIRUS (WTV) 90-107 |
| 265-291 |
| PNS10 |
| PVP14-- EBV PROBABLE MEMBRANE EPSTEIN-BARR VIRUS (STRAIN 694-715 |
| 857-879 1124-1145 |
| ANTIGEN P140 B95-8) |
| PVP19-- EBV PROB CAPSID ASSEMBLY AND EPSTEIN-BARR VIRUS (STRAIN |
| 346-364 |
| DNA MATUR PROTEI B95-8) |
| PVP19-- HCMVA PROB CAPSID ASSEMBLY AND HUMAN CYTOMEGALOVIRUS |
| 77-101 122-149 200-216 |
| DNA MATUR PROTEI (STRAIN AD169) |
| PVP19-- HSVSA PROB CAPSID ASSEMBLY AND HERPESVIRUS SAIMIRI |
| 238-265 |
| DNA MATUR PROTEI (STRAIN 11) |
| PVP19-- VZVD CAPSID ASSEMBLY AND VARICELLA-ZOSTER VIRUS 5-31 |
| DNA MATUR PROTEIN (STRAIN DUMAS) |
| PVP1-- SSVI STRUCTURAL PROTEIN VP1 SULFOLOBUS VIRUS-LIKE 8-35 |
| PRECURSOR PARTICLE SSV1 |
| PVP21-- AMCV CORE PROTEIN P21 ARTICHOKE MOTTLED CRINKLE 37-63 |
| VIRUS |
| PVP21-- CNV CORE PROTEIN P21 CUCUMBER NECROSIS VIRUS 40-65 |
| PVP21-- CRV CORE PROTEIN P21 CYMBIDIUM RINGSPOT VIRUS 40-63 |
| PVP21-- TBSVC CORE PROTEIN P21 TOMATO BUSHY STUNT VIRUS 40-63 |
| (STRAIN CHERRY) |
| PVP23-- HCMVA PROBABLE CAPSID PROTEIN HUMAN CYTOMEGALOVIRUS |
| 141-165 187-202 261-282 |
| VP23 (STRAIN AD169) |
| PVP23-- HSVII CAPSID PROTEIN VP23 HERPES SIMPLEX VIRUS (TYPE |
| 197-220 |
| 1/STRAIN 17) |
| PVP23-- HSV6U PROBABLE CAPSID PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 206-232 |
| VP23 6/STRAIN UGANDA-1102) |
| PVP23-- VZVD PROBABLE CPASID PROTEIN VARICELLA-ZOSTER VIRUS |
| 117-132 |
| VP23 (STRAIN DUMAS) |
| PV26-- AHSV4 P26 PROTEIN AUTOGRAPHA CALIFORNICA 12-31 58-76 |
| 117-141 |
| NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP2-- BTV10 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SERO- |
| 361-381 399-424 564-586 829-849 |
| TYPE 10/ISOLATE USA) |
| PVP2-- BTV11 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SERO- |
| 361-381 399-424 829-849 |
| TYPE 11/ISOLATE USA) |
| PVP2-- BTV13 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SERO- |
| 362-382 420-438 617-632 657-676 |
| TYPE 13/ISOLATE USA) |
| PVP2-- BTV17 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SERO- |
| 361-381 |
| TYPE 17/ISOLATE USA) |
| PVP2-- BTVIA OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SERO- |
| 420-438 654-681 |
| TYPE 1/ISOLATE AUSTRALIA) |
| PVP2-- BTVIS OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SERO- |
| 14-31 117-140 420-438 654-681 |
| TYPE 1/ISOLATE SOUTH AFRICA) |
| PVP2-- EHDV1 OUTER CAPSID PROTEIN VP2 EPIZZOTIC HEMORRHAGIC |
| 153-168 229-252 |
| DISEASE VIRUS (SEROTYPE 1) |
| PVP2-- ROTBR RNA-BINDING PROTEIN VP2 BOVINE ROTAVIRUS (STRAIN |
| 301-317 334-360 522-543 673-699 764-789 |
| RF) |
| PVP2-- ROTBU RNA-BINDING PROTEIN VP2 BOVINE ROTAVIRUS (STRAIN |
| 301-317 334-360 523-544 765-790 |
| UK) |
| PVP2-- ROTHW RNA-BINDING PROTEIN VP2 HUMAN ROTAVIRUS (SEROTYPE |
| 309-325 342-363 532-553 674-700 774-799 |
| 1/STRAIN WA) |
| PVP2-- ROTPC RNA-BINDING PROTEIN VP2 PROCINE ROTAVIRUS (GROUP |
| 51-75 303-391 408-425 514-535 665-691 |
| C/STRAIN COWDEN) |
| PVP2-- ROTS1 RNA-BINDING PROTEIN VP2 SIMIAN 11 ROTAVIRUS 34-57 |
| 219-240 302-318 335-361 523-544 674-700 765-790 |
| (STRAIN SA11) |
| PVP30-- MABVP MINOR NUCLEOPROTEIN VP30 MARBURG VIRUS (STRAIN |
| 50-75 |
| MUSOKE) |
| PVP32-- ASFB7 PHOSPHOPROTEIN P32 AFRICAN SWINE FEVER VIRUS |
| 174-197 |
| (STRAIN BA71V) |
| PVP35-- |
| EBOV POLYMERASE COMPLEX EBOLA VIRUS 233-256 PROTEIN |
| VP35 |
| PVP35-- MABVM POLYMERASE COMPLEX MARBURG VIRUS (STRAIN 49-75 |
| 78-104 |
| PROTEIN VP35 MUSOKE) |
| PVP35-- MABVP POLYMERASE COMPLEX MARBURG VIRUS (STRAIN 49-75 |
| 78-104 |
| PROTEIN VP35 POPP) |
| PVP35-- VACCC IMMUNODOMINANT ENVELOPE VACCINIA VIRUS (STRAIN |
| 278-304 |
| PROTEIN P35 COPENHAGEN) |
| PVP35-- VACCV IMMUNODOMINANT ENVELOPE VACCINIA VIRUS (STRAIN WR) |
| 278-304 |
| PROTEIN P35 |
| PVP35-- VARV IMMUNODOMINANT ENVELOPE VARIOLA VIRUS 279-305 |
| PROTEIN P35 |
| PVP38-- HSVMG 38 KD PHOSPHOPROTEIN MAREK'S DISEASE HERPES- |
| 255-270 |
| VIRUS (STRAIN GA) |
| PVP38-- HSVMN 38 KD PHOSPHOPROTEIN MAREK'S DISEASE HERPES- |
| 225-270 |
| VIRUS (STRAIN MD11/75C/R2) |
| PVP39-- NPVAC MAJOR CAPSID PROTEIN AUTOGRAPHA CALIFORNICA 296-311 |
| NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP39-- NPVOP MAJOR CAPSID PROTEIN ORGYIA PSEUDOTSUGATA 107-134 |
| 214-240 295-316 |
| MULTICAPSID POLYHEDROSIS |
| VIRUS |
| PVP3-- AHSV4 VP3 CORE PROTEIN AFRICAN HORSE SICKNESS 65-85 |
| 126-147 215-230 845-862 |
| VIRUS (SEROTYPE 4/STRAIN |
| VACCINE) |
| PVP3-- BTV10 VP3 CORE PROTEIN BLUETONGUE VIRUS (SERO- 123-144 |
| 212-227 |
| TYPE 10/ISOLATE USA) |
| PVP3-- BTV17 VP3 CORE PROTEIN BLUETONGUE VIRUS (SERO- 123-144 |
| 212-227 |
| TYPE 17/ISOLATE USA) |
| PVP3-- BTVIA VP3 CORE PROTEIN BLUETONGUE VIRUS (SERO- 123-144 |
| 212-227 |
| TYPE 1/ISOLATE AUSTRALIA) |
| PVP3-- EHDVI VP3 CORE PROTEIN EPIZOOTIC HEMORRHAGIC 121-142 |
| 671-695 |
| DISEASE VIRUS (SEROTYPE 1) |
| PVP3-- EHDVA VP3 CORE PROTEIN EPIZOOTIC HEMORRHAGIC 121-142 |
| 675-695 |
| DISEASE VIRUS (SEROTYPE |
| 2/STRAIN AUS |
| PVP3-- RDV MAJOR 114 KD STRUCTURAL RICE DWARF VIRUS (RDV) 89-108 |
| 340-360 367-393 690-717 742-768 748-768 960-975 |
| PROTEIN |
| PVP3-- ROTPC INNER CORE PROTEIN VP3 PORCINE ROTAVIRUS (GROUP |
| 405-429 |
| C/STRAIN COWDEN) |
| PVP3-- ROTSI INNER CORE PROTEIN VP3 SIMIAN 11 ROTAVIRUS (STRAIN |
| 401-425 426-444 512-536 796-822 |
| SA11) |
| PVP40-- EBV CAPSID PROTEIN P40 EPSTEIN-BARR VIRUS (STRAIN 429-454 |
| B95-8) |
| PVP40-- HSVII CAPSID PROTEIN P40 HERPES SIMPLEX VIRUS (TYPE |
| 141-168 472-492 |
| 1/STRAIN 17) |
| PVP40-- HSVEB CAPSID PROTEIN P40 EQUINE HERPESVIRUS TYPE 1 50-67 |
| 95-119 483-504 |
| (STRAIN AB4P) |
| PVP40-- HSVSA CAPSID PROTEIN P40 HERPESVIRUS SAIMIRI 342-368 |
| (STRAIN 11) |
| PVP40-- ILTVT CAPSID PROTEIN P40 INFECTIOUS LARYNGOTRA- 506-528 |
| CHEITCIS VIRUS (STRAIN |
| THORNE V882) |
| PVP40-- MABVM MATRIX PROTEIN VP40 MARBURG VIRUS (STRAIN 95-110 |
| MUSOKE) |
| PVP40-- MABVP MATRIX PROTEIN VP40 MARBURG VIRUS (STRAIN 95-110 |
| POPP) |
| PVP40-- NPVBM STRUCTURAL GLYCOPROTEIN BOMBYX MORI NUCLEAR 223-242 |
| 256-272 |
| P40 POLYHEDROSIS VIRUS |
| PVP40-- VZVD CAPSID PROTEIN VP24 VARICELLA-ZOSTER VIRUS 47-64 |
| (STRAIN DUMAS) |
| PVP41-- NPVAC STRUCTURAL GLYCOPROTEIN AUTOGRAPHA CALIFORNICA |
| 229-248 262-278 |
| GP41 NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP41-- ROTS1 OUTER CAPSID PROTEIN VP4 SIMIAN 11 ROTAVIRUS |
| (STRAIN 483-508 |
| SA11) |
| PVP42-- ROTS1 OUTER CAPSID PROTEIN VP4 SIMIAN 11 ROTAVIRUS |
| (STRAIN 395-411 483-508 |
| SA11) |
| PVP47-- NPVAC VIRAL TRANSCRPTION AUTOGRAPHA CALIFORNICA 14-38 |
| REGULATOR P47 NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP48-- |
| NPVOP P48 PROTEIN ORGYIA PSEUDOTSUGATA 136-157 MULTICAPSID |
| POLYHEDROSIS |
| VIRUS |
| PVP4A-- VARV MAJOR CORE PROTEIN P4A VARIOLA VIRUS 273-288 |
| PRECURSOR |
| PVP4B-- VACCC MAJOR CORE PROTEIN P4B VACCINIA VIRUS (STRAIN |
| 331-358 |
| PRECURSOR COPENHAGEN) |
| PVP4B-- VACCV MAJOR CORE PROTEIN P4B VACCINIA VIRUS (STRAIN WR) |
| 331-358 |
| PRECURSOR |
| PVP4B-- VARV MAJOR CORE PROTEIN P4B VARIOLA VIRUS 331-358 |
| PRECURSOR |
| PVP4-- BTV10 VP4 CORE PROTEIN BLUETONGUE VIRUS (SERO- 174-193 |
| 233-249 545-561 |
| TYPE 10/ISOLATE USA) |
| PVP4-- BTV11 VP4 CORE PROTEIN BLUETONGUE VIRUS (SERO- 174-193 |
| 233-249 535-551 |
| TYPE 11/ISOLATE USA) |
| PVP4-- BTV13 VP4 CORE PROTEIN BLUETONGUE VIRUS (SERO- 174-193 |
| 233-249 535-551 |
| TYPE 13/ISOLATE USA) |
| PVP4-- BTV2A VP4 CORE PROTEIN BLUETONGUE VIRUS (SERO- 174-193 |
| 233-249 535-551 |
| TYPE 2/ISOLATE USA) |
| PVP4-- NCDV OUTER CAPSID PROTEIN VP4 NEBRASKA CALF DIARRHEA |
| 483-508 |
| VIRUS (STRAIN NCDV-LINCOLN) |
| PVP4-- RDV NONSTRUCTURAL PROTEIN RICE DWARF VIRUS 386-407 493-514 |
| 626-645 |
| PNS4 |
| PVP4-- ROTB4 OUTER CAPSID PROTEIN VP4 BOVINE ROTAVIRUS (SERO- |
| 483-508 |
| TYPE 6/STRAIN B641) |
| PVP4-- ROTBC OUTER CAPSID PROTEIN VP4 BOVINE ROTAVIRUS (STRAIN |
| 483-508 |
| C486) |
| PVP4-- ROTBU OUTER CAPSID PROTEIN VP4 BOVINE ROTAVIRUS (STRAIN |
| 483-508 |
| UK) |
| PVP4-- ROTEH OUTER CAPSID PROTEIN VP4 EQUINE ROTAVIRUS (STRAIN |
| 226-250 483-508 |
| H-2) |
| PVP4-- ROTH1 OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 181-207 234-249 482-507 |
| 1/STRAIN 1076) |
| PVP4-- ROTH5 OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 181-207 234-249 482-507 |
| 2/STRAIN RV-5) |
| PVP4-- ROTH6 OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 483-508 |
| 1/STRAIN 69M) |
| PVP4-- ROTHD OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 181-207 234-249 482-507 |
| 2/STRAIN DSI) |
| PVP4-- ROTHJ OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (STRAIN |
| 483-508 524-548 |
| K8) |
| PVP4-- ROTHK OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (STRAIN |
| 76-91 181-207 234-249 482-507 |
| KU) |
| PVP4-- ROTHL OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (STRAIN |
| 181-27 234-249 482-507 |
| L26) |
| PVP4-- ROTHM OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 181-207 234-249 482-507 |
| 1/STRAIN M37) |
| PVP4-- ROTHN OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 181-208 235-250 483-508 |
| 3/STRAIN MCN13) |
| PVP4-- ROTHP OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 181-207 234-249 482-507 |
| 3/STRAIN P) |
| PVP4-- ROTHT OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 181-207 234-249 482-507 |
| 4/STRAIN ST THOMAS 3) |
| PVP4-- ROTHV OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 181-207 482-507 |
| 4/STRAIN VA70) |
| PVP4-- ROTHW OUTER CAPSID PROTEIN VP4 HUMAN ROTAVIRUS (SEROTYPE |
| 181-207 482-507 |
| 1/STRAIN WA) |
| PVP4-- ROTP5 OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (SERO- |
| 235-250 483-508 |
| TYPE 5/STRAIN OSU) |
| PVP4-- ROTPC OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (GROUP |
| 487-512 |
| C/STRAIN COWDEN) |
| PVP4-- ROTPG OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (STRAIN |
| 234-249 482-507 |
| GOTTFIRED) |
| PVP4-- ROTPY OUTER CAPSID PROTEIN VP4 PORCINE ROTAVIRUS (STRAIN |
| 235-250 483-508 |
| YM) |
| PVP4-- ROTRH OUTER CAPSID PROTEIN VP4 RHESUS ROTAVIRUS 483-508 |
| PVP4-- ROTSF OUTER CAPSID PROTEIN VP4 SIMIAN 11 ROTAVIRUS |
| (STRAIN483-508 |
| SA11-FEM) |
| PVP4-- ROTSS OUTER CAPSID PROTEIN VP4 SIMIAN 11 ROTOVIRUS (STRAIN |
| 483-508 |
| SA11-SEM) |
| PVP4-- |
| SBMV P4 PROTEIN SOUTHERN BEAN MOSAIC 90-114 VIRUS |
| PVP4-- WTV NONSTRUCTURAL PROTEIN WOUND TUMOR VIRUS 192-215 |
| 416-438 498-519 564-591 |
| PNS4 |
| PVP5-- BTV10 OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SERO- |
| 295-317 326-345 494-517 |
| TYPE 10/ISOLATE USA) |
| PVP5-- BTV11 OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SERO- |
| 295-317 326-345 494-517 |
| TYPE 11/ISOLATE USA) |
| PVP5-- BTV13 OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SERO- |
| 295-317 494-517 |
| TYPE 13/ISOLATE USA) |
| PVP5-- BTV1A OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SERO- |
| 87-102 295-317 |
| TYPE 1/ISOLATE AUSTRALIA) |
| PVP5-- BTVIS OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SERO- |
| 295-317 |
| TYPE 1/ISOLATE SOUTH |
| AFRICA) |
| PVP5-- BTV2A OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SERO- |
| 295-317 |
| TYPE 2/ISOLATE USA) |
| PVP5-- RDV OUTER COAT PROTEIN P5 RICE DWARF VIRUS 265-284 622-639 |
| 690-715 |
| PVP61-- BTV10 VP6 PROTEIN BLUETONGUE VIRUS (SERO- 5-23 257-272 |
| TYPE 10/ISOLATE USA) |
| PVP61-- NPVAC 61 KD PROTEIN AUTOGRAPHA CALIFORNICA 321-337 |
| 438-462 |
| NUCLEAR POLYHEDROSIS |
| VIRUS) |
| PVP62-- BVT10 VP6 PROTEIN BLUETONGUE VIRUS (SERO- 9-27 232-249 |
| 261-276 |
| TYPE 10/ISOLATE USA) |
| PVP62-- MRDV PROB NONSTRUCTURAL 36 MAIZE ROUGH DWARF VIRUS |
| 130-146 |
| 3 KD PROTEIN |
| PVP64-- NPVOP MAJOR ENV GLYCOPROTEIN ORGYIA PSEUDOTSUGATA 81-99 |
| 235-252 286-313 |
| PREC MULTICAPSID POLYHEDROSIS |
| VIRUS |
| PVP67-- NPVAC MAJOR ENV GLYCOPROTEIN AUTOGRAPHA CALIFORNICA |
| 84-102 238-255 |
| PREC NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP6-- BTV11 VP6 PROTEIN BLUETONGUE VIRUS (SERO- 5-23 228-245 |
| 257-272 |
| TYPE 11/ISOLATE USA) |
| PVP6-- BTV13 VP6 PROTEIN BLUETONGUE VIRUS (SERO-5-23 228-245 |
| 257-272 |
| TYPE 13/ISOLATE USA) |
| PVP6-- BTV17 VP6 PROTEIN BLUETONGUE VIRUS (SERO- 5-23 228-245 |
| 257-272 |
| TYPE 17/ISOLATE USA) |
| PVP6-- BTV1S VP6 PROTEIN BLUETONGUE VIRUS (SERO- 9-27 232-249 |
| 261-276 |
| TYPE 1/ISOLATE SOUTH |
| AFRICA) |
| PVP6-- BTV2A VP6 PROTEIN BLUETONGUE VIRUS (SERO- 204-221 233-248 |
| TYPE 2/ISOLATE USA) |
| PVP6-- WTV STRUCTURAL PROTEIN P6 WOUND TUMOR VIRUS 374-397 |
| PVP6-- WTVNJ STRUCTURAL PROTEIN P6 WOUND TUMOR VIRUS |
| 374-397 |
| (STRAIN NJ) |
| PVP74-- |
| NPVAC P74 PROTEIN AUTOGRAPHA CALIFORNICA 254-275 NUCLEAR |
| POLYHEDROSIS |
| VIRUS |
| PVP75-- HSVSA PROBABLE MEMBRANE HERPESVIRUS SAIMIRI 127-147 |
| ANTIGEN 75 (STRAIN 11) |
| PVP79-- NPVAC 79 KD PROTEIN AUTOGRAPHA CALIFORNICA 274-301 |
| 405-420 678-704 |
| NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP7-- BTV13 VP7 CORE PROTEIN BLUETONGUE VIRUS (SERO- 197-222 |
| TYPE 13/ISOLATE USA) |
| PVP7-- EHDV1 VP7 CORE PROTEIN EPIZOOTIC HEMORRHAGIC 205-222 |
| 301-323 |
| DISEASE VIRUS (SEROTYPE 1) |
| PVP7-- RDV NONSTRUCTURAL PROTEIN RICE DWARF VIRUS 400-416 |
| PNS7 |
| PVP7-- WTV NONSTRUCTURAL PROTEIN WOUND TUMOR VIRUS 262-285 |
| PNS7 |
| PVP80-- NPVAC CAPSID PROTEIN P80 AUTOGRAPHA CALIFORNICA 98-123 |
| 638-660 |
| NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVP87-- NPVOP CAPSID PROTEIN P87 ORGYIA PSEUDOTSUGATA 571-593 |
| MULTICAPSID POLYHEDROSIS |
| VIRUS |
| PVP8-- BTV10 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SERO- |
| 104-120 |
| TYPE 10/ISOLATE USA) |
| PVP8-- BTV11 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SERO- |
| 104-120 |
| TYPE 11/ISOLATE USA) |
| PVP8-- BTV13 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SERO- |
| 104-120 |
| TYPE 13/ISOLATE USA) |
| PVP8-- BTV17 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SERO- |
| 104-120 |
| TYPE 17/ISOLATE USA) |
| PVP8-- BTV1A NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SERO- |
| 104-120 |
| TYPE 1/ISOLATE AUSTRALIA) |
| PVP8-- BTV1S NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SERO- |
| 104-120 |
| TYPE 1/ISOLATE SOUTH |
| AFRICA) |
| PVP8-- BTV2A NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SERO- |
| 104-120 |
| TYPE 2/ISOLATE USA) |
| PVP8-- RDV OUTER CAPSID PROTEIN P8 RICE DWARF VIRUS 374-400 |
| PVP8-- RGDV OUTER CAPSID PROTEIN PU RICE GALL DWARF VIRUS |
| 177-202 216-242 398-425 |
| PVP8-- VACCC STRUCTURAL PROTEIN VP8 VACCINIA VIRUS (STRAIN |
| 225-242 |
| PRECURSOR COPENHAGEN) |
| PVP8-- VACCV STRUCTURAL PROTEIN VP8 VACCINIA VIRUS (STRAIN WR) |
| 225-242 |
| PRECURSOR |
| PVP8-- |
| VARV STRUCTURAL PROTEIN VP8 VARIOLA VIRUS 225-242 PRECURSOR |
| PVP8-- WTV OUTER CAPSID PROTEIN P8 WOUND TUMOR VIRUS 111-129 |
| 214-241 251-271 379-405 |
| PVP9-- |
| RDV NONSTRUCTURAL PROTEIN RICE DWARF VIRUS 51-72 PNS9 |
| PVP9-- RGDV NONSTRUCTURAL PROTEIN RICE GALL DWARF VIRUS |
| 151.175 |
| PNS9 |
| PVPHE-- NPVAC 29 KD POLYHEDRAL ENVELOPE AUTOGRAPHA CALIFORNICA |
| 145-166 225-245 |
| PROTEIN NUCLEAR POLYHEDROSIS |
| VIRUS |
| PVPHE-- NPVOP 32 KD POLYHEDRAL ENVELOPE ORGYIA PSEUDOTSUGATA |
| 122-144 |
| PROTEIN MULTICAPSID POLYHEDROSIS |
| VIRUS |
| PRPRT-- ADE12 ENDOPROTEASE HUMAN ADENOVIRUS TYPE 12 161-181 |
| PRPRT-- MMTVB PROTEASE MOUSE MAMMARY TUMOR VIRUS 42-63 |
| (STRAIN BR6) |
| PRPRT-- |
| MPMV PROTEASE SIMIAN MASON-PFIZER VIRUS 80-99 PRPRT-- |
| SMRVH PROTEASE SQUIRREL MONKEY RETRO- 256-271 |
| VIRUS |
| PRPRT-- |
| SRV1 PROTEASE SIMIAN RETROVIRUS SRV-1 80-99 PVPU-- |
| HV1B1 VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-27 |
| VIRUS TYPE 1 (BH10 ISOLATE |
| HXB3) |
| PVPU-- |
| HV1B8 VPU PROTEIN HUMAN IMMUNODEFICIENCY 4-27 VIRUS |
| TYPE 1 (BH8 ISOLATE) |
| PVPU-- |
| HV1BN VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-28 VIRUS |
| TYPE 1 (BRAIN ISOLATE) |
| PVPU-- |
| HV1BR VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-27 VIRUS |
| TYPE 1 (BRU ISOLATE) |
| PVPU-- |
| HV1EL VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-26 VIRUS |
| TYPE 1 (ELI ISOLATE) |
| PVPU-- |
| HV1H2 VPU PROTEIN HUMAN IMMUNODEFICIENCY 4-27 VIRUS |
| TYPE 1 (HXB2 ISOLATE) |
| PVPU-- |
| HV1JR VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-28 VIRUS |
| TYPE 1 (JRCSF ISOLATE) |
| PVPU-- |
| HV1MA VPU PROTEIN HUMAN IMMUNODEFICIENCY 2-27 VIRUS |
| TYPE 1 (MAL ISOLATE) |
| PVPU-- |
| HV1MN VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-20 VIRUS |
| TYPE 1 (MN ISOLATE) |
| PVPU-- |
| HV1ND VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-28 VIRUS |
| TYPE 1 (NDK ISOLATE) |
| PVPU-- |
| HV1PV VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-27 VIRUS |
| TYPE 1 (PV22 ISOLATE) |
| PVPU-- |
| HV1S1 VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-28 VIRUS |
| TYPE 1 (SF162 ISOLATE) |
| PVPU-- |
| HV1SC VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-28 VIRUS |
| TYPE 1 (SC ISOLATE) |
| PVPU-- |
| HVIZ2 VPU PROTEIN HUMAN IMMUNODEFICIENCY 3-28 VIRUS |
| TYPE 1 (Z2/CDC-Z34 |
| ISOLATE) |
| PVPU-- |
| JSRV VPU PROTEIN SHEEP PULMONARY ADENO- 24-45 MATOSIS |
| VIRUS (JAAGSIEKTE |
| SHEEP RET |
| PVPX-- |
| HV2BE VPX PROTEIN HUMAN IMMUNODEFICIENCY 10-32 VIRUS |
| TYPE 2 (ISOLATE BEN) |
| PVPX-- |
| HV2CA VPX PROTEIN HUMAN IMMUNODEFICIENCY 10-32 VIRUS |
| TYPE 2 (ISOLATE CAM2 |
| PVPX-- |
| HV2D1 VPX PROTEIN HUMAN IMMUNODEFICIENCY 10-32 VIRUS |
| TYPE 2 (ISOLATE D194) |
| PVPX-- |
| HV2D2 VPX PROTEIN HUMAN IMMUNODEFICIENCY 9-31 VIRUS |
| TYPE 2 (ISOLATE D205.7) |
| PVPX-- |
| HV2G1 VPX PROTEIN HUMAN IMMUNODEFICIENCY 10-32 VIRUS |
| TYPE 2 (ISOLATE |
| GHANA-1) |
| PVPX-- |
| HV2NZ VPX PROTEIN HUMAN IMMUNODEFICIENCY 10-32 VIRUS |
| TYPE 2 (ISOLATE NIH-Z) |
| PVPX-- |
| HV2RO VPX PROTEIN HUMAN IMMUNODEFICIENCY 10-32 VIRUS |
| TYPE 2 (ISOLATE ROD) |
| PVPX-- |
| HV2SB VPX PROTEIN HUMAN IMMUNODEFICIENCY 10-32 VIRUS |
| TYPE 2 (ISOLATE SBLISY) |
| PVPX-- |
| HV2ST VPX PROTEIN HUMAN IMMUNODEFICIENCY 10-32 VIRUS |
| TYPE 2 (ISOALTE ST) |
| PVPX-- |
| LDV VPX PROTEIN LACTATE DEHYDROGENASE- 145-165 ELEVATING |
| VIRUS |
| PVPX-- |
| SIVAI VPX PROTEIN SIMIAN IMMUNODEFICIENCY 66-84 VIRUS |
| (ISOLATE AGM/CLONE |
| GRI-1) (S |
| PVPX-- |
| SIVMI VPX PROTEIN SIMIAN IMMUNODEFICIENCY 10-32 VIRUS |
| (MM142-83 ISOLATE) |
| (SIV-MAC) |
| PVPX-- |
| SIVMK VPX PROTEIN SIMIAN IMMUNODEFICIENCY 10-32 VIRUS |
| (K6W ISOLATE) (SIV-MAC) |
| PVPX-- |
| SIVML VPX PROTEIN SIMIAN IMMUNODEFICIENCY 10-32 VIRUS |
| (K78 ISOLATE) (SIV-MAC) |
| PVPX-- |
| SIVS4 VPX PROTEIN SIMIAN IMMUNODEFICIENCY 10-32 VIRUS |
| (F236/SMH4 ISOLATE) |
| (SOOTY M |
| PVPX-- |
| SIVSP VPX PROTEIN SIMIAN IMMUNODEFICIENCY 10-32 VIRUS |
| (PBJ/BC13 ISOLATE) |
| (SOOTY MA |
| PVRNA-- BSMV ALPHA-A PROTEIN BARLEY STRIP MOSAIC VIRUS 290-312 |
| 904-929 |
| (BSMV) |
| PVS05-- ROTBR NONSTRUCTURAL PROTEIN BOVINE ROTAVIRUS (STRAIN |
| 140-157 461-487 |
| NCVP2 RF) |
| PVS05-- ROTHI NONSTRUCTURAL PROTEIN HUMAN ROTAVIRUS (STRAIN |
| 140-157 428-450 457-473 |
| NCVP2 IGV-80-3) |
| PVS05-- ROTPC NONSTRUCTURAL PROTEIN PORCINE ROTAVIRUS (GROUP |
| 88-112 |
| NS53 C/STRAIN COWDEN) |
| PVS05-- ROTSI NONSTRUCTURAL PROTEIN SIMIAN 11 ROTAVIRUS (STRAIN |
| 399-414 |
| NCVP2 SA11) |
| PVS06-- ROTBR VP6 PROTEIN BOVINE ROTAVIRUS (STRAIN 202-225 |
| RF) |
| PVS06-- |
| ROTBS VP6 PROTEIN BOVINE ROTAVIRUS (GROUP 64-85 C/STRAIN |
| SHINTOKU) |
| PVS06-- ROTBU VP6 PROTEIN BOVINE ROTAVIRUS (STRAIN 202-225 |
| UK) |
| PVS06-- ROTEF VP6 PROTEIN EQUINE ROTAVIRUS (STRAIN 202-225 |
| F1-14) |
| PVS06-- ROTEH VP6 PROTEIN EQUINE ROTAVIRUS (STRAIN 202-225 |
| H-2) |
| PVS06-- ROTGA VP6 PROTEIN ROTAVIRUS (GROUP B/STRAIN 22-40 |
| ADRV)(ADULT DIARRHEA |
| ROTAVIRUS |
| PVS06-- ROTGI VP6 PROTEIN ROTAVIRUS (GROUP B/STRAIN 22-40 |
| IDIR) |
| PVS06-- ROTHC VP6 PROTEIN HUMAN ROTAVIRUS (SEROTYPE 202-225 |
| 1/STRAIN 1076) |
| PVS06-- ROTHS VP6 PROTEIN HUMAN ROTAVIRUS (SEROTYPE 202-225 |
| 2/STRAIN S2) |
| PVS06-- ROTHW VP6 PROTEIN HUMAN ROTAVIRUS (SEROTYPE 202-225 |
| 1/STRAIN WA) |
| PVS06-- ROTPC VP6 PROTEIN PORCINE ROTAVIRUS (GROUP 64-85 314-340 |
| C/STRAIN COWDEN) |
| PVS06-- ROTPG VP6 PROTEIN PORCINE ROTAVIRUS (STRAIN 202-225 |
| GOTTFIRED) |
| PVS07-- ROTBJ GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN 131-151 |
| KN-4) |
| PVS08-- ROTPC GLYCOPROTEIN VP7Y PORCINE ROTAVIRUS (GROUP 117-136 |
| PRECURSOR C/STRAIN COWDEN) |
| PVS08-- ROSI NONSTRUCTURAL PROTEIN SIMIAN 11 ROTAVIRUS (STRAIN |
| 274-295 |
| NCVP4 SA11) |
| PVS09-- ROTB6 GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (SEROTYPE 131-155 |
| 6/STRAIN 61A) |
| PVS09-- ROTBA GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN 131-155 |
| A44) |
| PVS09-- ROTBB GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (SEROTYPE 131-155 |
| 10/STRAIN B223) |
| PVS09-- ROTBK GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (STRAIN 131-155 |
| KK3) |
| PVS09-- ROTBT GLYCOPROTEIN VP7 BOVINE ROTAVIRUS (SEROTYPE 131-155 |
| 1/STRAIN T449) |
| PVS09-- ROTC7 GLYCOPROTEIN VP7 CHICKEN ROTAVIRUS A (SERO- 134-158 |
| TYPE 7/STRAIN CH2) |
| PVS09-- ROTEL GLYCOPROTEIN VP7 EQUINE ROTAVIRUS (STRAIN 131-155 |
| L338) |
| PVS09-- ROTGI GLYCOPROTEIN VP7 ROTAVIRUS (GROUP B/STRAIN 205-232 |
| PRECURSOR IDIR) |
| PVS09-- ROTH4 GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 131-155 |
| 197-212 |
| 4/STRAIN RV-4) |
| PVS09-- ROTHA GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 197-212 |
| 2/STRAIN HU5) |
| PVS09-- ROTHD GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 197-212 |
| 2/STRAIN DSI) |
| PVS09-- ROTHH GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 197-212 |
| 2/STRAIN HN126) |
| PVS09-- ROTHL GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (STRAIN 131-155 |
| 197-212 |
| L26) |
| PVS09-- ROTHM GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 131-155 |
| 197-212 |
| 1/STRAIN M37) |
| PVS09-- ROTHO GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 131-155 |
| 197-212 |
| 1/STRAIN MO AND STRAIN D) |
| PVS09-- ROTHP GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 131-155 |
| 3/STRAIN P) |
| PVS09-- ROTHR GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 131-155 |
| 3/STRAIN RRV) |
| PVS09-- ROTHS GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 197-212 |
| 2/STRAIN S2) |
| PVS09-- ROTHV GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 197-212 |
| 4/STRAIN VA70) |
| PVS09-- ROTHW GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 131-155 |
| 197-212 |
| 1/STRAIN WA) |
| PVS09-- ROTP5 GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SERO- 131-155 |
| 197-212 |
| TYPE 5/STRAIN OSU) |
| PVS09-- ROTP6 GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SERO- 131-155 |
| TYPE 5/STRAIN TFR-41) |
| PVS09-- ROTPB GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SERO- 197-212 |
| TYPE 4/STRAIN BEN-144) |
| PVS09-- ROTPM GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SERO- 197-212 |
| TYPE 4/STRAIN BMI-1) |
| PVS09-- |
| ROTRH GLYCOPROTEIN VP7 RHESUS ROTAVIRUS 131-155 PVS09-- |
| ROTSI GLYCOPROTEIN VP7 SIMIAN 11 ROTAVIRUS (STRAIN 131-155 |
| SA11) |
| PVS11-- ROTGA NONSTRUCTURAL PROTEIN ROTAVIRUS (GROUP B/STRAIN |
| 136-153 |
| ADRV) (ADULT DIARRHEA |
| ROTAVIRUS |
| PVSH-- HRSVA SMALL HYDROPHOBIC HUMAN RESPIRATORY SYNCY- 16-41 |
| PROTEIN TIAL VIRUS (STRAIN A2) |
| PVSH-- MUMP1 SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN SBL-1), 7-29 |
| PROTEIN AND MUMPS VIRUS (STRAIN |
| SBL) |
| PVSH-- |
| MUMP2 SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 7-29 PROTEIN |
| EDINGBURGH 2 & 6) |
| PVSH-- |
| MUMP4 SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 7-29 PROTEIN |
| EDINGBURGH 4) |
| PVSH-- |
| MUMPA SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 10-29 PROTEIN |
| MATSUYAMA) |
| PVSH-- |
| MUMPB SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 7-29 PROTEIN |
| BELFAST |
| PVSH-- |
| MUMPE SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 7-29 PROTEIN |
| ENDERS) |
| PVSH-- |
| MUMPJ SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 7-29 PROTEIN |
| JERYL-LYNN) |
| PVSH-- |
| MUMPK SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 7-29 PROTEIN |
| KILHAM) |
| PVSH-- |
| MUMPL SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 6-29 PROTEIN |
| BRISTOL I) |
| PVSH-- |
| MUMPM SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 10-29 PROTEIN |
| MIYAHARA VACCINE) |
| PVSH-- MUMPR SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN RW) 7-29 |
| PROTEIN |
| PVSH-- |
| MUMPT SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 10-29 PROTEIN |
| TAKAHASHI) |
| PVSH-- |
| MUMPU SMALL HYDROPHOBIC MUMPS VIRUS (STRAIN 10-29 PROTEIN |
| URABE VACCINE AM9) |
| PVS11-- REOVL SIGMA 1 PROTEIN PRECURSOR REOVIRUS (TYPE 1/STRAIN |
| 110-136 |
| LANG) |
| PVS13-- REOVD SIGMA 3 PROTEIN REOVIRUS (TYPE 3/STRAIN 152-170 |
| DEARING) |
| PVS13-- REOVJ SIGMA 3 PROTEIN REOVIRUS (TYPE 2/STRAIN 152-170 |
| D5/JONES) |
| PVS13-- REOVL SIGMA 3 PROTEIN REOVIRUS (TYPE 1/STRAIN 152-170 |
| LANG) |
| PVSIS-- REOVL SIGMA 1-S PROTEIN REOVIRUS (TYPE 1/STRAIN 79-101 |
| LANG) |
| PVST2-- HEVBU STRUCTURAL PROTEIN 2 HEPATITIS E VIRUS (STRAIN |
| 292-311 |
| PRECURSOR BURMA) |
| PVST2-- HEVME STRUCTURAL PROTEIN 2 HEPATITIS E VIRUS (STRAIN |
| 292-311 |
| PRECURSOR MEXICO) |
| PVST2-- HEVMY STRUCTURAL PROTEIN 2 HEPATITIS E VIRUS (STRAIN |
| 292-311 |
| PRECURSOR MYANMAR) |
| PVST2-- HEVPA STRUCTURAL PROTEIN 2 HEPATITIS E VIRUS (STRAIN |
| 292-311 |
| PRECURSOR PAKISTAN) |
| PVST2-- HEVRH STRUCTURAL PROTEIN 2 HEPATITIS E VIRUS (ISOLATE |
| 160-179 |
| RHESUS) |
| PVT2-- MYXVL TUMOR NECROSIS FACTOR SOL MYXOMA VIRUS (STRAIN |
| 261-283 |
| RECEPTOR PREC LAUSANNE) |
| PVT2-- SFVKA TUMOR NECROSIS FACTOR SOL SHOPE FIBROMA VIRUS |
| 270-289 |
| RECEPTOR PREC (STRAIN KASZA) |
| PVT3A-- CAPVI PROTEIN T3A CAPRIPOXVIRUS (STRAIN INS-1) 116-138 |
| PVT4-- |
| SFVKA T4 PROTEIN SHOPE FIBROMA VIRUS 125-148 (STRAIN |
| KASZA) |
| PVTER-- EBV PROBABLE DNA PACKAGING EPSTEIN-BARR VIRUS (STRAIN |
| 117-139 166-192 227-250 |
| PROTEIN B958) |
| PVTER-- HCMVA PROBABLE DNA PACKAGING HUMAN CYTOMEGALOVIRUS |
| 409-430 |
| PROTEIN (STRAIN AD169) |
| PVTER-- HSVII PROBABLE DNA PACKAGING HERPES SIMPLEX VIRUS (TYPE |
| 363-380 673-688 |
| PROTEIN 1/STRAIN 17) |
| PVTER-- HSV6U PROBABLE DNA PACKAGING HERPES SIMPLEX VIRUS (TYPE |
| 260-278 |
| PROTEIN 6/STRAIN UGANDA-1102) |
| PVTER-- HSVEB PROBABLE DNA PACKAGING EQUINE HERPESVIRUS TYPE 1 |
| 364-381 |
| PROTEIN (STRAIN AB4P) |
| PVTER-- HSVII PROBABLE DNA PACKAGING ICTALURID HERPESVIRUS 1 |
| 309-333 756-781 |
| PROTEIN |
| PVTER-- HSVSA PROBABLE DNA PACKAGING HERPESVIRUS SAIMIRI 218-241 |
| PROTEIN (STRAIN 11) |
| PVTER-- VZVD PROBABLE DNA PACKAGING VARICELLA-ZOSTER VIRUS |
| 372-389 |
| PROTEIN (STRAIN DUMAS) |
| PX-- |
| HPBGS PROTEIN X GROUND SQUIRREL HEPATITIS 68-85 VIRUS |
| PX-- |
| WHV1 PROTEIN X WOODCHUCK HEPATITIS 68-85 VIRUS 1 |
| PX-- |
| WHV59 PROTEIN X WOODCHUCK HEPATITIS 68-85 VIRUS |
| 59 |
| PX-- |
| WHV7 PROTEIN X WOODCHUCK HEPATITIS 68-85 VIRUS 7 |
| PX-- |
| WHV8 PROTEIN X WOODCHUCK HEPATITIS 68-85 VIRUS 8 |
| PX-- |
| WHV8I PROTEIN X WOODCHUCK HEPATITIS VIRUS 68-85 8 |
| (INFECTIOUS CLONE) |
| PX-- |
| WHVW6 PROTEIN X WOODCHUCK HEPATITIS VIRUS 68-85 W64 |
| (ISOLATE PWS23) |
| PY104-- ADE07 HYPOTHETICAL 10 4 KD EARLY HUMAN ADENOVIRUS TYPE 7 |
| 55-73 |
| PROTEIN |
| PY108-- SSV1 HYPOTHETICAL 10 8 KD SULFOLOBUS VIRUS-LIKE 66-90 |
| PROTEIN PARTICLE SSVI |
| PY10K-- MSVS HYPOTHETICAL 10 9 KD MAIZE STREAK VIRUS (SOUTH- |
| 24-47 |
| PROTEIN AFRICAN ISOLATE) |
| PY118-- SSV1 HYPOTHETICAL 11 8 KD SULFOLOBUS VIRUS-LIKE 42-59 |
| PROTEIN PARTICLE SSV1 |
| PY11K-- PSV HYPOTHETICAL 11 9 KD PANICUM STREAK VIRUS 29-52 |
| PROTEIN |
| PY12K-- BNYVG RNA-3 HYPOTHETICAL 11 6 KD BEET NECROTIC YELLOW |
| VEIN 15-42 |
| PROTEIN MOSAIC VIRUS (ISOLATE G) |
| PY12K-- CMVSI HYPOTHETICAL 12 R KD CYMBIDIUM MOSAIC VIRUS 8-30 |
| PROTEIN (STRAIN SINGAPORE) |
| PY137-- ADE02 HYPOTHETICAL PROTEIN B-137 HUMAN ADENOVIRUS TYPE 2 |
| 28-50 |
| PY13K-- CLVK HYPOTHETICAL 13 1 KD CASSAVA LATENT VIRUS 34-55 |
| PROTEIN (STRAIN WEST KENYAN 844) |
| PY13K-- CLVN HYPOTHETICAL 13 1 KD CASSAVA LETENT VIRUS 34-55 |
| PROTEIN (STRAIN NIGERIAN) |
| PY13K-- TYLCM HYPOTHETICAL 13 3 KD TOMATO YELLOW LEAF CURL 10-27 |
| PROTEIN VIRUS (STRAIN MARMANDE) |
| PY13K-- TYLCV HYPOTHETICAL 13 4 KD TOMATO YELLOW LEAF CURL 34-55 |
| PROTEIN VIRUS |
| PY145-- ADE07 HYPOTHETICAL 14 5 KD EARLY HUMAN ADENOVIRUS TYPE 7 |
| 108-132 |
| PROTEIN |
| PY14K-- CSMV HYPOTHETICAL 14 5 KD CHLORIS STRIATE MOSAIC 54-80 |
| PROTEIN VIRUS |
| PY18K-- SSVI HYPOTHETICAL 18 0 KD SULFOLOBUS VIRUS-LIKE 100-125 |
| 141-162 |
| PROTEIN PARTICLE SSVI |
| PY206-- ADE07 HYPOTHETICAL 20 6 KD EARLY HUMAN ADENOVIRUS TYPE 7 |
| 108-132 |
| PROTEIN |
| PY25K-- BNYVF RNA-3 HYPOTHETICAL 24 7 KD BEET NECROTIC YELLOW |
| VEIN 163-188 |
| PROTEIN MOSAIC VIRUS (ISOLATE F2) |
| PY29K-- NPVAC HYPOTHETICAL 29 9 KD AUTOGRAPHA CALIFORNICA 90-106 |
| PROTEIN NUCLEAR POLYHEDROSIS |
| VIRUS |
| PY2-- SOCMV HYPOTHETICAL PROTEIN 2 SOYBEAN CHLOROTIC MOTTLE 65-90 |
| VIRUS |
| PY32K-- SSVI HYPOTHETICAL 21 7 KD SULFOLOBUS VIRUS-LIKE 122-142 |
| PROTEIN PARTICLE SSVI |
| PY6K0-- SSVI HYPOTHETICAL 6 0 KD SULFOLOBUS VIRUS-LIKE 23-44 |
| PROTEIN PARTICLE SSVI |
| PY7K4-- VACCV HYPOTHETICAL 7 4 KD VACCINIA VIRUS (STRAIN WR) |
| 21-36 |
| PROTEIN |
| PY7K-- MEASH HYPOTHETICAL 7 KD PROTEIN MEASLES VIRUS (STRAIN 3-25 |
| HALLE) |
| PY7-- SOCMV HYPOTHETICAL PROTEIN 7 SOYBEAN CHLOROTIC MOTTLE |
| 96-120 |
| VIRUS |
| PY85K-- SSVI HYPOTHETICAL 85 7 KD SULFOLOBUS VIRUS-LIKE 80-105 |
| 155-173 543-565 657-675 764-784 |
| PROTEIN PARTICLE SSVI |
| PY8-- SOCMV HPOTHETICAL PROTEIN 8 SOYBEAN CHLOROTIC MOTTLE 10-27 |
| VIRUS |
| PY97-- AD07 HYPOTHETICAL 9 7 KD EARLY HUMAN ADENOVIRUS TYPE 7 |
| 54-77 |
| PROTEIN |
| PY9K2-- SSVI HYPOTHETICAL 9 2 KD SULFOLOBUS VIRUS-LIKE 16-41 |
| 62-77 |
| PROTEIN PARTICLE SSVI |
| PYALI-- EBV HYPOTHETICAL BALF1 EPSTEIN-BARR VIRUS (STRAIN 205-220 |
| PROTEIN B95-8) |
| PYB01-- FOWPM HYPOTHETICAL BAMHI-ORF1 FOWLPOX VIRUS (ISOLATE |
| 354-374 |
| PROTEIN HP-438[MUNICH]) |
| PYB07-- FOWPM HYPOTHETICAL BAMHI-ORF7 FOWLPOX VIRUS (ISOLATE |
| 104-121 |
| PROTEIN HP-438[MUNICH]) |
| PYB09-- FOWPM HYPOTHETICAL BAMHI-ORF9 FOWLPOX VIRUS (ISOLATE |
| 49-67 |
| PROTEIN HP-438[MUNICH]) |
| PYB10-- FOWPM HYPOTHETICAL BAMHI-ORF10 FOWLPOX VIRUS (ISOLATE |
| 84-100 |
| PROTEIN HP-438[MUNICH]) |
| PYB12-- FOWPM HYPOTHETICAL BAMHI-ORF12 FOWLPOX VIRUS (ISOLATE |
| 114-134 154-169 |
| PROTEIN HP-438[MUNICH]) |
| PYBL2-- SFV3L BEL-3 PROTEIN SIMIAN FOAMY VIRUS (TYPE 113-128 |
| 3/STRAIN LK3) |
| PYBL3-- |
| FOAMV BEL-3 PROTEIN HUMAN SPUMARETROVIRUS 52-78 PYDH1-- |
| HSVSC HYP 28 7 KD PROTEIN IN DHFR HERPESVIRUS SAIMIRI (SUB- 206-230 |
| 3'REGION GROUP C/STRAIN 488) |
| PYDH3-- HSVSC HYP 9 5 KD PROTEIN IN DHRF HERPESVIRUS SAIMIRI |
| (SUB- 69-90 |
| 3'REGION GROUP C/STRAIN 488) |
| PYEC4-- EBV HYPOTHETICAL EC-RF4 EPSTEIN-BARR VIRUS (STRAIN |
| 200-222 |
| PROTEIN B95-8) |
| PYGA1-- HSVMB HYPOTHETICAL 23 6 KD MAREK'S DISEASE HERPES- |
| 175-190 |
| PROTEIN VIRUS (STRAIN BC-1) |
| PYGA1-- HSVMM HYPOTHETICAL 23 6 KD MAREK'S DISEASE HERPES- |
| 175-190 |
| PROTEIN VIRUS (STRAIN MD5) |
| PYHL4-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 101-121 |
| HHLF4 (STRAIN AD169) |
| PYHR3-- VACCV HYP HOST RANGE 27 4 KD VACCINIA VIRUS (STRAIN WR) |
| 86-102 |
| PROTEIN |
| PYIO2-- CVMA5 HYP PROTEIN IN NUCLEO- MURINE CORONAVIRUS MHV |
| 141-156 |
| CAPSID ORF |
| PYIOR-- CVM1 HYP PROTEIN IN NUCLEO- MURINE CORONAVIRUS MHV |
| 141-156 |
| CAPSID ORF |
| PYIOR-- CVMS HYP PROTEIN IN NUCLEO- MURINE CORONAVIRUS MHV 7-33 |
| CAPSID ORF |
| PYKR2-- EBV HYPOTHETICAL BKRF2 EPSTEIN-BARR VIRUS (STRAIN 67-90 |
| PROTEIN B95-8) |
| PYL12-- ADE41 HYPOTHETICAL 8 0 KD HUMAN ADENOVIRUS TYPE 41 53-73 |
| PROTEIN |
| PYMR2-- EBV BMRF2 PROTEIN EPSTEIN-BARR VIRUS (STRAIN 76-100 |
| 128-155 215-241 330-350 |
| B95-8) |
| PYMSP-- IRV22 HYPOTHETICAL 15 9 KD SIMULIUM IRIDESCENT VIRUS |
| 23-46 |
| PROTEIN (INSECT IRIDESCENT VIRUS |
| TYPE 22) |
| PYOR1-- ADEGI HYPOTHETICAL PROTEIN AVIAN ADENOVIRUS GAL1 59-80 |
| (STRAIN PHELPS) (FOWL |
| ADENOVIRUS 1) |
| PYOR1-- COYMV HYPOTHETICAL 23 KD COMMELINA YELLOW MOTTLE 56-83 |
| PROTEIN VIRUS |
| PYOR1-- TTV1 HYPOTHETICAL 7 9 KD THERMOPROTEIUS TENAX 13-40 |
| PORTEIN VIRUS 1 (STRAIN KRA1) |
| PYOR2-- COYMV HYPOTHETICAL 15 KD COMMELINA YELLOW MOTTLE 23-49 |
| PROTEIN VIRUS |
| PYOR2-- EAV HYPOTHETICAL 25 6 KD EQUINE ARTERITIS VIRUS 165-192 |
| PROTEIN |
| PYOR2-- |
| LELV HYPOTHETICAL28 4 KD LELYSTAD VIRUS 196-212 PROTEIN |
| PYOR3-- |
| LVX HYPOTHETICAL 11 8 KD LILY VIRUS X 71-92 PROTEIN |
| PYOR3-- NMV HYPOTHETICAL 14 KD NARCISSUS MOSAIC VIRUS 7-30 |
| PROTEIN |
| PYOR3-- |
| PVX HYPOTHETICAL 12 KD POTATO VIRUS X 11-34 PROTEIN |
| PYOR3-- PVXCP HYPOTHETICAL 12 KD POTATO VIRUS X (STRAIN CP) |
| 11-34 |
| PROTEIN |
| PYOR3-- WCMVM HYPOTHETICAL 13 KD WHITE CLOVER MOSAIC VIRUS 9-29 |
| PROTEIN (STRAIN M) |
| PYOR3-- WCMVO HYPOTHETICAL 13 KD WHITE CLOVER MOSAIC VIRUS 9-31 |
| PROTEIN (STRAIN O) |
| PYOR5-- ADEGI HYPOTHETICAL 31 5 KD AVIAN ADENOVIRUS GAL1 69-86 |
| PROTEIN (STRAIN PHELPS) (FOWL |
| ADENOVIRUS 1) |
| PYOR5-- EAV HYPOTHETICAL 28 7 KD EQUINE ARTERITIS VIRUS 139-158 |
| PROTEIN |
| PYOR6-- NMV HYPOTHETICAL 10 KD NARCISSUS MOSAIC VIRUS 10-26 |
| PROTEIN |
| PYORI-- TTV1 HYPOTHETICAL 16 6 KD THERMOPROTEUS TENAX 13-32 |
| PROTEIN VIRUS 1 (STRAIN KRA1) |
| PYORL-- TTV1 HYPOTHETICAL 16 5 KD THERMOPROTEUS TENAX 16-39 |
| PROTEIN VIRUS 1 (STRAIN KRA1) |
| PYORM-- TTV1 HYPOTHETICAL 38 6 KD THERMOPROTEUS TENAX 82-102 |
| 233-256 |
| PROTEIN VIRUS 1 (STRAIN KRA1) |
| PYORP-- TTV1 HYPOTHETICAL 20 2 KD THERMOPROTEUS TENAX 91-115 |
| PROTEIN VIRUS 1 (STRAIN KRA1) |
| PYP24-- RTBV HYPOTHETICAL P24 PROTEIN RICE TUNGRO BACILLIFORM |
| 2-25 104-126 |
| VIRUS |
| PYP24-- RTBVP HYPOTHETICAL P24 PROTEIN RICE TUNGRO BACILLIFORM |
| 2-25 104-126 |
| VIRUS (ISOLATE PHILIPPINES) |
| PYP47-- NPVAC HYPOTHETICAL 43 5 KD AUTOGRAPHA CALIFORNICA 211-234 |
| PROTEIN NUCLEAR POLYHEDROSIS |
| VIRUS |
| PYP62-- NPVOP HYPOTHETICAL 12 2 KD ORGYIA PSEUDOTSUGATA 82-108 |
| PROTEIN MULTICAPSID POLYHEDROSIS |
| VIRUS (OP |
| PYP63-- NPVOP HYPOTHETICAL 40 0 KD ORGYIA PSEUDOTSUGATA 27-54 |
| 215-230 |
| PROTEIN MULTICAPSID POLYHEDROSIS |
| VIRUS (OP |
| PYP7B-- TNVD HYPOTHETICAL P7B PROTEIN TOBACCO NECROSIS VIRUS |
| 13-31 |
| (STRAIN D) (TNV) |
| PYPO4-- NPVLD HYPOTHETICAL 8 5 KD LYMANTRIA DISPAR MULTI- 16-35 |
| PROTEIN CAPSID NUCLEAR POLY- |
| HEDROSIS VIRUS |
| PYRF1-- HSV6G HYPOTHETICAL PROTEIN RF1 HERPES SIMPLEX VIRUS (TYPE |
| 42-66 |
| 6/STRAIN GS) |
| PYRF2-- HSV6G HYPOTHETICAL PROTEIN RF2 HERPES SIMPLEX VIRUS (TYPE |
| 55-74 |
| 6/STRAIN GS) |
| PYRF3-- HSV6G HYPOTHETICAL PROTEIN RF3 HERPES SIMPLEX VIRUS (TYPE |
| 32-56 |
| 6/STRAIN GS) |
| PYRP1-- IRV6 REPETITIVE PROTEIN ORF1 CHILO IRIDESCENT VIRUS (CIV) |
| 20-43 |
| (INSECT IRIDESCENT VIRUS |
| TYPE 6) |
| PYRP4-- IRV6 REPETITIVE PROTEIN ORF4 CHILO IRIDESCENT VIRUS (CIV) |
| 44-69 |
| (INSECT IRIDESCENT VIRUS |
| TYPE 6) |
| PYRP5-- IRV6 REPETITIVE PROTEIN ORF5 CHILO IRIDESCENT VIRUS (CIV) |
| 98-123 179-204 260-285 |
| (INSECT IRIDESCENT VIRUS |
| TYPE 6) |
| PYRR1-- EBV HYPOTHETICAL BRRF1 EPSTEIN-BARR VIRUS 199-223 |
| PROTEIN (STRAIN B95-8) |
| PYRR2-- EBV HYPOTHETICAL BRRF2 EPSTEIN-BARR VIRUS 164-182 |
| PROTEIN (STRAIN B95-8) |
| PYSR1-- EBV HYPOTHETICAL BSRF1 EPSTEIN-BARR VIRUS 92-113 |
| PROTEIN (STRAIN B95-8) |
| PYTR2-- EBV HYPOTHETICAL BTRF1 EPSTEIN-BARR VIRUS 383-401 |
| PROTEIN (STRAIN B95-8) |
| PYUB2-- NPVOP HYPOTHETICAL 24 0 KD ORGYIA PSEUDOTSUGATA 133-152 |
| PROTEIN MULTICAPSID POLYHEDROSIS |
| VIRUS (OP |
| PYVAE-- VACCC HYPOTHETICAL 18 2 KD VACCINIA VIRUS (STRAIN 82-99 |
| 140-156 |
| PROTEIN COPENHAGEN) |
| PYVAF-- VACCC HYPOTHETICAL 8 4 KD VACCINIA VIRUS (STRAIN 17-40 |
| 51-68 |
| PROTEIN COPENHAGEN) |
| PYVAL-- VACCV HYPOTHETICAL 9 9 KD VACCINIA VIRUS (STRAIN 21-43 |
| PROTEIN WR), AND VACCINIA |
| VIRUS (STRAIN COPE |
| PYVAT-- VACCV HYPOTHETICAL 8 9 KD VACCINIA VIRUS (STRAIN 28-46 |
| PROTEIN WR), AND VACCINIA |
| VIRUS (STRAIN COPE |
| PYVBE-- VACCV HYPOTHETICAL 10 5 VACCINIA VIRUS (STRAIN 9-28 |
| PROTEIN WR), AND VACCINIA |
| VIRUS (STRAIN COPE |
| PYVBG-- VACCC HYPOTHETICAL 11 2 KD KD VACCINIA VIRUS (STRAIN |
| 37-54 |
| PROTEIN COPENHAGEN) |
| PYVCA-- VACCC HYPOTHETICAL 8 0 VACCINIA VIRUS (STRAIN 18-35 |
| PROTEIN COPENHAGEN) |
| PYVD2-- VACCV HYPOTHETICAL 8 6 KD VACCINIA VIRUS (STRAIN 5-26 |
| 36-52 |
| PROTEIN WR), AND VACCINIA |
| VIRUS (STRAIN COPE |
| PYVDA-- VACCC HYPOTHETICAL 9 2 KD VACCINIA VIRUS (STRAIN 22-38 |
| 44-64 |
| PROTEIN COPENHAGEN) |
| PYVDA-- VACCV HYPOTHETICAL 9 2 KD PROTEIN VACCINIA VIRUS (STRAIN |
| WR) 3-18 22-38 |
| 44-64 PYVFA-- |
| VACCC HYPOTHETICAL 7 1 KD VACCINIA VIRUS (STRAIN |
| 48-67 PROTEIN COPENHAGEN) |
| PYVFF-- VACCC HYPOTHETICAL 8 8 KD VACCINIA VIRUS (STRAIN 23-42 |
| PROTEIN COPENHAGEN) |
| PYVGA-- VACCC HYPOTHETICAL 14 3 KD VACCINIA VIRUS (STRAIN 105-127 |
| PROTEIN COPENHAGEN) |
| PYVKB-- VACCC HYPOTHETICAL 9 0 KD VACCINIA VIRUS (STRAIN 54-70 |
| PROTEIN COPENHAGEN) |
| PYZL2-- EBV HYPOTHETICAL BZLF2 PROTEIN EPSTEIN-BARR VIRUS 150-166 |
| (STRAIN B95-8) |
| PY14K-- CSMV HYPOTHETICAL 14 5 KD CHLORIS STRIATE MOSAIC 54-80 |
| PROTEIN VIRUS |
| PY18K-- SSV1 HYPOTHETICAL 18 0 KD SULFOLOBUS VIRUS-LIKE 100-125 |
| 141-162 |
| PROTEIN PARTICLE SSV1 |
| PY206-- ADE07 HYPOTHETICAL 20 6 KD HUMAN ADENOVIRUS TYPE 7 50-73 |
| PROTEIN |
| PY25K-- BNYVF RNA-3 HYPOTHETICAL 24 7 KD BEET NECROTIC YELLOW |
| VEIN 163-188 |
| PROTEIN MOSAIC VIRUS (ISOLATE F2) |
| PY29K-- NPVAC HYPOTHETICAL 29 9 KD AUTOGRAPHA CALIFORNICA 90-106 |
| PROTEIN NUCLEAR POLYHEDROSIS |
| VIRUS |
| PY2-- SOCMV HYPOTHETICAL SOYBEAN CHLOROTIC MOTTLE |
| 65-90 PROTEIN VIRUS |
| PY32K-- SSV1 HYPOTHETICAL 31 7 KD SULFOLOBUS VIRUS-LIKE 122-142 |
| PROTEIN PARTICLE SSV1 |
| PY6K0-- SSV1 HYPOTHETICAL 6 0 KD SULFOLOBUS VIRUS-LIKE 23-44 |
| PROTEIN PARTICLE SSV1 |
| PY7K4-- VACCV HYPOTHETICAL 7 4 KD VACCINIA VIRUS (STRAIN WR) |
| 21-36 |
| PROTEIN |
| PY7K-- MEASH HYPOTHETICAL 7 KD MEASLES VIRUS (STRAIN 3-25 |
| PROTEIN HALLE) |
| PY7-- SOCMV HYPOTHETICAL KD SOYBEAN CHLOROTIC MOTTLE 96-120 |
| PROTEIN VIRUS |
| PU85K-- SSV1 HYPOTHETICAL 85 7 SULFOLOBUS VIRUS-LIKE 80-105 |
| 155-173 543-565 657-675 764-784 |
| PROTEIN PARTICLE SSV1 |
| PY8-- SOCMV HYPOTHETICAL PROTEIN 8 SOYBEAN CHLOROTIC MOTTLE |
| 10-27 |
| VIRUS |
| PY97-- SSV1 HYPOTHETICAL 9 7 KD EARLY HUMAN ADENOVIRUS TYPE 7 |
| 54-77 |
| PROTEIN |
| PY9K2-- SSV1 HYPOTHETICAL 9 2 KD SULFOLOBUS VIRUS-LIKE 16-41 |
| 62-77 |
| PROTEIN PARTICLE SSV1 |
| PYL1-- EBV HYPOTHETICAL BALF1 KD EPSTEIN-BARR VIRUS 205-220 |
| PROTEIN (STRAIN B95-8) |
| PYB01-- FOWPM HYPOTHETICAL BAMHI-ORF1 FOWLPOX VIRUS (ISOLATE |
| 354-374 |
| KD PROTEIN HP-438[MUNICH]) |
| PYB07-- FOWPM HYPOTHETICAL BAMHI-ORF7 FOWLPOX VIRUS (ISOLATE |
| 104-121 |
| KD PROTEIN HP-438[MUNICH]) |
| PYB09-- FOWPM HYPOTHETICAL BAMHI-ORF9 FOWLPOX VIRUS (ISOLATE |
| 49-67 |
| KD PROTEIN HP-438[MUNICH]) |
| PYB10-- FOWPM HYPOTHETICAL BAMHI-ORF10 FOWLPOX VIRUS (ISOLATE |
| 84-100 |
| KD PROTEIN HP-438[MUNICH]) |
| PYB12-- FOWPM HYPOTHETICAL BAMHI-ORF12 FOWLPOX VIRUS (ISOLATE |
| 114-134 154-169 |
| KD PROTEIN HP-438[MUNICH]) |
| PYBL2-- SFV3L BEL-2 KD PROTEIN SIMIAN FOAMY VIRUS 113-128 |
| (TYPE 3 0/STRAIN LK3) |
| PYBL3-- FOAMV BEL-3 KD PROTEIN HUMAN SPUMARETROVIRUS 52-78 |
| PYDH1-- HSVCS HYPOTHETICAL 28 7 KD HERPES VIRUS SAIMIRI |
| 206-230 |
| PROTEIN (SUBGROUP C / STRAIN 488) |
| PYDH3-- HSVCS HYPOTHETICAL 9 5 KD HERPES VIRUS SAIMIRI 69-90 |
| PROTEIN (SUBGROUP C / STRAIN 488) |
| PYEC4-- EBV HYPOTHETICAL EC-RF4 EPSTEIN-BARR VIRUS 200-222 |
| PROTEIN (STRAIN B95-8) |
| PYGA1-- HSVMB HYPOTHETICAL 23 6 KD MAREK'S DISEASE HERPES 175-190 |
| PROTEIN VIRUS (STRAIN BC-1) |
| PYGA1--HSVMM HYPOTHETICAL 23 6 KD MAREK'S DISEASE HERPES 175-190 |
| PROTEIN VIRUS (STRAIN MD-5) |
| PYHL4-- HCMVA HYPOTHETICAL PROTEIN HUMAN CYTOMEGALOVIRUS 101-121 |
| HHLF4 (STRAIN AD169) |
| PYHR3-- VACCV HYPOTHETICAL HOST RANGE VACCINIA VIRUS (STRAIN WR) |
| 86-102 |
| 27 4 KD PROTEIN |
| PY1O2-- CVMA5 HYPOTHETICAL PROTEIN IN MURINE CORONA VIRUS MHV |
| 141-156 |
| NUCLEOCAPSID ORF |
| PYIOR-- CVMS HYPOTHETICAL PROTEIN IN MURINE CORONA VIRUS MHV |
| 141-156 |
| NUCLEOCAPSID ORF |
| PYIOR-- CVMS HYPOTHETICAL PROTEIN IN MURINE CORONA VIRUS MHV |
| 7-33 |
| NUCLEOCAPSID ORF |
| PYKR2-- EBV HYPOTHETICAL BKRF2 EPSTEIN-BARR VIRUS |
| 67-90 PROTEIN (STRAIN B95-8) |
| PYL12-- ADE41 HYPOTHETICAL 80 KD HUMAN ADENOVIRUS TYPE 41 53-73 |
| PROTEIN |
| PUMR2-- EBV BMRF2 PROTEIN EPSTEIN-BARR VIRUS 76-100 128-155 |
| 215-241 330-350 |
| (STRAIN B95-8) |
| PYMSP-- IRV22 HYPOTHETICAL 15 9 KD SIMULIUM IRIDESCENT VIRUS |
| 23-46 |
| PROTEIN (INSECT IRIDESCENT |
| VIRUS TYPE 22) |
| PYOR1-- ADEG1 HYPOTHETICAL PROTEIN AVIAN ADENOVIRUS GAL1 59-80 |
| (STRAIN PHELPS) (FOWL |
| ADENOVIRUS 1) |
| PYOR1-- COYMV HYPOTHETICAL 23 KD COMMELINA YELLOW MOTTLE 56-83 |
| PROTEIN VIRUS |
| PYOR1-- TTV1 HYPOTHETICAL 7 9 KD THERMOPROTEUS TENAX 13-40 |
| PROTEIN VIRUS 1 (STRAIN KRA1) |
| PYOR2-- COYMV HYPOTHETICAL 15 KD COMMELINA YELLOW MOTTLE 23-49 |
| PROTEIN VIRUS |
| PYOR2-- EAV HYPOTHETICAL 25 6 KD EQUINE ARTERITIS VIRUS 165-192 |
| PROTEIN |
| PYOR2-- |
| LELV HYPOTHETICAL 28 4 KD LELYSTAD VIRUS 196-212 PROTEIN |
| PYOR3-- |
| LVX HYPOTHETICAL 11 8 KD LILY VIRUS X 71-92 PROTEIN |
| PYOR3-- NMV HYPOTHETICAL 14 KD NARCISSUS MOSAIC VIRUS 7-30 |
| PROTEIN |
| PYOR3-- |
| PVX HYPOTHETICAL 12 KD POTATO VIRUS X 11-34 PROTEIN |
| PYOR3-- PVXCP HYPOTHETICAL 12 KD POTATO VIRUS X (STRAIN CP) |
| 11-34 |
| PROTEIN |
| PYOR3-- WCMVM HYPOTHETICAL 13 KD WHITE CLOVER MOSAIC 9-29 |
| PROTEIN VIRUS (STRAIN M) |
| PYOR3-- WCMVO HYPOTHETICAL 13 KD WHITE CLOVER MOSAIC 9-31 |
| PROTEIN VIRUS (STRAIN O) |
| PYOR5-- ADEG1 HYPOTHETICAL 31 5 KD AVIAN ADENOVIRUS GAL1 69-86 |
| PROTEIN (STRAIN PHELPS) (FOWL |
| ADENOVIRUS 1) |
| PYOR5-- EAV HYPOTHETICAL 28 7 KD EQUINE ARTERITIS VIRUS 139-158 |
| PROTEIN |
| PYOR6-- NMV HYPOTHETICAL 10 KD NARCISSUS MOSAIC VIRUS 10-26 |
| PORTEIN |
| PYORI-- TTV1 HYPOTHETICAL 16 6 KD THERMOPROTEUS TENAX 13-32 |
| PROTEIN VIRUS 1 (STRAIN KRA1) |
| PYORL-- TTV1 HYPOTHETICAL 16 5 KD THERMOPROTEUS TENAX 16-39 |
| PROTEIN VIRUS 1 (STRAIN KRA1) |
| PYORM-- TTV1 HYPOTHETICAL 38 6 KD THERMOPROTEUS TENAX 82-102 |
| 233-256 |
| PROTEIN VIRUS 1 (STRAIN KRA1) |
| PYORP-- TTV1 HYPOTHETICAL 20 2 KD THERMOPROTEUS TENAX 91-115 |
| PROTEIN VIRUS 1 (STRAIN KRA1) |
| PYP24-- RTBV HYPOTHETICAL P24 PROTEIN RICE TUNGRO BACILLIFORM |
| 2-25 104-126 |
| VIRUS |
| PYP24-- RTBVP HYPOTHETICAL P24 PROTEIN RICE TUNGRO BACILLIFORM |
| 2-25 104-126 |
| VIRUS (ISOLATE PHILIPPINES) |
| PYP47-- NPVAC HYPOTHETICAL 43 5 KD AUTOGRAPHA CALIFORNICA 211-234 |
| PROTEIN IN P47 3'REGION NUCLEAR POLYHEDROSIS |
| VIRUS |
| PYP62-- NPVOP HYPOTHETICAL 12 2 KD ORGYIA PSEUDOTSUGATA 82-108 |
| PROTEIN IN P6 5 5'REGION MULTICAPSID POLYHEDROSIS |
| VIRUS (OP |
| PYP63-- NPVOP HYPOTHETICAL 40 0 KD ORGYIA PSEUDOTSUGATA 27-54 |
| 215-230 |
| PROTEIN IN P6 5 5'REGION MULTICAPSID POLYHEDROSIS |
| VIRUS (OP |
| PYP7B-- TNVD HYPOTHETICAL P7B PROTEIN TOBACCO NECROSIS VIRUS |
| 13-31 |
| (STRAIN D) (TNV) |
| PYPO4-- NPVLD HYPOTHETICAL 8 5 KD LYMANTRIA DISPAR MULTI- 16-35 |
| PROTEIN IN POL 3'REGION CAPSID NUCLEAR POLY- |
| HEDROSIS VIRUS |
| PYRF1-- HSV6G HYPOTHETICAL PROTEIN RF1 HERPES SIMPLEX VIRUS (TYPE |
| 42-66 |
| 6/STRAIN GS) |
| PYRF2-- HSV6G HYPOTHETICAL PROTEIN RF2 HERPES SIMPLEX VIRUS (TYPE |
| 55-74 |
| 6/STRAIN GS) |
| PYRF3-- HSV6G HYPOTHETICAL PROTEIN RF3 HERPES SIMPLEX VIRUS (TYPE |
| 32-56 |
| 6/STRAIN GS) |
| PYRP1-- IRV6 REPETITIVE PROTEIN ORF1 CHILO IRIDESCENT VIRUS (CIV) |
| 20-43 |
| (INSECT IRIDESCENT VIRUS |
| TYPE 6) |
| PYRP4-- IRV6 REPETITIVE PROTEIN ORF4 CHILO IRIDESCENT VIRUS (CIV) |
| 44-69 |
| (INSECT IRIDESCENT VIRUS |
| TYPE 6) |
| PYRP5-- IRV6 REPETITIVE PROTEIN ORF5 CHILO IRIDESCENT VIRUS (CIV) |
| 98-123 179-204 260-285 |
| (INSECT IRIDESCENT VIRUS |
| TYPE 6) |
| PYRR1-- EBV HYPOTHETICAL BRRF1 EPSETIN-BARR VIRUS (STRAIN 199-223 |
| PROTEIN B95-8) |
| PYRR2-- EBV HYPOTHETICAL BRRF2 EPSETIN-BARR VIRUS (STRAIN 164-182 |
| PROTEIN B95-8) |
| PYSR1-- EBV HYPOTHETICAL BRRF1 EPSETIN-BARR VIRUS (STRAIN 92-113 |
| PROTEIN B95-8) |
| PYTR1-- EBV HYPOTHETICAL BRRF1 EPSETIN-BARR VIRUS (STRAIN 383-401 |
| PROTEIN B95-8) |
| PYUB2-- NPVOP HYPOTHETICAL 24 0 KD ORGYIA PSEUDOTSUGATA 133-152 |
| PROTEIN MULTICAPSID POLYHEDROSIS |
| VIRUS (OP |
| PYVAE-- VACCC HYPOTHETICAL 18 2 KD VACCINIA VIRUS (STRAIN 82-99 |
| 140-156 |
| PROTEIN COPENHAGEN) |
| PYVAF-- VACCC HYPOTHETICAL 8 4 KD VACCINIA VIRUS (STRAIN 17-40 |
| 51-68 |
| PROTEIN COPENHAGEN) |
| PYVAL-- VACCV HYPOTHETICAL 9 9 KD VACCINIA VIRUS (STRAIN WR), |
| 21-43 |
| PROTEIN AND VACCINIA VIRUS (STRAIN |
| COPE |
| PYVAT-- VACCC HYPOTHETICAL 8 9 KD VACCINIA VIRUS (STRAIN WR), |
| 28-46 |
| PROTEIN AND VACCINIA VIRUS (STRAIN |
| COPE |
| PYVBE-- VACCC HYPOTHETICAL 10 5 KD VACCINIA VIRUS (STRAIN WR), |
| 9-28 |
| PROTEIN AND VACCINIA VIRUS (STRAIN |
| COPE |
| PYVBG-- VACCC HYPOTHETICAL 11 2 KD VACCINIA VIRUS (STRAIN 37-54 |
| PROTEIN COPENHAGEN) |
| PYVCA-- VACCC HYPOTHETICAL 8 0 KD VACCINIA VIRUS (STRAIN 18-35 |
| PROTEIN COPENHAGEN) |
| PYVD2-- VACCV HYPOTHETICAL 8 6 KD VACCINIA VIRUS (STRAIN WR), |
| 5-26 36-52 |
| PROTEIN AND VACCINIA VIRUS (STRAIN |
| COPE |
| PYVDA-- VACCC HYPOTHETICAL 9 2 KD VACCINIA VIRUS (STRAIN 48-67 |
| PROTEIN COPENHAGEN) |
| PYVDA-- VACCV HYPOTHETICAL 9 2 KD VACCINIA VIRUS (STRAIN WR) 3-18 |
| 22-38 44-64 |
| PROTEIN |
| PYVFA-- VACCC HYPOTHETICAL 7 1 KD VACCINIA VIRUS (STRAIN 48-67 |
| PROTEIN COPENHAGEN) |
| PYVFF-- VACCC HYPOTHETICAL 8 8 KD VACCINIA VIRUS (STRAIN 23-42 |
| PROTEIN COPENHAGEN) |
| PYVGA-- VACCC HYPOTHETICAL 14 3 KD VACCINIA VIRUS (STRAIN 105-127 |
| PROTEIN COPENHAGEN) |
| PYVKB-- VACCC HYPOTHETICAL 9 0 KD VACCINIA VIRUS (STRAIN 54-70 |
| PROTEIN COPENHAGEN) |
| PYZL2-- EBV HYPOTHETICAL BZLF2 EPSTEIN-BARR VIRUS (STRAIN 150-166 |
| PROTEIN B95-8) |
| TABLE XIV |
| __________________________________________________________________________ |
| SEARCH RESULTS SUMMARY FOR P23TLZIPC MOTIF |
| __________________________________________________________________________ |
| PCGENE P23CTLZIP All Viruses (no bacteriophages) |
| FILE NAME PROTEIN VIRUS |
| __________________________________________________________________________ |
| PPOL2-- TBRVS RNA2 POLYPROTEIN TOMATO BLACK RING VIRUS (STRAIN S) |
| (TBRV) |
| PPOL2-- TRSVR RNA2 POLYPROTEIN TOMATO RINGSPOT VIRUS (ISOLATE |
| RASPBERRY) |
| (TOMRSV) |
| PPOLG-- BOVEV GENOME POLYPROTEIN BOVINE ENTEROVIRUS (STRAIN |
| VG-5-27) (BEV) |
| PPOLG-- BVDVN GENOME POLYPROTEIN BOVINE VIRAL DIARRHEA VIRUS |
| (SOLATE NADL) |
| PPOLG-- BVDVS GENOME POLYPROTEIN BOVINE VIRAL DIARRHEA VIRUS |
| (STRAINS SD-1) |
| PPOLG-- BYMV GENOME POLYPROTEIN BEAN YELLOW MOSAIC VIRUS |
| PPOLG-- COXA2 GENOME POLYPROTEIN COXSACKIEVIRUS A21 (STRAIN COE) |
| PPOLG-- COXA3 GENOME POLYPROTEI |
| N COXSACKIEVIRUS A23 (ECHO 9 VIRUS) |
| (EC-9-V) |
| PPOLG-- COXA9 GENOME POLYPROTEIN COXSACKIEVIRUS A9 (STRAIN GRIGGS) |
| PPOLG-- COXB1 GENOME POLYPROTEIN COXSACKIEVIRUS B1 |
| PPOLG-- COXB3 GENOME POLYPROTEIN COXSACKIEVIRUS B3 |
| PPOLG-- COXB4 GENOME POLYPROTEIN COXSACKIEVIRUS B4 |
| PPOLG-- COXB5 GENOME POLYPROTEIN COXSACKIEVIRUS B5 |
| PPOLG-- DEN1S GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN |
| SINGAPORE |
| S275/90) |
| PPOLG-- DEN1W GENOME POLYPROTEIN DENGUE VIRUS TYPE 1 (STRAIN |
| WESTERN PACIFIC) |
| PPOLG-- DEN26 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| 16681) |
| PPOLG-- DEN27 GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| 16681-PDK53) |
| PPOLG-- DEN2D GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| D2-04) |
| PPOLG-- DEN2J GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN |
| JAMAICA) |
| PPOLG-- DEN2N GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN NEW |
| GUINA C) |
| PPOLG-- DEN2P GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN PR |
| 159/S1) |
| PPOLG-- DEN2T GENOME POLYPROTEIN DENGUE VIRUS TYPE 2 (STRAIN TONGA |
| 1974 |
| PPOLG-- DEN3 GENOME POLYPROTEIN DENGUE VIRUS TYPE 3 |
| PPOLG-- DEN4 GENOME POLYPROTEIN DENGUE VIRUS TYPE 4 |
| PPOLG-- ECHG GENOME POLYPROTEIN ECHOVIRUS 11 (STRAIN GREGORY) |
| PPOLG-- EMCV GENOME POLYPROTEIN |
| ENCEPHALOMYOCARDITIS VIRUS |
| PPOLG-- EMCVB GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS VIRUS |
| (STRAIN EMC-B |
| NONDIABETOGENIC) |
| PPOLG-- EMCVD GENOME POLYPROTEIN ENCEPHALOMYOCARDITIS VIRUS |
| (STRAIN EMC-D |
| DIABETOGENIC) |
| PPOLG-- FMDV1 GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAIN |
| A10-61) (APHTHOVIRUS A) |
| PPOLG-- FMDVA GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAIN A12) |
| (APHTHOVIRUS A) |
| PPOLG-- FMDVO GENOME POLYPROTEIN FOOT-AND-MOUTH DISEASE VIRUS |
| (STRAINS O1K |
| AND O1BFS) |
| PPOLG-- HCV1 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE 1) |
| (HCV) |
| PPOLG-- HCVA GENOME POLYPROTEIN HOG CHOLERA VIRUS (STRAIN ALFORT) |
| (SWINE |
| FEVER VIRUS) |
| PPOLG-- HCVB GENOME POLYPROTEIN HOG CHOLERA VIRUS (STRAIN BRESCIA) |
| (SWINE FEVER VIRUS) |
| PPOLG-- HCVBK GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE BK) |
| (HCV) |
| PPOLG-- HCVH GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE H) |
| (HCV) |
| PPOLG-- HCVH4 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| HCV-476) (HCV) |
| PPOLG-- HCVJ6 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE HC-J6) |
| (HCV) |
| PPOLG-- HCVJ8 GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE HC-J8) |
| (HCV) |
| PPOLG-- HCVJA GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| JAPANESE) (HCV) |
| PPOLG-- HCVJT GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE HC-JT) |
| (HCV) |
| PPOLG-- HCVTW GENOME POLYPROTEIN HEPATITIS C VIRUS (ISOLATE |
| TAIWAN) (HCV |
| PPOLG-- HPAV2 GENOME POLYPROTEIN HEPATITIS A VIRUS (STRAIN 24A) |
| PPOLG-- HPAV4 GENOME POLYPROTEI |
| N HEPATITIS A VIRUS (STRAIN 43 C) |
| PPOLG-- HPAV8 GENOME POLYPROTEI |
| N HEPATITIS A VIRUS (STRAIN 18F) |
| PPOLG-- HPAVH GENOME POLYPROTEI |
| N HEPATITIS A VIRUS (STRAIN HM-175) |
| PPOLG-- HPAVL GENOME POLYPROTEI |
| N HEPATITIS A VIRUS (STRAIN LA) |
| PPOLG-- HPAVM GENOME POLYPROTEI |
| N HEPATITIS A VIRUS (STRAIN MBB) |
| PPOLG-- HPAVS GENOME POLYPROTEI |
| N SIMIAN HEPATISIS A VIRUS (STRAIN |
| AGM-27) |
| PPOLG-- HRV14 GENOME POLYPROTEIN HUMAN RHINOVIRUS 14 (HRV-14) |
| PPOLG-- HRV1B GENOME POLYPROTEI |
| N HUMAN RHINOVIRUS 1B (HRV-1B) |
| PPOLG-- HRV2 GENOME POLYPROTEIN |
| HUMAN RHINOVIRUS 2 (HRV-2) |
| PPOLG-- HRV89 GENOME POLYPROTEIN HUMAN RHINOVIRUS 89 (HRV-89) |
| PPOLG-- HUEV7 GENOME POLYPROTEI |
| N HUMAN ENTEROVIRUS 70 (STRAIN |
| J670/71 |
| PPOLG-- IBDVO STRUCTURAL POLYPROTEIN AVIAN INFECTIOUS BURSAL |
| DISEASE VIRUS |
| (STRAIN OH) |
| PPOLG-- JAEV1 GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN SA-14) |
| PPOLG-- JAEV5 GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN SA(V)) |
| PPOLG-- JAEVJ GENOME POLYPROTEIN JAPANESE ENCEPHALITIS VIRUS |
| (STRAIN |
| JAOARS982) |
| PPOLG-- JAEVN GENOME POLYPROTEIN JAPANESE ENCEPHALITS VIRUS |
| (STRAIN |
| NAKAYAMA) |
| PPOLG-- KUNJM GENOME POLYPROTEIN KUNJIN VIRUS (STRAIN MRM61C) |
| PPOLG-- LANVT GENOME POLYPROTEI |
| N LANGAT VIRUS (STRAIN TP21) |
| PPOLG-- MCFA GENOME POLYPROTEIN |
| MOSQUITO CELL FUSING AGENT (CFA |
| FLAVIVURUS) |
| PPOLG-- MDMV GENOME POLYPROTEIN MAIZE DWARF MOSACI VIRUS (MDMV) |
| PPOLG-- MVEV GENOME POLYPROTEIN |
| MURRAY VALLEY ENCEPHALITIS VIRUS |
| PPOLG-- OMV GENOME POLYPROTEIN |
| ORNITHOGALUM MOSAIC VIRUS |
| PPOLG-- PEMVC GENOME POLYPROTEIN PEPPER MOTTLE VIRUS (CALIFORNIA |
| ISOLATE) |
| (PEMV) |
| PPOLG-- POL1M GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN |
| MAHONEY) |
| PPOLG-- POL1S GENOME POLYPROTEIN POLIOVIRUS TYPE 1 (STRAIN SABIN) |
| PPOLG-- POL2L GENOME POLYPROTEI |
| N POLIOVIRUS TYPE 2 (STRAIN LANSING) |
| PPOLG-- POL2W GENOME POLYPROTEIN POLIOVIRUS TYPE 2 (STRAIN W-2) |
| PPOLG-- POL32 GENOME POLYPROTEI |
| N POLIOVIRUS TYPE 3 (STRAIN 23127) |
| PPOLG-- POL3L GENOME POLYPROTEI |
| N POLIOVIRUS TYPE 3 (STRAINS |
| P3/LEON/37 AND P3/ |
| LEON 12A[1]B) |
| PPOLG-- PPVD GENOME POLYPROTEIN PLUM POX POTYVIRUS (STRAIN D ) |
| (PPV) |
| PPOLG-- PPVEA GENOME POLYPROTEIN PLUM POX POTYVIRUS (STRAIN EL |
| AMAR) (PPV) |
| PPOLG-- PPVNA GENOME POLYPROTEIN PLUM POX POTYVIRUS (ISOLATE NAT) |
| (PPV) |
| PPOLG-- PPVRA GENOME POLYPROTEIN PLUM POX POTYVIRUS (STRAIN |
| RANKOVIC) (PPV) |
| PPOLG-- PSBMV GENOME POLYPROTEIN PEA SEED-BORNE MOSAIC VIRUS |
| (STRAIN DPDI) |
| PPOLG-- PVYHU GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN HUNGARIAN) |
| (PVY) |
| PPOLG-- PVYN GENOME POLYPROTEIN POTATO VIRUS Y (STRAIN N) (PVY) |
| PPOLG-- PYFV1 GENOME POLYPROTEI |
| N PARSNIP YELLOW FLECK VIRUS |
| (ISOLATE P-121) |
| (PYFV) |
| PPOLG-- SBMVN GENOME POLYPROTEIN SOYBEAN MOSAIC VIRUS (STRAIN N) |
| PPOLG-- STEVM GENOME POLYPROTEI |
| N ST. LOUIS ENCEPHALITIS VIRUS |
| (STRAIN MS1-7) |
| PPOLG-- SUMVS GENOME POLYPROTEIN SUGARCANE MOSAIC VIRUS (STRAIN |
| SC) |
| PPOLG-- SVDVH GENOME POLYPROTEIN SWINE VESICULAR DISEASE VIRUS |
| (STRAIN |
| H/3 '76) |
| PPOLG-- SVDVU GENOME POLYPROTEIN SWINE VESICULAR DISEASE VIRUS |
| (STRAIN |
| UKG/27/72) |
| PPOLG-- TBEVS GENOME POLYPROTEIN TICK-BORNE ENCEPHALITIS VIRUS |
| (STRAIN |
| SOFJIN) (TBEV) |
| PPOLG-- TBEVW GENOME POLYPROTEIN TICK-BORNE ENCEPHALITIS VIRUS |
| (WESTERN |
| SUBTYPE) (TBEV) |
| PPOLG-- TEV GENOME POLYPROTEIN TOBACCO ETCH VIRUS (TEV) |
| PPOLG-- TMEVB GENOME POLYPROTEIN THEILER'S MURINE ENCEPHALOMYELITIS |
| VIRUS |
| (STRAIN BEAN 8386) |
| PPOLG-- TMEVD GENOME POLYPROTEIN THEILER'S MURINE ENCEPHALOMYELITIS |
| VIRUS |
| (STRAIN DA) |
| PPOLG-- TEMVG GENOME POLYPROTEIN THEILER'S MURINE ENCEPHALOMYELITIS |
| VIRUS |
| (STRAIN GDVII) |
| PPOLG-- TUMV GENOME POLYPROTEIN TURNIP MOSAIC VIRUS (TUMV) |
| PPOLG-- TVMV GENOME POLYPROTEIN |
| TOBACCO VEIN MOTTLING VIRUS (TVMV) |
| PPOLG-- WMV2 GENOME POLYPROTEIN |
| WATERMELON MOSAIC VIRUS II |
| PPOLG-- WNV GENOME POLYPROTEIN WEST NILE VIRUS |
| PPOLG-- YEFV1 GENOME POLYPROTEIN YELLOW FEVER VIRUS (STRAIN 17D) |
| PPOLG-- YEFV2 GENOME POLYPROTEI |
| N YELLOW FEVER VIRUS (STRAIN PASTEUR |
| 17D-204) |
| PPOLG-- ZYMV GENOME POLYPROTEIN ZUCCHINI YELLOW MOSAIC VIRUS |
| (ZYMV) |
| PPOLH-- POLIM GENOME POLYPROTEIN POLIOVIRUS TYPE I (STRAIN |
| MAHONEY) |
| PPOLH-- WMV2 GENOME POLYPROTEIN WATERMELON MOSAIC VIRUS II |
| PPOLN-- EEVVT NONSTRUCTURAL |
| POLYPROTEIN VENEZUELAN EQUINE |
| ENCEPHALITIS VIRUS |
| (STRAIN TRINIDAD DONKEY) |
| PPOLN-- FCVC6 NONSTRUCTURAL POLYPROTEIN FELINE CALICIVIRUS (STRAIN |
| CF1/68 FIV) (FCV) |
| PPOLN-- FCVF4 NONSTRUCTURAL POLYPROTEIN FELINE CALICIVIRUS (STRAIN |
| JAPANESE F4) (FCV) |
| PPOLN-- FCVF9 NONSTRUCTURAL POLYPROTEIN FELINE CALICIVIRUS (STRAIN |
| F9 (FCV) |
| PPOLN-- HEVBU NONSTRUCTURAL POLYPROTEIN HEPATITIS E VIRUS (STRAIN |
| BURMA) (HEV) |
| PPOLN-- HEVME NONSTRUCTURAL POLYPROTEIN HEPATITIS E VIRUS (STRAIN |
| MEXICO) (HEV) |
| PPOLN-- HEVMY NONSTRUCTURAL POLYPROTEIN HEPATITIS E VIRUS (STRAIN |
| MYANMAR) (HEV) |
| PPOLN-- HEVPA NONSTRUCTURAL POLYPROTEIN HEPATITIS E VIRUS (STRAIN |
| PAKISTAN) (HEV) |
| PPOLN-- MIDDV NONSTRUCTURAL POLYPROTEIN MIDDELBURG VIRUS |
| PPOLN-- ONYVG NONSTRUCTURAL POLYPROTEIN O'NYONG-NYONG VIRUS |
| (STRAIN GULU) (ONN) |
| PPOLN-- RHDV NONSTRUCTURAL POLYPROTEIN RABBIT HEMORRHAGIC DISEASE |
| VIRU (RHDV |
| PPOLN-- SFV NONSTRUCTURAL POLYPROTEIN SEMLIKI FOREST VIRUS |
| PPOLN-- SINDO NONSTRUCTURAL |
| POLYPROTEIN SINDBIS VIRUS (SUBTYPE |
| OCKELBO/STRAIN |
| EDSBYN 82-5) |
| PPOLN-- SINDV NONSTRUCTURAL POLYPROTEIN SINDBIS VIRUS (STRAIN |
| HRSP) |
| PPOLS-- EEEV STRUCTURAL POLYPROTEIN EASTERN EQUINE ENCEPHALITIS |
| VIRUS |
| PPOLS-- EEEV3 STRUCTURAL POLYPROTEIN EASTERN EQUINE ENCEPHALITIS |
| VIRUS (STRAIN |
| VA33[TEN BROECK]) |
| PPOLS-- EEVV8 STRUCTURAL POLYPROTEIN VENEZUELAN EQUINE ENCEPHALITIS |
| VIRUS |
| (STRAIN TC-83) |
| PPOLS-- EEVVT STRUCTURAL POLYPROTEIN VENEZUELAN EQUINE ENCEPHALITIS |
| VIRUS |
| (STRAIN TRINIDAD DONKEY) |
| PPOLS-- ONNVG STRUCTURAL POLYPROTEIN O'NYONG-NYONG VIRUS (STRAIN |
| GULU) (ONN) |
| PPOLS-- RRVN STRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN |
| NB5092) (RRV) |
| PPOLS-- RRVT STRUCTURAL POLYPROTEIN ROSS RIVER VIRUS (STRAIN T48) |
| (RRB) |
| PPOLS-- SFV STRUCTURAL POLYPROTEIN SEMLIKI FOREST VIRUS |
| PPOLS-- SINDO STRUCTURAL POLYPROTEIN SINDBIS VIRUS (SUBTYPE |
| OCKLEBO/STRAIN |
| EDBYN 82-5) |
| PPOLS-- SINDV STRUCTURAL POLYPROTEIN SINDBIS VIRUS (STRAINS HRSP |
| AND HRLP) |
| PPOLS-- WEEV STRUCTURAL POLYPROTEIN WESTERN EQUINE ENCEPHALITIS |
| VIRUS |
| PPOL-- BIV06 POL POLYPROTEIN BOVINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE 106) (BIV) |
| PPOL-- BIV27 POL POLYPROTEIN BOVINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE 127) (BIV) |
| PPOL-- BLVAU POL POLYPROTEIN BOVINE LEUKEMIA VIRUS (AUSTRALIAN |
| ISOLATE) |
| (BLV) |
| PPOL-- CAEVC POL POLYPROTEIN CAPRINE ARTHRITIS ENCEPHALITIS VIRUS |
| (STRAIN CORK) (CAEV) |
| PPOL-- COYMV PUTATIVE POLYPROTEIN COMMELINA YELLOW MOTTLE VIRUS |
| (COYMV) |
| PPOL-- EIAV9 POL POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| 1369) |
| (EIAV) |
| PPOL-- EIAVC POL POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| CL22) |
| (EIAV) |
| PPOL-- EIAVY POL POLYPROTEIN EQUINE INFECTIOUS ANEMIA VIRUS |
| (ISOLATE |
| WYOMING) (EIAV) |
| PPOL-- FOAMV POL POLYPROTEIN HUMAN SPUMARETROVIRUS (FOAMY VIRUS) |
| PPOL-- GALV POL POLYPROTEIN |
| GIBBON APE LEUKEMIA VIRUS |
| PPOL-- HTL1A POL POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 |
| (STRAIN |
| ATK) (HTLV-1) |
| PPOL-- HTL1C POL POLYPROTEIN HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 |
| CARIBBEAN ISOLATE) (HTLV-1) |
| PPOL-- HV1A2 POL POLYPROTEIN |
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ARV2/SF2 ISOLATE) (HIV-1) |
| PPOL-- HV1B1 POL POLYPROTEIN |
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BH10 ISOLATGE) (HIV-1) |
| PPOL-- HV1B5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BH5 ISOLATE) (HIV-1) |
| PPOL-- HV1BR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| BRU ISOLATE) (HIV-1) |
| PPOL-- HV1EL POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| ELI ISOLATE) (HIV-1) |
| PPOL-- HV1H2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (HXB2 ISOLATE) (HIV-1) |
| PPOL-- HV1JR POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (JRCSF ISOLATE) (HIV-1) |
| PPOL-- HV1MA POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (MAL ISOLATE) (HIV-1) |
| PPOL-- HV1MN POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (MN ISOLATE) (HIV-1) |
| PPOL-- HV1N5 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (NEW YORK-5 ISOLATE) (HIV-1) |
| PPOL-- HV1ND POL POLYPROTEIN |
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (NDK ISOLATE) (HIV-1) |
| PPOL-- HV1OY POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (OY1 ISOLATE) (HIV-1) |
| PPOL-- HV1PV POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (PV22 ISOLATE) (HIV-1) |
| PPOL-- HV1RH POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (RF/HAT ISOALTE) (HIV-1) |
| PPOL-- HV1U4 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (STRAIN UGANDAN/ISOLATE |
| PPOL-- HV1Z2 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (Z2/CDC-234 ISOLATE) (HIV-1) |
| PPOL-- HV2CA POL POLYPROTEIN |
| HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE CAM2) (HIV-2) |
| PPOL-- HV2NZ POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE NIH-Z) (HIV-2) |
| PPOL-- HV2RO POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE ROD) (HIV-2) |
| PPOL-- IPHA PUTATIVE POL POLYPROTEIN HAMSTER INTRACISTERNAL |
| A-PARTICLE (IAP-H18 |
| PPOL-- JSRV POL POLYPROTEIN SHEEP PULMONARY ADENOMATOSIS VIRUS |
| PPOL-- MPMV POL POLYPROTEIN |
| SIMIAN MASON-PFIZER VIRUS (MPMV) |
| PPOL-- OMVVS POL POLYPROTEIN |
| OVINE LENTIVIRUS (STRAIN SA-OMVV) |
| PPOL-- RTBV POLYPROTEIN RICE |
| TUNGRO BACILLIFORM VIRUS (RTHV) |
| PPOL-- RTHVP POLYPROTEIN RICE |
| TUNGRO BACILLIFORM VIRUS (ISOLATE |
| PHILIPPINES) (RTHV) |
| PPOL-- SFV3L POL POLYPROTEIN SIMIAN FOAMY VIRUS (TYPE 3/STRAIN |
| LK3) (SFV-3) |
| PPOL-- SIVCL POL POLYPROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| (SIV(CPZ) (CIV) |
| PPOL-- SOCMV ENZYMATIC POLYPROTEIN SOYBEAN CHLOROTIC MOTTLE VIRUS |
| PPOL-- SRVL POL POLYPROTEIN |
| SIMIAN RETROVIRUS SRV-1 |
| PPOL-- VILV POL POLYPROTEIN VISNA LENTIVIRUS (STRAIN 1514) |
| PPOL-- VILV1 POL POLYPROTEIN |
| VISNA LENTIVIRUS (STRAIN 1514/CLONE |
| LV1-1KS1) |
| PPOL-- VILV2 POL POLYPROTEIN VISNA LENTIVIRUS (STRAIN 1514/CLONE |
| LVI-1KS2) |
| PPP41-- HSV6G PHOSPHOPROTEIN P41 HERPES SIMPLEX VIRUS (TYPE 6/ |
| STRAIN GS) |
| PPTP-- NPVAC PROTEIN-TYROSINE PHOSPHATASE AUTOGRAPHA CALIFORNICA |
| NUCLEAR |
| POLYHEDROSIS VIRUS |
| PREEP-- CSV REPEAT ELEMENT PROTEIN CAMPOLETIS SONORENSIS VIRUS |
| (CSV) |
| PREV-- BIV27 REV PROTEIN BOVINE IMMUNODEFICIENCY VIRUS (ISOLATE |
| 127) |
| (BIV) |
| PREV-- EIAV9 REV PROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (CLONE |
| 1369) |
| (EIAV) |
| PREV-- EIAVC REV PROTEIN EQUINE INFECTIONS ANEMIA VIRUS (CLONE |
| (CL22) |
| (EIAV) |
| PREV-- EIAVY REV PROTEIN EQUINE INFECTIOUS ANEMIA VIRUS (ISOLATE |
| (WYOMING) (EIAV) |
| PREV-- SIVAT REV PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (TYO- |
| ISOLATE) (SIV-AGM) |
| PRIR1-- ASFM2 RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CH |
| AFRICAN SWINE FEVER VIRUS (ISOLATE |
| MALAWI |
| LIL 20/1) (ASFV) |
| PRIR1-- HCMVA RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CH HUMAN |
| CYTOMEGALOVIRUS (STRAIN AB4P) |
| (EHV-1) |
| PRIR1-- HSVEB RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CH EQUINE |
| HERPESVIRUS TYPE 1 (STRAIN AB4P) |
| (EHV-1) |
| PRIR1-- VACCC RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CH |
| VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PRIR1-- VACCV RIBONUCLEOSIDE-DI |
| PHOSPHATE REDUCTASE LARGE CH |
| VACCINIA VIRUS (STRAIN WR) |
| PRIR1-- VARV RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CH VARIOLA |
| VIRUS |
| PRIR1-- VZVD RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CH |
| VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) (VZV) |
| PRMIL-- AVEVR RMIL SERINE/THRONINE-PROTEIN KINASE TRANSFORM AVIAN |
| ROUS-ASSOCIATED VIRUS TYPE 1 |
| PRMIL-- AVII1 RMIL SERINE/THRON |
| INE-PROTEIN KINASE TRANSFORM AVIAN |
| RETROVIRUS IC10 |
| PRP94-- VACCV RNA-POLYMERASE-ASSOCIATED TRANSCRIPTION SPECIF |
| VACCINIA VIRUS (STRAIN WR), AND |
| VACCINIA |
| VIRUS (STRAIN COPENHAGE |
| PRP94-- VARV RNA-POLYMERASE-ASSOCIATED TRANSCRIPTION SPECIF |
| VARIOLA VIRUS |
| PRPO1-- VACCV DNA-DIRECTED RNA POLYMERASE 147 KD POLYPEPTIDE |
| PRPO2-- CAPVK DNA-DIRECTED RNA |
| POLYMERASE 132 KD POLYPEPTIDE |
| CAPRIPOXVIRUS (STRAIN KS-1) |
| PRPO2-- COWPX DNA-DIRECTED RNA POLYMERASE 132 KD POLYPEPTIDE |
| COWPOX VIRUS (CPV) |
| PRPO2-- VACCV DNA-DIRECTED RNA POLYMERASE 132 KD POLYPEPTIDE |
| VACCINIA VIRUS (STRAIN WR), AND |
| VACCINIA |
| VIRUS (STRAIN COPENHAGE |
| PRPO2-- VARV DNA-DIRECTED RNA POLYMERASE 132 KD POLYPEPTIDE |
| VARIOLA VIRUS |
| PRPO7-- VACCV DNA-DIRECTED RNA POLYMERASE 19 KD POLYPEPTIDE |
| FOWLPOX CIRUS (STRAIN FP-1) |
| PRPO7-- VARV DNA-DIRECTED RNA POLYMERASE 19 KD POLYPEPTIDE VARIOLA |
| VIRUS |
| PRPO8-- FOWP1 DNA-DIRECTED RNA POLYMERASE 18 KD POLYPEPTIDE |
| FOWLPOX VIRUS (STRAIN FP-1) |
| PRPOA-- LELV RNA-DIRECTED RNA POLYMERASE LELYSTAD VIRUS (LV) |
| PROPOL-- EAV RNA-DIRECTED RNA |
| POLYMERASE EQUINE ARTERITIS VIRUS |
| (EAV) |
| PRRP1-- DHVI1 RNA-DIRECTED RNA POLYMERASE SUBUNIT P1 DHORI VIRUS |
| (STRAIN INDIAN/1313/61) (DHO) |
| PRRP1-- IAVI7 RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P1 INFLUENZA A |
| VIRUS (STRAIN A/VICTORIA/3/75) |
| PRRP1-- INCJJ RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P1 INFLUENZA C |
| VIRUS (STRAIN C/JJ/50) |
| PRRP2-- IAANN RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/ANN ARBOR/6/60) |
| PRRP2-- IADH2 RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/DUCK/HOKKAIDO/ |
| 8/80) |
| PRRP2-- IAFPR RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/FOWL PLAGUE |
| VIRUS/ROSTOCK/34) |
| PRRP2-- IAGU2 RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/GULL/MARYLAND/ |
| 704/77) |
| PRRP2-- IAHLO RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/EQUINE/LONDON/ |
| 1416/73) |
| PRRP2-- IAHTE RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/EQUINE/ |
| TENNESSEE/5/86) |
| PRRP2-- IAKOR RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/KOREA/426/68) |
| PRRP2-- IALE1 RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/LENINGRAD/ |
| 134/57) |
| PRRP2-- IALE2 RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/LENINGRAD/ |
| 134/17/57) |
| PRRP2-- IAMAN RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/MALLARD/NEW |
| YORK/6750/78) |
| PRRP2-- IANT6 RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/NT/60/68 |
| PRRP2-- IAP10 RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/PINTAIL/ALBERTA/ |
| 119/79) |
| PRRP2-- IAPUE RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/PUERTO RICO/8/34 |
| PRRP2-- IARUD RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/RUDDY |
| TURNSTONE/NEW JERSEY/47/85) |
| PRRP2-- IASIN RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/SINGAPORE/1/57) |
| PRRP2-- IATKM RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/TURKEY/ |
| MINNESOTA/833/80 |
| PRRP2-- IAVI7 RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/VICTORIA/3/75) |
| PRRP2-- IAWIL RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/WILSON-SMITH/33) |
| PRRP2-- IAZH2 RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/SWINE/HONG KING/ |
| 81/78) |
| PRRP2-- IAZH3 RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/SWINE/HONG KONG/ |
| 126/82) |
| PRRP2-- IAZI1 RNA-DIRECTED RNA POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/SWINE/IOWA/15/30) |
| PRRP2-- IAZTF RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P2 INFLUENZA A |
| VIRUS (STRAIN A/SWINE/TENNESSEE/ |
| 26/77) |
| PRRP3-- IABOD RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/BUDGERIGAR/ |
| HOKKAIDO/1/77) |
| PRRP3-- IAFPR RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/FOWL PLAGUE |
| VIRUS/ROSTOCK/34) |
| PRRP3-- IAFPW RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/FOWL PLAGUE |
| VIRUS/WEYBRIDGE) |
| PRRP3-- IAGU2 RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/GULL/MARYLAND/ |
| 704/77) |
| PRRP3-- IAGUA RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A GULL/ASTRAKHAN |
| /227/84) |
| PRRP3-- IAHPR RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/EQUINE/PRAGUE/ |
| 1/56) |
| PRRP3-- IAMAN RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/MALLARD/NEW |
| YORK/6750/78) |
| PRRP3-- IARUD RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/RUDDY |
| TURNSTONE/NEW JERSEY/4/7/85) |
| PRRP3-- IASE2 RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/SEAL/ |
| MASSACHUSETTS/133/82) |
| PRRP3-- IATKM RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/TURKEY/ |
| MINNESOTA/833/80) |
| PRRP3-- IAZI1 RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| VIRUS (STRAIN A/SWINE/ |
| IOWA/15/30) |
| PRRP3-- IAZTE RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA B |
| VIRUS (STRAIN A/SWINE/ |
| TENNESSEE/24/77) |
| PRRP3-- INBAC RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA B |
| VIRUS (STRAIN B/ANN ARBOR/1/66 |
| [COLD-ADAPTED]) |
| PRRP3-- INBAD RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA B |
| VIRUS (STRAIN B/ANN ARBOR/1/66 |
| [WILD-TYPE]) |
| PRRP3-- INCBE RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA C |
| VIRUS (STRAIN C/BERLIN/1/85) |
| PRRP3-- INCJJ RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT P3 INFLUENZA C |
| VIRUS (STRAIN C/JJ/50) |
| PRRP3-- THOGV RNA-DIRECTED RNA POLYMERASE SUBUNIT P3 INFLUENZA A |
| THOGOTO VIRUS (THO) |
| PRRPA-- CVH22 RNA-DIRECTED RNA POLYMERASE HUMAN CORONAVIRUS |
| (STRAIN A59) |
| PRRPA-- CVMJH RNA-DIRECTED RNA POLYMERASE MURINE CORONAVIRUS MHV |
| (STRAIN JHM) |
| PRRPB-- BEV RNA-DIRECTED RNA POLYMERASE BERNE VIRUS (BEV) |
| PRRPB-- CVMA5 RNA-DIRECTED RNA POLYMERASE MURINE CORONAVIRUS NHV |
| (STRAIN A59) |
| PRRPB-- CVMJH RNA-DIRECTED RNA POLYMERASE MURINE CORONAVIRUS MHV |
| (STRAIN JHM) |
| PRRPB-- CVPFS RNA-DIRECTED RNA POLYMERASE PORCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| CORONAVIRUS |
| PRRPB-- CVPR8 RNA-DIRECTED RNA POLYMERASE PORCINE RESPIRATORY |
| CORONAVIRUS |
| PRRPB-- IBVB RNA-DIRECTED RNA POLYMERASE AVIAN INFECTIOUS BRONCHITI |
| S VIRUS |
| (STRAIN BEAUDETTE) (IBV) |
| PRRPL-- BUNYW RNA POLYMERASE BUNYAMWERA VIRUS |
| PRRPL-- HANTV RNA POLYMERASE HANTAAN VIRUS (STRAIN 76-118) |
| (KOREAN HEMORRHAGIC FEVER VIRUS) |
| PRRPL-- HRSVA RNA POLYMERASE |
| BETA SUBUNIT HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS |
| (STRAIN A2) |
| PRRPL-- MABVM RNA-DIRECTED RNA POLYMERASE MARBURG VIRUS (STRAIN |
| MUSOKE) |
| PRRPL-- MABVP RNA-DIRECTED RNA POLYMERASE MARBURG VIRUS (STRAIN |
| POPP) |
| PRRPL-- MEASE RNA POLYMERASE BETA SUBUNIT MEASLES VIRUS (STRAIN |
| EDMONSTON) |
| PRRPL-- MUMPM RNA POLYMERASE BETA SUBUNIT MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) |
| PRRPL-- NDVB RNA POLYMERASE BETA SUBUNIT NEWCASTLE DISEASE VIRUS |
| (STRAIN BEAUDETTE |
| C/45) (NDV) |
| PRRPL-- PI2HT RNA POLYMERASE BETA SUBUNIT HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN |
| TOSHIBA) (PIV-2) |
| PRRPL-- PI3H4 RNA POLYMERASE BETA SUBUNIT HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN |
| NIH 47885) |
| PRRPL-- RABVP RNA POLYMERASE BETA SUBUNIT RABIES VIRUS (STRAIN PV) |
| PRRPL-- RABVS RNA POLYMERASE BETA SUBUNIT RABIES VIRUS (STRAIN SAD |
| B19) |
| PRRPL-- RDV RNA-DIRECTED RNA POLYMERASE RICE DWARF VIRUS (RDV) |
| PRRPL-- RVFVZ RNA-DIRECTED RNA |
| POLYMERASE RIFT VALLEY FEVER VIRUS |
| (STRAIN |
| ZH-548 M12) (RVFV) |
| PRRPL-- SEND5 RNA POLYMERASE BETA SUBUNIT SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) |
| PRRPL-- SENDE RNA POLYMERASE BETA SUBUNIT SENDAI VIRUS (STRAIN |
| ENDERS) |
| PRRPL-- SENDZ RNA POLYMERASE BETA SUBUNIT SENDAI VIRUS (STRAIN Z) |
| PRRPL-- SEOU8 RNA-DIRECTED RNA |
| POLYMERASE SEOUL VIRUS (STRAIN |
| 80-39) |
| PRRPL-- SV5WR RNA POLYMERASE BETA SUBUNIT SIMIAN VIRUS 5 (STRAIN |
| 21004-WR) (SV5) |
| PRRPL-- SYNV RNA POLYMERASE BETA SUBUNIT SONCHUS YELLOW NET VIRUS |
| (SYNV) |
| PRRPL-- TSWVB RNA-DIRECTED RNA POLYMERASE TOMATO SPOTTED WILT |
| VIRUS (BRAZILIAN |
| ISOLATE CPNH1/BR-01) (TSWV) |
| PRRPL-- UUK RNA-- POLYMERASE UUKUNIEMI VIRUS (UUK) |
| PRRPL-- VSVJH RNA POLYMERASE BETA SUBUNIT VESICULAR STOMATITIS |
| VIRUS |
| PRRPL-- VSVJO RNA POLYMERASE BETA SUBUNIT VESICULAR STOMATITIS |
| VIRUS |
| PRRPL-- VSVSJ RNA POLYMERASE BETA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (STRAIN |
| (SAN JUAN) |
| PRRPO-- BWYVF PUTATIVE RNA-DIRECTED RNA POLYMERASE BEET WESTERN |
| YELLOWS VIRUS (ISOLATE FL-1) |
| (BWYV) |
| PRRPO-- BYDV1 PUTATIVE RNA-DIRECTED RNA POLYMERASE BARLEY YELLOW |
| DWARF VIRUS (ISOLATE |
| MAV-PSI) (BYDV) |
| PRRPO-- BYDVP PUTATIVE RNA-DIRECTED RNA POLYMERASE BARLEY YELLOW |
| DWARF VIRUS (ISOLATE PAV) |
| (BYDV) |
| PRRPO-- BYDVR PUTATIVE RNA-DIRECTED RNA POLYMERASE BARLEY YELLOW |
| DWARF VIRUS (ISOLATE P-PAV) |
| PRRPO-- CABMV PROBABLE RNA-DIRECTED RNA POLYMERASE CARNATION |
| MOTTLE VIRUS (CARMV) |
| PRRPO-- CGMVS PUTATIVE RNA-DIRECTED RNA POLYMERASE CUCUMBER GREEN |
| MOTTLE MOSAIC VIRUS |
| (WATERMELON STRAIN SH) |
| PRRPO-- CNV PROBABLE RNA-DIRECTED RNA POLYMERASE CUCUMBER NECROSIS |
| VIRUS (CNV) |
| PRRPO-- CRM PROBABLE RNA-DIRECTED RNA POLYMERASE CYMBIDIUM |
| RINGSPOT VIRUS |
| PRRPO-- IBDV5 PUTATIVE RNA-DIRECTED RNA POLYMERASE AVIAN INFECTIOUS |
| VURSAL DISEASE VIRUS |
| (STRAIN 52/70) (IBDV) |
| PRRPO-- IBDVA PUTATIVE RNA-DIRECTED RNA POLYMERASE AVIAN INFECTIOUS |
| BURSAL DISEASE VIRUS |
| PRRPO-- IPNVJ PUTATIVE RNA-DIRECTED RNA POLYMERASE INFECTIOUS |
| PANCREATIC NECROSIS VIRUS |
| (SEROTYPE JASPER) |
| PRRPO-- IPNVS PUTATIVE RNA-DIRECTED RNA POLYMERASE INFECTIOUS |
| PANCREATIC NECROSIS VIRUS |
| (SEROTYPE SP) (IPNV) |
| PRRPO-- LYCVA RNA POLYMERASE LYMPHOCYTIC CHORIOMENINGITIS VIRUS |
| (STRAIN ARMSTRONG) |
| PRRPO-- LYCVW RNA POLYMERASE LYMPHOCYTIC CHORIOMENINGITIS VIRUS |
| (STRAIN WE) |
| PRRPO-- MCMV PROBABLE RNA-DIRECTED RNA POLYMERASE MAIZE CHLOROTIC |
| MOTTLE VIRUS (MCMV) |
| PRRPO-- PLRV1 PUTATIVE RNA-DIRECTED RNA POLYMERASE POTATO LEAFROLL |
| VIRUS (STRAIN 1) (PLRV |
| PRRPO-- PLRVW PUTATIVE RNA-DIRECTED RNA POLYMERASE POTATO LEAFROLL |
| VIRUS (STRAIN WAGENINGEN) |
| (PLRV) |
| PRRPO-- PPMVS PUTATIVE RNA-DIRECTED RNA POLYMERASE PEPPER MILD |
| MOTTLE VIRUS (STRAIN SPAIN) |
| (PPMV) |
| PRRPO-- RCNMV PUTATIVE RNA-DIRECTED RNA POLYMERASE RED CLOVER |
| NECROTIC MOSAIC VIRUS (RCNMV) |
| PRRPO-- REOVJ RNA-DIRECTED RNA |
| POLYMERASE REOVIRUS (TYPE 2/STRAIN |
| D5/JONES) |
| PRRPO-- ROTBR RNA-DIRECTED RNA POLYMERASE SUBUNIT VP1 BOVINE |
| ROTAVIRUS (STRAIN RF) |
| PRRPO-- ROTBU RNA-DIRECTED RNA POLYMERASE SUBUNIT VP1 BOVINE |
| ROTAVIRUS (STRAIN UK) |
| PRRPO-- ROTPG RNA-DIRECTED RNA POLYMERASE SUBUNIT VP1 PORCINE |
| ROTAVIRUS (STRAIN GOTTFRIED) |
| PRRPO-- ROTS1 RNA-DIRECTED RNA |
| POLYMERASE SUBUNIT VP1 SIMIAN 11 |
| ROTAVIRUS (STRAIN SA11) |
| PRRPO-- TACV RNA POLYMERASE TACARIBE VIRUS |
| PRRPO-- TBSVC PROBABLE RNA-DIRECTED RNA POLYMERASE TOMATO BUSHY |
| STUNT VIRUS (STRAIN CHERRY) |
| (TBSV) |
| PRRPO-- TCV PROBABLE RNA-DIRECTED RNA POLYMERASE TURNIP CRINKLE |
| VIRUS (TCV) |
| PRRPO-- TMGMV PUTATIVE RNA-DIRECTED RNA POLYMERASE TOBACCO MILD |
| GREEN MOSAIC VIRUS (TMV |
| STRAIN U2) |
| PRRPO-- TMV PUTATIVE RNA-DIRECTED RNA POLYMERASE TOBACCO MOSAIC |
| VIRUS (VULGARE) (TMV) |
| PRRPO-- TMVKR PUTATIVE RNA-DIRECTED RNA POLYMERASE TOBACCO MOSAIC |
| VIRUS (STRAIN KOREAN) (TMV) |
| PRRPO-- TMVTO PUTATIVE RNA-DIRECTED RNA POLYMERASE TOBACCO MOSAIC |
| VIRUS (STRAIN TOMATO/L) |
| (TMV) |
| PRRPO-- TNVA RNA-DIRECTED RNA POLYMERASE TOBACCO NECROSIS VIRUS |
| (STRAIN A) (TNV) |
| PRRPO-- TNVD RNA-DIRECTED RNA POLYMERASE TOBACCO NECROSIS VIRUS |
| (STRAIN D) (TNV) |
| PRRPP-- CDVO RNA POLYMERASE ALPHA SUBUNIT CANINE DISTEMPER VIRUS |
| (STRAIN |
| ONDERSTEPOORT) (CDV) |
| PRRPP-- MEASE RNA POLYMERASE ALPHA SUBUNIT MEASLES VIRUS (STRAIN |
| EDMONSTON) |
| PRRPP-- MEASI RNA POLYMERASE ALPHA SUBUNIT MEASLES VIRUS (STRAIN |
| P-3-CA) |
| PRRPP-- MEASY RNA POLYMERASE ALPHA SUBUNIT MEASLES VIRUS (STRAIN |
| YAMAGATA-1) |
| PRRPP-- MUMP1 RNA POLYMERASE ALPHA SUBUNIT MUMPS VIRUS (STRAIN |
| SBL-1) |
| PRRPP-- MUMPE RNA POLYMERASE ALPHA SUBUNIT MUMPS VIRUS (STRAIN |
| ENDERS) |
| PRRPP-- MUMPM RNA POLYMERASE ALPHA SUBUNIT MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) |
| PRRPP-- NDVA RNA POLYMERASE ALPHA SUBUNIT NEWCASTLE DISEASE VIRUS |
| (STRAIN AUSTRALIA- |
| VICTORIA/32) (NDV) |
| PRRPP-- NDVB RNA POLYMERASE ALPHA SUBUNIT NEWCASTLE DISEASE VIRUS |
| (STRAIN BEAUDETTE |
| C/45) (NDV) |
| PRRPP-- PI2H RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 2 |
| VIRUS (PIV-2 |
| PRRPP-- PI2HT RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 2 |
| VIRUS (STRAIN |
| TOSHIBA) (PIV-2) |
| PRRPP-- PI4HA RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 4A |
| VIRUS (STRAIN |
| TOSHIBA) (PIV-4A) |
| PRRPP-- PI4HB RNA POLYMERASE ALPHA SUBUNIT HUMAN PARAINFLUENZA 4B |
| VIRUS (STRAIN 68-333) |
| (PIV-4B) |
| PRRPP-- PIRYV RNA POLYMERASE ALPHA SUBUNIT PIRY VIRUS |
| PRRPP-- RABVA RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS (STRAIN |
| AVO1) |
| PRRPP-- RABVC RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS (STRAIN |
| CVS-11) |
| PRRPP-- RABVE RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS (STRAIN |
| ERA), AND RABIES VIRUS |
| (STRAIN PM) |
| PRRPP-- RABVP RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS (STRAIN |
| PV) |
| PRRPP-- RABVS RNA POLYMERASE ALPHA SUBUNIT RABIES VIRUS (STRAIN |
| SAD B19) |
| PRRPP-- SEND5 RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) |
| PRRPP-- SEND6 RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| 6/94) |
| PRRPP-- SENDF RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| FUSHIMI) |
| PRRPP-- SENDH RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN |
| HARRIS) |
| PRRPP-- SENDZ RNA POLYMERASE ALPHA SUBUNIT SENDAI VIRUS (STRAIN Z) |
| PRRPP-- SV5 RNA POLYMERASE ALPHA SUBUNIT SIMIAN VIRUS 5 (STRAIN |
| W3) (SV5) |
| PRRPP-- VSVJM RNA POLYMERASE ALPHA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE NEW |
| JERSEY/STRAIN MISSOUR |
| PRRPP-- VSVJO RNA POLYMERASE ALPHA SUBUNIT VESICULAR STOMATITIS |
| VIRUS (SEROTYPE NEW |
| JERSEY/STRAIN OGDEN) |
| PSODC-- VACCC SUPEROXIDE DISMUTASE LIKE PROTEIN VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| PSODC-- VACCV SUPEROXIDE DISMUTASE LIKE PROTEIN VACCINIA VIRUS |
| (STRAIN WR) |
| PSODC-- VARV SUPEROXIDE DISMUTASE LIKE PROTEIN VARIOLA VIRUS |
| PSPHR-- AMEPV SPHEROIDIN |
| AMSACTA MOOREI ENTOMOPOXVIRUS |
| (AMEPV) |
| PSP11-- MYXVL SERPIN 1 MYXOMA VIRUS (STRAIN LAUSANNE) |
| PSP13-- VACCC SERINE PROTEINASE INHIBITOR 3 VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PSP13-- VACCV SERINE PROTEINASE INHIBITOR 3 VACCINIA VIRUS (STRAIN |
| WR) |
| PSP13-- VARV SERINE PROTEINASE INHIBITOR 1 VARIOLA VIRUS |
| PTAG8-- FOWPV TRANS-ACTIVATOR PROTEIN FP0 FOWLPOX VIRUS |
| PTALA-- BFDV LARGE T ANTIGEN BUDGERIGAR FLEDGLING DISEASE VIRUS |
| (BFDV) |
| PTAM1-- POVHA MIDDLE T ANTIGEN HAMSTER POLYOMAVIRUS |
| PTAM1-- POVM3 MIDDLE T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN 3) |
| PTAM1-- POVMA MIDDLE T ANTIGEN |
| MOUSE POLYOMAVIRUS (STRAIN A2) |
| PTAM1-- POVMC MIDDLE T ANTIGEN |
| MOUSE POLYOMAVIRUS (STRAIN CRAWFORD |
| SMALL-PLAQUE) |
| PTASM-- POVBA SMALL T ANTIGEN POLYOMAVIRUS BK (STRAIN AS) |
| PTASM-- POVBK SMALL T ANTIGEN POLYOMAVIRUS BK |
| PTASM-- POVHA SMALL T ANTIGEN HAMSTER POLYOMAVIRUS |
| PTASM-- POVMA SMALL T ANTIGEN MOUSE POLYOMAVIRUS (STRAIN A2) |
| PTASM-- SV40 SMALL T ANTIGEN |
| SIMIAN VIRUS 40 (SV40) |
| PTEGU-- EBV LARGE TEGUMENT PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PTEGU-- HCMVA PROBABLY LARGE TEGUMENT PROTEIN HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PTEGU-- HSV6G LARGE TEGUMENT PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) |
| PTEGU-- HSVEB LARGE TEGUMENT PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| (EHV-1) |
| PTEGU-- HSVSA PROBABLY LARGE TEGUMENT PROTEIN HERPESVIRUS SAIMIUI |
| (STRAIN 11) |
| PTERM-- ADE07 DNA TERMINAL PROTEIN HUMAN ADENOVIRUS TYPE 7 |
| PTMAF-- AVIS4 TRANSFORMING |
| PROTEIN MAF AVIAN MUSCULOAPONEUROTIC |
| FIBROSARCOMA |
| VIRUS AS42 |
| PTOP2-- ASFB7 DNA TOPOISOMERASE 11 AFRICAN SWINE FEVER VIRUS |
| (STRAIN BA71V) |
| (ASFV) |
| PTOP2-- ASFM2 DNA TOPOISOMERASE 11 AFRICAN SWINE FEVER VIRUS |
| (ISOLATE MALAWI |
| LIL 20/1) (ASFV) |
| PTREL-- AVIRE REL TRANSFORMING PROTEIN AVIAN RETICULOENDOTHELIOSIS |
| VIRUS |
| PTYSY-- VZVD THYMIDYLATE SYNTHASE VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) (VZV) |
| PU1L-- HSV6U PROTEIN 1L HERPES SIMPLEX VIRUS (TYPE 6/STRAIN |
| UGANDA- |
| 1102) |
| PUDPE-- NPVAC ECDYSTEROID UDP-GLUCOSYL TRANSFERASE AUTOGRAPHA |
| CALIFORNICA NUCLEAR |
| PERCURSO POLYHEDROSIS VIRUS (ACMNPV) |
| PUL02-- HCMVA HYPOTHETICAL PROTEIN UL2 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL06-- EBV VIRION PROTEIN BBRF1 EPSTEIN-BARR BIRUS (STRAIN B95-8) |
| (HUMAN |
| HERPESVIRUS 4) |
| PUL06-- HSV11 VIRION PROTEIN UL6 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| PUL06-- HSVEB VIRION GENE 56 PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| (EHV-1) |
| PUL06-- HSVSA VIRION GENE 43 PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| PUL06-- VZVD VIRION GENE 54 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| (VZV) |
| PUL07-- HCMVA HYPOTHETICAL PROTEIN UL7 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL07-- HSVEB GENE 55 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) |
| (EHV-1) |
| PUL08-- HCMVA HYPOTHETICAL PROTEIN UL8 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL08-- HSV11 PROTEIN UL8 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| PUL08-- VZVD GENE 52 PROTEIN |
| VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| (VZV) |
| PUL09-- HSV11 ORIGION OF REPLICATIONI BINDING PROTEIN HERPES |
| SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| PUL09-- VZVD ORIGION OF |
| REPLICATIONI BINDING PROTEIN |
| VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| (VZV) |
| PUL14-- PRVN3 UL14 PROTEIN HOMOLOG PSEUDORABIES VIRUS (STRAIN |
| NIA-3) (PRV) |
| PUL16-- HSV11 PROTEIN UL16 HERPES SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| PUL17-- HSV6U PROTEIN 10R HERPES SIMPLEX VIRUS (TYPE 6/STRAIN |
| UGANDA-1102) |
| PUL21-- HSVEB GENE 40 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) |
| (EHV-1) |
| PUL21-- PRVN3 PROTEIN UL21 HOMOLOG PSEUDORABIES VIRUS (STRAIN |
| NIA-3) (PRV) |
| PUL21-- VZVD GENE 38 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN DUMAS) |
| (VZV) |
| PUL24-- HCMVA HYPOTHETICAL PROTEIN UL24 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL24-- ILTVT PROTEIN UL24 HOMOLOG INFECTIOUS LARYNGOTRACHEITIS |
| VIRUS (STRAIN |
| THORNE V882) |
| PUL25-- HSVEB VIRION PROTEIN UL25 EQUINE HERPESVIRUS TYE 1 (STRAIN |
| AB4P) |
| (EHV-1) |
| PUL25-- HSVSA VIRION GENE 19 PROTEIN HERPESVIRUS SAIMIRI (STRAIN |
| 11) |
| PUL25-- VZVD VIRION GENE 34 PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| (VZV) |
| PUL28-- HCMVA HYPOTHETICAL PROTEIN UL28 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL31-- HCMVA HYPOTHETICAL PROTEIN UL31 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL31-- HSVSA GENE 69 PROTEIN HEREPESVIRUS SAIMIRI (STRAIN 11) |
| PUL32-- EBV PROBABLE MAJOR |
| ENVELOPE GLYCOPROTEIN BFLF1 EPSTEIN-B |
| ARR VIRUS (STRAIN B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PUL32-- HSV11 PROBABLE MAJOR ENVELOPE GLYCOPROTEIN UL32 HERPES |
| SIMPLEX VIRUS (TYPE 1/STRAIN 17) |
| PUL32-- HSVEB MAJOR ENVELOPE |
| GLYCOPROTEIN 300 EQUINE HERPESVIRUS |
| TYPE 1 |
| PUL32-- HSVSA PROBABLE MAJOR ENVELOPE GLYCOPROTEIN 68 HERPESVIRUS |
| SAIMIRI (STRAIN 11) |
| PUL32-- VZVD PROBABLE MAJOE ENVELOPE GLYCOPROTEIN 26 VARICELLA-ZOST |
| ER VIRUS (STRAIN DUMAS) |
| (VZV) |
| PUL34-- HSVSA GENE 67 PROTEIN HERPES VIRUS SAIMIRI (STRAIN 11) |
| PUL35-- HCMVA HYPOTHETICAL |
| PROTEIN UL35 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL36-- HCMVA HYPOTHETICAL PROTEIN UL46 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL37-- EBV PROTEIN BOLF1 EPSTEIN-BARR VIRUS (STRAIN B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PUL37-- HSVEB GENE 23 PROTEIN EQUINE HERPESVIRUS TYPE 1 (STRAIN |
| AB4P) |
| (EHV-1) |
| PUL37-- HSVSA GENE 63 PROTEIN HERPESVIRUS SAIMIRI (STRAIN 11) |
| PUL37-- VZVD GENE 21 PROTEIN |
| VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| (VZV) |
| PUL38-- HCMVA HYPOTHETICAL PROTEIN UL38 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL41-- VZVD HOST SHUTOFF VIRION PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| (VZV) |
| PUL43-- HSV11 MEMBRANE PROTEIN UL41 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| PUL45-- HSV11 GENE 15 MEMBRANE PROTEIN VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| (VZV) |
| PUL47-- HCMVA PROTEIN UL47 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PUL47-- HSVE4 97 KD ALPHA |
| TRANS-INDUCING PROTEIN EQUINE |
| HERPESVIRUS TYPE 4 |
| PUL47-- HSVEB 97 KD ALPHA TRANS-INDUCING PROTEIN EQUINE HERPESVIRUS |
| TYPE 1 (STRAIN AB4P) |
| (EHV-1) |
| PUL49-- HSV11 TEGUMENT PROTEIN UL49 HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17 |
| PUL49-- HSVBP TEGUMENT PROTEIN UL49 HOMOLOG BOVINE HERPESVIRUS |
| TYPE 1 (STRAIN P8-2) |
| PUL52-- EBV PROBABLE DNA REPLICATION PROTEIN BSLF1 EPSTEIN-BARR |
| VIRUS (STRAIN B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PUL52-- HSV11 DNA REPLICATION PROTEIN UL52 HERPES SIMPLEX VIRUS |
| (TYPE 1/STRAIN 17) |
| PUL52-- HSVEB DNA REPLICATION PROTEIN UL52 EQUINE HERPESVIRUS TYPE |
| 1 (STRAIN AB4P) |
| (EVH-1) |
| PUL52-- HSVSA PROBABLE DNA REPLICATION GENE 56 PROTEIN HERPESVIRUS |
| SAIMIRI (STRAIN 11) |
| PUL53-- HCMVA PROTEIN UL53 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PUL53-- HSV6U UL53 PROTEIN |
| HOMOLOG HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN UGANDA- |
| 1102) |
| PUL60-- HCMVA HYPOTHETICAL PROTEIN UL60 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169 |
| PUL70-- HCMVA PROBABLE DNA REPLICATION PROTEIN UL70 HUMAN CYTOMEGAL |
| OVIRUS (STRAIN AD169) |
| PUL77-- HCMVA VIRION PROTEIN UL77 HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| PUL78-- HCMVA HYPOTHETICAL PROTEIN UL78 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL79-- HSVSA HYPOTHETICAL GENE 18 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PUL87-- HSV6U HYPOTHETICAL PROTEIN 5R HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN UGANDA- |
| 1102) |
| PUL87-- HSVSA HYPOTHETICAL GENE 24 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PUL88-- HCMVA HYPOTHETICAL PROTEIN UL88 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUL88-- HSV6U HYPOTHETICAL PROTEIN 6R HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN UGANDA- |
| 1102) |
| PUL91-- HSVSA HYPOTHETICAL GENE 30 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PUL92-- EBV HYPOTHETICAL PROTEIN BDLF4 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PUL92-- HSVSA HYPOTHETICAL GENE 31 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PUL93-- HCMVA PROTEIN UL93 HUMAN CYTOMEGALOVIRUS (STRAIN AD169) |
| PUL95-- EBV HYPOTHETICAL |
| PROTEIN BGLF3 EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PULB8-- HCMVA HYPOTHETICAL PROTEIN UL118 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169 |
| PULC1-- HCMVA HYPOTHETICAL PROTEIN UL121 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PULC8-- HCMVA HYPOTHETICAL PROTEIN UL128 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PULC9-- HCMVA HYPOTHETICAL PROTEIN UL129 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PULD0-- HCMVA HYPOTHETICAL PROTEIN UL130 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUNG-- EBV URACIL-DNA GLYCOSYLASE EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PUNG-- VACCC URACIL-DNA GLYCOSYLASE VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PUNG-- VACCV URACIL-DNA GLYCOSYLASE VACCINIA VIRUS (STRAIN WR) |
| PUNG-- VARV URACIL-DNA |
| GLYCOSYLASE VARIOLA VIRUS |
| PUS02-- HCMVA HYPOTHETICAL PROTEIN HQLF2 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS07-- HCMVA HYPOTHETICAL PROTEIN HXLF5 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS09-- HCMVA HYPOTHETICAL PROTEIN HXLF3 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS10-- HCMVA HYPOTHETICAL PROTEIN HXLF2 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS12-- HCMVA HYPOTHETICAL PROTEIN HVLF6 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS13-- HCMVA HYPOTHETICAL PROTEIN HVLF5 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS15-- HCMVA HYPOTHETICAL PROTEIN HVLF3 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169 |
| PUS16-- HCMVA HYPOTHETICAL PROTEIN HVLF2 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS18-- HCMVA MEMBRANE PROTEIN HWLF5 HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| PUS22-- HCMVA EARLY NUCLEAR PROTEIN HWLF1 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS26-- HCMVA HYPOTHETICAL PROTEIN HHLF5 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS27-- HCMVA G-PROTEIN COUPLED RECEPTOR HOMOLOG US27 HUMAN |
| CYTOMEGALOVIRUS (STRAIN AD169) |
| PUS29-- HCMVA HYPOTHETICAL |
| PROTEIN HHRF4 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PUS30-- HCMVA HYPOTHETICAL PROTEIN HHRF5 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PV125-- AMVLE 125 KD PROTEIN ALFALFA MOSAIC VIRUS (STRAIN 425/ISOLA |
| TE |
| LEIDEN |
| PV13K-- TRVPL 16 KD PROTEIN TOBACCO RATTLE VIRUS (STRAIN PLB) |
| PV143-- NPVAC HELICASE |
| AUTOGRAPHA CALIFORNICA NUCLEAR |
| POLYHEDROSIS VIRUS |
| PV17K-- BSMV 17 KD PROTEIN BARLEY STRIPOE MOSAIC VIRUS (BSMV) |
| PV1A-- CMVFN 1A PROTEIN |
| CUCUMBER MOSAIC VIRUS (STRAIN FNY) |
| (CMV) |
| PV270-- ASFB7 L270 PROTEIN AFRICAN SWINE FEVER VIRUS (STRAIN |
| BA71V) |
| (ASFV) |
| PV2A-- BBMV 2A PROTEIN BROAD BEAN MOTTLE VIRUS |
| PV2A-- CCMV 2A PROTEIN COWPEA CHLOROTIC MOTTLE VIRUS (CCMV) |
| PV2A-- CMVFN 2A PROTEIN |
| CUCUMBER MOSAIC VIRUS (STRAIN FNY) |
| (CMV) |
| PV2A-- CMVQ 2A PROTEIN CUCUMBER MOSAIC VIRUS (STRAIN Q) (CMV) |
| PV2A-- TAV 2A PROTEIN TOMATO |
| ASPERMY VIRUS (TAV) |
| PV30K-- TRVTC 29.1 KD PROTEIN TOBACCO RATTLE VIRUS (STRAIN TCM) |
| PV3A-- BBMV 3A PROTEIN BROAD |
| BEAN MOTTLE VIRUS |
| PV3A-- BMV 3A PROTEIN BROME MOSAIC VIRUS (BMV) |
| PV3A-- CCMV 3A PROTEIN COWPEA CHLOROTIC MOTTLE VIRUS (CCMV) |
| PV3A-- IBVB 3A PROTEIN AVIAN |
| INFECTIOUS BRONCHITIS VIRUS (STRAIN |
| BEAUDETTE) (IBV) |
| PV3A-- IBVM 3A PROTEIN AVIAM INFECTIOUS BRONCHITIS VIRUS (STRAIN |
| M41) (IBV) |
| PV3A-- IBVP3 3A PROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| PV3A-- IBVU5 3A PROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS (STRAIN |
| UK/183/66) (IBV) |
| PV51K-- ACLSV 50.8 KD PROTEIN APPLE CHLOROTIC LEAF SPOT VIRUS |
| (ACLSV) |
| PV51K-- BWYVF 51 KID PROTEIN BEET WESTERN YELLOWS VIRUS (ISOLATE |
| FL-1) |
| (BWYV) |
| PV51K-- BWYVG 51 KID PROTEIN BEET WESTERN YELLOWS VIRUS (ISOLATE |
| GB1) |
| (BWYV) |
| PV56K-- PLRV1 56 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN 1) |
| (PLRV) |
| PV56K-- PLRVW 56 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN WAGENINGE |
| N) |
| (PLRV) |
| PV58K-- BSMV 58 KD PROTEIN BARLEY STRIPE MOSAIC VIRUS (BSMV) |
| PV70K-- PLRV1 69.7 KD PROTEIN |
| POTATO LEAFROLL VIRUS (STRAIN 1) |
| (PLRV) |
| PV70K-- PLRVW 69.7 KD PROTEIN POTATO LEAFROLL VIRUS (STRAIN |
| WAGENINGEN) |
| (PLRV) |
| PV90K-- AMVLE 90 KD PROTEIN ALFALFA MOSAIC VIRUS (STRAIN 425/ISOLAT |
| E |
| LEIDEN) |
| PVA04-- VACCC PROTEIN A4 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA04-- VACCV PROTEIN A4 |
| VACCINIA VIRUS (STRAIN WR) |
| PVA04-- VARV PROTEIN A4 VARIOLA VIRUS |
| PVA11-- VACCC PROTEIN A11 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA11-- VARV PROTEIN A11 |
| VARIOLA VIRUS |
| PVA18-- VACCC 56 KD ABORTIVE LATE PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PVA18-- VACCV 56 KD ABORTIVE LATE PROTEIN VACCINIA VIRUS (STRAIN |
| WR) |
| PVA18-- VARV 56 KD ABORTIVE LATE PROTEIN VARIOLA VIRUS |
| PVA23-- VACCC PROTEIN A23 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA23-- VARV PROTEIN A23 |
| VARIOLA VIRUS |
| PVA31-- VACCC PROTEIN A31 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA31-- VACCV PROTEIN A31 |
| VACCINIA VIRUS (STRAIN WR) |
| PVA31-- VARV PROTEIN A31 VARIOLA VIRUS |
| PVA32-- VACCV PROTEIN A32 VACCINIA VIRUS (STRAIN WR), AND VACCINIA |
| VIRUS (STRAIN COPENHAG |
| PVA32-- VARV PROTEIN A32 VARIOLA VIRUS |
| PVA40-- VACCC PROTEIN A40 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA43-- VACCC PROTEIN A43 |
| VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA43-- VACCV PROTEIN A43 |
| VACCINIA VIRUS (STRAIN WR) |
| PVA43-- VARV PROTEIN A43 VARIOLA VIRUS |
| PVA51-- VACCC PROTEIN A51 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVA51-- VACCV PROTEIN A51 |
| VACCINIA VIRUS (STRAIN WR) |
| PVAL1-- BCTV AL1 PROTEIN BEET CURLY TOP VIRUS (BCTV) |
| PVAL1-- BGMV AL1 PROTEIN BEAN GOLDEN MOSAIC VIRUS |
| PVAL1-- CLVK AL1 PROTEIN CASSAVA LATENT VIRUS (STRAIN WEST KENYAN |
| 844 |
| PVAL1-- CLVN AL1 PROTEIN CASSAVA LATENT VIRUS (STRAIN NIGERIAN) |
| PVAL1-- PYMVV AL1 PROTEIN |
| POTATO YELLOW MOSAIC VIRUS (ISOLATE |
| VENEZUELA) |
| PVAL1-- TGMV AL1 PROTEIN TOMATO GOLDEN MOSAIC VIRUS (TGMV) |
| PVAL1-- TYLCM AL1 PROTEIN |
| TOMATO YELLOW LEAF CURL VIRUS |
| (STRAIN |
| MARMANDE) (TYLCV) |
| PVAL1-- TYLCV AL1 PROTEIN TOMATO YELLOW LEAF CURL VIRUS (TYLCV) |
| PVAL3-- BCTV AL3 PROTEIN BEET |
| CURLY TOP VIRUS (BCTV) |
| PVAL3-- CLVK AL3 PROTEIN CASSAVA LATENT VIRUS (STRAIN WEST KENYAN |
| 844) |
| PVAL3-- CLVN AL3 PROTEIN CASSAVA LATENT VIRUS (STRAIN NIGERIAN) |
| PVAL3-- TYLCM AL3 PROTEIN |
| TOMATO YELLOW LEAF CURL VIRUS |
| (STRAIN |
| MARMANDE) (TYLCV) |
| PVAL3-- TYLCV AL3 PROTEIN TOMATO YELLOW LEAF CURL VIRUS (TYLCV |
| PVAT-- CAMVC APHID TRANSMISSION |
| PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN CM-1841) |
| (CAMV) |
| PVAT-- CAMVD APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN D/H) |
| (CAMV |
| PVAT-- CAMVE APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN BBC) |
| (CAMV) |
| PVAT-- CAMVN APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN NY8153) |
| (CAMV) |
| PVAT-- CAMVP APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN PV147) |
| (CAMV) |
| PVAT-- CAMVS APHID TRANSMISSION PROTEIN CAULIFLOWER MOSAIC VIRUS |
| (STRAIN |
| STRASBOURG) (CAMV) |
| PVB04-- VACCC PROTEIN B4 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVB04-- VACCV PROTEIN B4 |
| VACCINIA VIRUS (STRAIN WR) |
| PVB04-- VARV PROTEIN B4 VARIOLA VIRUS |
| PVB16-- COWPX INTERLEUKIN-1 BINDING PROTEIN PRECURSOR COWPOX VIRUS |
| (CPV) |
| PVB16-- VACCV INTERLUEKIN-1 BINDING PROTEIN PRECURSOR VACCINIA |
| VIRUS (STRAIN WR) |
| PVB19-- VACCC SURFACE ANTIGEN S PRECURSOR VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PVB19-- VACCD SURFACE ANTIGEN S PRECURSOR VACCINIA VIRUS (STRAIN |
| DAIREN 1) |
| PVB19-- VACCV SURFACE ANTIGEN S PRECURSOR VACCINIA VIRUS (STRAIN |
| WR) |
| PVB19-- VARV SURFACE ANTIGEN S PRECURSOR VARIOLA VIRUS |
| PVBR1-- BGMV BR1 PROTEIN BEAN GOLDEN MOSAIC VIRUS |
| PVC03-- SFVKA G-PROTEIN COUPLED RECEPTOR HOMOLOG C3 SHOPE FIBROMA |
| VIRUS (STRAIN KASZA) (SFV) |
| PVC04-- VACCC PROTEIN C4 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC04-- VACCV PROTEIN C4 |
| VACCINIA VIRUS (STRAIN WR) |
| PVC04-- VARV PROTEIN C4 VARIOLA VIRUS |
| PVC06-- VACCC PROTEIN C6 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC06-- VACCV PROTEIN C6 |
| VACCINIA VIRUS (STRAIN WR) |
| PVC06-- VARV PROTEIN C6 VARIOLA VIRUS |
| PVC07-- SFVKA HYPOTHETICAL PROTEIN C7 SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) (SFV) |
| PVC09-- VACCC PROTEIN C9 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC09-- VACCV PROTEIN C9 |
| VACCINIA VIRUS (STRAIN WR) |
| PVC10-- SFVKA HYPOTHETICAL PROTEIN C10 SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) (SFV) |
| PVC10-- VACCC PROTEIN C10 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVC10-- VACCV PROTEIN C10 |
| VACCINIA VIRUS (STRAIN WR) |
| PVC10-- VARV PROTEIN C10 VARIOLA VIRUS |
| PVC21-- VACCC PROTEIN C21/B27 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVCAP-- EBV MAJOR CAPSID |
| PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PVCAP-- HCMVA MAJOR CAPSID PROTEIN HUMAN CYTOMEGALOVIRUS (STRAIN |
| AD169) |
| PVCAP-- HSV11 MAJOR CAPSID PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| PVCAP-- HSV6U MAJOR CAPSID PROTEIN HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN UGANDA- |
| 1102) |
| PVCAP-- HSVEB MAJOR CAPSID PROTEIN EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| (EHV-1) |
| PVCAP-- HSVSA MAJOR CAPSID PROTEIN HERPESVIRUS SAIMIRI (STRAIN 11) |
| PVCAP-- PRVIS MAJOR CAPSID PROTEIN PSUEDORABIES VIRUS (STRAIN |
| INDIANA S) |
| (PRV) |
| PVCAP-- VZVD MAJOR CAPSID PROTEIN VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| (VZV) |
| PVCOM-- ADE02 MINOR CORE PROTEIN HUMAN ADENOVIRUS TYPE 2 |
| PVCOM-- ADE05 MINOR CORE PROTEIN HUMAN ADENOVIRUS TYPE 5 |
| PVD03-- VACCC PROTEIN D3 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVD03-- VACCV PROTEIN D3 |
| VACCINIA VIRUS (STRAIN WR) |
| PVD03-- VARV PROTEIN D3 VARIOLA VIRUS |
| PVD05-- FOWP1 92.6 KD PROTEIN FOWLPOX VIRUS (STRAIN FP-1) |
| PVD05-- VACCC PROTEIN D5 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVD05-- VACCV PROTEIN D5 |
| VACCINIA VIRUS (STRAIN WR) |
| PVD05-- VARV PROTEIN D5 VARIOLA VIRUS |
| PVD10-- FOWP1 PROTEIN D10 FOWLPOX VIRUS (STRAIN FP-1) |
| PVE05-- VACCD PROTEIN E5 VACCINIA VIRUS (STRAIN DAIREN 1) |
| PVE06-- VACCC PROTEIN E6 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVE06-- VACCV PROTEIN E6 |
| VACCINIA VIRUS (STRAIN WR) |
| PVE06-- VARV PROTEIN E6 VARIOLA VIRUS |
| PVE10-- VACCC PROTEIN E10 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVE10-- VACCV PROTEIN E10 |
| VACCINIA VIRUS (STRAIN WR) |
| PVE10-- VARV PROTEIN E10 VARIOLA VIRUS |
| PVE12-- HPV16 PROBABLE E1 PROTEIN 2 HUMAN PAPILLOMAVIRUS TYPE 16 |
| PVE18-- NPVAC EARLY 18.5 KD |
| PROTEIN AUTOGRAPHA CALIFORNICA |
| NUCLEAR |
| POLYHEDROSIS VIRUS (ACMNPV) |
| PVE1-- HPV05 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5 |
| PVE1-- HPV11 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 11 |
| PVE1-- HPV13 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 13 |
| PVE1-- HPV33 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 33 |
| PVE1-- HPV35 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 35 |
| PVE1-- HPV39 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 39 |
| PVE1-- HPV41 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 |
| PVE1-- HPV58 E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 58 |
| PVE1-- HPV5B E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5B |
| PVE1-- HPV6B E1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 6B |
| PVE1-- PAPVD E1 PROTEIN DEER PAPILLOMAVIRUS |
| PVE1-- PCPV1 E1 PROTEIN PYGMY CHIMPANZEE PAPILLOMAVIRUS TYPE 1 |
| PVE26-- NPVAC EARLY 25.9 KD |
| PROTEIN AUTOGRAPHA CALIFORNICA |
| NUCLEAR |
| POLYHEDROSIS VIRUS (ACMNPV) |
| PVE2-- HPV57 E2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 57 |
| PVE2-- RHPV1 E2 PROTEIN RHESUS PAPILLOMAVIRUS TYPE 1 (RHPV 1) |
| PVE41-- NPVAC EARLY 40.9 KD |
| PROTEIN AUTOGRAPHA CALIFORNICA |
| NUCLEAR |
| POLYHEDROSIS VIRUS (ACMNPV) |
| PVE5A-- HPV11 PROBABLE E5A PROTEIN HUMAN PAPILLOMAVIRUS TYPE 11 |
| PVE5A-- HPV6B PROBABLE E5A |
| PROTEIN HUMAN PAPILLOMAVIRUS TYPE 6B |
| PVE5A-- HPV6C PROBABLE E5A PROTEIN HUMAN PAPILLOMAVIRUS TYPE 6C |
| PVE5-- HPV13 PROBABLE E5 |
| PROTEIN HUMAN PAPILLOMAVIRUS TYPE 13 |
| PVE5-- HPV5B PROBABLE E5 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5B |
| PVE5-- PCPV1 PROBABLE E5 |
| PROTEIN PYGMY CHIMPANZEE PAPILLOMAVIR |
| US TYPE 1 |
| PVE5-- RHPV1 PROBABLE E5 PROTEIN RHESUS PAPILLOMAVIRUS TYPE 1 |
| (RHPV 1) |
| PVE6-- HPV1A E6 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 1A |
| PVE7-- HPV05 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5 |
| PVE7-- HPV08 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 8 |
| PVE7-- HPV11 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 11 |
| PVE7-- HPV16 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 16 |
| PVE7-- HPV1A E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 1A |
| PVE7-- HPV31 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 31 |
| PVE7-- HPV33 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 33 |
| PVE7-- HPV35 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 35 |
| PVE7-- HPV41 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 41 |
| PVE7-- HPV47 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 47 |
| PVE7-- HPV51 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 51 |
| PVE7-- HPV58 E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 58 |
| PVE7-- HPV5B E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5B |
| PVE7-- HPV6B E7 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 6B |
| PVE7-- PAPVD E7 PROTEIN DEER PAPILLOMAVIRUS |
| PVE7-- PAPVE 37 PROTEIN EUROPEAN ELK PAPILLOMAVIRUS (EEPV) |
| PVE94-- NPVAC EARLY 94 KD |
| PROTEIN AUTOGRAPHA CALIFORNICA |
| NUCLEAR |
| POLYHEDROSIS VIRUS (ACMNPV) |
| PVEF-- GVTN VIRAL ENHANCING FACTOR TRICHLOPLUSIA NI GRANULOSIS |
| VIRUS (TNGV) |
| PVENV-- BEY ENVELOPE PROTEIN BERNE VIRUS (BEV) |
| PVENV-- DHO11 ENVELOPER GLYCOPROTEIN PRECURSOR DHORI VIRUS (STRAIN |
| INDIAN/1313/61) (DHO) |
| PVENV-- MCV1 MAJOR ENVELOPE PROTEIN MOLLUSCUM CONTAGIOSUM VIRUS |
| SUBTYPE 1 |
| (MCVI) |
| PVENV-- MCV2 MAJOR ENVELOPE PROTEIN MOLLUSCUM CONTAGIOSUM VIRUS |
| SUBTYPE 2 |
| (MCVII) |
| PVENV-- VACCC MAJOR ENVELOPE PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PVENV-- VACCI MAJOR ENVELOPE PROTEIN VACCINIA VIRUS (STRAIN IHD-J) |
| PVENV-- VACCP MAJOR ENVELOPE PROTEIN VACCINIA VIRUS (STRAIN L0IVP) |
| PVENV-- VACCV MAJOR ENVELOPE PROTEIN VACCINIA VIRUS (STRAIN WR) |
| PVENV-- VARV MAJOR ENVELOPE |
| PROTEIN VARIOLA VIRUS |
| PVF03-- VACCC PROTEIN F3 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVF03-- VACCV PROTEIN F3 |
| VACCINIA VIRUS (STRAIN WR) |
| PVFP1-- FOWPV PROTEIN FP1 FOWLPOX VIRUS |
| PVFP4-- FOWPV PROTEIN FP4 FOWLPOX VIRUS |
| PVFP7-- CAPVK PROTEIN F7 CAPRIPOXVIRUS (STRAIN KS-1) |
| PVFUS-- VACCC 14 KD FUSION PROTEIN VACCINIA VIRUS (STRAIN COPENHAGE |
| N) |
| PVFUS-- VACCV 14 KD FUSION PROTEIN VACCINIA VIRUS (STRAIN WR) |
| PVFUS-- VARV 14 KD FUSION |
| PROTEIN VARIOLA VIRUS |
| PVG01-- HSV11 HYPOTHETICAL GENE 1 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG02-- HSVEB HYPOTHETICAL GENE 2 PROTEIN EQUINE HERPESVIRUS TYPE |
| 1 (STRAIN AB4P) |
| (EHV-1) |
| PVG02-- VACCV ISATIN-BETA-THIOSEMICARBAZONE DEPENDENT PROTEI |
| VACCINIA VIRUS (STRAIN WR), AND |
| VACCINIA VIRUS (STRAIN COPENHAGE |
| PVG02-- VARV ISATIN-BETA-THIOSE |
| MICARBAZONE DEPENDENT PROTEI VARIOLA |
| VIRUS |
| PVG03-- HSV11 HYPOTHETICAL GENE 3 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PVG06-- HSV11 HYPOTHETICAL GENE 6 MEMBRANE PROTEIN ICTALURID |
| HERPESVIRUS 1 (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PVG06-- VACCC PROTEIN G6 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVG06-- VARV PROTEIN G6 |
| VARIOLA VIRUS |
| PVG07-- VACCC PROTEIN G7 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVG07-- VARV PROTEIN G7 |
| VARIOLA VIRUS |
| PVG09-- VACCC PROTEIN F1 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVG09-- VACCV PROTEIN F1 |
| VACCINIA VIRUS (STRAIN WR) |
| PVG09-- VARV PROTEIN F1 VARIOLA VIRUS |
| PVG11-- HSV11 HYPOTHETICAL GENE 11 ZINC-BINDING PROTEIN ICTALURID |
| HERPESVIRUS 1 (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG12-- HSV11 HYPOTHETICAL GENE 12 ZINC-BINDING PROTEIN ICTALURID |
| HERPESVIRUS 1 (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PVG12-- HSVSA HYPOTHETICAL GENE 12 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PVG1-- SPV1R CAPSID PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B |
| PVG22-- HSV11 HYPOTHETICAL GENE 22 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG23-- HSV11 HYPOTHETICAL GENE 23 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PVG26-- HSV11 HYPOTHETICAL GENE 26 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PVG27-- HSVSA HYPOTHETICAL GENE 27 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PVG28-- HSV11 HYPOTHETICAL GENE 28 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PVG2R-- AMEPV HYPOTHETICAL G2R PROTEIN AMSACTA MOORE1 ENTOMOPOXVIRU |
| S (AMEPV) |
| PVG2-- SPV4 GENE 2 PROTEIN SPIROPLASMA VIRUS 4 (SPV4) |
| PVG35-- HSV11 HYPOTHETICAL GENE 35 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG36-- HSVSA POSSIBLE TYROSINE-PROTEIN KINASE HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PVG39-- HSV11 HYPOTHETICAL GENE 39 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PVG40-- HSVSA HYPOTHETICAL GENE 40 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PVG41-- HSV11 HYPOTHETICAL GENE 41 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PVG42-- HSV11 HYPOTHETICAL GENE 42 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PVG43-- HSV11 HYPOTHETICAL GENE 43 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CAHNNEL CATFISH |
| VIRUS) (CCV) |
| PCG46-- HSV11 PROBABLE MAJOR GLYCOPROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG48-- HSVSA HYPOTHETICAL GENE 48 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PVG50-- HSVSA PROBABLE TRANSCIPTION ACTIVATOR-EDRF1 HERPESVIRUS |
| SAIMIRI (STRAIN 11) |
| PVG51-- HSV11 HYPOTHETICAL GENE 51 MEMBRANE PROTEIN ICTALURID |
| HERPESVIRUS 1 (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG52-- HSV11 HYPOTHETICAL GENE 52 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG55-- HSV11 HYPOTHETICAL GENE 55 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG56-- HSV11 HYPOTHETICAL GENE 56 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG58-- HSV11 HYPOTHETICAL GENE 58 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG58-- HSVSA GENE 58 PROTEIN HERPESVIRUS SAIMIRI (STRAIN 11) |
| PVG59-- HSV11 HYPOTHETICAL |
| GENE 59 MEMBRANE PROTEIN ICTALURID |
| HERPESVIRUS 1 (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG61-- HSV11 HYPOTHETICAL GENE 61 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG64-- HSV11 HYPOTHETICAL GENE 64 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG65-- HSV11 HYPOTHETICAL GENE 65 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG67-- HSV11 HYPOTHETICAL GENE 67 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG6-- SPV1R GENE 6 PROTEIN SPRIOPLASMA SPV1-R8A2 B |
| PVG71-- HSVSA HYPOTHETICAL GENE 71 PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PVG72-- HSV11 HYPOTHETICAL GENE 72 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG75-- HSV11 HYPOTHETICAL GENE 75 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG76-- HSV11 HYPOTHETICAL GENE 76 PROTEIN ICTALURID HERPESVIRUS 1 |
| (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVG7-- SPV1R GENE 7 PROTEIN SPIROPLASMA VIRUS SPV1-R8A2 B |
| PVGF1-- 1BVB F1 PROTEIN AVAIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN BEAUDETTE) (IBV) |
| PVGH3-- HCMVA GLYCOPROTEIN H301 PREWCURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVGL2-- CVBF E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS (STRAIN |
| F15) |
| PVGL2-- CVBL9 E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS (STRAIN |
| L9) |
| PVGL2-- CVBLY E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS (STRAIN |
| LY-138) |
| PVGL2-- CVBM E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS (STRAIN |
| MEBUS) |
| PVGL2-- CVBQ E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS (STRAIN |
| QUEBEC) |
| PVGL2-- CVBV E2 GLYCOPROTEIN PRECURSOR BOVINE CORONAVIRUS (STRAIN |
| VACCINE) |
| PVGL2-- CVH22 E2 GLYCOPROTEIN PRECURSOR HUMAN CORONAVIRUS (STRAIN |
| 229E) |
| PVGL2-- CVM4 E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS MHV |
| (STRAIN WILD |
| TYPE 4) (MHV-4) |
| PVGL2-- CVMA5 E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS MHV |
| (STRAIN A59 |
| PVGL2-- CVMJC E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS MHV |
| (STRAIN JHMV/ |
| VARIANT CL-2) |
| PVGL2-- CVMJH E2 GLYCOPROTEIN PRECURSOR MURINE CORONAVIRUS MHV |
| (STRAIN JHM) |
| PVGL2-- CVPFS E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| CORONAVIRUS |
| PVGL2-- CVPMI E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| CORONAVIRUS |
| PVGL2-- CVPPR E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| CORONAVIRUS |
| PVGL2-- CVPPU E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| CORONAVIRUS |
| PVGL2-- CVPR8 E2 GLYCOPROTEIN PRECURSOR PORCINE RESPIRATORY |
| CORONAVIRUS |
| PVGL2-- CVPRM E2 GLYCOPROTEIN PRECURSOR PORCINE RESPIRATORY |
| CORONAVIRUS (STRAIN |
| RM4) (PRCV) |
| PVGL2-- CVPRT E2 GLYCOPROTEIN PRECURSOR PORCINE TRANSMISSION |
| GASTROENTERITIS |
| CORONAVIRUS (STRAIN NEB7 |
| PVGL2-- FIPV E2 GLYCOPROTEIN PRECURSOR FELINE INFECTIOUS PERINTONIT |
| IS VIRUS |
| (STRAIN 79-1146) (FIPV) |
| PVGL2-- IBVB E2 GLYCOPROTEIN PRECURSOR AVIAN INFECTIOUS BRONCHITIS |
| VIRUS (STRAIN |
| BEAUDETTE) (IBV) |
| PVGLB-- HCMVA GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVGLB-- HCMVT GLYCOPROTEIN B PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN TOWNE) |
| PVGLB-- HSV6U GLYCOPROTEIN B HERPES SIMPLEX VIRUS (TYPE 6/STRAIN |
| UGANDA- |
| 1102) |
| PVGLB-- HSVB1 GLYCOPROTEIN 1 PRECURSOR BOVINE HERPESVIRUS TYPE 1 |
| PVGLB-- HSVB2 GLYCOPROTEIN B-1 |
| PRECURSOR BOVINE HERPESVIRUS TYPE 2 |
| (STRAIN BMV) |
| (BOVINE MAMMILLITIS VIRUS |
| PVGLB-- HSVBC GLYCOPROTEIN 1 PRECURSOR BOVINE HERPESVIRUS TYPE 1 |
| (STRAIN COOPER |
| PVGLB-- ILTV6 GLYCOPROTEIN B PRECURSOR INFECTIOUS LARYNGOTRACHEITIS |
| VIRUS |
| (STRAIN 632) (ILIV) |
| PVGLB-- ILTVS GLYCOPROTEIN B PRECURSOR INFECTIOUS LARYNGOTRACHEITIS |
| VIRUS |
| (STRAIN SA-2) (ILTV) |
| PVGLB-- ILTVT GLYCOPROTEIN B PRECURSOR INFECTIOUS LARYNGOTRACHEITIS |
| VIRUS |
| (STRAIN THRONE V882) (ILTV) |
| PVGLB-- MCMB5 GLYCOPROTEIN B PRECURSOR MURINE CYTOMEGALOVIRUS |
| (STRAIN SMITH) |
| PVGLC-- HSV11 GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN 17) |
| PVGLC-- HSV1K GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 1/STRAIN KOS) |
| PVGLC-- HSV2 GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 2) |
| PVGLC-- HSV23 GLYCOPROTEIN C PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 2/STRAIN 333) |
| PVGLC-- HSVBC GLYCOPROTEIN G111 PRECURSOR BOVINE HERPESVIRUS (TYPE |
| 1 (STRAIN COOPER) |
| PVGLC-- VZVD GLYCOPROTEIN GPV VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| (VZV) |
| PVGLC-- VZVS GLYCOPROTEIN GPV VARICELLA-ZOSTER VIRUS (STRAIN |
| SCOTT) |
| (VZV) |
| PVGLD-- HSVEA GLYCOPROTEIN D PRECURSPR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB1) |
| (EHV-1) |
| PVGLD-- HSVEB GLYCOPROTEIN D PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| PVGLD-- HSVEK GLYCOPROTEIN D |
| PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| PVGLE-- HSVE4 GLYCOPROTEIN E |
| EQUINE HERPESVIRUS TYPE 4 |
| PVGLE-- HSVEB GLYCOPROTEIN E PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| PVGLE-- HSVEL GLYCOPROTEIN E |
| PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| PVGLE-- PRVRi GLYCOPROTEIN G1 |
| PRECURSOR PSEUDORABIES VIRUS (STRAIN |
| RICE) (PRV) |
| PVGLF-- BRSVA FUSION GLYCOPROTEIN PRECURSOR BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS (STRAIN |
| A51908) (BRS) |
| PVGLF-- BRSVC FUSION GLYCORPROTEIN PRECURSOR BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS |
| (STRAIN COPENHAGEN) (BRS) |
| PVGLF-- BRSVR FUSION GLYCORPROTEIN PRECURSOR BOVINE RESPIRATORY |
| SYNCYTIAL VIRUS |
| (STRAIN RB94) (BRS) |
| PVGLF-- CDVO FUSION GLYCORPROTEIN PRECURSOR CANINE DISTEMPER VIRUS |
| (STRAIN |
| (ONDERSTEPOORT) (CDV) |
| PVGLF-- HRSV1 FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS |
| (SUBGROUP B/STRAIN 18537) |
| PVGLF-- HRSVA FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS |
| (STRAIN A2) |
| PVGLF-- HRSVL FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS |
| SUBGROUP A/STRAIN LONG) |
| PVGLF-- HRSVR FUSION GLYCOPROTEIN PRECURSOR HUMAN RESPIRATORY |
| SYNCYTIAL VIRUS |
| (STRAIN RSS-2) |
| PVGLF-- MEASE FUSION GLYCOPROTEIN PRECURSOR MEASLES VIRUS (STRAIN |
| EDMONSTON) |
| PVGLF-- MEAS1 FUSION GLYCOPROTEIN PRECURSOR MEASLES VIRUS (STRAIN |
| IP-3-CA |
| PVGLF-- MEASY FUSION GLYCOPROTEIN PRECURSOR MEASLES VIRUS (STRAIN |
| YAMAGATA-1) |
| PVGLF-- MUMP1 FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| SBL-1) |
| PVGLF-- MUMPM FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| MIYAHARA VACCINE) |
| PVGLF-- MUMPR FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| RW) |
| PVGLF-- MUMPS FUSION GLYCOPROTEIN PRECURSOR MUMPS VIRUS (STRAIN |
| SBL) |
| PVGLF-- NDVI FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN |
| ITALIEN/45) (NDV) |
| PVGLF-- NDVL FUSION GLYCOPROTEIN PRECURSOR NEWCASTLE DISEASE VIRUS |
| (STRAIN LAS/46) |
| (NDV) |
| PVGLF-- PHODV FUSION GLYCOPROTEIN PRECURSOR PHOCINE DISTEMPER |
| VIRUS |
| PVGLF-- P11HC FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 1 |
| VIRUS (STRAIN C39) |
| PVGLF-- P13B FUSION GLYCOPROTEIN PRECURSOR BOVINE PARAINFLUENZA 3 |
| VIRUS |
| PVGLF-- P13H4 FUSION GLYCOPROTEIN PRECURSOR HUMAN PARAINFLUENZA 3 |
| VIRUS (STRAIN NIH |
| 47885 |
| PVGLF-- RINDK FUSION GLYCOPROTEIN PRECURSOR ( RINDERPEST VIRUS |
| (STRAIN KABETE O) |
| (RDV) |
| PVGLF-- RINDL FUSION GLYCOPROTEIN PRECURSOR RINDERPEST VIRUS |
| (STRAIN L) (RDV) |
| PVGLF-- SEND5 FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| Z/HOST MUTANTS) |
| PVGLF-- SENDF FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| FUSHIMI) |
| PVGLF-- SENDH FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| HARRIS) |
| PVGLF-- SENDJ FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| HVJ) |
| PVGLF-- SENDZ FUSION GLYCOPROTEIN PRECURSOR SENDAI VIRUS (STRAIN |
| Z) |
| PVGLF-- SV5 FUSION GLYCOPROTEIN PRECURSOR SIMIAN VIRUS 5 (STRAIN |
| W3) (SV5) |
| PVGLF-- TRTV FUSION GLYCOPROTEIN PRECURSOR TURKEY RHINOTRACHEITIS |
| VIRUS (TRTV) |
| PVGLG-- HSVEB GLYCOPROTEIN G PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| (STRAIN AB4P) |
| (EHV-1) |
| PVGLG-- SYNV SPIKE GLYCOPROTEIN PRECURSOR SOCHUS YELLOW NET VIRUS |
| (SYNV) |
| PVGLG-- VSV1G SPIKE GLYCOPROTEIN PRECURSOR VESICULAR STOMATITIS |
| VIRUS (SEROTYPE |
| INDIANA/STRAIN GLASGOW) |
| PVGLG-- VSVJO SPIKE GLYCOPROTEIN PRECURSOR VESCICULAR STOMATITIS |
| VIRUS (SEROTYPE |
| NEW JERSEY/STRAIN OGEDEN) |
| PVGLG-- VSVO SPIKE GLYCOPROTEIN PRECURSOR VESCICULAR STOMATITIS |
| VIRUS (STRAIN ORSAY) |
| PVGLG-- VSVSJ SPIKE GLYCOPROTEIN PRECURSOR VESCICULAR STOMATITIS |
| VIRUS (STRAIN SAN |
| JUAN) |
| PVGLH-- HCMVA GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVGLH-- HCMVT GLYCOPROTEIN H PRECURSOR HUMAN CYTOMEGALOVIRUS |
| (STRAIN TOWNE) |
| PVGLH-- HSV6G GLYCOPROTEIN H PRECURSOR HERPES SIMPLEX VIRUS (TYPE |
| 6/STRAIN GS) |
| PVGLH-- HSVE4 GLYCOPROTEIN H PRECURSOR EQUINE HERPESVIRUS TYPE 4 |
| PVGLH-- HSVEB GLYCOPROTEIN H |
| PRECURSOR EQUINE HERPESVIRUS TYPE 1 |
| PVGLI-- HCMVA IMMEDIATE: EARLY |
| GLYCOPROTEIN PRECURSOR HUMAN |
| CYTOMEGALOVIRUS (STRAIN AD169) |
| PVGLM-- BUNGE M POLYPROTEIN |
| PRECURSOR BUNYAVIRUS GERMISTON |
| PVGLM-- BUNL7 M POLYPROTEIN |
| PRECURSOR BUNYAVIRUS LA CROSSE |
| (ISOLATE 1.74) |
| PVGLM-- BUNSH M POLYPROTEIN PRECURSOR BUNYAVIRUS SNOWSHOE HARE |
| PVGLM-- BUNYW M POLYPROTEIN |
| PRECURSOR BUNYAMWERA VIRUS |
| PVGLM-- DUGBV M POLYPROTEIN PRECURSOR DUGBE VIRUS |
| PVGLM-- HANTB M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STAIN B-1) |
| (KOREAN |
| HEMORRHAGIC FEVER VIRUS) |
| PVGLM-- HANTH M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN HOJO) |
| PVGLM-- HANTL M POLYPROTEIN |
| PRECURSOR HANTAAN VIRUS (STRAIN LEE) |
| PVGLM-- HANTV M POLYPROTEIN PRECURSOR HANTAAN VIRUS (STRAIN |
| 76-118) |
| PVGLM-- INSV M POLYPROTEIN PRECURSOR IMPATIENTS NECROTIC SPOT |
| VIRUS (INSV) |
| PVGLM-- PHV M POLYPROTEIN PRECURSOR PROSPECT HILL VIRUS (PHV) |
| PVGLM-- PTPV M POLYPROTEIN |
| PRECURSOR PUNTA TORO PHLEBOVIRUS |
| PVGLM-- PUUMH M POLYPROTEIN |
| PRECURSOR PUUMALA VIRUS (STRAIN |
| HALLNAS B1) |
| PVGLM-- PUUMS M POLYPROTEIN PRECURSOR PUUMALA VIRUS (STRAIN |
| SOTKAMAO) |
| PVGLM-- RVFV M POLYPROTEIN PRECURSOR RIFT VALLEY FEVER VIRUS |
| (RVFV) |
| PVGLM-- RVFVZ M POLYPROTEIN PRECURSOR RIFT VALLEY FEVER VIRUS |
| (STRAIN ZH-548 M12) |
| (RVFV) |
| PVGLM-- SEOU8 M POLYPROTEIN PRECURSOR SEOUL VIRUS (STRAIN 80-39) |
| PVGLM-- SEOUR M POLYPROTEIN |
| PRECURSOR SEOUL VIRUS (STRAIN R22) |
| PVGLM-- SEOUS M POLYPROTEIN |
| PRECURSOR SEOUL VIRUS (STRAIN SR-11) |
| (SAPPORO RAT |
| VIRUS) |
| PVGLM-- UUK M POLYPROTEIN PRECURSOR UUKUNIEMI VIRUS (UUK) |
| PVGLP-- BEV PREPOLYMER GLYCOPROTEIN PRECURSOR BERNE VIRUS (BEV) |
| PVGLY-- JUNIN GLYCOPROTEIN |
| POLYPROTEIN PRECURSOR JUNIN ARENA |
| VIRUS |
| PVGLY-- LASSG GLYCOPROTEIN POLYPROTEIN PRECURSOR LASSA VIRUS |
| (STRAIN GA391) |
| PVGLY-- LASSJ GLYCOPROTEIN POLYPROTEIN PRECURSOR LASSA VIRUS |
| (STRAIN JOSIAH) |
| PVGLY-- PIARV GLYCOPROTEIN POLYPROTEIN PRECURSOR PICHNDE ARENAVIRUS |
| PVGLY-- TACV GLYCOPROTEIN POLYPROTEIN PRECURSOR TACARIBE VIRUS |
| PVGLY-- TACV5 GLYCOPROTEIN |
| POLYPROTEIN PRECURSOR TACARIBE VIRUS |
| (STRAIN V5 |
| PVGLY-- TACV7 GLYCOPROTEIN POLYPROTEIN PRECURSOR TACARIBE VIRUS |
| (STRAIN V7) |
| PVGLY-- TACVT GLYCOPROTEIN POLYPROTEIN PRECURSOR TACARIBE VIRUS |
| (STRAIN TRVL 11598) |
| PVGNB-- CPMV GENOME POLYPROTEIN B COWPEA MOSAIC VIRUS (CPMV) |
| PVGNM-- CPMV GENOME POLYPROTEIN |
| M COWPEA MOSAIC VIRUS (CPMV) |
| PVGNM-- CPSMV GENOME POLYPROTEI |
| N M COWPEA SEVERE MOSAIC VIRUS |
| (STRAIN DG) |
| PVGNM-- RCMV GENOME POLYPROTEIN M RED CLOVER MOTTLE VIRUS (RMCV) |
| PVGP2-- EBV PROBABLE MEMBRANE |
| ANTIGEN GP220 EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PVGP3-- EBV ENVELOPE GLYCOPROTEIN GP340 EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PVH02-- VACCC LATE PROTEIN H2 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVH02-- VACCC LATE PROTEIN H2 |
| VACCINIA VIRUS (STRAIN WR) |
| PVH02-- VAVR LATE PROTEIN H2 VARIOLA VIRUS |
| PVH05-- VACCC PROTEIN H5 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVH05-- VACCC PROTEIN H5 |
| VACCINIA VIRUS (STRAIN WR) |
| PVH05-- VAVR PROTEIN H5 VARIOLA VIRUS |
| PVHEL-- LSV PROBABLE HELICASE LILY SYMPTOMLESS VIRUS (LSV) |
| PVI01-- VACCC PROTEIN 11 |
| VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVI01-- VARV PROTEIN 11 |
| VARIOLA VIRUS |
| PVI06-- VACCC PROTEIN 16 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVI06-- VARV PROTEIN 16 |
| VARIOLA VIRUS |
| PVI08-- VACCC PUTATIVE RNA HELICASE 18 VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PVI08-- VACCC PUTATIVE RNA HELICASE 18 VACCINIA VIRUS (STRAIN WR) |
| PVI08-- VACCC PUTATIVE RNA |
| HELICASE 18 VARIOLA VIRUS |
| PVIE1-- HCMVA 55 KD IMMEDIATE-EARLY PROTEIN 1 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVIE1-- HCMVT 55 KD IMMEDIATE-EARLY PROTEIN 1 HUMAN CYTOMEGALOVIRUS |
| (STRAIN TOWNE) |
| PVIF-- BIV06 VIRION INFECTIVITY FACTOR BOVINE IMMUNODEFICIENCY |
| VIRUS |
| (ISOLATE 106) (BIV) |
| PVIF-- BIV27 VIRION INFECTIVITY FACTOR BOVINE IMMUNODEFICIENCY |
| VIRUS |
| (ISOLATE 127) (BIV) |
| PVIF-- SIVGB VIRION INFECTIVITY FACTOR SIMIAN IMMUNODEFICIENCY |
| VIRUS |
| (ISOLATE GB1) |
| PVIF-- SIVMK VIRION INFECTIVITY FACTOR SIMIAN IMMUNODEFICIENCY |
| VIRUS |
| (K6W ISOLATE) (SIV-MAC) |
| PVIMP-- EBV PROBABLE INTEGRAL MEMBRANE PROTEIN BBRF3 EPSTEIN-BARR |
| VIRUS (STRAIN B95-8) |
| (HUMAN HERPESVIRUS 4) |
| PVIMP-- HCMVA PROBABLE INTEGRAL MEMBRANE PROTEIN HUMAN CYTOMEGALOVI |
| RUS (STRAIN AD169) |
| PVIMP-- HSV11 PROBABLE INTEGRAL MEMBRANE PROTEIN HERPES SIMPLEX |
| VIRUS (TYPE 1/STRAIN 17) |
| PVIMP-- HSVEB PROBABLE INTEGRAL MEMBRANE PROTEIN EQUINE HERPESVIRUS |
| TYPE 1 (STRAIN ABRP) |
| (EHV-1) |
| PVIMP-- HSVSA INTEGRAL MEMBRANE PROTEIN HERPESVIRUS SAIMIRI |
| (STRAIN 11) |
| PVINT-- SSV1 PROBABLE INTEGRASE SULFOLOBUS VIRUS-LIKE PARTICLE |
| SSV1 |
| PVJ05-- VACCC PROTEIN J5 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVJ05-- VACCV PROTEIN J5 |
| VACCINIA VIRUS (STRAIN WR) |
| PVJ05-- VARV PROTEIN J5 VARIOLA VIRUS |
| PVK04-- VACCC PROTEIN K4 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVK04-- VACCV PROTEIN K4 |
| VACCINIA VIRUS (STRAIN WR) |
| PVK05-- VACCC PROTEIN K5 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVK05-- VACCV PROTEIN K5 |
| VACCINIA VIRUS (STRAIN WR) |
| PVL02-- VACCC PROTEIN L2 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVL02-- VACCV PROTEIN L2 |
| VACCINIA VIRUS (STRAIN WR) |
| PVL02-- VARV PROTEIN L2 VARIOLA VIRUS |
| PVL03-- VACCC PROTEIN L3 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVL03-- VACCV PROTEIN L3 |
| VACCINIA VIRUS (STRAIN WR) |
| PVL03-- VARV PROTEIN L3 VARIOLA VIRUS |
| PVL05-- VACCV PROTEIN L5 VACCINIA VIRUS (STRAIN WR), AND |
| VACCINIA VIRUS (STRAIN COPEHNHAGEN) |
| PVL05-- VARV PROTEIN L5 VARIOLA VIRUS |
| PVL1-- HPV5B PROBABLE L1 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5B |
| PVL2-- CRPVK PROBABLE L2 |
| PROTEIN COTTONTAIL RABBIT (SHOPE) |
| PAPILLOMAVIRUS (STRAIN KANSAS) |
| (CRPV) |
| PVL2-- HPV05 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5 |
| PVL2-- HPV08 PROBABLE L2 |
| PROTEIN HUMAN PAPILLOMAVIRUS TYPE 8 |
| PVL2-- HPV1A PROBABLE L2 |
| PROTEIN HUMAN PAPILLOMAVIRUS TYPE 1A |
| PVL2-- HPV39 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 39 |
| PVL2-- HPV42 PROBABLE L2 |
| PROTEIN HUMAN PAPILLOMAVIRUS TYPE 42 |
| PVL2-- HPV47 PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 47 |
| PVL2-- HPV51 PROBABLE L2 |
| PROTEIN HUMAN PAPILLOMAVIRUS TYPE 51 |
| PVL2-- HPV5B PROBABLE L2 PROTEIN HUMAN PAPILLOMAVIRUS TYPE 5B |
| PVL2-- HPVME PROBABLE L2 |
| PROTEIN HUMAN PAPILLOMAVIRUS TYPE |
| M3180 |
| PVL2-- PCPV1 PROBABLE L2 PROTEIN PIGMY CHIMPANZEE PAPILLOMAVIRUS |
| TYPE 1 |
| PVL96-- IRV1 L96 PROTEIN TIPULA IRIDESCENT VIRUS (TIV) (INSECT |
| IRIDESCENT VIRUS TYPE 1) |
| PVM1-- REOVD MINOR VIRION STRUCTURAL PROTEIN MU-2 REOVIRUS (TYPE |
| 3/STRAIN DEARING |
| PVM1-- REOVL MINOR VIRION STRUCTURAL PROTEIN MU-2 REOVIRUS (TYPE |
| 1/STRAIN LANG) |
| PVM21-- REOVD MAJOR VIRION STRUCTURAL PROTEINMU-1/MU-1C REOVIRUS |
| (TYPE 3/STRAIN DEARING) |
| PVM22-- REOVD MAJOR VIRION STRUCTURAL PROTEIN MU-1/MU-1C REOVIRUS |
| (TYPE 3/STRAIN DEARING) |
| PVM2-- REOVJ MAJOR VIRION STRUCTURAL PROTEIN MU-1/MU-1C REOVIRUS |
| (TYPE 2/STRAIN D5/JONES) |
| PVM2-- REOVL MAJOR VIRION STRUCTURAL PROTEIN MU-1/MU-1C REOVIRUS |
| (TYPE 1/STRAIN LANG) |
| PVM3-- REOVD MAJOR NONSTRUCTURAL PROTEIN MU-NS REOVIRUS (TYPE |
| 3/STRAIN DEARING) |
| PVMAT-- SV5 MATRIX PROTEIN SIMIAN VIRUS 5 (STRAIN W3) (SV5) |
| PVMAT-- TRTV MATRIX PROTEIN |
| TURKEY RHINOTRACHEITIS VIRUS (TRTV) |
| PVME1-- CVBM E1 GLYCOPROTEIN |
| BOVINE CORONAVIRUS (STRAIN MEBUS) |
| PVME1-- CVHOC E1 GLYCOPROTEIN |
| HUMAN CORONAVIRUS (STRAIN OC43) |
| PVME1-- CVMA5 E1 GLYCOPROTEIN |
| MURINE CORONAVIRUS MHV (STRAIN A59) |
| PVME1-- CVMJH E1 GLYCOPROTEIN |
| MURINE CORONAVIRUS MHV (STRAIN JHM) |
| PVME1-- CVTKE E1 GLYCOPROTEIN |
| TURKEY ENTERIC CORONAVIRUS (TCV) |
| PVME1-- IBVB E1 GLYCOPROTEIN |
| AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN |
| BEAUDETTE) (IBV) |
| PVME1-- IBVB2 E1 GLYCOPROTEIN AVIAN INFECTIOUS BRONCHITIS VIRUS |
| (STRAIN |
| BEAUDETTE M42) (IBV) |
| PVMEM-- EBV PROBABLE MEMBRANE PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PVMP-- CERV MOVEMENT PROTEIN CARNATION ETCHED RING VIRUS (CERV) |
| PVMP-- SOCMV MOVEMENT PROTEIN |
| SOYBEAN CHLOROTIC MOTTLE VIRUS |
| PVMSA-- HPBDB MAJOR SURFACE |
| ANTIGEN PRECURSOR DUCK HEPATITIS B |
| VIRUS (BROWN SHANGHHAI |
| DUCK ISOLATE S5) (DHBV) |
| PVMSA-- HPBDC MAJOR SURFACE ANTIGEN PRECURSOR DUCK HEPATITIS B |
| VIRUS (STRAIN CHINA) |
| (DHBV) |
| PVMSA-- HPBDU MAJOR SURFACE ANTIGEN PRECURSOR DUCK HEPATITIS B |
| VIRUS (DHBV) |
| PVMSA-- HPBDW MAJOR SURFACE ANTIGEN PRECURSOR DUCK HEPATITIS B |
| VIRUS (WHITE SHANGHAI |
| DUCK ISOLATE S31) (DHBV) |
| PVMSA-- HPBGS MAJOR SURFACE ANTIGEN PRECURSOR GROUND SQUIRREL |
| HEPATITIS VIRUS (GSHV) |
| PVMSA-- HPBHE MAJOR SURFACE ANTIGEN PRECURSOR HERON HEPATITIS B |
| VIRUS |
| PVMSA-- HPBV0 MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS |
| PVMSA-- HPBV2 MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADW2) |
| PVMSA-- HPBV4 MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADR4) |
| PVMSA-- HPBV9 MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADW/ |
| STRAIN 991) |
| PVMSA-- HPBVA MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (STRAIN ALPHA1) |
| PVMSA-- HPBVD MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE AD) |
| PVMSA-- HPBVI MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADW/STRAIN |
| INDONESIA/PIDW420) |
| PVMSA-- HPBVJ MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADW/STRAIN |
| JAPAN/PJDW233) |
| PVMSA-- HPBVL MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (STRAIN LSH/ |
| CHIMPANZEE ISOLATE) |
| PVMSA-- HPBVN MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE |
| ADR/STRAIN NC-1) |
| PVMSA-- HPBVO MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADW/STRAIN |
| OKINAWA/PODW282) |
| PVMSA-- HPBVP MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADW/STRAIN |
| PHILIPPINO/PFDW294) |
| PVMSA-- HPBVR MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADR) |
| PVMSA-- HPBVS MAJOR SURFACE ANTIGEN HEPATITIS B VIRUS (SUBTYPE AR) |
| PVMSA-- HPBVW MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADW) |
| PVMSA-- HPBVY MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE AYW) |
| PVMSA-- HPBVZ MAJOR SURFACE ANTIGEN PRECURSOR HEPATITIS B VIRUS |
| (SUBTYPE ADYW) |
| PVMSA-- WHV1 MAJOR SURFACE ANTIGEN PRECURSOR WOODCHUCK HEPATITIS |
| VIRUS 1 |
| PVMSA-- WHV59 MAJOR SURFACE ANTIGEN PRECURSOR WOODCHUCK HEPATITIS |
| VIRUS 59 |
| PVMSA-- WHV7 MAJOR SURFACE ANTIGEN PRECURSOR WOODCHUCK HEPATITIS |
| VIRUS 7 |
| PVMSA-- WHV8 MAJOR SURFACE ANTIGEN PRECURSOR WOODCHUCK HEPATITIS |
| VIRUS 8 |
| PVMSA-- WHV81 PROBABLE MAJOR SURFACE ANTIGEN PRECURSOR WOODCHUCK |
| HEPATITIS VIRUS 8 (INFECTIOUS |
| CLONE) |
| PVMSA-- WHVW6 MAJOR SURFACE ANTIGEN PRECURSOR WOODCHUCK HEPATITIS |
| VIRUS W64 (ISOLATE |
| PWS23) |
| PVMT2-- JAZH MATRIX (M2) PROTEIN INFLUENZA A VIRUS (STRAIN |
| A/SWINE/IOWA/ |
| 15/30) |
| PVMT8-- MYXVL M-T8 PROTEIN MYXOMA VIRUS (STRAIN LAUSANNE) |
| PVMT9-- MYXVL MT-9 PROTEIN MYXOMA VIRUS (STRAIN LAUSANNE) |
| PVN02-- VACCC PROTEIN N2 VACCINIA VIRUS (STRAIN COPENHAGEN |
| PVN02-- VACCV PROTEIN N2 |
| VACCINIA VIRUS (STRAIN WR) |
| PVN02-- VARV PROTEIN N2 VARIOLA VIRUS |
| PVN34-- ROTPC NONSTRUCTURAL PROTEIN NS34 PORCINE ROTAVIRUS |
| (GROUPS/ |
| STRAIN COWDEN) |
| PVNCA-- AAV2 DNA REPLICATION PROTEIN ADENO-ASSOCIATED VIRUS 2 |
| (AAV2) |
| PVNCS-- PAVBO PROBABLE NONCAPSID PROTEIN NS1 BOVINE PARVOVIRUS |
| (BPV) |
| PVNS1-- AHSV4 NONSTRUCTURAL PROTEIN NS1 AFRICAN HORSE SICKNESS |
| VIRUS (SEROTYPE |
| 4/STRAIN VACCINE) |
| PVNS1-- IAALA NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ALASKA/6/77) |
| PVNS1-- IAANN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/ANN ARBOR/6/60) |
| PVNS1-- IACHI NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/CHILE/1/83) |
| PVNS1-- IACKG NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/ |
| GERMANY/N/49) |
| PVNS1-- IACKJ NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/CHICKEN/JAPAN/ |
| 24) |
| PVNS1-- IADA2 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ALBERTA/ |
| 60/76) |
| PVNS1-- IADE1 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/DUCK/ENGLAND/ |
| 1/56) |
| PVNS1-- IADU3 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/DUCK/UKRAINE/ |
| 1/63) |
| PVNS1-- IAFOM NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/FORT |
| MONMOUTH/1/47) |
| PVNS1-- IAFOW NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/FORT WARREN/ |
| 1/50) |
| PVNS1-- IAFPR NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/FOWL PLAGUE |
| VIRUS/ROSTOCK/34) |
| PVNS1-- IALE1 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/ |
| 134/57) |
| PVNS1-- IALEN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/LENINGRAD/ |
| 54/1) |
| PVNS1-- IAM16 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ |
| ALBERTA/88/76) |
| PVNS1-- IAMAN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ |
| NEW YORK/6750/78) |
| PVNS1-- IAMAO NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/MALLARD/ |
| NEW YORK/6874/78) |
| PVNS1-- IAMYN NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/MYNAH/ |
| HANEDA-THAI/76) |
| PVNS1-- IAP10 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ |
| ALBERTA/119/79) |
| PVNS1-- IAP11 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ALBERTA/ |
| 121/79) |
| PVNS1-- IAP12 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ALBERTA/ |
| 268/78) |
| PVNS1-- IAP13 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PINTAIL/ALBERTA/ |
| 358/79) |
| PVNS1-- IAPUE NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/PUERTO RICO/8/34) |
| PVNS1-- IATKB NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/ |
| BETHLEHEM-GLILIT/1492-B/82) |
| PVNS1-- IATKC NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TURKEY/CANADA/ |
| 63) |
| PVNS1-- IATRS NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TERN/SOUTH |
| AFRICA/61) |
| PVNS1-- IATRT NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/TERN/ |
| TURKMENIA/18/72) |
| PVNS1-- IAUDO NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/UDORN/307/72) |
| PVNS1-- IAUSS NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/USSR/90/77) |
| PVNS1-- IAZ11 NONSTRUCTURAL PROTEIN NS1 INFLUENZA A VIRUS (STRAIN |
| A/SWINE/IOWA/15/30) |
| PVNS1-- INBPA NONSTRUCTURAL PROTEIN NS1 INFLUENZA B VIRUS (STRAIN |
| B/PA/79) |
| PVNS1-- INCAA NONSTRUCTURAL PROTEIN NS1 INFLUENZA C VIRUS (STRAIN |
| C/ANN ARBOR/ |
| 1/50) |
| PVNS1-- INCCA NONSTRUCTURAL PROTEIN NS1 INFLUENZA C VIRUS (STRAIN |
| C/CALIFORNIA/78) |
| PVNS2-- HRSV1 NONSTRUCTURAL PROTEIN 2 HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS |
| (SUBGROUP B/STRAIN 18537) |
| PVNS2-- HRSVA NONSTRUCTURAL PROTEIN 2 HUMAN RESPIRATORY SYNCYTIAL |
| VIRUS |
| (STRAIN A2) |
| PVNS2-- INBLE NONSTRUCTURAL PROTEIN NS2 INFLUENZA B VIRUS (STRAIN |
| B/LEE/40) |
| PVNS2-- INBYA NONSTRUCTURAL PROTEIN NS2 INFLUENZA B VIRUS (STRAIN |
| B/YAMAGATA/1/73) |
| PVNS4-- CVMS NONSTRUCTURAL PROTEIN 4 MURINE CORONAVIRUS MHV |
| (STRAIN S) |
| PVNS4-- CVPFS NONSTRUCTURAL PROTEIN 4 PORCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| CORONAVIRUS (STRAIN FS77 |
| PVNS4-- CVPPU NONSTRUCTURAL PROTEIN 4 PORCINE TRANSMISSIBLE |
| GASTROENTERITIS |
| CORONAVIRUS (STRAIN PUR |
| PVNST-- CVPRM NONSTRUCTURAL PROTEIN 4 PORCINE RESPIRATORY CORONAVIR |
| US |
| PVNST-- CVMA5 30 KD NONSTRUCTURAL PROTEIN MURINE CORONAVIRUS MHV |
| (STRAIN A59) |
| PVNST-- CVMJH 30 KD NONSTRUCTURAL PROTEIN MURINE CORONAVIRUS MHV |
| (STRAIN JHM) |
| PVNST-- INCGL NONSTRUCTURAL PROTEINS NS1-NS2 INFLUENZA C VIRUS |
| (STRAIN C/GREAT LAKES/ |
| 1167/54) |
| PVNST-- INCJH NONSTRUCTURAL PROTEINS NS1-NS2 INFLUENZA C VIRUS |
| (STRAIN C/JOHANNESBURG/ |
| 1/66) |
| PVNST-- INCMI NONSTRUCTURAL PROTEINS NS1-NS2 INFLUENZA C VIRUS |
| (STRAIN C/MISSISSIPPI/80) |
| PVNST-- INCYA NONSTRUCTURAL PROTEINS NS1-NS2 INFLUENZA C VIRUS |
| (STRAIN C/YAMAGATA/10/81) |
| PVNUA-- PRVKA PROBABLE NUCLEAR ANTIGEN PSEUDORABIES VIRUS (STRAIN |
| KAPLAN) (PRV) |
| PVNUC-- DHVH NUCLEOPROTEIN DHORI VIRUS (STRAIN INDIAN/1313/61) |
| (DHO) |
| PVNUC-- IACKP NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/CHICKEN/ |
| PENNSYLVANIA/1/83) |
| PVNUC-- IAHLO NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/LOND |
| ON/ |
| 1416/73) |
| PVNUC-- IAHPR NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/PRAG |
| UE/ |
| 1/56) |
| PVNUC-- IAHTE NUCLEOPROTEIN INFLUENZA A VIRUS (STRAIN A/EQUINE/TENN |
| ESSEE/ |
| 5/86) |
| PVNUC-- MABVM NUCLEOPROTEIN MARBURG VIRUS (STRAIN MUSOKE) |
| PVNUC-- MABVP NUCLEOPROTEIN MARBURG VIRUS (STRAIN POPP) |
| PVO01-- VACCC PROTEIN O1 VACCINIA VIRUS (STRAIN COPENHAGEN) |
| PVO01-- VARV PROTEIN O1 |
| VARIOLA VIRUS |
| PVOR1-- NMV 186 KD PROTEIN NARCISSUS MOSAIC VIRUS (NMV) |
| PVOR1-- PVMR 223 KD PROTEIN POTATO VIRUS M (STRAIN RUSSIAN) (PVM) |
| PVOR1-- SMYEA 150 KD PROTEIN |
| STRAWBERRY MILD YELLOW EDGE- |
| ASSOCIATED VIRUS (SMYEAV) |
| PVP03-- HSVSA PROBABLE |
| MEMBRANE ANTIGEN 3 HERPESVIRUS |
| SAIMIRI (STRAIN 11) |
| PVP10-- NPVAC P10 PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR POLY- |
| HEDROSIS VIRUS (ACMNPV) |
| PVP10-- NPVOP P10 PROTEIN ORGYIA PSEUDOTSUGATA MULTICAPSID |
| POLYHEDROSIS VIRUS (OPMNPV) |
| PVP10-- RBSDV PROTEIN S10 RICE |
| BLACK STREAKED DWARF VIRUS (RBSDV) |
| PVP19-- HSVEB CAPSID ASSEMBLY |
| AND DNA MATURATION PROTEIN EQUINE |
| HERPESVIRUS TYPE 1 (STRAIN AB4P) |
| (EVH-1) |
| PVP23-- HCMVA PROBABLE CAPSID PROTEIN VP23 HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVP23-- HSV6U PROBABLE CAPSID PROTEIN VP23 HERPES SIMPLEX VIRUS |
| (TYPE 6/STRAIN UGANDA- |
| 1102) |
| PVP23-- HSVEVB PROBABLE CAPSID PROTEIN VP23 EQUINE HERPESVIRUS |
| TYPE 1 (STRAIN AB4P) |
| (EHV-1) |
| PVP23-- VZVD PROBABLE CAPSID PROTEIN VP23 VARICELLA-ZOSTER VIRUS |
| (STRAIN DUMAS) |
| (VZV) |
| PVP2-- AHSV4 OUTER CAPSID PROTEIN VP2 AFRICAN HORSE SICKNESS VIRUS |
| (SEROTYPE 4/ |
| STRAIN VACCINE) |
| PVP2-- BTV10 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 10/ISOLATE USA) |
| PVP2-- BTV11 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 11/ISOLATE USA) |
| PVP2-- BTV17 OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 17/ISOLATE USA) |
| PVP2-- BTV1A OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE |
| AUSTRALIA) |
| PVP2-- BTV1S OUTER CAPSID PROTEIN VP2 BLUETONGUE VIRUS (SEROTYPE |
| I/ISOLATE |
| SOUTH AFRICA) |
| PVP2-- EHDV1 OUTER CAPSID PROTEIN VP2 EPIZOOTIC HEMORRHAGIC |
| DISEASE VIRUS |
| (SEROTYPE 1) (EHDV-1) |
| PVP2-- ROTBR RNA-BINDING PROTEIN VP2 BOVINE ROTAVIRUS (STRAIN RF) |
| PVP2-- ROTBU RNA-BINDING |
| PROTEIN VP2 BOVINE ROTAVIRUS (STRAIN |
| UK) |
| PVP2-- ROTHW RNA-BINDING PROTEIN VP2 HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN WA) |
| PVP2-- ROTPC RNA-BINDING PROTEIN VP2 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) |
| PVP2-- ROTS1 RNA-BINDING PROTEIN VP2 SIMIAN 11 ROTAVIRUS (STRAIN |
| SA11) |
| PVP35-- VACCC IMMUNODOMINANT ENVELOPE PROTEIN P35 VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| PVP35-- VACCV IMMUNODOMINANT ENVELOPE PROTEIN P35 VACCINIA VIRUS |
| (STRAIN WR) |
| PVP35-- VARV IMMUNODOMINANT ENVELOPE PROTEIN P35 VARIOLA VIRUS |
| PVP39-- NPVOP MAJOR CAPSID |
| PROTEIN ORGYIA PSEUDOTSUGATA |
| MULTICAPSID POLY- |
| HEDROSIS VIRUS (OPMNPV) |
| PVP3-- EHDV1 VP3 CORE PROTEIN EPIZOOTIC HEMORRHAGIC DISEASE VIRUS |
| (SEROTYPE 1) (EHDV-1) |
| PVP3-- EHDVA VP3 CORE PROTEIN EPIZOOTIC HEMORRHAGIC DISEASE VIRUS |
| PVP3-- RDV MAJOR 114 KD |
| STRUCTURAL PROTEIN RICE DWARF VIRUS |
| (RDV) |
| PVP3-- ROTS1 INNER CORE PROTEIN VP3 SIMAIN 11 ROTAVIRUS (STRAIN |
| SA11) |
| PVP40-- EBV CAPSID PROTEIN P40 EPSTEIN-BARR VIRUS (STRAIN B95-8) |
| (HUMAN HERPESVIRUS 4) |
| PVP40-- HSVSA CAPSID PROTEIN P40 HERPESVIRUS SAIMIRI (STRAIN 11 |
| PVP40-- ILTVT CAPSID PROTEIN |
| P40 INFECTIOUS LARYNGOTRACHEITIS |
| VIRUS |
| (STRAIN THRONE V882) (ILTV) |
| PVP40-- VZVD CAPSID PROTEIN P40 VARICELLA-ZOSTER VIRUS (STRAIN |
| DUMAS) |
| (VZV |
| PVP47-- NPVAC VIRAL TRANSCRIPTION REGULATOR P47 AUTOGRAPHA |
| CALIFORNICA NULCEAR POLY- |
| HEDROSIS VIRUS (ACMNPV) |
| PVP4A-- VACCC MAJOR CORE PROTEIN P4A PRECURSOR VACCINIA VIRUS |
| (STRAIN COPENHAGEN) |
| PVP4A-- VACCV MAJOR CORE PROTEIN P4A PRECURSOR VACCINIA VIRUS |
| (STRAIN WR) |
| PVP4A-- VARV MAJOR CORE PROTEIN P4A PRECURSOR VARIOLA VIRUS |
| PVP4-- ROTGI OUTER CAPSID |
| PROTEIN VP4 ROTAVIRUS (GROUP |
| B/STRAIN IDIR) |
| PVP4-- WTV NONSTRUCTURAL PROTEIN PNS4 WOUND TUMOR VIRUS (WTV) |
| PVP5-- BRD OUTER CAPSID |
| PROTEIN VP5 BROADHAVEN VIRUS (BRD) |
| PVP5-- BTVIA OUTER CAPSID |
| PROTEIN VP5 BLUETONGUE VIRUS |
| (SEROTYPE 1/ISOLATE |
| AUSTRALIA) |
| PVP5-- BTVIS OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE |
| SOUTH AFRICA) |
| PVP5-- BTV2A OUTER CAPSID PROTEIN VP5 BLUETONGUE VIRUS (SEROTYPE |
| 2/ISOLATE USA) |
| PVP5-- EHDV1 OUTER CAPSID PROTEIN VP5 EIPZOOTIC HEMORRHAGIC |
| DISEASE VIRUS |
| (SEROTYPE 1) (ENDV-1) |
| PVP5-- WTV OUTER COAT PROTEIN P5 WOUND TUMOR VIRUS (WTV) |
| PVP61-- BTV10 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE |
| USA) |
| PVP62-- BTV10 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 10/ISOLATE |
| USA) |
| PVP62-- MRDV PROBABLE NONSTRUCTURAL 36.3 KD PROTEIN MAIZE ROUGH |
| DWARF VIRUS (MRDV) |
| PVP64-- NPVOP MAJOR ENVELOPE GLYICOPROTEIN PRECURSOR ORGYIA |
| PSEUDOTSUGATA MULTICAPSID POLY- |
| HEDROSIS VIRUS (OPMNPV) |
| PVP67-- NPVAC MAJOR ENVELOPE GLYICOPROTEIN PRECURSOR AUTOGRAPHA |
| CALIFORNICA NUCLEAR POLY- |
| HEDROSIS VIRUS (ACMNPV) |
| PVP67-- NPVGM MAJOR ENVELOPE GLYCOPROTEIN GALLERIA MELLONELLA |
| NUCLEAR POLY- |
| HEDROSIS VIRUS (GMNPV) |
| PVP6-- BTV11 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 11/ISOLATE |
| USA) |
| PVP6-- BTV17 VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 17/ISOLATE |
| USA) |
| PVP6-- BTV1S VP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 1/ISOLATE |
| SOUTH AFRICA) |
| PVP6-- BTV2A BP6 PROTEIN BLUETONGUE VIRUS (SEROTYPE 2/ISOLATE USA) |
| PVP6-- WTV STRUCTURAL PROTEIN P6 WOUND TUMOR VIRUS (WTV) |
| PVP6-- WTVNJ STRUCTURAL PROTEIN P6 WOUND TUMOR VIRUS (STRAIN NJ) |
| (WTV) |
| PFP79-- NPVAC 79 KD PROTEIN AUTOGRAPHA CALIFORNICA NUCLEAR POLY- |
| HEDROSIS VIRUS (ACMNPV) |
| PVP7-- WTV NONSTRUCTURAL PROTEIN PNS7 WOUND TUMOR VIRUS (WTV) |
| PVP87-- NPVOP CAPSID PROTEIN |
| P87 ORGYIA PSEUDOTSUGATA MULTICAPSID |
| POLYHEDROSIS VIRUS (OPMNPV) |
| PVP8-- BTV10 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 10/ISOLATE USA) |
| PVP8-- BTV11 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 11/ISOLATE USA) |
| PVP8-- BTV13 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 13/ISOLATE USA) |
| PVP8-- BTV17 NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 17/ISOLATE USA) |
| PVP8-- BTV1A NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE |
| AUSTRAILIA) |
| PVP8-- BTV1S NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 1/ISOLATE |
| SOUTH AFRICA) |
| PVP8-- BTV2A NONSTRUCTURAL PROTEIN P8 BLUETONGUE VIRUS (SEROTYPE |
| 2/ISOLATE USA) |
| PVP8-- RDV OUTER CAPSID PROTEIN P8 RICE DWARF VIRUS (RDV) |
| PVP8-- WTV OUTER CAPSID PROTEIN P8 WOUND TUMOR VIRUS (WTV) |
| PVPHE-- NPVAC 29 KD POLYHEDRAL |
| ENVELOPE PROTEIN AUTOGRAPHA CALIFORNI |
| CA NULCEAR |
| POLYHEDROSIS VIRUS (ACMNPV) |
| PVPHE-- NPVOP 32 KD POLYHEDRAL ENVELOPE PROTEIN ORGYIA PSEUDOTSUGAT |
| A MULTICAPSID |
| POLYHEDROSIS VIRUS (OPMNPV) |
| PVPR-- HV1A2 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (ARV2/SF2 ISOLATE) (HIV-1) |
| PVPR-- HV2BE VPR PROTEIN HUMAN |
| IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE BEN) (HIV-2) |
| PVPR-- HV2CA VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE CAM2) (HIV-2) |
| PVPR-- HV2D1 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE D194) (HIV-2) |
| PVPR-- HV2D2 VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE D205, 7) (HIV-2) |
| PVPR-- HV2NZ VPR PROTEIN HUMAN |
| IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE NI-Z) (HIV-2) |
| PVPR-- HV2RO VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE ROD) (HIV-2) |
| PVPR-- HV2SB VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE SBLISY) (HIV-2) |
| PVPR-- HV2ST VPR PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 |
| (ISOLATE ST) (HIV-2) |
| PVPR-- SIVCZ VPR PROTEIN CHIMPANZEE IMMUNODEFICIENCY VIRUS |
| (SIV(CPZ)) (CIV) |
| PVPR-- SIVM1 VPR PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (MM142-83 |
| ISOLATE) SIV-MAC) |
| PVPR-- SIVMK VPR PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (K6W |
| ISOLATE) (SIV-MAC) |
| PVPR-- SIVML VPR PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS 9K78 |
| ISOLATE) (SIV-MAC) |
| PVPR-- SIVS4 VPR PROTEIN SIMIAN IMMUNODEFICIENCY VIRUS (F236/ |
| SMIW ISOLATE) (SOOTY MANGA |
| PVPR-- SIVSP VPR PROTEIN |
| SIMIAN IMMUNODEFICIENCY VIRUS |
| PBJ/BC13 |
| ISOLATE) (SOOTY MANGABE |
| PVPU-- HV1B1 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BH10 ISOLATE, HXB3 ISOLATE) |
| PVPU-- HV1B8 VPU PROTEIN HUMAN |
| IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BH8 ISOLATE) (HIV-1) |
| PVPU-- HV1BN VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BRAIN ISOLATE) (HIV-1) |
| PVPU-- HV1BR VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (BRU ISOLATE) (HIV-1) |
| PVPU-- HV1H2 VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (HXB2 ISOLATE) (HIV-1) |
| PVPU-- HV1JR VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (JRCSF ISOLATE) (HIV-1) |
| PVPU-- HV1PV VPU PROTEIN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| (PV22 ISOLATE) (HIV-1) |
| PVPU-- JSRV VPU PROTEIN SHEEP PULMONARY ADENOMATOSIS VIRUS |
| PVPX-- LDV VPX PROTEIN LACTATE |
| DEHYDROGENASE-ELEVATING VIRUS |
| (LDV) |
| PVPY-- BIV2 ORF-Y PROTEIN BOVINE IMMUNODEFICIENCY VIRUS |
| (ISOLATE 127) (BIV) |
| PVRNA-- BSMV ALPHA-A PROTEIN BARLEY STRIPE MOSAIC VIRUS (BSMV) |
| PVS05-- ROTHI NONSTRUCTURAL |
| PROTEIN NCVP2 HUMAN ROTAVIRUS |
| (STRAIN IGV-80-3) |
| PVS05-- ROTHC NONSTRUCTURAL PROTEIN NS53 PORCINE ROTAVIRUS (GROUP |
| C/STRAIN COWDEN) |
| PVS05-- ROTS1 NONSTRUCTURAL PROTEIN NCVP2 SIMIAN 11 ROTAVIRUS |
| (STRAIN SA11) |
| PVS06-- ROTBR VP6 PROTEIN BOVINE ROTAVIRUS (STRAIN RF) |
| PVS06-- ROTBS VP6 PROTEIN BOVINE ROTAVIRUS (GROUP C/STRAIN |
| SHINTOKU) |
| PVS06-- ROTBU VP6 PROTEIN BOVINE ROTAVIRUS (STRAIN UK) |
| PVS06-- ROTEF VP6 PROTEIN EQUINE ROTAVIRUS (STRAIN FI-14) |
| PVS06-- ROTEH VP6 PROTEIN EQUINE ROTAVIRUS (STRAIN H-2) |
| PVS06-- ROTH1 VP6 PROTEIN HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN 1076) |
| PVS06-- ROTHC VP6 PROTEIN HUMAN ROTAVIRUS (GROUP C/STRAIN BRISTOL) |
| PVS06-- ROTHS VP6 PROTEIN HUMAN ROTAVIRUS (SEROTYPE 2/STRAIN S2) |
| PVS06-- ROTHW VP6 PROTEIN |
| HUMAN ROTAVIRUS (SEROTYPE 1/STRAIN |
| WA) |
| PVS06-- ROTPC VP6 PROTEIN PORCINE ROTAVIRUS (GROUP C/STRAIN COWDEN |
| PVS06-- ROTPG VP6 PROTEIN PORCINE ROTAVIRUS (STRAIN GOTTFRIED) |
| PVS06-- ROTS1 VP6 PROTEIN |
| SIMIAN 11 ROTAVIRUS (STRAIN SA11) |
| PVS08-- ROTS1 NONSTRUCTURAL |
| PROTEIN NCVP4 SIMIAN 11 ROTAVIRUS |
| (STRAIN SA11) |
| PVS09-- ROTHT GLYCOPROTEIN VP7 HUMAN ROTAVIRUS (SEROTYPE 4/STRAIN |
| ST. THOMAS 3) |
| PVS09-- ROTPB GLYCOPROTEIN VP7 PORCINE ROTAVIRUS (SEROTYPE |
| 4/STRAIN |
| BEN-144) |
| PVS10-- ROTBN NONSTRUCTURAL GLYCOPROTEIN VCVP5 BOVINE ROTAVIRUS |
| (STRAIN NCDV) |
| PVS10-- ROTBU NONSTRUCTURAL GLYCOPROTEIN VCVP5 BOVINE ROTAVIRUS |
| (STRAIN UK) |
| PVS10-- ROTH2 NONSTRUCTURAL GLYCOPROTEIN VCVP5 HUMAN ROTAVIRUS |
| (STRAIN A28) |
| PVS10-- ROTH7 NONSTRUCTURAL GLYCOPROTEIN VCVP5 HUMAN ROTAVIRUS |
| (STRAIN A64/CLONE 2) |
| PVS10-- ROTH8 NONSTRUCTURAL GLYCOPROTEIN VCVP5 HUMAN ROTAVIRUS |
| (STRAIN A64/CLONE 6 |
| PVS10-- ROTHW NONSTRUCTURAL GLYCOPROTEIN VCVP5 HUMAN ROTAVIRUS |
| (STRAIN 1/STRAIN WA) |
| PVS10-- ROTS1 NONSTRUCTURAL GLYCOPROTEIN VCVP5 SIMIAN 11 ROTAVIRUS |
| (STRAIN SA11) |
| PVS11-- ROTHW MINOR OUTER CAPSID PROTEIN HUMAN ROTAVIRUS (SEROTYPE |
| 1/STRAIN WA) |
| PVS11-- REOVJ SIGMA I PROTEIN PRECURSOR REOVIRUS (TYPE 2/STRAIN |
| D5/JONES) |
| PVS11-- REOVL SIGMA I PROTEIN PRECURSOR REOVIRUS (TYPE 1/STRAIN |
| LANG) |
| PVT1-- SFVKA PROTEIN T1 PRECURSOR SHOPE FIBROMA VIRUS (STRAIN |
| KASZA) (SFV) |
| PVT2-- MYXVL TUMOR NECROSIS FACTOR SOLUBLE RECEPTOR PRECUR MYXOMA |
| VIRUS (STRAIN LAUSANNE) |
| PVT2-- SFVKA TUMOR NECROSIS FACTOR SOLUBLE RECEPTOR PRECUR SHOPE |
| FIBROMA VIRUS (STRAIN KASZA) (SFV) |
| PTV3A-- CAPVI PROTEIN T3A |
| CAPRIPOXVIRUS (STRAIN INS-1) |
| PVTER-- EBV PROBABLE DNA |
| PACKAGING PROTEIN EPSTEIN-BARR VIRUS |
| (STRAIN B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PVTER-- HCMVA PROBABLE DNA PACKAGING PROTEIN HUMAN CYTOMEGALOVIRUS |
| (STRAIN AD169) |
| PVTER-- HSV11 PROBABLE DNA PACKAGING PROTEIN ICTALURID HERPESVIRUS |
| 1 (CHANNEL CATFISH |
| VIRUS) (CCV) |
| PVX-- SEN6 X PROTEIN SENDAI VIRUS (STRAIN 6/94) |
| PY104-- ADE07 HYPOTHETICAL 10.4 KD EARLY PROTEIN HUMAN ADENOVIRUS |
| TYPE 7 |
| PY10K-- MSVS HYPOTHETICAL 10.9 KD PROTEIN MAIZE STREAK VIRUS |
| (SOUTH-AFRICAN |
| ISOLATE) (MVS) |
| PY10K-- WDV HYPOTHETICAL 10 KD PROTEIN WHEAT DWARF VIRUS (WDV) |
| PY119-- SSV1 HYPOTHETICAL 11.9 |
| KD PROTEIN SULFOLOBUS VIRUS-LIKE |
| PARTICLE SSV1 |
| PY11K-- PASV HYPOTHETICAL 11.9 KD PROTEIN (ORF VI) PANICUM STREAK |
| VIRUS |
| PY11K-- ROTS1 hYPOTHETICAL 11 KD PROTEIN IN SEGMENT S11 SIMIAN 11 |
| ROTAVIRUS (STRAIN SA11) |
| PY11K-- TYDVA HYPOTHETICAL 11.2 KD PROTEIN TOBACCO YELLOW DWARF |
| VIRUS (STRAIN |
| (AUSTRALIA) (TYDV) |
| PY14K-- NPVAC HYPOTHETICAL 13.8 KD PROTEIN IN 39 KD PROTEIN 5' |
| AUTOGRAPHA CALIFORNICA NUCLEAR |
| POLY-0 |
| REG HEDROSIS VIRUS (ACMNPV) |
| PY18K-- SSV1 HYPOTHETICAL 18.0 KD PROTEIN (ORF B-166) SULFOLOBUS |
| VIRUS-LIKE PARTICLE SSV1 |
| PY20K-- SSV1 HYPOTHETICAL 20.4 KD PROTEIN (ORF E-178) SULFOLOBUS |
| VIRUS-LIKE PARTICLE SSV1 |
| PY21K-- MSVN HYPOTHETICAL 21.7 KD PROTEIN MAIZE STREAK VIRUS |
| (NIGERIAN ISOLATE) (MSV) |
| PY2-- SOCMV HYPOTHETICAL PROTEI N2 (ORF II) SOYBEAN CHLOROTIC |
| MOTTLE VIRUS |
| PY38K-- NPVAC HYPOTHETICAL 37.7 KD PROTEIN (ORF2) AUTOGRAPHA |
| CALIFORNICA NUCLEAR |
| POLYHEDROSIS VIRUS (ACMNPV) |
| PY85-- SSV1 HYPOTHERICAL 85.7 KD PROTEIN (C-792) SULFOLOBUS |
| VIRU-LIKE PARTICLE SSV1 |
| PYB13-- FOWPM HYPOTHERICAL BAMHI-ORF13 PROTEIN (FRAGMENT) FOWLPOX |
| VIRUS (ISOLATE HP-438[MUNICH]) |
| PYDH1-- HSVSC HYPOTHETICAL |
| 28.7 KD PROTEIN IN DHFR 3'REGION |
| HERPESVIRUS SAIMIRI (SUBGROUP |
| C/STRAIN 488) |
| (ORF |
| PYDH3-- HSVSC HYPOTHETICAL 9.5 KD PROTEIN IN DHFR'3'REGION |
| HERPESVIRUS SAIMIRI (SUBGROPU |
| C/STRAIN 488) |
| (ORF3 |
| PYEC4-- EBV HYPOTHETICAL EC-RF4 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PYIO1-- CVBM HYPOTHETICAL PROTEIN IORF1 BOVINE CORONAVIRUS |
| PYIOR-- CVBF HYPOTHETICAL |
| PROTEIN IN NUCLEOCAPSID OFR (IORF) |
| BOVINE CORONAVIRUS (STRAIN F15) |
| PYIOR-- CVBM HYPOTHETICAL |
| PROTEIN IN NUCLEOCAPSID OFR (IORF) |
| BOVINE CORONAVIRUS (STRAIN MEBUS) |
| PYIOR-- CVTKE HYPOTHETICAL |
| PROTEIN IN NUCLEOCAPSID OFR (IORF) |
| TURKEY ENTERIC CORONAVIRUS (TCV) |
| PYKR2-- EBV HYPOTHETICAL BKRF2 |
| PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PYMR2-- EBV BKRF2 PROTEIN EPSTEIN-BARR VIRUS (STRAIN B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PYOR1-- COYMV HYPOTHETICAL 23 KD PROTEIN (ORF1) COMMELINA YELLOW |
| MOTTLE VIRUS (COYMV) |
| PYOR2-- COYMV HYPOTHETICAL 15 KD PROTEIN (ORF2) COMMELINA YELLOW |
| MOTTLE VIRUS (COYMV) |
| PYOR3-- PVXXC HYPOTHETICAL 12 KD PROTEIN (ORF 3) (FRAGMENT) POTATO |
| VIRUS X (STRAIN XC) (PVX) |
| PYOR3-- WCMVM HYPOTHETICAL 13 KD PROTEIN (ORF 3) WHITE CLOVER |
| MOSIAC VIRUS (STRAIN M) |
| (WCMV) |
| PYOR3-- WCMVO HYPOTHETICAL 13 KD PROTEIN (ORF 3) WHITE CLOVER |
| MOSAIC VIRUS (STRAIN O) |
| (WCMV) |
| PYOR5-- ADEG1 HYPOTHETICAL 31.5 KD PROTEIN (ORF 5) AVIAN ADENOVIRUS |
| GAL1 |
| PYORG-- TTV1 HYPOTHETICAL 7.1 KD PROTEIN THERMOPROTEUS TENAX VIRUS |
| 1 (STRAIN KRA1) |
| (TTV1) |
| PYORM-- TTV1 HYPOTHETICAL 38.6 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS 1 (STRAIN KRA1) |
| (TTV1) |
| PYORP-- TTV1 HYPOTHETICAL 20.2 KD PROTEIN THERMOPROTEUS TENAX |
| VIRUS 1 (STRAIN KRA1) |
| (TTV1) |
| PYP24-- RTBV HYPOTHETICAL P24 PROTEIN (ORF 1 RICE TUNGRO BACILLIFOR |
| MVIRUS (RTBV) |
| PYP24-- RTBV HYPOTHETICAL P24 PROTEIN (ORF 1 RICE TUNGRO BACILLIFOR |
| MVIRUS (ISOLATE |
| PHILIPPINES) (RTBV) |
| PYP47-- NPVAC HYPOTHETICAL 43.5 KD PROTEIN IN P47 3'REGION |
| AUTOGRAPHA CALIFORNICA NUCLEAR |
| POLYHEDROSIS VIRUS (ACMNPVP) |
| PYRF5-- HSV6G HYPOTHETICAL |
| PROTEIN RF5 HERPES SIMPLEX VIRUS |
| (TYPE 6/STRAIN GS) |
| PYRR2-- EBV HYPOTHETICAL BRRF2 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PYSR1-- EBV HYPOTHETICAL BSRF1 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PYTR1-- EBV HYPOTHETICAL BTRF1 PROTEIN EPSTEIN-BARR VIRUS (STRAIN |
| B95-8) (HUMAN |
| HERPESVIRUS 4) |
| PYVAE-- VACCC HYPOTHETICAL 18.2 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PYVAL-- VACCV HYPOTHETICAL 9.9 KD PROTEIN VACCINIA VIRUS (STRAIN |
| WR), AND |
| VACCINIA VIRUS (STRAIN COPENHAGE |
| PYVBC-- VACCC HYPOTHETICAL 10.8 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PYVDG-- VACCV HYPOTHETICAL 10.4 KD PROTEIN VACCINIA VIRUS (STRAIN |
| WR), AND VACCINIA |
| VIRUS (STRAIN COPENHAGE |
| PYVEF-- VACCC HYPOTHETICAL 12.9 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PYVFC-- VACCC HYPOTHETICAL 11.6 KD PROTEIN VACCINIA VIRUS (STRAIN |
| COPENHAGEN) |
| PZNFP-- LYCVA ZINC FINGER PROTEIN LYMPHOCYTIC CHORIOMENINGITIS |
| VIRUS |
| (STRAIN ARMSTRONG) |
| PZNFP-- LYCVP AINC FINGER PROTEIN (FRAGMENT) LYMPHOCYTIC CHORIOMENI |
| NGITIS VIRUS |
| (STRAIN PASTEUR) |
| PCGENE |
| FILE NAME AREA 1 AREA 2 AREA 3 AREA 4 AREA 5 AREA 6 AREA 7 |
| __________________________________________________________________________ |
| PPOL2-- TBRV5 617-651 1041-1077 |
| PPOL2-- TRSVR 316-347 |
| PPOLG-- BOVEV 1833-1866 2001-2037 |
| PPOLG-- BVDVN 102-135 1650-1678 3220-3248 |
| PPOLG-- BVDVS 102-135 1560-1588 3130-3158 |
| PPOLG-- BYMV 226-255 |
| PPOLG-- COXA2 1120-1157 |
| PPOLG-- COXA3 67-99 |
| PPOLG-- COXA9 1601-1633 |
| PPOLG-- COXB1 1582-1614 |
| PPOLG-- COXB3 1585-1617 |
| PPOLG-- COXB4 1583-1615 |
| PPOLG-- COXB5 835-868 1585-1617 |
| PPOLG-- DEN1S 1111-1145 1485-1519 2401-2434 |
| PPOLG-- DEN1W 1112-1146 |
| PPOLG-- DEN26 61-95 1112-1146 |
| PPOLG-- DEN27 61-95 1112-1146 |
| PPOLG-- DEN2D 61-95 |
| PPOLG-- DEN2J 61-95 1112-1146 |
| PPOLG-- DEN2N 364-398 |
| PPOLG-- DEN2P 61-95 1112-1146 |
| PPOLG-- DEN2T 832-866 |
| PPOLG-- DEN3 61-95 2399-2432 |
| PPOLG-- DEN4 60-94 |
| PPOLG-- ECHG 774-806 |
| PPOLG-- EMCV 1194-1226 1463-1501 |
| PPOLG-- EMCVB 1196-1228 1465-1503 |
| PPOLG-- EMCVD 1196-1228 1465-1503 |
| PPOLG-- FMDV1 1036-1064 1098-1133 1167-1199 1465-1501 |
| PPOLG-- FMDVA 1036-1074 1098-1133 1167-1199 1465-1501 |
| PPOLG-- FMDVO 1098-1133 1167-1199 1465-1501 |
| PPOLG-- HCV1 1640-1670 |
| PPOLG-- HCVA 1363-1393 1560-1588 3131-3159 |
| PPOLG-- HCVB 102-135 1560-1588 3131-3159 |
| PPOLG-- HCVBK 1640-1670 |
| PPOLG-- HCVH 1640-1670 |
| PPOLG-- HCVH4 254-291 |
| PPOLG-- HCVJ6 711-742 |
| PPOLG-- HCVJ8 711-742 1893-1924 |
| PPOLG-- HCVJA 1640-1670 |
| PPOLG-- HCVJT 1640-1670 |
| PPOLG-- HCVTW 1640-1670 |
| PPOLG-- HPAV2 1514-1550 2068-2099 |
| PPOLG-- HPAV4 1514-1550 2068-2099 |
| PPOLG-- HPAV8 1514-1550 2068-2099 |
| PPOLG-- HPAVH 1515-1551 2069-2100 |
| PPOLG-- HPAVL 1515-1551 2069-2100 |
| PPOLG-- HPAVM 1515-1551 2069-2100 |
| PPOLG-- HPAVS 831-868 1517-1553 |
| PPOLG-- HRV14 1094-1132 2005-2041 |
| PPOLG-- HRV1B 1453-1485 1816-1849 1983-2019 |
| PPOLG-- HRV2 1446-1475 1809-1842 1976-2012 |
| PPOLG-- HRV89 1460-1492 1823-1856 1990-2026 |
| PPOLG-- HUEV7 1108-1145 |
| PPOLG-- IBDVO 222-260 |
| PPOLG-- JAEV1 61-95 1233-1269 1516-1549 2779-2813 3274-3311 |
| PPOLG-- |
| JAEV5 61-95 |
| 1233-1269 |
| 1516-1549 |
| 2779-2813 |
| 3274-3311 |
| PPOLG-- |
| JAEVJ 61-95 |
| 1233-1269 |
| 1516-1549 |
| 2779-2882 |
| 3274-3311 |
| PPOLG-- |
| JAEVN 1161-1197 |
| PPOLG-- |
| KUNJM 61-95 |
| 561-594 3275-3312 |
| PPOLG-- LANVT 1157-1188 1519-1551 2230-2264 2366-23989 3095-3132 |
| PPOLG-- |
| MCFA 1174-1206 |
| 1330-1359 |
| PPOLG-- |
| MDMV 322-351 |
| PPOLG-- |
| MVEV 61-95 |
| 1305-1342 |
| PPOLG-- |
| OMV 344-376 |
| PPOLG-- |
| PEMVC 826-859 |
| 1086-1124 |
| PPOLG-- |
| POL1M 1121-1158 |
| PPOLG-- |
| POL1S 1122-1159 |
| PPOLG-- |
| POL2L 1120-1157 |
| PPOLG-- |
| POL2W 1120-1157 |
| PPOLG-- |
| POL32 1119-1156 |
| PPOLG-- |
| POL3L 1119-1156 |
| PPOLG-- |
| PPVD 2960-2991 |
| 3084-3113 |
| PPOLG-- |
| PPVEA 1337-1368 |
| 1461-1490 |
| PPOLG-- |
| PPVNA 2944-2975 |
| 3068-3097 |
| PPOLG-- |
| PPVRA 2959-2990 |
| 3083-3112 |
| PPOLG-- |
| PSBMV 931-966 |
| 1411-1445 |
| 3149-3178 |
| PPOLG-- |
| PVYHU 1302-1336 |
| 3004-3033 |
| PPOLG-- |
| PVYN 1302-1336 |
| PPOLG-- |
| PYFV1 230-262 |
| 1110-1139 |
| 1903-1931 |
| PPOLG-- |
| SBMVN 245-274 |
| PPOLG-- |
| STEVM 61-95 |
| 1301-1331 |
| PPOLG-- |
| SUMVS 307-336 |
| PPOLG-- |
| SVDVH 1585-1617 |
| PPOLG-- |
| SVDVU 1585-1617 |
| PPOLG-- |
| TBEVS 835-869 |
| 1157-1188 |
| 2366-2398 |
| 3093-3130 |
| PPOLG-- |
| TBEVW 1157-1188 |
| 2366-2398 |
| 3095-3132 |
| PPOLG-- |
| TEV 827-865 |
| 2998-3027 |
| PPOLG-- |
| TMEVB 1074-1102 |
| 1193-1221 |
| 1470-1508 |
| 1908-1939 |
| PPOLG-- |
| TMEVD 1072-1100 |
| 1191-1219 |
| 1468-1506 |
| 1906-1937 |
| PPOLG-- |
| TMEVG 1074-1102 |
| 1193-1221 |
| 1470-1508 |
| 1908-1939 |
| PPOLG-- |
| TUMV 1573-1602 |
| PPOLG-- |
| TVMV 2698-2733 |
| PPOLG-- |
| WMV2 958-987 |
| PPOLG-- |
| WNV 61-95 |
| 557-590 3272-3309 |
| PPOLG-- YEFV1 1157-1186 1228-1266 1495-1531 2308-2340 3092-3127 |
| PPOLG-- |
| YEFV2 1157-1186 |
| 1228-1266 |
| 1495-1531 |
| 2308-2340 |
| 3092-3127 |
| PPOLG-- |
| ZYMV 329-358 |
| PPOLH-- |
| POLIM 1122-1159 |
| PPOLH-- |
| WMV2 244-273 |
| PPOLN-- |
| EEVVT 613-648 |
| 1436-1468 |
| PPOLN-- |
| FCVC6 327-365 |
| PPOLN-- |
| FCVF4 300-333 |
| PPOLN-- |
| FCVF9 803-841 |
| PPOLN-- |
| HEVBU 1618-1652 |
| PPOLN-- |
| HEVME 1616-1650 |
| PPOLN-- |
| HEVMY 1618-1652 |
| PPOLN-- |
| HEVPA 1617-1651 |
| PPOLN-- |
| MIDDV 25-57 |
| PPOLN-- |
| ONNVG 1144-1180 |
| 1404-1439 |
| PPOLN-- |
| RHDV 299-337 |
| 1562-1594 |
| PPOLN-- |
| SFV 1146-1175 |
| 1406-1441 |
| PPOLN-- |
| SINDO 1454-1486 |
| PPOLN-- |
| SINDV 1454-1486 |
| PPOLS-- |
| EEEV 524-556 |
| PPOLS-- |
| EEEV3 525-557 |
| PPOLS-- |
| EEVV8 1203-1239 |
| PPOLS-- |
| EEVVT 1203-1239 |
| PPOLS-- |
| ONNVG 1150-1182 |
| 1201-1235 |
| PPOLS-- |
| RRVN 1216-1250 |
| PPOLS-- |
| RRVT 1216-1250 |
| PPOLS-- |
| SFV 1215-1251 |
| PPOLS-- |
| SINDO 1197-1233 |
| PPOLS-- |
| SINDV 1197-1233 |
| PPOLS-- |
| WEEV 1188-1224 |
| PPOL-- |
| BIV06 742-773 |
| PPOL-- |
| BIV27 742-773 |
| PPOL-- |
| BLVAU 343-374 |
| PPOL-- |
| CAEVC 206-240 |
| 322-355 |
| PPOL-- COYMV 1234-1267 1484-1518 1750-1788 1800-1831 |
| PPOL-- EIAV9 166-198 506-539 |
| PPOL-- EIAVC 166-198 506-539 |
| PPOL-- EIAVY 166-198 505-538 |
| PPOL-- FOAMV 126-154 |
| PPOL-- GALV 348-378 |
| PPOL-- HTL1A 657-688 |
| PPOL-- HTL1C 657-688 |
| PPOL-- HV1A2 331-364 500-537 |
| PPOL-- HV1B1 343-376 512-549 |
| PPOL-- HV1B5 343-376 512-549 |
| PPOL-- HV1BR 343-376 512-549 |
| PPOL-- HV1EL 330-363 499-536 |
| PPOL-- HV1H2 331-364 500-537 |
| PPOL-- HV1JR 335-368 504-541 |
| PPOL-- HV1MA 330-363 |
| PPOL-- HV1MN 334-367 503-540 |
| PPOL-- HV1N5 331-364 500-537 |
| PPOL-- HV1ND 330-363 499-536 |
| PPOL-- HV1OY 331-364 500-537 |
| PPOL-- HV1PV 343-376 512-549 |
| PPOL-- HV1RH 330-363 499-536 |
| PPOL-- HV1U4 330-363 499-536 |
| PPOL-- HV1Z2 330-363 499-536 |
| PPOL-- HV2CA 353-386 |
| PPOL-- HV2NZ 353-386 |
| PPOL-- HV2RO 354-387 |
| PPOL-- IPHA 460-496 |
| PPOL-- JSRV 186-220 |
| PPOL-- MPMV 650-681 |
| PPOL-- OMVVS 61-98 102-130 182-216 298-331 |
| PPOL-- RTBV 788-824 891-919 1399-1433 |
| PPOL-- RTHVP 788-824 891-919 1399-1433 |
| PPOL-- SFV3L 337-365 |
| PPOL-- SIVCZ 355-388 524-561 |
| PPOL-- SOCMV 17-55 58-89 |
| PPOL-- SRV1 650-681 |
| PPOL-- VILV 80-117 201-235 317-350 |
| PPOL-- VILV1 80-117 317-350 |
| PPOL-- VILV2 80-117 201-235 317-350 |
| PPP41-- HSV6G 60-91 |
| PPTP-- NPVAC 53-85 |
| PREEP-- CSV 113-149 |
| PREV-- BIV27 74-109 |
| PREV-- EIAV9 44-79 |
| PREV-- EIAVC 44-79 |
| PREV-- EIAVY 74-109 |
| PREV-- SIVAT 25-62 |
| PRIR1-- ASFM2 630-666 |
| PRIR1-- HCMVA 279-311 393-430 449-477 |
| PRIR1-- HSVEB 60-92 503-531 |
| PRIR1-- VACCC 203-235 |
| PRIR1-- VACCV 203-235 |
| PRIR1-- VARV 203-235 |
| PRIR1-- VZVD 34-72 221-254 488-516 |
| PRMIL-- AVEVR 149-177 |
| PRMIL-- AVI11 133-161 |
| PRP94-- VACCV 399-427 |
| PRP94-- VARV 399-427 |
| PRPO1-- VACCV 1005-1033 |
| PRPO2-- CAPVK 297-333 667-696 |
| PRPO2-- COWPX 202-236 542-578 |
| PRPO2-- VACCV 202-236 542-578 |
| PRPO2-- VARV 202-236 542-578 |
| PRPO7-- VACCV 38-66 |
| PRPO7-- VARV 38-66 |
| PRPO8-- FOWP1 57-88 |
| PRPOA-- LELV 1233-1268 3133-3163 3426-3457 |
| PRPOL-- EAV 171-207 3041-3072 |
| PRRP1-- DHV11 96-125 199-234 |
| PRRP1-- IAVI7 138-170 |
| PRRP1-- INCJJ 564-598 |
| PRRP2-- IAANN 398-435 484-518 |
| PRRP2-- IADH2 484-518 |
| PRRP2-- IAFPR 484-518 |
| PRRP2-- IAGU2 484-518 |
| PRRP2-- IAHLO 484-518 |
| PRRP2-- IAHTE 484-518 |
| PRRP2-- IAKOR 484-518 |
| PRRP2-- IALE1 484-518 |
| PRRP2-- IALE2 484-518 |
| PRRP2-- IAMAN 484-518 |
| PRRP2-- IANT6 484-518 |
| PRRP2-- IAP10 484-518 |
| PRRP2-- IAPUE 484-518 |
| PRRP2-- IARUD 484-518 |
| PRRP2-- IASIN 484-518 |
| PRRP2-- IATKM 484-518 |
| PRRP2-- IAV17 484-518 |
| PRRP2-- IAW1L 484-518 |
| PRRP2-- JAZH2 484-518 |
| PRRP2-- IAZH3 484-518 |
| PRRP2-- IAZI1 484-518 |
| PRRP2-- IAZTF 484-518 |
| PRRP3-- IABUD 515-553 585-613 |
| PRRP3-- IAFPR 585-613 |
| PRRP3-- IAFPW 579-613 |
| PRRP3-- IAGU2 585-613 |
| PRRP3-- IAGUA 585-613 |
| PRRP3-- IAHPR 585-613 |
| PRRP3-- IAMAN 585-613 |
| PRRP3-- IASE2 585-613 |
| PRRP3-- IATKM 585-613 |
| PRRP3-- IAZI1 585-613 |
| PRRP3-- IAZTE 585-613 |
| PRRP3-- INBAC 735-769 |
| PRRP3-- INBAD 735-769 |
| PRRP3-- INCBE 609-641 |
| PRRP3-- INCJJ 609-641 |
| PRRP3-- THOGV 109-145 324-356 |
| PRRPA-- CVH22 410-443 712-745 1262-1295 1963-1999 2078-2112 |
| 2474-2508 |
| 3153-3191 |
| PRRPA-- |
| CVMJH 708-740 |
| 3544-3577 |
| 3575-3785 |
| 3933-3961 |
| PRRPB-- |
| BEV 941-969 |
| 2137-2169 |
| 2178-2206 |
| PRRPB-- |
| CVMA5 346-380 |
| 684-714 1689-1722 |
| 2698-2730 |
| PRRPB-- |
| CVMJH 346-380 |
| 684-714 1687-1720 |
| 2356-2391 |
| 2696-2728 |
| PRRPB-- |
| CPVFS 173-207 |
| 322-350 482-515 |
| PRRPB-- |
| CVPR8 80-113 |
| PRRPB-- |
| IBVB 636-670 |
| PRRPL-- |
| BUNYW 303-331 |
| 1096-1128 |
| PRRPL-- |
| HANTV 1938-1971 |
| PRRPL-- |
| HRSVA 892-922 |
| 1181-1213 |
| PRRPL-- |
| MABVM 144-176 |
| 698-736 1042-1074 |
| 1797-1832 |
| PRRPL-- |
| MABVP 144-176 |
| 698-736 1042-1074 |
| 2223-2253 |
| PRRPL-- |
| MEASE 193-227 |
| 647-683 788-825 |
| 1160-1192 |
| 1886-1914 |
| PRRPL-- |
| MUMPM 1882-1913 |
| PRRPL-- |
| NDVB 626-661 |
| 1571-1603 |
| PRRPL-- |
| PI2HT 268-305 |
| 558-595 654-688 |
| 1562-1599 |
| 1881-1912 |
| 2025-2053 |
| PRRPL-- |
| PI3H4 41-76 |
| 735-764 784-814 |
| 2111-2139 |
| PRRPL-- |
| RABVP 60-90 |
| 804-837 1365-1394 |
| 1930-1962 |
| PRRPL-- |
| RABVS 60-90 |
| 804-837 1365-1394 |
| 1930-1962 |
| PRRPL-- |
| RDV 1293-1323 |
| PRRPL-- |
| RVFV2 1018-1055 |
| 2009-2044 |
| PRRPL-- |
| SEND5 194-231 |
| 233-269 735-764 |
| 784-814 2140-2177 |
| PRRPL-- SENDE 14-51 53-89 555-584 1927-1955 1960-1997 |
| PRRPL-- SENDZ 194-231 233-269 735-764 784-814 2140-2177 |
| PRRPL-- SEOU8 394-431 1938-1971 2081-2119 |
| PRRPL-- SV5WR 557-594 1094-1122 2020-2051 |
| PRRPL-- SYNV 126-164 605-634 820-856 918-951 1484-1517 |
| PRRPL-- TSWVB 43-79 843-880 2266-2298 2369-2403 2481-2511 2805-2840 |
| PRRPL-- UUK 1017-1051 1147-1177 1293-1321 2060-2095 |
| PRRPL-- VSVJH 209-246 312-349 1011-1039 1662-1697 1956-1989 |
| PRRPL-- |
| VSVJG 1011-1039 |
| 1956-1989 |
| PRRPL-- |
| VSVSJ 138-171 |
| 209-246 312-349 |
| 961-999 1011-1039 |
| 1739-1772 |
| 2051-2087 |
| PRRPO-- |
| BWYVF 346-374 |
| PRRPO-- |
| BYDV1 722-755 |
| PRRPO-- |
| BYDVP 722-755 |
| PRRPO-- |
| BYDVR 722-755 |
| PRRPO-- |
| CABMV 4-37 |
| PRRPO-- |
| CGMVS 443-481 |
| 725-755 1095-1132 |
| 1565-1597 |
| PRRPO-- |
| CNV 470-501 |
| PRRPO-- |
| CRV 28-62 |
| 267-300 470-501 |
| PRRPO-- |
| IBDV5 186-218 |
| 274-302 |
| PRRPO-- IBDVA 260-288 511-543 599-627 |
| PRRPO-- IPNVJ 360-390 749-778 |
| PRRPO-- IPNVS 360-390 749-778 |
| PRRPO-- LYCVA 109-137 263-291 2077-2106 |
| PRRPO-- LYCVW 109-137 |
| PRRPO-- MCMV 16-48 53-81 |
| PRRPO-- PLRV1 576-607 |
| PRRPO-- PLRVW 576-607 |
| PRRPO-- PPMVS 375-407 702-730 859-891 1069-1106 1533-1565 |
| PRRPO-- RCNMV 278-314 320-353 |
| PRRPO-- REOVJ 284-315 |
| PRRPO-- ROTBR 25-60 200-231 247-276 |
| PRRPO-- ROTBU 200-231 247-276 |
| PRRPO-- ROTPG 200-231 247-276 |
| PRRPO-- ROTS1 25-60 200-231 247-276 |
| PRRPO-- TACV 17-52 109-138 2078-2112 |
| PRRPO-- TBSVC 470-501 |
| PRRPO-- TCV 280-318 |
| PRRPO-- TMGMV 67-97 128-159 209-244 375-406 450-483 855-887 |
| 1527-1559 |
| PRRPO-- |
| TMV 128-159 |
| 376-406 700-728 |
| 1533-1565 |
| PRRPO-- |
| TMVKR 128-159 |
| 376-406 700-728 |
| 1533-1565 |
| PRRPO-- |
| TMVTO 128-159 |
| 376-406 700-728 |
| 857-889 1533-1565 |
| PRRPO-- TNVA 231-263 |
| PRRPO-- TNVD 5-40 234-270 |
| PRRPP-- CDVO 295-332 |
| PRRPP-- MEASE 295-332 |
| PRRPP-- MEASI 295-332 |
| PRRPP-- MEASY 295-332 |
| PRRPP-- MUMP1 211-248 |
| PRRPP-- MUMPE 212-249 |
| PRRPP-- MUMPM 212-249 |
| PRRPP-- NDVA 220-255 |
| PRRPP-- NDVB 220-255 |
| PRRPP-- PI2H 216-253 |
| PRRPP-- PI2HT 216-253 |
| PRRPP-- PI4HA 220-257 332-364 |
| PRRPP-- PI4HB 220-257 332-364 |
| PRRPP-- PIRYV 134-168 |
| PRRPP-- RABVA 216-244 |
| PRRPP-- RABVC 216-244 |
| PRRPP-- RABVE 216-244 |
| PRRPP-- RABVP 89-122 216-244 |
| PRRPP-- RABVS 216-244 |
| PRRPP-- SEND5 530-566 |
| PRRPP-- SEND6 530-566 |
| PRRPP-- SENDF 530-566 |
| PRRPP-- SENDH 530-566 |
| PRRPP-- SENDZ 530-566 |
| PRRPP-- SV5 199-236 |
| PRRPP-- VSVJM 198-230 |
| PRRPP-- VSVJO 197-230 |
| PSODC-- VACCC 19-55 |
| PSODC-- VACCV 19-55 |
| PSODC-- VARV 19-55 |
| PSPHR-- AMEPV 58-86 138-172 627-659 671-701 |
| PSP11-- MYXVL 167-200 |
| PSP13-- VACCC 112-140 |
| PSP13-- VACCV 112-140 |
| PSP13-- VARV 116-144 |
| PTAG8-- FOWPV 199-230 |
| PTALA-- BFDV 99-129 172-210 461-491 |
| PTAM1-- POVHA 106-138 |
| PTAM1-- POVM3 43-80 |
| PTAM1-- POVMA 43-80 |
| PTAM1-- POVMC 43-80 |
| PTASM-- POVBA 130-162 |
| PTASM-- POVBK 130-162 |
| PTASM-- POVHA 106-138 |
| PTASM-- POVMA 43-80 |
| PTASM-- SV40 132-164 |
| PTEGU-- EBV 143-173 1469-1503 1791-1819 3102-3137 |
| PTEGU-- HCMVA 161-192 699-736 812-840 2199-2228 |
| PTEGU-- HSV6G 222-259 566-601 615-643 1436-1469 2037-2072 |
| PTEGU-- HSVEB 265-297 559-589 1072-1106 3363-3392 |
| PTEGU-- HSVSA 467-505 714-751 823-861 926-960 1503-1536 2421-2457 |
| PTERM-- |
| ADE07 369-400 |
| PTMAF-- |
| AVIS4 230-267 |
| PTOP2-- |
| ASFB7 119-153 |
| 1105-1142 |
| PTOP2-- |
| ASFM2 119-153 |
| 1104-1141 |
| PTREL-- |
| AVIRE 189-226 |
| PTYSY-- |
| VZVD 121-156 |
| PU1L-- |
| HSV6U 171-203 |
| PUDPE-- |
| NPVAC 185-219 |
| 387-425 452-484 |
| PUL02-- |
| HCMVA 25-59 |
| PUL06-- |
| EBV 355-386 |
| PUL06-- |
| HSV11 404-436 |
| PUL06-- |
| HSVEB 222-251 |
| 437-475 |
| PUL06-- HSVSA 299-330 |
| PUL06-- VZVD 223-252 502-530 |
| PUL07-- HCMVA 186-216 |
| PUL07-- HSVEB Nov-39 |
| PUL08-- HCMVA 65-96 |
| PUL08-- HSV11 614-648 |
| PUL08-- VZVD 227-255 |
| PUL09-- HSV11 678-713 |
| PUL09-- VZVD 168-204 |
| PUL14-- PRVN3 40-76 |
| PUL16-- HSV11 22-52 |
| PUL17-- HSV6U 302-339 |
| PUL21-- HSVEB 294-328 |
| PUL21-- PRVN3 242-271 |
| PUL21-- VZVD 56-92 375-412 |
| PUL24-- HCMVA 52-87 |
| PUL24-- ILTVT 158-196 |
| PUL25-- HSVEB 343-379 |
| PUL25-- HSVSA 290-323 |
| PUL25-- VZVD 540-571 |
| PUL28-- HCMVA 287-316 |
| PUL31-- HCMVA 464-501 |
| PUL31-- HSVSA 163-197 |
| PUL32-- EBV 367-405 |
| PUL32-- HSV11 404-438 564-592 |
| PUL32-- HSVEB 81-115 |
| PUL32-- HSVSA 276-307 |
| PUL32-- VZVD 553-581 |
| PUL34-- HSVSA 98-130 |
| PUL35-- HCMVA 138-169 |
| PUL36-- HCMVA 186-223 |
| PUL37-- EBV 85-123 |
| PUL37-- HSVEB 702-732 778-812 |
| PUL37-- HSVSA 566-602 |
| PUL37-- VZVD 598-629 706-736 776-806 |
| PUL38-- HCMVA 157-188 |
| PUL41-- VZVD 274-307 |
| PUL43-- HSV11 41-70 |
| PUL45-- HSV11 34-64 277-308 |
| PUL47-- HCMVA 438-471 741-777 |
| PUL47-- HSVE4 580-615 |
| PUL47-- HSVEB 587-622 |
| PUL49-- HSV11 226-259 |
| PUL49-- HSVBP 135-168 |
| PUL52-- EBV 582-617 |
| PUL52-- HSV11 599-629 771-805 |
| PUL52-- HSVEB 316-344 580-618 912-947 |
| PUL52-- HSV5A 229-267 374-411 |
| PUL53-- HCMVA 213-248 |
| PUL53-- HSV6IJ 105-139 |
| PUL60-- HCMVA 120-148 |
| PUL70-- HCMVA 36-65 626-664 |
| PUL77-- HCMVA 381-413 565-598 |
| PUL78-- HCMVA 262-290 303-341 |
| PUL79-- HSVSA 158-195 |
| PUL87-- HSV6U 130-159 |
| PUL87-- HSVSA 322-355 |
| PUL88-- HCMVA 309-337 |
| PUL88-- HSV6U 150-187 238-272 |
| PUL91-- HSVSA 23-53 |
| PUL92-- EBV 106-144 |
| PUL92-- HSVSA 123-157 |
| PUL93-- HCMVA 387-420 |
| PUL95-- EBV 111-145 |
| PULB8-- HCMVA 102-130 152-181 |
| PULC1-- HCMVA 129-165 |
| PULC8-- HCMVA 64-96 |
| PULC9-- HCMVA 66-99 |
| PULD0-- HCMVA 81-114 |
| PUNG-- EBV 159-189 |
| PUNG-- VACCC 82-117 |
| PUNG-- VACCV 82-117 |
| PUNG-- VARV 82-117 |
| PUS02-- HCMVA 43-73 |
| PUS07-- HCMVA 153-190 |
| PUS09-- HCMVA 179-213 |
| PUS10-- HCMVA 137-170 |
| PUS12-- HCMVA 29-67 113-142 |
| PUS13-- HCMVA 11-45 |
| PUS15-- HCMVA 343-375 |
| PUS16-- HCMVA 151-188 243-274 |
| PUS18-- HCMVA 185-222 |
| PUS22-- HCMVA 270-299 |
| PUS26-- HCMVA 132-164 |
| PUS27-- HCMVA 247-285 |
| PUS29-- HCMVA 246-276 |
| PUS30-- HCMVA 208-246 |
| PV125-- AMVLE 263-292 |
| PV13K-- TRVPL 24-62 |
| PV143-- NPVAC 312-342 |
| PV17K-- BSMV 40-75 |
| PV1A-- CMVEN 674-709 |
| PV270-- ASFB7 103-135 |
| PV2A-- BBMV 636-673 |
| PV2A-- CCMV 325-363 639-673 762-799 |
| PV2A-- CMVEN 208-243 292-320 |
| PV2A-- CMVQ 205-240 |
| PV2A-- TAV 297-325 |
| PV30K-- TRVTC 102-133 |
| PV3A-- BBMV 155-187 |
| PV3A-- BMV 159-189 |
| PV3A-- CCMV 160-188 |
| PV3A-- IBVB 5-43 |
| PV3A-- IBVM 5-42 |
| PV3A-- IBVP3 5-42 |
| PV3A-- IBVU5 5-42 |
| PV51K-- ACLSV 70-106 |
| PV51K-- BWYVF 366-398 |
| PV51K-- BWYVG 366-398 |
| PV56K-- PLRV1 360-392 |
| PV56K-- PLRVW 360-392 |
| PV58K-- BSMV 320-353 |
| PV70K-- PLRV1 220-257 |
| PV70K-- PLRVW 220-257 |
| PV90K-- AMVLE 103-131 |
| PVA04-- VACCC 217-251 |
| PVA04-- VACCV 217-251 |
| PVA04-- VARV 207-241 |
| PVA11-- VACCC 95-132 |
| PVA11-- VARV 96-133 |
| PVA18-- VACCC 390-421 |
| PVA18-- VACCV 390-421 |
| PVA18-- VARV 390-421 |
| PVA23-- VACCC 81-111 170-203 |
| PVA23-- VARV 81-111 170-203 |
| PVA31-- VACCC 42-76 |
| PVA31-- VACCV 42-76 |
| PVA31-- VARV 42-76 |
| PVA32-- VACCV 48-79 |
| PVA32-- VARV 18-49 |
| PVA40-- VACCC 4-37 |
| PVA43-- VACCC 94-129 |
| PVA43-- VACCV 94-129 |
| PVA43-- VARV 95-130 |
| PVA51-- VACCC 109-143 |
| PVA51-- VACCV 109-143 |
| PVAL1-- BCTV 89-118 |
| PVAL1-- BGMV 89-118 |
| PVAL1-- CLVK 88-117 |
| PVAL1-- CLVN 88-117 |
| PVAL1-- PYMVV 89-118 |
| PVAL1-- TGMV 90-119 |
| PVAL1-- TYLCM 89-118 |
| PVAL1-- TYLCV 87-116 |
| PVAL3-- BCTV 82-115 |
| PVAL3-- CLVK 77-113 |
| PVAL3-- CLVN 77-113 |
| PVAL3-- TYLCM 78-116 |
| PVAL3-- TYLCV 77-113 |
| PVAT-- CAMVC 20-53 81-116 |
| PVAT-- CAMVD 20-53 102-130 |
| PVAT-- CAMVE 20-53 81-116 |
| PVAT-- CAMVN 20-53 81-116 |
| PVAT-- CAMVP 20-53 81-116 |
| PVAT-- CAMVS 20-53 81-116 |
| PVB04-- VACCC 124-156 489-525 |
| PVB04-- VACCV 124-156 489-525 |
| PVB04-- VARV 489-525 |
| PVB16-- COWPX 89-126 |
| PVB16-- VACCV 89-126 |
| PVB19-- VACCC 213-244 |
| PVB19-- VACCD 211-242 |
| PVB19-- VACCV 211-242 |
| PVB19-- VARV 211-242 |
| PVBR1-- BGMV 166-198 |
| PVC03-- SFVKA 98-130 |
| PVC04-- VACCC 109-139 182-216 |
| PVC04-- VACCV 109-139 183-215 |
| PVC04-- VARV 109-139 |
| PVC06-- VACCC 36-67 |
| PVC06-- VACCV 36-67 |
| PVC06-- VARV 36-67 |
| PVC07-- SFVKA 60-97 |
| PVC09-- VACCC 573-610 |
| PVC09-- VACCV 573-610 |
| PVC10-- SFVKA 85-121 |
| PVC10-- VACCC 121-158 |
| PVC10-- VACCV 121-158 |
| PVC10-- VARV 121-158 |
| PVC21-- VACCC 3-34 |
| PVCAP-- EBV 148-183 200-230 |
| PVCAP-- HCMVA 43-78 128-161 258-286 |
| PVCAP-- HSV11 19-49 |
| PVCAP-- HSV6U 124-161 666-696 841-869 |
| PVCAP-- HSVEB 17-54 198-232 272-301 |
| PVCAP-- HSVSA 144-179 196-226 734-769 1062-1096 |
| PVCAP-- PRVIS 189-221 260-289 |
| PVCAP-- VZVD 31-68 |
| PVCOM-- ADE02 86-115 |
| PVCOM-- ADE05 85-114 |
| PVD03-- VACCC 12-50 146-182 |
| PVD03-- VACCV 12-50 146-182 |
| PVD03-- VARV 12-50 146-182 |
| PVD05-- FOWP1 315-352 |
| PVD05-- VACCC 320-348 |
| PVD05-- VACCV 320-348 |
| PVD03-- VARV 320-348 |
| PVD10-- FOWP1 114-143 |
| PVE05-- VACCD 31-60 |
| PVE06-- VACCC 226-260 430-458 511-540 |
| PVE06-- VACCV 226-260 430-458 511-540 |
| PVE06-- VARV 430-458 511-540 |
| PVE10-- VACCC 3-41 |
| PVE10-- VACCV 3-41 |
| PVE10-- VARV 3-41 |
| PVE12-- HPV16 102-131 |
| PVE18-- NPVAC 45-77 |
| PVE1-- HPV05 4-35 |
| PVE1-- HPV11 258-291 |
| PVE1-- HPV13 255-288 |
| PVE1-- HPV33 238-267 519-547 |
| PVE1-- HPV35 230-263 |
| PVE1-- HPV39 242-271 |
| PVE1-- HPV41 105-138 193-231 |
| PVE1-- HPV58 238-267 |
| PVE1-- HPV58 6-35 |
| PVE1-- HPV6B 258-291 |
| PVE1-- PAPVD 163-201 |
| PVE1-- PCPV1 257-290 |
| PVE26-- NPVAC 118-150 |
| PV2-- HPV57 151-182 |
| PVE2-- RHPV1 117-147 |
| PVE41-- NPVAC 14-52 |
| PVE5A-- HPV11 19-56 |
| PVE5A-- HPV6B 19-56 |
| PVE5A-- HPV6C 19-56 |
| PVE5-- HPV13 19-56 |
| PVE5-- HPV5B 89-118 |
| PVE5-- PCPV1 21-58 |
| PVE5-- RHPV1 109-140 |
| PVE6-- HPVIA 91-128 |
| PVE7-- HPV05 55-90 |
| PVE7-- HPV08 55-90 |
| PVE7-- HPV11 47-83 |
| PVE7-- HPV16 47-83 |
| PVE7-- HPV1A 45-77 |
| PVE7-- HPV31 47-83 |
| PVE7-- HPV33 47-83 |
| PVE7-- HPV35 48-84 |
| PVE7-- HPV41 63-94 |
| PVE7-- HPV47 55-90 |
| PVE7-- HPV51 61-94 |
| PVE7-- HPV58 48-84 |
| PVE7-- HPV5B 55-90 |
| PVE7-- HPV6B 47-83 |
| PVE7-- PAPVD 48-86 |
| PVE7-- PAPVE 60-93 |
| PVE94-- NPVAC 123-157 650-678 |
| PVEF-- GVTN 154-182 |
| PVENV-- BEV 16-51 87-117 |
| PVENV-- DHV11 297-335 |
| PVENV-- MCV1 203-236 |
| PVENV-- MCV2 203-236 |
| PVENV-- VACCC 208-241 |
| PVENV-- VACC1 208-241 |
| PVENV-- VACCP 208-241 |
| PVENV-- VACCV 208-241 |
| PVENV-- VARV 155-187 208-241 |
| PVF03-- VACCC 2-40 61-93 |
| PVF03-- VACCV 2-40 61-93 |
| PVFP1-- FOWPV 297-330 |
| PVFP4-- FOWPV 237-267 |
| PVFP7-- CAPVK 89-118 |
| PVFUS-- VACCC 28-61 |
| PVFUS-- VACCV 28-61 |
| PVFUS-- VARV 28-61 |
| PVG01-- HSV11 317-346 |
| PVG02-- HSVEB 163-196 |
| PVG02-- VACCV 92-120 |
| PVG02-- VARV 92-120 |
| PVG03-- HSV11 108-136 |
| PVG06-- HSV11 54-83 |
| PVG06-- VACCC 99-136 |
| PVG06-- VARV 99-136 |
| PVG07-- VACCC 113-145 |
| PVG07-- VARV 113-145 |
| PVG09-- VACCC 303-338 |
| PVG09-- VACCV 266-301 |
| PVG09-- VARV 303-338 |
| PVG11-- HSV11 150-183 |
| PVG12-- HSV11 206-243 |
| PVG12-- HSVSA 68-106 |
| PVG1-- SPV1R 254-292 303-337 414-452 |
| PVG22-- HSV11 300-337 647-678 |
| PVG23-- HSV11 70-108 |
| PVG26-- HSV11 94-125 |
| PVG27-- HSVSA 36-74 |
| PVG28-- HSV11 491-521 |
| PVG28-- AMEPV 180-217 |
| PVG2-- SPV4 209-244 |
| PVG35-- HSV11 15-56 190-226 |
| PVG36-- HSVSA 151-185 |
| PVG39-- HSV11 543-577 648-682 |
| PVG40-- HSVSA 187-216 |
| PVG41-- HSV11 11-45 202-233 |
| PVG42-- HSV11 91-125 |
| PVG43-- HSV11 109-140 157-185 |
| PVG46-- HSV11 888-925 |
| PVG48-- HSVSA 329-357 |
| PVG50-- HSVSA 113-141 |
| PVG51-- HSV11 29-64 84-120 |
| PVG52-- HSV11 96-134 |
| PVG55-- HSV11 100-129 |
| PVG56-- HSV11 364-396 631-667 1091-1126 |
| PVG58-- HSV11 342-375 480-508 |
| PVG58-- HSVSA 25-60 195-233 |
| PVG59-- HSV11 82-118 |
| PVG61-- HSV11 76-109 |
| PVG64-- HSV11 55-89 363-401 420-452 |
| PVG65-- HSV11 801-836 1146-1174 1290-1326 |
| PVG67-- HSV11 1150-1185 |
| PVG6-- SPV1R 60-89 |
| PVG71-- HSVSA 128-158 |
| PVG72-- HSV11 445-478 720-751 1158-1189 1252-1285 |
| PVG75-- HSV11 263-291 387-422 |
| PVG76-- HSV11 187-221 |
| PVG7-- SPV1R 18-46 |
| PVGF1-- IBVB 1719-1747 1856-1891 2108-2146 3601-3633 |
| PVGH3-- HCMVA 80-115 157-185 |
| PVGL2-- CVBF 1259-1294 |
| PVGL2-- CVBL9 651-681 |
| PVGL2-- CVBLY 1259-1294 |
| PVGL2-- CVBM 1259-1294 |
| PVGL2-- CVBQ 1259-1294 |
| PVGL2-- CVBV 1259-1294 |
| PVGL2-- CVH22 1053-1088 |
| PVGL2-- CVM4 1267-1304 |
| PVGL2-- CVMA5 1215-1252 |
| PVGL2-- CVMJC 1267-1304 |
| PVGL2-- CVMJH 1126-1163 |
| PVGL2-- CVPFS 632-665 736-764 1328-1363 |
| PVGL2-- CVPM1 632-665 736-764 1328-1363 |
| PVGL2-- CVPPR 630-663 734-762 1326-1361 |
| PVGL2-- CVPPU 630-663 734-762 1326-1361 |
| PVGL2-- CVPR8 512-540 1104-1139 |
| PVGL2-- CVPRM 408-441 512-540 1104-1139 |
| PVGL2-- CVPRT 630-663 734-762 1326-1361 |
| PVGL2-- FIPV 635-668 739-767 1331-1366 |
| PVGL2-- IBVB 153-188 |
| PVGLB-- HCMVA 116-147 706-743 |
| PVGLB-- HCMVT 116-147 707-744 |
| PVGLB-- HSV6U 72-110 |
| PVGLB-- HSVB1 254-288 |
| PVGLB-- HSVB2 745-774 |
| PVGLB-- HSVBC 253-287 |
| PVGLB-- ILTV6 442-472 |
| PVGLB-- ILTVS 452-482 |
| PVGLB-- ILTVT 452-482 |
| PVGLB-- MCMVS 135-163 738-776 |
| PVGLC-- HSV11 467-500 |
| PVGLC-- HSV1K 467-500 |
| PVGLC-- HSV2 435-465 |
| PVGLC-- HSV23 436-466 |
| PVGLC-- HSVBC 475-507 |
| PVGLC-- VZVD 351-388 513-548 |
| PVGLC-- VZVS 351-388 513-548 |
| PVGLD-- HSVEA 340-370 |
| PVGLD-- HSVEB 41-70 390-420 |
| PVGLD-- HSVEK 41-70 390-420 |
| PVGLE-- HSVE4 95-125 |
| PVGLE-- HSV3B 63-100 390-420 |
| PVGLE-- HSVEL 63-100 392-422 |
| PVGLE-- PRVR1 332-369 |
| PVGLF-- BRSVA 265-301 482-511 |
| PVGLF-- BRSVC 484-513 |
| PVGLF-- BRSVR 484-513 |
| PVGLF-- CDVO 562-596 |
| PVGLF-- HRSV1 484-513 |
| PVGLF-- HRSVA 484-513 |
| PVGLF-- HRSVL 484-513 |
| PVGLF-- HRSVR 484-513 |
| PVGLF-- MEASE 224-256 451-484 |
| PVGLF-- MEAS1 227-259 454-487 |
| PVGLF-- MEASY 224-256 451-484 |
| PVGLF-- MUMP1 5-38 446-474 |
| PVGLF-- MUMPM 446-484 |
| PVGLF-- MUMPR 446-474 |
| PVGLF-- MUMPS 5-38 446-474 |
| PVGLF-- NDV1 132-165 |
| PVGLF-- NDVL 132-165 |
| PVGLF-- PHODV 531-565 |
| PVGLF-- P11HC 456-484 |
| PVGLF-- P13B 453-481 |
| PVGLF-- P13H4 453-481 |
| PVGLF-- RINDK 220-252 447-480 |
| PVGLF-- RINDL 220-252 447-480 |
| PVGLF-- SEND5 460-488 |
| PVGLF-- SENDF 460-488 |
| PVGLF-- SENDH 460-488 |
| PVGLF-- SENDJ 460-488 |
| PVGLF-- SENDZ 460-488 |
| PVGLF-- SV5 446-474 |
| PVGLF-- TRTV 452-481 |
| PVGLG-- HSVEB 327-364 |
| PVGLG-- SYNV 524-553 |
| PVGLG-- VSV1G 450-488 |
| PVGLG-- VSVJO 457-492 |
| PVGLG-- VSVO 450-488 |
| PVGLG-- VSVSJ 450-488 |
| PVGLH-- HCMVA 691-719 |
| PVGLH-- HCMVT 690-718 |
| PVGLH-- HSV6G 215-247 640-677 |
| PVGLH-- HSVE4 814-850 |
| PVGLH-- HSVEB 807-843 |
| PVGLL-- HCMVA 158-194 |
| PVGLM-- BUNGE 197-227 438-468 982-1020 1049-1084 |
| PVGLM-- BUNL7 190-220 |
| PVGLM-- BUNSH 190-220 344-381 |
| PVGLM-- BUNYW 193-228 434-472 823-854 |
| PVGLM-- DUGBV 244-273 637-672 886-915 935-965 1403-1441 |
| PVGLM-- HANTB 610-641 1081-1119 |
| PVGLM-- HANTH 188-222 612-643 1082-1120 |
| PVGLM-- HANTL 188-222 612-643 1083-1121 |
| PVGLM-- HANTV 188-222 612-643 1083-1121 |
| PVGLM-- INSV 269-307 1028-1062 |
| PVGLM-- PHV 616-649 1088-1121 |
| PVGLM-- PTPV 949-982 1275-1309 |
| PVGLM-- PUUMH 620-653 1092-1125 |
| PVGLM-- PUUMS 620-653 1092-1125 |
| PVGLM-- RVFV 620-650 830-863 |
| PVGLM-- RVFVZ 620-650 830-863 1156-1185 |
| PVGLM-- SEOU8 610-641 1081-1119 |
| PVGLM-- SEOUR 605-641 1082-1120 |
| PVGLM-- SEOUS 610-641 1081-1119 |
| PVGLM-- UUK 431-468 966-995 |
| PVGLP-- BEV 1491-1526 |
| PVGLY-- JUNIN 12-45 |
| PVGLY-- LASSG 237-265 |
| PVGLY-- LASSJ 238-266 |
| PVGLY-- PIARV 12-50 |
| PVGLY-- TACV 12-50 |
| PVGLY-- TACV5 12-50 89-124 |
| PVGLY-- TACV7 12-50 89-124 |
| PVGLY-- TACVT 12-50 89-124 |
| PVGNB-- CPMV 1527-1555 |
| PVGNM-- CPMV 209-242 741-771 |
| PVGNM-- CPSMV 50-86 479-515 |
| PVGNM-- RCMV 766-799 |
| PVGP2-- EBV 78-111 |
| PVGP3-- EBV 78-111 |
| PVH02-- VACCC 54-89 |
| PVH02-- VACCV 54-89 |
| PVH02-- VARV |
| PVH05-- VACCC 115-149 |
| PVH05-- VACCV 115-149 |
| PVH05-- VARV 133-167 |
| PVHEL-- LSV 107-143 |
| PVI01-- VACCC 54-82 |
| PVI01-- VARV 54-82 |
| PVI06-- VACCV 55-88 |
| PVI06-- VARV 55-88 |
| PVI08-- VACCC 591-624 |
| PVI08-- VACCV 591-624 |
| PVI08-- VARV 591-624 |
| PVIE1-- HCMVA 243-271 |
| PVIE1-- HCMVT 243-271 |
| PVIF-- BIV06 42-78 |
| PVIF-- BIV27 42-78 |
| PVIF-- SIVGB 46-78 |
| PVIF-- SIVMK 82-111 |
| PVIMP-- EBV 125-159 |
| PVIMP-- HCMVA 68-100 |
| PVIMP-- HSV11 83-114 136-171 250-282 |
| PVIMP-- HSVEB 24-56 93-127 145-180 332-361 |
| PVIMP-- HSVSA 76-111 |
| PVINT-- SSV1 253-291 |
| PVJ05-- VACCC 54-85 |
| PVJ05-- VACCV 54-85 |
| PVJ05-- VARV 54-85 |
| PVK04-- VACCC 87-120 |
| PVK04-- VACCV 87-120 |
| PVK05-- VACCC 74-103 |
| PVK05-- VACCV 87-116 |
| PVL02-- VACCC 39-76 |
| PVL02-- VACCV 39-76 |
| PVL02-- VARV 39-76 |
| PVL03-- VACCC 292-322 |
| PVL03-- VACCV 292-322 |
| PVL03-- VARV 291-321 |
| PVL05-- VACCV 16-45 |
| PVL05-- VARV 16-45 |
| PVL1-- HPV5B 373-406 |
| PVL2-- CRPVK 26-57 |
| PVL2-- HPV05 27-57 |
| PVL2-- HPV08 27-57 |
| PVL2-- HPV1A 26-56 |
| PVL2-- HPV39 29-59 285-313 |
| PVL2-- HPV42 344-379 |
| PVL2-- HPV47 26-57 |
| PVL2-- HPV51 29-59 |
| PVL2-- HPV5B 27-57 |
| PVL2-- HPVME 29-59 |
| PVL2-- PCPV1 29-59 |
| PVL96-- IRV1 144-177 686-718 |
| PVM1-- REOVD 280-318 324-361 |
| PVM1-- REOVL 280-318 |
| PVM21-- REOVD 168-199 |
| PVM22-- REOVD 168-199 |
| PVM2-- REOVJ 168-199 |
| PVM2-- REOVL 168-199 |
| PVM3-- REOVD 333-364 |
| PVMAT-- SV5 308-342 |
| PVMAT-- TRTV 122-150 |
| PVME1-- CVBM 64-102 |
| PVME1-- CVHOC 64-102 |
| PVME1-- CVMAS 65-103 |
| PVME1-- CVMJH 65-103 |
| PVME1-- CVTKE 64-102 |
| PVME1-- IBVB 73-101 |
| PVME1-- IBVB2 73-101 |
| PVMEM-- EBV 178-213 |
| PVMP-- CERV 93-126 |
| PVMP-- SOCMV 66-98 273-303 |
| PVMSA-- HPBDB 201-238 269-302 |
| PVMSA-- HPBDC 194-227 268-301 |
| PVMSA-- HPBDU 157-19 231-264 |
| PVMSA-- HPBDW 194-228 269-302 |
| PVMSA-- HPBGS 209-243 271-307 |
| PVMSA-- HPBHE 159-195 236-269 |
| PVMSA-- HPBV0 70-98 |
| PVMSA-- HPBV2 244-272 |
| PVMSA-- HPBV4 244-272 |
| PVMSA-- HPBV9 244-272 |
| PVMSA-- HPBVA 233-261 |
| PVMSA-- HPBVD 70-98 |
| PVMSA-- HPBV1 233-261 |
| PVMSA-- HPBVJ 233-261 |
| PVMSA-- HPBVL 233-261 |
| PVMSA-- HPBVN 70-98 |
| PVMSA-- HPBVO 233-261 |
| PVMSA-- HPBVP 244-272 |
| PVMSA-- HPBVR 244-272 |
| PVMSA-- HPBVS 70-98 |
| PVMSA-- HPBVW 233-261 |
| PVMSA-- HPBVY 233-261 |
| PVMSA-- HPBVZ 233-261 |
| PVMSA-- WHV1 207-241 269-305 |
| PVMSA-- WHV59 212-246 274-310 |
| PVMSA-- WHV7 212-246 274-310 |
| PVMSA-- WHV8 212-246 274-310 |
| PVMSA-- WHV81 212-246 274-305 |
| PVMSA-- WHVW6 125-161 |
| PVMT2-- IAZH 10-42 |
| PVMT8-- MYXVL 5-34 141-170 |
| PVMT9-- MYXVL 246-282 |
| PVN02-- VACCC 31-68 |
| PVN02-- VACCV 31-68 |
| PVN02-- VARV 31-68 |
| PVN34-- ROTPC 336-366 |
| PVNCA-- AAV2 163-196 365-401 |
| PVNCS-- PARVO 180-217 346-377 439-471 |
| PVNS1-- AHSV4 351-380 |
| PVNS1-- IAALA 114-144 |
| PVNS1-- IAANN 114-144 |
| PVNS1-- IACHI 114-144 |
| PVNS1-- IACKG 107-144 |
| PVNS1-- IACKJ 104-141 |
| PVNS1-- IADA2 107-144 |
| PVNS1-- IADE1 104-141 |
| PVNS1-- IADU3 104-141 |
| PVNS1-- IAFOM 114-144 |
| PVNS1-- IAFOW 114-144 |
| PVNS1-- IAFPR 107-144 |
| PVNS1-- IALE1 114-144 |
| PVNS1-- IALEN 114-144 |
| PVNS1-- IAMA6 107-144 |
| PVNS1-- IAMAN 107-144 |
| PVNS1-- IAMAO 107-144 |
| PVNS1-- IAMYN 104-141 |
| PVNS1-- IAP10 107-144 |
| PVNS1-- IAP11 107-144 |
| PVNS1-- IAP12 107-144 |
| PVNS1-- IAP13 107-144 |
| PVNS1-- IAPUE 114-144 |
| PVNS1-- IATKB 107-144 |
| PVNS1-- IATKC 107-144 |
| PVNS1-- IATRS 104-141 |
| PVNS1-- IATRT 107-144 |
| PVNS1-- IAUDO 114-144 |
| PVNS1-- IAUSS 114-144 |
| PVNS1-- IAZI1 107-144 |
| PVNS1-- INBPA 266-295 |
| PVNS1-- INCAA 222-255 |
| PVNS1-- INCCA 222-255 |
| PVNS2-- HRSV1 20-49 |
| PVNS2-- HRSVA 20-49 |
| PVNS2-- INBLE 48-77 |
| PVNS2-- INBYA 48-77 |
| PVNS4-- CVMS 17-45 |
| PVNS4-- CVPFS 4-34 |
| PVNS4-- CVPPU 4-39 |
| PVNS4-- CVPRM 4-39 |
| PVNST-- CVMA5 45-80 |
| PVNST-- SCMJH 49-84 |
| PVNST-- INCGL 222-255 |
| PVNST-- INCJH 222-255 |
| PVNST-- INCM1 222-225 |
| PVNST-- INCYA 222-255 |
| PVNUA-- PRVKA 756-784 |
| PVNUC-- DHVH 297-331 441-470 |
| PVNUC-- IACKP 354-388 |
| PVNUC-- IAHLO 354-388 |
| PVNUC-- IAHPR 354-388 |
| PVNUC-- IAHTE 354-388 |
| PVNUC-- MABVM 16-46 |
| PVNUC-- MABVP 16-46 |
| PVO01-- VACCC 511-539 550-581 |
| PVO01-- VARV 511-539 |
| PVOR1-- NMV 121-150 641-671 |
| PVO01-- PVMR 1667-1703 |
| PVO01-- SMYEA 121-153 |
| PVP03-- HSVSA 462-493 |
| PVP10-- NPVAC 4-38 |
| PVP10-- NPVOP 4-38 |
| PVP10-- RBSDV 260-291 |
| PVP19-- HSVEB 239-268 287-325 |
| PVP23-- HCMVA 141-172 |
| PVP23-- HSV6U 46-79 206-238 |
| PVP23-- HSVEB 18-48 |
| PVP23-- VZVD 224-253 |
| PVP2-- AHSV4 408-441 |
| PVP2-- BTV10 649-683 |
| PVP2-- BTV11 558-586 649-683 |
| PVP2-- BTV17 391-424 564-593 |
| PVP2-- BTV1A 654-688 |
| PVP2-- BTV1S 654-688 |
| PVP2-- EHDV1 878-915 |
| PVP2-- ROTBR 334-367 522-557 |
| PVP2-- ROTBU 334-367 523-558 |
| PVP2-- ROTHW 342-377 532-567 |
| PVP2-- ROTPC 514-549 589-617 811-841 |
| PVP2-- ROTS1 335-368 523-558 |
| PVP35-- VACCC 278-311 |
| PVP35-- VACCV 278-311 |
| PVP35-- VARV 279-312 |
| PVP39-- NPVOP 107-141 |
| PVP3-- EHDV1 383-412 734-770 |
| PVP3-- EHDVA 383-412 734-770 |
| PVP3-- RDV 297-330 |
| PVP3-- ROTS1 652-688 |
| PVP40-- EBV 429-457 |
| PVP40-- HSVSA 119-152 |
| PVP40-- ILTVT 84-119 |
| PVP40-- VZVD 485-516 |
| PVP47-- NPVAC 239-270 |
| PVP4A-- VACCC 553-591 |
| PVP4A-- VACCV 553-591 |
| PVP4A-- VARV 554-592 |
| PVP4-- ROTG1 93-122 468-499 |
| PVP4-- WTV 278-308 624-659 |
| PVP5-- BRD 96-133 295-326 |
| PVP5-- BTV1A 295-324 |
| PVP5-- BTV1B 295-324 |
| PVP5-- BTV2A 295-324 |
| PVP5-- EHDV1 290-325 |
| PVP5-- WTV 691-719 |
| PVP61-- BTV10 159-187 |
| PVP62-- BTV10 155-183 210-245 |
| PVP62-- MRDV 25-61 222-257 |
| PVP64-- NPVOP 285-313 |
| PVP67-- NPVAC 281-316 |
| PVP67-- NPVGM 198-233 |
| PVP6-- BTV11 155-183 |
| PVP6-- BTV17 155-183 |
| PVP6-- BTV1S 159-187 |
| PVP6-- BTV2A 131-159 |
| PVP6-- WTV 180-209 |
| PVP6-- WTVNJ 180-209 |
| PVP79-- NPVAC 405-442 |
| PVP7-- WTV 454-490 |
| PVP87-- NPVOP 77-112 |
| PVP8-- BTV10 104-139 |
| PVP8-- BTV11 104-139 |
| PVP8-- BTV13 104-139 |
| PVP8-- BTV17 104-139 |
| PVP8-- BTV1A 104-139 |
| PVP8-- BTV1S 104-139 |
| PVP8-- BTV2A 104-139 |
| PVP8-- RDV 374-412 |
| PVP8-- WTV 164-195 379-412 |
| PVPHE-- NPVAC 145-173 |
| PVPHE-- NPVOP 122-151 |
| PVPR-- HV1A2 37-74 |
| PVPR-- HV2BE 41-73 |
| PVPR-- HV2CA 41-73 |
| PVPR-- HV2DH 41-73 |
| PVPR-- HV2D2 41-73 |
| PVPR-- HV2NZ 41-73 |
| PVPR-- HV2RO 41-73 |
| PVPR-- HV2SB 41-73 |
| PVPR-- HV2ST 40-72 |
| PVPR-- SIVCZ 37-74 |
| PVPR-- SIVM1 37-69 |
| PVPR-- SIVMK 37-69 |
| PVPR-- ISVML 17-69 |
| PVPR-- SIVS4 37-69 |
| PVPR-- SVISP 37-69 |
| PVPU-- HV1B1 3-33 |
| PVPU-- HV1B8 4-33 |
| PVPU-- HV1BN 3-34 |
| PVPU-- HV1BR 3-33 |
| PVPU-- HV1H2 4-33 |
| PVPU-- HV1JR 3-34 |
| PVPU-- HV1PV 3-33 |
| PVPU-- JSRV 116-154 |
| PVPX-- LDV 25-55 |
| PVPY-- BIV2 35-71 |
| PVRNA-- BSMV 290-319 676-705 |
| PVS05-- ROTHI 198-230 |
| PVS05-- ROTPC 88-119 358-392 |
| PVS05-- ROTS1 315-347 |
| PVS06-- ROTBR 55-92 |
| PVS06-- ROTBS 64-92 312-340 |
| PVS06-- ROTBU 55-92 |
| PVS06-- ROTEF 55-92 |
| PVS06-- ROTEH 55-92 |
| PVS06-- ROTH1 55-92 |
| PVS06-- ROTHC 64-92 312-340 |
| PVS06-- ROTHS 55-92 |
| PVS06-- ROTHW 55-92 313-349 |
| PVS06-- ROTPC 64-92 |
| PVS06-- ROTPG 55-92 313-349 |
| PVS06-- ROTS1 55-92 313-349 |
| PVS08-- ROTS1 274-302 |
| PVS09-- ROTHT 131-159 |
| PVS09-- ROTPB 131-159 |
| PVS10-- ROTBN 52-89 |
| PVS10-- ROTTBU 52-89 |
| PVS10-- ROTH2 52-89 |
| PVS10-- ROTH7 52-89 |
| PVS10-- ROTH8 52-89 |
| PVS10-- ROTHW 52-89 |
| PVS10-- ROTS1 52-89 |
| PVS11-- ROTHW 99-130 |
| PVS11-- REOVJ 346-384 |
| PVS11-- REOVL 110-147 |
| PVT1-- SFVKA 147-182 |
| PVT2-- MYXVL 261-290 |
| PVT2-- SFVKA 211-249 |
| PVT3A-- CAPV1 116-150 |
| PVTER-- EBV 166-199 505-543 |
| PVTER-- HCMVA 176-209 |
| PVTER-- HSV11 756-788 |
| PVD-- SEND6 57-93 |
| PY104-- AD307 55-83 |
| PY10K-- MSVS 24-54 |
| PY10K-- WDV 22-59 |
| PY119-- SSV1 29-64 |
| PY11K-- PASV 29-61 |
| PY11K-- ROTS1 53-87 |
| PY11K-- TYDVA 28-62 |
| PT14K-- NPVAC 65-101 |
| PY18K-- SSV1 100-132 |
| PY20K-- SSV1 129-167 |
| PY21K-- MSVN 122-155 |
| PY2-- SOCMV 99-137 |
| PY38K-- NPVAC 250-282 |
| PY85K-- SSV1 274-312 543-580 |
| PYB13-- FOWPM 114-150 |
| PYDH1-- HSVSC 206-244 |
| PYDH3-- HSVSC 69-97 |
| PYEC4-- EBV 34-68 |
| PYI01-- CVBM 84-122 |
| PYIOR-- CVBF 41-75 137-165 |
| PYIOR-- CVBM 41-74 137-165 |
| PYIOR-- CVTKE 41-74 137-165 |
| PYKR2-- EBV 67-100 |
| PYMR2-- EBV 250-284 |
| PYOR1-- COYMV 93-130 166-198 |
| PYOR2-- COYMV 23-56 |
| PYOR3-- PVXXC 7-39 |
| PYOR3-- WCMVM 63-94 |
| PYOR3-- WCMVO 64-95 |
| PYOR5-- ADEG1 237-272 |
| PYORG-- TTV1 5-34 |
| PYORM-- TTV1 233-263 |
| PYORP-- TTV1 91-124 |
| PYP24-- RTBV 104-133 159-191 |
| PYP24-- RTBVP 104-133 159-191 |
| PYP47-- NPVAC 23-51 |
| PYRF5-- HSV6G 180-216 |
| PYRR2-- EBV 13-42 |
| PYSR1-- EBV 92-120 |
| PYTR1-- EBV 306-336 |
| PYVAE-- VACCC 21-53 |
| PYVAL-- VACCV 21-49 |
| PYVBC-- VACCC 22-53 |
| PYVDG-- VACCV 31-64 |
| PYVEF-- VACCC 8-42 |
| PYVFC-- VACCC 7-35 |
| PZNFP-- LYCVA 29-57 |
| PZNFP-- LYCVP 8-32 |
| __________________________________________________________________________ |
| TABLE XV |
| __________________________________________________________________________ |
| RESPIRATORY SYNCYTIAL VIRUS DP107 F2 REGION ANALOG |
| CARBOXY TRUNCATIONS |
| __________________________________________________________________________ |
| X-YTS-Z |
| - X-YTSV-Z |
| - X-YTSVI-Z |
| - X-YTSVIT-Z |
| - X-YTSVITI-Z |
| - X-YTSVITIE-Z |
| - X-YTSVITIEL-Z |
| - X-YTSVITIELS-Z |
| - X-YTSVITIELSN-Z |
| - X-YTSVITIELSNI-Z |
| - X-YTSVITIELSNIK-Z |
| - X-YTSVITIELSNIKE-Z |
| - X-YTSVITIELSNIKEN-Z |
| - X-YTSVITIELSNIKENK-Z |
| - X-YTSVITIELSNIKENKC-Z |
| - X-YTSVITIELSNIKENKCN-Z |
| - X-YTSVITIELSNIKENKCNG-Z |
| - X-YTSVITIELSNIKENKCNGT-Z |
| - X-YTSVITIELSNIKENKCNGTD-Z |
| - X-YTSVITIELSNIKENKCNGTDA-Z |
| - X-YTSVITIELSNIKENKCNGTDAK-Z |
| - X-YTSVITIELSNIKENKCNGTDAKV-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVK-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKL-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLI-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIK-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQ-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQE-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQEL-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELD-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDK-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKY-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYK-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKN-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNA-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAV-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVT-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTE-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTEL-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQ-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQL-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLL-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLM-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQ-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQS-Z |
| - X-YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| __________________________________________________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| 9fluorenylmethoxy-carbonyl (FMOC) group; # a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE XVI |
| __________________________________________________________________________ |
| RESPIRATORY SYNCYTIAL VIRUS F2 DP178/DP107 |
| REGION ANALOG AMINO TRUNCATIONS |
| __________________________________________________________________________ |
| X-QST-Z |
| - X-MQST-Z |
| - X-LMQST-Z |
| - X-LLMQST-Z |
| - X-QLLMQST-Z |
| - X-LQLLMQST-Z |
| - X-ELQLLMQST-Z |
| - X-TELQLLMQST-Z |
| - X-VTELQLLMQST-Z |
| - X-AVTELQLLMQST-Z |
| - X-NAVTELQLLMQST-Z |
| - X-KNAVTELQLLMQST-Z |
| - X-YKNAVTELQLLMQST-Z |
| - X-KYKNAVTELQLLMQST-Z |
| - X-DKYKNAVTELQLLMQST-Z |
| - X-LDKYKNAVTELQLLMQST-Z |
| - X-ELDKYKNAVTELQLLMQST-Z |
| - X-QELDKYKNAVTELQLLMQST-Z |
| - X-KQELDKYKNAVTELQLLMQST-Z |
| - X-IKQELDKYKNAVTELQLLMQST-Z |
| - X-LIKQELDKYKNAVTELQLLMQST-Z |
| - X-KLIKQELDKYKNAVTELQLLMQST-Z |
| - X-VKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-KVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-AKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-DAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-TDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-GTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-NGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-CNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-KCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-NKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-KENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-IKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-NIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-SNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-LSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-ELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-IELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-TIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-ITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-VITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-SVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| - X-TSVITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST-Z |
| __________________________________________________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| 9fluorenylmethoxy-carbonyl (FMOC) group; # a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE XVII |
| ______________________________________ |
| RESPIRATORY SYNCYTIAL VIRUS F1 DP178 |
| REGION ANALOG CARBOXY TRUNCATIONS |
| ______________________________________ |
| X-FYD-Z |
| - X-FYDP-Z |
| - X-FYDPL-Z |
| - X-FYDPLV-Z |
| - X-FYDPLVF-Z |
| - X-FYDPLVFP-Z |
| - X-FYDPLVFPS-Z |
| - X-FYDPLVFPSD-Z |
| - X-FYDPLVFPSDE-Z |
| - X-FYDPLVFPSDEF-Z |
| - X-FYDPLVFPSDEFD-Z |
| - X-FYDPLVFPSDEFDA-Z |
| - X-FYDPLVFPSDEFDAS-Z |
| - X-FYDPLVFPSDEFDASI-Z |
| - X-FYDPLVFPSDEFDASIS-Z |
| - X-FYDPLVFPSDEFDASISQ-Z |
| - X-FYDPLVFPSDEFDASISQV-Z |
| - X-FYDPLVFPSDEFDASISQVN-Z |
| - X-FYDPLVFPSDEFDASISQVNE-Z |
| - X-FYDPLVFPSDEFDASISQVNEK-Z |
| - X-FYDPLVFPSDEFDASISQVNEKI-Z |
| - X-FYDPLVFPSDEFDASISQVNEKIN-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQ-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQS-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSL-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLA-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLAF-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLAFI-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLAFIR-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLAFIRK-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLAFIRKS-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSD-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDE-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDEL-Z |
| - X-FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDELL-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| 9fluorenylmethoxy-carbonyl (FMOC) group; # a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE XVIII |
| ______________________________________ |
| RESPIRATORY SYNCYTIAL VIRUS F1 DP178 |
| REGION ANALOG AMINO TRUNCATIONS |
| ______________________________________ |
| X-DELL-Z |
| - X-SDELL-Z |
| - X-KSDELL-Z |
| - X-RKSDELL-Z |
| - X-IRKSDELL-Z |
| - X-FIRKSDELL-Z |
| - X-AFIRKSDELL-Z |
| - X-LAFIRKSDELL-Z |
| - X-SLAFIRKSDELL-Z |
| - X-QSLAFIRKSDELL-Z |
| - X-NQSLAFIRKSDELL-Z |
| - X-INQSLAFIRKSDELL-Z |
| - X-KINQSLAFIRKSDELL-Z |
| - X-EKINQSLAFIRKSDELL-Z |
| - X-NEKINQSLAFIRKSDELL-Z |
| - X-VNEKINQSLAFIRKSDELL-Z |
| - X-QVNEKINQSLAFIRKSDELL-Z |
| - X-SQVNEKINQSLAFIRKSDELL-Z |
| - X-ISQVNEKINQSLAFIRKSDELL-Z |
| - X-SISQVNEKINQSLAFIRKSDELL-Z |
| - X-ASISQVNEKINQSLAFIRKSDELL-Z |
| - X-DASISQVNEKINQSLAFIRKSDELL-Z |
| - X-FDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-EFDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-DEFDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-SDEFDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-PSDEFDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-FPSDEFDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-VFPSDEFDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-LVFPSDEFDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-PLVFPSDEFDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-DPLVFPSDEFDASISQVNEKINQSLAFIRKSDELL-Z |
| - X-YDPLVFPSDEFDASISQVNEKINQSLAFIRKSDELL-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| 9fluorenylmethoxy-carbonyl (FMOC) group; # a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE XIX |
| ______________________________________ |
| HUMAN PARAINFLUENZA VIRUS 3 F1 REGION DP178 |
| ANALOG CARBOXY TRUNCATIONS |
| ______________________________________ |
| X-ITL-Z |
| - X-ITLN-Z |
| - X-ITLNN-Z |
| - X-ITLNNS-Z |
| - X-ITLNNSV-Z |
| - X-ITLNNSVA-Z |
| - X-ITLNNSVAL-Z |
| - X-ITLNNSVALD-Z |
| - X-ITLNNSVALDP-Z |
| - X-ITLNNSVALDPI-Z |
| - X-ITLNNSVALDPID-Z |
| - X-ITLNNSVALDPIDI-Z |
| - X-ITLNNSVALDPIDIS-Z |
| - X-ITLNNSVALDPIDISI-Z |
| - X-ITLNNSVALDPIDISIE-Z |
| - X-ITLNNSVALDPIDISIEL-Z |
| - X-ITLNNSVALDPIDISIELN-Z |
| - X-ITLNNSVALDPIDISIELNK-Z |
| - X-ITLNNSVALDPIDISIELNKA-Z |
| - X-ITLNNSVALDPIDISIELNKAK-Z |
| - X-ITLNNSVALDPIDISIELNKAKS-Z |
| - X-ITLNNSVALDPIDISIELNKAKSD-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDL-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLE-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLEE-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLEES-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLEESK-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLEESKE-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLEESKEW-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLEESKEWI-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLEESKEWIR-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLEESKEWIRR-Z |
| - X-ITLNNSVALDPIDISIELNKAKSDLEESKEWIRRS-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| 9fluorenylmethoxy-carbonyl (FMOC) group; # a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE XX |
| ______________________________________ |
| HUMAN PARAINFLUENZA VIRUS 3 F1 REGION DP178 |
| ANALOG AMINO TRUNCATIONS |
| ______________________________________ |
| X-RRS-Z |
| - X-IRRS-Z |
| - X-WIRRS-Z |
| - X-EWIRRS-Z |
| - X-KEWIRRS-Z |
| - X-SKEWIRRS-Z |
| - X-ESKEWIRRS-Z |
| - X-EESKEWIRRS-Z |
| - X-LEESKEWIRRS-Z |
| - X-DLEESKEWIRRS-Z |
| - X-SDLEESKEWIRRS-Z |
| - X-KSDLEESKEWIRRS-Z |
| - X-AKSDLEESKEWIRRS-Z |
| - X-KAKSDLEESKEWIRRS-Z |
| - X-NKAKSDLEESKEWIRRS-Z |
| - X-LNKAKSDLEESKEWIRRS-Z |
| - X-ELNKAKSDLEESKEWIRRS-Z |
| - X-IELNKAKSDLEESKEWIRRS-Z |
| - X-SIELNKAKSDLEESKEWIRRS-Z |
| - X-ISIELNKAKSDLEESKEWIRRS-Z |
| - X-DISIELNKAKSDLEESKEWIRRS-Z |
| - X-IDISIELNKAKSDLEESKEWIRRS-Z |
| - X-PIDISIELNKAKSDLEESKEWIRRS-Z |
| - X-DPIDISIELNKAKSDLEESKEWIRRS-Z |
| - X-LDPIDISIELNKAKSDLEESKEWIRRS-Z |
| - X-ALDPIDISIELNKAKSDLEESKEWIRRS-Z |
| - X-VALDPIDISIELNKAKSDLEESKEWIRRS-Z |
| - X-SVALDPIDISIELNKAKSDLEESKEWIRRS-Z |
| - X-NSVALDPIDISIELNKAKSDLEESKEWIRRS-Z |
| - X-NNSVALDPIDISIELNKAKSDLEESKEWIRRS-Z |
| - X-LNNSVALDPIDISIELNKAKSDLEESKEWIRRS-Z |
| - X-TLNNSVALDPIDISIELNKAKSDLEESKEWIRRS-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| 9fluorenylmethoxy-carbonyl (FMOC) group; # a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE XXI |
| ______________________________________ |
| HUMAN PARAINFLUENZA VIRUS 3 F1 REGION |
| DP107 ANALOG CARBOXY TRUNCATIONS |
| ______________________________________ |
| X-ALG-Z |
| - X-ALGV-Z |
| - X-ALGVA-Z |
| - X-ALGVAT-Z |
| - X-ALGVATS-Z |
| - X-ALGVATSA-Z |
| - X-ALGVATSAQ-Z |
| - X-ALGVATSAQI-Z |
| - X-ALGVATSAQIT-Z |
| - X-ALGVATSAQITA-Z |
| - X-ALGVATSAQITAA-Z |
| - X-ALGVATSAQITAAV-Z |
| - X-ALGVATSAQITAAVA-Z |
| - X-ALGVATSAQITAAVAL-Z |
| - X-ALGVATSAQITAAVALV-Z |
| - X-ALGVATSAQITAAVALVE-Z |
| - X-ALGVATSAQITAAVALVEA-Z |
| - X-ALGVATSAQITAAVALVEAK-Z |
| - X-ALGVATSAQITAAVALVEAKQ-Z |
| - X-ALGVATSAQITAAVALVEAKQA-Z |
| - X-ALGVATSAQITAAVALVEAKQAR-Z |
| - X-ALGVATSAQITAAVALVEAKQARS-Z |
| - X-ALGVATSAQITAAVALVEAKQARSD-Z |
| - X-ALGVATSAQITAAVALVEAKQARSDI-Z |
| - X-ALGVATSAQITAAVALVEAKQARSDIE-Z |
| - X-ALGVATSAQITAAVALVEAKQARSDIEK-Z |
| - X-ALGVATSAQITAAVALVEAKQARSDIEKL-Z |
| - X-ALGVATSAQITAAVALVEAKQARSDIEKLK-Z |
| - X-ALGVATSAQITAAVALVEAKQARSDIEKLKE-Z |
| - X-ALGVATSAQITAAVALVEAKQARSDIEKLKEA-Z |
| - X-ALGVATSAQITAAVALVEAKQARSDIEKLKEAI-Z |
| - X-ALGVATSAQITAAVALVEAKQARSDIEKLKEAIR-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| 9fluorenylmethoxy-carbonyl (FMOC) group; # a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE XXII |
| ______________________________________ |
| HUMAN PARAINFLUENZA VIRUS 3 F1 REGION |
| DP107 ANALOG AMINO TRUNCATIONS |
| ______________________________________ |
| X-IRD-Z |
| - X-AIRD-Z |
| - X-EAIRD-Z |
| - X-KEAIRD-Z |
| - X-LKEAIRD-Z |
| - X-KLKEAIRD-Z |
| - X-EKLKEAIRD-Z |
| - X-IEKLKEAIRD-Z |
| - X-DIEKLKEAIRD-Z |
| - X-SDIEKLKEAIRD-Z |
| - X-RSDIEKLKEAIRD-Z |
| - X-ARSDIEKLKEAIRD-Z |
| - X-QARSDIEKLKEAIRD-Z |
| - X-KQARSDIEKLKEAIRD-Z |
| - X-AKQARSDIEKLKEAIRD-Z |
| - X-EAKQARSDIEKLKEAIRD-Z |
| - X-VEAKQARSDIEKLKEAIRD-Z |
| - X-LVEAKQARSDIEKLKEAIRD-Z |
| - X-ALVEAKQARSDIEKLKEAIRD-Z |
| - X-VALVEAKQARSDIEKLKEAIRD-Z |
| - X-AVALVEAKQARSDIEKLKEAIRD-Z |
| - X-AAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-TAAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-ITAAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-QITAAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-AQITAAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-SAQITAAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-TSAQITAAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-ATSAQITAAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-VATSAQITAAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-GVATSAQITAAVALVEAKQARSDIEKLKEAIRD-Z |
| - X-LGVATSAQITAAVALVEAKQARSDIEKLKEAIRD-Z |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| 9fluorenylmethoxy-carbonyl (FMOC) group; # a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
| TABLE XXIII |
| ______________________________________ |
| REPRESENTATIVE DP107/DP178 ANALOG ANTIVIRAL PEPTIDES |
| ______________________________________ |
| Anti-Respiratory syncytial virus peptides |
| X-TSVITIELSNIKENKCNGTDAKVKLIKQELDKYKN-Z |
| X-SVITIELSNIKENKCNGTDAKVKLIKQELDKYKNA-Z |
| - X-VITIELSNIKENKCNGTDAKVKLIKQELDKYKNAV-Z |
| - X-VAVSKVLHLEGEVNKIALLSTNKAVVSLSNGVS-Z |
| - X-AVSKVLHLEGEVNKIALLSTNKAVVSLSNGVSV-Z |
| - X-VSKVLHLEGEVNKIALLSTNKAVVSLSNGVSVL-Z |
| - X-SKVLHLEGEVNKIALLSTNKAVVSLSNGVSVLT-Z |
| - X-KVLHLEGEVNKIALLSTNKAVVSLSNGVSVLTS-Z |
| - X-LEGEVNKIALLSTNKAVVSLSNGVSVLTSKVLD-Z |
| - X-GEVNKIALLSTNKAVVSLSNGVSVLTSKVLDLK-Z |
| - X-EVNKIALLSTNKAVVSLSNGVSVLTSKVLDLKN-Z |
| - X-VNKIALLSTNKAVVSLSNGVSVLTSKVLDLKNY-Z |
| - X-NKIALLSTNKAVVSLSNGVSVLTSKVLDLKNYI-Z |
| - X-KIALLSTNKAVVSLSNGVSVLTSKVLDLKNYID-Z |
| - X-IALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDK-Z |
| - X-ALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQ-Z |
| - X-VAVSKVLHLEGEVNKIALLSTNKAVVSLSNGVS-Z |
| - X-AVSKVLHLEGEVNKIALLSTNKAVVSLSNGVSV-Z- |
| - X-VSKVLHLEGEVNKIALLSTNKAVVSLSNGVSVL-Z- |
| - X-SKVLHLEGEVNKIALLSTNKAVVSLSNGVSVLT-Z- |
| - X-KVLHLEGEVNKIALLSTNKAVVSLSNGVSVLTS-Z- |
| - X-LEGEVNKIALLSTNKAVVSLSNGVSVLTSKVLD-Z- |
| - X-GEVNKIALLSTNKAVVSLSNGVSVLTSKVLDLK-Z- |
| - X-EVNKIALLSTNKAVVSLSNGVSVLTSKVLDLKN-Z- |
| - X-VNKIALLSTNKAVVSLSNGVSVLTSKVLDLKNY-Z- |
| - X-NKIALLSTNKAVVSLSNGVSVLTSKVLDLKNYI-Z- |
| - X-KIALLSTNKAVVSLSNGVSVLTSKVLDLKNYID-Z- |
| - X-IALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDK-Z- |
| - X-ALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQ-Z- |
| - Anti-human parainfluenza virus 3 peptides |
| X-TLNNSVALDPIDISIELNKAKSDLEESKEWIRRSN-Z- |
| - X-LNNSVALDPIDISIELNKAKSDLEESKEWIRRSNQ-Z- |
| - X-NNSVALDPIDISIELNKAKSDLEESKEWIRRSNQK-Z- |
| - X-NSVALDPIDISIELNKAKSDLEESKEWIRRSNQKL-Z- |
| - X-SVALDPIDISIELNKAKSDLEESKEWIRRSNQKLD-Z- |
| - X-VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDS-Z- |
| - X-ALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI-Z- |
| - X-LDPIDISIELNKAKSDLEESKEWIRRSNQKLDSIG-Z- |
| - X-DPIDISIELNKAKSDLEESKEWIRRSNQKLDSIGN-Z- |
| - X-PIDISIELNKAKSDLEESKEWIRRSNQKLDSIGNW-Z- |
| - X-IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH-Z- |
| - X-DISIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQ-Z- |
| - X-ISIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQS-Z- |
| - X-SIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSS-Z- |
| - X-IELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSST-Z- |
| - X-ELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSSTT-Z- |
| - X-TAAVALVEAKQARSDIEKLKEAIRDTNKAVQSVQS-Z- |
| - X-AVALVEAKQARSDIEKLKEAIRDTNKAVQSVQSSI-Z- |
| - X-LVEAKQARSDIEKLKEAIRDTNKAVQSVQSSIGNL-Z- |
| - X-VEAKQARSDIEKLKEAIRDTNKAVQSVQSSIGNLI-Z- |
| - X-EAKQARSDIEKLKEAIRDTNKAVQSVQSSIGNLIV-Z- |
| - X-AKQARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVA-Z- |
| - X-KQARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAI-Z- |
| - X-QARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIK-Z- |
| - X-ARSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKS-Z- |
| - X-RSDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKSV-Z- |
| - X-SDIEKLKEAIRDTNKAVQSVQSSIGNLIVAIKSVQ-Z- |
| - X-KLKEAIRDTNKAVQSVQSSIGNLIVAIKSVQDYVN-Z- |
| - X-LKEAIRDTNKAVQSVQSSIGNLIVAIKSVQDYVNK-Z- |
| - X-AIRDTNKAVQSVQSSIGNLIVAIKSVQDYVNKEIV-Z- |
| - Anti-simian immunodeficiency virus peptides |
| - X-WQEWERKVDFLEENITALLEEAQIQQEKNMYELQK-Z- |
| - X-QEWERKVDFLEENITALLEEAQIQQEKNMYELQKL-Z- |
| - X-EWERKVDFLEENITALLEEAQIQQEKNMYELQKLN-Z- |
| - X-WERKVDFLEENITALLEEAQIQQEKNMYELQKLNS-Z- |
| - X-ERKVDFLEENITALLEEAQIQQEKNMYELQKLNSW-Z- |
| - X-RKVDFLEENITALLEEAQIQQEKNMYELQKLNSWD-Z- |
| - X-KVDFLEENITALLEEAQIQQEKNMYELQKLNSWDV-Z- |
| - X-VDFLEENITALLEEAQIQQEKNMYELQKLNSWDVF-Z- |
| - X-DFLEENITALLEEAQIQQEKNMYELQKLNSWDVFG-Z- |
| - X-FLEENITALLEEAQIQQEKNMYELQKLNSWDVFGN-Z- |
| - Anti-measles virus peptides |
| - X-LHRIDLGPPISLERLDVGTNLGNAIAKLEAKELL-Z- |
| - X-HRIDLGPPISLERLDVGTNLGNAIAKLEAKELLE-Z- |
| - X-RIDLGPPISLERLDVGTNLGNAIAKLEAKELLES-Z- |
| - X-IDLGPPISLERLDVGTNLGNAIAKLEAKELLESS-Z- |
| - X-DLGPPISLERLDVGTNLGNAIAKLEAKELLESSD-Z- |
| - X-LGPPISLERLDVGTNLGNAIAKLEAKELLESSDQ-Z- |
| - X-GPPISLERLDVGTNLGNAIAKLEAKELLESSDQI-Z- |
| - X-PPISLERLDVGTNLGNAIAKLEAKELLESSDQIL-Z- |
| - X-PISLERLDVGTNLGNAIAKLEAKELLESSDQILR-Z- |
| - X-SLERLDVGTNLGNAIAKLEAKELLESSDQILRSM-Z- |
| - X-LERLDVGTNLGNAIAKLEAKELLESSDQILRSMK-Z- |
| ______________________________________ |
| The one letter amino acid code is used. |
| Additionally, |
| "X" may represent an amino group, a hydrophobic group, including but not |
| limited to carbobenzoxyl, dansyl, or Tbutyloxycarbonyl; an acetyl group; |
| 9fluorenylmethoxy-carbonyl (FMOC) group; # a macromolecular carrier grou |
| including but not limited to lipidfatty acid conjugates, polyethylene |
| glycol, or carbohydrates. |
| "Z" may represent a carboxyl group; an amido group; a Tbutyloxycarbonyl |
| group; a macromolecular carrier group including but not limited to |
| lipidfatty acid conjugates, polyethylene glycol, or carbohydrates. |
5.4. SYNTHESIS OF PEPTIDES
The peptides of the invention may be synthesized or prepared by techniques well known in the art. See, for example, Creighton, 1983, Proteins: Structures and Molecular Principles, W. H. Freeman and Co., N.Y., which is incorporated herein by reference in its entirety. Short peptides, for example, can be synthesized on a solid support or in solution. Longer peptides may be made using recombinant DNA techniques. Here, the nucleotide sequences encoding the peptides of the invention may be synthesized, and/or cloned, and expressed according to techniques well known to those of ordinary skill in the art. See, for example, Sambrook, et al., 1989, Molecular Cloning, A Laboratory Manual, Vols. 1-3, Cold Spring Harbor Press, N.Y.
The peptides of the invention may alternatively be synthesized such that one or more of the bonds which link the amino acid residues of the peptides are non-peptide bonds. These alternative non-peptide bonds may be formed by utilizing reactions well known to those in the art, and may include, but are not limited to imino, ester, hydrazide, semicarbazide, and azo bonds, to name but a few. In yet another embodiment of the invention, peptides comprising the sequences described above may be synthesized with additional chemical groups present at their amino and/or carboxy termini, such that, for example, the stability, bioavailability, and/or inhibitory activity of the peptides is enhanced. For example, hydrophobic groups such as carbobenzoxyl, dansyl, or t-butyloxycarbonyl groups, may be added to the peptides' amino termini. Likewise, an acetyl group or a 9-fluorenylmethoxy-carbonyl group may be placed at the peptides' amino termini. (See "X" in Tables I to IV, above.) Additionally, the hydrophobic group, t-butyloxycarbonyl, or an amido group may be added to the peptides' carboxy termini. (See "Z" in Tables I to IV, above.)
Further, the peptides of the invention may be synthesized such that their steric configuration is altered. For example, the D-isomer of one or more of the amino acid residues of the peptide may be used, rather than the usual L-isomer.
Still further, at least one of the amino acid residues of the peptides of the invention may be substituted by one of the well known non-naturally occurring amino acid residues. Alterations such as these may serve to increase the stability, bioavailability and/or inhibitory action of the peptides of the invention.
Any of the peptides described above may, additionally, have a macromolecular carrier group covalently attached to their amino and/or carboxy termini. Such macromolecular carrier groups may include, for example, lipid-fatty acid conjugates, polyethylene glycol, carbohydrates or additional peptides. "X", in Tables I to IV, above, may therefore additionally represent any of the above macromolecular carrier groups covalently attached to the amino terminus of a peptide, with an additional peptide group being preferred. Likewise, "Z", in Tables I to IV, may additionally represent any of the macromolecular carrier groups described above.
5.5. ASSAYS FOR ANTI-MEMBRANE FUSION ACTIVITY
Described herein, are methods for ability of a compound, such as the peptides of the invention, to inhibit membrane fusion events. Specifically, assays for cell fusion events are described in Section 5.5.1, below, and assays for antiviral activity are described in Section 5.5.2, below.
5.5.1 ASSAYS FOR CELL FUSION EVENTS
Assays for cell fusion events are well known to those of skill in the art, and may be used in conjunction, for example, with the peptides of the invention to test the peptides' antifusogenic capabilities.
Cell fusion assays are generally performed in vitro. Such an assay may comprise culturing cells which, in the absence of any treatment would undergo an observable level of syncytial formation. For example, uninfected cells may be incubated in the presence of cells chronically infected with a virus that induces cell fusion. Such viruses may include, but are not limited to, HIV, SIV, or respiratory syncytial virus.
For the assay, cells are incubated in the presence of a peptide to be assayed. For each peptide, a range of peptide concentrations may be tested. This range should include a control culture wherein no peptide has been added.
Standard conditions for culturing cells, well known to those of ordinary skill in the art, are used. After incubation for an appropriate period (24 hours at 37°C, for example) the culture is examined microscopically for the presence of multinucleated giant cells, which are indicative of cell fusion and syncytial formation. Well known stains, such as crystal violet stain, may be used to facilitate the visualization of syncytial formation.
5.5.2 ASSAYS FOR ANTIVIRAL ACTIVITY
The antiviral activity exhibited by the peptides of the invention may be measured, for example, by easily performed in vitro assays, such as those described below, which can test the peptides' ability to inhibit syncytia formation, or their ability to inhibit infection by cell-free virus. Using these assays, such parameters as the relative antiviral activity of the peptides, exhibit against a given strain of virus and/or the strain specific inhibitory activity of the peptide can be determined.
A cell fusion assay may be utilized to test the peptides' ability to inhibit viral-induced, such as HIV-induced, syncytia formation in vitro. Such an assay may comprise culturing uninfected cells in the presence of cells chronically infected with a syncytial-inducing virus and a peptide to be assayed.
For each peptide, a range of peptide concentrations may be tested. This range should include a control culture wherein no peptide has been added. Standard conditions for culturing, well known to those of ordinary skill in the art, are used. After incubation for an appropriate period (24 hours at 37°C, for example) the culture is examined microscopically for the presence of multinucleated giant cells, which are indicative of cell fusion and syncytia formation. Well known stains, such as crystal violet stain, may be used to facilitate syncytial visualization. Taking HIV as an example, such an assay would comprise CD-4+ cells (such as Molt or CEM cells, for example) cultured in the presence of chronically HIV-infected cells and a peptide to be assayed.
Other well known characteristics of viral infection may also be assayed to test a peptide's antiviral capabilities. Once again taking HIV as an example, a reverse transcriptase (RT) assay may be utilized to test the peptides' ability to inhibit infection of CD-4+ cells by cell-free HIV. Such an assay may comprise culturing an appropriate concentration (i.e., TCID50) of virus and CD-4+ cells in the presence of the peptide to be tested. Culture conditions well known to those in the art are used. As above, a range of peptide concentrations may be used, in addition to a control culture wherein no peptide has been added. After incubation for an appropriate period (e.g., 7 days) of culturing, a cell-free supernatant is prepared, using standard procedures, and tested for the present of RT activity as a measure of successful infection. The RT activity may be tested using standard techniques such as those described by, for example, Goff et al. (Goff, S. et al., 1981, J. Virol. 38:239-248) and/or Willey et al. (Willey, R. et al., 1988, J. Virol. 62:139-147). These references are incorporated herein by reference in their entirety.
Standard methods which are well-known to those of skill in the art may be utilized for assaying non-retroviral activity. See, for example, Pringle et al. (Pringle, C. R. et al., 1985, J. Medical Virology 17:377-386) for a discussion of respiratory syncytial virus and parainfluenza virus activity assay techniques. Further, see, for example, "Zinsser Microbiology", 1988, Joklik, W. K. et al., eds., Appleton & Lange, Norwalk, Conn., 19th ed., for a general review of such techniques. These references are incorporated by reference herein in their entirety. In addition, the Examples presented below, in Sections 17, 18, 26 and 27 each provide additional assays for the testing of a compound's antiviral capability.
In vivo assays may also be utilized to test, for example, the antiviral activity of the peptides of the invention. To test for anti-HIV activity, for example, the in vivo model described in Barnett et al. (Barnett, S. W. et al., 1994, Science 266:642-646) may be used.
Additionally, anti-RSV activity can be assayed in vivo via well known mouse models. For example, RSV can be administered intranasally to mice of various inbred strains. Virus replicates in lungs of all strains, but the highest titers are obtained in P/N, C57L/N and DBA/2N mice. Infection of BALB/c mice produces an asymptomatic bronchiolitis characterized by lymphocytic infiltrates and pulmonary virus titers of 104 to 105 pfu/g of lung tissue (Taylor, G. et al., 1984, Infect. Immun. 43:649-655).
Cotton rat models of RSV are also well known. Virus replicates to high titer in the nose and lungs of the cotton rat but produces few if any signs of inflammation.
5.6. USES OF THE PEPTIDES OF THE INVENTION
The peptides of the invention may be utilized as antifusogenic or antiviral compounds, or as compounds which modulate intracellular processes involving coiled coil peptide structures. Further, such peptides may be used to identify agents which exhibit antifusogenic, antiviral or intracellular modulatory activity. Still further, the peptides of the invention may be utilized as organism or viral type/subtype-specific diagnostic tools.
The antifusogenic capability of the peptides of the invention may additionally be utilized to inhibit or treat/ameliorate symptoms caused by processes involving membrane fusion events. Such events may include, for example, virus transmission via cell-cell fusion, abnormal neurotransmitter exchange via cell-fusion, and sperm-egg fusion. Further, the peptides of the invention may be used to inhibit free viral, such as retroviral, particularly HIV, transmission to uninfected cells wherein such viral infection involves membrane fusion events or involves fusion of a viral structure with a cell membrane. Among the intracellular disorders involving coiled coil peptides structures which may be ameliorated by the peptides of the invention are disorders involving, for example, bacterial toxins.
With respect to antiviral activity, the viruses whose transmission may be inhibited by the peptides of the invention include, but are not limited to all strains of the viruses listed above, in Tables V through VII, and IX through XIV.
These viruses include, for example, human retroviruses, particularly HIV-1 and HIV-2 and the human T-lymphocyte viruses (HTLV-I and II). The non-human retroviruses whose transmission may be inhibited by the peptides of the invention include, but are not limited to bovine leukosis virus, feline sarcoma and leukemia viruses, simian immunodeficiency, sarcoma and leukemia viruses, and sheep progress pneumonia viruses.
Non retroviral viruses whose transmission may be inhibited by the peptides of the invention include, but are not limited to human respiratory syncytial virus, canine distemper virus, newcastle disease virus, human parainfluenza virus, influenza viruses, measles viruses, Epstein-Barr viruses, hepatitis B viruses, and simian Mason-Pfizer viruses.
Non enveloped viruses whose transmission may be inhibited by the peptides of the invention include, but are not limited to picornaviruses such as polio viruses, hepatitis A virus, enterovirus, echoviruses and coxsackie viruses, papovaviruses such as papilloma virus, parvoviruses, adenoviruses and reoviruses.
As discussed more fully, below, in Section 5.5.1 and in the Example presented, below, in Section 8, DP107, DP178, DP107 analog and DP178 analog peptides form non-covalent protein-protein interactions which are required for normal activity of the virus. Thus, the peptides of the invention may also be utilized as components in assays for the identification of compounds that interfere with such protein-protein interactions and may, therefore, act as antiviral agents. These assays are discussed, below, in Section 5.5.1.
As demonstrated in the Example presented below in Section 6, the antiviral activity of the peptides of the invention may show a pronounced type and subtype specificity, i.e., specific peptides may be effective in inhibiting the activity of only specific viruses. This feature of the invention presents many advantages. One such advantage, for example, lies in the field of diagnostics, wherein one can use the antiviral specificity of the peptide of the invention to ascertain the identity of a viral isolate. With respect to HIV, one may easily determine whether a viral isolate consists of an HIV-1 or HIV-2 strain. For example, uninfected CD-4+ cells may be co-infected with an isolate which has been identified as containing HIV the DP178 (SEQ ID:1) peptide, after which the retroviral activity of cell supernatants may be assayed, using, for example, the techniques described above in Section 5.2. Those isolates whose retroviral activity is completely or nearly completely inhibited contain HIV-1. Those isolates whose viral activity is unchanged or only reduced by a small amount, may be considered to not contain HIV-1. Such an isolate may then be treated with one or more of the other DP178 peptides of the invention, and subsequently be tested for its viral activity in order to determine the identify of the viral isolate. The DP107 and DP178 analogs of the invention may also be utilized in a diagnostic capacity specific to the type and subtype of virus or organism in which the specific peptide sequence is found. A diagnostic procedure as described, above, for DP178, may be used in conjunction with the DP107/DP178 analog of interest.
5.5.1. SCREENING ASSAYS
As demonstrated in the Example presented in Section 8, below, DP107 and DP178 portions of the TM protein gp41 form non-covalent protein-protein interactions. As is also demonstrated, the maintenance of such interactions is necessary for normal viral infectivity. Thus, compounds which bind DP107, bind DP178, and/or act to disrupt normal DP107/DP178 protein-protein interactions may act as antifusogenic, antiviral or cellular modulatory agents. Described below are assays for the identification of such compounds. Note that, while, for ease and clarity of discussion, DP107 and DP178 peptides will be used as components of the assays described, but it is to be understood that any of the DP107 analog or DP178 analog peptides described, above, in Sections 5.1 through 5.3 may also be utilized as part of these screens for compounds.
Compounds which may be tested for an ability to bind DP107, DP178, and/or disrupt DP107/DP178 interactions, and which therefore, potentially represent antifusogenic, antiviral or intracellular modulatory compounds, include, but are not limited to, peptides made of D- and/or L-configuration amino acids (in, for example, the form of random peptide libraries; see Lam, K. S. et al., 1991, Nature 354:82-84), phosphopeptides (in, for example, the form of random or partially degenerate, directed phosphopeptide libraries; see, for example, Songyang, Z. et al., 1993, Cell 72:767-778), antibodies, and small organic or inorganic molecules. Synthetic compounds, natural products, and other sources of potentially effective materials may be screened in a variety of ways, as described in this Section.
The compounds, antibodies, or other molecules identified may be tested, for example, for an ability to inhibit cell fusion or viral activity, utilizing, for example, assays such as those described, above, in Section 5.5.
Among the peptides which may be tested are soluble peptides comprising DP107 and/or DP178 domains, and peptides comprising DP107 and/or DP178 domains having one or more mutations within one or both of the domains, such as the M41-P peptide described, below, in the Example presented in Section 8, which contains a isoleucine to proline mutation within the DP178 sequence.
In one embodiment of such screening methods is a method for identifying a compound to be tested for antiviral ability comprising:
(a) exposing at least one compound to a peptide comprising a DP107 peptide for a time sufficient to allow binding of the compound to the DP107 peptide;
(b) removing non-bound compounds; and
(c) determining the presence of the compound bound to the DP107 peptide, thereby identifying an agent to be tested for antiviral ability.
In a second embodiment of such screening methods is a method for identifying a compound to be tested for antiviral ability comprising:
(a) exposing at least one compound to a peptide comprising a DP178 peptide for a time sufficient to allow binding of the compound to the DP178 peptide;
(b) removing non-bound compounds; and
(c) determining the presence of the compound bound to the DP178 peptide, thereby identifying an agent to be tested for antiviral ability.
One method utilizing these types of approaches that may be pursued in the isolation of such DP107-binding or DP178-binding compounds is an assay which would include the attachment of either the DP107 or the DP178 peptide to a solid matrix, such as, for example, agarose or plastic beads, microtiter plate wells, petri dishes, or membranes composed of, for example, nylon or nitrocellulose. In such an assay system, either the DP107 or DP178 protein may be anchored onto a solid surface, and the compound, or test substance, which is not anchored, is labeled, either directly or indirectly. In practice, microtiter plates are conveniently utilized. The anchored component may be immobilized by non-covalent or covalent attachments. Non-covalent attachment may be accomplished simply by coating the solid surface with a solution of the protein and drying.
Alternatively, an immobilized antibody, preferably a monoclonal antibody, specific for the protein may be used to anchor the protein to the solid surface. The surfaces may be prepared in advance and stored.
In order to conduct the assay, the labeled compound is added to the coated surface containing the anchored DP107 or DP178 peptide. After the reaction is complete, unreacted components are removed (e.g., by washing) under conditions such that any complexes formed will remain immobilized on the solid surface. The detection of complexes anchored on the solid surface can be accomplished in a number of ways. Where the compound is pre-labeled, the detection of label immobilized on the surface indicates that complexes were formed. Where the labeled component is not pre-labeled, an indirect label can be used to detect complexes anchored on the surface; e.g., using a labeled antibody specific for the compound (the antibody, in turn, may be directly labeled or indirectly labeled with a labeled anti-Ig antibody).
Alternatively, such an assay can be conducted in a liquid phase, the reaction products separated from unreacted components, and complexes detected; e.g., using an immobilized antibody specific for DP107 or DP178, whichever is appropriate for the given assay, or ab antibody specific for the compound, i.e., the test substance, in order to anchor any complexes formed in solution, and a labeled antibody specific for the other member of the complex to detect anchored complexes.
By utilizing procedures such as this, large numbers of types of molecules may be simultaneously screened for DP107 or DP178-binding capability, and thus potential antiviral activity.
Further, compounds may be screened for an ability to inhibit the formation of or, alternatively, disrupt DP107/DP178 complexes. Such compounds may then be tested for antifusogenic, antiviral or intercellular modulatory capability. For ease of description, DP107 and DP178 will be referred to as "binding partners." Compounds that disrupt such interactions may exhibit antiviral activity. Such compounds may include, but are not limited to molecules such as antibodies, peptides, and the like described above.
The basic principle of the assay systems used to identify compounds that interfere with the interaction between the DP107 and DP178 peptides involves preparing a reaction mixture containing peptides under conditions and for a time sufficient to allow the two peptides to interact and bind, thus forming a complex. In order to test a compound for disruptive activity, the reaction is conducted in the presence and absence of the test compound, ie., the test compound may be initially included in the reaction mixture, or added at a time subsequent to the addition of one of the binding partners; controls are incubated without the test compound or with a placebo. The formation of any complexes between the binding partners is then detected. The formation of a complex in the control reaction, but not in the reaction mixture containing the test compound indicates that the compound interferes with the interaction of the DP107 and DP178 peptides.
The assay for compounds that interfere with the interaction of the binding partners can be conducted in a heterogeneous or homogeneous format. Heterogeneous assays involve anchoring one of the binding partners onto a solid phase and detecting complexes anchored on the solid phase at the end of the reaction. In homogeneous assays, the entire reaction is carried out in a liquid phase. In either approach, the order of addition of reactants can be varied to obtain different information about the compounds being tested. For example, test compounds that interfere with the interaction between the binding partners, e.g., by competition, can be identified by conducting the reaction in the presence of the test substance; i.e., by adding the test substance to the reaction mixture prior to or simultaneously with the binding partners. On the other hand, test compounds that disrupt preformed complexes, e.g. compounds with higher binding constants that displace one of the binding partners from the complex, can be tested by adding the test compound to the reaction mixture after complexes have been formed. The various formats are described briefly below.
In a heterogeneous assay system, one binding partner, e.g., either the DP107 or DP178 peptide, is anchored onto a solid surface, and its binding partner, which is not anchored, is labeled, either directly or indirectly. In practice, microtiter plates are conveniently utilized. The anchored species may be immobilized by non-covalent or covalent attachments. Non-covalent attachment may be accomplished simply by coating the solid surface with a solution of the protein and drying. Alternatively, an immobilized antibody specific for the protein may be used to anchor the protein to the solid surface. The surfaces may be prepared in advance and stored.
In order to conduct the assay, the binding partner of the immobilized species is added to the coated surface with or without the test compound. After the reaction is complete, unreacted components are removed (e.g., by washing) and any complexes formed will remain immobilized on the solid surface. The detection of complexes anchored on the solid surface can be accomplished in a number of ways. Where the binding partner was pre-labeled, the detection of label immobilized on the surface indicates that complexes were formed. Where the binding partner is not pre-labeled, an indirect label can be used to detect complexes anchored on the surface; e.g., using a labeled antibody specific for the binding partner (the antibody, in turn, may be directly labeled or indirectly labeled with a labeled anti-Ig antibody). Depending upon the order of addition of reaction components, test compounds which inhibit complex formation or which disrupt preformed complexes can be detected.
Alternatively, the reaction can be conducted in a liquid phase in the presence or absence of the test compound, the reaction products separated from unreacted components, and complexes detected; e.g., using an immobilized antibody specific for one binding partner to anchor any complexes formed in solution, and a labeled antibody specific for the other binding partner to detect anchored complexes. Again, depending upon the order of addition of reactants to the liquid phase, test compounds which inhibit complex or which disrupt preformed complexes can be identified.
In an alternate embodiment of the invention, a homogeneous assay can be used. In this approach, a preformed complex of the DP107 and DP178 peptides is prepared in which one of the binding partners is labeled, but the signal generated by the label is quenched due to complex formation (see, e.g., U.S. Pat. No. 4,109,496 by Rubenstein which utilizes this approach for immunoassays). The addition of a test substance that competes with and displaces one of the binding partners from the preformed complex will result in the generation of a signal above background. In this way, test substances which disrupt DP-107/DP-178 protein-protein interaction can be identified.
In an alternative screening assay, test compounds may be assayed for the their ability to disrupt a DP178/DP107 interaction, as measured immunometrically using an antibody specifically reactive to a DP107/DP178 complex (i.e., an antibody that recognizes neither DP107 nor DP178 individually). Such an assay acts as a competition assay, and is based on techniques well known to those of skill in the art.
The above competition assay may be described, by way of example, and not by way of limitation, by using the DP178 and M41A178 peptides and by assaying test compounds for the disruption of the complexes formed by these two peptides by immunometrically visualizing DP178/M41Δ178 complexes via the human recombinant Fab, Fab-d, as described, below, in the Example presented in Section 8. M41Δ78 is a maltose binding fusion protein containing a gp41 region having its DP178 domain deleted, and is described, below, in the Example presented in Section 8.
Utilizing such an assay, M41Δ178 may be immobilized onto solid supports such as microtiter wells. A series of dilutions of a test compound may then be added to each M41Δ178-containing well in the presence of a constant concentration of DP-178 peptide. After incubation, at, for example, room temperature for one hour, unbound DP-178 and test compound are removed from the wells and wells are then incubated with the DP178/M41Δ178-specific Fab-d antibody. After incubation and washing, unbound Fab-d is removed from the plates and bound Fab-d is quantitated. A no-inhibitor control should also be conducted. Test compounds showing an ability to disrupt DP178/M41Δ178 complex formation are identified by their concentration-dependent decrease in the level of Fab-d binding.
A variation of such an assay may be utilized to perform a rapid, high-throughput binding assay which is capable of directly measuring DP178 binding to M41Δ178 for the determination of binding constants of the ligand of inhibitory constants for competitors of DP178 binding.
Such an assay takes advantage of accepted radioligand and receptor binding principles. (See, for example, Yamamura, H. I. et al., 1985, "Neurotransmitter Receptor Binding", 2nd ed., Raven Press, N.Y.) As above, M41Δ178 is immobilized onto a solid support such as a microtiter well. DP178 binding to M41Δ178 is then quantitated by measuring the fraction of DP178 that is bound as 125 I-DP178 and calculating the total amount bound using a value for specific activity (dpm/μg peptide) determined for each labeled DP178 preparation. Specific binding to M41Δ178 is defined as the difference of the binding of the labeled DP178 preparation in the microtiter wells (totals) and the binding in identical wells containing, in addition, excess unlabeled DP178 (nonspecifics).
5.5 PHARMACEUTICAL FORMULATIONS, DOSAGES AND MODES OF ADMINISTRATION
The peptides of the invention may be administered using techniques well known to those in the art. Preferably, agents are formulated and administered systemically. Techniques for formulation and administration may be found in "Remington's Pharmaceutical Sciences", 18th ed., 1990, Mack Publishing Co., Easton, Pa. Suitable routes may include oral, rectal, transmucosal, or intestinal administration; parenteral delivery, including intramuscular, subcutaneous, intramedullary injections, as well as, intrathecal, direct intraventricular, intravenous, intraperitoneal, intranasal, or intraocular injections, just to name a few. For injection, the agents of the invention may be formulated in aqueous solutions, preferably in physiologically compatible buffers such as Hanks' solution, Ringer's solution, or physiological saline buffer. For such transmucosal administration, penetrants appropriate to the barrier to be permeated are used in the formulation. Such penetrants are generally known in the art.
In instances wherein intracellular administration of the peptides of the invention or other inhibitory agents is preferred, techniques well known to those of ordinary skill in the art may be utilized. For example, such agents may be encapsulated into liposomes, then administered as described above. Liposomes are spherical lipid bilayers with aqueous interiors. All molecules present in an aqueous solution at the time of liposome formation are incorporated into the aqueous interior. The liposomal contents are both protected from the external microenvironment and, because liposomes fuse with cell membranes, are effectively delivered into the cell cytoplasm. Additionally, due to their hydrophobicity, when small molecules are to be administered, direct intracellular administration may be achieved.
Nucleotide sequences encoding the peptides of the invention which are to be intracellularly administered may be expressed in cells of interest, using techniques well known to those of skill in the art. For example, expression vectors derived from viruses such as retroviruses, vaccinia viruses, adeno-associated viruses, herpes viruses, or bovine papilloma viruses, may be used for delivery and expression of such nucleotide sequences into the targeted cell population. Methods for the construction of such vectors and expression constructs are well known. See, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor N.Y., and Ausubel et al., 1989, Current Protocols in Molecular Biology, Greene Publishing Associates and Wiley Interscience, N.Y.
With respect to HIV, peptides of the invention, particularly DP107 and DP178, may be used as therapeutics in the treatment of AIDS. In addition, the peptides may be used as prophylactic measures in previously uninfected individuals after acute exposure to an HIV virus. Examples of such prophylactic use of the peptides may include, but are not limited to, prevention of virus transmission from mother to infant and other settings where the likelihood of HIV transmission exists, such as, for example, accidents in health care settings wherein workers are exposed to HIV-containing blood products. The successful use of such treatments do not rely upon the generation of a host immune response directed against such peptides.
Effective dosages of the peptides of the invention to be administered may be determined through procedures well known to those in the art which address such parameters as biological half-life, bioavailability, and toxicity. Given the data presented below in Section 6, DP178, for example, may prove efficacious in vivo at doses required to achieve circulating levels of about 1 to about 10 ng per ml of peptide.
A therapeutically effective dose refers to that amount of the compound sufficient to result in amelioration of symptoms or a prolongation of survival in a patient. Toxicity and therapeutic efficacy of such compounds can be determined by standard pharmaceutical procedures in cell cultures or experimental animals, e.g., for determining the LD50 (the dose lethal to 50% of the population) and the ED50 (the dose therapeutically effective in 50% of the population). The dose ratio between toxic and therapeutic effects is the therapeutic index and it can be expressed as the ratio LD50 /ED50. Compounds which exhibit large therapeutic indices are preferred. The data obtained from these cell culture assays and animal studies can be used in formulating a range of dosage for use in humans. The dosage of such compounds lies preferably within a range of circulating concentrations that include the ED50 with little or no toxicity. The dosage may vary within this range depending upon the dosage form employed and the route of administration utilized. For any compound used in the method of the invention, the therapeutically effective dose can be estimated initially from cell culture assays. A dose may be formulated in animal models to achieve a circulating plasma concentration range that includes the IC50 (e.g., the concentration of the test compound which achieves a half-maximal inhibition of the fusogenic event, such as a half-maximal inhibition of viral infection relative to the amount of the event in the absence of the test compound) as determined in cell culture. Such information can be used to more accurately determine useful doses in humans. Levels in plasma may be measured, for example, by high performance liquid chromatography (HPLC).
The peptides of the invention may, further, serve the role of a prophylactic vaccine, wherein the host raises antibodies against the peptides of the invention, which then serve to neutralize HIV viruses by, for example, inhibiting further HIV infection.
Administration of the peptides of the invention as a prophylactic vaccine, therefore, would comprise administering to a host a concentration of peptides effective in raising an immune response which is sufficient to neutralize HIV, by, for example, inhibiting HIV ability to infect cells. The exact concentration will depend upon the specific peptide to be administered, but may be determined by using standard techniques for assaying the development of an immune response which are well known to those of ordinary skill in the art. The peptides to be used as vaccines are usually administered intramuscularly.
The peptides may be formulated with a suitable adjuvant in order to enhance the immunological response. Such adjuvants may include, but are not limited to mineral gels such as aluminum hydroxide; surface active substances such as lysolecithin, pluronic polyols, polyanions; other peptides; oil emulsions; and potentially useful human adjuvants such as BCG and Corynebacterium parvum. Many methods may be used to introduce the vaccine formulations described here. These methods include but are not limited to oral, intradermal, intramuscular, intraperitoneal, intravenous, subcutaneous, and intranasal routes.
Alternatively, an effective concentration of polyclonal or monoclonal antibodies raised against the peptides of the invention may be administered to a host so that no uninfected cells become infected by HIV. The exact concentration of such antibodies will vary according to each specific antibody preparation, but may be determined using standard techniques well known to those of ordinary skill in the art.
Administration of the antibodies may be accomplished using a variety of techniques, including, but not limited to those described in this section.
For all such treatments described above, the exact formulation, route of administration and dosage can be chosen by the individual physician in view of the patient's condition. (See e.g. Fingl et al., 1975, in "The Pharmacological Basis of Therapeutics", Ch. 1 p1).
It should be noted that the attending physician would know how to and when to terminate, interrupt, or adjust administration due to toxicity, or to organ dysfunctions. Conversely, the attending physician would also know to adjust treatment to higher levels if the clinical response were not adequate (precluding toxicity). The magnitude of an administrated dose in the management of the oncogenic disorder of interest will vary with the severity of the condition to be treated and the route of administration. The dose and perhaps dose frequency, will also vary according to the age, body weight, and response of the individual patient. A program comparable to that discussed above may be used in veterinary medicine.
Use of pharmaceutically acceptable carriers to formulate the compounds herein disclosed for the practice of the invention into dosages suitable for systemic administration is within the scope of the invention. With proper choice of carrier and suitable manufacturing practice, the compositions of the present invention, in particular, those formulated as solutions, may be administered parenterally, such as by intravenous injection. The compounds can be formulated readily using pharmaceutically acceptable carriers well known in the art into dosages suitable for oral administration. Such carriers enable the compounds of the invention to be formulated as tablets, pills, capsules, liquids, gels, syrups, slurries, suspensions and the like, for oral ingestion by a patient to be treated.
Pharmaceutical compositions suitable for use in the present invention include compositions wherein the active ingredients are contained in an effective amount to achieve its intended purpose. Determination of the effective amounts is well within the capability of those skilled in the art, especially in light of the detailed disclosure provided herein.
In addition to the active ingredients, these pharmaceutical compositions may contain suitable pharmaceutically acceptable carriers comprising excipients and auxiliaries which facilitate processing of the active compounds into preparations which can be used pharmaceutically. The preparations formulated for oral administration may be in the form of tablets, dragees, capsules, or solutions.
The pharmaceutical compositions of the present invention may be manufactured in a manner that is itself known, e.g., by means of conventional mixing, dissolving, granulating, dragee-making, levigating, emulsifying, encapsulating, entrapping or lyophilizing processes.
Pharmaceutical formulations for parenteral administration include aqueous solutions of the active compounds in water-soluble form. Additionally, suspensions of the active compounds may be prepared as appropriate oily injection suspensions. Suitable lipophilic solvents or vehicles include fatty oils such as sesame oil, or synthetic fatty acid esters, such as ethyl oleate or triglycerides, or liposomes. Aqueous injection suspensions may contain substances which increase the viscosity of the suspension, such as sodium carboxymethyl cellulose, sorbitol, or dextran. Optionally, the suspension may also contain suitable stabilizers or agents which increase the solubility of the compounds to allow for the preparation of highly concentrated solutions.
Pharmaceutical preparations for oral use can be obtained by combining the active compounds with solid excipient, optionally grinding a resulting mixture, and processing the mixture of granules, after adding suitable auxiliaries, if desired, to obtain tablets or dragee cores. Suitable excipients are, in particular, fillers such as sugars, including lactose, sucrose, mannitol, or sorbitol; cellulose preparations such as, for example, maize starch, wheat starch, rice starch, potato starch, gelatin, gum tragacanth, methyl cellulose, hydroxypropylmethyl-cellulose, sodium carboxymethylcellulose, and/or polyvinylpyrrolidone (PVP). If desired, disintegrating agents may be added, such as the cross-linked polyvinyl pyrrolidone, agar, or alginic acid or a salt thereof such as sodium alginate.
Dragee cores are provided with suitable coatings. For this purpose, concentrated sugar solutions may be used, which may optionally contain gum arabic, talc, polyvinyl pyrrolidone, carbopol gel, polyethylene glycol, and/or titanium dioxide, lacquer solutions, and suitable organic solvents or solvent mixtures. Dyestuffs or pigments may be added to the tablets or dragee coatings for identification or to characterize different combinations of active compound doses.
Pharmaceutical preparations which can be used orally include push-fit capsules made of gelatin, as well as soft, sealed capsules made of gelatin and a plasticizer, such as glycerol or sorbitol. The push-fit capsules can contain the active ingredients in admixture with filler such as lactose, binders such as starches, and/or lubricants such as talc or magnesium stearate and, optionally, stabilizers. In soft capsules, the active compounds may be dissolved or suspended in suitable liquids, such as fatty oils, liquid paraffin, or liquid polyethylene glycols. In addition, stabilizers may be added.
In this example, DP178 (SEQ ID:1) is shown to be a potent inhibitor of HIV-1 mediated CD-4+ cell-cell fusion and infection by cell free virus. In the fusion assay, this peptide completely blocks virus induced syncytia formation at concentrations of from 1-10 ng/ml. In the infectivity assay the inhibitory concentration is somewhat higher, blocking infection at 90 ng/ml. It is further shown that DP178 (SEQ ID:1) shows that the antiviral activity of DP178 (SEQ ID:1) is highly specific for HIV-1. Additionally, a synthetic peptide, DP-185 (SEQ ID:3), representing a HIV-1-derived DP178 homolog is also found to block HIV-1-mediated syncytia formation.
6.1. MATERIALS AND METHODS
6.1.1. PEPTIDE SYNTHESIS
Peptides were synthesized using Fast Moc chemistry on an Applied Biosystems Model 431A peptide synthesizer. Generally, unless otherwise noted, the peptides contained amidated carboxy termini and acetylated amino termini. Amidated peptides were prepared using Rink resin (Advanced Chemtech) while peptides containing free carboxy termini were synthesized on Wang (p-alkoxy-benzyl-alcohol) resin (Bachem). First residues were double coupled to the appropriate resin and subsequent residues were single coupled. Each coupling step was followed by acetic anhydride capping. Peptides were cleaved from the resin by treatment with trifluoracetic acid (TFA) (10 ml), H2 O (0.5 ml), thioanisole (0.5 ml), ethanedithiol (0.25 ml), and crystalline phenol (0.75 g). Purification was carried out by reverse phase HPLC. Approximately 50 mg samples of crude peptide were chromatographed on a Waters Delta Pak C18 column (19 mm×30 cm, 15μ spherical) with a linear gradient; H2 O/acetonitrile 0.1% TFA. Lyophilized peptides were stored desiccated and peptide solutions were made in water at about 1 mg/ml. Electrospray mass spectrometry yielded the following results: DP178 (SEQ ID:1):4491.87 (calculated 4491.94); DP-180 (SEQ ID:2):4491.45 (calculated 4491.94); DP-185 (SEQ ID:3):not done (calculated 4546.97).
6.1.2. VIRUS
The HIV-1LAI virus was obtained from R. Gallo (Popovic, M. et al., 1984, Science 224:497-508) and propagated in CEM cells cultured in RPMI 1640 containing 10% fetal calf serum. Supernatant from the infected CEM cells was passed through a 0.2 μm filter and the infectious titer estimated in a microinfectivity assay using the AA5 cell line to support virus replication. For this purpose, 25 μl of serial diluted virus was added to 75 μl AA5 cells at a concentration of 2×105 /ml in a 96-well microtitre plate. Each virus dilution was tested in triplicate. Cells were cultured for eight days by addition of fresh medium every other day. On day 8 post infection, supernatant samples were tested for virus replication as evidenced by reverse transcriptase activity released to the supernatant. The TCID50 was calculated according to the Reed and Muench formula (Reed, L. J. et al., 1938, Am. J. Hyg. 27:493-497). The titer of the HIV-1LAI and HIV-1MN stocks used for these studies, as measured on the AA5 cell line, was approximately 1.4×106 and 3.8×104 TCID50 /ml, respectively.
6.1.3. CELL FUSION ASSAY
Approximately 7×104 Molt cells were incubated with 1×104 CEM cells chronically infected with the HIV-1LAI virus in 96-well plates (one-half area cluster plates; Costar, Cambridge, MA) in a final volume of 100 μl culture medium as previously described (Matthews, T. J. et al., 1987, Proc. Natl. Acad. Sci. USA 84: 5424-5428). Peptide inhibitors were added in a volume of 10 μl and the cell mixtures were incubated for 24 hr. at 37°C At that time, multinucleated giant cells were estimated by microscopic examination at a 40× magnification which allowed visualization of the entire well in a single field.
6.1.4. CELL FREE VIRUS INFECTION ASSAY
Synthetic peptides were incubated at 37°C with either 247 TCID50 (for experiment depicted in FIG. 2), or 62 TCID50 (for experiment depicted in FIG. 3) units of HIV-1LAI virus or 25 TCID50 units of HIV-2NIHZ and CEM CD4+ cells at peptide concentrations of 0, 0.04, 0.4, 4.0, and 40 μg/ml for 7 days. The resulting reverse transcriptase (RT) activity in counts per minute was determined using the assay described, below, in Section 6.1.5. See, Reed, L. J. et al., 1938, Am. J. Hyg. 27: 493-497 for an explanation of TCID50 calculations.
6.1.5. REVERSE TRANSCRIPTASE ASSAY
The micro-reverse transcriptase (RT) assay was adapted from Goff et al. (Goff, S. et al., 1981, J. Virol. 38:239-248) and Willey et al. (Willey, R. et al., 1988, J. Virol. 62:139-147). Supernatants from virus/cell cultures are adjusted to 1% Triton-X100. A 10 μl sample of supernatant was added to 50 μl of RT cocktail in a 96-well U-bottom microtitre plate and the samples incubated at 37°C for 90 min. The RT cocktail contained 75 mM KCl, 2 mM dithiothreitol, 5 mM MgCl2, 5 μg/ml poly A (Pharmacia, cat. No. 27-4110-01), 0.25 units/ml oligo dT (Pharmacia, cat. No. 27-7858-01), 0.05% NP40, 50 mM Tris-HCl, pH 7.8, 0.5 μM non-radioactive dTTP, and 10 μCi/ml 32 P-dTTP (Amersham, cat. No. PB.10167).
After the incubation period, 40 μl of reaction mixture was applied to a Schleicher and Schuell (S+S) NA45 membrane (or DE81 paper) saturated in 2×SSC buffer (0.3M NaCl and 0.003M sodium citrate) held in a S+S Minifold over one sheet of GB003 (S+S) filter paper, with partial vacuum applied. Each well of the minifold was washed four times with 200 μl 2×SSC, under full vacuum. The membrane was removed from the minifold and washed 2 more times in a pyrex dish with an excess of 2×SSC. Finally, the membrane was drained on absorbent paper, placed on Whatman #3 paper, covered with Saran wrap, and exposed to film overnight at -70°C
6.2. RESULTS
6.2.1. PEPTIDE INHIBITION OF INFECTED CELL-INDUCED SYNCYTIA FORMATION
The initial screen for antiviral activity assayed peptides' ability to block syncytium formation induced by overnight co-cultivation of uninfected Molt4 cells with chronically HIV-1 infected CEM cells. The results of several such experiments are presented herein. In the first of these experiments, serial DP178 (SEQ ID:1) peptide concentrations between 10 μg/ml and 12.5 ng/ml were tested for blockade of the cell fusion process. For these experiments, CEM cells chronically infected with either HIV-1LAI, HIV-1MN, HIV-1RF, or HIV-1SF2 virus were cocultivated overnight with uninfected Molt 4 cells. The results (FIG. 4) show that DP178 (SEQ ID:1) afforded complete protection against each of the HIV-1 isolates down to the lowest concentration of DP178 (SEQ ID:1) used. For HIVLAI inhibition, the lowest concentration tested was 12.5 ng/ml; for all other HIV-1 viruses, the lowest concentration of DP178 (SEQ ID:1) used in this study was 100 ng/ml. A second peptide, DP-180 (SEQ ID:2), containing the same amino acid residues as DP178 (SEQ ID:1) but arranged in a random order exhibited no evidence of anti-fusogenic activity even at the high concentration of 40 μg/ml (FIG. 4). These observations indicate that the inhibitory effect of DP178 (SEQ ID:1) is primary sequence-specific and not related to non-specific peptide/protein interactions. The actual endpoint (i.e., the lowest effective inhibitory concentration) of DP178 inhibitory action is within the range of 1-10 ng/ml.
The next series of experiments involved the preparation and testing of a DP178 (SEQ ID:1) homolog for its ability to inhibit HIV-1-induced syncytia formation. As shown in FIG. 1, the sequence of DP-185 (SEQ ID:3) is slightly different from DP178 (SEQ ID:1) in that its primary sequence is taken from the HIV-1SF2 isolate and contains several amino acid differences relative to DP178 (SEQ ID:1) near the N terminus. As shown in FIG. 4, DP-185 (SEQ ID:3), exhibits inhibitory activity even at 312.5 ng/ml, the lowest concentration tested.
The next series of experiments involved a comparison of DP178 (SEQ ID:1) HIV-1 and HIV-2 inhibitory activity. As shown in FIG. 5, DP178 (SEQ ID:1) blocked HIV-1-mediated syncytia formation at peptide concentrations below 1 ng/ml. DP178 (SEQ ID:1) failed, however, to block HIV-2 mediated syncytia formation at concentrations as high as 10 μg/ml. This striking 4 log selectivity of DP178 (SEQ ID:1) as an inhibitor of HIV-1-mediated cell fusion demonstrates an unexpected HIV-1 specificity in the action of DP178 (SEQ ID:1). DP178 (SEQ ID:1) inhibition of HIV-1-mediated cell fusion, but the peptide's inability to inhibit HIV-2 medicated cell fusion in the same cell type at the concentrations tested provides further evidence for the high degree of selectivity associated with the antiviral action of DP178 (SEQ ID:1).
6.2.2. PEPTIDE INHIBITION OF INFECTION BY CELL-FREE VIRUS
DP178 (SEQ ID:1) was next tested for its ability to block CD-4+ CEM cell infection by cell free HIV-1 virus. The results, shown in FIG. 2, are from an experiment in which DP178 (SEQ ID:1) was assayed for its ability to block infection of CEM cells by an HIV-1LAI isolate. Included in the experiment were three control peptides, DP-116 (SEQ ID:9), DP-125 (SEQ ID:8), and DP-118 (SEQ ID:10). DP-116 (SEQ ID:9) represents a peptide previously shown to be inactive using this assay, and DP-125 (SEQ ID:8; Wild, C. et al., 1992, Proc. Natl. Acad, Sci. USA 89:10,537) and DP-118 (SEQ ID:10) are peptides which have previously been shown to be active in this assay. Each concentration (0, 0.04, 0.4, 4, and 40 μg/ml) of peptide was incubated with 247 TCID50 units of HIV-1LAI virus and CEM cells. After 7 days of culture, cell-free supernatant was tested for the presence of RT activity as a measure of successful infection. The results, shown in FIG. 2, demonstrate that DP178 (SEQ ID:1) inhibited the de novo infection process mediated by the HIV-1 viral isolate at concentrations as low as 90 ng/ml (IC50=90 ng/ml). In contrast, the two positive control peptides, DP-125 (SEQ: ID:8) and DP-118 (SEQ ID:10), had over 60-fold higher IC50 concentrations of approximately 5 μg/ml.
In a separate experiment, the HIV-1 and HIV-2 inhibitory action of DP178 (SEQ ID:1) was tested with CEM cells and either HIV-1LAI or HIV-2NIHZ. 62 TCID50 HIV-1LAI or 25 GCID50 HIV-2NIHZ were used in these experiments, and were incubated for 7 days. As may be seen in FIG. 3, DP178 (SEQ ID:1) inhibited HIV-1 infection with an IC50 of about 31 ng/ml. In contrast, DP178 (SEQ ID:1) exhibited a much higher IC50 for HIV-2NIHZ, thus making DP178 (SEQ ID:1) two logs more potent as a HIV-1 inhibitor than a HIV-2 inhibitor. This finding is consistent with the results of the fusion inhibition assays described, above, in Section 6.2.1, and further supports a significant level of selectivity (i.e., for HIV-1 over HIV-2).
In this Example, the 36 amino acid synthetic peptide inhibitor DP178 (SEQ ID:1) is shown to be non-cytotoxic to cells in culture, even at the highest peptide concentrations (40 μg/ml) tested.
7.1. MATERIALS AND METHODS
Cell proliferation and toxicity assay: Approximately 3.8×105 CEM cells for each peptide concentration were incubated for 3 days at 37°C in T25 flasks. Peptides tested were DP178 (SEQ ID:1) and DP-116 (SEQ ID:9), as described in FIG. 1. Peptides were synthesized as described, above, in Section 6.1. The concentrations of each peptide used were 0, 2.5, 10, and 40 μg/ml. Cell counts were taken at incubation times of 0, 24, 48, and 72 hours.
7.2. RESULTS
Whether the potent HIV-1 inhibitor DP178 (SEQ ID:1) exhibited any cytotoxic effects was assessed by assaying the peptide's effects on the proliferation and viability of cells in culture. CEM cells were incubated in the presence of varying concentrations of DP178 (SEQ ID:1), and DP-116 (SEQ ID:9), a peptide previously shown to be ineffective as a HIV inhibitor (Wild, C. et al., 1992, Proc. Natl. Acad. Sci. USA 89:10,537-10,541). Additionally, cells were incubated in the absence of either peptide.
The results of the cytotoxicity study demonstrate that DP178 (SEQ ID:1) exhibits no cytotoxic effects on cells in culture. As can be seen, below, in Table XXIV, even the proliferation and viability characteristics of cells cultured for 3 days in the presence of the highest concentration of DP178 (SEQ ID:1) tested (40 μg/ml) do not significantly differ from the DP-116 (SEQ ID:9) or the no-peptide controls. The cell proliferation data is also represented in graphic form in FIG. 6. As was demonstrated in the Working Example presented above in Section 6, DP178 (SEQ ID:1) completely inhibits HIV-1 mediated syncytia formation at peptide concentrations between 1 and 10 ng/ml, and completely inhibits cell-free viral infection at concentrations of at least 90 ng/ml. Thus, this study demonstrates that even at peptide concentrations greater than 3 log higher than the HIV inhibitory dose, DP178 (SEQ ID:1) exhibits no cytotoxic effects.
| TABLE XXIV |
| ______________________________________ |
| % Viability |
| Peptide at time (hours) |
| Peptide Concentration μg/ml |
| 0 24 48 72 |
| ______________________________________ |
| DP178 40 98 97 95 97 |
| (SEQ |
| ID:1) |
| 10 98 97 98 98 |
| 2.5 98 93 96 96 |
| DP116 40 98 95 98 97 |
| (SEQ |
| ID:9) |
| 10 98 95 93 98 |
| 2.5 98 96 98 99 |
| No 0 98 97 99 98 |
| Peptide |
| ______________________________________ |
Soluble recombinant forms of gp41 used in the example described below provide evidence that the DP178 peptide associates with a distal site on gp41 whose interactive structure is influenced by the DP107 leucine zipper motif. A single mutation disrupting the coiled-coil structure of the leucine zipper domain transformed the soluble recombinant gp41 protein from an inactive to an active inhibitor of HIV-1 fusion. This transformation may result from liberation of the potent DP178 domain from a molecular clasp with the leucine zipper, DP107, determinant. The results also indicate that the anti-HIV activity of various gp41 derivatives (peptides and recombinant proteins) may be due to their ability to form complexes with viral gp41 and interfere with its fusogenic process.
8.1. MATERIALS AND METHODS
8.1.1. CONSTRUCTION OF FUSION PROTEINS AND GP41 MUTANTS
Construction of fusion proteins and mutants shown in FIG. 7 was accomplished as follows: the DNA sequence corresponding to the extracellular domain of gp41 (540-686) was cloned into the Xmn I site of the expression vector pMal-p2 (New England Biolab) to give M41. The gp41 sequence was amplified from pgtat (Malim et al., 1988, Nature 355: 181-183) by using polymerase chain reaction (PCR) with upstream primer 5'-ATGACGCTGACGGTACAGGCC-3' (primer A) and downstream primer 5'-TGACTAAGCTTAATACCACAGCCAATTTGTTAT-3' (primer B). M41-P was constructed by using the T7-Gen in vitro mutagenesis kit from United States Biochemicals (USB) following the supplier's instructions. The mutagenic primer (5'-GGAGCTGCTTGGGGCCCCAGAC-3') introduces an Ile to Pro mutation in M41 at position 578. M41Δ107, from which the DP-107 region has been deleted, was made using a deletion mutagenic primer 5'-CCAAATCCCCAGGAGCTGCTCGAGCTGCACTATACCAGAC-3' (primer C) following the USB T7-Gen mutagenesis protocol. M41Δ178, from which the DP-178 region has been deleted, was made by cloning the DNA fragment corresponding to gp41 amino acids 540-642 into the Xmn I site of pMal-p2. Primer A and 5'-ATAGCTTCTAGATTAATTGTTAATTTCTCTGTCCC-3' (primer D) were used in the PCR with the template pgtat to generate the inserted DNA fragments. M41-P was used as the template with primer A and D in PCR to generate M41-PΔ178. All inserted sequences and mutated residues were checked by restriction enzyme analysis and confirmed by DNA sequencing.
8.1.2. PURIFICATION AND CHARACTERIZATION OF FUSION PROTEINS
The fusion proteins were purified according to the protocol described in the manufacturer's brochure of protein fusion and purification systems from New England Biolabs (NEB). Fusion proteins (10 ng) were analyzed by electrophoresis on 8% SDS polyacrylamide gels. Western blotting analysis was performed as described by Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, 2d Ed, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., Ch. 18, pp. 64-75. An HIV-1 positive serum diluted 1000-fold, or a human Fab derived from repertoire cloning was used to react with the fusion proteins. The second antibody was HRP-conjugated goat antihuman Fab. An ECL Western blotting detection system (Amersham) was used to detect the bound antibody. A detailed protocol for this detection system was provided by the manufacturer. Rainbow molecular weight markers (Amersham) were used to estimate the size of fusion proteins.
8.1.3. CELL FUSION ASSAYS FOR ANTI-HIV ACTIVITY
Cell fusion assays were performed as previously described (Matthews et al., 1987, Proc. Natl. Acad. Sci. USA 84: 5424-5481). CEM cells (7×104) were incubated with HIV-1IIIB chronically infected CEM cells (104) in 96-well flat-bottomed half-area plates (Costar) in 100 μl culture medium. Peptide and fusion proteins at various concentrations in 10 μl culture medium were incubated with the cell mixtures at 37°C for 24 hours. Multinucleated syncytia were estimated with microscopic examination. Both M41 and M41-P did not show cytotoxicity at the concentrations tested and shown in FIG. 8.
Inhibition of HIV-1 induced cell-cell fusion activity was carried out in the presence of 10 nM DP178 and various concentrations of M41Δ178 or M41-PΔ178 as indicated in FIG. 9. There was no observable syncytia in the presence of 10 nM DP178. No peptide or fusion protein was added in the control samples.
8.1.4. ELISA ANALYSIS OF DP178 BINDING TO THE LEUCINE ZIPPER MOTIF OF GP41
The amino acid sequence of DP178 used is: YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF. For enzyme linked immunoassay (ELISA), M41Δ178 or M41-PΔ178 (5 μg/ml) in 0.1M NaHCO3, pH 8.6, were coated on 96 wells Linbro ELISA plates (Flow Lab, Inc.) overnight. Each well was washed three times with distilled water then blocked with 3% bovine serum albumin (BSA) for 2 hours. After blocking, peptides with 0.5% BSA in TBST (40 mM Tris-HCl pH7.5, 150 mM NaCl, 0.05% Tween 20) were added to the ELISA plates and incubated at room temperature for 1 hour. After washing three times with TBST, Fab-d was added at a concentration of 10 ng/ml with 0.5% BSA in TBST. The plates were washed three times with TBST after incubation at room temperature for 1 hour. Horse radish peroxidase (HRP) conjugated goat antihuman Fab antiserum at a 2000 fold dilution in TBST with 0.5% BSA was added to each well and incubated at room temperature for 45 minutes. The plates were then washed four times with TBST. The peroxidase substrate o-phenylene diamine (2.5 mg/ml) and 0.15% H2 O2 were added to develop the color. The reaction was stopped with an equal volume of 4.5 N H2 SO4 after incubation at room temperature for 10 minutes. The optical density of the stopped reaction mixture was measured with a micro plate reader (Molecular Design) at 490 nm. Results are shown in FIG. 10.
8.2. RESULTS
8.2.1. THE EXPRESSION AND CHARACTERIZATION OF THE ECTODOMAIN OF gp41
As a step toward understanding the roles of the two helical regions in gp41 structure and function, the ectodomain of gp41 was expressed as a maltose binding fusion protein (M41) (FIG. 7). The fusogenic peptide sequence at the N-terminal of gp41 was omitted from this recombinant protein and its derivatives to improve solubility. The maltose binding protein facilitated purification of the fusion proteins under relatively mild, non-denaturing conditions. Because the M41 soluble recombinant gp41 was not glycosylated, lacked several regions of the transmembrane protein (i.e., the fusion peptide, the membrane spanning, and the cytoplasmic domains), and was expressed in the absence of gp120, it was not expected to precisely reflect the structure of native gp41 on HIV-1 virions. Nevertheless, purified M41 folded in a manner that preserved certain discontinuous epitopes as evidenced by reactivity with human monoclonal antibodies, 98-6, 126-6, and 50-69, previously shown to bind conformational epitopes on native gp41 expressed in eukaryotic cells (Xu et al., 1991, J. Virol. 65: 4832-4838; Chen, 1994, J. Virol. 68:2002-2010). Thus, at least certain regions of native gp41 defined by these antibodies appear to be reproduced in the recombinant fusion protein M41. Furthermore, M41 reacted with a human recombinant Fab (Fab-d) that recognizes a conformational epitope on gp41 and binds HIV-1 virions as well as HIV-1 infected cells but not uninfected cells as analyzed by FACS. Deletion of either helix motif, i.e., DP107 or DP178, of the M41 fusion protein eliminated reactivity with Fab-d. These results indicate that both helical regions, separated by 60 amino acids in the primary sequence, are required to maintain the Fab-d epitope.
8.2.2. ANTI-HIV ACTIVITY OF THE RECOMBINANT ECTODOMAIN OF GP41
The wild type M41 fusion protein was tested for anti-HIV-1 activity. As explained, supra, synthetic peptides corresponding to the leucine zipper (DP107) and the C-terminal putative helix (DP178) show potent anti-HIV activity. Despite inclusion of both these regions, the recombinant M41 protein did not affect HIV-1 induced membrane fusion at concentrations as high as 50 μM (Table XXV, below).
| TABLE XXV |
| ______________________________________ |
| DISRUPTION OF THE LEUCINE ZIPPER OF |
| GP41 FREES THE ANTI-HIV MOTIF |
| DP107 DP178 M41 M41-P M41-PΔ178 |
| ______________________________________ |
| Cell fusion |
| 1 μM 1 nM >50 μM |
| 83 nM >50 μM |
| (IC90) |
| Fab-D -- -- 3.5 × 10-9 2.5 × 10-8 -- |
| binding (kD) |
| HIV infect- 1 μM 80 nM >16 μM 66 nM >8 μM |
| ivity (IC90) |
| ______________________________________ |
| 1 The affinity constants of Fabd binding to the fusion proteins were |
| determined using a protocol described by B. Friguet et al., 1985, J. |
| Immunol. Method. 77:305-319. |
| -- = No detectable binding of Fabd to the fusion proteins. |
| Antiviral Infectivity Assays. 20 μl of serially diluted virus stock wa |
| incubated for 60 minutes at ambient temperature with 20 μl of the |
| indicated concentration of purified recombinant fusion protein in RPMI |
| 1640 containing 10% fetal bovine serum and antibiotics in a 96well |
| microtiter plate. # 20 μl of CEM4 cells at 6 × 105 cells/m |
| were added to each well, and cultures were incubated at 37°C in |
| humidified CO2 incubator. Cells were cultured for 9 days by the |
| addition of fresh medium every 2 to 3 days. On days 5, 7, and 9 |
| postinfection, supernatant samples were # assayed for reverse |
| transcriptase (RT) activity, as described below, to monitor viral |
| replication. The 50% tissue culture infectious dose (TCID50) was |
| calculated for each condition according to the formula of Reed & Muench, |
| 1937, Am. J. Hyg. 27:493-497. RT activity was determined by a modificatio |
| of the published methods of Goff et al., # 1981, J. Virol, 38:239-248 an |
| Willey et al., 1988, J. Virol. 62:139-147 as described in Chen et al., |
| 1993, AIDS Res. Human Retroviruses 9:1079-1086. |
Surprisingly, a single amino acid substitution, proline in place of isoleucine in the middle of the leucine zipper motif, yielded a fusion protein (M41-P) which did exhibit antiviral activity (Table XXV and FIG. 8). As seen in Table XXV, M41-P blocked syncytia formation by 90% at approximately 85 nM and neutralized HIV-1IIIB infection by 90% at approximately 70 nM concentrations. The anti-HIV-1 activity of M41-P appeared to be mediated by the C-terminal helical sequence since deletion of that region from M41-P yielded an inactive fusion protein, M41-PΔ178 (Table XXV). This interpretation was reinforced by experiments demonstrating that a truncated fusion protein lacking the DP178 sequence, M41Δ178, abrogated the potent anti-fusion activity of the DP178 peptide in a concentration-dependent manner (FIG. 9). The same truncated fusion protein containing the proline mutation disrupting the leucine zipper, M41-PΔ178, was not active in similar competition experiments (FIG. 9). The results indicate that the DP178 peptide associates with a second site on gp41 whose interactive structure is dependent on a wild type leucine zipper sequence. A similar interaction may occur within the wild type fusion protein, M41, and act to form an intramolecular clasp which sequesters the DP178 region, making it unavailable for anti-viral activity.
A specific association between these two domains is also indicated by other human monoclonal Fab-d studies. For example, Fab-d failed to bind either the DP178 peptide or the fusion protein M4Δ178, but its epitope was reconstituted by simply mixing these two reagents together (FIG. 10). Again, the proline mutation in the leucine zipper domain of the fusion protein, M41-PΔ178, failed to reconstitute the epitope in similar mixing experiments.
A number of known coiled-coil sequences have been well described in the literature and contain heptad repeat positioning for each amino acid. Coiled-coil nomenclature labels each of seven amino acids of a heptad repeat A through G, with amino acids A and D tending to be hydrophobic positions. Amino acids E and G tend to be charged. These four positions (A, D, E, and G) form the amphipathic backbone structure of a monomeric alphα-helix. The backbones of two or more amphipathic helices interact with each other to form di-, tri-, tetrameric, etc., coiled-coil structures. In order to begin to design computer search motifs, a series of well characterized coiled coils were chosen including yeast transcription factor GCN4, Influenza Virus hemagglutinin loop 36, and human proto-oncogenes c-Myc, c-Fos, and c-Jun. For each peptide sequence, a strict homology for the A and D positions, and a list of the amino acids which could be excluded for the B, C, E, F, and G positions (because they are not observed in these positions) was determined. Motifs were tailored to the DP107 and DP178 sequences by deducing the most likely possibilities for heptad positioning of the amino acids of HIV-1 Bru DP-107, which is known to have coiled-coil structure, and HIV-1 Bru DP178, which is still structurally undefined. The analysis of each of the sequences is contained in FIG. 12. For example, the motif for GCN4 was designed as follows:
1. The only amino acids (using standard single letter amino acid codes) found in the A or D positions of GCN4 were [LMNV].
2. All amino acids were found at B, C, E, F, and G positions except {CFGIMPTW}.
3. The PESEARCH motif would, therefore, be written as follows:
[LMNV]-{CFGIMPTW}(2)-[LMNV]-{CFGIMPTW}(3)--
[LMNV]-{CFGIMPTW}(2)-[LMNV]-{CFGIMPTW}(3)--
[LMNV]-{CFGIMPTW}(2)-[LMNV]-{CFGIMPTW}(3)--
[LMNV]-{CFGIMPTW}(2)-[LMNV]-{CFGIMPTW}(3)
Translating or reading the motif: "at the first A position either L, M, N, or V must occur; at positions B and C (the next two positions) accept everything except C, F, G, I, M, P, T, or W; at the D position either L, M, N, or V must occur; at positions E, F, and G (the next 3 positions) accept everything except C, F, G, I, M, P, T, or W." This statement is contained four times in a 28-mer motif and five times in a 35-mer motif. The basic motif key then would be: [LMNV]-{CFGIMPTW}. The motif keys for the remaining well described coiled-coil sequences are summarized in FIG. 12.
The motif design for DP107 and DP178 was slightly different than the 28-mer model sequences described above due to the fact that heptad repeat positions are not defined and the peptides are both longer than 28 residues. FIG. 13 illustrates several possible sequence alignments for both DP107 and DP178 and also includes motif designs based on 28-mer, 35-mer, and full-length peptides. Notice that only slight differences occur in the motifs as the peptides are lengthened. Generally, lengthening the base peptide results in a less stringent motif. This is very useful in broadening the possibilities for identifying DP107-or DP-178-like primary amino acid sequences referred to in this document as "hits".
In addition to making highly specific motifs for each type peptide sequence to be searched, it is also possible to make "hybrid" motifs. These motifs are made by "crossing" two or more very stringent motifs to make a new search algorithm which will find not only both "parent" motif sequences but also any peptide sequences which have similarities to one, the other, or both "parents". For example, in FIG. 14 the "parent" sequence of GCN4 is crossed with each of the possible "parent" motifs of DP-107. Now the hybrid motif must contain all of the amino acids found in the A and D positions of both parents, and exclude all of the amino acids not found in either parent at the other positions. The resulting hybrid from crossing GCN4 or [LMNV]{CFGIMPTW} and DP107 (28-mer with the first L in the D position) or [ILQT]{CDFIMPST}, is [ILMNQTV]{CFIMPT}. Notice that now only two basic hybrid motifs exist which cover both framing possibilities, as well as all peptide lengths of the parent DP-107 molecule. FIG. 15 represents the "hybridizations" of GCN4 with DP-178. FIG. 16 represents the "hybridizations" of DP107 and DP178. It is important to keep in mind that the represented motifs, both parent and hybrid, are motif keys and not the depiction of the full-length motif needed to actually do the computer search.
Hybridizations can be performed on any combination of two or more motifs. FIG. 17 summarizes several three-motif hybridizations including GCN4, DP107 (both frames), and DP178 (also both frames). Notice that the resulting motifs are now becoming much more similar to each other. In fact, the first and third hybrid motifs are actually subsets of the second and fourth hybrid motifs respectively. This means that the first and third hybrid motifs are slightly more stringent than the second and fourth. It should also be noted that with only minor changes in these four motifs, or by hybridizing them, a single motif could be obtained which would find all of the sequences. However, it should be remembered that stringency is also reduced. Finally, the most broad-spectrum and least-stringent hybrid motif is described in FIG. 18 which summarizes the hybridization of GCN4, DP107 (both frames), DP178 (both frames), c-Fos, c-Jun, c-Myc, and Flu loop 36.
A special set of motifs was designed based on the fact that DP-178 is located only approximately ten amino acids upstream of the transmembrane spanning region of gp41 and just C-terminal to a proline which separates DP107 and DP178. It has been postulated that DP178 may be an amphipathic helix when membrane associated, and that the proline might aid in the initiation of the helix formation. The same arrangement was observed in Respiratory Syncytial Virus; however, the DP178-like region in this virus also had a leucine zipper just C-terminal to the proline. Therefore, N-terminal proline-leucine zipper motifs were designed to analyze whether any other viruses might contain this same pattern. The motifs are summarized in FIG. 19.
The PC/Gene protein database contains 5879 viral amino acid sequences (library file PVIRUSES; CD-ROM release 11.0). Of these, 1092 are viral enveloped or glycoprotein sequences (library file PVIRUSE1). Tables V through XIV contain lists of protein sequence names and motif hit locations for all the motifs searched.
FIG. 20 represents search results for HIV-1 BRU isolate gp41 (PC/Gene protein sequence PENV-- HV1BR). Notice that the hybrid motif which crosses DP-107 and DP-178 (named 107×178×4; the same motif as found in FIG. 16 found three hits including amino acids 550-599, 636-688, and 796-823. These areas include DP-107 plus eight N-terminal and four C-terminal amino acids; DP178 plus seven N-terminal and ten C-terminal amino acids; and an area inside the transmembrane region (cytoplasmic). FIG. 20 also contains the results obtained from searching with the motif named ALLMOTI5, for which the key is found in FIG. 17 ({CDGHP} {CFP}×5). This motif also found three hits including DP107 (amino acids 510-599), DP178 (615-717), and a cytoplasmic region (772-841). These hits overlap the hits found by the motif 107×178×4 with considerable additional sequences on both the amino and carboxy termini. This is not surprising in that 107×178×4 is a subset of the ALLMOTI5 hybrid motif. Importantly, even though the stringency of ALLMOTI5 is considerably less than 107×178×4, it still selectively identifies the DP107 and DP178 regions of gp41 shown to contain sequences for inhibitory peptides of HIV-1. The results of these two motif searches are summarized in Table V under the PC/Gene protein sequence name PENV HV1BR. The proline-leucine zipper motifs also gave several hits in HIV-1 BRU including 503-525 which is at the very C-terminus of gp120, just upstream of the cleavage site (P7LZIPC and P12LZIPC); and 735-768 in the cytoplasmic domain of gp41 (P23LZIPC). These results are found in Tables VIII, IX, and X under the same sequence name as mentioned above. Notice that the only area of HIV-1 BRU which is predicted by the Lupas algorithm to contain a coiled-coil region, is from amino acids 635-670. This begins eight amino acids N-terminal to the start and ends eight amino acids N-terminal to the end of DP178. DP107, despite the fact that it is a known coiled coil, is not predicted to contain a coiled-coil region using the Lupas method.
FIG. 21 represents search results for Human Respiratory Syncytial Virus (RSV; Strain A2) fusion glycoprotein F1 (PC/Gene protein sequence name PVGLF-- HRSVA). Motif 107×178×4 finds three hits including amino acids 152-202, 213-243, and 488-515. The arrangement of these hits is similar to what is found in HIV-1 except that the motif finds two regions with similarities to DP-178, one just downstream of what would be called the DP107 region or amino acids 213-243, and one just upstream of the transmembrane region (also similar to DP178) or amino acids 488-515. Motif ALLMOTI5 also finds three areas including amino acids 116-202, 267-302, and 506-549. The proline-leucine zipper motifs also gave several hits including amino acids 205-221 and 265-287 (PLLZIPC 265-280, P12LZIPC), and 484-513 (P7LZIPC and P12LZIPC 484-506, P23LZIPC). Notice that the PLZIP motifs also identify regions which share location similarities with DP-178 of HIV-1.
Motif hits for Simian immunodeficiency Virus gp41 (AGM3 isolate; PC/Gene protein sequence name PENV-- SIVAG) are shown in FIG. 22. Motif 107×178×4 finds three hits including amino acids 566-593, 597-624, and 703-730. The first two hits only have three amino acids between them and could probably be combined into one hit from 566-624 which would represent a DP107-like hit. Amino acids 703 to 730 would then represent a DP178-like hit. ALLMOTI5 also finds three hits including amino acids 556-628 (DP107-like), 651-699 (DP178-like), and 808-852 which represents the transmembrane spanning region. SIV also has one region from 655-692 with a high propensity to form a coiled coil as predicted by the Lupas algorithm. Both 107×178×4 and ALLMOTI5 motifs find the same region. SIV does not have any PLZIP motif hits in gp41.
The identification of DP178/DP107 analogs for a second SIV isolate (MM251) is demonstrated in the Example presented, below, in Section 19.
Canine Distemper Virus (strain Onderstepoort) fusion glycoprotein F1 (PC/Gene Protein sequence name PVGLF-- CDVO) has regions similar to Human RSV which are predicted to be DP107-like and DP178-like (FIG. 23). Motif 107×178×4 highlights one area just C-terminal to the fusion peptide at amino acids 252-293. Amino acids 252-286 are also predicted to be coiled coil using the Lupas algorithm. Almost 100 amino acids C-terminal to the first region is a DP178-like area at residues 340-367. ALLMOTI5 highlights three areas of interest including: amino acids 228-297, which completely overlaps both the Lupas prediction and the DP107-like 107×178×4 hit; residues 340-381, which overlaps the second 107×178×4 hit; and amino acids 568-602, which is DP178-like in that it is located just N-terminal to the transmembrane region. It also overlaps another region (residues 570-602) predicted by the Lupas method to have a high propensity to form a coiled coil. Several PLZIP motifs successfully identified areas of interest including P6 and P12LZIPC which highlight residues 336-357 and 336-361 respectively; P1 and P12LZIPC which find residues 398-414; and P12 and P23LZIPC which find residues 562-589 and 562-592 respectively.
FIG. 24 shows the motif hits found in Newcastle Disease Virus (strain Australia-Victoria/32; PC Gene protein sequence name PVGLF-- NDVA). Motif 107×178×4 finds two areas including a DP107-like hit at amino acids 151-178 and a DP178-like hit at residues 426-512. ALLMOTI5 finds three areas including residues 117-182, 231-272, and 426-512. The hits from 426-512 include a region which is predicted by the Lupas method to have a high coiled-coil propensity (460-503). The PLZIP motifs identify only one region of interest at amino acids 273-289 (P1 and 12LZIPC).
Both motifs 107×178×4 and ALLMOTI5 exhibit DP107-like hits in the same region, 115-182 and 117-182 respectively, of Human Parainfluenza Virus (strain NIH 47885; PC/Gene protein sequence name PVGLF-- p13H4; (FIG. 25). In addition, the two motifs have a DP178-like hit just slightly C-terminal at amino acids 207-241. Both motifs also have DP178-like hits nearer the transmembrane region including amino acids 457-497 and 462-512 respectively. Several PLZIP motif hits are also observed including 283-303 (P5LZIPC), 283-310 (P12LZIPC), 453-474 (P6LZIPC), and 453-481 (P23LZIPC). The Lupas algorithm predicts that amino acids 122-176 may have a propensity to form a coiled-coil.
FIG. 26 illustrates the Lupas prediction for a coiled coil in Influenza A Virus (strain A/Aichi/2/68) at residues 379-436, as well as the motif hits for 107×178×4 at amino acids 387-453, and for ALLMOTI5 at residues 380-456. Residues 383-471 (38-125 of HA2) were shown by Carr and Kim to be an extended coiled coil when under acidic pH (Carr and Kim, 1993, Cell 73: 823-832). The Lupas algorithm predicts a coiled-coil at residues 379-436. All three methods successfully predicted the region shown to actually have coiled-coil structure; however, ALLMOTI5 predicted the greatest portion of the 88 residue stretch.
In the Example presented herein, respiratory syncytial virus (RSV) peptides identified by utilizing the computer-assisted search motifs described in the Examples presented in Sections 9 and 11, above, were tested for anti-RSV activity. Additionally, circular dichroism (CD) structural analyses were conducted on the peptides, as discussed below. It is demonstrated that several of the identified peptides exhibit potent antiviral capability. Additionally, it is shown that several of these peptides exhibit a substantial helical character.
17.1. MATERIALS AND METHODS
Structural analyses: The CD spectra were measured in a 10 mm sodium phosphate, 150 mM sodium chloride, pH 7.0, buffer at approximately 10 mM concentrations, using a 1 cm pathlength cell on a Jobin/Yvon Autodichrograph Mark V CD spectrophotometer. Peptides were synthesized according to the methods described, above, in Section 6.1. Peptide concentrations were determined from A280 using Edlehochts method (1967, Biochemistry 6:1948).
Anti-RSV antiviral activity assays: The assay utilized herein tested the ability of the peptides to disrupt the ability of HEp2 cells acutely infected with RSV (i.e., cells which are infected with a multiplicity of infection of greater than 2) to fuse and cause syncytial formation on a monolayer of uninfected an uninfected line of Hep-2 cells. The lower the observed level of fusion, the greater the antiviral activity of the peptide was determined to be.
Uninfected confluent monolayers of Hep-2 cells were grown in microtiter wells in 3% EMEM (Eagle Minimum Essential Medium w/o L-glutamine [Bio Whittaker Cat. No. 12-125F], with fetal bovine serum [FBS; which had been heat inactivated for 30 minutes at 56°C; Bio Whittaker Cat. No. 14-501F) supplemented at 3%, antibiotics (penicillin/streptomycin; Bio Whittaker Cat. No. 17-602E) added at 1%, and glutamine added at 1%.
To prepare Hep2 cells for addition to uninfected cells, cultures of acutely infected Hep2 cells were washed with DPBS (Dulbecco's Phosphate Buffered Saline w/o calcium or magnesium; Bio Whittaker Cat. No. 17-512F) and cell monolayers were removed with Versene (1:5000; Gibco Life Technologies Cat. No. 15040-017). The cells were spun 10 minutes and resuspended in 3% FBS. Cell counts were performed using a hemacytometer. Persistent cells were added to the uninfected Hep-2 cells.
The antiviral assay was conducted by, first, removing all media from the wells containing uninfected Hep-2 cells, then adding peptides (at the dilutions described below) in 3% EMEM, and 100 acutely RSV-infected Hep2 cells per well. Wells were then incubated at 37°C for 48 hours.
After incubation, cells in control wells were checked for fusion centers, media was removed from the wells, followed by addition, to each well, of either Crystal Violet stain or XTT. With respect to Crystal Violet, approximately 50 μl 0.25% Crystal Violet stain in methanol were added to each well. The wells were rinsed immediately, to remove excess stain, and were allowed to dry. The number of syncytia per well were then counted, using a dissecting microscope.
With respect to XTT (2,3-bis[2-Methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxyanilide inner salt), 50 μl XTT (1 mg/ml in RPMI buffered with 100 mM HEPES, pH 7.2-7.4, plus 5% DMSO) were added to each well. The OD450/690 was measured (after blanking against growth medium without cells or reagents, and against reagents) according to standard procedures.
Peptides: The peptides characterized in the study presented herein were:
1) peptides T-142 to T-155 and T-575, as shown in FIGS. 27A-C, and peptides T-22 to T-27, T-68, T-334 and T-371 to T-375 and T-575, as shown in FIG. 27C;
2) peptides T-120 to T-141 and T-576, as shown in FIGS. 27D-F, and peptides T-12, T-13, T-15, T-19, T-28 to T-30, T-66, T-69, T-70 and T-576, as shown in FIG. 27F; and
3) peptides T-67 and T-104 to T-119 and T-384, as shown in FIGS. 28A-C, and peptides T-71, T-613 to T-617, T-662 to T-676 and T-730, as shown in FIG. 28C.
The peptides of group 1 represent portions of the RSV F2 protein DP178/107-like region. The peptides of group 2 represent portions of the RSV F1 protein DP107-like region. The peptides of groups 3 represent portions of the RSV F1 protein DP178-like region.
Each peptide was tested at 2-fold serial dilutions ranging from 100 μg/ml to approximately 100 ng/ml. For each of the assays, a well containing no peptide was also used. The IC50 data for each peptide represents the average of several experiments conducted utilizing that peptide.
17.2 RESULTS
The data summarized in FIGS. 27A-C and 28A-C represent antiviral and structural information obtained from peptides derived from the RSV F2 DP178/DP107-like F2 region (FIGS. 27A-C), the RSV F1 DP-107-like region (FIGS. 27D-F) and the RSV DP178-like F2 region (FIGS. 28A-C).
As shown in FIGS. 27A-F, a number of the RSV DP178/DP107-like peptides exhibited a detectable level of antiviral activity. Peptides from the RSV DP178/DP107-like F2 region (FIGS. 27A-C), for example, T-142 to T-145 and T-334 purified peptides, exhibited detectable levels of antiviral activity, as evidenced by their IC50 values. Further, a number of RSV F1 DP107-like peptides (FIGS. 27D-F) exhibited a sizable level of antiviral activity as purified peptides, including, for example, peptides T-124 to T-127, T-131, T-135 and T-137 to T-139, as demonstrated by their low IC50 values. In addition, CD analysis FIGS. 27A-B, 27D-E) reveals that many of the peptides exhibit some detectable level of helical structure.
The results summarized in FIGS. 28A-C demonstrate that a number of DP178-like purified peptides exhibit a range of potent anti-viral activity. These peptides include, for example, T-67, T-104, T-105 and T-107 to T-119, as listed in FIGS. 28A-B, and T-665 to T-669 and T-671 to T-673, as listed in FIG. 28C. In addition, some of the DP178-like peptides exhibited some level of helicity.
Thus, the computer assisted searches described, hereinabove, successfully identified viral peptide domains that represent highly promising anti-RSV antiviral compounds.
In the Example presented herein, human parainfluenza virus type 3 (HPIV3) peptides identified by utilizing the computer-assisted search motifs described in the Examples presented in Sections 9 and 15, above, were tested for anti-HPIV3 activity. Additionally, circular dichroism (CD) structural analyses were conducted on the peptides, as discussed below. It is demonstrated that several of the identified peptides exhibit potent antiviral capability. Additionally, it is shown that several of these peptides exhibit a substantial helical character.
18.1 MATERIALS AND METHODS
Structural analyses: Structural analyses consisted of circular dichroism (CD) studies. The CD spectra were measured in a 10 mM sodium phosphate, 150 mM sodium chloride, pH 7.0, buffer at approximately 10 mM concentrations, using a 1 cm pathlength cell on a Jobin/Yvon Autodichrograph Mark V CD spectrophotometer. Peptide concentrations were determined from A280 using Edlehoch's method (1967, Biochemistry 6:1948).
Anti-HPIV3 antiviral activity assays: The assay utilized herein tested the ability of the peptides to disrupt the ability of Hep2 cells chronically infected with HPIV3 to fuse and cause syncytial formation on a monolayer of an uninfected line of CV-1W cells. The more potent the lower the observed level of fusion, the greater the antiviral activity of the peptide.
Uninfected confluent monolayers of CV-1W cells were grown in microtiter wells in 3% EMEM (Eagle Minimum Essential Medium w/o L-glutamine [Bio Whittaker Cat. No. 12-125F], with fetal bovine serum [FBS; which had been heat inactivated for 30 minutes at 56°C; Bio Whittaker Cat. No. 14-501F) supplemented at 3%, antibiotics/antimycotics (Gibco BRL Life Technologies Cat. No. 15040-017) added at 1%, and glutamine added at 1%.
To prepare Hep2 cells for addition to uninfected cells, cultures of chronically infected Hep2 cells were washed with DPBS (Dulbeccots Phosphate Buffered Saline w/o calcium or magnesium; Bio Whittaker Cat. No. 17-512F) and cell monolayers were removed with Versene (1:5000; Gibco Life Technologies Cat. No. 15040-017). The cells were spun 10 minutes and resuspended in 3% FBS. Cell counts were performed using a hemacytometer. Persistent cells were added to the uninfected CV-1W cells.
The antiviral assay was conducted by, first, removing all media from the wells containing uninfected CV-1W cells, then adding peptides (at the dilutions described below) in 3% EMEM, and 500 chronically HPIV3-infected Hep2 cells per well. Wells were then incubated at 37°C for 24 hours.
On day 2, after cells in control wells were checked for fusion centers, media was removed from the wells, followed by addition, to each well, of approximately 50 μl 0.25% Crystal Violet stain in methanol. Wells were rinsed immediately, to remove excess stain and were then allowed to dry. The number of syncytia per well were then counted, using a dissecting microscope.
Alternatively, instead of Crystal Violet analysis, cells were assayed with XTT, as described, above, in Section 17.1.
Peptides: The peptides characterized in the study presented herein were:
1) Peptides 157 to 188, as shown in FIGS. 29A-C, and peptides T-38 to T-40, T-42 to T-46 and T-582, as shown in FIGS. 29D-E. These peptides are derived from the DP107 region of the HPIV3 F1 fusion protein (represented by HPF3 107, as shown in FIGS. 29A-C); and
2) Peptides 189 to 210, as shown in FIGS. 30A-B, and T-269, T-626, T-383 and T-577 to T-579, as shown in FIG. 30C. These peptides are primarily derived from the DP178 region of the HPIV3 F1 fusion protein (represented by HPF3 178, as shown in FIGS. 30A-B). Peptide T-626 contains two mutated amino acid resides (represented by a shaded background). Additionally, peptide T-577 represents F1 amino acids 65-100, T-578 represents F1 amino acids 207-242 and T-579 represents F1 amino acids 273-309.
Each peptide was tested at 2-fold serial dilutions ranging from 500 μg/ml to approximately 500 ng/ml. For each of the assays, a well containing no peptide was also used.
18.2 RESULTS
The data summarized in FIGS. 29A-E and 30A-C represent antiviral and structural information obtained from peptides derived from the HPIV3 fusion protein DP107-like region (FIGS. 29A-E) and the HPIV3 fusion protein DP178-like region (FIGS. 30A-C).
As shown in FIGS. 29A-E, a number of the HPIV3 DP107-like peptides exhibited potent levels of antiviral activity. These peptides include, for example, peptides T-40, T-172 to T-175, T-178, T-184 and T-185.
CD analysis reveals that a number of the peptides exhibit detectable to substantial level of helical structure.
The results summarized in FIGS. 30A-C demonstrate that a number of the DP178-like peptides tested exhibit a range of anti-viral activity. These peptides include, for example, peptides 194 to 211, as evidenced by their low IC50 values. In fact, peptides 201 to 205 exhibit IC50 values in the nanogram/ml range. In addition, many of the DP178-like peptides exhibited some level of helicity.
Thus, the computer assisted searches described, hereinabove, have successfully identified viral peptide domains that represent highly promising anti-HPIV3 antiviral compounds.
FIG. 31 represents search results for SIV isolate MM251 (PC/Gene® protein sequence PENV-- SIVM2). Both 107×178×4 and ALLMOTI5 search motifs identified two regions with similarities to DP107 and/or DP178.
The peptide regions found by 107×178×4 were located at amino acid residues 156-215 and 277-289. The peptide regions found by ALLMOTI5 were located at amino acid residues 156-219 and 245-286. Both motifs, therefore, identify similar regions.
Interestingly, the first SIV peptide region (i.e., from amino acid residue 156 to approximately amino acid residue 219) correlates with a DP107 region, while the second region identified (i.e., from approximately amino acid residue 245 to approximately amino acid residue 289) correlates with the DP178 region of HIV. In fact, an alignment of SIV isolate MM251 and HIV isolate BRU, followed by a selection of the best peptide matches for HIV DP107 and DP178, reveals that the best matches are found within the peptide regions identified by the 107×178×4 and ALLMOTI5 search motifs.
It should be noted that a potential coiled-coil region at amino acid residues 242-282 is predicted by the Lupas program. This is similar to the observation in HIV in which the coiled-coil is predicted by the Lupas program to be in the DP178 rather than in the DP107 region. It is possible, therefore, that SIV may be similar to HIV in that it may contain a coiled-coil structure in the DP107 region, despite such a structure being missed by the Lupas algorithm. Likewise, it may be that the region corresponding to a DP178 analog in SIV may exhibit an undefined structure, despite the Lupas program's prediction of a coiled-coil structure.
The results presented herein describe the identification of DP178/DP107 analogs within two different Epstein-Barr Virus proteins. Epstein-Barr is a human herpes virus which is the causative agent of, for example, infectious mononucleosis (IM), and is also associated with nasopharyngeal carcinomas (NPC), Burkitt's lymphoma and other diseases. The virus predominantly exists in the latent form and is activated by a variety of stimuli.
FIG. 32 depicts the search motif results for the Epstein-Barr Virus (Strain B95-8; PC/Gene® protein sequence PVGLB-- EBV) glycoprotein gp110 precursor (gp115). The 107×178×4 motif identified two regions of interest, namely the regions covered by amino acid residues 95-122 and 631-658. One PZIP region was identified at amino acid residue 732-752 which is most likely a cytoplasmic region of the protein. The Lupas algorithm predicts a coiled-coil structure for amino acids 657-684. No ALLMOTI5 regions were identified.
FIG. 33 depicts the search motif results for the Zebra (or EB1) trans-activator protein (BZLF1) of the above-identified Epstein-Barr virus. This protein is a transcription factor which represents the primary mediator of viral reactivation. It is a member of the b-ZIP family of transcription factors and shares significant homology with the basic DNA-binding and dimerization domains of the cellular oncogenes c-fos and C/EBP. The Zebra protein functions as a homodimer.
Search results demonstrate that the Zebra protein exhibits a single region which is predicted to be either of DP107 or DP178 similarity, and is found between the known DNA binding and dimerization regions of the protein. Specifically, this region is located at amino acid residues 193-220, as shown in FIG. 33. The Lupas program predicted no coiled-coil regions.
FIG. 34 illustrates the motif search results for the fusion protein F1 of measles virus, strain Edmonston (PC Genes® protein sequence PVGLF MEASE), successfully identifying DP178/DP107 analogs.
The 107×178×4 motif identifies a single region at amino acid residues 228-262. The ALLMOTI5 search motif identifies three regions, including amino acid residues 116-184, 228-269 and 452-500. Three regions containing proline residues followed by a leucine zipper-like sequence were found beginning at proline residues 214, 286 and 451.
The Lupas program identified two regions it predicted had potential for coiled-coil structure, which include amino acid residues 141-172 and 444-483.
FIG. 35 depicts the results of a PZIP motif search conducted on the Hepatitis B virus subtype AYW. Two regions of interest within the major surface antigen precursor S protein were identified. The first lies just C-terminal to the proposed fusion peptide of the major surface antigen (Hbs) which is found at amino acid residues 174-191. The second region is located at amino acid residues 233-267. The Lupas program predicts no coiled-coil repeat regions.
In order to test the potential anti-HBV antiviral activity of these D178/DP107 analog regions, peptides derived from area around the analog regions are synthesized, as shown in FIGS. 52A-B. These peptides represent one amino acid peptide "walks" through the putative DP178/DP107 analog regions. The peptides are synthesized according to standard Fmoc chemistry on Rinkamide MBHA resins to provide for carboxy terminal blockade (Chang, C. D. and Meinhofer, J., 1978, Int. J. Pept. Protein Res. 11:246-249; Fields, G. B. and Noble, R. L., 1990, Int. J. Pept. Protein Res. 35:161-214). Follwing complete synthesis, the peptide amino-terminus is blocked through automated acetylation and the peptide is cleaved with trifluoroacetic acid (TFA) and the appropriate scavengers (King, D. S. et al., 1990, Int. J. Pept. Res. 36:255-266). After cleavage, the peptide is precipitated with ether and dried under vacuum for 24 hours.
The anti-HBV activity of the peptides is tested by utilizing standard assays to determine the test peptide concentration required to cause an acceptable (e.g., 90%) decrease in the amount of viral progeny formed by cells exposed to an HBV viral inoculum. Candidate antivial peptides are further characterized in model systems such as wood chuck tissue culture and animal sytems, prior to testing on humans.
The results depicted herein illustrate the results of search motifs conducted on the Simian Mason-Pfizer monkey virus. The motifs reveal DP178/DP107 analogs within the enveloped (TM) protein GP20, as shown in FIG. 36.
The 107×178×4 motifs identifies a region at amino acid residues 422-470. The ALLMOTI5 finds a region at amino acid residues 408-474. The Lupas program predicted a coiled-coil structure a amino acids 424-459.
The results presented herein demonstrate the identification of DP178/DP107 analogs corresponding to sequences present in proteins of a variety of bacterial species.
FIG. 37 depicts the search motif results for the Pseudomonas aeruginosa fimbrial protein (Pilin). Two regions were identified by motifs 107×178×4 and ALLMOTI5. The regions located at amino acid residues 30-67 and 80-144 were identified by the 107×178×4 motif. The regions at amino acid residues 30-68 and 80-125 were identified by the ALLMOTI5.
FIG. 38 depicts the search motif results for the Pseudomonas gonorrhoeae fimbrial protein (Pilin). A single region was identified by both the 107×178×4 and the ALLMOTI5 motifs. The region located at amino acid residues 66-97 was identified by the 107×178×4 motif. The region located at amino acid residues 66-125 were identified by the ALLMOTI5 search motif. No coiled-coil regions were predicted by the Lupas program.
FIG. 39 depicts the search motif results for the Hemophilus Influenza fimbrial protein (Pilin). A single region was identified by both the 107×178×4 and the ALLMOTI5 motifs. The region located at amino acid residues 102-129 was identified by the 107×178×4 motif. The region located at amino acid residues 102-148 were identified by the ALLMOTI5 search motif. No coiled-coil regions were predicted by the Lupas program.
FIG. 40 depicts the search motif results for the Staphylococcus aureus toxic shock syndrome Hemophilus Influenza fimbrial protein (Pilin). A single region was identified by both the 107×178×4 and the ALLMOTI5 motifs. The region located at amino acid residues 102-129 was identified by the 107×178×4 motif. The region located at amino acid residues 102-148 were identified by the ALLMOTI5 search motif. No coiled-coil regions were predicted by the Lupas program.
FIG. 41 summarizes the motif search results conducted on the Staphylococcus aureus enterotoxin Type E protein. These results demonstrate the successful identification of DP178/DP107 analogs corresponding to peptide sequences within this protein, as described below.
The ALLMOTI5 motif identified a region at amino acid residues 22-27. The 107×178×4 motif identified two regions, with the first at amino acid residues 26-69 and the second at 88-115. A P12LZIPC motif search identified two regions, at amino acid residues 163-181 and 230-250.
The Lupas program predicted a region with a high propensity for coiling at amino acid residues 25-54. This sequence is completely contained within the first region identified by both ALLMOTI5 and 107×178×4 motifs.
FIG. 42 depicts the search motif results conducted on a second Staphylococcus aureus toxin, enterotoxin A. Two regions were identified by the ALLMOTI5 motif, at amino acid residues 22-70 and amino acid residues 164-205. The 107×178×4 motif found two regions, the first at amino acid residues 26-69 and the second at amino acid residues 165-192. A P23LZIPC motif search revealed a region at amino acid residues 216-250. No coiled-coil regions were predicted by the Lupas program.
FIG. 43 shows the motif search results conducted on the E. coli heat labile enterotoxin A protein, demonstrating that identification of DP178/DP107 analogs corresponding to peptides located within this protein. Two regions were identified by the ALLMOTI5 motif, with the first residing at amino acid residues 55-115, and the second residing at amino acid residues 216-254. The 107×178×4 motif identified a single region at amino acid residues 78-105. No coiled-coil regions were predicted by the Lupas program.
The results presented herein demonstrate the identification of DP178/DP107 analogs corresponding to peptide sequences present within several different human proteins.
FIG. 44 illustrates the search motif results conducted on the human c-fos oncoprotein. The ALLMOTI5 motif identified a single region at amino acid residues 155-193. The 107×178×4 motif identified one region at amino acid residues 162-193. The Lupas program predicted a region at amino acid residues 148-201 to have coiled-coil structure.
FIG. 45 illustrates the search motif results conducted on the human lupus KU autoantigen protein P70. The ALLMOTI5 motif identified a single region at amino acid residues 229-280. The 107×178×4 motif identified one region at amino acid residues 235-292. The Lupas program predicted a region at amino acid residues 232-267 to have coiled-coil structure.
FIG. 46 illustrates the search motif results conducted on the human zinc finger protein 10. The ALLMOTI5 motif identified a single region at amino acid residues 29-81. The 107×178×4 motif identified one region at amino acid residues 29-56. A P23LZIPC motif search found a single region at amino acid residues 420-457. The Lupas program predicted no coiled-coil regions.
In the Example presented herein, measles (MeV) virus DP178-like peptides identified by utilizing the computer-assisted search motifs described in the Examples presented in Sections 9 and 21, above, are tested for anti-MeV activity. Additionally, circular dichroism (CD) structural analyses are conducted on the peptides, as discussed below. It is demonstrated that several of the identified peptides exhibit potent antiviral capability. Additionally, it is shown that none of the these peptides exhibit a substantial helical character.
26.1 MATERIALS AND METHODS
Structural analyses: The CD spectra were measured in a 10 mM sodium phosphate, 150 mM sodium chloride, pH 7.0, buffer at approximately 10 mM concentrations, using a 1 cm pathlength cell on a Jobin/Yvon Autodichrograph Mark V CD spectrophotometer. Peptide concentrations were determined from A280 using Edlehoch's method (1967, Biochemistry 6:1948).
Anti-MeV antiviral activity syncytial reduction assay: The assay utilized herein tested the ability of the peptides to disrupt the ability of Vero cells acutely infected with MeV (i.e., cells which are infected with a multiplicity of infection of 2-3) to fuse and cause syncytial formation on a monolayer of an uninfected line of Vero cells. The more potent the peptide, the lower the observed level of fusion, the greater the antiviral activity of the peptide.
Uninfected confluent monolayers of Vero cells were grown in microtiter wells in 10% FBS EMEM (Eagle Minimum Essential Medium w/o L-glutamine [Bio Whittaker Cat. No. 12-125F], with fetal bovine serum [FBS; which had been heat inactivated for 30 minutes at 56°C; Bio Whittaker Cat. No. 14-501F) supplemented at 10%, antibiotics/antimycotics (Bio Whittaker Cat. No. 17-602E) added at It, and glutamine added at 1%.
To prepare acutely infected Vero cells for addition to the uninfected cells, cultures of acutely infected Vero cells were washed twice with HBSS (Bio Whittaker Cat. No. 10-543F) and cell monolayers were removed with trypsin (Bio Whittaker Cat. No. 17-161E). Once cells detached, media was added, any remaining clumps of cells were dispersed, and hemacytometer cell counts were performed.
The antiviral assay was conducted by, first, removing all media from the wells containing uninfected Vero cells, then adding peptides (at the dilutions described below) in 10% FBS EMEM, and 50-100 acutely MeV-infected Vero cells per well. Wells were then incubated at 37° C. for a maximum of 18 hours.
On day 2, after cells in control wells were checked for fusion centers, media was removed from the wells, followed by addition, to each well, of approximately 50 μl 0.25% Crystal Violet stain in methanol. Wells were rinsed twice with water immediately, to remove excess stain and were then allowed to dry. The number of syncytia per well were then counted, using a dissecting microscope.
Anti-MeV antiviral activity plague reduction assay: The assay utilized herein tested the ability of the peptides to disrupt the ability of MeV to infect permissive, uninfected Vero cells, leading to the infected cells' fusing with uninfected cells to produce syncytia. The lower the observed level of syncytial formation, the greater the antiviral activity of the peptide.
Monolayers of uninfected Vero cells are grown as described above.
The antiviral assay was conducted by, first, removing all media from the wells containing uninfected Vero cells, then adding peptides (at the dilutions described below) in 10% FBS EMEM, and MeV stock virus at a final concentration of 30 plaque forming units (PFU) per well. Wells were then incubated at 37°C for a minimum of 36 hours and a maximum of 48 hours.
On day 2, after cells in control wells were checked for fusion centers, media was removed from the wells, followed by addition, to each well, of approximately 50 μl 0.25% Crystal Violet stain in methanol. Wells were rinsed twice with water immediately, to remove excess stain and were then allowed to dry. The number of syncytia per well were then counted, using a dissecting microscope.
Peptides: The peptides characterized in the study presented herein were peptides T-252A0 to T-256A0, T-257B1/C1, and T-258B1 to T-265B0, and T-266A0 to T-268A0, as shown in FIGS. 47A-B. These peptides represent a walk through the DP178-like region of the MeV fusion protein.
Each peptide was tested at 2-fold serial dilutions ranging from 100 μg/ml to approximately 100 ng/ml. For each of the assays, a well containing no peptide was also used.
26.2 RESULTS
The data summarized in FIGS. 47A-B represents antiviral and structural information obtained via "peptide walks" through the DP178-like region of the MeV fusion protein.
As shown in FIGS. 47A-B, the MeV DP178-like peptides exhibited a range of antiviral activity as crude peptides. Several of these peptides were chosen for purification and further antiviral characterization. The IC50 values for such peptides were determined, as shown in FIGS. 47A-B, and ranged from 1.35 μg/ml (T-257B1/C1) to 0.072 μg/ml (T-265B1). None of the DP178-like peptides showed, by CD analysis, a detectable level of helicity.
Thus, the computer assisted searches described, hereinabove, as in for example, the Example presented in Section 9, for example, successfully identified viral peptide domains that represent highly promising anti-MeV antiviral compounds.
In the Example presented herein, simian immunodeficiency virus (SIV) DP178-like peptides identified by utilizing the computer-assisted search motifs described in the Examples presented in Sections 9, 12 and 19, above, were tested for anti-SIV activity. It is demonstrated that several of the identified peptides exhibit potent antiviral capability.
27.1 MATERIALS AND METHODS
Anti-SIV antiviral assays: The assay utilized herein were as reported in Langolis et al. (Langolis, A. J. et al., 1991, AIDS Research and Human Retroviruses 7:713-720).
Peptides: The peptides characterized in the study presented herein were peptides T-391 to T-400, as shown in FIGS. 48A-B. These peptides represent a walk through the DP178-like region of the SIV TM protein.
Each peptide was tested at 2-fold serial dilutions ranging from 100 μg/ml to approximately 100 ng/ml. For each of the assays, a well containing no peptide was also used.
27.2 RESULTS
The data summarized in FIGS. 48A-B represents antiviral information obtained via "peptide walks" through the DP178-like region of the SIV TM protein.
As shown in FIGS. 48A-B, peptides T-391 to T-400 were tested and exhibited a potent antiviral activity as crude peptides.
Thus, the computer assisted searches described, hereinabove, as in for example, the Example presented in Section 9, for example, successfully identified viral peptide domains that represent highly promising anti-SIV antiviral compounds.
The Example presented in this Section represents a study of the antiviral activity of DP107 and DP178 truncations and mutations. It is demonstrated that several of these DP107 and DP178 modified peptides exhibit substantial antiviral activity.
28.1 MATERIALS AND METHODS
Anti-HIV assays: The antiviral assays performed were as those described, above, in Section 6.1. Assays utilized HIV-1/IIIb and/or HIV-2 NIHZ isolates. Purified peptides were used, unless otherwise noted in FIGS. 49A-L.
Peptides: The peptides characterized in the study presented herein were:
1) FIGS. 49A-L present peptides derived from the region around and containing the DP178 region of the HIV-1 BRU isolate. Specifically, this region spanned from gp41 amino acid residue 615 to amino acid residue 717. The peptides listed contain truncations of this region and/or mutations which vary from the DP178 sequence amino acid sequence. Further, certain of the peptides have had amino- and/or carboxy-terminal groups either added or removed, as indicated in the figures; and
2) FIGS. 50A-B. presents peptides which represent truncations of DP107 and/or the gp41 region surrounding the DP107 amino acid sequence of HIV-1 BRU isolate. Certain of the peptides are unblocked or biotinylated, as indicated in the figure.
Blocked peptides contained an acyl N-terminus and an amido C-terminus.
28.2 RESULTS
Anti-HIV antiviral data was obtained with the group 1 DP178-derived peptides listed in FIGS. 49A-L. The full-length, non-mutant DP178 peptide (referred to in FIGS. 49A-L as T20) results shown are for 4 ng/ml.
In FIGS. 49A-D, a number of the DP178 truncations exhibited a high level of antiviral activity, as evidenced by their low IC50 values. These include, for example, test peptides T-50, T-624, T-636 to T-641, T-645 to T-650, T-652 to T-654 and T-656. T-50 represents a test peptide which contains a point mutation, as indicated by the residue's shaded background. The HIV-1-derived test peptides exhibited a distinct strain-specific antiviral activity, in that none of the peptides tested on the HIV-2 NIHZ isolate demonstrated appreciable anti-HIV-2 antiviral activity.
Among the peptides listed in FIGS. 49E-H, are test peptides representing the amino (T-4) and carboxy (T-3) terminal halves of DP178 were tested. The amino terminal peptide was not active (IC50 >400 μg/ml) whereas activity (IC50 =3 μg/ml). A number of additional test peptides also exhibited a high level of antiviral activity. These included, for example, T-61/T-102, T-217 to T-221, T-235, T-381, T-677, T-377, T-590, T-378, T-591, T-271 to T-272, T-611, T-222 to T-223 and T-60/T-224. Certain of the antiviral peptides contain point mutations and/or amino acid residue additions which vary from the DP178 amino acid sequence.
In FIGS. 49I-L, point mutations and/or amino and/or carboxy-terminal modifications are introduced into the DP178 amino acid sequence itself. As shown in the figure, the majority of the test peptides listed exhibit potent antiviral activity.
Truncations of the DP107 peptide (referred to in FIGS. 50A-B as T21) were also produced and tested, as shown in FIGS. 50A-B. FIGS. 50A-B also presents data concerning blocked and unblocked peptides which contain additional amino acid residues from the gp41 region in which the DP107 sequence resides. Most of these peptides showed antiviral activity, as evidenced by their low IC50 values.
Thus, the results presented in this Section demonstrate that not only do the full length DP107 and DP178 peptides exhibit potent antiviral activity, but truncations and/or mutant versions of these peptides can also possess substantial antiviral character.
In the Example presented herein, peptides derived from the Epstein-Barr (EBV) DP-178/DP107 analog region of the Zebra protein identified, above, in the Example presented in Section 20 are described and tested for anti-EBV activity. It is demonstrated that among these peptides are ones which exhibit potential anti-viral activity.
29.1 MATERIALS AND METHODS
Electrophoretic Mobility Shift Assays (EMSA): Briefly, an EBV Zebra protein was synthesized utilizing SP6 RNA polymerase in vitro transcription and wheat germ in vitro translation systems (Promega Corporation recommendations; Butler, E. T. and Chamberlain, M. J., 1984, J. Biol. Chem. 257:5772; Pelham, H. R. B. and Jackson, R. J., 1976, Eur. J. Biochem. 67:247). The in vitro translated Zebra protein was then preincubated with increasing amounts of peptide up to 250 ng/ml prior to the addition of 10,000 to 20,000 c.p.m. of a 32 P-labeled Zebra response element DNA fragment. After a 20 minute incubation in the presence of the response element, the reaction was analyzed on a 4% non-denaturing polyacrylamide gel, followed by autoradiography, utilizing standard gel-shift procedures. The ability of a test peptide to prevent Zebra homodimer DNA binding was assayed by the peptide's ability to abolish the response element gel migration retardation characteristic of a protein-bound nucleic acid molecule.
Peptides: The peptides characterized in this study represent peptide walks through the region containing, and flanked on both sides by, the DP178/DP107 analog region identified in the Example presented in Section 20, above, and shown as shown in FIG. 33. Specifically, the peptide walks covered the region from amino acid residue 173 to amino acid residue 246 of the EBV Zebra protein.
Each of the tested peptides were analyzed at a range of concentrations, with 150 ng/ml being the lowest concentration at which any of the peptides exerted an inhibitory effect.
29.2 RESULTS
The EBV Zebra protein transcription factor contains a DP178/DP107 analog region, as demonstrated in the Example presented, above, in Section 20. This protein appears to be the primary factor responsible for the reactivation capability of the virus. A method by which the DNA-binding function of the Zebra virus may be abolished may, therefore, represent an effective antiviral technique. In order to identify potential anti-EBV DP178/DP107 peptides, therefore, peptides derived from the region identified in Section 20, above, were tested for their ability to inhibit Zebra protein DNA binding.
The test peptides' ability to inhibit Zebra protein DNA binding was assayed via the EMSA assays described, above, in Section 28.1. The data summarized in FIGS. 51A-C presents the results of EMSA assays of the listed EBV test peptides. These peptides represent one amino acid "walks" through the region containing, and flanked on both sides by, the DP178/DP107 analog region identified in the Example presented in Section 20, above, and shown as shown in FIG. 33. As shown in FIGS. 51A-C, the region from which these peptides are derived lies from EBV Zebra protein amino acid residue 173 to 246. A number of the test peptides which were assayed exhibited an ability to inhibit Zebra protein homodimer DNA binding, including 439, 441, 444 and 445.
Those peptides which exhibit an ability to inhibit Zebra protein DNA binding represent potential anti-EBV antiviral compounds whose ability to inhibit EBV infection can be further characterized.
The present invention is not to be limited in scope by the specific embodiments described which are intended as single illustrations of individual aspects of the invention, and functionally equivalent methods and components are within the scope of the invention.
Indeed, various modifications of the invention, in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description and accompanying drawings. Such modifications are intended to fall within the scope of the appended claims.
| __________________________________________________________________________ |
| # SEQUENCE LISTING |
| - - - - (1) GENERAL INFORMATION: |
| - - (iii) NUMBER OF SEQUENCES: 245 |
| - - - - (2) INFORMATION FOR SEQ ID NO:1: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln |
| Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:2: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: |
| - - Ser Ser Glu Ser Phe Thr Leu Leu Glu Gln Tr - #p Asn Asn Trp Lys Leu |
| 1 5 - # 10 - # 15 |
| - - Gln Leu Ala Glu Gln Trp Leu Glu Gln Ile As - #n Glu Lys His Tyr Leu |
| 20 - # 25 - # 30 |
| - - Glu Asp Ile Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:3: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: |
| - - Tyr Thr Asn Thr Ile Tyr Thr Leu Leu Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:4: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: |
| - - Tyr Thr Gly Ile Ile Tyr Asn Leu Leu Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Asn Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:5: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: |
| - - Tyr Thr Ser Leu Ile Tyr Ser Leu Leu Glu Ly - #s Ser Gln Thr Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:6: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: |
| - - Leu Glu Ala Asn Ile Ser Lys Ser Leu Glu Gl - #n Ala Gln Ile Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Met Tyr Glu Leu Gln Lys Leu As - #n Ser Trp Asp Ile Phe |
| 20 - # 25 - # 30 |
| - - Gly Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:7: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: |
| - - Leu Glu Ala Asn Ile Ser Gln Ser Leu Glu Gl - #n Ala Gln Ile Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Met Tyr Glu Leu Gln Lys Leu As - #n Ser Trp Asp Val Phe |
| 20 - # 25 - # 30 |
| - - Thr Asn Trp Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:8: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 41 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: |
| - - Cys Gly Gly Asn Asn Leu Leu Arg Ala Ile Gl - #u Ala Gln Gln His Leu |
| 1 5 - # 10 - # 15 |
| - - Leu Gln Leu Thr Val Trp Gly Ile Lys Gln Le - #u Gln Ala Arg Ile Leu |
| 20 - # 25 - # 30 |
| - - Ala Val Glu Arg Tyr Leu Lys Asp Gln |
| 35 - # 40 |
| - - - - (2) INFORMATION FOR SEQ ID NO:9: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 17 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: |
| - - Leu Gln Ala Arg Ile Leu Ala Val Glu Arg Ty - #r Leu Lys Asp Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Gln |
| - - - - (2) INFORMATION FOR SEQ ID NO:10: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 38 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: |
| - - Gln Gln Leu Leu Asp Val Val Lys Arg Gln Gl - #n Glu Met Leu Arg Leu |
| 1 5 - # 10 - # 15 |
| - - Thr Val Trp Gly Thr Lys Asn Leu Gln Ala Ar - #g Val Thr Ala Ile Glu |
| 20 - # 25 - # 30 |
| - - Lys Tyr Leu Lys Asp Gln |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:11: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 21 base - #pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| - - (ii) MOLECULE TYPE: DNA |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11: |
| - - ATGACGCTGA CGGTACAGGC C - # - # |
| - #21 |
| - - - - (2) INFORMATION FOR SEQ ID NO:12: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 base - #pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| - - (ii) MOLECULE TYPE: DNA |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: |
| - - TGACTAAGCT TAATACCACA GCCAATTTGT TAT - # - # |
| 33 |
| - - - - (2) INFORMATION FOR SEQ ID NO:13: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 22 base - #pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| - - (ii) MOLECULE TYPE: DNA |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: |
| - - GGAGCTGCTT GGGGCCCCAG AC - # - # |
| 22 |
| - - - - (2) INFORMATION FOR SEQ ID NO:14: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 40 base - #pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| - - (ii) MOLECULE TYPE: DNA |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14: |
| - - CCAAATCCCC AGGAGCTGCT CGAGCTGCAC TATACCAGAC - # |
| - # 40 |
| - - - - (2) INFORMATION FOR SEQ ID NO:15: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 base - #pairs |
| (B) TYPE: nucleic acid |
| (C) STRANDEDNESS: single |
| (D) TOPOLOGY: linear |
| - - (ii) MOLECULE TYPE: DNA |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15: |
| - - ATAGCTTCTA GATTAATTGT TAATTTCTCT GTCCC - # - |
| # 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:16: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 48 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16: |
| - - Tyr Thr Ser Val Ile Thr Ile Glu Leu Ser As - #n Ile Lys Glu Asn Lys |
| 1 5 - # 10 - # 15 |
| - - Cys Asn Gly Thr Asp Ala Lys Val Lys Leu Il - #e Lys Gln Glu Leu Asp |
| 20 - # 25 - # 30 |
| - - Lys Tyr Lys Asn Ala Val Thr Glu Leu Gln Le - #u Leu Met Gln Ser Thr |
| 35 - # 40 - # 45 |
| - - - - (2) INFORMATION FOR SEQ ID NO:17: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 37 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17: |
| - - Phe Tyr Asp Pro Leu Val Phe Pro Ser Asp Gl - #u Phe Asp Ala Ser Ile |
| 1 5 - # 10 - # 15 |
| - - Ser Gln Val Asn Glu Lys Ile Asn Gln Ser Le - #u Ala Phe Ile Arg Lys |
| 20 - # 25 - # 30 |
| - - Ser Asp Glu Leu Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:18: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18: |
| - - Ile Thr Leu Asn Asn Ser Val Ala Leu Asp Pr - #o Ile Asp Ile Ser Ile |
| 1 5 - # 10 - # 15 |
| - - Glu Leu Asn Lys Ala Lys Ser Asp Leu Glu Gl - #u Ser Lys Glu Trp Ile |
| 20 - # 25 - # 30 |
| - - Arg Arg Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:19: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19: |
| - - Ala Leu Gly Val Ala Thr Ser Ala Gln Ile Th - #r Ala Ala Val Ala Leu |
| 1 5 - # 10 - # 15 |
| - - Val Glu Ala Lys Gln Ala Arg Ser Asp Ile Gl - #u Lys Leu Lys Glu Ala |
| 20 - # 25 - # 30 |
| - - Ile Arg |
| - - - - (2) INFORMATION FOR SEQ ID NO:20: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20: |
| - - Val Ala Val Ser Lys Val Leu His Leu Glu Gl - #y Glu Val Asn Lys Ile |
| 1 5 - # 10 - # 15 |
| - - Ala Leu Leu Ser Thr Asn Lys Ala Val Val Se - #r Leu Ser Asn Gly Val |
| 20 - # 25 - # 30 |
| - - Ser |
| - - - - (2) INFORMATION FOR SEQ ID NO:21: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: |
| - - Ala Val Ser Lys Val Leu His Leu Glu Gly Gl - #u Val Asn Lys Ile Ala |
| 1 5 - # 10 - # 15 |
| - - Leu Leu Ser Thr Asn Lys Ala Val Val Ser Le - #u Ser Asn Gly Val Ser |
| 20 - # 25 - # 30 |
| - - Val |
| - - - - (2) INFORMATION FOR SEQ ID NO:22: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22: |
| - - Val Ser Lys Val Leu His Leu Glu Gly Glu Va - #l Asn Lys Ile Ala Leu |
| 1 5 - # 10 - # 15 |
| - - Leu Ser Thr Asn Lys Ala Val Val Ser Leu Se - #r Asn Gly Val Ser Val |
| 20 - # 25 - # 30 |
| - - Leu |
| - - - - (2) INFORMATION FOR SEQ ID NO:23: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23: |
| - - Ser Lys Val Leu His Leu Glu Gly Glu Val As - #n Lys Ile Ala Leu Leu |
| 1 5 - # 10 - # 15 |
| - - Ser Thr Asn Lys Ala Val Val Ser Leu Ser As - #n Gly Val Ser Val Leu |
| 20 - # 25 - # 30 |
| - - Thr |
| - - - - (2) INFORMATION FOR SEQ ID NO:24: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24: |
| - - Lys Val Leu His Leu Glu Gly Glu Val Asn Ly - #s Ile Ala Leu Leu Ser |
| 1 5 - # 10 - # 15 |
| - - Thr Asn Lys Ala Val Val Ser Leu Ser Asn Gl - #y Val Ser Val Leu Thr |
| 20 - # 25 - # 30 |
| - - Ser |
| - - - - (2) INFORMATION FOR SEQ ID NO:25: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25: |
| - - Leu Glu Gly Glu Val Asn Lys Ile Ala Leu Le - #u Ser Thr Asn Lys Ala |
| 1 5 - # 10 - # 15 |
| - - Val Val Ser Leu Ser Asn Gly Val Ser Val Le - #u Thr Ser Lys Val Leu |
| 20 - # 25 - # 30 |
| - - Asp |
| - - - - (2) INFORMATION FOR SEQ ID NO:26: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: |
| - - Gly Glu Val Asn Lys Ile Ala Leu Leu Ser Th - #r Asn Lys Ala Val Val |
| 1 5 - # 10 - # 15 |
| - - Ser Leu Ser Asn Gly Val Ser Val Leu Thr Se - #r Lys Val Leu Asp Leu |
| 20 - # 25 - # 30 |
| - - Lys |
| - - - - (2) INFORMATION FOR SEQ ID NO:27: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27: |
| - - Glu Val Asn Lys Ile Ala Leu Leu Ser Thr As - #n Lys Ala Val Val Ser |
| 1 5 - # 10 - # 15 |
| - - Leu Ser Asn Gly Val Ser Val Leu Thr Ser Ly - #s Val Leu Asp Leu Lys |
| 20 - # 25 - # 30 |
| - - Asn |
| - - - - (2) INFORMATION FOR SEQ ID NO:28: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28: |
| - - Val Asn Lys Ile Ala Leu Leu Ser Thr Asn Ly - #s Ala Val Val Ser Leu |
| 1 5 - # 10 - # 15 |
| - - Ser Asn Gly Val Ser Val Leu Thr Ser Lys Va - #l Leu Asp Leu Lys Asn |
| 20 - # 25 - # 30 |
| - - Tyr |
| - - - - (2) INFORMATION FOR SEQ ID NO:29: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29: |
| - - Asn Lys Ile Ala Leu Leu Ser Thr Asn Lys Al - #a Val Val Ser Leu Ser |
| 1 5 - # 10 - # 15 |
| - - Asn Gly Val Ser Val Leu Thr Ser Lys Val Le - #u Asp Leu Lys Asn Tyr |
| 20 - # 25 - # 30 |
| - - Ile |
| - - - - (2) INFORMATION FOR SEQ ID NO:30: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:30: |
| - - Lys Ile Ala Leu Leu Ser Thr Asn Lys Ala Va - #l Val Ser Leu Ser Asn |
| 1 5 - # 10 - # 15 |
| - - Gly Val Ser Val Leu Thr Ser Lys Val Leu As - #p Leu Lys Asn Tyr Ile |
| 20 - # 25 - # 30 |
| - - Asp |
| - - - - (2) INFORMATION FOR SEQ ID NO:31: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31: |
| - - Ile Ala Leu Leu Ser Thr Asn Lys Ala Val Va - #l Ser Leu Ser Asn Gly |
| 1 5 - # 10 - # 15 |
| - - Val Ser Val Leu Thr Ser Lys Val Leu Asp Le - #u Lys Asn Tyr Ile Asp |
| 20 - # 25 - # 30 |
| - - Lys |
| - - - - (2) INFORMATION FOR SEQ ID NO:32: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:32: |
| - - Ala Leu Leu Ser Thr Asn Lys Ala Val Val Se - #r Leu Ser Asn Gly Val |
| 1 5 - # 10 - # 15 |
| - - Ser Val Leu Thr Ser Lys Val Leu Asp Leu Ly - #s Asn Tyr Ile Asp Lys |
| 20 - # 25 - # 30 |
| - - Gln |
| - - - - (2) INFORMATION FOR SEQ ID NO:33: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:33: |
| - - Thr Leu Asn Asn Ser Val Ala Leu Asp Pro Il - #e Asp Ile Ser Ile Glu |
| 1 5 - # 10 - # 15 |
| - - Leu Asn Lys Ala Lys Ser Asp Leu Glu Glu Se - #r Lys Glu Trp Ile Arg |
| 20 - # 25 - # 30 |
| - - Arg Ser Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:34: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:34: |
| - - Leu Asn Asn Ser Val Ala Leu Asp Pro Ile As - #p Ile Ser Ile Glu Leu |
| 1 5 - # 10 - # 15 |
| - - Asn Lys Ala Lys Ser Asp Leu Glu Glu Ser Ly - #s Glu Trp Ile Arg Arg |
| 20 - # 25 - # 30 |
| - - Ser Asn Gln |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:35: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:35: |
| - - Asn Asn Ser Val Ala Leu Asp Pro Ile Asp Il - #e Ser Ile Glu Leu Asn |
| 1 5 - # 10 - # 15 |
| - - Lys Ala Lys Ser Asp Leu Glu Glu Ser Lys Gl - #u Trp Ile Arg Arg Ser |
| 20 - # 25 - # 30 |
| - - Asn Gln Lys |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:36: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:36: |
| - - Asn Ser Val Ala Leu Asp Pro Ile Asp Ile Se - #r Ile Glu Leu Asn Lys |
| 1 5 - # 10 - # 15 |
| - - Ala Lys Ser Asp Leu Glu Glu Ser Lys Glu Tr - #p Ile Arg Arg Ser Asn |
| 20 - # 25 - # 30 |
| - - Gln Lys Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:37: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:37: |
| - - Ser Val Ala Leu Asp Pro Ile Asp Ile Ser Il - #e Glu Leu Asn Lys Ala |
| 1 5 - # 10 - # 15 |
| - - Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Il - #e Arg Arg Ser Asn Gln |
| 20 - # 25 - # 30 |
| - - Lys Leu Asp |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:38: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:38: |
| - - Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Gl - #u Leu Asn Lys Ala Lys |
| 1 5 - # 10 - # 15 |
| - - Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Ar - #g Arg Ser Asn Gln Lys |
| 20 - # 25 - # 30 |
| - - Leu Asp Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:39: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:39: |
| - - Ala Leu Asp Pro Ile Asp Ile Ser Ile Glu Le - #u Asn Lys Ala Lys Ser |
| 1 5 - # 10 - # 15 |
| - - Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Ar - #g Ser Asn Gln Lys Leu |
| 20 - # 25 - # 30 |
| - - Asp Ser Ile |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:40: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:40: |
| - - Leu Asp Pro Ile Asp Ile Ser Ile Glu Leu As - #n Lys Ala Lys Ser Asp |
| 1 5 - # 10 - # 15 |
| - - Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Se - #r Asn Gln Lys Leu Asp |
| 20 - # 25 - # 30 |
| - - Ser Ile Gly |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:41: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:41: |
| - - Asp Pro Ile Asp Ile Ser Ile Glu Leu Asn Ly - #s Ala Lys Ser Asp Leu |
| 1 5 - # 10 - # 15 |
| - - Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser As - #n Gln Lys Leu Asp Ser |
| 20 - # 25 - # 30 |
| - - Ile Gly Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:42: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:42: |
| - - Pro Ile Asp Ile Ser Ile Glu Leu Asn Lys Al - #a Lys Ser Asp Leu Glu |
| 1 5 - # 10 - # 15 |
| - - Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Gl - #n Lys Leu Asp Ser Ile |
| 20 - # 25 - # 30 |
| - - Gly Asn Trp |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:43: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:43: |
| - - Ile Asp Ile Ser Ile Glu Leu Asn Lys Ala Ly - #s Ser Asp Leu Glu Glu |
| 1 5 - # 10 - # 15 |
| - - Ser Lys Glu Trp Ile Arg Arg Ser Asn Gln Ly - #s Leu Asp Ser Ile Gly |
| 20 - # 25 - # 30 |
| - - Asn Trp His |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:44: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:44: |
| - - Asp Ile Ser Ile Glu Leu Asn Lys Ala Lys Se - #r Asp Leu Glu Glu Ser |
| 1 5 - # 10 - # 15 |
| - - Lys Glu Trp Ile Arg Arg Ser Asn Gln Lys Le - #u Asp Ser Ile Gly Asn |
| 20 - # 25 - # 30 |
| - - Trp His Gln |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:45: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:45: |
| - - Ile Ser Ile Glu Leu Asn Lys Ala Lys Ser As - #p Leu Glu Glu Ser Lys |
| 1 5 - # 10 - # 15 |
| - - Glu Trp Ile Arg Arg Ser Asn Gln Lys Leu As - #p Ser Ile Gly Asn Trp |
| 20 - # 25 - # 30 |
| - - His Gln Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:46: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:46: |
| - - Ser Ile Glu Leu Asn Lys Ala Lys Ser Asp Le - #u Glu Glu Ser Lys Glu |
| 1 5 - # 10 - # 15 |
| - - Trp Ile Arg Arg Ser Asn Gln Lys Leu Asp Se - #r Ile Gly Asn Trp His |
| 20 - # 25 - # 30 |
| - - Gln Ser Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:47: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:47: |
| - - Ile Glu Leu Asn Lys Ala Lys Ser Asp Leu Gl - #u Glu Ser Lys Glu Trp |
| 1 5 - # 10 - # 15 |
| - - Ile Arg Arg Ser Asn Gln Lys Leu Asp Ser Il - #e Gly Asn Trp His Gln |
| 20 - # 25 - # 30 |
| - - Ser Ser Thr |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:48: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:48: |
| - - Glu Leu Asn Lys Ala Lys Ser Asp Leu Glu Gl - #u Ser Lys Glu Trp Ile |
| 1 5 - # 10 - # 15 |
| - - Arg Arg Ser Asn Gln Lys Leu Asp Ser Ile Gl - #y Asn Trp His Gln Ser |
| 20 - # 25 - # 30 |
| - - Ser Thr Thr |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:49: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:49: |
| - - Thr Ala Ala Val Ala Leu Val Glu Ala Lys Gl - #n Ala Arg Ser Asp Ile |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Leu Lys Glu Ala Ile Arg Asp Thr As - #n Lys Ala Val Gln Ser |
| 20 - # 25 - # 30 |
| - - Val Gln Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:50: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:50: |
| - - Ala Val Ala Leu Val Glu Ala Lys Gln Ala Ar - #g Ser Asp Ile Glu Lys |
| 1 5 - # 10 - # 15 |
| - - Leu Lys Glu Ala Ile Arg Asp Thr Asn Lys Al - #a Val Gln Ser Val Gln |
| 20 - # 25 - # 30 |
| - - Ser Ser Ile |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:51: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:51: |
| - - Leu Val Glu Ala Lys Gln Ala Arg Ser Asp Il - #e Glu Lys Leu Lys Glu |
| 1 5 - # 10 - # 15 |
| - - Ala Ile Arg Asp Thr Asn Lys Ala Val Gln Se - #r Val Gln Ser Ser Ile |
| 20 - # 25 - # 30 |
| - - Gly Asn Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:52: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:52: |
| - - Val Glu Ala Lys Gln Ala Arg Ser Asp Ile Gl - #u Lys Leu Lys Glu Ala |
| 1 5 - # 10 - # 15 |
| - - Ile Arg Asp Thr Asn Lys Ala Val Gln Ser Va - #l Gln Ser Ser Ile Gly |
| 20 - # 25 - # 30 |
| - - Asn Leu Ile |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:53: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:53: |
| - - Glu Ala Lys Gln Ala Arg Ser Asp Ile Glu Ly - #s Leu Lys Glu Ala Ile |
| 1 5 - # 10 - # 15 |
| - - Arg Asp Thr Asn Lys Ala Val Gln Ser Val Gl - #n Ser Ser Ile Gly Asn |
| 20 - # 25 - # 30 |
| - - Leu Ile Val |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:54: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:54: |
| - - Ala Lys Gln Ala Arg Ser Asp Ile Glu Lys Le - #u Lys Glu Ala Ile Arg |
| 1 5 - # 10 - # 15 |
| - - Asp Thr Asn Lys Ala Val Gln Ser Val Gln Se - #r Ser Ile Gly Asn Leu |
| 20 - # 25 - # 30 |
| - - Ile Val Ala |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:55: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:55: |
| - - Lys Gln Ala Arg Ser Asp Ile Glu Lys Leu Ly - #s Glu Ala Ile Arg Asp |
| 1 5 - # 10 - # 15 |
| - - Thr Asn Lys Ala Val Gln Ser Val Gln Ser Se - #r Ile Gly Asn Leu Ile |
| 20 - # 25 - # 30 |
| - - Val Ala Ile |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:56: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:56: |
| - - Gln Ala Arg Ser Asp Ile Glu Lys Leu Lys Gl - #u Ala Ile Arg Asp Thr |
| 1 5 - # 10 - # 15 |
| - - Asn Lys Ala Val Gln Ser Val Gln Ser Ser Il - #e Gly Asn Leu Ile Val |
| 20 - # 25 - # 30 |
| - - Ala Ile Lys |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:57: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:57: |
| - - Ala Arg Ser Asp Ile Glu Lys Leu Lys Glu Al - #a Ile Arg Asp Thr Asn |
| 1 5 - # 10 - # 15 |
| - - Lys Ala Val Gln Ser Val Gln Ser Ser Ile Gl - #y Asn Leu Ile Val Ala |
| 20 - # 25 - # 30 |
| - - Ile Lys Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:58: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:58: |
| - - Arg Ser Asp Ile Glu Lys Leu Lys Glu Ala Il - #e Arg Asp Thr Asn Lys |
| 1 5 - # 10 - # 15 |
| - - Ala Val Gln Ser Val Gln Ser Ser Ile Gly As - #n Leu Ile Val Ala Ile |
| 20 - # 25 - # 30 |
| - - Lys Ser Val |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:59: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:59: |
| - - Ser Asp Ile Glu Lys Leu Lys Glu Ala Ile Ar - #g Asp Thr Asn Lys Ala |
| 1 5 - # 10 - # 15 |
| - - Val Gln Ser Val Gln Ser Ser Ile Gly Asn Le - #u Ile Val Ala Ile Lys |
| 20 - # 25 - # 30 |
| - - Ser Val Gln |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:60: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:60: |
| - - Lys Leu Lys Glu Ala Ile Arg Asp Thr Asn Ly - #s Ala Val Gln Ser Val |
| 1 5 - # 10 - # 15 |
| - - Gln Ser Ser Ile Gly Asn Leu Ile Val Ala Il - #e Lys Ser Val Gln Asp |
| 20 - # 25 - # 30 |
| - - Tyr Val Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:61: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:61: |
| - - Leu Lys Glu Ala Ile Arg Asp Thr Asn Lys Al - #a Val Gln Ser Val Gln |
| 1 5 - # 10 - # 15 |
| - - Ser Ser Ile Gly Asn Leu Ile Val Ala Ile Ly - #s Ser Val Gln Asp Tyr |
| 20 - # 25 - # 30 |
| - - Val Asn Lys |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:62: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:62: |
| - - Ala Ile Arg Asp Thr Asn Lys Ala Val Gln Se - #r Val Gln Ser Ser Ile |
| 1 5 - # 10 - # 15 |
| - - Gly Asn Leu Ile Val Ala Ile Lys Ser Val Gl - #n Asp Tyr Val Asn Lys |
| 20 - # 25 - # 30 |
| - - Glu Ile Val |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:63: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:63: |
| - - Trp Gln Glu Trp Glu Arg Lys Val Asp Phe Le - #u Glu Glu Asn Ile Thr |
| 1 5 - # 10 - # 15 |
| - - Ala Leu Leu Glu Glu Ala Gln Ile Gln Gln Gl - #u Lys Asn Met Tyr Glu |
| 20 - # 25 - # 30 |
| - - Leu Gln Lys |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:64: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:64: |
| - - Gln Glu Trp Glu Arg Lys Val Asp Phe Leu Gl - #u Glu Asn Ile Thr Ala |
| 1 5 - # 10 - # 15 |
| - - Leu Leu Glu Glu Ala Gln Ile Gln Gln Glu Ly - #s Asn Met Tyr Glu Leu |
| 20 - # 25 - # 30 |
| - - Gln Lys Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:65: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:65: |
| - - Glu Trp Glu Arg Lys Val Asp Phe Leu Glu Gl - #u Asn Ile Thr Ala Leu |
| 1 5 - # 10 - # 15 |
| - - Leu Glu Glu Ala Gln Ile Gln Gln Glu Lys As - #n Met Tyr Glu Leu Gln |
| 20 - # 25 - # 30 |
| - - Lys Leu Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:66: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:66: |
| - - Trp Glu Arg Lys Val Asp Phe Leu Glu Glu As - #n Ile Thr Ala Leu Leu |
| 1 5 - # 10 - # 15 |
| - - Glu Glu Ala Gln Ile Gln Gln Glu Lys Asn Me - #t Tyr Glu Leu Gln Lys |
| 20 - # 25 - # 30 |
| - - Leu Asn Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:67: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:67: |
| - - Glu Arg Lys Val Asp Phe Leu Glu Glu Asn Il - #e Thr Ala Leu Leu Glu |
| 1 5 - # 10 - # 15 |
| - - Glu Ala Gln Ile Gln Gln Glu Lys Asn Met Ty - #r Glu Leu Gln Lys Leu |
| 20 - # 25 - # 30 |
| - - Asn Ser Trp |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:68: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:68: |
| - - Arg Lys Val Asp Phe Leu Glu Glu Asn Ile Th - #r Ala Leu Leu Glu Glu |
| 1 5 - # 10 - # 15 |
| - - Ala Gln Ile Gln Gln Glu Lys Asn Met Tyr Gl - #u Leu Gln Lys Leu Asn |
| 20 - # 25 - # 30 |
| - - Ser Trp Asp |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:69: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:69: |
| - - Lys Val Asp Phe Leu Glu Glu Asn Ile Thr Al - #a Leu Leu Glu Glu Ala |
| 1 5 - # 10 - # 15 |
| - - Gln Ile Gln Gln Glu Lys Asn Met Tyr Glu Le - #u Gln Lys Leu Asn Ser |
| 20 - # 25 - # 30 |
| - - Trp Asp Val |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:70: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:70: |
| - - Val Asp Phe Leu Glu Glu Asn Ile Thr Ala Le - #u Leu Glu Glu Ala Gln |
| 1 5 - # 10 - # 15 |
| - - Ile Gln Gln Glu Lys Asn Met Tyr Glu Leu Gl - #n Lys Leu Asn Ser Trp |
| 20 - # 25 - # 30 |
| - - Asp Val Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:71: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:71: |
| - - Asp Phe Leu Glu Glu Asn Ile Thr Ala Leu Le - #u Glu Glu Ala Gln Ile |
| 1 5 - # 10 - # 15 |
| - - Gln Gln Glu Lys Asn Met Tyr Glu Leu Gln Ly - #s Leu Asn Ser Trp Asp |
| 20 - # 25 - # 30 |
| - - Val Phe Gly |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:72: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:72: |
| - - Phe Leu Glu Glu Asn Ile Thr Ala Leu Leu Gl - #u Glu Ala Gln Ile Gln |
| 1 5 - # 10 - # 15 |
| - - Gln Glu Lys Asn Met Tyr Glu Leu Gln Lys Le - #u Asn Ser Trp Asp Val |
| 20 - # 25 - # 30 |
| - - Phe Gly Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:73: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:73: |
| - - Leu His Arg Ile Asp Leu Gly Pro Pro Ile Se - #r Leu Glu Arg Leu Asp |
| 1 5 - # 10 - # 15 |
| - - Val Gly Thr Asn Leu Gly Asn Ala Ile Ala Ly - #s Leu Glu Ala Lys Glu |
| 20 - # 25 - # 30 |
| - - Leu Leu |
| - - - - (2) INFORMATION FOR SEQ ID NO:74: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:74: |
| - - His Arg Ile Asp Leu Gly Pro Pro Ile Ser Le - #u Glu Arg Leu Asp Val |
| 1 5 - # 10 - # 15 |
| - - Gly Thr Asn Leu Gly Asn Ala Ile Ala Lys Le - #u Glu Ala Lys Glu Leu |
| 20 - # 25 - # 30 |
| - - Leu Glu |
| - - - - (2) INFORMATION FOR SEQ ID NO:75: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:75: |
| - - Arg Ile Asp Leu Gly Pro Pro Ile Ser Leu Gl - #u Arg Leu Asp Val Gly |
| 1 5 - # 10 - # 15 |
| - - Thr Asn Leu Gly Asn Ala Ile Ala Lys Leu Gl - #u Ala Lys Glu Leu Leu |
| 20 - # 25 - # 30 |
| - - Glu Ser |
| - - - - (2) INFORMATION FOR SEQ ID NO:76: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:76: |
| - - Ile Asp Leu Gly Pro Pro Ile Ser Leu Glu Ar - #g Leu Asp Val Gly Thr |
| 1 5 - # 10 - # 15 |
| - - Asn Leu Gly Asn Ala Ile Ala Lys Leu Glu Al - #a Lys Glu Leu Leu Glu |
| 20 - # 25 - # 30 |
| - - Ser Ser |
| - - - - (2) INFORMATION FOR SEQ ID NO:77: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:77: |
| - - Asp Leu Gly Pro Pro Ile Ser Leu Glu Arg Le - #u Asp Val Gly Thr Asn |
| 1 5 - # 10 - # 15 |
| - - Leu Gly Asn Ala Ile Ala Lys Leu Glu Ala Ly - #s Glu Leu Leu Glu Ser |
| 20 - # 25 - # 30 |
| - - Ser Asp |
| - - - - (2) INFORMATION FOR SEQ ID NO:78: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:78: |
| - - Leu Gly Pro Pro Ile Ser Leu Glu Arg Leu As - #p Val Gly Thr Asn Leu |
| 1 5 - # 10 - # 15 |
| - - Gly Asn Ala Ile Ala Lys Leu Glu Ala Lys Gl - #u Leu Leu Glu Ser Ser |
| 20 - # 25 - # 30 |
| - - Asp Gln |
| - - - - (2) INFORMATION FOR SEQ ID NO:79: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:79: |
| - - Gly Pro Pro Ile Ser Leu Glu Arg Leu Asp Va - #l Gly Thr Asn Leu Gly |
| 1 5 - # 10 - # 15 |
| - - Asn Ala Ile Ala Lys Leu Glu Ala Lys Glu Le - #u Leu Glu Ser Ser Asp |
| 20 - # 25 - # 30 |
| - - Gln Ile |
| - - - - (2) INFORMATION FOR SEQ ID NO:80: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:80: |
| - - Pro Pro Ile Ser Leu Glu Arg Leu Asp Val Gl - #y Thr Asn Leu Gly Asn |
| 1 5 - # 10 - # 15 |
| - - Ala Ile Ala Lys Leu Glu Ala Lys Glu Leu Le - #u Glu Ser Ser Asp Gln |
| 20 - # 25 - # 30 |
| - - Ile Leu |
| - - - - (2) INFORMATION FOR SEQ ID NO:81: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:81: |
| - - Pro Ile Ser Leu Glu Arg Leu Asp Val Gly Th - #r Asn Leu Gly Asn Ala |
| 1 5 - # 10 - # 15 |
| - - Ile Ala Lys Leu Glu Ala Lys Glu Leu Leu Gl - #u Ser Ser Asp Gln Ile |
| 20 - # 25 - # 30 |
| - - Leu Arg |
| - - - - (2) INFORMATION FOR SEQ ID NO:82: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:82: |
| - - Ser Leu Glu Arg Leu Asp Val Gly Thr Asn Le - #u Gly Asn Ala Ile Ala |
| 1 5 - # 10 - # 15 |
| - - Lys Leu Glu Ala Lys Glu Leu Leu Glu Ser Se - #r Asp Gln Ile Leu Arg |
| 20 - # 25 - # 30 |
| - - Ser Met |
| - - - - (2) INFORMATION FOR SEQ ID NO:83: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 1 |
| (D) OTHER INFORMATION: - #/label= A |
| /note= - #"Preceeding this amino acid, there may be an - |
| #amino |
| group, a - #hydrophobic group, an acetyl group, a |
| 9-fluorenylm - #ethoxycarbonyl group, or a macromolecular |
| carrier g - #roup." |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 48 |
| (D) OTHER INFORMATION: - #/label= B |
| /note= - #"Following this amino acid, there may be a |
| carboxyl - #group, an amido group, a T-butyloxycarbonyl |
| group, or - # a macromolecular carrier group." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:83: |
| - - Leu Glu Arg Leu Asp Val Gly Thr Asn Leu Gl - #y Asn Ala Ile Ala Lys |
| 1 5 - # 10 - # 15 |
| - - Leu Glu Ala Lys Glu Leu Leu Glu Ser Ser As - #p Gln Ile Leu Arg Ser |
| 20 - # 25 - # 30 |
| - - Met Lys |
| - - - - (2) INFORMATION FOR SEQ ID NO:84: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ - #ID NO:84: |
| - - Met Lys Gln Leu Glu Asp Lys Val - # Glu Glu Leu Leu Ser Lys |
| Asn Tyr |
| 1 - # 5 - # 10 - # |
| 15 |
| - - His Leu Glu Asn Glu Val Ala Arg - # Leu Lys Lys Leu |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:85: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:85: |
| - - Thr Asp Thr Leu Gln Ala Glu Thr Asp Gln Le - #u Glu Asp Glu Lys |
| Ser |
| 1 5 - # 10 - # 15 |
| - - Ala Leu Gln Thr Glu Ile Ala Asn Leu Leu Ly - #s Glu |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:86: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:86: |
| - - Ile Ala Arg Leu Glu Glu Lys Val Lys Thr Le - #u Lys Ala Gln Asn Ser |
| 1 5 - # 10 - # 15 |
| - - Glu Leu Ala Ser Thr Ala Asn Met Leu Arg Gl - #u Gln |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:87: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:87: |
| - - Glu Gln Lys Leu Ile Ser Glu Glu Asp Leu Le - #u Glu Lys Arg Arg Glu |
| 1 5 - # 10 - # 15 |
| - - Gln Leu Lys His Lys Leu Glu Gln Leu Arg As - #n Ser |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:88: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:88: |
| - - Ile Glu Lys Thr Asn Glu Lys Phe His Gln Il - #e Glu Lys Glu Phe Ser |
| 1 5 - # 10 - # 15 |
| - - Glu Val Glu Gly Arg Ile Gln Asp Leu Glu Ly - #s Tyr |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:89: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 38 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:89: |
| - - Asn Asn Leu Leu Arg Ala Ile Glu Ala Gln Gl - #n His Leu Leu Gln Leu |
| 1 5 - # 10 - # 15 |
| - - Thr Val Trp Gly Ile Lys Gln Leu Gln Ala Ar - #g Ile Leu Ala Val Glu |
| 20 - # 25 - # 30 |
| - - Arg Tyr Leu Lys Asp Gln |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:90: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 338 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:90: |
| - - Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Th - #r Met Gly Ala Arg Ser |
| 1 5 - # 10 - # 15 |
| - - Met Thr Leu Thr Val Gln Ala Arg Gln Leu Le - #u Ser Gly Ile Val Gln |
| 20 - # 25 - # 30 |
| - - Gln Gln Asn Asn Leu Leu Arg Ala Ile Glu Al - #a Gln Gln His Leu Leu |
| 35 - # 40 - # 45 |
| - - Gln Leu Thr Val Trp Gly Ile Lys Gln Leu Gl - #n Ala Arg Ile Leu Ala |
| 50 - # 55 - # 60 |
| - - Val Glu Arg Tyr Leu Lys Asp Gln Gln Leu Le - #u Gly Ile Trp Gly Cys |
| 65 - #70 - #75 - #80 |
| - - Ser Gly Lys Leu Ile Cys Thr Thr Ala Val Pr - #o Trp Asn Ala Ser Trp |
| 85 - # 90 - # 95 |
| - - Ser Asn Lys Ser Leu Glu Gln Ile Trp Asn As - #n Met Thr Trp Met Glu |
| 100 - # 105 - # 110 |
| - - Trp Asp Arg Glu Ile Asn Asn Tyr Thr Ser Le - #u Ile His Ser Leu Ile |
| 115 - # 120 - # 125 |
| - - Glu Glu Ser Gln Asn Gln Gln Glu Lys Asn Gl - #u Gln Glu Leu Leu Glu |
| 130 - # 135 - # 140 |
| - - Leu Asp Lys Trp Ala Ser Leu Trp Asn Trp Ph - #e Asn Ile Thr Asn Trp |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Leu Trp Tyr Ile Lys Ile Phe Ile Met Ile Va - #l Gly Gly Leu Val |
| Gly |
| 165 - # 170 - # 175 |
| - - Leu Arg Ile Val Phe Ala Val Leu Ser Ile Va - #l Asn Arg Val Arg Gln |
| 180 - # 185 - # 190 |
| - - Gly Tyr Ser Pro Leu Ser Phe Gln Thr His Le - #u Pro Thr Pro Arg Gly |
| 195 - # 200 - # 205 |
| - - Pro Asp Arg Pro Glu Gly Ile Glu Glu Glu Gl - #y Gly Glu Arg Asp Arg |
| 210 - # 215 - # 220 |
| - - Asp Arg Ser Ile Arg Leu Val Asn Gly Ser Le - #u Ala Leu Ile Trp Asp |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Asp Leu Arg Ser Leu Cys Leu Phe Ser Tyr Hi - #s Arg Leu Arg Asp |
| Leu |
| 245 - # 250 - # 255 |
| - - Leu Leu Ile Val Thr Arg Ile Val Glu Leu Le - #u Gly Arg Arg Gly Trp |
| 260 - # 265 - # 270 |
| - - Glu Ala Leu Lys Tyr Trp Trp Asn Leu Leu Gl - #n Tyr Trp Ser Gln Glu |
| 275 - # 280 - # 285 |
| - - Leu Lys Asn Ser Ala Val Ser Leu Leu Asn Al - #a Thr Ala Ile Ala Val |
| 290 - # 295 - # 300 |
| - - Ala Glu Gly Thr Asp Arg Val Ile Glu Val Va - #l Gln Gly Ala Cys Arg |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Ala Ile Arg His Ile Pro Arg Arg Ile Arg Gl - #n Gly Leu Glu Arg |
| Ile |
| 325 - # 330 - # 335 |
| - - Leu Leu |
| - - - - (2) INFORMATION FOR SEQ ID NO:91: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 437 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:91: |
| - - Phe Leu Gly Phe Leu Leu Gly Val Gly Ser Al - #a Ile Ala Ser Gly Val |
| 1 5 - # 10 - # 15 |
| - - Ala Val Ser Lys Val Leu His Leu Glu Gly Gl - #u Val Asn Lys Ile Lys |
| 20 - # 25 - # 30 |
| - - Ser Ala Leu Leu Ser Thr Asn Lys Ala Val Va - #l Ser Leu Ser Asn Gly |
| 35 - # 40 - # 45 |
| - - Val Ser Val Leu Thr Ser Lys Val Leu Asp Le - #u Lys Asn Tyr Ile Asp |
| 50 - # 55 - # 60 |
| - - Lys Gln Leu Leu Pro Ile Val Asn Lys Gln Se - #r Cys Ser Ile Ser Asn |
| 65 - #70 - #75 - #80 |
| - - Ile Glu Thr Val Ile Glu Phe Gln Gln Lys As - #n Asn Arg Leu Leu Glu |
| 85 - # 90 - # 95 |
| - - Ile Thr Arg Glu Phe Ser Val Asn Ala Gly Va - #l Thr Thr Pro Val Ser |
| 100 - # 105 - # 110 |
| - - Thr Met Leu Thr Asn Ser Glu Leu Leu Ser Le - #u Ile Asn Asp Met Pro |
| 115 - # 120 - # 125 |
| - - Ile Thr Asn Asp Gln Lys Lys Leu Met Ser As - #n Asn Val Gln Ile Val |
| 130 - # 135 - # 140 |
| - - Arg Gln Gln Ser Tyr Ser Ile Met Ser Ile Il - #e Lys Glu Glu Val Leu |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Ala Tyr Val Val Gln Leu Pro Leu Tyr Gly Va - #l Ile Asp Thr Pro |
| Cys |
| 165 - # 170 - # 175 |
| - - Trp Lys Leu His Thr Ser Pro Leu Cys Thr Th - #r Asn Thr Lys Glu Gly |
| 180 - # 185 - # 190 |
| - - Ser Asn Ile Cys Leu Thr Arg Thr Asp Arg Gl - #y Trp Tyr Cys Asp Asn |
| 195 - # 200 - # 205 |
| - - Ala Gly Ser Val Ser Phe Phe Pro Gln Ala Gl - #u Thr Cys Lys Val Gln |
| 210 - # 215 - # 220 |
| - - Ser Asn Arg Val Phe Cys Asp Thr Met Asn Se - #r Leu Thr Leu Pro Ser |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Glu Ile Asn Leu Cys Asn Val Asp Ile Phe As - #n Pro Lys Tyr Asp |
| Cys |
| 245 - # 250 - # 255 |
| - - Lys Ile Met Thr Ser Lys Thr Asp Val Ser Se - #r Ser Val Ile Thr Ser |
| 260 - # 265 - # 270 |
| - - Leu Gly Ala Ile Val Ser Cys Tyr Gly Lys Th - #r Lys Cys Thr Ala Ser |
| 275 - # 280 - # 285 |
| - - Asn Lys Asn Arg Gly Ile Ile Lys Thr Phe Se - #r Asn Gly Cys Asp Tyr |
| 290 - # 295 - # 300 |
| - - Val Ser Asn Lys Gly Met Asp Thr Val Ser Va - #l Gly Asn Thr Leu Tyr |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Tyr Val Asn Lys Gln Glu Gly Lys Ser Leu Ty - #r Val Lys Gly Glu |
| Pro |
| 325 - # 330 - # 335 |
| - - Ile Ile Asn Phe Tyr Asp Pro Leu Val Phe Pr - #o Ser Asp Glu Phe Asp |
| 340 - # 345 - # 350 |
| - - Ala Ser Ile Ser Gln Val Asn Glu Lys Ile As - #n Gln Ser Leu Ala Phe |
| 355 - # 360 - # 365 |
| - - Ile Arg Lys Ser Asp Glu Leu Leu His Asn Va - #l Asn Ala Gly Lys Ser |
| 370 - # 375 - # 380 |
| - - Thr Thr Asn Ile Met Ile Thr Thr Ile Ile Il - #e Val Ile Ile Val Ile |
| 385 3 - #90 3 - #95 4 - |
| #00 |
| - - Leu Leu Ser Leu Ile Ala Val Gly Leu Leu Le - #u Tyr Cys Lys Ala |
| Arg |
| 405 - # 410 - # 415 |
| - - Ser Thr Pro Val Thr Leu Ser Lys Asp Gln Le - #u Ser Gly Ile Asn Asn |
| 420 - # 425 - # 430 |
| - - Ile Ala Phe Ser Asn |
| 435 |
| - - - - (2) INFORMATION FOR SEQ ID NO:92: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 328 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:92: |
| - - Phe Leu Gly Phe Leu Gly Ala Ala Gly Thr Al - #a Met Gly Ala Ala Ala |
| 1 5 - # 10 - # 15 |
| - - Thr Ala Leu Thr Val Gln Ser Gln His Leu Le - #u Ala Gly Ile Leu Gln |
| 20 - # 25 - # 30 |
| - - Gln Gln Lys Asn Leu Leu Ala Ala Val Glu Al - #a Gln Gln Gln Met Leu |
| 35 - # 40 - # 45 |
| - - Lys Leu Thr Ile Trp Gly Val Lys Asn Leu As - #n Ala Arg Val Thr Ala |
| 50 - # 55 - # 60 |
| - - Leu Glu Lys Tyr Leu Glu Asp Gln Ala Arg Le - #u Asn Ala Trp Gly Cys |
| 65 - #70 - #75 - #80 |
| - - Ala Trp Lys Gln Val Cys His Thr Thr Val Pr - #o Trp Gln Trp Asn Asn |
| 85 - # 90 - # 95 |
| - - Arg Thr Pro Asp Trp Asn Asn Met Thr Trp Le - #u Glu Trp Glu Arg Gln |
| 100 - # 105 - # 110 |
| - - Ile Ser Tyr Leu Glu Gly Asn Ile Thr Thr Gl - #n Leu Glu Glu Ala Arg |
| 115 - # 120 - # 125 |
| - - Ala Gln Glu Glu Lys Asn Leu Asp Ala Tyr Gl - #n Lys Leu Ser Ser Trp |
| 130 - # 135 - # 140 |
| - - Ser Asp Phe Trp Ser Trp Phe Asp Phe Ser Ly - #s Trp Leu Asn Ile Leu |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Lys Ile Gly Phe Leu Asp Val Leu Gly Ile Il - #e Gly Leu Arg Leu |
| Leu |
| 165 - # 170 - # 175 |
| - - Tyr Thr Val Tyr Ser Cys Ile Ala Arg Val Ar - #g Gln Gly Tyr Ser Pro |
| 180 - # 185 - # 190 |
| - - Leu Ser Pro Gln Ile His Ile His Pro Trp Ly - #s Gly Gln Pro Asp Asn |
| 195 - # 200 - # 205 |
| - - Ala Glu Gly Pro Gly Glu Gly Gly Asp Lys Ar - #g Lys Asn Ser Ser Glu |
| 210 - # 215 - # 220 |
| - - Pro Trp Gln Lys Glu Ser Gly Thr Ala Glu Tr - #p Lys Ser Asn Trp Cys |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Lys Arg Leu Thr Asn Trp Cys Ser Ile Ser Se - #r Ile Trp Leu Tyr |
| Asn |
| 245 - # 250 - # 255 |
| - - Ser Cys Leu Thr Leu Leu Val His Leu Arg Se - #r Ala Phe Gln Tyr Ile |
| 260 - # 265 - # 270 |
| - - Gln Tyr Gly Leu Gly Glu Leu Lys Ala Ala Al - #a Gln Glu Ala Val Val |
| 275 - # 280 - # 285 |
| - - Ala Leu Ala Arg Leu Ala Gln Asn Ala Gly Ty - #r Gln Ile Trp Leu Ala |
| 290 - # 295 - # 300 |
| - - Cys Arg Ser Ala Tyr Arg Ala Ile Ile Asn Se - #r Pro Arg Arg Val Arg |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Gln Gly Leu Glu Gly Ile Leu Asn |
| 325 |
| - - - - (2) INFORMATION FOR SEQ ID NO:93: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 438 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:93: |
| - - Phe Ala Gly Val Val Leu Ala Gly Val Ala Le - #u Gly Val Ala Thr |
| Ala |
| 1 5 - # 10 - # 15 |
| - - Ala Gln Ile Thr Ala Gly Ile Ala Leu His Gl - #n Ser Asn Leu Asn Ala |
| 20 - # 25 - # 30 |
| - - Gln Ala Ile Gln Ser Leu Arg Thr Ser Leu Gl - #u Gln Ser Asn Lys Ala |
| 35 - # 40 - # 45 |
| - - Ile Glu Glu Ile Arg Glu Ala Thr Gln Glu Th - #r Val Ile Ala Val Gln |
| 50 - # 55 - # 60 |
| - - Gly Val Gln Asp Tyr Val Asn Asn Glu Leu Va - #l Pro Ala Met Gln His |
| 65 - #70 - #75 - #80 |
| - - Met Ser Cys Glu Leu Val Gly Gln Arg Leu Gl - #y Leu Arg Leu Leu Arg |
| 85 - # 90 - # 95 |
| - - Tyr Tyr Thr Glu Leu Leu Ser Ile Phe Gly Pr - #o Ser Leu Arg Asp Pro |
| 100 - # 105 - # 110 |
| - - Ile Ser Ala Glu Ile Ser Ile Gln Ala Leu Il - #e Tyr Ala Leu Gly Gly |
| 115 - # 120 - # 125 |
| - - Glu Ile His Lys Ile Leu Glu Lys Leu Gly Ty - #r Ser Gly Ser Asp Met |
| 130 - # 135 - # 140 |
| - - Ile Ala Ile Leu Glu Ser Arg Gly Ile Lys Th - #r Lys Ile Thr His Val |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Asp Leu Pro Gly Lys Phe Ile Ile Leu Ser Il - #e Ser Tyr Pro Thr |
| Leu |
| 165 - # 170 - # 175 |
| - - Ser Glu Val Lys Gly Val Ile Val His Arg Le - #u Glu Ala Val Ser Tyr |
| 180 - # 185 - # 190 |
| - - Asn Ile Gly Ser Gln Glu Trp Tyr Thr Thr Va - #l Pro Arg Tyr Ile Ala |
| 195 - # 200 - # 205 |
| - - Thr Asn Gly Tyr Leu Ile Ser Asn Phe Asp Gl - #u Ser Ser Cys Val Phe |
| 210 - # 215 - # 220 |
| - - Val Ser Glu Ser Ala Ile Cys Ser Gln Asn Se - #r Leu Tyr Pro Met Ser |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Pro Leu Leu Gln Gln Cys Ile Arg Gly Asp Th - #r Ser Ser Cys Ala |
| Arg |
| 245 - # 250 - # 255 |
| - - Thr Leu Val Ser Gly Thr Met Gly Asn Lys Ph - #e Ile Leu Ser Lys Gly |
| 260 - # 265 - # 270 |
| - - Asn Ile Val Ala Asn Cys Ala Ser Ile Leu Cy - #s Lys Cys Tyr Ser Thr |
| 275 - # 280 - # 285 |
| - - Ser Thr Ile Ile Asn Gln Ser Pro Asp Lys Le - #u Leu Thr Phe Ile Ala |
| 290 - # 295 - # 300 |
| - - Ser Asp Thr Cys Pro Leu Val Glu Ile Asp Gl - #y Ala Thr Ile Gln Val |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Gly Gly Arg Gln Tyr Pro Asp Met Val Tyr Gl - #u Gly Lys Val Ala |
| Leu |
| 325 - # 330 - # 335 |
| - - Gly Pro Ala Ile Ser Leu Asp Arg Leu Asp Va - #l Gly Thr Asn Leu Gly |
| 340 - # 345 - # 350 |
| - - Asn Ala Leu Lys Lys Leu Asp Asp Ala Lys Va - #l Leu Ile Asp Ser Ser |
| 355 - # 360 - # 365 |
| - - Asn Gln Ile Leu Glu Thr Val Arg Arg Ser Se - #r Phe Asn Phe Gly Ser |
| 370 - # 375 - # 380 |
| - - Leu Leu Ser Val Pro Ile Leu Ser Cys Thr Al - #a Leu Ala Leu Leu Leu |
| 385 3 - #90 3 - #95 4 - |
| #00 |
| - - Leu Ile Tyr Cys Cys Lys Arg Arg Tyr Gln Gl - #n Thr Leu Lys Gln |
| His |
| 405 - # 410 - # 415 |
| - - Thr Lys Val Asp Pro Ala Phe Lys Pro Asp Le - #u Thr Gly Thr Ser Lys |
| 420 - # 425 - # 430 |
| - - Ser Tyr Val Arg Ser Leu |
| 435 |
| - - - - (2) INFORMATION FOR SEQ ID NO:94: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 436 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:94: |
| - - Phe Ile Gly Ala Ile Ile Gly Ser Val Ala Le - #u Gly Val Ala Thr Ala |
| 1 5 - # 10 - # 15 |
| - - Ala Gln Ile Thr Ala Ala Ser Ala Leu Ile Gl - #n Ala Asn Gln Asn Ala |
| 20 - # 25 - # 30 |
| - - Ala Asn Ile Leu Arg Leu Lys Glu Ser Ile Th - #r Ala Thr Ile Glu Ala |
| 35 - # 40 - # 45 |
| - - Val His Glu Val Thr Asp Gly Leu Ser Gln Le - #u Ala Val Ala Val Gly |
| 50 - # 55 - # 60 |
| - - Lys Met Gln Gln Phe Val Asn Asp Gln Phe As - #n Asn Thr Ala Gln Glu |
| 65 - #70 - #75 - #80 |
| - - Leu Asp Cys Ile Lys Ile Thr Gln Gln Val Gl - #y Val Glu Leu Asn Leu |
| 85 - # 90 - # 95 |
| - - Tyr Leu Thr Glu Leu Thr Thr Val Phe Gly Pr - #o Gln Ile Thr Ser Pro |
| 100 - # 105 - # 110 |
| - - Ala Leu Thr Gln Leu Thr Ile Gln Ala Leu Ty - #r Asn Ala Gly Gly Asn |
| 115 - # 120 - # 125 |
| - - Met Asp Tyr Leu Leu Thr Lys Leu Gly Val Gl - #y Asn Asn Gln Leu Ser |
| 130 - # 135 - # 140 |
| - - Ser Leu Ile Gly Ser Gly Leu Ile Thr Gly As - #n Pro Ile Leu Tyr Asp |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Ser Gln Thr Gln Leu Leu Gly Ile Gln Val Th - #r Leu Pro Ser Val |
| Gly |
| 165 - # 170 - # 175 |
| - - Asn Leu Asn Asn Met Arg Ala Thr Tyr Leu Gl - #u Thr Leu Ser Val Ser |
| 180 - # 185 - # 190 |
| - - Thr Thr Lys Gly Phe Ala Ser Ala Leu Val Pr - #o Lys Val Val Thr Gln |
| 195 - # 200 - # 205 |
| - - Val Gly Ser Val Ile Glu Glu Leu Asp Thr Se - #r Tyr Cys Ile Glu Thr |
| 210 - # 215 - # 220 |
| - - Asp Leu Asp Leu Tyr Cys Thr Arg Ile Val Th - #r Phe Pro Met Ser Pro |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Gly Ile Tyr Ser Cys Leu Asn Gly Asn Thr Se - #r Ala Cys Met Tyr |
| Ser |
| 245 - # 250 - # 255 |
| - - Lys Thr Glu Gly Ala Leu Thr Thr Pro Tyr Me - #t Thr Leu Lys Gly Ser |
| 260 - # 265 - # 270 |
| - - Val Ile Ala Asn Cys Lys Met Thr Thr Cys Ar - #g Cys Ala Asp Pro Pro |
| 275 - # 280 - # 285 |
| - - Gly Ile Ile Ser Gln Asn Tyr Gly Glu Ala Va - #l Ser Leu Ile Asp Arg |
| 290 - # 295 - # 300 |
| - - His Ser Cys Asn Val Leu Ser Leu Asp Gly Il - #e Thr Leu Arg Leu Ser |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Gly Glu Phe Asp Ala Thr Tyr Gln Lys Asn Il - #e Ser Ile Leu Asp |
| Ser |
| 325 - # 330 - # 335 |
| - - Gln Val Ile Val Thr Gly Asn Leu Asp Ile Se - #r Thr Glu Leu Gly Asn |
| 340 - # 345 - # 350 |
| - - Val Asn Asn Ser Ile Ser Asn Ala Leu Asp Ly - #s Leu Glu Glu Ser Asn |
| 355 - # 360 - # 365 |
| - - Ser Lys Leu Asp Lys Val Asn Val Lys Leu Th - #r Ser Thr Ser Ala Leu |
| 370 - # 375 - # 380 |
| - - Ile Thr Tyr Ile Ala Leu Thr Ala Ile Ser Le - #u Val Cys Gly Ile Leu |
| 385 3 - #90 3 - #95 4 - |
| #00 |
| - - Ser Leu Val Leu Ala Cys Tyr Leu Met Tyr Ly - #s Gln Lys Ala Gln |
| Gln |
| 405 - # 410 - # 415 |
| - - Lys Thr Leu Leu Trp Leu Gly Asn Asn Thr Le - #u Gly Gln Met Arg Ala |
| 420 - # 425 - # 430 |
| - - Thr Thr Lys Met |
| 435 |
| - - - - (2) INFORMATION FOR SEQ ID NO:95: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 430 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:95: |
| - - Phe Phe Gly Gly Val Ile Gly Thr Ile Ala Le - #u Gly Val Ala Thr Ser |
| 1 5 - # 10 - # 15 |
| - - Ala Gln Ile Thr Ala Ala Val Ala Leu Val Gl - #u Ala Lys Gln Ala Arg |
| 20 - # 25 - # 30 |
| - - Ser Asp Ile Glu Lys Leu Lys Glu Ala Ile Ar - #g Asp Thr Asn Lys Ala |
| 35 - # 40 - # 45 |
| - - Val Gln Ser Val Gln Ser Ser Ile Gly Asn Le - #u Ile Val Ala Ile Lys |
| 50 - # 55 - # 60 |
| - - Ser Val Gln Asp Tyr Val Asn Lys Glu Ile Va - #l Pro Ser Ile Ala Arg |
| 65 - #70 - #75 - #80 |
| - - Leu Gly Cys Glu Ala Ala Gly Leu Gln Leu Gl - #y Ile Ala Leu Thr Gln |
| 85 - # 90 - # 95 |
| - - His Tyr Ser Glu Leu Thr Asn Ile Phe Gly As - #p Asn Ile Gly Ser Leu |
| 100 - # 105 - # 110 |
| - - Gln Glu Lys Gly Ile Lys Leu Gln Gly Ile Al - #a Ser Leu Tyr Arg Thr |
| 115 - # 120 - # 125 |
| - - Asn Ile Thr Glu Ile Phe Thr Thr Ser Thr Va - #l Asp Lys Tyr Asp Ile |
| 130 - # 135 - # 140 |
| - - Tyr Asp Leu Leu Phe Thr Glu Ser Ile Lys Va - #l Arg Val Ile Asp Val |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Asp Leu Asn Asp Tyr Ser Ile Thr Leu Gln Va - #l Arg Leu Pro Leu |
| Leu |
| 165 - # 170 - # 175 |
| - - Thr Arg Leu Leu Asn Thr Gln Ile Tyr Arg Va - #l Asp Ser Ile Ser Tyr |
| 180 - # 185 - # 190 |
| - - Asn Ile Gln Asn Arg Glu Trp Tyr Ile Pro Le - #u Pro Ser His Ile Met |
| 195 - # 200 - # 205 |
| - - Thr Lys Gly Ala Phe Leu Gly Gly Ala Asp Va - #l Lys Glu Cys Ile Glu |
| 210 - # 215 - # 220 |
| - - Ala Phe Ser Ser Tyr Ile Cys Pro Ser Asp Pr - #o Gly Phe Val Leu Asn |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - His Glu Met Glu Ser Cys Leu Ser Gly Asn Il - #e Ser Gln Cys Pro |
| Arg |
| 245 - # 250 - # 255 |
| - - Thr Val Val Lys Ser Asp Ile Val Pro Arg Ty - #r Ala Phe Val Asn Gly |
| 260 - # 265 - # 270 |
| - - Gly Val Val Ala Asn Cys Ile Thr Thr Thr Cy - #s Thr Cys Asn Gly Ile |
| 275 - # 280 - # 285 |
| - - Gly Asn Arg Ile Asn Gln Pro Pro Asp Gln Gl - #y Val Lys Ile Ile Thr |
| 290 - # 295 - # 300 |
| - - His Lys Glu Cys Asn Thr Ile Gly Ile Asn Gl - #y Met Leu Phe Asn Thr |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Asn Lys Glu Gly Thr Leu Ala Phe Tyr Thr Pr - #o Asn Asp Ile Thr |
| Leu |
| 325 - # 330 - # 335 |
| - - Asn Asn Ser Val Ala Leu Asp Pro Ile Asp Il - #e Ser Ile Glu Leu Asn |
| 340 - # 345 - # 350 |
| - - Lys Ala Lys Ser Asp Leu Glu Glu Ser Lys Gl - #u Trp Ile Arg Arg Ser |
| 355 - # 360 - # 365 |
| - - Asn Gln Lys Leu Asp Ser Ile Gly Asn Trp Hi - #s Gln Ser Ser Thr Thr |
| 370 - # 375 - # 380 |
| - - Ile Ile Ile Val Leu Ile Met Ile Ile Ile Le - #u Phe Ile Ile Asn Val |
| 385 3 - #90 3 - #95 4 - |
| #00 |
| - - Thr Ile Ile Ile Ile Ala Val Lys Tyr Tyr Ar - #g Ile Gln Lys Arg |
| Asn |
| 405 - # 410 - # 415 |
| - - Arg Val Asp Gln Asn Asp Lys Pro Tyr Val Le - #u Thr Asn Lys |
| 420 - # 425 - # 430 |
| - - - - (2) INFORMATION FOR SEQ ID NO:96: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 221 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:96: |
| - - Gly Leu Phe Gly Ala Ile Ala Gly Phe Ile Gl - #u Asn Gly Trp Glu Gly |
| 1 5 - # 10 - # 15 |
| - - Met Ile Asp Gly Trp Tyr Gly Phe Arg His Gl - #n Asn Ser Glu Gly Thr |
| 20 - # 25 - # 30 |
| - - Gly Gln Ala Ala Asp Leu Lys Ser Thr Gln Al - #a Ala Ile Asp Gln Ile |
| 35 - # 40 - # 45 |
| - - Asn Gly Lys Leu Asn Arg Val Ile Glu Lys Th - #r Asn Glu Lys Phe His |
| 50 - # 55 - # 60 |
| - - Gln Ile Glu Lys Glu Phe Ser Glu Val Glu Gl - #y Arg Ile Gln Asp Leu |
| 65 - #70 - #75 - #80 |
| - - Glu Lys Tyr Val Glu Asp Thr Lys Ile Asp Le - #u Trp Ser Tyr Asn Ala |
| 85 - # 90 - # 95 |
| - - Glu Leu Leu Val Ala Leu Glu Asn Gln His Th - #r Ile Asp Leu Thr Asp |
| 100 - # 105 - # 110 |
| - - Ser Glu Met Asn Lys Leu Phe Glu Lys Thr Ar - #g Arg Gln Leu Arg Glu |
| 115 - # 120 - # 125 |
| - - Asn Ala Glu Glu Met Gly Asn Gly Cys Phe Ly - #s Ile Tyr His Lys Cys |
| 130 - # 135 - # 140 |
| - - Asp Asn Ala Cys Ile Glu Ser Ile Arg Asn Gl - #y Thr Tyr Asp His Asp |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Val Tyr Arg Asp Glu Ala Leu Asn Asn Arg Ph - #e Gln Ile Lys Gly |
| Val |
| 165 - # 170 - # 175 |
| - - Glu Leu Lys Ser Gly Tyr Lys Asp Trp Ile Le - #u Trp Ile Ser Phe Ala |
| 180 - # 185 - # 190 |
| - - Ile Ser Cys Phe Leu Leu Cys Val Val Leu Le - #u Gly Phe Ile Met Trp |
| 195 - # 200 - # 205 |
| - - Ala Cys Gln Arg Gly Asn Ile Arg Cys Asn Il - #e Cys Ile |
| 210 - # 215 - # 220 |
| - - - - (2) INFORMATION FOR SEQ ID NO:97: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 46 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:97: |
| - - Tyr Thr Ser Val Ile Thr Ile Glu Leu Ser As - #n Ile Lys Glu Asn Lys |
| 1 5 - # 10 - # 15 |
| - - Cys Asn Gly Ala Lys Val Lys Leu Ile Lys Gl - #n Glu Leu Asp Lys Tyr |
| 20 - # 25 - # 30 |
| - - Lys Asn Ala Val Thr Glu Leu Gln Leu Leu Me - #t Gln Ser Thr |
| 35 - # 40 - # 45 |
| - - - - (2) INFORMATION FOR SEQ ID NO:98: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 54 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:98: |
| - - Ala Ser Gly Val Ala Val Ser Lys Val Leu Hi - #s Leu Glu Gly Glu Val |
| 1 5 - # 10 - # 15 |
| - - Asn Lys Ile Ala Leu Leu Ser Thr Asn Lys Al - #a Val Val Ser Leu Ser |
| 20 - # 25 - # 30 |
| - - Asn Gly Val Ser Val Leu Thr Ser Lys Val Le - #u Asp Leu Lys Asn Tyr |
| 35 - # 40 - # 45 |
| - - Ile Asp Lys Gln Leu Leu |
| 50 |
| - - - - (2) INFORMATION FOR SEQ ID NO:99: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 53 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:99: |
| - - Gly Glu Pro Ile Ile Asn Phe Tyr Asp Pro Le - #u Val Phe Pro Ser Asp |
| 1 5 - # 10 - # 15 |
| - - Glu Phe Asp Ala Ser Ile Ser Gln Val Asn Gl - #u Lys Ile Asn Gln Ser |
| 20 - # 25 - # 30 |
| - - Leu Ala Phe Ile Arg Lys Ser Asp Glu Leu Le - #u His Asn Val Asn Ala |
| 35 - # 40 - # 45 |
| - - Gly Lys Ser Thr Thr |
| 50 |
| - - - - (2) INFORMATION FOR SEQ ID NO:100: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 70 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:100: |
| - - Gly Thr Ile Ala Leu Gly Val Ala Thr Ser Al - #a Gln Ile Thr Ala Ala |
| 1 5 - # 10 - # 15 |
| - - Val Ala Leu Val Glu Ala Lys Gln Ala Arg Se - #r Asp Ile Glu Lys Leu |
| 20 - # 25 - # 30 |
| - - Lys Glu Ala Ile Arg Asp Thr Asn Lys Ala Va - #l Gln Ser Val Gln Ser |
| 35 - # 40 - # 45 |
| - - Ser Ile Gly Asn Leu Ile Val Ala Ile Lys Se - #r Val Gln Asp Tyr Val |
| 50 - # 55 - # 60 |
| - - Asn Lys Glu Ile Val Pro |
| 65 - #70 |
| - - - - (2) INFORMATION FOR SEQ ID NO:101: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 56 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:101: |
| - - Tyr Thr Pro Asn Asp Ile Thr Leu Asn Asn Se - #r Val Ala Leu Asp Pro |
| 1 5 - # 10 - # 15 |
| - - Ile Asp Ile Ser Ile Glu Leu Asn Lys Ala Ly - #s Ser Asp Leu Glu Glu |
| 20 - # 25 - # 30 |
| - - Ser Lys Glu Trp Ile Arg Arg Ser Asn Gln Ly - #s Leu Asp Ser Ile Gly |
| 35 - # 40 - # 45 |
| - - Asn Trp His Gln Ser Ser Thr Thr |
| 50 - # 55 |
| - - - - (2) INFORMATION FOR SEQ ID NO:102: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 249 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:102: |
| - - Arg Asn Lys Arg Gly Val Phe Val Leu Gly Ph - #e Leu Gly Phe Leu Ala |
| 1 5 - # 10 - # 15 |
| - - Thr Ala Gly Ser Ala Met Gly Ala Ala Ser Xa - #a Xaa Xaa Xaa Ala Gln |
| 20 - # 25 - # 30 |
| - - Ser Arg Thr Leu Leu Ala Gly Ile Val Gln Gl - #n Gln Gln Gln Leu Leu |
| 35 - # 40 - # 45 |
| - - Asp Val Val Lys Arg Gln Gln Glu Leu Leu Ar - #g Leu Thr Val Trp Gly |
| 50 - # 55 - # 60 |
| - - Thr Lys Asn Leu Gln Thr Arg Val Thr Ala Il - #e Glu Lys Tyr Leu Lys |
| 65 - #70 - #75 - #80 |
| - - Asp Gln Ala Gln Leu Asn Ala Trp Gly Cys Al - #a Phe Arg Gln Val Cys |
| 85 - # 90 - # 95 |
| - - His Thr Thr Val Pro Trp Pro Asn Ala Ser Le - #u Thr Pro Asp Trp Asn |
| 100 - # 105 - # 110 |
| - - Asn Asp Thr Trp Gln Glu Trp Glu Arg Lys Va - #l Asp Phe Leu Glu Glu |
| 115 - # 120 - # 125 |
| - - Asn Ile Thr Ala Leu Leu Glu Glu Ala Gln Il - #e Gln Gln Glu Lys Asn |
| 130 - # 135 - # 140 |
| - - Met Tyr Glu Leu Gln Lys Leu Asn Ser Trp As - #p Val Phe Gly Asn Xaa |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xa - #a Xaa Xaa Xaa Xaa |
| Xaa |
| 165 - # 170 - # 175 |
| - - Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Il - #e Tyr Ile Val Met Leu |
| 180 - # 185 - # 190 |
| - - Ala Lys Leu Arg Gln Gly Tyr Arg Pro Val Ph - #e Ser Ser Pro Pro Ser |
| 195 - # 200 - # 205 |
| - - Tyr Phe Gln Xaa Thr His Thr Gln Gln Asp Pr - #o Ala Leu Pro Thr Arg |
| 210 - # 215 - # 220 |
| - - Glu Gly Lys Glu Gly Asp Gly Gly Glu Gly Gl - #y Gly Asn Ser Ser Trp |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Pro Trp Gln Ile Glu Tyr Ile His Phe |
| 245 |
| - - - - (2) INFORMATION FOR SEQ ID NO:103: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 856 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:103: |
| - - Met Thr Arg Arg Arg Val Leu Ser Val Val Va - #l Leu Leu Ala Ala |
| Leu |
| 1 5 - # 10 - # 15 |
| - - Ala Cys Arg Leu Gly Ala Gln Thr Pro Glu Gl - #n Pro Ala Pro Pro Ala |
| 20 - # 25 - # 30 |
| - - Thr Thr Val Gln Pro Thr Ala Thr Arg Gln Gl - #n Thr Ser Phe Pro Phe |
| 35 - # 40 - # 45 |
| - - Arg Val Cys Glu Leu Ser Ser His Gly Asp Le - #u Phe Arg Phe Ser Ser |
| 50 - # 55 - # 60 |
| - - Asp Ile Gln Cys Pro Ser Phe Gly Thr Arg Gl - #u Asn His Thr Glu Gly |
| 65 - #70 - #75 - #80 |
| - - Leu Leu Met Val Phe Lys Asp Asn Ile Ile Pr - #o Tyr Ser Phe Lys Val |
| 85 - # 90 - # 95 |
| - - Arg Ser Tyr Thr Lys Ile Val Thr Asn Ile Le - #u Ile Tyr Asn Gly Trp |
| 100 - # 105 - # 110 |
| - - Tyr Ala Asp Ser Val Thr Asn Arg His Glu Gl - #u Lys Phe Ser Val Asp |
| 115 - # 120 - # 125 |
| - - Ser Tyr Glu Thr Asp Gln Met Asp Thr Ile Ty - #r Gln Cys Tyr Asn Ala |
| 130 - # 135 - # 140 |
| - - Val Lys Met Thr Lys Asp Gly Leu Thr Arg Va - #l Tyr Val Asp Arg Asp |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Gly Val Asn Ile Thr Val Asn Leu Lys Pro Th - #r Gly Gly Leu Ala |
| Asn |
| 165 - # 170 - # 175 |
| - - Gly Val Arg Arg Tyr Ala Ser Gln Thr Glu Le - #u Tyr Asp Ala Pro Gly |
| 180 - # 185 - # 190 |
| - - Trp Leu Ile Trp Thr Tyr Arg Thr Arg Thr Th - #r Val Asn Cys Leu Ile |
| 195 - # 200 - # 205 |
| - - Thr Asp Met Met Ala Lys Ser Asn Ser Pro Ph - #e Asp Phe Phe Val Thr |
| 210 - # 215 - # 220 |
| - - Thr Thr Gly Gln Thr Val Glu Met Ser Pro Ph - #e Tyr Asp Gly Lys Asn |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Lys Glu Thr Phe His Glu Arg Ala Asp Ser Ph - #e His Val Arg Thr |
| Asn |
| 245 - # 250 - # 255 |
| - - Tyr Lys Ile Val Asp Tyr Asp Asn Arg Gly Th - #r Asn Pro Gln Gly Glu |
| 260 - # 265 - # 270 |
| - - Arg Arg Ala Phe Leu Asp Lys Gly Thr Tyr Th - #r Leu Ser Trp Lys Leu |
| 275 - # 280 - # 285 |
| - - Glu Asn Arg Thr Ala Tyr Cys Pro Leu Gln Hi - #s Trp Gln Thr Phe Asp |
| 290 - # 295 - # 300 |
| - - Ser Thr Ile Ala Thr Glu Thr Gly Lys Ser Il - #e His Phe Val Thr Asp |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Glu Gly Thr Ser Ser Phe Val Thr Asn Thr Th - #r Val Gly Ile Glu |
| Leu |
| 325 - # 330 - # 335 |
| - - Pro Asp Ala Phe Lys Cys Ile Glu Glu Gln Va - #l Asn Lys Thr His Glu |
| 340 - # 345 - # 350 |
| - - Lys Tyr Glu Ala Val Gln Asp Arg Tyr Thr Ly - #s Gly Gln Glu Ala Ile |
| 355 - # 360 - # 365 |
| - - Thr Tyr Phe Ile Thr Ser Gly Gly Leu Leu Le - #u Ala Trp Leu Pro Leu |
| 370 - # 375 - # 380 |
| - - Thr Pro Arg Ser Leu Ala Thr Val Lys Asn Le - #u Thr Glu Leu Thr Thr |
| 385 3 - #90 3 - #95 4 - |
| #00 |
| - - Pro Thr Ser Ser Pro Pro Ser Ser Pro Ser Pr - #o Pro Ala Pro Ser |
| Ala |
| 405 - # 410 - # 415 |
| - - Ala Arg Gly Ser Thr Pro Ala Ala Val Leu Ar - #g Arg Arg Arg Arg Asp |
| 420 - # 425 - # 430 |
| - - Ala Gly Asn Ala Thr Thr Pro Val Pro Pro Th - #r Ala Pro Gly Lys Ser |
| 435 - # 440 - # 445 |
| - - Leu Gly Thr Leu Asn Asn Pro Ala Thr Val Gl - #n Ile Gln Phe Ala Tyr |
| 450 - # 455 - # 460 |
| - - Asp Ser Leu Arg Arg Gln Ile Asn Arg Met Le - #u Gly Asp Leu Ala Arg |
| 465 4 - #70 4 - #75 4 - |
| #80 |
| - - Ala Trp Cys Leu Glu Gln Lys Arg Gln Asn Me - #t Val Leu Arg Glu |
| Leu |
| 485 - # 490 - # 495 |
| - - Thr Lys Ile Asn Pro Thr Thr Val Met Ser Se - #r Ile Tyr Gly Lys Ala |
| 500 - # 505 - # 510 |
| - - Val Ala Ala Lys Arg Leu Gly Asp Val Ile Se - #r Val Ser Gln Cys Val |
| 515 - # 520 - # 525 |
| - - Pro Val Asn Gln Ala Thr Val Thr Leu Arg Ly - #s Ser Met Arg Val Pro |
| 530 - # 535 - # 540 |
| - - Gly Ser Glu Thr Met Cys Tyr Ser Arg Pro Le - #u Val Ser Phe Ser Phe |
| 545 5 - #50 5 - #55 5 - |
| #60 |
| - - Ile Asn Asp Thr Lys Thr Tyr Glu Gly Gln Le - #u Gly Thr Asp Asn |
| Glu |
| 565 - # 570 - # 575 |
| - - Ile Phe Leu Thr Lys Lys Met Thr Glu Val Cy - #s Gln Ala Thr Ser Gln |
| 580 - # 585 - # 590 |
| - - Tyr Tyr Phe Gln Ser Gly Asn Glu Ile His Va - #l Tyr Asn Asp Tyr His |
| 595 - # 600 - # 605 |
| - - His Phe Lys Thr Ile Glu Leu Asp Gly Ile Al - #a Thr Leu Gln Thr Phe |
| 610 - # 615 - # 620 |
| - - Ile Ser Leu Asn Thr Ser Leu Ile Glu Asn Il - #e Asp Phe Ala Ser Leu |
| 625 6 - #30 6 - #35 6 - |
| #40 |
| - - Glu Leu Tyr Ser Arg Asp Glu Gln Arg Ala Se - #r Asn Val Phe Asp |
| Leu |
| 645 - # 650 - # 655 |
| - - Glu Gly Ile Phe Arg Glu Tyr Asn Phe Gln Al - #a Gln Asn Ile Ala Gly |
| 660 - # 665 - # 670 |
| - - Leu Arg Lys Asp Leu Asp Asn Ala Val Ser As - #n Gly Arg Asn Gln Phe |
| 675 - # 680 - # 685 |
| - - Val Asp Gly Leu Gly Glu Leu Met Asp Ser Le - #u Gly Ser Val Gly Gln |
| 690 - # 695 - # 700 |
| - - Ser Ile Thr Asn Leu Val Ser Thr Val Gly Gl - #y Leu Phe Ser Ser Leu |
| 705 7 - #10 7 - #15 7 - |
| #20 |
| - - Val Ser Gly Phe Ile Ser Phe Phe Lys Asn Pr - #o Phe Gly Gly Met |
| Leu |
| 725 - # 730 - # 735 |
| - - Ile Leu Val Leu Val Ala Gly Val Val Ile Le - #u Val Ile Ser Leu Thr |
| 740 - # 745 - # 750 |
| - - Arg Arg Thr Arg Gln Met Ser Gln Gln Pro Va - #l Gln Met Leu Tyr Pro |
| 755 - # 760 - # 765 |
| - - Gly Ile Asp Glu Leu Ala Gln Gln His Ala Se - #r Gly Glu Gly Pro Gly |
| 770 - # 775 - # 780 |
| - - Ile Asn Pro Ile Ser Lys Thr Glu Leu Gln Al - #a Ile Met Leu Ala Leu |
| 785 7 - #90 7 - #95 8 - |
| #00 |
| - - His Glu Gln Asn Gln Glu Gln Lys Arg Ala Al - #a Gln Arg Ala Ala |
| Gly |
| 805 - # 810 - # 815 |
| - - Pro Ser Val Ala Ser Arg Ala Leu Gln Ala Al - #a Arg Asp Arg Phe Pro |
| 820 - # 825 - # 830 |
| - - Gly Leu Arg Arg Arg Arg Tyr His Asp Pro Gl - #u Thr Ala Ala Ala Leu |
| 835 - # 840 - # 845 |
| - - Leu Gly Glu Ala Glu Thr Glu Phe |
| 850 - # 855 |
| - - - - (2) INFORMATION FOR SEQ ID NO:104: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 245 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:104: |
| - - Met Met Asp Pro Asn Ser Thr Ser Glu Asp Va - #l Lys Phe Thr Pro Asp |
| 1 5 - # 10 - # 15 |
| - - Pro Tyr Gln Val Pro Phe Val Gln Ala Phe As - #p Gln Ala Thr Arg Val |
| 20 - # 25 - # 30 |
| - - Tyr Gln Asp Leu Gly Gly Pro Ser Gln Ala Pr - #o Leu Pro Cys Val Leu |
| 35 - # 40 - # 45 |
| - - Trp Pro Val Leu Pro Glu Pro Leu Pro Gln Gl - #y Gln Leu Thr Ala Tyr |
| 50 - # 55 - # 60 |
| - - His Val Ser Thr Ala Pro Thr Gly Ser Trp Ph - #e Ser Ala Pro Gln Pro |
| 65 - #70 - #75 - #80 |
| - - Ala Pro Glu Asn Ala Tyr Gln Ala Tyr Ala Al - #a Pro Gln Leu Phe Pro |
| 85 - # 90 - # 95 |
| - - Val Ser Asp Ile Thr Gln Asn Gln Gln Thr As - #n Gln Ala Gly Gly Glu |
| 100 - # 105 - # 110 |
| - - Ala Pro Gln Pro Gly Asp Asn Ser Thr Val Gl - #n Thr Ala Ala Ala Val |
| 115 - # 120 - # 125 |
| - - Val Phe Ala Cys Pro Gly Ala Asn Gln Gly Gl - #n Gln Leu Ala Asp Ile |
| 130 - # 135 - # 140 |
| - - Gly Val Pro Gln Pro Ala Pro Val Ala Ala Pr - #o Ala Arg Arg Thr Arg |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Lys Pro Gln Gln Pro Glu Ser Leu Glu Glu Cy - #s Asp Ser Glu Leu |
| Glu |
| 165 - # 170 - # 175 |
| - - Ile Lys Arg Tyr Lys Asn Arg Val Ala Ser Ar - #g Lys Cys Arg Ala Lys |
| 180 - # 185 - # 190 |
| - - Phe Lys Gln Leu Leu Gln His Tyr Arg Glu Va - #l Ala Ala Ala Lys Ser |
| 195 - # 200 - # 205 |
| - - Ser Glu Asn Asp Arg Leu Arg Leu Leu Leu Ly - #s Gln Met Cys Pro Ser |
| 210 - # 215 - # 220 |
| - - Leu Asp Val Asp Ser Ile Ile Pro Arg Thr Pr - #o Asp Val Leu His Glu |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Asp Leu Leu Asn Phe |
| 245 |
| - - - - (2) INFORMATION FOR SEQ ID NO:105: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 438 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:105: |
| - - Phe Ala Gly Val Val Leu Ala Gly Ala Ala Le - #u Gly Val Ala Thr |
| Ala |
| 1 5 - # 10 - # 15 |
| - - Ala Gln Ile Thr Ala Gly Ile Ala Leu His Gl - #n Ser Met Leu Asn Ser |
| 20 - # 25 - # 30 |
| - - Gln Ala Ile Asp Asn Leu Arg Ala Ser Leu Gl - #u Thr Thr Asn Gln Ala |
| 35 - # 40 - # 45 |
| - - Ile Glu Ala Ile Arg Gln Ala Gly Gln Glu Me - #t Ile Leu Ala Val Gln |
| 50 - # 55 - # 60 |
| - - Gly Val Gln Asp Tyr Ile Asn Asn Glu Leu Il - #e Pro Ser Met Asn Gln |
| 65 - #70 - #75 - #80 |
| - - Leu Ser Cys Asp Leu Ile Gly Gln Lys Leu Gl - #y Leu Lys Leu Leu Arg |
| 85 - # 90 - # 95 |
| - - Tyr Tyr Thr Glu Ile Leu Ser Leu Phe Gly Pr - #o Ser Leu Arg Asp Pro |
| 100 - # 105 - # 110 |
| - - Ile Ser Ala Glu Ile Ser Ile Gln Ala Leu Se - #r Tyr Ala Leu Gly Gly |
| 115 - # 120 - # 125 |
| - - Asp Ile Asn Lys Val Leu Glu Lys Leu Gly Ty - #r Ser Gly Gly Asp Leu |
| 130 - # 135 - # 140 |
| - - Leu Gly Ile Leu Glu Ser Arg Gly Ile Lys Al - #a Arg Ile Thr His Val |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Asp Thr Glu Ser Tyr Phe Ile Val Leu Ser Il - #e Ala Tyr Pro Thr |
| Leu |
| 165 - # 170 - # 175 |
| - - Ser Glu Ile Lys Gly Val Ile Val His Arg Le - #u Glu Gly Val Ser Tyr |
| 180 - # 185 - # 190 |
| - - Asn Ile Gly Ser Gln Glu Trp Tyr Thr Thr Va - #l Pro Lys Tyr Val Ala |
| 195 - # 200 - # 205 |
| - - Thr Gln Gly Tyr Leu Ile Ser Asn Phe Asp Gl - #u Ser Ser Cys Thr Phe |
| 210 - # 215 - # 220 |
| - - Met Pro Glu Gly Thr Val Cys Ser Gln Asn Al - #a Leu Tyr Pro Met Ser |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Pro Leu Leu Gln Glu Cys Leu Arg Gly Ser Th - #r Lys Ser Cys Ala |
| Arg |
| 245 - # 250 - # 255 |
| - - Thr Leu Val Ser Gly Ser Phe Gly Asn Arg Ph - #e Ile Leu Ser Gln Gly |
| 260 - # 265 - # 270 |
| - - Asn Leu Ile Ala Asn Cys Ala Ser Ile Leu Cy - #s Lys Cys Tyr Thr Thr |
| 275 - # 280 - # 285 |
| - - Gly Thr Ile Ile Asn Gln Asp Pro Asp Lys Il - #e Leu Thr Tyr Ile Ala |
| 290 - # 295 - # 300 |
| - - Ala Asp His Cys Pro Val Val Glu Val Asn Gl - #y Val Thr Ile Gln Val |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Gly Ser Arg Arg Tyr Pro Asp Ala Val Tyr Le - #u His Arg Ile Asp |
| Leu |
| 325 - # 330 - # 335 |
| - - Gly Pro Pro Ile Ser Leu Glu Arg Leu Asp Va - #l Gly Thr Asn Leu Gly |
| 340 - # 345 - # 350 |
| - - Asn Ala Ile Ala Lys Leu Glu Asp Ala Lys Gl - #u Leu Leu Glu Ser Ser |
| 355 - # 360 - # 365 |
| - - Asp Gln Ile Leu Arg Ser Met Lys Gly Leu Se - #r Ser Thr Ser Ile Val |
| 370 - # 375 - # 380 |
| - - Tyr Ile Leu Ile Ala Val Cys Leu Gly Gly Le - #u Ile Gly Ile Pro Ala |
| 385 3 - #90 3 - #95 4 - |
| #00 |
| - - Leu Ile Cys Cys Cys Arg Gly Arg Cys Asn Ly - #s Lys Gly Glu Gln |
| Val |
| 405 - # 410 - # 415 |
| - - Gly Met Ser Arg Pro Gly Leu Lys Pro Asp Le - #u Thr Gly Thr Ser Lys |
| 420 - # 425 - # 430 |
| - - Ser Tyr Val Arg Ser Leu |
| 435 |
| - - - - (2) INFORMATION FOR SEQ ID NO:106: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 389 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:106: |
| - - Met Gly Gln Asn Leu Ser Thr Ser Asn Pro Le - #u Gly Phe Phe Pro Asp |
| 1 5 - # 10 - # 15 |
| - - His Gln Leu Asp Pro Ala Phe Arg Ala Asn Th - #r Ala Asn Pro Asp Trp |
| 20 - # 25 - # 30 |
| - - Asp Phe Asn Pro Asn Lys Asp Thr Trp Pro As - #p Ala Asn Lys Val Gly |
| 35 - # 40 - # 45 |
| - - Ala Gly Ala Phe Gly Leu Gly Phe Thr Pro Pr - #o His Gly Gly Leu Leu |
| 50 - # 55 - # 60 |
| - - Gly Trp Ser Pro Gln Ala Gln Gly Ile Leu Gl - #n Thr Leu Pro Ala Asn |
| 65 - #70 - #75 - #80 |
| - - Pro Pro Pro Ala Ser Thr Asn Arg Gln Ser Gl - #y Arg Gln Pro Thr Pro |
| 85 - # 90 - # 95 |
| - - Leu Ser Pro Pro Leu Arg Asn Thr His Pro Gl - #n Ala Met Gln Trp Asn |
| 100 - # 105 - # 110 |
| - - Ser Thr Thr Phe His Gln Thr Leu Gln Asp Pr - #o Arg Val Arg Gly Leu |
| 115 - # 120 - # 125 |
| - - Tyr Phe Pro Ala Gly Gly Ser Ser Ser Gly Th - #r Val Asn Pro Val Leu |
| 130 - # 135 - # 140 |
| - - Thr Thr Ala Ser Pro Leu Ser Ser Ile Phe Se - #r Arg Ile Gly Asp Pro |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Ala Leu Asn Met Glu Asn Ile Thr Ser Gly Ph - #e Leu Gly Pro Leu |
| Leu |
| 165 - # 170 - # 175 |
| - - Val Leu Gln Ala Gly Phe Phe Leu Leu Thr Ar - #g Ile Leu Thr Ile Pro |
| 180 - # 185 - # 190 |
| - - Gln Ser Leu Asp Ser Trp Trp Thr Ser Leu As - #n Phe Leu Gly Gly Thr |
| 195 - # 200 - # 205 |
| - - Thr Val Cys Leu Gly Gln Asn Ser Gln Ser Pr - #o Thr Ser Asn His Ser |
| 210 - # 215 - # 220 |
| - - Pro Thr Ser Cys Pro Pro Thr Cys Pro Gly Ty - #r Arg Trp Met Cys Leu |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Arg Arg Phe Ile Ile Phe Leu Phe Ile Leu Le - #u Leu Cys Leu Ile |
| Phe |
| 245 - # 250 - # 255 |
| - - Leu Leu Val Leu Leu Asp Tyr Gln Gly Met Le - #u Pro Val Cys Pro Leu |
| 260 - # 265 - # 270 |
| - - Ile Pro Gly Ser Ser Thr Thr Ser Thr Gly Pr - #o Cys Arg Thr Cys Met |
| 275 - # 280 - # 285 |
| - - Thr Thr Ala Gln Gly Thr Ser Met Tyr Pro Se - #r Cys Cys Cys Thr Lys |
| 290 - # 295 - # 300 |
| - - Pro Ser Asp Gly Asn Cys Thr Cys Ile Pro Il - #e Pro Ser Ser Trp Ala |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Phe Gly Lys Phe Leu Trp Glu Trp Ala Ser Al - #a Arg Phe Ser Trp |
| Leu |
| 325 - # 330 - # 335 |
| - - Ser Leu Leu Val Pro Phe Val Gln Trp Phe Va - #l Gly Leu Ser Pro Thr |
| 340 - # 345 - # 350 |
| - - Val Trp Leu Ser Val Ile Trp Met Met Trp Ty - #r Trp Gly Pro Ser Leu |
| 355 - # 360 - # 365 |
| - - Tyr Ser Ile Leu Ser Pro Phe Leu Pro Leu Le - #u Pro Ile Phe Phe Cys |
| 370 - # 375 - # 380 |
| - - Leu Trp Val Tyr Ile |
| 385 |
| - - - - (2) INFORMATION FOR SEQ ID NO:107: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 192 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:107: |
| - - Ala Ile Gln Leu Ile Pro Leu Phe Val Gly Le - #u Gly Ile Thr Thr Ala |
| 1 5 - # 10 - # 15 |
| - - Val Ser Thr Gly Ala Ala Gly Leu Gly Val Se - #r Ile Thr Gln Tyr Thr |
| 20 - # 25 - # 30 |
| - - Lys Leu Ser His Gln Leu Ile Ser Asp Val Gl - #n Ala Ile Ser Ser Thr |
| 35 - # 40 - # 45 |
| - - Ile Gln Asp Leu Gln Asp Gln Val Asp Ser Le - #u Ala Glu Val Val Leu |
| 50 - # 55 - # 60 |
| - - Gln Asn Arg Arg Gly Leu Asp Leu Leu Thr Al - #a Glu Gln Gly Gly Ile |
| 65 - #70 - #75 - #80 |
| - - Cys Leu Ala Leu Gln Glu Lys Cys Cys Phe Ty - #r Ala Asn Lys Ser Gly |
| 85 - # 90 - # 95 |
| - - Ile Val Arg Asp Lys Ile Lys Asn Leu Gln As - #p Asp Leu Glu Arg Arg |
| 100 - # 105 - # 110 |
| - - Arg Arg Gln Leu Ile Asp Asn Pro Phe Trp Th - #r Ser Phe His Gly Phe |
| 115 - # 120 - # 125 |
| - - Leu Pro Tyr Val Met Pro Leu Leu Gly Pro Le - #u Leu Cys Leu Leu Leu |
| 130 - # 135 - # 140 |
| - - Val Leu Ser Phe Gly Pro Ile Ile Phe Asn Ly - #s Leu Met Thr Phe Ile |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Lys His Gln Ile Glu Ser Ile Gln Ala Lys Pr - #o Ile Gln Val His |
| Tyr |
| 165 - # 170 - # 175 |
| - - His Arg Leu Glu Gln Glu Asp Ser Gly Gly Se - #r Tyr Leu Thr Leu Thr |
| 180 - # 185 - # 190 |
| - - - - (2) INFORMATION FOR SEQ ID NO:108: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 154 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:108: |
| - - Met Lys Ala Gln Lys Gly Phe Thr Leu Ile Gl - #u Leu Met Ile Val Val |
| 1 5 - # 10 - # 15 |
| - - Ala Ile Ile Gly Ile Leu Ala Ala Ile Ala Il - #e Pro Gln Tyr Gln Asp |
| 20 - # 25 - # 30 |
| - - Tyr Thr Ala Arg Thr Gln Val Thr Arg Ala Va - #l Ser Glu Val Ser Ala |
| 35 - # 40 - # 45 |
| - - Leu Lys Thr Ala Ala Glu Ser Ala Ile Leu Gl - #u Gly Lys Glu Ile Val |
| 50 - # 55 - # 60 |
| - - Ser Ser Ala Thr Pro Lys Asp Thr Gln Tyr As - #p Ile Gly Phe Thr Glu |
| 65 - #70 - #75 - #80 |
| - - Ser Thr Leu Leu Asp Gly Ser Gly Lys Ser Gl - #n Ile Gln Val Thr Asp |
| 85 - # 90 - # 95 |
| - - Asn Gln Asp Gly Thr Val Glu Leu Val Ala Th - #r Leu Gly Lys Ser Ser |
| 100 - # 105 - # 110 |
| - - Gly Ser Ala Ile Lys Gly Ala Val Ile Thr Va - #l Ser Arg Lys Asn Asp |
| 115 - # 120 - # 125 |
| - - Gly Val Trp Asn Cys Lys Ile Thr Lys Thr Pr - #o Thr Ala Trp Lys Pro |
| 130 - # 135 - # 140 |
| - - Asn Tyr Ala Pro Ala Asn Cys Pro Lys Ser |
| 145 1 - #50 |
| - - - - (2) INFORMATION FOR SEQ ID NO:109: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 167 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:109: |
| - - Met Asn Thr Leu Gln Lys Gly Phe Thr Leu Il - #e Glu Leu Met Ile Val |
| 1 5 - # 10 - # 15 |
| - - Ile Ala Ile Val Gly Ile Leu Ala Ala Val Al - #a Leu Pro Ala Tyr Gln |
| 20 - # 25 - # 30 |
| - - Asp Tyr Thr Ala Arg Ala Gln Val Ser Glu Al - #a Ile Leu Leu Ala Glu |
| 35 - # 40 - # 45 |
| - - Gly Gln Lys Ser Ala Val Thr Glu Tyr Tyr Le - #u Asn His Gly Ile Trp |
| 50 - # 55 - # 60 |
| - - Pro Lys Asp Asn Thr Ser Ala Gly Val Ala Se - #r Ser Ser Ser Ile Lys |
| 65 - #70 - #75 - #80 |
| - - Gly Lys Tyr Val Lys Glu Val Lys Val Glu As - #n Gly Val Val Thr Ala |
| 85 - # 90 - # 95 |
| - - Thr Met Asn Ser Ser Asn Val Asn Lys Glu Il - #e Gln Gly Lys Lys Leu |
| 100 - # 105 - # 110 |
| - - Ser Leu Trp Ala Lys Arg Gln Asp Gly Ser Va - #l Lys Trp Phe Cys Gly |
| 115 - # 120 - # 125 |
| - - Gln Pro Val Thr Arg Asn Ala Lys Asp Asp Th - #r Val Thr Ala Asp Ala |
| 130 - # 135 - # 140 |
| - - Thr Gly Asn Asp Gly Lys Ile Asp Thr Lys Hi - #s Leu Pro Ser Thr Cys |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Arg Asp Asn Phe Asp Ala Ser |
| 165 |
| - - - - (2) INFORMATION FOR SEQ ID NO:110: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 213 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:110: |
| - - Met Lys Lys Thr Leu Leu Gly Ser Leu Ile Le - #u Leu Ala Phe Ala |
| Gly |
| 1 5 - # 10 - # 15 |
| - - Asn Val Gln Ala Asp Ile Asn Thr Glu Thr Se - #r Gly Lys Val Thr Phe |
| 20 - # 25 - # 30 |
| - - Phe Gly Lys Val Val Glu Asn Thr Cys Lys Va - #l Lys Thr Glu His Lys |
| 35 - # 40 - # 45 |
| - - Asn Leu Ser Val Val Leu Asn Asp Val Gly Ly - #s Asn Ser Leu Ser Thr |
| 50 - # 55 - # 60 |
| - - Lys Val Asn Thr Ala Met Pro Thr Pro Phe Th - #r Ile Thr Leu Gln Asn |
| 65 - #70 - #75 - #80 |
| - - Cys Asp Pro Thr Thr Ala Asn Gly Thr Ala As - #n Lys Ala Asn Lys Val |
| 85 - # 90 - # 95 |
| - - Gly Leu Tyr Phe Tyr Ser Trp Lys Asn Val As - #p Lys Glu Asn Asn Phe |
| 100 - # 105 - # 110 |
| - - Thr Leu Lys Asn Glu Gln Thr Thr Ala Asp Ty - #r Ala Thr Asn Val Asn |
| 115 - # 120 - # 125 |
| - - Ile Gln Leu Met Glu Ser Asn Gly Thr Lys Al - #a Ile Ser Val Val Gly |
| 130 - # 135 - # 140 |
| - - Lys Glu Thr Glu Asp Phe Met His Thr Asn As - #n Asn Gly Val Ala Leu |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Asn Gln Thr His Pro Asn Asn Ala His Ile Se - #r Gly Ser Thr Gln |
| Leu |
| 165 - # 170 - # 175 |
| - - Thr Thr Gly Thr Asn Glu Leu Pro Leu His Ph - #e Ile Ala Gln Tyr Tyr |
| 180 - # 185 - # 190 |
| - - Ala Thr Asn Lys Ala Thr Ala Gly Lys Val Gl - #n Ser Ser Val Asp Phe |
| 195 - # 200 - # 205 |
| - - Gln Ile Ala Tyr Glu |
| 210 |
| - - - - (2) INFORMATION FOR SEQ ID NO:111: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 234 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:111: |
| - - Met Asn Lys Lys Leu Leu Met Asn Phe Phe Il - #e Val Ser Pro Leu Leu |
| 1 5 - # 10 - # 15 |
| - - Leu Ala Thr Thr Ala Thr Asp Phe Thr Pro Va - #l Pro Leu Ser Ser Asn |
| 20 - # 25 - # 30 |
| - - Gln Ile Ile Lys Thr Ala Lys Ala Ser Thr As - #n Asp Asn Ile Lys Asp |
| 35 - # 40 - # 45 |
| - - Leu Leu Asp Trp Tyr Ser Ser Gly Ser Asp Th - #r Phe Thr Asn Ser Glu |
| 50 - # 55 - # 60 |
| - - Val Leu Asp Asn Ser Leu Gly Ser Met Arg Il - #e Lys Asn Thr Asp Gly |
| 65 - #70 - #75 - #80 |
| - - Ser Ile Ser Leu Ile Ile Phe Pro Ser Pro Ty - #r Tyr Ser Pro Ala Phe |
| 85 - # 90 - # 95 |
| - - Thr Lys Gly Glu Lys Val Asp Leu Asn Thr Ly - #s Arg Thr Lys Lys Ser |
| 100 - # 105 - # 110 |
| - - Gln His Thr Ser Glu Gly Thr Tyr Ile His Ph - #e Gln Ile Ser Gly Val |
| 115 - # 120 - # 125 |
| - - Thr Asn Thr Glu Lys Leu Pro Thr Pro Ile Gl - #u Leu Pro Leu Lys Val |
| 130 - # 135 - # 140 |
| - - Lys Val His Gly Lys Asp Ser Pro Leu Lys Ty - #r Gly Pro Lys Phe Asp |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Lys Lys Gln Leu Ala Ile Ser Thr Leu Asp Ph - #e Glu Ile Arg His |
| Gln |
| 165 - # 170 - # 175 |
| - - Leu Thr Gln Ile His Gly Leu Tyr Arg Ser Se - #r Asp Lys Thr Gly Gly |
| 180 - # 185 - # 190 |
| - - Tyr Trp Lys Ile Thr Met Asn Asp Gly Ser Th - #r Tyr Gln Ser Asp Leu |
| 195 - # 200 - # 205 |
| - - Ser Lys Lys Phe Glu Tyr Asn Thr Glu Lys Pr - #o Pro Ile Asn Ile Asp |
| 210 - # 215 - # 220 |
| - - Glu Ile Lys Thr Ile Glu Ala Glu Ile Asn |
| 225 2 - #30 |
| - - - - (2) INFORMATION FOR SEQ ID NO:112: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 257 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:112: |
| - - Met Lys Lys Thr Ala Phe Ile Leu Leu Leu Ph - #e Ile Ala Leu Thr Leu |
| 1 5 - # 10 - # 15 |
| - - Thr Thr Ser Pro Leu Val Asn Gly Ser Glu Ly - #s Ser Glu Glu Ile Asn |
| 20 - # 25 - # 30 |
| - - Glu Lys Asp Leu Arg Lys Lys Ser Glu Leu Gl - #n Arg Asn Ala Leu Ser |
| 35 - # 40 - # 45 |
| - - Asn Leu Arg Gln Ile Tyr Tyr Tyr Asn Glu Ly - #s Ala Ile Thr Glu Asn |
| 50 - # 55 - # 60 |
| - - Lys Glu Ser Asp Asp Gln Phe Leu Glu Asn Th - #r Leu Leu Phe Lys Gly |
| 65 - #70 - #75 - #80 |
| - - Phe Phe Thr Gly His Pro Trp Tyr Asn Asp Le - #u Leu Val Asp Leu Gly |
| 85 - # 90 - # 95 |
| - - Ser Lys Asp Ala Thr Asn Lys Tyr Lys Gly Ly - #s Lys Val Asp Leu Tyr |
| 100 - # 105 - # 110 |
| - - Gly Ala Tyr Tyr Gly Tyr Gln Cys Ala Gly Gl - #y Thr Pro Asn Lys Thr |
| 115 - # 120 - # 125 |
| - - Ala Cys Met Tyr Gly Gly Val Thr Leu His As - #p Asn Asn Arg Leu Thr |
| 130 - # 135 - # 140 |
| - - Glu Glu Lys Lys Val Pro Ile Asn Leu Trp Il - #e Asp Gly Lys Gln Thr |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Thr Val Pro Ile Asp Lys Val Lys Thr Ser Ly - #s Lys Glu Val Thr |
| Val |
| 165 - # 170 - # 175 |
| - - Gln Glu Leu Asp Leu Gln Ala Arg His Tyr Le - #u His Gly Lys Phe Gly |
| 180 - # 185 - # 190 |
| - - Leu Tyr Asn Ser Asp Ser Phe Gly Gly Lys Va - #l Gln Arg Gly Leu Ile |
| 195 - # 200 - # 205 |
| - - Val Phe His Ser Ser Glu Gly Ser Thr Val Se - #r Tyr Asp Leu Phe Asp |
| 210 - # 215 - # 220 |
| - - Ala Gln Gly Gln Tyr Pro Asp Thr Leu Leu Ar - #g Ile Tyr Arg Asp Asn |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Lys Thr Ile Asn Ser Glu Asn Leu His Ile As - #p Leu Tyr Leu Tyr |
| Thr |
| 245 - # 250 - # 255 |
| - - Thr |
| - - - - (2) INFORMATION FOR SEQ ID NO:113: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 257 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:113: |
| - - Met Lys Lys Thr Ala Phe Thr Leu Leu Leu Ph - #e Ile Ala Leu Thr Leu |
| 1 5 - # 10 - # 15 |
| - - Thr Thr Ser Pro Leu Val Asn Gly Ser Glu Ly - #s Ser Glu Glu Ile Asn |
| 20 - # 25 - # 30 |
| - - Glu Lys Asp Leu Arg Lys Lys Ser Glu Leu Gl - #n Gly Thr Ala Leu Gly |
| 35 - # 40 - # 45 |
| - - Asn Leu Lys Gln Ile Tyr Tyr Tyr Asn Glu Ly - #s Ala Lys Thr Glu Asn |
| 50 - # 55 - # 60 |
| - - Lys Glu Ser His Asp Gln Phe Leu Gln His Th - #r Ile Leu Phe Lys Gly |
| 65 - #70 - #75 - #80 |
| - - Phe Phe Thr Asp His Ser Trp Tyr Asn Asp Le - #u Leu Val Asp Phe Asp |
| 85 - # 90 - # 95 |
| - - Ser Lys Asp Ile Val Asp Lys Tyr Lys Gly Ly - #s Lys Val Asp Leu Tyr |
| 100 - # 105 - # 110 |
| - - Gly Ala Tyr Tyr Gly Tyr Gln Cys Ala Gly Gl - #y Thr Pro Asn Lys Thr |
| 115 - # 120 - # 125 |
| - - Ala Cys Met Tyr Gly Gly Val Thr Leu His As - #p Asn Asn Arg Leu Thr |
| 130 - # 135 - # 140 |
| - - Glu Glu Lys Lys Val Pro Ile Asn Leu Trp Le - #u Asp Gly Lys Gln Asn |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Thr Val Pro Leu Glu Thr Val Lys Thr Asn Ly - #s Lys Asn Val Thr |
| Val |
| 165 - # 170 - # 175 |
| - - Gln Glu Leu Asp Leu Gln Ala Arg Arg Tyr Le - #u Gln Glu Lys Tyr Asn |
| 180 - # 185 - # 190 |
| - - Leu Tyr Asn Ser Asp Val Phe Asp Gly Lys Va - #l Gln Arg Gly Leu Ile |
| 195 - # 200 - # 205 |
| - - Val Phe His Thr Ser Thr Glu Pro Ser Val As - #n Tyr Asp Leu Phe Gly |
| 210 - # 215 - # 220 |
| - - Ala Gln Gly Gln Tyr Ser Asn Thr Leu Leu Ar - #g Ile Tyr Arg Asp Asn |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Lys Thr Ile Asn Ser Glu Asn Met His Ile As - #p Ile Tyr Leu Tyr |
| Thr |
| 245 - # 250 - # 255 |
| - - Ser |
| - - - - (2) INFORMATION FOR SEQ ID NO:114: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 254 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:114: |
| - - Met Lys Asn Ile Thr Phe Ile Phe Phe Ile Le - #u Leu Ala Ser Pro Leu |
| 1 5 - # 10 - # 15 |
| - - Tyr Ala Asn Gly Asp Arg Leu Tyr Arg Ala As - #p Ser Arg Pro Pro Asp |
| 20 - # 25 - # 30 |
| - - Glu Ile Lys Arg Phe Arg Ser Leu Met Pro Ar - #g Gly Asn Glu Tyr Phe |
| 35 - # 40 - # 45 |
| - - Asp Arg Gly Thr Gln Met Asn Ile Asn Leu Ty - #r Asp His Ala Arg Gly |
| 50 - # 55 - # 60 |
| - - Thr Gln Thr Gly Phe Val Arg Tyr Asp Asp Gl - #y Tyr Val Ser Thr Ser |
| 65 - #70 - #75 - #80 |
| - - Leu Ser Leu Arg Ser Ala His Leu Ala Gly Gl - #n Tyr Ile Leu Ser Gly |
| 85 - # 90 - # 95 |
| - - Tyr Ser Leu Thr Ile Tyr Ile Val Ile Ala As - #n Met Phe Asn Val Asn |
| 100 - # 105 - # 110 |
| - - Asp Val Ile Ser Val Tyr Ser Pro His Pro Ty - #r Glu Gln Glu Val Ser |
| 115 - # 120 - # 125 |
| - - Ala Leu Gly Gly Ile Pro Tyr Ser Gln Ile Ty - #r Gly Trp Tyr Arg Val |
| 130 - # 135 - # 140 |
| - - Asn Phe Gly Val Ile Asp Glu Arg Leu His Ar - #g Asn Arg Glu Tyr Arg |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Asp Arg Tyr Tyr Arg Asn Leu Asn Ile Ala Pr - #o Ala Glu Asp Gly |
| Tyr |
| 165 - # 170 - # 175 |
| - - Arg Leu Ala Gly Phe Pro Pro Asp His Gln Al - #a Trp Arg Glu Glu Pro |
| 180 - # 185 - # 190 |
| - - Trp Ile His His Ala Pro Gln Gly Cys Gly As - #p Ser Ser Arg Thr Ile |
| 195 - # 200 - # 205 |
| - - Thr Gly Asp Thr Cys Asn Glu Glu Thr Gln As - #n Leu Ser Thr Ile Tyr |
| 210 - # 215 - # 220 |
| - - Leu Arg Glu Tyr Gln Ser Lys Val Lys Arg Gl - #n Ile Phe Ser Asp Tyr |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Gln Ser Glu Val Asp Ile Tyr Asn Arg Ile Ar - #g Asp Glu Leu |
| 245 - # 250 |
| - - - - (2) INFORMATION FOR SEQ ID NO:115: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 380 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:115: |
| - - Met Met Phe Ser Gly Phe Asn Ala Asp Tyr Gl - #u Ala Ser Ser Ser Arg |
| 1 5 - # 10 - # 15 |
| - - Cys Ser Ser Ala Ser Pro Ala Gly Asp Ser Le - #u Ser Tyr Tyr His Ser |
| 20 - # 25 - # 30 |
| - - Pro Ala Asp Ser Phe Ser Ser Met Gly Ser Pr - #o Val Asn Ala Gln Asp |
| 35 - # 40 - # 45 |
| - - Phe Cys Thr Asp Leu Ala Val Ser Ser Ala As - #n Phe Ile Pro Thr Val |
| 50 - # 55 - # 60 |
| - - Thr Ala Ile Ser Thr Ser Pro Asp Leu Gln Tr - #p Leu Val Gln Pro Ala |
| 65 - #70 - #75 - #80 |
| - - Leu Val Ser Ser Val Ala Pro Ser Gln Thr Ar - #g Ala Pro His Pro Phe |
| 85 - # 90 - # 95 |
| - - Gly Val Pro Ala Pro Ser Ala Gly Ala Tyr Se - #r Arg Ala Gly Val Val |
| 100 - # 105 - # 110 |
| - - Lys Thr Met Thr Gly Gly Arg Ala Gln Ser Il - #e Gly Arg Arg Gly Lys |
| 115 - # 120 - # 125 |
| - - Val Glu Gln Leu Ser Pro Glu Glu Glu Glu Ly - #s Arg Arg Ile Arg Arg |
| 130 - # 135 - # 140 |
| - - Glu Arg Asn Lys Met Ala Ala Ala Lys Cys Ar - #g Asn Arg Arg Arg Glu |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Leu Thr Asp Thr Leu Gln Ala Glu Thr Asp Gl - #n Leu Glu Asp Glu |
| Lys |
| 165 - # 170 - # 175 |
| - - Ser Ala Leu Gln Thr Glu Ile Ala Asn Leu Le - #u Lys Glu Lys Glu Lys |
| 180 - # 185 - # 190 |
| - - Leu Glu Phe Ile Leu Ala Ala His Arg Pro Al - #a Cys Lys Ile Pro Asp |
| 195 - # 200 - # 205 |
| - - Asp Leu Gly Phe Pro Glu Glu Met Ser Val Al - #a Ser Leu Asp Leu Thr |
| 210 - # 215 - # 220 |
| - - Gly Gly Leu Pro Glu Val Ala Thr Pro Glu Se - #r Glu Glu Ala Phe Thr |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Leu Pro Leu Leu Asn Asp Pro Glu Pro Lys Pr - #o Ser Val Glu Pro |
| Val |
| 245 - # 250 - # 255 |
| - - Lys Ser Ile Ser Ser Met Glu Leu Lys Thr Gl - #u Pro Phe Asp Asp Phe |
| 260 - # 265 - # 270 |
| - - Leu Phe Pro Ala Ser Ser Arg Pro Ser Gly Se - #r Glu Thr Ala Arg Ser |
| 275 - # 280 - # 285 |
| - - Val Pro Asp Met Asp Leu Ser Gly Ser Phe Ty - #r Ala Leu Pro Leu Leu |
| 290 - # 295 - # 300 |
| - - Asn Asp Pro Glu Pro Lys Pro Ser Val Glu Pr - #o Val Lys Ser Ile Ser |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Ser Met Glu Leu Lys Thr Glu Pro Phe Asp As - #p Phe Leu Phe Pro |
| Ala |
| 325 - # 330 - # 335 |
| - - Ser Ser Arg Pro Ser Gly Ser Glu Thr Ala Ar - #g Ser Val Pro Asp Met |
| 340 - # 345 - # 350 |
| - - Asp Leu Ser Gly Ser Phe Tyr Ala Gly Ser Se - #r Ser Asn Glu Pro Ser |
| 355 - # 360 - # 365 |
| - - Ser Asp Ser Leu Ser Ser Pro Thr Leu Leu Al - #a Leu |
| 370 - # 375 - # 380 |
| - - - - (2) INFORMATION FOR SEQ ID NO:116: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 607 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:116: |
| - - Ser Gly Trp Glu Ser Tyr Tyr Lys Thr Glu Gl - #y Asp Glu Glu Ala Glu |
| 1 5 - # 10 - # 15 |
| - - Glu Glu Gln Glu Glu Asn Leu Glu Ala Ser Gl - #y Asp Tyr Lys Tyr Ser |
| 20 - # 25 - # 30 |
| - - Gly Arg Asp Ser Leu Ile Phe Leu Val Asp Al - #a Ser Lys Ala Met Phe |
| 35 - # 40 - # 45 |
| - - Glu Ser Gln Ser Glu Asp Glu Leu Thr Pro Ph - #e Asp Met Ser Ile Gln |
| 50 - # 55 - # 60 |
| - - Cys Ile Gln Ser Val Tyr Ile Ser Lys Ile Il - #e Ser Ser Asp Arg Asp |
| 65 - #70 - #75 - #80 |
| - - Leu Leu Ala Val Val Phe Tyr Gly Thr Glu Ly - #s Asp Lys Asn Ser Val |
| 85 - # 90 - # 95 |
| - - Asn Phe Lys Asn Ile Tyr Val Leu Gln Glu Le - #u Asp Asn Pro Gly Ala |
| 100 - # 105 - # 110 |
| - - Lys Arg Ile Leu Glu Leu Asp Gln Phe Lys Gl - #y Gln Gln Gly Gln Lys |
| 115 - # 120 - # 125 |
| - - Arg Phe Gln Asp Met Met Gly His Gly Ser As - #p Tyr Ser Leu Ser Glu |
| 130 - # 135 - # 140 |
| - - Val Leu Trp Val Cys Ala Asn Leu Phe Ser As - #p Val Gln Phe Lys Met |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Ser His Lys Arg Ile Met Leu Phe Thr Asn Gl - #u Asp Asn Pro His |
| Gly |
| 165 - # 170 - # 175 |
| - - Asn Asp Ser Ala Lys Ala Ser Arg Ala Arg Th - #r Lys Ala Gly Asp Leu |
| 180 - # 185 - # 190 |
| - - Arg Asp Thr Gly Ile Phe Leu Asp Leu Met Hi - #s Leu Lys Lys Pro Gly |
| 195 - # 200 - # 205 |
| - - Gly Phe Asp Ile Ser Leu Phe Tyr Arg Asp Il - #e Ile Ser Ile Ala Glu |
| 210 - # 215 - # 220 |
| - - Asp Glu Asp Leu Arg Val His Phe Glu Glu Se - #r Ser Lys Leu Glu Asp |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Leu Leu Arg Lys Val Arg Ala Lys Glu Thr Ar - #g Lys Arg Ala Leu |
| Ser |
| 245 - # 250 - # 255 |
| - - Arg Leu Lys Leu Lys Leu Asn Lys Asp Ile Va - #l Ile Ser Val Gly Ile |
| 260 - # 265 - # 270 |
| - - Tyr Asn Leu Val Gln Lys Ala Leu Lys Pro Pr - #o Pro Ile Lys Leu Tyr |
| 275 - # 280 - # 285 |
| - - Arg Glu Thr Asn Glu Pro Val Lys Thr Lys Th - #r Arg Thr Phe Asn Thr |
| 290 - # 295 - # 300 |
| - - Ser Thr Gly Gly Leu Leu Leu Pro Ser Asp Th - #r Lys Arg Ser Gln Ile |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Tyr Gly Ser Arg Gln Ile Ile Leu Glu Lys Gl - #u Glu Thr Glu Glu |
| Leu |
| 325 - # 330 - # 335 |
| - - Lys Arg Phe Asp Asp Pro Gly Leu Met Leu Me - #t Gly Phe Lys Pro Leu |
| 340 - # 345 - # 350 |
| - - Val Leu Leu Lys Lys His His Leu Arg Pro Se - #r Leu Phe Val Tyr Pro |
| 355 - # 360 - # 365 |
| - - Glu Glu Ser Leu Val Ile Gly Ser Ser Thr Le - #u Phe Ser Ala Leu Leu |
| 370 - # 375 - # 380 |
| - - Ile Lys Cys Leu Glu Lys Glu Val Ala Ala Le - #u Cys Arg Tyr Thr Pro |
| 385 3 - #90 3 - #95 4 - |
| #00 |
| - - Arg Arg Asn Ile Pro Pro Tyr Phe Val Ala Le - #u Val Pro Gln Glu |
| Glu |
| 405 - # 410 - # 415 |
| - - Glu Leu Asp Asp Gln Lys Ile Gln Val Thr Pr - #o Pro Gly Phe Gln Leu |
| 420 - # 425 - # 430 |
| - - Val Phe Leu Pro Phe Ala Asp Asp Lys Arg Ly - #s Met Pro Phe Thr Glu |
| 435 - # 440 - # 445 |
| - - Lys Ile Met Ala Thr Pro Glu Gln Val Gly Ly - #s Met Lys Ala Ile Val |
| 450 - # 455 - # 460 |
| - - Glu Lys Leu Arg Phe Thr Tyr Arg Ser Asp Se - #r Phe Glu Asn Pro Val |
| 465 4 - #70 4 - #75 4 - |
| #80 |
| - - Leu Gln Gln His Phe Arg Asn Leu Glu Ala Le - #u Ala Leu Asp Leu |
| Met |
| 485 - # 490 - # 495 |
| - - Glu Pro Glu Gln Ala Val Asp Leu Thr Leu Pr - #o Lys Val Glu Ala Met |
| 500 - # 505 - # 510 |
| - - Asn Lys Arg Leu Gly Ser Leu Val Asp Glu Ph - #e Lys Glu Leu Val Tyr |
| 515 - # 520 - # 525 |
| - - Pro Pro Asp Tyr Asn Pro Glu Gly Lys Val Th - #r Lys Arg Lys His Asp |
| 530 - # 535 - # 540 |
| - - Asn Glu Gly Ser Gly Ser Lys Arg Pro Lys Va - #l Glu Tyr Ser Glu Glu |
| 545 5 - #50 5 - #55 5 - |
| #60 |
| - - Glu Leu Lys Thr His Ile Ser Lys Gly Thr Le - #u Gly Lys Phe Thr |
| Val |
| 565 - # 570 - # 575 |
| - - Pro Met Leu Lys Glu Ala Cys Arg Ala Tyr Gl - #y Leu Lys Ser Gly Leu |
| 580 - # 585 - # 590 |
| - - Lys Lys Gln Glu Leu Leu Glu Ala Leu Thr Ly - #s His Phe Gln Asp |
| 595 - # 600 - # 605 |
| - - - - (2) INFORMATION FOR SEQ ID NO:117: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 462 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: protein |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:117: |
| - - Gly Gly Gly Ala Leu Ser Pro Gln His Ser Al - #a Val Thr Gln Gly Ser |
| 1 5 - # 10 - # 15 |
| - - Ile Ile Lys Asn Lys Glu Gly Met Asp Ala Ly - #s Ser Leu Thr Ala Trp |
| 20 - # 25 - # 30 |
| - - Ser Arg Thr Leu Val Thr Phe Lys Asp Val Ph - #e Val Asp Phe Thr Arg |
| 35 - # 40 - # 45 |
| - - Glu Glu Trp Lys Leu Leu Asp Thr Ala Gln Gl - #n Ile Val Tyr Arg Asn |
| 50 - # 55 - # 60 |
| - - Val Met Leu Glu Asn Tyr Lys Asn Leu Val Se - #r Leu Gly Tyr Gln Leu |
| 65 - #70 - #75 - #80 |
| - - Thr Lys Pro Asp Val Ile Leu Arg Leu Glu Ly - #s Gly Glu Glu Pro Trp |
| 85 - # 90 - # 95 |
| - - Leu Val Glu Arg Glu Ile His Gln Glu Thr Hi - #s Pro Asp Ser Glu Thr |
| 100 - # 105 - # 110 |
| - - Ala Phe Glu Ile Lys Ser Ser Val Ser Ser Ar - #g Ser Ile Phe Lys Asp |
| 115 - # 120 - # 125 |
| - - Lys Gln Ser Cys Asp Ile Lys Met Glu Gly Me - #t Ala Arg Asn Asp Leu |
| 130 - # 135 - # 140 |
| - - Trp Tyr Leu Ser Leu Glu Glu Val Trp Lys Cy - #s Arg Asp Gln Leu Asp |
| 145 1 - #50 1 - #55 1 - |
| #60 |
| - - Lys Tyr Gln Glu Asn Pro Glu Arg His Leu Ar - #g His Gln Leu Ile |
| His |
| 165 - # 170 - # 175 |
| - - Thr Gly Glu Lys Pro Tyr Glu Cys Lys Glu Cy - #s Gly Lys Ser Phe Ser |
| 180 - # 185 - # 190 |
| - - Arg Ser Ser His Leu Ile Gly His Gln Lys Th - #r His Thr Gly Glu Glu |
| 195 - # 200 - # 205 |
| - - Pro Tyr Glu Cys Lys Glu Cys Gly Lys Ser Ph - #e Ser Trp Phe Ser His |
| 210 - # 215 - # 220 |
| - - Leu Val Thr His Gln Arg Thr His Thr Gly As - #p Lys Leu Tyr Thr Cys |
| 225 2 - #30 2 - #35 2 - |
| #40 |
| - - Asn Gln Cys Gly Lys Ser Phe Val His Ser Se - #r Arg Leu Ile Arg |
| His |
| 245 - # 250 - # 255 |
| - - Gln Arg Thr His Thr Gly His Lys Pro Tyr Gl - #u Cys Pro Glu Cys Gly |
| 260 - # 265 - # 270 |
| - - Lys Ser Phe Arg Gln Ser Thr His Leu Ile Le - #u His Gln Arg Thr His |
| 275 - # 280 - # 285 |
| - - Val Arg Val Arg Pro Tyr Glu Cys Asn Glu Cy - #s Gly Lys Ser Tyr Ser |
| 290 - # 295 - # 300 |
| - - Gln Arg Ser His Leu Val Val His His Arg Il - #e His Thr Gly Leu Lys |
| 305 3 - #10 3 - #15 3 - |
| #20 |
| - - Pro Phe Glu Cys Lys Asp Cys Gly Lys Cys Ph - #e Ser Arg Ser Ser |
| His |
| 325 - # 330 - # 335 |
| - - Leu Tyr Ser His Gln Arg Thr His Thr Gly Gl - #u Lys Pro Tyr Glu Cys |
| 340 - # 345 - # 350 |
| - - His Asp Cys Gly Lys Ser Phe Ser Gln Ser Se - #r Ala Leu Ile Val His |
| 355 - # 360 - # 365 |
| - - Gln Arg Ile His Thr Gly Glu Lys Pro Tyr Gl - #u Cys Cys Gln Cys Gly |
| 370 - # 375 - # 380 |
| - - Lys Ala Phe Ile Arg Lys Asn Asp Leu Ile Ly - #s His Gln Arg Ile His |
| 385 3 - #90 3 - #95 4 - |
| #00 |
| - - Val Gly Ala Glu Thr Tyr Lys Cys Asn Gln Cy - #s Gly Ile Ile Phe |
| Ser |
| 405 - # 410 - # 415 |
| - - Gln Asn Ser Pro Phe Ile Val His Gln Ile Al - #a His Thr Gly Glu Gln |
| 420 - # 425 - # 430 |
| - - Phe Leu Thr Cys Asn Gln Cys Gly Thr Ala Le - #u Val Asn Thr Ser Asn |
| 435 - # 440 - # 445 |
| - - Leu Ile Gly Tyr Gln Thr Asn His Ile Arg Gl - #u Asn Ala Tyr |
| 450 - # 455 - # 460 |
| - - - - (2) INFORMATION FOR SEQ ID NO:118: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:118: |
| - - Pro Asp Ala Val Tyr Leu His Arg Ile Asp Le - #u Gly Pro Pro Ile Ser |
| 1 5 - # 10 - # 15 |
| - - Leu Glu Arg Leu Asp Val Gly Thr Asn Leu Gl - #y Asn Ala Ile Ala Lys |
| 20 - # 25 - # 30 |
| - - Leu Glu Asp |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:119: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 34 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:119: |
| - - Leu Glu Arg Leu Asp Val Gly Thr Asn Leu Gl - #y Asn Ala Ile Ala Lys |
| 1 5 - # 10 - # 15 |
| - - Leu Glu Ala Lys Glu Leu Leu Glu Ser Ser As - #p Gln Ile Leu Arg Ser |
| 20 - # 25 - # 30 |
| - - Met Lys |
| - - - - (2) INFORMATION FOR SEQ ID NO:120: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 47 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:120: |
| - - Thr Trp Gln Glu Trp Glu Arg Lys Val Asp Ph - #e Leu Glu Glu Asn Ile |
| 1 5 - # 10 - # 15 |
| - - Thr Ala Leu Leu Glu Glu Ala Gln Ile Gln Gl - #n Glu Lys Asn Met Tyr |
| 20 - # 25 - # 30 |
| - - Glu Leu Gln Lys Leu Asn Ser Trp Asp Val Ph - #e Gly Asn Trp Phe |
| 35 - # 40 - # 45 |
| - - - - (2) INFORMATION FOR SEQ ID NO:121: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 42 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:121: |
| - - Ile Glu Leu Ser Asn Ile Lys Glu Asn Lys Cy - #s Asn Gly Thr Asp Ala |
| 1 5 - # 10 - # 15 |
| - - Lys Val Lys Leu Ile Lys Gln Glu Leu Asp Ly - #s Tyr Lys Asn Ala Val |
| 20 - # 25 - # 30 |
| - - Thr Glu Leu Gln Leu Leu Met Gln Ser Thr |
| 35 - # 40 |
| - - - - (2) INFORMATION FOR SEQ ID NO:122: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 27 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:122: |
| - - Val Ser Lys Gly Tyr Ser Ala Leu Arg Thr Gl - #y Trp Tyr Thr Ser Val |
| 1 5 - # 10 - # 15 |
| - - Ile Thr Ile Glu Leu Ser Asn Ile Lys Glu As - #n |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:123: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:123: |
| - - Ala Phe Ile Arg Lys Ser Asp Glu Leu Leu Hi - #s Asn Val |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:124: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 17 |
| (D) OTHER INFORMATION: - #/product= "OTHER" |
| /note= - #"X represents U, the standard designation for |
| C-abu, a - #modified cysteine." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:124: |
| - - Tyr Thr Ser Val Ile Thr Ile Glu Leu Ser As - #n Ile Lys Glu Asn Lys |
| 1 5 - # 10 - # 15 |
| - - Xaa Asn Gly Thr Asp Ala Lys Val Lys Leu Il - #e Lys Gln Glu Leu Asp |
| 20 - # 25 - # 30 |
| - - Lys Tyr Lys |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:125: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 16 |
| (D) OTHER INFORMATION: - #/product= "OTHER" |
| /note= - #"X represents U, the standard designation for |
| C-abu, a - #modified cysteine." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:125: |
| - - Thr Ser Val Ile Thr Ile Glu Leu Ser Asn Il - #e Lys Glu Asn Lys Xaa |
| 1 5 - # 10 - # 15 |
| - - Asn Gly Thr Asp Ala Lys Val Lys Leu Ile Ly - #s Gln Glu Leu Asp Lys |
| 20 - # 25 - # 30 |
| - - Tyr Lys Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:126: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 15 |
| (D) OTHER INFORMATION: - #/product= "OTHER" |
| /note= - #"X represents U, the standard designation for |
| C-abu, a - #modified cysteine." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:126: |
| - - Ser Val Ile Thr Ile Glu Leu Ser Asn Ile Ly - #s Glu Asn Lys Xaa Asn |
| 1 5 - # 10 - # 15 |
| - - Gly Thr Asp Ala Lys Val Lys Leu Ile Lys Gl - #n Glu Leu Asp Lys Tyr |
| 20 - # 25 - # 30 |
| - - Lys Asn Ala |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:127: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 8 |
| (D) OTHER INFORMATION: - #/product= "OTHER" |
| /note= - #"X represents U, the standard designation for |
| C-abu, a - #modified cysteine." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:127: |
| - - Ser Asn Ile Lys Glu Asn Lys Xaa Asn Gly Th - #r Asp Ala Lys Val Lys |
| 1 5 - # 10 - # 15 |
| - - Leu Ile Lys Gln Glu Leu Asp Lys Tyr Lys As - #n Ala Val Thr Glu Leu |
| 20 - # 25 - # 30 |
| - - Gln Leu Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:128: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 5 |
| (D) OTHER INFORMATION: - #/product= "OTHER" |
| /note= - #"X represents U, the standard designation for |
| C-abu, a - #modified cysteine." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:128: |
| - - Lys Glu Asn Lys Xaa Asn Gly Thr Asp Ala Ly - #s Val Lys Leu Ile Lys |
| 1 5 - # 10 - # 15 |
| - - Gln Glu Leu Asp Lys Tyr Lys Asn Ala Val Th - #r Glu Leu Gln Leu Leu |
| 20 - # 25 - # 30 |
| - - Met Gln Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:129: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (ix) FEATURE: |
| (A) NAME/KEY: Modified-sit - #e |
| (B) LOCATION: 31 |
| (D) OTHER INFORMATION: - #/product= "OTHER" |
| /note= - #"X represents U, the standard designation for |
| C-abu, a - #modified cysteine." |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:129: |
| - - Ala Val Ser Lys Gly Tyr Leu Ser Ala Leu Ar - #g Thr Gly Trp Tyr Thr |
| 1 5 - # 10 - # 15 |
| - - Ser Val Ile Thr Ile Glu Leu Ser Asn Ile Ly - #s Glu Asn Lys Xaa Asn |
| 20 - # 25 - # 30 |
| - - Gly Thr Asp Ala |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:130: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 27 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:130: |
| - - Val Val Ser Leu Ser Asn Gly Val Ser Val Le - #u Thr Ser Lys Val Leu |
| 1 5 - # 10 - # 15 |
| - - Asp Leu Lys Asn Tyr Ile Asp Lys Gln Leu Le - #u |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:131: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:131: |
| - - Leu Leu Ser Thr Asn Lys Ala Val Val Ser Le - #u Ser Asn Gly Val Ser |
| 1 5 - # 10 - # 15 |
| - - Val Leu Thr Ser Lys Val Leu Asp Leu Lys As - #n Tyr |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:132: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:132: |
| - - Val Leu His Leu Glu Gly Glu Val Asn Lys Il - #e Lys Ser Ala Leu Leu |
| 1 5 - # 10 - # 15 |
| - - Ser Thr Asn Lys Ala Val Val Ser Leu Ser As - #n Gly |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:133: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:133: |
| - - Leu Leu Ser Thr Asn Lys Ala Val Val Ser Le - #u Ser Asn Gly Val Ser |
| 1 5 - # 10 - # 15 |
| - - Val Leu Thr Ser Lys Val Leu Asp Leu Lys As - #n Tyr |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:134: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 37 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:134: |
| - - Ala Ser Gly Val Ala Val Ser Lys Val Leu Hi - #s Leu Glu Gly Glu Val |
| 1 5 - # 10 - # 15 |
| - - Asn Lys Ile Lys Ser Ala Leu Leu Ser Thr As - #n Lys Ala Val Val Ser |
| 20 - # 25 - # 30 |
| - - Leu Ser Asn Gly Val |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:135: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:135: |
| - - Val Leu His Leu Glu Gly Glu Val Asn Lys Il - #e Lys Ser Ala Leu Leu |
| 1 5 - # 10 - # 15 |
| - - Ser Thr Asn Lys Ala Val Val Ser Leu Ser As - #n Gly Val Ser Val Leu |
| 20 - # 25 - # 30 |
| - - Thr Ser Lys |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:136: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:136: |
| - - Asn Asp Gln Lys Lys Leu Met Ser Asn Asn Va - #l Gln Ile Val Arg Gln |
| 1 5 - # 10 - # 15 |
| - - Gln Ser Tyr Ser Ile Met Ser Ile Ile Lys Gl - #u Glu |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:137: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:137: |
| - - Ser Ile Ser Asn Ile Glu Thr Val Ile Glu Ph - #e Gln Gln Lys Asn Asn |
| 1 5 - # 10 - # 15 |
| - - Arg Leu Leu Glu Ile Thr Arg Glu Phe Ser Va - #l Asn Ala Gly Val Thr |
| 20 - # 25 - # 30 |
| - - Thr Pro Val Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:138: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:138: |
| - - Pro Ile Ile Asn Phe Tyr Asp Pro Leu Val Ph - #e Pro Ser Asp Glu Phe |
| 1 5 - # 10 - # 15 |
| - - Asp Ala Ser Ile Ser Gln Val Asn Glu Lys Il - #e Asn Gln Ser Leu Ala |
| 20 - # 25 - # 30 |
| - - Phe Ile Arg |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:139: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 29 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:139: |
| - - Arg Met Lys Gln Leu Glu Asp Lys Val Glu Gl - #u Leu Leu Ser Lys Leu |
| 1 5 - # 10 - # 15 |
| - - Ala Phe Ile Arg Lys Ser Asp Glu Leu Leu Hi - #s Asn Val |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:140: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 19 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:140: |
| - - Ala Phe Ile Arg Lys Ser Asp Glu Leu Leu Hi - #s Asn Val Asn Ala Gly |
| 1 5 - # 10 - # 15 |
| - - Lys Ser Thr |
| - - - - (2) INFORMATION FOR SEQ ID NO:141: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 19 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:141: |
| - - Phe Asp Ala Ser Ile Ser Gln Val Asn Glu Ly - #s Ile Asn Gln Ser Leu |
| 1 5 - # 10 - # 15 |
| - - Ala Phe Ile |
| - - - - (2) INFORMATION FOR SEQ ID NO:142: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 21 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:142: |
| - - Ser Leu Ala Phe Ile Arg Lys Ser Asp Glu Le - #u Leu His Asn Val Asn |
| 1 5 - # 10 - # 15 |
| - - Ala Gly Lys Ser Thr |
| 20 |
| - - - - (2) INFORMATION FOR SEQ ID NO:143: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:143: |
| - - Phe Asp Ala Ser Ile Ser Gln Val Asn Glu Ly - #s Ile Asn Gln Ser Leu |
| 1 5 - # 10 - # 15 |
| - - Ala Phe Ile Arg Lys Ser Asp Glu Leu Leu Hi - #s Asn Val Asn Ala Gly |
| 20 - # 25 - # 30 |
| - - Lys |
| - - - - (2) INFORMATION FOR SEQ ID NO:144: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:144: |
| - - Ala Ser Ile Ser Gln Val Asn Glu Lys Ile As - #n Gln Ser Leu Ala Phe |
| 1 5 - # 10 - # 15 |
| - - Ile Arg Lys Ser Asp Glu Leu Leu His Asn Va - #l Asn Ala Gly Lys Ser |
| 20 - # 25 - # 30 |
| - - Thr |
| - - - - (2) INFORMATION FOR SEQ ID NO:145: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:145: |
| - - Phe Asp Ala Ser Ile Ser Gln Val Asn Glu Ly - #s Ile Asn Gln Ser Leu |
| 1 5 - # 10 - # 15 |
| - - Ala Phe Ile Arg Lys Ser Asp Glu Leu Leu Hi - #s Asn Val Asn Ala Gly |
| 20 - # 25 - # 30 |
| - - Lys Ser Thr |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:146: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:146: |
| - - Ala Thr Ser Ala Gln Ile Thr Ala Ala Val Al - #a Leu Val Glu Ala Lys |
| 1 5 - # 10 - # 15 |
| - - Gln Ala Arg Ser Asp Ile Glu Lys Leu Lys Gl - #u Ala |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:147: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:147: |
| - - Ala Ala Val Ala Leu Val Glu Ala Lys Gln Al - #a Arg Ser Asp Ile Glu |
| 1 5 - # 10 - # 15 |
| - - Lys Leu Lys Glu Ala Ile Arg Asp Thr Asn Ly - #s Ala Val Gln Ser Val |
| 20 - # 25 - # 30 |
| - - Gln Ser Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:148: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:148: |
| - - Ala Lys Gln Ala Arg Ser Asp Ile Glu Lys Le - #u Lys Glu Ala Ile Arg |
| 1 5 - # 10 - # 15 |
| - - Asp Thr Asn Lys Ala Val Gln Ser Val Gln Se - #r Ser Ile Gly Asn Leu |
| 20 - # 25 - # 30 |
| - - Ile Val Ala |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:149: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:149: |
| - - Ile Arg Asp Thr Asn Lys Ala Val Gln Ser Va - #l Gln Ser Ser Ile Gly |
| 1 5 - # 10 - # 15 |
| - - Asn Leu Ile Val Ala Ile Lys Ser Val Gln As - #p Tyr |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:150: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:150: |
| - - Ala Val Gln Ser Val Gln Ser Ser Ile Gly As - #n Leu Ile Val Ala Ile |
| 1 5 - # 10 - # 15 |
| - - Lys Ser Val Gln Asp Tyr Val Asn Lys Glu Il - #e Val |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:151: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:151: |
| - - Leu Lys Glu Ala Ile Arg Asp Thr Asn Lys Al - #a Val Gln Ser Val Gln |
| 1 5 - # 10 - # 15 |
| - - Ser Ser Ile Gly Asn Leu Ile Val Ala Ile Ly - #s Ser |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:152: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:152: |
| - - Glu Trp Ile Arg Arg Ser Asn Gln Lys Leu As - #p Ser Ile |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:153: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:153: |
| - - Ile Asp Ile Ser Ile Glu Leu Asn Lys Ala Ly - #s Ser Asp Leu Glu Glu |
| 1 5 - # 10 - # 15 |
| - - Ser Lys Glu Trp Ile Lys Lys Ser Asn Gln Ly - #s Leu Asp Ser Ile Gly |
| 20 - # 25 - # 30 |
| - - Asn Trp His |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:154: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 29 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:154: |
| - - Arg Met Lys Gln Leu Glu Asp Lys Val Glu Gl - #u Leu Leu Ser Lys Leu |
| 1 5 - # 10 - # 15 |
| - - Glu Trp Ile Arg Arg Ser Asn Gln Lys Leu As - #p Ser Ile |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:155: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:155: |
| - - Asp Gln Gln Ile Lys Gln Tyr Lys Arg Leu Le - #u Asp Arg Leu Ile Ile |
| 1 5 - # 10 - # 15 |
| - - Pro Leu Tyr Asp Gly Leu Arg Gln Lys Asp Va - #l Ile Val Ser Asn Gln |
| 20 - # 25 - # 30 |
| - - Glu Ser Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:156: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:156: |
| - - Tyr Ser Glu Leu Thr Asn Ile Phe Gly Asp As - #n Ile Gly Ser Leu Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Gly Ile Lys Leu Gln Gly Ile Ala Se - #r Leu Tyr Arg Thr Asn |
| 20 - # 25 - # 30 |
| - - Ile Thr Glu Ile |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:157: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:157: |
| - - Thr Ser Ile Thr Leu Gln Val Arg Leu Pro Le - #u Leu Thr Arg Leu Leu |
| 1 5 - # 10 - # 15 |
| - - Asn Thr Gln Ile Tyr Arg Val Asp Ser Ile Se - #r Tyr Asn Ile Gln Asn |
| 20 - # 25 - # 30 |
| - - Arg Glu Trp Tyr |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:158: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 57 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:158: |
| - - Asn Lys Ser Leu Glu Gln Ile Trp Asn Asn Me - #t Thr Trp Met Glu Trp |
| 1 5 - # 10 - # 15 |
| - - Asp Arg Glu Ile Asn Asn Tyr Thr Ser Leu Il - #e His Ser Leu Ile Glu |
| 20 - # 25 - # 30 |
| - - Glu Gln Asn Gln Gln Glu Lys Asn Glu Gln Gl - #u Leu Leu Glu Leu Asp |
| 35 - # 40 - # 45 |
| - - Lys Trp Ala Ser Leu Trp Asn Trp Phe |
| 50 - # 55 |
| - - - - (2) INFORMATION FOR SEQ ID NO:159: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:159: |
| - - Trp Met Glu Trp Asp Arg Glu Ile Asn Asn Ty - #r Thr Ser Leu Ile Gly |
| 1 5 - # 10 - # 15 |
| - - Ser Leu Ile Glu Glu Ser Gln Asn Gln Gln Gl - #u Lys Asn Glu Gln Glu |
| 20 - # 25 - # 30 |
| - - Leu Leu Glu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:160: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 49 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:160: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe Asn Ile Thr Asn Trp Leu Tr - #p Leu Ile Lys Ile Phe |
| 35 - # 40 - # 45 |
| - - Ile |
| - - - - (2) INFORMATION FOR SEQ ID NO:161: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:161: |
| - - Glu Ala Ala Ala Arg Glu Ala Ala Ala Arg Gl - #u Ala Ala Ala Arg Leu |
| 1 5 - # 10 - # 15 |
| - - Glu Leu Asp Lys Trp Ala Ser Leu Trp Asn Tr - #p Phe |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:162: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:162: |
| - - Arg Met Lys Gln Leu Glu Asp Lys Val Glu Gl - #u Leu Leu Ser Lys Leu |
| 1 5 - # 10 - # 15 |
| - - Glu Leu Asp Lys Trp Ala Ser Leu Trp Asn Tr - #p Phe |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:163: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:163: |
| - - Phe Trp Asn Trp Leu Ser Ala Trp Lys Asp Le - #u Glu Leu Lys Ser Leu |
| 1 5 - # 10 - # 15 |
| - - Leu Glu Glu Val Lys Asp Glu Leu Gln Lys Me - #t Arg |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:164: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:164: |
| - - Arg Met Lys Gln Leu Glu Asp Lys Val Glu Gl - #u Leu Leu Ser Lys Asn |
| 1 5 - # 10 - # 15 |
| - - Tyr His Leu Glu Asn Glu Leu Glu Leu Asp Ly - #s Trp Ala Ser Leu Trp |
| 20 - # 25 - # 30 |
| - - Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:165: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 30 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:165: |
| - - Phe Trp Asn Trp Leu Ser Ala Trp Lys Asp Le - #u Glu Leu Tyr Pro Gly |
| 1 5 - # 10 - # 15 |
| - - Ser Leu Glu Leu Asp Lys Trp Ala Ser Leu Tr - #p Asn Trp Phe |
| 20 - # 25 - # 30 |
| - - - - (2) INFORMATION FOR SEQ ID NO:166: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 15 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:166: |
| - - Cys Leu Glu Leu Asp Lys Trp Ala Ser Leu Tr - #p Asn Trp Phe Cys |
| 1 5 - # 10 - # 15 |
| - - - - (2) INFORMATION FOR SEQ ID NO:167: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 15 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:167: |
| - - Cys Leu Glu Leu Asp Lys Trp Ala Ser Leu Al - #a Asn Trp Phe Cys |
| 1 5 - # 10 - # 15 |
| - - - - (2) INFORMATION FOR SEQ ID NO:168: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 15 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:168: |
| - - Cys Leu Glu Leu Asp Lys Trp Ala Ser Leu Tr - #p Asn Phe Phe Cys |
| 1 5 - # 10 - # 15 |
| - - - - (2) INFORMATION FOR SEQ ID NO:169: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:169: |
| - - Leu Glu Leu Asp Lys Trp Ala Ser Leu Ala As - #n Ala Phe |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:170: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:170: |
| - - Leu Glu Leu Asp Lys Trp Ala Ser Leu Phe As - #n Phe Phe |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:171: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:171: |
| - - Leu Glu Leu Asp Lys Trp Ala Ser Leu Trp As - #n Ala Phe |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:172: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:172: |
| - - Leu Glu Leu Asp Lys Trp Ala Ser Leu Trp As - #n Trp Ala |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:173: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:173: |
| - - Leu Glu Leu Asp Lys Trp Ala Ser Ala Trp As - #n Trp Phe |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:174: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:174: |
| - - Leu Glu Leu Asp Lys Ala Ala Ser Leu Trp As - #n Trp Phe |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:175: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:175: |
| - - Leu Lys Leu Asp Lys Trp Ala Ser Leu Trp As - #n Trp Phe |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:176: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 13 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:176: |
| - - Leu Glu Leu Lys Lys Trp Ala Ser Leu Trp As - #n Trp Phe |
| 1 5 - # 10 |
| - - - - (2) INFORMATION FOR SEQ ID NO:177: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 39 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:177: |
| - - Cys Gly Gly Tyr Thr Ser Leu Ile His Ser Le - #u Ile Glu Glu Ser Gln |
| 1 5 - # 10 - # 15 |
| - - Asn Gln Gln Glu Lys Asn Glu Gln Glu Leu Le - #u Glu Leu Asp Lys Trp |
| 20 - # 25 - # 30 |
| - - Ala Ser Leu Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:178: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:178: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Ala Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:179: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:179: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Ala Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:180: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:180: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Gln Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:181: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:181: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Gln Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:182: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:182: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Gln Gln Glu Leu Leu Gln Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:183: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:183: |
| - - Tyr Thr Ser Leu Ile Gln Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:184: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:184: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Gln Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:185: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:185: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #n Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:186: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:186: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #n Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:187: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:187: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Gln Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:188: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:188: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Gln Gl - #n Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Gln Lys Asn Gln Gln Gln Leu Leu Gln Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:189: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:189: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Ala Asn Ala Ala |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:190: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:190: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Gln Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:191: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:191: |
| - - Tyr Thr Ser Leu Ile Gln Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Gln Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:192: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:192: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Phe Asn Phe Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:193: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:193: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Leu Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:194: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:194: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Leu Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:195: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:195: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Phe As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:196: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:196: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Pro Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:197: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:197: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Pro |
| 20 - # 25 - # 30 |
| - - Trp Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:198: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:198: |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 1 5 - # 10 - # 15 |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Trp Asn Ser Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:199: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:199: |
| - - Leu Leu Asp Asn Phe Glu Ser Thr Trp Glu Gl - #n Ser Lys Glu Leu Trp |
| 1 5 - # 10 - # 15 |
| - - Glu Gln Gln Glu Ile Ser Ile Gln Asn Leu Hi - #s Lys Ser Ala Leu Gln |
| 20 - # 25 - # 30 |
| - - Glu Tyr Trp Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:200: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:200: |
| - - Leu Ser Asn Leu Leu Gln Ile Ser Asn Asn Se - #r Asp Glu Trp Leu Glu |
| 1 5 - # 10 - # 15 |
| - - Ala Leu Glu Ile Glu His Glu Lys Trp Lys Le - #u Thr Gln Trp Gln Ser |
| 20 - # 25 - # 30 |
| - - Tyr Glu Gln Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:201: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 63 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:201: |
| - - Met Thr Leu Thr Val Gln Ala Arg Gln Leu Le - #u Ser Gly Ile Val Gln |
| 1 5 - # 10 - # 15 |
| - - Gln Gln Asn Asn Leu Leu Arg Ala Ile Glu Al - #a Gln Gln His Leu Leu |
| 20 - # 25 - # 30 |
| - - Gln Leu Thr Val Trp Gly Ile Lys Gln Leu Gl - #n Ala Arg Ile Leu Ala |
| 35 - # 40 - # 45 |
| - - Val Glu Arg Tyr Leu Lys Asp Gln Gln Leu Le - #u Gly Ile Trp Gly |
| 50 - # 55 - # 60 |
| - - - - (2) INFORMATION FOR SEQ ID NO:202: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 45 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:202: |
| - - Ser Glu Leu Glu Ile Lys Arg Tyr Lys Asn Ar - #g Val Ala Ser Arg Lys |
| 1 5 - # 10 - # 15 |
| - - Cys Arg Ala Lys Phe Gln Leu Leu Gln His Ty - #r Arg Glu Val Ala Ala |
| 20 - # 25 - # 30 |
| - - Ala Lys Ser Ser Glu Asn Asp Arg Leu Arg Le - #u Leu Leu |
| 35 - # 40 - # 45 |
| - - - - (2) INFORMATION FOR SEQ ID NO:203: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 45 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:203: |
| - - Ala Ser Arg Lys Cys Arg Ala Lys Phe Lys Gl - #n Leu Leu Gln His Tyr |
| 1 5 - # 10 - # 15 |
| - - Arg Glu Val Ala Ala Ala Lys Ser Ser Glu As - #n Asp Arg Leu Arg Leu |
| 20 - # 25 - # 30 |
| - - Leu Leu Lys Gln Met Cys Pro Ser Leu Asp Va - #l Asp Ser |
| 35 - # 40 - # 45 |
| - - - - (2) INFORMATION FOR SEQ ID NO:204: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:204: |
| - - Leu Leu Gln His Tyr Arg Glu Val Ala Ala Al - #a Lys Ser Ser Glu Asn |
| 1 5 - # 10 - # 15 |
| - - Asp Arg Leu Arg Leu Leu Leu Lys Gln Met Cy - #s Pro Ser Leu Asp Val |
| 20 - # 25 - # 30 |
| - - Asp Ser Ile |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:205: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 45 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:205: |
| - - Leu Gln His Tyr Arg Glu Val Ala Ala Ala Ly - #s Ser Ser Glu Asn Asp |
| 1 5 - # 10 - # 15 |
| - - Arg Leu Arg Leu Leu Leu Lys Gln Met Cys Pr - #o Ser Leu Asp Val Asp |
| 20 - # 25 - # 30 |
| - - Ser Ile Ile Pro Arg Thr Pro Asp Val Leu Hi - #s Glu Asp |
| 35 - # 40 - # 45 |
| - - - - (2) INFORMATION FOR SEQ ID NO:206: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:206: |
| - - Ser Ser Glu Asn Asp Arg Leu Arg Leu Leu Le - #u Lys Gln Met Cys Pro |
| 1 5 - # 10 - # 15 |
| - - Ser Leu Asp Val Asp Ser Ile Ile Pro Arg Th - #r Pro Asp Val Leu His |
| 20 - # 25 - # 30 |
| - - Glu Asp Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:207: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 37 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:207: |
| - - Ser Glu Asn Asp Arg Leu Arg Leu Leu Leu Ly - #s Gln Met Cys Pro Ser |
| 1 5 - # 10 - # 15 |
| - - Leu Asp Val Asp Ser Ile Ile Pro Arg Thr Pr - #o Asp Val Leu His Glu |
| 20 - # 25 - # 30 |
| - - Asp Leu Leu Asn Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:208: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 46 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:208: |
| - - Pro Leu Leu Val Leu Gln Ala Gly Phe Phe Le - #u Leu Thr Arg Ile Leu |
| 1 5 - # 10 - # 15 |
| - - Thr Ile Pro Gln Ser Leu Asp Ser Trp Trp Th - #r Ser Leu Asn Phe Leu |
| 20 - # 25 - # 30 |
| - - Gly Gly Thr Thr Val Cys Leu Gly Gln Asn Se - #r Gln Ser Pro |
| 35 - # 40 - # 45 |
| - - - - (2) INFORMATION FOR SEQ ID NO:209: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 57 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:209: |
| - - Pro Gly Tyr Arg Trp Met Cys Leu Arg Arg Ph - #e Ile Ile Phe Leu Phe |
| 1 5 - # 10 - # 15 |
| - - Ile Leu Leu Leu Cys Leu Ile Phe Leu Leu Va - #l Leu Leu Asp Tyr Gln |
| 20 - # 25 - # 30 |
| - - Gly Met Leu Pro Val Cys Pro Leu Ile Pro Gl - #y Ser Ser Thr Ser Thr |
| 35 - # 40 - # 45 |
| - - Gly Pro Cys Arg Thr Cys Met Thr Thr |
| 50 - # 55 |
| - - - - (2) INFORMATION FOR SEQ ID NO:210: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 58 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:210: |
| - - Asn Lys Ser Leu Glu Gln Ile Trp Asn Asn Me - #t Thr Trp Met Glu Trp |
| 1 5 - # 10 - # 15 |
| - - Asp Arg Glu Ile Asn Asn Tyr Thr Ser Leu Il - #e His Ser Leu Ile Glu |
| 20 - # 25 - # 30 |
| - - Glu Ser Gln Asn Gln Gln Glu Lys Asn Glu Gl - #n Glu Leu Leu Glu Leu |
| 35 - # 40 - # 45 |
| - - Asp Lys Trp Ala Ser Leu Trp Asn Trp Phe |
| 50 - # 55 |
| - - - - (2) INFORMATION FOR SEQ ID NO:211: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:211: |
| - - Ser Leu Glu Gln Ile Trp Asn Asn Met Thr Tr - #p Met Glu Trp Asp Arg |
| 1 5 - # 10 - # 15 |
| - - Glu Ile Asn Asn Tyr Thr Ser Leu Ile His Se - #r Leu Ile Glu Glu Ser |
| 20 - # 25 - # 30 |
| - - Gln Asn Gln Gln |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:212: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:212: |
| - - Leu Glu Gln Ile Trp Asn Asn Met Thr Trp Me - #t Glu Trp Asp Arg Glu |
| 1 5 - # 10 - # 15 |
| - - Ile Asn Asn Tyr Thr Ser Leu Ile His Ser Le - #u Ile Glu Glu Ser Gln |
| 20 - # 25 - # 30 |
| - - Asn Gln Gln Arg |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:213: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:213: |
| - - Glu Gln Ile Trp Asn Asn Met Thr Trp Met Gl - #u Trp Asp Arg Glu Ile |
| 1 5 - # 10 - # 15 |
| - - Asn Asn Tyr Thr Ser Leu Ile His Ser Leu Il - #e Glu Glu Ser Gln Asn |
| 20 - # 25 - # 30 |
| - - Gln Gln Glu Lys |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:214: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:214: |
| - - Gln Ile Trp Asn Asn Met Thr Trp Met Glu Tr - #p Asp Arg Glu Ile Asn |
| 1 5 - # 10 - # 15 |
| - - Asn Tyr Thr Ser Leu Ile His Ser Leu Ile Gl - #u Glu Ser Gln Asn Gln |
| 20 - # 25 - # 30 |
| - - Gln Glu Lys Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:215: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:215: |
| - - Ile Trp Asn Asn Met Thr Trp Met Glu Trp As - #p Arg Glu Ile Asn Asn |
| 1 5 - # 10 - # 15 |
| - - Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Gl - #u Ser Gln Asn Gln Gln |
| 20 - # 25 - # 30 |
| - - Glu Lys Asn Glu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:216: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:216: |
| - - Trp Asn Asn Met Thr Trp Met Glu Trp Asp Ar - #g Glu Ile Asn Asn Tyr |
| 1 5 - # 10 - # 15 |
| - - Thr Ser Leu Ile His Ser Leu Ile Glu Glu Se - #r Gln Asn Gln Gln Glu |
| 20 - # 25 - # 30 |
| - - Lys Asn Glu Gln |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:217: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:217: |
| - - Asn Asn Met Thr Trp Met Glu Trp Asp Arg Gl - #u Ile Asn Asn Tyr Thr |
| 1 5 - # 10 - # 15 |
| - - Ser Leu Ile His Ser Leu Ile Glu Glu Ser Gl - #n Asn Gln Gln Glu Lys |
| 20 - # 25 - # 30 |
| - - Asn Glu Gln Glu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:218: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:218: |
| - - Asn Met Thr Trp Met Glu Trp Asp Arg Glu Il - #e Asn Asn Tyr Thr Ser |
| 1 5 - # 10 - # 15 |
| - - Leu Ile His Ser Leu Ile Glu Glu Ser Gln As - #n Gln Gln Glu Lys Asn |
| 20 - # 25 - # 30 |
| - - Glu Gln Glu Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:219: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 47 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:219: |
| - - Met Thr Trp Met Glu Trp Asp Arg Glu Ile As - #n Asn Tyr Thr Ser Leu |
| 1 5 - # 10 - # 15 |
| - - Ile His Ser Leu Ile Glu Glu Ser Gln Asn Gl - #n Gln Glu Lys Asn Glu |
| 20 - # 25 - # 30 |
| - - Gln Glu Leu Leu Glu Leu Asp Lys Trp Ala Se - #r Leu Trp Asn Trp |
| 35 - # 40 - # 45 |
| - - - - (2) INFORMATION FOR SEQ ID NO:220: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:220: |
| - - Thr Trp Met Glu Trp Asp Arg Glu Ile Asn As - #n Tyr Thr Ser Leu Ile |
| 1 5 - # 10 - # 15 |
| - - His Ser Leu Ile Glu Glu Ser Gln Asn Gln Gl - #n Glu Lys Asn Glu Gln |
| 20 - # 25 - # 30 |
| - - Glu Leu Leu Glu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:221: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:221: |
| - - Trp Met Glu Trp Asp Arg Glu Ile Asn Asn Ty - #r Thr Ser Leu Ile His |
| 1 5 - # 10 - # 15 |
| - - Ser Leu Ile Glu Glu Ser Gln Asn Gln Gln Gl - #u Lys Asn Glu Gln Glu |
| 20 - # 25 - # 30 |
| - - Leu Leu Glu Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:222: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:222: |
| - - Trp Met Glu Trp Asp Arg Glu Ile Asn Asn Ty - #r Thr Ser Leu Ile His |
| 1 5 - # 10 - # 15 |
| - - Ser Leu Ile Glu Glu Ser Gln Asn Gln Gln Gl - #u Lys Asn Glu Gln Glu |
| 20 - # 25 - # 30 |
| - - Leu Leu Glu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:223: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:223: |
| - - Met Glu Trp Asp Arg Glu Ile Asn Asn Tyr Th - #r Ser Leu Ile His Ser |
| 1 5 - # 10 - # 15 |
| - - Leu Ile Glu Glu Ser Gln Asn Gln Gln Glu Ly - #s Asn Glu Gln Glu Leu |
| 20 - # 25 - # 30 |
| - - Leu Glu Leu Asp |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:224: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:224: |
| - - Glu Trp Asp Arg Glu Ile Asn Asn Tyr Thr Se - #r Leu Ile His Ser Leu |
| 1 5 - # 10 - # 15 |
| - - Ile Glu Glu Ser Gln Asn Gln Gln Glu Lys As - #n Glu Gln Glu Leu Leu |
| 20 - # 25 - # 30 |
| - - Glu Leu Asp Lys |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:225: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:225: |
| - - Trp Asp Arg Glu Ile Asn Asn Tyr Thr Ser Le - #u Ile His Ser Leu Ile |
| 1 5 - # 10 - # 15 |
| - - Glu Glu Ser Gln Asn Gln Gln Glu Lys Asn Gl - #u Gln Glu Leu Leu Glu |
| 20 - # 25 - # 30 |
| - - Leu Asp Lys Trp |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:226: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:226: |
| - - Asp Arg Glu Ile Asn Asn Tyr Thr Ser Leu Il - #e His Ser Leu Ile Glu |
| 1 5 - # 10 - # 15 |
| - - Glu Ser Gln Asn Gln Gln Glu Lys Asn Glu Gl - #n Glu Leu Leu Glu Leu |
| 20 - # 25 - # 30 |
| - - Asp Lys Trp Ala |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:227: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:227: |
| - - Arg Glu Ile Asn Asn Tyr Thr Ser Leu Ile Hi - #s Ser Leu Ile Glu Glu |
| 1 5 - # 10 - # 15 |
| - - Ser Gln Asn Gln Gln Glu Lys Asn Glu Gln Gl - #u Leu Leu Glu Leu Asp |
| 20 - # 25 - # 30 |
| - - Lys Trp Ala Ser |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:228: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:228: |
| - - Glu Ile Asn Asn Tyr Thr Ser Leu Ile His Se - #r Leu Ile Glu Glu Ser |
| 1 5 - # 10 - # 15 |
| - - Gln Asn Gln Gln Glu Lys Asn Glu Gln Glu Le - #u Leu Glu Leu Asp Lys |
| 20 - # 25 - # 30 |
| - - Trp Ala Ser Leu |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:229: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:229: |
| - - Ile Asn Asn Tyr Thr Ser Leu Ile His Ser Le - #u Ile Glu Glu Ser Gln |
| 1 5 - # 10 - # 15 |
| - - Asn Gln Gln Glu Lys Asn Glu Gln Glu Leu Le - #u Glu Leu Asp Lys Trp |
| 20 - # 25 - # 30 |
| - - Ala Ser Leu Trp |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:230: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:230: |
| - - Asn Tyr Thr Ser Leu Ile His Ser Leu Ile Gl - #u Glu Ser Gln Asn Gln |
| 1 5 - # 10 - # 15 |
| - - Gln Glu Lys Asn Glu Gln Glu Leu Leu Glu Le - #u Asp Lys Trp Ala Ser |
| 20 - # 25 - # 30 |
| - - Leu Trp Asn Trp |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:231: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:231: |
| - - Thr Ser Leu Ile His Ser Leu Ile Glu Glu Se - #r Gln Asn Gln Gln Glu |
| 1 5 - # 10 - # 15 |
| - - Lys Asn Glu Gln Glu Leu Leu Glu Leu Asp Ly - #s Trp Ala Ser Leu Trp |
| 20 - # 25 - # 30 |
| - - Asn Trp Phe Asn |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:232: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:232: |
| - - Ser Leu Ile His Ser Leu Ile Glu Glu Ser Gl - #n Asn Gln Gln Glu Lys |
| 1 5 - # 10 - # 15 |
| - - Asn Glu Gln Glu Leu Leu Glu Leu Asp Lys Tr - #p Ala Ser Leu Trp Asn |
| 20 - # 25 - # 30 |
| - - Trp Phe Asn Ile |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:233: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:233: |
| - - Leu Ile His Ser Leu Ile Glu Glu Ser Gln As - #n Gln Gln Glu Lys Asn |
| 1 5 - # 10 - # 15 |
| - - Glu Gln Glu Leu Leu Glu Leu Asp Lys Trp Al - #a Ser Leu Trp Asn Trp |
| 20 - # 25 - # 30 |
| - - Phe Asn Ile Thr |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:234: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 35 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:234: |
| - - Thr Ser Leu Ile His Ser Leu Ile Glu Glu Se - #r Gln Asn Gln Gln Glu |
| 1 5 - # 10 - # 15 |
| - - Lys Asn Glu Gln Glu Leu Leu Glu Leu Asp Ly - #s Trp Ala Ser Leu Trp |
| 20 - # 25 - # 30 |
| - - Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:235: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 33 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:235: |
| - - Leu Ile His Ser Leu Ile Glu Glu Ser Gln As - #n Gln Gln Glu Lys Asn |
| 1 5 - # 10 - # 15 |
| - - Glu Gln Glu Leu Leu Glu Leu Asp Lys Trp Al - #a Ser Leu Trp Asn Trp |
| 20 - # 25 - # 30 |
| - - Phe |
| - - - - (2) INFORMATION FOR SEQ ID NO:236: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 26 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:236: |
| - - Glu Ser Gln Asn Gln Gln Glu Lys Asn Glu Gl - #n Glu Leu Leu Glu Leu |
| 1 5 - # 10 - # 15 |
| - - Asp Lys Trp Ala Ser Leu Trp Asn Trp Phe |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:237: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 23 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:237: |
| - - Asn Gln Gln Glu Lys Asn Glu Gln Glu Leu Le - #u Glu Leu Asp Lys Trp |
| 1 5 - # 10 - # 15 |
| - - Ala Ser Leu Trp Asn Trp Phe |
| 20 |
| - - - - (2) INFORMATION FOR SEQ ID NO:238: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 20 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:238: |
| - - Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu As - #p Lys Trp Ala Ser Leu |
| 1 5 - # 10 - # 15 |
| - - Trp Asn Trp Phe |
| 20 |
| - - - - (2) INFORMATION FOR SEQ ID NO:239: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 28 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ ID NO:239: |
| - - Leu Arg Ala Ile Glu Ala Gln Gln His Leu Le - #u Gln Leu Thr Val Trp |
| 1 5 - # 10 - # 15 |
| - - Gln Ile Lys Gln Leu Gln Ala Arg Ile Leu Al - #a Val |
| 20 - # 25 |
| - - - - (2) INFORMATION FOR SEQ ID NO:240: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 36 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ I - #D NO:240: |
| - - Thr Ser Leu Ile Tyr Ser Leu Leu Glu Lys Se - #r Gln Ile Gln Gln |
| 5 - # 10 - # 15 |
| - - Lys Asn Glu Gln Glu Leu Leu Glu Leu Asp Ly - #s Trp Ala Ser Leu |
| 20 - # 25 - # 30 |
| - - Asn Trp Phe |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:241: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 38 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ I - #D NO:241: |
| - - Asn Leu Leu Arg Ala Ile Glu Ala Gln Gln Gl - #y Leu Leu Gln Leu |
| 5 - # 10 - # 15 |
| - - Val Trp Gly Ile Lys Gln Leu Gln Ala Arg Il - #e Leu Ala Val Glu |
| 20 - # 25 - # 30 |
| - - Tyr Leu Lys Asp Gln |
| 35 |
| - - - - (2) INFORMATION FOR SEQ ID NO:242: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 41 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ I - #D NO:242: |
| - - Asn Leu Leu Arg Ala Ile Glu Ala Gln Gln Hi - #s Leu Leu Gln Leu |
| 5 - # 10 - # 15 |
| - - Val Trp Gly Ile Lys Gln Leu Gln Ala Arg Il - #e Leu Ala Val Glu |
| 20 - # 25 - # 30 |
| - - Tyr Leu Lys Asp Gln Gly Gly Cys |
| 35 - # 40 |
| - - - - (2) INFORMATION FOR SEQ ID NO:243: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 41 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ I - #D NO:243: |
| - - Asn Leu Leu Arg Ala Ile Glu Ala Gln Gln Hi - #s Leu Leu Gln Leu |
| 5 - # 10 - # 15 |
| - - Val Trp Gly Ile Lys Gln Leu Gln Ala Arg Il - #e Leu Ala Val Glu |
| 20 - # 25 - # 30 |
| - - Tyr Leu Lys Asp Gln Gly Gly Cys |
| 35 - # 40 |
| - - - - (2) INFORMATION FOR SEQ ID NO:244: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 43 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ I - #D NO:244: |
| - - Gly Gly Asn Asn Leu Leu Arg Ala Ile Glu Al - #a Gln Gln His Leu |
| 5 - # 10 - # 15 |
| - - Gln Leu Thr Val Trp Gly Ile Lys Gln Leu Gl - #n Ala Arg Ile Leu |
| 20 - # 25 - # 30 |
| - - Val Glu Arg Tyr Lys Asp Gln Gly Gly Cys |
| 35 - # 40 |
| - - - - (2) INFORMATION FOR SEQ ID NO:245: |
| - - (i) SEQUENCE CHARACTERISTICS: |
| (A) LENGTH: 39 amino - #acids |
| (B) TYPE: amino acid |
| (C) STRANDEDNESS: |
| (D) TOPOLOGY: unknown |
| - - (ii) MOLECULE TYPE: peptide |
| - - (xi) SEQUENCE DESCRIPTION: SEQ I - #D NO:245: |
| - - Ser Gly Ile Val Gln Gln Gln Asn Asn Leu Le - #u Arg Ala Ile Glu |
| 5 - # 10 - # 15 |
| - - Gln Gln His Leu Leu Gln Leu Thr Val Trp Gl - #y Ile Lys Gln Leu |
| 20 - # 25 - # 30 |
| - - Ala Arg Ile Leu Ala Val |
| 35 |
| __________________________________________________________________________ |
Barney, Shawn O'Lin, Lambert, Dennis Michael, Petteway, Stephen Robert
| Patent | Priority | Assignee | Title |
| 6288569, | Feb 25 1999 | XILINX, Inc. | Memory array with hard and soft decoders |
| Patent | Priority | Assignee | Title |
| 4659669, | Mar 02 1981 | Regents of the Univ. of California; Genentech, Inc. | Microbial expression of human influenza hemagglutinin proteins |
| 4707358, | Jan 30 1984 | UNIVERSITY OF CHICAGO, THE | Vaccine against Epstein-Barr Virus |
| 4761470, | Dec 16 1985 | MERCK & CO , INC | Immunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibody |
| 5075211, | Apr 29 1985 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
| 5116725, | Aug 08 1984 | SCRIPPS RESEARCH INSTITUTE, THE, A CORP OF CA | Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides |
| 5141867, | Feb 02 1987 | Du Pont Merck Pharmaceutical Company | Nucleotide sequence encoding a human immunodeficiency virus antigen |
| 5444044, | Mar 26 1992 | NEW YORK BLOOD CENTER, THE | Synthetic polypeptides as inhibitors of HIV-1 |
| EP323157, | |||
| EP362927, | |||
| FR2677346, | |||
| WO8808429, | |||
| WO8902935, | |||
| WO9007119, | |||
| WO9109872, | |||
| WO9200997, | |||
| WO9222654, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Jun 07 1995 | Trimeris, Inc. | (assignment on the face of the patent) | / |
| Date | Maintenance Fee Events |
| Date | Maintenance Schedule |
| Feb 01 2003 | 4 years fee payment window open |
| Aug 01 2003 | 6 months grace period start (w surcharge) |
| Feb 01 2004 | patent expiry (for year 4) |
| Feb 01 2006 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Feb 01 2007 | 8 years fee payment window open |
| Aug 01 2007 | 6 months grace period start (w surcharge) |
| Feb 01 2008 | patent expiry (for year 8) |
| Feb 01 2010 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Feb 01 2011 | 12 years fee payment window open |
| Aug 01 2011 | 6 months grace period start (w surcharge) |
| Feb 01 2012 | patent expiry (for year 12) |
| Feb 01 2014 | 2 years to revive unintentionally abandoned end. (for year 12) |